FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hadhazy, A
AF Hadhazy, Adam
TI Hidden Zika Detection
SO NATURAL HISTORY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURAL HISTORY MAGAZINE
PI NEW YORK
PA 36 WEST 25TH STREET, FIFTH FLOOR, NEW YORK, NY 10010 USA
SN 0028-0712
J9 NAT HIST
JI Nat. Hist.
PD NOV
PY 2019
VL 127
IS 10
BP 7
EP 7
PG 1
WC Biodiversity Conservation; Ecology
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA JH5GP
UT WOS:000492797400005
DA 2020-07-08
ER

PT J
AU Majerova, T
   Novotny, P
   Krysova, E
   Konvalinka, J
AF Majerova, Tatana
   Novotny, Pavel
   Krysova, Eliska
   Konvalinka, Jan
TI Exploiting the unique features of Zika and Dengue proteases for
   inhibitor design
SO BIOCHIMIE
LA English
DT Review
DE Active-site inhibitors; Allosteric inhibitors; Aptamers; Precursor;
   Dengue protease; Zika protease
ID VIRUS NS2B-NS3 PROTEASE; SMALL-MOLECULE INHIBITORS; NS2B/NS3
   SERINE-PROTEASE; TYPE-1 GAGPOL PRECURSOR; NS3 PROTEASE; NONCOMPETITIVE
   INHIBITORS; NONSTRUCTURAL PROTEINS; PEPTIDE INHIBITORS; MEMBRANE
   TOPOLOGY; CRYSTAL-STRUCTURE
AB Zika and Dengue viruses have attracted substantial attention from researchers in light of recent outbreaks of Dengue fever and increases in cases of congenital microcephaly in areas with Zika incidence. This review summarizes the current state of knowledge about Zika and Dengue proteases. These enzymes have several interesting features: 1) NS3 serine protease requires the activating co-factor NS2B, which is anchored in the membrane of the endoplasmic reticulum; 2) NS2B displays extensive conformational dynamics; 3) NS3 is a multidomain protein with proteolytic, NTPase, RNA 5' triphosphatase and helicase activity and has many protein-protein interaction partners; 4) NS3 is autoproteolytically released from its precursor. Attempts to design tight-binding and specific active-site inhibitors are complicated by the facts that the substrate pocket of the NS2B-NS3 protease is flat and the active-site ligands are charged. The ionic character of potential active-site inhibitors negatively influences their cell permeability. Possibilities to block cis-autoprocessing of the protease precursor have recently been considered. Additionally, potential allosteric sites on NS2B-NS3 proteases have been identified and allosteric compounds have been designed to impair substrate binding and/or block the NS2B-NS3 interaction. Such compounds could be specific to viral proteases, without off-target effects on host serine proteases, and could have favorable pharmacokinetic profiles. This review discusses various groups of inhibitors of these proteases according to their mechanisms of action and chemical structures. (C) 2019 Published by Elsevier B.V.
C1 [Majerova, Tatana; Novotny, Pavel; Krysova, Eliska; Konvalinka, Jan] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610 6, Czech Republic.
   [Novotny, Pavel; Konvalinka, Jan] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic.
   [Krysova, Eliska] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague 12843, Czech Republic.
RP Konvalinka, J (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610 6, Czech Republic.
EM jan.konvalinka@uochb.cas.cz
RI Majerova, Tatana/G-9296-2014
OI Majerova, Tatana/0000-0001-5536-3587; Konvalinka,
   Jan/0000-0003-0695-9266
FU Ministry of Education, Youth and Sports of the Czech RepublicMinistry of
   Education, Youth & Sports - Czech Republic [LO 1302]
FX We thank Pavel Sacha, Evzen Boura, Kamil Hercik, Edward A. Curtis,
   Martin Hradilek and Pavel Majer for helpful discussions and Hillary
   Hoffman for language corrections. We acknowledge the financial support
   of the project InterBioMed LO 1302 from the Ministry of Education, Youth
   and Sports of the Czech Republic.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Anez G, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01583-15
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Aravapalli S, 2012, BIOORGAN MED CHEM, V20, P4140, DOI 10.1016/j.bmc.2012.04.055
   Balasubramanian A, 2019, ANTIVIR RES, V162, P71, DOI 10.1016/j.antiviral.2018.12.002
   Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v
   BIEDRZYCKA A, 1987, J GEN VIROL, V68, P1317, DOI 10.1099/0022-1317-68-5-1317
   BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brinkworth RI, 1999, J GEN VIROL, V80, P1167, DOI 10.1099/0022-1317-80-5-1167
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107
   Chen JN, 2018, COMPUT BIOL CHEM, V77, P261, DOI 10.1016/j.compbiolchem.2018.09.010
   Chen WN, 2016, J AM CHEM SOC, V138, P4539, DOI 10.1021/jacs.6b00416
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Chippaux JP, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-44
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Chu JJH, 2015, ANTIVIR RES, V118, P68, DOI 10.1016/j.antiviral.2015.03.010
   Clapham HE, 2018, T ROY SOC TROP MED H, V112, P367, DOI 10.1093/trstmh/try070
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   Cohen J, 2018, SCIENCE, V362, P1225, DOI 10.1126/science.362.6420.1225
   Constant DA, 2018, P NATL ACAD SCI USA, V115, P10136, DOI 10.1073/pnas.1805195115
   Cregar-Hernandez Lynne, 2011, Antiviral Chemistry & Chemotherapy, V21, P209, DOI 10.3851/IMP1767
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Deng J, 2012, J MED CHEM, V55, P6278, DOI 10.1021/jm300146f
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dong YC, 2016, BIOCHEM BIOPH RES CO, V473, P648, DOI 10.1016/j.bbrc.2016.03.120
   Duclair S, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.1
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Euanorasetr J, 2019, J GEN APPL MICROBIOL, V65, P197, DOI 10.2323/jgam.2018.10.001
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x
   Gal SW, 1998, EUR J BIOCHEM, V252, P553, DOI 10.1046/j.1432-1327.1998.2520553.x
   Gibbs AC, 2018, BIOCHEMISTRY-US, V57, P1591, DOI 10.1021/acs.biochem.7b01127
   Gruba N, 2018, ACS MED CHEM LETT, V9, P1025, DOI 10.1021/acsmedchemlett.8b00316
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Hariono M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210869
   Heh CH, 2013, CHEM BIOL DRUG DES, V82, P1, DOI 10.1111/cbdd.12122
   Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508
   Hirao I, 2018, BIOCHIMIE, V145, P15, DOI 10.1016/j.biochi.2017.09.007
   Holmes KV, 2003, J CLIN INVEST, V111, P1605, DOI [10.1172/JCI18819, 10.1172/JCI200318819]
   Huang LQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36730-4
   Huang LQ, 2013, FUTURE MED CHEM, V5, P1215, DOI 10.4155/fmc.13.89
   Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79
   Humpolickova J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28638-w
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Kautz TF, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110600
   Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030
   Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006
   Kim KS, 2019, CURR MED CHEM, V26, P2974, DOI 10.2174/0929867325666181105121146
   Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Kolesnikova S, 2017, NUCLEIC ACIDS RES, V45, P8684, DOI 10.1093/nar/gkx637
   Konvalinka J, 2015, VIROLOGY, V479, P403, DOI 10.1016/j.virol.2015.03.021
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lai HG, 2013, ANTIVIR RES, V97, P74, DOI 10.1016/j.antiviral.2012.10.009
   Lai HG, 2013, BIOORGAN MED CHEM, V21, P102, DOI 10.1016/j.bmc.2012.10.058
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li HD, 2019, NEURON, V101, P1089, DOI 10.1016/j.neuron.2019.01.010
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2018, BIOCHEM BIOPH RES CO, V503, P691, DOI 10.1016/j.bbrc.2018.06.062
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim L, 2019, PROG BIOPHYS MOL BIO, V143, P52, DOI 10.1016/j.pbiomolbio.2018.08.009
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Lin KH, 2017, J VIROL, V91, DOI 10.1128/JVI.00045-17
   Lin KH, 2016, ACS INFECT DIS, V2, P734, DOI 10.1021/acsinfecdis.6b00131
   Liu HL, 2014, BIOORGAN MED CHEM, V22, P6344, DOI 10.1016/j.bmc.2014.09.057
   Liu LM, 2010, J VIROL METHODS, V163, P10, DOI 10.1016/j.jviromet.2009.04.011
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Lupold SE, 2002, CANCER RES, V62, P4029
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Majerova T, 2018, BIOCHEMISTRY-US, V57, P4052, DOI 10.1021/acs.biochem.8b00252
   Majerova T, 2010, COLLECT CZECH CHEM C, V75, P81, DOI 10.1135/cccc2009087
   Majerova-Uhlikova T, 2006, J CLIN VIROL, V36, P50, DOI 10.1016/j.jcv.2006.01.014
   MARKOFF L, 1989, J VIROL, V63, P3345, DOI 10.1128/JVI.63.8.3345-3352.1989
   MARKOFF L, 1994, VIROLOGY, V204, P526, DOI 10.1006/viro.1994.1566
   Mehand MS, 2018, ANTIVIR RES, V159, P63, DOI 10.1016/j.antiviral.2018.09.009
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Mirza SB, 2016, J MOL GRAPH MODEL, V66, P99, DOI 10.1016/j.jmgm.2016.03.008
   Mukhametov A, 2014, J MOL GRAPH MODEL, V52, P103, DOI 10.1016/j.jmgm.2014.06.008
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2018, ADV EXP MED BIOL, V1062, P175, DOI 10.1007/978-981-10-8727-1_13
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Nitsche C, 2011, BIOORGAN MED CHEM, V19, P7318, DOI 10.1016/j.bmc.2011.10.061
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k
   Pambudi S, 2013, BIOCHEM BIOPH RES CO, V440, P393, DOI 10.1016/j.bbrc.2013.09.078
   Park JH, 2016, BIOCHEMISTRY-US, V55, P2390, DOI 10.1021/acs.biochem.6b00012
   Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005
   Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pinkham AM, 2018, CHEM COMMUN, V54, P12357, DOI 10.1039/c8cc07448h
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Prusis P, 2013, BIOCHEM BIOPH RES CO, V434, P767, DOI 10.1016/j.bbrc.2013.03.139
   Raut R, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0248-x
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Russo Krauss I, 2012, NUCLEIC ACIDS RES, V40, P8119, DOI 10.1093/nar/gks512
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Saw WG, 2019, PROG BIOPHYS MOL BIO, V143, P67, DOI 10.1016/j.pbiomolbio.2018.08.008
   Schimer J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7461
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Shannon AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep37539
   Shannon AE, 2016, PROTEIN EXPRES PURIF, V119, P124, DOI 10.1016/j.pep.2015.11.022
   Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Silva EM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39157-7
   Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1
   Stabell AC, 2018, ELIFE, V7, DOI [10.7554/eLife.31919, 10.7554/elife.31919]
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Sukhralia S, 2019, EUR J CLIN MICROBIOL, V38, P3, DOI 10.1007/s10096-018-3375-7
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Sylte I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200237
   Takagi Y, 2017, BIOORG MED CHEM LETT, V27, P3586, DOI 10.1016/j.bmcl.2017.05.027
   Takeno H, 1999, J BIOCHEM-TOKYO, V125, P1115, DOI 10.1093/oxfordjournals.jbchem.a022393
   Tangsongcharoen C, 2019, BBA-PROTEINS PROTEOM, V1867, P89, DOI 10.1016/j.bbapap.2018.10.016
   Tien C., 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0191372, DOI 10.1371/JOURNAL.PONE]
   Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003
   Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006
   Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10
   Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Weng ZB, 2017, EUR J MED CHEM, V125, P751, DOI 10.1016/j.ejmech.2016.09.063
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xu SQ, 2012, J MED CHEM, V55, P6881, DOI 10.1021/jm300655h
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zhang Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24050941
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhou GC, 2013, BIOORG MED CHEM LETT, V23, P6549, DOI 10.1016/j.bmcl.2013.10.071
   Zou CL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007202
   Zuo ZL, 2009, J VIROL, V83, P1060, DOI 10.1128/JVI.01325-08
NR 176
TC 4
Z9 4
U1 4
U2 13
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD NOV
PY 2019
VL 166
BP 132
EP 141
DI 10.1016/j.biochi.2019.05.004
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JG8FW
UT WOS:000492314700012
PM 31077760
DA 2020-07-08
ER

PT J
AU Mishra, N
   Ng, J
   Rakeman, JL
   Perry, MJ
   Centurioni, DA
   Dean, AB
   Price, A
   Thakkar, R
   Angus, AG
   Williamson, P
   Delwart, E
   Carrington, C
   Sahadeo, N
   Che, XY
   Briese, T
   Tokarz, R
   Lipkin, WI
AF Mishra, Nischay
   Ng, James
   Rakeman, Jennifer L.
   Perry, Michael J.
   Centurioni, Dominick A.
   Dean, Amy B.
   Price, Adam
   Thakkar, Riddhi
   Angus, Andreina Garcia
   Williamson, Phillip
   Delwart, Eric
   Carrington, Christine
   Sahadeo, Nikita
   Che, Xiaoyu
   Briese, Thomas
   Tokarz, Rafal
   Lipkin, W. Ian
TI One-step pentaplex real-time polymerase chain reaction assay for
   detection of zika, dengue, chikungunya, West nile viruses and a human
   housekeeping gene
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE qPCR; Zika virus; Dengue virus; Chikungunya virus; West nile virus;
   Arboviruses; CII-ArboViroPlex rRT PCR
ID EPIDEMIC
AB Background: Recent emergence of Zika virus (ZIKV), and the global spread of dengue (DENV), chikungunya (CHIKV) and West Nile viruses (WNV) raised urgent need of accurate and affordable molecular diagnosis of these clinically indistinguishable arboviral infections.
   Objectives: We established a pentaplex real-time reverse transcription PCR (rRT-PCR) assay (CII-ArboViroPlex rRT-PCR) for specific and sensitive detection of the African and American genotypes of ZIKV, all four serotypes of DENV, CHIKV, WNV and a housekeeping gene as internal control in single reaction.
   Study design: Specific primers and probe sets were designed for ZIKV, DENV, CHIKV, WNV and RNase P (housekeeping gene) and tested for in-vitro transcribed RNA standards, virus cultures, clinical samples positive for ZIKV, DENV, CHIKV and WNV and limit of detection (LOD) were determined for each. Results Using ten-fold serially diluted in-vitro transcribed RNA, CII-ArboViroPlex rRT-PCR assay has LOD of 100 RNA copies/reaction (Rn) for ZIKV in serum or urine, 100 RNA copies/Rn for DENV in serum, and 10 RNA copies/Rn for CHIKV and WNV in serum. LODs from sera spiked with quantitated viral stocks were 2.6 x 10(2) GEQ/Rn for ZIKV, 2.2 x 10(1) GEQ/Rn for DENV-1, 9.4 x 10(0) GEQ/Rn for DENV-2, 2.3 x 10(2) GEQ/Rn for DENV-3, 1.4 x 10(3) GEQ/Rn for DENV-4, 2.7 x 10(2) GEQ/Rn for CHIKV, and 1.05 x 10(1) GEQ/Rn for WNV.
   Conclusions: The CII-ArboViroPlex rRT-PCR assay is a quantitative one-step pentaplex rRT-PCR assay for the molecular detection and differential diagnosis of ZIKV, DENV, CHIKV, WNV and a human housekeeping gene control in a single-PCR reaction.
C1 [Mishra, Nischay; Ng, James; Price, Adam; Thakkar, Riddhi; Angus, Andreina Garcia; Che, Xiaoyu; Briese, Thomas; Tokarz, Rafal; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
   [Rakeman, Jennifer L.] New York City Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA.
   [Perry, Michael J.; Centurioni, Dominick A.] New York State Dept Hlth, Wadsworth Ctr, Biodef Lab, Albany, NY USA.
   [Dean, Amy B.] New York State Dept Hlth, Wadsworth Ctr, Virol Lab, Albany, NY USA.
   [Williamson, Phillip] Creat Testing Solut, Tempe, AZ USA.
   [Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Carrington, Christine; Sahadeo, Nikita] Univ West Indies, Fac Med Sci, Dept Preclin Sci, St Augustine, Trinidad Tobago.
   [Angus, Andreina Garcia] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
RP Mishra, N (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
EM nm2641@cumc.columbia.edu
OI Mishra, Nischay/0000-0002-1177-9641; Carrington,
   Christine/0000-0001-6533-9302; Perry, Michael/0000-0001-5576-3265
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19AI109761]
FX The authors are grateful to the patients, clinicians, Boca Biolistics
   [FL, USA] and Creative Testing Solutions [AZ, USA] who provided samples
   without which this work could not have been done. We also thank Adam
   Nitodo [CII] and Dakai Liu, Taryn Burke and Aaron Olsen [New York City
   Department of Health and Mental Hygiene] for technical assistance, and
   Sydney Silverman and Gregory J. Keough [CII] for organizing sample
   transport and project logistics. Financial support for this study was
   provided by National Institutes of Health award U19AI109761 [CETR:
   Center for Research in Diagnostics and Discovery].
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Briese T, 2005, J NEUROVIROL, V11, P469, DOI 10.1080/13550280500187617
   Briese T, 2000, LANCET, V355, P1614, DOI 10.1016/S0140-6736(00)02220-0
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   CDC, 2013, CDC DENV 1 4 REAL TI
   Center for Infection and Immunity CU, 2017, CII ARBOVIROPLEX RRT
   Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1
   Nyan DC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17925
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   PAHO-WHO, 2018, ZIK SUSP CONF CAS RE
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wu WH, 2018, J MED VIROL, V90, P1681, DOI 10.1002/jmv.25253
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 25
TC 0
Z9 0
U1 13
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD NOV
PY 2019
VL 120
BP 44
EP 50
DI 10.1016/j.jcv.2019.08.011
PG 7
WC Virology
SC Virology
GA JG1YN
UT WOS:000491873600009
PM 31557664
DA 2020-07-08
ER

PT J
AU Nazeer, AA
   Rajan, HV
   Vijaykumar, SD
   Saravanan, M
AF Nazeer, Abdul Azeez
   Rajan, Haryanth Vaman
   Vijaykumar, Sudarshana Deepa
   Saravanan, Muthupandian
TI Evaluation of Larvicidal and Repellent Activity of Nanocrystal Emulsion
   Synthesized from F. glomerata and Neem Oil Against Mosquitoes
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Nanocrystal; Nanoemulsion; Ficus glomerata; Bioactive compound;
   Repellant activity; Larvicidal activity; Mosquito
ID PHENOL-2,4-BIS 1,1-DIMETHYLETHYL; ANTIOXIDANT ACTIVITIES; CONTACT
   ALLERGY; ORAL DELIVERY; NANOEMULSION; COMPOUND; PRODUCTS; EXTRACT; ACID;
   L.
AB Aedes aegypti, Culex quinquefasciatus, and Anopheles stephensi are the domestic vectors of tropical diseases include dengue, malaria, zika, filariasis. To control these vectors, ethnobotanical knowledge provides pragmatic solutions that are compatible with nature. Hence an attempt has been made to coalesce the ethnobotanical knowledge of tribes from Kadambur hills with the nano emulsification technology to formulate an herbal-based larvicidal and repellent nanocrystal emulsion. The ethanol extract from Ficus glomerata was used as the larvicidal and repellant agent against A. aegypti, C. quinquefasciatus and A. stephensi. For the improved stability, shelf life and sustained release of bioactive compounds, a novel methodology has been followed to synthesize nanocrystal emulsion. F. glomerata extract based nanocrystal emulsion (FON) was prepared by ultrasonication and characterized by Zeta potential (- 73.6 mV) and dynamic light scattering (104 nm), ATR-FTIR for the functional groups, high-resolution transmission electron microscope and selective area energy diffraction. The maximum shelf life was evaluated to be more than 3 years. The prepared nanocrystal emulsion was challenged for larvicidal and repellent activities against all the three species. The FON larvicidal results were comparable to the conventional neem oil based nanoemulsion and the repellant activity results were effective than the commercial formulation.
C1 [Nazeer, Abdul Azeez; Rajan, Haryanth Vaman; Vijaykumar, Sudarshana Deepa] Bannari Amman Inst Technol, Dept Biotechnol, Nanobio Translat Res Lab, Sathyamangalam 638401, Erode, India.
   [Saravanan, Muthupandian] Mekelle Univ, Coll Hlth Sci, Sch Med, Dept Med Microbiol & Immunol,Div Biomed Sci, Mekelle 1871, Ethiopia.
RP Vijaykumar, SD (corresponding author), Bannari Amman Inst Technol, Dept Biotechnol, Nanobio Translat Res Lab, Sathyamangalam 638401, Erode, India.
EM abdulazeez@bitsathy.ac.in; haryanthvaman.bt15@bitsathy.ac.in;
   sudarshanadeepav@bitsathy.ac.in; saravanan.muthupandian@mu.edu.et
FU Department of Science and Technology-Science and Engineering Research
   Board (DST-SERB) [YSS/2014/000637]
FX The authors are grateful to the Department of Science and
   Technology-Science and Engineering Research Board (DST-SERB-File No.
   YSS/2014/000637) for funding our project. Authors are thankful to The
   South Indian Textile Research Association (SITRA), Coimbatore, India for
   their help in GC-MS instrumentation, Vector Control Research Centre
   (VCRC), Madurai, India for kindly providing us the mosquito larvae and
   Sophisticated Test & Instrumentation Centre (STIC), Cochin, India for
   the help in HR-TEM instrumentation.
CR Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bali V, 2010, COLLOID SURFACE B, V76, P410, DOI 10.1016/j.colsurfb.2009.11.021
   Baranitharan M, 2017, PROCESS SAF ENVIRON, V106, P23, DOI 10.1016/j.psep.2016.12.003
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Cantrell CL, 2016, J AGR FOOD CHEM, V64, P8352, DOI 10.1021/acs.jafc.6b01668
   Coria-Tellez AV, 2018, ARAB J CHEM, V11, P662, DOI 10.1016/j.arabjc.2016.01.004
   Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121
   Elzey B, 2016, FOOD CONTROL, V68, P303, DOI 10.1016/j.foodcont.2016.04.008
   Eshwarappa RSB, 2015, PHARMACOGN RES, V7, P114, DOI 10.4103/0974-8490.147225
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Hagvall L, 2016, ACTA DERM-VENEREOL, V96, P679, DOI 10.2340/00015555-2319
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Hogade M.G., 2015, INDIAN DRUGS, V58, P9
   Hoi Amber Gigi, 2014, Evolution Medicine and Public Health, P162, DOI 10.1093/emph/eou030
   Jiraungkoorskul W, 2015, WALAILAK J SCI TECHN, V13, P133, DOI DOI 10.14456/wjst.2016.14
   Kalpana SP, 2006, J NAT REMEDIES, V6, P120, DOI [10.18311/jnr/2006/453, DOI 10.18311/JNR/2006/453]
   Kanis LA, 2018, IND CROP PROD, V122, P148, DOI 10.1016/j.indcrop.2018.05.055
   Kaur Riat A, 2017, TURK J ZOOL, V41, P763, DOI 10.3906/zoo-1701-4
   Kee YL, 2015, CHEMOSPHERE, V136, P111, DOI 10.1016/j.chemosphere.2015.04.074
   Kumari S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24871-5
   Mahyoub J. A., 2016, Asian Pacific Journal of Tropical Disease, V6, P361
   Manthey JA, 2001, J AGR FOOD CHEM, V49, P3268, DOI 10.1021/jf010011r
   Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335
   Teresa RCM, 2014, PHYSIOL MOL PLANT P, V87, P32, DOI 10.1016/j.pmpp.2014.05.003
   McClements DJ, 2013, THER DELIV, V4, P841, DOI [10.4155/TDE.13.46, 10.4155/tde.13.46]
   Mishra P, 2018, ENVIRON SCI POLLUT R, V25, P2211, DOI 10.1007/s11356-017-0591-0
   Murthy Hosakatte Niranjana, 2017, J Parasit Dis, V41, P666, DOI 10.1007/s12639-016-0863-5
   Nazeer AA, 2019, J CLUST SCI, V30, P813, DOI 10.1007/s10876-019-01543-6
   Osanloo M, 2018, ENVIRON SCI POLLUT R, V25, P6466, DOI 10.1007/s11356-017-0822-4
   Padmavathi AR, 2014, BIOFOULING, V30, P1111, DOI 10.1080/08927014.2014.972386
   PANAYOTAN, 1973, BIOCHEM J, V133, P263, DOI DOI 10.1042/BJ1330263
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Poorani TR, 2017, INT J PHARM SCI RES, V8, P4159, DOI 10.13040/IJPSR.0975-8232.8(10).4159-71
   Priyanka K, 2018, J DRUG DELIV SCI TEC, V43, P94, DOI 10.1016/j.jddst.2017.08.006
   Rabea P, 2015, J PHARM BIOALLIED SC, V7, P321, DOI [10.4103/0975-7406.168037, DOI 10.4103/0975-7406.168037]
   Rangel-Sanchez G, 2014, J PLANT PHYSIOL, V171, P189, DOI 10.1016/j.jplph.2013.07.004
   Rao CV, 2008, J ETHNOPHARMACOL, V115, P323, DOI 10.1016/j.jep.2007.09.019
   Rao RAK, 2010, J HAZARD MATER, V181, P405, DOI 10.1016/j.jhazmat.2010.05.025
   Ray A, 2015, CURR OPIN NEUROBIOL, V34, P158, DOI 10.1016/j.conb.2015.06.014
   Sabroe RA, 2016, CONTACT DERMATITIS, V74, P236, DOI 10.1111/cod.12528
   Sakulku U, 2009, INT J PHARMACEUT, V372, P105, DOI 10.1016/j.ijpharm.2008.12.029
   Silva AE, 2013, INT J PHARMACEUT, V454, P641, DOI 10.1016/j.ijpharm.2013.05.044
   Sugumar S, 2014, B ENTOMOL RES, V104, P393, DOI 10.1017/S0007485313000710
   Tisgratog R, 2016, ACTA TROP, V157, P136, DOI 10.1016/j.actatropica.2016.01.024
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105
   Yusufuddin I, 2011, FREE RADIC ANTIOXID, V1, P69, DOI [10.5530/ax.2011.4.11, DOI 10.5530/AX.2011.4.11]
NR 50
TC 1
Z9 1
U1 3
U2 7
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD NOV
PY 2019
VL 30
IS 6
BP 1649
EP 1661
DI 10.1007/s10876-019-01611-x
PG 13
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA JG2ZT
UT WOS:000491944800027
DA 2020-07-08
ER

PT J
AU Hueston, L
   Grau, GE
   Mahalingam, S
AF Hueston, Linda
   Grau, Georges E.
   Mahalingam, Suresh
TI Inhibition of Interleukin 1 beta Signaling by Anakinra Ameliorates
   Proinflammatory Cytokine Responses in Zika Virus-Infected Human
   Blood-Brain Barrier Endothelial Cells
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
C1 [Hueston, Linda] Westmead Hosp, NSW Hlth Pathol, CIDMLS ICPMR, Arbovirus Emerging Dis Unit, Westmead, NSW, Australia.
   [Grau, Georges E.] Univ Sydney, Sydney Med Sch, Discipline Pathol, Vasc Immunol Unit, Sydney, NSW, Australia.
   [Mahalingam, Suresh] Griffith Univ, Emerging Viruses & Inflammat Res Grp, Inst Glyc, Gold Coast, Qld 4222, Australia.
RP Mahalingam, S (corresponding author), Griffith Univ, Emerging Viruses & Inflammat Res Grp, Inst Glyc, Gold Coast, Qld 4222, Australia.
EM s.mahalingam@griffith.edu.au
RI Grau, Georges/D-7690-2014
OI Grau, Georges/0000-0002-0442-0462
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia [APP1079086, APP11544347]
FX This work was supported by the Australian National Health and Medical
   Research Council (grant APP1079086 and Senior Research Fellowship
   (APP11544347 to S. M.).
CR Cavalli G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01157
   Fox E, 2010, J NEUROIMMUNOL, V223, P138, DOI 10.1016/j.jneuroim.2010.03.022
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Lahmann C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134476
   Liang XH, 1999, J VIROL, V73, P2563, DOI 10.1128/JVI.73.3.2563-2567.1999
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005
   Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16
   Wolf S, 2019, ARTHRITIS RHEUMATOL, V71, P1185, DOI 10.1002/art.40856
NR 10
TC 0
Z9 0
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 1
PY 2019
VL 220
IS 9
BP 1539
EP 1540
DI 10.1093/infdis/jiz276
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9EU
UT WOS:000490992100020
PM 31116849
DA 2020-07-08
ER

PT J
AU He, ZJ
   Chen, JH
   Zhu, X
   An, S
   Wu, JH
   Li, MF
AF He, Zhenjian
   Chen, Jiahui
   Zhu, Xun
   An, Shu
   Wu, Jueheng
   Li, Mengfeng
TI Inhibition of Interleukin 1 beta Signaling by Anakinra Ameliorates
   Proinflammatory Cytokine Responses in Zika Virus-Infected Human
   Blood-Brain Barrier Endothelial Cells Reply
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID INFLAMMASOME; IL-1-BETA; NLRP3
C1 [He, Zhenjian] Sun Yat Sen Univ, Minist Educ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Chen, Jiahui; Zhu, Xun; An, Shu; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Minist Educ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.
   [He, Zhenjian; Chen, Jiahui; Zhu, Xun; An, Shu; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.
RP Li, MF (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
EM limf@mail.sysu.edu.cn
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia [APP1079086, APP11544347]
FX This work was supported by the Australian National Health and Medical
   Research Council (grant APP1079086 and Senior Research Fellowship
   (APP11544347 to S.M.).
CR Cavalli G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01157
   Chen WQ, 2017, NAT MICROBIOL, V2, P1435, DOI 10.1038/s41564-017-0015-4
   Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550
   Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940
   Fox E, 2010, J NEUROIMMUNOL, V223, P138, DOI 10.1016/j.jneuroim.2010.03.022
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Krishnan SM, 2014, BRIT J PHARMACOL, V171, P5589, DOI 10.1111/bph.12876
   Moll M, 2013, CLIN IMMUNOL, V147, P242, DOI 10.1016/j.clim.2013.04.008
   Satoh T, 2015, IMMUNOTHERAPY-UK, V7, P243, DOI [10.2217/IMT.14.106, 10.2217/imt.14.106]
   Shao BZ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00320
NR 10
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 1
PY 2019
VL 220
IS 9
BP 1540
EP 1542
DI 10.1093/infdis/jiz277
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9EU
UT WOS:000490992100021
PM 31116847
DA 2020-07-08
ER

PT J
AU Duraes-Carvalho, R
   Ludwig-Begall, LF
   Salemi, M
   Lins, RD
   Marques, ETA
AF Duraes-Carvalho, Ricardo
   Ludwig-Begall, Louisa F.
   Salemi, Marco
   Lins, Roberto D.
   Marques, Ernesto T. A.
TI Influence of directional positive Darwinian selection-driven evolution
   on arboviruses Dengue and Zika virulence and pathogenesis
SO MOLECULAR PHYLOGENETICS AND EVOLUTION
LA English
DT Article
DE Arbovirus; Selection-driven evolution; Virulence; Pathogenesis
ID VIRUS; POPULATION; PROTEINS; DISEASE; PALMITOYLATION; EMERGENCE;
   DYNAMICS; GENETICS; ACCURATE
AB Dengue (DENV) and Zika (ZIKV) viruses are antigenically and evolutionarily related; immunological cross-reactions between them have been associated to both cross-protection and infection-enhanced mechanisms. Here, DENV-1-4 and ZIKV were investigated through Bayesian coalescent-based approaches and selection-driven Darwinian evolution methods using robust datasets. Our findings show that both DENV and ZIKV, driven essentially by directional positive selection, have undergone evolution and diversification and that their entire polyproteins are subject to an intense directional evolution. Interestingly, positively selected codons mapped here are directly associated to DENV-1-2 virulence as well as the ZIKV burgeoning 2015-16 outbreak in the Americas, therefore, having impact on the pathogenesis of these viruses. Biochemical prediction analysis focusing on markers involved in virulence and viral transmission dynamics identified alterations in NGlycosylation-, Phosphorylation- and Palmitoylation-sites in ZIKV sampled from different countries, hosts and isolation sources. Taking into account both DENV-ZIKV co-circulation either into and/or out of flavivirus-endemic regions, as well as recombination and quasispecies scenarios, these results indicate the action of a selection-driven evolution affecting the biology, virulence and pathogenesis of these pathogens in a non-randomized environment.
C1 [Duraes-Carvalho, Ricardo; Lins, Roberto D.; Marques, Ernesto T. A.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Dept Virol, BR-50740465 Recife, PE, Brazil.
   [Ludwig-Begall, Louisa F.] Univ Liege, Fac Vet Med, FARAH Res Ctr, Vet Virol & Anim Viral Dis,Dept Infect & Parasit, Liege, Belgium.
   [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32608 USA.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Duraes-Carvalho, R (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Dept Virol, BR-50740465 Recife, PE, Brazil.
EM rdcarval@gmail.com
RI Marques, Ernesto T. A/L-4967-2013; Lins, Roberto D/J-7511-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Lins, Roberto
   D/0000-0002-3983-8025
FU FACEPE; MCT/CNPq DCR, Brazil [300063/2018-0, DCR-0026-2.12/16,
   APQ-1776-2.12/15]
FX Duraes-Carvalho was supported by FACEPE and MCT/CNPq DCR grants
   [300063/2018-0, DCR-0026-2.12/16 and APQ-1776-2.12/15], Brazil.
CR Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Bagno FF, 2019, J CLIN VIROL, V113, P27, DOI 10.1016/j.jcv.2019.02.006
   Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456
   Chevillon C, 2003, TRENDS MICROBIOL, V11, P415, DOI 10.1016/S0966-842X(03)00206-3
   de Borba L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001624
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   dos Santos CND, 2000, VIROLOGY, V274, P292, DOI 10.1006/viro.2000.0457
   Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   Dyer MD, 2007, BIOINFORMATICS, V23, pI159, DOI 10.1093/bioinformatics/btm208
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   GARCIABARRENO B, 1989, J VIROL, V63, P925
   Gutierrez S, 2012, CURR OPIN VIROL, V2, P546, DOI 10.1016/j.coviro.2012.08.001
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Huang YJS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00022
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497
   Keck F, 2015, VIRUSES-BASEL, V7, P5257, DOI 10.3390/v7102872
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009
   Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   R Core Team, 2014, R LANG ENV STAT COMP
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Richt JA, 2003, J CLIN MICROBIOL, V41, P3198, DOI 10.1128/JCM.41.7.3198-3205.2003
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Schneider WL, 2001, J VIROL, V75, P6566, DOI 10.1128/JVI.75.14.6566-6571.2001
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Valiant WG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44323-y
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003
   Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225
   Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002
   Wargo AR, 2012, CURR OPIN VIROL, V2, P538, DOI 10.1016/j.coviro.2012.07.007
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zou CL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007202
NR 63
TC 0
Z9 0
U1 10
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1055-7903
EI 1095-9513
J9 MOL PHYLOGENET EVOL
JI Mol. Phylogenet. Evol.
PD NOV
PY 2019
VL 140
AR 106607
DI 10.1016/j.ympev.2019.106607
PG 9
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA JD0TF
UT WOS:000489688500021
PM 31473337
DA 2020-07-08
ER

PT J
AU Nutho, B
   Rungrotmongkol, T
AF Nutho, Bodee
   Rungrotmongkol, Thanyada
TI Binding recognition of substrates in NS2B/NS3 serine protease of Zika
   virus revealed by molecular dynamics simulations
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE Molecular dynamics; NS2B/NS3 serine protease; Substrate specificity;
   Zika virus
ID NS2B-NS3 PROTEASE; NS3 PROTEASES; DENGUE; INHIBITORS; SUSCEPTIBILITY;
   SPECIFICITY
AB Zika virus (ZIKV) has become a global public health concern. The recent epidemiological data has revealed a possible association of ZIKV infection with more serious complications, particularly for Guillain-Barre syndrome in adults and microcephaly in newborn children. Till now, there is no vaccine or effective drug commercially available to combat with ZIKV infection. An attractive drug target for the ZIKV treatment is the NS2B/NS3 serine protease, which is essential for viral polyprotein processing. Herein, classical molecular dynamics (MD) simulations were performed on the ZIKV NS2B/NS3 serine protease in complex with four peptide substrates to investigate the binding recognition and protein-substrate interactions. The obtained results indicate that the P1 and P2 positions of the substrate play a significant role in binding with the protease enzyme, while the P3 and P4 positions show a minor contribution in binding interaction. Moreover, the binding free energy calculation based on the MM/PBSA method suggests that among the four similar peptide substrates, the peptide Ac-D-RKOR-ACC displays the strongest binding affinity towards the ZIKV protease due to the high energy contribution at the S2 subsite particularly for the NS3 residue D75 with the P2(O) residue of this substrate, which is in line with the experimental data. Thus, the information derived from MD simulations presented here would be useful for the design of potent protease inhibitors. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Nutho, Bodee] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.
RP Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Bangkok 10330, Thailand.
EM thanyada.r@chula.ac.th
FU Research Chair Grant, the National Science and Technology Development
   Agency (NSTDA), Thailand; Royal Golden Jubilee PhD ProgramThailand
   Research Fund (TRF) [PHD/0020/2558]; 90th Anniversary of Chulalongkorn
   University Fund (Ratchadaphiseksomphot Endowment Fund)Chulalongkorn
   University
FX This research was supported by the Research Chair Grant, the National
   Science and Technology Development Agency (NSTDA), Thailand. B.N. is
   thankful for the Royal Golden Jubilee PhD Program (PHD/0020/2558) for
   PhD scholarship and the 90th Anniversary of Chulalongkorn University
   Fund (Ratchadaphiseksomphot Endowment Fund) for research funding.
CR BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Frisch M. J., 2009, GAUSSIAN 09
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Henriksen NM, 2014, J CHEM INF MODEL, V54, P1758, DOI 10.1021/ci500132c
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kongkaew S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37038-z
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a
   Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nutho B, 2019, J PHYS CHEM B, V123, P2889, DOI 10.1021/acs.jpcb.9b02157
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Patick AK, 1998, CLIN MICROBIOL REV, V11, P614, DOI 10.1128/CMR.11.4.614
   Phanich J, 2016, J COMPUT AID MOL DES, V30, P917, DOI 10.1007/s10822-016-9981-5
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Skorenski M, 2016, FUTURE VIROL, V11, P745, DOI 10.2217/fvl-2016-0106
   TIDOR B, 1994, J MOL BIOL, V238, P405, DOI 10.1006/jmbi.1994.1300
   Timiri AK, 2016, EUR J MED CHEM, V117, P125, DOI 10.1016/j.ejmech.2016.04.008
   Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473
   Wang J, 1999, PROTEINS, V34, P69, DOI 10.1002/(SICI)1097-0134(19990101)34:1<69::AID-PROT6>3.0.CO;2-C
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977
   Yotmanee P, 2015, J MOL GRAPH MODEL, V60, P24, DOI 10.1016/j.jmgm.2015.05.008
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 42
TC 3
Z9 3
U1 1
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1093-3263
EI 1873-4243
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD NOV
PY 2019
VL 92
BP 227
EP 235
DI 10.1016/j.jmgm.2019.08.001
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA JA1GN
UT WOS:000487565600024
PM 31401441
DA 2020-07-08
ER

PT J
AU Zhang, C
   Gao, JG
   Sun, HQ
   Wang, JL
AF Zhang, Chao
   Gao, Jianguo
   Sun, Hongquan
   Wang, Jinliang
TI Dynamics of a reaction-diffusion SVIR model in a spatial heterogeneous
   environment
SO PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS
LA English
DT Article
DE Spatial heterogeneity; Basic reproduction number; SVIR model;
   Vaccination
ID POSITIVE STEADY-STATE; HOST-PATHOGEN SYSTEM; EPIDEMIC MODEL;
   TRANSMISSION DYNAMICS; ASYMPTOTIC PROFILES; GLOBAL STABILITY;
   REPRODUCTION NUMBERS; ZIKA VIRUS; INFECTION; VACCINATION
AB In this paper, a reaction-diffusion SVIR epidemic model in a spatial heterogeneous environment is proposed. We defined the basic reproduction number 910 and showed that it is a threshold parameter, which determines the disease extinction or persistence in the case of a bounded domain. The global attractiveness of the constant positive steady state and the explicit formula of 910 are obtained when the space is homogeneous. Simulation results reveal that the spatial heterogeneity can enhance the spread risk of the disease. It is found that the distribution of infected individuals is affected by different diffusion rate and its prevalence becomes higher when a larger diffusion rate is used. The relationship among the basic reproduction number, the vaccination rate and recovery rate of vaccinated individuals and infected individuals are also addressed. If the recovery rates of vaccinated individuals and infected individuals are sufficiently large, disease can be eradicated by conducting suitable vaccination strategy, which reveals that increasing the recovery rates of vaccinated individuals and infected individuals seems more important than increasing vaccination rate. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Zhang, Chao; Gao, Jianguo] North Minzu Univ, Dept Math & Informat Sci, Ningxia 750021, Peoples R China.
   [Sun, Hongquan; Wang, Jinliang] Heilongjiang Univ, Sch Math Sci, Harbin 150080, Heilongjiang, Peoples R China.
RP Wang, JL (corresponding author), Heilongjiang Univ, Sch Math Sci, Harbin 150080, Heilongjiang, Peoples R China.
EM 1498425756@qq.com; gaojguo@163.com; sunhongquan@hlju.edu.cn;
   jinliangwang@hlju.edu.cn
FU Graduate Innovation Project of North Minzu University, China [YCX19129];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [61761002, 11871179]; First-Class Disciplines
   Foundation of Ningxia, China [NXYLXK2017809]; Natural Science Foundation
   of Heilongjiang ProvinceNatural Science Foundation of Heilongjiang
   Province [LC2018002]; Heilongjiang Provincial Key Laboratory of the
   Theory and Computation of Complex Systems, China
FX The authors would like to thank the editors and the referees for their
   helpful comments. C. Zhang was supported by the Graduate Innovation
   Project of North Minzu University, China (No. YCX19129). J. Gao was
   supported by National Natural Science Foundation of China (No. 61761002)
   and the First-Class Disciplines Foundation of Ningxia, China (No.
   NXYLXK2017809). J. Wang was supported by National Natural Science
   Foundation of China (Nos. 11871179), Natural Science Foundation of
   Heilongjiang Province (No. LC2018002) and Heilongjiang Provincial Key
   Laboratory of the Theory and Computation of Complex Systems, China.
CR Allen LJS, 2008, DISCRETE CONT DYN-A, V21, P1
   BROWN KJ, 1981, J DIFFER EQUATIONS, V40, P232, DOI 10.1016/0022-0396(81)90020-6
   Cai YL, 2019, APPL MATH LETT, V92, P190, DOI 10.1016/j.aml.2019.01.015
   Cai YL, 2019, NONLINEAR ANAL-REAL, V46, P178, DOI 10.1016/j.nonrwa.2018.09.006
   Cai YL, 2019, PHYSICA A, V514, P729, DOI 10.1016/j.physa.2018.09.100
   Cai YL, 2018, NONLINEAR ANAL-REAL, V40, P444, DOI 10.1016/j.nonrwa.2017.10.001
   Cai YL, 2016, NONLINEAR ANAL-REAL, V30, P99, DOI 10.1016/j.nonrwa.2015.12.002
   Cai YL, 2015, COMPUT MATH APPL, V70, P1906, DOI 10.1016/j.camwa.2015.08.003
   Chen YM, 2014, MATH BIOSCI ENG, V11, P449, DOI [10.3934/mbe.2014.11.449, 10.3934/mbe.2014.11. 449]
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Duan XC, 2014, COMPUT MATH APPL, V68, P288, DOI 10.1016/j.camwa.2014.06.002
   Gabbuti A, 2007, VACCINE, V25, P3129, DOI 10.1016/j.vaccine.2007.01.045
   Hagenaars TJ, 2004, J THEOR BIOL, V229, P349, DOI 10.1016/j.jtbi.2004.04.002
   HESS P, 1991, PERIODIC PARABOLIC B, V247
   HETHCOTE HW, 1987, MATH BIOSCI, V84, P85, DOI 10.1016/0025-5564(87)90044-7
   Iannelli M, 2005, MATH BIOSCI, V195, P23, DOI 10.1016/j.mbs.2005.01.004
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Liu XN, 2008, J THEOR BIOL, V253, P1, DOI 10.1016/j.jtbi.2007.10.014
   Lou YJ, 2011, J MATH BIOL, V62, P543, DOI 10.1007/s00285-010-0346-8
   Magal P, 2005, SIAM J MATH ANAL, V37, P251, DOI 10.1137/S0036141003439173
   MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4
   Peng R, 2013, PHYSICA D, V259, P8, DOI 10.1016/j.physd.2013.05.006
   Peng R, 2009, J DIFFER EQUATIONS, V247, P1096, DOI 10.1016/j.jde.2009.05.002
   Peng R, 2009, NONLINEAR ANAL-THEOR, V71, P239, DOI 10.1016/j.na.2008.10.043
   Smith H. L., 1995, MONOTONE DYNAMICAL S, V41
   Smith HL, 2001, NONLINEAR ANAL-THEOR, V47, P6169, DOI 10.1016/S0362-546X(01)00678-2
   Thieme HR, 2009, SIAM J APPL MATH, V70, P188, DOI 10.1137/080732870
   THIEME HR, 1993, SIAM J APPL MATH, V53, P1447, DOI 10.1137/0153068
   THIEME HR, 1992, J MATH BIOL, V30, P755
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wang FB, 2015, COMMUN PUR APPL ANAL, V14, P2535, DOI 10.3934/cpaa.2015.14.2535
   Wang JL, 2016, IMA J APPL MATH, V81, P321, DOI 10.1093/imamat/hxv039
   Wang WM, 2018, J FRANKLIN I, V355, P7226, DOI 10.1016/j.jfranklin.2018.07.014
   Wang WD, 2015, SIAM J APPL MATH, V75, P1142, DOI 10.1137/140981769
   Wang WD, 2012, SIAM J APPL DYN SYST, V11, P1652, DOI 10.1137/120872942
   Wang WD, 2011, SIAM J APPL MATH, V71, P147, DOI 10.1137/090775890
   Wu YX, 2018, J DIFFER EQUATIONS, V264, P4989, DOI 10.1016/j.jde.2017.12.027
   Wu YX, 2016, J DIFFER EQUATIONS, V261, P4424, DOI 10.1016/j.jde.2016.06.028
NR 38
TC 0
Z9 0
U1 4
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-4371
EI 1873-2119
J9 PHYSICA A
JI Physica A
PD NOV 1
PY 2019
VL 533
AR 122049
DI 10.1016/j.physa.2019.122049
PG 15
WC Physics, Multidisciplinary
SC Physics
GA IY4KP
UT WOS:000486360200021
DA 2020-07-08
ER

PT J
AU Vijayakumar, V
   Malathi, D
   Subramaniyaswamy, V
   Saravanan, P
   Logesh, R
AF Vijayakumar, V.
   Malathi, D.
   Subramaniyaswamy, V.
   Saravanan, P.
   Logesh, R.
TI Fog computing-based intelligent healthcare system for the detection and
   prevention of mosquito-borne diseases
SO COMPUTERS IN HUMAN BEHAVIOR
LA English
DT Article
DE Mosquito-borne diseases; Mosquito sensors; Fog computing; Internet of
   things; Fuzzy k-nearest neighbor classifier; Social network analysis
ID RECOMMENDER SYSTEM; FRAMEWORK; OPTIMIZATION; CHIKUNGUNYA; SECURITY; ZIKA
AB In recent years, fog computing emerges as a proactive solution for healthcare service as it facilitates continuous monitoring of remote patient health and early detection of mosquito-borne diseases. In addition, fog computing reduces the latency and communication cost that is normally an immense concern of cloud computing. The key objective of the proposed intelligent system is to detect and control the mosquito-borne diseases at the early stage. For this purpose, wearable and IoT sensors are used to gather the required information and fog computing is used to analyze, categorize and share medical information among the user and healthcare service providers. We utilize similarity coefficient to differentiate the various mosquito-borne diseases based on patient's symptoms, and the fuzzy k-nearest neighbor approach is employed to categorize the user into infected or uninfected class. Further, on the cloud layer, Social Network Analysis (SNA) is employed to represent the outbreak of mosquito-borne diseases. The likelihood of the registered user to receive or spread the disease is measured by computing PDO (Probability of Disease Outbreak) which is used to provide the location-based awareness to avert the outbreak. The experimental evaluation reveals the improved performance of the proposed F-HMRAS with 95.9% classification accuracy.
C1 [Vijayakumar, V.] Vellore Inst Technol, Sch Comp Sci & Engn, Chennai, Tamil Nadu, India.
   [Malathi, D.; Subramaniyaswamy, V.; Saravanan, P.; Logesh, R.] SASTRA Deemed Univ, Sch Comp, Thanjavur, India.
RP Malathi, D (corresponding author), SASTRA Deemed Univ, Sch Comp, Thanjavur, India.
EM vijayakumar.v@vit.ac.in; malathipuducherry@gmail.com;
   vsubramaniyaswamy@gmail.com; sharan.doit@gmail.com; LogeshPhD@gmail.com
OI , Subramaniyaswamy/0000-0001-5328-7672
FU SASTRA Deemed University, Thanjavur
FX The authors are grateful and express their gratitude to SASTRA Deemed
   University, Thanjavur, for the financial support and infra structural
   facilities provided to carry out this research work.
CR Abbas A, 2014, IEEE J BIOMED HEALTH, V18, P1431, DOI 10.1109/JBHI.2014.2300846
   Ahmad M, 2016, J SUPERCOMPUT, V72, P3677, DOI 10.1007/s11227-016-1634-x
   Ali Z, 2018, FUTURE GENER COMP SY, V85, P19, DOI 10.1016/j.future.2018.02.021
   Balasaravanan K., 2017, INT J ENG TECHNOLOGY, V7, P13
   Barik RK, 2019, J AMB INTEL HUM COMP, V10, P551, DOI 10.1007/s12652-018-0702-x
   Caicedo-Torres W, 2017, COMM COM INF SC, V735, P472, DOI 10.1007/978-3-319-66562-7_34
   Campion M, 2016, PROCEEDINGS OF 2016 FUTURE TECHNOLOGIES CONFERENCE (FTC), P310, DOI 10.1109/FTC.2016.7821628
   Costanzo Alfio, 2016, 2016 13th IEEE Annual Consumer Communications & Networking Conference (CCNC), P972, DOI 10.1109/CCNC.2016.7444920
   Dastjerdi AV, 2016, COMPUTER, V49, P112, DOI 10.1109/MC.2016.245
   Devarajan M, 2019, MULTIMED TOOLS APPL, V78, P32695, DOI 10.1007/s11042-018-6898-0
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Ghanavati S, 2017, CLUSTER COMPUT, V20, P1843, DOI 10.1007/s10586-017-0847-y
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Hagan RW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24893-z
   Jagadeeswari V, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-018-0049-x
   Jalali F, 2016, IEEE J SEL AREA COMM, V34, P1728, DOI 10.1109/JSAC.2016.2545559
   John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338
   Kakarla SG, 2019, SCI TOTAL ENVIRON, V647, P66, DOI 10.1016/j.scitotenv.2018.07.461
   KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426
   Khan NA, 2014, INT JOINT CONF COMP, P263, DOI 10.1109/JCSSE.2014.6841878
   Kirk RA, 2017, LECT NOTES COMPUT SC, V10274, P223, DOI 10.1007/978-3-319-58524-6_20
   Lambert B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22712-z
   Linder N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104855
   Liu XZ, 2015, APPL MATH MODEL, V39, P3194, DOI 10.1016/j.apm.2014.10.035
   Logesh R, 2020, NEURAL COMPUT APPL, V32, P2141, DOI 10.1007/s00521-018-3891-5
   Logesh R, 2019, MOBILE NETW APPL, V24, P1018, DOI 10.1007/s11036-018-1059-2
   Logesh R, 2018, FUTURE GENER COMP SY, V83, P653, DOI 10.1016/j.future.2017.08.060
   Logesh R., 2018, Electronic Government, V14, P90
   Logesh R, 2017, WIRELESS PERS COMMUN, V97, P2751, DOI 10.1007/s11277-017-4633-1
   Logesh R, 2017, BIOMED RES-INDIA, V28, P5646
   Logesh R., 2019, COGNITIVE INFORM SOF, P535
   Logesh R, 2017, J INFORM SCI ENG, V33
   Lounis A, 2016, FUTURE GENER COMP SY, V55, P266, DOI 10.1016/j.future.2015.01.009
   Malathi D, 2019, COMPUT ELECTR ENG, V73, P114, DOI 10.1016/j.compeleceng.2018.11.009
   Nandyala C., 2016, INT J SMART HOME, V10, P187, DOI DOI 10.14257/IJSH.2016.10.2.18
   Noor N. M., 2017, J THEORETICAL APPL I, V95
   Oluwagbemi Olugbenga, 2016, Informatics in Medicine Unlocked, V2, P12, DOI 10.1016/j.imu.2015.12.001
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pirbhulal S, 2018, COMPUT ELECTR ENG, V71, P546, DOI 10.1016/j.compeleceng.2018.08.004
   Poostchi M, 2018, TRANSL RES, V194, P36, DOI 10.1016/j.trsl.2017.12.004
   Rani S, 2019, IEEE INTERNET THINGS, V6, P1306, DOI 10.1109/JIOT.2018.2802898
   Rao VSH, 2012, IEEE T INF TECHNOL B, V16, P112, DOI 10.1109/TITB.2011.2171978
   Ravi L, 2016, COMPUT INTEL NEUROSC, DOI 10.1155/2016/1291358
   Sandhu R, 2016, J COMPUT SCI-NETH, V12, P11, DOI 10.1016/j.jocs.2015.11.001
   Sareen S, 2017, ENTERP INF SYST-UK, V11, P1436, DOI 10.1080/17517575.2016.1277558
   Sareen S, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0579-1
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Shah Tejal, 2016, IET Cyber-Physical Systems: Theory & Applications, V1, P40, DOI 10.1049/iet-cps.2016.0023
   Singh S, 2018, INT J PERVASIVE COMP, V14, P197, DOI 10.1108/IJPCC-D-18-00012
   Sodhro AH, 2019, INT J INFORM MANAGE, V45, P308, DOI 10.1016/j.ijinfomgt.2018.08.004
   Song SH, 2016, INT CONF ADV COMMUN, P455, DOI 10.1109/ICACT.2016.7423430
   Sood SK, 2018, FUTURE GENER COMP SY, V88, P764, DOI 10.1016/j.future.2018.01.008
   Sood SK, 2018, IEEE INTERNET THINGS, V5, P794, DOI 10.1109/JIOT.2017.2768407
   Sood SK, 2017, COMPUT IND, V91, P33, DOI 10.1016/j.compind.2017.05.006
   Sousa L, 2018, INFORM SYST, V75, P26, DOI 10.1016/j.is.2018.02.003
   Srivastava B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1060-1
   Subramaniyaswamy V, 2019, J SUPERCOMPUT, V75, P3184, DOI 10.1007/s11227-018-2331-8
   Subramaniyaswamy V., 2018, International Journal of Advanced Intelligence Paradigms, V10, P103
   Subramaniyaswamy V, 2017, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON INTELLIGENT SUSTAINABLE SYSTEMS (ICISS 2017), P182, DOI 10.1109/ISS1.2017.8389394
   Subramaniyaswamy V, 2017, WIRELESS PERS COMMUN, V97, P2229, DOI 10.1007/s11277-017-4605-5
   Subramaniyaswamy V, 2017, J ORGAN END USER COM, V29, P51, DOI 10.4018/JOEUC.2017100103
   Subramaniyaswamy V., 2017, International Journal of High Performance Computing and Networking, V10, P54
   Subramaniyaswamy V, 2015, PROCEDIA COMPUT SCI, V50, P466, DOI 10.1016/j.procs.2015.04.016
   Subramaniyaswamy V, 2015, PROCEDIA COMPUT SCI, V50, P456, DOI 10.1016/j.procs.2015.04.015
   Subramaniyaswamy V, 2015, PROCEDIA COMPUT SCI, V50, P447, DOI 10.1016/j.procs.2015.04.014
   Vairavasundaram S., 2018, DEV TRENDS INTELLIGE, P48
   Vairavasundaram S, 2015, WIRES DATA MIN KNOWL, V5, P87, DOI 10.1002/widm.1149
   Vijayakumar V., 2019, International Journal of Web Portals, V11, P1, DOI 10.4018/IJWP.2019010101
   Wang XL, 2014, IEEE J BIOMED HEALTH, V18, P739, DOI 10.1109/JBHI.2013.2286157
   WHO, MOSQ BORN DIS
   Wu F, 2018, COMPUT ELECTR ENG, V68, P107, DOI 10.1016/j.compeleceng.2018.03.030
   Wu WQ, 2018, FUTURE GENER COMP SY, V86, P515, DOI 10.1016/j.future.2018.04.024
   Yannuzzi M, 2014, IEEE INT WORKSH COMP, P325, DOI 10.1109/CAMAD.2014.7033259
   Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020
   Zheng YL, 2014, IEEE T BIO-MED ENG, V61, P1538, DOI 10.1109/TBME.2014.2309951
   Zhu GH, 2019, SCI TOTAL ENVIRON, V651, P969, DOI 10.1016/j.scitotenv.2018.09.182
NR 76
TC 6
Z9 6
U1 6
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0747-5632
EI 1873-7692
J9 COMPUT HUM BEHAV
JI Comput. Hum. Behav.
PD NOV
PY 2019
VL 100
BP 275
EP 285
DI 10.1016/j.chb.2018.12.009
PG 11
WC Psychology, Multidisciplinary; Psychology, Experimental
SC Psychology
GA IW3HP
UT WOS:000484871400027
DA 2020-07-08
ER

PT J
AU Yang, B
   Kong, JL
   Fang, XE
AF Yang, Bin
   Kong, Jilie
   Fang, Xueen
TI Bandage-like wearable flexible microfluidic recombinase polymerase
   amplification sensor for the rapid visual detection of nucleic acids
SO TALANTA
LA English
DT Article
DE Flexible microfluidic; Nucleic acids; Recombinase polymerase
   amplification; Visual analysis; Wearable sensor
ID PLATFORM; CHALLENGES; SKIN
AB With the development of flexible advanced materials and microfluidic technology, wearable biosensors provide a new strategy for the continuous monitoring of health. In this study, a novel bandage-like wearable flexible microfluidic recombinase polymerase amplification (RPA) sensor was constructed for the rapid and visual detection of nucleic acids. This wearable sensor is triggered by human body heat (30 degrees C-37 degrees C) and allows for visual nucleic acid (a conserved nucleic acid fragments of zika virus) detection within 10 min. The sensor displays good sensitivity and selectivity, with a detection limit of 10 copies/mu L. The wearable sensor has exhibited well-defined accuracy when applied to testing clinical serum samples. In addition, the wearable RPA sensor was proved to be feasible by human trials under different daily activities. This wearable sensor of nucleic acids will probably be of great significance in the field of online pathogen detection for wounds, for tumour biomarker diagnosis, and for the detection of epidermal cell molecular lesions.
C1 [Kong, Jilie; Fang, Xueen] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China.
   Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.
RP Kong, JL; Fang, XE (corresponding author), Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China.
EM jlkong@fudan.edu.cn; fxech@fudan.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21505024, 21427806, 21175029, 21335002]; Introduce
   Talents of Fudan University Research Funding [JIH1615032]; Shanghai
   Leading Academic Discipline ProjectShanghai Leading Academic Discipline
   Project [13109]
FX This work was supported by the National Natural Science Foundation of
   China (21505024, 21427806, 21175029, and 21335002), the Introduce
   Talents of Fudan University Research Funding (JIH1615032) and the
   Shanghai Leading Academic Discipline Project (13109).
CR Bandodkar AJ, 2014, BIOSENS BIOELECTRON, V54, P603, DOI 10.1016/j.bios.2013.11.039
   Bowen J. J., 2018, ANGEW CHEM, V130, P1250
   Chen YH, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701629
   Coffey JW, 2018, BIOMATERIALS, V170, P49, DOI 10.1016/j.biomaterials.2018.03.039
   Crannell ZA, 2014, ANAL CHEM, V86, P5615, DOI 10.1021/ac5011298
   Dossi N, 2019, TALANTA, V199, P14, DOI 10.1016/j.talanta.2019.01.126
   Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521
   Gao WY, 2017, ANAL CHEM, V89, P6161, DOI 10.1021/acs.analchem.7b01000
   Gao ZF, 2018, NPG ASIA MATER, V10, P177, DOI 10.1038/s41427-018-0024-7
   Gowers SAN, 2015, ANAL CHEM, V87, P7763, DOI 10.1021/acs.analchem.5b01353
   Groisman A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.094501
   Han S, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4950
   He XC, 2018, ANAL CHEM, V90, P14105, DOI 10.1021/acs.analchem.8b04536
   Heikenfeld J, 2018, LAB CHIP, V18, P217, DOI 10.1039/c7lc00914c
   Kim J, 2018, TALANTA, V177, P163, DOI 10.1016/j.talanta.2017.08.077
   Kim J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600418
   Kim J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14997
   Kim SB, 2018, SMALL, V14, DOI 10.1002/smll.201703334
   Koh A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2593
   Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6
   Lee H, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601314
   Lillis L, 2016, MOL CELL PROBE, V30, P74, DOI 10.1016/j.mcp.2016.01.009
   Lipani L, 2018, NAT NANOTECHNOL, V13, P504, DOI 10.1038/s41565-018-0112-4
   Long Z, 2018, ANAL CHEM, V90, P577, DOI 10.1021/acs.analchem.7b04737
   Mimee M, 2018, SCIENCE, V360, P915, DOI 10.1126/science.aas9315
   Miyamoto A, 2017, NAT NANOTECHNOL, V12, P907, DOI [10.1038/NNANO.2017.125, 10.1038/nnano.2017.125]
   Nyein HYY, 2016, ACS NANO, V10, P7216, DOI 10.1021/acsnano.6b04005
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shen Y, 2017, ANGEW CHEM INT EDIT, V56, P16333, DOI 10.1002/anie.201710899
   Sultan N, 2015, INT J INFORM MANAGE, V35, P521, DOI 10.1016/j.ijinfomgt.2015.04.010
   Dao TNT, 2018, ANAL BIOCHEM, V544, P87, DOI 10.1016/j.ab.2017.12.030
   Wang R, 2017, ANAL CHEM, V89, P4413, DOI 10.1021/acs.analchem.7b00964
   Xu TL, 2017, ACS NANO, V11, P621, DOI 10.1021/acsnano.6b06896
   Yu JC, 2015, P NATL ACAD SCI USA, V112, P8260, DOI 10.1073/pnas.1505405112
   Zhao YY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2492
NR 36
TC 3
Z9 4
U1 23
U2 94
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD NOV 1
PY 2019
VL 204
BP 685
EP 692
DI 10.1016/j.talanta.2019.06.031
PG 8
WC Chemistry, Analytical
SC Chemistry
GA IQ3PS
UT WOS:000480664200085
PM 31357353
DA 2020-07-08
ER

PT J
AU Pilaquinga, F
   Morejon, B
   Ganchala, D
   Morey, J
   Pina, N
   Debut, A
   Neira, M
AF Pilaquinga, Fernanda
   Morejon, Bianca
   Ganchala, Danny
   Morey, Jeroni
   Pina, Neus
   Debut, Alexis
   Neira, Marco
TI Green synthesis of silver nanoparticles using Solanum mammosum L.
   (Solanaceae) fruit extract and their larvicidal activity against Aedes
   aegypti L. (Diptera: Culicidae)
SO PLOS ONE
LA English
DT Article
ID INSECTICIDE RESISTANCE; MOSQUITOS; PESTICIDES; TOXICITY; EFFICACY; PLANT
AB The family of mosquitoes (Diptera: Culicidae) contains several species of major public health relevance due to their role as vectors of human disease. One of these species, Aedes aegypti, is responsible for the transmission of some of the most important vector-borne viruses affecting humankind, including dengue fever, chikungunya and Zika. Traditionally, control of Ae. aegypti and other arthropod species has relied on the use of a relatively small diversity of chemical insecticides. However, widespread and intensive use of these substances has caused significant adverse environmental effects and has contributed to the appearance of pesticide-resistant populations in an increasing number of locations around the world, thereby dramatically reducing their efficiency. Therefore, it becomes urgent to develop novel alternative tools for vector control. In that context, our study aimed at evaluating the insecticidal activity against Ae. aegypti of aqueous extracts obtained from the fruits of Solanum mammosum L., as well as silver nanoparticles synthesized using aqueous extracts from this plant species (SmAgNPs). To perform the test, third instar Ae. aegypti larvae were exposed to increasing concentrations of plant extract and SmAgNPs for 24 h. Our results suggest that both the aqueous extract and SmAgNPs were toxic to the larvae, with SmAgNPs displaying a much higher level of toxicity than the extract alone, as reflected in their LC50 values (0.06 ppm vs 1631.27 ppm, respectively). These results suggest that both S. mammosum extracts and SmAgNPs exhibit noteworthy larvicidal activity, and should be further explored as potential source of alternative tools in the fight against insect vectors of human disease.
C1 [Pilaquinga, Fernanda; Morey, Jeroni; Pina, Neus] Univ Balearic Isl, Dept Chem, Palma De Mallorca, Balearic Island, Spain.
   [Pilaquinga, Fernanda; Ganchala, Danny] Pontificia Univ Catolica Ecuador, Dept Exact & Nat Sci, Lab Nanotechnol, Quito, Ecuador.
   [Morejon, Bianca; Neira, Marco] Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer, Dept Exact & Nat Sci, Quito, Ecuador.
   [Debut, Alexis] Univ Fuerzas Armadas ESPE, Ctr Nanociencia & Nanotecnol, Sangolqui, Ecuador.
RP Neira, M (corresponding author), Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer, Dept Exact & Nat Sci, Quito, Ecuador.
EM mvneira@puce.edu.ec
RI Pina, M Nieves/L-1190-2014
OI Pina, M Nieves/0000-0002-3363-0004; Debut, Alexis/0000-0002-8269-7619;
   Pilaquinga, Fernanda/0000-0002-0841-6313
FU Pontificia Universidad Catolica del Ecuador [N13409, O13083]
FX This study was performed in part with funds from the following sources:
   MN received grant N13409 from Pontificia Universidad Catolica del
   Ecuador (website: www.puce.edu.ec).FP received grant O13083 from
   Pontificia Universidad Catolica del Ecuador (website:
   www.puce.edu.ec).All bioassays were performed using the infrastructure
   available at the Center for Research on Health in Latin America,
   Pontificia Universidad Cato ' lica del Ecuador. Nanoparticle
   characterization was performed with technical support provided by
   Universidad de las Islas Baleares Chemistry Department (Organic
   Chemistry Area) and ESPE's Laboratory for Nanomaterial Characterization.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. There was no
   additional external funding received for this study.
CR Aguirre A., 2016, THESIS
   Aguirre-Obando OA, 2015, ZOOLOGIA-CURITIBA, V32, P14, DOI 10.1590/S1984-46702015000100003
   Bastidas Beltrán Danny, 2015, Bol Mal Salud Amb, V55, P173
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisset J, 2006, J MED ENTOMOL, V43, P1185, DOI 10.1603/0022-2585(2006)43[1185:SOIAAA]2.0.CO;2
   Borase HP, 2013, J NANOMEDINE BIOTHER, V3, P1, DOI [10.4172/2155-983X.1000111, DOI 10.4172/2155-983X.1000111]
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   CDC, 2017, INT MOSQ MAN
   CHOWANSKI S, 2016, TOXINS, V8, P13006, DOI DOI 10.3390/TOXINS5010060
   Chowdhury N, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-10
   Cook GC, 2008, MANSONS TROPICAL DIS
   De la Torre L., 2008, ENCICLOPEDIA PLANTAS
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   Finney D.T., 1971, PROBIT ANAL
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   HAYA K, 1989, ENVIRON TOXICOL CHEM, V8, P381, DOI 10.1002/etc.5620080504
   Jerzykiewicz Jolanta, 2007, Postepy Biochem, V53, P280
   Jorgensen P.M., 1999, MONOGRAPHS SYSTEMATI, V75, P1
   Kumar B, 2015, COGENT CHEM, V1, DOI 10.1080/23312009.2015.1120982
   Kumar B, 2016, BIONANOSCIENCE, V6, P15, DOI 10.1007/s12668-016-0193-1
   Kumar PM, 2012, PARASITOL RES, V110, P2541, DOI 10.1007/s00436-011-2797-2
   Manjarres-Suarez Alejandra, 2013, Rev. costarric. salud pública, V22, P68
   Margni M, 2002, AGR ECOSYST ENVIRON, V93, P379, DOI 10.1016/S0167-8809(01)00336-X
   MILLER RH, 1969, BOT GAZ, V130, P230, DOI 10.1086/336496
   Mondal NK, 2015, IJSR PUB, V3, P47
   Morejon B, 2018, J NANOTECHNOL, V2018, DOI 10.1155/2018/6917938
   Muktar Y, 2016, J TROP DIS, V4, DOI [10.4172/2329-891X.1000101, DOI 10.4172/2329-891X.1000101]
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Patil CD, 2011, PARASITOL RES, V108, P1253, DOI 10.1007/s00436-010-2174-6
   Pradeep T., 2003, TXB NANOSCIENCE NANO
   Premalatha S, 2013, ASIAN PAC J TROP MED, V6, P854, DOI 10.1016/S1995-7645(13)60152-2
   R Team Core, 2013, R LANG ENV STAT COMP
   Raghavendra K, 2009, INDIAN J MED RES, V130, P74
   Ramesh S, 2016, BIOMATER SCI-UK, V4, P1713, DOI 10.1039/c6bm00688d
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Roghelia V, 2017, RES REV J HLTH PROFE, V7, P30
   Siegwart M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00381
   Vizuete KS, 2017, GREEN PROCESS SYNTH, V6, P23, DOI 10.1515/gps-2016-0015
   Sorescu A A, 2016, 4 INT VIRT C ADV SCI, V1, P188, DOI [10.18638/scieconf.2016.4.1.386, DOI 10.18638/SCIECONF.2016.4.1.386]
   Spring P, 2016, 5 INT C INN RES ENG
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Thiyagarajan P., 2014, ACTA BIOL INDICA, V3, P527
   Venables W. N., 2002, MODERN APPL STAT S
   Yufera E., 1995, QUIMICA ORGANICA BAS
   Zhang XF, 2016, INT J MOL SCI, V17, DOI [10.3390/ijms17091534, 10.3390/ijms17020153]
NR 50
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 31
PY 2019
VL 14
IS 10
AR e0224109
DI 10.1371/journal.pone.0224109
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LN0YA
UT WOS:000532670600024
PM 31671165
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Osterlund, P
   Jiang, M
   Westenius, V
   Kuivanen, S
   Jarvi, R
   Kakkola, L
   Lundberg, R
   Melen, K
   Korva, M
   Avsic-Zupanc, T
   Vapalahti, O
   Julkunen, I
AF Osterlund, Pamela
   Jiang, Miao
   Westenius, Veera
   Kuivanen, Suvi
   Jarvi, Riia
   Kakkola, Laura
   Lundberg, Rickard
   Melen, Krister
   Korva, Misa
   Avsic-Zupanc, Tatjana
   Vapalahti, Olli
   Julkunen, Ilkka
TI Asian and African lineage Zika viruses show differential replication and
   innate immune responses in human dendritic cells and macrophages
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GENE-EXPRESSION; INTERFERONS; ACTIVATION; INFECTION; OUTBREAK; SYSTEM;
   STAT2
AB Zika virus (ZIKV) infections in humans are considered to be mild or subclinical. However, during the recent epidemics in the Pacific Islands and the Americas, the infection was associated with Quillain-Barre syndrome and congenital infections with fetal brain abnormalities, including microcephaly. Thus, more detailed understanding of ZIKV-host cell interactions and regulation of innate immune responses by strains of differential evolutionary origin is required. Here, we characterized the infection and immune responses triggered by two epidemic Asian/American lineage viruses, including an isolate from fetal brains, and a historical, low passage 1947 African lineage virus in human monocyte-derived dendritic cells (DCs) and macrophages. The epidemic Asian/American ZIKV replicated well and induced relatively good antiviral responses in human DCs whereas the African strain replicated less efficiently and induced weaker immune responses. In macrophages both the African and Asian strains showed limited replication and relatively weak cytokine gene expression. Interestingly, in macrophages we observed host protein degradation, especially IRF3 and STAT2, at early phases of infection with both lineage viruses, suggesting an early proteasomal activation in phagocytic cells. Our data indicates that ZIKV evolution has led to significant phenotypic differences in the replication characteristics leading to differential regulation of host innate immune responses.
C1 [Osterlund, Pamela; Jiang, Miao; Westenius, Veera; Jarvi, Riia; Melen, Krister] Finnish Inst Hlth & Welf, Expert Microbiol Unit, Helsinki 00300, Finland.
   [Kuivanen, Suvi; Vapalahti, Olli] Univ Helsinki, Dept Virol, Haartmaninkatu 3, FIN-00290 Helsinki, Finland.
   [Kakkola, Laura; Lundberg, Rickard; Melen, Krister; Julkunen, Ilkka] Univ Turku, Inst Biomed, FIN-20520 Turku, Finland.
   [Kakkola, Laura; Lundberg, Rickard; Melen, Krister; Julkunen, Ilkka] Turku Univ Hosp, FIN-20520 Turku, Finland.
   [Korva, Misa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana 1000, Slovenia.
RP Osterlund, P (corresponding author), Finnish Inst Hlth & Welf, Expert Microbiol Unit, Helsinki 00300, Finland.
EM pamela.osterlund@thl.fi
RI Osterlund, Pamela/L-2528-2015
OI Osterlund, Pamela/0000-0002-2229-6661; Kakkola,
   Laura/0000-0001-9271-4059; Westenius, Veera/0000-0003-3117-3732;
   Vapalahti, Olli/0000-0003-2270-6824
FU European Virus Archive goes Global (EVAg) project - European Union
   [653316]; Medical Research Council of the Academy of FinlandAcademy of
   Finland [297329]; Jane and Aatos Erkko Foundation; Sigrid Juselius
   FoundationSigrid Juselius Foundation; Oscar Oflund Foundation
FX We are grateful to Hanna Valtonen, Riitta Santanen, Johanna Rintamaki,
   Svetlana Kaijalainen and Anu Haveri for their expert technical
   assistance, and we appreciate the help from Susanna Sissonen on
   biosafety aspects. This publication was supported by the European Virus
   Archive goes Global (EVAg) project that has received funding from the
   European Union's Horizon 2020 research and innovation program under
   grant agreement No 653316. The work was supported by the Medical
   Research Council of the Academy of Finland (grant no. 297329), the Jane
   and Aatos Erkko, the Sigrid Juselius and Oscar Oflund Foundations. The
   funders had no role in study design, data collection and interpretation,
   or the decision to submit the work for publication.
CR Airenne KJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng102
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, N ENGL J MED
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hertzog J, 2018, EUR J IMMUNOL
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Italiani P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087680
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Khaiboullina S. F, 2017, SCI REPORTS, V7, P1
   Kuivanen S, 2017, J GEN VIROL, V98, P1744, DOI 10.1099/jgv.0.000857
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lehtonen A, 1997, J IMMUNOL, V159, P794
   Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542
   Melen K, 2017, J VIROL METHODS, V242, P35, DOI 10.1016/j.jviromet.2016.12.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005
   Pagni S, 2012, IMMUNOL RES, V54, P152, DOI 10.1007/s12026-012-8334-2
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5
   Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   RONNI T, 1993, J IMMUNOL, V150, P1715
   SHEN J, 1995, IMMUNOLOGY, V84, P254
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Veckman V, 2003, J LEUKOCYTE BIOL, V74, P395, DOI 10.1189/jlb.0402212
   Veckman V, 2004, J LEUKOCYTE BIOL, V75, P764, DOI 10.1189/jlb.1003461
   Vielle N. J., 2018, SCI REPORTS, V8, P1
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
NR 54
TC 0
Z9 0
U1 2
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 31
PY 2019
VL 9
AR 15710
DI 10.1038/s41598-019-52307-1
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JI4LW
UT WOS:000493439600008
PM 31673117
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Venancio, FA
   Bernal, MEQ
   Ramos, MDDV
   Chaves, NR
   Hendges, MV
   de Souza, MMR
   de Medeiros, MJ
   Pinto, CDS
   de Oliveira, EF
AF Venancio, Fabio Antonio
   Bernal, Maria Eulina Quiliao
   Ramos, Maria da Conceicao de Barros Vieira
   Chaves, Neuma Rocha
   Hendges, Marcos Vinicius
   de Souza, Mattheus Marques Rodrigues
   de Medeiros, Marcio Jose
   Pinto, Claudia Du Bocage Santos
   de Oliveira, Everton Falcao
TI Congenital Zika Syndrome in a Brazil-Paraguay-Bolivia border region:
   Clinical features of cases diagnosed between 2015 and 2018 (vol 14,
   e0223408, 2019)
SO PLOS ONE
LA English
DT Correction
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)CAPES; Universidade Federal de Mato Grosso do Sul (UFMS)
FX The Funding statement is incorrect. The correct Funding statement is as
   follows: This study was financed in part by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)
   (https://www.capes.gov.br/) and by Universidade Federal de Mato Grosso
   do Sul (UFMS) (https://www.ufms.br/).The funders did not have any
   additional role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Venancio FA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223408
NR 1
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 30
PY 2019
VL 14
IS 10
AR e0224842
DI 10.1371/journal.pone.0224842
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LN0VZ
UT WOS:000532664700051
PM 31665186
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hopperstad, KA
   Reiskind, MH
   Labadie, PE
   Reiskind, MOB
AF Hopperstad, Kristen A.
   Reiskind, Michael H.
   Labadie, Paul E.
   Reiskind, Martha O. Burford
TI Patterns of genetic divergence among populations of Aedes aegypti L.
   (Diptera: Culicidae) in the southeastern USA
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Genetic structure; Competitive exclusion; Satyrization
ID HABITAT SEGREGATION; ALBOPICTUS DIPTERA; STEGOMYIA-AEGYPTI; SOUTH
   FLORIDA; SOFTWARE; MOSQUITO; PHYLOGEOGRAPHY; SATYRIZATION; COEXISTENCE;
   COMPETITION
AB Background: The yellow fever mosquito, Aedes aegypti is a public health concern in the USA, especially in the wake of emergent diseases such as Zika and chikungunya. Aedes aegypti populations dwindled after the invasion of Aedes albopictus in the 1980s and many populations were extirpated. However, in some areas Ae. aegypti persisted in small populations and there are reports of recent resurgences of Ae. aegypti in Florida, Louisiana, Nevada and California. We assessed the population genetic structure of Ae. aegypti in Florida and Georgia, which has concomitant consequences related to mosquito dispersal, pesticide resistance and vectorial capacity.
   Methods: We collected Ae. aegypti across Florida and in Georgia using ovitraps. We hatched the eggs and reared them to adults, and after sacrifice we extracted their DNA. We then probed each individual for variation in 6 microsatellite markers, which we used to address population genetic characteristics.
   Results: We collected Ae. aegypti and genotyped seven Florida populations and one Georgia population using microsatellite markers. We found evidence of isolation by distance model of gene flow supported by driving distance among cities within Florida and two theoretic genetic clusters.
   Conclusions: Significant genetic structure between some populations with substantial gene flow between geographically distant cities suggests regional genetic structuring of Ae. aegypti in Florida. This study provides information on the genetic exchange between populations of Ae. aegypti in the southeastern USA and suggests potential routes of spread of this species.
C1 [Hopperstad, Kristen A.; Reiskind, Michael H.; Labadie, Paul E.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.
   [Reiskind, Martha O. Burford] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.
RP Reiskind, MOB (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.
EM mbreiski@ncsu.edu
OI Burford Reiskind, Martha/0000-0001-6826-9215
FU National Science Foundation Graduate Research FellowshipNational Science
   Foundation (NSF) [DGE-1252376]; Triangle Center for Evolutionary
   Medicine
FX This material is based upon work supported by the National Science
   Foundation Graduate Research Fellowship under Grant No. (DGE-1252376)
   and the Triangle Center for Evolutionary Medicine.
CR Bargielowski I, 2014, EVOL ECOL, V28, P193, DOI 10.1007/s10682-013-9669-4
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803
   Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098
   Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532
   BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170
   Bradburd GS, 2018, GENETICS, V210, P33, DOI 10.1534/genetics.118.301333
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brown JE, 2013, J MED ENTOMOL, V50, P294, DOI 10.1603/ME12173
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   CDC, 2018, DIV VECT BORN DIS
   CHAKRABORTY R, 1992, HUM GENET, V88, P267, DOI 10.1007/BF00197257
   da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x
   Damal K, 2013, AM J TROP MED HYG, V89, P482, DOI 10.4269/ajtmh.13-0102
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Gloria-Soria A, 2016, MED VET ENTOMOL, V30, P235, DOI 10.1111/mve.12153
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   Hopperstad KA, 2016, J MED ENTOMOL, V53, P836, DOI 10.1093/jme/tjw050
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004765
   Huber K, 2004, ACTA TROP, V90, P23, DOI 10.1016/j.actatropica.2003.09.012
   Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325
   Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281
   Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387
   Lounibos LP, 2018, BIOL INVASIONS, V20, P1913, DOI 10.1007/s10530-018-1674-7
   Lounibos LP, 2016, J MED ENTOMOL, V53, P1385, DOI 10.1093/jme/tjw122
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lovin DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-590
   Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304
   MOORE CG, 1988, J AM MOSQUITO CONTR, V4, P356
   MORLAN HB, 1965, AM J TROP MED HYG, V14, P892, DOI 10.4269/ajtmh.1965.14.892
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Pritchard JK, 2000, GENETICS, V155, P945
   Rasheed SB, 2013, MED VET ENTOMOL, V27, P430, DOI 10.1111/mve.12001
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Reiskind MOB, 2016, MOL ECOL RESOUR, V16, P1303, DOI 10.1111/1755-0998.12527
   Reiskind MOB, 2018, MOL ECOL, V27, P3641, DOI 10.1111/mec.14821
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
NR 56
TC 0
Z9 0
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 30
PY 2019
VL 12
IS 1
AR 511
DI 10.1186/s13071-019-3769-0
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JT1TA
UT WOS:000500779100007
PM 31666113
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marshall, JM
   Raban, RR
   Kandul, NP
   Edula, JR
   Leon, TM
   Akbari, OS
AF Marshall, John M.
   Raban, Robyn R.
   Kandul, Nikolay P.
   Edula, Jyotheeswara R.
   Leon, Tomas M.
   Akbari, Omar S.
TI Winning the Tug-of-War Between Effector Gene Design and Pathogen
   Evolution in Vector Population Replacement Strategies
SO FRONTIERS IN GENETICS
LA English
DT Review
DE clustered regularly interspaced short palindromic repeats; clustered
   regularly interspaced short palindromic repeats-associated protein 9;
   gene drive; homing; malaria; dengue; Zika
ID IMMUNODEFICIENCY-VIRUS TYPE-1; PLASMODIUM-FALCIPARUM RESISTANCE;
   ANTIMALARIAL-DRUG RESISTANCE; RNA INTERFERENCE RNAI; COMBINATION
   THERAPIES; SECONDARY MUTATIONS; MALARIA PARASITES; SINGLE MUTATION;
   MOLECULAR-BASIS; TRANSMISSION
AB While efforts to control malaria with available tools have stagnated, and arbovirus outbreaks persist around the globe, the advent of clustered regularly interspaced short palindromic repeat (CRISPR)-based gene editing has provided exciting new opportunities for genetics-based strategies to control these diseases. In one such strategy, called "population replacement", mosquitoes, and other disease vectors are engineered with effector genes that render them unable to transmit pathogens. These effector genes can be linked to "gene drive" systems that can bias inheritance in their favor, providing novel opportunities to replace disease-susceptible vector populations with disease-refractory ones over the course of several generations. While promising for the control of vector-borne diseases on a wide scale, this sets up an evolutionary tug-of-war between the introduced effector genes and the pathogen. Here, we review the disease-refractory genes designed to date to target Plasmodium falciparum malaria transmitted by Anopheles gambiae, and arboviruses transmitted by Aedes aegypti, including dengue serotypes 2 and 3, chikungunya, and Zika viruses. We discuss resistance concerns for these effector genes, and genetic approaches to prevent parasite and viral escape variants. One general approach is to increase the evolutionary hurdle required for the pathogen to evolve resistance by attacking it at multiple sites in its genome and/or multiple stages of development. Another is to reduce the size of the pathogen population by other means, such as with vector control and antimalarial drugs. We discuss lessons learned from the evolution of resistance to antimalarial and antiviral drugs and implications for the management of resistance after its emergence. Finally, we discuss the target product profile for population replacement strategies for vector-borne disease control. This differs between early phase field trials and wide-scale disease control. In the latter case, the demands on effector gene efficacy are great; however, with new possibilities ushered in by CRISPR-based gene editing, and when combined with surveillance, monitoring, and rapid management of pathogen resistance, the odds are increasingly favoring effector genes in the upcoming evolutionary tug-of-war.
C1 [Marshall, John M.; Leon, Tomas M.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.
   [Marshall, John M.] Innovat Genom Inst, Berkeley, CA 94720 USA.
   [Raban, Robyn R.; Kandul, Nikolay P.; Edula, Jyotheeswara R.; Akbari, Omar S.] Univ Calif San Diego, Sect Cell & Dev Biol, San Diego, CA 92103 USA.
   [Akbari, Omar S.] Univ Calif San Diego, Tata Inst Genet & Soc, San Diego, CA 92103 USA.
RP Marshall, JM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.; Marshall, JM (corresponding author), Innovat Genom Inst, Berkeley, CA 94720 USA.; Akbari, OS (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, San Diego, CA 92103 USA.; Akbari, OS (corresponding author), Univ Calif San Diego, Tata Inst Genet & Soc, San Diego, CA 92103 USA.
EM john.marshall@berkeley.edu; oakbari@ucsd.edu
OI Kandul, Nikolay/0000-0001-7347-5558
FU Defense Advanced Research Project Agency (DARPA) Safe Genes
   ProgramUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [HR0011-17-2-0047]; UC Irvine Malaria Initiative
FX This work was supported by funding from the Defense Advanced Research
   Project Agency (DARPA) Safe Genes Program Grant (HR0011-17-2-0047)
   awarded to O.S.A. and J.M.M. Funds from the UC Irvine Malaria Initiative
   supported J.M.M.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022
   Beaucourt S, 2014, CURR OPIN VIROL, V8, P10, DOI 10.1016/j.coviro.2014.04.011
   Behera AK, 2015, GENE, V557, P19, DOI 10.1016/j.gene.2014.12.003
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Bloom JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022201
   Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816
   Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003
   Brackney DE, 2015, J VIROL, V89, P4035, DOI 10.1128/JVI.02612-14
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101
   Buchman A., 2019, SSRN ELECT J, DOI [10.2139/ssrn.3398490, DOI 10.2139/SSRN.3398490]
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   Burt A, 2018, J RESPONSIBLE INNOV, V5, pS66, DOI 10.1080/23299460.2017.1419410
   Carballar-Lejarazu R, 2017, PATHOG GLOB HEALTH, V111, P424, DOI 10.1080/20477724.2018.1427192
   Carter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139899
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Ceccherini-Silberstein F, 2005, J VIROL, V79, P10718, DOI 10.1128/JVI.79.16.10718-10729.2005
   Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Costa GL, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1806-z
   Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0
   Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598
   Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004
   Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004
   Debing Y, 2014, GASTROENTEROLOGY, V147, P1008, DOI 10.1053/j.gastro.2014.08.040
   Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Dong YM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006898
   Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004
   Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Duru V, 2016, AM J TROP MED HYG, V95, P1228, DOI 10.4269/ajtmh.16-0234
   Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   Feachem RGA, 2019, LANCET, V394, P1056, DOI 10.1016/S0140-6736(19)31139-0
   Feng XM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38792-4
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Ford SA, 2019, NAT MICROBIOL, V4, P1832, DOI 10.1038/s41564-019-0533-3
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569
   Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005
   Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020
   Hyde JL, 2015, VIRUS RES, V206, P99, DOI 10.1016/j.virusres.2015.01.016
   Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   James S, 2018, AM J TROP MED HYG, V98, P1, DOI 10.4269/ajtmh.18-0083
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000211
   Kiware SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187680
   Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x
   Koh C, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vez012
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lee Y, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5586-4
   Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205
   Li M., 2019, DEV CONFINABLE GENE, DOI [10.1101/645440, DOI 10.1101/645440]
   Lindsey ARI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040141
   Macias V, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P423
   Marshall JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02744-7
   Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667
   Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x
   Mathur K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38065
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007
   Mishra P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060163
   Morley VJ, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey012
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Nishitsuji H, 2006, J VIROL, V80, P7658, DOI 10.1128/JVI.00078-06
   Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964
   Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Ouji M, 2018, PARASITE, V25, DOI 10.1051/parasite/2018021
   Patterson EI, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey001
   Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100
   Raban R, 2017, PATHOG GLOB HEALTH, V111, P399, DOI 10.1080/20477724.2017.1453587
   Ryan S. J., 2019, BIORXIV, V13, P1, DOI DOI 10.1101/172221
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915
   Shah NK, 2011, LANCET INFECT DIS, V11, P57, DOI 10.1016/S1473-3099(10)70214-0
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C
   Travanty EA, 2004, INSECT BIOCHEM MOLEC, V34, P607, DOI 10.1016/j.ibmb.2004.03.013
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Wale N, 2017, P NATL ACAD SCI USA, V114, P13774, DOI 10.1073/pnas.1715874115
   Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0
   WEAVER SC, 1992, CURR TOP MICROBIOL, V176, P99
   Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220
   White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7
   Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005
   Wu ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026304
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029
   Yen PS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0011-5
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
NR 113
TC 2
Z9 2
U1 6
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD OCT 30
PY 2019
VL 10
AR 1072
DI 10.3389/fgene.2019.01072
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA JO2IO
UT WOS:000497406900001
PM 31737050
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guimaraes, CD
   Macedo, MS
   Barbosa, MA
   Marques, SM
   Costa, PS
   de Oliveira, EC
AF Guimaraes, Claudia de Paula
   Macedo, Myrella Silveira
   Barbosa, Maria Alves
   Marques, Solomar Martins
   Costa, Paulo Sucasas
   de Oliveira, Enio Chaves
TI Clinical findings in congenital infection by Zika virus: a retrospective
   study in a reference hospital in Central-West Brazil
SO BMC PEDIATRICS
LA English
DT Article
DE Zika virus; Microcephaly; Malformations
AB Background: An increased number of congenital Zika virus infections with neurological and musculoskeletal malformations have been diagnosed worldwide, however, there are still several gaps in the knowledge about this infection, its associated mechanism, timing of transmission, and description of throughout findings of signs and symptoms, which is described in this paper. The purpose of this study is to describe aspects of congenital Zika syndrome (CZS) beyond the central nervous system comprising detailed delineation of all the other clinical findings.
   Methods: A retrospective research developed using electronic medical records. We analyzed the files of 69 children with an initial diagnosis of microcephaly by Zika virus who were born in 2015, 2016 and 2017, treated during the period from 2016 to 2017.
   Results: The newborns presented several neurological and musculoskeletal malformations, eye damage, hearing impairment and other malformations.
   Conclusions: The present study has significant impact for health care teams following lactents with Congenital Zika Syndrome.
C1 [Guimaraes, Claudia de Paula] Univ Fed Goias, EBSERH, Hosp Clin, Goiania, Go, Brazil.
   [Macedo, Myrella Silveira] Secretaria Municipal Saude, Goiania, Go, Brazil.
   [Barbosa, Maria Alves] Univ Fed Goias, Fac Enfermagem, Goiania, Go, Brazil.
   [Marques, Solomar Martins; Costa, Paulo Sucasas; de Oliveira, Enio Chaves] Univ Fed Goias, Fac Med, Goiania, Go, Brazil.
RP Guimaraes, CD (corresponding author), Univ Fed Goias, EBSERH, Hosp Clin, Goiania, Go, Brazil.
EM enfguimaraes@yahoo.com.br
RI Costa, Paulo/L-5460-2016
OI Costa, Paulo/0000-0001-9370-9139; Barbosa, Maria/0000-0002-0861-9655;
   Cancado, Myrella/0000-0002-0006-7745
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Icheky V., 2017, J MPE MOL PATHOLOGIC, V2
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Meaney-Delman, 2016, OBSTET GYNECOLOGY
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Ribeiro, 2018, EPIDEMIOL SERV SAUDE, V27
   Santa Rita Ticiane Henriques, 2017, BMC Res Notes, V10, P457, DOI 10.1186/s13104-017-2796-1
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P7
   van der Linden, 2018, NEW ENGL J MED, V379, P9
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   World Health Organization (WHO), ZIK SIT REP
NR 18
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD OCT 29
PY 2019
VL 19
IS 1
AR 389
DI 10.1186/s12887-019-1762-6
PG 5
WC Pediatrics
SC Pediatrics
GA JV4SX
UT WOS:000502356300001
PM 31660908
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cable, J
   Srikantiah, P
   Crowe, JE
   Pulendran, B
   Hill, A
   Ginsberg, A
   Koff, W
   Mathew, A
   Ng, T
   Jansen, K
   Glenn, G
   Permar, S
   Wilson, I
   Weiner, DB
   Weissman, D
   Rappuoli, R
AF Cable, Jennifer
   Srikantiah, Padmini
   Crowe, James E., Jr.
   Pulendran, Bali
   Hill, Adrian
   Ginsberg, Ann
   Koff, Wayne
   Mathew, Anuja
   Ng, Tony
   Jansen, Kathrin
   Glenn, Gregory
   Permar, Sallie
   Wilson, Ian
   Weiner, David B.
   Weissman, Drew
   Rappuoli, Rino
TI Vaccine innovations for emerging infectious diseases-a symposium report
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Editorial Material
DE vaccine; vaccinology; monoclonal antibodies; RNA vaccine; DNA vaccine;
   infectious disease; antimicrobial resistance; maternal immunization;
   tuberculosis; malaria; HIV; RSV; CMV; Ebola; Zika; MERS; influenza;
   systems vaccinology
ID MATERNAL INFLUENZA IMMUNIZATION; ACELLULAR PERTUSSIS;
   HEMAGGLUTININ-STEM; SYSTEMS-ANALYSIS; ANTIBODY; DIPHTHERIA; TETANUS;
   SAFETY; PREVENTION; PROTECTION
AB Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled "Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats," held on May 20, 2019.
C1 [Srikantiah, Padmini] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Pulendran, Bali] Stanford Univ, Dept Pathol, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.
   [Pulendran, Bali] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Hill, Adrian] Univ Oxford, Jenner Inst, Oxford, England.
   [Ginsberg, Ann] Int AIDS Vaccine Initiat, New York, NY USA.
   [Koff, Wayne] Human Vaccines Project, New York, NY USA.
   [Mathew, Anuja] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA.
   [Ng, Tony] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA.
   [Jansen, Kathrin] Pfizer, New York, NY USA.
   [Glenn, Gregory] Novavax, Rockville, MD USA.
   [Permar, Sallie] Duke Univ, Durham, NC USA.
   [Wilson, Ian] Scripps Res Inst, Dept Integrat Struct & Computat Biol, San Diego, CA USA.
   [Weiner, David B.] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Weissman, Drew] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Rappuoli, Rino] GlaxoSmithKline, Brentford, England.
RP Srikantiah, P (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.
EM annals@nyas.org
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079
FU PfizerPfizer; GSKGlaxoSmithKline; MerckMerck & Company; Novavax;
   Serendipity Foundation; GAVI, the Vaccine Alliance; Human Vaccines
   Project; Inflammation Research Association; International AIDS Vaccine
   Initiative
FX This report stems from a symposium of the New York Academy of Sciences
   Microbiology and Infectious Diseases Discussion Group that occurred at
   the Academy headquarters in New York City May 20, 2019. The symposium
   organizers were Annaliesa Anderson (Pfizer), Melanie Brickman Borchard
   (the New York Academy of Sciences), Wayne Koff (the Human Vaccines
   Project), Gregory Glenn (Novavax), Stanley Plotkin (University of
   Pennsylvania), and George Zavoico (B. Riley FBR). Sponsors of the event
   included Pfizer and GSK (silver); Merck and Novavax (bronze); the
   Serendipity Foundation; GAVI, the Vaccine Alliance; the Human Vaccines
   Project; the Inflammation Research Association; and the International
   AIDS Vaccine Initiative.
CR Adam A, 2018, J IMMUNOL, V201, P3804, DOI 10.4049/jimmunol.1800892
   Aggarwal C., 2015, PHASE 1B 2A MULTICEN
   Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586
   [Anonymous], REVEAL 2 TRIAL EV VG
   [Anonymous], 1 IN CLASS DNA ENC M
   [Anonymous], STUD DESCR SAF IMM R
   [Anonymous], PHAS 1 2 RAND PLAC O
   [Anonymous], 2017, LANCET HIV, V2, pe115
   [Anonymous], REVEAL 1 EVALUATION
   [Anonymous], NOV ANN TOPL RES PHA
   [Anonymous], TRIAL EV SAF TOL IMM
   Bangaru S, 2019, CELL, V177, P1136, DOI 10.1016/j.cell.2019.04.011
   Bialas KM, 2015, P NATL ACAD SCI USA, V112, P13645, DOI 10.1073/pnas.1511526112
   Bratton KN, 2015, CLIN INFECT DIS, V60, pE11, DOI 10.1093/cid/ciu915
   Buurman ET, 2019, J INFECT DIS, V220, P105, DOI 10.1093/infdis/jiz062
   Clinicaltrials.gov, STUD DET NEW TYP MAL
   Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4
   Collins KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46621
   Corbett KS, 2019, MBIO, V10, DOI 10.1128/mBio.02810-18
   Donegan K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4219
   Dormitzer P.R., 2018, RES DEV STRATEGIC PA
   Esquivel RN, 2019, MOL THER, V27, P974, DOI 10.1016/j.ymthe.2019.03.005
   European Medicines Agency, 2018, 1 MAL VACC REC POS S
   Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031
   Fourati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10369
   Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123
   Gola A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9128
   Graham BS, 2017, CURR OPIN VIROL, V23, P107, DOI 10.1016/j.coviro.2017.03.012
   Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Klein SL, 2016, MBIO, V7, DOI 10.1128/mBio.00514-16
   Kwong JC, 2009, CLIN INFECT DIS, V49, P750, DOI 10.1086/605087
   Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184
   Laursen NS, 2018, SCIENCE, V362, P598, DOI 10.1126/science.aaq0620
   Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Mire CE, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8711
   Moderna Inc., 2019, MOD ANN DOS 1 MON AN
   Morgan JL, 2015, OBSTET GYNECOL, V125, P1433, DOI 10.1097/AOG.0000000000000862
   Munoz FM, 2014, CLIN INFECT DIS, V59, pS415, DOI 10.1093/cid/ciu727
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nelson CS, 2018, P NATL ACAD SCI USA, V115, P6267, DOI 10.1073/pnas.1800177115
   Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/nejmoa1714021, 10.1056/NEJMoa1714021]
   Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373
   ONeill J., 2016, TACKLING DRUG RESIST
   Oyen D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8529
   Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114
   Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]
   Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   Patel A, 2018, CELL REP, V25, P1982, DOI 10.1016/j.celrep.2018.10.062
   Patel N, 2019, VACCINE, V37, P6112, DOI 10.1016/j.vaccine.2019.07.089
   Petitdemange C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126047
   Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Royal Society, 2017, VAL VACC AV ANT RES
   Shakib JH, 2013, J PEDIATR-US, V163, P1422, DOI 10.1016/j.jpeds.2013.06.021
   Shi ST, 2019, VACCINE, V37, P3167, DOI 10.1016/j.vaccine.2019.04.055
   Smith G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050852
   Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10
   Sukumaran L, 2015, OBSTET GYNECOL, V126, P1069, DOI 10.1097/AOG.0000000000001066
   Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513
   Tebas P, 2019, J INFECT DIS, V220, P400, DOI 10.1093/infdis/jiz132
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   United Nations Children's Fund (UNICEF), VACC BRING 7 DIS CON
   United Nations Children's Fund (UNICEF), EL MAT NEON TET
   Van der Meeren O, 2018, NEW ENGL J MED, V379, P1621, DOI 10.1056/NEJMoa1803484
   von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914
   WHO, WHO Q A MAL VACC IMP
   Wilcox CR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01294
   Wooden SL, 2018, HUM VACC IMMUNOTHER, V14, P2214, DOI 10.1080/21645515.2018.1476813
   World Health Organization, 2018, GLOB TUB REP 2018
   World Health Organization, 2014, G A C V S SAF IMM PR
   World Health Organization, 2018, TOP 10 CAUS DEATH
   Wu NC, 2018, NAT STRUCT MOL BIOL, V25, P115, DOI 10.1038/s41594-018-0025-9
   Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
NR 81
TC 0
Z9 0
U1 5
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0077-8923
EI 1749-6632
J9 ANN NY ACAD SCI
JI Ann. N.Y. Acad. Sci.
PD FEB
PY 2020
VL 1462
IS 1
BP 14
EP 26
DI 10.1111/nyas.14235
EA OCT 2019
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KM9FM
UT WOS:000492850800001
PM 31659752
DA 2020-07-08
ER

PT J
AU Satyanarayana, M
AF Satyanarayana, Megha
TI INFECTIOUS DISEASE DHA may slow Zika-induced microcephaly in mice
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
CR YANG W, 2019, SCI ADV, DOI DOI 10.1126/SCIADV.AAX7142
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD OCT 28
PY 2019
VL 97
IS 42
BP 8
EP 8
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA JH5GZ
UT WOS:000492798400009
DA 2020-07-08
ER

PT J
AU Yazbeck, AS
   Soucat, A
AF Yazbeck, Abdo S.
   Soucat, Agnes
TI When Both Markets and Governments Fail Health
SO HEALTH SYSTEMS & REFORM
LA English
DT Article
DE common goods for health; market failure
ID MEDICAL-CARE; EXPENDITURE; STORES; COSTS; FAT
AB This paper presents the rationale and motivation for countries and the global development community to tackle a critical set of functions in the health sector that appear to be under-prioritized and underfunded. The recent eruptions of Ebola outbreaks in Africa and other communicable diseases like Zika and SARS elsewhere led scientific and medical commissions to call for global action. The calls for action motivated the World Health Organization (WHO) to respond by defining a new construct within the health sector: Common Good for Health (CGH). While the starting point for developing the CGH construct was the re-emergence of communicable diseases, it extends to additional outcomes resulting from failures to act and finance within and outside the health sector. This paper summarizes global evidence on failures to address CGHs effectively, identifies potential reasons for the public and private sectors' failures to respond, and lays out the first phase of the WHO program as represented by the papers in this special issue of Health Systems & Reform.
C1 [Yazbeck, Abdo S.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21218 USA.
   [Soucat, Agnes] WHO, Geneva, Switzerland.
RP Yazbeck, AS (corresponding author), Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21218 USA.
EM abdo.yazbeck@gmail.com
FU World Health OrganizationWorld Health Organization; Finland's Ministry
   of Social Affairs and Health; European CommissionEuropean Commission
   Joint Research Centre; UK Department for International Development
FX This article was supported by the World Health Organization. Funding
   from Finland's Ministry of Social Affairs and Health, the UK Department
   for International Development, and the European Commission is gratefully
   acknowledged.
CR [Anonymous], 2017, BBC NEWS
   Baumol WJ, 1967, AM ECON REV, V57, P415
   Bawden S, 2017, DIABETES OBES METAB, V19, P70, DOI 10.1111/dom.12784
   Bommer C, 2018, DIABETES CARE, V41, P963, DOI 10.2337/dc17-1962
   Bump G, 2019, HLTH SYST, V5
   Burns A., 2008, EVALUATING EC CONSEQ
   Clements B, 2012, EC PUBLIC HLTH CARE
   Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483
   Fan VY, 2018, B WORLD HEALTH ORGAN, V96, P129, DOI 10.2471/BLT.17.199588
   Frangoul A, 2014, CNBC
   Fung J, 2018, DIABETES CODE PREVEN
   Gaudin S, 2019, HEALTH SYST REFORM, V5, P280, DOI 10.1080/23288604.2019.1656028
   GHRF Commission, 2016, NEGL DIM GLOB SEC FR
   Hanssen O, 2018, INVESTING GLOBAL INV
   Interagency Coordination Group on Antimicrobiol Resistance, 2019, NO TIM WAIT SEC FUT
   Ke X, 2018, PUBLIC SPENDING HLTH
   Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0
   Lo S, 2019, HLTH SYST REFORM, V5
   MANNING WG, 1987, AM ECON REV, V77, P251
   Musgrave RA, 1973, PUBLIC FINANCE THEOR
   Musgrove P, 1999, HEALTH POLICY, V47, P207, DOI 10.1016/S0168-8510(99)00024-X
   Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y
   NEWHOUSE JP, 1977, J HUM RESOUR, V12, P115, DOI 10.2307/145602
   NEWHOUSE JP, 1992, J ECON PERSPECT, V6, P3, DOI 10.1257/jep.6.3.3
   OECD, 2018, STEMM SUP TID JUST F, DOI [10.1787/9789264307599-en, DOI 10.1787/9789264307599-EN]
   OECD, 2006, OECD EC DEP WORKING, V477
   Okunade AA, 2002, J HEALTH ECON, V21, P147, DOI 10.1016/S0167-6296(01)00122-9
   Pan American Health Organization/World Health Organization Centers for Disease Control and Prevention Centro Latinoamericano de Investigaciones en Sistems de Salud, 2010, PERF MEAS ESS PUBL H
   Peters DH, 2019, HEALTH SYST REFORM, V5, P307, DOI 10.1080/23288604.2019.1660104
   PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509
   Review on Antimicrobial Resistance, 2014, REV ANTIMICROBIAL RE
   Schaferhoff M, 2019, HEALTH SYST REFORM, V5, P350, DOI 10.1080/23288604.2019.1663646
   Sparkes S, 2019, HLTH SYST REFORM, V5, pxx
   Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8
   Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932
   Tavernise S, 2016, NY TIMES
   Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9
   Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1
   World Health Organization, 2016, GLOB REP DIAB
   Yamey G, 2019, HLTH SYST REFORM, V5
   Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4
NR 42
TC 6
Z9 6
U1 4
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2328-8604
EI 2328-8620
J9 HEALTH SYST REFORM
JI Health Syst. Reform
PD OCT 2
PY 2019
VL 5
IS 4
SI SI
BP 268
EP 279
DI 10.1080/23288604.2019.1660756
EA OCT 2019
PG 12
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA JZ5AA
UT WOS:000494055000001
PM 31684822
OA Bronze
DA 2020-07-08
ER

PT J
AU Rotejanaprasert, C
   Lawson, AB
   Iamsirithaworn, S
AF Rotejanaprasert, Chawarat
   Lawson, Andrew B.
   Iamsirithaworn, Sopon
TI Spatiotemporal multi-disease transmission dynamic measure for emerging
   diseases: an application to dengue and zika integrated surveillance in
   Thailand
SO BMC MEDICAL RESEARCH METHODOLOGY
LA English
DT Article
DE Emerging disease; Surveillance; Integrative; Bayesian; Spatiotemporal;
   Zika; Dengue
ID REPRODUCTION NUMBER; EPIDEMIC; VIRUSES; MODELS
AB Background New emerging diseases are public health concerns in which policy makers have to make decisions in the presence of enormous uncertainty. This is an important challenge in terms of emergency preparation requiring the operation of effective surveillance systems. A key concept to investigate the dynamic of infectious diseases is the basic reproduction number. However it is difficult to be applicable in real situations due to the underlying theoretical assumptions. Methods In this paper we propose a robust and flexible methodology for estimating disease strength varying in space and time using an alternative measure of disease transmission within the hierarchical modeling framework. The proposed measure is also extended to allow for incorporating knowledge from related diseases to enhance performance of surveillance system. Results A simulation was conducted to examine robustness of the proposed methodology and the simulation results demonstrate that the proposed method allows robust estimation of the disease strength across simulation scenarios. A real data example is provided of an integrative application of Dengue and Zika surveillance in Thailand. The real data example also shows that combining both diseases in an integrated analysis essentially decreases variability of model fitting. Conclusions The proposed methodology is robust in several simulated scenarios of spatiotemporal transmission force with computing flexibility and practical benefits. This development has potential for broad applicability as an alternative tool for integrated surveillance of emerging diseases such as Zika.
C1 [Rotejanaprasert, Chawarat] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok 10400, Thailand.
   [Rotejanaprasert, Chawarat] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand.
   [Lawson, Andrew B.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.
   [Iamsirithaworn, Sopon] Minist Publ Hlth, Dept Dis Control, Nonthaburi 11000, Thailand.
RP Rotejanaprasert, C (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok 10400, Thailand.; Rotejanaprasert, C (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand.
EM chawarat.rot@mahidol.ac.th
FU Mahidol University; ICTM grant from the Faculty of Tropical Medicine
FX This research was supported by the new researcher grant of Mahidol
   University and ICTM grant from the Faculty of Tropical Medicine. The
   funding body had no role in the design or analysis of the study,
   interpretation of results, or writing of the manuscript.
CR Banerjee S., 2015, HIERARCHICAL MODELIN
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Brauer F, 2008, LECT NOTES MATH, V1945, P19
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Diggle PJ, 2010, J R STAT SOC C-APPL, V59, P191, DOI 10.1111/j.1467-9876.2009.00701.x
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758
   Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1
   Gelfand AE, 2003, BIOSTATISTICS, V4, P11, DOI 10.1093/biostatistics/4.1.11
   Gelfand AE, 2012, ENVIRONMETRICS, V23, P565, DOI 10.1002/env.2169
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Knorr-Held L, 2001, J R STAT SOC A STAT, V164, P73, DOI 10.1111/1467-985X.00187
   Lawson A, 2016, HDB SPATIAL EPIDEMIO
   Lawson A. B., 2013, STAT METHODS SPATIAL
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li J, 2011, COMPUT MATH METHOD M, DOI 10.1155/2011/527610
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Nishiura H, 2010, INT J ENV RES PUB HE, V7, P291, DOI 10.3390/ijerph7010291
   Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031
NR 29
TC 0
Z9 0
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2288
J9 BMC MED RES METHODOL
JI BMC Med. Res. Methodol.
PD OCT 26
PY 2019
VL 19
IS 1
AR 200
DI 10.1186/s12874-019-0833-6
PG 11
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA JH9HU
UT WOS:000493079500003
PM 31655546
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Delafiori, J
   Lima, ED
   Dabaja, MZ
   Dias-Audibert, FL
   de Oliveira, DN
   Melo, CFOR
   Morishita, KN
   Sales, GM
   Ruiz, ALTG
   da Silva, GG
   Lancellotti, M
   Catharino, RR
AF Delafiori, Jeany
   Lima, Estela de Oliveira
   Dabaja, Mohamed Ziad
   Dias-Audibert, Flavia Luisa
   de Oliveira, Diogo Noin
   Rodrigues Melo, Carlos Fernando Odir
   Morishita, Karen Noda
   Sales, Geovana Manzan
   Tasca Gois Ruiz, Ana Lucia
   da Silva, Gisele Goulart
   Lancellotti, Marcelo
   Catharino, Rodrigo Ramos
TI Molecular signatures associated with prostate cancer cell line (PC-3)
   exposure to inactivated Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NRF2; METHYLTRANSFERASE; GLYCOSYLATION; REPLICATION; PROGRESSION;
   MODULATION; MECHANISMS; PREVENTION; INFECTION; PROTEINS
AB The recent outbreak of Zika virus (ZIKV) infection associated with microcephaly cases has elicited much research on the mechanisms involved in ZIKV-host cell interactions. It has been described that Zika virus impairs cell growth, raising a hypothesis about its oncolytic potential against cancer cells. ZIKV tumor cell growth inhibition was later confirmed for glioblastoma. It was also demonstrated that an inactivated ZIKV prototype (ZVp) based on bacterial outer membrane vesicles has antiproliferative activity upon other cancer cell lines, such as PC-3 prostate cancer cell. This study aims at understanding the pathways that might be involved with the antiproliferative effect of Zika virus against prostate cancer cells. A metabolomic approach based on high-resolution mass spectrometry analysis led to the identification of 21 statistically relevant markers of PC-3 cells treated with ZVp. The markers were associated with metabolic alterations that trigger lipid remodeling, endoplasmic reticulum stress, inflammatory mediators, as well as disrupted porphyrin and folate metabolism. These findings highlight molecular signatures of ZVp-induced response that may be involved on cellular pathways triggered by its antiproliferative effect. To our knowledge, this is the first reported metabolomic assessment of ZIKV effect on prostate cancer cells, a promising topic for further research.
C1 [Delafiori, Jeany; Dabaja, Mohamed Ziad; Dias-Audibert, Flavia Luisa; de Oliveira, Diogo Noin; Rodrigues Melo, Carlos Fernando Odir; Morishita, Karen Noda; Sales, Geovana Manzan; Catharino, Rodrigo Ramos] Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, UNICAMP, Campinas, SP, Brazil.
   [Lima, Estela de Oliveira] Sao Paulo State Univ UNESP, Med Sch, Botucatu, SP, Brazil.
   [Tasca Gois Ruiz, Ana Lucia] Univ Estadual Campinas, Sch Pharmaceut Sci, UNICAMP, Campinas, SP, Brazil.
   [Tasca Gois Ruiz, Ana Lucia; da Silva, Gisele Goulart] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, UNICAMP, Piracicaba, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, Sch Pharmaceut Sci, Lab Biotechnol, UNICAMP, Campinas, SP, Brazil.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, UNICAMP, Campinas, SP, Brazil.
EM rodrigo.catharino@fcf.unicamp.br
RI Lima, Estela/W-5105-2019; Ruiz, Ana Lucia Tasca Gois/C-2249-2012; de
   Oliveira, Diogo Noin/C-3939-2013
OI Lima, Estela/0000-0003-0479-0364; Ruiz, Ana Lucia Tasca
   Gois/0000-0002-0844-8702; de Oliveira, Diogo Noin/0000-0002-2725-476X;
   Melo, Carlos/0000-0003-0334-1065
FU OCRC (Obesity Comorbidities Research Center) CEPID: CMPO - Centro
   Multidisciplinar de Pesquisa em Obesidade e Doencas Associadas (FAPESP)
   [13/07607-8]; Coordination for the Improvement of Higher Education
   Personnel (CAPES)CAPES [88882.305824/2013-01]; National Council for
   Scientific and Technological Development (CNPQ)National Council for
   Scientific and Technological Development (CNPq) [141200/2018-9,
   1578388]; Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2016/17066-2, 2018/14657-5]
FX This work was supported by the OCRC (Obesity Comorbidities Research
   Center) CEPID: CMPO - Centro Multidisciplinar de Pesquisa em Obesidade e
   Doencas Associadas (FAPESP number: 13/07607-8). The members of Innovare
   Biomarkers Laboratory would like to thank Professor Edson Durigon for
   providing the ZIKV strain. This research was funded by Coordination for
   the Improvement of Higher Education Personnel (CAPES) for the fellowship
   granted for DO (PNPD No. 88882.305824/2013-01) and scholarships of JD
   and MD; by the National Council for Scientific and Technological
   Development (CNPQ) grant numbers 141200/2018-9 and 1578388 (PNPD) for
   FD-A and EL fellowship, respectively; and by the Sao Paulo Research
   Foundation (FAPESP) grant number 2016/17066-2 for CM fellowship and
   2018/14657-5 for research funding.
CR Alves D, 2013, J VACCINES VACCIN, DOI [10.4172/2157-7560.1000196, DOI 10.4172/2157-7560.1000196]
   Arboleda G, 2009, BRAIN RES REV, V59, P333, DOI 10.1016/j.brainresrev.2008.10.001
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brys M, 2013, MOL CELL BIOCHEM, V372, P149, DOI 10.1007/s11010-012-1455-z
   Bylund J, 2000, CYTOCHROME P450 ENZY
   Chen HX, 2016, FRONT BIOSCI-LANDMRK, V21, P1084
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Dabaja MZ, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0243-1
   Dando I, 2019, BIOL REV, V94, P1530, DOI 10.1111/brv.12513
   Dean Wendy, 2005, Birth Defects Res C Embryo Today, V75, P98, DOI 10.1002/bdrc.20037
   El Kalamouni C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010002
   Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79
   GOTTLIEB C, 1988, FERTIL STERIL, V49, P322
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heger Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep33379
   Jadoon S, 2018, BIOCH PHARM ANGEL, V7, P2, DOI [10.4172/2167-0501.1000246, DOI 10.4172/2167-0501.1000246]
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Jayakumar S, 2014, BBA-GEN SUBJECTS, V1840, P485, DOI 10.1016/j.bbagen.2013.10.006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x
   Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kurosu M, 2018, J MOL PHARM ORGANIC, V6, DOI [10.4172/2329-9053.1000141, DOI 10.4172/2329-9053.1000141]
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Leier HC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lima ED, 2018, J MASS SPECTROM, V53, P257, DOI 10.1002/jms.4058
   Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y
   Majumdar S, 2011, CURR GENOMICS, V12, P486, DOI 10.2174/138920211797904061
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martins P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26508-z
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02373
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Milkovic L, 2017, REDOX BIOL, V12, P727, DOI 10.1016/j.redox.2017.04.013
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Moon EJ, 2015, FREE RADICAL BIO MED, V79, P292, DOI 10.1016/j.freeradbiomed.2014.11.009
   Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197
   Nakano T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198345
   No Jae Hong, 2014, J Cancer Prev, V19, P111, DOI 10.15430/JCP.2014.19.2.111
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Paschos A, 2013, PROSTATE CANCER P D, V16, P217, DOI 10.1038/pcan.2013.13
   Perez-Garcia LA, 2017, CURR PROTEIN PEPT SC, V18, P1090, DOI 10.2174/1389203717666160813161729
   Rockenfeller P, 2015, CELL DEATH DIFFER, V22, P499, DOI 10.1038/cdd.2014.219
   Roman WA, 2017, REV BRAS FARMACOGN, V27, P592, DOI 10.1016/j.bjp.2017.05.007
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Song YH, 2011, MODERN PATHOL, V24, P1272, DOI 10.1038/modpathol.2011.76
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Strating JRPM, 2017, CURR OPIN CELL BIOL, V47, P24, DOI 10.1016/j.ceb.2017.02.005
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073
   Xu Yi, 2014, Biomed J, V37, P112, DOI 10.4103/2319-4170.131378
   Yang X, 2015, INT J MOL SCI, V16, P25865, DOI 10.3390/ijms161025865
   Yu SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008579
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   2008, VITAM HORM, V79, P1
NR 63
TC 0
Z9 0
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 25
PY 2019
VL 9
AR 15351
DI 10.1038/s41598-019-51954-8
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JH5RK
UT WOS:000492825800061
PM 31653965
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Chase, C
   Vasquez, C
   Carvajal, A
   Medina, J
   Petrie, WD
   Beier, JC
AF Wilke, Andre B. B.
   Chase, Catherine
   Vasquez, Chalmers
   Carvajal, Augusto
   Medina, Johana
   Petrie, William D.
   Beier, John C.
TI Urbanization creates diverse aquatic habitats for immature mosquitoes in
   urban areas
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AUTOCHTHONOUS DENGUE-FEVER; AEDES-AEGYPTI; ZIKA VIRUS; FLORIDA;
   TRANSMISSION; HISTORY
AB Global increases in temperatures and urbanization are impacting the epidemiology of mosquito-borne diseases. Urbanization processes create suitable habitats for vector mosquitoes in which there are a reduced number of predators, and human hosts are widely available. We hypothesize that mosquito vector species, especially Aedes aegypti, are locally concentrated primarily in those specific habitats at the neighborhood levels that provide suitable conditions and environmental resources needed for mosquito survival. Determining how mosquito vector species composition and abundance depend on environmental resources across habitats addresses where different types of vector control need to be applied. Therefore, our goal was to analyze and identify the most productive aquatic habitats for mosquitoes in Miami-Dade County, Florida. Immature mosquito surveys were conducted throughout Miami-Dade County from April 2018 to June 2019, totaling 2,488 inspections. Mosquitoes were collected in 76 different types of aquatic habitats scattered throughout 141 neighborhoods located in the urbanized areas of Miami-Dade County. A total of 44,599 immature mosquitoes were collected and Ae. aegypti was the most common and abundant species, comprising 43% of all specimens collected. Aedes aegypti was primarily found in buckets, bromeliads, and flower pots, concentrated in specific neighborhoods. Our results showed that aquatic habitats created by anthropogenic land-use modifications (e.g., ornamental bromeliads, buckets, etc.) were positively correlated with the abundance of Ae. aegypti. This study serves to identify how vector mosquitoes utilize the resources available in urban environments and to determine the exact role of these specific urban features in supporting populations of vector mosquito species. Ultimately, the identification of modifiable urban features will allow the development of targeted mosquito control strategies optimized to preventatively control vector mosquitoes in urban areas.
C1 [Wilke, Andre B. B.; Chase, Catherine; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Vasquez, Chalmers; Carvajal, Augusto; Medina, Johana; Petrie, William D.] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [1U01CK00051003]
FX We would like to thank the staff of Miami-Dade County Mosquito Control
   Division for their help with field collections. We would also like to
   thank the residents of Miami-Dade County that graciously allowed us to
   enter their properties for surveys. This research was supported by CDC
   (https://www.cdc.gov/) grant 1U01CK00051003: Southeastern Regional
   Center of Excellence in Vector-Borne Diseases: The Gateway Program. CDC
   had no role in the design of the study and collection, analysis, and
   interpretation of data and in writing the manuscript.
CR Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Buzas MA, 1998, J FORAMIN RES, V28, P233
   Ceretti W, 2015, J AM MOSQUITO CONTR, V31, P172, DOI 10.2987/14-6457R
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Darsie Jr RF, 2000, KEYS ADULT FEMALES 4, V1
   Gill J, 2000, EMERG INFECT DIS, V6, P30
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Islam S, 2019, ACTA TROP, V193, P50, DOI 10.1016/j.actatropica.2019.02.019
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   POND WL, 1966, AM J TROP MED HYG, V15, P205, DOI 10.4269/ajtmh.1966.15.205
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reba M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.34
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Rochlin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13604
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Troyo A, 2008, J VECTOR ECOL, V33, P76, DOI 10.3376/1081-1710(2008)33[76:SPOAAD]2.0.CO;2
   United States Department of Justice, 2007, BUILD 311 SYST CAS S
   Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2
   Vora Neil, 2008, Medscape J Med, V10, P238
   Wilke ABB, 2019, CURR OPIN INSECT SCI, V35, P1, DOI 10.1016/j.cois.2019.06.002
   Wilke ABB, 2019, TRENDS PARASITOL, V35, P607, DOI 10.1016/j.pt.2019.05.009
   Wilke ABB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45337-2
   Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217177
   Wilke ABB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209625
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   Zohdy S, 2019, TRENDS PARASITOL, V35, P399, DOI 10.1016/j.pt.2019.03.010
NR 40
TC 3
Z9 3
U1 2
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 25
PY 2019
VL 9
AR 15335
DI 10.1038/s41598-019-51787-5
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JH5RK
UT WOS:000492825800045
PM 31653914
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gao, F
   Lin, XH
   He, LL
   Wang, RK
   Wang, H
   Shi, XL
   Zhang, FC
   Yin, CB
   Zhang, LQ
   Zhu, J
   Yu, L
AF Gao, Fei
   Lin, Xiaohe
   He, Linling
   Wang, Ruoke
   Wang, Han
   Shi, Xuanling
   Zhang, Fuchun
   Yin, Chibiao
   Zhang, Linqi
   Zhu, Jiang
   Yu, Lei
TI Development of a Potent and Protective Germline-Like Antibody Lineage
   Against Zika Virus in a Convalescent Human
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus infection; Guillain-Barre syndrome; microcephaly;
   neutralizing antibody; antibody repertoire; next-generation sequencing
ID NEUTRALIZING HUMAN-ANTIBODIES; STRUCTURAL BASIS; HIV-1-NEUTRALIZING
   ANTIBODIES; INFECTION; EMERGENCE; HISTORY; PROTEIN; BRAZIL; MICE
AB Zika virus (ZIKV) specific neutralizing antibodies hold great promise for antibody-based interventions and vaccine design against ZIKV infection. However, their development in infected patients remains unclear. Here, we applied next-generation sequencing (NGS) to probe the dynamic development of a potent and protective ZIKV E DIII-specific antibody ZK2B10 isolated from a ZIKV convalescent individual. The unbiased repertoire analysis showed dramatic changes in the usage of antibody variable region germline genes. However, lineage tracing of ZK2B10 revealed limited somatic hypermutation and transient expansion during the 12 months following the onset of symptoms. The NGS-derived, germline-like ZK2B10 somatic variants neutralized ZIKV potently and protected mice from lethal challenge of ZIKV without detectable cross-reactivity with Dengue virus (DENV). Site-directed mutagenesis identified two residues within the lambda chain, N31 and S91, that are essential to the functional maturation of ZK2B10. The repertoire and lineage features unveiled here will help elucidate the developmental process and protective potential of E DIII-directed antibodies against ZIKV infection.
C1 [Gao, Fei; Wang, Ruoke; Wang, Han; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Sch Med, Beijing Adv Innovat Ctr Struct Biol, Dept Basic Med Sci,Comprehens AIDS Res Ctr, Beijing, Peoples R China.
   [Lin, Xiaohe; He, Linling; Zhu, Jiang] Scripps Res Inst, Dept Immunol & Microbiol, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
   [Zhang, Fuchun; Yin, Chibiao; Yu, Lei] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
RP Zhang, LQ (corresponding author), Tsinghua Univ, Sch Med, Beijing Adv Innovat Ctr Struct Biol, Dept Basic Med Sci,Comprehens AIDS Res Ctr, Beijing, Peoples R China.; Zhu, J (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Yu, L (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
EM zhanglinqi@mail.tsinghua.edu.cn; jiang@scripps.edu; leiyuforngs@126.com
FU National Natural Science Foundation AwardNational Natural Science
   Foundation of China [81530065]; National Science and Technology Major
   Projects [2017ZX10305501-003]; Special Program of Guangdong Provincial
   Department of Science and Technology [2016A020248001]; Guangzhou Health
   Care and Cooperation Innovation Major grant [201704020229]; HIV Vaccine
   Research and Design (HIVRAD) program [P01 AI124337]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI129698, AI140844, AI123861]
FX We are grateful to the ZIKV convalescent patient for donating his blood
   samples from which mAbs were isolated and Drs. Jiang Wang, Wenxin Hong,
   and Lingzhai Zhao for providing the patient with treatment and care. We
   thank Drs. ChengFeng Qin and Gong Cheng for providing the Zika virus
   isolate GZ01 and MR766. We are also grateful for Institute Pasteur of
   Shanghai, Chinese Academy of Sciences for kindly providing AG6 mice.
   This study was funded by the National Natural Science Foundation Award
   (81530065). The project was also supported by the National Science and
   Technology Major Projects (2017ZX10305501-003), the Special Program of
   Guangdong Provincial Department of Science and Technology
   (#2016A020248001), the Guangzhou Health Care and Cooperation Innovation
   Major grant (201704020229). The work related to the NGS analysis of Pt1
   repertoire was funded in part by HIV Vaccine Research and Design
   (HIVRAD) program (P01 AI124337) (to JZ), and NIH Grants AI129698,
   AI140844, and AI123861 (to JZ).
CR ABBASI J, 2016, JAMA-J AM MED ASSOC, V316, P1249, DOI DOI 10.1001/JAMA.2016.19328
   Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Dai KF, 2015, MBIO, V6, DOI 10.1128/mBio.01375-15
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782
   Godoy-Lozano EE, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0276-1
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   He LL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01025
   He LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06778
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Koff WC, 2014, NAT IMMUNOL, V15, P589, DOI 10.1038/ni.2871
   Kong L, 2016, IMMUNITY, V44, P939, DOI 10.1016/j.immuni.2016.03.006
   Krebs SJ, 2019, IMMUNITY, V50, P677, DOI 10.1016/j.immuni.2019.02.008
   Lai HF, 2018, VACCINE, V36, P1846, DOI 10.1016/j.vaccine.2018.02.073
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tzarum N, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1882
   Wang L, 2019, CELL REP, V26, P3360, DOI 10.1016/j.celrep.2019.02.062
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhu J, 2013, P NATL ACAD SCI USA, V110, pE4088, DOI 10.1073/pnas.1306262110
   Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110
   Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315
NR 58
TC 1
Z9 1
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD OCT 24
PY 2019
VL 10
AR 2424
DI 10.3389/fimmu.2019.02424
PG 13
WC Immunology
SC Immunology
GA JO1HT
UT WOS:000497336800001
PM 31708914
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cirne-Santos, CC
   Barros, CD
   Nogueira, CCR
   Azevedo, RC
   Yamamoto, KA
   Meira, GLS
   de Vasconcelos, ZFM
   Ratcliffe, NA
   Teixeira, VL
   Schmidt-Chanasit, J
   Ferreira, DF
   Paixao, LCND
AF Cirne-Santos, Claudio Cesar
   Barros, Caroline de Souza
   Richter Nogueira, Caio Cesar
   Azevedo, Renata Campos
   Yamamoto, Kristie Aimi
   Silva Meira, Guilherme Louzada
   Meira de Vasconcelos, Zilton Farias
   Ratcliffe, Norman Arthur
   Teixeira, Valeria Laneuville
   Schmidt-Chanasit, Jonas
   Ferreira, Davis Fernandes
   Nunes de Palmer Paixao, Lzabel Christina
TI Inhibition by Marine Algae of Chikungunya Virus Isolated From Patients
   in a Recent Disease Outbreak in Rio de Janeiro
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE chikungunya; arbovirus; seaweed; antiviral; crude extracts
ID AVIAN RETINAL NEURONS; ZIKA VIRUS; SURVIVAL; SEAWEED;
   DOLABELLADIENETRIOL; ANTI-HSV-1; ACTIVATION; ANTIVIRALS; EXPRESSION;
   DISCOVERY
AB Chikungunya virus (CHIKV) infection is one of the most challenging re-emergent diseases caused by a virus, and with no specific antiviral treatment it has now become a major public health concern. In this investigation, 25 blood samples were collected from patients with characteristic CHIKV symptoms and submitted to a virus isolation protocol, which detected 3 CHIKV isolates. These samples were evaluated by sequencing for the characterization of the strains and any homology to viruses circulating in Brazil during a recent outbreak. These viruses were used for the development of antiviral assays. Subsequently, the inhibitory effects of seaweed extracts on CHIKV replication were studied. The marine species of algae tested were Bryothamnion triquetrum, Caulerpa racemosa, Laurencia dendroidea, Osmundaria obtusiloba, Ulva fasciata, and Kappaphycus alvarezii, all of which are found in different countries including Brazil. The results revealed high levels of CHIKV inhibition, including extracts of O. obtusiloba with inhibition values of 1.25 mu g/mL and a selectivity index of 420. Viral inhibition was dependent on the time of addition of extract of O. obtusiloba to the infected cells, with the optimal inhibition occurring up to 16 h after infection. Neuron evaluations with O. obtusiloba were performed and demonstrated low toxicity, and in infected neurons we observed high inhibitory activity in a dose-dependent manner. These results indicate that the algal extracts may be promising novel candidates for the development of therapeutic agents against CHIKV infections.
C1 [Cirne-Santos, Claudio Cesar; Barros, Caroline de Souza; Richter Nogueira, Caio Cesar; Nunes de Palmer Paixao, Lzabel Christina] Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, Lab Virol Mol & Biotecnol Marinha,Programa Posgra, Niteroi, RJ, Brazil.
   [Cirne-Santos, Claudio Cesar] Univ Salgado Oiiveira, Curso Farm, Dept Ensino, Niteroi, RJ, Brazil.
   [Richter Nogueira, Caio Cesar; Teixeira, Valeria Laneuville] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Lab Prod Nat Algas Marinhas ALGAMAR, Niteroi, RJ, Brazil.
   [Azevedo, Renata Campos; Yamamoto, Kristie Aimi; Silva Meira, Guilherme Louzada; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes IMPPG, Rio De Janeiro, Brazil.
   [Meira de Vasconcelos, Zilton Farias] Fundacao Oswaido Cruz Fiocruz, IFF, Rio De Janeiro, Brazil.
   [Ratcliffe, Norman Arthur] Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales.
   [Teixeira, Valeria Laneuville] Univ Fed Estado Rio de Janeiro, Inst Biociencias, Programa Posgrad Biodiversidade Neotrop, Lab Biol & Taxon Algas LABIOTAL, Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Ferreira, Davis Fernandes] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RP Paixao, LCND (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, Lab Virol Mol & Biotecnol Marinha,Programa Posgra, Niteroi, RJ, Brazil.; Ferreira, DF (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes IMPPG, Rio De Janeiro, Brazil.; Ferreira, DF (corresponding author), North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
EM davisf@micro.ufrj.br; izabeluff@gmail.com
RI Paixao, Izabel/AAM-1668-2020; Azevedo, Renata/V-3130-2019; Barros,
   Caroline/S-7840-2019
OI Barros, Caroline/0000-0002-4678-3093
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [443930/2014-7, 304070/2014-9]; FAPERJ (Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/201.442/2014]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior)CAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.344/2016];
   postgraduate program in sciences and biotechnology of UFF (PPBI-UFF)
FX The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for financial support and for Productivity
   Fellowships to IP and VT (443930/2014-7 and 304070/2014-9). IP and VT
   (E-26/201.442/2014) also thank the FAPERJ (Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro) for the Cientista do Nosso Estado
   Fellowship. CC-S thanks CAPES (Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior) for the Postdoc fellowship and CB thanks FAPERJ for
   the Postdoc fellowship (E-26/201.344/2016). Support also came from the
   postgraduate program in sciences and biotechnology of UFF (PPBI-UFF).
CR Abdelnabi R, 2015, ANTIVIR RES, V121, P59, DOI 10.1016/j.antiviral.2015.06.017
   ADLER R, 1984, J CELL BIOL, V99, P1173, DOI 10.1083/jcb.99.3.1173
   Ahmadi A, 2016, RSC ADV, V6, P69421, DOI 10.1039/c6ra16640g
   Ahmadi A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825203
   Anccasi RM, 2013, PURINERG SIGNAL, V9, P15, DOI 10.1007/s11302-012-9324-5
   Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606
   Barros CD, 2017, J APPL PHYCOL, V29, P769, DOI 10.1007/s10811-016-0865-9
   Bourjot M, 2012, J NAT PROD, V75, P2183, DOI 10.1021/np300637t
   Brasil, 2018, B EPIDEMIOLOGICO
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Ching KC, 2015, J MED CHEM, V58, P9196, DOI 10.1021/acs.jmedchem.5b01047
   Cirne-Santos Claudio C, 2018, J MED PLANTS RES, V12, P387, DOI [10.5897/JMPR2018.6624, DOI 10.5897/JMPR2018.6624]
   Cirne-Santos CC, 2008, ANTIVIR RES, V77, P64, DOI 10.1016/j.antiviral.2007.08.006
   Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006
   Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI [10.1089/vbz.2006.0648, 10.1089/vbz.2007.7272]
   de Alencar DB, 2016, ASIAN PAC J TROP MED, V9, P363, DOI 10.1016/j.apjtm.2016.03.015
   Carvalho Luciana Retz de, 2006, Braz. J. Bot., V29, P453, DOI 10.1590/S0100-84042006000300012
   De Souza Barros C., 2018, J MED PLANTS RES, V12, P217
   de Souza LM, 2012, MAR DRUGS, V10, P918, DOI 10.3390/md10040918
   Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209
   Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009
   dos Santos AO, 2010, MAR DRUGS, V8, P2733, DOI 10.3390/md8112733
   Ferreira JM, 2001, BRAIN RES, V900, P169, DOI 10.1016/S0006-8993(01)02279-X
   Lira ML, 2016, J APPL PHYCOL, V28, P591, DOI 10.1007/s10811-015-0538-0
   Galabov A. S., 2007, GMS KRANKENHAUSHYG I, V2, P1
   Garrido V, 2017, REGUL TOXICOL PHARM, V86, P193, DOI 10.1016/j.yrtph.2017.03.007
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Lani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11421
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4
   Lu YE, 2000, J VIROL, V74, P7708, DOI 10.1128/JVI.74.17.7708-7719.2000
   Mejia-Garcia TA, 2007, J NEUROCHEM, V100, P382, DOI 10.1111/j.1471-4159.2006.04244.x
   Mejia-Garcia TA, 2013, CELL SIGNAL, V25, P2424, DOI 10.1016/j.cellsig.2013.08.001
   Montagnier L, 2010, VIROLOGY, V397, P248, DOI 10.1016/j.virol.2009.10.045
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Paes-de-Carvalho R, 2003, NEUROCHEM RES, V28, P1583, DOI 10.1023/A:1025686812298
   Perez MJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14030052
   Macedo NRPV, 2012, REV BRAS FARMACOGN, V22, P861, DOI 10.1590/S0102-695X2012005000072
   Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0
   Purpura LJ, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30330-9
   Rocha FD, 2007, PHYTOTHER RES, V21, P170, DOI 10.1002/ptr.2038
   Rothan HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126360
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Sokoloski KJ, 2013, J VIROL, V87, P12216, DOI 10.1128/JVI.02437-13
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tan Y, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006670
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Pinto AMV, 2012, REV BRAS FARMACOGN, V22, P813, DOI 10.1590/S0102-695X2012005000060
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
NR 52
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 24
PY 2019
VL 10
AR 2426
DI 10.3389/fmicb.2019.02426
PG 11
WC Microbiology
SC Microbiology
GA JL2RG
UT WOS:000495378900001
PM 31708898
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chien, LC
   Sy, F
   Perez, A
AF Chien, Lung-Chang
   Sy, Francisco
   Perez, Adriana
TI Identifying high risk areas of Zika virus infection by meteorological
   factors in Colombia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus infection; Meteorological factors; Geographic disparities;
   Colombia
ID STRUCTURED ADDITIVE REGRESSION; AEDES-AEGYPTI; DENGUE-FEVER;
   TEMPERATURE; TRANSMISSION; POPULATION; CLIMATE; DISEASE; VECTOR
AB Background Several Zika virus (ZIKV) outbreaks have occurred since October 2015. Because there is no effective treatment for ZIKV infection, developing an effective surveillance and warning system is currently a high priority to prevent ZIKV infection. Despite Aedes mosquitos having been known to spread ZIKV, the calculation approach is diverse, and only applied to local areas. This study used meteorological measurements to monitor ZIKV infection due to the high correlation between climate change and Aedes mosquitos and the convenience to obtain meteorological data from weather monitoring stations. Methods This study applied the Bayesian structured additive regression modeling approach to include spatial interactive terms with meteorological factors and a geospatial function in a zero-inflated Poisson model. The study area contained 32 administrative departments in Colombia from October 2015 to December 2017. Weekly ZIKV infection cases and daily meteorological measurements were collected. Mapping techniques were adopted to visualize spatial findings. A series of model selections determined the best combinations of meteorological factors in the same model. Results When multiple meteorological factors are considered in the same model, both total rainfall and average temperature can best assess the geographic disparities of ZIKV infection. Meanwhile, a 1-in. increase in rainfall is associated with an increase in the logarithm of relative risk (logRR) of ZIKV infection of at most 1.66 (95% credible interval [CI] = 1.09, 2.15) as well as a 1 degrees F increase in average temperature is significantly associated with at most 0.79 (95% CI = 0.12, 1.22) increase in the logRR of ZIKV. Moreover, after controlling rainfall and average temperature, an independent geospatial function in the model results in two departments with an excessive ZIKV risk which may be explained by unobserved factors other than total rainfall and average temperature. Conclusion Our study found that meteorological factors are significantly associated with ZIKV infection across departments. The study determined both total rainfall and average temperature as the best meteorological factors to identify high risk departments of ZIKV infection. These findings can help governmental agencies monitor at risk areas according to meteorological measurements, and develop preventions in those at risk areas in priority.
C1 [Chien, Lung-Chang; Sy, Francisco] Univ Nevada, Dept Environm & Occupat Hlth, Sch Publ Hlth, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.
   [Perez, Adriana] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, UTHlth, Austin Campus,1616 Guadalupe,Suite 6-300, Austin, TX 78071 USA.
RP Chien, LC (corresponding author), Univ Nevada, Dept Environm & Occupat Hlth, Sch Publ Hlth, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.
EM lung-chang.chien@unlv.edu
OI Chien, Lung-Chang/0000-0003-4515-0080
FU University of Nevada, Las Vegas; University of Texas Health Science
   Center at Houston-UTHealth; Michael & Susan Dell Foundation [8075]
FX The study was supported by the University of Nevada, Las Vegas, the
   University of Texas Health Science Center at Houston-UTHealth, and the
   Michael & Susan Dell Foundation [Grant 8075] during the writing of this
   manuscript. The funding of the three institutes was not involved in the
   design of the study, data collection, data analysis, interpretation, and
   the writing of this manuscript.
CR Martinez-Bello DA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071376
   Aguiar BS, 2018, INT J INFECT DIS, V70, P20, DOI 10.1016/j.ijid.2018.02.007
   Alaniz AJ, 2017, INT J EPIDEMIOL, V46, P966, DOI 10.1093/ije/dyw366
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   [Anonymous], 2011, COMPR GUID PREV CONT
   Asher J., 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barrera R, 2019, MED VET ENTOMOL, V33, P68, DOI 10.1111/mve.12338
   Brezger A, 2005, J STAT SOFTW, V14, P1
   Chien LC, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3085-x
   Darrow W, 2018, HEALTH EDUC BEHAV, V45, P967, DOI 10.1177/1090198118760687
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Development R, 2011, R LANG ENV STAT COMP
   Fahrmeir L, 2004, STAT SINICA, V14, P731
   Fahrmeir L, 2006, APPL STOCH MODEL BUS, V22, P351, DOI 10.1002/asmb.631
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gleiser RM, 2000, MED VET ENTOMOL, V14, P38, DOI 10.1046/j.1365-2915.2000.00217.x
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Harris M, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1578
   Hii Yien Ling, 2016, Curr Environ Health Rep, V3, P81, DOI 10.1007/s40572-016-0078-z
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Jiang D, 2018, ACTA TROP, V185, P391, DOI 10.1016/j.actatropica.2018.06.021
   Kolikonda Murali K, 2017, Innov Clin Neurosci, V14, P11
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   Liang D, 2013, ATMOS ENVIRON, V72, P60, DOI 10.1016/j.atmosenv.2013.02.034
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Nance J, 2018, J VECTOR ECOL, V43, P138, DOI 10.1111/jvec.12293
   Perkin TA, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100357
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Ryan SJ, 2017, EMERG INFECT DIS, V23, P1926, DOI 10.3201/eid2311.171140
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Vasconcelos PFC, 2018, EMERGENCE CHIKUNGUNY, P215
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Weber AV, 2018, PAPERS APPL GEOGR, V4, P100, DOI [10.1080/23754931.2017.1401954, DOI 10.1080/23754931.2017.1401954]
   Wu XC, 2018, SCI TOTAL ENVIRON, V628-629, P766, DOI 10.1016/j.scitotenv.2018.02.136
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yi Bintang, 2003, Wei Sheng Yan Jiu, V32, P152
NR 46
TC 0
Z9 0
U1 2
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 24
PY 2019
VL 19
IS 1
AR 888
DI 10.1186/s12879-019-4499-9
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA JH6DT
UT WOS:000492859100004
PM 31651247
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Harvim, P
   Zhang, H
   Georgescu, P
   Zhang, L
AF Harvim, Prince
   Zhang, Hong
   Georgescu, Paul
   Zhang, Lai
TI Transmission Dynamics and Control Mechanisms of Vector-Borne Diseases
   with Active and Passive Movements Between Urban and Satellite Cities
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Vector-borne disease; Passive mobility; Metapopulation model; Sexual
   transmission; Control mechanism
ID ZIKA VIRUS; SEXUAL TRANSMISSION; MATHEMATICAL-MODEL; MALARIA; INFECTION;
   MOBILITY; SPREAD; SENSITIVITY; STRATEGIES
AB A metapopulation model which explicitly integrates vector-borne and sexual transmission of an epidemic disease with passive and active movements between an urban city and a satellite city is formulated and analysed. The basic reproduction number of the disease is explicitly determined as a combination of sexual and vector-borne transmission parameters. The sensitivity analysis reveals that the disease is primarily transmitted via the vector-borne mode, rather than via sexual transmission, and that sexual transmission by itself may not initiate or sustain an outbreak. Also, increasing the population movements from one city to the other leads to an increase in the basic reproduction number of the later city but a decrease in the basic reproduction number of the former city. The influence of other significant parameters is also investigated via the analysis of suitable partial rank correlation coefficients. After gauging the effects of mobility, we explore the potential effects of optimal control strategies relying upon several distinct restrictions on population movement.
C1 [Harvim, Prince] Jiangsu Univ, Fac Sci, Zhenjiang 212013, Jiangsu, Peoples R China.
   [Zhang, Hong] Changzhou Inst Technol, Sch Econ & Management, Changzhou 213032, Jiangsu, Peoples R China.
   [Georgescu, Paul] Tech Univ Iasi, Dept Math, Bd Copou 11A, Iasi 700506, Romania.
   [Zhang, Lai] Yangzhou Univ, Sch Math Sci, Yangzhou 225002, Jiangsu, Peoples R China.
RP Zhang, L (corresponding author), Yangzhou Univ, Sch Math Sci, Yangzhou 225002, Jiangsu, Peoples R China.
EM princeharvim@yahoo.com; zhanghong2018@czu.cn; v.p.georgescu@gmail.com;
   lai.zhang@yzu.edu.cn
RI Georgescu, Paul/N-7082-2017
OI Georgescu, Paul/0000-0002-7302-2070
FU PRC Grant NSFC [11571301, 11871065]; NSF of Jiangsu Province
   [BK20181450]; Jiangsu Distinguished Professor Program; Yangzhou Talent
   Program 'LvYangJinFeng'
FX L.Z. acknowledges the financial support by the PRC Grant NSFC (11571301,
   11871065), the NSF of Jiangsu Province (BK20181450), the Jiangsu
   Distinguished Professor Program, and the Yangzhou Talent Program
   'LvYangJinFeng'.
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   ARINO J., 2003, MATH POPUL STUD, V10, P175, DOI DOI 10.1080/08898480306720
   Arino J, 2016, MATH MED BIOL, V33, P29, DOI 10.1093/imammb/dqv001
   Arino J, 2015, J MATH BIOL, V71, P1243, DOI 10.1007/s00285-014-0854-z
   Baker MG, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2424
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Blayneh K, 2009, DISCRETE CONT DYN-B, V11, P587, DOI 10.3934/dcdsb.2009.11.587
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Cai LM, 2017, MATH BIOSCI, V288, P94, DOI 10.1016/j.mbs.2017.03.003
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941
   Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013
   Dhirasakdanon Thanate, 2007, J Biol Dyn, V1, P363, DOI 10.1080/17513750701605465
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Furuya Hiroyuki, 2007, Environmental Health and Preventive Medicine, V12, P78, DOI 10.1007/BF02898153
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   HETHCOTE HW, 1978, THEOR POPUL BIOL, V14, P338, DOI 10.1016/0040-5809(78)90011-4
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501
   Knipl D, 2016, ELECTRON J QUAL THEO, DOI 10.14232/ejqtde.2016.1.74
   LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237
   Lima A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10650
   MacPherson DW, 2007, B WORLD HEALTH ORGAN, V85, P200, DOI 10.2471/BLT.06.036962
   Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448
   Majumder M, 2016, B WORLD HEALTH ORGAN, V9, pBLT16171009
   Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8
   Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Njagarah JBH, 2014, APPL MATH COMPUT, V241, P317, DOI 10.1016/j.amc.2014.05.036
   Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
   Rodrigues HS, 2014, MATH BIOSCI, V247, P1, DOI 10.1016/j.mbs.2013.10.006
   SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B
   Shen MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15818
   Stefanescu R, 2012, NUMER FUNC ANAL OPT, V33, P661, DOI 10.1080/01630563.2012.660591
   Thieme H.R., 2003, MATH POPULATION BIOL
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   World Health Organization, 2016, TECH REP
   Zhang H, 2017, J BIOL SYST, V25, P625, DOI 10.1142/S0218339017400058
NR 48
TC 0
Z9 0
U1 2
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD NOV
PY 2019
VL 81
IS 11
SI SI
BP 4518
EP 4563
DI 10.1007/s11538-019-00671-4
EA OCT 2019
PG 46
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA JU1PV
UT WOS:000494191800001
PM 31641984
DA 2020-07-08
ER

PT J
AU Zhu, XL
   Hu, CHT
   Yang, JX
   Joyce, LA
   Qiu, MD
   Ward, MD
   Kahr, B
AF Zhu, Xiaolong
   Hu, Chunhua T.
   Yang, Jingxiang
   Joyce, Leo A.
   Qiu, Mengdi
   Ward, Michael D.
   Kahr, Bart
TI Manipulating Solid Forms of Contact Insecticides for Infectious Disease
   Prevention
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID BETA-HEMATIN; MALARIA PIGMENT; ZIKA VIRUS; INHIBITORS; LETHALITY;
   QUINOLINE; DDT
AB Malaria control is under threat by the development of vector resistance to pyrethroids in long-lasting insecticidal nets, which has prompted calls for a return to the notorious crystalline contact insecticide DDT. A faster acting difluoro congener, DFDT, was developed in Germany during World War II, but in 1945 Allied inspectors dismissed its superior performance and reduced toxicity to mammals. It vanished from public health considerations. Herein, we report the discovery of amorphous and crystalline forms of DFDT and a mono-fluorinated chiral congener, MFDT. These solid forms were evaluated against Drosophila as well as Anopheles and Aedes mosquitoes, the former identified as disease vectors for malaria and the latter for Zika, yellow fever, dengue, and chikungunya. Contact insecticides are transmitted to the insect when its feet contact the solid surface of the insecticide, resulting in absorption of the active agent. Crystalline DFDT and MFDT were much faster killers than DDT, and their amorphous forms were even faster. The speed of action (a.k.a. knockdown time), which is critical to mitigating vector resistance, depends inversely on the thermodynamic stability of the solid form. Furthermore, one enantiomer of the chiral MFDT exhibits faster knockdown speeds than the other, demonstrating chiral discrimination during the uptake of the insecticide or when binding at the sodium channel, the presumed destination of the neurotoxin. These observations demonstrate an unambiguous link between thermodynamic stability and knockdown time for important disease vectors, suggesting that manipulation of the solid-state chemistry of contact insecticides, demonstrated here for DFDT and MFDT, is a viable strategy for mitigating insect-borne diseases, with an accompanying benefit of reducing environmental impact.
C1 [Zhu, Xiaolong; Hu, Chunhua T.; Yang, Jingxiang; Qiu, Mengdi; Ward, Michael D.; Kahr, Bart] NYU, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA.
   [Zhu, Xiaolong; Hu, Chunhua T.; Yang, Jingxiang; Qiu, Mengdi; Ward, Michael D.; Kahr, Bart] NYU, Mol Design Inst, 100 Washington Sq East, New York, NY 10003 USA.
   [Joyce, Leo A.] Merck & Co Inc, Dept Proc Res & Dev, Rahway, NJ 07065 USA.
RP Ward, MD; Kahr, B (corresponding author), NYU, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA.; Ward, MD; Kahr, B (corresponding author), NYU, Mol Design Inst, 100 Washington Sq East, New York, NY 10003 USA.
EM mdw3@nyu.edu; bart.kahr@nyu.edu
OI Yang, Jingxiang/0000-0002-0859-6668
FU New York University Materials Research Science and Engineering Center
   (MRSEC) program of the National Science Foundation [DMR-1420073];
   NSFNational Science Foundation (NSF) [CRIF/CHE-0840277]
FX This work was primarily supported by the New York University Materials
   Research Science and Engineering Center (MRSEC) program of the National
   Science Foundation under award number DMR-1420073. The NYU X-ray
   facility is supported partially by the NSF under Award Number
   CRIF/CHE-0840277.
CR [Anonymous], 2019, GUID MAL VECT CONTR
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Bohle DS, 1998, J AM CHEM SOC, V120, P8255, DOI 10.1021/ja980962u
   Brooks G. T, 1974, CHLORINATED INSECTIC, VI
   Cantillana T, 2009, CHEMOSPHERE, V76, P805, DOI 10.1016/j.chemosphere.2009.04.042
   CARSON R., 1962, SILENT SPRING
   Curtis F. J, 1945, PHARM INSECTICIDES I
   Fitzroy SM, 2017, LANGMUIR, V33, P7529, DOI 10.1021/acs.langmuir.7b01132
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hall S. A., 1945, INSECTICIDES INSECT
   Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   Kilgore L. B., 1945, SOAP, V21, P138
   Kinkela David, 2011, DDT AM CENTURY GLOBA
   Li H, 2014, J AM CHEM SOC, V136, P13562, DOI 10.1021/ja507692y
   LINDQUIST AW, 1946, J ECON ENTOMOL, V39, P55, DOI 10.1093/jee/39.1.55
   Lozano-Fuentes S, 2012, J AM MOSQUITO CONTR, V28, P59, DOI 10.2987/11-6192.1
   Mandavilli A, 2006, NATURE, V443, P250, DOI 10.1038/443250b
   MATSUBARA H, 1967, AGR BIOL CHEM TOKYO, V31, P1130, DOI 10.1080/00021369.1967.10858953
   METCALF RL, 1948, J ECON ENTOMOL, V41, P416, DOI 10.1093/jee/41.3.416
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Nobel Foundation, 1964, NOB LECT PHYSL MED 1
   Olafson KN, 2018, ACS APPL MATER INTER, V10, P29288, DOI 10.1021/acsami.8b08579
   Olafson KN, 2017, P NATL ACAD SCI USA, V114, P7531, DOI 10.1073/pnas.1700125114
   Perryman MS, 2013, CHEM COMMUN, V49, P10022, DOI 10.1039/c3cc46070c
   Riemschneider R., 1947, SUDDEUTSCHE APOTHEKE, V87, P62
   Simmons J. S, 1945, SATURDAY EVENING POS, V217, P18
   Simon C, 1999, DDT KULTURGESCHICHTE
   Smol JP, 2012, NATURE, V483, pS12, DOI 10.1038/483S12a
   Solomonov I, 2007, J AM CHEM SOC, V129, P2615, DOI 10.1021/ja0674183
   Sumerford W. T, 1950, AGR CONTROL CHEM, P160
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   Tyler PC, 2007, J AM CHEM SOC, V129, P6872, DOI 10.1021/ja0708363
   World Health Organization, 2015, IND RES SPRAYING OP
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Health Organization (WHO), 2008, GLOB MAL CONTR EL RE
   Yang JX, 2019, CRYST GROWTH DES, V19, P1839, DOI 10.1021/acs.cgd.8b01800
   Yang JX, 2017, ANGEW CHEM INT EDIT, V56, P10165, DOI 10.1002/anie.201703028
   Yoo E, 2018, J AM CHEM SOC, V140, P11424, DOI 10.1021/jacs.8b06656
   Zhao YY, 2013, J AM CHEM SOC, V135, P12940, DOI 10.1021/ja4058635
NR 40
TC 1
Z9 1
U1 6
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD OCT 23
PY 2019
VL 141
IS 42
BP 16858
EP 16864
DI 10.1021/jacs.9b08125
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA JH5HU
UT WOS:000492800500040
PM 31601104
DA 2020-07-08
ER

PT J
AU Chien, YW
   Ho, TC
   Huang, PW
   Ko, NY
   Ko, WC
   Perng, GC
AF Chien, Yu-Wen
   Ho, Tzu-Chuan
   Huang, Pei-Wen
   Ko, Nai-Ying
   Ko, Wen-Chien
   Perng, Guey Chuen
TI Low seroprevalence of Zika virus infection among adults in Southern
   Taiwan
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Seroprevalence; Neutralization tests; Plaque reduction
   neutralization tests; Flaviviruses
ID PREGNANT-WOMEN; AEDES-AEGYPTI
AB Background We recently conducted a serosurvey of newly arrived workers in Taiwan from four Southeast Asian countries which revealed that 1% of the migrant workers had laboratory-confirmed recent Zika virus (ZIKV) infection. Taiwan, where Aedes mosquitoes are prevalent, has a close relationship with Southeast Asian countries. Up to now, 21 imported cases of ZIKV infection have been reported in Taiwan, but there has been no confirmed indigenous case. The aim of this serosurvey was to assess whether there was unrecognized ZIKV infections in Taiwan. Methods A total of 212 serum samples collected in a cross-sectional seroepidemiologic study conducted during the end of the 2015 dengue epidemic in Tainan, Taiwan, were analyzed. Anti-ZIKV IgM and IgG were tested using commercial enzyme-linked immunosorbent assays (ELISAs). Plaque reduction neutralization tests (PRNTs) for ZIKV and four dengue virus (DENV) serotypes were performed for samples with positive anti-ZIKV antibodies. A confirmed case of ZIKV infection was defined by ZIKV PRNT90 titer ratio >= 4 compared to four DENV serotypes. Results The mean age of the 212 participants was 54.0 years (standard deviation 13.7 years), and female was predominant (67.0%). Anti-ZIKV IgM and IgG were detected in 0 (0%) and 9 (4.2%) of the 212 participants, respectively. For the 9 samples with anti-ZIKV IgG, only 1 sample had 4 times higher ZIKV PRNT90 titers compared to PRNT90 titers against four dengue virus serotypes; this individual denied having traveled abroad. Conclusions The results suggest that undetected indigenous ZIKV transmission might have occurred in Taiwan. The findings also suggest that the threat of epidemic transmission of ZIKV in Taiwan does exist due to extremely low-level of herd immunity. Our study also indicates that serological tests for ZIKV-specific IgG remain a big challenge due to cross-reactivity, even in dengue non-endemic countries.
C1 [Chien, Yu-Wen; Huang, Pei-Wen] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan.
   [Chien, Yu-Wen] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Coll Med, Tainan, Taiwan.
   [Ho, Tzu-Chuan; Perng, Guey Chuen] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan.
   [Ko, Nai-Ying] Natl Cheng Kung Univ, Dept Nursing, Coll Med, Tainan, Taiwan.
   [Ko, Wen-Chien] Natl Cheng Kung Univ, Dept Med, Coll Med, Tainan, Taiwan.
   [Perng, Guey Chuen] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan.
   [Perng, Guey Chuen] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan, Taiwan.
RP Perng, GC (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan.; Perng, GC (corresponding author), Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan.
EM gperng@mail.ncku.edu.tw
OI Perng, Oscar/0000-0001-7510-4486
FU Taiwan's National Health Research Institutes [NHRI-106A1-MRCO-0517171];
   Ministry of Health and WelfareMinistry of Health, Labour and Welfare,
   Japan [MOHW104-CDC-C-114-114901-H105002]; Taiwan Ministry of Science and
   Technology [MOST 106-2320-B-006-036, MOST-105-2321-B-006 -024]
FX This work was supported by Taiwan's National Health Research Institutes
   (grant no. NHRI-106A1-MRCO-0517171[YWC]); Ministry of Health and Welfare
   (MOHW104-CDC-C-114-114901-H105002 [GCP]); and Taiwan Ministry of Science
   and Technology (MOST 106-2320-B-006-036 [YWC] and MOST-105-2321-B-006
   -024 -[GCP]). The funding bodies did not have any role in the design of
   the study or sample collection, analysis, or interpretation of data or
   in writing the manuscript.
CR Alayed MS, 2018, ANN SAUDI MED, V38, P408, DOI 10.5144/0256-4947.2018.408
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Chepkorir E, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1176-y
   Chien YW, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3946-y
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Kao JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160230
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Langerak T, 2019, J INFECT DIS, V220, P28, DOI 10.1093/infdis/jiz063
   Lee CYP, 2018, MICROBES INFECT, V20, P635, DOI 10.1016/j.micinf.2018.02.009
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mathe P, 2018, J CLIN VIROL, V105, P35, DOI 10.1016/j.jcv.2018.05.011
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   Perng GC, 2019, EMERG INFECT DIS, V25, P814, DOI 10.3201/eid2504.181449
   Rainwater-Lovett K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-233
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Seruyange E, 2018, J MED VIROL, V90, P1290, DOI 10.1002/jmv.25198
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Ward MJ, 2018, AM J TROP MED HYG, V99, P780, DOI 10.4269/ajtmh.18-0237
   Yang CF, 2014, ACTA TROP, V130, P17, DOI 10.1016/j.actatropica.2013.10.013
NR 37
TC 1
Z9 1
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 23
PY 2019
VL 19
IS 1
AR 884
DI 10.1186/s12879-019-4491-4
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA JG8RI
UT WOS:000492344800002
PM 31646973
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ho, YJ
   Lu, JW
   Huang, YL
   Lai, ZZ
AF Ho, Yi-Jung
   Lu, Jeng-Wei
   Huang, Yu-Ling
   Lai, Zheng-Zong
TI Palmatine inhibits Zika virus infection by disrupting virus binding,
   entry, and stability
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Antiviral; Zika virus; Palmatine; Entry; Stability
ID NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; IDENTIFICATION
AB Zika virus (ZIKV) is an emerging vector-borne virus that is associated with severe congenital cerebral anomalies in fetuses and paralytic Guillain-Barre syndrome in adults. In the current global health crisis, there are no vaccines or therapeutics available for the treatment of ZIKV infection. In the present study, we evaluated the efficacy of the protoberberine alkaloid, palmatine, in inhibiting ZIKV and Japanese encephalitis virus (JEV). Palmatine was shown to bind to restricted viruses, inhibit ZIKV infection, and resist ZIKV-induced cytopathic effects. Palmatine was also shown to inhibit JEV infection in multiple cell lines. Overall, the effects of palmatine in disrupting ZIKV binding, entry, and stability indicate that this small molecule would be a good starting point for the development of treatments aimed at inhibiting ZIKV infection. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Ho, Yi-Jung] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.
   [Ho, Yi-Jung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.
   [Lu, Jeng-Wei] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
   [Huang, Yu-Ling] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan.
   [Lai, Zheng-Zong] Natl Def Med Ctr, Dept & Grad Inst Pharmacol, Taipei, Taiwan.
   [Lai, Zheng-Zong] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pharm Practice, Taipei, Taiwan.
   [Lai, Zheng-Zong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.
RP Lai, ZZ (corresponding author), Natl Def Med Ctr, Dept & Grad Inst Pharmacol, Taipei, Taiwan.
EM laizengzong@gmail.com
FU Ministry of Science and Technology [MOST 107-2320-B-016-006-, MOST
   108-2320-B-016 -011 -MY2]; Ministry of National Defense at Taiwan
   [MAB-108-061]
FX The authors' work was supported in part by grants from the Ministry of
   Science and Technology (MOST 107-2320-B-016-006-and MOST 108-2320-B-016
   -011 -MY2), and the grants from Ministry of National Defense
   (MAB-108-061) at Taiwan.
CR AVILAPEREZ G, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10110597
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baz M, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030101
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Chang YL, 1999, LIFE SCI, V64, P597, DOI 10.1016/S0024-3205(98)00602-X
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gao YH, 2019, J PHARMACEUT BIOMED, V174, P123, DOI 10.1016/j.jpba.2019.05.045
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Ho YJ, 2018, ANTIVIR RES, V159, P134, DOI 10.1016/j.antiviral.2018.10.005
   Ho YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133511
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jia F, 2010, ARCH VIROL, V155, P1325, DOI 10.1007/s00705-010-0702-4
   Jung J, 2014, TOX RESEARCH, V30, P45, DOI 10.5487/TR.2014.30.1.045
   Kim YM, 2009, FOOD CHEM TOXICOL, V47, P2097, DOI 10.1016/j.fct.2009.05.031
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar P, 2018, BIOCHIMIE, V147, P153, DOI 10.1016/j.biochi.2018.02.002
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Liu YY, 2019, PSYCHOPHARMACOLOGY, V236, P3169, DOI 10.1007/s00213-019-05275-3
   Lu JW, 2017, BIOCHEM BIOPH RES CO, V491, P595, DOI 10.1016/j.bbrc.2017.07.157
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Saiz J.C., 2017, ANTIMICROB AGENTS CH, V61
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tan HL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00362
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   Wang HJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24142638
   Wu J, 2016, PHOTODIAGN PHOTODYN, V15, P133, DOI 10.1016/j.pdpdt.2016.07.006
   Xiao CW, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0680-x
   Xin AY, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4292
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 46
TC 4
Z9 4
U1 1
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 22
PY 2019
VL 518
IS 4
BP 732
EP 738
DI 10.1016/j.bbrc.2019.08.120
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KB3MD
UT WOS:000506403000019
PM 31472967
DA 2020-07-08
ER

PT J
AU Krasnow, MR
   Maldonado, YA
   Contopoulos-Ioannidis, DG
AF Krasnow, Maya R.
   Maldonado, Yvonne A.
   Contopoulos-Ioannidis, Despina G.
TI Congenital microcephaly hospitalizations in California infants:
   1999-2013
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE congenital microcephaly; incidence risk; Electronic Health Record data;
   ICD9 diagnosis code
ID ZIKA VIRUS; PREVALENCE
AB IntroductionPopulation-level changes in microcephaly incidence risk (IR) could signal circulation of neurotropic pathogens or potential emerging teratogen exposure.
   MethodsIn this retrospective population cohort study, we estimated the IR of hospitalizations with a microcephaly ICD-9-CM discharge diagnosis code among infants <= 1 year over a 15-year period (1999-2013) using the Electronic Health Record (EHR) database from all hospital discharges in California from the Office of Statewide Hospital Planning and Development (OSHPD) database. We calculated the overall and yearly IRs per 10,000 live births (LBs) and per 10,000 hospitalizations in infants <= 1 year, and explored the impact in the IR estimates when children with microcephaly associated comorbidities were excluded or not.
   ResultsAmong 8,860,153 hospital discharges of infants <= 1 year in the OSHPD database over this 15year period, we identified 6,004 hospitalizations with a microcephaly discharge diagnosis code; 3,526 of those were in neonates <= 30days. The IR of microcephaly hospitalizations for infants <= 1 year was 7.70/10,000 LB (for neonates it was 4.52/10,000 LB) and 6.78 per 10,000 hospitalizations <= 1 year. There was large heterogeneity in the yearly microcephaly IRs (I-2 =66.6%).
   DiscussionEHR collected data could be used as a complementary approach to track epidemiologic changes in microcephaly IRs. However, standardization in the use of microcephaly discharge diagnosis code and harmonization in the types of additional comorbidities to be excluded across analyses is mandatory to allow for prompt identification of true changes in microcephaly rates over time.
C1 [Krasnow, Maya R.; Maldonado, Yvonne A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA.
   [Maldonado, Yvonne A.; Contopoulos-Ioannidis, Despina G.] Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Room G312,300 Pasteur Dr, Stanford, CA 94305 USA.
RP Contopoulos-Ioannidis, DG (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Room G312,300 Pasteur Dr, Stanford, CA 94305 USA.
EM dcontop@stanford.edu
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   California Department of Public Health, 2018, CDPH MONTHL UPD NUMB, DOI 10.1007/s13665-018-0210-7
   California Department of Public Health, 2017, AED AEG AED ALB MOSQ
   Centers for Disease Control and Prevention, 2019, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2018, DAT STAT BIRTH DEF
   Centers for Disease Control and Prevention, 2019, DAT STAT ZIK PREGN
   Centers for Disease Control and Prevention, 2018, EST POT RANG AED AEG
   Centers for Disease Control and Prevention, 2017, BIRTHW GEST
   Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities, 2013, MAJ BIRTH DEF DAT PO
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   European Centre for Disease Prevention and Control, 2019, ZIK VIR TRANSM WORLD, DOI 10.1002/jts.22439
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Hansen M, 2017, MED J AUSTRALIA, V206, P351, DOI 10.5694/mja16.00966
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   National Birth Defects Prevention Network, 2016, GUIDELINES CONDUCTIN
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Steele A, 2016, BIRTH DEFECTS RES A, V106, P983, DOI 10.1002/bdra.23593
   WHO, 2016, SCREEN ASS MAN NEON
NR 22
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD NOV 15
PY 2019
VL 111
IS 19
BP 1535
EP 1542
DI 10.1002/bdr2.1604
EA OCT 2019
PG 8
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA JM8RZ
UT WOS:000494229900001
PM 31639287
DA 2020-07-08
ER

PT J
AU Bellmann, J
   Monette, A
   Tripathy, V
   Sojka, A
   Abo-Rady, M
   Janosh, A
   Bhatnagar, R
   Bickle, M
   Mouland, AJ
   Sterneckert, J
AF Bellmann, Jessica
   Monette, Anne
   Tripathy, Vadreenath
   Sojka, Anna
   Abo-Rady, Masin
   Janosh, Antje
   Bhatnagar, Rajat
   Bickle, Marc
   Mouland, Andrew J.
   Sterneckert, Jared
TI Viral Infections Exacerbate FUS-ALS Phenotypes in iPSC-Derived Spinal
   Neurons in a Virus Species-Specific Manner
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Article
DE amyotrophic lateral sclerosis; induced pluripotent stem cells; FUS;
   rabies virus; HIV-1; Zika virus
ID AMYOTROPHIC-LATERAL-SCLEROSIS; REVERSE-TRANSCRIPTASE ACTIVITY;
   POLYMERASE-CHAIN-REACTION; STRESS GRANULES; HIV-1; RNA; CORD;
   QUANTIFICATION; AGGREGATION; SEQUENCES
AB Amyotrophic lateral sclerosis (ALS) arises from an interplay of genetic mutations and environmental factors. ssRNA viruses are possible ALS risk factors, but testing their interaction with mutations such as in FUS, which encodes an RNA-binding protein, has been difficult due to the lack of a human disease model. Here, we use isogenic induced pluripotent stem cell (iPSC)-derived spinal neurons (SNs) to investigate the interaction between ssRNA viruses and mutant FUS. We find that rabies virus (RABV) spreads ALS phenotypes, including the formation of stress granules (SGs) with aberrant composition due to increased levels of FUS protein, as well as neurodegeneration and reduced restriction activity by FUS mutations. Consistent with this, iPSC-derived SNs harboring mutant FUS are more sensitive to human immunodeficiency virus (HIV-1) and Zika viruses (ZIKV). We demonstrate that RABV and HIV-1 exacerbate cytoplasmic mislocalization of FUS. Our results demonstrate that viral infections worsen ALS pathology in SNs with genetic risk factors, suggesting a novel role for viruses in modulating patient phenotypes.
C1 [Bellmann, Jessica; Tripathy, Vadreenath; Sojka, Anna; Abo-Rady, Masin; Sterneckert, Jared] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany.
   [Monette, Anne; Mouland, Andrew J.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.
   [Monette, Anne; Mouland, Andrew J.] McGill Univ, Dept Med, Montreal, PQ, Canada.
   [Janosh, Antje; Bickle, Marc] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
   [Bhatnagar, Rajat] Verge Genom, San Francisco, CA USA.
RP Sterneckert, J (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany.
EM jared.sterneckert@tu-dresden.de
OI Sterneckert, Jared/0000-0002-7688-3124
FU Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG);
   CRTD part of the TUD; DFG Research CenterGerman Research Foundation
   (DFG) [DFG FZT 111]; DFG Cluster of ExcellenceGerman Research Foundation
   (DFG) [DFG EXC 168]; European Union's Horizon 2020 Research and
   Innovation Program [643417]; Bundesministerium fur Bildung und
   ForschungFederal Ministry of Education & Research (BMBF) [01ED1601B];
   Bundesministerium fur Bildung und Forschung, GermanyFederal Ministry of
   Education & Research (BMBF); Ministry of Health, Israel; Ministero
   dell'Istruzione dell'Universita e della Ricerca, ItalyMinistry of
   Education, Universities and Research (MIUR); Swedish Research Council,
   SwedenSwedish Research Council; Swiss National Science Foundation,
   SwitzerlandSwiss National Science Foundation (SNSF); Hans und Ilse
   Breuer Stiftung; Canadian Institutes of Health ResearchCanadian
   Institutes of Health Research (CIHR) [MOP-56974]
FX We gratefully acknowledge the financial support from the Deutsche
   Forschungsgemeinschaft (DFG) and the CRTD, which is part of the TUD.
   This work was financed by the DFG Research Center (DFG FZT 111) and the
   Cluster of Excellence (DFG EXC 168), including a seed grant. JS was
   supported by the European Union's Horizon 2020 Research and Innovation
   Program (643417) and the Bundesministerium fur Bildung und Forschung
   (01ED1601B). This is an EU Joint Programme - Neurodegenerative Disease
   Research (JPND) project supported by the following funding organizations
   under the aegis of JPND -www.jpnd.eu: Bundesministerium fur Bildung und
   Forschung, Germany; Ministry of Health, Israel; Ministero
   dell'Istruzione dell'Universita e della Ricerca, Italy; Swedish Research
   Council, Sweden; and Swiss National Science Foundation, Switzerland. JB
   was sponsored by the Hans und Ilse Breuer Stiftung. AJM was supported by
   the Canadian Institutes of Health Research (MOP-56974).
CR Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464
   Alfahad T, 2013, ANTIVIR RES, V99, P180, DOI 10.1016/j.antiviral.2013.05.006
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Andrews WD, 2000, J MED VIROL, V61, P527, DOI 10.1002/1096-9071(200008)61:4&lt;527::AID-JMV17&gt;3.0.CO;2-A
   Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002
   Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20
   Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200
   Braak H., 2017, NEUROL INT OPEN, V1, pE136, DOI DOI 10.1055/S-0043-111375
   Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221
   Bursch F, 2019, HUM MOL GENET, V28, P2835, DOI 10.1093/hmg/ddz107
   Canto-Noges C, 2005, J MOL NEUROSCI, V27, P79, DOI 10.1385/JMN:27:1:079
   Cermelli C, 2003, EUR J EPIDEMIOL, V18, P123, DOI 10.1023/A:1023067728557
   Conlon EG, 2018, ELIFE, V7, DOI 10.7554/eLife.37754
   Conte A, 2012, NEUROMUSCULAR DISORD, V22, P73, DOI 10.1016/j.nmd.2011.08.003
   Cook C, 2019, NEURON, V101, P1057, DOI 10.1016/j.neuron.2019.02.032
   Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116
   Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108
   Droppelmann CA, 2014, AMYOTROPH LAT SCL FR, V15, P321, DOI 10.3109/21678421.2014.881377
   Dunker W, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070359
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209
   Giraud P, 2001, NEUROLOGY, V56, P1777, DOI 10.1212/WNL.56.12.1777
   Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562
   Guo WT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00911-y
   He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833
   Hetz C, 2017, NAT REV NEUROL, V13, P477, DOI 10.1038/nrneurol.2017.99
   IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995
   Jaiswal MK, 2019, MED RES REV, V39, P733, DOI 10.1002/med.21528
   Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264
   Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040
   Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
   Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08
   Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044
   Limongi D, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6547248
   Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250
   Lloyd RE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002741
   Lopez-Erauskin J, 2018, NEURON, V100, P816, DOI 10.1016/j.neuron.2018.09.044
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238
   MacGowan DJL, 2007, NEUROLOGY, V68, P1944, DOI 10.1212/01.wnl.0000263188.77797.99
   Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002
   Marrone L, 2019, ACTA NEUROPATHOL, V138, P67, DOI 10.1007/s00401-019-01998-x
   Marrone L, 2018, STEM CELL REP, V10, P375, DOI 10.1016/j.stemcr.2017.12.018
   McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4
   Milev MP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00367
   Miller MS, 2015, NAT IMMUNOL, V16, P485, DOI 10.1038/ni.3132
   Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064
   Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736
   Mouland AJ, 2002, VIROLOGY, V292, P321, DOI 10.1006/viro.2001.1261
   Moulignier A, 2001, NEUROLOGY, V57, P995, DOI 10.1212/WNL.57.6.995
   Naumann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02299-1
   Nikolic J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005942
   Nomura T, 2014, J BIOL CHEM, V289, P1192, DOI 10.1074/jbc.M113.516492
   Norris F H Jr, 1977, Neurol Neurocir Psiquiatr, V18, P443
   NUOVO GJ, 1994, AM J PATHOL, V144, P659
   Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011
   Ramalho FS, 2017, CLIN INFECT DIS, V65, P687, DOI 10.1093/cid/cix374
   Ravits J, 2005, AMYOTROPH LATERAL SC, V6, P77, DOI 10.1080/14660820510027026
   Shahheydari H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00119
   Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315
   Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008
   Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.2
   Steele AJ, 2005, NEUROLOGY, V64, P454, DOI 10.1212/01.WNL.0000150899.76130.71
   Sun SY, 2015, P NATL ACAD SCI USA, V112, pE6993, DOI 10.1073/pnas.1520639112
   Talbott EO, 2016, HAND CLINIC, V138, P225, DOI 10.1016/B978-0-12-802973-2.00013-6
   Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819
   Vandenberghe N, 2010, AMYOTROPH LATERAL SC, V11, P277, DOI 10.3109/17482960903262083
   VAZEUX R, 1987, AM J PATHOL, V126, P403
   VIOLA MV, 1975, J EXP MED, V142, P483, DOI 10.1084/jem.142.2.483
   Vyboh K, 2012, JOVE-J VIS EXP, DOI 10.3791/4002
   White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001
   Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033
   WOODALL CJ, 1994, BRIT MED J, V308, P1541, DOI 10.1136/bmj.308.6943.1541
   Xue YC, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00063
   Zukor K, 2018, J NEUROVIROL, V24, P273, DOI 10.1007/s13365-017-0595-z
NR 80
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD OCT 22
PY 2019
VL 13
AR 480
DI 10.3389/fncel.2019.00480
PG 18
WC Neurosciences
SC Neurosciences & Neurology
GA JJ9HN
UT WOS:000494463000001
PM 31695598
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pinto, J
   Palomino, M
   Mendoza-Uribe, L
   Sinti, C
   Liebman, KA
   Lenhart, A
AF Pinto, Jesus
   Palomino, Miriam
   Mendoza-Uribe, Leonardo
   Sinti, Carmen
   Liebman, Kelly A.
   Lenhart, Audrey
TI Susceptibility to insecticides and resistance mechanisms in three
   populations of Aedes aegypti from Peru
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Insecticide resistance; Peru
ID MOSQUITO PROTEIN MICROASSAY; MICROPLATE ASSAY ANALYSIS; SODIUM-CHANNEL
   GENE; PYRETHROID RESISTANCE; SMALL PORTIONS; MUTATION; CULICIDAE;
   DIPTERA; DDT
AB Background Epidemics of dengue, chikungunya and Zika are a growing threat to areas where Aedes aegypti are present. The efficacy of chemical control of Ae. aegypti is threatened by the increasing frequency of insecticide resistance. The objective of this study was to determine the susceptibility status as well as the biochemical and molecular mechanisms underlying insecticide resistance in three populations of Ae. aegypti in high risk areas of dengue, chikungunya, and Zika in Peru. Methods Bioassays were conducted on adult Ae. aegypti to evaluate their susceptibility to insecticides used currently or historically for mosquito control in Peru, including six pyrethroids, three organophosphates and one organochlorine, in populations of Ae. aegypti from the districts of Chosica (Department of Lima), Punchana (Department of Loreto) and Piura (Department of Piura). Resistance mechanisms were determined by biochemical assays to assess activity levels of key detoxification enzyme groups (nonspecific esterases, multi-function oxidases, glutathione S-transferases and insensitive acetylcholinesterase). Real-time PCR assays were used to detect two kdr mutations (V1016I and F1534C) on the voltage-gated sodium channel gene. Results Resistance to DDT was detected in all three populations, and resistance to pyrethroids was detected in all populations except the population from Chosica, which still exhibited susceptibility to deltamethrin. Resistance to organophosphates was also detected, with the exception of populations from Punchana and Piura, which still demonstrated susceptibility to malathion. In general, no increase or alteration of activity of any enzyme group was detected. Both 1016I and 1534C alleles were detected in Punchana and Piura, while only the 1534C allele was detected in Chosica. Conclusions The results suggest that resistance to multiple classes of insecticides exist in areas important to Ae. aegypti-borne disease transmission in Peru. The F1534C mutation was present in all 3 populations and the V1016I mutation was present in 2 populations. To our knowledge, this is the first report of the presence of 1016I and 1534C in Ae. aegypti in Peru. The absence of highly elevated enzymatic activity suggests that target site resistance is a key mechanism underlying insecticide resistance in these populations, although further research is needed to fully understand the role of metabolic resistance mechanisms in these populations.
C1 [Pinto, Jesus; Palomino, Miriam; Mendoza-Uribe, Leonardo] Inst Nacl Salud, Lima, Peru.
   [Sinti, Carmen] Inst Nacl Salud, Ctr Invest Enfermedades Trop Maxime Kuczynski CIE, Iquitos, Peru.
   [Liebman, Kelly A.] Amer Soc Microbiol, Washington, DC USA.
   [Liebman, Kelly A.; Lenhart, Audrey] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
RP Lenhart, A (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
EM AJL8@cdc.gov
OI Mendoza Uribe, Leonardo/0000-0003-1378-6455; Lenhart,
   Audrey/0000-0002-9156-4228
CR Alout H, 2008, CHEM-BIOL INTERACT, V175, P138, DOI 10.1016/j.cbi.2008.03.018
   Andrade CS, 2001, MEM I OSWALDO CRUZ, V96, P657, DOI 10.1590/S0074-02762001000500011
   [Anonymous], 2014, THE MR4 METHODS IN A
   Arata A, 1999, MALARIA PERUVIAN AMA
   Ardila-Roldan S, 2013, BIOMEDICA, V33, P446, DOI 10.7705/biomedica.v33i3.1534
   Arslan A, 2016, J VECTOR DIS, V53, P136
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisset Juan A, 2007, Rev Cubana Med Trop, V59, P202
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   BROGDON WG, 1988, COMP BIOCHEM PHYS C, V90, P145, DOI 10.1016/0742-8413(88)90110-7
   BROGDON WG, 1988, B WORLD HEALTH ORGAN, V66, P339
   BROGDON WG, 1984, COMP BIOCHEM PHYS B, V79, P457, DOI 10.1016/0305-0491(84)90405-X
   BROGDON WG, 1984, COMP BIOCHEM PHYS B, V79, P461, DOI 10.1016/0305-0491(84)90406-1
   BROGDON WG, 1988, J AM MOSQUITO CONTR, V4, P152
   Cabezas César, 2015, Rev. perú. med. exp. salud publica, V32, P146
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Ministerio de Salud Peru, 2018, B EPIDEMIOL PERU, V27, P540
   Muthusamy R, 2015, ACTA TROP, V148, P137, DOI 10.1016/j.actatropica.2015.04.026
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Pan American Health Organization, 1967, CE568 PAN AM HLTH OR
   Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0
   Sala de Situacion de Salud, 2011, EP DIR GEN EP
   SCHLIESSMANN DJ, 1974, MOSQ NEWS, V34, P1
   Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7
   WHO, 2013, TEST PROC INREMO
   Yadav K, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0754-0
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 36
TC 2
Z9 2
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 22
PY 2019
VL 12
IS 1
AR 494
DI 10.1186/s13071-019-3739-6
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JG2KG
UT WOS:000491904100006
PM 31640810
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wurzel, S
   Ford, MA
   Dority, D
   Tronstad, L
AF Wurzel, Sarah
   Ford, Morgan Alexander
   Dority, Delina
   Tronstad, Lusha
TI Evaluating the impact of Permethrin on non-target invertebrates in an
   urban stream
SO HYDROBIOLOGIA
LA English
DT Article
DE Aquatic insects; Drift; Benthos; Insecticide; Mosquito control
ID AQUATIC ORGANISMS; DRIFT; TROUT
AB Insecticides are broadly applied in many urban areas of the western United States to control mosquito populations and reduce the prevalence of diseases such as West Nile and Zika Virus. We assessed the extent to which incidental exposure to the insecticide Permethrin affected drifting and benthic invertebrates in Spring Creek, Laramie, WY, USA. We collected drift samples before, immediately after (similar to 3-6 h), and 1 day after (similar to 28 h) insecticide application. We collected benthic invertebrates with a Hess sampler twice before and twice after spraying began. We measured an 11 x increase in the density of drifting aquatic insects immediately after pesticide application. Additionally, we observed an increase in drifting aquatic invertebrates 2.25 km downstream from treatment. A decrease in the biomass of benthic invertebrates and an increase in taxa richness at the end of the summer suggested that invertebrates are colonizing the stream but may be unable to persist. Fewer aquatic invertebrates in the stream may have cascading effects on the ecosystem by altering resources available to fish and riparian insectivores (e.g., bats, spiders, and amphibians). Understanding the unintended ecological impacts of current pest control practices could lead to more effective and less detrimental management strategies.
C1 [Wurzel, Sarah; Ford, Morgan Alexander; Dority, Delina; Tronstad, Lusha] Univ Wyoming, Wyoming Nat Divers Database, 1000 E Univ Ave, Laramie, WY 82071 USA.
RP Tronstad, L (corresponding author), Univ Wyoming, Wyoming Nat Divers Database, 1000 E Univ Ave, Laramie, WY 82071 USA.
EM tronstad@uwyo.edu
FU Wyoming Research Scholars Program, the University of Wyoming
   Biodiversity Institute; Laramie Rivers Conservation District; Wyoming
   IDeA Networks for Biomedical Research Excellence
FX We thank the Wyoming Natural Diversity Database staff, Alexis Lester and
   Katrina Cook for their help with benthic samples, Oliver Wilmot for his
   help collecting field samples, and Keith Wardlaw and the Mosquito and
   Integrated Pest Management of Laramie for logistical support. The
   Wyoming Research Scholars Program, the University of Wyoming
   Biodiversity Institute, Laramie Rivers Conservation District, and
   Wyoming IDeA Networks for Biomedical Research Excellence supported this
   project. Conversations with Mark Andersen sparked this project's
   creation. This project was Sarah Wurzel and Morgan Ford's undergraduate
   research project.
CR [Anonymous], 2014, ZIK VIR
   Anziska Y, 2017, MUSCLE NERVE, V55, pE11, DOI 10.1002/mus.25434
   Baser S, 2003, CHEMOSPHERE, V51, P469, DOI 10.1016/S0045-6535(03)00033-X
   Bates D., 2013, R PACKAGE VERSION 1
   Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447
   BRITTAIN JE, 1988, HYDROBIOLOGIA, V166, P77, DOI 10.1007/BF00017485
   Chang XL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002889
   Chung K., 1993, Limnologica, V23, P93
   COATS JR, 1989, ENVIRON TOXICOL CHEM, V8, P671, DOI 10.1002/etc.5620080805
   COX RL, 1984, ENVIRON ENTOMOL, V13, P375, DOI 10.1093/ee/13.2.375
   Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329
   DAVIES PE, 1993, AQUAT TOXICOL, V27, P201, DOI 10.1016/0166-445X(93)90055-6
   Downing JA, 1984, FRESH WATERS, V18, P566
   Epanchin PN, 2010, ECOLOGY, V91, P2406, DOI 10.1890/09-1974.1
   EVERTS JW, 1983, ARCH ENVIRON CON TOX, V12, P91, DOI 10.1007/BF01055007
   Ganihar SR, 1997, J BIOSCIENCE, V22, P219, DOI 10.1007/BF02704734
   Gore James A., 1996, P53
   Grant PBC, 2013, ENVIRON TOXICOL CHEM, V32, P2576, DOI 10.1002/etc.2358
   Hasenbein S, 2015, ECOTOXICOLOGY, V24, P746, DOI 10.1007/s10646-015-1420-1
   Impoinvil DE, 2007, HEALTH POLICY, V83, P196, DOI 10.1016/j.healthpol.2007.01.009
   Johnson KR, 2008, ENVIRON TOXICOL CHEM, V27, P397, DOI 10.1897/07-185R1.1
   Kells SA, 2017, PEST MANAG SCI, V73, P113, DOI 10.1002/ps.4294
   KREUTZWEISER DP, 1991, ARCH ENVIRON CON TOX, V20, P330, DOI 10.1007/BF01064398
   Merritt R. W., 2008, INTRO AQUATIC INSECT
   Moore MT, 2014, B ENVIRON CONTAM TOX, V93, P574, DOI 10.1007/s00128-014-1357-8
   Oksanen J, 2013, VEGAN COMMUNITY ECOL
   Peterson RKD, 2016, PEERJ, V4, DOI 10.7717/peerj.2167
   R Core Development Team, 2017, R LANG ENV STAT COMP
   Reactions Weekly, 2015, REACTIONS WEEKLY, V1539, P236
   Reactions Weekly, 2011, REACTIONS WEEKLY, V1372, P28
   Sparkes A, 2016, VET REC, V178, DOI 10.1136/vr.i2524
   SUNDARAM KMS, 1991, PESTIC SCI, V31, P281, DOI 10.1002/ps.2780310304
   SupYoon K, 2008, INSECT BIOCHEM MOLEC, V38, P296, DOI 10.1016/j.ibmb.2007.11.011
   Thorp JH, 2010, AQUAT ECOL SER, P1
   Toynton K, 2009, PERMETHRIN GEN FACT
   U.S. Environmental Protection Agency, 2009, 738R0906 US EPA
   Wallace R.R., 1981, P237
   WATERS TF, 1969, LIMNOL OCEANOGR, V14, P813, DOI 10.4319/lo.1969.14.5.0813
   WATERS TF, 1972, ANNU REV ENTOMOL, V17, P253, DOI 10.1146/annurev.en.17.010172.001345
   WERNER RA, 1992, J ECON ENTOMOL, V85, P860, DOI 10.1093/jee/85.3.860
   WHILES MR, 1992, FRESHWATER BIOL, V28, P81, DOI 10.1111/j.1365-2427.1992.tb00564.x
   Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01
NR 42
TC 0
Z9 0
U1 9
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0018-8158
EI 1573-5117
J9 HYDROBIOLOGIA
JI Hydrobiologia
PD JAN
PY 2020
VL 847
IS 1
BP 91
EP 104
DI 10.1007/s10750-019-04074-3
EA OCT 2019
PG 14
WC Marine & Freshwater Biology
SC Marine & Freshwater Biology
GA JV6DS
UT WOS:000491797500002
DA 2020-07-08
ER

PT J
AU Laurent-Rolle, M
   Morrison, J
AF Laurent-Rolle, Maudry
   Morrison, Juliet
TI The Role of NS5 Protein in Determination of Host Cell Range for Yellow
   Fever Virus
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE yellow fever virus; NS5; interferon; interferon antagonism;
   ubiquitination; STAT2
ID RNA-POLYMERASE NS5; INTERFERON; FLAVIVIRUS; EXPRESSION; ANTAGONIST;
   SEQUENCE; RECEPTOR
AB Yellow fever virus (YFV) tropism is restricted to human and nonhuman primates. The nonstructural protein 5 (NS5) protein of YFV binds to primate signal transducer and activator of transcription 2 (STAT2) and antagonizes interferon (IFN) signaling. However, YFV NS5 is unable to bind mouse STAT2 and antagonize murine IFN signaling. A similar observation has been made with the NS5 protein of both dengue virus (DENV) and Zika virus (ZIKV). However, the key difference between the NS5 protein of YFV and those of DENV and ZIKV is that YFV NS5 binds human STAT2 in an IFN-dependent manner. In human cells, IFN-I treatment induces K63-linked ubiquitination on lysine (K) 6 of YFV NS5, which is required for binding human STAT2. This IFN-induced ubiquitination of YFV NS5 is absent in murine cells resulting in the lack of binding of YFV NS5 and human STAT2 in murine cells. This highlights the importance of YFV NS5 ubiquitination in determining the host cell range for YFV.
C1 [Laurent-Rolle, Maudry] Yale Univ, Sect Infect Dis, New Haven, CT USA.
   [Morrison, Juliet] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
RP Morrison, J (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
EM juliet.morrison@ucr.edu
CR Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Au-Yeung N, 2018, CYTOKINE GROWTH F R, V44, P11, DOI 10.1016/j.cytogfr.2018.10.003
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   MANDL CW, 1989, VIROLOGY, V173, P291, DOI 10.1016/0042-6822(89)90246-8
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Mesev EV, 2019, NAT MICROBIOL, V4, P914, DOI 10.1038/s41564-019-0421-x
   Miorin L, 2019, J VIROL, V93, DOI 10.1128/JVI.00151-19
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Monath TP, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00155-5
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605
   Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27, DOI 10.18388/abp.2007_3266
   WHO, 2019, YELL FEV BRAZ
NR 30
TC 1
Z9 1
U1 4
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD DEC 1
PY 2019
VL 38
IS 12
BP 1414
EP 1417
DI 10.1089/dna.2019.5115
EA OCT 2019
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA JS9XO
UT WOS:000492175600001
PM 31633391
DA 2020-07-08
ER

PT J
AU del Carpio-Orantes, L
AF del Carpio-Orantes, Luis
TI Congenital Zika syndrome, time to communicate experiences
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Editorial Material
ID INFECTION
C1 [del Carpio-Orantes, Luis] Inst Mexicano Seguro Social Delegac Veracruz, Norte, Veracruz, Mexico.
RP del Carpio-Orantes, L (corresponding author), Inst Mexicano Seguro Social Delegac Veracruz, Norte, Veracruz, Mexico.
EM neurona23@hotmail.com
RI Del Carpio-Orantes, Luis/H-6745-2017
OI Del Carpio-Orantes, Luis/0000-0003-2436-5744
CR [Anonymous], 2018, CAS CONF SINDR CONG
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Neto NN, 2017, NEUROLOGY S, V88, pS40
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pan American Health Organization/World Health Organization, 2017, ZIK SUSP CONF CAS RE
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
NR 8
TC 1
Z9 1
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD OCT 18
PY 2019
VL 32
IS 20
BP 3509
EP 3510
DI 10.1080/14767058.2018.1465916
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IG0YZ
UT WOS:000473518300030
PM 29669451
OA Bronze
DA 2020-07-08
ER

PT J
AU Vojtech, L
   Zhang, MY
   Dave, V
   Levy, C
   Hughes, SM
   Wang, RF
   Calienes, F
   Prlic, M
   Nance, E
   Hladik, F
AF Vojtech, Lucia
   Zhang, Mengying
   Dave, Veronica
   Levy, Claire
   Hughes, Sean M.
   Wang, Ruofan
   Calienes, Fernanda
   Prlic, Martin
   Nance, Elizabeth
   Hladik, Florian
TI Extracellular vesicles in human semen modulate antigen-presenting cell
   function and decrease downstream antiviral T cell responses
SO PLOS ONE
LA English
DT Article
ID HUMAN SEMINAL PLASMA; INDOLEAMINE 2,3-DIOXYGENASE; ORGANELLES
   PROSTASOMES; REGULATORY ACTIVITY; HIV-1 TRANSMISSION; IMMUNE-RESPONSES;
   LANGERHANS CELLS; DENDRITIC CELLS; CYTOKINE; EXOSOMES
AB Human semen contains trillions of extracellular vesicles (SEV) similar in size to sexually transmitted viruses and loaded with potentially bioactive miRNAs, proteins and lipids. SEV were shown to inhibit HIV and Zika virus infectivity, but whether SEV are able also to affect subsequent immune responses is unknown. We found that SEV efficiently bound to and entered antigen-presenting cells (APC) and thus we set out to further dissect the impact of SEV on APC function and the impact on downstream T cell responses. In an APC-T cell co-culture system, SEV exposure to APC alone markedly reduced antigen-specific cytokine production, degranulation and cytotoxicity by antigen -specific memory CD8+ T cells. In contrast, inhibition of CD4+ T cell responses required both APC and T cell exposure to SEV. Surprisingly, SEV did not alter MHC or co-stimulatory receptor expression on APCs, but caused APCs to upregulate indoleamine 2,3 deoxygenase, an enzyme known to indirectly inhibit T cells. Thus, SEV reduce the ability of APCs to activate T cells. We propose here that these immune-inhibitory properties of SEV may be intended to prevent immune responses against semen-derived antigens, but can be hi-jacked by genitally acquired viral infections to compromise adaptive cellular immunity.
C1 [Vojtech, Lucia; Levy, Claire; Hughes, Sean M.; Wang, Ruofan; Calienes, Fernanda; Hladik, Florian] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Zhang, Mengying; Nance, Elizabeth] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA.
   [Dave, Veronica; Prlic, Martin; Hladik, Florian] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Dave, Veronica; Prlic, Martin] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Prlic, Martin] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Nance, Elizabeth] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   [Hladik, Florian] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98115 USA.
RP Vojtech, L; Hladik, F (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Hladik, F (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Hladik, F (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98115 USA.
EM luciav@uw.edu; fhladik@fredhutch.org
RI ; Hladik, Florian/G-1041-2012
OI Vojtech, Lucia/0000-0003-2343-0719; Hughes, Sean/0000-0002-9409-9405;
   Hladik, Florian/0000-0002-0375-2764
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI095023, R01 DA040386, R01
   AI123323, T32AI007509]; University of WashingtonUniversity of Washington
   [A97523]; Interdisciplinary Training Grant in Cancer [2T32CA080416];
   Burroughs Wellcome Fund Career Award at Scientific InterfacesBurroughs
   Wellcome Fund; Center for Exposures, Diseases, Genomics, and Environment
FX This work was supported by NIH grants R21 AI095023 and R01 DA040386, a
   Royalty Research Grant (A97523) from the University of Washington (all
   F.H.), an Interdisciplinary Training Grant in Cancer 2T32CA080416
   (L.V.), NIH R01 AI123323 to (M.P.), T32AI007509 (V.D.), the Center for
   Exposures, Diseases, Genomics, and Environment (E.N.), and the Burroughs
   Wellcome Fund Career Award at Scientific Interfaces (E.N.).; The authors
   would like to thank the semen and blood donors who contributed to this
   study. M. Juliana McElrath is head of the clinic where samples were
   collected. John Amory, Consuelo Pete, Julie Czartoski, Janine Maenza,
   Christine Galloway and Gina Braun assisted with collecting samples and
   with donor recruitment.
CR Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007
   ALLEN RD, 1986, AM J REPROD IMMUNOL, V11, P59
   Arienti G, 1998, ARCH BIOCHEM BIOPHYS, V358, P391, DOI 10.1006/abbi.1998.0876
   Arienti G, 1998, BBA-GEN SUBJECTS, V1425, P36, DOI 10.1016/S0304-4165(98)00047-6
   ARVIDSON G, 1989, BIOCHIM BIOPHYS ACTA, V984, P167, DOI 10.1016/0005-2736(89)90212-5
   Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11
   Barnhart KT, 2006, HUM REPROD, V21, P1618, DOI 10.1093/humrep/del022
   Belladonna ML, 2008, J IMMUNOL, V181, P5194, DOI 10.4049/jimmunol.181.8.5194
   Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5
   BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0
   Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11
   Brouwers JF, 2013, PROTEOMICS, V13, P1660, DOI 10.1002/pmic.201200348
   Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312
   Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064
   Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x
   Evers Heidrun, 2011, Arch Kriminol, V228, P11
   Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x
   Fraser JD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001145
   Haderk F, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5509
   HANDSFIELD HH, 1985, J INFECT DIS, V151, P344, DOI 10.1093/infdis/151.2.344
   Harden JL, 2012, IMMUNOL INVEST, V41, P738, DOI 10.3109/08820139.2012.676122
   Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748
   Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002
   Introini A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006402
   Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029
   Kelleher RJ, 2015, CANCER IMMUNOL RES, V3, P1269, DOI 10.1158/2326-6066.CIR-15-0086
   Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028
   Kelly RW, 1999, INT J ANDROL, V22, P2
   Kelly RW, 1997, HUM REPROD, V12, P677, DOI 10.1093/humrep/12.4.677
   KELLY RW, 1991, CLIN EXP IMMUNOL, V86, P550
   Kikete S, 2016, CYTOTECHNOLOGY, V68, P2223, DOI 10.1007/s10616-016-9975-0
   Kim BJ, 2015, P NATL ACAD SCI USA, V112, P1559, DOI 10.1073/pnas.1413493112
   KITAMURA M, 1995, IMMUNOLOGY, V84, P626
   Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7
   Madison MN, 2015, VIROLOGY, V482, P189, DOI 10.1016/j.virol.2015.03.040
   Matsumoto A, 2017, J PHARM SCI-US, V106, P168, DOI 10.1016/j.xphs.2016.07.022
   McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
   Muller M, 2006, ENDOCRINOLOGY, V147, P3356, DOI 10.1210/en.2005-1429
   O'Neill David W, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22f04s67
   Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077
   Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184
   Poloso NJ, 2013, MOL IMMUNOL, V54, P284, DOI 10.1016/j.molimm.2012.12.010
   Rametse CL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02721
   Rametse CL, 2014, VIRAL IMMUNOL, V27, P200, DOI 10.1089/vim.2013.0136
   Lenicov FR, 2014, MED HYPOTHESES, V83, P208, DOI 10.1016/j.mehy.2014.04.028
   Lenicov FR, 2012, J IMMUNOL, V189, P4777, DOI 10.4049/jimmunol.1202089
   Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622
   Robertson SA, 1997, AM J REPROD IMMUNOL, V37, P438
   Robertson SA, 2009, BIOL REPROD, V80, P1036, DOI 10.1095/biolreprod.108.074658
   RONQUIST G, 1985, BIOCHIM BIOPHYS ACTA, V822, P203, DOI 10.1016/0304-4157(85)90008-5
   ROONEY IA, 1993, J EXP MED, V177, P1409, DOI 10.1084/jem.177.5.1409
   Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Selva KJ, 2019, AIDS RES HUM RETROV, V35, P553, DOI [10.1089/aid.2018.0219, 10.1089/AID.2018.0219]
   Sharkey DJ, 2012, J IMMUNOL, V189, P1024, DOI 10.4049/jimmunol.1200005
   Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736
   Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706
   STITES DP, 1975, NATURE, V253, P727, DOI 10.1038/253727a0
   Tarazona R, 2011, IMMUNOBIOLOGY, V216, P41, DOI 10.1016/j.imbio.2010.03.002
   Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x
   Thomas R, 2006, J MED VIROL, V78, P1204, DOI 10.1002/jmv.20682
   Van Elssen CHMJ, 2011, BLOOD, V118, P2473, DOI 10.1182/blood-2010-09-307835
   Vendelova E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00333
   Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347
   von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507
   Welch JL, 2018, J VIROL, V92, DOI 10.1128/JVI.00731-18
   Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066
   York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369
   Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109
NR 72
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2019
VL 14
IS 10
AR e0223901
DI 10.1371/journal.pone.0223901
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LM9KP
UT WOS:000532567300068
PM 31622420
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiese, D
   Escalante, AA
   Murphy, H
   Henry, KA
   Gutierrez-Velez, VH
AF Wiese, Daniel
   Escalante, Ananias A.
   Murphy, Heather
   Henry, Kevin A.
   Gutierrez-Velez, Victor Hugo
TI Integrating environmental and neighborhood factors in MaxEnt modeling to
   predict species distributions: A case study of Aedes albopictus in
   southeastern Pennsylvania
SO PLOS ONE
LA English
DT Article
ID SPATIAL-DISTRIBUTION; AEGYPTI; MOSQUITO; CLIMATE; DENGUE; URBAN;
   PRECIPITATION; DIFFERENCE; ECOLOGY; AREA
AB Aedes albopictus is a viable vector for several infectious diseases such as Zika, West Nile, Dengue viruses and others. Originating from Asia, this invasive species is rapidly expanding into North American temperate areas and urbanized places causing major concerns for public health. Previous analyses show that warm temperatures and high humidity during the mosquito season are ideal conditions for A. albopictus development, while its distribution is correlated with population density. To better understand A. albopictus expansion into urban places it is important to consider the role of both environmental and neighborhood factors. The present study aims to assess the relative importance of both environmental variables and neighborhood factors in the prediction of A. albopictus' presence in Southeast Pennsylvania using MaxEnt (version 3.4.1) machine-learning algorithm. Three models are developed that include: (1) exclusively environmental variables, (2) exclusively neighborhood factors, and (3) a combination of environmental variables and neighborhood factors. Outcomes from the three models are compared in terms of variable importance, accuracy, and the spatial distribution of predicted A. albopictus'presence. All three models predicted the presence of A. albopictus in urban centers, however, each to a different spatial extent. The combined model resulted in the highest accuracy (74.7%) compared to the model with only environmental variables (73.5%) and to the model with only neighborhood factors (72.1%) separately. Although the combined model does not essentially increase the accuracy in the prediction, the spatial patterns of mosquito distribution are different when compared to environmental or neighborhood factors alone. Environmental variables help to explain conditions associated with mosquitoes in suburban/rural areas, while neighborhood factors summarize the local conditions that can also impact mosquito habitats in predominantly urban places. Overall, the present study shows that MaxEnt is suitable for integrating neighborhood factors associated with mosquito presence that can complement and improve species distribution modeling.
C1 [Wiese, Daniel; Henry, Kevin A.; Gutierrez-Velez, Victor Hugo] Temple Univ, Coll Liberal Arts, Dept Geog & Urban Studies, Philadelphia, PA 19122 USA.
   [Murphy, Heather] Temple Univ, Coll Publ Hlth, Dept Biostat & Epidemiol, Philadelphia, PA 19122 USA.
   [Escalante, Ananias A.] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA.
RP Gutierrez-Velez, VH (corresponding author), Temple Univ, Coll Liberal Arts, Dept Geog & Urban Studies, Philadelphia, PA 19122 USA.
EM tug61163@temple.edu
OI Escalante, Ananias/0000-0002-1532-3430
FU Office of the Vice President for Research Administration at Temple
   University under the Targeted Funding Program; Colleges of Liberal Arts,
   Public Health and Science and Technology at Temple University under the
   Targeted Funding Program
FX This work was made possible by funding from the Office of the Vice
   President for Research Administration and the Colleges of Liberal Arts,
   Public Health and Science and Technology at Temple University under the
   Targeted Funding Program. Publication of this article was funded in part
   by the Temple University Libraries Open Access Publishing Fund. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; The authors
   choose to use the FLAE (first-last-author-emphasis) norm, with
   Gutierrez-Velez as the senior and corresponding author. This work was
   made possible by funding from the Office of the Vice President for
   Research Administration and the Colleges of Liberal Arts, Public Health
   and Science and Technology at Temple University under the Targeted
   Funding Program. We would like to thank Michael Hutchinson from the
   PA-DEP for making the mosquito data available. We would like to dedicate
   this paper to the memory of Dr. Deborah Nelson (PhD) who was part of the
   original research team, had a passion for public health and research,
   she passed away during the course of this research.
CR Armstrong PM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005623
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396
   Buckner EA, 2011, J VECTOR ECOL, V36, P269, DOI 10.1111/j.1948-7134.2011.00167.x
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P651
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2
   Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guillera-Arroita G, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02445
   Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Hijmans RJ, 2016, PACKAGE RASTER R PAC
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096
   Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038
   Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Estallo EL, 2012, INT J REMOTE SENS, V33, P4254, DOI 10.1080/01431161.2011.640962
   Little E, 2017, J MED ENTOMOL, V54, P1183, DOI 10.1093/jme/tjx103
   Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058
   Manson S, 2017, IPUMS NATL HIST GEOG
   Medeiros MCI, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005347
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Muller GC, 2011, ACTA TROP, V118, P45, DOI 10.1016/j.actatropica.2011.01.009
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Peterson AT, 2011, MONOGRAPHS POPULATIO
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280
   Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783
   Sallam MF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101230
   Team RC, 2013, R LANG ENV STAT COMP
   TRPIS M, 1972, B WORLD HEALTH ORGAN, V47, P433
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Vargas REM, 2013, INFECT GENET EVOL, V13, P242, DOI 10.1016/j.meegid.2012.08.008
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1
   Whiteman A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102179
   Witten I.H., 2016, DATA MINING PRACTICA
   Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004
   Yarnal B., 1995, GEOGRAPHY PENNSYLVAN, P44
NR 54
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2019
VL 14
IS 10
AR e0223821
DI 10.1371/journal.pone.0223821
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LM9KP
UT WOS:000532567300048
PM 31622396
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goncalves, RL
   Menezes, GD
   Sussuchi, L
   Moreli, ML
   Mottin, M
   Andrade, CH
   Pereira, M
   da Silva, RA
AF Goncalves, Ricardo Lemes
   Menezes, Gabriela de Lima
   Sussuchi, Luciane
   Moreli, Marcos Lazaro
   Mottin, Melina
   Andrade, Carolina Horta
   Pereira, Maristela
   da Silva, Roosevelt Alves
TI Dynamic behavior of Dengue and Zika viruses NS1 protein reveals
   monomer?monomer interaction mechanisms and insights to rational drug
   design
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
ID MEMBRANE ASSOCIATION
AB Communicated by Ramaswamy H. Sarma
C1 [Goncalves, Ricardo Lemes; Menezes, Gabriela de Lima; Sussuchi, Luciane; Moreli, Marcos Lazaro; da Silva, Roosevelt Alves] Univ Fed Goias, Nucleo Colaborat BioSistemas, Jatai, Go, Brazil.
   [Mottin, Melina; Andrade, Carolina Horta] Univ Fed Goias, Fac Farm, LabMol Lab Mol Modeling & Drug Design, Goiania, Go, Brazil.
   [Pereira, Maristela] Univ Fed Goias, Lab Biol Mol, Goiania, Go, Brazil.
RP da Silva, RA (corresponding author), Univ Fed Goias, Nucleo Colaborat BioSistemas, Jatai, Go, Brazil.
EM rooseveltfisicaufg@gmail.com
RI da Silva, Roosevelt/Y-5923-2019; Mottin, Melina/D-8700-2016; da Silva,
   Roosevelt/AAF-1577-2019; Andrade, Carolina/C-3960-2014; Sussuchi da
   Silva, Luciane/A-8833-2019
OI da Silva, Roosevelt/0000-0001-5624-4790; Mottin,
   Melina/0000-0003-0878-9029; de Lima Menezes,
   Gabriela/0000-0002-8944-8148; Andrade, Carolina/0000-0003-0101-1492;
   Sussuchi da Silva, Luciane/0000-0002-7470-4655; Moreli,
   Marcos/0000-0002-9599-361X; Lemes Goncalves, Ricardo/0000-0002-3498-965X
FU Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (MCTI/CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado de Goias (FAPEG); Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior -CAPESCAPES [23038010055/2013-29]; Financiadora de
   Estrategias de Interacao Patogeno-Hospedeiro (INCT-IPH); CAPESCAPES;
   CNPq/FAPEG DCR [300508/2017-4]; L'Oreal-UNESCO-ABC Para Mulheres na
   Ciencia; L'Oreal-UNESCO International Rising Talents
FX This work, performed at Universidade Federal de Goias, was supported by
   the Ministerio da Ciencia e Tecnologia/Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (MCTI/CNPq), Fundacao de Amparo
   a Pesquisa do Estado de Goias (FAPEG), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior -CAPES (grant 23038010055/2013-29),
   Financiadora de Estrategias de Interacao Patogeno-Hospedeiro (INCT-IPH).
   Additionally, RLG, LS and GLM were supported by fellowships from CAPES.
   MM appreciate financial support of CNPq/FAPEG DCR (grant 300508/2017-4).
   CHA is CNPq research fellow and also thanks the 'L'Oreal-UNESCO-ABC Para
   Mulheres na Ciencia' and 'L'Oreal-UNESCO International Rising Talents'
   for the awards and fellowships received, which partially funded this
   work.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Lai YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07308-3
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Raza Saad, 2019, IEEE/ACM Trans Comput Biol Bioinform, DOI 10.1109/TCBB.2019.2911081
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 15
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2019.1677504
EA OCT 2019
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA JE9RJ
UT WOS:000491024800001
PM 31594455
DA 2020-07-08
ER

PT J
AU Heinzelman, P
   Low, A
   Simeon, R
   Wright, GA
   Chen, ZL
AF Heinzelman, Pete
   Low, Alyssa
   Simeon, Rudo
   Wright, Gus A.
   Chen, Zhilei
TI De Novo Isolation & Affinity Maturation of yeast-displayed
   Virion-binding human fibronectin domains by flow cytometric screening
   against Virions
SO JOURNAL OF BIOLOGICAL ENGINEERING
LA English
DT Article
DE Flow cytometry; Zika virus; Human Immunodeficiency Virus; AIDS; yeast
   display; fibronectin; protein engineering; antibody engineering;
   directed evolution; phage display
ID CHAIN RECOMBINANT ANTIBODIES; FN3 DOMAINS; VIRUS; STABILITY; SELECTION;
   PROTEINS; PURIFICATION; LYMPHOCYTE; PROTECTION; STRAND
AB Background The promise of biopharmaceuticals comprising one or more binding domains motivates the development of novel methods for de novo isolation and affinity maturation of virion-binding domains. Identifying avenues for overcoming the challenges associated with using virions as screening reagents is paramount given the difficulties associated with obtaining high-purity virus-associated proteins that retain the conformation exhibited on the virion surface. Results Fluorescence activated cell sorting (FACS) of 1.5 x 10(7) clones taken from a naive yeast surface-displayed human fibronectin domain (Fn3) against whole virions yielded two unique binders to Zika virions. Construction and FACS of site-directed binding loop mutant libraries based on one of these binders yielded multiple progeny clones with enhanced Zika-binding affinities. These affinity-matured clones bound Zika virions with low double- or single-digit nanomolar affinity in ELISA assays, and expressed well as soluble proteins in E. coli shake flask culture, with post-purification yields exceeding 10 mg/L. Conclusions FACS of a yeast-displayed binding domain library is an efficient method for de novo isolation of virion-binding domains. Affinities of isolated virion-binding clones are readily enhanced via FACS screening of mutant progeny libraries. Given that most binding domains are compatible with yeast display, the approach taken in this work may be broadly utilized for generating virion-binding domains against many different viruses for use in passive immunotherapy and the prevention of viral infection.
C1 [Heinzelman, Pete; Low, Alyssa; Simeon, Rudo; Chen, Zhilei] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA.
   [Wright, Gus A.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.
RP Chen, ZL (corresponding author), Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA.
EM zchen4@tamu.edu
OI Chen, Zhilei/0000-0002-0244-3556
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DP2OD024146, AG056574]
FX This work was supported by NIH grants DP2OD024146 (to ZC and PH) and
   AG056574 (to PH). The funding agencies did not participate in the
   collection, analysis, or interpretation of data or in writing the
   manuscript.
CR Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859
   Bidokhti MRM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006811
   Boersma YL, 2011, J BIOL CHEM, V286, P41273, DOI 10.1074/jbc.M111.293266
   Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94
   Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X
   DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492
   Diem MD, 2014, PROTEIN ENG DES SEL, V27, P419, DOI 10.1093/protein/gzu016
   Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027
   Fecek RJ, 2006, J IMMUNOL METHODS, V314, P30, DOI 10.1016/j.jim.2006.05.008
   Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785
   Gilbreth RN, 2014, PROTEIN ENG DES SEL, V27, P411, DOI 10.1093/protein/gzu024
   Hu JZ, 2010, J CHROMATOGR A, V1217, P3489, DOI 10.1016/j.chroma.2010.03.023
   Hulseweh B, 2014, MABS-AUSTIN, V6, P717, DOI 10.4161/mabs.28170
   Jacobs SA, 2012, PROTEIN ENG DES SEL, V25, P107, DOI 10.1093/protein/gzr064
   Janas AM, 2009, CURR PROTOC CELL BIO, DOI 10.1002/0471143030.cb2605s43
   Laursen NS, 2018, SCIENCE, V362, P598, DOI 10.1126/science.aaq0620
   Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063
   Liu H, 2014, J VIROL METHODS, V205, P61, DOI 10.1016/j.jviromet.2014.04.008
   Liu H, 2013, J VIROL METHODS, V194, P178, DOI 10.1016/j.jviromet.2013.08.017
   McMahon C, 2018, NAT STRUCT MOL BIOL, V25, P289, DOI 10.1038/s41594-018-0028-6
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Ohtaki N, 2011, J VIROL METHODS, V174, P131, DOI 10.1016/j.jviromet.2011.03.021
   Porebski BT, 2015, PROTEIN ENG DES SEL, V28, P67, DOI 10.1093/protein/gzv002
   Rajab A, 2017, INT J LAB HEMATOL, V39, P76, DOI 10.1111/ijlh.12678
   Schneider K, 2015, VIRUSES-BASEL, V7, P5875, DOI 10.3390/v7112912
   Segura MD, 2005, BIOTECHNOL BIOENG, V90, P391
   Sun KY, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1185-5
   Teplyakov A, 2014, PROTEINS, V82, P1359, DOI 10.1002/prot.24502
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Wegener J, 2016, J INSECT PHYSIOL, V91-92, P1, DOI 10.1016/j.jinsphys.2016.06.004
   Woldring DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138956
   Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630
   Zhang S, 2011, JOVE-J VIS EXP, DOI 10.3791/3168
NR 33
TC 0
Z9 0
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-1611
J9 J BIOL ENG
JI J. Biol. Eng.
PD OCT 16
PY 2019
VL 13
IS 1
AR 76
DI 10.1186/s13036-019-0203-2
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA JE5PL
UT WOS:000490744300001
PM 31636701
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baskar, D
   Amalnath, D
   Mandal, J
AF Baskar, D.
   Amalnath, D.
   Mandal, J.
TI Antibodies to Zika virus, Campylobacter jejuni, gangliosides in Guillain
   Barre syndrome. A prospective single centre study from southern India
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT World Congress of Neurology (WCN)
CY OCT 27-31, 2019
CL Emirates Neurol Soc, Dubai, U ARAB EMIRATES
SP World Federat Neurol
HO Emirates Neurol Soc
C1 [Baskar, D.; Amalnath, D.; Mandal, J.] JIPMER, Dept Med, Pondicherry, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2019
VL 405
SU S
MA WCN19-0112
AR UNSP 103939
DI 10.1016/j.jns.2019.10.277
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KQ2PN
UT WOS:000516770701080
OA Bronze
DA 2020-07-08
ER

PT J
AU Pardo-Villamizar, CA
   Parra, B
   Osorio, L
   Zea-Vera, AF
   JImenez-Arango, JA
   Lopez, R
   Gonzalez-Manrique, G
   Angarita, J
   Lizarazo, J
   Vargas, J
AF Pardo-Villamizar, C. A.
   Parra, B.
   Osorio, L.
   Zea-Vera, A. F.
   JImenez-Arango, J. A.
   Lopez, R.
   Gonzalez-Manrique, G.
   Angarita, J.
   Lizarazo, J.
   Vargas, J.
TI Guillain-Barre syndrome and the Zika epidemic in Latin America: Lessons
   learn and the current situation
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT World Congress of Neurology (WCN)
CY OCT 27-31, 2019
CL Emirates Neurol Soc, Dubai, U ARAB EMIRATES
SP World Federat Neurol
HO Emirates Neurol Soc
C1 [Pardo-Villamizar, C. A.] Johns Hopkins Univ, Neurol, Sch Med, Baltimore, MD USA.
   [Parra, B.] Univ Valle, Microbiol, Cali, Colombia.
   [Osorio, L.] Univ Valle, Microbiol, Cali, Colombia.
   [Zea-Vera, A. F.] Univ Valle, Neurol, Cali, Colombia.
   [JImenez-Arango, J. A.; Lopez, R.] Univ Antioquia, Neurol, Medellin, Colombia.
   [Gonzalez-Manrique, G.] Univ Surcolombiana, Neurol, Neiva, Colombia.
   [Angarita, J.] Clin Medilaser, Neurol, Neiva, Colombia.
   [Lizarazo, J.] Hosp Univ Erasmo Meoz, Neurol, Cucuta, Colombia.
   [Vargas, J.] Clin Misericordia Int, Neurol, Barranquilla, Colombia.
FU European Union's Horizon 2020 Research and Innovation Programme
   [734584]; Bart McLean Fund for Neuroimmunology Research
FX This work was partially funded by the European Union's Horizon 2020
   Research and Innovation Programme under Grant Agreement no. 734584 and
   by the Bart McLean Fund for Neuroimmunology Research.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2019
VL 405
SU S
MA WCN19-2302
AR UNSP 103715
DI 10.1016/j.jns.2019.10.054
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KQ2PN
UT WOS:000516770700055
OA Bronze
DA 2020-07-08
ER

PT J
AU Limonta, D
   Jovel, J
   Kumar, A
   Lu, J
   Hou, S
   Airo, AM
   Lopez-Orozco, J
   Wong, CP
   Saito, L
   Branton, W
   Wong, GKS
   Mason, A
   Power, C
   Hobman, TC
AF Limonta, Daniel
   Jovel, Juan
   Kumar, Anil
   Lu, Julia
   Hou, Shangmei
   Airo, Adriana M.
   Lopez-Orozco, Joaquin
   Wong, Cheung Pang
   Saito, Leina
   Branton, William
   Wong, Gane Ka-Shu
   Mason, Andrew
   Power, Christopher
   Hobman, Tom C.
TI Fibroblast Growth Factor 2 Enhances Zika Virus Infection in Human Fetal
   Brain
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; fibroblast growth factor 2; astrocytes; fetal brain;
   explant; interferon; congenital; MAP kinase
ID FAMILY; REPLICATION; APOPTOSIS; BGJ398; ROLES
AB Zika virus (ZIKV) is an emerging pathogen that can cause microcephaly and other neurological defects in developing fetuses. The cellular response to ZIKV in the fetal brain is not well understood. Here, we show that ZIKV infection of human fetal astrocytes (HFAs), the most abundant cell type in the brain, results in elevated expression and secretion of fibroblast growth factor 2 (FGF2). This cytokine was shown to enhance replication and spread of ZIKV in HFAs and human fetal brain explants. The proviral effect of FGF2 is likely mediated in part by suppression of the interferon response, which would represent a novel mechanism by which viruses antagonize host antiviral defenses. We posit that FGF2-enhanced virus replication in the fetal brain contributes to the neurodevelopmental disorders associated with in utero ZIKV infection. As such, targeting FGF2-dependent signaling should be explored further as a strategy to limit replication of ZIKV.
C1 [Limonta, Daniel; Kumar, Anil; Hou, Shangmei; Lopez-Orozco, Joaquin; Wong, Cheung Pang; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, 5-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.
   [Jovel, Juan; Saito, Leina; Branton, William; Wong, Gane Ka-Shu; Mason, Andrew; Power, Christopher; Hobman, Tom C.] Univ Alberta, Dept Med, Edmonton, AB, Canada.
   [Lu, Julia; Airo, Adriana M.; Mason, Andrew; Power, Christopher] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.
   [Mason, Andrew; Power, Christopher; Hobman, Tom C.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
   [Mason, Andrew; Hobman, Tom C.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.
   [Wong, Gane Ka-Shu] BGI Grp, Shenzhen, Peoples R China.
RP Hobman, TC (corresponding author), Univ Alberta, Dept Cell Biol, 5-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.
EM tom.hobman@ualberta.ca
RI ; Wong, Gane Ka-Shu/G-5784-2013
OI Kumar, Anil/0000-0002-6179-4516; Branton, William/0000-0002-3259-2544;
   Wong, Gane Ka-Shu/0000-0001-6108-5560
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [PJT-148699, ZV1149782]; Women and Children's Health
   Research Institute; Li Ka Shing Institute of Virology
FX This work was funded by the Canadian Institutes of Health Research
   (grants PJT-148699 and ZV1149782 to T. C. H.), the Women and Children's
   Health Research Institute, and the Li Ka Shing Institute of Virology.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   AbuSara N, 2015, CANCER LETT, V357, P575, DOI 10.1016/j.canlet.2014.12.017
   Airo AM, 2018, VIROLOGY, V516, P147, DOI 10.1016/j.virol.2018.01.009
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brewer JR, 2016, GENE DEV, V30, P751, DOI 10.1101/gad.277137.115
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Forrester JV, 2008, MUCOSAL IMMUNOL, V1, P372, DOI 10.1038/mi.2008.27
   Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200
   Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245
   Hallinan N, 2016, CANCER TREAT REV, V46, P51, DOI 10.1016/j.ctrv.2016.03.015
   Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005
   Ilkow CS, 2015, NAT MED, V21, P530, DOI 10.1038/nm.3848
   Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006
   Javle M, 2018, J CLIN ONCOL, V36, P276, DOI 10.1200/JCO.2017.75.5009
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Komatsu Y, 2015, ONCOGENE, V34, P3985, DOI 10.1038/onc.2014.331
   Komatsu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160529
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Lindqvist R, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1119-3
   Liu X, 2015, J IMMUNOL, V195, P4943, DOI 10.4049/jimmunol.1501503
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miho Y, 1999, CELL DEATH DIFFER, V6, P463, DOI 10.1038/sj.cdd.4400506
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Van ND, 2016, GUT, V65, P1015, DOI 10.1136/gutjnl-2014-308003
   Nogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048
   Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176
   Panchenko MV, 2016, GENE, V589, P1, DOI 10.1016/j.gene.2016.05.002
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252
   Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 48
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD OCT 15
PY 2019
VL 220
IS 8
BP 1377
EP 1387
DI 10.1093/infdis/jiz073
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9DF
UT WOS:000490988000017
PM 30799482
DA 2020-07-08
ER

PT J
AU Silva, MMO
   Inure, LB
   Kikuti, M
   Anjos, RO
   Santos, VC
   Gonsalves, TSF
   Paploski, IAD
   Moreira, PSS
   Nascimento, LCJ
   Campos, GS
   Ko, AI
   Weaver, SC
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Silva, Monaise M. O.
   Inure, Laura B.
   Kikuti, Mariana
   Anjos, Rosangela O.
   Santos, Viviane C.
   Gonsalves, Thaiza S. F.
   Paploski, Igor A. D.
   Moreira, Patricia S. S.
   Nascimento, Leile C. J.
   Campos, Gubio S.
   Ko, Albert, I
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI Concomitant Transmission of Dengue, Chikungunya, and Zika Viruses in
   Brazil: Clinical and Epidemiological Findings From Surveillance for
   Acute Febrile Illness
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE dengue virus; chikungunya virus; Zika virus; arbovirus; coinfection
ID OUTBREAK; SALVADOR; TIME
AB Background. Since their emergence in the Americas, chikungunya (CHIKV) and Zika (ZIKV) viruses co-circulate with dengue virus (DENV), hampering clinical diagnosis. We investigated clinical and epidemiological characteristics of arboviral infections during the introduction and spread of CHIKV and ZIKV through northeastern Brazil.
   Methods. Surveillance for arboviral diseases among febrile patients was performed at an emergency health unit of Salvador, Brazil, between September 2014 and July 2016. We interviewed patients to collect data on symptoms, reviewed medical records to obtain the presumptive diagnoses, and performed molecular and serological testing to confirm DENV, CHIKV, ZIKV, or nonspecific flavivirus (FLAV) diagnosis.
   Results. Of 948 participants, 247 (26.1%) had an acute infection, of which 224 (23.6%) were single infections (DENV, 32 [3.4%]; CHIKV, 159 [16.7%]; ZIKV, 13 [1.4%]; and FLAV, 20 [2.1%]) and 23 (2.4%) coinfections (DENV/CHIKV, 13 [1.4%]; CHIKV/FLAV, 9 [0.9%]; and DENV/ZIKV, 1 [0.1%]). An additional 133 (14.0%) patients had serological evidence for a recent arboviral infection. Patients with ZIKV presented with rash and pruritus (69.2% each) more frequently than those with DENV (37.5% and 31.2%, respectively) and CHIKV (22.9% and 14.7%, respectively) (P <.001 for both comparisons). Conversely, arthralgia was more common in CHIKV (94.9%) and FLAV/CHIKV (100.0%) than in DENV (59.4%) and ZIKV (53.8%) (P <.001). A correct presumptive clinical diagnosis was made for 9%-23% of the confirmed patients.
   Conclusions. Arboviral infections are frequent causes of febrile illness. Coinfections are not rare events during periods of intense, concomitant arboviral transmission. Given the challenge to clinically distinguish these infections, there is an urgent need for rapid, point-of-care, multiplex diagnostics.
C1 [Silva, Monaise M. O.; Inure, Laura B.; Kikuti, Mariana; Anjos, Rosangela O.; Santos, Viviane C.; Gonsalves, Thaiza S. F.; Moreira, Patricia S. S.; Nascimento, Leile C. J.; Ko, Albert, I; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Inure, Laura B.] Consejo Nacl Invest Cient & Tecn, Inst Nacl Med Trop, Puerto Iguazu, Argentina.
   [Kikuti, Mariana; Paploski, Igor A. D.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Paploski, Igor A. D.] Univ Minnesota, St Paul, MN 55108 USA.
   [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Ko, Albert, I] Yale Sch Publ Hlth, New Haven, CT USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Reis, Mitermayer G.; Ribeiro, Guilherme S.] Med Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; Paploski, Igor AD/D-7015-2014; Ko,
   Albert Icksang/P-2343-2015; Kikuti, Mariana/G-2313-2017; Ribeiro,
   Guilherme/B-6624-2008
OI Reis, Mitermayer/0000-0002-3051-9060; Paploski, Igor
   AD/0000-0002-3689-2042; Ko, Albert Icksang/0000-0001-9023-2339; Kikuti,
   Mariana/0000-0001-8119-7236; Ribeiro, Guilherme/0000-0002-6798-2059
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [400830/2013-2, 440891/2016-7]; Bahia Foundation for Research
   Support [PET0026/2013, APP0044/2016, PET0022/2016]; Coordination for the
   Improvement of Higher Education Personnel, Brazilian Ministry of
   Education [440891/2016-7]; US National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 TW009504, R01 AI121207, U01 AI088752, R24 AI AI120942]; Yale
   School of Public Health; Federal University of Bahia; Oswaldo Cruz
   Foundation
FX This work was supported by the Brazilian National Council for Scientific
   and Technological Development (grant numbers 400830/2013-2 and
   440891/2016-7 to G.S.R.; and scholarships to I. A. D. P., L. B. T., U.
   K., M. G. R., and G. S. R.); the Bahia Foundation for Research Support
   (grant numbers PET0026/2013, APP0044/2016, and PET0022/2016 to G. S. R.,
   and scholarship to M. M. O. S.); the Coordination for the Improvement of
   Higher Education Personnel, Brazilian Ministry of Education (grant
   number 440891/2016-7 to G. S. R. and scholarship to M. K.); the US
   National Institutes of Health (grant numbers R01 TW009504, R01 AI121207,
   and U01 AI088752 to A. I. K. and R24 AI AI120942 to S. C. W.); the Yale
   School of Public Health; the Federal University of Bahia; and the
   Oswaldo Cruz Foundation.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Azeredo EL, 2018, PLOS CURR, V2, P1
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P368, DOI 10.1309/AJCPMPSINQ9BRMU6
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, P1, DOI [10.1371/joureatpred.0004199, DOI 10.1371/JOUREATPRED.0004199]
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 9
Z9 9
U1 2
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2019
VL 69
IS 8
BP 1353
EP 1359
DI 10.1093/cid/ciy1083
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JD5DW
UT WOS:000490004300012
PM 30561554
OA Green Published
DA 2020-07-08
ER

PT J
AU Qian, YS
   Li, XZ
   Miao, RD
   Liu, SF
   Xin, HB
   Huang, XT
   Wang, TT
   Fu, MG
AF Qian, Yisong
   Li, Xiuzhen
   Miao, Ruidong
   Liu, Shufeng
   Xin, Hong-Bo
   Huang, Xiaotian
   Wang, Tony T.
   Fu, Mingui
TI Selective degradation of plasmid-derived mRNAs by MCPIP1 RNase
SO BIOCHEMICAL JOURNAL
LA English
DT Article
ID VIRAL-RNA; VIRUS; RECOGNITION; REGNASE-1; CELLS; REPLICATION;
   EXPRESSION; INFECTION; BINDING
AB Detection and degradation of foreign nucleic acids is an ancient form of host defense. However, the underlying mechanisms are not completely clear. MCPIP1 is an endoribonuclease and an important regulator in both innate and adaptive immunity by targeting inflammatory mRNA degradation. Here we report that MCPIP1 RNase can also selectively detect and degrade the mRNAs encoded by transfected plasmids. In transient transfection, MCPIP1 expression potently degraded the mRNA from exogenously transfected vectors, which is independent on the vector, genes and cell types used. Conversely, the expression of transfected plasmids in MCPIP1-null cells is significantly higher than that in wild-type cells. Interestingly, overexpression of MCPIP1 or MCPIP1 deficiency does not affect the expression of the exogenous genes incorporated into the host genome in a stable cell line or the global gene expression of host genome. This ability is not associated with PKR/RNase L system, as PKR inhibitors does not block MCPIP1-mediated mRNA degradation of exogenously transfected genes. Lastly, expression of MCPIP1 suppressed replication of Zika virus in infected cells. The study may provide a model for understanding the antiviral mechanisms of MCPIP1, and a putative tool to increase the expression of transfected exogenous genes.
C1 [Qian, Yisong; Li, Xiuzhen; Fu, Mingui] Univ Missouri, Shock Trauma Res Ctr, Sch Med, 2411 Holmes St, Kansas City, MO 64108 USA.
   [Qian, Yisong; Li, Xiuzhen; Fu, Mingui] Univ Missouri, Sch Med, Dept Biomed Sci, 2411 Holmes St, Kansas City, MO 64108 USA.
   [Qian, Yisong; Xin, Hong-Bo] Nanchang Univ, Inst Translat Med, Natl Engn Res Ctr Bioengn Drugs & Technol, 1299 Xuefu Rd, Nanchang 330031, Jiangxi, Peoples R China.
   [Li, Xiuzhen; Huang, Xiaotian] Nanchang Univ, Sch Med, Dept Microbiol, 999 Xuefu Rd, Nanchang 332300, Jiangxi, Peoples R China.
   [Miao, Ruidong] Lanzhou Univ, Sch Life Sci, 222 Tianshui S Rd, Lanzhou 730000, Gansu, Peoples R China.
   [Liu, Shufeng; Wang, Tony T.] US FDA, Lab Vector Borne Viral Dis, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20903 USA.
RP Fu, MG (corresponding author), Univ Missouri, Shock Trauma Res Ctr, Sch Med, 2411 Holmes St, Kansas City, MO 64108 USA.; Fu, MG (corresponding author), Univ Missouri, Sch Med, Dept Biomed Sci, 2411 Holmes St, Kansas City, MO 64108 USA.; Wang, TT (corresponding author), US FDA, Lab Vector Borne Viral Dis, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20903 USA.
EM tony.wang@fda.hhs.gov; fum@umkc.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI138116]
FX This investigation was supported by National Institutes of Health
   (AI138116 to M.F.).
CR Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891
   Fu MG, 2017, NAT REV IMMUNOL, V17, P130, DOI 10.1038/nri.2016.129
   Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590
   Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007
   Huang SP, 2012, CELL SIGNAL, V24, P569, DOI 10.1016/j.cellsig.2011.10.011
   Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282
   Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Li HM, 2016, J GEN VIROL, V97, P1693, DOI 10.1099/jgv.0.000482
   Li M, 2018, MED MICROBIOL IMMUN, V207, P27, DOI 10.1007/s00430-017-0523-0
   Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200
   Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641
   Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880
   Lin RJ, 2014, J IMMUNOL, V193, P4159, DOI 10.4049/jimmunol.1400337
   Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu SF, 2013, P NATL ACAD SCI USA, V110, P19083, DOI 10.1073/pnas.1316208110
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042
   Mao RF, 2017, CELL MOL IMMUNOL, V14, P412, DOI 10.1038/cmi.2016.70
   Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924
   McCormick KD, 2012, ANTIMICROB AGENTS CH, V56, P3399, DOI 10.1128/AAC.06425-11
   Miao RD, 2013, IMMUNOL CELL BIOL, V91, P368, DOI 10.1038/icb.2013.11
   Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029
   NILSEN TW, 1979, P NATL ACAD SCI USA, V76, P2600, DOI 10.1073/pnas.76.6.2600
   Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Terenzi F, 1999, NUCLEIC ACIDS RES, V27, P4369, DOI 10.1093/nar/27.22.4369
   Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034
   Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001
   Yokogawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22324
   Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x
NR 34
TC 0
Z9 0
U1 2
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD OCT 15
PY 2019
VL 476
BP 2927
EP 2938
DI 10.1042/BCJ20190646
PN 19
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JD1KF
UT WOS:000489732900014
PM 31530713
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Rassias, G
   Zogali, V
   Swarbrick, CMD
   Chan, KWK
   Chan, SA
   Gwee, CP
   Wang, S
   Kaplanai, E
   Canko, A
   Kiousis, D
   Lescar, J
   Luo, DH
   Matsoukas, MT
   Vasudevan, SG
AF Rassias, Gerasimos
   Zogali, Vasiliki
   Swarbrick, Crystall M. D.
   Chan, Kitti Wing Ki
   Chan, Shu Ann
   Gwee, Chin Piaw
   Wang, Sai
   Kaplanai, Entzy
   Canko, Aleksander
   Kiousis, Dimitrios
   Lescar, Julien
   Luo, Dahai
   Matsoukas, Minos-Timotheos
   Vasudevan, Subhash G.
TI Cell-active carbazole derivatives as inhibitors of the zika virus
   protease
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Flavivirus; Zika; Protease; Inhibitors; Carbazoles; Amidines
ID NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; NS3 PROTEASES; DENGUE; HELICASE;
   IDENTIFICATION; ACTIVATION; MECHANISM; INFECTION; DOCKING
AB Zika virus (ZIKV) infection recently resulted in an international health emergency the Americas in and despite its high profile there is currently no approved treatment for ZIKV infection with millions of people being at risk. ZIKV is a member of Flaviviridae family which includes prominent members such as dengue virus (DENV) and West Nile virus (WNV). One of the best validated targets for developing antiflaviviral treatment for DENV and WNV infection is the NS2B/NS3 protease. However the inhibitors reported to date have shown limited promise for further clinical development largely due to poor cellular activity. Prompted by the conserved nature of the viral NS2B/NS3 protease across flaviviruses, we envisaged that small molecule inhibitors of the ZIKVpro may be developed by applying rational design on previously reported scaffolds with demonstrated activity against other flaviviral proteases. Starting with an earlier WNVpro hit we performed a scaffold hopping exercise and discovered that certain carbazole derivatives bearing amidine groups possessed submicromolar potency and significant cellular activity against ZIKV. We successfully addressed various issues with the synthesis of novel N-substituted carbazole-based amidines thus permitting a targeted SAR campaign. The in vitro biochemical and cellbased inhibitory profiles exhibited by the lead molecule described in this work (ZIKVpro IC50 0.52 mu M, EC50 1.25 mu M), is among the best reported to date. Furthermore, these molecules possess capacity for further optimization of pharmacokinetics and may evolve to broad spectrum flaviviral protease inhibitors. (C) 2019 Elsevier Masson SAS. All rights reserved.
C1 [Rassias, Gerasimos; Zogali, Vasiliki; Kaplanai, Entzy; Canko, Aleksander; Kiousis, Dimitrios] Univ Patras, Dept Chem, Patras 26504, Greece.
   [Swarbrick, Crystall M. D.; Chan, Kitti Wing Ki; Chan, Shu Ann; Gwee, Chin Piaw; Wang, Sai; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
   [Swarbrick, Crystall M. D.] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld, Australia.
   [Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Matsoukas, Minos-Timotheos] Univ Patras, Dept Pharm, Patras 26504, Greece.
RP Rassias, G (corresponding author), Univ Patras, Dept Chem, Patras 26504, Greece.; Vasudevan, SG (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
EM rassiasg@upatras.gr; subhash.vasudevan@duke-nus.edu.sg
OI Rassias, Gerasimos/0000-0002-8937-4986; Swarbrick,
   Crystall/0000-0002-9337-3361
FU Estate of Tan Sri Khoo Teck Puat; National University of
   SingaporeNational University of Singapore; National Medical Research
   CouncilMedical Research Council UK (MRC) [NMRC/CBRG/0103/2016]; National
   Research Foundation [NRF2016NRF-CRP001-063]
FX The members of the Vasudevan Lab at Duke-NUS Medical School are thanked
   for technical support and valuable comments during the course of this
   study. CMDS would like to acknowledge the Estate of Tan Sri Khoo Teck
   Puat and the National University of Singapore for supporting this
   research through a Khoo Postdoctoral Fellowship Award. The research was
   supported by National Medical Research Council grant NMRC/CBRG/0103/2016
   (PI), National Research Foundation grant NRF2016NRF-CRP001-063 (Co-PI)
   to SGV.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Ekonomiuk D, 2009, J MED CHEM, V52, P4860, DOI 10.1021/jm900448m
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Gubler D., 2007, FLAVIVIRUSES FIELDS
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hilgenfeld R, 2018, ADV EXP MED BIOL, V1062, P131, DOI 10.1007/978-981-10-8727-1_10
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lescar J, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P101
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Lin TI, 2009, ANTIMICROB AGENTS CH, V53, P1377, DOI 10.1128/AAC.01058-08
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Waldrop GL, 2009, BIOCHEM MOL BIOL EDU, V37, P11, DOI 10.1002/bmb.20243
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zou J, 2019, CURR OPIN VIROL, V35, P19, DOI 10.1016/j.coviro.2019.01.005
NR 41
TC 2
Z9 2
U1 3
U2 12
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD OCT 15
PY 2019
VL 180
BP 536
EP 545
DI 10.1016/j.ejmech.2019.07.007
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA JB1FV
UT WOS:000488307100040
PM 31344613
DA 2020-07-08
ER

PT J
AU Khachatoorian, R
   Micewicz, ED
   Micewicz, A
   French, SW
   Ruchala, P
AF Khachatoorian, Ronik
   Micewicz, Ewa D.
   Micewicz, Alina
   French, Samuel W.
   Ruchala, Piotr
TI Optimization of 1,3-disubstituted urea-based inhibitors of Zika virus
   infection
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Antivirals; Zika inhibitors; Zika virus; Plaque assay
ID SMALL-MOLECULE INHIBITORS; SEXUAL TRANSMISSION; ANTIVIRAL ACTIVITY;
   NS2B-NS3 PROTEASE; IDENTIFICATION; BRAZIL; REPLICATION; BRAIN; DRUGS;
   CELLS
AB Zika virus (ZIKV) has become a public health concern worldwide due to its association with congenital abnormalities and neurological diseases. To date, no effective vaccines or antiviral drugs have been approved for the treatment of ZIKV infection, and new inexpensive therapeutic options are urgently needed. In this study, we have used an in vitro plaque assay to assess an antiviral activity of the second generation of anti-ZIKV compounds, based on 1,3-disubstituted (thio)urea scaffold. Several compounds in the library were found to possess excellent activity against Zika virus with IC50 values < 200 pM. The most active analog, A5 exhibited an exceptional IC50 = 85.1 +/- 1.7 pM. Further analysis delineated structural requirements necessary for potent antiviral effects of this class of compounds. Collectively, our findings suggest that 1,3-disubstituted (thio)urea derivatives are excellent preclinical candidates for the development of anti-ZIKV therapeutics.
C1 [Khachatoorian, Ronik; French, Samuel W.] Univ Calif Los Angeles, Dept Pathol & Lab Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Micewicz, Ewa D.] Univ Calif Los Angeles, Dept Radiat Oncol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Micewicz, Alina] UCLA, David Geffen Sch Med, Volunteering Program, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [French, Samuel W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [French, Samuel W.] Univ Calif Los Angeles, UCLA AIDS Inst, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Ruchala, Piotr] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.
   [Ruchala, Piotr] Jane & Terry Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, 760 Westwood Plaza, Los Angeles, CA 90024 USA.
RP Ruchala, P (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.
EM pruchala@mednet.ucla.edu
OI RUCHALA, PIOTR/0000-0002-5574-2779
FU Department of Pathology and Laboratory Medicine (SWF)
FX This project was partially supported by funds from the Department of
   Pathology and Laboratory Medicine (SWF). The authors thank
   Vaithilingaraja Arumugaswami for providing the virus and guidance, Asim
   Dasgupta for providing lab resources, and Christine Mona and Gustavo
   Garcia for technical assistance.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ximenes ASFC, 2019, J MATERN-FETAL NEO M, V32, P493, DOI 10.1080/14767058.2017.1384459
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gharbaran R, 2017, PATHOLOGY, V49, P707, DOI 10.1016/j.pathol.2017.07.008
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   ISAACS D, 2018, J PAEDIATR CHILD H, V54, P926
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liu PP, 2016, BIOORGAN MED CHEM, V24, P1866, DOI 10.1016/j.bmc.2016.03.013
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Rocker AE, 2018, ANTIVIR RES, V152, P26, DOI 10.1016/j.antiviral.2018.02.003
   Saiz J.C., 2017, ANTIMICROB AGENTS CH, P61
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wiwanitkit S, 2017, ASIAN PAC J TROP MED, V10, P682, DOI 10.1016/j.apjtm.2017.06.012
   Wlostowski M, 2010, TETRAHEDRON LETT, V51, P5977, DOI 10.1016/j.tetlet.2010.08.097
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 57
TC 1
Z9 1
U1 1
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD OCT 15
PY 2019
VL 29
IS 20
AR UNSP 126626
DI 10.1016/j.bmcl.2019.126626
PG 5
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA IY7ZA
UT WOS:000486612500018
PM 31477351
DA 2020-07-08
ER

PT J
AU Wang, X
   Shen, MW
   Xiao, YN
   Rong, LB
AF Wang, Xia
   Shen, Mingwang
   Xiao, Yanni
   Rong, Libin
TI Optimal control and cost-effectiveness analysis of a Zika virus
   infection model with comprehensive interventions
SO APPLIED MATHEMATICS AND COMPUTATION
LA English
DT Article
DE Zika; Mosquito-to-human transmission; Human-to-human transmission; Basic
   reproduction number; Sensitivity analysis; Cost-effectiveness; Optimal
   control
ID SEXUAL TRANSMISSION; REPRODUCTION NUMBERS; PERSISTENCE; OUTBREAK
AB Zika virus is a mosquito-borne virus and can spread to humans via bites by infected vectors or through sexual contact with infectious humans. Various protective and control measures such as the use of insecticide-treated nets, condoms, indoor residual spraying and medical treatment of infected humans may mitigate the infection. In this paper, we formulate and analyze a mathematical model that incorporates these comprehensive interventions to study the impact of mosquito-to-human and sexual transmission on the disease dynamics. We obtain the basic reproduction number, study when the disease dies out, and investigate the sensitivity of the basic reproduction number on each control. Numerical results suggest that vector transmission contributes more to the basic reproduction number than sexual transmission. We also formulate the optimal control problem and obtain the necessary conditions that minimize the population of infected individuals and the associated costs. Using the cost effectiveness analysis, we show that a combination of condom use and medical treatment of infected people provides the most cost-effective strategy to control the disease. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Wang, Xia; Rong, Libin] Xinyang Normal Univ, Coll Math & Stat, Xinyang 464000, Peoples R China.
   [Shen, Mingwang] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710061, Shaanxi, Peoples R China.
   [Shen, Mingwang; Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Dept Appl Math, Xian 710049, Shaanxi, Peoples R China.
   [Rong, Libin] Univ Florida, Dept Math, Gainesville, FL 32611 USA.
RP Rong, LB (corresponding author), Xinyang Normal Univ, Coll Math & Stat, Xinyang 464000, Peoples R China.
EM libinrong@ufl.edu
FU NSFCNational Natural Science Foundation of China [11771374, 11801435,
   11631012]; Nanhu Scholar Program for Young Scholars of Xinyang Normal
   University; Program for Science and Technology Innovation Talents in
   Universities of Henan Province [17HASTIT011]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2018M631134];
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [xjh012019055]; National
   Megaproject of Science Research [2017ZX10201101-002-002]; NSFNational
   Science Foundation (NSF) [DMS-1758290]
FX This work is supported by the NSFC (11771374, 11801435, 11631012), Nanhu
   Scholar Program for Young Scholars of Xinyang Normal University, Program
   for Science and Technology Innovation Talents in Universities of Henan
   Province (17HASTIT011), China Postdoctoral Science Foundation
   (2018M631134), Fundamental Research Funds for the Central Universities
   (xjh012019055), National Megaproject of Science Research
   (2017ZX10201101-002-002), and the NSF grant DMS-1758290.
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Aldila D, 2013, MATH BIOSCI, V242, P9, DOI 10.1016/j.mbs.2012.11.014
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bock W, 2018, MATH METHOD APPL SCI, V41, P3231, DOI 10.1002/mma.4812
   Cai LM, 2017, MATH BIOSCI, V288, P94, DOI 10.1016/j.mbs.2017.03.003
   Chaikham N, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-017-1220-4
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard D. T., 2016, MMWR-MORBID MORTAL W, V2016, P65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P23
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gupta N.K., 1973, Mathematical Biosci, V18, P383, DOI 10.1016/0025-5564(73)90012-6
   HALE JK, 1989, SIAM J MATH ANAL, V20, P388, DOI 10.1137/0520025
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Keeling M. J., 2008, MODELING INFECT DIS
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Maxian  O., 2017, EPIDEMICS
   Momoh A . A, 2017, OPERAT RES HLTH CARE
   Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008
   Padmanabhan P, 2017, COMPUT MATH METHOD M, DOI 10.1155/2017/4290825
   Padmanabhan P., 2017, LETT BIOMATHEMATICS, V4, P148, DOI DOI 10.1080/23737867.2017.1319746
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
   Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   World Health Organization, WHO FACT SHEETS VECT
NR 40
TC 2
Z9 1
U1 1
U2 73
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0096-3003
EI 1873-5649
J9 APPL MATH COMPUT
JI Appl. Math. Comput.
PD OCT 15
PY 2019
VL 359
BP 165
EP 185
DI 10.1016/j.amc.2019.04.026
PG 21
WC Mathematics, Applied
SC Mathematics
GA HZ9UV
UT WOS:000469203800012
DA 2020-07-08
ER

PT J
AU Arrieta, G
   Mattar, S
   Villero-Wolf, Y
   Gomezcaceres, L
   Doria, A
AF Arrieta, German
   Mattar, Salim
   Villero-Wolf, Yeneiris
   Gomezcaceres, Luty
   Doria, Amanda
TI Evaluation of serological test of Zika in an endemic area of flavivirus
   in the Colombian Caribbean
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Article
DE Diagnosis differential; Reagent kits; Diagnostic; Epidemiology;
   Arbovirus infections; Tropical medicine
ID VIRUS-INFECTION; DENGUE
AB The Zika virus (ZIKV) is an emerging flavivirus transmitted primarily through arthropods, endemic in Africa, Asia, and the Americas, and is considered a global threat by the World Health Organization.
   Objective: To evaluate a commercial Zika virus test (IgG/IgM catalog number B815C, Biocan, Canada.
   Methods: We evaluated 30 sera of patients diagnosed with Dengue, Leptospira, Malaria, Hantavirus, and Chikungunya. To establish the sensitivity of the test, two groups of sera were analyzed, the first one was patients with Zika RT-qPCR positive, and the second were patients RT-qPCR negative but with clinical suspicion of Zika.
   Results: The specificity was of 23.3% (7/30), the sensitivity in acute patients with positive RT-qPCR was of 63.6%, the patients with clinical suspicion of Zika the sensitivity (IgM) was of 80% (n = 8/10). Overall sensitivity (IgM) of both groups was of 71.4% (15/21).
   Conclusions: The test showed a low specificity to be used as a serological test in an endemic area of flavivirus infection.
C1 [Arrieta, German; Mattar, Salim; Villero-Wolf, Yeneiris; Doria, Amanda] Univ Cordoba, Inst Invest Biol Trop, Monteria, Cordoba, Colombia.
   [Arrieta, German; Mattar, Salim] Clin Salud Social, Sincelejo, Sucre, Colombia.
   [Arrieta, German; Gomezcaceres, Luty] Corp Univ Caribe CECAR, Grp Salud Publ, Sincelejo, Sucre, Colombia.
RP Arrieta, G (corresponding author), Univ Cordoba, Inst Invest Biol Trop, Monteria, Cordoba, Colombia.; Arrieta, G (corresponding author), Clin Salud Social, Sincelejo, Sucre, Colombia.; Arrieta, G (corresponding author), Corp Univ Caribe CECAR, Grp Salud Publ, Sincelejo, Sucre, Colombia.
EM arrietager@yahoo.es
FU University of Cordoba, project sustainability groups
   FMVZ-01-2017-2018-Corporacion Universitaria del Caribe-CECAR 2017 [666]
FX To the University of Cordoba, project sustainability groups
   FMVZ-01-2017-2018-Project Cod. 666-Corporacion Universitaria del
   Caribe-CECAR 2017. To Clinica Salud Social, Sincelejo (Sucre). We also
   thank to Lee Gehrke Ph.D and Irene Bosch Ph.D, for the donation of
   reagents and the critical contributions for improving the manuscript.
CR Alvis-Guzman N, 2017, REV MVZ CORDOBA, V22, P5994, DOI 10.21897/rmvz.1069
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Instituto Nacional de Salud, 2017, PROT VIG SAL PUBL EN
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mattar S, 2017, J INFECT PUBLIC HEAL, V10, P507, DOI 10.1016/j.jiph.2016.09.014
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, WHOZIKVLAB161
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 20
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD OCT 14
PY 2019
VL 18
IS 1
AR 29
DI 10.1186/s12941-019-0328-7
PG 5
WC Microbiology
SC Microbiology
GA JV3NX
UT WOS:000502274100001
PM 31610778
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xu, Y
   Dong, YQ
   Xu, YZ
   Lai, ZT
   Jin, BB
   Hao, YQ
   Gao, YH
   Sun, Y
   Chen, XG
   Gu, JB
AF Xu, Ye
   Dong, Yunqiao
   Xu, Yazhou
   Lai, Zetian
   Jin, Binbin
   Hao, Yanqiang
   Gao, Yonghui
   Sun, Yan
   Chen, Xiao-guang
   Gu, Jinbao
TI Differentiation of Long Non-Coding RNA and mRNA Expression Profiles in
   Male and Female Aedes albopictus
SO FRONTIERS IN GENETICS
LA English
DT Article
DE lncRNAs; Aedes albopictus; transcriptome; sex; mosquitoes
ID GENE; AEGYPTI; SEX; IDENTIFICATION; TRANSCRIPTOME; CHIKUNGUNYA;
   COMPETENCE; ANNOTATION; DOUBLESEX; STRINGTIE
AB The Asia tiger mosquito (Aedes albopictus) is an important vector of arboviruses, and females can transmit pathogens such as the dengue, zika, and chikungunya viruses. Understanding sex-related differences in this mosquito is fundamental for vector control. However, there are no reports of systematic characterization of long non-coding RNAs (lncRNAs) in male and female Ae. albopictus. To investigate the roles of coding and non-coding RNAs in both sexes of Ae. albopictus, RNA sequencing was performed on male and female samples. The results showed 305 differentially expressed protein-coding genes (DEGs) between males and females, of which 198 were highly expressed in males and 125 were highly expressed in females. Sex-associated gene ontology terms were enriched. Analysis with the FEELnc software identified 2,623 novel lncRNAs, of which 26 showed male high expression and 11 showed female high expression. Quantitative real-time PCR of randomly selected DEGs and lncRNAs supported the validity of the RNA sequencing results. Knocking down male high-expressed gene AALF000433 in male adults reduced the egg hatching rate. This study provides valuable data on sex-specific expression of protein-coding genes and lncRNAs in adult Ae. albopictus, which will guide further studies aimed at understanding sex development and determination mechanisms in this species.
C1 [Xu, Ye; Xu, Yazhou; Lai, Zetian; Jin, Binbin; Gao, Yonghui; Sun, Yan; Chen, Xiao-guang; Gu, Jinbao] Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.
   [Dong, Yunqiao] Guangdong Women & Children Hosp, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China.
   [Hao, Yanqiang] Guangdong Women & Children Hosp, Dept Lab Med, Guangzhou, Guangdong, Peoples R China.
RP Gu, JB (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.
EM gujinbao@smu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81672054]; Natural Science Foundation of Guangdong
   ProvinceNational Natural Science Foundation of Guangdong Province
   [2017A030313120]; Research Team Program of the Natural Science
   Foundation of Guangdong [2014A030312016]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2018M633078]
FX This work was supported by the National Natural Science Foundation of
   China (81672054), the Natural Science Foundation of Guangdong Province
   (2017A030313120), the Research Team Program of the Natural Science
   Foundation of Guangdong (2014A030312016), and the China Postdoctoral
   Science Foundation (2018M633078).
CR Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Arun G, 2012, MOL CELL BIOL, V32, P3140, DOI 10.1128/MCB.00006-12
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175
   Che TD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193552
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Donato L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35086-z
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Etebari K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005069
   Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784
   Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172
   Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Huang MG, 2016, ONCOTARGET, V7, P47186, DOI 10.18632/oncotarget.9706
   Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248
   Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848
   Jarroux J, 2017, ADV EXP MED BIOL, V1008, P1, DOI 10.1007/978-981-10-5203-3_1
   Jenkins AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1507-3
   Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87
   Kimura S, 2013, FEBS LETT, V587, P922, DOI 10.1016/j.febslet.2013.02.019
   Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391
   Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245
   Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857
   Ledon-Rettig CC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14593
   Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311
   Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McAfee A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000256
   McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435
   Miller JR, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix135
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Mulvey BB, 2014, BBA-GENE REGUL MECH, V1839, P773, DOI 10.1016/j.bbagrm.2014.06.007
   Nolasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042536
   Padron A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-636
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Prescott P, 2004, ENCY STAT SCI, P8372
   R Core Team, 2013, R LANG ENV STAT COMP
   Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022
   Shichino Y, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140022
   Shirangi TR, 2016, DEV CELL, V37, P533, DOI 10.1016/j.devcel.2016.05.012
   Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646
   Tsujimoto H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171345
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251
   Villegas VE, 2014, MOL ONCOL, V8, P912, DOI 10.1016/j.molonc.2014.03.009
   Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006
   Wang Y, 2018, GENOMICS, V110, P35, DOI 10.1016/j.ygeno.2017.08.003
   Wucher V, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1306
   Xu J, 2017, INSECT BIOCHEM MOLEC, V80, P42, DOI 10.1016/j.ibmb.2016.11.005
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang L, 2010, BIOCHEM BIOPH RES CO, V400, P696, DOI 10.1016/j.bbrc.2010.08.130
NR 54
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD OCT 14
PY 2019
VL 10
AR 975
DI 10.3389/fgene.2019.00975
PG 16
WC Genetics & Heredity
SC Genetics & Heredity
GA JO2QF
UT WOS:000497426800001
PM 31681418
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McLaughlin, GM
   Dearden, PK
AF McLaughlin, Gemma M.
   Dearden, Peter K.
TI Invasive Insects: Management Methods Explored
SO JOURNAL OF INSECT SCIENCE
LA English
DT Review
DE invasive insect; pesticide; biocontrol; gene editing; RNA interference
ID LISTRONOTUS-BONARIENSIS; BIOLOGICAL-CONTROL; RNA INTERFERENCE; SELFISH
   GENES; SOCIAL WASPS; CANE TOAD; RESISTANCE; CRISPR/CAS9; HYMENOPTERA;
   DROSOPHILA
AB Invasive insect species can act as a plague across the globe, capable of vast expansion and rapid, proliferate reproduction.The spread of pathogens of serious diseases such as malaria and Zika virus and damages to agricultural crops number some of the afflictions invasive insects provide to humans alone. Additionally, an escape from predators can fail to keep invasive insects in check, providing potential threats such as extra resource competition to native species when insects invade. A variety of methods are employed to combat these invasive species, each with their own varying levels of success. Here, we explore the more traditional methods of invasive insect pest control, such as pesticides and biological control. In lieu of several unintended consequences resulting from such practices, we suggest some should be abandoned. We evaluate the potential of new techniques, in particular, those with a genetic component, regarding the costs, benefits and possible consequences of implementing them. And finally, we consider which techniques should be the focus of future research, if we truly wish to manage or even eradicate invasive insects in their introduced lands.
C1 [McLaughlin, Gemma M.; Dearden, Peter K.] Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.
   [Dearden, Peter K.] Univ Otago, Genom Aotearoa, POB 56, Dunedin 9054, New Zealand.
RP McLaughlin, GM (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.
EM mclge271@student.otago.ac.nz
RI Dearden, Peter/B-7607-2008
OI Dearden, Peter/0000-0001-7790-9675
CR ABBAS G., 2015, ADV ENTOMOLOGY, V3, P16, DOI [10.4236/ae.2015.31003, DOI 10.4236/AE.2015.31003]
   ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360
   Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5
   Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659
   Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004
   Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020
   Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359
   Beekman M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0440
   Beeman RW, 1999, HEREDITY, V82, P529, DOI 10.1038/sj.hdy.6885150
   Begley S, 2016, MONSANTO LICENSES CR
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   BROMILOW RH, 1990, WEED SCI, V38, P305, DOI 10.1017/S0043174500056575
   BROWN AWA, 1986, J AM MOSQUITO CONTR, V2, P123
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   CALTAGIRONE LE, 1989, ANNU REV ENTOMOL, V34, P1, DOI 10.1146/annurev.en.34.010189.000245
   CAMPBELL FT, 1994, FADING FORESTS N AM
   Carroll M, 2017, MICROBIOL RES, V201, P63, DOI 10.1016/j.micres.2017.04.012
   CARSON R., 1962, SILENT SPRING
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002
   Champer J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006796
   Charles J. G., 2005, New Zealand Plant Protection, V58, P12
   Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757
   CLARKE B, 1984, PAC SCI, V38, P97
   Dearden P, 2017, J ROYAL SOC NZ, V48, P225, DOI DOI 10.1080/03036758.2017.1385030)
   DONOVAN BJ, 1987, NEW ZEAL J ZOOL, V14, P329, DOI 10.1080/03014223.1987.10423002
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Edwards E, 2017, INT J PEST MANAGE, V63, P266, DOI 10.1080/09670874.2017.1308581
   Esvelt KM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003850
   Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117
   Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945
   Gemmell NJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2549
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199
   Gorman K, 2016, PEST MANAG SCI, V72, P618, DOI 10.1002/ps.4151
   Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713
   Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2
   HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413
   Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744
   Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004
   Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513
   Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x
   Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0
   KINZIE RA, 1992, BIOL CONSERV, V60, P149, DOI 10.1016/0006-3207(92)91248-Q
   Krishna VV, 2012, AGR SYST, V107, P47, DOI 10.1016/j.agsy.2011.11.005
   Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390
   Lester PJ, 2014, DIVERS DISTRIB, V20, P964, DOI 10.1111/ddi.12223
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   LINDQUIST DA, 1992, MED VET ENTOMOL, V6, P2, DOI 10.1111/j.1365-2915.1992.tb00027.x
   LIU G, 1939, PSYCHE, V46, P23, DOI DOI 10.1155/1939/74632
   Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2
   LOWE S, 2000, ALIENS INVASIVE SPEC, V12, P12
   LUBIN YD, 1984, BIOL J LINN SOC, V21, P229, DOI 10.1111/j.1095-8312.1984.tb02064.x
   MacIntyre P, 2015, INT PEST CONTROL, V57, P162
   Mao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048718
   McMeniman C. J., 2010, PLOS NEGLECT TROP D, V4, P1
   McNeill MR, 2002, BIOL CONTROL, V24, P167, DOI 10.1016/S1049-9644(02)00018-X
   Min J., 2017, BIORXIV, DOI DOI 10.1101/104877
   Min J., 2017, BIORXIV, DOI [10.1101/115618, DOI 10.1101/115618]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOLLER H, 1991, NEW ZEAL J ZOOL, V18, P171, DOI 10.1080/03014223.1991.10757964
   Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801
   Noble C, 2016, PNAS, V116, P8275
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Paull J, 2013, R CARSON LETT MAKING, P51
   Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x
   Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a
   Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002
   Popay A. J., 2011, New Zealand Plant Protection, V64, P55
   Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203
   RAJU NB, 1994, MYCOLOGIA, V86, P461, DOI 10.2307/3760737
   Richardson B., 2005, New Zealand Plant Protection, V58, P17
   Roques A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120864
   Schimenti J, 2000, TRENDS GENET, V16, P240, DOI 10.1016/S0168-9525(00)02020-5
   Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014
   Siviter H, 2018, NATURE, V561, P109, DOI 10.1038/s41586-018-0430-6
   Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228
   Slater R, 2011, PEST MANAG SCI, V67, P633, DOI 10.1002/ps.2101
   Stanley DA, 2015, NATURE, V528, P548, DOI 10.1038/nature16167
   Suh E, 2017, ACTA TROP, V172, P232, DOI 10.1016/j.actatropica.2017.05.015
   Swevers Luc, 2012, P177
   Swezey O. H, 1931, HDB INSECTS OTHER IN, P400
   TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671
   Tauber Maurice J., 2000, American Entomologist, V46, P26
   Tomasetto F, 2017, P NATL ACAD SCI USA, V114, P3885, DOI 10.1073/pnas.1618416114
   Tomizawa M, 2011, J AGR FOOD CHEM, V59, P2883, DOI 10.1021/jf103856c
   Travanty EA, 2004, INSECT BIOCHEM MOLEC, V34, P607, DOI 10.1016/j.ibmb.2004.03.013
   van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007
   Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24
   Vreysen MJB, 2007, AREA WIDE CONTROL IN
   Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007
   Wolff JN, 2017, ELIFE, V6, DOI 10.7554/eLife.23551
   World Health Organization, 2017, WORLD MAL REP 2017
   Yan H, 2017, CELL, V170, P736, DOI 10.1016/j.cell.2017.06.051
   Yang NW, 2014, BIOL CONTROL, V68, P92, DOI 10.1016/j.biocontrol.2013.06.012
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825
   Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746
   Zentner GE, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700109
   ZETTLER JL, 1990, J ECON ENTOMOL, V83, P1677, DOI 10.1093/jee/83.5.1677
NR 107
TC 1
Z9 1
U1 5
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
EI 1536-2442
J9 J INSECT SCI
JI J Insect Sci.
PD OCT 14
PY 2019
VL 19
IS 5
AR 17
DI 10.1093/jisesa/iez085
PG 9
WC Entomology
SC Entomology
GA JH9LU
UT WOS:000493090600002
PM 31612947
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mattiuzz, G
   Knezevic, I
   Hassall, M
   Ashall, J
   Myhill, S
   Faulkner, V
   Hockley, J
   Rigsby, P
   Wilkinson, DE
   Page, M
   Donolato, M
   Baylis, S
   Yue, C
   Elgner, F
   Yoon, IK
   Yang, JS
   Song, M
   Gonzalez-Escobar, G
   Brindle, R
   Tedder, R
   Dicks, S
   Ushiro-Lumb, I
   Williams-McDonald, S
   Kumar, S
   Peden, K
   Golding, H
   Khurana, S
   Bonaparte, M
   Durbin, A
   Dean, H
   Sonnberg, S
   Hogrefe, W
   Crowe, J
   Voss, T
   Collins, SM
   Pierson, T
   Burgomaster, K
   Dowd, K
   Sigismondi, L
   Gunasekera, D
   Wassenberg, J
   Eckels, K
   De La Barrer, R
AF Mattiuzz, Giada
   Knezevic, Ivana
   Hassall, Mark
   Ashall, James
   Myhill, Sophie
   Faulkner, Valwynne
   Hockley, Jason
   Rigsby, Peter
   Wilkinson, Dianna E.
   Page, Mark
   Donolato, Marco
   Baylis, Sally
   Yue, Constanza
   Elgner, Fabian
   Yoon, In-Kyu
   Yang, Jae Seung
   Song, Manki
   Gonzalez-Escobar, Gabriel
   Brindle, Richard
   Tedder, Richard
   Dicks, Steve
   Ushiro-Lumb, Ines
   Williams-McDonald, Sarah
   Kumar, Sanjai
   Peden, Keith
   Golding, Hana
   Khurana, Surender
   Bonaparte, Matthew
   Durbin, Anna
   Dean, Hansi
   Sonnberg, Stephanie
   Hogrefe, Wayne
   Crowe, James
   Voss, Thomas
   Collins, Matthew S.
   Pierson, Theodore
   Burgomaster, Katherine
   Dowd, Kimberly
   Sigismondi, Louise
   Gunasekera, Dhammika
   Wassenberg, James
   Eckels, Kenneth
   De La Barrer, Rafael
CA Collaborative Study Participants
TI Harmonization of Zika neutralization assays by using the WHO
   International Standard for anti-Zika virus antibody
SO NPJ VACCINES
LA English
DT Article
ID HUMAN POLYCLONAL ANTIBODIES; INFECTION; TRANSMISSION; DIAGNOSIS
AB During outbreaks of emerging viruses, such as the Zika outbreak in 2015-2016, speed and accuracy in detection of infection are critical factors to control the spread of the disease; often serological and diagnostic methods for emerging viruses are not well developed and validated. Thus, vaccines and treatments are difficult to evaluate due to the lack of comparable methods. In this study, we show how the 1st WHO International Standard for anti-Zika antibody was able to harmonize the neutralization titres of a panel of serological Zika-positive samples from laboratories worldwide. Expression of the titres in International Unit per millilitre reduced the inter-laboratory variance, allowing for greater comparability between laboratories. We advocate the use of the International Standard for anti-Zika virus antibodies for the calibration of neutralization assays to create a common language, which will permit a clear evaluation of the results of different clinical trials and expedite the vaccine/treatment development.
C1 [Mattiuzz, Giada; Hassall, Mark; Ashall, James; Myhill, Sophie; Faulkner, Valwynne; Wilkinson, Dianna E.; Page, Mark; Dicks, Steve; Williams-McDonald, Sarah] NIBSC, Div Virol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
   [Knezevic, Ivana] WHO, Dept Essential Med & Hlth Prod, Ave Appia 20, CH-1211 Geneva, Switzerland.
   [Hockley, Jason; Rigsby, Peter] NIBSC, Dept Biostat, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
   [Donolato, Marco] BlueSense Diagnost ApS, Copenhagen, Denmark.
   [Baylis, Sally; Yue, Constanza; Elgner, Fabian] Paul Ehrlich Inst, Langen, Germany.
   [Yoon, In-Kyu; Yang, Jae Seung; Song, Manki] Int Vaccine Inst, Seoul, South Korea.
   [Gonzalez-Escobar, Gabriel; Brindle, Richard] Caribbean Publ Hlth Agcy, St Clair Port Of Spain, Trinidad Tobago.
   [Ushiro-Lumb, Ines] Publ Hlth England, Virus Reference Dept, London, England.
   [Tedder, Richard; Kumar, Sanjai; Peden, Keith; Golding, Hana; Khurana, Surender] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA.
   [Bonaparte, Matthew] Sanofi Pasteur, Swiftwater, PA USA.
   [Durbin, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Dean, Hansi; Sonnberg, Stephanie] Takeda Vaccines Inc, Deerfield, IL USA.
   [Hogrefe, Wayne] Focus Diagnost Inc, Q2 Solut Vaccines, San Juan Capistrano, CA USA.
   [Crowe, James; Voss, Thomas] Vanderbilt Univ, Med Ctr, Nashville, TN USA.
   [Collins, Matthew S.] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Pierson, Theodore; Burgomaster, Katherine; Dowd, Kimberly] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Sigismondi, Louise; Gunasekera, Dhammika] Chembio Diagnost Syst Inc, Medford, NY USA.
   [Wassenberg, James] DiaSorin Inc, Stillwater, MN USA.
   [Eckels, Kenneth; De La Barrer, Rafael] Walter Reed Army Inst Res, Silver Spring, MD USA.
RP Mattiuzz, G (corresponding author), NIBSC, Div Virol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
EM Giada.Mattiuzzo@nibsc.org
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079; Knezevic,
   Ivana/0000-0002-6441-7601; Mattiuzzo, Giada/0000-0001-9475-1590; Tedder,
   Richard/0000-0002-9672-5721
FU NIHR Policy Research Programme (NIBSC Regulatory Science Research Unit)
FX We gratefully acknowledge the important contributions of the
   collaborative study participants. We would also like to thank NIBSC
   Standards Production and Development for distribution of the candidate
   materials. We also thank David Wood and Micha Nuebling of the WHO and
   participants of teleconferences for their support, guidance and advice,
   and Steven A. Rubin, Swati Verma, Hira Nakhasi, and Uwe Scherf FDA/CBER,
   USA for facilitating the sample permits and shipments to laboratories in
   the USA. This paper is based on independent research commissioned and
   funded by the NIHR Policy Research Programme (NIBSC Regulatory Science
   Research Unit). The views expressed in the publication are those of the
   author(s) and not necessarily those of the NHS, the NIHR, the Department
   of Health, 'arms' length bodies or other government departments.
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2019, TEST ZIK
   CDC, 2018, DIAGN TESTS ZIK VIR
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dianna E. W., 2015, WHOBS20152280
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EDQM, 2013, COMBISTATS
   Ferguson M, 2004, BIOLOGICALS, V32, P195, DOI 10.1016/j.biologicals.2004.09.003
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heath A., 2005, WHOBS052209
   Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Mukherjee R, 2015, JALA-J LAB AUTOM, V20, P519, DOI 10.1177/2211068214563794
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   WHO, 2018, BLOOD PROD REL BIOL
   WHO, 2016, ZIK SIT REP NEUR SYN
   WHO, 1998, WHO TECHN REP SER, V872
   WHO, 2018, ZIK VACC DEV TECHN R
   WHO/UNICEF, 2017, WHO UNICEF ZIK VIR Z
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wilkinson D. E., 2017, WHOBS20172316
   World Health Organization, 2019, WHO TECHN REP SER, V4
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 43
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD OCT 14
PY 2019
VL 4
AR 42
DI 10.1038/s41541-019-0135-3
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JD7UR
UT WOS:000490188100001
PM 31632743
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Motoki, MT
   Fonseca, DM
   Miot, EF
   Demari-Silva, B
   Thammavong, P
   Chonephetsarath, S
   Phommavanh, N
   Hertz, JC
   Kittayapong, P
   Brey, PT
   Marcombe, S
AF Motoki, Maysa Tiemi
   Fonseca, Dina Madera
   Miot, Elliott Frederic
   Demari-Silva, Bruna
   Thammavong, Phoutmany
   Chonephetsarath, Somsanith
   Phommavanh, Nothasine
   Hertz, Jeffrey Conrad
   Kittayapong, Pattamaporn
   Brey, Paul Trevor
   Marcombe, Sebastien
TI Population genetics of Aedes albopictus (Diptera: Culicidae) in its
   native range in Lao People's Democratic Republic
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; cox1 gene; Genetic population; Lao PDR
ID ASIAN TIGER MOSQUITO; SKUSE DIPTERA; VECTOR STATUS; GLOBAL RISK; DENGUE;
   MITOCHONDRIAL; CHIKUNGUNYA; SOFTWARE; AEGYPTI; VIRUS
AB Background The Asian tiger mosquito, Aedes (Stegomyia) albopictus (Skuse) is an important worldwide invasive species and can be a locally important vector of chikungunya, dengue and, potentially, Zika. This species is native to Southeast Asia where populations thrive in both temperate and tropical climates. A better understanding of the population structure of Ae. albopictus in Lao PDR is very important in order to support the implementation of strategies for diseases prevention and vector control. In the present study, we investigated the genetic variability of Ae. albopictus across a north-south transect in Lao PDR. Methods We used variability in a 1337-bp fragment of the mitochondrial cytochrome c oxidase subunit 1 gene (cox1), to assess the population structure of Ae. albopictus in Lao PDR. For context, we also examined variability at the same genetic locus in samples of Ae. albopictus from Thailand, China, Taiwan, Japan, Singapore, Italy and the USA. Results We observed very high levels of genetic polymorphism with 46 novel haplotypes in Ae. albopictus from 9 localities in Lao PDR and Thailand populations. Significant differences were observed between the Luangnamtha population and other locations in Lao PDR. However, we found no evidence of isolation by distance. There was overall little genetic structure indicating ongoing and frequent gene flow among populations or a recent population expansion. Indeed, the neutrality test supported population expansion in Laotian Ae. albopictus and mismatch distribution analyses showed a lack of low frequency alleles, a pattern often seen in bottlenecked populations. When samples from Lao PDR were analyzed together with samples from Thailand, China, Taiwan, Japan, Singapore, Italy and the USA, phylogenetic network and Bayesian cluster analysis showed that most populations from tropical/subtropical regions are more genetically related to each other, than populations from temperate regions. Similarly, most populations from temperate regions are more genetically related to each other, than those from tropical/subtropical regions. Conclusions Aedes albopictus in Lao PDR are genetically related to populations from tropical/subtropical regions (i.e. Thailand, Singapore, and California and Texas in the USA). The extensive gene flow among locations in Lao PDR indicates that local control is undermined by repeated introductions from untreated sites.
C1 [Motoki, Maysa Tiemi; Miot, Elliott Frederic; Thammavong, Phoutmany; Chonephetsarath, Somsanith; Phommavanh, Nothasine; Brey, Paul Trevor; Marcombe, Sebastien] Inst Pasteur Laos, Med Entomol & Vector Borne Dis Unit, Viangchan, Laos.
   [Motoki, Maysa Tiemi] Vysnova Partners Inc, Landover, MD 20785 USA.
   [Motoki, Maysa Tiemi] Museum Support Ctr, Smithsonian Inst, Walter Reed Biosystemat Unit, MRC 534, Suitland, MD 20746 USA.
   [Fonseca, Dina Madera] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.
   [Fonseca, Dina Madera] Rutgers State Univ, Dept Entomol, New Brunswick, NJ USA.
   [Miot, Elliott Frederic] Univ Paris 06, Cellule Pasteur UPMC, Paris, France.
   [Miot, Elliott Frederic] Inst Pasteur, Dept Genomes & Genet, Insect Virus Interact Grp, Paris, France.
   [Miot, Elliott Frederic] CNRS, Unite Mixte Rech 2000, F-2000 Paris, France.
   [Demari-Silva, Bruna] Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil.
   [Hertz, Jeffrey Conrad] US Naval Med Res Unit TWO, Singapore, Singapore.
   [Kittayapong, Pattamaporn] Mahidol Univ, Bangkok, Thailand.
RP Motoki, MT (corresponding author), Inst Pasteur Laos, Med Entomol & Vector Borne Dis Unit, Viangchan, Laos.; Motoki, MT (corresponding author), Vysnova Partners Inc, Landover, MD 20785 USA.; Motoki, MT (corresponding author), Museum Support Ctr, Smithsonian Inst, Walter Reed Biosystemat Unit, MRC 534, Suitland, MD 20746 USA.
EM maysatm@gmail.com
FU U.S. Naval Medical Research Unit TWO [D1428]; Military Infectious
   Diseases Research Program; Institut Pasteur du Laos
FX The views expressed in this publication are those of the author and do
   not necessarily reflect the official policy or position of the
   Department of the Navy, Department of Defense, nor the U.S. Government.
   This study was partially supported by the U.S. Naval Medical Research
   Unit TWO, work unit number D1428, in support of the Military Infectious
   Diseases Research Program and Institut Pasteur du Laos. I (JCH) am a
   military service member. This work was prepared as part of my official
   duties. Title 17, U.S.C., 105 provides that copyright protection under
   this title is not available for any work of the U.S. Government. Title
   17, U.S.C., 101 defines a U.S. Government work as a work prepared by a
   military service member or employee of the U.S. Government as part of
   that person's official duties.
CR Banu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089440
   Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Bounlu K, 1992, JPN J TROP MED HYG, V38, P172
   Campos M, 2012, ECOL EVOL, V2, P2794, DOI 10.1002/ece3.392
   Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Fu YX, 1997, GENETICS, V147, P915
   Fukunaga T, 1994, TROP MED, V35, P219
   Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guo XF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-70
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Ismail NA, 2015, J AM MOSQUITO CONTR, V31, P305, DOI 10.2987/moco-31-04-305-312.1
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Khampapongpane B, 2014, WEST PAC SURVEILL RE, V5, DOI [10.5365/wpsar.2014.5.1.001, 10.5365/WPSAR.2014.5.1.001]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115569
   Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624
   Makino Y, 1995, TROP MED, V36, P131
   MANTEL N, 1967, CANCER RES, V27, P209
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Mendenhall IH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005667
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321
   Novak R, 1992, AEDES ALBOPICTUS WIN, V3, P5
   Paily KP, 2013, PARASITOL RES, V112, P1299, DOI 10.1007/s00436-012-3265-3
   Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Pritchard JK, 2000, GENETICS, V155, P945
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   Rattanarithikul Rampa, 2010, Southeast Asian J Trop Med Public Health, V41 Suppl 1, P1
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x
   ROGERS AR, 1992, MOL BIOL EVOL, V9, P552
   ROSEN L, 1985, AM J TROP MED HYG, V34, P603, DOI 10.4269/ajtmh.1985.34.603
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Schmidt TL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006009
   SLATKIN M, 1991, GENETICS, V129, P555
   Sumodan P. K., 2015, Socio-ecological dimensions of infectious diseases in Southeast Asia, P155
   TAJIMA F, 1989, GENETICS, V123, P585
   Tangena JAA, 2017, J MED ENTOMOL, V54, P1589, DOI 10.1093/jme/tjx071
   Tangena JAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005802
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709
   Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   WELLMER H, 1983, DENGUE HAEMORRHAGIC
   WHO, 2017, UPD DENG SIT W PAC R
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zarza E, 2008, MOL ECOL, V17, P3259, DOI 10.1111/j.1365-294X.2008.03826.x
   Zawani MKN, 2014, GENET MOL RES, V13, P8184, DOI 10.4238/2014.October.7.13
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
   Zitko T, 2011, EUR J ENTOMOL, V108, P501, DOI 10.14411/eje.2011.065
NR 76
TC 0
Z9 0
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 14
PY 2019
VL 12
IS 1
AR 477
DI 10.1186/s13071-019-3740-0
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JD7FT
UT WOS:000490147300004
PM 31610813
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Verdin-Betancourt, FA
   Figueroa, M
   Lopez-Gonzalez, MD
   Gomez, E
   Bernal-Hernandez, YY
   Rojas-Garcia, AE
   Sierra-Santoyo, A
AF Alberto Verdin-Betancourt, Francisco
   Figueroa, Mario
   de Lourdes Lopez-Gonzalez, Ma
   Gomez, Elizabeth
   Yvette Bernal-Hernandez, Yael
   Elizabeth Rojas-Garcia, Aurora
   Sierra-Santoyo, Adolfo
TI In vitro inhibition of human red blood cell acetylcholinesterase (AChE)
   by temephos-oxidized products
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SOLID-PHASE EXTRACTION; TRANSFORMATION PRODUCTS; LIQUID-CHROMATOGRAPHY;
   BISPHENOL-S; ABATE INSECTICIDE; IDENTIFICATION; CHLORPYRIFOS;
   METABOLISM; COMPLEXES; TOXICITY
AB Temephos (Tem) is an organophosphorus pesticide widely used to kill and prevent the growth of the main vectors for the transmission of dengue, zika, and chikungunya viruses. In chlorinated water, Tern is oxidized to its dioxon-sulfoxide (Tern-dox-SO), dioxon-sulfone (Tern-dox-SO2), and sulfoxide (Tern-SO) derivatives; however, these compounds are not commercially available to be used as standards and in toxicological studies. In the present study, we synthesized and characterized the Tem-oxidation products and the compound 4,4'-sulfinyldiphenol. These compounds were obtained by a simple reaction between Tem or 4,4'-thiodiphenol with sodium hypochlorite or potassium periodate, and were characterized by IR, NMR, and U PLC-H RESIMS. The in vitro evaluation of inhibitory potency of Tem-oxidized products on human red blood cell acetylcholinesterase (RBC AChE) showed that Tem-dox-SO2 was the most potent inhibitor of human RBC AChE, and its effect was more pronounced than that observed for ethyl-paraoxon, a potent typical inhibitor of AChE. An HPLC-DAD method for the analysis of metabolic products of Tem was developed, which may be useful for monitoring in biological and environmental samples. The ability of Tern-oxidized metabolites to inhibit human RBC AChE suggests that the addition of Tern to chlorinated drinking water could result in an increase in the risk of RBC AChE inhibition after exposure.
C1 [Alberto Verdin-Betancourt, Francisco; de Lourdes Lopez-Gonzalez, Ma; Sierra-Santoyo, Adolfo] Inst Politecn Nacl Cinvestav IPN, Ctr Invest & Estudios Avanzados, Dept Toxicol, Ciudad De Mexico 07360, Mexico.
   [Figueroa, Mario] Univ Nacl Autonoma Mexico, Fac Quim, Ciudad De Mexico 04510, Mexico.
   [Gomez, Elizabeth] Univ Nacl Autonoma Mexico, Inst Quim, Ciudad De Mexico 04510, Mexico.
   [Yvette Bernal-Hernandez, Yael; Elizabeth Rojas-Garcia, Aurora] Univ Autonoma Nayarit, Lab Contaminac & Toxicol Ambiental, Tepic 63155, Nayarit, Mexico.
RP Sierra-Santoyo, A (corresponding author), Inst Politecn Nacl Cinvestav IPN, Ctr Invest & Estudios Avanzados, Dept Toxicol, Ciudad De Mexico 07360, Mexico.
EM asierra@cinvestav.mx
RI Figueroa, Mario/AAQ-5286-2020
OI figueroa, mario/0000-0001-7004-0591
FU Mexican Toxicology Network-CONACyT [294303]; UNAM-DGAPAUniversidad
   Nacional Autonoma de Mexico [205017, PAIP 5000-9145];  [CONACyT-CB
   236564];  [INFRA 252226]
FX The authors are grateful to the Mexican Toxicology Network-CONACyT
   (Grant 294303) for the financial support to conduct the cholinesterase
   inhibition assays. M.F. grateful for the partial financial support from
   CONACyT-CB 236564 and -INFRA 252226, and UNAM-DGAPA 205017 and -PAIP
   5000-9145. The authors thank Maria del Carmen Garcia and Luis Velasco
   for their technical support, and QFB Adrian De la Rosa-Lizarraga for his
   support in the writing of the article.
CR Bernal-Hernandez Y. Y., 2018, REV INT CONTAM AMBIE, V34, P25
   BLINN RC, 1969, J AGR FOOD CHEM, V17, P118, DOI 10.1021/jf60161a614
   BLINN RC, 1968, J AGR FOOD CHEM, V16, P441, DOI 10.1021/jf60157a026
   da Silva BS, 2019, ENVIRON POLLUT, V250, P312, DOI 10.1016/j.envpol.2019.03.100
   Duirk SE, 2006, ENVIRON SCI TECHNOL, V40, P546, DOI 10.1021/es0516615
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   EPA U.S. Environmental Protection Agency, 2008, RER EL DEC RED TEM
   Eyer F., 2006, TOXICOL REV, V22, P143
   FERGUSON PW, 1985, ARCH ENVIRON CON TOX, V14, P143, DOI 10.1007/BF01055604
   Guo JX, 2006, CHEM RES TOXICOL, V19, P209, DOI 10.1021/tx050090r
   Kamel A, 2009, WATER RES, V43, P522, DOI 10.1016/j.watres.2008.10.038
   Kiran V, 2015, EXPRESS POLYM LETT, V9, P1053, DOI 10.3144/expresspolymlett.2015.95
   Lacorte S, 1997, J CHROMATOGR A, V777, P99, DOI 10.1016/S0021-9673(97)00557-8
   LACORTE S, 1995, J CHROMATOGR A, V712, P103, DOI 10.1016/0021-9673(95)00425-M
   Lacorte S, 1996, ENVIRON SCI TECHNOL, V30, P917, DOI 10.1021/es9503589
   LEESCH JG, 1972, PESTIC BIOCHEM PHYS, V2, P223, DOI 10.1016/0048-3575(72)90025-9
   LEONARD NJ, 1962, J ORG CHEM, V27, P282, DOI 10.1021/jo01048a504
   Lovell J. B., 1968, INT CL A45B CL, P135
   Molina-Molina JM, 2013, TOXICOL APPL PHARM, V272, P127, DOI 10.1016/j.taap.2013.05.015
   Ortega-Alfaro MC, 2004, J ORGANOMET CHEM, V689, P885, DOI 10.1016/j.jorganchem.2003.12.015
   Ramachandran T., 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P929
   Regueiro J, 2015, J CHROMATOGR A, V1422, P230, DOI 10.1016/j.chroma.2015.10.046
   Renshaw W., 2006, JOINT FAO WHO SUPPOR
   Seger MR, 2006, ENVIRON SCI TECHNOL, V40, P552, DOI 10.1021/es051734k
   Shrivastava A., 2011, CHRON YOUNG SCI, V2, P21, DOI [10.4103/2229-5186.79345, DOI 10.4103/2229-5186.79345]
   Wu JG, 2003, ENVIRON TOXICOL CHEM, V22, P261, DOI [10.1002/etc.5620220204, 10.1897/1551-5028(2003)022&lt;0261:ATOCTC&gt;2.0.CO;2]
   Zhao F, 2018, ECOTOX ENVIRON SAFE, V147, P794, DOI 10.1016/j.ecoenv.2017.09.048
   Zheng S, 2018, WATER RES, V132, P167, DOI 10.1016/j.watres.2017.12.071
   ZINGARO RA, 1961, J PHYS CHEM-US, V65, P1132, DOI 10.1021/j100825a010
NR 29
TC 1
Z9 1
U1 2
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 14
PY 2019
VL 9
AR 14758
DI 10.1038/s41598-019-51261-2
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JD2QN
UT WOS:000489819200028
PM 31611606
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Patchin, PM
AF Patchin, Paige Marie
TI Thresholds of Empire: Women, Biosecurity, and the Zika Chemical Vector
   Program in Puerto Rico
SO ANNALS OF THE AMERICAN ASSOCIATION OF GEOGRAPHERS
LA English
DT Article; Early Access
ID IMPERIAL; HEALTH; CONTRACEPTION; BIOPOLITICS; CITIZENSHIP; DISEASE;
   ACCESS; PURITY; SPACE
AB La reciente aparici?n de una nueva cepa del virus Zika pone de presente el entrelazamiento global de las ecolog?as virales, humanas y animales en un planeta din?mico. Al demostrar su capacidad de configurar el desarrollo fisiol?gico en el ?tero y ser transmisible tanto por mosquitos como en las relaciones sexuales, el Zika prendi? las alarmas acerca de lo pl?stico de la forma humana frente a enfermedades contagiosas, la permeabilidad de las fronteras entre naciones y estados a la enfermedad infecciosa y el enorme costo de atenci?n m?dica vitalicia que representan este tipo de enfermedades. Estas aprensiones fueron cartografiadas en los Estados Unidos en el ?territorio no incorporado? de Puerto Rico, donde se predijo que un quinto de la poblaci?n contraer?a el virus. Este art?culo examina la intervenci?n qu?mica del gobierno americano en Puerto Rico, de la cual arguyo fue basada en una cartograf?a contradictoria de la isla como si ?sta estuviese ubicada dentro de los Estados Unidos en t?rminos del riesgo, y al mismo tiempo fuera de los Estados Unidos en t?rminos de derechos. Las mujeres portorrique?as fuero espacializadas a manera de umbral entre la agencia del virus y el futuro de la poblaci?n americana. Al ser ellas percibidas como un fracaso en el manejo apropiado de sus cuerpos y hogares, se amenaz? con una fumigaci?n qu?mica a?rea en un despliegue agresivo del poder soberano de los EE.UU. Este art?culo ofrece un cuidadoso an?lisis geogr?fico cr?tico sobre c?mo el poder del estado imperial es expandido a nombre de la salud y c?mo se convierte a las mujeres en diferentes lugares en objetos de bioseguridad. Se hace notar tambi?n una l?gica destructiva de mayor alcance que posiciona las capacidades reproductivas de las mujeres pobres, fuera de los estados norte?os, como el fiel entre un mundo cada d?a m?s desmandado e inhumano, y el futuro. Palabras clave: bioseguridad, geograf?as qu?micas, g?nero, imperio (Puerto Rico), Zika.
C1 [Patchin, Paige Marie] Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada.
RP Patchin, PM (corresponding author), Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada.
EM paige.patchin@geog.ubc.ca
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Agard-Jones A., 2014, SOMATOSPHERE
   Agencia EFE, 2016, IGL CAT PUERT RIC RE
   Ahuja Neel, 2016, BIOINSECURITIES DIS
   [Anonymous], 2009, LANCET, V374, P949, DOI 10.1016/S0140-6736(09)61643-3
   [Anonymous], 2016, DIRECTOR WIC CULPA C
   Ayala C., 2006, PUERTO RICO AM CENTU
   Begnaud D., 2016, CBS NEWS
   Berman-Santana D., 1996, KICKING BOOTSTRAPS E
   Bingham N, 2008, ENVIRON PLANN A, V40, P1528, DOI 10.1068/a4173
   Blaut J., 1983, ANTIPODE, V15, P35
   Blaut JM, 1975, ANTIPODE, V7, P1
   Blaut JM, 1974, ANTIPODE, V6, P37
   Bonilla Yarimar, 2017, WASHINGTON POST
   Braun B, 2007, CULT GEOGR, V14, P6, DOI 10.1177/1474474007072817
   Braun B, 2005, ENVIRON PLANN D, V23, P802
   Breidenbaugh Mark, 2008, US Army Med Dep J, P54
   Briggs Laura, 2002, REPRODUCING EMPIRE R
   Caro Gonzalez L, 2016, NUEVO DIA       0721
   Centers for Disease Control and Prevention, 2017, INS RES TEST PUERT R
   Centers for Disease Control and Prevention, 2018, ZIK VIR PREV TRANSM
   Centers for Disease Control and Prevention, 2016, CDCS RESP ZIK AER SP
   Cooper M, 2006, THEOR CULT SOC, V23, P113, DOI 10.1177/0263276406065121
   Coto D., 2016, ASS PRESS
   Criollo Oquero A., 2016, NOTICEL         0810
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Davies SE, 2008, INT AFF, V84, P295, DOI 10.1111/j.1468-2346.2008.00704.x
   Davis JS, 2007, GEOJOURNAL, V69, P165, DOI 10.1007/s10708-007-9095-7
   Derby L, 2008, PAST PRESENT, P290
   Deutscher Penelope, 2017, FOUCAULTS FUTURES CR
   Edelman Lee., 2004, NO FUTURE QUEER THEO
   Ehlers N., 2017, SUBPRIME HLTH DEBT R, P31
   Fearnley L, 2008, ENVIRON PLANN A, V40, P1615, DOI 10.1068/a4060
   Fonseca J., 2016, FACEBOOK PAGE
   Fonseca M, 2019, INTERVENTIONS-UK, V21, P747, DOI 10.1080/1369801X.2019.1585917
   Foucault M, 1980, HIST SEXUALITY
   Galt R., 2017, GEOHUMANITIES, V3, P162, DOI [10.1080/2373566X.2017.1298972, DOI 10.1080/2373566X.2017.1298972]
   Garriga-Lopez A, 2016, REV 80 GRADOS
   Goldstein A., 2016, THEORY EVENT, V19, P1
   Gomez S, 2016, TELEMUNDO       0620
   Gooch H., 2017, PESTMANAGEMENT PROFE
   Gregory D., 2014, WAR EBOLA       1025
   Gregory D, 2006, GEOGR ANN B, V88B, P405, DOI 10.1111/j.0435-3684.2006.00230.x
   Grosfoguel Ramon, 2003, COLONIAL SUBJECTS PU
   Gruendel J., 2016, CISC VIS NETW IND GL
   Guthman J, 2016, AGR HUM VALUES, V33, P575, DOI 10.1007/s10460-015-9626-7
   Guthman J, 2013, PROG HUM GEOG, V37, P486, DOI 10.1177/0309132512463258
   Harris A., 2016, MIAMI HERALD
   Holpuch Amanda, 2017, GUARDIAN
   Ingram A., 2005, GEOPOLITICS, V10, P522, DOI DOI 10.1080/14650040591003516
   Jackson PSB, 2013, CULT GEOGR, V20, P43, DOI 10.1177/1474474012455017
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   LeBron M, 2016, NACLA REPORT AM, V28, P115, DOI [10.1080/10714839.2016.1201266, DOI 10.1080/10714839.2016.1201266]
   Leefeldt E., 2016, CBS NEWS
   LIVINGSTONE Grace, 2009, AM BACKYARD US LATIN
   Mansfield B, 2012, ANN ASSOC AM GEOGR, V102, P969, DOI 10.1080/00045608.2012.657496
   Markel H, 2002, MILBANK Q, V80, P757, DOI 10.1111/1468-0009.00030
   Martinez L, 2016, ACTUALIZACION PROVEE
   Mawani R., 2003, LAW SOCIAL JUSTICE G, V1
   McNeil D., 2016, ZIKA EMERGING EPIDEM
   McNeil Jr Donald G., 2016, NY TIMES
   Melendez E, 2013, CENTRO J, V25, P106
   Murphy M., 2017, EC LIFE
   Murphy M, 2017, CULT ANTHROPOL, V32, P494, DOI 10.14506/ca32.4.02
   Nash L, 2008, ENVIRON HIST-US, V13, P651
   Newkirk V.R., 2016, ATLANTIC
   Ora Bannan N. L., 2015, CUNY LAW REV, V19, P287
   Pulido L., 1998, RACE GENDER CLASS, V6, P33
   Quintero L., 2016, VOCERO PUERTO RICO
   Quintero L., 2016, VOCERO PUERTO R 0720
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rigau-Perez J, 2018, P R HEALTH SCI J, V37, P15
   Rigau-Perez J, 2018, P R HEALTH SCI J, V37, P24
   Roberts D, 2013, DU BOIS REV, V10, P313, DOI 10.1017/S1742058X13000210
   Rodriguez-Diaz CE, 2017, INT J INFECT DIS, V65, P144, DOI 10.1016/j.ijid.2017.07.017
   Rose N., 2007, POLITICS LIFE ITSELF
   Santana Deborah, 2002, SOCIAL JUSTICE, P37
   SASSER JS, 2014, J RES PRACT, V10
   Sheldon R, 2016, CHILD COME LIFE HUMA
   Sparke M, 2012, HEALTH PLACE, V18, P726, DOI 10.1016/j.healthplace.2011.09.001
   Stepan N., 2007, ERADICATION RIDDING
   Stoler AL, 2006, PUBLIC CULTURE, V18, P125, DOI 10.1215/08992363-18-1-125
   Sun L., 2016, WASHINGTON POST
   Sun L. H., 2018, WASHINGTON POST
   Sundberg J, 2015, ENVIRON PLANN D, V33, P209, DOI 10.1068/d14040p
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Torruella J. R, 2017, CTR J, V29, P108
   Wald P, 2008, CONTAGIOUS CULTURES
   Worland J., 2016, TIME
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 90
TC 0
Z9 0
U1 4
U2 6
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2469-4452
EI 2469-4460
J9 ANN AM ASSOC GEOGR
JI Ann. Am. Assoc. Geogr.
DI 10.1080/24694452.2019.1655386
EA OCT 2019
PG 16
WC Geography
SC Geography
GA JD2ON
UT WOS:000489814000001
DA 2020-07-08
ER

PT J
AU Geiser, DL
   Thai, TN
   Love, MB
   Winzerling, JJ
AF Geiser, Dawn L.
   Thai, Theresa N.
   Love, Maria B.
   Winzerling, Joy J.
TI Iron and Ferritin Deposition in the Ovarian Tissues of the Yellow Fever
   Mosquito (Diptera: Culicidae)
SO JOURNAL OF INSECT SCIENCE
LA English
DT Article
DE Aedes aegypti; ferritin; iron; mosquito; ovary
ID DROSOPHILA-MELANOGASTER FERRITIN; MOLECULAR-CLONING; SECRETED FERRITIN;
   LOADED FERRITIN; BLOOD MEAL; SUBUNIT; IDENTIFICATION; MICRONUTRIENTS;
   LOCALIZATION; APOFERRITIN
AB Dengue, yellow fever, and Zika are viruses transmitted by yellow fever mosquito, Aedes aegypti [Linnaeus (Diptera: Culicidae)], to thousands of people each year. Mosquitoes transmit these viruses while consuming a blood meal that is required for oogenesis. Iron, an essential nutrient from the blood meal, is required for egg development. Mosquitoes receive a high iron load in the meal; although iron can be toxic, these animals have developed mechanisms for dealing with this load. Our previous research has shown iron from the blood meal is absorbed in the gut and transported by ferritin, the main iron transport and storage protein, to the ovaries. We now report the distribution of iron and ferritin in ovarian tissues before blood feeding and 24 and 72 h post-blood meal. Ovarian iron is observed in specific locations. Timing post-blood feeding influences the location and distribution of the ferritin heavy-chain homolog, light-chain homolog 1, and light-chain homolog 2 in ovaries. Understanding iron deposition in ovarian tissues is important to the potential use of interference in iron metabolism as a vector control strategy for reducing mosquito fecundity, decreasing mosquito populations, and thereby reducing transmission rates of vector-borne diseases.
C1 [Geiser, Dawn L.; Thai, Theresa N.; Love, Maria B.; Winzerling, Joy J.] Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Tucson, AZ 85721 USA.
RP Geiser, DL (corresponding author), Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Tucson, AZ 85721 USA.
EM dlgeiser@email.arizona.edu
OI Geiser, Dawn/0000-0002-6004-8407
FU Agricultural Experiment Station; College of Agriculture and Life
   Sciences; Undergraduate Biology Research Program; Honors College at the
   University of Arizona
FX The authors thank Dr. Michael Riehle, Department of Entomology,
   University of Arizona, and his laboratory for allowing us to use the
   facilities for mosquito rearing and microscopy. We also thank Patricia
   L. Jansma for her technical expertise and support in imaging. This work
   was supported by funds from the Agricultural Experiment Station, the
   College of Agriculture and Life Sciences, the Undergraduate Biology
   Research Program, and the Honors College at the University of Arizona.
   All authors declare that there are no relationships, financial or
   otherwise, that may pose a conflict of interest.
CR Ahmed S, 2014, AM J TROP MED HYG, V91, P1049, DOI 10.4269/ajtmh.14-0142
   ANDERSON WA, 1971, J CELL BIOL, V50, P201, DOI 10.1083/jcb.50.1.201
   Arosio P, 2015, BIOCHEM J, V472, P1, DOI 10.1042/BJ20150787
   Bernacchioni C, 2015, BBA-PROTEINS PROTEOM, V1854, P1118, DOI 10.1016/j.bbapap.2015.02.011
   Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n
   Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021
   Charlesworth A, 1997, EUR J BIOCHEM, V247, P470, DOI 10.1111/j.1432-1033.1997.00470.x
   Clements A.N, 1992, BIOL MOSQUITOES
   CLEMENTS AN, 1984, PHYSIOL ENTOMOL, V9, P1, DOI 10.1111/j.1365-3032.1984.tb00675.x
   Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]
   Dunkov BC, 1999, DNA CELL BIOL, V18, P937, DOI 10.1089/104454999314791
   Dunkov Boris C, 2002, J Insect Sci, V2, P7
   Fei DQ, 2018, DEV COMP IMMUNOL, V86, P130, DOI 10.1016/j.dci.2018.05.012
   Ferrer P, 2015, ANTIMICROB AGENTS CH, V59, P1418, DOI 10.1128/AAC.04642-14
   Geiser DL, 2007, INSECT BIOCHEM MOLEC, V37, P418, DOI 10.1016/j.ibmb.2007.01.003
   Geiser DL, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex096
   Geiser DL, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev049
   Geiser DL, 2013, INSECT SCI, V20, P601, DOI 10.1111/j.1744-7917.2012.01581.x
   Geiser DL, 2009, COMP BIOCHEM PHYS B, V152, P352, DOI 10.1016/j.cbpb.2009.01.002
   Geiser DL, 2006, INSECT BIOCHEM MOLEC, V36, P177, DOI 10.1016/j.ibmb.2005.12.001
   Geiser DL, 2003, EUR J BIOCHEM, V270, P3667, DOI 10.1046/j.1432-1033.2003.03709.x
   Georgieva T, 2002, INSECT BIOCHEM MOLEC, V32, P295, DOI 10.1016/S0965-1748(01)00090-X
   Georgieva T, 1999, P NATL ACAD SCI USA, V96, P2716, DOI 10.1073/pnas.96.6.2716
   Georgieva T., 2002, J INSECT SCI, V2, P17
   Gill AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003224
   Gomes AC, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11030084
   Gonzalez-Morales N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133499
   Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074
   Heath JL, 2013, NUTRIENTS, V5, P2836, DOI 10.3390/nu5082836
   Jaglarz MK, 2008, DEV GENES EVOL, V218, P399, DOI 10.1007/s00427-008-0233-0
   Kim BY, 2009, COMP BIOCHEM PHYS B, V153, P165, DOI 10.1016/j.cbpb.2009.02.014
   KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709
   Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630
   LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3
   Li S, 2010, CELL RES, V20, P1148, DOI 10.1038/cr.2010.102
   LOCKE M, 1991, TISSUE CELL, V23, P367, DOI 10.1016/0040-8166(91)90054-W
   LOCKE M, 1991, J INSECT PHYSIOL, V37, P297, DOI 10.1016/0022-1910(91)90064-7
   Mardones G, 2003, J IMMUNOL METHODS, V275, P169, DOI 10.1016/S0022-1759(03)00015-2
   Martinez-Barnetche J, 2007, INSECT BIOCHEM MOLEC, V37, P532, DOI 10.1016/j.ibmb.2007.02.009
   Masaldan S, 2019, FREE RADICAL BIO MED, V133, P221, DOI 10.1016/j.freeradbiomed.2018.09.033
   Mehta A, 2009, BIOCHIMIE, V91, P1331, DOI 10.1016/j.biochi.2009.05.003
   Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103
   Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150
   NICHOL H, 1990, TISSUE CELL, V22, P767, DOI 10.1016/0040-8166(90)90042-8
   Nichol H, 1999, INSECT BIOCHEM MOLEC, V29, P999, DOI 10.1016/S0965-1748(99)00076-4
   Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237
   Philpott CC, 2019, FREE RADICAL BIO MED, V133, P112, DOI 10.1016/j.freeradbiomed.2018.10.411
   Pitts J. R., 2014, J INSECT PHYSL, V11
   Riehle MA, 2002, CELL TISSUE RES, V308, P409, DOI 10.1007/s00441-002-0561-8
   Rivera-Perez C, 2017, CURR OPIN INSECT SCI, V23, P112, DOI 10.1016/j.cois.2017.07.002
   Rosas-Arellano A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020027
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Shakes DC, 2012, METHOD CELL BIOL, V107, P35, DOI 10.1016/B978-0-12-394620-1.00002-3
   Tang XN, 2013, IUBMB LIFE, V65, P863, DOI 10.1002/iub.1211
   Tang XN, 2013, FASEB J, V27, P288, DOI 10.1096/fj.12-213595
   Tsujimoto H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00380
   Uchida K, 2001, J MED ENTOMOL, V38, P572, DOI 10.1603/0022-2585-38.4.572
   Wajnberg E, 2018, EUR BIOPHYS J BIOPHY, V47, P641, DOI 10.1007/s00249-018-1293-3
   Walter-Nuno AB, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00019
   Wang D, 2009, COMP BIOCHEM PHYS B, V152, P20, DOI 10.1016/j.cbpb.2008.09.082
   Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x
   Xiao GR, 2014, ELIFE, V3, DOI 10.7554/eLife.03191
   Yu HZ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102126
   Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009
   Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014
NR 65
TC 0
Z9 0
U1 1
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
EI 1536-2442
J9 J INSECT SCI
JI J Insect Sci.
PD OCT 13
PY 2019
VL 19
IS 5
AR 11
DI 10.1093/jisesa/iez089
PG 9
WC Entomology
SC Entomology
GA JE2UP
UT WOS:000490550500002
PM 31606748
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sanford, TJ
   Mears, HV
   Fajardo, T
   Locker, N
   Sweeney, TR
AF Sanford, Thomas J.
   Mears, Harriet, V
   Fajardo, Teodoro, Jr.
   Locker, Nicolas
   Sweeney, Trevor R.
TI Circularization of flavivirus genomic RNA inhibits de novo translation
   initiation
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; ZIKA VIRUS; CYCLIZATION SEQUENCES;
   FUNCTIONAL-ANALYSIS; MESSENGER-RNAS; REPLICATION; MECHANISM; BINDING;
   CODON
AB Members of the Flaviviridae family, including dengue virus (DENV) and yellow fever virus, cause serious disease in humans, whilst maternal infection with Zika virus (ZIKV) can induce microcephaly in newborns. Following infection, flaviviral RNA genomes are translated to produce the viral replication machinery but must then serve as a template for the transcription of new genomes. However, the ribosome and viral polymerase proceed in opposite directions along the RNA, risking collisions and abortive replication. Whilst generally linear, flavivirus genomes can adopt a circular conformation facilitated by long-range RNA-RNA interactions, shown to be essential for replication. Using an in vitro reconstitution approach, we demonstrate that circularization inhibits de novo translation initiation on ZIKV and DENV RNA, whilst the linear conformation is translation-competent. Our results provide a mechanism to clear the viral RNA of ribosomes in order to promote efficient replication and, therefore, define opposing roles for linear and circular conformations of the flavivirus genome.
C1 [Sanford, Thomas J.; Mears, Harriet, V; Fajardo, Teodoro, Jr.; Sweeney, Trevor R.] Univ Cambridge, Dept Pathol, Div Virol, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.
   [Locker, Nicolas] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7HX, Surrey, England.
RP Sweeney, TR (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.
EM ts629@cam.ac.uk
OI Mears, Harriet/0000-0003-0300-0885; Sweeney, Trevor/0000-0003-4016-7326;
   Sanford, Thomas/0000-0002-5091-1457
FU Royal Society/Wellcome Trust Sir Henry Dale Fellowship [202471/Z/16/Z];
   BBSRC Project GrantBiotechnology and Biological Sciences Research
   Council (BBSRC) [BB/S007350/1, BB/S006931/1]; Wellcome TrustWellcome
   Trust [105389/Z/14/Z]; University of Cambridge, Department of Pathology
   PhD Studentship
FX Royal Society/Wellcome Trust Sir Henry Dale Fellowship [202471/Z/16/Z to
   T.R.S.]; BBSRC Project Grant [BB/S007350/1 to T.R.S., BB/S006931/1 to
   N.L.]; Wellcome Trust PhD Studentship [105389/Z/14/Z to T.J.S.];
   University of Cambridge, Department of Pathology PhD Studentship (to
   H.V.M.). Funding for open access charge: Wellcome Trust Grant (to
   T.R.S.).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Barton DJ, 1999, J VIROL, V73, P10104, DOI 10.1128/JVI.73.12.10104-10112.1999
   Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dhote V, 2012, P NATL ACAD SCI USA, V109, pE3150, DOI 10.1073/pnas.1208014109
   Ding T, 2019, MBIO, V10, DOI 10.1128/mBio.01296-19
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Fleith RC, 2018, NUCLEIC ACIDS RES, V46, P5269, DOI 10.1093/nar/gky191
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Friedrich S, 2018, J VIROL, V92, DOI 10.1128/JVI.01647-17
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hosmillo M, 2014, J VIROL, V88, P12213, DOI 10.1128/JVI.01650-14
   Huber RG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09391-8
   Ivanyi-Nagy R, 2012, VIRUS RES, V169, P448, DOI 10.1016/j.virusres.2012.09.009
   Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838
   Javorovic M, 2005, MOL THER, V12, P734, DOI 10.1016/j.ymthe.2005.03.034
   Johnson B, 2018, IMMUNITY, V48, P487, DOI 10.1016/j.immuni.2018.01.014
   Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   KOZAK M, 1991, J BIOL CHEM, V266, P19867
   Li P, 2018, CELL HOST MICROBE, V24, P875, DOI 10.1016/j.chom.2018.10.011
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000
   Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07
   Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118
   Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902
   Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67
   Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X
   Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703
   Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4
   Pisareva VP, 2016, NUCLEIC ACIDS RES, V44, P4252, DOI 10.1093/nar/gkw240
   Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Silva JVJ, 2018, ACTA TROP, V182, P257, DOI 10.1016/j.actatropica.2018.03.009
   Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510
   Sweeney TR, 2014, EMBO J, V33, P76, DOI 10.1002/embj.201386124
   Vashist S, 2011, DNA CELL BIOL, V30, P339, DOI 10.1089/dna.2010.1114
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Yu YP, 2011, EMBO J, V30, P4423, DOI 10.1038/emboj.2011.306
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Ziv O, 2018, NAT METHODS, V15, P785, DOI 10.1038/s41592-018-0121-0
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 75
TC 3
Z9 3
U1 1
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT 10
PY 2019
VL 47
IS 18
BP 9789
EP 9802
DI 10.1093/nar/gkz686
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JF2UO
UT WOS:000491241400033
PM 31392996
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Berry, N
   Ferguson, D
   Ham, C
   Hall, J
   Jenkins, A
   Giles, E
   Devshi, D
   Kempster, S
   Rose, N
   Dowall, S
   Fritzsche, M
   Bleazard, T
   Hewson, R
   Almond, N
AF Berry, Neil
   Ferguson, Deborah
   Ham, Claire
   Hall, Jo
   Jenkins, Adrian
   Giles, Elaine
   Devshi, Dhruti
   Kempster, Sarah
   Rose, Nicola
   Dowall, Stuart
   Fritzsche, Martin
   Bleazard, Thomas
   Hewson, Roger
   Almond, Neil
TI High susceptibility, viral dynamics and persistence of South American
   Zika virus in New World monkey species
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INFECTION; RHESUS; EPIDEMIC; CELLS
AB South American Zika virus (ZIKV) recently emerged as a novel human pathogen, linked with neurological disorders. However, comparative ZIKV infectivity studies in New World primates are lacking. Two members of the Callitrichidae family, common marmosets (Callithrixjacchus) and red-bellied tamarins (Saguinus labiatus), were highly susceptible to sub-cutaneous challenge with the Puerto Rico-origin ZIKV(PRVABC59) strain. Both exhibited rapid, high, acute viraemia with early neuroinvasion (3 days) in peripheral and central nervous tissue. ZIKV RNA levels in blood and tissues were significantly higher in New World hosts compared to Old World species (Macaca mulatta, Macaca fascicularis). Tamarins and rhesus macaques exhibited loss of zonal occludens-1 (ZO-1) staining, indicative of a compromised blood-brain barrier 3 days post-ZIKV exposure. Early, widespread dissemination across multiple anatomical sites distant to the inoculation site preceded extensive ZIKV persistence after 100 days in New and Old World lineages, especially lymphoid, neurological and reproductive sites. Prolonged persistence in brain tissue has implications for otherwise resolved human ZIKV infection. High susceptibility of distinct New World species underscores possible establishment of ZIKV sylvatic cycles in primates indigenous to ZIKV endemic regions. Tamarins and marmosets represent viable New World models for ZIKV pathogenesis and therapeutic intervention studies, including vaccines, with contemporary strains.
C1 [Berry, Neil; Ferguson, Deborah; Ham, Claire; Hall, Jo; Jenkins, Adrian; Giles, Elaine; Devshi, Dhruti; Kempster, Sarah; Almond, Neil] Natl Inst Biol Stand & Controls, Div Infect Dis Diagnost, Blanche Lane, S Mimms EN6 3QG, Herts, England.
   [Rose, Nicola] Natl Inst Biol Stand & Controls, Div Virol, Blanche Lane, S Mimms EN6 3QG, Herts, England.
   [Dowall, Stuart; Hewson, Roger] PHE Porton, Natl Infect Serv, Virol & Pathogenesis, Manor Farm Rd, Salisbury SP4 0JG, Wilts, England.
   [Fritzsche, Martin; Bleazard, Thomas] Natl Inst Biol Stand & Controls, Analyt Sci Grp, Blanche Lane, S Mimms EN6 3QG, Herts, England.
RP Berry, N (corresponding author), Natl Inst Biol Stand & Controls, Div Infect Dis Diagnost, Blanche Lane, S Mimms EN6 3QG, Herts, England.
EM neil.berry@nibsc.org
OI kempster, sarah/0000-0002-4309-1489
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Aguilar Claire, 2018, F1000Res, V7, DOI 10.12688/f1000research.14262.1
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   [Anonymous], 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004636, DOI 10.1371/JOURNAL.PNTD.0004636]
   Azar SR, 2019, EMERG MICROBES INFEC, V8, P242, DOI 10.1080/22221751.2018.1561157
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Favoretto SR, 2019, ECOHEALTH, V16, P61, DOI 10.1007/s10393-019-01394-7
   Ferguson D, 2016, AIDS, V30, P2439, DOI 10.1097/QAD.0000000000001178
   Ferguson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104390
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hood SP, 2014, VIRUS RES, V179, P93, DOI 10.1016/j.virusres.2013.11.006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicastri E, 2016, EUROSURVEILLANCE, V11, P21, DOI DOI 10.2807/1560-7917
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Soilleux EJ, 2001, BLOOD, V98, P1987, DOI 10.1182/blood.V98.6.1987
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Volpi VG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28257-5
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
NR 51
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 10
PY 2019
VL 9
AR 14495
DI 10.1038/s41598-019-50918-2
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JC8VW
UT WOS:000489555200007
PM 31601848
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Metz, SW
   Thomas, A
   Brackbill, A
   Forsberg, J
   Miley, MJ
   Lopez, CA
   Lazear, HM
   Tian, SM
   de Silva, AM
AF Metz, Stefan W.
   Thomas, Ashlie
   Brackbill, Alex
   Forsberg, John
   Miley, Michael J.
   Lopez, Cesar A.
   Lazear, Helen M.
   Tian, Shaomin
   de Silva, Aravinda M.
TI Oligomeric state of the ZIKV E protein defines protective immune
   responses
SO NATURE COMMUNICATIONS
LA English
DT Article
ID DOMAIN III; ENVELOPE PROTEIN; DENGUE VACCINE; VIRUS; ANTIBODIES;
   DETERMINANTS; TYPE-2
AB The current leading Zika vaccine candidates in clinical testing are based on live or killed virus platforms, which have safety issues, especially in pregnant women. Zika subunit vaccines, however, have shown poor performance in preclinical studies, most likely because the antigens tested do not display critical quaternary structure epitopes present on Zika E protein homodimers that cover the surface of the virus. Here, we produce stable recombinant E protein homodimers that are recognized by strongly neutralizing Zika specific monoclonal antibodies. In mice, the dimeric antigen stimulate strongly neutralizing antibodies that target epitopes that are similar to epitopes recognized by human antibodies following natural Zika virus infection. The monomer antigen stimulates low levels of E-domain III targeting neutralizing antibodies. In a Zika challenge model, only E dimer antigen stimulates protective antibodies, not the monomer. These results highlight the importance of mimicking the highly structured flavivirus surface when designing subunit vaccines.
C1 [Metz, Stefan W.; Thomas, Ashlie; Lopez, Cesar A.; Lazear, Helen M.; Tian, Shaomin; de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Brackbill, Alex; Forsberg, John; Miley, Michael J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.
RP Metz, SW; de Silva, AM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
EM swmetz@med.unc.edu; aravinda_desilva@med.unc.edu
RI Metz, Stefan/J-1974-2019
OI Metz, Stefan/0000-0002-9249-2844; Lazear, Helen/0000-0002-8649-4579;
   Lopez, Cesar/0000-0001-9301-4177
FU NIH-NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1-R01-AI107331-01, U19 AI109784-01]; US
   Department of DefenseUnited States Department of Defense
   [W81-XWH-18-2-0035]; European Union Zika Plan Research Consortium
FX This work was supported by grants from the NIH-NIAID grants
   1-R01-AI107331-01 (PI A. de Silva), U19 AI109784-01 PI J.Ting), US
   Department of Defense grant W81-XWH-18-2-0035 (PI A. de Silva) and the
   European Union Zika Plan Research Consortium.
CR ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004
   Brien J. D., 2013, CURR PROTOC MICROBIO, V31
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Collins MH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124588
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Fahimi H, 2018, APPL MICROBIOL BIOT, V102, P2977, DOI 10.1007/s00253-018-8822-y
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Gallichotte EN, 2018, ADV EXP MED BIOL, V1062, P63, DOI 10.1007/978-981-10-8727-1_5
   Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI 10.1586/ERV.09.139
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Luo YY, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-194
   Martin J, 2016, ACTA VIROL, V60, P3, DOI 10.4149/av_2016_01_3
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Pitcher TJ, 2015, J GEN VIROL, V96, P288, DOI 10.1099/vir.0.070813-0
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhou Y, 2013, VIROLOGY, V439, P57, DOI 10.1016/j.virol.2013.01.022
NR 29
TC 3
Z9 3
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD OCT 10
PY 2019
VL 10
AR 4606
DI 10.1038/s41467-019-12677-6
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JC8WU
UT WOS:000489557600001
PM 31601808
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Musso, D
   Ko, AI
   Baud, D
AF Musso, Didier
   Ko, Albert I.
   Baud, David
TI Zika Virus Infection - After the Pandemic
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID PREGNANCY OUTCOMES; BIRTH-DEFECTS; INFANTS; BRAZIL; SURVEILLANCE;
   PATHOGENESIS; ENHANCEMENT; TERRITORIES; EMERGENCE; OUTBREAK
AB Zika is a mosquito-borne flavivirus that can cause congenital defects, including microcephaly. Although most Zika virus infections are asymptomatic, rash, fever, arthralgia, myalgia, and conjunctivitis can develop in some people. The Guillain-Barre syndrome occurs in 2 to 3 patients per 10,000 with Zika virus infection.
C1 [Musso, Didier] Aix Marseille Univ, AP HM, IRD, Serv Sante Armees,Vecteurs Infect Trop & Mediterr, Marseille, France.
   [Musso, Didier] Inst Hosp Univ Mediterranee Infect, Marseille, France.
   [Musso, Didier] Lab Eurofins Labazur Guyane, Eurofins, French Guiana.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Infect Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Baud, David] Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Femme Mere Enfant, Maternofoetal & Obstet Res Unit, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.
RP Musso, D (corresponding author), POB 380,222 Tamanu Punaauia, F-98713 Tahiti, French Polynesi, France.
EM didiermusso@mail.pf
RI Ko, Albert Icksang/P-2343-2015; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Baud,
   David/0000-0001-9914-6496
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, ASS MAN GUILL BARR S
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bloch EM, 2018, NEW ENGL J MED, V378, P1837, DOI 10.1056/NEJMsb1704752
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Centers for Disease Control and Prevention, 2017, OV ZIK VIR TEST GUID
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto SR, 2019, ECOHEALTH, V16, P61, DOI 10.1007/s10393-019-01394-7
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018
   Grubaugh ND, 2019, TRENDS MICROBIOL, V27, P381, DOI 10.1016/j.tim.2019.02.004
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Halpin AL, 2018, EPIDEMIOL INFECT, V146, P1740, DOI 10.1017/S0950268818001802
   Hay JA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006991
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hill SC, 2019, EMERGENCE ZIKA VIRUS
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Masmejan S, 2018, EXPERT REV ANTI-INFE, V16, P471, DOI 10.1080/14787210.2018.1483239
   Maykin MM, 2019, CLIN INFECT DIS
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morain SR, 2017, NEW ENGL J MED, V377, P1505, DOI 10.1056/NEJMp1707273
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization, ZIK CAS CONG SYNDR A
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von Seidlein L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002219
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 75
TC 27
Z9 27
U1 3
U2 9
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD OCT 10
PY 2019
VL 381
IS 15
BP 1444
EP 1457
DI 10.1056/NEJMra1808246
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA JC9YG
UT WOS:000489631900009
PM 31597021
OA Bronze
DA 2020-07-08
ER

PT J
AU Carpentier, KS
   Davenport, BJ
   Haist, KC
   McCarthy, MK
   May, NA
   Robison, A
   Ruckert, C
   Ebel, GD
   Morrison, TE
AF Carpentier, Kathryn S.
   Davenport, Bennett J.
   Haist, Kelsey C.
   McCarthy, Mary K.
   May, Nicholas A.
   Robison, Alexis
   Ruckert, Claudia
   Ebel, Gregory D.
   Morrison, Thomas E.
TI Discrete viral E2 lysine residues and scavenger receptor MARCO are
   required for clearance of circulating alphaviruses
SO ELIFE
LA English
DT Article
ID ROSS RIVER VIRUS; EQUINE ENCEPHALITIS-VIRUS; CHIKUNGUNYA VIRUS;
   HEPARAN-SULFATE; ZIKA VIRUS; SINDBIS VIRUS; MOUSE MODEL; INNATE
   IMMUNITY; ONYONG-NYONG; BINDING
AB The magnitude and duration of vertebrate viremia is a critical determinant of arbovirus transmission, geographic spread, and disease severity. We find that multiple alphaviruses, including chikungunya (CHIKV), Ross River (RRV), and o'nyong 'nyong (ONNV) viruses, are cleared from the circulation of mice by liver Kupffer cells, impeding viral dissemination. Clearance from the circulation was independent of natural antibodies or complement factor C3, and instead relied on scavenger receptor SR-A6 (MARCO). Remarkably, lysine to arginine substitutions at distinct residues within the E2 glycoproteins of CHIKV and ONNV (E2 K200R) as well as RRV (E2 K251R) allowed for escape from clearance and enhanced viremia and dissemination. Mutational analysis revealed that viral clearance from the circulation is strictly dependent on the presence of lysine at these positions. These findings reveal a previously unrecognized innate immune pathway that controls alphavirus viremia and dissemination in vertebrate hosts, ultimately influencing disease severity and likely transmission efficiency.
C1 [Carpentier, Kathryn S.; Davenport, Bennett J.; Haist, Kelsey C.; McCarthy, Mary K.; May, Nicholas A.; Morrison, Thomas E.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.
   [Robison, Alexis; Ruckert, Claudia; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RP Morrison, TE (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.
EM thomas.morrison@ucdenver.edu
OI Ruckert, Claudia/0000-0003-3732-6752
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI123348, F32 AI140567, T32 AI007405]
FX National Institute of Allergy and Infectious Diseases R01 AI123348
   Thomas E Morrison; National Institute of Allergy and Infectious Diseases
   F32 AI140567 Kathryn S Carpentier; National Institute of Allergy and
   Infectious Diseases T32 AI007405 Kathryn S Carpentier
CR Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x
   Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731
   Ashbrook AW, 2014, J VIROL, V88, P12180, DOI 10.1128/JVI.01672-14
   Azevedo Cristina, 2015, Advances in Biological Regulation, V60, P144, DOI 10.1016/j.jbior.2015.09.008
   Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Bowdish DME, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-47
   Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x
   Bryan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191690
   Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998
   Byrnes AP, 2000, J VIROL, V74, P644, DOI 10.1128/JVI.74.2.644-651.2000
   Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x
   Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Chen RB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003591
   Chen YY, 2006, J BIOL CHEM, V281, P12767, DOI 10.1074/jbc.M513628200
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015
   da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480
   Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522
   de St Maurice A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006460
   DOHERTY R. L., 1963, AUSTRALIAN J SCI, V26, P183
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gerardin P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-5
   Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582
   Hawman DW, 2017, J VIROL, V91, DOI 10.1128/JVI.00816-17
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Heil ML, 2001, J VIROL, V75, P6303, DOI 10.1128/JVI.75.14.6303-6309.2001
   Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532
   High M, 2016, EBIOMEDICINE, V11, P73, DOI 10.1016/j.ebiom.2016.08.011
   JAHRLING PB, 1975, J INFECT DIS, V132, P667, DOI 10.1093/infdis/132.6.667
   Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691
   Jones JA, 2017, MBIO, V8, DOI [10.1128/mBio.00621-17, 10.1128/mbio.00621-17]
   Jupille HJ, 2013, J VIROL, V87, P5970, DOI 10.1128/JVI.03326-12
   Jupille HJ, 2011, VIROLOGY, V410, P216, DOI 10.1016/j.virol.2010.11.012
   KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0
   Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998
   Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11
   Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415
   KUHN RJ, 1991, VIROLOGY, V182, P430, DOI 10.1016/0042-6822(91)90584-X
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Lanciotti RS, 1998, VIROLOGY, V252, P258, DOI 10.1006/viro.1998.9437
   Lao WT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2595-2
   Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855
   Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085
   Lindsay M, 1996, EMERG INFECT DIS, V2, P117, DOI 10.3201/eid0202.960206
   Liu WJ, 2011, J VIROL, V85, P5674, DOI 10.1128/JVI.02622-10
   Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024069
   MacLeod DT, 2015, J INVEST DERMATOL, V135, P142, DOI 10.1038/jid.2014.330
   MacLeod DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2963
   Maler MD, 2017, MBIO, V8, DOI 10.1128/mBio.00670-17
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Novakowski KE, 2018, MOL BIOL EVOL, V35, P440, DOI 10.1093/molbev/msx298
   PEARSON AM, 1993, J BIOL CHEM, V268, P3546
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9
   Pozo-Aguilar JO, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0590-7
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Seiler P, 1997, EUR J IMMUNOL, V27, P2626, DOI 10.1002/eji.1830271023
   Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13
   Smit JM, 2002, J VIROL, V76, P10128, DOI 10.1128/JVI.76.20.10128-10137.2002
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Stoermer KA, 2012, J IMMUNOL, V189, P4047, DOI 10.4049/jimmunol.1201240
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Vanlandingham DL, 2005, AM J TROP MED HYG, V72, P616, DOI 10.4269/ajtmh.2005.72.616
   Vanlandingham DL, 2005, INSECT BIOCHEM MOLEC, V35, P1162, DOI 10.1016/j.ibmb.2005.05.008
   VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83
   VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Vijayakumar K, 2013, SE ASIAN J TROP MED, V44, P54
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490
   Westhaus S, 2017, J HEPATOL, V67, P237, DOI 10.1016/j.jhep.2017.03.020
   Yap NVL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00342
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zeng ZT, 2016, CELL HOST MICROBE, V20, P99, DOI 10.1016/j.chom.2016.06.002
NR 99
TC 2
Z9 2
U1 0
U2 0
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD OCT 9
PY 2019
VL 8
AR e49163
DI 10.7554/eLife.49163
PG 26
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA JM9YX
UT WOS:000496563000001
PM 31596239
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Poole, E
   Huang, CJZ
   Forbester, J
   Shnayder, M
   Nachshon, A
   Kweider, B
   Basaj, A
   Smith, D
   Jackson, SE
   Liu, B
   Shih, J
   Kiskin, FN
   Roche, K
   Murphy, E
   Wills, MR
   Morrell, NW
   Dougan, G
   Stern-Ginossar, N
   Rana, AA
   Sinclair, J
AF Poole, Emma
   Huang, Christopher J. Z.
   Forbester, Jessica
   Shnayder, Miri
   Nachshon, Aharon
   Kweider, Baraa
   Basaj, Anna
   Smith, Daniel
   Jackson, Sarah Elizabeth
   Liu, Bin
   Shih, Joy
   Kiskin, Fedir N.
   Roche, K.
   Murphy, E.
   Wills, Mark R.
   Morrell, Nicholas W.
   Dougan, Gordon
   Stern-Ginossar, Noam
   Rana, Amer A.
   Sinclair, John
TI An iPSC-Derived Myeloid Lineage Model of Herpes Virus Latency and
   Reactivation
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE human cytomegalovirus; latency; induced pluripotent stem cells;
   C2-iPSCs; viral carriage; myeloid; dendritic cells; endothelial
   progenitor cells
ID HUMAN CYTOMEGALOVIRUS LATENCY; PLURIPOTENT STEM-CELLS; DENDRITIC CELLS;
   ACTIVIN-A; INFECTION; DIFFERENTIATION; DISEASE; SUSCEPTIBILITY;
   SECRETION; MONOCYTES
AB Herpesviruses undergo life-long latent infection which can be life-threatening in the immunocompromised. Models of latency and reactivation of human cytomegalovirus (HCMV) include primary myeloid cells, cells known to be important for HCMV latent carriage and reactivation in vivo. However, primary cells are limited in availability, and difficult to culture and to genetically modify; all of which have hampered our ability to fully understand virus/host interactions of this persistent human pathogen. We have now used iPSCs to develop a model cell system to study HCMV latency and reactivation in different cell types after their differentiation down the myeloid lineage. Our results show that iPSCs can effectively mimic HCMV latency/reactivation in primary myeloid cells, allowing molecular interrogations of the viral latent/lytic switch. This model may also be suitable for analysis of other viruses, such as HIV and Zika, which also infect cells of the myeloid lineage.
C1 [Poole, Emma; Huang, Christopher J. Z.; Kweider, Baraa; Basaj, Anna; Smith, Daniel; Jackson, Sarah Elizabeth; Liu, Bin; Shih, Joy; Kiskin, Fedir N.; Wills, Mark R.; Morrell, Nicholas W.; Dougan, Gordon; Rana, Amer A.; Sinclair, John] Univ Cambridge, Dept Med, Cambridge, England.
   [Forbester, Jessica] Cardiff Univ, Div Infect & Immun, Sch Med, Cardiff, S Glam, Wales.
   [Shnayder, Miri; Nachshon, Aharon; Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.
   [Roche, K.; Murphy, E.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA.
   [Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England.
RP Poole, E; Rana, AA; Sinclair, J (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.
EM emmapoole2003@yahoo.co.uk; ar332@cam.ac.uk; js152@cam.ac.uk
RI Jackson, Sarah Elizabeth/J-5729-2019; Huang, Christopher J.
   Z./F-6959-2010
OI Jackson, Sarah Elizabeth/0000-0002-4230-9220; Kiskin,
   Fedir/0000-0002-6984-9622; Forbester, Jessica/0000-0002-3834-615X
FU MRC Programme grant: RCUK \ Medical Research Council (MRC) [G:0701279];
   British Heart Foundation (BHF)British Heart Foundation [PG/14/31/]; BHF
   Cambridge Centre of Research Excellence; Cambridge National Institute
   for Health Research Biomedical Research Centre (NIHR BRC); Dinosaur
   Trust [DT001]
FX This work was funded by an MRC Programme grant: RCUK vertical bar
   Medical Research Council (MRC, grant G:0701279), the British Heart
   Foundation (BHF) project grant (PG/14/31/), the BHF Cambridge Centre of
   Research Excellence, the Cambridge National Institute for Health
   Research Biomedical Research Centre (NIHR BRC), and the Dinosaur Trust
   (project grant DT001).
CR Albright ER, 2013, J VIROL, V87, P9802, DOI 10.1128/JVI.01436-13
   Avdic S, 2016, J VIROL, V90, P3819, DOI 10.1128/JVI.03066-15
   Beisser PS, 2001, J VIROL, V75, P5949, DOI 10.1128/JVI.75.13.5949-5957.2001
   Belzile JP, 2014, J VIROL, V88, P4021, DOI 10.1128/JVI.03492-13
   Berger AA, 2015, J VIROL, V89, P11159, DOI 10.1128/JVI.01742-15
   Bigley TM, 2013, J VIROL, V87, P7393, DOI 10.1128/JVI.02825-12
   Boyette LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176460
   Brown RM, 2019, J VIROL, V93, DOI 10.1128/JVI.00957-19
   Cosset E, 2015, BIOMATERIALS, V53, P296, DOI 10.1016/j.biomaterials.2015.02.094
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   Delannoy AS, 1997, PATHOL BIOL, V45, P394
   Geti I, 2012, STEM CELL TRANSL MED, V1, P855, DOI 10.5966/sctm.2012-0093
   Gonzalez F, 2016, DEV DYNAM, V245, P788, DOI [10.1002/DVDY.24414, 10.1002/dvdy.24414]
   Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937
   Hertel L, 2003, J VIROL, V77, P7563, DOI 10.1128/JVI.77.13.7563-7574.2003
   Hijdra D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00339
   JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141
   Kamata M, 2010, HUM GENE THER, V21, P1555, DOI 10.1089/hum.2010.050
   Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342
   Kiskin FN, 2018, AM J RESP CRIT CARE, V198, P271, DOI 10.1164/rccm.201801-0049LE
   Krishna BA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14321
   Krishna BA, 2016, SCI REP-UK, V6, DOI 10.1038/srep24674
   Kumar S, 2018, METHODS MOL BIOL, V1706, P17, DOI 10.1007/978-1-4939-7471-9_2
   Lau B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31205
   Lee SH, 2016, J VIROL, V90, P9483, DOI 10.1128/JVI.01547-16
   Lee SH, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501164
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Maslin CLV, 2005, CURR HIV RES, V3, P303, DOI 10.2174/157016205774370401
   Mason GM, 2012, P NATL ACAD SCI USA, V109, P14538, DOI 10.1073/pnas.1204836109
   Nakamura Hiroyuki, 2013, Herpesviridae, V4, P2, DOI 10.1186/2042-4280-4-2
   Neumann AK, 2008, J CELL SCI, V121, P634, DOI 10.1242/jcs.022418
   O'Connor CM, 2012, J VIROL, V86, P9854, DOI 10.1128/JVI.01278-12
   Ormiston ML, 2015, JOVE-J VIS EXP, DOI 10.3791/53384
   Penkert RR, 2013, MBIO, V4, DOI 10.1128/mBio.00298-13
   Poole E, 2014, J VIROL, V88, P13947, DOI 10.1128/JVI.02424-14
   Poole E, 2014, METHODS MOL BIOL, V1119, P81, DOI 10.1007/978-1-62703-788-4_6
   Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0
   Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102
   Roche KL, 2018, J VIROL, V92, DOI 10.1128/JVI.00880-18
   Rolland M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005547
   Sachamitr P, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01935
   Shnayder M, 2018, MBIO, V9, DOI 10.1128/mBio.00013-18
   Silk KM, 2011, METHODS MOL BIOL, V767, P449, DOI 10.1007/978-1-61779-201-4_33
   Sinclair J, 2014, FUTURE VIROL, V6, P7
   SISSONS JGP, 1991, KIDNEY INT, V40, pS8
   Straschewski S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009174
   Taylor JP, 2018, J LEUKOCYTE BIOL, V103, P1225, DOI 10.1002/JLB.3MIA0917-352R
   Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031
   Wildgruber M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39483
   Yeung ATY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15013
NR 50
TC 3
Z9 3
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 9
PY 2019
VL 10
AR 2233
DI 10.3389/fmicb.2019.02233
PG 11
WC Microbiology
SC Microbiology
GA JF4DB
UT WOS:000491336300001
PM 31649625
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Riedl, W
   Acharya, D
   Lee, JH
   Liu, GQ
   Serman, T
   Chiang, C
   Chan, YK
   Diamond, MS
   Gack, MU
AF Riedl, William
   Acharya, Dhiraj
   Lee, Jung-Hyun
   Liu, Guanqun
   Serman, Taryn
   Chiang, Cindy
   Chan, Ying Kai
   Diamond, Michael S.
   Gack, Michaels U.
TI Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize
   RIG-I- and MDA5-Mediated Innate Immunity
SO CELL HOST & MICROBE
LA English
DT Article
ID INTERFERON-PRODUCTION; STRUCTURAL BASIS; PHOSPHATASE PP1; PROTEIN;
   DENGUE; DNA; ASSOCIATION; BINDING; EVASION; CELLS
AB 14-3-3 protein family members facilitate the translocation of RIG-I-like receptors (RLRs) to organelles that mediate downstream RLR signaling, leading to interferon production. 14-3-3 epsilon promotes the cytosolic-to-mitochondrial translocation of RIG-I, while 14-3-3 eta facilitates MDA5 translocation to mitochondria. We show that the NS3 protein of Zika virus (ZIKV) antagonizes antiviral gene induction by RIG-I and MDA5 by binding to and sequestering the scaffold proteins 14-3-3 epsilon and 14-3-3 eta 14-3-3-binding is mediated by a negatively charged RLDP motif in NS3 that is conserved in ZIKV strains of African and Asian lineages and is similar to the one found in dengue and West Nile viruses. ZIKV NS3 is sufficient to inhibit the RLR-14-3-3 epsilon/eta interaction and to suppress antiviral signaling. Mutational perturbation of 14-3-3 epsilon/eta binding in a recombinant ZIKV leads to enhanced innate immune responses and impaired growth kinetics. Our study provides molecular understanding of immune evasion functions of ZIKV, which may guide vaccine and anti-flaviviral therapy development.
C1 [Riedl, William; Acharya, Dhiraj; Lee, Jung-Hyun; Liu, Guanqun; Serman, Taryn; Chiang, Cindy; Gack, Michaels U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.
   [Chan, Ying Kai] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.
   [Chan, Ying Kai] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Gack, MU (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.
EM mgack@uchicago.edu
RI Liu, GuanQun L./AAJ-2681-2020; Diamond, Michael/AAH-1733-2019
OI Liu, GuanQun L./0000-0003-2520-7625; Diamond,
   Michael/0000-0002-8791-3165; Lee, Jung-hyun/0000-0003-1913-0027
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI127774,
   R01 AI087846]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32 GM007183]
FX We greatly thank Matthew Evans (Mount Sinai), Jae Jung (University of
   Southern California), Tom Hobman (University of Alberta), and Jan
   Rehwinkel (Oxford University) for providing reagents. We are grateful to
   Andrea Watson (University of Chicago) for help with generating the
   cladogram. This study was supported by the US National Institutes of
   Health grants R01 AI127774 (to M.U.G. and M.S.D.) and R01 AI087846 (to
   M.U.G.). W.R. and T.S. received support from NIH training grant T32
   GM007183.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brien J.D, 2013, CURR OPIN MICROBIOL, V31
   Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Davis ME, 2014, CELL HOST MICROBE, V16, P19, DOI 10.1016/j.chom.2014.06.007
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Full F, 2019, NAT MICROBIOL, V4, P164, DOI 10.1038/s41564-018-0285-5
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hatzivassiliou E, 1997, BIOCHEMISTRY-US, V36, P9221, DOI 10.1021/bi963145k
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lin JP, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007582
   Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000
   Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777
   Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200
   van de Weijer ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4832
   Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 46
TC 10
Z9 10
U1 3
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD OCT 9
PY 2019
VL 26
IS 4
BP 493
EP +
DI 10.1016/j.chom.2019.09.012
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA JC5DS
UT WOS:000489300700008
PM 31600501
DA 2020-07-08
ER

PT J
AU Rojas, A
   Cardozo, F
   Cantero, C
   Stittleburg, V
   Lopez, S
   Bernal, C
   Acosta, FEG
   Mendoza, L
   Pinsky, BA
   de Guillen, IA
   Paez, M
   Waggoner, J
AF Rojas, Alejandra
   Cardozo, Fatima
   Cantero, Cesar
   Stittleburg, Victoria
   Lopez, Sanny
   Bernal, Cynthia
   Gimenez Acosta, Francisco Eugenio
   Mendoza, Laura
   Pinsky, Benjamin A.
   Arevalo de Guillen, Ivalena
   Paez, Malvina
   Waggoner, Jesse
TI Characterization of dengue cases among patients with an acute illness,
   Central Department, Paraguay
SO PEERJ
LA English
DT Article
DE Dengue virus; NS1; RT-PCR; Diagnosis; Hospitalization; Anti-NS1
   antibody; Viral load
ID SEROTYPE-SPECIFIC DIFFERENCES; REVERSE TRANSCRIPTION-PCR; EARLY
   CLINICAL-FEATURES; LABORATORY FEATURES; NS1 ANTIGEN; NONSTRUCTURAL
   PROTEIN-1; FEBRILE ILLNESSES; VIRUS-INFECTION; SINGLE-REACTION; DISEASE
AB Background. In 2018, Paraguay experienced a large dengue virus (DENV) outbreak. The primary objective of this study was to characterize dengue cases in the Central Department, where the majority of cases occur, and identify factors associated with DENV infection.
   Methods. Patients were enrolled from January-May 2018 if they presented with a suspected arboviral illness. Acute-phase specimens (<= 8 days after symptom onset) were tested using rRT-PCR, a rapid diagnostic test for DENV nonstructural protein 1 (NS1) and anti-DENV IgM and IgG, and ELISA for IgG against NS1 from Zika virus (ZIKV).
   Results. A total of 231 patients were enrolled (95.2% adults) at two sites: emergency care and an outpatient clinical site. Patients included 119 (51.5%) dengue cases confirmed by rRT-PCR (n = 115, 96.6%) and/or the detection of NS1 and anti-DENV IgM (n = 4, 3.4%). DENV-1 was the predominant serotype (109/115, 94.8%). Epidemiologically, dengue cases and non-dengue cases were similar, though dengue cases were less likely to reside in a house/apartment or report a previous dengue case. Clinical and laboratory findings associated with dengue included red eyes, absence of sore throat, leucopenia and thrombocytopenia. At an emergency care site, 26% of dengue cases (26/100) required hospitalization. In univariate analysis, hospitalization was associated with increased viral load, anti-DENV IgG, and thrombocytopenia. Among dengue cases that tested positive for IgG against ZIKV NS1, the odds of DENV NS1 detection in the acute phase were decreased 10-fold (OR 0.1, 0.0-0.3).
   Conclusions. Findings from a predominantly adult population demonstrate clinical and laboratory factors associated with DENV infections and the potential severity of dengue in this group. The combination of viral load and specific IgG antibodies warrant further study as a prognostic to identify patients at risk for severe disease.
C1 [Rojas, Alejandra; Cantero, Cesar; Lopez, Sanny; Bernal, Cynthia; Arevalo de Guillen, Ivalena] Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Prod, San Lorenzo, Paraguay.
   [Cardozo, Fatima; Mendoza, Laura; Paez, Malvina] Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Salud Publ, San Lorenzo, Paraguay.
   [Stittleburg, Victoria; Waggoner, Jesse] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Gimenez Acosta, Francisco Eugenio] Hosp Dist Villa Elisa, Area Ambulatoria, Asuncion, Paraguay.
   [Pinsky, Benjamin A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Dept Med, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Waggoner, Jesse] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA.
RP Rojas, A (corresponding author), Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Prod, San Lorenzo, Paraguay.; Waggoner, J (corresponding author), Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.; Waggoner, J (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA.
EM alerojaspy@gmail.com; jesse.waggoner@emoryhealthcare.org
OI Pinsky, Benjamin/0000-0001-8751-4810
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K08 AI110528];
   Consejo Nacional de Ciencia y Tecnologia (CONACYT) in ParaguayConsejo
   Nacional de Ciencia y Tecnologia (CONACyT) [PVCT16-66, PVCT17-65]
FX Research was supported by National Institutes of Health grant K08
   AI110528 (Jesse Waggoner). In addition, the development of this
   collaboration was supported by funding from the Consejo Nacional de
   Ciencia y Tecnologia (CONACYT) in Paraguay (Alejandra Rojas: PVCT16-66
   and Jesse Waggoner: PVCT17-65). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Burattini MN, 2016, CLINICS, V71, P455, DOI 10.6061/clinics/2016(08)08
   Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Erra EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065900
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Gregory CJ, 2010, AM J TROP MED HYG, V82, P922, DOI 10.4269/ajtmh.2010.09-0552
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halsey ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001638
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Jayathilaka D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07667-z
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   Lee J, 2015, DIAGN MICR INFEC DIS, V82, P128, DOI 10.1016/j.diagmicrobio.2015.03.009
   Lindsay SW, 2017, B WORLD HEALTH ORGAN, V95, P607, DOI 10.2471/BLT.16.189688
   Lovera D, 2016, PEDIATR INFECT DIS J, V35, P1294, DOI 10.1097/INF.0000000000001308
   Lovera D, 2014, PEDIATR INFECT DIS J, V33, P933, DOI 10.1097/INF.0000000000000340
   Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191
   Luppe MJ, 2019, TRAVEL MED INFECT DI, V30, P25, DOI 10.1016/j.tmaid.2019.05.002
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Morch K, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2764-3
   Pan American Health Organization, 2018, DENGUE
   Pavia-Ruz N, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006748
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rojas Alejandra, 2016, Mem. Inst. Investig. Cienc. Salud, V14, P68, DOI 10.18004/Mem.iics/1812-9528/2016.014(02)68-074
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Suppiah J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006817
   Thomas L, 2014, AM J TROP MED HYG, V91, P138, DOI 10.4269/ajtmh.13-0595
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Vazquez-Prokopec GM, 2016, T ROY SOC TROP MED H, V110, P567, DOI 10.1093/trstmh/trw070
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   WATERMAN SH, 1985, AM J TROP MED HYG, V34, P625, DOI 10.4269/ajtmh.1985.34.625
   *WHO, 1997, DENG HEM FEV DIAGN T
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yung CF, 2015, AM J TROP MED HYG, V92, P999, DOI 10.4269/ajtmh.14-0628
NR 51
TC 0
Z9 0
U1 0
U2 0
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD OCT 9
PY 2019
VL 7
AR e7852
DI 10.7717/peerj.7852
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JC4TJ
UT WOS:000489269900004
PM 31616598
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Blackman, MA
   Marchionni, MA
   Gilly, J
   Hepburn, M
   Innis, BL
   Barrett, ADT
   Kester, KE
   Mascola, JR
   Cummings, JF
   Monath, TP
   Cassetti, MC
   Kim, JH
   Saville, M
   Thomas, SJ
AF Blackman, Marcia A.
   Marchionni, Mark A.
   Gilly, John
   Hepburn, Matthew
   Innis, Bruce L.
   Barrett, Alan D. T.
   Kester, Kent E.
   Mascola, John R.
   Cummings, James F.
   Monath, Thomas P.
   Cassetti, M. Cristina
   Kim, Jerome H.
   Saville, Melanie
   Thomas, Stephen J.
TI Summit proceedings: Biomedical countermeasure development for emerging
   vector-borne viral diseases
SO VACCINE
LA English
DT Article
ID ENCEPHALITIS; PROTECTION
AB Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current "gaps," and prospect what could be done to improve our position. Herein we describe the summit proceedings, "Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases," held October 2-3, 2018, at the Trudeau Institute in Saranac Lake, NY.
C1 [Blackman, Marcia A.; Marchionni, Mark A.; Gilly, John] Trudeau Inst, Saranac Lake, NY USA.
   [Hepburn, Matthew] DARPA, Biol Technol Off, Arlington, VA USA.
   [Innis, Bruce L.] PATH, Washington, DC USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Kester, Kent E.] Sanofi Pasteur, Swiftwater, PA USA.
   [Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Cummings, James F.] ICON Govt & Publ Hlth Solut, Washington, DC USA.
   [Monath, Thomas P.] Crozet BioPharma LLC, Devens, MA USA.
   [Cassetti, M. Cristina] NIAID, Virol Branch, Div Microbiol & Infect Dis, NIH, Rockville, MD USA.
   [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea.
   [Saville, Melanie] CEPI, London, England.
   [Thomas, Stephen J.] SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA.
RP Thomas, SJ (corresponding author), SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA.
RI Kester, Kent/AAF-8235-2020
OI Kester, Kent/0000-0002-5056-0802
FU Trudeau Institute; State University of New York Upstate Medical
   University
FX We thank Dr. Atsuo Kuki, President and Director, and the scientists and
   staff at the Trudeau Institute for the use of the Institute's facilities
   and their hard work and dedication to convene and host this Summit
   meeting. Financial support for the meeting was provided by the Trudeau
   Institute and the State University of New York Upstate Medical
   University. This research did not receive any specific grant from
   funding agencies in the public, commercial, or not-for-profit sectors.
   We thank Tina Lupone for sharing her detailed meeting notes, which were
   instrumental in putting together this meeting review. We thank all the
   attendees for their vigorous discussion: Wataru Akahata-VLP
   Therapeutics, Frances Burghouwt-Oviawe-Janssen Global, Holly
   Chanatry-State University of New York Upstate Medical University,
   Claudia Christian-FHI 360, Beth-Ann Coller-Merck and Company, Aravinda
   deSilvaUniversity of North Carolina, Diane
   Epperson-Booze/Allen/Hamilton, Thomas Friedrich-University of Wisconsin,
   Richard Jarman-Walter Reed Army Institute of Research, Viral Diseases
   Branch, David Kaslow-PATH Center for Vaccine Innovation and Access, Mark
   Kristiansen-Cormac Life Sciences, LLC, Atsuo KukiTrudeau Institute,
   Kathleen Lanzer-Trudeau Institute, Christina Lupone-State University of
   New York Upstate Medical University, Christian Mandl-Themis Bioscience,
   Joel Maslow-GeneOne Life Science, Kristopher Paolino-State University of
   New York Upstate Medical University, Steven Projan-Beat the Reaper, LLC,
   Katrin Ramsauer-Themis Bioscience, William Reiley-Trudeau Institute,
   Christine Roberts-GeneOne Life Science, Alan Rothman-University of Rhode
   Island, Rajni Samavedam-Booz/Allen/Hamilton, Alexander Schmidt-Bill and
   Melinda Gates Medical Research Institute, Mark Schmitt-State University
   of New York Upstate Medical University, Peter Sifuna-US Army Medical
   Research DirectorateKenya, Jonathan Smith-PaxVax, Inc., Saravanan
   Thangamani-State University of New York Upstate Medical University,
   Marnix Van Loock-Janssen Global, David Vaughn-Bill and Melinda Gates
   Foundation, Benjamin Wizel-GlaxoSmithKline, and In-Kyu
   Yoon-International Vaccine Institute.
CR [Anonymous], SHATT LECT
   CDC centers for disease control and prevention, EB
   Diakite I, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004866
   Graham BS, 2018, NAT IMMUNOL, V19, P20, DOI 10.1038/s41590-017-0007-9
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2
   Li XF, 2013, J GEN VIROL, V94, P2700, DOI 10.1099/vir.0.059436-0
   Li Y, 2014, ORGANOGENESIS, V10, P159, DOI 10.4161/org.28918
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13
   Sun EC, 2013, VET MICROBIOL, V166, P145, DOI 10.1016/j.vetmic.2013.05.026
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Zeitlin L, 2016, P NATL ACAD SCI USA, V113, P4458, DOI 10.1073/pnas.1600996113
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD OCT 8
PY 2019
VL 37
IS 43
BP 6248
EP 6254
DI 10.1016/j.vaccine.2019.08.061
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JF9EH
UT WOS:000491685100002
PM 31500964
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Albalawi, Y
   Nikolov, NS
   Buckley, J
AF Albalawi, Yahya
   Nikolov, Nikola S.
   Buckley, Jim
TI Trustworthy Health-Related Tweets on Social Media in Saudi Arabia: Tweet
   Metadata Analysis
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE social media; new media; misinformation; trustworthiness; dissemination;
   health communication
ID INFORMATION-SEEKING; TWITTER; PROMOTION; ZIKA; PROVIDERS; PURPOSES;
   DISEASE; CRISIS; FEXACT; TRUST
AB Background: Social media platforms play a vital role in the dissemination of health information. However, evidence suggests that a high proportion of Twitter posts (ie, tweets) are not necessarily accurate, and many studies suggest that tweets do not need to be accurate, or at least evidence based, to receive traction. This is a dangerous combination in the sphere of health information.
   Objective: The first objective of this study is to examine health-related tweets originating from Saudi Arabia in terms of their accuracy. The second objective is to find factors that relate to the accuracy and dissemination of these tweets, thereby enabling the identification of ways to enhance the dissemination of accurate tweets. The initial findings from this study and methodological improvements will then be employed in a larger-scale study that will address these issues in more detail.
   Methods: A health lexicon was used to extract health-related tweets using the Twitter application programming interface and the results were further filtered manually A total of 300 tweets were each labeled by two medical doctors; the doctors agreed that 109 tweets were either accurate or inaccurate. Other measures were taken from these tweets' metadata to see if there was any relationship between the measures and either the accuracy or the dissemination of the tweets. The entire range of this metadata was analyzed using Python, version 3.6.5 (Python Software Foundation), to answer the research questions posed.
   Results: A total of 34 out of 109 tweets (31.2%) in the dataset used in this study were classified as untrustworthy health information. These came mainly from users with a non-health care background and social media accounts that had no corresponding physical (ie, organization) manifestation. Unsurprisingly, we found that traditionally trusted health sources were more likely to tweet accurate health information than other users. Likewise, these provisional results suggest that tweets posted in the morning are more trustworthy than tweets posted at night, possibly corresponding to official and casual posts, respectively. Our results also suggest that the crowd was quite good at identifying trustworthy information sources, as evidenced by the number of times a tweet's author was tagged as favorited by the community.
   Conclusions: The results indicate some initially surprising factors that might correlate with the accuracy of tweets and their dissemination. For example, the time a tweet was posted correlated with its accuracy, which may reflect a difference between professional (ie, morning) and hobbyist (ie, evening) tweets. More surprisingly, tweets containing a kashida-a decorative element in Arabic writing used to justify the text within lines-were more likely to be disseminated through retweets. These findings will be further assessed using data analysis techniques on a much larger dataset in future work.
C1 [Albalawi, Yahya; Nikolov, Nikola S.; Buckley, Jim] Univ Limerick, Dept Comp Sci & Informat Syst, Tierney Bldg, Limerick V94 NYD3, Ireland.
   [Albalawi, Yahya] Taibah Univ, Coll Arts & Sci, Dept Comp & Informat Sci, Al Ula, Saudi Arabia.
   [Albalawi, Yahya; Nikolov, Nikola S.; Buckley, Jim] Univ Limerick, Irish Software Res Ctr, Limerick, Ireland.
RP Albalawi, Y (corresponding author), Univ Limerick, Dept Comp Sci & Informat Syst, Tierney Bldg, Limerick V94 NYD3, Ireland.
EM yahalbalawi@gmail.com
RI Nikolov, Nikola S/B-8669-2015
OI Nikolov, Nikola S/0000-0001-8022-0297; Albalawi,
   Yahya/0000-0003-4264-6355
FU Taibah University, Al-Ula, Saudi Arabia; Science Foundation
   IrelandScience Foundation Ireland [13/RC/2094]
FX lWe would like to thank Dr Yousef Albalawi and Dr Khaled Shahat for
   their valuable advice. In addition, we thank all the doctors who
   participated in the process of evaluating health tweets in this study.
   This work was supported, in part, by Taibah University, Al-Ula, Saudi
   Arabia, and by a grant from the Science Foundation Ireland (grant
   number: 13/RC/2094).
CR Abbass Mohammed Ali A, 2017, Clin Colon Rectal Surg, V30, P281, DOI 10.1055/s-0037-1604258
   Al-Nazer A, 2009, NSS: 2009 3RD INTERNATIONAL CONFERENCE ON NETWORK AND SYSTEM SECURITY, P447, DOI 10.1109/NSS.2009.21
   Albalawi Y, 2017, HEALTH PROMOT INT, V32, P456, DOI 10.1093/heapro/dav103
   Allem Jon-Patrick, 2017, JMIR Public Health Surveill, V3, pe98, DOI 10.2196/publichealth.8641
   Alnemer KA, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4898
   Alsobayel Hana, 2016, JMIR Med Educ, V2, pe15
   Altshuler AL, 2015, CONTRACEPTION, V91, P226, DOI 10.1016/j.contraception.2014.11.009
   An L, 2019, DATA INF MANAG, V3, P102, DOI [10.2478/dim-2018-0013, DOI 10.2478/DIM-2018-0013]
   Bender JL, 2011, J MED INTERNET RES, V13, P165, DOI 10.2196/jmir.1560
   Bhattacharya S, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0447-z
   Bhattacharya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112235
   Bobicev V, 2018, P 2018 EMP METH NAT, P22, DOI [10.18653/v1/w18-5906, DOI 10.18653/V1/W18-5906]
   Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567
   Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679
   Castillo C., 2011, P 20 INT C WORLD WID, P675, DOI DOI 10.1145/1963405.1963500
   Chan WSY, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8382
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Chung JE, 2016, J HEALTH COMMUN, V21, P517, DOI 10.1080/10810730.2015.1103332
   CLARKSON DB, 1993, ACM T MATH SOFTWARE, V19, P484, DOI 10.1145/168173.168412
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Crook B, 2016, COMMUN RES REP, V33, P349, DOI 10.1080/08824096.2016.1224171
   Davis MA, 2015, SOC SCI MED, V131, P40, DOI 10.1016/j.socscimed.2015.02.038
   de Winter JC, 2010, PRACT ASSESS RES EVA, V15, P1
   Donohue JM, 2009, AM J GERIATR PHARMAC, V7, P105, DOI 10.1016/j.amjopharm.2009.04.005
   Dumbrell D, 2013, P ANN HICSS, P2666, DOI 10.1109/HICSS.2013.578
   Edwards C, 2016, COMPUT HUM BEHAV, V65, P666, DOI 10.1016/j.chb.2016.07.003
   El Gayar N, 2017, COMPUTATIONAL LINGUI
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2016, AM J INFECT CONTROL, V44, P1660, DOI 10.1016/j.ajic.2016.05.011
   Ghenai Amira, 2018, Proceedings of the ACM on Human-Computer Interaction, V2, DOI 10.1145/3274327
   Ghenai A, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), P518, DOI 10.1109/ICHI.2017.58
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Gold J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-583
   Graham M, 2014, PROF GEOGR, V66, P568, DOI 10.1080/00330124.2014.907699
   Gray NJ, 2005, SOC SCI MED, V60, P1467, DOI 10.1016/j.socscimed.2004.08.010
   Guidry JPD, 2019, EMERG INFECT DIS, V25, P179, DOI 10.3201/eid2501.180824
   Hagg E, 2018, INT J MED INFORM, V115, P92, DOI 10.1016/j.ijmedinf.2018.04.010
   Heldman AB, 2013, PUBLIC HEALTH REV, V35, DOI 10.1007/BF03391698
   Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618
   Howard PN, 2018, J INF TECHNOL POLITI, V15, P81, DOI 10.1080/19331681.2018.1448735
   Ibahrine M, 2016, POLITICAL ISLAM AND GLOBAL MEDIA: THE BOUNDARIES OF RELIGIOUS IDENTITY, P203
   Jamal A, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4312
   Jamison AM, 2019, AM J PUBLIC HEALTH, V109, P688, DOI 10.2105/AJPH.2019.304969
   Jiang Lan, 2017, Journal of Foodservice Business Research, V20, P568, DOI 10.1080/15378020.2016.1222746
   Juric R, 2017, P 50 HAW INT C SYST, DOI [10.24251/hicss.2017.395, DOI 10.24251/HICSS.2017.395]
   Kalyanam J, 2015, 21 ACM SIGKDD C KNOW
   Kalyanam J, 2017, CURR ADDICT REP, V4, P397, DOI [10.1007/s40429-017-0169-4, DOI 10.1007/S40429-017-0169-4]
   Kim Annice, 2017, JMIR Public Health Surveill, V3, pe63, DOI 10.2196/publichealth.8060
   Kim Annice E., 2013, Journal of the National Cancer Institute Monographs, P140, DOI 10.1093/jncimonographs/lgt026
   Kim Y, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4738
   Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x
   Levac JJ, 2010, INTERDISCIP J HLTH S, V1, P47, DOI DOI 10.18192/RISS-IJHS.V1I1.1534
   Lowe B, 2011, J MARKET EDUC, V33, P183, DOI 10.1177/0273475311410851
   McInnes Colin John, 2018, OBS*, V12, P23
   Meadows CZ, 2019, AM J INFECT CONTROL, V47, P1314, DOI 10.1016/j.ajic.2019.05.007
   Medlock S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3749
   MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Morris MR, 2012, P ACM 2012 C COMP SU, P441, DOI DOI 10.1145/2145204.2145274
   Nastasi A, 2018, J CANCER EDUC, V33, P695, DOI 10.1007/s13187-017-1168-9
   Neiger BL, 2012, HEALTH PROMOT PRACT, V13, P159, DOI 10.1177/1524839911433467
   Omair MA, 2015, RHEUMATOLOGY SUNNYVA, V5, P165
   Omrani AS, 2015, J HOSP INFECT, V91, P188, DOI 10.1016/j.jhin.2015.08.002
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Park H, 2016, J HEALTH COMMUN, V21, P188, DOI 10.1080/10810730.2015.1058435
   Passerello GL, 2019, BJPSYCH BULL, V43, P158, DOI 10.1192/bjb.2018.115
   Plotkin Boghardt L., 2013, WASHINGTON I NEAR E
   Prabhu V, 2015, BJU INT, V116, P65, DOI 10.1111/bju.12748
   R Core Team, 2019, LANG ENV STAT COMP
   Riquelme F, 2016, INFORM PROCESS MANAG, V52, P949, DOI 10.1016/j.ipm.2016.04.003
   Salzmann-Erikson M, 2017, QUAL HEALTH RES, V27, P285, DOI 10.1177/1049732315627364
   Schmidt AL, 2018, VACCINE, V36, P3606, DOI 10.1016/j.vaccine.2018.05.040
   Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791
   Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142209
   Statista Clement J., 2019, LEAD COUNTR BAS NUMB
   Stautz K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015493
   Straton N, 2016, 2016 IEEE 18TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES (HEALTHCOM), P442
   Suh B., 2010, 2010 IEEE 2 INT C SO, P177, DOI DOI 10.1109/SOCIALCOM.2010.33
   Tang L, 2018, AM J INFECT CONTROL, V46, P962, DOI 10.1016/j.ajic.2018.02.010
   Volkova S, 2015, PROCEEDINGS OF THE TWENTY-NINTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2325
   Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495
   Wong R, 2017, J PUBLIC HEALTH MAN, V23, pE16, DOI 10.1097/PHH.0000000000000342
   WORSLEY A, 1989, Health Education Research, V4, P367, DOI 10.1093/her/4.3.367
   Yang K.-C., 2019, HUMAN BEHAV EMERGING, V1, P48, DOI DOI 10.1002/HBE2.115
   Yin XX, 2008, IEEE T KNOWL DATA EN, V20, P796, DOI 10.1109/TKDE.2007.190745
   Yoo E, 2016, J OPER MANAG, V45, P123, DOI 10.1016/j.jom.2016.05.007
   Young R, 2018, INFORM COMMUN SOC, V21, P499, DOI 10.1080/1369118X.2017.1301518
   Zhao L, 2016, COMPUT COMMUN, V76, P1, DOI 10.1016/j.comcom.2015.08.001
   Zhuang KC, 2017, MULTIMED TOOLS APPL, V76, P3169, DOI 10.1007/s11042-016-3818-z
NR 91
TC 1
Z9 1
U1 6
U2 11
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD OCT 8
PY 2019
VL 21
IS 10
AR e14731
DI 10.2196/14731
PG 22
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA JC4QB
UT WOS:000489260400001
PM 31596242
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Borghetti, IA
   Zambenedetti, MR
   Requiao, L
   Vieira, DS
   Krieger, MA
   Rampazzo, RDP
AF Borghetti, Ivo Alberto
   Zambenedetti, Miriam Ribas
   Requiao, Luciana
   Vieira, Deusilene Souza
   Krieger, Marco Aurelio
   Pontello Rampazzo, Rita de Cassia
TI External Control Viral-Like Particle Construction for Detection of
   Emergent Arboviruses by Real-Time Reverse-Transcription PCR
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
AB Arboviruses have been emerging and reemerging worldwide, predominantly in tropical and subtropical areas. As many arbovirus infections, including dengue (DENV), Zika (ZIKV), and chikungunya (CHIKV), have similar signs and symptoms, clinical diagnosis of arbovirus infections is challenging. Therefore, reliable laboratory tests are necessary to improve the clinical management of patients with suspected arbovirus infections. Real-time reverse-transcription PCR (RT-qPCR) is among the more effective methods to distinguish these viruses. The aim of this study was to construct a unique positive external control derived from a unique plasmid using genetic engineering for specific use in RT-qPCR assays to detect Zika, dengue (1-4), and chikungunya. An external control derived from the MS2 bacteriophage was constructed using sequences from arbovirus and human genomes. Laboratories were asked to test the control in the ZDC Biomol kit, a RT-qPCR kit which is able to detect Zika, dengue serotypes 1-4, chikungunya, and an internal human control. RNA extracted from the external control was able to be amplified and detected in RT-qPCR assays for each virus detected by using the ZDC Biomol kit. The external control, samples from viral culture, and infected patient samples display similar amplification using this assay. The pET47b(+)MS2-ZDC vector is a viable expression system for the production of external control viral-like particles (MS2-ZDC). The RNA from the recombinant particles can be easily extracted and can function as a tool to validate all steps of process from the extraction to the amplification of all targets in specific reaction. Thus, the MS2-ZDC particles are laboratory-safe in order to avoid risk for operators, and the phages are effective as positive control for use in the ZDC Biomol kit amplifying all kit targets making them effective for commercial profile.
C1 [Borghetti, Ivo Alberto; Zambenedetti, Miriam Ribas; Requiao, Luciana; Krieger, Marco Aurelio; Pontello Rampazzo, Rita de Cassia] IBMP, Curitiba, PR, Brazil.
   [Borghetti, Ivo Alberto; Krieger, Marco Aurelio] Univ Fed Parana, Programa Posgrad Engn Bioproc & Biotecnol, Curitiba, PR, Brazil.
   [Vieira, Deusilene Souza] Fiocruz MS, Porto Velho, Rondonia, Brazil.
   [Krieger, Marco Aurelio] Fiocruz MS, ICC, Curitiba, PR, Brazil.
RP Rampazzo, RDP (corresponding author), IBMP, Curitiba, PR, Brazil.
EM rcprampazzo@gmail.com
RI Rampazzo, Rita/AAA-4590-2020; Krieger, Marco/AAE-8611-2020
OI Rampazzo, Rita/0000-0002-8367-999X; 
CR [Anonymous], 2019, EPIDEMIOLOGIA DENGUE
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Hodinka RL, 2013, J CLIN MICROBIOL, V51, P2, DOI 10.1128/JCM.02593-12
   Musso D., 2016, VIROL J, V13, P1
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Sanchez-Carbonel Jose, 2018, BMC Res Notes, V11, P175, DOI 10.1186/s13104-018-3290-0
   Sharma R, 2018, J MED VIROL, V90, P1406, DOI 10.1002/jmv.25193
   Storch GA, 2000, CLIN INFECT DIS, V31, P739, DOI 10.1086/314015
   Yung CF, 2015, AM J TROP MED HYG, V92, P999, DOI 10.4269/ajtmh.14-0628
   Zambenedetti MR, 2017, MEM I OSWALDO CRUZ, V112, P339, DOI 10.1590/0074-02760160380
NR 13
TC 0
Z9 0
U1 1
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD OCT 7
PY 2019
VL 2019
AR 2560401
DI 10.1155/2019/2560401
PG 4
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA JH7MG
UT WOS:000492951300003
PM 31687381
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Venancio, FA
   Bernal, MEQ
   Ramos, MDDV
   Chaves, NR
   Hendges, MV
   de Souza, MMR
   de Medeiros, MJ
   Pinto, CDS
   de Oliveira, EF
AF Venancio, Fabio Antonio
   Quiliao Bernal, Maria Eulina
   de Barros Vieira Ramos, Maria da Conceicao
   Chaves, Neuma Rocha
   Hendges, Marcos Vinicius
   Rodrigues de Souza, Mattheus Marques
   de Medeiros, Marcio Jose
   Santos Pinto, Claudia Du Bocage
   de Oliveira, Everton Falcao
TI Congenital Zika Syndrome in a Brazil-Paraguay-Bolivia border region:
   Clinical features of cases diagnosed between 2015 and 2018
SO PLOS ONE
LA English
DT Article
ID VIRUS-INFECTION; INFANTS; GROWTH; DENGUE; BRAIN
AB Congenital Zika Syndrome (CZS) is a unique pattern of congenital abnormalities found in fetuses and neonates infected with the Zika virus (ZIKV). Here, we clinically identify and characterize infants with CZS between 2015 and 2018 in Mato Grosso do Sul, Brazil-a border area with Paraguay and Bolivia. This cross-sectional study, based on primary and secondary data, tracks the cases registered in the Brazilian Public Health Reporting System through the following stages: (1) preliminary data analysis, (2) identification of the congenital syndrome cases, (3) etiologic classification of the cases, (4) active search, and (5) clinical assessment. Of the 72 investigated cases, 16 were probable cases of CZS. Of these, it was only possible to clinically assess 11 infants. Considering the 16 probable cases of CZS, nine were classified as confirmed cases, and five as potential cases of the syndrome. Regarding clinical features, brain palsy was identified in all analyzed infants. Moreover, microcephaly and pseudobulbar syndrome were found in eight infants, and hydrocephalus was found in three individuals. In addition to these conditions, seven children were malnourished. Our study may provide significant insights for other researches that aim to elucidate CZS and its clinical and populational consequences.
C1 [Venancio, Fabio Antonio; de Oliveira, Everton Falcao] Univ Fed Mato Grosso do Sul, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil.
   [Quiliao Bernal, Maria Eulina] Assoc Pais & Amigos Excepcionais, Ctr Especializado Reabilitacao, Campo Grande, MS, Brazil.
   [de Barros Vieira Ramos, Maria da Conceicao; Chaves, Neuma Rocha] Secretaria Municipal Saude Publ Campo Grande, Coordenadoria Vigilancia Epidemiol, Campo Grande, MS, Brazil.
   [Hendges, Marcos Vinicius; Rodrigues de Souza, Mattheus Marques] Univ Fed Mato Grosso do Sul, Fac Med, Campo Grande, MS, Brazil.
   [de Medeiros, Marcio Jose] Univ Fed Rio de Janeiro, Campus Macae, Rio De Janeiro, Brazil.
   [Santos Pinto, Claudia Du Bocage; de Oliveira, Everton Falcao] Univ Fed Mato Grosso do Sul, Inst Integrad Saude, Campo Grande, MS, Brazil.
RP Venancio, FA; de Oliveira, EF (corresponding author), Univ Fed Mato Grosso do Sul, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil.; de Oliveira, EF (corresponding author), Univ Fed Mato Grosso do Sul, Inst Integrad Saude, Campo Grande, MS, Brazil.
EM venanciofab@gmail.com; everton.falcao@ufms.br
RI Falcao de Oliveira, Everton/L-3261-2016
OI Falcao de Oliveira, Everton/0000-0002-0074-5278
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adams RD, 1997, PRINCIPLES NEUROLOGY
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Benfer KA, PEDIATRICS, V414, DOI [10.3201/eid2303.161499, DOI 10.3201/EID2303.161499]
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bischoff AR, 2016, PEDIATR INFECT DIS J, V35, P1313, DOI 10.1097/INF.0000000000001307
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Brasil. Ministerio da Saude, 2019, B EPIDEMIOLOGICO, V50
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Cabral CM, 2017, EPIDEMIOL SERV SAUDE, V26, P245, DOI [10.5123/S1679-49742017000200002, 10.5123/s1679-49742017000200002]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC-Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/s1679-49742018000200014
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martins RS, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300012, 10.5123/s1679-49742018000300012]
   Ministerio da Saude, 2016, SECR AT ZER 3 AN COM
   Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, SECR AT INT VIG AT S
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2015, PROT VIG RESP SIST N
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Pedrosa CSG, 2019, BIORXIV755066
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Estado de Saude do Rio de Janeiro. Centro de Informac de Vigilncia em Saude/Unidade de Resposta Rapida (CIEVS), 2019, 0122019 CIEVS
   Secretaria de Vigilncia em Saude, 2013, DEP INF NEL MON NASC
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   van der Linden V, 2019, JAMA NEUROL, V76, P203, DOI 10.1001/jamaneurol.2018.3553
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Whitehead SS, 2019, NATURE, V567, P467, DOI 10.1038/d41586-019-00868-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 44
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 4
PY 2019
VL 14
IS 10
AR e0223408
DI 10.1371/journal.pone.0223408
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LM7CZ
UT WOS:000532407600027
PM 31584972
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Magoro, T
   Dandekar, A
   Jennelle, LT
   Bajaj, R
   Lipkowitz, G
   Angelucci, AR
   Bessong, PO
   Hahn, YS
AF Magoro, Tshifhiwa
   Dandekar, Aditya
   Jennelle, Lucas T.
   Bajaj, Rohan
   Lipkowitz, Gabriel
   Angelucci, Angelina R.
   Bessong, Pascal O.
   Hahn, Young S.
TI IL-1 beta/TNF-alpha/IL-6 inflammatory cytokines promote STAT1-dependent
   induction of CH25H in Zika virus-infected human macrophages
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE flavivirus; infection; inflammation; innate immunity; macrophage;
   cholesterol 25-hydroxylase
ID PATTERN-RECOGNITION RECEPTORS; CHOLESTEROL 25-HYDROXYLASE;
   25-HYDROXYCHOLESTEROL; INNATE; APOPTOSIS; ACTIVATION; TRANSCRIPTION;
   MECHANISMS; SREBPS; ATF3
AB Zika virus (ZIKV)(3) is an enveloped, single-stranded, positive-sense RNA virus of the Flaviviridae family that has emerged as a public health threat because of its global transmission and link to microcephaly. Currently there is no vaccine for this virus. Conversion of cholesterol to 25-hydroxycholesterol by cholesterol 25-hydroxylase (CH25H) has been shown to have broad antiviral properties. However, the molecular basis of induction of CH25H in humans is not known. Elucidation of signaling and transcriptional events for induction of CH25H expression is critical for designing therapeutic antiviral agents. In this study, we show that CH25H is induced by ZIKV infection or Toll-like receptor stimulation. Interestingly, CH25H is induced by pro-inflammatory cytokines, including IL-1 beta, tumor necrosis factor alpha, and IL-6, and this induction depends on the STAT1 transcription factor. Additionally, we observed that cAMP-dependent transcription factor (ATF3) weakly binds to the CH25H promoter, suggesting cooperation with STAT1. However, ZIKV-induced CH25H was independent of type I interferon. These findings provide important information for understanding how the Zika virus induces innate inflammatory responses and promotes the expression of anti-viral CH25H protein.
C1 [Magoro, Tshifhiwa; Bessong, Pascal O.] Univ Venda, Dept Microbiol, HIV AIDS & Global Hlth Res Program, Thohoyandou, Limpopo, South Africa.
   [Magoro, Tshifhiwa; Dandekar, Aditya; Jennelle, Lucas T.; Bajaj, Rohan; Lipkowitz, Gabriel; Angelucci, Angelina R.; Hahn, Young S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.
   [Magoro, Tshifhiwa; Dandekar, Aditya; Jennelle, Lucas T.; Bajaj, Rohan; Lipkowitz, Gabriel; Angelucci, Angelina R.; Hahn, Young S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, 345 Crispell Dr,MR6 Bldg,Rm 3715, Charlottesville, VA 22908 USA.
RP Hahn, YS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, 345 Crispell Dr,MR6 Bldg,Rm 3715, Charlottesville, VA 22908 USA.
EM ysh5e@virginia.edu
RI Magoro, Tshifhiwa/X-3466-2018
OI Magoro, Tshifhiwa/0000-0002-9295-1027
FU Global Infectious Diseases Research Training Programme of the Fogarty
   International Center/National Institute of Health [D43 TW006578];
   Research and Publication Committee of the University of Venda, South
   Africa; Global Infectious Diseases Institute of University of Virginia,
   Seed Grant
FX This study was partially supported by Global Infectious Diseases
   Research Training Programme of the Fogarty International Center/National
   Institute of Health Grant D43 TW006578 and the Research and Publication
   Committee of the University of Venda, South Africa. This work was also
   funded by a Global Infectious Diseases Institute of University of
   Virginia, Seed Grant (to Y. S. H.). The authors declare that they have
   no conflicts of interest with the contents of this article. The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200
   Anggakusuma,, 2015, HEPATOLOGY, V62, P702, DOI 10.1002/hep.27913
   Ares MPS, 1997, J LIPID RES, V38, P2049
   AyalaTorres S, 1997, EXP CELL RES, V235, P35, DOI 10.1006/excr.1997.3630
   Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106
   Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004
   Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598
   Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Choi YK, 2008, FREE RADICAL RES, V42, P544, DOI 10.1080/10715760802146062
   Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755
   Diczfalusy U, 2013, BIOCHIMIE, V95, P455, DOI 10.1016/j.biochi.2012.06.016
   Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200
   Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461
   Keyel PA, 2012, J IMMUNOL, V189, P4621, DOI 10.4049/jimmunol.1200828
   Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049
   Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318
   Pfaender S, 2015, APPL ENVIRON MICROB, V81, P1616, DOI 10.1128/AEM.03580-14
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104
   Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790
   Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637
   Shrivastava-Ranjan P, 2016, MBIO, V7, DOI [10.1128/mBio.01808-16, 10.1128/mbio.01808-16]
   Sood V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08584-9
   Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x
   Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014
   Wang WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25482
   Xiang Y, 2015, J VIROL, V89, P6805, DOI 10.1128/JVI.00587-15
   York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045
   Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10
NR 46
TC 3
Z9 3
U1 6
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 4
PY 2019
VL 294
IS 40
BP 14591
EP 14602
DI 10.1074/jbc.RA119.007555
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JP0II
UT WOS:000497955000008
PM 31375561
DA 2020-07-08
ER

PT J
AU Sumbria, D
   Berber, E
   Rouse, BT
AF Sumbria, Deepak
   Berber, Engin
   Rouse, Barry T.
TI Factors Affecting the Tissue Damaging Consequences of Viral Infections
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE viral infection; immunopathology; outcome of past and concomitant
   infections; influence of microbiome and virome; therapeutic management
   of infections
ID HERPES-SIMPLEX-VIRUS; REGULATORY T-CELLS; ZIKA VIRUS; ROTAVIRUS
   INFECTION; DENGUE VIRUS; MEDIATED INFLAMMATION; HETEROLOGOUS IMMUNITY;
   ANTIBIOTIC-TREATMENT; INTESTINAL VIROME; INFLUENZA
AB Humans and animals are infected by multiple endogenous and exogenous viruses but few agents cause overt tissue damage. We review the circumstances which favor overt disease expression. These can include intrinsic virulence of the agent, new agents acquired from heterologous species, the circumstances of infection such as dose and route, current infection with other agents which includes the composition of the microbiome at mucosal and other sites, past history of exposure to other infections as well as the immune status of the host. We also briefly discuss promising therapeutic strategies that can expand immune response patterns that minimize tissue damaging responses to viral infections.
C1 [Sumbria, Deepak; Berber, Engin; Rouse, Barry T.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.
RP Rouse, BT (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.
EM btr@utk.edu
RI BERBER, ENGIN/AAG-9297-2019
OI BERBER, ENGIN/0000-0003-0420-7714
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 EY 005093]
FX This work was supported by the NIH Grant R01 EY 005093.
CR Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2
   Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8
   Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10
   Arthur C.P., 1988, Revue Scientifique et Technique Office International des Epizooties, V7, P937, DOI 10.20506/rst.7.4.385
   Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Aslan N, 2017, MBIO, V8, DOI 10.1128/mBio.01841-17
   Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469
   BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6
   Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762
   Baxter VK, 2017, VIROLOGY, V508, P134, DOI 10.1016/j.virol.2017.05.013
   Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001
   Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181
   Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008
   Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655
   Bhela S, 2018, MICROBES INFECT, V20, P461, DOI 10.1016/j.micinf.2017.12.007
   Bhela S, 2014, J IMMUNOL, V192, P2734, DOI 10.4049/jimmunol.1302326
   Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103
   BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605
   Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467
   Britt WJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080405
   Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020
   Carding SR, 2017, ALIMENT PHARM THER, V46, P800, DOI 10.1111/apt.14280
   Carneiro-Sampaio M, 2007, INFECT IMMUN, V75, P1545, DOI 10.1128/IAI.00787-06
   Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346
   Cavanaugh VJ, 1998, J VIROL, V72, P2630, DOI 10.1128/JVI.72.4.2630-2637.1998
   CLARKE GL, 1978, VET PATHOL, V15, P68, DOI 10.1177/030098587801500109
   Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07
   DEPERRE PV, 2008, LANCET INFECT DIS, V8, P490, DOI DOI 10.1016/S1473-3099(08)70181-6
   DIANZANI F, 1975, Ricerca in Clinica e in Laboratorio, V5, P196
   Dropulic LK, 2011, CLIN INFECT DIS, V53, P897, DOI 10.1093/cid/cir610
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8
   Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420
   Garcia-Sastre A, 2002, MICROBES INFECT, V4, P647, DOI 10.1016/S1286-4579(02)01583-6
   Gil A, 2015, T ROY SOC TROP MED H, V109, P62, DOI 10.1093/trstmh/tru198
   Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   Goka EA, 2015, EPIDEMIOL INFECT, V143, P37, DOI 10.1017/S0950268814000302
   Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002
   Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x
   Gualdoni GA, 2018, P NATL ACAD SCI USA, V115, pE7158, DOI 10.1073/pnas.1800525115
   Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P54, DOI 10.1097/00005176-200001000-00018
   Haller O, 2015, J INTERF CYTOK RES, V35, P239, DOI 10.1089/jir.2015.1500
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Honce R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01071
   Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026
   de Oya NJ, 2019, EMERG MICROBES INFEC, V8, P624, DOI 10.1080/22221751.2019.1604084
   John AR, 2017, INFECT DIS CLIN N AM, V31, P811, DOI 10.1016/j.idc.2017.07.016
   Johnson DB, 2018, JAMA-J AM MED ASSOC, V320, P1702, DOI 10.1001/jama.2018.13995
   Kamaladasa A, 2016, ANTIVIR RES, V133, P183, DOI 10.1016/j.antiviral.2016.07.016
   Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718
   Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888
   Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009
   Kumar N, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00111-17
   Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Langlois RA, 2010, J IMMUNOL, V184, P4440, DOI 10.4049/jimmunol.0902984
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006
   Li L, 2010, PUBLIC HEALTH NUTR, V13, P276, DOI 10.1017/S1368980009990590
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903
   Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753
   MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381
   Malavige GN, 2017, IMMUNOLOGY, V151, P261, DOI 10.1111/imm.12748
   Malvy D, 2019, LANCET, V393, P936, DOI 10.1016/S0140-6736(18)33132-5
   Manivannan S, 2016, J VIROL, V90, P9251, DOI 10.1128/JVI.01045-16
   MARCUS PHILIP I., 1967, J VIROL, V1, P334
   Masopust D, 2017, J IMMUNOL, V199, P383, DOI 10.4049/jimmunol.1700453
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007
   McFarlane AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1068, DOI 10.1016/j.jaci.2017.01.016
   Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086
   Milner JJ, 2015, J IMMUNOL, V194, P4846, DOI 10.4049/jimmunol.1402295
   Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002
   Mulik S, 2013, INVEST OPHTH VIS SCI, V54, P563, DOI 10.1167/iovs.12-11094
   Mulik S, 2012, AM J PATHOL, V181, P525, DOI 10.1016/j.ajpath.2012.04.014
   Neil JA, 2018, J IMMUNOL, V201, P1615, DOI 10.4049/jimmunol.1800631
   Nikolay B, 2019, NEW ENGL J MED, V380, P1804, DOI 10.1056/NEJMoa1805376
   Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318
   Nolan N, 2017, IDCases, V10, P123, DOI 10.1016/j.idcr.2017.10.008
   Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001
   O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70
   O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862
   O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004
   Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2
   Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942
   Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383
   Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246
   PALESTINE AG, 1988, REV INFECT DIS, V10, pS515
   PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921
   Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454
   Pearce-Duvet JMC, 2006, BIOL REV, V81, P369, DOI 10.1017/S1464793106007020
   Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06
   PEPOSE JS, 1996, OCULAR INFECT IMMUNI, P905
   Picarda G, 2018, J IMMUNOL, V200, P3881, DOI 10.4049/jimmunol.1800171
   Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248
   Plotkin Stanley A, 2020, J Pediatric Infect Dis Soc, V9, P107, DOI 10.1093/jpids/piy140
   Ramakrishna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09884-6
   Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517
   Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003
   Ressel S, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1535
   Rezaee SAR, 2006, J GEN VIROL, V87, P1781, DOI 10.1099/vir.0.81919-0
   Rezende RM, 2017, SEMIN IMMUNOL, V30, P3, DOI 10.1016/j.smim.2017.07.004
   Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004
   Rochell SJ, 2015, J ANIM SCI, V93, P2987, DOI 10.2527/jas.2014-8462
   Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802
   Roy S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02922
   Ruffner MA, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.00665, 10.1126/sciimmunol.aar2548]
   Saeidi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02569
   Salzberger B, 2005, INFECTION, V33, P345, DOI 10.1007/s15010-005-5050-z
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Schleiss Mark R, 2018, Contemp Pediatr, V35, P16
   Sehrawat S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00177
   Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705
   Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306
   Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841
   SIMMONS A, 1984, J VIROL, V52, P816, DOI 10.1128/JVI.52.3.816-821.1984
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Souquette A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01071
   Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tahamtan A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01377
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   Tebit DM, 2012, CURR HIV RES, V10, P3, DOI 10.2174/157016212799304689
   Thackray LB, 2018, CELL REP, V22, P3440, DOI 10.1016/j.celrep.2018.03.001
   Thepaut M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0239-3
   Thomas S, 2017, CANCER RES, V77, P1783, DOI 10.1158/0008-5472.CAN-16-2929
   Thounaojam MC, 2014, J VIROL, V88, P4798, DOI 10.1128/JVI.02979-13
   Tomov VT, 2013, J VIROL, V87, P7015, DOI 10.1128/JVI.03389-12
   Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022
   Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037
   VANN VR, 1991, INVEST OPHTH VIS SCI, V32, P2462
   Varanasi SK, 2017, J IMMUNOL, V199, P1748, DOI 10.4049/jimmunol.1700472
   Varyukhina S, 2012, MICROBES INFECT, V14, P273, DOI 10.1016/j.micinf.2011.10.007
   Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036
   Walter J, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-19
   Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026
   Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106
   Wang KN, 2017, J CLIN INVEST, V127, P2626, DOI 10.1172/JCI88990
   Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x
   Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035
   Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454
   Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999
   Zhu B, 2015, J IMMUNOL, V195, P2251, DOI 10.4049/jimmunol.1500370
NR 153
TC 2
Z9 2
U1 3
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 4
PY 2019
VL 10
AR 2314
DI 10.3389/fmicb.2019.02314
PG 13
WC Microbiology
SC Microbiology
GA JF4CD
UT WOS:000491333800001
PM 31636623
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mohd, A
   Zainal, N
   Tan, KK
   AbuBakar, S
AF Mohd, Azirah
   Zainal, Nurhafiza
   Tan, Kim-Kee
   AbuBakar, Sazaly
TI Resveratrol affects Zika virus replication in vitro
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEALTHY-VOLUNTEERS; DENGUE; INHIBITION; TRANSMISSION; AGENT; HOST;
   EPIDEMIOLOGY; ANTIOXIDANT; MECHANISMS; GAMMA
AB Zika virus (ZIKV) infection is a serious public health concern. ZIKV infection has been associated with increased occurrences of microcephaly among newborns and incidences of Guillain-Barre syndrome among adults. No specific therapeutics or vaccines are currently available to treat and protect against ZIKV infection. Here, a plant-secreted phytoalexin, resveratrol (RES), was investigated for its ability to inhibit ZIKV replication in vitro. Several RES treatment regimens were used. The ZIKV titers of mockand RES-treated infected cell cultures were determined using the focus-forming assay and the Zika mRNA copy number as determined using qRT-PCR. Our results suggested that RES treatment reduced ZIKV titers in a dose-dependent manner. A reduction of >90% of virus titer and ZIKV mRNA copy number was achieved when infected cells were treated with 80 mu M of RES post-infection. Pre-incubation of the virus with 80 mu M RES showed >30% reduction in ZIKV titers and ZIKV mRNA copy number, implying potential direct virucidal effects of RES against the virus. The RES treatment reduced >70% virus titer in the anti-adsorption assay, suggesting the possibility that RES also interferes with ZIKV binding. However, there was no significant decrease in ZIKV titer when a short-period of RES treatment was applied to cells before ZIKV infection (pre-infection) and after the virus bound to the cells (virus internalization inhibition), implying that RES acts through its continuous presence in the cell cultures after virus infection. Overall, our results suggested that RES exhibited direct virucidal activity against ZIKV and possessed anti-ZIKV replication properties, highlighting the need for further exploration of RES as a potential antiviral molecule against ZIKV infection.
C1 [Mohd, Azirah; Zainal, Nurhafiza; Tan, Kim-Kee; AbuBakar, Sazaly] Univ Malaya, TIDREC, Kuala Lumpur, Malaysia.
   [Zainal, Nurhafiza; AbuBakar, Sazaly] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia.
   [Mohd, Azirah; Zainal, Nurhafiza; Tan, Kim-Kee; AbuBakar, Sazaly] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia.
RP AbuBakar, S (corresponding author), Univ Malaya, TIDREC, Kuala Lumpur, Malaysia.; AbuBakar, S (corresponding author), Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia.; AbuBakar, S (corresponding author), Univ Malaya, Fac Med, Kuala Lumpur, Malaysia.
EM sazaly@um.edu.my
RI Tan, Kim Kee/P-7285-2014
OI Tan, Kim Kee/0000-0002-5816-9146
FU Ministry of Education Malaysia under Long Term Research Grant Scheme
   (LRGS MRUN Phase 1) [LRGS MRUN/F1/01/2018]
FX This study was supported by Ministry of Education Malaysia under Long
   Term Research Grant Scheme (LRGS MRUN Phase 1: LRGS MRUN/F1/01/2018).
CR Abba Y, 2015, ADV VIROL, V2015, DOI 10.1155/2015/184241
   de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156
   Allard PM, 2012, PHYTOCHEMISTRY, V84, P160, DOI 10.1016/j.phytochem.2012.07.023
   Anlar H. G, 2016, TURKISH J PHARM SCI, V13, P109
   Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082
   Behrendt P, 2017, ANTIVIR RES, V147, P19, DOI 10.1016/j.antiviral.2017.09.006
   Besnard M, 2014, EURO SURVEILL, V19
   Bierlaire D, 2014, TRANSFUS CLIN BIOL, V21, P234, DOI DOI 10.1016/J.TRACLI.2014.08.005
   Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022
   Bourjot M, 2012, J NAT PROD, V75, P752, DOI 10.1021/np300059n
   Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan CN, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00408-17
   Cheng KB, 2014, CELL BIOCHEM BIOPHYS, V70, P1305, DOI 10.1007/s12013-014-0055-9
   Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002
   de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X
   Docherty JJ, 2006, ANTIVIR RES, V72, P171, DOI 10.1016/j.antiviral.2006.07.004
   Espinoza JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051306
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Evers DL, 2004, ANTIVIR RES, V63, P85, DOI 10.1016/j.antiviral.2004.03.002
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Han YS, 2017, J MED VIROL, V89, P397, DOI 10.1002/jmv.24660
   Heredia A, 2014, AIDS, V28, P317, DOI 10.1097/QAD.0000000000000168
   Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kapadia GJ, 2002, PHARMACOL RES, V45, P499, DOI 10.1006/phrs.2002.0992
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261
   Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L
   Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339
   Lopez-Velez M, 2003, CRIT REV FOOD SCI, V43, P233, DOI 10.1080/10408690390826509
   Matias AA, 2010, INT J FOOD SCI NUTR, V61, P357, DOI 10.3109/09637480903430990
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Moghaddam E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05452
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nakamura M, 2010, WORLD J GASTROENTERO, V16, P184, DOI 10.3748/wjg.v16.i2.184
   Nunes T, 2009, J CLIN PHARMACOL, V49, P1477, DOI 10.1177/0091270009339191
   Palamara AT, 2005, J INFECT DIS, V191, P1719, DOI 10.1086/429694
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Sharifi-Mood B, 2016, INT J INFECT, V3, P3
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Shu MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22332
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Teixeira RR, 2014, MOLECULES, V19, P8151, DOI 10.3390/molecules19068151
   Teoh BT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-213
   Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885
   Xie XH, 2012, INFLAMMATION, V35, P1392, DOI 10.1007/s10753-012-9452-7
   Yin Low J, 2009, J ANTIVIR ANTIRETROV, V1
   Zainal N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42998
   Zandi K, 2012, MOLECULES, V17, P2437, DOI 10.3390/molecules17032437
   Zang N, 2011, J VIROL, V85, P13061, DOI 10.1128/JVI.05869-11
   Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116879
NR 59
TC 2
Z9 2
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 4
PY 2019
VL 9
AR 14336
DI 10.1038/s41598-019-50674-3
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JC1AN
UT WOS:000489011000044
PM 31586088
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maslow, JN
AF Maslow, Joel N.
TI Challenges and solutions in the development of vaccines against emerging
   and neglected infectious diseases
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE Vaccine; emerging infectious disease; neglected infectious disease;
   vaccine development; flavivirus; bunyavirus; filovirus
ID ZIKA INFECTION; DENGUE; ENHANCEMENT; ANTIBODIES
AB Emerging and emergent infectious diseases (EIDs) represent a significant and growing cause of morbidity and mortality with increased potential for pandemics due to globalization and international trade. Challenges remain to the approach toward vaccine development for EIDs. This Special Feature explores areas related to vaccine development and testing, including unique challenges posed in the developing world. Vaccines against multiple pathogens spanning a number of viral families are explored with respect to past activities through to future commercialization. Cost drivers balanced against clinical need are discussed and unique challenges posed by rare diseases are considered.
C1 [Maslow, Joel N.] Gene One Life Sci Inc, Seoul, South Korea.
   [Maslow, Joel N.] Morristown Med Ctr, Dept Med, Morristown, NJ USA.
   [Maslow, Joel N.] Morristown Med Ctr, Med, Morristown, NJ 07960 USA.
RP Maslow, JN (corresponding author), Gene One Life Sci Inc, Seoul, South Korea.; Maslow, JN (corresponding author), Morristown Med Ctr, Med, Morristown, NJ 07960 USA.
EM jmaslow@geneonels-us.com
CR Bottazzi ME, 2019, HUM VACC IMMUNOTHER, V15, P2235, DOI 10.1080/21645515.2019.1629254
   Breitbach ME, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007766
   Castanha PMS, 2017, J INFECT DIS, V216, P614, DOI 10.1093/infdis/jix346
   Du RX, 2019, HUM VACC IMMUNOTHER, V15, P2343, DOI 10.1080/21645515.2019.1565266
   Fathi A, 2019, HUM VACC IMMUNOTHER, V15, P2269, DOI 10.1080/21645515.2019.1649532
   Galula JU, 2019, HUM VACC IMMUNOTHER, V15, P2328, DOI 10.1080/21645515.2019.1643676
   Gouglas D, 2018, LANCET GLOB HEALTH, V6, pE1386, DOI 10.1016/S2214-109X(18)30346-2
   Graham BS, 2018, JAMA-J AM MED ASSOC, V319, P1431, DOI 10.1001/jama.2018.0345
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hueston L, 2017, J INFECT DIS, V216, P612, DOI 10.1093/infdis/jix344
   Kasabi GS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002025
   Ma J, 2019, HUM VACC IMMUNOTHER, V15, P2286, DOI 10.1080/21645515.2019.1627820
   Maslow JN, 2019, HUM VACC IMMUNOTHER, V15, P2249, DOI 10.1080/21645515.2019.1633875
   Maslow JN, 2017, HUM VACC IMMUNOTHER, V13, P2918, DOI 10.1080/21645515.2017.1358325
   Maslow JN, 2017, VACCINE, V35, P5437, DOI 10.1016/j.vaccine.2017.02.015
   Tran NH, 2019, HUM VACC IMMUNOTHER, V15, P2315, DOI 10.1080/21645515.2019.1578595
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Racine T, 2019, HUM VACC IMMUNOTHER, V15, P2264, DOI 10.1080/21645515.2019.1597595
   Rajaiah P, 2019, HUM VACC IMMUNOTHER, V15, P2243, DOI 10.1080/21645515.2019.1602431
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Reyes-Sandoval A, 2019, HUM VACC IMMUNOTHER, V15, P2351, DOI 10.1080/21645515.2019.1574149
   Roberts CC, 2019, HUM VACC IMMUNOTHER, V15, P2258, DOI 10.1080/21645515.2019.1634992
   Roberts CC, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040070
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Suschak John J, 2019, Hum Vaccin Immunother, V15, P2359, DOI 10.1080/21645515.2019.1651140
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Thomas SJ, 2019, HUM VACC IMMUNOTHER, V15, P2295, DOI 10.1080/21645515.2019.1658503
   Ulbert S, 2019, HUM VACC IMMUNOTHER, V15, P2337, DOI 10.1080/21645515.2019.1621149
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
NR 30
TC 0
Z9 0
U1 3
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD OCT 3
PY 2019
VL 15
IS 10
BP 2230
EP 2234
DI 10.1080/21645515.2019.1661209
PG 5
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA JG2QG
UT WOS:000491919700003
PM 31644396
OA Bronze
DA 2020-07-08
ER

PT J
AU Tannock, GA
   Kim, H
   Xue, LM
AF Tannock, Gregory A.
   Kim, Hyunsuh
   Xue, Lumin
TI Why are vaccines against many human viral diseases still unavailable; an
   historic perspective?
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review; Early Access
DE human; immunity; vaccine development; veterinary; viruses
ID ADAPTED INFLUENZA-A; VIRUS-INFECTION; HERPES-ZOSTER; ZIKA VIRUS;
   SEASONAL INFLUENZA; VARICELLA VACCINE; PROTECTS MICE; HEMAGGLUTININ;
   ANTIBODIES; RESPONSES
AB The number of new and improved human viral vaccines licensed in recent years contrasts sharply with what could be termed the golden era (1955-1990) when vaccines against polio-, measles, mumps, rubella, and hepatitis B viruses first became available. Here, we attempt to explain why vaccines, mainly against viruses other than human immunodeficiency virus and hepatitis C virus, are still unavailable. They include human herpesviruses other than varicella-zoster virus, respiratory syncytial and most other respiratory, enteric and arthropod-borne viruses. Improved oral poliovirus vaccines are also urgently required. Their unavailability is attributable to regulatory/economic factors and the properties of individual viruses, but also to an absence of relevant animal models and ethical problems for the conduct of clinical of trials in pediatric and other critical populations. All are portents of likely difficulties for the licensing of effective vaccines against emerging pathogens, such as avian influenza, Ebola, and Zika viruses.
C1 [Tannock, Gregory A.] Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.
   [Kim, Hyunsuh] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.
   [Xue, Lumin] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.
RP Tannock, GA (corresponding author), Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.
EM greg.tannock@burnet.edu.au
OI Tannock, Gregory/0000-0001-9629-1460
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams A, 2015, SCIENCE, V350, P609, DOI 10.1126/science.aad7294
   [Anonymous], 2018, Wkly Epidemiol Rec, V93, P142
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   Baz M, 2015, MBIO, V6, DOI 10.1128/mBio.01487-15
   Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368
   Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651
   Black S, 2015, EXPERT REV VACCINES, V14, P1543, DOI 10.1586/14760584.2015.1091733
   Bommakanti G, 2012, J VIROL, V86, P13434, DOI 10.1128/JVI.01429-12
   Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107
   Centers for Disease Control and Prevention, 2016, ACIP VOT US LAIV 201
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P577
   Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761
   Cox MMJ, 2008, INFLUENZA OTHER RESP, V2, P211, DOI 10.1111/j.1750-2659.2008.00053.x
   Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800
   DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016
   Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   EVANS DMA, 1985, NATURE, V314, P548, DOI 10.1038/314548a0
   Fauci AS, 2015, SCIENCE, V349, P386, DOI 10.1126/science.aac6300
   Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007
   Flannery B, 2018, MMWR-MORBID MORTAL W, V67, P180, DOI 10.15585/mmwr.mm6706a2
   Flint J, 2015, PRINCIPLES VIROLOGY, P254
   Francis TJ, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806
   Gabutti G, 2014, J Prev Med Hyg, V55, P130
   Galea SA, 2008, J INFECT DIS, V197, pS165, DOI 10.1086/522125
   Geisbert TW, 2017, LANCET, V389, P479, DOI 10.1016/S0140-6736(16)32618-6
   GIBBS CP, 1984, P NATL ACAD SCI-BIOL, V81, P3365, DOI 10.1073/pnas.81.11.3365
   Glass RI, 2006, NEW ENGL J MED, V354, P75, DOI 10.1056/NEJMe058285
   Halsey NA, 2006, BRIT MED J, V333, P1234, DOI 10.1136/bmj.39058.361620.BE
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hessel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088340
   Heyman B, 2014, CURR TOP MICROBIOL, V382, P201, DOI 10.1007/978-3-319-07911-0_9
   Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003
   Houot R, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.941740
   Jackwood MW, 2008, COUNC AGR SCI TECHNO, P38
   KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954
   Lambour J, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.97
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696
   Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x
   Lu Y, 2014, P NATL ACAD SCI USA, V111, P125, DOI 10.1073/pnas.1308701110
   MAK NK, 1982, INFECT IMMUN, V38, P218, DOI 10.1128/IAI.38.1.218-225.1982
   Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111
   Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12
   Moekotte AL, 2016, EXPERT OPIN INV DRUG, V25, P1325, DOI 10.1080/13543784.2016.1240785
   Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046
   Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242
   Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595
   Nasser R, 2010, J VIROL, V84, P10169, DOI 10.1128/JVI.00568-10
   Neuzil KM, 2014, STATUS VACCINE RES D
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oxman MN, 2008, J INFECT DIS, V197, pS228, DOI 10.1086/522159
   Powell TJ, 2012, J VIROL, V86, P13397, DOI 10.1128/JVI.01820-12
   RAUH LW, 1965, AM J DIS CHILD, V109, P232, DOI 10.1001/archpedi.1965.02090020234007
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1
   Ryder AB, 2016, J VIROL, V90, P2544, DOI 10.1128/JVI.02598-15
   Sarawar S, 2016, VACCINE, V34, P5090, DOI 10.1016/j.vaccine.2016.08.061
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298
   SMORODIN.AA, 1969, ARCH ENVIRON HEALTH, V18, P105, DOI 10.1080/00039896.1969.10665376
   SMORODINTSEV A A, 1959, Bull World Health Organ, V20, P1053
   Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10
   Straub OC, 2004, COMP IMMUNOL MICROB, V27, P1, DOI 10.1016/S0147-9571(02)00078-4
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   TAKAHASHI M, 1986, PEDIATRICS, V78, P736
   Tang DCC, 2009, EXPERT REV VACCINES, V8, P469, DOI 10.1586/ERV.09.1
   Tannock G, 1991, NATL LIB AUST COLLEC, V3, P12
   TANNOCK GA, 1995, ARCH VIROL, V140, P201, DOI 10.1007/BF01309736
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796
   WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5
   World Health Organization, 1998, WHO TECHN REP SER, V50, P878
   World Health Organization, TECHN ADV GROUP DENG
   World Health Organization, 2009, H5N1 WORK GROUP APR, P1
   World Health Organization, 2002, STAT WHO CONS POT EB
   YAMASHITA K, 1989, J EXP MED, V170, P997, DOI 10.1084/jem.170.3.997
   Yang XM, 2013, MOL THER, V21, P91, DOI 10.1038/mt.2012.184
NR 80
TC 1
Z9 1
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25593
EA OCT 2019
PG 10
WC Virology
SC Virology
GA JB5KB
UT WOS:000488600000001
PM 31502669
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Valentine, MJ
   Murdock, CC
   Kelly, PJ
AF Valentine, Matthew John
   Murdock, Courtney Cuin
   Kelly, Patrick John
TI Sylvatic cycles of arboviruses in non-human primates
SO PARASITES & VECTORS
LA English
DT Review
DE Sylvatic; Primates; Enzootic; Arboviruses; Mosquitoes; Chikungunya;
   Dengue; Zika; Yellow fever
ID MACAQUES MACACA-SINICA; DENGUE VIRUS; CHIKUNGUNYA-VIRUS; ZIKA VIRUS;
   YELLOW-FEVER; MAYARO-VIRUS; SEROLOGICAL EVIDENCE; MATO-GROSSO;
   HOST-RANGE; TRANSMISSION
AB Arboviruses infecting people primarily exist in urban transmission cycles involving urban mosquitoes in densely populated tropical regions. For dengue, chikungunya, Zika and yellow fever viruses, sylvatic (forest) transmission cycles also exist in some regions and involve non-human primates and forest-dwelling mosquitoes. Here we review the investigation methods and available data on sylvatic cycles involving non-human primates and dengue, chikungunya, Zika and yellow fever viruses in Africa, dengue viruses in Asia and yellow fever virus in the Americas. We also present current putative data that Mayaro, o'nyong'nyong, Oropouche, Spondweni and Lumbo viruses exist in sylvatic cycles.
C1 [Valentine, Matthew John] Ross Univ, Hlth Ctr Zoonoses & Trop Vet Med 1, Sch Vet Med, Isl Main Rd, West Farm, Basseterre, St Kitts & Nevi.
   [Murdock, Courtney Cuin] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Murdock, Courtney Cuin] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Murdock, Courtney Cuin] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.
   [Murdock, Courtney Cuin] Univ Georgia, Ctr Trop & Global Emerging Dis, Athens, GA 30602 USA.
   [Kelly, Patrick John] Ross Univ, Dept Clin Sci, Sch Vet Med, Isl Main Rd, West Farm, Basseterre, St Kitts & Nevi.
RP Valentine, MJ (corresponding author), Ross Univ, Hlth Ctr Zoonoses & Trop Vet Med 1, Sch Vet Med, Isl Main Rd, West Farm, Basseterre, St Kitts & Nevi.
EM mvalentine@students.rossu.edu
OI Valentine, Matthew John/0000-0001-5584-7813
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [1R21AI128407-01]; Ross University School of Veterinary Medicine
FX MJV's stipend as a PhD student was partly funded by the National
   Institute of Allergy and Infectious Diseases grant number
   1R21AI128407-01 and the Ross University School of Veterinary Medicine.
CR Althouse BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03332-7
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Althouse BM, 2014, VIROLOGY, V452, P237, DOI 10.1016/j.virol.2014.01.015
   Althouse BM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001928
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Apandi Y, 2009, J GEN MOL VIROL, P35
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Batista PM, 2012, REV SOC BRAS MED TRO, V45, P168, DOI 10.1590/S0037-86822012000200006
   Bernardo L, 2008, CLIN VACCINE IMMUNOL, V15, P439, DOI 10.1128/CVI.00208-07
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423
   Catenacci LS, 2018, ECOHEALTH, V15, P777, DOI 10.1007/s10393-018-1361-2
   Chen CI, 2010, AM J TROP MED HYG, V83, P1249, DOI 10.4269/ajtmh.2010.10-0290
   Chippaux JP, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0162-y
   CORNET M, 1984, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V22, P313
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   De Silva AM, 1999, AM J TROP MED HYG, V60, P300, DOI 10.4269/ajtmh.1999.60.300
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Eastwood G, 2017, AM J TROP MED HYG, V97, P1399, DOI 10.4269/ajtmh.17-0126
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gubler DJ, 2016, ARBOVIRUSES MOL BIOL
   HALSTEAD SB, 1966, B WORLD HEALTH ORGAN, V35, P89
   Hammon WMCD, 1961, SEATO MED RES MONOGR, V2, P45
   Hanley KA, 2014, AM J TROP MED HYG, V91, P672, DOI 10.4269/ajtmh.13-0492
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hemme RR, 2016, AM J TROP MED HYG, V94, P1095, DOI 10.4269/ajtmh.15-0262
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Higgs S, 2010, J CLIN INVEST, V120, P657, DOI 10.1172/JCI42392
   Inoue S, 2003, J MED PRIMATOL, V32, P89, DOI 10.1034/j.1600-0684.2003.00015.x
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445
   Kato F, 2013, J GEN VIROL, V94, P2202, DOI 10.1099/vir.0.055343-0
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   KOKERNOT RH, 1962, AM J TROP MED HYG, V11, P678, DOI 10.4269/ajtmh.1962.11.678
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Lambert AJ, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P271
   Lourencode-Oliveira R, 2017, PLOS NEGLECT TROP D, V11
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   MARCHETTE N J, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P317
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McIntosh B M, 1970, S Afr J Med Sci, V35, P65
   MCINTOSH BM, 1964, ANN TROP MED PARASIT, V58, P45, DOI 10.1080/00034983.1964.11686213
   Mishra B, 2016, J POSTGRAD MED, V62, P249, DOI 10.4103/0022-3859.191006
   MONATH TP, 1973, TROP GEOGR MED, V25, P28
   Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005351
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nakgoi K, 2014, AM J PRIMATOL, V76, P97, DOI 10.1002/ajp.22213
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Paulo M, 2015, J ENV ANAL CHEM, V2, P155
   PEIRIS JSM, 1993, J MED PRIMATOL, V22, P240
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rezza G, 2017, PATHOG GLOB HEALTH, V111, P271, DOI 10.1080/20477724.2017.1355431
   RODHAIN F, 1991, COMP IMMUNOL MICROB, V14, P9, DOI 10.1016/0147-9571(91)90036-D
   ROSEN L, 1958, AM J HYG, V68, P45, DOI 10.1093/oxfordjournals.aje.a119948
   RUDNICK A, 1967, JPN J MED SCI BIOL, VS 20, P69
   RUDNICK A, 1986, I MED RES MALAYS B, V23, P51
   RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203, DOI 10.1093/jmedent/2.2.203
   Sakkas H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040175
   SALUZZO JF, 1986, B SOC PATHOL EXOT, V79, P313
   Sam IC, 2015, EMERG INFECT DIS, V21, P1683, DOI 10.3201/eid2109.150439
   SEYMOUR C, 1983, AM J TROP MED HYG, V32, P854, DOI 10.4269/ajtmh.1983.32.854
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   SIMMONS JAMES STEVENS, 1931, PHILIPPINE JOUR SCI, V44, P1
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Sow A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx259
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Vourc'h G, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-52
   Weaver SC, 2005, ARCH VIROL, P33
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wei LJ, 2014, APPL MICROBIOL BIOT, V98, P5579, DOI 10.1007/s00253-014-5659-x
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   YUWONO J, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P194
NR 103
TC 1
Z9 1
U1 3
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 2
PY 2019
VL 12
IS 1
AR 463
DI 10.1186/s13071-019-3732-0
PG 18
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KN8QS
UT WOS:000515110700002
PM 31578140
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Routhu, NK
   Lehoux, SD
   Rouse, EA
   Bidokhti, MRM
   Giron, LB
   Anzurez, A
   Reid, S
   Abdel-Mohsen, M
   Cummings, RD
   Byrareddy, SN
AF Routhu, Nanda Kishore
   Lehoux, Sylvain D.
   Rouse, Emily A.
   Bidokhti, Mehdi R. M.
   Giron, Leila B.
   Anzurez, Alitzel
   Reid, St Patrick
   Abdel-Mohsen, Mohamed
   Cummings, Richard D.
   Byrareddy, Siddappa N.
TI Glycosylation of Zika Virus is Important in Host-Virus Interaction and
   Pathogenic Potential
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE host-virus interactions; Zika virus; envelope (E) protein; glycoprotein;
   N-linked glycans; mass spectrometry; lectin array; host cell surface
   glycans
ID N-LINKED GLYCANS; DC-SIGN; LECTIN MICROARRAY; ENVELOPE PROTEIN;
   STRUCTURAL BASIS; INFECTION; ARRAYS; TRANSMISSION; ASSOCIATION;
   EXPRESSION
AB Zika virus (ZIKV) is a global public health issue due to its association with severe developmental disorders in infants and neurological disorders in adults. ZIKV uses glycosylation of its envelope (E) protein to interact with host cell receptors to facilitate entry; these interactions could also be important for designing therapeutics and vaccines. Due to a lack of proper information about Asn-linked (N-glycans) on ZIKV E, we analyzed ZIKV E of various strains derived from different cells. We found ZIKV E proteins being extensively modified with oligomannose, hybrid and complex N-glycans of a highly heterogeneous nature. Host cell surface glycans correlated strongly with the glycomic features of ZIKV E. Mechanistically, we observed that ZIKV N-glycans might play a role in viral pathogenesis, as mannose-specific C-type lectins DC-SIGN and L-SIGN mediate host cell entry of ZIKV. Our findings represent the first detailed mapping of N-glycans on ZIKV E of various strains and their functional significance.
C1 [Routhu, Nanda Kishore; Bidokhti, Mehdi R. M.; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Lehoux, Sylvain D.; Cummings, Richard D.] Beth Israel Deaconess Med Ctr, Natl Ctr Funct Glyc, Boston, MA 02115 USA.
   [Lehoux, Sylvain D.; Rouse, Emily A.] Beth Israel Deaconess Med Ctr Glyc Core, Boston, MA 02115 USA.
   [Giron, Leila B.; Anzurez, Alitzel; Abdel-Mohsen, Mohamed] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Reid, St Patrick] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
RP Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
EM nanda.kishore.routhu@emory.edu; slehoux@bidmc.harvard.edu;
   erouse@bidmc.harvard.edu; mehdi.bidokhti@unmc.edu; lgiron@wistar.org;
   aanzurez@Wistar.org; patrick.reid@unmc.edu; mmohsen@wistar.org;
   rcummin1@bidmc.harvard.edu; sid.byrareddy@unmc.edu
RI Giron, Leila B/A-9642-2015; Routhu, Nanda Kishore/U-4106-2019
OI Giron, Leila B/0000-0002-3898-5680; Routhu, Nanda
   Kishore/0000-0003-2080-819X; Byrareddy, Siddappa/0000-0002-6889-4640;
   Anzurez, Alitzel/0000-0002-6994-3897
FU Nebraska Neuroscience Alliance Endowed Fund Award [R01AI113883];
   National Center for Functional Glycomics Grant [P41GM103694]
FX This work was supported in part by R01AI113883, Nebraska Neuroscience
   Alliance Endowed Fund Award to S.N.B., and the National Center for
   Functional Glycomics Grant P41GM103694 to R.D.C.
CR Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002
   Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baribaud F, 2002, J VIROL, V76, P9135, DOI 10.1128/JVI.76.18.9135-9142.2002
   Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Burd I, 2016, J ASSIST REPROD GEN, V33, P439, DOI 10.1007/s10815-016-0687-3
   Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Carlsson J, 2005, ANAL CHIM ACTA, V530, P167, DOI 10.1016/j.aca.2004.09.022
   Chambers MT, 2018, J VIROL, V92, DOI [10.1128/JVI.00505-18, 10.1128/jvi.00505-18]
   Chen P, 2008, J CANCER RES CLIN, V134, P851, DOI 10.1007/s00432-008-0357-7
   Chen SY, 2007, ANAL CHEM, V79, P5698, DOI 10.1021/ac070423k
   Choi HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34438-z
   Cruz E, 2018, HUM VACC IMMUNOTHER, V14, P508, DOI 10.1080/21645515.2017.1377871
   Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fromell K, 2005, COLLOID SURFACE B, V46, P84, DOI 10.1016/j.colsurfb.2005.06.017
   Go EP, 2015, J VIROL, V89, P8245, DOI 10.1128/JVI.00628-15
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752
   HSIEH P, 1984, J BIOL CHEM, V259, P2375
   Ishak H, 2001, MICROBIOL IMMUNOL, V45, P327, DOI 10.1111/j.1348-0421.2001.tb02627.x
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lei Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132122
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023
   Matsuda A, 2008, BIOCHEM BIOPH RES CO, V370, P259, DOI 10.1016/j.bbrc.2008.03.090
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Nam JH, 2008, BIOTECHNOL BIOENG, V100, P1178, DOI 10.1002/bit.21853
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g
   van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009
   Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yap SSL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01415
   Zhang PQ, 2016, DRUG DISCOV TODAY, V21, P740, DOI 10.1016/j.drudis.2016.01.006
   Zhang X., 2017, VIRUSES, P9
   Zheng T, 2005, J AM CHEM SOC, V127, P9982, DOI 10.1021/ja0505550
NR 65
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT 2
PY 2019
VL 20
IS 20
AR 5206
DI 10.3390/ijms20205206
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA JQ3AZ
UT WOS:000498822800238
PM 31640124
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freitas, LP
   Cruz, OG
   Lowe, R
   Carvalho, MS
AF Freitas, Lais Picinini
   Cruz, Oswaldo Goncalves
   Lowe, Rachel
   Carvalho, Marilia Sa
TI Space-time dynamics of a triple epidemic: dengue, chikungunya and Zika
   clusters in the city of Rio de Janeiro
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE dengue; Zika; chikungunya; cluster analysis; spatio-temporal analysis
ID SURVEILLANCE SYSTEM; VIRUS-INFECTION; DISEASE; SCAN; BRAZIL; RISK
AB Dengue, an arboviral disease transmitted by Aedes mosquitoes, has been endemic in Brazil for decades. However, vector-control strategies have not led to a significant reduction in the disease burden and have not been sufficient to prevent chikungunya and Zika entry and establishment in the country. In Rio de Janeiro city, the first Zika and chikungunya epidemics were detected between 2015 and 2016, coinciding with a dengue epidemic. Understanding the behaviour of these diseases in a triple epidemic scenario is a necessary step for devising better interventions for prevention and out-break response. We applied scan statistics analysis to detect spatio-temporal clustering for each disease separately and for all three simultaneously. In general, dusters were not detected in the same locations and time periods, possibly owing to competition between viruses for host resources, depletion of susceptible population, different introduction times and change in behaviour of the human population (e.g. intensified vector-control activities in response to increasing cases of a particular arbovirus). Simultaneous clusters of the three diseases usually included neighbourhoods with high population density and low socioeconomic status, particularly in the North region of the city. The use of space-time cluster detection can guide intensive interventions to high-risk locations in a timely manner, to improve clinical diagnosis and management, and pinpoint vector-control measures.
C1 [Freitas, Lais Picinini] Fundacao Oswaldo Cruz, Escola Natl Saude Publ Sergio Arouca ENSP, Rio De Janeiro, Brazil.
   [Cruz, Oswaldo Goncalves; Carvalho, Marilia Sa] Fundacao Oswaldo Cruz, Programa Comp Cient PROCC, Rio De Janeiro, Brazil.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London, England.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.
RP Freitas, LP (corresponding author), Fundacao Oswaldo Cruz, Escola Natl Saude Publ Sergio Arouca ENSP, Rio De Janeiro, Brazil.
EM lais.picinini.freitas@gmail.com
RI CARVALHO, MARILIA/AAD-8283-2020
OI CARVALHO, MARILIA/0000-0002-9566-0284; Freitas,
   Lais/0000-0001-9012-9382; Lowe, Rachel/0000-0003-3939-7343
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)CAPES [001]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_26/201.356/2014]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [304101/2017-6]; Royal Society Dorothy Hodgkin
   FellowshipRoyal Society of London
FX This work was supported in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior-Brasil (CAPES,
   http://www.capes.gov.br/)-Finance Code 001, to L.P.F. M.S.C. received
   grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ, http://www.faperj.br/, grant no.
   E_26/201.356/2014) and support from Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, http://www.cnpq.br/, grant no.
   304101/2017-6). R.L. was funded by a Royal Society Dorothy Hodgkin
   Fellowship (https://royalsociety.org).The funders did not influence the
   content of this manuscript nor the decision to submit it for
   publication.
CR Barbosa JR, 2015, EPIDEMIOL SERV SAUDE, V24, P49, DOI 10.5123/S1679-49742015000100006
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Bonifay T, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx247
   BRASIL(c). Ministerio da Saude, 2017, CHIK MAN CLIN
   Brasil Ministerio da Saude, 2016, NOT INF SVS MS ASS P
   Brasil Ministerio da Saude Secretaria de Vigitancia em Departamento de Vigilancia das Doencas Transmissiveis, 2016, DENG DIAGN MAN CLIN
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Carvalho S, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051006239, 10.11606/s1518-8787.2017051006239]
   Cavallieri F., 2012, FAVELAS CIDADE RIO J
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Cohen J, 2017, SCIENCE, V355, P1362, DOI 10.1126/science.355.6332.1362
   Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68
   Costa MA, 2005, ENVIRON ECOL STAT, V12, P301, DOI 10.1007/s10651-005-1515-6
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Desjardins MR, 2018, ACTA TROP, V185, P77, DOI 10.1016/j.actatropica.2018.04.023
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Farinelli EC, 2018, ACTA TROP, V180, P47, DOI 10.1016/j.actatropica.2018.01.005
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Instituto Pereira Passos, 2018, IDH M AN IND DES HUM
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377
   Kulldorff M., 2018, SATSCANT USER GUIDE
   Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Mercado-Reyes M, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s095026881800359x, 10.1017/S095026881800359X]
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003977
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Prefeitura do Rio de Janeiro, 2018, RIO SINT
   QGIS Development Team, 2019, QGIS GEOGR INF SYST
   R Core Team, 2019, R LANG ENV STAT COMP
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Robertson C, 2010, SPAT SPATIO-TEMPORAL, V1, P105, DOI 10.1016/j.sste.2009.12.001
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Santos DN, 2016, DOCUMENTO POSICAO TR
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Xavier DR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00186615, 10.1590/0102-311x00186615]
   Xu ZW, 2019, SCI TOTAL ENVIRON, V656, P889, DOI 10.1016/j.scitotenv.2018.11.395
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 54
TC 0
Z9 0
U1 2
U2 3
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD OCT 2
PY 2019
VL 286
IS 1912
AR 20191867
DI 10.1098/rspb.2019.1867
PG 10
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA JE2UW
UT WOS:000490551300016
PM 31594497
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Bordoni, V
   Lalle, E
   Colavita, F
   Baiocchini, A
   Nardacci, R
   Falasca, L
   Carletti, F
   Cimini, E
   Bordi, L
   Kobinger, G
   D'Ambrosio, V
   Natale, F
   Giancotti, A
   Manganaro, L
   Del Nonno, F
   Zumla, A
   Liuzzi, G
   Ippolito, G
   Capobianchi, MR
   Agrati, C
   Castilletti, C
AF Bordoni, Veronica
   Lalle, Eleonora
   Colavita, Francesca
   Baiocchini, Andrea
   Nardacci, Roberta
   Falasca, Laura
   Carletti, Fabrizio
   Cimini, Eleonora
   Bordi, Licia
   Kobinger, Gary
   D'Ambrosio, Valentina
   Natale, Fabio
   Giancotti, Antonella
   Manganaro, Lucia
   Del Nonno, Franca
   Zumla, Alimuddin
   Liuzzi, Giuseppina
   Ippolito, Giuseppe
   Capobianchi, Maria Rosaria
   Agrati, Chiara
   Castilletti, Concetta
TI Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived
   Mesenchymal Cells Long After the Resolution of the Infection
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; vertical transmission; placenta; mesenchymal cells; viral
   reservoir
AB The Zika virus (ZIKV) genome, its negative-strand viral proteins, and virus-like particles were detected in placenta-derived mesenchymal cells (MSCs), indicating that ZIKV persists after virus clearance from maternal blood and can be rescued by in vitro cultivation. We report for the first time the presence of replication-competent ZIKV in MSCs from an asymptomatic woman who acquired infection during pregnancy.
C1 [Bordoni, Veronica; Cimini, Eleonora; Agrati, Chiara] IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Cellular Immunol & Pharmacol, Via Portuense 292, I-00149 Rome, Italy.
   [Lalle, Eleonora; Colavita, Francesca; Carletti, Fabrizio; Bordi, Licia; Capobianchi, Maria Rosaria; Castilletti, Concetta] IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy.
   [Baiocchini, Andrea; Del Nonno, Franca] IRCCS, Natl Inst Infect Dis L Spallanzani, Unit Pathol, Rome, Italy.
   [Nardacci, Roberta; Falasca, Laura] IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Electron Microscopy, Rome, Italy.
   [Kobinger, Gary] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada.
   [D'Ambrosio, Valentina; Natale, Fabio; Giancotti, Antonella] Sapienza Univ Rome, Policlin Umberto I Hosp, Dept Maternal & Child Hlth & Urol Sci, Rome, Italy.
   [Manganaro, Lucia] Sapienza Univ Rome, Policlin Umberto I Hosp, Dept Radiol Oncol & Pathol Sci, Rome, Italy.
   [Zumla, Alimuddin] UCL, Div Infect & Immun, Ctr Clin Microbiol, London, England.
   [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, London, England.
   [Liuzzi, Giuseppina] IRCCS, Natl Inst Infect Dis L Spallanzani, Ctr Prevent & Treatment Infect Pregnancy, Rome, Italy.
   [Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis L Spallanzani, Sci Direct, Rome, Italy.
RP Agrati, C (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Cellular Immunol & Pharmacol, Via Portuense 292, I-00149 Rome, Italy.
EM chiara.agrati@inmi.it
RI Nardacci, Roberta/K-6555-2016
OI Nardacci, Roberta/0000-0002-9209-1207; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735
FU Italian Ministry of HealthMinistry of Health, Italy [RF-2016-02364155,
   GR-2016-02362110]; European Union's Horizon 2020 Research and Innovation
   Programme European Virus Archive (EVAg) [653316]
FX This study was supported by funds from the Italian Ministry of Health
   (Ricerca Corrente, line 1, RF-2016-02364155 and GR-2016-02362110) and
   from the European Union's Horizon 2020 Research and Innovation Programme
   European Virus Archive (EVAg, 653316).
CR Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beys-da-Silva WO, 2019, MOL NEUROBIOL, V56, P4708, DOI 10.1007/s12035-018-1417-x
   Liu W, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.5
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Ministerio da Saude, B EP SECR VIG SAUD
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Winchester SA, 2013, J CLIN MICROBIOL, V51, P1622, DOI 10.1128/JCM.03239-12
NR 16
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD OCT
PY 2019
VL 6
IS 10
AR ofz342
DI 10.1093/ofid/ofz342
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KG7YI
UT WOS:000510164000009
PM 31660333
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lichtenberger, PN
   Ricciardi, MJ
   Solorzano, D
   Raccamarich, P
   Leda, A
   Sharkey, M
   Watkins, DI
   El Sahly, H
   Rouphael, N
   Mulligan, MJ
   Doblecki-Lewis, S
   Stevenson, M
   Alcaide, ML
AF Lichtenberger, Paola N.
   Ricciardi, Michael J.
   Solorzano, Dalhila
   Raccamarich, Patricia
   Leda, Ana
   Sharkey, Mark
   Watkins, David I.
   El Sahly, Hana
   Rouphael, Nadine
   Mulligan, Mark J.
   Doblecki-Lewis, Susanne
   Stevenson, Mario
   Alcaide, Maria L.
TI Occupational Exposure to the Ugandan Research Strain (MR766) of Zika
   Virus
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Editorial Material
DE antibody responses; occupational exposure; viral persistence; ZIKV
ID INFECTION
AB A laboratory worker suffered an accidental needle-stick resulting in an exposure to the Ugandan strain (MR766) of Zika virus, which has rarely been studied in humans. We report the clinical presentation and outcomes, molecular and serological diagnostic results, and antibody response.
C1 [Lichtenberger, Paola N.; Solorzano, Dalhila; Raccamarich, Patricia; Sharkey, Mark; Doblecki-Lewis, Susanne; Stevenson, Mario; Alcaide, Maria L.] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA.
   [Ricciardi, Michael J.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Leda, Ana] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA.
   [El Sahly, Hana] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Rouphael, Nadine] Emory Univ, Dept Med, Atlanta, GA 30322 USA.
   [Mulligan, Mark J.] NYU, Vaccine Ctr, New York, NY USA.
   [Mulligan, Mark J.] NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY USA.
RP Alcaide, ML (corresponding author), 1120 NW 14th St,Suite 849, Miami, FL 33136 USA.
EM malcaide@med.miami.edu
OI Leda, Ana/0000-0003-0276-0487
FU Florida ZIKA Research Grant Initiative [7ZK27]; National Institutes of
   Health awardUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R41AI138720]
FX This study was supported by the Florida ZIKA Research Grant Initiative
   (7ZK27 to M.S.) and the National Institutes of Health award (R41AI138720
   to D.W.).
CR Brown CK, 2019, AM J IND MED, V62, P455, DOI 10.1002/ajim.22978
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Shugart JM, 2019, APPL BIOSAF, V24, P8
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
NR 14
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD OCT
PY 2019
VL 6
IS 10
AR ofz420
DI 10.1093/ofid/ofz420
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA KG7YI
UT WOS:000510164000066
PM 31667199
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, LH
   Wilson, ME
AF Chen, Lin H.
   Wilson, Mary E.
TI Zika circulation, congenital syndrome, and current guidelines: making
   sense of it all for the traveller
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE congenital; epidemiology; pregnancy; sexual transmission; travel; Zika
ID VIRUS-INFECTION; AEDES-AEGYPTI; TRANSMISSION; BRAZIL; COMPETENCE;
   AMERICA; SPREAD; RISK
AB Purpose of review Zika virus (ZIKV) swept through the Americas and led to recognition of its neurotropism. Zika circulation elsewhere in the world, nonvector transmission including maternal-fetal/sexual/transfusion routes, and additional reports on congenital Zika syndrome (CZS) and Guillain-Barre syndrome (GBS) have been published. Recent findings In 2018-2019, ZIKV transmission occurred in Cuba, India, and is suspected to appear sporadically in other countries. Maternal-fetal ZIKV transmission appears to occur in about 26% of ZIKV-infected pregnant women. The US ZIKV Pregnancy and Infant Registry identified 6% of live births to have at least one ZIKV-associated birth defect; 9% had at least one neurodevelopmental abnormality; 1% had both. Infectious virus was rarely isolated from semen of ZIKV-infected male patients beyond day 38 after symptom onset. Brazilian blood donations had low ZIKV prevalence in 2015-2016; in the United States, screening donations was cost-effective only in the high mosquito season in Puerto Rico. ZIKV transmission continues; many countries with competent mosquitoes are at risk. Transmission can occur without detection where surveillance is poor and laboratory capacity limited. Travelers are important sentinels. Variations exist among ZIKV strains and Aedes mosquitoes that influence competence for transmission. Maternal-fetal transmission results in significant rates of abnormality. Identification of infectious virus in semen clarifies sexual transmission risk, with updated recommendations for preconception planning. ZIKV neurotropism requires further research and long-term follow-up.
C1 [Chen, Lin H.] Mt Auburn Hosp, Div Infect Dis & Travel Med, 330 Mt Auburn St, Cambridge, MA 02138 USA.
   [Chen, Lin H.] Harvard Med Sch, Boston, MA 02115 USA.
   [Wilson, Mary E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
   [Wilson, Mary E.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA.
RP Chen, LH (corresponding author), Mt Auburn Hosp, Div Infect Dis & Travel Med, 330 Mt Auburn St, Cambridge, MA 02138 USA.
EM lchen@hms.harvard.edu
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Benites BD, 2019, AM J TROP MED HYG, V100, P174, DOI 10.4269/ajtmh.17-0843
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay095
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, P1
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gonzalez MA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3359-1
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   Grubaugh ND, 2019, TRENDS MICROBIOL, V27, P381, DOI 10.1016/j.tim.2019.02.004
   Grubaugh ND, INT TRAVELERS GENOMI, DOI [10.1101/496901, DOI 10.1101/496901]
   Hamer DH, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz012
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Lindsey NP, 2020, CLIN INFECT DIS, V70, P227, DOI 10.1093/cid/ciz195
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2017, LANCET INFECT DIS, V17, P782, DOI 10.1016/S1473-3099(17)30251-7
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pereira JP, 2019, CLIN INFECT DIS, V69, P713, DOI 10.1093/cid/ciz013
   Pereira JP, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6529
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P339
   Russell WA, 2019, ANN INTERN MED, V170, P164, DOI 10.7326/M18-2238
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Watts Alexander G, 2018, J Travel Med, V25, DOI 10.1093/jtm/tay132
   Whitehead SS, 2019, NATURE, V567, P467, DOI 10.1038/d41586-019-00868-6
   WHO, PREV SEX TRANSM ZIK
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 80
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 2019
VL 32
IS 5
BP 381
EP 389
DI 10.1097/QCO.0000000000000575
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA KC6PC
UT WOS:000507296200001
PM 31305494
DA 2020-07-08
ER

PT J
AU Tripathy, K
   Aleman, TS
AF Tripathy, Koushik
   Aleman, Tomas S.
TI Diagnostic and Therapeutic Challenges
SO RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
LA English
DT Editorial Material
ID LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; NMNAT1 MUTATIONS;
   MACULAR PIGMENT; ZIKA VIRUS; DEGENERATION; DYSTROPHY; DISEASE
C1 [Tripathy, Koushik] ICARE Eye Hosp & Postgrad Inst, Dept Vitreoretina & Uvea, Noida, Uttar Pradesh, India.
RP Tripathy, K (corresponding author), ICARE Eye Hosp & Postgrad Inst, Dept Vitreoretina & Uvea, Noida, Uttar Pradesh, India.
RI Tripathy, Koushik/E-7204-2014
OI Tripathy, Koushik/0000-0002-9756-128X
CR Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023
   Ajmal M, 2014, J MED GENET, V51, P444, DOI 10.1136/jmedgenet-2014-102316
   Akuffo KO, 2017, BRIT J OPHTHALMOL, V101, P190, DOI 10.1136/bjophthalmol-2016-308418
   Aleman TS, 2007, INVEST OPHTH VIS SCI, V48, P1319, DOI 10.1167/iovs.06-0764
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Aleman TS, 2015, OPHTHALMIC GENET, V36, P339, DOI 10.3109/13816810.2014.885059
   Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701
   Bonafede L, 2015, INVEST OPHTH VIS SCI, V56, P7875, DOI 10.1167/iovs.15-17857
   Boon CJF, 2009, OPHTHALMOLOGY, V116, P771, DOI 10.1016/j.ophtha.2008.12.019
   Brown T H, 1937, Br J Ophthalmol, V21, P645, DOI 10.1136/bjo.21.12.645
   Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370
   Cideciyan AV, 2005, INVEST OPHTH VIS SCI, V46, P4739, DOI 10.1167/iovs.05-0805
   Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102
   Clarke E, 1927, Br J Ophthalmol, V11, P97, DOI 10.1136/bjo.11.3.97
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Eandi CM, 2012, RETINA-J RET VIT DIS, V32, P1915, DOI 10.1097/IAE.0b013e31825f3851
   Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361
   FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502
   Fujinami K, 2013, AM J OPHTHALMOL, V156, P487, DOI 10.1016/j.ajo.2013.05.003
   Garg A, 2017, OPHTHALMIC GENET, V38, P575, DOI 10.1080/13816810.2017.1323339
   Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de
   Goodson NB, 2018, DEV BIOL, V434, P149, DOI 10.1016/j.ydbio.2017.12.003
   Greenwald SH, 2016, AM J PATHOL, V186, P1925, DOI 10.1016/j.ajpath.2016.03.013
   Huemer M, 2017, J INHERIT METAB DIS, V40, P21, DOI 10.1007/s10545-016-9991-4
   Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001
   Kiernan DF, 2011, OPHTHALMOLOGY, V118, P1435, DOI 10.1016/j.ophtha.2010.10.041
   Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356
   Kohl S, 2015, NAT GENET, V47, P757, DOI 10.1038/ng.3319
   Li SS, 2018, MOL GENET GENOMICS, V293, P699, DOI 10.1007/s00438-018-1417-6
   Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200
   Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005
   Mohamed MD, 2003, BRIT J OPHTHALMOL, V87, P473, DOI 10.1136/bjo.87.4.473
   Motta FL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09035-1
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   NUCCI P, 1994, OPHTHALMIC GENET, V15, P161, DOI 10.3109/13816819409057844
   Ozgul R, 2006, EYE, V20, P817, DOI 10.1038/sj.eye.6702024
   PEARLMAN JT, 1978, AM J OPHTHALMOL, V85, P215, DOI 10.1016/S0002-9394(14)75951-3
   Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357
   Pierrache LHM, 2017, OPHTHALMOLOGY, V124, P992, DOI 10.1016/j.ophtha.2017.03.010
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Shaikh RS, 2015, EUR J HUM GENET, V23, P473, DOI 10.1038/ejhg.2014.136
   Shona OA, 2019, RETINA-J RET VIT DIS, V39, P514, DOI 10.1097/IAE.0000000000001950
   SKALKA HW, 1979, AM J OPHTHALMOL, V87, P286, DOI 10.1016/0002-9394(79)90064-3
   Small K W, 1997, Mol Vis, V3, P1
   Small KW, 2016, OPHTHALMOLOGY, V123, P9, DOI 10.1016/j.ophtha.2015.10.006
   Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005
   Sunness JS, 2008, J VISUAL IMPAIR BLIN, V102, P600
   TRABOULSI EI, 1986, ARCH OPHTHALMOL-CHIC, V104, P1636
   Tsui Edmund, 2018, Retin Cases Brief Rep, V12 Suppl 1, pS3, DOI 10.1097/ICB.0000000000000645
   van Huet RAC, 2014, INVEST OPHTH VIS SCI, V55, P7467, DOI 10.1167/iovs.13-13825
   Wang SJ, 2018, METAB BRAIN DIS, V33, P829, DOI 10.1007/s11011-018-0189-3
   Weisfeld-Adams JD, 2015, MOL GENET METAB, V114, P537, DOI 10.1016/j.ymgme.2015.01.012
   WEITER JJ, 1988, AM J OPHTHALMOL, V106, P286, DOI 10.1016/0002-9394(88)90363-7
NR 53
TC 0
Z9 0
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0275-004X
EI 1539-2864
J9 RETINA-J RET VIT DIS
JI Retin.-J. Retin. Vitr. Dis.
PD OCT
PY 2019
VL 39
IS 10
BP 2053
EP 2058
DI 10.1097/IAE.0000000000002277
PG 6
WC Ophthalmology
SC Ophthalmology
GA KC9EX
UT WOS:000507475300026
PM 30074523
DA 2020-07-08
ER

PT J
AU Godbey, EA
   Thibodeaux, SR
AF Godbey, Elizabeth A.
   Thibodeaux, Suzanne R.
TI Ensuring safety of the blood supply in the United States: Donor
   screening, testing, emerging pathogens, and pathogen inactivation
SO SEMINARS IN HEMATOLOGY
LA English
DT Article
DE Transfusion-transmitted infections; Transfusion safety; Blood supply
ID WEST NILE VIRUS; ZIKA VIRUS; BACTERIAL-CONTAMINATION; TRANSFUSION;
   TRANSMISSION; INTERVENTIONS; REDUCTION; IMPACT; RISK
AB Safety of the blood supply has been a critical aspect of the transfusion medicine field since its inception, including infections that can be passed to a blood product recipient. Reactive efforts to identify potentially infected blood products are used throughout the blood donation process and afterward. Before donation, potential donors are provided educational materials about infection risks, examined and then screened through a series of questions that help temporarily, permanently, or indefinitely defer donors who could harbor acute and/or chronic infections. During donation, aseptic technique and diversion pouches reduce the potential to introduce bacteria into the blood product. Before transfusion, the blood products are tested for several infectious diseases by serology, nucleic acid testing, or a combination. During transfusion, the patient is monitored closely, and suspected transfusion reactions should be reported and investigated. The FDA regularly publishes guidance documents to incorporate knowledge gained regarding transfusion-transmitted infections, so that information can be shared and practices updated so that transfusion-related patient care can be optimized over time. Pathogen reduction processes are being developed and deployed that provide a proactive approach to both recognized and emerging pathogens. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Godbey, Elizabeth A.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA.
   [Thibodeaux, Suzanne R.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, 425 South Euclid Ave,Campus Box 8118, St Louis, MO 63122 USA.
RP Thibodeaux, SR (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, 425 South Euclid Ave,Campus Box 8118, St Louis, MO 63122 USA.
EM srthibodeaux@wustl.edu
CR AABB Donor History Task Force, 2016, FULL LENGTH BLOOD DO
   AABB Donor History Task Force, 2016, MED DEF LIST VERS 2
   AABB Donor History Task Force, 2016, BLOOD DON ED MAT VER
   AABB Donor History Task Force, 2016, BLOOD DON HIST QUEST
   [Anonymous], 2014, INTERCEPT BLOOD SYST
   [Anonymous], 2014, BP140143 PMA
   [Anonymous], 1997, FDA2013S0610 CBER
   [Anonymous], INTERCEPT BLOOD SYST
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Brecher ME, 2005, CLIN MICROBIOL REV, V18, P195, DOI 10.1128/CMR.18.1.195-204.2005
   Cerus Corporation, 2016, INTERCEPT BLOOD SYST
   CHAMBERS RW, 1969, TRANSFUSION, V9, P32, DOI 10.1111/j.1537-2995.1969.tb04909.x
   College of American Pathologists Commission on Laboratory Accreditation, 2019, TRANSF MED CHECKL
   Corash L, 2011, EXPERT REV HEMATOL, V4, P509, DOI [10.1586/EHM.11.53, 10.1586/ehm.11.53]
   Dodd RY, 2019, TRANSFUSION, V59, P1016, DOI 10.1111/trf.15118
   Dodd RY, 2016, TRANSFUSION, V56, P2781, DOI 10.1111/trf.13759
   Dodd RY, 2018, LANDSCAPE INFECT DIS
   Edens C, 2019, TRANSFUSION, V59, P524, DOI 10.1111/trf.15008
   Epstein JS, 2010, TRANSFUSION, V50, P1408, DOI 10.1111/j.1537-2995.2010.02728.x
   Food and Drug Administration, 2019, FDA2005D0140 CTR BIO
   Food. and Drug Administration, 2019, BLOOD PROD ADV COMM
   Fryk JJ, 2017, TRANSFUSION, V57, P2677, DOI 10.1111/trf.14256
   Gravemann U, 2019, TRANSFUSION, V59, P1324, DOI 10.1111/trf.15119
   Groves JA, 2017, TRANSFUSION, V57, P850, DOI 10.1111/trf.14018
   Haass KA, 2019, TRANSFUS MED REV, V33, P84, DOI 10.1016/j.tmrv.2019.01.001
   Heddle NM, 2016, TRANSFUSION, V56, P1581, DOI 10.1111/trf.13503
   Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944
   Katz LM, 2019, TRAVEL RELATED HLTH
   Leiby DA, 2019, VOX SANG, V114, P17, DOI 10.1111/vox.12727
   Marks P, 2019, TRANSFUSION, V59, P3026, DOI 10.1111/trf.15410
   McDonald CP, 2011, TRANSFUS MED HEMOTH, V38, P255, DOI 10.1159/000330474
   McDonald CP, 2004, VOX SANG, V86, P178, DOI 10.1111/j.0042-9007.2004.00404.x
   O'Brien SF, 2018, VOX SANG, V113, P750, DOI 10.1111/vox.12722
   Ooley P, 2018, STANDARDS BLOOD BANK
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Ronca SE, 2019, EMERG INFECT DIS, V25, P325, DOI 10.3201/eid2502.180765
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Shih AW, 2019, TRANSFUSION, V59, P2292, DOI 10.1111/trf.15317
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tonnetti L, 2019, TRANSFUSION, V59, P593, DOI 10.1111/trf.15043
   Tonnetti L, 2009, TRANSFUSION, V49, P2557, DOI 10.1111/j.1537-2995.2009.02317.x
   Transfusion Transmitted Diseases Committee AABB., FACT SHEETS CREAT UP
   Vishram B, 2019, VOX SANG, V114, P394, DOI 10.1111/vox.12767
   Ward SJ, 2018, TRANSFUSION, V58, P1916, DOI 10.1111/trf.14912
   Weisberg SP, 2017, ARCH PATHOL LAB MED, V141, P1705, DOI 10.5858/arpa.2016-0461-OA
   Wiltshire M, 2016, TRANSFUSION MED, V26, P208, DOI 10.1111/tme.12298
   Zou S, 2007, TRANSFUSION, V47, P1990, DOI 10.1111/j.1537-2995.2007.01422.x
NR 47
TC 0
Z9 0
U1 3
U2 3
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0037-1963
EI 1532-8686
J9 SEMIN HEMATOL
JI Semin. Hematol.
PD OCT
PY 2019
VL 56
IS 4
BP 229
EP 235
DI 10.1053/j.seminhematol.2019.11.004
PG 7
WC Hematology
SC Hematology
GA JX7ME
UT WOS:000503914000002
PM 31836028
DA 2020-07-08
ER

PT J
AU Agner, S
   Smith, A
   Diamond, M
   Miner, J
   Klein, R
AF Agner, S.
   Smith, A.
   Diamond, M.
   Miner, J.
   Klein, R.
TI A Neurodevelopmental Mouse Model of Congenital Zika Virus Infection
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 23-26, 2019
CL Charlotte, NC
SP Child Neurol Soc
DE Infections/Neuroimmunology; Cognitive/Behavioral Disorders
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2019
VL 86
SU 23
MA 103
BP S88
EP S88
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JW2DL
UT WOS:000502868300123
DA 2020-07-08
ER

PT J
AU Chamberlain, L
   Giuberti, C
   Dietze, R
   Abraham, T
   Webster, H
   Singh, T
   Corey, G
   Permar, S
   Tchapyjnikov, D
AF Chamberlain, L.
   Giuberti, C.
   Dietze, R.
   Abraham, T.
   Webster, H.
   Singh, T.
   Corey, G.
   Permar, S.
   Tchapyjnikov, D.
TI Neurodevelopmental Outcomes in Infants with Congenital Zika Virus
   Exposure: Data from a Prospective Cohort in Vitoria, Brazil
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 23-26, 2019
CL Charlotte, NC
SP Child Neurol Soc
DE Neonatal Neurology; Infections/Neuroimmunology; Cognitive/Behavioral
   Disorders
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2019
VL 86
SU 23
MA 137
BP S102
EP S103
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JW2DL
UT WOS:000502868300157
DA 2020-07-08
ER

PT J
AU Kousa, Y
   Mansour, T
   Mulkey, S
   Leslie, E
   Dick, A
   Vezina, G
   Bulas, D
   Cavalcanti, D
   Murray, J
   DeBiasi, R
   Cure, C
   Cordero, J
   Vilain, E
   Maximilian, M
   du Plessis, A
AF Kousa, Y.
   Mansour, T.
   Mulkey, S.
   Leslie, E.
   Dick, A.
   Vezina, G.
   Bulas, D.
   Cavalcanti, D.
   Murray, J.
   DeBiasi, R.
   Cure, C.
   Cordero, J.
   Vilain, E.
   Maximilian, M.
   du Plessis, A.
TI Human Genetic Risk and Protective Factors in Congenital Zika Syndrome
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 23-26, 2019
CL Charlotte, NC
SP Child Neurol Soc
DE Genetics; Neonatal Neurology; Rare Diseases
RI Youssef A Kousa/AAR-3064-2020
OI Youssef A Kousa/0000-0001-6049-8144
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2019
VL 86
SU 23
MA 86
BP S83
EP S83
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JW2DL
UT WOS:000502868300106
DA 2020-07-08
ER

PT J
AU Mulkey, S
   Arroyave-Wessel, M
   Bulas, D
   Vezina, G
   Fourzali, Y
   Morales, A
   Russo, S
   Kousa, Y
   Peyton, C
   Msall, M
   Jiang, J
   McCarter, R
   DeBiasi, R
   du Plessis, D
   Cure, C
AF Mulkey, S.
   Arroyave-Wessel, M.
   Bulas, D.
   Vezina, G.
   Fourzali, Y.
   Morales, A.
   Russo, S.
   Kousa, Y.
   Peyton, C.
   Msall, M.
   Jiang, J.
   McCarter, R.
   DeBiasi, R.
   du Plessis, D.
   Cure, C.
TI Neurodevelopment in Apparently Normal Newborns from Zika Virus Positive
   Pregnancies
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 23-26, 2019
CL Charlotte, NC
SP Child Neurol Soc
DE Infections/Neuroimmunology; Cognitive/Behavioral Disorders
RI Youssef A Kousa/AAR-3064-2020
OI Youssef A Kousa/0000-0001-6049-8144
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2019
VL 86
SU 23
MA 111
BP S91
EP S92
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JW2DL
UT WOS:000502868300131
DA 2020-07-08
ER

PT J
AU Singh, R
   Gupta, V
   Malhotra, B
   Singh, S
   Ravindran, P
   Meena, D
   Gupta, J
   Mathur, VK
   Mathur, RP
   Singh, S
   Sharma, P
   Sharma, H
   Bhandari, S
   Gupta, N
   Sapkal, G
   Mourya, DT
   Speer, MD
AF Singh, Ruchi
   Gupta, Veenu
   Malhotra, Bharti
   Singh, Sujeet
   Ravindran, P.
   Meena, Deepa
   Gupta, Jyoti
   Mathur, V. K.
   Mathur, Ravi Prakash
   Singh, Sunil
   Sharma, Pratibha
   Sharma, Himanshu
   Bhandari, Sudhir
   Gupta, Nivedita
   Sapkal, Gajanan
   Mourya, Devendera T.
   Speer, Maclane Davis
TI Cluster containment strategy: addressing Zika virus outbreak in
   Rajasthan, India
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID INFECTION; BRAZIL
AB India is at risk of Zika virus transmission due to high prevalence of its vector Aedes aegypti. Rajasthan, a state in the north-west region of India, has also high prevalence of Aedes mosquito. First laboratory confirmed case of Zika virus disease in Rajasthan was reported on 21 September 2018 in Jaipur. The Government of Rajasthan quickly implemented a containment strategy to contain the outbreak and prevent further spread of this disease. Strategy included active human and mosquito surveillance, laboratory testing and sequencing of the virus, integrated vector control measures, intersectoral coordination, risk communication and social mobilisation, all in a predefined geographic area around the epicentre. Timely action with appropriate coordination at all levels with multiple stakeholders contained the outbreak successfully. In all, 159 confirmed cases were reported from in and around the 3 km containment zone in Shastri Nagar area of Jaipur City and routine surveillance. Following this, a specially developed laboratory-based surveillance strategy was put in place to ensure that the disease does not spread beyond the containment zone. No fresh case was reported subsequently within or beyond the containment zone.
C1 [Singh, Ruchi] Med & Hlth Serv, State Microbiologist IDSP Directorate, Med & Hlth GOR, Jaipur, Rajasthan, India.
   [Gupta, Veenu] Govt Rajasthan, Med & Hlth, Jaipur, Rajasthan, India.
   [Malhotra, Bharti; Sharma, Pratibha; Sharma, Himanshu] SMS Med Coll & Hosp, Microbiol, Jaipur, Rajasthan, India.
   [Singh, Sujeet] Govt India, Minist Hlth & Family Welf, Natl Ctr Dis Control, Delhi, India.
   [Ravindran, P.] Union Govt, Emergency Med Relief, New Delhi, India.
   [Meena, Deepa; Gupta, Jyoti; Mathur, V. K.; Mathur, Ravi Prakash; Singh, Sunil; Speer, Maclane Davis] Govt Rajasthan, Directorate Med & Hlth, Jaipur, Rajasthan, India.
   [Bhandari, Sudhir] SMS Med Coll & Hosp, Med, Jaipur, Rajasthan, India.
   [Gupta, Nivedita] Govt India, Indian Council Med Res, Epidemiol & Communicable Dis, Delhi, India.
   [Sapkal, Gajanan; Mourya, Devendera T.] Natl Inst Virol, Virol, Pune, Maharashtra, India.
   [Speer, Maclane Davis] Dickinson Coll, Publ Hlth, Carlisle, PA 17013 USA.
RP Malhotra, B (corresponding author), SMS Med Coll & Hosp, Microbiol, Jaipur, Rajasthan, India.
EM DRBHARTIMALHOTRA@GMAIL.COM
CR [Anonymous], HINDU
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   NVBDCP, MAN INT VECT MAN
   Sapkal GN, 2018, J INFECTION, V76, P314, DOI 10.1016/j.jinf.2017.09.020
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, WHOZIKALA161
NR 8
TC 0
Z9 0
U1 1
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD OCT
PY 2019
VL 4
IS 5
AR e001383
DI 10.1136/bmjgh-2018-001383
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JS7IF
UT WOS:000500476500003
PM 31565402
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Longo, E
   de Campos, AC
   Schiariti, V
AF Longo, Egmar
   de Campos, Ana Carolina
   Schiariti, Veronica
TI Zika Virus After Emergency Response: Can the ICF Guide Rehabilitation of
   Children With Microcephaly?
SO PEDIATRIC PHYSICAL THERAPY
LA English
DT Article
DE children; congenital Zika syndrome; ICF; rehabilitation
ID HEALTH; DIAGNOSIS
AB The outbreak of Zika in Brazil almost 3 years ago had harmful medical, financial, and social consequences for children and their families. It also significantly increased the statistics of Brazilian children with disabilities being followed up in rehabilitation centers. Actions promoting the use of the International Classification of Functioning, Disability and Health (ICF) framework are encouraged in view of the complex health needs identified in this population, which cover all areas of functioning, and gain special relevance when it comes to a vulnerable context. This perspective article discusses the challenges related to the implementation of the ICF in rehabilitation services for children with congenital syndrome.
C1 [Longo, Egmar] Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, Grad Program Rehabil Sci & Collect Hlth, Santa Cruz, Brazil.
   [de Campos, Ana Carolina] Univ Fed Sao Carlos, Dept Physiotherapy, Grad Program Phys Therapy, Sao Carlos, SP, Brazil.
   [Schiariti, Veronica] Univ Victoria, Div Med Sci, Victoria, BC, Canada.
RP Longo, E (corresponding author), Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, BR-59200 Santa Cruz, Brazil.
EM egmarlongo@yahoo.es
CR [Anonymous], 2018, STROKE, V49, pe233
   [Anonymous], 2001, INT CLASS FUNCT DIS
   Rocha NACF, 2017, INFANT BEHAV DEV, V49, P70, DOI 10.1016/j.infbeh.2017.07.002
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47
   Novak I, 2014, J CHILD NEUROL, V29, P1141, DOI 10.1177/0883073814535503
   Pernambuco Andrei Pereira, 2018, Fisioter. Pesqui., V25, P134, DOI 10.1590/1809-2950/16765225022018
   Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028
   Scherzer AL, 2012, DEV MED CHILD NEUROL, V54, P1079, DOI 10.1111/j.1469-8749.2012.04348.x
   Schiariti V, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091899
   Schiariti V, 2015, DEV MED CHILD NEUROL, V57, P149, DOI 10.1111/dmcn.12551
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
NR 12
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0898-5669
EI 1538-005X
J9 PEDIATR PHYS THER
JI Pediatr. Phys. Ther.
PD OCT
PY 2019
VL 31
IS 4
BP 370
EP 372
DI 10.1097/PEP.0000000000000647
PG 3
WC Pediatrics; Rehabilitation
SC Pediatrics; Rehabilitation
GA JT9XG
UT WOS:000501334100023
PM 31568386
DA 2020-07-08
ER

PT J
AU Monaghan, AJ
   Eisen, RJ
   Eisen, L
   McAllister, J
   Savage, HM
   Mutebi, JP
   Johansson, MA
AF Monaghan, Andrew J.
   Eisen, Rebecca J.
   Eisen, Lars
   McAllister, Janet
   Savage, Harry M.
   Mutebi, John-Paul
   Johansson, Michael A.
TI Consensus and uncertainty in the geographic range of Aedes aegypti and
   Aedes albopictus in the contiguous United States: Multi-model assessment
   and synthesis
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID ASIAN TIGER MOSQUITO; DIPTERA-CULICIDAE; STEGOMYIA-AEGYPTI; REPORTED
   DISTRIBUTION; YELLOW-FEVER; ZIKA VIRUS; AMERICA; SUITABILITY; INVASION;
   CLIMATE
AB Aedes (Stegomyia) aegypti (L.) and Ae. (Stegomyia) albopictus (Skuse) mosquitoes can transmit dengue, chikungunya, yellow fever, and Zika viruses. Limited surveillance has led to uncertainty regarding the geographic ranges of these vectors globally, and particularly in regions at the present-day margins of habitat suitability such as the contiguous United States. Empirical habitat suitability models based on environmental conditions can augment surveillance gaps to describe the estimated potential species ranges, but model accuracy is unclear. We identified previously published regional and global habitat suitability models for Ae. aegypti (n = 6) and Ae. albopictus (n = 8) for which adequate information was available to reproduce the models for the contiguous U.S. Using a training subset of recently updated county-level surveillance records of Ae. aegypti and Ae. albopictus and records of counties conducting surveillance, we constructed accuracy-weighted, probabilistic ensemble models from these base models. To assess accuracy and uncertainty we compared individual and ensemble model predictions of species presence or absence to both training and testing data. The ensemble models were among the most accurate and also provided calibrated probabilities of presence for each species. The quantitative probabilistic framework enabled identification of areas with high uncertainty and model bias across the U.S. where improved models or additional data could be most beneficial. The results may be of immediate utility for counties considering surveillance and control programs for Ae. aegypti and Ae. albopictus. Moreover, the assessment framework can drive future efforts to provide validated quantitative estimates to support these programs at local, national, and international scales.
   Author summary Aedes aegypti and Ae. albopictus mosquitoes can transmit dengue, chikungunya, yellow fever, and Zika viruses, yet because of limited data the edges of the geographic range of these important species remain uncertain. We assessed numerous previously published model-based estimates of the range of these mosquitoes in the United States and combined those models to produce calibrated estimates of the probability of finding each mosquito in each county. Comparing these estimates to county-level data, we found that there are areas of substantial uncertainty and specific areas where model-based predictions do not align well with available data. The results provide specific information that can help guide national- or state-level efforts to monitor and control Ae. aegypti and Ae. albopictus. Beyond the specific findings, this approach to leveraging limited data and multiple quantitative models can be employed in other settings to better characterize the distribution of these species and other medically important vectors globally.
C1 [Monaghan, Andrew J.] Univ Colorado, Res Comp, Boulder, CO 80309 USA.
   [Eisen, Rebecca J.; Eisen, Lars; McAllister, Janet; Savage, Harry M.; Mutebi, John-Paul] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.
RP Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.
EM mjohansson@cdc.gov
OI Johansson, Michael/0000-0002-5090-7722
FU United States Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA
FX This work was supported by the United States Centers for Disease Control
   and Prevention. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. The
   findings and conclusions in this report are those of the authors and do
   not necessarily represent the official position of the Centers for
   Disease Control and Prevention.
CR [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Britch SC, 2008, J AM MOSQUITO CONTR, V24, P115, DOI 10.2987/5594.1
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Capinha C, 2014, ECOHEALTH, V11, P420, DOI 10.1007/s10393-014-0918-y
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Centers for Disease Control and Prevention, 2019, SURV CONTR AED AEG A
   Christophers S., 1960, AEDES AEGYPTI L YELL
   EDELSBRUNNER H, 1983, IEEE T INFORM THEORY, V29, P551, DOI 10.1109/TIT.1983.1056714
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   European Centre for Disease Prevention and Control (ECDC), 2009, DEV AEDES ALBOPICTUS, P45
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fischer D, 2014, EUROSURVEILLANCE, P19
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Kecman Vojislav, 2001, LEARNING SOFT COMPUT
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Koch LK, 2016, PARASITOL RES, V115, P957, DOI 10.1007/s00436-015-4822-3
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Liaw A, 2002, R NEWS, V2, P6
   Little E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005828
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Metzger ME, 2017, J MED ENTOMOL, V54, P533, DOI 10.1093/jme/tjw237
   Mogi M, 2012, J MED ENTOMOL, V49, P1233, DOI 10.1603/ME12104
   Murphy K.P., 2012, MACHINE LEARNING PRO
   NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314
   Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391
   SUTHERST RW, 1999, CLIMEX PREDICTING EF
   Wilson ME, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0457-2
NR 58
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD OCT
PY 2019
VL 15
IS 10
AR e1007369
DI 10.1371/journal.pcbi.1007369
PG 19
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA JT1SB
UT WOS:000500776600010
PM 31600194
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abreu, LS
   do Nascimento, YM
   Costa, RD
   Guedes, MLS
   Souza, BNRF
   Pena, LJ
   Costa, VCD
   Scotti, MT
   Braz, R
   Barbosa, JM
   da Silva, MS
   Velozo, ED
   Tavares, JF
AF Abreu, Lucas Silva
   do Nascimento, Yuri Mangueira
   Costa, Rafael dos Santos
   Silva Guedes, Maria Lenise
   Rosario Fernandes Souza, Barbara Nayane
   Pena, Lindomar Jose
   de Oliveira Costa, Vicente Carlos
   Scotti, Marcus Tullius
   Braz-Filho, Raimundo
   Barbosa-Filho, Jose Maria
   da Silva, Marcelo Sobral
   Velozo, Eudes da Silva
   Tavares, Josean Fechine
TI Tri- and Diterpenoids from Stillingia loranthacea as Inhibitors of Zika
   Virus Replication
SO JOURNAL OF NATURAL PRODUCTS
LA English
DT Article
ID TIGLIANE DITERPENOIDS; MOLECULAR NETWORKING; ANTIVIRAL ACTIVITY;
   CHIKUNGUNYA VIRUS; TONANTZITLOLONE; TRITERPENES; ESTERS; ROOTS;
   PROLIFERATION; CONSTITUENTS
AB This study represents the first phytochemical analysis of Stillingia loranthacea (S. loranthacea) and describes new terpenoids obtained from the root bark of this species. The fractionation of the hexane extract from the root bark led to the isolation of two new 28-nor-taraxarenes derivatives, loranthones A and B (1 and 2), four new tigliane diterpenes (5-8), three known tigliane diterpenes (9-11), and three known flexibilene diterpenes, tonantzitlolones A-C (12-14). The investigation of these compounds and the use of a molecular networking-based prioritization approach afforded two other new 28-nor-taraxarenes, loranthones C and D (3 and 4). The cytotoxicity of compounds 1, 2, and 5-14 was evaluated against Vero cells, and their 20% cytotoxic concentration (CC20) values varied from 8.7 to 328 mu M; antiviral activity was tested against an epidemic Zika virus (ZIKV) strain circulating in Brazil. Six out of 12 compounds (2, 5, 9-11, and 14) exhibited significant antiviral effects against ZIKV. Specifically, compounds 2 and 5 offered the most promise as lead compounds as they had a 1.7 and 1.8 log(10) TCID50/mL reduction in ZIKV replication, respectively. Together, the present findings have identified S. loranthacea terpenoids as potent anti-ZIKV inhibitors and pave the way to the development of possible new treatments against this devastating pathogen.
C1 [Abreu, Lucas Silva; do Nascimento, Yuri Mangueira; de Oliveira Costa, Vicente Carlos; Scotti, Marcus Tullius; Barbosa-Filho, Jose Maria; da Silva, Marcelo Sobral; Tavares, Josean Fechine] Univ Fed Paraiba, Inst Res Pharmaceut & Medicat, BR-58051900 Joao Pessoa, Paraiba, Brazil.
   [Costa, Rafael dos Santos; Velozo, Eudes da Silva] Univ Fed Bahia, Sch Pharm, Res Lab Materia Med, BR-40170290 Salvador, BA, Brazil.
   [Silva Guedes, Maria Lenise] Univ Fed Bahia, Inst Biol, BR-40110060 Salvador, BA, Brazil.
   [Rosario Fernandes Souza, Barbara Nayane; Pena, Lindomar Jose] Oswaldo Cruz Fdn Fiocruz, Dept Virol, BR-50740465 Recife, PE, Brazil.
   [Braz-Filho, Raimundo] Univ Fed Rural Rio de Janeiro, Inst Chem, Dept Chem, BR-23890000 Seropedica, Brazil.
RP Tavares, JF (corresponding author), Univ Fed Paraiba, Inst Res Pharmaceut & Medicat, BR-58051900 Joao Pessoa, Paraiba, Brazil.
EM josean@ltf.ufpb.br
RI Scotti, Marcus/G-2981-2012; Filho, Jose Maria Barbosa/B-3951-2010;
   Abreu, Lucas Silva/U-6240-2019; Costa, Vicente CO/O-3356-2018; Filho,
   Raimundo Braz/AAG-6537-2019; Nascimento, Yuri Mangueira do/N-9362-2018
OI Scotti, Marcus/0000-0003-4863-8057; Filho, Jose Maria
   Barbosa/0000-0002-9567-4096; Abreu, Lucas Silva/0000-0001-5620-8095;
   Costa, Vicente CO/0000-0002-0117-5094; Filho, Raimundo
   Braz/0000-0001-7217-3494; Nascimento, Yuri Mangueira
   do/0000-0002-9732-6191
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)CAPES [001]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The authors acknowledge the Brazilian agencies Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) (Finance
   Code 001) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) for financial support and fellowships. We are also
   thankful for collaborating with Rede Norte-Nordeste de Fitoterapicos
   (INCT-RENNOFITO).
CR ADOLF W, 1980, TETRAHEDRON LETT, V21, P2887, DOI 10.1016/S0040-4039(00)78635-7
   AGETA H, 1983, PHYTOCHEMISTRY, V22, P1801, DOI 10.1016/S0031-9422(00)80275-7
   Allard PM, 2016, ANAL CHEM, V88, P3317, DOI 10.1021/acs.analchem.5b04804
   Apel MA, 2004, J ESSENT OIL RES, V16, P437, DOI 10.1080/10412905.2004.9698766
   Athie-Souza SM, 2014, SYST BOT, V39, P510, DOI 10.1600/036364414X680915
   Badria FA, 2003, Z NATURFORSCH C, V58, P505
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   Bourjot M, 2012, J NAT PROD, V75, P2183, DOI 10.1021/np300637t
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Busch T, 2016, ORG BIOMOL CHEM, V14, P9040, DOI 10.1039/c6ob01697a
   CHAPUIS JC, 1988, J ETHNOPHARMACOL, V23, P273, DOI 10.1016/0378-8741(88)90006-2
   Chiang YM, 2001, J NAT PROD, V64, P436, DOI 10.1021/np0004808
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cota BB, 2011, REV BRAS FARMACOGN, V21, P70, DOI 10.1590/S0102-695X2011005000016
   de Carvalho OV, 2017, INT J ANTIMICROB AG, V50, P718, DOI 10.1016/j.ijantimicag.2017.08.016
   DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Drager G, 2007, EUR J ORG CHEM, V2007, P5020, DOI 10.1002/ejoc.200700184
   Esser Hans-Joachim, 2012, Rodriguésia, V63, P209, DOI 10.1590/S2175-78602012000100013
   EVANS FJ, 1977, TOXICON, V16, P51
   Forgo P, 2011, J NAT PROD, V74, P639, DOI 10.1021/np100673s
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V
   HIROTA M, 1979, AGR BIOL CHEM TOKYO, V43, P2523, DOI 10.1080/00021369.1979.10863840
   Imre G, 2003, J MOL STRUC-THEOCHEM, V666, P51, DOI 10.1016/j.theochem.2003.08.013
   Kirira PG, 2007, J NAT PROD, V70, P842, DOI 10.1021/np0604174
   Lin CY, 2004, AUST J CHEM, V57, P365, DOI 10.1071/CH03263
   Lin Liang-Tzung, 2014, J Tradit Complement Med, V4, P24, DOI 10.4103/2225-4110.124335
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232
   Mo DJ, 2018, NAT PROD COMMUN, V13, P21
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nothias-Scaglia LF, 2015, J NAT PROD, V78, P1277, DOI 10.1021/acs.jnatprod.5b00073
   Olivon F, 2019, J NAT PROD, V82, P330, DOI 10.1021/acs.jnatprod.8b00800
   Olivon F, 2017, ACS CHEM BIOL, V12, P2644, DOI 10.1021/acschembio.7b00413
   Olivon F, 2015, J NAT PROD, V78, P1119, DOI 10.1021/acs.jnatprod.5b00116
   Pfeffer TJ, 2016, EUR J MED CHEM, V112, P164, DOI 10.1016/j.ejmech.2016.02.022
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Remy S, 2019, MOLECULES, V24, DOI 10.3390/molecules24122336
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   SHIOJIMA K, 1992, CHEM PHARM BULL, V40, P1683
   Sourbier C, 2015, ONCOTARGET, V6, P29963, DOI 10.18632/oncotarget.4676
   Tan QW, 2014, MOLECULES, V19, P17619, DOI 10.3390/molecules191117619
   Tang Q, 2012, PHYTOCHEM LETT, V5, P214, DOI 10.1016/j.phytol.2011.12.011
   Techer S, 2015, PHYTOCHEM LETT, V12, P313, DOI 10.1016/j.phytol.2015.04.023
   Van Kiem P, 2004, ARCH PHARM RES, V27, P1109
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Vilegas JHY, 1997, J BRAZIL CHEM SOC, V8, P529, DOI 10.1590/S0103-50531997000500016
   Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597
   Wang YB, 2006, J NAT PROD, V69, P967, DOI 10.1021/np0600088
   Wube AA, 2011, BIOORGAN MED CHEM, V19, P567, DOI 10.1016/j.bmc.2010.10.060
   Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s
NR 51
TC 0
Z9 0
U1 10
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0163-3864
EI 1520-6025
J9 J NAT PROD
JI J. Nat. Prod.
PD OCT
PY 2019
VL 82
IS 10
BP 2721
EP 2730
DI 10.1021/acs.jnatprod.9b00251
PG 10
WC Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy
GA JS0TC
UT WOS:000500026300006
PM 31599155
DA 2020-07-08
ER

PT J
AU Cheng, YS
   Williamson, PR
   Zheng, W
AF Cheng, Yu-Shan
   Williamson, Peter R.
   Zheng, Wei
TI Improving therapy of severe infections through drug repurposing of
   synergistic combinations
SO CURRENT OPINION IN PHARMACOLOGY
LA English
DT Article
ID ZIKA VIRUS; COLISTIN HETERORESISTANCE; ANTIMICROBIAL SYNERGY;
   POLYMYXIN-B; BAD BUGS; RESISTANCE; ANTIBIOTICS; CHALLENGES; INHIBITORS;
   UPDATE
AB Infections from multidrug resistant (MDR) pathogens and emerging viruses present challenges for effective clinical treatments. Drug repurposing and combination screens may provide therapies at a fraction of the time and cost of traditional methods of drug development. Synergistic combinations of two or three known compounds can increase therapeutic efficacy and reduce concentrations required for individual drugs, in turn, reducing the risk of drug toxicity. Using libraries of approved drugs, traditionally non-antibiotic compounds identified in repurposing screens can quickly move into clinical trials, since safety profiles have been previously established. Herein we summarize recent advances in identifying synergistic drug combinations and the use of drug screens for personalized medicine treatments of infections caused by MDR pathogens and emerging viruses.
C1 [Cheng, Yu-Shan; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA.
   [Williamson, Peter R.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA.; Williamson, PR (corresponding author), NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM williamsonpr@mail.nih.gov; wzheng@mail.nih.gov
FU National Center for Advancing Translational Sciences (NCATS)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS); National Institute of Allergy and Infectious Diseases
   (NIAID)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); National Institutes of Health (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA
FX This work was partly supported by the Intramural Research Programs of
   the National Center for Advancing Translational Sciences (NCATS),
   National Institute of Allergy and Infectious Diseases (NIAID), and the
   National Institutes of Health (NIH). The authors thank Dr. DeeAnn Visk,
   a medical writer and editor, for editing the manuscript.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Baker SK, 2018, P NATL ACAD SCI USA, V115, pE9687, DOI [10.1073/pnas.1717160115, 10.1073/pnas.1811172115]
   Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/ERI.12.78, 10.1586/eri.12.78]
   Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008
   Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011
   Brennan-Krohn T, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00873-18
   Brown D, 2015, NAT REV DRUG DISCOV, V14, P821, DOI 10.1038/nrd4675
   Bulik CC, 2011, ANTIMICROB AGENTS CH, V55, P3002, DOI 10.1128/AAC.01420-10
   Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86
   Butler MM, 2012, ANTIMICROB AGENTS CH, V56, P4786, DOI 10.1128/AAC.00508-12
   Center for Disease Control and Prevention, 2019, 2014 2016 EB OUTBR D
   Doern CD, 2014, J CLIN MICROBIOL, V52, P4124, DOI 10.1128/JCM.01121-14
   Domalaon R, 2018, CLIN MICROBIOL REV, V31, DOI [10.1128/CMR.00077-17, 10.1128/cmr.00077-17]
   Dyall J, 2018, J INFECT DIS, V218, pS672, DOI 10.1093/infdis/jiy304
   Dye C, 2015, PHILOS T R SOC LON B, V369
   Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]
   Gonzalez-Bello C, 2017, BIOORG MED CHEM LETT, V27, P4221, DOI 10.1016/j.bmcl.2017.08.027
   Gorityala BK, 2016, J MED CHEM, V59, P8441, DOI 10.1021/acs.jmedchem.6b00867
   Wertheim H, 2013, J GLOB ANTIMICROB RE, V1, P131, DOI 10.1016/j.jgar.2013.03.012
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hu Y, 2014, US Patent, Patent No. [US975742762, 975742762]
   Hussein MH, 2017, MICROB DRUG RESIST, V23, P640, DOI 10.1089/mdr.2016.0196
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Law GL, 2013, CURR OPIN IMMUNOL, V25, P588, DOI 10.1016/j.coi.2013.08.004
   Lenhard JR, 2016, INT J ANTIMICROB AG, V48, P607, DOI 10.1016/j.ijantimicag.2016.09.014
   Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1
   Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06
   Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7
   Meletis G, 2011, J ANTIMICROB CHEMOTH, V66, P946, DOI 10.1093/jac/dkr007
   Mukhopadhyay R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005717
   Novac N, 2013, TRENDS PHARMACOL SCI, V34, P267, DOI 10.1016/j.tips.2013.03.004
   Otto RG, 2019, INT J ANTIMICROB AG, V53, P34, DOI 10.1016/j.ijantimicag.2018.09.003
   Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201
   Pessetto ZY, 2014, MOL CANCER THER, V13, P2276, DOI 10.1158/1535-7163.MCT-14-0043
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Schneider EK, 2017, ESSAYS BIOCHEM, V61, P115, DOI 10.1042/EBC20160058
   Schneider EK, 2016, ACS INFECT DIS, V2, P478, DOI 10.1021/acsinfecdis.6b00035
   Sleire L, 2017, PHARMACOL RES, V124, P74, DOI 10.1016/j.phrs.2017.07.013
   Souli M, 2008, EURO SURVEILL, V13
   Srinivas P, 2018, DIAGN MICR INFEC DIS, V91, P194, DOI 10.1016/j.diagmicrobio.2018.01.028
   STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451
   Sun W, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00267
   Sun W, 2017, ANTIVIR RES, V137, P165, DOI 10.1016/j.antiviral.2016.11.017
   Sun W, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.123
   Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015
   Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11
   Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572
   Vaithinathan AG, 2018, PERSPECT PUBLIC HEAL, V138, P87, DOI 10.1177/1757913917743881
   Ventola C Lee, 2015, P T, V40, P277
   World Health Organization, 2018, TOP 10 CAUS DEATH
   World Health Organization, 2019, EB VIR DISDEM REP CO
   Worthington RJ, 2013, TRENDS BIOTECHNOL, V31, P177, DOI 10.1016/j.tibtech.2012.12.006
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang S, 2018, CELL DISCOV, V4
NR 57
TC 3
Z9 3
U1 3
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4892
EI 1471-4973
J9 CURR OPIN PHARMACOL
JI Curr. Opin. Pharmacol.
PD OCT
PY 2019
VL 48
BP 92
EP 98
DI 10.1016/j.coph.2019.07.006
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JS0XB
UT WOS:000500036700015
PM 31454708
OA Other Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Cavallo, E
   Guarnizo-Mendez, J
   Yepez-Terrill, A
   Cardenas-Rivero, A
   Diaz-Castillo, F
   Mendez-Cuadro, D
AF Rodriguez-Cavallo, Erika
   Guarnizo-Mendez, Javier
   Yepez-Terrill, Adriana
   Cardenas-Rivero, Aury
   Diaz-Castillo, Fredyc
   Mendez-Cuadro, Dario
TI Protein carbonylation is a mediator in larvicidal mechanisms of
   Tabernaemontana cymosa ethanolic extract
SO JOURNAL OF KING SAUD UNIVERSITY SCIENCE
LA English
DT Article
DE Protein carbonylation; Carbonyl index; Aedes aegypti; Midgut proteins;
   Temephos; Tabernaemontana cymosa; Pro-oxidant effect
ID AEDES-AEGYPTI; EXPRESSION; ALKALOIDS; MIDGUT
AB Aedes aegypti mosquito is considered the most efficient vector for the spread of dengue, chikungunya, and zika viruses around the world and it is commonly controlled with synthetic insecticides. Despite their effectiveness, they have created problems like insecticide resistance become urgent to find novel insecticides or alternative methods for controlling it. Here, plants extracts, offer great promise as source of phytochemicals toxic against adult and immature mosquito stages. However, extracts are complexes mixture of compounds acting along at the same time on different biological targets and representing a real challenge when it is necessary to identify the mechanisms of action. Considering proteins are the main molecular targets of drugs, we used methods of redox proteomics to characterize pro-oxidant effects for larvicides, Ethanolic Extract of Tabernaemontana cymosa seeds (EETC) and the organophosphate temephos (Abate) on Aedes aegypti larvae midgut proteome. Initially, global oxidative damage caused by EETC and temephos was measured by carbonyl index quantitation in dot blot assay. After, combining Western blots with mass spectrometry, larvae proteins involved at the energy metabolism were identified as target of the pro-oxidant action. Results indicate that protein carbonylation plays an important role into the larvicide mechanisms of EETC and temephos. Finally, by phytochemical test were identified alkaloids, flavonoids and saponins as the major constituents. (C) 2018 The Authors. Production and hosting by Elsevier B.V.
C1 [Rodriguez-Cavallo, Erika; Guarnizo-Mendez, Javier; Yepez-Terrill, Adriana; Cardenas-Rivero, Aury] Univ Cartagena, Dept Pharm, Analyt Chem & Biomed Grp, Cartagena, Colombia.
   [Cardenas-Rivero, Aury; Diaz-Castillo, Fredyc] Univ Cartagena, Lab Phytochem & Pharmacol Res, Cartagena, Colombia.
   [Mendez-Cuadro, Dario] Univ Cartagena, Dept Biol, Analyt Chem & Biomed Grp, Cartagena, Colombia.
RP Mendez-Cuadro, D (corresponding author), Univ Cartagena, Fac Exact & Nat Sci, Dept Biol, Campus San Pablo, Cartagena, Colombia.; Rodriguez-Cavallo, E (corresponding author), Univ Cartagena, Fac Pharmaceut Sci, Dept Pharm, Campus Zaragocilla, Cartagena, Colombia.
EM erodriguezc1@unicartagena.edu.co; dmendezc@unicartagena.edu.co
RI Mendez-Cuadro, Dario/W-5137-2019
OI Mendez-Cuadro, Dario/0000-0002-3905-6859; Rodriguez-Cavallo,
   Erika/0000-0002-5113-4725
FU Departamento Administrativo de Ciencia, Tecnologia e
   Investigacion-COLCIENCIAS [Administrative Department of Science,
   Technology and Research]; University Hospital of the Caribbean;
   University of Cartagena [1107-545-31632]; ColcienciasDepartamento
   Administrativo de Ciencia, Tecnologia e Innovacion Colciencias; 
   [PT13/0001]
FX This work was funded by the Departamento Administrativo de Ciencia,
   Tecnologia e Investigacion-COLCIENCIAS [Administrative Department of
   Science, Technology and Research], the University Hospital of the
   Caribbean and The University of Cartagena. Grant 1107-545-31632. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Adriana Yepez and
   Javier Guarnizo were funded by Young Research Program of Colciencias
   2015-2016. The proteomic analysis was performed in the Proteomics Unit
   at Complutense University of Madrid that belongs to ProteoRed,
   PRB2-ISCIII, supported by grant PT13/0001.
CR Camini F.C., 2017, VIRUS RES
   Chang J, 2016, NAT PROD REP, V33, P719, DOI 10.1039/c5np00107b
   Chowanski S, 2016, TOXINS, V8, DOI 10.3390/toxins8030060
   Di Domenico F, 2017, ANTIOXID REDOX SIGN, V26, P364, DOI 10.1089/ars.2016.6759
   Evans WC, 2009, TREASE EVANS PHARMAC
   Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381
   Games PD, 2016, MED VET ENTOMOL, V30, P253, DOI 10.1111/mve.12172
   Gomez-Calderon C, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1562-1
   Huang ZQ, 2012, ARCH INSECT BIOCHEM, V79, P1, DOI 10.1002/arch.21001
   Kasote DM, 2015, INT J BIOL SCI, V11, P982, DOI 10.7150/ijbs.12096
   Lao YZ, 2014, J ETHNOPHARMACOL, V155, P1, DOI 10.1016/j.jep.2014.05.022
   Madian AG, 2011, J PROTEOME RES, V10, P3959, DOI 10.1021/pr200140x
   Marinho FF, 2016, FITOTERAPIA, V114, P127, DOI 10.1016/j.fitote.2016.09.002
   Mesquita CS, 2014, ANAL BIOCHEM, V458, P69, DOI 10.1016/j.ab.2014.04.034
   Mohankumar TK, 2016, J ARTHROPOD-BORNE DI, V10, P305
   Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014
   Park K, 2008, COMP BIOCHEM PHYS B, V151, P349, DOI 10.1016/j.cbpb.2008.08.004
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Salvador-Reyes LA, 2015, NAT PROD REP, V32, P478, DOI 10.1039/c4np00104d
   Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005
   Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031
   Toure S, 2017, J NAT PROD, V80, P384, DOI 10.1021/acs.jnatprod.6b00850
   Vihakas M, 2014, PHYTOCHEMISTRY, V103, P76, DOI 10.1016/j.phytochem.2014.02.019
   Wagner H., 1996, PLANT DRUG ANAL THIN
   Wang X, 2016, ENVIRON RES, V149, P86, DOI 10.1016/j.envres.2016.05.003
   Wehr NB, 2012, ANAL BIOCHEM, V423, P241, DOI 10.1016/j.ab.2012.01.031
   WHO/OMS, 2005, GUID LAB FIELD TEST, P41
NR 27
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1018-3647
EI 2213-686X
J9 J KING SAUD UNIV SCI
JI J. King Saud Univ. Sci.
PD OCT
PY 2019
VL 31
IS 4
BP 464
EP 471
DI 10.1016/j.jksus.2018.04.019
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JR4OD
UT WOS:000499605300006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zhang, W
   Qu, PK
   Li, DP
   Zhang, C
   Liu, QW
   Zou, G
   Dupont-Rouzeyrol, M
   Lavillette, D
   Jin, X
   Yin, FF
   Huang, Z
AF Zhang, Wei
   Qu, Panke
   Li, Dapeng
   Zhang, Chao
   Liu, Qingwei
   Zou, Gang
   Dupont-Rouzeyrol, Myrielle
   Lavillette, Dimitri
   Jin, Xia
   Yin, Feifei
   Huang, Zhong
TI Yeast-produced subunit protein vaccine elicits broadly neutralizing
   antibodies that protect mice against Zika virus lethal infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; EDIII domain; Yeast; Vaccine; Neutralizing antibody
ID DENGUE-VIRUS; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY; PICHIA-PASTORIS;
   DNA VACCINE; DOMAIN-III; IMMUNOGENICITY; REPLICATION; STRATEGIES;
   CHALLENGE
AB Zika virus (ZIKV) infection is a serious public health concern due to its ability to induce neurological defects and its potential for rapid transmission at a global scale. However, no vaccine is currently available to prevent ZIKV infection. Here, we report the development of a yeast-derived subunit protein vaccine for ZIKV. The envelope protein domain III (EDIII) of ZIKV was produced as a secretory protein in the yeast Pichia pastoris. The yeast-derived EDIII could inhibit ZIKV infection in vitro in a dose-dependent manner, suggesting that it had acquired an appropriate conformation to bind to cellular receptors of ZIKV. Immunization with recombinant EDIII protein effectively induced antigen-specific binding antibodies and cellular immune responses. The resulting anti-EDIII sera could efficiently neutralize ZIKV representative strains from both Asian and African lineages. Passive transfer with the anti-EDIII neutralizing sera could confer protection against lethal ZIKV challenge in mice. Importantly, we found that purified anti-EDIII antibodies did not cross-react with closely related dengue virus (DENV) and therefore did not enhance DENV infection. Collectively, our results demonstrate that yeast-produced EDIII is a safe and effective ZIKV vaccine candidate.
C1 [Zhang, Wei; Qu, Panke; Li, Dapeng; Zhang, Chao; Liu, Qingwei; Zou, Gang; Lavillette, Dimitri; Jin, Xia; Huang, Zhong] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
   [Dupont-Rouzeyrol, Myrielle] Inst Pasteur New Caledonia, Dengue & Arboviruses Res & Expertise Unit, Noumea, New Caledonia.
   [Yin, Feifei] Hainan Med Univ, Univ Hong Kong, Hainan Med Univ, Joint Lab Trop Infect Dis, Haikou 571101, Hainan, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Dept Minist Educ, Key Lab Translat Med Trop Dis, Haikou 571101, Hainan, Peoples R China.
RP Huang, Z (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Yin, FF (corresponding author), Hainan Med Univ, Univ Hong Kong, Hainan Med Univ, Joint Lab Trop Infect Dis, Haikou 571101, Hainan, Peoples R China.
EM yinfeifeiff@163.com; huangzhong@ips.ac.cn
OI Lavillette, Dimitri/0000-0002-4706-1519
FU Chinese Ministry of Science and Technology for EU-China
   Inter-governmental S&T Cooperation program [2016YFE0133500]; National
   Major R&D Program of China [2016YFC1201000]; Chinese Academy of
   SciencesChinese Academy of Sciences [XDB29040300, 153831KYSB20170043];
   European Union Horizon 2020 Research and Innovation program [734548];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81860367]; Key Research and Development Plan of
   Hainan Province, Ministry of Science and Technology [ZDYF2017091];
   Higher Educational Scientific Research Project of Hainan Province, the
   Ministry of Education [Hnky2017ZD-16]
FX We thank the Microorganisms & Viruses Culture Collection Center, Wuhan
   Institute of Virology, Chinese Academy of Sciences, for providing the
   ZIKV strain SsZ-WIV01. This study was supported by a grant
   (2016YFE0133500) from the Chinese Ministry of Science and Technology for
   EU-China Inter-governmental S&T Cooperation program, a grant
   (2016YFC1201000) from the National Major R&D Program of China, grants
   (XDB29040300 and 153831KYSB20170043) from the Chinese Academy of
   Sciences, a grant (ZIKAlliance Grant Agreement 734548) from the European
   Union Horizon 2020 Research and Innovation program, a grant (81860367)
   from the National Natural Science Foundation of China, a grant (no.
   ZDYF2017091) from the Key Research and Development Plan of Hainan
   Province, Ministry of Science and Technology, and a grant (no.
   Hnky2017ZD-16) from the Higher Educational Scientific Research Project
   of Hainan Province, the Ministry of Education.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Ghaffar KA, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040077
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li DP, 2016, J VIROL, V90, P10486, DOI 10.1128/JVI.01462-16
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu QW, 2011, J VIROL METHODS, V173, P115, DOI 10.1016/j.jviromet.2011.01.016
   Looser V, 2015, BIOTECHNOL ADV, V33, P1177, DOI 10.1016/j.biotechadv.2015.05.008
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Zhang C, 2015, VACCINE, V33, P2335, DOI 10.1016/j.vaccine.2015.03.034
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 58
TC 2
Z9 2
U1 3
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD OCT
PY 2019
VL 170
AR 104578
DI 10.1016/j.antiviral.2019.104578
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9KP
UT WOS:000499935500022
PM 31394119
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Monteiro, LMC
   Cruz, GND
   Fontes, JM
   de Araujo, GF
   Ventura, T
   Monteiro, AC
   Moreira, MEL
AF Costa Monteiro, L. M.
   Cruz, G. N. de O.
   Fontes, J. M.
   de Araujo, G. F.
   Ventura, T.
   Monteiro, A. C.
   Moreira, M. E. L.
TI Neurogenic bladder in the settings of congenital Zika syndrome: a
   confirmed and unknown condition for urologists
SO JOURNAL OF PEDIATRIC UROLOGY
LA English
DT Article
DE Neurogenic bladder; Congenital Zika syndrome; Zika virus; Urinary tract
   infection; Microcephaly
AB Introduction
   Congenital Zika syndrome (CZS) is a recently discovered condition that affects central nervous system structures that control the lower urinary tract. The first cases of neurogenic bladder (NB) were recently reported as a sequalae of CZS in neurologically impaired children.
   Objective
   Our goal is to further evaluate NB in the setting of CZS, identifying urological risk indicators in hopes that early diagnosis will mitigate the impact of the disease.
   Study design
   Urological assessment was performed in all patients with CZS and neurological impairment who were referred to our urodynamic clinic between June 2016 and May 2018. Neurogenic bladder was confirmed by urodynamic evaluation, and urological risk was based on urodynamic results.
   Results
   Sixty-nine patients with CZS were tested. The majority (63 patients, 91.3%) presented with overactive bladder with increased pressures and reduced capacity for age (table 1). Different urodynamic patterns were observed, and the association of reduced bladder capacity for age, high bladderfilling pressure, and increased postvoid residual were frequently observed.
   Discussion
   NB continues to be consistently diagnosed in our cohort of CZS, mostly with high-risk indicators for renal impairment. When not intervened upon in a timely manner, NB can cause progressive damage to the urinary tract, but the lack of knowledge that CZS causes NB delays investigation and treatment. Parents and health professionals will need to be sensitized to the risks that ZIKV can pose to the urinary tract so that appropriate therapies are initiated to prevent irreversible renal damage.
   Conclusion
   NB is a common condition among our patients with CZS and microcephaly. This is a new cause of NB, unknown to urologists. While further investigation is necessary to understand long-term disease behavior and therapeutic response, increased knowledge among urologists may help to reduce morbidity related to untreated NB and to mitigate the disease burden for patients and families.
C1 [Costa Monteiro, L. M.; Cruz, G. N. de O.; Fontes, J. M.; de Araujo, G. F.; Ventura, T.; Moreira, M. E. L.] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Monteiro, A. C.] UCLA, Div Pulm & Crit Care Med, Los Angeles, CA USA.
RP Monteiro, LMC (corresponding author), Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM luciacostamonteiro@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Monteiro, Lucia Maria
   Costa/O-7903-2014
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Monteiro, Lucia
   Maria Costa/0000-0002-7612-7249; Marin Fontes,
   Juliana/0000-0003-4098-7324
FU CAPES/MECCAPESSpanish Government; CNPq/MCTI; Decit/SCTIE/MS
   [440580/20161]
FX The research is funded by a research grant from the CAPES/MEC, CNPq/MCTI
   and Decit/SCTIE/MS (grant number 440580/20161). These are Brazilian
   Agencies that support research to Prevent and Fight the Zika virus.
CR Alcendor DJ, 2018, J MOL MED, V96, P1145, DOI 10.1007/s00109-018-1692-z
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Austin PF, 2016, NEUROUROL URODYNAM, V35, P471, DOI 10.1002/nau.22751
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bauer SB, 2015, NEUROUROL URODYNAM, V34, P640, DOI 10.1002/nau.22783
   Bauer SB, 2012, NEUROUROL URODYNAM, V31, P610, DOI 10.1002/nau.22247
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CDC report, 2018, PREGN WOM AN LAB EV
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Costa Monteiro LM, 2017, CRITERIA EVALUATE NE
   Monteiro LMC, 2017, J PEDIAT-BRAZIL, V93, P420, DOI 10.1016/j.jped.2016.11.010
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Dik P, 2006, EUR UROL, V49, P908, DOI 10.1016/j.eururo.2005.12.056
   Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Nogueira PCK, 2016, J PEDIAT-BRAZIL, V92, pS57, DOI 10.1016/j.jped.2016.01.006
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   (PAHO) Pan American Health Organization, 2018, ZIK CUM CAS
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
NR 24
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-5131
EI 1873-4898
J9 J PEDIATR UROL
JI J. Pediatr. Urol
PD OCT
PY 2019
VL 15
IS 5
DI 10.1016/j.jpurol.2019.04.018
PG 7
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA JQ4OT
UT WOS:000498927800007
PM 31142443
DA 2020-07-08
ER

PT J
AU Ferraris, P
   Yssel, H
   Misse, D
AF Ferraris, Pauline
   Yssel, Hans
   Misse, Dorothee
TI Zika virus infection: an update
SO MICROBES AND INFECTION
LA English
DT Review
DE Zika; Arbovirus; Vector control; Epidemiology; Innate immunity;
   Treatment
ID HUMAN-ANTIBODY RESPONSES; NEURAL PROGENITORS; CEREBRAL ORGANOIDS;
   GLIAL-CELLS; WOLBACHIA; VACCINE; AXL; TRANSMISSION; DENGUE; PROTECTION
AB Since the ZIKV outbreak in Brazil in 2015, the scientific community has joined efforts to gather more information on the epidemiology, clinical features and pathogenicity of the virus. Here, we summarize the most important advances made recently and discuss promising, innovative approaches to understand and control ZIKV infection. (C) 2019 Published by Elsevier Masson SAS on behalf of Institut Pasteur.
C1 [Ferraris, Pauline; Misse, Dorothee] Univ Montpellier, CNRS, MIVEGEC, IRD, Montpellier, France.
   [Yssel, Hans] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, UPMC,Ctr Immunol & Malad Infect,Inserm,U1135, Paris, France.
RP Misse, D (corresponding author), Univ Montpellier, CNRS, MIVEGEC, IRD, Montpellier, France.
EM dorothee.misse@ird.fr
RI Ferraris, Pauline/F-9077-2017
OI Ferraris, Pauline/0000-0002-8796-3074
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-ANR-14-CE14-0029, ANR-15CE15-00029]; European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant [734548];
   French National Research Agency under the "Investissements d'avenir"
   programmeFrench National Research Agency (ANR) [ANR-16-IDEX-0006]
FX This work was supported by grants from the Agence Nationale de la
   Recherche (grants ANR-ANR-14-CE14-0029 and ANR-15CE15-00029), the
   European Union's Horizon 2020 research and innovation programme under
   ZIKAlliance grant agreement No. 734548. This work was also publicly
   funded through the French National Research Agency under the
   "Investissements d'avenir" programme with the reference
   ANR-16-IDEX-0006.
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Achee NL, 2018, PLOS NEGLECTED TROPI
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lo D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192120
   Lynch RM, 2019, J INFECT DIS, V219, P26, DOI 10.1093/infdis/jiy466
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Masmejan S, 2018, EXPERT REV ANTI-INFE, V16, P471, DOI 10.1080/14787210.2018.1483239
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pena LJ, 2018, J GEN VIROL, V99, P1529, DOI 10.1099/jgv.0.001153
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Soto-Acosta R, 2018, ELIFE, V7, DOI 10.7554/eLife.39023
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taguwa S, 2019, CELL REP, V26, P906, DOI 10.1016/j.celrep.2018.12.095
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07782-x
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Venter M, 2018, CURR OPIN VIROL, V28, P74, DOI 10.1016/j.coviro.2017.11.004
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 137
TC 5
Z9 5
U1 5
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD OCT-NOV
PY 2019
VL 21
IS 8-9
BP 353
EP 360
DI 10.1016/j.micinf.2019.04.005
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JQ6XN
UT WOS:000499085900003
PM 31158508
DA 2020-07-08
ER

PT J
AU Valdes, V
   Zorrilla, CD
   Gabard-Durnam, L
   Muler-Mendez, N
   Rahman, ZI
   Rivera, D
   Nelson, CA
AF Valdes, Viviane
   Zorrilla, Carmen D.
   Gabard-Durnam, Laurel
   Muler-Mendez, Natalia
   Rahman, Zarin Ibnat
   Rivera, Diego
   Nelson, Charles A.
TI Cognitive Development of Infants Exposed to the Zika Virus in Puerto
   Rico
SO JAMA NETWORK OPEN
LA English
DT Article
ID PATIENT HEALTH QUESTIONNAIRE-9; PRENATAL MATERNAL STRESS; POSTNATAL
   DEPRESSION; SPANISH VERSION; INFECTION; VALIDATION; ASSOCIATION;
   MECHANISMS; EMPLOYMENT; PREGNANCY
AB IMPORTANCE Existing research has established a causal link between Zika virus (ZIKV) infection and severe birth defects or consequent health impairments; however, more subtle cognitive impairments have not been explored.
   OBJECTIVE To determine whether infants of mothers with at least 1 positive ZIKV test show differences in cognitive scores at ages 3 to 6 months and ages 9 to 12 months.
   DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study recruited infants enrolled in existing ZIKV study cohorts associated with the Maternal-Infant Studies Center and the Puerto Rico Clinical and Translational Research Consortium at the University of Puerto Rico and from the broader San Juan metropolitan area. The study took place at the Puerto Rico Clinical and Translational Research Consortium at the University of Puerto Rico. Participants were recruited through convenience sampling if their mothers underwent ZIKV testing prenatally and were at the target ages during the study period. Infants who were born preterm (<36 weeks' gestational age), with low birth weight (<2500 g), or with a known genetic disorder were excluded. Infants were tested from ages 3 to 6 months or ages 9 to 12 months from May 2018 to April 2019. Data analysis was performed from March to April 2019.
   EXPOSURES Zika virus status was measured prenatally and in the early postnatal period using real-time polymerase chain reaction or a ZIKV IgM antibody capture enzyme-linked immunosorbent assay.
   MAIN OUTCOMES AND MEASURES The infants' development was assessed using the Mullen Scales of Early Learning (translated to Spanish and adapted for Puerto Rico), and assessors were blinded to each infant's ZIKV status.
   RESULTS A total of 65 study participants were included. The mean (SD) age of the infants at the time of cognitive testing was 8.98 (3.19) months. Most of the infants were white (55 [84.6%]) and Puerto Rican (64 [98.5%]); 38 of the infants were male (58.5%). General cognitive and domain-specific scores did not differ significantly between prenatally ZIKV-positive and ZIKV-negative infants except for receptive language score (mean difference = 5.52; t = 2.10; P = .04). Exposure to ZIKV (B = -5.69; beta = -0.26 [95% CI -11.01 to -0.36]; P = .04) and a measure of Hurricane Maria exposure (time without water, B = -0.05; beta = -0.27 [95% CI, -0.10 to -0.01]; P = .03) were both independently and significantly associated with receptive language scores after adjusting for key confounders.
   CONCLUSIONS AND RELEVANCE Although infants exposed to ZIKV prenatally showed unaffected motor and visually mediated cognitive development, they did show deficits in receptive language scores. Receptive language skills were also associated with the degree of exposure to Hurricane Maria, with those who spent more time without water after the hurricane having lower receptive language scores.
C1 [Valdes, Viviane; Gabard-Durnam, Laurel; Rahman, Zarin Ibnat; Nelson, Charles A.] Harvard Med Sch, Boston Childrens Hosp, Labs Cognit Neurosci, 1 Autumn St, Boston, MA 02215 USA.
   [Zorrilla, Carmen D.; Muler-Mendez, Natalia; Rivera, Diego] Univ Puerto Rico, Sch Med, Obstet & Gynecol Maternal Infant Studies Ctr, Med Sci Campus, San Juan, PR 00936 USA.
   [Nelson, Charles A.] Harvard Grad Sch Educ, Cambridge, MA USA.
RP Nelson, CA (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Labs Cognit Neurosci, 1 Autumn St, Boston, MA 02215 USA.
EM charles_nelson@harvaid.edu
FU National Institute on Minority Health and Health DisparitiesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Minority Health & Health
   Disparities (NIMHD) [5UM1AI069415];  [U54MD007587]
FX This project was supported by a supplement to grant 5UM1AI069415 to Dr
   Zorrilla (Integrated UPR-Clinical Trials Unit, principal investigator)
   and by the National Institute on Minority Health and Health Disparities
   and the National Institute of Allergy and Infectious Diseases of the
   National Institutes of Health under award U54MD007587.
CR Bernal R, 2008, INT ECON REV, V49, P1173, DOI 10.1111/j.1468-2354.2008.00510.x
   Branswell H., FEUD ERUPTED CDC PUE
   Branswell H., THEYRE JUST HIDING E
   Brooks-Gunn J, 2002, CHILD DEV, V73, P1052, DOI 10.1111/1467-8624.00457
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carr A, 2012, DEV PSYCHOL, V48, P543, DOI 10.1037/a0025888
   Centers for Disease Control and Prevention, ZIK INF INCR RAP PUE
   Centers for Disease Control and Prevention, ZIK VIR 2017 CAS COU
   Centers for Disease Control and Prevention, 2017, TRIOPL REAL TIM RT P
   Centers for Disease Control and Prevention, ZIK MAC ELISA INSTR
   Centers for Disease Control and Prevention, ZIK VIR 2016 CAS COU
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Coussons-Read ME, 2013, OBSTET MED, V6, P52, DOI 10.1177/1753495X12473751
   COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8
   Gely-Rojas L, 2018, P R HEALTH SCI J, V37, pS77
   Han WJ, 2005, CHILD DEV, V76, P137, DOI 10.1111/j.1467-8624.2005.00835.x
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x
   HUTTENLOCHER J, 1974, THEORIES COGNITIVE P, P331
   Jadresic E, 1995, J PSYCHOSOM OBST GYN, V16, P187, DOI 10.3109/01674829509024468
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   King S, 2005, STRESS, V8, P35, DOI 10.1080/10253890500108391
   King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026
   Koura KG, 2013, J DEV BEHAV PEDIATR, V34, P486, DOI 10.1097/DBP.0b013e31829d211c
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44
   Lebov JF, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2430-4
   Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merz EL, 2011, CULT DIVERS ETHN MIN, V17, P309, DOI 10.1037/a0023883
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Newman MG, 2002, BEHAV THER, V33, P215, DOI 10.1016/S0005-7894(02)80026-0
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Parker VJ, 2010, J REPROD IMMUNOL, V85, P86, DOI 10.1016/j.jri.2009.10.011
   Pierce LJ, 2019, JAMA PEDIATR, V173, P561, DOI 10.1001/jamapediatrics.2019.0492
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Sanz-Carrillo C, 2002, J PSYCHOSOM RES, V52, P167, DOI 10.1016/S0022-3999(01)00275-6
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896
   Tees MT, 2010, MATERN CHILD HLTH J, V14, P511, DOI 10.1007/s10995-009-0486-x
   US Census Bureau, 2018, CENS QUICKFACTS SAN
   Vega-Dienstmaier JM, 2002, ACTAS ESP PSIQUIATRI, V30, P106
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191
NR 55
TC 2
Z9 2
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD OCT
PY 2019
VL 2
IS 10
AR e1914061
DI 10.1001/jamanetworkopen.2019.14061
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA JP0XK
UT WOS:000497997100092
PM 31651970
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sarkar, S
   Heise, MT
AF Sarkar, Sanjay
   Heise, Mark T.
TI Mouse Models as Resources for Studying Infectious Diseases
SO CLINICAL THERAPEUTICS
LA English
DT Editorial Material
DE mouse models; infectious diseases; genetics; host/pathogen interactions
ID SYNDROME CORONAVIRUS INFECTION; MEASLES-VIRUS INFECTION; ANIMAL-MODELS;
   COLLABORATIVE CROSS; ZIKA VIRUS; INFLUENZA-A; MICE; PATHOGENESIS;
   RECEPTOR; LETHAL
AB Mouse models are important tools both for studying the pathogenesis of infectious diseases and for the preclinical evaluation of vaccines and therapies against a wide variety of human pathogens. The use of genetically defined inbred mouse strains, humanized mice, and gene knockout mice has allowed the research community to explore how pathogens cause disease, define the role of specific host genes in either controlling or promoting disease, and identify potential targets for the prevention or treatment of a wide range of infectious agents. This review discusses several of the most commonly used mouse model systems, as well as new resources such as the Collaborative Cross as models for studying infectious diseases. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Sarkar, Sanjay; Heise, Mark T.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.
   [Heise, Mark T.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
RP Heise, MT (corresponding author), Univ N Carolina, 9039 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.
EM mark_heisem@med.unc.edu
FU National Institute for Allergy and Infectious Diseases (NIAID)/National
   Institutes of Health (NIH), U.S.A. [U19 AI100625, U01 AI149644]
FX This work was supported by the National Institute for Allergy and
   Infectious Diseases (NIAID)/National Institutes of Health (NIH), U.S.A.
   grants U19 AI100625 and U01 AI149644. The figures were developed in part
   using a license from BioRender.
CR Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Balla KM, 2013, CELL MICROBIOL, V15, P1313, DOI 10.1111/cmi.12152
   Baseler L, 2016, VET PATHOL, V53, P521, DOI 10.1177/0300985815620845
   BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143
   Bennett RS, 2017, CURR TOP MICROBIOL, V411, P171, DOI 10.1007/82_2017_20
   Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0
   Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800
   Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23
   Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530
   Buddle BM, 2016, MICROBIOL SPECTR, V4
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226
   Cockrell AS, 2014, J VIROL, V88, P5195, DOI 10.1128/JVI.03764-13
   Coleman CM, 2014, J GEN VIROL, V95, P408, DOI 10.1099/vir.0.060640-0
   Day TA, 2013, CURR HIV RES, V11, P441, DOI 10.2174/1570162X113116660051
   DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0
   Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   Enkirch T, 2015, VIROLOGY, V479, P259, DOI 10.1016/j.virol.2015.03.017
   Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196
   Gao Y, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040167
   Garrison AR, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070590
   Gaska JM, 2019, ELIFE, V8, DOI 10.7554/eLife.44436
   Gaska Jenna M, 2019, Methods Mol Biol, V1911, P481, DOI 10.1007/978-1-4939-8976-8_33
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Graham JB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005996
   Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15
   Gralinski LE, 2017, G3-GENES GENOM GENET, V7, P1653, DOI 10.1534/g3.117.041434
   Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   Hufford MM, 2015, CURR TOP MICROBIOL, V386, P423, DOI 10.1007/82_2014_397
   Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639
   Krishnakumar V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030252
   Lambkin-Williams R, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0784-1
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009
   Li K, 2017, P NATL ACAD SCI USA, V114, pE3119, DOI 10.1073/pnas.1619109114
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Hernandez YL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00038
   Margine I, 2014, PATHOGENS, V3, P845, DOI 10.3390/pathogens3040845
   Marsden MD, 2017, ANNU REV VIROL, V4, P393, DOI 10.1146/annurev-virology-101416-041703
   Masopust D, 2017, J IMMUNOL, V199, P383, DOI 10.4049/jimmunol.1700453
   Maurizio PL, 2018, G3-GENES GENOM GENET, V8, P427, DOI 10.1534/g3.117.300438
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Noll KE, 2019, CELL HOST MICROBE, V25, P484, DOI 10.1016/j.chom.2019.03.009
   Ohno S, 2007, J VIROL, V81, P1650, DOI 10.1128/JVI.02134-06
   Palha N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003619
   Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112
   Peck KM, 2015, J VIROL, V89, P4696, DOI 10.1128/JVI.03445-14
   Pyrc K, 2010, J VIROL, V84, P11255, DOI 10.1128/JVI.00947-10
   Rall GF, 1997, P NATL ACAD SCI USA, V94, P4659, DOI 10.1073/pnas.94.9.4659
   Ramani S, 2018, CURR OPIN VIROL, V29, P79, DOI 10.1016/j.coviro.2018.04.001
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1
   Seydel KB, 1997, INFECT IMMUN, V65, P1631, DOI 10.1128/IAI.65.5.1631-1639.1997
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005
   Siragam V, 2018, ZOOL RES, V39, P15, DOI 10.24272/j.issn.2095-8137.2017.053
   Smith CM, 2016, MBIO, V7, DOI [10.1128/mbio.01516-16, 10.1128/mBio.01516-16]
   STEINHOFF U, 1995, VIROLOGY, V69, P2153
   Tao XR, 2016, J VIROL, V90, P57, DOI 10.1128/JVI.02009-15
   Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13
   THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5
   Torraca V, 2018, TRENDS CELL BIOL, V28, P143, DOI 10.1016/j.tcb.2017.10.002
   Valbuena G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004063
   van Doremalen N, 2015, ANTIVIR RES, V122, P28, DOI 10.1016/j.antiviral.2015.07.005
   Vered K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-865
   Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332
   Wong G, 2018, ZOOL RES, V39, P3, DOI 10.24272/j.issn.2095-8137.2017.052
   Zhang J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4667-0
   Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111
   Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650
NR 78
TC 3
Z9 3
U1 4
U2 4
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0149-2918
EI 1879-114X
J9 CLIN THER
JI Clin. Ther.
PD OCT
PY 2019
VL 41
IS 10
BP 1912
EP 1922
DI 10.1016/j.clinthera.2019.08.010
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JP7XO
UT WOS:000498474000004
PM 31540729
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Sharma, R
   Agarwal, M
   Gupta, M
   Singh, R
   Mahavar, S
   Sharma, R
   Meena, D
AF Sharma, Raman
   Agarwal, Madhulata
   Gupta, Mayank
   Singh, Ruchi
   Mahavar, SunilKumar
   Sharma, Rajni
   Meena, Deepa
TI Clinicodemographic Profiling of Zika Outbreak in Jaipur, Rajasthan
SO INDIAN JOURNAL OF MEDICAL SPECIALITIES
LA English
DT Article
DE Clinicodemographic; maculopapular rash; pregnancy; Zika virus disease
ID VIRUS-INFECTION; PREGNANT-WOMEN; TRANSMISSION; STATES
AB Background: The 2018 postmonsoon outbreak of Zika virus infection, in a localized pocket of city of Jaipur, Rajasthan, so far the largest in India, alarmed the health authorities to optimize surveillance and measures. Hence, a community-based study to analyze the clinicodemographic profile was conducted to gain better understanding of its squeal. This study aimed to analyze the clinicodemographic profile of this new entrant viral infection. Methods: The study was designed as a community-based observational study. 1,488,870 people in vicinity of the index case were surveyed clinically from October to November 2018. A total of 1925 febrile individuals including pregnant ones in various trimesters of their pregnancy were screened for Zika infection by reverse-transcriptase-polymerase-chain-reaction (RT-PCR). Among these, 153 were RT-PCR positive and 111 cases consenting for the study were included and data collected were analyzed using SPSS 16 software. Results: The mean age of the study population was 27.51 years (95% confidence interval = 24.78-30.25), 53% of the patients were females. Out of 59 Zika-positive females, 27 (46%) were pregnant 12 (44.4%) were in first trimester and 9 (33%) and 6 (22.2%) in second and third trimester, respectively. The incubation period ranged from 2 to 10 days, the most common symptom being low grade fever in 82%, followed by myalgia in 64.9% and arthralgia in rheumatoid distribution in 55.9%. On examination, a widely distributed blanching maculopapular rash was seen in 28.8%; nonpurulent conjunctivitis differentiating it from dengue was seen in 16.2%. Conclusions: Although Zika, a commonly prevalent virus in dengue endemic belts, yet unknown to our territory, usually causes a mild febrile illness, it can be a cause of intense apprehension to many if infection occurs in the first trimester of pregnancy. Formulating guidelines to tackle Zika pregnancy is a daunting task and needs collaboration across the globe to carry out future research and to get the knowhow.
C1 [Sharma, Raman; Agarwal, Madhulata; Gupta, Mayank; Mahavar, SunilKumar] Govt Rajasthan, Dept Med, SMS Med Coll, Jaipur, Rajasthan, India.
   [Sharma, Rajni] Govt Rajasthan, Dept Microbiol, SMS Med Coll, Jaipur, Rajasthan, India.
   [Singh, Ruchi; Meena, Deepa] Govt Rajasthan, Directorate Med & Hlth Serv, Integrated Dis Surveillance Project, Jaipur, Rajasthan, India.
RP Gupta, M (corresponding author), Hardik Med, S-81, Jaipur 302015, Rajasthan, India.
EM mayankkkg@yahoo.co.in
CR [Anonymous], 2014, RAP RISK ASS ZIK VIR
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, ZIK VIR DIS Q A
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   Jimenez Corona ME, 2016, PLOSCURR, V8
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, ZIK VIR DIS
NR 26
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0976-2884
EI 0976-2892
J9 INDIAN J MED SPEC
JI Indian J. Med. Spec.
PD OCT-DEC
PY 2019
VL 10
IS 4
BP 184
EP 189
DI 10.4103/INJMS.INJMS_65_19
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA JP1XG
UT WOS:000498064300002
DA 2020-07-08
ER

PT J
AU Hubert, M
   Chiche, A
   Legros, V
   Jeannin, P
   Montange, T
   Gessain, A
   Ceccaldi, PE
   Vidy, A
AF Hubert, Mathieu
   Chiche, Aurelie
   Legros, Vincent
   Jeannin, Patricia
   Montange, Thomas
   Gessain, Antoine
   Ceccaldi, Pierre-Emmanuel
   Vidy, Aurore
TI Productive Infection of Mouse Mammary Glands and Human Mammary
   Epithelial Cells by Zika Virus
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; dissemination; mammary glands; tropism; primary cells;
   luminal cells; myoepithelial cells
ID SEXUAL TRANSMISSION; PROLONGED DETECTION; VAGINAL SECRETIONS; MILK;
   SEMEN; RNA
AB Zika virus (ZIKV) belongs to the large category of arboviruses. Surprisingly, several human-to-human transmissions of ZIKV have been notified, either following sexual intercourse or from the mother to fetus during pregnancy. Importantly, high viral loads have been detected in the human breast milk of infected mothers, and the existence of breastfeeding as a new mode of mother-to-child transmission of ZIKV was recently hypothesized. However, the maternal origin of infectious particles in breast milk is currently unknown. Here, we show that ZIKV disseminates to the mammary glands of infected mice after both systemic and local exposure with differential kinetics. Ex vivo, we demonstrate that primary human mammary epithelial cells were sensitive and permissive to ZIKV infection in this study. Moreover, by using in vitro models, we prove that mammary luminal- and myoepithelial-phenotype cell lines are both able to produce important virus progeny after ZIKV exposure. Our data suggest that the dissemination of ZIKV to the mammary glands and subsequent infection of the mammary epithelium could be one mechanism of viral excretion in human breast milk.
C1 [Hubert, Mathieu; Legros, Vincent; Jeannin, Patricia; Montange, Thomas; Gessain, Antoine; Ceccaldi, Pierre-Emmanuel; Vidy, Aurore] Inst Pasteur, UMR Ctr Natl Rech Sci 3569, Dept Virol, Unite Epidemiol & Physiopathol Virus Oncogenes, F-75015 Paris, France.
   [Hubert, Mathieu; Legros, Vincent; Ceccaldi, Pierre-Emmanuel; Vidy, Aurore] Univ Paris, F-75013 Paris, France.
   [Chiche, Aurelie] Inst Pasteur, Dept Biol Dev & Cellules Souches, Grp 5 Ans Plasticite Cellulaire & Modelisat Malad, F-75015 Paris, France.
RP Ceccaldi, PE; Vidy, A (corresponding author), Inst Pasteur, UMR Ctr Natl Rech Sci 3569, Dept Virol, Unite Epidemiol & Physiopathol Virus Oncogenes, F-75015 Paris, France.; Ceccaldi, PE; Vidy, A (corresponding author), Univ Paris, F-75013 Paris, France.
EM mathieu.hubert@pasteur.fr; aurelie.chiche@pasteur.fr;
   vincent.legros@ens-lyon.fr; patricia.jeannin@pasteur.fr;
   thomas.montange@pasteur.fr; antoine.gessain@pasteur.fr;
   pierre-emmanuel.ceccaldi@pasteur.fr; aurore.vidy@pasteur.fr
FU French ministry of education and research
FX This research received no external funding. M.H. was the recipient of a
   PhD fellowship from the French ministry of education and research.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Blohm GM, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00231-17, 10.1128/genomea.00231-17]
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Conzelmann C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070591
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hubert M., 2019, COMMUNICATION
   Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   METKA K, 1992, BIOL CELL, V75, P211, DOI 10.1016/0248-4900(92)90142-N
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Regla-Nava JA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007080
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
NR 34
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2019
VL 11
IS 10
AR 950
DI 10.3390/v11100950
PG 13
WC Virology
SC Virology
GA JP6VH
UT WOS:000498400400071
PM 31619008
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moutailler, S
   Yousfi, L
   Mousson, L
   Devillers, E
   Vazeille, M
   Vega-Rua, A
   Perrin, Y
   Jourdain, F
   Chandre, F
   Cannet, A
   Chantilly, S
   Restrepo, J
   Guidez, A
   Dusfour, I
   de Abreu, FVS
   dos Santos, TP
   Jiolle, D
   Visser, TM
   Koenraadt, CJM
   Wongsokarijo, M
   Diallo, M
   Diallo, D
   Gaye, A
   Boyer, S
   Duong, V
   Piorkowski, G
   Paupy, C
   de Oliveira, RL
   de Lamballerie, X
   Failloux, AB
AF Moutailler, Sara
   Yousfi, Lena
   Mousson, Laurence
   Devillers, Elodie
   Vazeille, Marie
   Vega-Rua, Anubis
   Perrin, Yvon
   Jourdain, Frederic
   Chandre, Fabrice
   Cannet, Arnaud
   Chantilly, Sandrine
   Restrepo, Johana
   Guidez, Amandine
   Dusfour, Isabelle
   de Abreu, Filipe Vieira Santos
   dos Santos, Taissa Pereira
   Jiolle, Davy
   Visser, Tessa M.
   Koenraadt, Constantianus J. M.
   Wongsokarijo, Merril
   Diallo, Mawlouth
   Diallo, Diawo
   Gaye, Alioune
   Boyer, Sebastien
   Duong, Veasna
   Piorkowski, Geraldine
   Paupy, Christophe
   de Oliveira, Ricardo Lourenco
   de Lamballerie, Xavier
   Failloux, Anna-Bella
TI A New High-Throughput Tool to Screen Mosquito-Borne Viruses in Zika
   Virus Endemic/Epidemic Areas
SO VIRUSES-BASEL
LA English
DT Article
DE mosquito-borne viruses; molecular epidemiology; surveillance;
   microfluidic analysis
ID DENGUE; TRANSMISSION; CHIKUNGUNYA; COINFECTIONS; DYNAMICS; OUTBREAK;
   GENOME
AB Mosquitoes are vectors of arboviruses affecting animal and human health. Arboviruses circulate primarily within an enzootic cycle and recurrent spillovers contribute to the emergence of human-adapted viruses able to initiate an urban cycle involving anthropophilic mosquitoes. The increasing volume of travel and trade offers multiple opportunities for arbovirus introduction in new regions. This scenario has been exemplified recently with the Zika pandemic. To incriminate a mosquito as vector of a pathogen, several criteria are required such as the detection of natural infections in mosquitoes. In this study, we used a high-throughput chip based on the BioMark (TM) Dynamic arrays system capable of detecting 64 arboviruses in a single experiment. A total of 17,958 mosquitoes collected in Zika-endemic/epidemic countries (Brazil, French Guiana, Guadeloupe, Suriname, Senegal, and Cambodia) were analyzed. Here we show that this new tool can detect endemic and epidemic viruses in different mosquito species in an epidemic context. Thus, this fast and low-cost method can be suggested as a novel epidemiological surveillance tool to identify circulating arboviruses.
C1 [Moutailler, Sara; Yousfi, Lena; Devillers, Elodie] Univ Paris Est, ANSES, Ecole Natl Vet Alfort, INRA,Anim Hlth Lab,UMR BIPAR, F-94700 Maisons Alfort, France.
   [Mousson, Laurence; Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors, F-75015 Paris, France.
   [Vega-Rua, Anubis] Inst Pasteur Guadeloupe Lieu Dit Morne Joliviere, Lab Vector Control Res, F-97139 Les Abymes, Guadeloupe, France.
   [Perrin, Yvon; Jourdain, Frederic; Chandre, Fabrice; Cannet, Arnaud] CNEV, IRD, F-34000 Montpellier, France.
   [Jourdain, Frederic; Chandre, Fabrice; dos Santos, Taissa Pereira; Jiolle, Davy; Paupy, Christophe] Montpellier Univ, UMR MIVEGEC, IRD, CNRS, F-34000 Montpellier, France.
   [Chantilly, Sandrine; Restrepo, Johana] CTG, Direct Demousticat, F-97300 Cayenne, France.
   [Guidez, Amandine; Dusfour, Isabelle] Inst Pasteur Guyane, Unite Adaptat & Controle Vecteurs, F-97300 Cayenne, France.
   [de Abreu, Filipe Vieira Santos; de Oliveira, Ricardo Lourenco] Fiocruz MS, Lab Mosquitos Transmissores Hematozoarios, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil.
   [Visser, Tessa M.; Koenraadt, Constantianus J. M.] Wageningen Univ & Res, Lab Entomol, NL-6708 PB Wageningen, Netherlands.
   [Wongsokarijo, Merril] Bur Publ Hlth, Cent Lab, POB 1863, Paramaribo, Suriname.
   [Diallo, Mawlouth; Diallo, Diawo; Gaye, Alioune] Inst Pasteur, Unite Entomol Med, BP 220, Dakar, Senegal.
   [Boyer, Sebastien; Duong, Veasna] Inst Pasteur Cambodge, Med Entomol Platform & Virol Unit, POB 983, Phnom Penh, Cambodia.
   [Piorkowski, Geraldine; de Lamballerie, Xavier] Aix Marseille Univ, UVE, IHUMediterranee Infect, IRD 190,INSERM 1207, F-13385 Marseille, France.
RP Moutailler, S (corresponding author), Univ Paris Est, ANSES, Ecole Natl Vet Alfort, INRA,Anim Hlth Lab,UMR BIPAR, F-94700 Maisons Alfort, France.; Failloux, AB (corresponding author), Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors, F-75015 Paris, France.
EM sara.moutailler@anses.fr; lenayousfi@hotmail.fr;
   laurence.mousson@pasteur.fr; elodie.devillers@anses.fr;
   marie.vazeille@pasteur.fr; anubis.vega-rua@pasteur.fr;
   yperrin@eid-med.org; frederic.jourdain@ird.fr; fabrice.chandre@ird.fr;
   ar.cannet@gmail.com; sandrine.chantilly@ctguyane.fr;
   johana.restrepo@ctguyane.fr; aguidez@pasteur-cayenne.fr;
   isabelle.dusfour@pasteur.fr; gigante_bio@yahoo.com.br;
   tayssadnz@gmail.com; davy_jiolle@hotmail.com; tessa.visser@wur.nl;
   sander.koenraadt@wur.nl; mer_wongso@hotmail.com;
   Mawlouth.DIALLO@pasteur.sn; diawo.diallo@pasteur.sn;
   alioune.gaye@pasteur.sn; sboyer@pasteur-kh.org; dveasna@pasteur-kh.org;
   geraldine.piorkowski@inserm.fr; christophe.paupy@ird.fr;
   lourenco@ioc.fiocruz.br; xavier.de-lamballerie@univ-amu.fr;
   anna-bella.failloux@pasteur.fr
RI Veasna, Duong/I-9684-2014; Paupy, Christophe/I-4847-2017; Sara,
   Moutailler/J-9633-2019; Abreu, Filipe/F-6364-2019
OI Veasna, Duong/0000-0003-0353-1678; Paupy,
   Christophe/0000-0002-7122-2079; Sara, Moutailler/0000-0003-3010-6968;
   FAILLOUX, Anna-Bella/0000-0001-6890-0820; Dusfour,
   Isabelle/0000-0002-5265-8432; Visser, Tessa/0000-0003-0899-7450; Abreu,
   Filipe/0000-0001-9768-4688; Boyer, Sebastien/0000-0002-2946-586X;
   Jourdain, Frederic/0000-0001-6485-8952; DIALLO,
   Diawo/0000-0002-7478-5248
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance [734548]; 2014 PTR Anses-Institut Pasteur project [511];
   European Union's Horizon 2020 Research and Innovation Programme under
   EVAg Grant [653316]; "Investissement d'Avenir" 'grant from the Agence
   Nationale de la RechercheFrench National Research Agency (ANR) [CEBA
   ANR-10-LABX-2501]; French General Directorate of Health; Programme
   Operationnel FEDER-Guadeloupe-Conseil Regional 2014-2020 [2015-FED-192]
FX We thank Christelle Delannay and the staff of the Regional Health Agency
   of Guadeloupe for their support during the sampling campaigns. This work
   was supported by the European Union's Horizon 2020 Research and
   Innovation Programme under ZIKAlliance Grant Agreement no. 734548. The
   project also received funding from the 2014 PTR Anses-Institut Pasteur
   project (No 511) for CHIPARBO, and the European Union's Horizon 2020
   Research and Innovation Programme under EVAg Grant Agreement no. 653316,
   and from an "Investissement d'Avenir" 'grant from the Agence Nationale
   de la Recherche (CEBA ANR-10-LABX-2501 grant) supporting the project
   TIGERAMAZON.. The French General Directorate of Health funded the work
   performed in Guadeloupe and French Guiana. The Programme Operationnel
   FEDER-Guadeloupe-Conseil Regional 2014-2020 (grant 2015-FED-192)
   supported the researchers from Guadeloupe. The authors declare they have
   no conflict of interest.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Eklund C., 1985, INT CATALOGUE ARBOVI, P1035
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Gondard M, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty083
   Groseth A, 2015, ARCH VIROL, V160, P2637, DOI 10.1007/s00705-015-2532-x
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Malmsten J, 2019, VECTOR-BORNE ZOONOT, V19, P207, DOI 10.1089/vbz.2018.2277
   Mascheretti M, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004341
   Michelet L, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00103
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nielsen EM, 2003, J CLIN MICROBIOL, V41, P2884, DOI 10.1128/JCM.41.7.2884-2893.2003
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Shannon RC, 1938, SCIENCE, V88, P110, DOI 10.1126/science.88.2274.110
   Vaddadi K, 2017, EPIDEMIOL INFECT, V145, P2563, DOI 10.1017/S0950268817001479
   Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 4
Z9 4
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2019
VL 11
IS 10
AR 904
DI 10.3390/v11100904
PG 19
WC Virology
SC Virology
GA JP6VH
UT WOS:000498400400025
PM 31569736
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nelemans, T
   Kikkert, M
AF Nelemans, Tessa
   Kikkert, Marjolein
TI Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus
   Infections
SO VIRUSES-BASEL
LA English
DT Review
DE positive-sense single-stranded RNA viruses; innate immune evasion; type
   I and III interferons; viral pathogenesis
ID ACUTE RESPIRATORY SYNDROME; INTERFERON-STIMULATED GENES; NF-KAPPA-B;
   CHIKUNGUNYA VIRUS; SYNDROME CORONAVIRUS; ZIKA VIRUS; III INTERFERON;
   SARS-COV; MOUSE MODEL; CLINICAL-ASPECTS
AB Positive-sense single-stranded RNA (+ssRNA) viruses comprise many (re-)emerging human pathogens that pose a public health problem. Our innate immune system and, in particular, the interferon response form the important first line of defence against these viruses. Given their genetic flexibility, these viruses have therefore developed multiple strategies to evade the innate immune response in order to optimize their replication capacity. Already many molecular mechanisms of innate immune evasion by +ssRNA viruses have been identified. However, research addressing the effect of host innate immune evasion on the pathology caused by viral infections is less prevalent in the literature, though very relevant and interesting. Since interferons have been implicated in inflammatory diseases and immunopathology in addition to their protective role in infection, antagonizing the immune response may have an ambiguous effect on the clinical outcome of the viral disease. Therefore, this review discusses what is currently known about the role of interferons and host immune evasion in the pathogenesis of emerging coronaviruses, alphaviruses and flaviviruses.
C1 [Nelemans, Tessa; Kikkert, Marjolein] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2333 ZA Leiden, Netherlands.
RP Kikkert, M (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2333 ZA Leiden, Netherlands.
EM tessa-nelemans@hotmail.com; m.kikkert@lumc.nl
RI Kikkert, Marjolein/AAK-5514-2020
OI Kikkert, Marjolein/0000-0002-5779-7386
FU Leiden University Medical Center
FX This work and publication costs were funded by Leiden University Medical
   Center via M.K.'s institutional permanent position as an Associate
   Professor.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V20, P42, DOI 10.1016/j.ijid.2013.12.003
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001
   Brechot C, 2019, ANTIVIR RES, V163, P140, DOI 10.1016/j.antiviral.2019.01.013
   Butthep P, 2012, PEDIATR INFECT DIS J, V31, pE232, DOI 10.1097/INF.0b013e31826fd456
   Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chan YH, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810092
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chien JY, 2006, RESPIROLOGY, V11, P715, DOI 10.1111/j.1440-1843.2006.00942.x
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309
   Christofferson RC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-127
   Clavarino G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002708
   Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0
   DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005
   DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51
   Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
   Faure E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088716
   Fehr AR, 2016, MBIO, V7, DOI 10.1128/mBio.01721-16
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07
   Frieman MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000849
   Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002
   Fros JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060166
   Galan-Huerta KA, 2015, MED U, V17, P175, DOI [10.1016/j.rmu.2015.06.001, DOI 10.1016/J.RMU.2015.06.001]
   Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012
   Gardner CL, 2012, VIROLOGY, V425, P103, DOI 10.1016/j.virol.2011.12.020
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gokhale NS, 2014, FUTURE VIROL, V9, P1061, DOI 10.2217/FVL.14.89
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Her ZS, 2015, EMBO MOL MED, V7, P24, DOI 10.15252/emmm.201404459
   Hilleman MR, 2004, P NATL ACAD SCI USA, V101, P14560, DOI 10.1073/pnas.0404758101
   Hogan RJ, 2004, J VIROL, V78, P11416, DOI 10.1128/JVI.78.20.11416-11421.2004
   Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim ES, 2016, J KOREAN MED SCI, V31, P1717, DOI 10.3346/jkms.2016.31.11.1717
   Kindler E, 2016, ADV VIRUS RES, V96, P219, DOI 10.1016/bs.aivir.2016.08.006
   Knaap R.C.M., 2019, DEUBIQUITINATING ACT, DOI [10.1101/751578, DOI 10.1101/751578]
   Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06
   Kotenko SV, 2017, J BIOL CHEM, V292, P7295, DOI 10.1074/jbc.R117.777102
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kumaki Y, 2011, ANTIVIR RES, V89, P75, DOI 10.1016/j.antiviral.2010.11.007
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Li SF, 2018, CELL PHYSIOL BIOCHEM, V51, P2377, DOI 10.1159/000495897
   Liu DX, 2014, ANTIVIR RES, V109, P97, DOI 10.1016/j.antiviral.2014.06.013
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Lo AWI, 2006, J PATHOL, V208, P142, DOI 10.1002/path.1897
   Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Mahlakoiv T, 2012, J GEN VIROL, V93, P2601, DOI 10.1099/vir.0.046284-0
   Malavige GN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-341
   da Silva MHM, 2019, MED MICROBIOL IMMUN, V208, P703, DOI 10.1007/s00430-019-00588-8
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Menachery VD, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00346-17
   Menachery VD, 2017, MBIO, V8, DOI 10.1128/mBio.00665-17
   Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Mielech AM, 2014, VIRUS RES, V194, P184, DOI 10.1016/j.virusres.2014.01.025
   Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morales L, 2017, CELL HOST MICROBE, V21, P344, DOI 10.1016/j.chom.2017.01.015
   Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Ng LFP, 2017, ANNU REV VIROL, V4, P413, DOI 10.1146/annurev-virology-101416-041808
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7
   Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077
   Noorbakhsh F, 2019, IRAN J PUBLIC HEALTH, V48, P20
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X
   Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Pardy RD, 2019, CYTOKINE, V119, P7, DOI 10.1016/j.cyto.2019.02.009
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Piret J, 2018, J GEN VIROL, V99, P209, DOI 10.1099/jgv.0.000992
   Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16
   Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2
   Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323
   Schaecher SR, 2008, VIROLOGY, V380, P312, DOI 10.1016/j.virol.2008.07.026
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Shalhoub S, 2015, J ANTIMICROB CHEMOTH, V70, P2129, DOI 10.1093/jac/dkv085
   Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756
   Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   Teng TS, 2015, J INFECT DIS, V211, P1925, DOI 10.1093/infdis/jiv049
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Thornbrough JM, 2016, MBIO, V7, DOI 10.1128/mBio.00258-16
   Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15
   Uno N, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0168-0
   Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Werneke SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002322
   White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10
   WHO, 2003, WKLY EPIDEMIOL REC, V78, P373
   WHO, MIDDL E RESP SYNDR C
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005
   Yu SY, 2005, WORLD J GASTROENTERO, V11, P5037, DOI 10.3748/wjg.v11.i32.5037
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111
   Zhao J, 2009, J VIROL, V83, P2368, DOI 10.1128/JVI.02371-08
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
   Zielecki F, 2013, J VIROL, V87, P5300, DOI 10.1128/JVI.03496-12
NR 154
TC 5
Z9 5
U1 8
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2019
VL 11
IS 10
AR 961
DI 10.3390/v11100961
PG 23
WC Virology
SC Virology
GA JP6VH
UT WOS:000498400400082
PM 31635238
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pardy, RD
   Richer, MJ
AF Pardy, Ryan D.
   Richer, Martin J.
TI Zika Virus Pathogenesis: From Early Case Reports to Epidemics
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; pathogenesis; Guillain-Barre syndrome; fetal microcephaly;
   congenital Zika syndrome
ID GUILLAIN-BARRE-SYNDROME; SEXUAL TRANSMISSION; INFECTION; SEMEN;
   OUTBREAK; STATES
AB For the first 60 years following its isolation, Zika virus (ZIKV) remained a relatively poorly described member of the Flaviviridae family. However, since 2007, it has caused a series of increasingly severe outbreaks and is now associated with neurological symptoms such as Guillain-Barre syndrome and congenital Zika syndrome (CZS). A number of reports have improved our understanding of rare complications that may be associated with ZIKV infection in adults, the areas of the body to which it spreads, and viral persistence in various tissues. Likewise, studies on the effect of ZIKV infection during pregnancy have identified risk factors for CZS and the impact this syndrome has on early childhood. Understanding these outcomes and the factors that drive ZIKV pathogenesis are key to developing vaccination and therapeutic approaches to avoid these severe and potentially debilitating symptoms.
C1 [Pardy, Ryan D.; Richer, Martin J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
   [Pardy, Ryan D.; Richer, Martin J.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada.
RP Richer, MJ (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.; Richer, MJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada.
EM ryan.pardy@mail.mcgill.ca; martin.j.richer@mcgill.ca
OI Pardy, Ryan/0000-0002-0024-8888
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [PJT-152903, PJT-162212]; Natural Sciences and
   Engineering Research CouncilNatural Sciences and Engineering Research
   Council of Canada [RGPIN-2016-04713]; Fonds de Recherche du
   Quebec-SanteFonds de la Recherche en Sante du Quebec [32807]; Canada
   Foundation for InnovationCanada Foundation for Innovation; Frederick
   Banting and Charles Best Canada Graduate Scholarships-Doctoral Award
   from the Canadian Institutes of Health ResearchCanadian Institutes of
   Health Research (CIHR)
FX The Richer Lab is funded by the Canadian Institutes of Health Research,
   grant number PJT-152903 and PJT-162212; the Natural Sciences and
   Engineering Research Council, grant number RGPIN-2016-04713; Fonds de
   Recherche du Quebec-Sante, grant number 32807; and the Canada Foundation
   for Innovation. R.D.P is supported by the Frederick Banting and Charles
   Best Canada Graduate Scholarships-Doctoral Award from the Canadian
   Institutes of Health Research.
CR Adachi Kristina, 2020, Clin Infect Dis, V70, P2663, DOI 10.1093/cid/ciz704
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Vianna RAD, 2019, J TROP PEDIATRICS, V65, P592, DOI 10.1093/tropej/fmz019
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Sahly HM, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy352
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lima GP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3908-4
   Lindsey NP, 2020, CLIN INFECT DIS, V70, P227, DOI 10.1093/cid/ciz195
   Soto-Hernandez JL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00435
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Marinho PES, 2019, J NEUROVIROL, V25, P893, DOI 10.1007/s13365-019-00770-x
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO, 2015, ZIK SUSP CONF CAS RE
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Robbiani DF, 2019, J EXP MED, V216, P2302, DOI 10.1084/jem.20191061
   Rodriguez-Morales AJ, 2019, INT J INFECT DIS, V83, P160, DOI 10.1016/j.ijid.2019.03.002
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tozetto-Mendoza TR, 2019, REV INST MED TROP SP, V61, DOI [10.1590/S1678-9946201961019, 10.1590/s1678-9946201961019]
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wright JK, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0661-1
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   Zambrano LI, 2019, INT J INFECT DIS, V84, P136, DOI 10.1016/j.ijid.2019.05.008
NR 60
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2019
VL 11
IS 10
AR 886
DI 10.3390/v11100886
PG 9
WC Virology
SC Virology
GA JP6VH
UT WOS:000498400400007
PM 31546589
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Serman, TM
   Gack, MU
AF Serman, Taryn M.
   Gack, Michaela U.
TI Evasion of Innate and Intrinsic Antiviral Pathways by the Zika Virus
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; Zika virus; innate immunity; antiviral; interferon; stress
   response; nonsense-mediated mRNA Decay; autophagy
ID WEST-NILE-VIRUS; I INTERFERON-PRODUCTION; RIG-I; DENGUE VIRUS; NS5
   PROTEIN; JAPANESE ENCEPHALITIS; SIGNALING CONTROLS; ADAPTER PROTEIN;
   RNA; INFECTION
AB The Zika virus (ZIKV) is a recently emerged mosquito-borne flavivirus that, while typically asymptomatic, can cause neurological symptoms in adults and birth defects in babies born to infected mothers. The interactions of ZIKV with many different pathways in the human host ultimately determine successful virus replication and ZIKV-induced pathogenesis; however, the molecular mechanisms of such host-ZIKV interactions have just begun to be elucidated. Here, we summarize the recent advances that defined the mechanisms by which ZIKV antagonizes antiviral innate immune signaling pathways, with a particular focus on evasion of the type I interferon response in the human host. Furthermore, we describe emerging evidence that indicated the contribution of several cell-intrinsic mechanisms to an effective restriction of ZIKV infection, such as nonsense-mediated mRNA decay, stress granule formation, and "reticulophagy", a type of selective autophagy. Finally, we summarize the recent work that identified strategies by which ZIKV modulated these intrinsic antiviral responses.
C1 [Serman, Taryn M.; Gack, Michaela U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.
RP Gack, MU (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.
EM taryn@uchicago.edu; mgack@uchicago.edu
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI087846,
   R01 AI127774, R21 AI148082]; ClayCo Foundation; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [T32 GM007183]
FX Current research in the Gack laboratory is supported by National
   Institutes of Health (NIH) grants (R01 AI087846, R01 AI127774 and R21
   AI148082) and an award from the ClayCo Foundation. T.M.S. received
   support from NIH training grant T32 GM007183.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Balistreri G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010024
   Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bonenfant G, 2019, J VIROL, V93, DOI [10.1128/JVI.00520-19, 10.1128/jvi.00520-19]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chiang JJ, 2014, CYTOKINE GROWTH F R, V25, P491, DOI 10.1016/j.cytogfr.2014.06.005
   Choi Y, 2018, NAT REV MICROBIOL, V16, P340, DOI 10.1038/s41579-018-0003-6
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Fontaine KA, 2018, MBIO, V9, DOI [10.1128/mBio.02126-18, 10.1128/mbio.02126-18]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022
   Joyce MA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007949
   Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461
   Ke PY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123940
   Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li MH, 2019, NAT MICROBIOL, V4, P985, DOI 10.1038/s41564-019-0375-z
   Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin JP, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007582
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   MacFadden A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02604-y
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montero H, 2011, VIRUSES-BASEL, V3, P2328, DOI 10.3390/v3112328
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Nakatogawa H, 2015, AUTOPHAGY, V11, P2377, DOI 10.1080/15548627.2015.1106665
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004
   Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Riedl W, 2019, CELL HOST MICROBE, V26, P493, DOI 10.1016/j.chom.2019.09.012
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sabouri AH, 2014, BRAIN RES, V1574, P84, DOI 10.1016/j.brainres.2014.05.049
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Serquina AKP, 2013, J VIROL, V87, P8853, DOI 10.1128/JVI.00925-13
   Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Strange DP, 2019, MBIO, V10, DOI 10.1128/mBio.01372-19
   Sun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03932-1
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
NR 122
TC 1
Z9 1
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2019
VL 11
IS 10
AR 970
DI 10.3390/v11100970
PG 19
WC Virology
SC Virology
GA JP6VH
UT WOS:000498400400091
PM 31652496
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yager, EJ
   Konan, KV
AF Yager, Eric J.
   Konan, Kouacou V.
TI Sphingolipids as Potential Therapeutic Targets against Enveloped Human
   RNA Viruses
SO VIRUSES-BASEL
LA English
DT Review
DE sphingolipids; glycosphingolipids; viruses; lipid biosynthesis;
   antiviral
ID ZIKA-VIRUS; SERINE PALMITOYLTRANSFERASE; QUANTITATIVE-ANALYSIS;
   INTRACELLULAR-TRANSPORT; GLYCOSPHINGOLIPID GM3; GALACTOSYL CERAMIDE;
   HIV-1 GP120; CELL-LINES; REPLICATION; MEMBRANE
AB Several notable human diseases are caused by enveloped RNA viruses: Influenza, AIDS, hepatitis C, dengue hemorrhagic fever, microcephaly, and Guillain-Barre Syndrome. Being enveloped, the life cycle of this group of viruses is critically dependent on host lipid biosynthesis. Viral binding and entry involve interactions between viral envelope glycoproteins and cellular receptors localized to lipid-rich regions of the plasma membrane. Subsequent infection by these viruses leads to reorganization of cellular membranes and lipid metabolism to support the production of new viral particles. Recent work has focused on defining the involvement of specific lipid classes in the entry, genome replication assembly, and viral particle formation of these viruses in hopes of identifying potential therapeutic targets for the treatment or prevention of disease. In this review, we will highlight the role of host sphingolipids in the lifecycle of several medically important enveloped RNA viruses.
C1 [Yager, Eric J.] Albany Coll Pharm & Hlth Sci, Dept Basic & Clin Sci, Albany, NY 12208 USA.
   [Konan, Kouacou V.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA.
RP Konan, KV (corresponding author), Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA.
EM Eric.Yager@acphs.edu; KonanK@amc.edu
FU Albany Medical College Bridge Grant; Albany College of Pharmacy and
   Health Sciences Scholarship of Discovery Grant
FX K.V.K. is supported by the Albany Medical College Bridge Grant. E.J.Y.
   is supported by an Albany College of Pharmacy and Health Sciences
   Scholarship of Discovery Grant.
CR Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132
   Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034
   Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07
   Aligo J, 2009, VIROLOGY, V393, P68, DOI 10.1016/j.virol.2009.07.033
   Asselah T, 2018, LIVER INT, V38, P7, DOI 10.1111/liv.13673
   Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07
   Barman S, 2017, VACCINE, V35, P1424, DOI 10.1016/j.vaccine.2017.01.061
   Bejaoui K, 2002, J CLIN INVEST, V110, P1301, DOI 10.1172/JCI200216450
   BHAT S, 1991, P NATL ACAD SCI USA, V88, P7131, DOI 10.1073/pnas.88.16.7131
   Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Bukrinsky M, 2004, MOL MED, V10, P1
   Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9
   Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cox TM, 2010, CURR OPIN INVEST DR, V11, P1169
   Desai M, 2012, INDIAN J PHARMACOL, V44, P288, DOI 10.4103/0253-7613.96296
   Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002
   Fantini J, 1997, J BIOL CHEM, V272, P7245, DOI 10.1074/jbc.272.11.7245
   Freed E.O., 2001, FIELDS VIROLOGY
   Fuller M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-113
   Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175
   Hammache D, 1998, BIOCHEM BIOPH RES CO, V246, P117, DOI 10.1006/bbrc.1998.8531
   Hammonds JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006181
   Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006
   HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969
   Hayes CN, 2019, EXPERT REV GASTROENT, V13, P839, DOI 10.1080/17474124.2019.1651642
   Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860
   Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025
   Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000
   Hulkova H, 2012, GLYCOBIOLOGY, V22, P725, DOI 10.1093/glycob/cws050
   Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001315
   JACKSON DA, 1982, NATURE, V296, P366, DOI 10.1038/296366a0
   Khan I, 2014, J VIROL, V88, P12276, DOI 10.1128/JVI.00970-14
   Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003
   Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049
   Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f
   Li Darrick K, 2019, Methods Mol Biol, V1911, P3, DOI 10.1007/978-1-4939-8976-8_1
   Li GD, 2016, MICROBIOL MOL BIOL R, V80, P679, DOI 10.1128/MMBR.00065-15
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934
   Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200
   Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6
   Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   McClellan K, 2001, DRUGS, V61, P263, DOI 10.2165/00003495-200161020-00011
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009
   Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645
   Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Patwardhan GA, 2011, PROG LIPID RES, V50, P104, DOI 10.1016/j.plipres.2010.10.003
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Puryear WB, 2012, P NATL ACAD SCI USA, V109, P7475, DOI 10.1073/pnas.1201104109
   Rawat SS, 2004, J VIROL, V78, P7360, DOI 10.1128/JVI.78.14.7360-7368.2004
   Ribeiro RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002881
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010
   Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501
   Seo YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075005
   Shao WH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081650
   Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017
   SKIBBENS JE, 1989, J CELL BIOL, V108, P821, DOI 10.1083/jcb.108.3.821
   Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06
   Sullards MC, 2011, BBA-MOL CELL BIOL L, V1811, P838, DOI 10.1016/j.bbalip.2011.06.027
   Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003
   Tafesse FG, 2013, P NATL ACAD SCI USA, V110, P6406, DOI 10.1073/pnas.1219909110
   Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100
   Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148
   Turpin Jim A, 2003, Expert Rev Anti Infect Ther, V1, P97, DOI 10.1586/14787210.1.1.97
   Wang KZ, 2016, INT J BIOL SCI, V12, P872, DOI 10.7150/ijbs.15641
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   YAHI N, 1992, J VIROL, V66, P4848, DOI 10.1128/JVI.66.8.4848-4854.1992
   Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142
   Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 83
TC 2
Z9 2
U1 6
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2019
VL 11
IS 10
AR 912
DI 10.3390/v11100912
PG 14
WC Virology
SC Virology
GA JP6VH
UT WOS:000498400400033
PM 31581580
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Miranda, J
   Martin-Tapia, D
   Valdespino-Vazquez, Y
   Alarcon, L
   Espejel-Nunez, A
   Guzman-Huerta, M
   Munoz-Medina, JE
   Shibayama, M
   Chavez-Munguia, B
   Estrada-Gutierrez, G
   Lievano, S
   Ludert, JE
   Gonzalez-Mariscal, L
AF Miranda, Jael
   Martin-Tapia, Dolores
   Valdespino-Vazquez, Yolotzin
   Alarcon, Lourdes
   Espejel-Nunez, Aurora
   Guzman-Huerta, Mario
   Esteban Munoz-Medina, Jose
   Shibayama, Mineko
   Chavez-Munguia, Bibiana
   Estrada-Gutierrez, Guadalupe
   Lievano, Samuel
   Ernesto Ludert, Juan
   Gonzalez-Mariscal, Lorenza
TI Syncytiotrophoblast of Placentae from Women with Zika Virus Infection
   Has Altered Tight Junction Protein Expression and Increased Paracellular
   Permeability
SO CELLS
LA English
DT Article
DE zika virus; flavivirus; tight junctions; claudins; ZO-1; blood-placental
   barrier; placenta
ID CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; BLOOD-BRAIN-BARRIER; CELLULAR
   JUNCTIONS; ZONULA OCCLUDENS-1; HUMAN ENDOMETRIUM; EPITHELIAL-CELLS;
   GENE-EXPRESSION; SURFACE; UTERUS; IMPLANTATION
AB The cytotrophoblast of human placenta transitions into an outer multinucleated syncytiotrophoblast (STB) layer that covers chorionic villi which are in contact with maternal blood in the intervillous space. During pregnancy, the Zika virus (ZIKV) poses a serious prenatal threat. STB cells are resistant to ZIKV infections, yet placental cells within the mesenchyme of chorionic villi are targets of ZIKV infection. We seek to determine whether ZIKV can open the paracellular pathway of STB cells. This route is regulated by tight junctions (TJs) which are present in the uppermost portion of the lateral membranes of STB cells. We analyzed the paracellular permeability and expression of E-cadherin, occludin, JAMs -B and -C, claudins -1, -3, -4, -5 and -7, and ZO-1, and ZO-2 in the STB of placentae from ZIKV-infected and non-infected women. In ZIKV-infected placentae, the pattern of expression of TJ proteins was preserved, but the amount of claudin-4 diminished. Placentae from ZIKV-infected women were permeable to ruthenium red, and had chorionic villi with a higher mean diameter and Hofbauer hyperplasia. Finally, ZIKV added to the basolateral surface of a trophoblast cell line reduced the transepithelial electrical resistance. These results suggest that ZIKV can open the paracellular pathway of STB cells.
C1 [Miranda, Jael; Martin-Tapia, Dolores; Alarcon, Lourdes; Gonzalez-Mariscal, Lorenza] Ctr Res & Adv Studies Cinvestav, Dept Physiol Biophys & Neurosci, Mexico City 07360, DF, Mexico.
   [Valdespino-Vazquez, Yolotzin; Espejel-Nunez, Aurora; Guzman-Huerta, Mario; Estrada-Gutierrez, Guadalupe] Inst Nacl Perinatol INPer Isidro Espinosa Reyes, Res Div, Mexico City 11000, DF, Mexico.
   [Esteban Munoz-Medina, Jose] Inst Mexicano Seguro Social, Lab Cent Epidemiol, Mexico City 02990, DF, Mexico.
   [Shibayama, Mineko; Chavez-Munguia, Bibiana; Ernesto Ludert, Juan] Ctr Res & Adv Studies Cinvestav, Dept Infect & Mol Pathogenesis, Mexico City 07360, DF, Mexico.
   [Lievano, Samuel] Mexican Inst Social Secur IMSS, Obstet & Gynecol Hosp 4, Qual Div, Mexico City 01090, DF, Mexico.
RP Gonzalez-Mariscal, L (corresponding author), Ctr Res & Adv Studies Cinvestav, Dept Physiol Biophys & Neurosci, Mexico City 07360, DF, Mexico.
EM jamiguz_316@hotmail.com; dolores@fisio.cinvestav.mx; yolotzin@gmail.com;
   lalarcon@fisio.cinvestav.mx; aurora_espnu@yahoo.com.mx;
   mguzmanhuerta@yahoo.com.mx; jose.munozm@imss.gob.mx;
   mineko@cinvestav.mx; bchavez@cinvestav.mx; gpestrad@gmail.com;
   samuel.lievano@yahoo.com.mx; jludert@cinvestav.mx;
   lorenza@fisio.cinvestav.mx
OI Munoz Medina, Jose Esteban/0000-0002-1289-4457; ESPEJEL NUNEZ,
   AURORA/0000-0001-9087-8017; Miranda, Jael/0000-0003-0122-5132
FU Mexican National Council of Science and Technology (Conacyt)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [C-623/2016]; ConacytConsejo
   Nacional de Ciencia y Tecnologia (CONACyT) [CB-254461, 262817]; Miguel
   Aleman Valdes Foundation; SEP-Cinvestav grant; INPer project
   [212250-1000-10107-01-16]; Mexiquense Council of Science and Technology
   (Comecyt) [2018AD0035-1]
FX This work was supported by grant C-623/2016 of the Mexican National
   Council of Science and Technology (Conacyt) to L.G-M., by grant
   CB-254461 of Conacyt to J.E.L.; by a grant from the Miguel Aleman Valdes
   Foundation to L.G-M.; by a SEP-Cinvestav grant to L.G-M. and by INPer
   project 212250-1000-10107-01-16. Jael Miranda was a recipient of a
   doctoral fellowship from Conacyt (262817) and the Mexiquense Council of
   Science and Technology (Comecyt, 2018AD0035-1).
CR Abdelhalim NY, 2018, ACTA HISTOCHEM, V120, P490, DOI 10.1016/j.acthis.2018.05.008
   Ahn C, 2015, STEROIDS, V100, P44, DOI 10.1016/j.steroids.2015.05.001
   Baktash Y, 2018, CELL HOST MICROBE, V23, P382, DOI 10.1016/j.chom.2018.02.005
   Bancher-Todesca D, 2001, HYPERTENS PREGNANCY, V20, P89
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benirschke K., 2006, PATHOLOGY HUMAN PLAC, P491
   Capaldo CT, 2014, MOL BIOL CELL, V25, P2710, DOI 10.1091/mbc.E14-02-0773
   Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871
   Castellucci M., 2006, PATHOLOGY HUMAN PLAC, P50, DOI [10.1007/0-387-26742-5_6., DOI 10.1007/0-387-26742-5_6]
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DEVIRGILIIS G, 1982, GYNECOL OBSTET INVES, V14, P263, DOI 10.1159/000299466
   Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654
   Fiala M, 1997, MOL MED, V3, P553, DOI 10.1007/BF03401701
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263
   Gonzalez-Mariscal L, 2011, METHODS MOL BIOL, V762, P213, DOI 10.1007/978-1-61779-185-7_15
   Gonzalez-Mariscal L, 2009, FRONT BIOSCI-LANDMRK, V14, P731, DOI 10.2741/3276
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107
   Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119
   Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215
   Leach L, 2000, PLACENTA, V21, P547, DOI 10.1053/plac.2000.0541
   Lievano S, 2006, CELL TISSUE RES, V324, P433, DOI 10.1007/s00441-005-0135-7
   Lu JH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001536
   Ortega-Olvera JM, 2018, TOXICOL APPL PHARM, V360, P257, DOI 10.1016/j.taap.2018.10.003
   Marozin S, 2004, J GEN VIROL, V85, P775, DOI 10.1099/vir.0.19530-0
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez-Pena AA, 2017, REPROD TOXICOL, V69, P106, DOI 10.1016/j.reprotox.2017.02.009
   Marzioni D, 2001, MOL HUM REPROD, V7, P279, DOI 10.1093/molehr/7.3.279
   Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07
   METZ J, 1979, ANAT EMBRYOL, V158, P41, DOI 10.1007/BF00315950
   MURPHY CR, 1981, CELL BIOPHYS, V3, P57, DOI 10.1007/BF02782153
   MURPHY CR, 1982, CELL TISSUE RES, V223, P281, DOI 10.1007/BF01258489
   Nava P, 2004, J CELL SCI, V117, P5509, DOI 10.1242/jcs.01425
   Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070
   Paria BC, 1999, DEV BIOL, V208, P488, DOI 10.1006/dbio.1999.9206
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Pidoux G, 2010, AM J PHYSIOL-CELL PH, V298, pC1517, DOI 10.1152/ajpcell.00484.2008
   Pirinen E, 2014, APMIS, V122, P530, DOI 10.1111/apm.12187
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Reyes L, 2017, RESULTS PROBL CELL D, V62, P45, DOI 10.1007/978-3-319-54090-0_3
   Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schelhaas M, 2003, J GEN VIROL, V84, P2473, DOI 10.1099/vir.0.19226-0
   Schumann S, 2015, HISTOCHEM CELL BIOL, V144, P571, DOI 10.1007/s00418-015-1361-z
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195
   Sufiawati I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088803
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008
   Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464
   Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003
   Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786
   Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1
   WANG T, 1987, ARCH GYNECOL OBSTET, V240, P211, DOI 10.1007/BF02134070
   Wang XH, 2004, J CELL SCI, V117, P53, DOI 10.1242/jcs.00826
   WHO, ZIKA VIRUS
   Xu JL, 2009, MOL BIOL CELL, V20, P4268, DOI 10.1091/mbc.E08-12-1236
   Xu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037886
   Zhang Yuan, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P125
   Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 67
TC 1
Z9 1
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD OCT
PY 2019
VL 8
IS 10
AR 1174
DI 10.3390/cells8101174
PG 21
WC Cell Biology
SC Cell Biology
GA JO1HP
UT WOS:000497336400063
PM 31569528
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de la Cruz-Ramos, JM
   Hernandez-Triana, LM
   Garcia-De la Pena, C
   Gonzalez-Alvarez, VH
   Weger-Lucarelli, J
   Siller-Rodriguez, QK
   Ramos, FJS
   Rodriguez, AD
   Ortega-Morales, AI
AF de la Cruz-Ramos, Josue M.
   Hernandez-Triana, Luis M.
   Garcia-De la Pena, Cristina
   Gonzalez-Alvarez, Vicente H.
   Weger-Lucarelli, James
   Karmy Siller-Rodriguez, Quetzaly
   Sanchez Ramos, Francisco J.
   Rodriguez, Americo D.
   Ortega-Morales, Aldo, I
TI Comparison of two DNA extraction methods from larvae, pupae, and adults
   of Aedes aegypti
SO HELIYON
LA English
DT Article
DE Microbiology; Genetics; Biochemistry; Molecular biology; Public health;
   Aedes aegypti; DNA extraction; Comparison; Chelex; CTAB
ID SOIL; PCR; AMPLIFICATION; MOSQUITOS
AB Mosquitoes are the most important arthropods from the point of view of public health, due to the fact that they can transmit a large number of pathogens which can cause diseases to humans and animals. Aedes aegypti (L.) is one of the most important vector species in the world, since it can transmit numerous pathogens such as dengue, Zika, and chikungunya. Therefore, studies involving the molecular aspects of this and other mosquitoes species are currently increasing. In this report, we describe the comparison between two DNA extraction techniques, Chelex and cetyltrimethylammonium bromide (CTAB), for carrying out DNA extraction in larvae, pupae and adult female of Ae. aegypti. The Chelex technique was superior in the amount and purity of DNA as compared to the CTAB technique in the three life stages we tested.
C1 [de la Cruz-Ramos, Josue M.; Sanchez Ramos, Francisco J.; Ortega-Morales, Aldo, I] Univ Autonoma Agr Antonio Narro, Unidad Laguna, Perifer & Carretera Santa Fe, Torreon 27084, Coahuila, Mexico.
   [de la Cruz-Ramos, Josue M.; Ortega-Morales, Aldo, I] Unidad Invest Entomol & Bioensayos Estado Durango, Perifer & Carretera Santa Fe, Torreon 27084, Coahuila, Mexico.
   [Hernandez-Triana, Luis M.] Anim & Plant Hlth Agcy, Virol Dept, Wildlife Zoonoses & Vector Borne Dis Res Grp, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
   [Garcia-De la Pena, Cristina; Karmy Siller-Rodriguez, Quetzaly] Univ Juarez Estado Durango, Fac Ciencias Biol, Av Univ, Gomez Palacio 35010, Durango, Mexico.
   [Gonzalez-Alvarez, Vicente H.] Univ Autonoma Guerrero, Fac Med Vet & Zootecnia, Ciajinicuilapa, Guerrero, Mexico.
   [Weger-Lucarelli, James] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
   [Rodriguez, Americo D.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.
RP Ortega-Morales, AI (corresponding author), Univ Autonoma Agr Antonio Narro, Unidad Laguna, Perifer & Carretera Santa Fe, Torreon 27084, Coahuila, Mexico.; Ortega-Morales, AI (corresponding author), Unidad Invest Entomol & Bioensayos Estado Durango, Perifer & Carretera Santa Fe, Torreon 27084, Coahuila, Mexico.
EM agrortega@hotmail.com
OI Siller, Quetzaly Karmy/0000-0003-2305-4856
FU Department for Environment Food and Rural Affair (DEFRA), Scottish
   Government [SV3045, SE4113]; Department for Environment Food and Rural
   Affair (DEFRA), Welsh Government [SV3045, SE4113]; EUEuropean Union (EU)
   [653316]
FX Luis M Hernandez-Triana would like to thank the Department for
   Environment Food and Rural Affairs (DEFRA), Scottish Government and
   Welsh Government through grants SV3045, and SE4113, and the EU Framework
   Horizon 2020 Innovation Grant, European Virus Archive (EVAg, grant no.
   653316) for funding.
CR Albers CN, 2013, GEOMICROBIOL J, V30, P675, DOI 10.1080/01490451.2012.758193
   Asghar U, 2015, ADV ENTOMOL, V3, P132, DOI DOI 10.4236/ae.2015.34016
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Casquet J, 2012, MOL ECOL RESOUR, V12, P136, DOI 10.1111/j.1755-0998.2011.03073.x
   CHANTEAU S, 1994, T ROY SOC TROP MED H, V88, P665, DOI 10.1016/0035-9203(94)90219-4
   Chen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011963
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x
   Dai ZM, 2017, SOIL BIOL BIOCHEM, V115, P129, DOI 10.1016/j.soilbio.2017.08.016
   DE ARMAS R YAXSIER, 2005, Rev. Colomb. Entomol., V31, P203
   Desloire S, 2006, VET RES, V37, P725, DOI 10.1051/vetres:2006031
   Fitzpatrick KA, 2010, APPL ENVIRON MICROB, V76, P4571, DOI 10.1128/AEM.02825-09
   Gould EM, 2011, APIDOLOGIE, V42, P721, DOI 10.1007/s13592-011-0077-x
   Gupta Shivani, 2012, Annals of Biological Research, V3, P1553
   Gutierrez-Lopez R, 2015, J VECTOR ECOL, V40, P11, DOI 10.1111/jvec.12127
   Haruyama N, 2008, SYST ENTOMOL, V33, P275, DOI 10.1111/j.1365-3113.2008.00418.x
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025
   Hernandez-Triana LM, 2019, ZOOKEYS, P57, DOI 10.3897/zookeys.832.32257
   Hernandez-Triana LM, 2012, ZOOTAXA, P43
   Ip SCY, 2015, SCI JUSTICE, V55, P200, DOI 10.1016/j.scijus.2015.01.005
   Irfan M, 2013, RES J BIOTECHNOL, V8, P41
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Kamgang B., 2018, WELLCOME OPEN RES, V3, P1
   KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196
   Manuahe Caroline, 2016, Journal of Entomology and Zoology Studies, V4, P498
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Musapa M, 2013, JOVE-J VIS EXP, DOI 10.3791/3281
   Neiman C.C., 2016, F1000 RES, V4, P1314
   Ridgeway J.A., 2014, J INSECT SCI, V1, P1, DOI [10.1093/jis/14.1.1, DOI 10.1093/JIS/14.1.1]
   Rivero Jose, 2004, International Journal of Tropical Insect Science, V24, P266, DOI 10.1079/IJT200430
   Roldan S., 2013, BIOMEDICA, V33, P203
   Sagar K, 2014, J MICROBIOL METH, V97, P68, DOI 10.1016/j.mimet.2013.11.008
   Sahu Sunil Kumar, 2012, ISRN Mol Biol, V2012, P205049, DOI 10.5402/2012/205049
   Sarma D.K., 2014, International Journal of Mosquito Research, V1, P15
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8
   Spitaleri S., 2006, INT C SER, V1288, P574, DOI DOI 10.1016/J.ICS.2005.11.055
   Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275
   Wang Q, 2012, PAK J ZOOL, V44, P421
   Zar J. H., 1999, BIOSTATISTICAL ANAL
NR 39
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD OCT
PY 2019
VL 5
IS 10
AR e02660
DI 10.1016/j.heliyon.2019.e02660
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JK1XQ
UT WOS:000494641300054
PM 31692696
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Smythe, T
   Duttine, A
   Vieira, ACD
   de Castro, BDM
   Kuper, H
AF Smythe, Tracey
   Duttine, Antony
   Vieira, Ana Carolina Dias
   de Castro, Barbara da Silveira Madeira
   Kuper, Hannah
TI Engagement of Fathers in Parent Group Interventions for Children with
   Congenital Zika Syndrome: A Qualitative Study
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Zika; disability; parent support; low and middle income; father
   engagement
ID ENGAGING FATHERS; DISABILITIES; INVOLVEMENT; SUPPORT; CARERS
AB We aimed to explore the engagement of fathers in a community-based group intervention (Juntos) for children with congenital Zika syndrome (CZS) and their caregivers in Brazil. Six Juntos groups were facilitated from August 2017 to May 2018. We conducted a qualitative study to evaluate the feasibility and acceptability of the intervention for fathers of children with CZS. Methods included participant observation, focus group discussions, and semi-structured interviews of fathers with a child enrolled in the program. Data collected were transcribed, coded and thematically analyzed to explore father preference for, and beliefs about the intervention and to assess potential barriers and enablers to their involvement. Forty-nine families (61 participants) enrolled, of whom 20% (12/61) were fathers. Seven (58%) fathers attended more than 7 out of 10 sessions. The content of Juntos was found to be acceptable to those fathers who attended. Participation in the group offered fathers the opportunity to share experiences of caring for their child and demonstrate their importance as care agents. Work commitments, and the view of mothers as primary caregivers were barriers to engagement of fathers. Facilitators to engagement included a presentation of clear objectives for fathers' involvement and the opportunity to learn a practical skill related to caring for their child. A better understanding of the perspectives of fathers is crucial to help increase their involvement in parenting interventions.
C1 [Smythe, Tracey; Duttine, Antony; Kuper, Hannah] London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Vieira, Ana Carolina Dias] Pontificia Univ Catolica Rio de Janeiro, BR-22451900 Rio De Janeiro, Brazil.
   [de Castro, Barbara da Silveira Madeira] Inst Fernandes Figueira Fiocruz, BR-20021140 Rio De Janeiro, Brazil.
RP Smythe, T (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.
EM tracey.smythe@lshtm.ac.uk; antony.duttine@lshtm.ac.uk;
   anadiasvieira@yahoo.com.br; barbarasmcastro@gmail.com;
   hannah.kuper@lshtm.ac.uk
RI ; Smythe, Tracey/N-7699-2017
OI Dias Vieira, Ana Carolina/0000-0002-3649-5696; Smythe,
   Tracey/0000-0003-3408-7362; da Silveira Madeira de Castro,
   Barbara/0000-0003-3185-3703
FU Wellcome; Department for International Development [206719/Z/17/Z]
FX The development and testing of the intervention for children with
   Congenital Zika Syndrome were supported by a grant from Wellcome and the
   Department for International Development (grant code 206719/Z/17/Z).
CR Amato V, 2018, J HUM BEHAV SOC ENVI, V28, P466, DOI 10.1080/10911359.2018.1426071
   Axford N, 2012, CHILD YOUTH SERV REV, V34, P2061, DOI 10.1016/j.childyouth.2012.06.011
   Bagner DM, 2013, J FAM PSYCHOL, V27, P650, DOI 10.1037/a0033465
   Bayley Julie, 2009, Community Pract, V82, P28
   Berlyn C, 2008, FAMILY MATTERS, P37
   Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Davys D, 2017, J INTELLECT DISABILI, V21, P175, DOI 10.1177/1744629516650129
   Duttine Antony, 2019, Wellcome Open Res, V4, P80, DOI 10.12688/wellcomeopenres.15085.1
   Feinberg ME, 2008, J FAM PSYCHOL, V22, P253, DOI 10.1037/0893-3200.22.2.253
   Flippin M, 2011, J EARLY INTERVENTION, V33, P24, DOI 10.1177/1053815111400415
   Glynn L, 2015, AOTEAROA N Z SOC WOR, V27, P59
   Gona JK, 2011, CHILD CARE HLTH DEV, V37, P175, DOI 10.1111/j.1365-2214.2010.01124.x
   Hartley S, 2005, CHILD CARE HLTH DEV, V31, P167, DOI 10.1111/j.1365-2214.2004.00464.x
   Kilburn JE, 2020, TOP EARLY CHILD SPEC, V39, P250, DOI 10.1177/0271121418767306
   Kuper H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030514
   Lindsay G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-962
   Lundahl BW, 2008, RES SOCIAL WORK PRAC, V18, P97, DOI 10.1177/1049731507309828
   Mobarak R, 2000, J PEDIATR PSYCHOL, V25, P427, DOI 10.1093/jpepsy/25.6.427
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nakamanya S, 2015, DISABIL REHABIL, V37, P1470, DOI 10.3109/09638288.2014.972582
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Salinas A, 2011, J PEDIATR NURS, V26, P304, DOI 10.1016/j.pedn.2010.01.008
   Santis Ligia de, 2017, Trends Psychol., V25, P941, DOI 10.9788/tp2017.3-03pt
   Scherer N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219888
   Thackeray LA, 2018, J APPL RES INTELLECT, V31, P179, DOI 10.1111/jar.12313
   Tokhi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191620
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Tully LA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4426-1
   Vanegas SB, 2016, J FAM SOC WORK, V19, P286, DOI 10.1080/10522158.2016.1218399
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   WHO, 2011, 1474547X WHO WORLD B
   Zuurmond M., 2016, EVALUATING IMPACT CO
   Zuurmond MA, 2015, DISABILITY CBR INCLU, V26, P5
   Zuurmond M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202096
NR 35
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2019
VL 16
IS 20
AR 3862
DI 10.3390/ijerph16203862
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA JK3XV
UT WOS:000494779100076
PM 31614765
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Nguyen, HC
   Park, H
   Shin, HJ
   Nguyen, NM
   Nguyen, ATV
   Trinh, TTT
   Duong, THY
   Tuong, HT
   Hoang, VT
   Seo, GE
   Sohn, HJ
   Yeo, SJ
AF Huu Chien Nguyen
   Park, Hyun
   Shin, Ho-Joon
   Ngoc Minh Nguyen
   Anh Thi Viet Nguyen
   Thuy-Tien Thi Trinh
   Thi Hai Yen Duong
   Hien Thi Tuong
   Vui Thi Hoang
   Seo, Ga-Eun
   Sohn, Hae-Jin
   Yeo, Seon-Ju
TI Fluorescent Immunosorbent Assay for Chikungunya Virus Detection
SO INTERVIROLOGY
LA English
DT Article
DE Chikungunya virus; Envelope 1 antigen; Monoclonal antibody;
   Coumarin-derived dendrimer
ID MONOCLONAL-ANTIBODIES; E2; EPIDEMIC; RISK; QUANTIFICATION; PROTEIN;
   EPITOPE; FEVER; ZIKA; E1
AB Background: When infected with the chikungunya virus (CHIKV), 3% to 28% of CHIKV-infected individuals remain asymptomatic, necessitating the development of improved high-throughput screening methods to overcome the limitations of molecular diagnostics or enzyme-linked immunosorbent assays (ELISAs). Objective: In this study, two novel monoclonal antibodies (mAbs) targeting envelope 1 (E1) of CHIKV were developed and applied in a fluorescence-linked immunosorbent assay (FLISA) using coumarin-derived dendrimer as the fluorophore. Methods: The performance of the FLISA was compared with that of ELISA. Results: Using the two novel mAbs (2B5 and 2C8), FLISA could detect 1 x 10(5) PFU/mL of CHIKV, exhibiting a 2-fold lower limit of detection (LOD) compared to ELISA. The LOD of FICT corresponded to a comparative threshold value of 23.95 and 4 x 10(6) of RNA copy number/mu L. In the presence of human sera and blood, virus detection by FLISA was 3-fold better than ELISA, with an LOD of 2 x 10(5) PFU/mL. Sera and blood interfered with the ELISA, resulting in 6 x 10(5) PFU/mL as the LOD. Conclusions: FLISA using two novel mAbs and coumarin-derived dendrimer is a superior diagnostic assay for detecting CHIKV in human sera and blood, compared to conventional ELISA.
C1 [Huu Chien Nguyen; Park, Hyun; Ngoc Minh Nguyen; Anh Thi Viet Nguyen; Thuy-Tien Thi Trinh; Thi Hai Yen Duong; Hien Thi Tuong; Vui Thi Hoang; Yeo, Seon-Ju] Wonkwang Univ, Sch Med, Dept Infect Biol, Zoonosis Res Ctr, 460 Iksan Daero, Iksan 54538, South Korea.
   [Shin, Ho-Joon; Seo, Ga-Eun; Sohn, Hae-Jin] Ajou Univ, Sch Med, Dept Microbiol, Suwon, South Korea.
RP Yeo, SJ (corresponding author), Wonkwang Univ, Sch Med, Dept Infect Biol, Zoonosis Res Ctr, 460 Iksan Daero, Iksan 54538, South Korea.
EM yeosj@wku.ac.kr
FU Priority Research Centers Program through the National Research
   Foundation of Korea (NRF) - Ministry of Education
   [NRF2015R1A6A1A03032236]
FX This research was supported by the Priority Research Centers Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education (NRF2015R1A6A1A03032236).
CR Appassakij H, 2014, TRANSFUSION, V54, P1945, DOI 10.1111/trf.12575
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Cho B, 2008, YONSEI MED J, V49, P828, DOI 10.3349/ymj.2008.49.5.828
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Chua CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171989
   Cross AR, 2017, INFECT DIS TESTING
   Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-108
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005
   Hundekar SL, 2002, INDIAN J MED RES, V115, P144
   Kaur P, 2016, METHODS MOL BIOL, V1426, P93, DOI 10.1007/978-1-4939-3618-2_9
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Lam S, 2015, MABS-AUSTIN, V7, P1178, DOI 10.1080/19420862.2015.1083664
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Petersen LR, 2014, TRANSFUSION, V54, P1911, DOI 10.1111/trf.12790
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Rohani A., 2005, Tropical Biomedicine, V22, P149
   Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Snyder AJ, 2012, J VIROL, V86, P13609, DOI 10.1128/JVI.01805-12
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Wang SM, 2016, METHODS MOL BIOL, V1426, P105, DOI 10.1007/978-1-4939-3618-2_10
   World Health Organization, 2017, CHIK
   Yathi KK, 2011, J IMMUNOL METHODS, V372, P171, DOI 10.1016/j.jim.2011.07.011
   Yeo SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08328-9
   Yeo SJ, 2017, BIOSENS BIOELECTRON, V94, P677, DOI 10.1016/j.bios.2017.03.068
   Yeo SJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-266
   Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025
NR 33
TC 0
Z9 0
U1 6
U2 7
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PD OCT
PY 2019
VL 62
IS 3-4
BP 145
EP 155
DI 10.1159/000502823
PG 11
WC Virology
SC Virology
GA JC3AF
UT WOS:000489148100006
PM 31533104
DA 2020-07-08
ER

PT J
AU Haddad, JG
   Picard, M
   Benard, S
   Desvignes, C
   Despres, P
   Diotel, N
   El Kalamouni, C
AF Haddad, Juliano G.
   Picard, Morgane
   Benard, Sebastien
   Desvignes, Claire
   Despres, Philippe
   Diotel, Nicolas
   El Kalamouni, Chaker
TI Ayapana triplinervis Essential Oil and Its Main Component
   Thymohydroquinone Dimethyl Ether Inhibit Zika Virus at Doses Devoid of
   Toxicity in Zebrafish
SO MOLECULES
LA English
DT Article
DE Ayapana triplinervis; Zika virus; essential oil; antiviral activity;
   zebrafish; medicinal plant
ID MEDICINAL-PLANTS; CELLS; VAHL; THYMOQUINONE; INFECTION; DISEASES;
   GENOME; ISLAND; ENTRY
AB Zika virus (ZIKV) is an emerging mosquito-borne virus of medical concern. ZIKV infection may represent a serious disease, causing neonatal microcephaly and neurological disorders. Nowadays, there is no approved antiviral against ZIKV. Several indigenous or endemic medicinal plants from Mascarene archipelago in Indian Ocean have been found able to inhibit ZIKV infection. The purpose of our study was to determine whether essential oil (EO) from Reunion Island medicinal plant Ayapana triplinervis, whose thymohydroquinone dimethyl ether (THQ) is the main component has the potential to prevent ZIKV infection in human cells. Virological assays were performed on human epithelial A549 cells infected with either GFP reporter ZIKV or epidemic viral strain. Zebrafish assay was employed to evaluate the acute toxicity of THQ in vivo. We showed that both EO and THQ inhibit ZIKV infection in human cells with IC50 values of 38 and 45 mu g/mL, respectively. At the noncytotoxic concentrations, EO and THQ reduced virus progeny production by 3-log. Time-of-drug-addition assays revealed that THQ could act as viral entry inhibitor. At the antiviral effective concentration, THQ injection in zebrafish does not lead to any signs of stress and does not impact fish survival, demonstrating the absence of acute toxicity for THQ. From our data, we propose that THQ is a new potent antiviral phytocompound against ZIKV, supporting the potential use of medicinal plants from Reunion Island as a source of natural and safe antiviral substances against medically important mosquito-borne viruses.
C1 [Haddad, Juliano G.; Picard, Morgane; Despres, Philippe; El Kalamouni, Chaker] Univ Reun, Unite Mixte Processus Infect Milieu Insulaire Tro, Plateforme Technol CYROI, INSERM U1187,CNRS UMR 9192,IRD UMR 249, F-94791 St Clotilde, La Reunion, France.
   [Benard, Sebastien] Plateforme Rech CYROI, 2 Rue Maxime Riviere, F-97490 St Clotilde, La Reunion, France.
   [Desvignes, Claire] SAS REUNION ECOEX, 2 Rue Maxime Riviere, F-97490 St Clotilde, La Reunion, France.
   [Diotel, Nicolas] Univ La Reunion, INSERM, UMR 1188, Diabete Atherothrombose Therapies Reunion Ocean I, F-97490 St Denis, Reunion, France.
RP El Kalamouni, C (corresponding author), Univ Reun, Unite Mixte Processus Infect Milieu Insulaire Tro, Plateforme Technol CYROI, INSERM U1187,CNRS UMR 9192,IRD UMR 249, F-94791 St Clotilde, La Reunion, France.; Diotel, N (corresponding author), Univ La Reunion, INSERM, UMR 1188, Diabete Atherothrombose Therapies Reunion Ocean I, F-97490 St Denis, Reunion, France.
EM juliano.haddad@univ-reunion.fr; picard.morgane.noelie@gmail.com;
   s.benard@cyroi.fr; claire.desvignes@reunionecoex.fr;
   philippe.despres@univ-reunion.fr; nicolas.diotel@univ-reunion.fr;
   chaker.el-kalamouni@univ-reunion.fr
FU POE FEDER 2014-20 of the Conseil Regional de La Reunion (ZIKAlert
   program) [SYNERGIE: RE00001902]; Research Federation BioST (ZIKAYA),
   Universite de La Reunion; ZIKAlert program
FX This research was funded by POE FEDER 2014-20 of the Conseil Regional de
   La Reunion (ZIKAlert program, No SYNERGIE: RE00001902) and Research
   Federation BioST (ZIKAYA), Universite de La Reunion. J.-G.H. received
   funding from the ZIKAlert program.
CR ADAMS RP, 2001, IDENTIFICATION ESSEN
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cheriyan BV, 2017, PHARMACOGN MAG, V13, P81, DOI 10.4103/0973-1296.197650
   Clain E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081860
   Clain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29183-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Ferraris P, 2019, MICROBES INFECT, V21, P353, DOI 10.1016/j.micinf.2019.04.005
   Frumence E, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030066
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Gauvin-Bialecki A, 2008, BIOCHEM SYST ECOL, V36, P853, DOI 10.1016/j.bse.2008.09.006
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gupta D, 2004, J ESSENT OIL RES, V16, P473, DOI 10.1080/10412905.2004.9698774
   Gupta M, 2002, FITOTERAPIA, V73, P168, DOI 10.1016/S0367-326X(02)00007-2
   Haddad JG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102382
   Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110
   Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111
   Jonville MC, 2011, J ETHNOPHARMACOL, V136, P525, DOI 10.1016/j.jep.2010.06.013
   Joshi RK, 2013, J ETHNOPHARMACOL, V145, P621, DOI 10.1016/j.jep.2012.11.045
   Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063
   Lee JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051101
   Maia JGS, 2002, BIOCHEM SYST ECOL, V30, P1071, DOI 10.1016/S0305-1978(02)00059-5
   Lopes TRM, 2015, PHARM BIOL, V53, P897, DOI 10.3109/13880209.2014.948634
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo AS, 2013, J ETHNOPHARMACOL, V147, P293, DOI 10.1016/j.jep.2013.03.002
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Owolabi MS, 2010, NAT PROD COMMUN, V5, P1135
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Samoisy AK, 2016, J ETHNOPHARMACOL, V194, P803, DOI 10.1016/j.jep.2016.10.041
   Samoisy AK, 2015, J ETHNOPHARMACOL, V173, P20, DOI 10.1016/j.jep.2015.06.036
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Tang TL, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040523
   Tariq S, 2019, MICROB PATHOGENESIS, V134, DOI 10.1016/j.micpath.2019.103580
   TRANG NTD, 1993, PLANTA MED, V59, P99, DOI 10.1055/s-2006-959619
   Unnikrishnan PK, 2014, J ESSENT OIL BEAR PL, V17, P652, DOI 10.1080/0972060X.2014.914000
   Williams CH, 2011, INT J MOL SCI, V12, P2262, DOI 10.3390/ijms12042262
   Youssouf L, 2019, CARBOHYD POLYM, V217, P35, DOI 10.1016/j.carbpol.2019.04.014
   Zhou YM, 2019, ENVIRON TOXICOL PHAR, V69, P80, DOI 10.1016/j.etap.2019.04.003
NR 47
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD OCT
PY 2019
VL 24
IS 19
AR 3447
DI 10.3390/molecules24193447
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA JM5GK
UT WOS:000496242300032
PM 31547527
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Almeida, KJ
   Martins, ACB
   Almendra, ICCGE
   de Meneses, GMS
   Sampaio, TDD
   Campelo, LDM
   Bor-Seng-Shu, E
AF Almeida, Kelson James
   Beserra Martins, Augusto Cesar
   Gayoso e Almendra, Isadora Costa Coelho
   Sobreira de Meneses, Gabriel Medina
   de Oliveira Sampaio, Tholes Daniel
   Moura Campelo, Lose do Cruz
   Bor-Seng-Shu, Edson
TI Clinical aspects of congenital microcephaly syndrome by Zika virus in a
   rehabilitation center for patients with microcephaly
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE Microcephaly; Zika virus; Epilepsy; Deglutition disorders
AB OBJECTIVE: In this study, we intend to identify the prevalence of clinical variables in children with microcephaly.
   METHODS: This is a cross-sectional and observational study with data collected from medical records of patients admitted to the microcephaly outpatient clinic of a referral center in Teresina-PI. Demographic (gender and age) and clinical data (presence of epilepsy, dysphagia, irritability, and associated comorbidities)were collected. The frequency of Zika virus as a probable etiology was determined from computed tomography patterns and the exclusion of other etiologies by serological tests.
   RESULTS: A total of 67 patient records were evaluated, of which 31 were male and 36 were female, with a mean age of 1 year and 10 months. The most prevalent clinical variables were epilepsy, present in 47 children (70.2%), and irritability in 37 (55.2%). Also with a high frequency, 22 had dysphagia (32.8%), and 13 had musculoskeletal comorbidities (19.4%). Only three patients in the sample had cardiac abnormalities (4.5%), and no endocrine comorbidity was found. A total of 38 children in the sample (56.7%) presented ZIKV as a probable etiology and, in these cases, there was a higher frequency of epilepsy and dysphagia compared to other etiologies, although not statistically significant.
   CONCLUSION: Epilepsy, irritability, dysphagia, and musculoskeletal comorbidities were the most frequent clinical variables in children with microcephaly. There was a high prevalence of congenital ZIKV microcephaly syndrome in this sample.
C1 [Almeida, Kelson James] Ctr Integrad Reabilitacao, Teresina, Piaui, Brazil.
   [Almeida, Kelson James; Beserra Martins, Augusto Cesar; Gayoso e Almendra, Isadora Costa Coelho; de Oliveira Sampaio, Tholes Daniel] Escola Med, Facid Wyden, Fac Integral Diferencial, Teresina, Piaui, Brazil.
   [Almeida, Kelson James; Bor-Seng-Shu, Edson] Univ Sao Paulo, Dept Neurol, Sao Paulo, SP, Brazil.
   [Sobreira de Meneses, Gabriel Medina] Univ Fed Piaui, Teresina, Piaui, Brazil.
   [Moura Campelo, Lose do Cruz] Ctr Univ Uninovafapi, Teresina, Piaui, Brazil.
RP Sampaio, TDD (corresponding author), Rua Vet Bugyja Brito,1354 Horto, BR-64049410 Teresina, PI, Brazil.
EM kelsonj@gmail.com
RI BOR-SENG-SHU, EDSON/H-7784-2013
OI BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Moura Campelo, Jose da
   Cruz/0000-0002-9371-0129
CR Almeida IMLM, 2018, J PEDIAT RIO J
   Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   Brasil. Ministerio da Saude, 2017, OR INT VIG AT SAUD A
   Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Watemberg N, 2002, J CHILD NEUROL, V17, P117, DOI 10.1177/088307380201700205
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD OCT
PY 2019
VL 65
IS 10
BP 1249
EP 1253
DI 10.1590/1806-9282.65.10.1249
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA JM0FD
UT WOS:000495898900005
PM 31721956
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Arora, K
   Natekar, J
   Rothan, H
   Kumar, M
AF Arora, Komal
   Natekar, Janhavi
   Rothan, Hussin
   Kumar, Mukesh
TI MicroRNA regulation of Zika virus Infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT 16th International Symposium on NeuroVirology
CY NOV 12-16, 2019
CL Atlanta, GA
C1 [Arora, Komal; Natekar, Janhavi; Rothan, Hussin; Kumar, Mukesh] Georgia State Univ, Atlanta, GA 30303 USA.
EM mkumar8@gsu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2019
VL 25
IS SUPPL 1
SU 1
MA P4
BP S2
EP S2
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA JL8MZ
UT WOS:000495782800005
DA 2020-07-08
ER

PT J
AU Donadoni, M
   Ozdener, MH
   Cicalese, S
   Spielman, A
   Garcia-Blanco, A
   Gordon, J
   Sariyer, IK
AF Donadoni, Martina
   Ozdener, Mehmet Hakan
   Cicalese, Stephanie
   Spielman, Andrew
   Garcia-Blanco, Alvaro
   Gordon, Jennifer
   Sariyer, Ilker Kudret
TI Zika Virus Infection in Chemosensory Cells
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT 16th International Symposium on NeuroVirology
CY NOV 12-16, 2019
CL Atlanta, GA
C1 [Donadoni, Martina; Cicalese, Stephanie; Gordon, Jennifer; Sariyer, Ilker Kudret] Temple Univ, Dept Neurosci, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
   [Donadoni, Martina; Cicalese, Stephanie; Gordon, Jennifer; Sariyer, Ilker Kudret] Temple Univ, Ctr Neurovirol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
   [Ozdener, Mehmet Hakan; Garcia-Blanco, Alvaro] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.
   [Spielman, Andrew] NYU, Coll Dent, New York, NY 10003 USA.
EM tug36939@temple.edu
RI Sariyer, Ilker/AAE-7677-2020
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2019
VL 25
IS SUPPL 1
SU 1
MA P40
BP S13
EP S13
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA JL8MZ
UT WOS:000495782800041
DA 2020-07-08
ER

PT J
AU Jimenez, O
   Narasipura, S
   Barbian, H
   Al-Harthi, L
AF Jimenez, Oscar
   Narasipura, Srinivas
   Barbian, Hannah
   Al-Harthi, Lena
TI Beta-catenin inhibits ZIKV early infection of Human Fetal Astrocytes
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT 16th International Symposium on NeuroVirology
CY NOV 12-16, 2019
CL Atlanta, GA
C1 [Jimenez, Oscar; Narasipura, Srinivas; Barbian, Hannah; Al-Harthi, Lena] Rush Univ, Coll Med, Dept Microbial Pathogens & Immun, Chicago, IL 60612 USA.
EM oscar_a_jimenez@rush.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2019
VL 25
IS SUPPL 1
SU 1
MA P58
BP S18
EP S18
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA JL8MZ
UT WOS:000495782800059
DA 2020-07-08
ER

PT J
AU Sariyer, I
   Gordon, J
   Burdo, T
   Wollebo, H
   Gianti, E
   Donadoni, M
   Bellizzi, A
   Cicalese, S
   Loomis, R
   Robinson, J
   Carnevale, V
   Steiner, J
   Ozdener, M
   Miller, A
   Amini, S
   Klain, M
   Khalili, K
AF Sariyer, Ilker
   Gordon, Jennifer
   Burdo, Tricia
   Wollebo, Hassen
   Gianti, Eleonora
   Donadoni, Martina
   Bellizzi, Anna
   Cicalese, Stephanie
   Loomis, Regina
   Robinson, Jake
   Carnevale, Vincenzo
   Steiner, Joseph
   Ozdener, Mehmet
   Miller, Andrew
   Amini, Shohreh
   Klain, Michael
   Khalili, Kamel
TI Suppression of Zika virus infection in brain by the antiretroviral drug,
   rilpivirine
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT 16th International Symposium on NeuroVirology
CY NOV 12-16, 2019
CL Atlanta, GA
C1 [Sariyer, Ilker; Gordon, Jennifer; Burdo, Tricia; Wollebo, Hassen; Donadoni, Martina; Bellizzi, Anna; Cicalese, Stephanie; Loomis, Regina; Robinson, Jake; Amini, Shohreh; Khalili, Kamel] Temple Univ, Dept Neurosci, Ctr Neurovirol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
   [Gianti, Eleonora; Carnevale, Vincenzo; Klain, Michael] Temple Univ, Dept Chem, Inst Computat Mol Sci, Coll Sci & Technol, Philadelphia, PA 19122 USA.
   [Steiner, Joseph] NINDS, Translat Neurosci Ctr, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Ozdener, Mehmet] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.
   [Miller, Andrew] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA.
EM isariyer@temple.edu
RI Sariyer, Ilker/AAE-7677-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2019
VL 25
IS SUPPL 1
SU 1
MA P127
BP S39
EP S39
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA JL8MZ
UT WOS:000495782800128
DA 2020-07-08
ER

PT J
AU Steiner, J
   Bachani, M
   Malik, N
   Li, WX
   Solis, J
   Abrams, R
   Sampson, K
   Tyagi, R
   Lee, MH
   Nath, A
AF Steiner, Joseph
   Bachani, Muzna
   Malik, Nasir
   Li, Wenxue
   Solis, Jamie
   Abrams, Rachel
   Sampson, Kevon
   Tyagi, Richa
   Lee, Myoung-Hwa
   Nath, Avindra
TI Zika envelope protein causes toxicity to human neural stem cells and
   neuronal cultures via GSK3beta
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT 16th International Symposium on NeuroVirology
CY NOV 12-16, 2019
CL Atlanta, GA
C1 [Steiner, Joseph; Bachani, Muzna; Malik, Nasir] NINDS, Translat Neurosci Ctr, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Li, Wenxue; Solis, Jamie; Abrams, Rachel; Sampson, Kevon; Tyagi, Richa; Lee, Myoung-Hwa; Nath, Avindra] NINDS, Sect Infect Nervous Syst, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
EM joe.steiner@nih.gov
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2019
VL 25
IS SUPPL 1
SU 1
MA P133
BP S41
EP S41
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA JL8MZ
UT WOS:000495782800134
DA 2020-07-08
ER

PT J
AU Stone, S
   Azouz, F
   Vuong, C
   Nakano, E
   Nerurkar, V
   Kumar, M
AF Stone, Shannon
   Azouz, Francine
   Vuong, Cindy
   Nakano, Eileen
   Nerurkar, Vivek
   Kumar, Mukesh
TI Congenital Zika Syndrome in Guinea Pigs
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT 16th International Symposium on NeuroVirology
CY NOV 12-16, 2019
CL Atlanta, GA
C1 [Stone, Shannon; Kumar, Mukesh] Georgia State Univ, Coll Arts & Sci, Dept Biol, Atlanta, GA 30303 USA.
   [Azouz, Francine; Vuong, Cindy; Nakano, Eileen; Nerurkar, Vivek] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
EM sstone12@student.gsu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2019
VL 25
IS SUPPL 1
SU 1
MA P135
BP S41
EP S42
PG 2
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA JL8MZ
UT WOS:000495782800136
DA 2020-07-08
ER

PT J
AU Montero, SB
   Gabrieli, P
   Severini, F
   Picci, L
   Di Luca, M
   Forneris, F
   Facchinelli, L
   Ponzi, M
   Lombardo, F
   Arca, B
AF Buezo Montero, Sara
   Gabrieli, Paolo
   Severini, Francesco
   Picci, Leonardo
   Di Luca, Marco
   Forneris, Federico
   Facchinelli, Luca
   Ponzi, Marta
   Lombardo, Fabrizio
   Arca, Bruno
TI Analysis in a murine model points to IgG responses against the 34k2
   salivary proteins from Aedes albopictus and Aedes aegypti as novel
   promising candidate markers of host exposure to Aedes mosquitoes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HUMAN-ANTIBODY RESPONSE; B-CELL EPITOPES; ANOPHELES-GAMBIAE; PREDICTION;
   INFECTION; ANTIGENS; INSIGHT; TRANSMISSION; BIOMARKER; EPIDEMIC
AB Background
   Aedes mosquitoes are vectors of arboviral diseases of great relevance for public health. The recent outbreaks of dengue, Zika, chikungunya and the rapid worldwide spreading of Aedes albopictus emphasize the need for improvement of vector surveillance and control. Host antibody response to mosquito salivary antigens is emerging as a relevant additional tool to directly assess vector-host contact, monitor efficacy of control interventions and evaluate risk of arboviral transmission.
   Methodology/principal findings
   Groups of four BALB/c mice were immunized by exposure to bites of either Aedes albopictus or Aedes aegypti. The 34k2 salivary proteins from Ae. albopictus (al34k2) and Ae. aegypti (ae34k2) were expressed in recombinant form and Ae. albopictus salivary peptides were designed through B-cell epitopes prediction software. IgG responses to salivary gland extracts, peptides, al34k2 and ae34k2 were measured in exposed mice. Both al34k2 and ae34k2, with some individual and antigen-specific variation, elicited a clearly detectable antibody response in immunized mice. Remarkably, the two orthologous proteins showed very low level of immune cross-reactivity, suggesting they may eventually be developed as species-specific markers of host exposure. The al34k2 immunogenicity and the limited immune cross-reactivity to ae34k2 were confirmed in a single human donor hyperimmune to Ae. albopictus saliva.
   Conclusions/significance
   Our study shows that exposure to bites of Ae. albopictus or Ae. aegypti evokes in mice species-specific IgG responses to al34k2 or ae34k2, respectively. Deeper understanding of duration of antibody response and validation in natural conditions of human exposure to Aedes mosquitoes are certainly needed. However, our findings point to the al34k2 salivary protein as a promising potential candidate for the development of immunoassays to evaluate human exposure to Ae. albopictus. This would be a step forward in the establishment of a serological toolbox for the simultaneous assessment of human exposure to Aedes vectors and the pathogens they transmit.
C1 [Buezo Montero, Sara; Lombardo, Fabrizio; Arca, Bruno] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Gabrieli, Paolo; Forneris, Federico] Univ Pavia, Dept Biol & Biotechnol L Spallanzani, Pavia, Italy.
   [Severini, Francesco; Picci, Leonardo; Di Luca, Marco; Ponzi, Marta] Ist Super Sanita, Dept Infect Dis, Rome, Italy.
   [Facchinelli, Luca] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.
   [Gabrieli, Paolo] Univ Milan, Dept Biosci, Milan, Italy.
RP Arca, B (corresponding author), Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.
EM bruno.arca@uniroma1.it
RI Forneris, Federico/AAL-5361-2020; Arca, Bruno/C-8383-2012; Gabrieli,
   Paolo/A-3206-2016
OI Forneris, Federico/0000-0002-7818-1804; Arca, Bruno/0000-0002-4029-0984;
   Facchinelli, Luca/0000-0002-8987-1472; Gabrieli,
   Paolo/0000-0002-4996-2468
FU Regione Lazio [FILAS-RU-2014-1034]; European Union (Infravec)European
   Union (EU) [FP7 228421]; Italian Ministry of University and Research
   (MIUR)Ministry of Education, Universities and Research (MIUR) [PRIN
   2010C2LKKJ_004]; Sapienza University of Rome [C26A14AKKH, C26A159YJT];
   PhD program in Infectious Diseases, Microbiology and Public Health,
   Sapienza University of Rome; Fondazione CariploFondazione Cariplo
   [2017-0798]; Giovanni Armenise-Harvard Career Development Award (2013);
   "Programma Rita Levi-Montalcini" (MIUR)Ministry of Education,
   Universities and Research (MIUR)
FX zio to the Department of Public Health and Infectious Diseases, Sapienza
   University of RomeGrant Number: This work was partly funded by a grant
   from Regione Lazio to the Department of Public Health and Infectious
   Diseases, Sapienza University of Rome (FILAS-RU-2014-1034). BA was
   supported by funds from European Union (Infravec, FP7 228421), Italian
   Ministry of University and Research (MIUR, PRIN 2010C2LKKJ_004) and
   Sapienza University of Rome (C26A14AKKH, C26A159YJT). S.B.M. was
   supported by a fellowship from the PhD program in Infectious Diseases,
   Microbiology and Public Health, Sapienza University of Rome. PG was
   supported from the Fondazione Cariplo (Project 2017-0798). F.F. was
   supported by the Giovanni Armenise-Harvard Career Development Award
   (2013) and the "Programma Rita Levi-Montalcini" (MIUR). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007
   Arca B, 2018, CURR OPIN INSECT SCI, V29, P102, DOI 10.1016/j.cois.2018.07.012
   Arca B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3579-8
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   CDC. Center for Disease Control and Prevention, 2019, DENG VACC
   Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06
   Doucoure S, 2013, INSECT MOL BIOL, V22, P411, DOI 10.1111/imb.12032
   Doucoure S, 2014, BIOMED RES INT, DOI 10.1155/2014/746509
   Doucoure S, 2012, AM J TROP MED HYG, V87, P504, DOI 10.4269/ajtmh.2012.11-0477
   Doucoure S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001487
   Drame PM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0800-6
   Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684
   Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596
   Espana G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007482
   Focks DA, 2014, REV ENTOMOLOGICAL SA
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gossner CM, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.24.1800268
   Idris ZM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2139-z
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   Kebaier C, 2010, INFECT IMMUN, V78, P545, DOI 10.1128/IAI.00807-09
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuo D, 2014, METHODS MOL BIOL, V1177, P71, DOI 10.1007/978-1-4939-1034-2_6
   Londono-Renteria B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081211
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Ndille EE, 2014, TROP MED INT HEALTH, V19, P576, DOI 10.1111/tmi.12280
   Ndille EE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001905
   OP026, 2016, J CROHNS COLITIS, V10, pS21
   Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012
   Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198
   Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472
   Proietti C, 2013, PARASITE IMMUNOL, V35, P164, DOI 10.1111/pim.12031
   Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Ribeiro JMC, 2018, INSECT BIOCHEM MOLEC, V95, P1, DOI 10.1016/j.ibmb.2018.03.001
   Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002
   Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2
   Rizzo C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0549-8
   Rizzo C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-206
   Rizzo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017980
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009
   Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643
   Sri-In C, 2019, INSECT BIOCHEM MOLEC, V111, DOI 10.1016/j.ibmb.2019.103181
   Stone W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040170
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7
   Trevejo RT, 2005, AM J TROP MED HYG, V72, P481, DOI 10.4269/ajtmh.2005.72.481
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   WHO, 2017, CHIK FACT SHEETS
   WHO, 2018, YELL FEV FACT SHEETS
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Ya-Umphan P, 2017, J INFECT DIS, V215, P396, DOI 10.1093/infdis/jiw543
   Yobo C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3572696
NR 63
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007806
DI 10.1371/journal.pntd.0007806
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700040
PM 31618201
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Dusfour, I
   Vontas, J
   David, JP
   Weetman, D
   Fonseca, DM
   Corbel, V
   Raghavendra, K
   Coulibaly, MB
   Martins, AJ
   Kasai, S
   Chandre, F
AF Dusfour, Isabelle
   Vontas, John
   David, Jean-Philippe
   Weetman, David
   Fonseca, Dina M.
   Corbel, Vincent
   Raghavendra, Kamaraju
   Coulibaly, Mamadou B.
   Martins, Ademir J.
   Kasai, Shinji
   Chandre, Fabrice
TI Management of insecticide resistance in the major Aedes vectors of
   arboviruses: Advances and challenges
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID MOSQUITO CULEX-PIPIENS; ANOPHELES-GAMBIAE; DIPTERA-CULICIDAE; GLOBAL
   PLAN; AEGYPTI; IMPACT; EVOLUTION; SUSCEPTIBILITY; SELECTION; EFFICACY
AB Background
   The landscape of mosquito-borne disease risk has changed dramatically in recent decades, due to the emergence and reemergence of urban transmission cycles driven by invasive Aedes aegypti and Ae. albopictus. Insecticide resistance is already widespread in the yellow fever mosquito, Ae. Aegypti; is emerging in the Asian tiger mosquito Ae. Albopictus; and is now threatening the global fight against human arboviral diseases such as dengue, yellow fever, chikungunya, and Zika. Because the panel of insecticides available for public health is limited, it is of primary importance to preserve the efficacy of existing and upcoming active ingredients. Timely implementation of insecticide resistance management (IRM) is crucial to maintain the arsenal of effective public health insecticides and sustain arbovirus vector control.
   Methodology and principal findings
   This Review is one of a series being generated by the Worldwide Insecticide resistance Network (WIN) and aims at defining the principles and concepts underlying IRM, identifying the main factors affecting the evolution of resistance, and evaluating the value of existing tools for resistance monitoring. Based on the lessons taken from resistance strategies used for other vector species and agricultural pests, we propose a framework for the implementation of IRM strategies for Aedes mosquito vectors.
   Conclusions and significance
   Although IRM should be a fixture of all vector control programs, it is currently often absent from the strategic plans to control mosquito-borne diseases, especially arboviruses. Experiences from other public health disease vectors and agricultural pests underscore the need for urgent action in implementing IRM for invasive Aedes mosquitoes. Based on a plan developed for malaria vectors, here we propose some key activities to establish a global plan for IRM in Aedes spp.
C1 [Dusfour, Isabelle] Inst Pasteur, Lab Entomol Med, Cayenne, French Guiana.
   [Vontas, John] FORTH, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.
   [Vontas, John] Agr Univ Athens, Pesticide Sci Lab, Athens, Greece.
   [David, Jean-Philippe] Univ Grenoble Alpes, Lab Ecol Alpine LECA, CNRS, Grenoble, France.
   [Weetman, David] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.
   [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.
   [Corbel, Vincent; Chandre, Fabrice] Univ Montpellier, MIVEGEC, IRD, CNRS, Montpellier, France.
   [Raghavendra, Kamaraju] Natl Inst Malaria Res, Dept Hlth Res, Delhi, India.
   [Coulibaly, Mamadou B.] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Bamako, Mali.
   [Martins, Ademir J.] Inst Oswaldo Cruz FIOCRUZ, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, Brazil.
   [Kasai, Shinji] Natl Inst Infect Dis, Lab Pesticide Sci, Dept Med Entomol, Tokyo, Japan.
RP Chandre, F (corresponding author), Univ Montpellier, MIVEGEC, IRD, CNRS, Montpellier, France.
EM fabrice.chandre@ird.fr
RI ; DAVID, jean-philippe/F-3077-2012
OI Martins, Ademir/0000-0001-5739-1215; Vontas, John/0000-0002-8704-2574;
   Dusfour, Isabelle/0000-0002-5265-8432; DAVID,
   jean-philippe/0000-0002-3950-5909
FU World Health Organization's Special Programme for Research and Training
   in Tropical Diseases WHO-TDR award; European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant [734548]; WIN
   network
FX This work was funded by an award of from the World Health Organization's
   Special Programme for Research and Training in Tropical Diseases WHO-TDR
   award to VC, JPD, and the WIN network. Authors ID, JV, JPD, DW, DMF, KR,
   VC, MBC, AJM, SK, FC received salaries from academic or research
   institutions from their respective countries. This work was also
   partially supported by the European Union's Horizon 2020 Research and
   Innovation Programme under ZIKAlliance Grant Agreement no. 734548. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   [Anonymous], 2012, GLOB STRAT DENG PREV
   [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47
   [Anonymous], 2010, NEW YORK TIMES  1007, VZ, P1, DOI DOI 10.1520/E0779-10.2
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Belinato TA, 2016, INSECTICIDES RESISTANCE, P243, DOI 10.5772/61826
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Berticat C, 2004, GENET RES, V83, P189, DOI 10.1017/S0016672304006792
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bourguet D, 2013, TRENDS ECOL EVOL, V28, P110, DOI 10.1016/j.tree.2012.09.001
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   BROGDON WG, 1989, PARASITOL TODAY, V5, P56, DOI 10.1016/0169-4758(89)90192-0
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117
   CURTIS CF, 1981, PESTIC SCI, V12, P557, DOI 10.1002/ps.2780120513
   CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346
   Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014
   Darriet F, 2013, PEST MANAG SCI, V69, P905, DOI 10.1002/ps.3446
   Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88
   David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174
   Dunbar MW, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007203
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Elamathi N, 2014, PARASITOL RES, V113, P3859, DOI 10.1007/s00436-014-4054-y
   ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291
   Faucon F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005526
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003
   Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895
   Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771
   Guedes RNC, 2017, PEST MANAG SCI, V73, P479, DOI 10.1002/ps.4452
   Hemingway J, 1997, PESTIC SCI, V51, P375, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;375::AID-PS636&gt;3.0.CO;2-K
   Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003
   Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110
   Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261
   IRAC, 2011, PREV MAN INS RES VEC
   Khot AC, 2008, PEST MANAG SCI, V64, P1139, DOI 10.1002/ps.1603
   Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205
   Labbe P, 2009, GENETICS, V182, P303, DOI 10.1534/genetics.109.101444
   Leeper JR, 1986, PESTICIDE RESISTANCE, P335
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Maharaj R, 2005, SAMJ S AFR MED J, V95, P871
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745
   Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muthusamy R, 2015, J VECTOR DIS, V52, P159
   Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Oppenoorth F. J., 1976, INSECTICIDE BIOCH PH, P507
   Owusu HF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0971-6
   Ping LT, 2001, J AM MOSQUITO CONTR, V17, P144
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004
   Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001
   Rawlins S C, 1998, Rev Panam Salud Publica, V4, P243
   Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Roush R.T., 1990, PESTICIDE RESISTANCE, P97
   ROUSH RT, 1989, PESTIC SCI, V26, P423, DOI 10.1002/ps.2780260409
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Schechtman H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123961
   Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Sternberg ED, 2018, EVOL APPL, V11, P404, DOI 10.1111/eva.12501
   Tabashnik BE, 1990, PESTICIDE RESISTANCE, P153
   Verdonschot PFM, 2014, LIMNOLOGICA, V45, P69, DOI 10.1016/j.limno.2013.11.002
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weetman D, 2015, T ROY SOC TROP MED H, V109, P291, DOI 10.1093/trstmh/trv017
   Weill M, 2004, CURR BIOL, V14, pR552, DOI 10.1016/j.cub.2004.07.008
   WHO, 2006, GUID TEST MOSQ AD IN
   WHO, 2012, GLOB PLAN INS RES MA
   WHO, 1992, WHO TECHN REP SER
   WHO, 2012, WHOHTMNTDVEM20123
   WHO, 1957, WHO TECHN REP SER, V125, P31
   WHO, 2016, MON MAN INS RES AED
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, TEST PROC INREMO
   World Health Organization, 1998, TECHNIQUES DETECT IN
   Yameogo L, 2003, TRENTE ANS LUTTE ONC
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Yunta C, 2016, INSECT BIOCHEM MOLEC, V78, P50, DOI 10.1016/j.ibmb.2016.09.001
NR 88
TC 4
Z9 4
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007615
DI 10.1371/journal.pntd.0007615
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700005
PM 31600206
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Kittayapong, P
   Ninphanomchai, S
   Limohpasmanee, W
   Chansang, C
   Chansang, U
   Mongkalangoon, P
AF Kittayapong, Pattamaporn
   Ninphanomchai, Suwannapa
   Limohpasmanee, Wanitch
   Chansang, Chitti
   Chansang, Uruyakorn
   Mongkalangoon, Piti
TI Combined sterile insect technique and incompatible insect technique: The
   first proof-of-concept to suppress Aedes aegypti vector populations in
   semi-rural settings in Thailand
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WOLBACHIA SYMBIONT; MOSQUITOS DIPTERA; DENGUE; DISEASE; VIRUS;
   RESISTANCE; BURDEN; MALES; URBAN
AB Background
   Important arboviral diseases, such as dengue, chikungunya, and Zika virus infections, are transmitted mainly by the Aedes aegypti vector. So far, controlling this vector species with current tools and strategies has not demonstrated sustainable and significant impacts. Our main objective was to evaluate whether open field release of sterile males, produced from combining the sterile insect technique using radiation with the insect incompatible technique through Wolbachia-induced incompatibility (SIT/IIT), could suppress natural populations of Ae. aegypti in semi-rural village settings in Thailand.
   Methodology/Principal findings
   Irradiated Wolbachia-infected Aedes aegypti males produced by the SIT/IIT approach were completely sterile and were able to compete with the wild fertile ones. Open field release of these sterile males was conducted in an ecologically isolated village in Chachoengsao Province, eastern Thailand. House-to-house visit and media reports resulted in community acceptance and public awareness of the technology. During intervention, approximately 100-200 sterile males were released weekly in each household. After 6 months of sterile male release, a significant reduction (p<0.05) of the mean egg hatch rate (84%) and the mean number of females per household (97.30%) was achieved in the treatment areas when compared to the control ones.
   Conclusions/Significance
   Our study represents the first open field release of sterile Ae. aegypti males developed from a combined SIT/IIT approach. Entomological assessment using ovitraps, adult sticky traps, and portable vacuum aspirators confirmed the success in reducing natural populations of Ae. aegypti females in treated areas. Public awareness through media resulted in positive support for practical use of this strategy in wider areas. Further study using a systematic randomized trial is needed to determine whether this approach could have a significant impact on the diseases transmitted by Ae. aegypti vector.
C1 [Kittayapong, Pattamaporn; Ninphanomchai, Suwannapa] Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Salaya, Nakhon Pathom, Thailand.
   [Kittayapong, Pattamaporn] Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand.
   [Limohpasmanee, Wanitch] Minist Sci & Technol, Thailand Inst Nucl Technol, Nakhon Nayok, Thailand.
   [Chansang, Chitti; Chansang, Uruyakorn] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand.
   [Mongkalangoon, Piti] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand.
RP Kittayapong, P (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Salaya, Nakhon Pathom, Thailand.; Kittayapong, P (corresponding author), Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand.
EM pkittayapong@gmail.com
FU International Development Research Centre [IDRC/FBLI/106556];
   International Atomic Energy AgencyInternational Atomic Energy Agency
   [IAEA/TC/RAS5066, IAEA/CRP/D44002/19059]; Mahidol University
FX This study received financial support from the International Development
   Research Centre (IDRC/FBLI/106556), the International Atomic Energy
   Agency (IAEA/TC/RAS5066 & IAEA/CRP/D44002/19059) and Mahidol University.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   [Anonymous], 2012, REGEN MED S3, V7, pS14
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Bellini R., 2007, AREA WIDE CONTROL IN
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998
   BRAIG HR, 1994, NATURE, V367, P453, DOI 10.1038/367453a0
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2
   Diop D, 2015, MOJ PUBLIC HLTH, V2, P181
   Dyck VA, 2005, STERILE INSECT TECHN, DOI [10.1007/1-4020-4051-2, DOI 10.1007/1-4020-4051-2]
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hancock PA, 2018, P NATL ACAD SCI USA, V115, P5938, DOI 10.1073/pnas.1801826115
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hertig M, 1924, J MED RES, V44, P329
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Kittayapong P, 2002, AM J TROP MED HYG, V66, P103, DOI 10.4269/ajtmh.2002.66.103
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Kittayapong P, 2018, PARASIT VEC S2, V11, P73
   Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Murray JV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00043
   O'Connor L., 2012, PLOS NEGLECT TROP D, V6, P1, DOI DOI 10.1371/J0UMAL.PNTD.0001797
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562
   Ruang-areerate T, 2006, P NATL ACAD SCI USA, V103, P12534, DOI 10.1073/pnas.0508879103
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Sinkins SP, 2013, FUTURE MICROBIOL, V8, P1249, DOI 10.2217/fmb.13.95
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123
   WHO/TDR, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2015, FACT SHEET WORLD MAL
   World Health Organization, 2017, WHOHTMNTDVEM201702
   Zhang D., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL
   Zhang D. H., 2016, POLYM COMPOSITE, V11, P1
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
NR 54
TC 1
Z9 1
U1 4
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007771
DI 10.1371/journal.pntd.0007771
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700026
PM 31658265
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kobres, PY
   Chretien, JP
   Johansson, MA
   Morgan, JJ
   Whung, PY
   Mukundan, H
   Del Valle, SY
   Forshey, BM
   Quandelacy, TM
   Biggerstaff, M
   Viboud, C
   Pollett, S
AF Kobres, Pei-Ying
   Chretien, Jean-Paul
   Johansson, Michael A.
   Morgan, Jeffrey J.
   Whung, Pai-Yei
   Mukundan, Harshini
   Del Valle, Sara Y.
   Forshey, Brett M.
   Quandelacy, Talia M.
   Biggerstaff, Matthew
   Viboud, Cecile
   Pollett, Simon
TI A systematic review and evaluation of Zika virus forecasting and
   prediction research during a public health emergency of international
   concern
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID REPRODUCTION NUMBER; AEDES-AEGYPTI; GLOBAL RISK; PUERTO-RICO;
   TRANSMISSION; INFECTION; EPIDEMIC; OUTBREAK; SPREAD; MOSQUITOS
AB Introduction
   Epidemic forecasting and prediction tools have the potential to provide actionable information in the midst of emerging epidemics. While numerous predictive studies were published during the 2016-2017 Zika Virus (ZIKV) pandemic, it remains unknown how timely, reproducible, and actionable the information produced by these studies was.
   Methods
   To improve the functional use of mathematical modeling in support of future infectious disease outbreaks, we conducted a systematic review of all ZIKV prediction studies published during the recent ZIKV pandemic using the PRISMA guidelines. Using MEDLINE, EMBASE, and grey literature review, we identified studies that forecasted, predicted, or simulated ecological or epidemiological phenomena related to the Zika pandemic that were published as of March 01, 2017. Eligible studies underwent evaluation of objectives, data sources, methods, timeliness, reproducibility, accessibility, and clarity by independent reviewers.
   Results
   2034 studies were identified, of which n = 73 met the eligibility criteria. Spatial spread, R-0 (basic reproductive number), and epidemic dynamics were most commonly predicted, with few studies predicting Guillain-Barre Syndrome burden (4%), sexual transmission risk (4%), and intervention impact (4%). Most studies specifically examined populations in the Americas (52%), with few African-specific studies (4%). Case count (67%), vector (41%), and demographic data (37%) were the most common data sources. Real-time internet data and pathogen genomic information were used in 7% and 0% of studies, respectively, and social science and behavioral data were typically absent in modeling efforts. Deterministic models were favored over stochastic approaches. Forty percent of studies made model data entirely available, 29% provided all relevant model code, 43% presented uncertainty in all predictions, and 54% provided sufficient methodological detail to allow complete reproducibility. Fifty-one percent of predictions were published after the epidemic peak in the Americas. While the use of preprints improved the accessibility of ZIKV predictions by a median of 119 days sooner than journal publication dates, they were used in only 30% of studies.
   Conclusions
   Many ZIKV predictions were published during the 2016-2017 pandemic. The accessibility, reproducibility, timeliness, and incorporation of uncertainty in these published predictions varied and indicates there is substantial room for improvement. To enhance the utility of analytical tools for outbreak response it is essential to improve the sharing of model data, code, and preprints for future outbreaks, epidemics, and pandemics.
C1 [Kobres, Pei-Ying] George Washington Univ, Sch Publ Hlth, Washington, DC USA.
   [Chretien, Jean-Paul] US Dept Def, Ft Detrick, MD USA.
   [Johansson, Michael A.; Quandelacy, Talia M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA USA.
   [Morgan, Jeffrey J.] Joint Res & Dev Inc, Stafford, VA USA.
   [Whung, Pai-Yei] US EPA, Off Res & Dev, Washington, DC 20460 USA.
   [Mukundan, Harshini; Del Valle, Sara Y.] Los Alamos Natl Lab, Los Alamos, NM USA.
   [Forshey, Brett M.] Armed Forces Hlth Surveillance Branch, Silver Spring, MD USA.
   [Quandelacy, Talia M.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA.
   [Biggerstaff, Matthew] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.
   [Viboud, Cecile] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Pollett, Simon] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Pollett, Simon] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.
   [Pollett, Simon] Univ Sydney, Marie Bashir Inst, Sydney, NSW, Australia.
RP Pollett, S (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.; Pollett, S (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.; Pollett, S (corresponding author), Univ Sydney, Marie Bashir Inst, Sydney, NSW, Australia.
EM simon.d.pollett.ctr@mail.mil
OI Biggerstaff, Matthew/0000-0001-5108-8311; Morgan,
   Jeff/0000-0002-7745-2625; Kobres, Pei-Ying/0000-0002-0821-2046;
   Johansson, Michael/0000-0002-5090-7722
CR Ahrens KA, 2017, MATERNAL CHILD HLTH
   Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   [Anonymous], 2016, EUR J PREV CARDIOL, V23, pNP1
   [Anonymous], 2016, BALKAN J GEOM APPL, V21, piii
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Bennett C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-168
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Butt AM, 2016, LANCET GLOB HEALTH, V4, pE913, DOI 10.1016/S2214-109X(16)30246-7
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Chowell G, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0811-y
   Chretien JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002109
   Chretien JP, 2015, ELIFE, V4, DOI 10.7554/eLife.09186
   Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799
   Correa-Oliveira GE, 2017, REV BRAS PSIQUIATR, V39, P381, DOI 10.1590/1516-4446-2017-2308
   Craig AT, 2017, B WORLD HEALTH ORGAN, V95, P69, DOI 10.2471/BLT.16.171892
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Diaz-Menendez M, 2016, REV CLIN ESPANOLA
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gonzalez-Salazar C, 2017, ECOHEALTH
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Huff A, 2016, PLOS CURR, V10, P8
   Iwema Carrie L, 2016, F1000Res, V5, P1396, DOI 10.12688/f1000research.8798.1
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002549
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Keegan LT, 2017, J INFECT DIS, V216, pS884, DOI 10.1093/infdis/jix437
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   Littler K, 2017, B WORLD HEALTH ORGAN, V95, P243, DOI 10.2471/BLT.17.192096
   Lourenco M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060327
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Moher D, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-1
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Moreno Victor M, 2017, Infect Dis Model, V2, P21, DOI 10.1016/j.idm.2016.12.002
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Ogden NH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1977-z
   Pan American Health Organization  World Health Organization, 2018, ZIK CUM CAS
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pollett S, 2018, INFECT GENET EVOL, V62, P279, DOI 10.1016/j.meegid.2018.04.032
   Pollett S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005871
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Riou J, 2017, EPIDEMICS
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rodriguez-Barraquer I, 2016, PREDICTING INTENSITI
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Saenz C, 2016, LANCET GLOB HEALTH, V4, pE686, DOI 10.1016/S2214-109X(16)30222-4
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Scata M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37105
   Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   Teng Y, 2017, J INFECT
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   United Nations Educational Scientific  and Cultural Organization, 2016, INF ENG INV LESS LEA
   Viennet E, 2016, PLOS CURRENTS, P8
   Wellcome Trust, 2016, STAT DAT SHAR PUBL H
   White RG, 2015, J CLIN EPIDEMIOL, V68, P1463, DOI 10.1016/j.jclinepi.2015.04.002
   WHO, 2017, IEEE T POWER SYSTEMS, V1~14, DOI DOI 10.13155/46607
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
   World Health Organization, 2016, ZIK SIT REP MICR GUI
   World Health Organization, 2009, 9 WHO
   World Health Organization, 2017, METH PRIOR SEV EM DI
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
   Zumla A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0686-3
NR 127
TC 1
Z9 1
U1 5
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007451
DI 10.1371/journal.pntd.0007451
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700003
PM 31584946
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Miot, EF
   Aubry, F
   Dabo, S
   Mendenhall, IH
   Marcombe, S
   Tan, CH
   Ng, LC
   Failloux, AB
   Pompon, J
   Brey, PT
   Lambrechts, L
AF Miot, Elliott F.
   Aubry, Fabien
   Dabo, Stephanie
   Mendenhall, Ian H.
   Marcombe, Sebastien
   Tan, Cheong H.
   Ng, Lee C.
   Failloux, Anna-Bella
   Pompon, Julien
   Brey, Paul T.
   Lambrechts, Louis
TI A peridomestic Aedes malayensis population in Singapore can transmit
   yellow fever virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEGYPTI; INFECTION; HOST
AB The case-fatality rate of yellow fever virus (YFV) is one of the highest among arthropod-borne viruses (arboviruses). Although historically, the Asia-Pacific region has remained free of YFV, the risk of introduction has never been higher due to the increasing influx of people from endemic regions and the recent outbreaks in Africa and South America. Singapore is a global hub for trade and tourism and therefore at high risk for YFV introduction. Effective control of the main domestic mosquito vector Aedes aegypti in Singapore has failed to prevent re-emergence of dengue, chikungunya and Zika viruses in the last two decades, raising suspicions that peridomestic mosquito species untargeted by domestic vector control measures may contribute to arbovirus transmission. Here, we provide empirical evidence that the peridomestic mosquito Aedes malayensis found in Singapore can transmit YFV. Our laboratory mosquito colony recently derived from wild Ae. malayensis in Singapore was experimentally competent for YFV to a similar level as Ae. aegypti controls. In addition, we captured Ae. malayensis females in one human-baited trap during three days of collection, providing preliminary evidence that host-vector contact may occur in field conditions. Finally, we detected Ae. malayensis eggs in traps deployed in high-rise building areas of Singapore. We conclude that Ae. malayensis is a competent vector of YFV and re-emphasize that vector control methods should be extended to target peridomestic vector species.
C1 [Miot, Elliott F.; Aubry, Fabien; Dabo, Stephanie; Lambrechts, Louis] Inst Pasteur, CNRS, UMR2000, Insect Virus Interact Unit, Paris, France.
   [Miot, Elliott F.] Sorbonne Univ, Coll Doctoral, Paris, France.
   [Miot, Elliott F.; Marcombe, Sebastien; Brey, Paul T.] Inst Pasteur Laos, Med Entomol & Vector Borne Dis Unit, Viangchan, Laos.
   [Mendenhall, Ian H.; Pompon, Julien] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
   [Tan, Cheong H.; Ng, Lee C.] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
   [Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors Unit, Paris, France.
   [Pompon, Julien] Univ Montpellier, CNRS, IRD, MIVEGEC, Montpellier, France.
RP Miot, EF; Lambrechts, L (corresponding author), Inst Pasteur, CNRS, UMR2000, Insect Virus Interact Unit, Paris, France.; Miot, EF (corresponding author), Sorbonne Univ, Coll Doctoral, Paris, France.; Miot, EF (corresponding author), Inst Pasteur Laos, Med Entomol & Vector Borne Dis Unit, Viangchan, Laos.
EM elliott.miot@gmail.com; louis.lambrechts@pasteur.fr
OI Mendenhall, Ian/0000-0003-4250-6459
FU Calmette and Yersin doctoral fellowship of the Institut Pasteur
   International Network; Agence Nationale de la RechercheFrench National
   Research Agency (ANR) [ANR-17-ERC2-0016-01]; French Government's
   Investissement d'Avenir program Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious DiseasesFrench National Research Agency
   (ANR) [ANR-10-LABX-62-IBEID]; European Union's Horizon 2020 research and
   innovation program under ZikaPLAN grant [734584]; City of Paris
   Emergence(s) program in Biomedical ResearchRegion Ile-de-France
FX EFM was supported by a Calmette and Yersin doctoral fellowship of the
   Institut Pasteur International Network. This work was funded by Agence
   Nationale de la Recherche (grant ANR-17-ERC2-0016-01 to LL), the French
   Government's Investissement d'Avenir program Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases (grant
   ANR-10-LABX-62-IBEID to LL), the European Union's Horizon 2020 research
   and innovation program under ZikaPLAN grant agreement no. 734584 (to
   LL), and the City of Paris Emergence(s) program in Biomedical Research
   (to LL). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR AITKEN THG, 1977, AM J TROP MED HYG, V26, P985, DOI 10.4269/ajtmh.1977.26.985
   AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Fox J., 2011, R COMPANION APPL REG
   GALUN R, 1963, SCIENCE, V142, P1674, DOI 10.1126/science.142.3600.1674
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Gubler DJ, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay097
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   Kassambara A, 2018, GGPUBR GGPLOT2 BASED, pGPL
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Mendenhall IH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005667
   Motoki Maysa T, 2018, US Army Med Dep J, P1
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Petrova E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010068
   Pongsiri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092971
   R Core Team, 2018, R LANG ENV STAT COMP
   Rattanarithikul Rampa, 2010, Southeast Asian J Trop Med Public Health, V41 Suppl 1, P1
   RODHAIN F, 1979, B SOC PATHOL EXOT, V72, P411
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   Tangena JAA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138735
   TEWARI SC, 1995, T ROY SOC TROP MED H, V89, P163, DOI 10.1016/0035-9203(95)90478-6
   Venables WN, 2003, SPRINGER SCI BUSINES
   WHO, 2019, YELL FEV BRAZ
   WHO, 2018, YELL FEV FACT SHEETS
   Wickham H., 2016, GGPLOT2
   World Health Organization (WHO), WHO WHO REP GLOB SUR
   World Health Organization (WHO), 2019, EM PREP RESP YELL FE
   World Health Organization (WHO), 2016, EM PREP RESP YELL FE
NR 40
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007783
DI 10.1371/journal.pntd.0007783
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700033
PM 31589616
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stewart-Ibarra, AM
   Romero, M
   Hinds, AQJ
   Lowe, R
   Mahon, R
   Van Meerbeeck, CJ
   Rollock, L
   Gittens-St Hilaire, M
   St Ville, S
   Ryan, SJ
   Trotman, AR
   Borbor-Cordova, MJ
AF Stewart-Ibarra, Anna M.
   Romero, Moory
   Hinds, Avery Q. J.
   Lowe, Rachel
   Mahon, Roche
   Van Meerbeeck, Cedric J.
   Rollock, Leslie
   Gittens-St Hilaire, Marquita
   St Ville, Sylvester
   Ryan, Sadie J.
   Trotman, Adrian R.
   Borbor-Cordova, Mercy J.
TI Co-developing climate services for public health: Stakeholder needs and
   perceptions for the prevention and control of Aedes-transmitted diseases
   in the Caribbean
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS OUTBREAK; DENGUE-FEVER; ZIKA; VARIABILITY; CHIKUNGUNYA;
   INFORMATION; ADAPTATION; DOMINICA; AEGYPTI; INDEXES
AB Background
   Small island developing states (SIDS) in the Caribbean region are challenged with managing the health outcomes of a changing climate. Health and climate sectors have partnered to co-develop climate services to improve the management of emerging arboviral diseases (e.g., dengue fever), for example, through the development of climate-driven early warning systems. The objective of this study was to identify health and climate stakeholder perceptions and needs in the Caribbean, with respect to the development of climate services for arboviruses.
   Methods
   Stakeholders included public decision makers and practitioners from the climate and health sectors at the regional (Caribbean) level and from the countries of Dominica and Barbados. From April to June 2017, we conducted interviews (n = 41), surveys (n = 32), and national workshops with stakeholders. Survey responses were tabulated, and audio recordings were transcribed and analyzed using qualitative coding to identify responses by research topic, country/region, and sector.
   Results
   Health practitioners indicated that their jurisdiction is currently experiencing an increased risk of arboviral diseases associated with climate variability, and most anticipated that this risk will increase in the future. National health sectors reported financial limitations and a lack of technical expertise in geographic information systems (GIS), statistics, and modeling, which constrained their ability to implement climate services for arboviruses. National climate sectors were constrained by a lack of personnel. Stakeholders highlighted the need to strengthen partnerships with the private sector, academia, and civil society. They identified a gap in local research on climate-arbovirus linkages, which constrained the ability of the health sector to make informed decisions. Strategies to strengthen the climate-health partnership included a top-down approach by engaging senior leadership, multi-lateral collaboration agreements, national committees on climate and health, and shared spaces of dialogue. Mechanisms for mainstreaming climate services for health operations to control arboviruses included climatic-health bulletins and an online GIS platform that would allow for regional data sharing and the generation of spatiotemporal epidemic forecasts. Stakeholders identified a 3-month forecast of arboviral illness as the optimal time frame for an epidemic forecast.
   Conclusions
   These findings support the creation of interdisciplinary and intersectoral 'communities of practice' and the co-design of climate services for the Caribbean public health sector. By fostering the effective use of climate information within health policy, research and practice, nations will have greater capacity to adapt to a changing climate.
C1 [Stewart-Ibarra, Anna M.; Romero, Moory] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Publ Hlth & Preventat Med, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] InterAmer Inst Global Change Res IAI, Dept Montevideo, Montevideo, Uruguay.
   [Romero, Moory] SUNY Coll Environm Sci & Forestry, Dept Environm Studies, Syracuse, NY 13210 USA.
   [Hinds, Avery Q. J.] Caribbean Publ Hlth Agcy, Port Of Spain, Trinidad Tobago.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London, England.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.
   [Mahon, Roche; Van Meerbeeck, Cedric J.; Trotman, Adrian R.] Caribbean Inst Meteorol & Hydrol, St James, Barbados.
   [Rollock, Leslie] Minist Hlth & Wellness, St Michael, Barbados.
   [Gittens-St Hilaire, Marquita] Univ West Indies, Fac Med Sci, Cave Hill, Bridgetown, Barbados.
   [Gittens-St Hilaire, Marquita] Minist Hlth, Best Dos Santos Publ Hlth Lab, St Michael, Barbados.
   [St Ville, Sylvester] Minist Hlth & Environm, Div Environm Hlth, Roseau, Dominica.
   [Ryan, Sadie J.] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab Grp, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral ESPOL, Fac Ingn Maritima & Ciencias Mar, Guayaquil, Ecuador.
RP Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.; Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.; Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Dept Publ Hlth & Preventat Med, Syracuse, NY 13210 USA.; Stewart-Ibarra, AM (corresponding author), InterAmer Inst Global Change Res IAI, Dept Montevideo, Montevideo, Uruguay.
EM astewart@dir.iai.int
OI Mahon, Roche/0000-0001-9621-7033; Lowe, Rachel/0000-0003-3939-7343
FU Caribbean Institute for Meteorology and Hydrology (CIMH) through the
   United States Agency for International Development's (USAID) Programme
   for Building Regional Climate Capacity in the Caribbean (BRCCC
   Programme)United States Agency for International Development (USAID)
   [AID-538-10-1400001]; Royal Society Dorothy Hodgkin FellowshipRoyal
   Society of London
FX This study was solicited by the Caribbean Institute for Meteorology and
   Hydrology (CIMH) through the United States Agency for International
   Development's (USAID, Grant ID: AID-538-10-1400001) Programme for
   Building Regional Climate Capacity in the Caribbean (BRCCC Programme:
   rcc.cimh.edu.bb/brccc) with funding made possible by the generous
   support of the American people. The authors thank Dr. Shelly-Ann Cox for
   her data collection and research support. RL was supported by a Royal
   Society Dorothy Hodgkin Fellowship. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahmed S, 2015, EMERG INFECT DIS, V21, P909, DOI 10.3201/eid2105.141813
   Amarakoon AMD, 2004, W INDIAN MED J S2, V53, P60
   Amarakoon D, 2008, MITIG ADAPT STRAT GL, V13, P341, DOI 10.1007/s11027-007-9114-5
   [Anonymous], 2014, HLTH EX US INT PLATF
   [Anonymous], 2014, ASS REL HUM HLTH CLI
   [Anonymous], ANN CAS REP DENG PAH
   [Anonymous], DOM IMP HURR MAR DIS
   [Anonymous], CLIM CHANG AD PROT H
   Balbus J, 2008, ENV DEFENSE FUND
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   BRIGUGLIO L, 1995, WORLD DEV, V23, P1615, DOI 10.1016/0305-750X(95)00065-K
   Bruno Soares Marta, 2018, Climate Services, V9, P5, DOI 10.1016/j.cliser.2017.06.001
   Caribbean Public Health Agency, 2013, STAT PUBL HLTH CAR R
   Caribbean Public Health Agency, 2019, CARPHA URG REG PREP
   Caribbean Public Health Agency, 2017, STAT PUBL HLTH CAR R
   Chadee DD, 2007, ANN TROP MED PARASIT, V101, P69, DOI 10.1179/136485907X157059
   Chen AA, 2006, CLIMATE CHANGE IMPAC
   Climate Services for Health, 2016, CLIM SERV HLTH
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1957, DOI 10.1289/ehp.8429
   Emmanuel K, 2009, WORLDW HOSP TOUR THE, V1, P252, DOI 10.1108/17554210910980594
   Fernandez-Montoya L., 2016, IMPROVING PUBLIC HLT
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Gould S, 2015, INT J ENV RES PUB HE, V12, P15649, DOI 10.3390/ijerph121215010
   Hamilton I, 2014, ANAL DENGUE CASES BA
   Handel Andrew S, 2016, Trop Dis Travel Med Vaccines, V2, P8, DOI 10.1186/s40794-016-0024-y
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Herdiana H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204659
   Heslop-Thoma C, 2008, CLIMATE CHANGE VULNE
   Huang CR, 2011, AM J PREV MED, V40, P183, DOI 10.1016/j.amepre.2010.10.025
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Kumar A, 2018, EPIDEMIOL INFECT, V146, P1048, DOI 10.1017/S0950268818000900
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lowe R, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002613
   Macpherson CC, 2015, PUBLIC HLTH ETHICS
   Mahon R, 2019, CLIM SERV, V13, DOI [10.1016/j.cliser.2019.01.002, DOI 10.1016/J.CLISER.2019.01.002]
   Maibach EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002838
   MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morss RE, 2005, B AM METEOROL SOC, V86, P1593, DOI 10.1175/BAMS-86-11-1593
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003977
   Ortiz PL, 2015, MEDICC REV, V17, P20
   PAHO, NUMB REP CAS CHIK FE
   PAHO/WHO, 2018, CLIM CHANG HLTH SMAL
   Parks W., 2004, PLANNING SOCIAL MOBI
   Paterson JA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-452
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   Ryan SJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050682
   Ryan SJ, 2018, AM J TROP MED HYG, V98, P1857, DOI 10.4269/ajtmh.17-0978
   Ryan SJ, 2017, EMERG INFECT DIS, V23, P1926, DOI 10.3201/eid2311.171140
   Saldana J., 2012, CODING MANUAL QUALIT
   Saldana J, 2009, CODING MANUAL QUALIT, P1
   So J, 2017, COMMUN MONOGR, V84, P5, DOI 10.1080/03637751.2016.1250429
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Street R., 2015, EUROPEAN RES INNOVAT
   Tompkins AM, 2015, J APPL METEOROL CLIM, V54, P521, DOI 10.1175/JAMC-D-14-0156.1
   Trotman AR, 2018, B WORLD METEOROLOGIC, V67
   US Climate and Health Alliance, AR WE READ REP 2 PRE
   Verret M, 2016, ASSESSMENT CLIMATE C, P144
   Wang M, 2018, DESIGN EPIDEMIAWEB C
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Wei JN, 2014, ENVIRON RES, V134, P301, DOI 10.1016/j.envres.2014.08.006
   West J., 2009, ECOLOGICAL ENV ANTHR, V5, P1
   Wimberly MC, 2014, 7 INT C ENV MOD SOFT
   WMO, 2014, HLTH EX US INT PLATF
   WMO, 2014, IMPL PLAN GLOB FRAM
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Ziervogel G, 2004, CLIMATIC CHANGE, V65, P73, DOI 10.1023/B:CLIM.0000037492.18679.9e
NR 73
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007772
DI 10.1371/journal.pntd.0007772
PG 26
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700027
PM 31658267
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ximenes, RAD
   Miranda, DD
   Brickley, EB
   Montarroyos, UR
   Martelli, CMT
   de Araujo, TVB
   Rodrigues, LC
   de Albuquerque, MDPM
   de Souza, WV
   Castanha, PMD
   Franca, RFO
   Dhalia, R
   Marques, ETA
   Alves, SV
   Bezerra, LCA
   Braga, MC
   Brainer, ACM
   Carvalho, MDCG
   Cordeiro, MT
   Dimech, G
   Eickmann, SH
   Brandao, SP
   Gois, ADL
   Goncalves, AV
   Gouveia, MDL
   de Melo, APL
   Muniz, LF
   Oliveira, DMD
   Pastich, F
   Pinto, MH
   Ramos, RCF
   Rocha, MAW
   Silva, PFS
   de Vasconcelos, RAL
   Ventura, CVDC
   Ventura, LMVD
AF Ximenes, Ricardo Arraes de Alencar
   Miranda-Filho, Democrito de Barros
   Brickley, Elizabeth B.
   Montarroyos, Ulisses Ramos
   Martelli, Celina Maria Turchi
   de Araujo, Thalia Velho Barreto
   Rodrigues, Laura C.
   de Albuquerque, Maria de Fatima Pessoa Militao
   de Souza, Wayner Vieira
   Castanha, Priscila Mayrelle da Silva
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
   Alves, Sandra Valongueiro
   Bezerra, Luciana Caroline Albuquerque
   Braga, Maria Cynthia
   Brainer, Alessandra Cintia Mertens
   Carvalho, Maria Durce Costa Gomes
   Cordeiro, Marli Tenorio
   Dimech, Geroge
   Eickmann, Sophie Helena
   Brandao Filho, Sinval Pinto
   Gois, Adriana de Oliveira Lima
   Goncalves, Andreia Veras
   Gouveia, Mariana de Carvalho Leal
   de Melo, Ana Paula Lopes
   Muniz, Lilian Ferreira
   Oliveira, Danielle Maria da Silva
   Pastich, Fabiana
   Pinto, Maria Helena
   Ramos, Regina Coeli Ferreira
   Rocha, Maria Angela Wanderley
   Silva, Paula Fabiana Sobral
   de Vasconcelos, Romulo Augusto Lucena
   Ventura, Camila Vieira de Oliveira Carvalho
   Ventura, Liana Maria Vieira de Oliveira
CA MERG
TI Zika virus infection in pregnancy: Establishing a case definition for
   clinical research on pregnant women with rash in an active transmission
   setting
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID US TERRITORIES; ANTIBODIES; EPIDEMIC; EXPOSURE; OUTCOMES; JANUARY;
   UPDATE; BRAZIL
AB Defining cases of Zika virus (ZIKV) infection is a critical challenge for epidemiological research. Due to ZIKV's overlapping clinical features and potential immunologic cross-reactivity with other flaviviruses and the current lack of an optimal ZIKV-specific diagnostic assay, varying approaches for identifying ZIKV infections have been employed to date. This paper presents the laboratory results and diagnostic criteria developed by the Microcephaly Epidemic Research Group for defining cases of maternal ZIKV infection in a cohort of pregnant women with rash (N = 694) recruited during the declining 2015-2017 epidemic in northeast Brazil. For this investigation, we tested maternal sera for ZIKV by quantitative reverse transcription polymerase chain reaction (qRT-PCR), Immunoglobulin (Ig) M and IgG3 enzyme-linked immunosorbent assays (ELISAs), and Plaque Reduction Neutralization Test (PRNT50). Overall, 23.8% of participants tested positive by qRT-PCR during pregnancy (range of detection: 0-72 days after rash onset). However, the inter-assay concordance was lower than expected. Among women with qRT-PCR-confirmed ZIKV and further testing, only 10.1% had positive IgM tests within 90 days of rash, and only 48.5% had ZIKV-specific PRNT50 titers >= 20 within 1 year of rash. Given the complexity of these data, we convened a panel of experts to propose an algorithm for identifying ZIKV infections in pregnancy based on all available lines of evidence. When the diagnostic algorithm was applied to the cohort, 26.9% of participants were classified as having robust evidence of a ZIKV infection during pregnancy, 4.0% as having moderate evidence, 13.3% as having limited evidence of a ZIKV infection but with uncertain timing, and 19.5% as having evidence of an unspecified flavivirus infection before or during pregnancy. Our findings suggest that integrating longitudinal data from nucleic acid and serologic testing may enhance diagnostic sensitivity and underscore the need for an on-going dialogue regarding the optimization of strategies for defining cases of ZIKV in research.
C1 [Ximenes, Ricardo Arraes de Alencar] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [Ximenes, Ricardo Arraes de Alencar; Miranda-Filho, Democrito de Barros] Univ Pernambuco, Dept Med Interna, Recife, PE, Brazil.
   [Brickley, Elizabeth B.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Montarroyos, Ulisses Ramos] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Martelli, Celina Maria Turchi; de Albuquerque, Maria de Fatima Pessoa Militao; de Souza, Wayner Vieira; Castanha, Priscila Mayrelle da Silva; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [de Araujo, Thalia Velho Barreto] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil.
   [Castanha, Priscila Mayrelle da Silva; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Castanha, Priscila Mayrelle da Silva] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
RP Ximenes, RAD (corresponding author), Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.; Ximenes, RAD (corresponding author), Univ Pernambuco, Dept Med Interna, Recife, PE, Brazil.
EM raaximenes@uol.com.br
RI Montarroyos, Ulisses/AAJ-7527-2020; Marques, Ernesto T. A/L-4967-2013;
   Dhalia, Rafael/AAD-5432-2020; CASTANHA, PRISCILA/G-1785-2012; Brickley,
   Elizabeth/U-3625-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; CASTANHA, PRISCILA/0000-0002-1220-5308;
   Brickley, Elizabeth/0000-0003-0280-2288
FU Wellcome TrustWellcome Trust [205377/Z/16/Z, MC_PC_15088]; UK's
   Department for International Development [205377/Z/16/Z]; Wellcome
   Trust's Enhancing Research Activity in Epidemic Situations programme
   [107779/Z/15/Z, ER1505, ER1601]; European Union's Horizon 2020 research
   and innovation program under ZikaPLAN grant [734584]; Medical Research
   Council on behalf of the Newton Fund [MC_PC_15088]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309722/2017-9, 308590/2013-9,
   306708/2014-0, 308491/2013-0, 306222/20132]; Secretaria de Vigilancia em
   Saude/Ministerio da Saude de Brasil Resposta a Emergencia em Saude
   Publica -Zika vi'rus e Microcefalia [837058/2016]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Departamento de
   Ciencia e Tecnologia [440839/2016-5]
FX This work was supported by the: Wellcome Trust & the UK's Department for
   International Development (205377/Z/16/Z to LCR;
   https://wellcome.ac.uk/), the Wellcome Trust's Enhancing Research
   Activity in Epidemic Situations programme (107779/Z/15/Z; with ER1505 &
   ER1601 to RAAX), the European Union's Horizon 2020 research and
   innovation program (https://ec.europa.eu/programmes/horizon2020/) under
   ZikaPLAN grant agreement No. 734584 (https://zikaplan.tghn.org/), the
   Medical Research Council on behalf of the Newton Fund and the Wellcome
   Trust (MC_PC_15088 to LCR; https://mrc.ukri.org/), the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico(309722/2017-9to RAAX,
   308590/2013-9 to DBMF, and 306708/2014-0 to CMTM, 308491/2013-0 to
   MFPMA, 306222/20132 to WVS;http://www.cnpq.br/), Secretaria de
   Vigilancia em Saude/Ministerio da Saude de Brasil Resposta a Emergencia
   em Saude Publica -Zika vi ' rus e Microcefalia (837058/2016 to RAAX),
   the Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico,
   the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (http://www.capes.gov.br/), & the Departamento de Ciencia e Tecnologia
   (http://rebrats.saude.gov.br/noticias/59DECIT)for Prevencao e Combate a
   o virus Zika I (440839/2016-5 to RAAX). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Castanha PMS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007246
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Centers for Disease Control and Prevention, 2018, ZIK MAC ELISA INSTR
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cortes F, 2018, ACTA TROP, V182, P190, DOI 10.1016/j.actatropica.2018.03.006
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay108
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rodriguez-Barraquer I, 2018, ZIKA EMERGENCE DENGU
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Secretaria de Vigilancia em Saude-Ministerio da Saude-Brasil. Ministerio da Saude SituacAo epidemiologica de ocorrencia de microcefalias no Brasil, 2015, B EPIDEMIOLOGICO, V46
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Zika virus disease, 2016, WHOZIKVSUR161
NR 30
TC 2
Z9 2
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007763
DI 10.1371/journal.pntd.0007763
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700021
PM 31589611
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Anand, P
   Kharal, GA
   Reda, H
   Venna, N
AF Anand, Pria
   Kharal, G. Abbas
   Reda, Haatem
   Venna, Nagagopal
TI Peripheral Neuropathies in Infectious Diseases
SO SEMINARS IN NEUROLOGY
LA English
DT Article
DE peripheral nerve; infection; HIV
ID GUILLAIN-BARRE-SYNDROME; C VIRUS-INFECTION; HEPATITIS-C;
   POLYARTERITIS-NODOSA; MIXED CRYOGLOBULINEMIA; CONTROLLED-TRIAL;
   RISK-FACTORS; ZIKA VIRUS; NEUROLOGICAL MANIFESTATIONS;
   CEREBROSPINAL-FLUID
AB Peripheral nerve disorders may be the presenting manifestation of a systemic infection, and early recognition of these syndromes is essential for prompt diagnosis and treatment. Mechanisms associated with infectious disorders of the peripheral nerve are often complex and multiple, with secondary inflammation, direct infectious invasion of nerves, and toxicities of antimicrobial medications playing a role. Here, we provide a complete review of the most common infectious pathogens that can affect the peripheral nerves.
C1 [Anand, Pria; Kharal, G. Abbas; Reda, Haatem; Venna, Nagagopal] Massachusetts Gen Hosp, Dept Neurol, 15 Parkman St,Suite 835, Boston, MA 02114 USA.
RP Venna, N (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 15 Parkman St,Suite 835, Boston, MA 02114 USA.
EM nvenna1@mgh.harvard.edu
CR Agrawal A, 2005, CLIN NEUROL NEUROSUR, V107, P445, DOI 10.1016/j.clineuro.2005.03.007
   AMAYO EO, 1991, E AFR MED J, V68, P948
   [Anonymous], 2012, Wkly Epidemiol Rec, V87, P317
   [Anonymous], 2013, WHO TECHN REP SER, P1
   Apartis E, 1996, J NEUROL NEUROSUR PS, V60, P661, DOI 10.1136/jnnp.60.6.661
   Aurelius E, 2002, SCAND J INFECT DIS, V34, P278, DOI 10.1080/00365540110080485
   BEHAR R, 1987, NEUROLOGY, V37, P557, DOI 10.1212/WNL.37.4.557
   BELEC L, 1989, J NEUROL, V236, P411, DOI 10.1007/BF00314900
   Brannagan TH, 2003, J NEUROL SCI, V208, P39, DOI 10.1016/S0022-510X(02)00418-5
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7
   Cacoub P, 2002, ARTHRITIS RHEUM, V46, P3317, DOI 10.1002/art.10699
   Cacoub P, 2005, ARTHRITIS RHEUM-US, V52, P911, DOI 10.1002/art.20958
   Cacoub P, 2019, CLIN GASTROENTEROL H, V17, P518, DOI 10.1016/j.cgh.2018.05.021
   Cacoub P, 2015, AM J MED, V128, P950, DOI 10.1016/j.amjmed.2015.02.017
   Cacoub P, 2014, DIGEST LIVER DIS, V46, pS165, DOI 10.1016/j.dld.2014.10.005
   Chalk CH, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008123.pub3
   Cheng J, 2018, HERPES ZOSTER POSTHE
   Chodkiewicz HM, 2013, CUTIS, V91, P181
   Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660
   Dartevel A, 2015, J CLIN VIROL, V69, P156, DOI 10.1016/j.jcv.2015.06.091
   David WS, 1996, MUSCLE NERVE, V19, P1596, DOI 10.1002/(SICI)1097-4598(199612)19:12<1596::AID-MUS9>3.3.CO;2-6
   de Carvalho JF, 2008, EUR J INTERN MED, V19, P575, DOI 10.1016/j.ejim.2007.06.035
   De Keyser F, 2000, CLIN EXP RHEUMATOL, V18, P81
   Diaz JH, 2010, J MED TOXICOL, V6, P15, DOI 10.1007/s13181-010-0028-3
   DUNK A, 1982, BRIT J VENER DIS, V58, P269
   Eberhardt O, 2004, NEUROLOGY, V63, P758, DOI 10.1212/01.WNL.0000134652.51657.10
   ELLIE E, 1994, J NEUROL NEUROSUR PS, V57, P869, DOI 10.1136/jnnp.57.7.869
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Ferri C, 2011, AUTOIMMUN REV, V11, P48, DOI 10.1016/j.autrev.2011.07.005
   Forbes HJ, 2016, PAIN, V157, P30, DOI 10.1097/j.pain.0000000000000307
   Geraci Anthony P., 2001, Comprehensive Therapy, V27, P232, DOI 10.1007/s12019-001-0020-6
   Ghrenassia E, 2015, J AUTOIMMUN, V59, P19, DOI 10.1016/j.jaut.2015.01.010
   GISSLEN M, 1994, SCAND J INFECT DIS, V26, P523, DOI 10.3109/00365549409011810
   Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674
   Golbus Jessica R, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P223, DOI 10.1177/1545109712442798
   GUILLEVIN L, 1995, MEDICINE, V74, P238, DOI 10.1097/00005792-199509000-00002
   GUMBER SC, 1995, ANN INTERN MED, V123, P615, DOI 10.7326/0003-4819-123-8-199510150-00008
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hadfield TL, 2000, J INFECT DIS, V181, pS116, DOI 10.1086/315551
   Hadley GR, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0548-x
   Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3
   Howard JF, 2013, PHYS MED REH CLIN N, V24, P169, DOI 10.1016/j.pmr.2012.08.013
   HUGHES JM, 1981, ANN INTERN MED, V95, P442, DOI 10.7326/0003-4819-95-4-442
   Jackson AC, 2013, ANTIVIR RES, V99, P61, DOI 10.1016/j.antiviral.2013.01.003
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7
   KEANE JR, 1994, NEUROLOGY, V44, P1198, DOI 10.1212/WNL.44.7.1198
   KIM YS, 1993, CLIN INFECT DIS, V17, P32, DOI 10.1093/clinids/17.1.32
   Kole A K, 2010, Indian J Med Sci, V64, P373, DOI 10.4103/0019-5359.100340
   Kume Kodai, 2013, Rinsho Shinkeigaku, V53, P362
   Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2
   Lamprecht P, 2003, ANN RHEUM DIS, V62, P1230, DOI 10.1136/ard.2002.004929
   Lehmann HC, 2011, ANN NEUROL, V69, P100, DOI 10.1002/ana.22150
   Levay PF, 2008, S AFR FAM PRACT, V50, P42, DOI 10.1080/20786204.2008.10873692
   Lidove O, 2001, ANN RHEUM DIS, V60, P290, DOI 10.1136/ard.60.3.290
   Lyons J, 2011, SEMIN NEUROL, V31, P254, DOI 10.1055/s-0031-1287653
   MARESSEGURA R, 1986, ANN NEUROL, V19, P100, DOI 10.1002/ana.410190126
   Mariotto Sara, 2014, Inflammation & Allergy Drug Targets, V13, P299
   Marra CM, 1998, NEUROLOGY, V51, P1678, DOI 10.1212/WNL.51.6.1678
   MARSHALL DW, 1988, ARCH NEUROL-CHICAGO, V45, P954, DOI 10.1001/archneur.1988.00520330032007
   Mazzaro C, 2018, CLIN EXP RHEUMATOL, V36, pS107
   McKee DH, 2000, NEUROLOGY, V55, P459, DOI 10.1212/WNL.55.3.459
   Mehndiratta M, 2013, J CLIN NEUROSCI, V20, P325, DOI 10.1016/j.jocn.2012.03.029
   Mochan A, 2016, J NEUROL SCI, V363, P39, DOI 10.1016/j.jns.2015.11.013
   Moretti R, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0751-9
   Morgello S, 2004, ARCH NEUROL-CHICAGO, V61, P546, DOI 10.1001/archneur.61.4.546
   Moyle GJ, 1998, DRUG SAFETY, V19, P481, DOI 10.2165/00002018-199819060-00005
   Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005
   Naarendorp M, 2001, J RHEUMATOL, V28, P2466
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Nemni R, 2003, J NEUROL NEUROSUR PS, V74, P1267, DOI 10.1136/jnnp.74.9.1267
   Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074
   PELLETIER G, 1985, DIGESTION, V32, P53, DOI 10.1159/000199217
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Piradov MA, 2001, ARCH NEUROL-CHICAGO, V58, P1438, DOI 10.1001/archneur.58.9.1438
   Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8
   Rosca EC, 2015, INT IMMUNOPHARMACOL, V29, P964, DOI 10.1016/j.intimp.2015.09.023
   ROULLET E, 1994, NEUROLOGY, V44, P2174, DOI 10.1212/WNL.44.11.2174
   Sabin T D, 2005, PERIPHERAL NEUROPATH
   Schifitto G, 2002, NEUROLOGY, V58, P1764, DOI 10.1212/WNL.58.12.1764
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Shah SS, 2003, CLIN INFECT DIS, V36, pE131, DOI 10.1086/374935
   Shepherd SJ, 2017, JMM CASE REP, V4, P8
   Simpson DM, 2010, NEUROLOGY, V74, P413, DOI 10.1212/WNL.0b013e3181ccc6ef
   Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c
   Simpson DM, 2014, PAIN, V155, P1943, DOI 10.1016/j.pain.2014.05.027
   Sise ME, 2016, HEPATOLOGY, V63, P408, DOI 10.1002/hep.28297
   Sneller MC, 2012, ARTHRITIS RHEUM-US, V64, P835, DOI 10.1002/art.34322
   Souayah Nizar, 2009, J Clin Neuromuscul Dis, V11, P1, DOI 10.1097/CND.0b013e3181aaa968
   STRICKER RB, 1992, NEUROLOGY, V42, P2103, DOI 10.1212/WNL.42.11.2103
   Sugimoto Hideki, 2006, Rinsho Shinkeigaku, V46, P561
   Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006
   Sweeney CJ, 2001, J NEUROL NEUROSUR PS, V71, P149, DOI 10.1136/jnnp.71.2.149
   TABOR E, 1987, J MED VIROL, V21, P207, DOI 10.1002/jmv.1890210303
   Perez-Gracia MT, 2014, INFECT GENET EVOL, V22, P40, DOI 10.1016/j.meegid.2014.01.002
   Uscategui T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006851.pub2
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Ventura F, 2009, EUR J DERMATOL, V19, P400, DOI 10.1684/ejd.2009.0695
   Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Zaja F, 2003, BLOOD, V101, P3827, DOI 10.1182/blood-2002-09-2856
   Zhang JC, 2010, CLIN TOXICOL, V48, P867, DOI 10.3109/15563650.2010.535003
NR 103
TC 0
Z9 0
U1 0
U2 0
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD OCT
PY 2019
VL 39
IS 5
BP 640
EP 650
DI 10.1055/s-0039-1688995
PG 11
WC Clinical Neurology
SC Neurosciences & Neurology
GA JK3BL
UT WOS:000494720300014
PM 31639846
DA 2020-07-08
ER

PT J
AU Nithiyanantham, SF
   Badawi, A
AF Nithiyanantham, Saiee F.
   Badawi, Alaa
TI Maternal infection with Zika virus and prevalence of congenital
   disorders in infants: systematic review and meta-analysis
SO CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
LA English
DT Review
DE Zika virus; Microcephaly; Congenital disease; Brain calcification;
   Systematic review
ID BIRTH-DEFECTS; FETUSES; BRAIN; PREGNANCY; UPDATE; WOMEN; RNA
AB Objective Zika virus (ZIKV) infection is a vector-borne disease that can be transmitted sexually and vertically. The vertical transmission of the virus may lead to congenital Zika syndrome in infants. The aim of this study is to conduct a systematic review and meta-analysis of published reports documenting the prevalence of congenital Zika-related disorders in infants of mothers infected with ZIKV during pregnancy. Methods We conducted a comprehensive search in Ovid MEDLINE, Ovid MEDLINE (R) Epub ahead of print, Embase, Embase Classic and Web of Science databases to identify human studies reporting prevalence of congenital disorders in infants of ZIKV-infected mothers. Results We identified 25 reports selected for inclusion in the current study (n = 4683 subjects). The majority of the studies were from South American high-risk countries. Only one third of the identified studies were conducted in the United States. Clinical maternal symptoms included maculopapular rash (76.9%), arthralgia (46.4%), fever (45.5%) and headache (31.8%) with myalgia and conjunctivitis only presented in 25% of the cases. The most prevalent congenital disorder in the newborns was brain calcifications (42.6; 95% CI, 30.8-54.4), followed by ventriculomegaly (21.8; 95% CI, 15.2-28.4), joint abnormalities (13.2; 95% CI, 9.4-18.2), ocular abnormalities (4.2; 95% CI, 1.0-7.5) and microcephaly (3.9; 95% CI, 2.4-5.4). Conclusion The current study highlights the high prevalence of a range of congenital disorders in newborns of mothers infected with ZIKV. It warrants developing studies to further clarify the mechanisms by which each of these disorders occurs in response to the viral infection during pregnancy and its vertical transmission to the infants.
C1 [Nithiyanantham, Saiee F.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada.
   [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, 180 Queen St West,Rm 8-15, Toronto, ON M5V 3L7, Canada.
   [Badawi, Alaa] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
RP Badawi, A (corresponding author), Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, 180 Queen St West,Rm 8-15, Toronto, ON M5V 3L7, Canada.; Badawi, A (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
EM alaa.badawi@canada.ca
FU Public Health Agency of Canada
FX This work was supported by the Public Health Agency of Canada (AB). The
   authors thank Mr. S.G. Ryoo for assistance with abstract selection,
   full-text screening and data analysis.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Alves L. V., 2016, REV BRASILEIRA SA S1, V16, DOI [10.1580/1806-9304201600s100003, DOI 10.1580/1806-9304201600S100003]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Badawi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200200
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Gregianini TS, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1943
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Isaacs AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204926
   Janssen S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00021-18
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kiroglu Y, 2010, DIAGN INTERV RADIOL, V16, P263, DOI 10.4261/1305-3825.DIR.2626-09.1
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136
   Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Millet JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01319
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rao R, 2017, OBSTET GYNECOL, V129, P1098, DOI 10.1097/AOG.0000000000002049
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sanz Cortes M, 2018, AM J OBSTET GYNECOL, V218, p440e1
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Sohan K, 2017, INT J GYNECOL OBSTET, V139, P278, DOI 10.1002/ijgo.12313
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wallace BC, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i05
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 49
TC 1
Z9 1
U1 2
U2 8
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0008-4263
EI 1920-7476
J9 CAN J PUBLIC HEALTH
JI Can. J. Public Health-Rev. Can. Sante Publ.
PD OCT
PY 2019
VL 110
IS 5
BP 638
EP 648
DI 10.17269/s41997-019-00215-2
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JI7QS
UT WOS:000493660100014
PM 31077071
OA Green Published
DA 2020-07-08
ER

PT J
AU Ji, MY
   Zhu, TY
   Xing, MC
   Luan, N
   Mwangi, J
   Yan, XW
   Mo, GX
   Rong, MQ
   Li, BW
   Lai, R
   Jin, L
AF Ji, Mengyao
   Zhu, Tengyu
   Xing, Meichen
   Luan, Ning
   Mwangi, James
   Yan, Xiuwen
   Mo, Guoxiang
   Rong, Mingqiang
   Li, Bowen
   Lai, Ren
   Jin, Lin
TI An Antiviral Peptide from Alopecosa nagpag Spider Targets NS2B-NS3
   Protease of Flaviviruses
SO TOXINS
LA English
DT Article
DE Alopecosa nagpag; dengue virus; Zika virus; host defense peptide;
   NS2B-NS3 protease; Flavivirus
ID CRYSTAL-STRUCTURE; VENOM PEPTIDES; VIRUS; INHIBITORS; PLECTASIN; DENGUE
AB Flaviviruses are single-stranded RNA viruses predominantly transmitted by the widely distributed Aedes mosquitoes in nature. As important human pathogens, the geographic reach of Flaviviruses and their threats to public health are increasing, but there is currently no approved specific drug for treatment. In recent years, the development of peptide antivirals has gained much attention. Natural host defense peptides which uniquely evolved to protect the hosts have been shown to have antiviral properties. In this study, we firstly collected the venom of the Alopecosa nagpag spider from Shangri-La County, Yunnan Province. A defense peptide named Av-LCTX-An1a (Antiviral-Lycotoxin-An1a) was identified from the spider venom, and its anti-dengue serotype-2 virus (DENV2) activity was verified in vitro. Moreover, a real-time fluorescence-based protease inhibition assay showed that An1a functions as a DENV2 NS2B-NS3 protease inhibitor. Furthermore, we also found that An1a restricts zika virus (ZIKV) infection by inhibiting the ZIKV NS2B-NS3 protease. Together, our findings not only demonstrate that An1a might be a candidate for anti-flavivirus drug but also indicate that spider venom is a potential resource library rich in antiviral precursor molecules.
C1 [Ji, Mengyao; Zhu, Tengyu; Xing, Meichen; Luan, Ning; Yan, Xiuwen; Mo, Guoxiang; Lai, Ren] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.
   [Ji, Mengyao; Zhu, Tengyu; Xing, Meichen; Mwangi, James; Li, Bowen; Lai, Ren; Jin, Lin] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Kunming 650223, Yunnan, Peoples R China.
   [Rong, Mingqiang] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China.
   [Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming 650223, Yunnan, Peoples R China.
   [Lai, Ren] Chinese Acad Sci, Sino African Joint Res Ctr, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China.
   [Lai, Ren] Chinese Acad Sci, Inst Drug Discovery & Dev, Shanghai 201203, Peoples R China.
   [Lai, Ren] Chinese Acad Sci, Ctr Biosafety Megasci, 44 Xiaohongshan,Wuchang Dist Huangjin Ind Pk, Wuhan 430207, Hubei, Peoples R China.
RP Lai, R (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.; Lai, R; Jin, L (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Kunming 650223, Yunnan, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming 650223, Yunnan, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci, Sino African Joint Res Ctr, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci, Inst Drug Discovery & Dev, Shanghai 201203, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, 44 Xiaohongshan,Wuchang Dist Huangjin Ind Pk, Wuhan 430207, Hubei, Peoples R China.
EM 2017116050@njau.edu.cn; 2017116049@njau.edu.cn; 2017116048@njau.edu.cn;
   2017216016@njau.edu.cn; jams@mail.kiz.ac.cn; yanxw@njau.edu.cn;
   mgx@njau.edu.cn; rongmq@hunnu.edu.cn; libowen@mail.kiz.ac.cn;
   rlai@mail.kiz.ac.cn; jinlin@mail.kiz.ac.cn
FU Chinese Academy of Sciences (CAS) "Light of West China" program; Youth
   Innovation Promotion Association [2019378]; National Natural Science
   Foundation of China (NSFC)National Natural Science Foundation of China
   [31900331]; NSFCNational Natural Science Foundation of China
   [21761142002]; CASChinese Academy of Sciences [XDB31000000, SAJC201606,
   KGFZD-135-17-011]; Yunnan Province Grant [2015HA023, 2019ZF003]
FX This research was funded by Chinese Academy of Sciences (CAS) "Light of
   West China" program and Youth Innovation Promotion Association (2019378)
   and funding from the National Natural Science Foundation of China (NSFC)
   Grant (31900331) to L.J. and funding from the NSFC Grant (21761142002),
   the CAS Grants (XDB31000000, SAJC201606 and KGFZD-135-17-011) and Yunnan
   Province Grant (2015HA023 and 2019ZF003) to R.L.
CR Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Boto A, 2018, MOLECULES, V23, DOI 10.3390/molecules23020311
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Bruzzoni-Giovanelli H, 2018, DRUG DISCOV TODAY, V23, P272, DOI 10.1016/j.drudis.2017.10.016
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen Jun, 2001, Acta Zootaxonomica Sinica, V26, P18
   Coronado MA, 2018, ANTIVIR RES, V160, P118, DOI 10.1016/j.antiviral.2018.10.019
   da Silva EF, 2019, BIOORGAN MED CHEM, V27, P3963, DOI 10.1016/j.bmc.2019.07.038
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591
   Hong W, 2014, ANTIVIR RES, V102, P1, DOI 10.1016/j.antiviral.2013.11.013
   Jin L, 2017, AMINO ACIDS, V49, P1237, DOI 10.1007/s00726-017-2425-2
   Jin L, 2016, J MED CHEM, V59, P1791, DOI 10.1021/acs.jmedchem.5b01264
   King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Primon-Barros M, 2017, CURR TOP MED CHEM, V17, P1119, DOI 10.2174/1568026616666160930151242
   Rothan HA, 2014, ANTIVIR RES, V108, P173, DOI 10.1016/j.antiviral.2014.05.019
   Rothan HA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-140
   Rothan HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094561
   Rothan HA, 2013, OMICS, V17, P560, DOI 10.1089/omi.2013.0056
   Sabotic J, 2012, APPL MICROBIOL BIOT, V93, P1351, DOI 10.1007/s00253-011-3834-x
   Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851
   Scott CJ, 2010, BIOCHIMIE, V92, P1681, DOI 10.1016/j.biochi.2010.03.010
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shartouny J.R., 2018, SEMINARS CELL DEV BI
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zeng ZY, 2016, TOXINS, V8, DOI 10.3390/toxins8050124
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao PC, 2018, PEPTIDES, V103, P48, DOI 10.1016/j.peptides.2018.03.011
NR 38
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6651
J9 TOXINS
JI Toxins
PD OCT
PY 2019
VL 11
IS 10
AR 584
DI 10.3390/toxins11100584
PG 11
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA JI5YE
UT WOS:000493542500044
PM 31658707
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ngan, NTT
   Kim, SJ
   Lee, JY
   Myoung, J
AF Nguyen Thi Thuy Ngan
   Kim, Seong-Jun
   Lee, Jeong Yoon
   Myoung, Jinjong
TI Zika Virus Proteins NS2A and NS4A Are Major Antagonists that Reduce
   IFN-beta Promoter Activity Induced by the MDA5/RIG-I Signaling Pathway
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Zika virus; interferon; evasion
ID DENGUE VIRUS; INHIBITION; ACTIVATION; REPLICATION; RECOGNITION;
   RESPONSES; PEPTIDE; VACCINE; ROLES; BRAIN
AB Zika virus (ZIKV) is a mosquito-transmitted, emerging Flavivirus that causes Guillain-Barre syndrome and microcephaly in adults and fetuses, respectively. Since ZIKV was first isolated in 1947, severe outbreaks have occurred at various places worldwide, including Yap Island in 2007, French Polynesia in 2013, and Brazil in 2015. Although incidences of ZIKV infection and dissemination have drastically increased, the mechanisms underlying the pathogenesis of ZIKV have not been sufficiently studied. In addition, despite extensive research, the exact roles of individual ZIKV genes in the viral evasion of the host innate immune responses remain elusive. Besides, it is still possible that more than one ZIKV-encoded protein may negatively affect type I interferon (IFN) induction. Hence, in this study, we aimed to determine the modulations of the IFN promoter activity, induced by the MDA5/RIG-I signaling pathway, by over-expressing individual ZIKV genes. Our results show that two nonstructural proteins, NS2A and NS4A, significantly down-regulated the promoter activity of IFN-beta by inhibiting multiple signaling molecules involved in the activation of IFN-beta. Interestingly, while NS2A suppressed both full-length and constitutively active RIG-I, NS4A had inhibitory activity only on full-length RIG-I. In addition, while NS2A inhibited all forms of IRF3 (full-length, regulatory domain-deficient, and constitutively active), NS4A could not inhibit constitutively active IRF3-5D. Taken together, our results showed that NS2A and NS4A play major roles as antagonists of MDA5/RIG-I-mediated IFN-beta induction and more importantly, these two viral proteins seem to inhibit induction of the type I IFN responses in differential mechanisms. We believe this study expands our understanding regarding the mechanisms via which ZIKV controls the innate immune responses in cells and may pave the way to development of ZIKV-specific therapeutics.
C1 [Nguyen Thi Thuy Ngan; Lee, Jeong Yoon; Myoung, Jinjong] Chonbuk Natl Univ, Korea Zoonosis Res Inst, Dept Bioact Mat Sci, Jeonju 54531, South Korea.
   [Nguyen Thi Thuy Ngan; Lee, Jeong Yoon; Myoung, Jinjong] Chonbuk Natl Univ, Genet Engn Res Inst, Jeonju 54531, South Korea.
   [Kim, Seong-Jun] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea.
RP Lee, JY; Myoung, J (corresponding author), Chonbuk Natl Univ, Korea Zoonosis Res Inst, Dept Bioact Mat Sci, Jeonju 54531, South Korea.; Lee, JY; Myoung, J (corresponding author), Chonbuk Natl Univ, Genet Engn Res Inst, Jeonju 54531, South Korea.
EM Jeongyoon.lee@jbnu.ac.kr; Jinjong.myoung@jbnu.ac.kr
FU Basic Science Research Program of the National Research Foundation (NRF)
   - Ministry of Education [2017R1D1A1B03035473, 2017R1A6A1A03015876]
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation (NRF) funded by the Ministry of Education
   (2017R1D1A1B03035473 and 2017R1A6A1A03015876).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11
   Baek YH, 2018, J MICROBIOL BIOTECHN, V28, P1928, DOI 10.4014/jmb.1806.06016
   Brisse M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01586
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042
   Hu YW, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0308-9
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Kang S, 2018, J MICROBIOL BIOTECHN, V28, P1554, DOI 10.4014/jmb.1808.08058
   Kang S, 2017, J MICROBIOL BIOTECHN, V27, P1727, DOI 10.4014/jmb.1708.08045
   Kang S, 2017, J MICROBIOL, V55, P319, DOI 10.1007/s12275-017-7075-2
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kim E, 2018, J MICROBIOL BIOTECHN, V28, P1908, DOI 10.4014/jmb.1809.09028
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee JY, 2019, J MICROBIOL BIOTECHN, V29, P1316, DOI 10.4014/jmb.1908.08004
   Lee JY, 2019, J MICROBIOL, V57, P803, DOI 10.1007/s12275-019-9272-7
   Lee JY, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00105-18
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li WJ, 2019, FASEB J, V33, P9929, DOI 10.1096/fj.201900260R
   Li XD, 2015, J GEN VIROL, V96, P1264, DOI 10.1099/vir.0.000044
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Myoung J, 2019, J MICROBIOL BIOTECHN, V29, P1137, DOI 10.4014/jmb.1905.05040
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Phuong NH, 2018, J MICROBIOL BIOTECHN, V28, P809, DOI 10.4014/jmb.1801.01002
   Nicastri E., 2016, EURO SURVEILL, V21
   Park MK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38870-7
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3
   Tong C, 2017, J MICROBIOL BIOTECHN, V27, P1701, DOI 10.4014/jmb.1704.04065
   Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   Wise J., 2016, BMJ-BRIT MED J, V352, pi1242
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xi HL, 2017, J MICROBIOL BIOTECHN, V27, P718, DOI 10.4014/jmb.1611.11062
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Zhang XW, 2019, EMERG MICROBES INFEC, V8, P585, DOI 10.1080/22221751.2019.1598291
   Zhao K, 2017, J MICROBIOL BIOTECHN, V27, P2060, DOI 10.4014/jmb.1708.08017
NR 57
TC 1
Z9 1
U1 1
U2 2
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
EI 1738-8872
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD OCT
PY 2019
VL 29
IS 10
BP 1665
EP 1674
DI 10.4014/jmb.1909.09017
PG 10
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA JI3TN
UT WOS:000493391600017
PM 31581385
DA 2020-07-08
ER

PT J
AU Wahl, A
   De, C
   Fernandez, MA
   Lenarcic, EM
   Xu, YY
   Cockrell, AS
   Cleary, RA
   Johnson, CE
   Schramm, NJ
   Rank, LM
   Newsome, IG
   Vincent, HA
   Sanders, W
   Aguilera-Sandoval, CR
   Boone, A
   Hildebrand, WH
   Dayton, PA
   Baric, RS
   Pickles, RJ
   Braunstein, M
   Moorman, NJ
   Goonetilleke, N
   Garcia, JV
AF Wahl, Angela
   De, Chandrav
   Fernandez, Maria Abad
   Lenarcic, Erik M.
   Xu, Yinyan
   Cockrell, Adam S.
   Cleary, Rachel A.
   Johnson, Claire E.
   Schramm, Nathaniel J.
   Rank, Laura M.
   Newsome, Isabel G.
   Vincent, Heather A.
   Sanders, Wes
   Aguilera-Sandoval, Christian R.
   Boone, Allison
   Hildebrand, William H.
   Dayton, Paul A.
   Baric, Ralph S.
   Pickles, Raymond J.
   Braunstein, Miriam
   Moorman, Nathaniel J.
   Goonetilleke, Nilu
   Garcia, J. Victor
TI Precision mouse models with expanded tropism for human pathogens
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID CD8(+) T-CELLS; HUMAN CYTOMEGALOVIRUS; IN-VIVO; ANIMAL-MODELS;
   IMMUNE-RESPONSES; HIV PERSISTENCE; VIRUS-INFECTION; MICE; CD4(+);
   PROLIFERATION
AB A major limitation of current humanized mouse models is that they primarily enable the analysis of human-specific pathogens that infect hematopoietic cells. However, most human pathogens target other cell types, including epithelial, endothelial and mesenchymal cells. Here, we show that implantation of human lung tissue, which contains up to 40 cell types, including nonhematopoietic cells, into immunodeficient mice (lung-only mice) resulted in the development of a highly vascularized lung implant. We demonstrate that emerging and clinically relevant human pathogens such as Middle East respiratory syndrome coronavirus, Zika virus, respiratory syncytial virus and cytomegalovirus replicate in vivo in these lung implants. When incorporated into bone marrow/liver/thymus humanized mice, lung implants are repopulated with autologous human hematopoietic cells. We show robust antigen-specific humoral and T-cell responses following cytomegalovirus infection that control virus replication. Lung-only mice and bone marrow/liver/thymus-lung humanized mice substantially increase the number of human pathogens that can be studied in vivo, facilitating the in vivo testing of therapeutics.
C1 [Wahl, Angela; De, Chandrav; Cleary, Rachel A.; Johnson, Claire E.; Schramm, Nathaniel J.; Aguilera-Sandoval, Christian R.; Garcia, J. Victor] Univ N Carolina, Div Infect Dis, Int Ctr Adv Translat Sci, Ctr AIDS Res,Sch Med, Chapel Hill, NC 27515 USA.
   [Fernandez, Maria Abad; Lenarcic, Erik M.; Xu, Yinyan; Rank, Laura M.; Vincent, Heather A.; Sanders, Wes; Boone, Allison; Baric, Ralph S.; Pickles, Raymond J.; Braunstein, Miriam; Moorman, Nathaniel J.; Goonetilleke, Nilu] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Lenarcic, Erik M.; Vincent, Heather A.; Sanders, Wes; Moorman, Nathaniel J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.
   [Cockrell, Adam S.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.
   [Newsome, Isabel G.; Dayton, Paul A.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27515 USA.
   [Newsome, Isabel G.; Dayton, Paul A.] North Carolina State Univ, Chapel Hill, NC USA.
   [Boone, Allison; Pickles, Raymond J.] Univ N Carolina, Marsico Lung Inst, Chapel Hill, NC 27515 USA.
   [Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.
   [Goonetilleke, Nilu] Univ N Carolina, UNC HIV Cure Ctr, Chapel Hill, NC 27515 USA.
   [Aguilera-Sandoval, Christian R.] BD Life Sci, San Jose, CA USA.
RP Wahl, A; Garcia, JV (corresponding author), Univ N Carolina, Div Infect Dis, Int Ctr Adv Translat Sci, Ctr AIDS Res,Sch Med, Chapel Hill, NC 27515 USA.
EM angela_wahl@med.unc.edu; victor_garcia@med.unc.edu
RI Abad, Maria/AAC-3146-2020
OI Newsome, Isabel/0000-0002-6145-591X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI103311, AI123811, AI110700,
   AI100625, P30 AI027763, AI113736, T32 HL069768, AI123010, AI111899,
   AI140799, MH108179, CA189479, CA170665]; North Carolina University
   Cancer Research Fund; UNC Center for AIDS Research (CFAR) [P30 AI050410]
FX This work was supported by NIH grants no. AI103311 (N.J.M.), no.
   AI123811 (N.J.M.), no. AI110700 (R.S.B.), no. AI100625 (R.S.B.), no. P30
   AI027763 (N.G.), no. AI113736 (R.J.P.), no. T32 HL069768 (I.G.N.), no.
   AI123010 (A.W.), no. AI111899 (J.V.G.), no. AI140799 (J.V.G.), no.
   MH108179 (J.V.G.), no. CA189479 (P.A.D.) and no. CA170665 (P.A.D) and
   the North Carolina University Cancer Research Fund (N.J.M.). This work
   was also supported by the UNC Center for AIDS Research (CFAR) (grant no.
   P30 AI050410). We thank K. Arend for the generation of HCMV virus stocks
   used in these experiments. We thank P. Collins and M. Peeples for
   recombinant RSV expressing GFP and C. O'Connor for recombinant HCMV
   TB40/E expressing luciferase. We thank G. Clutton for input on the
   analysis of antigen-specific T-cell responses. The authors thank members
   of the Garcia laboratory for technical assistance. We thank technicians
   at the UNC Animal Histopathology Core, The Marsico Lung Institute Tissue
   and Procurement Core, and the Department of Comparative Medicine. We
   also thank J. Schmitz and technicians at the UNC Clinical
   Microbiology/Immunology Laboratories. We thank J. Nelson and technicians
   at the UNC CFAR Virology Core Laboratory and K. Mollan at the UNC CFAR
   Biostatistics Core. The authors thank M.T. Heise, L.J. Picker and J.P.
   Ting for manuscript advice and helpful discussions.
CR AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7
   Arend KC, 2016, J VIROL, V90, P8855, DOI 10.1128/JVI.00741-16
   Azevedo LS, 2015, CLINICS, V70, P515, DOI 10.6061/clinics/2015(07)09
   Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005
   Braendstrup P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094892
   Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08
   Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226
   Cockrell AS, 2014, J VIROL, V88, P5195, DOI 10.1128/JVI.03764-13
   Coleman CM, 2014, J GEN VIROL, V95, P408, DOI 10.1099/vir.0.060640-0
   Crawford LB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01051-5
   Crawford LB, 2015, CURR OPIN VIROL, V13, P86, DOI 10.1016/j.coviro.2015.06.006
   Cunha BA, 2010, INFECT DIS CLIN N AM, V24, P147, DOI 10.1016/j.idc.2009.10.008
   Davis LS, 2002, AM J PATHOL, V160, P357, DOI 10.1016/S0002-9440(10)64379-9
   Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984
   Fonseca KL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006421
   Franks Teri J, 2008, Proc Am Thorac Soc, V5, P763, DOI 10.1513/pats.200803-025HR
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Fulcher M Leslie, 2005, Methods Mol Med, V107, P183
   Gamadia LE, 2004, HUM IMMUNOL, V65, P486, DOI 10.1016/j.humimm.2004.02.020
   Garcia JV, 2016, CURR OPIN VIROL, V19, P56, DOI 10.1016/j.coviro.2016.06.010
   Gessner R, 2010, IEEE T ULTRASON FERR, V57, P1772, DOI 10.1109/TUFFC.2010.1615
   Gessner RC, 2013, INT J BIOMED IMAGING, DOI 10.1155/2013/936593
   Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000
   Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006
   Gordon CL, 2017, J EXP MED, V214, P651, DOI 10.1084/jem.20160758
   Gupta UD, 2005, TUBERCULOSIS, V85, P277, DOI 10.1016/j.tube.2005.08.008
   Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Honeycutt JB, 2017, NAT MED, V23, P638, DOI 10.1038/nm.4319
   Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Huang SY, 2004, AM J PATHOL, V164, P747, DOI 10.1016/S0002-9440(10)63162-8
   Islas-Ohlmayer M, 2004, J VIROL, V78, P13891, DOI 10.1128/JVI.78.24.13891-13900.2004
   Jackson SE, 2014, J VIROL, V88, P10894, DOI 10.1128/JVI.01477-14
   Kessing CF, 2017, CELL REP, V21, P600, DOI 10.1016/j.celrep.2017.09.080
   Khan N, 2002, J INFECT DIS, V185, P1025, DOI 10.1086/339963
   Kovarova M, 2016, J ANTIMICROB CHEMOTH, V71, P1586, DOI 10.1093/jac/dkw042
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liesman RM, 2014, J CLIN INVEST, V124, P2219, DOI 10.1172/JCI72948
   Lilleri D, 2007, AM J TRANSPLANT, V7, P1997, DOI 10.1111/j.1600-6143.2007.01890.x
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lyon SM, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0032-2016
   Martinez-Torres F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108663
   Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Munro SC, 2005, J CLIN MICROBIOL, V43, P4713, DOI 10.1128/JCM.43.9.4713-4718.2005
   Nastke MD, 2005, CELL MOL LIFE SCI, V62, P77, DOI 10.1007/s00018-004-4363-x
   Nochi T, 2013, CELL REP, V3, P1874, DOI 10.1016/j.celrep.2013.05.037
   O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10
   Olesen R, 2016, J CLIN INVEST, V126, P892, DOI 10.1172/JCI64212
   Ostermann E., 2016, GENOME ANNOUNC, V4, P1
   Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014
   Pickles RJ, 2015, J PATHOL, V235, P266, DOI 10.1002/path.4462
   Pitt EA, 2016, ANTIVIR RES, V135, P15, DOI 10.1016/j.antiviral.2016.09.012
   Sacre K, 2008, J VIROL, V82, P10143, DOI 10.1128/JVI.00688-08
   Safronetz D, 2013, CURR OPIN VIROL, V3, P205, DOI 10.1016/j.coviro.2013.01.001
   Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020
   Schmitt K, 2018, VIROLOGY, V515, P235, DOI 10.1016/j.virol.2017.12.026
   Shelton SE, 2015, ULTRASOUND MED BIOL, V41, P1896, DOI 10.1016/j.ultrasmedbio.2015.02.012
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Sinclair E, 2004, VIRAL IMMUNOL, V17, P445, DOI 10.1089/0882824041857049
   Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0
   Smith MS, 2010, CELL HOST MICROBE, V8, P284, DOI 10.1016/j.chom.2010.08.001
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Taylor G, 2017, VACCINE, V35, P469, DOI 10.1016/j.vaccine.2016.11.054
   Tsai P, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2015.24
   Vaz-Santiago J, 2001, J VIROL, V75, P7840, DOI 10.1128/JVI.75.17.7840-7847.2001
   Wahl A, 2013, J VIROL, V87, P5437, DOI 10.1128/JVI.00281-13
   Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005
   Wang D, 2004, P NATL ACAD SCI USA, V101, P16642, DOI 10.1073/pnas.0407233101
   Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhou J, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0446-6
   Ziehr B, 2016, VIROLOGY, V489, P194, DOI 10.1016/j.virol.2015.12.009
NR 74
TC 18
Z9 18
U1 6
U2 10
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD OCT
PY 2019
VL 37
IS 10
BP 1163
EP +
DI 10.1038/s41587-019-0225-9
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA JI2ST
UT WOS:000493315800018
PM 31451733
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zhou, J
   Chi, XJ
   Cheng, M
   Huang, XY
   Liu, XY
   Fan, JJ
   Xu, H
   Lin, TL
   Shi, L
   Qin, CF
   Yang, W
AF Zhou, Jia
   Chi, Xiaojing
   Cheng, Min
   Huang, Xingyao
   Liu, Xiuying
   Fan, Jingjing
   Xu, Hua
   Lin, Tianli
   Shi, Lei
   Qin, Chengfeng
   Yang, Wei
TI Zika virus degrades the omega-3 fatty acid transporter Mfsd2a in brain
   microvascular endothelial cells and impairs lipid homeostasis
SO SCIENCE ADVANCES
LA English
DT Article
AB Zika virus (ZIKV) infection during pregnancy increases the risk of postnatal microcephaly. Neurovascular function provides a homeostatic environment for proper brain development. The major facilitator superfamily domain-containing protein 2 (Mfsd2a) is selectively expressed in human brain microvascular endothelial cells (hBMECs) and is the major transporter mediating the brain uptake of docosahexaenoic acid (DHA). We have discovered a pivotal role for Mfsd2a in the pathogenesis of ZIKV. ZIKV disrupted Mfsd2a both in cultured primary hBMECs and in the neonatal mouse brain. ZIKV envelope (E) protein specifically interacted with Mfsd2a and promoted Mfsd2a polyubiquitination for proteasome-dependent degradation. Infection with ZIKV or ectopic expression of ZIKV E impaired Mfsd2-amediated DHA uptake. Lipidomic analysis revealed obvious differences in DHA-containing lipids after ZIKV infection. Supplementation with DHA rescued ZIKV-caused growth restriction and microcephaly. Our findings suggest endothelial Mfsd2a as an important pathogenic mediator and supplementation with DHA as a potential therapeutic option for ZIKV infection.
C1 [Zhou, Jia; Chi, Xiaojing; Cheng, Min; Liu, Xiuying; Fan, Jingjing; Xu, Hua; Lin, Tianli; Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing, Peoples R China.
   [Zhou, Jia; Chi, Xiaojing; Cheng, Min; Liu, Xiuying; Fan, Jingjing; Xu, Hua; Lin, Tianli; Shi, Lei; Yang, Wei] Peking Union Med Coll, Beijing, Peoples R China.
   [Huang, Xingyao; Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Shi, Lei] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing, Peoples R China.
RP Yang, W (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing, Peoples R China.; Yang, W (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.
EM wyang@ipb.pumc.edu.cn
RI Zhou, Jia/AAG-7370-2020
OI Xu, Hua/0000-0001-8470-5558
FU CAMS Initiative for Innovative Medicine Grant [2016-I2M-3-020]; National
   Basic Research Program of ChinaNational Basic Research Program of China
   [2015CB554301]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81871667, 81672030]; National
   Science and Technology Major Project [2017ZX10304402-001-013]
FX This work was supported by CAMS Initiative for Innovative Medicine Grant
   2016-I2M-3-020, National Basic Research Program of China Grant
   2015CB554301, National Natural Science Foundation of China Grants
   81871667 and 81672030, and National Science and Technology Major Project
   2017ZX10304402-001-013.
CR Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043
   Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324
   Bozek K, 2015, NEURON, V85, P695, DOI 10.1016/j.neuron.2015.01.003
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu SH, 2012, BRAIN RES, V1451, P19, DOI 10.1016/j.brainres.2012.02.060
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Parletta N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156432
   SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X
   Xuan QH, 2018, ANAL CHEM, V90, P7608, DOI 10.1021/acs.analchem.8b01331
   Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 21
TC 1
Z9 1
U1 0
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD OCT
PY 2019
VL 5
IS 10
AR eaax7142
DI 10.1126/sciadv.aax7142
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JH9AP
UT WOS:000493059800025
PM 31681849
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Surnar, B
   Kamran, MZ
   Shah, AS
   Basu, U
   Kolishetti, N
   Deo, S
   Jayaweera, DT
   Daunert, S
   Dhar, S
AF Surnar, Bapurao
   Kamran, Mohammad Z.
   Shah, Anuj S.
   Basu, Uttara
   Kolishetti, Nagesh
   Deo, Sapna
   Jayaweera, Dushyantha T.
   Daunert, Sylvia
   Dhar, Shanta
TI Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus
SO ACS NANO
LA English
DT Article
DE oral delivery; viral disease; dry formulation; placental barrier;
   epithelial crossing; Fc receptor
ID NEONATAL FC-RECEPTOR; POLYMERIC NANOPARTICLES; DRUG-DELIVERY;
   IVERMECTIN; INHIBITORS; STABILITY; TRANSPORT; DESIGN; IGG
AB The spread of Zika virus (ZIKV) infection across the USA and various countries in the last three years will not only have a direct impact on the U.S. health care system but has caused international concerns as well. The ultimate impact of ZIKV infection remains to be understood. Currently, there are no therapeutic or vaccine options available to protect those infected by ZIKV. The drug ivermectin (IVM) was found to be a viable agent for the prevention of transmission of ZIKV. Ivermectin is unstable in the presence of water and does not remain in adequate concentration in the human bloodstream to be effective in treatment for ZIKV. Biodegradable nanoparticles would aid in the delivery of ivermectin by providing a high enough concentration of drug and ensuring the drug is gradually released to maintain an appropriate level in the body. The overall goal of this study was to develop and optimize an orally administrable nanoformulation of IVM which can circulate in the blood for a long period for efficient delivery. To achieve the goal, we synthesized and optimized a synthetic nanoformulation of IVM for oral use which can cross the intestinal epithelial barrier to enter the bloodstream. Our studies documented that when delivered with the synthetic nanoparticle (NP), IVM can be accumulated in the blood at a higher concentration and preliminary studies highlighted that NP delivered IVM has the ability to target nonstructural 1 protein of ZIKV. For potential clinical relevance, long-term storable formulation of IVM-nanoparticle in dry powder state for inclusion in a capsule form and cryoprotectant containing frozen forms revealed promising findings. Further, our preliminary in vitro studies documented that ivermectin crosses the placental barrier, thus making it unsafe for the pregnant ZIKV population, whereas the ivermectin-loaded nanoparticle did not show any significant placental barrier crossing, thus indicating its potential suitability for such population. We envision that this work will fill a great unmet need by developing safer and more effective therapies for the treatment of viral infections, including ZIKV.
C1 [Surnar, Bapurao; Kamran, Mohammad Z.; Shah, Anuj S.; Basu, Uttara; Kolishetti, Nagesh; Deo, Sapna; Daunert, Sylvia; Dhar, Shanta] Univ Miami, Leonard M Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA.
   [Surnar, Bapurao; Kamran, Mohammad Z.; Daunert, Sylvia; Dhar, Shanta] Univ Miami, Leonard M Miller Sch Med, Dr JT Macdonald Fdn Biomed Nanotechnol Inst, 1951 NW 7th Ave,Suite 475, Miami, FL 33136 USA.
   [Deo, Sapna; Daunert, Sylvia; Dhar, Shanta] Univ Miami, Leonard M Miller Sch Med, Sylvester Comprehens Canc Ctr, 1475 NW 12th Ave, Miami, FL 33136 USA.
   [Jayaweera, Dushyantha T.; Daunert, Sylvia] Univ Miami, Leonard M Miller Sch Med, Clin & Translat Sci Inst, 1120 NW 14th St,Suite 710, Miami, FL 33136 USA.
   [Jayaweera, Dushyantha T.] Univ Miami, Leonard M Miller Sch Med, Miami Ctr AIDS Res, Dept Med, 1580 NW 10th Ave, Miami, FL 33136 USA.
   [Kolishetti, Nagesh] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol & Nanomed, Miami, FL 33199 USA.
RP Dhar, S (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA.; Dhar, S (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dr JT Macdonald Fdn Biomed Nanotechnol Inst, 1951 NW 7th Ave,Suite 475, Miami, FL 33136 USA.; Dhar, S (corresponding author), Univ Miami, Leonard M Miller Sch Med, Sylvester Comprehens Canc Ctr, 1475 NW 12th Ave, Miami, FL 33136 USA.
EM shantadhar@med.miami.edu
RI ; Kolishetti, Nagesh/K-2810-2012
OI Daunert, Sylvia/0000-0003-4760-5528; Kolishetti,
   Nagesh/0000-0001-5574-673X; Dhar, Shanta/0000-0003-3042-5272; Surnar,
   Bapurao/0000-0001-5997-3120
FU Florida Department of Health Zika Research Grant Initiative Award
   [7ZK28]; Sylvester Comprehensive Cancer Center, University of Miami
   Miller School of Medicine; NIGMSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM114321,
   R01GM127706]; National Science FoundationNational Science Foundation
   (NSF) [CHE-1506740,, CBET-1841419]
FX This work was supported by the Florida Department of Health Zika
   Research Grant Initiative Award No. 7ZK28 and by the Sylvester
   Comprehensive Cancer Center, University of Miami Miller School of
   Medicine. S. Deo and S. Daunert thank NIGMS (R01GM114321, R01GM127706)
   and the National Science Foundation (CHE-1506740, CBET-1841419) for
   funding support. S. Daunert is grateful to the Miller School of Medicine
   of the University of Miami for the Lucille P. Markey Chair in
   Biochemistry and Molecular Biology. We thank Kathryn S. Smith for her
   initial involvement in these studies. We also thank Patricio Pichling
   for his help in synthesizing Mal-NHS.
CR Ali M, 2014, PARASITOL RES, V113, P681, DOI 10.1007/s00436-013-3696-5
   Barreiro P, 2016, AIDS REV, V18, P54
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Binnebose AM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004173
   Chopra S, 2017, ACS APPL MATER INTER, V9, P11440, DOI 10.1021/acsami.6b16854
   Cola DF, 2016, QUIM NOVA, V39, P1034, DOI 10.21577/0100-4042.20160123
   Croci R, 2016, INT J BIOMATER, DOI 10.1155/2016/8043983
   Dallmeier K, 2016, CELL HOST MICROBE, V20, P420, DOI 10.1016/j.chom.2016.09.011
   Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108
   Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   ELKASSABY MH, 1991, TROP MED PARASITOL, V42, P79
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550
   Guo DW, 2018, ARTIF CELL NANOMED B, V46, P255, DOI 10.1080/21691401.2017.1307207
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x
   Starkloff WJ, 2017, PHARM DEV TECHNOL, V22, P809, DOI 10.1080/10837450.2016.1200078
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   Tavares EJM, 2017, J NANOSCI NANOTECHNO, V17, P4218, DOI 10.1166/jnn.2017.13111
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Pridgen EM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007049
   RAGHAVAN M, 1993, BIOCHEMISTRY-US, V32, P8654, DOI 10.1021/bi00084a037
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Shi SJ, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801655
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Surnar B, 2018, P NATL ACAD SCI USA, V115, pE12333, DOI 10.1073/pnas.1816429115
   Gamboa GVU, 2016, PARASITOL RES, V115, P1945, DOI 10.1007/s00436-016-4937-1
   Ullio-Gamboa G, 2017, PARASITOL RES, V116, P2111, DOI 10.1007/s00436-017-5510-2
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007
   Zhu X, 2016, ANGEW CHEM INT EDIT, V55, P3309, DOI 10.1002/anie.201509183
NR 35
TC 2
Z9 2
U1 15
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD OCT
PY 2019
VL 13
IS 10
BP 11034
EP 11048
DI 10.1021/acsnano.9b02807
PG 15
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA JH5IF
UT WOS:000492801600016
PM 31603314
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Miao, M
   Yu, F
   Wang, DY
   Tong, YJ
   Yang, LT
   Xu, JY
   Qiu, Y
   Zhou, X
   Zhao, XL
AF Miao, Meng
   Yu, Fei
   Wang, Danya
   Tong, Yongjia
   Yang, Liuting
   Xu, Jiuyue
   Qiu, Yang
   Zhou, Xi
   Zhao, Xiaolu
TI Proteomics Profiling of Host Cell Response via Protein Expression and
   Phosphorylation upon Dengue Virus Infection
SO VIROLOGICA SINICA
LA English
DT Article
DE Dengue virus (DENV); Quantitative proteomics; Virus-host interaction;
   Protein expression; Protein phosphorylation
ID REGULATORY ELEMENT-BINDING; SPLICING INHIBITION; GENE ONTOLOGY; ZIKA
   VIRUS; REPLICATION; IDENTIFICATION; CYTOSCAPE; INTERACTS; OUTBREAK;
   REVEALS
AB Dengue virus (DENV) infection is a worldwide public health threat. To date, the knowledge about the pathogenesis and progression of DENV infection is still limited. Combining global profiling based on proteomic analysis together with functional verification analysis is a powerful strategy to investigate the interplay between the virus and host cells. In the present study, quantitative proteomics has been applied to evaluate host responses (as indicated by altered proteins and modifications) in human cells (using K562 cell line) upon DENV-2 infection, as DENV-2 spreads most widely among all DENV serotypes. Comparative analysis was performed to define differentially expressed proteins in the infected cells compared to the mock-control, and it revealed critical pathogen-induced changes covering a broad spectrum of host cellular compartments and processes. We also discovered more dramatic changes (> 20%, 160 regulated phosphoproteins) in protein phosphorylation compared to protein expression (14%, 321 regulated proteins). Most of these proteins/phosphoproteins were involved in transcription regulation, RNA splicing and processing, immune system, cellular response to stimulus, and macromolecule biosynthesis. Western blot analysis was also performed to confirm the proteomic data. Potential roles of these altered proteins were discussed. The present study provides valuable large-scale protein-related information for elucidating the functional emphasis of host cell proteins and their post-translational modifications in virus infection, and also provides insight and protein evidence for understanding the general pathogenesis and pathology of DENV.
C1 [Miao, Meng; Yu, Fei; Wang, Danya; Tong, Yongjia; Yang, Liuting; Zhou, Xi; Zhao, Xiaolu] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.
   [Yu, Fei; Wang, Danya; Tong, Yongjia; Yang, Liuting; Zhao, Xiaolu] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.
   [Xu, Jiuyue; Qiu, Yang; Zhou, Xi] Chinese Acad Sci, Wuhan Inst Virol, Lab RNA Virol, Wuhan 430071, Peoples R China.
RP Zhou, X; Zhao, XL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.; Zhao, XL (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Zhou, X (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Lab RNA Virol, Wuhan 430071, Peoples R China.
EM zhouxi@whu.edu.cn; zhaoxiaolu@whu.edu.cn
OI Zhou, Xi/0000-0002-3846-5079; Zhao, Xiaolu/0000-0003-1535-3880
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31870827, 31670161, 81873964]; Hubei Natural
   Science FoundationNatural Science Foundation of Hubei Province
   [2018CFB603]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [2042018kf0247]
FX This work was supported by the National Natural Science Foundation of
   China (31870827 to X.Zhao, 31670161 to X.Zhou., and 81873964 to Y.Q.),
   the Hubei Natural Science Foundation (2018CFB603 to X.Zhao) and the
   Fundamental Research Funds for the Central Universities (2042018kf0247
   to X.Zhao). We are grateful for the technical support provided by Dr.
   Hui Zhao (Beijing, China).
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Adams DJ, 2001, J CELL BIOL, V154, P25, DOI 10.1083/jcb.200010059
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Alvarez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073723
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Clements DR, 2017, J PROTEOME RES, V16, P3391, DOI 10.1021/acs.jproteome.7b00425
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Ersing I, 2017, CELL REP, V19, P1479, DOI 10.1016/j.celrep.2017.04.062
   Fliss MS, 1999, MOL ENDOCRINOL, V13, P644, DOI 10.1210/me.13.4.644
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Hsu JL, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0364
   Huynh VTT, 2016, J BIOL CHEM, V291, P22607, DOI 10.1074/jbc.M116.727081
   Komatsu T, 2018, J VIROL, V92, DOI 10.1128/JVI.00795-18
   Kong L, 2016, J VIROL, V90, P3093, DOI 10.1128/JVI.01540-15
   Li G, 2017, VIROL SIN, V32, P63, DOI 10.1007/s12250-016-3872-8
   Lindberg A, 2002, VIROLOGY, V294, P189, DOI 10.1006/viro.2001.1301
   Liu XF, 2018, VIROLOGY, V515, P11, DOI 10.1016/j.virol.2017.11.019
   Liu ZX, 2006, P NATL ACAD SCI USA, V103, P10917, DOI 10.1073/pnas.0602923103
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138
   Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Schubert OT, 2017, NAT PROTOC, V12, P1289, DOI 10.1038/nprot.2017.040
   Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Singh KK, 2010, RNA, V16, P2442, DOI 10.1261/rna.2304410
   Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463
   Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Thongtan T, 2004, J MED VIROL, V72, P436, DOI 10.1002/jmv.20004
   Viemann D, 2011, J IMMUNOL, V186, P164, DOI 10.4049/jimmunol.0904170
   Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859
   Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   World Health Organization, DENG SEV DENG
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k
   Zhang S, 2014, CLIN TRANSL ONCOL, V16, P293, DOI 10.1007/s12094-013-1072-7
   Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0
   Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548
   Zhao XL, 2014, J PROTEOME RES, V13, P2359, DOI 10.1021/pr401163t
NR 50
TC 1
Z9 1
U1 2
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD OCT
PY 2019
VL 34
IS 5
BP 549
EP 562
DI 10.1007/s12250-019-00131-2
PG 14
WC Virology
SC Virology
GA JH2JH
UT WOS:000492595700007
PM 31134586
OA Green Published
DA 2020-07-08
ER

PT J
AU Kim, J
   Yang, J
   Kim, YB
   Lee, HJ
   Kim, S
   Poo, H
AF Kim, Jaemoo
   Yang, Jihyun
   Kim, Young Bong
   Lee, Hee-Jung
   Kim, Sehyun
   Poo, Haryoung
TI Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya
   Diagnosis
SO VIROLOGICA SINICA
LA English
DT Article
DE Chikungunya virus (CHIKV); Envelope 2; Monoclonal antibody; Diagnosis;
   Sensitivity; Specificity
ID VIRUS; ALPHAVIRUSES; EPITOPE; E2; INFECTIONS; ANTIGEN; BINDING; ENTRY
AB Chikungunya fever is a vector-borne viral disease transmitted to humans by chikungunya virus (CHIKV)-infected mosquitoes. There have been many outbreaks of CHIKV infection worldwide, and the virus poses ongoing risks to global health. To prevent and control CHIKV infection, it is important to improve the current CHIKV diagnostic approaches to allow for the detection of low CHIKV concentrations and to correctly distinguish CHIKV infections from those due to other mosquito-transmitted viruses, including dengue virus (DENV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV). Here, we produced monoclonal antibodies (mAbs) against the CHIKV envelope 2 protein (CHIKV-E2) and compared their sensitivity and specificity with commercially available mAbs using enzyme-linked immunosorbent assays (ELISA). Two anti-CHIKV-E2 mAbs, 19-1 and 21-1, showed higher binding affinities to CHIKV-E2 protein than the commercial mAbs did. In particular, the 19-1 mAb had the strongest binding affinity to inactivated CHIKV. Moreover, the 19-1 mAb had very little cross-reactivity with other mosquito-borne viruses, such as ZIKV, JEV, and DENV. These results suggest that the newly produced anti-CHIKV-E2 mAb, 19-1, could be used for CHIKV diagnostic approaches.
C1 [Kim, Jaemoo; Yang, Jihyun; Poo, Haryoung] Korea Res Inst Biosci & Biotechnol, Infect Dis Res Ctr, Daejeon 34141, South Korea.
   [Kim, Jaemoo; Poo, Haryoung] Univ Sci & Technol, Dept Biosyst & Bioengn, Daejeon 34113, South Korea.
   [Kim, Young Bong; Lee, Hee-Jung] Konkuk Univ, Dept Biomed Sci & Engn, Seoul 05029, South Korea.
   [Kim, Young Bong; Kim, Sehyun] Konkuk Univ, Dept Bioind Technol, Seoul 05029, South Korea.
RP Poo, H (corresponding author), Korea Res Inst Biosci & Biotechnol, Infect Dis Res Ctr, Daejeon 34141, South Korea.; Poo, H (corresponding author), Univ Sci & Technol, Dept Biosyst & Bioengn, Daejeon 34113, South Korea.
EM haryoung@kribb.re.kr
FU R&D Convergence Program of National Research Council of Science
   Technology [CAP-16-02-KIST]; National Research Foundation of
   KoreaNational Research Foundation of Korea [NRF-2016M3A9B6918584]
FX This work was supported by Grants from the R&D Convergence Program of
   National Research Council of Science & Technology (No. CAP-16-02-KIST)
   and the National Research Foundation of Korea (No.
   NRF-2016M3A9B6918584).
CR Bhandarkar M, 2011, INT J PHARM PHARM TE, V1, P11
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028
   Burdino E, 2016, EMERG INFECT DIS, V22, P1837, DOI 10.3201/eid2210.151784
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Fumagalli MJ, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1028-1
   Garoff H, 2004, VIRUS RES, V106, P103, DOI 10.1016/j.virusres.2004.08.008
   Heo CK, 2010, INT J ONCOL, V36, P1453, DOI 10.3892/ijo_00000631
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Jain J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1000-0
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302
   Shukla J, 2009, DIAGN MICR INFEC DIS, V65, P142, DOI 10.1016/j.diagmicrobio.2009.06.017
   SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Warter L, 2011, J IMMUNOL, V186, P3258, DOI 10.4049/jimmunol.1003139
   Weger-Lucarelli J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004163
   Wu WH, 2018, J MED VIROL, V90, P1681, DOI 10.1002/jmv.25253
NR 30
TC 2
Z9 2
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD OCT
PY 2019
VL 34
IS 5
BP 563
EP 571
DI 10.1007/s12250-019-00135-y
PG 9
WC Virology
SC Virology
GA JH2JH
UT WOS:000492595700008
PM 31214999
OA Green Published
DA 2020-07-08
ER

PT J
AU Liu, T
   Tang, L
   Tang, H
   Wu, M
   Huang, X
AF Liu, T.
   Tang, L.
   Tang, H.
   Wu, M.
   Huang, X.
TI Zika virus infection induces acute kidney injury by activating NLRP3
   inflammasome in mice
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Liu, T.; Tang, L.; Tang, H.; Wu, M.; Huang, X.] Sun Yat Sen Univ, Program Infect & Immun, Affiliated Hosp 5, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA P2478
BP 222
EP 222
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026900418
DA 2020-07-08
ER

PT J
AU Wang, H
   Wang, R
   Hu, S
   Gao, F
   Xiang, Y
   Cheng, G
   Yu, L
   Shi, X
   Zhang, F
   Zhang, L
AF Wang, H.
   Wang, R.
   Hu, S.
   Gao, F.
   Xiang, Y.
   Cheng, G.
   Yu, L.
   Shi, X.
   Zhang, F.
   Zhang, L.
TI Human neutralizing antibodies against Zika virus preferentially bind to
   fully mature virions
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Wang, H.; Wang, R.; Hu, S.; Gao, F.; Xiang, Y.; Cheng, G.; Shi, X.; Zhang, L.] Tsinghua Univ, Sch Med, Beijing, Peoples R China.
   [Yu, L.; Zhang, F.] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA O051
BP 988
EP 989
PG 2
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026903158
DA 2020-07-08
ER

PT J
AU Chen, J
   Yang, YF
   Yang, Y
   Zou, P
   Chen, J
   He, Y
   Shui, S
   Cui, Y
   Bai, R
   Liang, Y
   Hu, Y
   Jiang, B
   Lu, L
   Zhang, X
   Liu, J
   Xu, J
AF Chen, J.
   Yang, Y. -F
   Yang, Y.
   Zou, P.
   Chen, J.
   He, Y.
   Shui, S.
   Cui, Y.
   Bai, R.
   Liang, Y.
   Hu, Y.
   Jiang, B.
   Lu, L.
   Zhang, X.
   Liu, J.
   Xu, J.
TI AXL promotes Zika virus infection in astrocytes by antagonizing type I
   interferon signalling
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Chen, J.; Yang, Y.; Zou, P.; He, Y.; Bai, R.; Hu, Y.; Lu, L.; Zhang, X.; Xu, J.] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   [Chen, J.; Yang, Y.; Zou, P.; He, Y.; Bai, R.; Hu, Y.; Lu, L.; Zhang, X.; Xu, J.] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol,Minist Educ Hlth, Shanghai, Peoples R China.
   [Yang, Y. -F; Shui, S.; Cui, Y.; Liang, Y.; Jiang, B.; Liu, J.] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China.
   [Chen, J.] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden.
RI Lu, Lu/K-7070-2014
OI Lu, Lu/0000-0002-2255-0391
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA O054
BP 990
EP 990
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026903161
DA 2020-07-08
ER

PT J
AU Liang, Y
   Yi, P
   Luo, H
   Escano, J
   Wang, T
   Sun, J
AF Liang, Y.
   Yi, P.
   Luo, H.
   Escano, J.
   Wang, T.
   Sun, J.
TI IL-33 promotes antiviral immunity and protects against congenital Zika
   disease in mice
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Liang, Y.; Yi, P.; Luo, H.; Escano, J.; Wang, T.; Sun, J.] Univ Texas Med Branch, Galveston, TX 77555 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA P0318
BP 1021
EP 1021
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026903218
DA 2020-07-08
ER

PT J
AU Wang, R
   Yu, L
   Wang, L
   Gao, F
   Xiang, Y
   Zhang, F
   Zhang, L
AF Wang, R.
   Yu, L.
   Wang, L.
   Gao, F.
   Xiang, Y.
   Zhang, F.
   Zhang, L.
TI Antibody response and neutralizing mechanism against Zika virus during
   natural infection
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Wang, R.; Wang, L.; Gao, F.; Xiang, Y.; Zhang, L.] Tsinghua Univ, Sch Med, Beijing, Peoples R China.
   [Yu, L.; Zhang, F.] Guangzhou Eighth Peoples Hosp, Guangzhou, Guangdong, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA P1484
BP 1039
EP 1039
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026903253
DA 2020-07-08
ER

PT J
AU Zhang, H
   Liu, WJ
   Gao, GF
AF Zhang, H.
   Liu, W. J.
   Gao, G. F.
TI Characterization of ZIKV EIV9 epitope-specific CD8 T-cells in the
   immuneprivilege organs in virus-infected mice
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Zhang, H.; Liu, W. J.; Gao, G. F.] China CDC, Beijing, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA P2078
BP 1059
EP 1059
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026903290
DA 2020-07-08
ER

PT J
AU Lin, HH
   Yang, SP
   Tsai, MJ
   Lin, GC
   Wu, HC
   Wu, SC
AF Lin, H-H.
   Yang, S-P.
   Tsai, M-J.
   Lin, G-C.
   Wu, H-C.
   Wu, S. C.
TI Dengue and Zika virus domain III-flagellin fusion and glycan-masking E
   antigen for a prime-boost vaccine design
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Lin, H-H.; Yang, S-P.; Tsai, M-J.; Lin, G-C.; Wu, S. C.] Natl Tsing Hua Univ, Hsinchu, Taiwan.
   [Wu, H-C.] Acad Sinica, Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA P1087
BP 1672
EP 1672
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026905313
DA 2020-07-08
ER

PT J
AU Gao, F
AF Gao, F.
TI Longitudinal analysis reveals a dynamic antibody repertoire response to
   Zika virus infection in convalescent human based on next generation
   sequencing
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
C1 [Gao, F.] Tsinghua Univ, Sch Med, Beijing, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA P1772
BP 2006
EP 2006
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026907002
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Beier, JC
   Benelli, G
AF Wilke, Andre B. B.
   Beier, John C.
   Benelli, Giovanni
TI Complexity of the relationship between global warming and urbanization -
   an obscure future for predicting increases in vector-borne infectious
   diseases
SO CURRENT OPINION IN INSECT SCIENCE
LA English
DT Review
ID CLIMATE-CHANGE; VISCERAL LEISHMANIASIS; AEDES-ALBOPICTUS; ZIKA VIRUS;
   MALARIA; TICK; DENGUE; TRANSMISSION; EVOLUTION; AEGYPTI
AB Arthropod vectors are responsible for the transmission of many infectious diseases. Currently, more than three billion people living in endemic areas are exposed to vector-borne pathogens. Substantial differences in the biology of arthropod vectors make it extremely challenging to predict the incidence of vector-borne diseases in the future. However, global warming and urbanization both profoundly affect the ecology and distribution of arthropod vectors. Such processes often result in a biotic homogenization of species in a non-random process of biodiversity loss. The data presently available indicate a trend towards progressive increases in the presence and abundance of vectors capable of thriving in urban environments amongst humans, thus, increasing the contact between vectors and human hosts. As a consequence, we expect the incidence of vector-borne diseases to increase. In our opinion, resources should be made available and directed to strategies within the Integrated Vector Management framework, focusing on proven vector control tools. Besides, a substantial reduction of IVM costs would be achieved by observing environmental guidelines and providing basic sanitary infrastructure at early stages of its development. This could help to increase IVM effectiveness in attenuating social determinants of health and social inequities due to exposure to vectors.
C1 [Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM giovanni.benelli@unipi.it
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
CR Aguiar BS, 2018, INT J INFECT DIS, V70, P20, DOI 10.1016/j.ijid.2018.02.007
   Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Anversa L, 2018, REV ASSOC MED BRAS, V64, P281, DOI 10.1590/1806-9282.64.03.281
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Caillouet KA, 2008, EMERG INFECT DIS, V14, P804, DOI 10.3201/eid1405.071066
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   De Castilho Sanguinette C, 2015, PARASITE VECTOR, V8, P1
   de Fuentes-Vicente JA, 2018, ACTA TROP, V183, P23, DOI 10.1016/j.actatropica.2018.04.008
   Dear NF, 2018, MALARIA J, V17, P1
   Delgado S, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-48
   Dinesh DS, 2010, PLOS NEGLECT TROP D, V4, P1
   Drake JM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-213
   Estrada-Pena A, 2001, J PARASITOL, V87, P978, DOI 10.1645/0022-3395(2001)087[0978:CWACIH]2.0.CO;2
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Gloria-Soria A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1506
   Grijalva MJ, 2015, PLOS NEGLECT TROP D, V9, P1
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hartelt K, 2008, PARASITOL RES, V103, pS109, DOI 10.1007/s00436-008-1059-4
   Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Jongejan F, 2018, PARASITOLOGY, V2005, pS3
   Kassem HA, 2017, ACTA TROP, V176, P335, DOI 10.1016/j.actatropica.2017.08.034
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Labbo R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1352-0
   Levy MZ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1003
   Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509
   Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33
   LINDSAY SW, 2001, GLOB CHANGE HUM HLTH, V2, P80, DOI DOI 10.1023/A:1011995115713
   Lizzi KM, 2014, TRENDS PARASITOL, V30, P394, DOI 10.1016/j.pt.2014.06.001
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Lukan M, 2010, EMERG INFECT DIS, V16, P524, DOI 10.3201/eid1603.081364
   Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Monteiro FA, 2018, ADV PARASIT, V99, P265, DOI 10.1016/bs.apar.2017.12.002
   Morrow MG, 2010, REV PANAM SALUD PUBL, V28, P19, DOI 10.1590/S1020-49892010000700003
   Multini LC, 2019, TRENDS PARASITOL, V35, P383, DOI 10.1016/j.pt.2019.03.009
   Musso D, 2018, LANCET INFECT DIS, V3099, P1
   O'Leary DR, 2002, AM J TROP MED HYG, V66, P35, DOI 10.4269/ajtmh.2002.66.35
   Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015
   Orsini L, 2013, MOL ECOL, V22, P5983, DOI 10.1111/mec.12561
   Parola P, 2008, PLOS NEGLECT TROP D, V2, P1
   Patino LH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005876
   Patricola CM, 2018, NATURE, V563, P339, DOI 10.1038/s41586-018-0673-2
   Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103
   Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Porretta D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-271
   Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369
   Randolph SE, 2000, P ROY SOC B-BIOL SCI, V267, P1741, DOI 10.1098/rspb.2000.1204
   Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025
   Reba M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.34
   Reiter P, 2004, LANCET INFECT DIS, V4, P323, DOI 10.1016/S1473-3099(04)01038-2
   Reiter P, 2000, EMERG INFECT DIS, V6, P438, DOI 10.3201/eid0604.000431
   Reiter P., 2008, MALAR J S1, V7, P1
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rogers DJ, 2000, SCIENCE, V289, P1763
   Rojas MR, 2002, SUBST USE MISUSE, V37, P687, DOI 10.1081/JA-120004279
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Serra-vega J, 1990, Earthwatch, P7
   Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956
   Silva-dos-Santos D, 2017, PLOS NEGLECT TROP D, V11, P1
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   Siraj AS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1383
   Suss J, 2008, J TRAVEL MED, V15, P39, DOI 10.1111/j.1708-8305.2007.00176.x
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO/UNICEF, 2017, EP UPD YELL FEV, P1
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Wilke ABB, 2018, INFECT GENET EVOL, V65, P333, DOI 10.1016/j.meegid.2018.08.017
   World Health Organization, 2017, GLOB MAL PROGR
   World Health Organization, 2012, HDB INT VECT MAN
   Wunderlich J, 2018, EPIDEMIOL INFECT, V146, P236, DOI 10.1017/S0950268817002801
   Zeman P, 2004, INT J MED MICROBIOL, V293, P48, DOI 10.1016/S1433-1128(04)80008-1
NR 107
TC 5
Z9 5
U1 16
U2 37
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2214-5745
EI 2214-5753
J9 CURR OPIN INSECT SCI
JI Curr. Opin. Insect Sci.
PD OCT
PY 2019
VL 35
SI SI
BP 1
EP 9
DI 10.1016/j.cois.2019.06.002
PG 9
WC Biology; Ecology; Entomology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Entomology
GA JE7VJ
UT WOS:000490898000003
PM 31279898
DA 2020-07-08
ER

PT J
AU Malekshahi, Z
   Schiela, B
   Bernklau, S
   Thielens, N
   Wurzner, R
   Weiss, G
   Banki, Z
   Stiasny, K
   Stoiber, H
AF Malekshahi, Zahra
   Schiela, Britta
   Bernklau, Sarah
   Thielens, Nicole
   Wuerzner, Reinhard
   Weiss, Guenter
   Banki, Zoltan
   Stiasny, Karin
   Stoiber, Heribert
TI INCORPORATION OF CD55 INTO THE VIRAL ENVELOPE CONTRIBUTES TO THE
   STABILITY OF ZIKA VIRUS AGAINST HUMAN COMPLEMENT
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th European Meeting on Complement in Human Disease (EMCHD)
CY SEP 14-17, 2019
CL Madrid, SPAIN
C1 [Malekshahi, Zahra; Schiela, Britta; Bernklau, Sarah; Wuerzner, Reinhard; Weiss, Guenter; Banki, Zoltan; Stoiber, Heribert] Med Univ Innsbruck, Innsbruck, Austria.
   [Thielens, Nicole] Univ Grenoble Alpes, CNRS, IBS, CEA, Grenoble, France.
   [Stiasny, Karin] Med Univ Vienna, Ctr Virol, Vienna, Austria.
RI Thielens, Nicole M/F-2512-2013
OI Thielens, Nicole M/0000-0002-7354-0302
FU FWF (FWF-Horos Doctoral Program) [W1253-B24, I-2550]
FX Supported by the FWF (FWF-Horos Doctoral Program, W1253-B24, and I-2550)
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD OCT
PY 2019
VL 114
MA 24
BP 419
EP 419
PG 1
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA JE3WN
UT WOS:000490625600089
DA 2020-07-08
ER

PT J
AU Girdler, G
   Gracia, T
   Fountain, D
   Fajardo, T
   Finlay, J
   Hallou, C
   Pollard, S
   Sweeney, T
   Gergely, F
   Rowitch, D
   Bulstrode, H
AF Girdler, Gemma
   Gracia, Tannia
   Fountain, Daniel
   Fajardo, Ted, Jr.
   Finlay, Jack
   Hallou, Clement
   Pollard, Steve
   Sweeney, Trevor
   Gergely, Fanni
   Rowitch, David
   Bulstrode, Harry
TI IDENTIFYING THE ZIKA VIRUS TARGET CELL IN MALIGNANT GLIOMA
SO NEURO-ONCOLOGY
LA English
DT Meeting Abstract
CT Meeting of the British-Neuro-Oncology-Society (BNOS)
CY JUL 03-05, 2019
CL Univ Winchester, Winchester, ENGLAND
SP British Neuro Oncol Soc, Soc Neuro Oncol, Japan Soc Appl Phys, SPARC
HO Univ Winchester
C1 [Girdler, Gemma; Bulstrode, Harry] Univ Cambridge, Dept Clin Neurosci, Wellcome MRC Stem Cell Inst, Cambridge, England.
   [Gracia, Tannia; Gergely, Fanni] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.
   [Pollard, Steve] MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.
   [Pollard, Steve] Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland.
   [Fajardo, Ted, Jr.; Sweeney, Trevor] Univ Cambridge, Dept Pathol, Div Virol, Cambridge, England.
   [Fountain, Daniel; Finlay, Jack; Hallou, Clement; Rowitch, David] Univ Cambridge, Wellcome MRC Stem Cell Inst, Dept Paediat, Cambridge, England.
   [Fountain, Daniel] Salford Royal NHS Fdn Trust, Dept Neurosurg, Salford, Lancs, England.
OI Rowitch, David/0000-0002-0079-0060
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1522-8517
EI 1523-5866
J9 NEURO-ONCOLOGY
JI Neuro-Oncology
PD OCT
PY 2019
VL 21
SU 4
BP 2
EP 2
DI 10.1093/neuonc/noz167.005
PG 1
WC Oncology; Clinical Neurology
SC Oncology; Neurosciences & Neurology
GA JF2UM
UT WOS:000491241200007
DA 2020-07-08
ER

PT J
AU Van der Beken, Y
   De Geyter, D
   Van Esbroeck, M
AF Van der Beken, Y.
   De Geyter, D.
   Van Esbroeck, M.
TI Performance evaluation of the Diasorin LIAISON (R) XL Zika capture IgM
   CLIA test
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Performance evaluation; ZIKV; Cross-reactivity; Diagnosis; Liaison XL;
   Diasorin
AB Because Zika virus (ZIKV) can cause serious birth defects and is involved in cases of Guillain-Barre syndrome, the ZIKV outbreak in the American continent in 2015 resulted in an enormous need for ZIKV diagnostic tools. We evaluated the LIAISON (R) XL Zika Capture IgM test on 106 samples from patients, mainly travelers, with a confirmed or probable ZIKV infection. Sensitivity between 0 and 84 days after onset of symptoms was 92.5%. Specificity was evaluated on a panel of 56 samples known to cause possible cross-reactions. Cross-reaction with DENV antibodies was limited (10.5%) but false-positive results occurred in samples from patients with malaria, CMV and EBV infections. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Van der Beken, Y.; Van Esbroeck, M.] Natl Reference Ctr Arboviruses, Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Van der Beken, Y.; De Geyter, D.] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Microbiol, Brussels, Belgium.
RP Van der Beken, Y (corresponding author), Laarbeeklaan 101, B-1090 Brussels, Belgium.
EM Yolien.vanderbeken@uzbrussel.be
FU Belgian Ministry of Social Affairs through a fund within the Health
   Insurance System
FX The LIAISON (R) XL Zika Capture IgM kit was provided by Diasorin. The
   national reference center for arboviruses is partially supported by the
   Belgian Ministry of Social Affairs through a fund within the Health
   Insurance System.
CR Basile AJ, 2018, J VIROL METHODS, V260, P26, DOI 10.1016/j.jviromet.2018.06.018
   Bingham AM, 2016, MMWR MORB MORTAL WKL, V65
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Diaz-Menendez M, 2018, ENFERM INFEC MICR CL, V36, P4, DOI 10.1016/j.eimc.2016.08.003
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, INT CAS DEF SURV ZIK
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sloan A, 2018, DIAGN MICR INFEC DIS, V90, P264, DOI 10.1016/j.diagmicrobio.2017.11.018
   Spiteri G, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.41.17-00254
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Van den Bossche D, 2019, EUR J CLIN MICROBIOL, V38, P771, DOI 10.1007/s10096-019-03472-8
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), 2017, SIT REP HIST ZIK VIR
NR 22
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD OCT
PY 2019
VL 95
IS 2
BP 144
EP 148
DI 10.1016/j.diagmicrobio.2019.05.004
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA JD5VJ
UT WOS:000490050200007
PM 31171395
DA 2020-07-08
ER

PT J
AU Hemme, RR
   Vizcaino, L
   Harris, AF
   Felix, G
   Kavanaugh, M
   Kenney, JL
   Nazario, NM
   Godsey, MS
   Barrera, R
   Miranda, J
   Lenhart, A
AF Hemme, Ryan R.
   Vizcaino, Lucrecia
   Harris, Angela F.
   Felix, Gilberto
   Kavanaugh, Michael
   Kenney, Joan L.
   Nazario, Nicole M.
   Godsey, Marvin S.
   Barrera, Roberto
   Miranda, Julieanne
   Lenhart, Audrey
TI Rapid Screening of Aedes aegypti Mosquitoes for Susceptibility to
   Insecticides as Part of Zika Emergency Response, Puerto Rico
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION; RESISTANCE; VIRUS; CULICIDAE; DIPTERA
AB In response to the 2016 Zika outbreak, Aedes aegypti mosquitoes from 38 locations across Puerto Rico were screened using Centers for Disease Control and Prevention bottle bioassays for sensitivity to insecticides used for mosquito control. All populations were resistant to pyrethroids. Naled, an organophosphate, was the most effective insecticide, killing all mosquitoes tested.
C1 [Hemme, Ryan R.; Harris, Angela F.; Felix, Gilberto; Barrera, Roberto] Ctr Dis Control & Prevent, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Vizcaino, Lucrecia; Lenhart, Audrey] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Kavanaugh, Michael] US Navy, Jacksonville, FL USA.
   [Kenney, Joan L.; Godsey, Marvin S.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Nazario, Nicole M.; Miranda, Julieanne] Puerto Rico Vector Control Unit, San Juan, PR USA.
RP Hemme, RR (corresponding author), Ctr Dis Control & Prevent, 1324 Calle Canada, San Juan, PR 00920 USA.
EM rhemme@cdc.gov
RI Kenney, Joan L./AAE-7416-2019
OI Kenney, Joanie/0000-0002-6761-4272
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX The Centers for Disease Control and Prevention provided funding for this
   study.
CR [Anonymous], 2016, VECT CONTR OP FRAM Z
   Centers for Disease Control and Prevention, GUIDELINE EVALUATING
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   FLYNN A. D., 1964, MOSQUITO NEWS, V24, P118
   FOX I, 1980, AM J TROP MED HYG, V29, P1456, DOI 10.4269/ajtmh.1980.29.1456
   HEMINGWAY J, 1989, B ENTOMOL RES, V79, P123, DOI 10.1017/S0007485300018630
   Hemme RR, 2016, ACTA TROP, V164, P369, DOI 10.1016/j.actatropica.2016.08.027
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 0
Z9 0
U1 2
U2 4
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2019
VL 25
IS 10
BP 1959
EP 1961
DI 10.3201/eid2510.181847
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA JD5IS
UT WOS:000490017300025
PM 31538919
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jacome, R
   Carrasco-Hernandez, R
   Campillo-Balderas, JA
   Lopez-Vidal, Y
   Lazcano, A
   Wenzel, RP
   de Leon, SP
AF Jacome, Rodrigo
   Carrasco-Hernandez, R.
   Alberto Campillo-Balderas, Jose
   Lopez-Vidal, Yolanda
   Lazcano, Antonio
   Wenzel, Richard P.
   Ponce de Leon, Samuel
TI A yellow flag on the horizon: The looming threat of yellow fever to
   North America
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Yellow fever virus; Arboviruses; Vaccination; Prevention; Flavivirus
ID AEDES-ALBOPICTUS; UNITED-STATES; ZIKA VIRUS; CHIKUNGUNYA VIRUS; DISEASE
   EMERGENCE; SINGLE MUTATION; CLIMATE-CHANGE; TRANSMISSION; DENGUE;
   AEGYPTI
AB Objectives: Yellow fever virus historically was a frequent threat to American and European coasts. Medical milestones such as the discovery of mosquitoes as vectors and subsequently an effective vaccine significantly reduced its incidence, in spite of which, thousands of cases of this deathly disease still occur regularly in Sub-Saharan Africa and the Amazonian basin in South America, which are usually not reported. An urban outbreak in Angola, consecutive years of increasing incidence near major Brazilian cities, and imported cases in China, South America and Europe, have brought this virus back to the global spotlight. The aim of this article is to underline that the preventive YFV measures, such as vaccination, need to be carefully revised in order to minimize the risks of new YFV outbreaks, especially in urban or immunologically vulnerable places. Furthermore, this article highlights the diverse factors that have favored the spread of other Aedes spp.-associated arboviral diseases like Dengue, Chikungunya and Zika, to northern latitudes causing epidemics in the United States and Europe, emphasizing the possibility that YFV might follow the path of these viruses unless enhanced surveillance and efficient control systems are urgently initiated. (C) 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Jacome, Rodrigo; Alberto Campillo-Balderas, Jose; Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Lab Origen Vida, Ave Univ 3000, Mexico City 04510, DF, Mexico.
   [Carrasco-Hernandez, R.] Univ Nacl Autonoma Mexico, Fac Med, Div Invest, Ave Univ 3000, Mexico City 04510, DF, Mexico.
   [Lopez-Vidal, Yolanda] Univ Nacl Autonoma Mexico, Fac Med, Programa Inmunol Mol Microbiana, Ave Univ 3000, Mexico City 04510, DF, Mexico.
   [Lazcano, Antonio] El Colegio Nacl, Mexico City, DF, Mexico.
   [Wenzel, Richard P.] VCU Hlth, Dept Internal Med, Richmond, VA USA.
   [Ponce de Leon, Samuel] Univ Nacl Autonoma Mexico, Programa Univ Invest Salud, Ave Univ 3000, Mexico City 04510, DF, Mexico.
RP de Leon, SP (corresponding author), Univ Nacl Autonoma Mexico, Programa Univ Invest Salud, Ave Univ 3000, Mexico City 04510, DF, Mexico.
EM sponce@unam.mx
FU Direccion General de Asuntos del Personal Academico (DGAPA), Universidad
   Nacional Autonoma de MexicoUniversidad Nacional Autonoma de Mexico;
   Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica,
   Direccion General de Asuntos del Personal Academico (DGAPA), Universidad
   Nacional Autonoma de Mexico [Iv200315]
FX This work was supported by the Direccion General de Asuntos del Personal
   Academico (DGAPA), Universidad Nacional Autonoma de Mexico (RJ and RCH),
   and the Programa de Apoyo a Proyectos de Investigacion e Innovacion
   Tecnologica [Project number -Iv200315], Direccion General de Asuntos del
   Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico
   (YLV). The funding sources had no involvement in the design, writing, or
   decision to submit this manuscript for publication.
CR Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.39.30361
   Amraoui F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32198-4
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P193
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P345
   [Anonymous], 2019, DIS OUTBREAK NE 0208
   [Anonymous], 2016, ECONOMIST
   Beck A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001910
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Bryan CS, 2004, INFECT DIS CLIN N AM, V18, P275, DOI 10.1016/j.idc.2004.01.007
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Butterworth MK, 2017, ENVIRON HEALTH PERSP, V125, P579, DOI 10.1289/EHP218
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Callender DM, 2019, GLOB PUBLIC HEALTH, V14, P445, DOI 10.1080/17441692.2018.1512144
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carrasco-Hernandez R, 2017, ILAR J, V58, P343, DOI 10.1093/ilar/ilx026
   Casey RM, 2019, NEW ENGL J MED, V381, P444, DOI 10.1056/NEJMoa1710430
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cui SJ, 2017, INT J INFECT DIS, V60, P93, DOI 10.1016/j.ijid.2017.05.001
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control and European Food Safety Authority, 2019, MOSQ MAPS
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gratz NG, 2000, B WORLD HEALTH ORGAN, V78, P995
   Green A, 2016, LANCET, V387, P2493, DOI 10.1016/S0140-6736(16)30835-2
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hardiman M, 2007, J TRAVEL MED, V14, P141, DOI 10.1111/j.1708-8305.2007.00117.x
   Hassell JM, 2017, TRENDS ECOL EVOL, V32, P55, DOI 10.1016/j.tree.2016.09.012
   Hillemand Bernard, 2006, Hist Sci Med, V40, P23
   Holmes EC, 2013, CURR OPIN VIROL, V3, P180, DOI 10.1016/j.coviro.2012.12.003
   Hughes HR, 2018, EMERG INFECT DIS, V24, P1598, DOI 10.3201/eid2408.180588
   Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0
   International Coordination Group, INT COORD GROUP VACC
   Javelle E, 2019, CLIN MICROBIOL INFEC, V25, P10, DOI 10.1016/j.cmi.2018.08.015
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kotsakiozi P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2933-2
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Martins RD, 2018, VACCINE, V36, P4112, DOI 10.1016/j.vaccine.2018.05.041
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   Mendes A., VACINA FEBRE AMARELA
   Ministerio da Saude do Brasil, 2018, 26 MIN SAUD BRAS
   Ministerio da Saude do Brasil, 2019, 10 MIN SAUD BRAS
   Ministerio da Saude do Brasil, 2018, 19 MIN SAUD BRAS
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monaghan AJ, 2018, CLIMATIC CHANGE, V146, P487, DOI 10.1007/s10584-016-1679-0
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Nava A, 2017, ILAR J, V58, P393, DOI 10.1093/ilar/ilx034
   Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060
   Organizacion Panamericana de la Salud/Organizacion Mundial de la Salud, 2018, ACT EP FIEBR AM 20 M
   Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041
   Porse CC, 2018, EMERG INFECT DIS, V24, P1626, DOI 10.3201/eid2409.180203
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Roukens AHE, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz024
   Roukens AHE, 2018, ANN INTERN MED, V169, P761, DOI 10.7326/M18-1529
   Sanna A, 2018, EURO SURVEILL, V23
   Santos de Sousa K, 2018, I EVANDRO CHAGAS DET
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schoener E, 2019, PARASITOL RES, V118, P1633, DOI 10.1007/s00436-019-06287-w
   Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x
   Seixas G, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3081-4
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   WHO, 2016, SIT REP YELL FEV
   WHO, 2016, AIRCR DIS MOSQ CONTR
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   World Health Organization, 2010, YELL FEV IN PROV OPP
   World Health Organization, 2018, DIS OUTBREAK NE 0208
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 83
TC 1
Z9 1
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2019
VL 87
BP 143
EP 150
DI 10.1016/j.ijid.2019.07.033
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA JC5BX
UT WOS:000489295200023
PM 31382047
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU O'Connor, M
   Tisoncik-Go, J
   Lewis, T
   Miller, C
   Bratt, D
   Moats, C
   Smedley, J
   Klatt, N
   Gale, M
   Fuller, D
AF O'Connor, Megan
   Tisoncik-Go, Jennifer
   Lewis, Thomas
   Miller, Charlene
   Bratt, Debra
   Moats, Cassie
   Smedley, Jeremy
   Klatt, Nichole
   Gale, Michael
   Fuller, Deborah
TI Contribution of innate and anti-viral adaptive immune responses to ZIKV
   viral persistence and control in pigtail macaques
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [O'Connor, Megan] Univ Washington, Seattle, WA 98195 USA.
   [O'Connor, Megan; Bratt, Debra] Washington Natl Primate Res Ctr, Seattle, WA USA.
   [Tisoncik-Go, Jennifer; Gale, Michael] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Lewis, Thomas; Fuller, Deborah] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.
   [Miller, Charlene] Univ Miami, Coral Gables, FL 33124 USA.
   [Moats, Cassie; Smedley, Jeremy] Oregon Natl Primate Res Ctr, Hillsboro, OR USA.
   [Klatt, Nichole] Univ Miami, Dept Pediat, Coral Gables, FL 33124 USA.
EM megan.oconnor@wanprc.org
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 17
BP 276
EP 276
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600019
DA 2020-07-08
ER

PT J
AU Schouest, B
   Scheef, EA
   Fahlberg, M
   Blair, RV
   Panganiban, AT
   Maness, NJ
AF Schouest, Blake
   Scheef, Elizabeth A.
   Fahlberg, Marissa
   Blair, Robert V.
   Panganiban, Antonito T.
   Maness, Nicholas J.
TI CD8(+) lymphocytes modulate acute ZIKV viremia, innate antiviral
   immunity and possibly tissue dissemination in nonhuman primates
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Schouest, Blake; Scheef, Elizabeth A.; Fahlberg, Marissa; Blair, Robert V.; Panganiban, Antonito T.; Maness, Nicholas J.] Tulane Natl Primate Res Ctr, Covington, LA USA.
EM bschoues@tulane.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 18
BP 276
EP 276
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600020
DA 2020-07-08
ER

PT J
AU Go, J
   Green, R
   Barrenas, CF
   Smith, E
   Rajagopal, L
   Waldorf, KM
   Gale, M
AF Go, Jenny
   Green, Richard
   Barrenas, Carl Fredrik
   Smith, Elise
   Rajagopal, Lakshmi
   Waldorf, Kristina M.
   Gale, Michael, Jr.
TI Transcriptomic analysis of fetal and dam tissues following Zika virus
   inoculation of pregnant nonhuman primates
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Go, Jenny] WaNPRC, Seattle, WA USA.
   [Green, Richard; Smith, Elise; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA.
   [Barrenas, Carl Fredrik] Uppsala Univ, Dept Cell & Mol Biol Computat Biol & Bioinformat, Uppsala, Sweden.
   [Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.
   [Waldorf, Kristina M.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
EM tisoncik@uw.edu
RI Go, Jennifer/AAQ-5306-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 19
BP 277
EP 277
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600021
DA 2020-07-08
ER

PT J
AU Mavigner, M
   Raper, J
   Kovacs-Balint, Z
   Gumber, S
   Sanchez, M
   Alvarado, M
   Chahroudi, A
AF Mavigner, Maud
   Raper, Jessica
   Kovacs-Balint, Zsofia
   Gumber, Sanjeev
   Sanchez, Mar
   Alvarado, Maria
   Chahroudi, Ann
TI Postnatal Zika virus infection causes persistent abnormalities in brain
   structure, function, and behavior in infant macaques: one year follow-up
   study
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Mavigner, Maud; Raper, Jessica; Kovacs-Balint, Zsofia; Gumber, Sanjeev; Sanchez, Mar; Alvarado, Maria; Chahroudi, Ann] Emory Univ, Atlanta, GA 30322 USA.
EM maud.mavigner@emory.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 20
BP 277
EP 277
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600022
DA 2020-07-08
ER

PT J
AU Miller, C
   Cheu, R
   Driscoll, C
   Hensley-McBain, T
   O'Connor, M
   Tisoncik-Go, J
   Manuzak, J
   Smith, E
   Bratt, D
   Smedley, J
   Fuller, D
   Gale, M
   Barouch, D
   Klatt, N
AF Miller, Charlene
   Cheu, Ryan
   Driscoll, Connor
   Hensley-McBain, Tiffany
   O'Connor, Megan
   Tisoncik-Go, Jennifer
   Manuzak, Jennifer
   Smith, Elise
   Bratt, Debbie
   Smedley, Jeremy
   Fuller, Deborah
   Gale, Michael
   Barouch, Dan
   Klatt, Nichole
TI Gut microbiome dysbiosis after Zika virus infection is associated with
   increased peripheral and nervous system inflammation in macaques and
   humans
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Miller, Charlene] Univ Miami, Coral Gables, FL 33124 USA.
   [Cheu, Ryan; Driscoll, Connor; Hensley-McBain, Tiffany; O'Connor, Megan; Tisoncik-Go, Jennifer; Smith, Elise; Bratt, Debbie; Fuller, Deborah; Gale, Michael] Univ Washington, Seattle, WA 98195 USA.
   [Manuzak, Jennifer; Klatt, Nichole] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.
   [Smedley, Jeremy] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Barouch, Dan] Harvard Med Sch, Boston, MA 02115 USA.
EM cjm297@med.miami.edu
NR 0
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 27
BP 280
EP 281
PG 2
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600029
DA 2020-07-08
ER

PT J
AU Van Rompay, K
   Keesler, RI
   Ardeshir, A
   Cruzen, C
   Watanabe, J
   Usachenko, J
   Singapuri, A
   Lemos, D
   Bliss-Moreau, E
   Murphey, A
   Dennis, M
   Singh, T
   Heimsath, H
   Morabito, K
   Foreman, BM
   Burgomaster, KE
   Dowd, KA
   Pierson, TC
   Permar, S
   Coffey, LL
   Graham, B
AF Van Rompay, Koen
   Keesler, Rebekah I.
   Ardeshir, Amir
   Cruzen, Christina
   Watanabe, Jennifer
   Usachenko, Jodie
   Singapuri, Anil
   Lemos, Danilo
   Bliss-Moreau, Eliza
   Murphey, Ashley
   Dennis, Maria
   Singh, Tulika
   Heimsath, Holly
   Morabito, Kaitlyn
   Foreman, Bryant M.
   Burgomaster, Katherine E.
   Dowd, Kimberly A.
   Pierson, Theodore C.
   Permar, Sallie
   Coffey, Lark L.
   Graham, Barney
TI Evaluation of a Zika virus DNA vaccine in a pregnant rhesus macaque
   model of congenital Zika syndrome
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Van Rompay, Koen] Calif Natl Primate Res Ctr, Davis, CA USA.
   [Keesler, Rebekah I.; Ardeshir, Amir; Cruzen, Christina; Watanabe, Jennifer; Usachenko, Jodie; Bliss-Moreau, Eliza; Murphey, Ashley] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Singapuri, Anil; Lemos, Danilo; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Dennis, Maria; Singh, Tulika; Heimsath, Holly; Permar, Sallie] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA.
   [Morabito, Kaitlyn; Graham, Barney] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Foreman, Bryant M.; Burgomaster, Katherine E.; Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
EM kkvanrompay@ucdavis.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 26
BP 280
EP 280
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600028
DA 2020-07-08
ER

PT J
AU Miller, C
   Cheu, R
   Driscoll, C
   Hensley-McBain, T
   O'Connor, M
   Tisoncik-Go, J
   Manuzak, J
   Smith, E
   Bratt, D
   Smedley, J
   Fuller, D
   Gale, M
   Barouch, D
   Klatt, N
AF Miller, Charlene
   Cheu, Ryan
   Driscoll, Connor
   Hensley-McBain, Tiffany
   O'Connor, Megan
   Tisoncik-Go, Jennifer
   Manuzak, Jennifer
   Smith, Elise
   Bratt, Debbie
   Smedley, Jeremy
   Fuller, Deborah
   Gale, Michael
   Barouch, Dan
   Klatt, Nichole
TI Gut microbiome dysbiosis after Zika virus infection is associated with
   increased peripheral and nervous system inflammation in macaques and
   humans
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Miller, Charlene] Univ Miami, Coral Gables, FL 33124 USA.
   [Cheu, Ryan; Driscoll, Connor; Hensley-McBain, Tiffany; O'Connor, Megan; Tisoncik-Go, Jennifer; Smith, Elise; Bratt, Debbie; Fuller, Deborah; Gale, Michael] Univ Washington, Seattle, WA 98195 USA.
   [Manuzak, Jennifer; Klatt, Nichole] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.
   [Smedley, Jeremy] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Barouch, Dan] Harvard Med Sch, Boston, MA 02115 USA.
EM cjm297@med.miami.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 56
BP 293
EP 293
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600058
DA 2020-07-08
ER

PT J
AU Lewis, T
   O'Connor, M
   Bomben, J
   Go, J
   Miller, C
   Bratt, D
   Moats, C
   Smedley, J
   Klatt, N
   Gale, M
   Fuller, D
AF Lewis, Thomas
   O'Connor, Megan
   Bomben, Jasmine
   Go, Jenny
   Miller, Charlene
   Bratt, Debra
   Moats, Cassie
   Smedley, Jeremy
   Klatt, Nichole
   Gale, Michael
   Fuller, Deborah
TI Characterization of ZIKV-specific antibody responses induced following
   ZIKV infection in a pigtail macaque model of infection
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Lewis, Thomas; O'Connor, Megan; Bratt, Debra; Gale, Michael; Fuller, Deborah] Univ Washington, Seattle, WA 98195 USA.
   [O'Connor, Megan; Go, Jenny; Moats, Cassie] Washington Natl Primate Res Ctr, Seattle, WA USA.
   [Bomben, Jasmine] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA.
   [Miller, Charlene; Klatt, Nichole] Univ Miami, Coral Gables, FL 33124 USA.
   [Smedley, Jeremy] Oregon Natl Primate Res Ctr, Beaverton, OR USA.
EM thomas.lewis@wanprc.org
RI Go, Jennifer/AAQ-5306-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 70
BP 300
EP 300
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600072
DA 2020-07-08
ER

PT J
AU Panganiban, N
   Blair, R
   Maness, N
   Schouest, B
   Gilbert, M
   MacLean, A
   Veazey, R
   Scheef, E
   Tatum, C
AF Panganiban, Nito
   Blair, Robert
   Maness, Nick
   Schouest, Blake
   Gilbert, Margaret
   MacLean, Andrew
   Veazey, Ronald
   Scheef, Elizabeth
   Tatum, Coty
TI Zika virus induced neuro-inflammation in rhesus macaques
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Panganiban, Nito; Blair, Robert; Maness, Nick; Schouest, Blake; Gilbert, Margaret; MacLean, Andrew; Veazey, Ronald; Scheef, Elizabeth; Tatum, Coty] Tulane Natl Primate Res Ctr, Covington, LA USA.
EM apangani@tulane.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 71
BP 300
EP 300
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600073
DA 2020-07-08
ER

PT J
AU Schouest, B
   Scheef, EA
   Fahlberg, M
   Blair, RV
   Panganiban, AT
   Maness, NJ
AF Schouest, Blake
   Scheef, Elizabeth A.
   Fahlberg, Marissa
   Blair, Robert V.
   Panganiban, Antonito T.
   Maness, Nicholas J.
TI CD8(+) lymphocytes modulate acute ZIKV viremia, innate antiviral
   immunity and possibly tissue dissemination in nonhuman primates
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Schouest, Blake; Scheef, Elizabeth A.; Fahlberg, Marissa; Blair, Robert V.; Panganiban, Antonito T.; Maness, Nicholas J.] Tulane Natl Primate Res Ctr, Covington, LA USA.
EM bschoues@tulane.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2019
VL 48
IS 5
SI SI
MA 73
BP 301
EP 301
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC9MQ
UT WOS:000489599600075
DA 2020-07-08
ER

PT J
AU do Carmo, RL
   Simao, AKA
   do Amaral, LLF
   Inada, BSY
   Silveira, CF
   Campos, CMD
   Freitas, LF
   Bonadio, V
   Marussi, VHR
AF do Carmo, Rafael Lourenco
   Alves Simao, Aylla Keiner
   Faria do Amaral, Lazaro Luis
   Yonekura Inada, Bruno Shigueo
   Silveira, Camila Filardi
   de Siqueira Campos, Christiane Monteiro
   Freitas, Leonardo Furtado
   Bonadio, Victor
   Rocha Marussi, Victor Hugo
TI Neuroimaging of Emergent and Reemergent Infections
SO RADIOGRAPHICS
LA English
DT Article; Proceedings Paper
CT 104th Scientific Assembly and Annual Meeting of the
   Radiological-Society-of-North-America (RSNA)
CY NOV 25-30, 2018
CL Chicago, IL
SP Radiol Soc N Amer
ID WEST-NILE-VIRUS; ST-LOUIS ENCEPHALITIS; SUBACUTE
   SCLEROSING-PANENCEPHALITIS; CHAGAS-DISEASE; ZIKA VIRUS; NEUROLOGICAL
   MANIFESTATIONS; IMAGING FINDINGS; UNITED-STATES; EPIDEMIOLOGY;
   CHIKUNGUNYA
AB Infectious diseases emerge and reemerge over the years, and many of them can cause neurologic disease. Several factors contribute to the emergence and reemergence of these conditions, including human population growth, an increase in international travel, the geographic expansion of recognized pathogens to areas where they were previously nonendemic, and greater contact with wild animal reservoirs. The antivaccination social movement has played an important role in the reemergence of infectious diseases, especially some viral conditions. The authors review different viral (arboviruses such as dengue, chikungunya, and Zika virus; enterovirus 71; measles; and influenza), bacterial (syphilis, Lyme disease, and listeriosis), and parasitic (Chagas disease) diseases, focusing primarily on their neurologic complications. Although there are several additional infectious diseases with central nervous system manifestations that could be classified as emergent or reemergent, those listed here are the most relevant from an epidemiologic standpoint and are representative of important public health issues on all continents. The infections caused by these pathogens often show a variety of neuroimaging patterns that can be identified at CT and MRI, and radiology is central to the diagnosis and follow-up of such conditions. Given the increasing relevance of emerging and reemerging infections in clinical practice and public health scenarios, radiologists should be familiar with these infections.
   Online supplemental material is available for this article. (c) RSNA, 2019 center dot radiographics.rsna.org
C1 [do Carmo, Rafael Lourenco; Alves Simao, Aylla Keiner; Faria do Amaral, Lazaro Luis; Yonekura Inada, Bruno Shigueo; Silveira, Camila Filardi; de Siqueira Campos, Christiane Monteiro; Freitas, Leonardo Furtado; Bonadio, Victor; Rocha Marussi, Victor Hugo] Beneficencia Portuguesa Sao Paulo, Dept Neuroradiol, R Maestro Cardim 769, BR-01323001 Sao Paulo, SP, Brazil.
RP do Carmo, RL (corresponding author), Beneficencia Portuguesa Sao Paulo, Dept Neuroradiol, R Maestro Cardim 769, BR-01323001 Sao Paulo, SP, Brazil.
EM rafael.lourenco@gmail.com
OI Bonadio, Victor/0000-0003-4891-0508; Carmo, Rafael/0000-0002-0044-7641;
   Yonekura Inada, Bruno Shigueo/0000-0002-3000-6687; AMARAL,
   LAZARO/0000-0003-2944-9947
CR Abdelgawad MS, 2016, EGYPT J RADIOL NUC M, V47, P1031, DOI 10.1016/j.ejrnm.2016.05.004
   Akgoz A, 2012, NEUROIMAG CLIN N AM, V22, P633, DOI 10.1016/j.nic.2012.05.015
   Ali M, 2005, AM J NEURORADIOL, V26, P289
   Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x
   [Anonymous], 2019, VACCINE, V37, P4848, DOI 10.1016/j.vaccine.2018.09.063
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Bengualid V, 2017, J NEUROSCI CLIN RES, V2, P1
   Bortolussi R, 2008, CAN MED ASSOC J, V179, P795, DOI 10.1503/cmaj.081377
   BRIGHTBILL TC, 1995, AM J NEURORADIOL, V16, P703
   Buchanan R, 2012, SEMIN PEDIATR NEUROL, V19, P107, DOI 10.1016/j.spen.2012.02.003
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV
   Cerna F, 1999, AM J NEURORADIOL, V20, P1281
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang PC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090890
   Chen F, 2013, EUR J PAEDIATR NEURO, V17, P486, DOI 10.1016/j.ejpn.2013.03.004
   Chow FC, 2014, NEUROHOSPITALIST, V4, P173, DOI 10.1177/1941874414540685
   Clauss Heather E, 2008, Curr Infect Dis Rep, V10, P300, DOI 10.1007/s11908-008-0049-0
   Conners EE, 2016, ACTA TROP, V156, P68, DOI 10.1016/j.actatropica.2016.01.002
   Cordova E, 2010, NEUROL RES, V32, P238, DOI 10.1179/016164110X12644252260637
   Curren EJ, 2018, MMWR-MORBID MORTAL W, V67, P1137, DOI 10.15585/mmwr.mm6741a1
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P215, DOI 10.1590/S0036-46652015000300006
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   DeBiasi RL, 2006, NAT CLIN PRACT NEURO, V2, P264, DOI 10.1038/ncpneuro0176
   do Amaral LLF, 2015, NEUROIMAG CLIN N AM, V25, P259, DOI 10.1016/j.nic.2015.01.006
   Fernandes HJ, 2017, AM J TROP MED HYG, V96, P292, DOI 10.4269/ajtmh.16-0225
   Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133
   Haktanir A, 2010, AM J NEURORADIOL, V31, P394, DOI 10.3174/ajnr.A2037
   Hildenbrand P, 2009, AM J NEURORADIOL, V30, P1079, DOI 10.3174/ajnr.A1579
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.2919
   da Cruz LCH, 2018, AM J NEURORADIOL, V39, P1967, DOI 10.3174/ajnr.A5649
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jugpal Tejeshwar Singh, 2017, Radiol Bras, V50, P285, DOI 10.1590/0100-3984.2016.0048
   Kakoti G, 2013, BIOMED RES INT, DOI 10.1155/2013/152656
   Kawada J, 2003, J INFECT DIS, V188, P690, DOI 10.1086/377101
   Khamaysi Z, 2014, INT J DERMATOL, V53, P812, DOI 10.1111/ijd.12095
   Koeller KK, 2017, RADIOGRAPHICS, V37, P199, DOI 10.1148/rg.2017160149
   Lee KY, 2003, NEURORADIOLOGY, V45, P100, DOI 10.1007/s00234-002-0884-x
   Leibovitch EC, 2016, NEUROTHERAPEUTICS, V13, P562, DOI 10.1007/s13311-016-0453-3
   Lindland ES, 2018, INSIGHTS IMAGING, V9, P833, DOI 10.1007/s13244-018-0646-x
   Lury KM, 2005, AM J ROENTGENOL, V185, P550, DOI 10.2214/ajr.185.2.01850550
   Lyon JB, 2010, PEDIATR RADIOL, V40, P200, DOI 10.1007/s00247-009-1487-z
   Marques RE, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0837-2
   Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Nett RJ, 2009, VECTOR-BORNE ZOONOT, V9, P511, DOI 10.1089/vbz.2008.0052
   Newberg A, 2002, NUCL MED COMMUN, V23, P773, DOI 10.1097/00006231-200208000-00011
   Oliveira J, 2009, J NEUROL, V256, P1363, DOI 10.1007/s00415-009-5105-7
   Ortiz-Martinez Yeimer, 2017, Infez Med, V25, P77
   Ozturk A, 2002, J CHILD NEUROL, V17, P25, DOI 10.1177/088307380201700106
   Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0
   Pearce JC, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay009
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Popescu CP, 2017, EMERG INFECT DIS, V23, P574, DOI 10.3201/eid2304.161317
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Ribeiro BG, 2017, RADIOGRAPHICS, V37, P1840, DOI 10.1148/rg.2017170023
   Rust RS, 2012, SEMIN PEDIATR NEUROL, V19, P130, DOI 10.1016/j.spen.2012.03.002
   Schwartz AM, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6622a1
   Sejvar James J, 2018, Continuum (Minneap Minn), V24, P1512, DOI 10.1212/CON.0000000000000652
   Sener RN, 2004, AM J NEURORADIOL, V25, P892
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stamm LV, 2016, MICROB CELL, V3, P363, DOI 10.15698/mic2016.09.523
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Vanjare HA, 2018, AM J NEURORADIOL, V39, P699, DOI 10.3174/ajnr.A5544
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Wasay M, 2000, ARCH NEUROL-CHICAGO, V57, P114, DOI 10.1001/archneur.57.1.114
   White GS, 2016, EMERG INFECT DIS, V22, P2185, DOI 10.3201/eid2212.160805
   WHO, 2014, BRIEF GUID EM INF DI
   Wilson ME, 2018, CHIKUNGUNYA FEVER
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xing JJ, 2016, AM J CLIN PATHOL, V146, P95, DOI 10.1093/ajcp/aqw089
   Yoshinari NH, 2010, REV ASSOC MED BRAS, V56, P363, DOI 10.1590/S0104-42302010000300025
   Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94
NR 76
TC 0
Z9 0
U1 0
U2 1
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0271-5333
J9 RADIOGRAPHICS
JI Radiographics
PD OCT
PY 2019
VL 39
IS 6
SI SI
BP 1649
EP 1671
DI 10.1148/rg.2019190020
PG 23
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA JC2MD
UT WOS:000489110200007
PM 31589575
DA 2020-07-08
ER

PT J
AU Robbiani, DF
   Olsen, PC
   Costa, F
   Wang, Q
   Oliveira, TY
   Nery, N
   Aromolaran, A
   do Rosario, MS
   Sacramento, GA
   Cruz, JS
   Khouri, R
   Wunder, EA
   Mattos, A
   Freitas, BD
   Sarno, M
   Archanjo, G
   Daltro, D
   Carvalho, GBS
   Pimentel, K
   de Siqueira, IC
   de Almeida, JRM
   Henriques, DF
   Lima, JA
   Vasconcelos, PFC
   Schaefer-Babajew, D
   Azzopardi, SA
   Bozzacco, L
   Gazumyan, A
   Belfort, R
   Alcantara, AP
   Carvalho, G
   Moreira, L
   Araujo, K
   Reis, MG
   Keesler, RI
   Coffey, LL
   Tisoncik-Go, J
   Gale, M
   Rajagopal, L
   Waldorf, KMA
   Dudley, DM
   Simmons, HA
   Mejia, A
   O'Connor, DH
   Steinbach, RJ
   Haese, N
   Smith, J
   Lewis, A
   Colgin, L
   Roberts, V
   Frias, A
   Kelleher, M
   Hirsch, A
   Streblow, DN
   Rice, CM
   MacDonald, MR
   de Almeida, ARP
   Van Rompay, KKA
   Ko, AI
   Nussenzweig, MC
AF Robbiani, Davide F.
   Olsen, Priscilla C.
   Costa, Federico
   Wang, Qiao
   Oliveira, Thiago Y.
   Nery Jr, Nivison
   Aromolaran, Adeolu
   do Rosario, Mateus S.
   Sacramento, Gielson A.
   Cruz, Jaqueline S.
   Khouri, Ricardo
   Wunder, Elsio A., Jr.
   Mattos, Adriana
   Freitas, Bruno de Paula
   Sarno, Manoel
   Archanjo, Gracinda
   Daltro, Dina
   Carvalho, Gustavo B. S.
   Pimentel, Kleber
   de Siqueira, Isadora C.
   de Almeida, Joo R. M.
   Henriques, Daniele F.
   Lima, Juliana A.
   Vasconcelos, Pedro F. C.
   Schaefer-Babajew, Dennis
   Azzopardi, Stephanie A.
   Bozzacco, Leonia
   Gazumyan, Anna
   Belfort Jr, Rubens
   Alcantara, Ana P.
   Carvalho, Gustavo
   Moreira, Licia
   Araujo, Katiaci
   Reis, Mitermayer G.
   Keesler, Rebekah, I
   Coffey, Lark L.
   Tisoncik-Go, Jennifer
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Waldorf, Kristina M. Adams
   Dudley, Dawn M.
   Simmons, Heather A.
   Mejia, Andres
   O'Connor, David H.
   Steinbach, Rosemary J.
   Haese, Nicole
   Smith, Jessica
   Lewis, Anne
   Colgin, Lois
   Roberts, Victoria
   Frias, Antonio
   Kelleher, Meredith
   Hirsch, Alec
   Streblow, Daniel N.
   Rice, Charles M.
   MacDonald, Margaret R.
   de Almeida, Antonio R. P.
   Van Rompay, Koen K. A.
   Ko, Albert, I
   Nussenzweig, Michel C.
TI Risk of Zika microcephaly correlates with features of maternal
   antibodies
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; PREGNANCY OUTCOMES;
   CROSS-REACTIVITY; INFECTION; DISEASE; TRANSMISSION; TERRITORIES; RNA
AB Zika virus (ZIKV) infection during pregnancy causes congenital abnormalities, including microcephaly. However, rates vary widely, and the contributing risk factors remain unclear. We examined the serum antibody response to ZIKV and other flaviviruses in Brazilian women giving birth during the 2015-2016 outbreak. Infected pregnancies with intermediate or higher ZIKV antibody enhancement titers were at increased risk to give birth to microcephalic infants compared with those with lower titers (P < 0.0001). Similarly, analysis of ZIKV-infected pregnant macaques revealed that fetal brain damage was more frequent in mothers with higher enhancement titers. Thus, features of the maternal antibodies are associated with and may contribute to the genesis of ZIKV-associated microcephaly.
C1 [Robbiani, Davide F.; Olsen, Priscilla C.; Oliveira, Thiago Y.; Schaefer-Babajew, Dennis; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.
   [Azzopardi, Stephanie A.; Bozzacco, Leonia; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
   [Olsen, Priscilla C.] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
   [Wang, Qiao] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
   [Nery Jr, Nivison; Sacramento, Gielson A.; Cruz, Jaqueline S.; Khouri, Ricardo; de Siqueira, Isadora C.; Reis, Mitermayer G.; Ko, Albert, I] Fundacao Oswald Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Aromolaran, Adeolu; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Costa, Federico; Sarno, Manoel; de Almeida, Joo R. M.; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Costa, Federico; Sarno, Manoel; de Almeida, Joo R. M.; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [do Rosario, Mateus S.; Mattos, Adriana; Freitas, Bruno de Paula; Archanjo, Gracinda; Daltro, Dina; Carvalho, Gustavo B. S.; Pimentel, Kleber] Hosp Geral Roberto Santos, Secreteria Saude Estado Bahia, Salvador, BA, Brazil.
   [Henriques, Daniele F.; Lima, Juliana A.; Vasconcelos, Pedro F. C.] Minist Saude Ananindeua, Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Freitas, Bruno de Paula; Belfort Jr, Rubens] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Araujo, Katiaci] Hosp Alianca, Salvador, BA, Brazil.
   [Alcantara, Ana P.; Carvalho, Gustavo; Moreira, Licia] Hosp Santo Amaro, Salvador, BA, Brazil.
   [Keesler, Rebekah, I; Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Coffey, Lark L.; Van Rompay, Koen K. A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Washington Natl Primate Res Ctr, Seattle, WA USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.; Rajagopal, Lakshmi; Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.
   [Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Simmons, Heather A.; Mejia, Andres] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Steinbach, Rosemary J.; Roberts, Victoria; Frias, Antonio; Kelleher, Meredith] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA.
   [Haese, Nicole; Colgin, Lois; Hirsch, Alec; Streblow, Daniel N.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.
   [Lewis, Anne] Oregon Natl Primate Res Ctr, Pathol Serv Unit, Div Comparat Med, Beaverton, OR USA.
   [Haese, Nicole; Smith, Jessica; Hirsch, Alec; Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.
   [Frias, Antonio] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Bozzacco, Leonia] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.
RP Robbiani, DF; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
EM drobbiani@rockefeller.edu; nussen@rockefeller.edu
RI Nussenzweig, Michel/AAE-7292-2019; Reis, Mitermayer/AAO-9742-2020; de
   Siqueira, Isadora Cristina/R-9953-2016; Ko, Albert Icksang/P-2343-2015;
   Haese, Nicole/AAN-4551-2020; Olsen, Priscilla C/I-8994-2012; Costa,
   Federico/G-1838-2015; Robbiani, Davide F./AAF-7662-2019; Wunder, Elsio
   Augusto/C-2733-2013
OI Reis, Mitermayer/0000-0002-3051-9060; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Ko, Albert Icksang/0000-0001-9023-2339;
   Olsen, Priscilla C/0000-0002-8795-037X; Costa,
   Federico/0000-0001-6951-2336; Robbiani, Davide F./0000-0001-7379-3484;
   Wunder, Elsio Augusto/0000-0002-5239-8511; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602; do Rosario, Mateus/0000-0001-7404-6392;
   Kelleher, Meredith/0000-0002-5313-004X; Wang, Qiao/0000-0001-6416-1733
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5R01AI121207,
   R01TW009504, R25TW009338, U19AI111825, UL1TR001866, R01AI037526,
   UM1AI100663, P01AI138938, R21AI129479, R01AI124690, U19AI057229,
   R01AI100989, R01AI133976, AI083019, AI104002, P51OD010425, P51 OD011092,
   R21-HD091032, R01-HD08633]; Rockefeller University Development Office;
   Fundacao de Amparo a Pesquisa do Estado da Bahia grant [PET0021/2016];
   National Institutes of Health Office of Research Infrastructure
   Programs/OD [P51OD011107, P51OD011106]; United States Food and Drug
   Administration [HHSF223201610542P]; DHHS/PHS/National Institutes of
   Health [R01Al116382-01A1]; Research Facilities Improvement ProgramUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [RR15459-01, RR020141-01]; Conselho Nacional de De-senvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [303999/2016-0, 439971/20016-0,
   440405/2016-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (Zika fast-track); Pew Latin American Fellows Program in the
   Biomedical Sciences; Studienstiftung des Deutschen Volkes
FX This work was supported by National Institutes of Health grants
   5R01AI121207, R01TW009504, and R25TW009338 to A.I. Ko; National
   Institutes of Health pilot awards U19AI111825 and UL1TR001866 to D.F.
   Robbiani; National Institutes of Health grants R01AI037526, UM1AI100663,
   U19AI111825, UL1TR001866, and P01AI138938 to M.C. Nussenzweig; National
   Institutes of Health grants R01AI124690 and U19AI057229 (Cooperative
   Center for Human Immunology pilot project); The Rockefeller University
   Development Office and anonymous donors (to C.M. Rice); Fundacao de
   Amparo a Pesquisa do Estado da Bahia grant PET0021/2016 (to M.G. Reis);
   National Institutes of Health grant R21AI129479-Supplement (to K.K.A.
   Van Rompay) and the National Institutes of Health Office of Research
   Infrastructure Programs/OD (P51OD011107 to the CNPRC); the United States
   Food and Drug Administration contract HHSF223201610542P (to L.L.
   Coffey); National Institutes of Health grants R01AI100989 and
   R01AI133976 (to L. Rajagopal and K.M. Adams Waldorf); and National
   Institutes of Health grants AI083019 and AI104002 (to M. Gale Jr.) and
   grant P51OD010425 to the WaNPRC (to K.M. Adams Waldorf, J. Tisoncik-Go,
   and M. Gale Jr.). Studies at WNPRC were supported by DHHS/PHS/National
   Institutes of Health grant R01Al116382-01A1 (to D.H. O'Connor), in part
   by the National Institutes of Health Office of Research Infrastructure
   Programs/OD (grant P51OD011106) awarded toWNPRC, at a facility
   constructed in part with support from Research Facilities Improvement
   Program grants RR15459-01 and RR020141-01; and National Institutes of
   Health core and pilot grant P51 OD011092 and grants R21-HD091032 and
   R01-HD08633 (to ONPRC). P.F.C. Vasconcelos was supported by Conselho
   Nacional de De-senvolvimento Cientifico e Tecnologico (projects
   303999/2016-0, 439971/20016-0, and 440405/2016-5) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Zika fast-track). P.C.
   Olsen is supported by the Pew Latin American Fellows Program in the
   Biomedical Sciences. D. Schaefer-Babajew is supported by Studienstiftung
   des Deutschen Volkes. F. Costa is a Wellcome Trust Fellow in Public
   Health and Tropical Medicine, and M.C. Nussenzweig is a Howard Hughes
   Medical Institute Investigator.
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Ministry of Health of Brazil, 2017, HLTH BRAZ 2015 2016
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 60
TC 6
Z9 6
U1 1
U2 6
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD OCT
PY 2019
VL 216
IS 10
BP 2302
EP 2315
DI 10.1084/jem.20191061
PG 14
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JC2PM
UT WOS:000489118900009
PM 31413072
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Stower, H
AF Stower, Hannah
TI Tracking hidden Zika
SO NATURE MEDICINE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD OCT
PY 2019
VL 25
IS 10
BP 1469
EP 1469
DI 10.1038/s41591-019-0616-y
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA JC3GJ
UT WOS:000489166700010
PM 31591585
OA Bronze
DA 2020-07-08
ER

PT J
AU Prisant, N
   Joguet, G
   Moriniere, C
   Pavili, L
   Lurel, S
   Herrmann-Stock, C
   Bujan, L
AF Prisant, Nadia
   Joguet, Guillaume
   Moriniere, Catherine
   Pavili, Lynda
   Lurel, Sylvia
   Herrmann-Stock, Cecile
   Bujan, Louis
TI Upper and lower genital tract Zika virus screening in a large cohort of
   reproductive-age women during the Americas epidemic
SO REPRODUCTIVE BIOMEDICINE ONLINE
LA English
DT Article
DE Endometrium; Female genital tract; Follicular fluid; Oocyte; Viral
   screening; Zika virus
ID INFECTED WOMEN; HEPATITIS-C; IMMUNODEFICIENCY-VIRUS; CULTURE-MEDIA;
   SEMEN; OOCYTES; TRANSMISSION; BRAZIL
AB Research question: To determine whether there is a risk of localized Zika virus (ZIKV) infection in the upper genital tract, specifically the oocytes, follicular fluids and endometrium, in exposed and/or recently infected reproductive-age women. ZIKV is an Aedes mosquito-borne Flavivirus that can lead to birth defects and to developmental anomalies when it infects pregnant women.
   Design: Controlled observational clinical study following 179 female patients undergoing oocyte vitrification cycles in an academic fertility centre during the ZIKV epidemic in the French territories of the Americas. At the time, the French Ministry of Health issued a ban on medically-induced pregnancies. Oocyte vitrification cycles were the only means of preserving fertility options and ensuring Zika-free oocyte cryopreservation for currently exposed and/or recently infected patients. Samples of serum, urine, lower genital tract, endometrium, follicular fluid and immature oocytes were tested for ZIKV RNA (vRNA) by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Serological analysis for ZIKV antibodies was performed in succession for the duration of the study. The follow-up protocol was set up for more than 6 months post-exposure or post-onset.
   Results: No vRNA was detected in the various samples from exposed patients. Furthermore, no vRNA was found in the upper genital tracts of women with a recent (3 months) history of acute infection.
   Conclusion: These findings represent evidence of a lack of vRNA persistence in the reproductive tract in ZIKV exposed and/or recently infected reproductive-age women and could help simplify current guidelines.
C1 [Prisant, Nadia; Joguet, Guillaume; Moriniere, Catherine; Pavili, Lynda; Lurel, Sylvia] CHU Pointe a Pitre, CCMR CECOS Carabes, Poie Parents Enfants, Guadeloupe FWI, Pointe A Pitre, Guadeloupe, France.
   [Prisant, Nadia] Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel.
   [Herrmann-Stock, Cecile] CHU Pointe a Pitre, Lab Microbiol Clin & Environm, Gaadeloape FWI, Pointe A Pitre, Guadeloupe, France.
   [Bujan, Louis] Toulouse III Univ, Res Grp Human Fertil EA3694, Toulouse, France.
   [Bujan, Louis] CHU Toulouse, CECOS Hop Paule Vigaier, Toulouse, France.
RP Prisant, N (corresponding author), CHU Pointe a Pitre, CCMR CECOS Carabes, Poie Parents Enfants, Guadeloupe FWI, Pointe A Pitre, Guadeloupe, France.; Prisant, N (corresponding author), Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel.
EM nprisant@gmail.com
OI Bujan, Louis/0000-0003-1540-0536
FU Agence de Ia biomedecine (ABM); Agence Regionale de Sante (ARS) of
   Guadeloupe
FX This study was supported by grants from the Agence de Ia biomedecine
   (ABM) and from the Agence Regionale de Sante (ARS) of Guadeloupe. The
   funding sources were not involved in the redaction of the article.
CR Araujo E, 2019, J BRAS REPROD ASSIST, V23, P172, DOI 10.5935/1518-0557.20180081
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Baud D., 2017, AM J REPROD IMMUNOL, P77, DOI DOI 10.1111/AJ.12614
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cobo A, 2012, FERTIL STERIL, V97, P74, DOI 10.1016/j.fertnstert.2011.10.006
   da Cruz TE, 2019, AM J TROP MED HYG, V100, P183, DOI 10.4269/ajtmh.18-0623
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Devaux A, 2003, HUM REPROD, V18, P2342, DOI 10.1093/humrep/deg431
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Feb 2013, 2013, FERT ASS TREATM PEOP
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fray MD, 2000, VET MICROBIOL, V77, P185, DOI 10.1016/S0378-1135(00)00275-3
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Matusali G, 2015, J VIROL, V89, P5772, DOI 10.1128/JVI.03628-14
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mendoza EJ, 2019, DIAGN MICR INFEC DIS, V94, P140, DOI 10.1016/j.diagmicrobio.2019.01.004
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nicastri E, 2016, EUROSURVEILLANCE, V11, P21, DOI DOI 10.2807/1560-7917
   NIKAS G, 1994, HUM REPROD, V9, P2135, DOI 10.1093/oxfordjournals.humrep.a138405
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Papaxanthos-Roche A, 2004, HUM REPROD, V19, P1170, DOI 10.1093/humrep/deh220
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Penot P, 2017, EUROSURVEILLANCE, V22, DOI [10.2807/560-7917F.201722330444, DOI 10.2807/1560-   7917.ES.2017.22.3.30444]
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stoop D, 2012, REPROD BIOMED ONLINE, V24, P180, DOI 10.1016/j.rbmo.2011.10.015
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vouga M, 2018, LANCET, V392, P818, DOI 10.1016/S0140-6736(18)31827-0
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   World Health Organization, 2016, 5 M EM COMM INT HLTH
NR 57
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1472-6483
EI 1472-6491
J9 REPROD BIOMED ONLINE
JI Reprod. Biomed. Online
PD OCT
PY 2019
VL 39
IS 4
BP 624
EP 632
DI 10.1016/j.rbmo.2019.05.013
PG 9
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA JB7VT
UT WOS:000488774100011
PM 31375360
DA 2020-07-08
ER

PT J
AU Martin, E
   Borucki, MK
   Thissen, J
   Garcia-Luna, S
   Hwang, M
   de Valdez, MW
   Jaing, CJ
   Hamer, GL
   Frank, M
AF Martin, Estelle
   Borucki, Monica K.
   Thissen, James
   Garcia-Luna, Selene
   Hwang, Mona
   de Valdez, Megan Wise
   Jaing, Crystal J.
   Hamer, Gabriel L.
   Frank, Matthias
TI Mosquito-Borne Viruses and Insect-Specific Viruses Revealed in
   Field-Collected Mosquitoes by a Monitoring Tool Adapted from a Microbial
   Detection Array
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Culex; Wolbachia; cell-fusing agent
   virus; Culex flavivirus; insect-specific virus; microarrays
ID WEST-NILE-VIRUS; PIPIENS DIPTERA-CULICIDAE; AEDES-AEGYPTI;
   CULEX-QUINQUEFASCIATUS; ZIKA VIRUS; RAPID DETECTION; CYTOPLASMIC
   INCOMPATIBILITY; BACTERIAL DIVERSITY; WOLBACHIA-PIPIENTIS; NHUMIRIM
   VIRUS
AB Several mosquito-borne diseases affecting humans are emerging or re-emerging in the United States. The early detection of pathogens in mosquito populations is essential to prevent and control the spread of these diseases. In this study, we tested the potential applicability of the Lawrence Livermore Microbial Detection Array (LLMDA) to enhance biosurveillance by detecting microbes present in Aedes aegypti, Aedes albopictus, and Culex mosquitoes, which are major vector species globally, including in Texas. The sensitivity and reproducibility of the LLMDA were tested in mosquito samples spiked with different concentrations of dengue virus (DENY), revealing a detection limit of >100 but <1,000 PFU/ml. Additionally, field-collected mosquitoes from Chicago, IL, and College Station, TX, of known infection status (West Nile virus (WNV) and Culex flavivirus (CxFLAVJ positive) were tested on the LLMDA to confirm its efficiency. Mosquito field samples of unknown infection status, collected in San Antonio, TX, and the Lower Rio Grande Valley (LRGV), TX, were run on the LLMDA and further confirmed by PCR or quantitative PCR (qPCR). The analysis of the field samples with the LLMDA revealed the presence of cellfusing agent virus (CFAV) in A. aegypti populations. Wolbachia was also detected in several of the field samples (A. albopictus and Culex spp.) by the LLMDA. Our findings demonstrated that the LLMDA can be used to detect multiple arboviruses of public health importance, including viruses that belong to the Flavivirus, Alphavirus, and Orthoburiyavirus genera. Additionally, insect-specific viruses and bacteria were also detected in field-collected mosquitoes. Another strength of this array is its ability to detect multiple viruses in the same mosquito pool, allowing for the detection of cocirculating pathogens in an area and the identification of potential ecological associations between different viruses. This array can aid in the biosurveillance of mosquito-borne viruses circulating in specific geographical areas.
   IMPORTANCE Viruses associated with mosquitoes have made a large impact on public and veterinary health. In the United States, several viruses, including WNV, DENY, and chikungunya virus (CHIKV), are responsible for human disease. From 2015 to 2018, imported Zika cases were reported in the United States, and in 2016 to 2017, local Zika transmission occurred in the states of Texas and Florida. With globalization and a changing climate, the frequency of outbreaks linked to arboviruses will increase, revealing a need to better detect viruses in vector populations. With the capacity of the LLMDA to detect viruses, bacteria, and fungi, this study highlights its ability to broadly screen field-collected mosquitoes and contribute to the surveillance and management of arboviral diseases.
C1 [Martin, Estelle; Garcia-Luna, Selene; Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Borucki, Monica K.; Thissen, James; Hwang, Mona; Jaing, Crystal J.; Frank, Matthias] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.
   [de Valdez, Megan Wise] Texas A&M Univ San Antonio, Program Biol, San Antonio, TX USA.
RP Frank, M (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.
EM frank1@llnl.gov
OI Garcia-Luna, Selene M./0000-0001-8420-5078
FU U.S. Department of Energy by the Lawrence Livermore National
   LaboratoryUnited States Department of Energy (DOE) [DE-AC52-07NA27344];
   LLNL grant; NIH R21 grantUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI128953]; Texas
   A&M AgriLife Research
FX This work was performed, in part, under the auspices of the U.S.
   Department of Energy by the Lawrence Livermore National Laboratory under
   contract DE-AC52-07NA27344. This work was supported by an internal LLNL
   grant, by an NIH R21 grant (R21AI128953), and by Texas A&M AgriLife
   Research.
CR Altinli M, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2777-9
   Contreras-Gutierrez MA, 2017, AM J TROP MED HYG, V97, P299, DOI 10.4269/ajtmh.16-0987
   Bittar C, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0614-3
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Centers for Disease Control and Prevention, 2018, CUM ZIK VIR DIS CAS
   Chandler JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00185
   Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013
   Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cataneo AHD, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180432
   Devault AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04245
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grubaugh ND, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002349
   Grubaugh ND, 2013, AM J TROP MED HYG, V88, P245, DOI 10.4269/ajtmh.2012.12-0048
   Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004765
   Jaing CJ, 2015, J VET DIAGN INVEST, V27, P313, DOI 10.1177/1040638715578484
   JOUSSET FX, 1993, VIRUS RES, V29, P99, DOI 10.1016/0168-1702(93)90052-O
   Kamtchum-Tatuene J, 2017, CURR OPIN INFECT DIS, V30, P108, DOI 10.1097/QCO.0000000000000342
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kim CH, 2015, J MED ENTOMOL, V52, P63, DOI 10.1093/jme/tju011
   Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2001, J CLIN MICROBIOL, V39, P4506, DOI 10.1128/JCM.39.12.4506-4513.2001
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Liang WK, 2015, ARCH VIROL, V160, P2259, DOI 10.1007/s00705-015-2492-1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Martin E, 2019, ACTA TROP, V192, P129, DOI 10.1016/j.actatropica.2019.02.006
   Micieli MV, 2014, J MED ENTOMOL, V51, P189, DOI 10.1603/ME13152
   Minard G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00059
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Mixao VDP, 2016, MED VET ENTOMOL, V30, P301, DOI 10.1111/mve.12179
   Morais SA, 2012, REV INST MED TROP SP, V54, P325, DOI 10.1590/S0036-46652012000600007
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morningstar RJ, 2012, J MED ENTOMOL, V49, P474, DOI 10.1603/ME11283
   Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Muturi EJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005377
   Newman CM, 2017, VECTOR-BORNE ZOONOT, V17, P567, DOI 10.1089/vbz.2017.2124
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Obara-Nagoya M, 2013, J MED ENTOMOL, V50, P300, DOI 10.1603/ME12159
   ONEILL SL, 1992, MED VET ENTOMOL, V6, P209, DOI 10.1111/j.1365-2915.1992.tb00608.x
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x
   Paterson A, 2005, VIROLOGY, V337, P253, DOI 10.1016/j.virol.2005.04.037
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318
   Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Rasgon JL, 2003, GENETICS, V165, P2029
   Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4
   Rosenstierne MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100813
   Sacco MA, 2000, J VIROL, V74, P1296, DOI 10.1128/JVI.74.3.1296-1306.2000
   Sacco MA, 2014, J GEN VIROL, V95, P2060, DOI 10.1099/vir.0.066852-0
   Sadeghi M, 2017, VIRUS RES, V242, P49, DOI 10.1016/j.virusres.2017.08.012
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Shi M, 2017, J VIROL, V91, DOI 10.1128/JVI.00680-17
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Thissen JB, 2014, J VIROL METHODS, V201, P73, DOI 10.1016/j.jviromet.2014.01.024
   Thongsripong P, 2018, ECOL EVOL, V8, P1352, DOI 10.1002/ece3.3676
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Yadav KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167409
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
   Zink SD, 2015, VIRUSES-BASEL, V7, P5619, DOI 10.3390/v7102886
   Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x
NR 83
TC 2
Z9 2
U1 2
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD OCT
PY 2019
VL 85
IS 19
AR e01202-19
DI 10.1128/AEM.01202-19
PG 14
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA JB8TO
UT WOS:000488849800016
PM 31350319
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wagner, SJ
   Leiby, DA
   Roback, JD
AF Wagner, Stephen J.
   Leiby, David A.
   Roback, John D.
TI Existing and Emerging Blood-Borne Pathogens Impact on the Safety of
   Blood Transfusion for the Hematology/Oncology Patient
SO HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Zika virus; Bacteria; Sepsis; Cytomegalovirus; Babesia; Babesiosis;
   Transfusion-transmitted
ID RED-CROSS EXPERIENCE; ZIKA VIRUS; BACTERIAL-CONTAMINATION; APHERESIS
   PLATELETS; SKIN DISINFECTION; CMV INFECTION; RESIDUAL RISK;
   CYTOMEGALOVIRUS; CULTURE; TRANSMISSION
AB Despite measures to mitigate risk of transfusion-transmitted infections, emerging agents contribute to morbidity and mortality. We outline the epidemiology, risk mitigation strategies, and impact on patients for Zika virus, bacteria, Babesia, and cytomegalovirus. Nucleic acid testing of blood has reduced risk of Zika infection and reduced transfusion-transmitted risk of Babesia. Other collection and testing measures have reduced but not eliminated the risk of sepsis from bacterially contaminated blood components. Cytomegalovirus has almost been eliminated by high-efficiency leukoreduction, but residual transmissions are difficult to distinguish from community-acquired infections and additional antibody testing of blood may confer further safety of susceptible recipients.
C1 [Wagner, Stephen J.] Amer Red Cross Holland Lab, Transfus Innovat Dept, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.
   [Leiby, David A.] US FDA, Div Emerging & Transfus Transmitted Dis, CBER, OBRR, 10903 New Hampshire Ave,Bldg 71,Room 4044, Silver Spring, MD 20993 USA.
   [Roback, John D.] Emory Univ, Sch Med, Dept Pathol & Lab Med, EUH D-655,1364 Clifton Rd NE, Atlanta, GA 30322 USA.
RP Wagner, SJ (corresponding author), Amer Red Cross Holland Lab, Transfus Innovat Dept, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.
EM stephen.wagner@redcross.org
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Benjamin RJ, 2014, VOX SANG, V106, P23, DOI 10.1111/vox.12065
   Benjamin RJ, 2011, TRANSFUSION, V51, P531, DOI 10.1111/j.1537-2995.2010.02868.x
   Bloch EM, 2018, TRANSFUSION, V58, P1647, DOI 10.1111/trf.14618
   Bloch EM, 2012, TRANSFUSION, V52, P1517, DOI 10.1111/j.1537-2995.2011.03467.x
   BOWDEN RA, 1995, BLOOD, V86, P3598, DOI 10.1182/blood.V86.9.3598.bloodjournal8693598
   Brazilian government (Brazil) M. d. S., MIN SAUD DIV B EP MI
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2018, CUM ZIK VIR DIS CAS
   Centers for Disease Control and Prevention, 2017, EST POT RANG AED AEG
   Cirino CM, 2008, ANN INTERN MED, V148, P794, DOI 10.7326/0003-4819-148-10-200805200-00018
   de Korte D, 2006, TRANSFUSION, V46, P476, DOI 10.1111/j.1537-2995.2006.00746.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eder AF, 2007, TRANSFUSION, V47, P1134, DOI 10.1111/j.1537-2995.2007.01248.x
   Eder AF, 2011, TRANSFUSION, V51, P1662, DOI 10.1111/j.1537-2995.2011.03083.x
   Eder AF, 2009, TRANSFUSION, V49, P1554, DOI 10.1111/j.1537-2995.2009.02192.x
   Fang CT, 2005, TRANSFUSION, V45, P1845, DOI 10.1111/j.1537-2995.2005.00650.x
   Fang DC, 2016, TRANSFUS MED REV, V30, P132, DOI 10.1016/j.tmrv.2016.04.002
   FDA, 2016, REV REC RED RISK ZIK
   Food and Drug Administration, 2018, BLOOD PROD ADV M
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Food and Drug Administration, 2018, FDA ANN REV GUID TES
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goldfinger D, 2018, TRANSFUSION, V58, P3038, DOI 10.1111/trf.15009
   GOLDMAN M, 1991, Transfusion Medicine Reviews, V5, P73, DOI 10.1016/S0887-7963(91)70194-6
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362
   Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944
   Jacobs MR, 2008, CLIN INFECT DIS, V46, P1214, DOI 10.1086/529143
   Jacobs MR, 2011, TRANSFUSION, V51, P2573, DOI 10.1111/j.1537-2995.2011.03308.x
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jordan CT, 2004, TRANSFUSION, V44, P1159, DOI 10.1111/j.1537-2995.2004.03351.x
   Josephson CD, 2014, JAMA PEDIATR, V168, P1054, DOI 10.1001/jamapediatrics.2014.1360
   Karkoska K, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26734
   Kaufman RM, 2014, TRANSFUSION, V54, P1704, DOI 10.1111/trf.12593
   Keil SD, 2015, TRANSFUSION, V55, P858, DOI 10.1111/trf.12945
   Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leclercq A, 2005, TRANSFUSION, V45, P814, DOI 10.1111/j.1537-2995.2005.04363.x
   Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10
   McDonald C, 2017, TRANSFUSION, V57, P1122, DOI 10.1111/trf.14085
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murphy WG, 2008, VOX SANG, V95, P13, DOI 10.1111/j.1423-0410.2008.01051.x
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Robillard P, 2011, TRANSFUSION, V51, P1405, DOI 10.1111/j.1537-2995.2010.03001.x
   Roth VR, 2000, TRANSFUSION, V40, P931, DOI 10.1046/j.1537-2995.2000.40080931.x
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Seed CR, 2015, VOX SANG, V109, P11, DOI 10.1111/vox.12250
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Skrabalo Z., 1957, Documenta de Medicina Geographica et Tropica, V9, P11
   Su LL, 2008, TRANSFUSION, V48, P1842, DOI 10.1111/j.1537-2995.2008.01763.x
   TABOR E, 1984, LANCET, V1, P1403
   Thiele T, 2011, TRANSFUSION, V51, P2620, DOI 10.1111/j.1537-2995.2011.03203.x
   Tonnetti L, 2019, TRANSFUSION, V59, P593, DOI 10.1111/trf.15043
   Vamvakas EC, 2003, TRANSFUSION, V43, P963, DOI 10.1046/j.1537-2995.2003.00426.x
   Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018
   Vichinsky E, 2014, TRANSFUSION, V54, P972, DOI 10.1111/trf.12348
   Vollmer T, 2010, J CLIN MICROBIOL, V48, P3475, DOI 10.1128/JCM.00542-10
   Wagner SJ, 2007, TRANSFUSION, V47, P430, DOI 10.1111/j.1537-2995.2007.01132.x
   Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 63
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0889-8588
EI 1558-1977
J9 HEMATOL ONCOL CLIN N
JI Hematol. Oncol. Clin. North Am.
PD OCT
PY 2019
VL 33
IS 5
BP 739
EP +
DI 10.1016/j.hoc.2019.05.002
PG 11
WC Oncology; Hematology
SC Oncology; Hematology
GA JB6ND
UT WOS:000488679900002
PM 31466601
DA 2020-07-08
ER

PT J
AU Hammack, C
   Ogden, SC
   Madden, JC
   Medina, A
   Xu, CC
   Phillips, E
   Son, YN
   Cone, A
   Giovinazzi, S
   Didier, RA
   Gilbert, DM
   Song, HJ
   Ming, GL
   Wen, ZX
   Brinton, MA
   Gunjan, A
   Tang, HL
AF Hammack, Christy
   Ogden, Sarah C.
   Madden, Joseph C., Jr.
   Medina, Angelica
   Xu, Chongchong
   Phillips, Ernest
   Son, Yuna
   Cone, Allaura
   Giovinazzi, Serena
   Didier, Ruth A.
   Gilbert, David M.
   Song, Hongjun
   Ming, Guoli
   Wen, Zhexing
   Brinton, Margo A.
   Gunjan, Akash
   Tang, Hengli
TI Zika Virus Infection Induces DNA Damage Response in Human Neural
   Progenitors That Enhances Viral Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE cell cycle; DNA damage; DNA damage checkpoints; DNA damage response; DNA
   replication; S phase; Zika virus; neural progenitors
ID S-PHASE; GLIAL-CELLS; STRESS; H2AX; PHOSPHORYLATION; CHECKPOINTS;
   ACTIVATION; KINASES; ARREST; CHK1
AB Zika virus (ZIKV) infection attenuates the growth of human neural progenitor cells (hNPCs). As these hNPCs generate the cortical neurons during early brain development, the ZIKV-mediated growth retardation potentially contributes to the neurodevelopmental defects of the congenital Zika syndrome. Here, we investigate the mechanism by which ZIKV manipulates the cell cycle in hNPCs and the functional consequence of cell cycle perturbation on the replication of ZIKV and related flaviviruses. We demonstrate that ZIKV, but not dengue virus (DENY), induces DNA double-strand breaks (DSBs), triggering the DNA damage response through the ATM/Chk2 signaling pathway while suppressing the ATR/Chk1 signaling pathway. Furthermore, ZIKV infection impedes the progression of cells through S phase, thereby preventing the completion of host DNA replication. Recapitulation of the S-phase arrest state with inhibitors led to an increase in ZIKV replication, but not of West Nile virus or DENY. Our data identify ZIKV's ability to induce DSBs and suppress host DNA replication, which results in a cellular environment favorable for its replication.
   IMPORTANCE Clinically, Zika virus (ZIKV) infection can lead to developmental defects in the cortex of the fetal brain. How ZIKV triggers this event in developing neural cells is not well understood at a molecular level and likely requires many contributing factors. ZIKV efficiently infects human neural progenitor cells (hNPCs) and leads to growth arrest of these cells, which are critical for brain development. Here, we demonstrate that infection with ZIKV, but not dengue virus, disrupts the cell cycle of hNPCs by halting DNA replication during S phase and inducing DNA damage. We further show that ZIKV infection activates the ATM/Chk2 checkpoint but prevents the activation of another checkpoint, the ATR/Chk1 pathway. These results unravel an intriguing mechanism by which an RNA virus interrupts host DNA replication. Finally, by mimicking virus-induced S-phase arrest, we show that ZIKV manipulates the cell cycle to benefit viral replication.
C1 [Hammack, Christy; Ogden, Sarah C.; Medina, Angelica; Gilbert, David M.; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
   [Madden, Joseph C., Jr.; Brinton, Margo A.] Georgia State Univ, Dept Biol, Atlanta, GA USA.
   [Xu, Chongchong; Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA.
   [Xu, Chongchong; Wen, Zhexing] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA USA.
   [Xu, Chongchong; Wen, Zhexing] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   [Phillips, Ernest; Son, Yuna; Cone, Allaura; Giovinazzi, Serena; Didier, Ruth A.; Gunjan, Akash] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.
   [Song, Hongjun; Ming, Guoli] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
EM tang@bio.fsu.edu
FU Public Health ServiceUnited States Public Health Service [U19 AI131130,
   R21 AI119530, R01 AI45135, U19AI131130, R01 GM083337]; Georgia State
   University Molecular Basis of Disease fellowship
FX This study was supported by Public Health Service grants U19 AI131130
   and R21 AI119530 to H.T., R01 AI45135 and U19AI131130 to M.A.B., U19
   AI131130 to Z.W., and R01 GM083337 to D.M.G. Partial support for J.C.M.
   was provided by a Georgia State University Molecular Basis of Disease
   fellowship.
CR Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7
   Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240
   Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163
   Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044
   Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523
   Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.c100466200
   Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114
   Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097
   Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016
   Lakshmi ANV, 1999, MUTAT RES-GEN TOX EN, V442, P53, DOI 10.1016/S1383-5718(99)00058-3
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li N, 2015, CELL MOL LIFE SCI, V72, P2973, DOI 10.1007/s00018-015-1879-1
   Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013
   Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548
   Marechal A, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A012716
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nakad R, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00147
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5
   Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004
   Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Schmid M, 2014, J VIROL, V88, P1404, DOI 10.1128/JVI.02046-13
   Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008
   Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055407
   Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001
   Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu LH, 2011, J BIOL CHEM, V286, P39546, DOI 10.1074/jbc.M111.242206
   Yu JH, 2015, CELL CYCLE, V14, P425, DOI 10.4161/15384101.2014.980631
   Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005
NR 52
TC 5
Z9 5
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2019
VL 93
IS 20
AR e00638-19
DI 10.1128/JVI.00638-19
PG 20
WC Virology
SC Virology
GA JB0XG
UT WOS:000488281200005
PM 31375586
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kam, CD
AF Kam, Cindy D.
TI Infectious Disease, Disgust, and Imagining the Other
SO JOURNAL OF POLITICS
LA English
DT Article
DE disgust; infectious disease; Ebola; Zika; ethnocentrism
ID BEHAVIORAL IMMUNE-SYSTEM; PUBLIC SUPPORT; MEDIA COVERAGE; FEAR; EBOLA;
   SENSITIVITY; CONTAGION; HYGIENE; ANXIETY; PURITY
AB In this article, I examine the American public's reaction to two recent infectious disease outbreaks: Ebola and Zika. Using a set of parallel questions, I investigate the ways in which public reactions to these distinct threats diverge and converge. I compare the microfoundations of public reactions to these two disparate infectious diseases-and, specifically, I use a behavioral immune system account to examine how disgust sensitivity and group-based prejudice shape understandings of these diseases and policies relating to them. I find the most prominent predictor of views on Ebola and Zika is disgust sensitivity-particularly individual differences in disgust-based reactions to contamination. The evidence in this article suggests that public opinion on these policies is grounded not necessarily in the cold cognition of scientific risk management but in visceral disgust reactions-reactions that can easily be distorted by imagination.
C1 [Kam, Cindy D.] Vanderbilt Univ, Polit Sci, Nashville, TN 37205 USA.
RP Kam, CD (corresponding author), Vanderbilt Univ, Polit Sci, Nashville, TN 37205 USA.
EM cindy.d.kam@vanderbilt.edu
FU National Science FoundationNational Science Foundation (NSF) [1559125];
   Vanderbilt University
FX I am grateful to have received constructive feedback from the anonymous
   reviewers, Jennifer Merolla, Jennifer Jerit, and Efren Perez. I thank
   Isaac Riddle for splendid research assistance. The Vanderbilt University
   Institutional Review Board reviewed and approved the protocols for data
   collection. The CCES data used in this work were supported by the
   National Science Foundation (award no. 1559125) and Vanderbilt
   University.
CR Aaroe L, 2017, AM POLIT SCI REV, V111, P277, DOI 10.1017/S0003055416000770
   Abedi-Anim MeCherri Denise, 2017, THESIS
   Albertson B, 2015, PS-POLIT SCI POLIT, V48, P8
   Bashi V, 1997, J BLACK STUD, V27, P668, DOI 10.1177/002193479702700505
   BISHOP GD, 1991, J APPL SOC PSYCHOL, V21, P1877, DOI 10.1111/j.1559-1816.1991.tb00511.x
   Borde Constance, 2009, 2 SEX
   Carey Benedict, 2014, NY TIMES
   CDC (Centers for Disease Control and Prevention), 2015, INT TABL STAT EB SCR
   Chapman HA, 2013, J EXP PSYCHOL GEN, V142, P1100, DOI 10.1037/a0030503
   Clifford S, 2018, AM J POLIT SCI, V62, P266, DOI 10.1111/ajps.12350
   Clifford S, 2017, POLIT BEHAV, V39, P503, DOI 10.1007/s11109-016-9366-4
   Clifford S, 2016, POLIT BEHAV, V38, P155, DOI 10.1007/s11109-015-9310-z
   Cohen J., 2016, SCIENCE
   CRANDALL CS, 1995, BRIT J SOC PSYCHOL, V34, P67, DOI 10.1111/j.2044-8309.1995.tb01049.x
   Curtis V, 2001, PERSPECT BIOL MED, V44, P17, DOI 10.1353/pbm.2001.0001
   Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3
   Devos T, 2005, J PERS SOC PSYCHOL, V88, P447, DOI 10.1037/0022-3514.88.3.447
   Dionne KY, 2015, PS-POLIT SCI POLIT, V48, P6
   Doucleff Michaeleen, 2014, NATL PUBLIC RADIO
   Eichelberger L, 2007, SOC SCI MED, V65, P1284, DOI 10.1016/j.socscimed.2007.04.022
   Engelhard IM, 2014, BEHAV THER, V45, P708, DOI 10.1016/j.beth.2014.04.003
   Evans Carter, 2014, CBS NEWS
   Evensen DT, 2012, SCI COMMUN, V34, P392, DOI 10.1177/1075547011421020
   Flynn Gerard, 2014, NEWSWEEK
   Hatemi P, 2012, PS-POLIT SCI POLIT, V45, P675, DOI 10.1017/S1049096512000686
   Henry J, 2016, KAISER HLTH TRACKING
   Kam CD, 2016, J POLIT, V78, P481, DOI 10.1086/684611
   KINDER DONALD R., 2009, US THEM ETHNOCENTRIC
   NELKIN D, 1988, SOC RES, V55, P361
   Novkov Julie, 2008, RACIAL UNION LAW INT
   Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823
   Olatunji BO, 2007, PSYCHOL ASSESSMENT, V19, P281, DOI 10.1037/1040-3590.19.3.281
   Olatunji BO, 2007, J ANXIETY DISORD, V21, P820, DOI 10.1016/j.janxdis.2006.11.004
   Prati G, 2016, RISK ANAL, V36, P2000, DOI 10.1111/risa.12537
   ROZIN P, 1992, J APPL SOC PSYCHOL, V22, P1081, DOI 10.1111/j.1559-1816.1992.tb00943.x
   ROZIN P, 1986, J PERS SOC PSYCHOL, V50, P703, DOI 10.1037/0022-3514.50.4.703
   SAID E, 1994, ORIENTALISM
   Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596
   Sell TK, 2016, PREV MED, V93, P115, DOI 10.1016/j.ypmed.2016.09.016
   Sturmer S, 2017, POLIT PSYCHOL, V38, P499, DOI 10.1111/pops.12354
   van Hooff JC, 2013, ACTA PSYCHOL, V143, P1, DOI 10.1016/j.actpsy.2013.02.001
   Weis L., 1995, ED FDN, V9, P17, DOI DOI 10.1108/17506200710779521
   Weiss ML, 2015, PS-POLIT SCI POLIT, V48, P5
   Zurcher Anthony, 2014, BBC NEWS
NR 44
TC 1
Z9 1
U1 5
U2 7
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0022-3816
EI 1468-2508
J9 J POLIT
JI J. Polit.
PD OCT 1
PY 2019
VL 81
IS 4
BP 1371
EP 1387
DI 10.1086/704438
PG 17
WC Political Science
SC Government & Law
GA JA3RP
UT WOS:000487743100018
DA 2020-07-08
ER

PT J
AU Gilboa, SM
   Gregory, CJ
   Honein, MA
AF Gilboa, Suzanne M.
   Gregory, Christopher J.
   Honein, Margaret A.
TI Better surveillance to protect mothers and infants from Zika
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID VIRUS
C1 [Gilboa, Suzanne M.; Honein, Margaret A.] US Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA.
   [Gregory, Christopher J.] US Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
RP Gilboa, SM (corresponding author), US Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA.
EM sgilboa@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Christianson A, 2006, MARCH DIMES GLOBAL R
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   US Centers for Disease Control and Prevention, PREGN WOM ZIK 2019
   WHO, INF TRAV VIS COUNTR
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 11
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2019
VL 19
IS 10
BP 1047
EP 1048
DI 10.1016/S1473-3099(19)30473-6
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA JA4ST
UT WOS:000487824300015
PM 31559951
OA Bronze
DA 2020-07-08
ER

PT J
AU Hill, SC
   Vasconcelos, J
   Neto, Z
   Jandondo, D
   Ze-Ze, L
   Aguiar, RS
   Xavier, J
   Theze, J
   Mirandela, M
   Candido, ALM
   Vaz, F
   Sebastiao, CD
   Wu, CH
   Kraemer, MUG
   Melo, A
   Schamber-Reis, BLF
   de Azevedo, GS
   Tanuri, A
   Higa, LM
   Clemente, C
   da Silva, SP
   Candido, DD
   Claro, IM
   Quibuco, D
   Domingos, C
   Pocongo, B
   Watts, AG
   Khan, K
   Alcantara, LCJ
   Sabino, EC
   Lackritz, E
   Pybus, OG
   Alves, MJ
   Afonso, J
   Faria, NR
AF Hill, Sarah C.
   Vasconcelos, Jocelyne
   Neto, Zoraima
   Jandondo, Domingos
   Ze-Ze, Libia
   Aguiar, Renato Santana
   Xavier, Joilson
   Theze, Julien
   Mirandela, Marinela
   Micolo Candido, Ana Luisa
   Vaz, Filipa
   Sebastiao, Cruz dos Santos
   Wu, Chieh-Hsi
   Kraemer, Moritz U. G.
   Melo, Adriana
   Schamber-Reis, Bruno L. F.
   de Azevedo, Girlene S.
   Tanuri, Amilcar
   Higa, Luiza M.
   Clemente, Carina
   da Silva, Sara Pereira
   Candido, Darlan da Silva
   Claro, Ingra M.
   Quibuco, Domingos
   Domingos, Cristovao
   Pocongo, Barbara
   Watts, Alexander G.
   Khan, Kamran
   Junior Alcantara, Luiz Carlos
   Sabino, Ester C.
   Lackritz, Eve
   Pybus, Oliver G.
   Alves, Maria-Joao
   Afonso, Joana
   Faria, Nuno R.
TI Emergence of the Asian lineage of Zika virus in Angola: an outbreak
   investigation
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION; AFRICA
AB Background Zika virus infections and suspected microcephaly cases have been reported in Angola since late 2016, but no data are available about the origins, epidemiology, and diversity of the virus. We aimed to investigate the emergence and circulation of Zika virus in Angola.
   Methods Diagnostic samples collected by the Angolan Ministry of Health as part of routine arboviral surveillance were tested by real-time reverse transcription PCR by the Instituto Nacional de Investigacao em Saude (Ministry of Health, Luanda, Angola). To identify further samples positive for Zika virus and appropriate for genomic sequencing, we also tested samples from a 2017 study of people with HIV in Luanda. Portable sequencing was used to generate Angolan Zika virus genome sequences from three people positive for Zika virus infection by real-time reverse transcription PCR, including one neonate with microcephaly. Genetic and mobility data were analysed to investigate the date of introduction and geographical origin of Zika virus in Angola. Brain CT and MRI, and serological assays were done on a child with microcephaly to confirm microcephaly and assess previous Zika virus infection.
   Findings Serum samples from 54 people with suspected acute Zika virus infection, 76 infants with suspected microcephaly, 24 mothers of infants with suspected microcephaly, 336 patients with suspected dengue virus or chikungunya virus infection, and 349 samples from the HIV study were tested by real-time reverse transcription PCR. Four cases identified between December, 2016, and June, 2017, tested positive for Zika virus. Analyses of viral genomic and human mobility data suggest that Zika virus was probably introduced to Angola from Brazil between July, 2015, and June, 2016. This introduction probably initiated local circulation of Zika virus in Angola that continued until at least June, 2017. The infant with microcephaly in whom CT and MRI were done had brain abnormalities consistent with congenital Zika syndrome and serological evidence for Zika virus infection.
   Interpretation Our analyses show that autochthonous transmission of the Asian lineage of Zika virus has taken place in Africa. Zika virus surveillance and surveillance of associated cases of microcephaly throughout the continent is crucial.
C1 [Hill, Sarah C.; Theze, Julien; Kraemer, Moritz U. G.; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Wu, Chieh-Hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Vasconcelos, Jocelyne; Neto, Zoraima; Jandondo, Domingos; Mirandela, Marinela; Micolo Candido, Ana Luisa; Vaz, Filipa; Sebastiao, Cruz dos Santos; Afonso, Joana] Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
   [Ze-Ze, Libia; Alves, Maria-Joao] Inst Nacl Saude Doutor Ricardo Jorge, Aguas De Moura, Portugal.
   [Ze-Ze, Libia] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.
   [Aguiar, Renato Santana; Tanuri, Amilcar; Higa, Luiza M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato Santana; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Dept Genet Ecol & Evolucao, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Sebastiao, Cruz dos Santos] Univ Agostinho Neto, Inst Super Ciencias Saude, Luanda, Angola.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA 02115 USA.
   [Melo, Adriana; de Azevedo, Girlene S.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Brazil.
   [Schamber-Reis, Bruno L. F.] Ctr Univ Unifacisa, Dept Human Genet, Campina Grande, Brazil.
   [Clemente, Carina; da Silva, Sara Pereira] Cligest Clin, Luanda, Angola.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Quibuco, Domingos] Hosp Pediat David Bernardino, Luanda, Angola.
   [Domingos, Cristovao; Pocongo, Barbara] Inst Nacl Luta SIDA, Luanda, Angola.
   [Watts, Alexander G.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Watts, Alexander G.; Khan, Kamran] BlueDot, Toronto, ON, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Junior Alcantara, Luiz Carlos] IOC Fundacao Oswaldo Cruz MS, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Lackritz, Eve] WHO, Geneva, Switzerland.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.; Afonso, J (corresponding author), Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
EM jfm.morais9@gmail.com; nuno.faria@zoo.ox.ac.uk
RI Pybus, Oliver g/B-2640-2012; Aguiar, Renato S/G-3542-2015; Higa,
   Luiza/W-2698-2019; Melo, Adriana S O/H-5650-2016; Sabino, Ester
   Cerdeira/F-7750-2010
OI Pybus, Oliver g/0000-0002-8797-2667; Aguiar, Renato
   S/0000-0001-5180-3717; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   Xavier, Joilson/0000-0003-3916-2018; Ze-Ze, Libia/0000-0001-7258-1439;
   Hill, Sarah/0000-0002-2995-2596; Alcantara, Luiz/0000-0002-6769-9931;
   Alves, Maria Joao/0000-0003-0065-9000
FU Sir Henry Dale Fellowship [204311/Z/16/Z]; internal Higher Education
   Funding Council for England Global Challenges Research Fund [005073];
   Africa Oxford Initiative [AfiOx-48, AfiOx-60]; John Fell Research Fund
   [005166]; Medical Research CouncilMedical Research Council UK (MRC)
   [MR/S0195/1, 2018/14389-0]; O Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [440900/2016-6, 440685/2016-8];
   Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [88881.130757/2016-01, 88887.130716/2016-00,
   88881.130728/2016-01]; European Research CouncilEuropean Research
   Council (ERC) [614725-PATHPHYLODYN]; Oxford Martin School; UK Medical
   Research CouncilMedical Research Council UK (MRC); Cancer Research
   UKCancer Research UK [ANR00310]
FX We thank the participants who participated in this study and the WHO
   Angolan country office for sharing information about suspected Zika and
   microcephaly cases. This research was supported by a Sir Henry Dale
   Fellowship (204311/Z/16/Z), internal Higher Education Funding Council
   for England Global Challenges Research Fund (005073), the Africa Oxford
   Initiative (AfiOx-48 and AfiOx-60), John Fell Research Fund (005166),
   and by the Medical Research Council (MR/S0195/1 and 2018/14389-0), O
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (440900/2016-6 and 440685/2016-8), Fundacao Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (88881.130757/2016-01,
   88887.130716/2016-00, and 88881.130728/2016-01), the European Research
   Council (FP7 grant agreement 614725-PATHPHYLODYN), and the Oxford Martin
   School. C-HW is supported by the UK Medical Research Council and Cancer
   Research UK (ANR00310). We thank Patricia Alvarez Baptista and Antonio
   Gomes Pinto Ferreira (Fundacao Oswaldo Cruz, Instituto de Tecnologia em
   Imunobiologicos Bio-Manguinhos, Rio de Janeiro, Brazil) for donating
   Bio-Manguinhos reagents, and Jorge Munoz-Jordan and Gilberto Santiago
   (CDC) for donating real-time reverse transcription PCR reagents.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hill SC, 2019, EMERG INFECT DIS, V25, P784, DOI 10.3201/eid2504.180958
   Lourenco J, 2018, PLOS CURR OUTBREAKS
   Melo AS, 2016, JAMA NEUROL
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Pan American Health Organization, 2018, DIG ZIK CAS INC RAT
   Pan American Health Organization WHO, 2018, ZIK CAS CONG SYNDR A
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Sharp TM, 2013, MMWR-MORBID MORTAL W, V62, P504
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Taiwan Centers for Disease Control, TRAV VIS RET ZIK AFF
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   WHO, 2016, SCREEN ASS MAN NEON
   WHO, 2017, WEEK, V48
   WHO, 2007, WHO CHILD GROWTH STA
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 32
TC 9
Z9 9
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2019
VL 19
IS 10
BP 1138
EP 1147
DI 10.1016/S1473-3099(19)30293-2
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA JA4ST
UT WOS:000487824300040
PM 31559967
OA Other Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Suhrbier, A
AF Suhrbier, Andreas
TI Rheumatic manifestations of chikungunya: emerging concepts and
   interventions
SO NATURE REVIEWS RHEUMATOLOGY
LA English
DT Review
ID ROSS-RIVER-VIRUS; NEUTRALIZING MONOCLONAL-ANTIBODIES; REGULATORY
   T-CELLS; ARTHRITOGENIC ALPHAVIRUSES; LABORATORY FEATURES; SYNOVIAL
   EFFUSIONS; CLINICAL-FEATURES; DENGUE-FEVER; RISK-FACTORS; MOUSE MODEL
AB The largest epidemic ever recorded for chikungunya, a disease caused by infection with the chikungunya virus (CHIKV), began in Africa in 2004 and spread to > 100 countries on four continents. The epidemic caused > 10 million cases of often debilitating rheumatic disease, classically involving rapid onset of fever and polyarthralgia, often with polyarthritis. The clinical diagnosis of chikungunya is often complicated by infections with dengue or Zika virus. For many individuals with chikungunya, the disease is benign and self-limiting; however, some patients have a complex spectrum of atypical and severe manifestations. Many patients also experience a chronic phase of the disease, primarily involving arthralgia (which can be protracted (> 1 year)), and a number of sequelae are also recognized. CHIKV-induced arthropathy arises from infection of multiple cell types in the joint and the infiltration of mainly mononuclear cells. Innate responses (primarily involving type I interferon responses and natural killer cells) and cognate responses (primarily involving CD4 T helper 1 cells), alongside activation of macrophages and monocytes, mediate CHIKV-induced arthritic immunopathology. Ideally, improved anti-inflammatory treatments should not compromise antiviral immunity. New concepts in mosquito control are being field tested and a number of CHIKV vaccines are being developed.
C1 [Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Lab, Brisbane, Qld, Australia.
   [Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Inflammat Biol Lab, Brisbane, Qld, Australia.; Suhrbier, A (corresponding author), Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
EM Andreas.Suhrbier@qimrberghofer.edu.au
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Akhrymuk I, 2019, J VIROL, V93, DOI 10.1128/JVI.02062-18
   Aly Mussa Manuel, 2017, BMC Res Notes, V10, P88, DOI [10.1186/s13104-017-2394-2, 10.1186/s13104-017-2417-z]
   Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   Alvis-Zakzuk Nelson J, 2018, Value Health Reg Issues, V17, P32, DOI 10.1016/j.vhri.2018.01.004
   Anders KL, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2670-z
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P410
   de Brito CAA, 2017, REV SOC BRAS MED TRO, V50, P585, DOI 10.1590/0037-8682-0479-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   Auerswald H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0010-0
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Badawi A, 2018, INT J INFECT DIS, V67, P107, DOI 10.1016/j.ijid.2017.12.018
   Baxter VK, 2018, MAMM GENOME, V29, P408, DOI 10.1007/s00335-018-9776-1
   Bedoui Y, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006634
   Bhooshan S, 2015, INT J HEALTHCARE BIO, V03, P117
   Blettery M, 2016, ARTHRITIS RHEUMATOL, V68, P2817, DOI 10.1002/art.39775
   Bolden JR, 2014, CLIN OBSTET GYNECOL, V57, P568, DOI 10.1097/GRF.0000000000000053
   Bonifay T, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx247
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Briggs AM, 2018, B WORLD HEALTH ORGAN, V96, P366, DOI [10.2471/BLT.17.204891, 10.2471/blt.17.204891]
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Butler D., 2018, NATURE
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Carissimo G, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900298
   Carpentier KS, 2018, CURR OPIN VIROL, V28, P53, DOI 10.1016/j.coviro.2017.11.006
   Carrillo FB, 2019, CLIN INFECT DIS, V68, P172, DOI 10.1093/cid/ciy535
   Centers for disease control and prevention, CHIKUNGUNYA CLIN MAN
   Chandorkar N, 2017, BMJ CASE REP, V2017, pbcr
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P585, DOI 10.1002/art.40383
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P578, DOI 10.1002/art.40384
   Chen WQ, 2017, NAT MICROBIOL, V2, P1435, DOI 10.1038/s41564-017-0015-4
   Chen WQ, 2015, TRENDS MICROBIOL, V23, P35, DOI 10.1016/j.tim.2014.09.005
   Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Choy EHS, 2018, RHEUMATOLOGY, V57, P1885, DOI 10.1093/rheumatology/kex391
   Chua CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171989
   Chua CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004960
   Contopoulos-Ioannidis D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006510
   Cook AD, 2018, TRENDS IMMUNOL, V39, P240, DOI 10.1016/j.it.2017.12.003
   Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   da Silva GB, 2018, AM J TROP MED HYG, V99, P1327, DOI 10.4269/ajtmh.18-0531
   Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760
   Das T, 2015, J GEN VIROL, V96, P294, DOI 10.1099/vir.0.071175-0
   Barreto FKD, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0329-2
   de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31
   Dorleans F, 2018, AM J TROP MED HYG, V98, P1819, DOI 10.4269/ajtmh.16-0719
   Drame M, 2018, AM J TROP MED HYG, V99, P552, DOI 10.4269/ajtmh.18-0468a
   Dubrocq G, 2017, J PEDIATR INFECT DIS, V6, pE158, DOI 10.1093/jpids/pix048
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Duvignaud A, 2018, EPIDEMIOL INFECT, V146, P633, DOI [10.1017/S0950268818000031, 10.1017/s0950268818000031]
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Edwards T, 2016, EMERG INFECT DIS, V22, P2003, DOI 10.3201/eid2211.161017
   Elsinga J, 2018, TRAVEL MED INFECT DI, V23, P34, DOI 10.1016/j.tmaid.2018.03.008
   Feldstein LR, 2018, AM J TROP MED HYG, V98, P845, DOI 10.4269/ajtmh.17-0799
   Escobar MF, 2020, J MATERN-FETAL NEO M, V33, P2445, DOI 10.1080/14767058.2018.1554044
   Fortuna C, 2018, EUROSURVEILLANCE, V23, P6, DOI 10.2807/1560-7917.ES.2018.23.22.1800246
   Fox J. M., 2019, SCI IMMUNOL, V4, P1
   Fox JM, 2016, J IMMUNOL, V197, P4210, DOI 10.4049/jimmunol.1601426
   FRASER JRE, 1984, AUST NZ J MED, V14, P505, DOI 10.1111/j.1445-5994.1984.tb03629.x
   FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Godaert L, 2017, J AM GERIATR SOC, V65, P2510, DOI 10.1111/jgs.15004
   Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004
   Goo L, 2016, J INFECT DIS, V214, P1487, DOI 10.1093/infdis/jiw431
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Guaraldo L, 2018, EXPERT REV ANTI-INFE, V16, P333, DOI 10.1080/14787210.2018.1450629
   Gunes UY, 2008, J CLIN NURS, V17, P2284, DOI 10.1111/j.1365-2702.2007.02272.x
   Guo C, 2018, CLIN EXP IMMUNOL, V194, P231, DOI 10.1111/cei.13167
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   Haist KC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006748
   Hanley M, 2019, OBSTET GYNECOL SURV, V74, P50, DOI 10.1097/OGX.0000000000000635
   Haroon N, 2008, J RHEUMATOL, V35, P975
   HAZELTON RA, 1985, AUST NZ J MED, V15, P336, DOI 10.1111/j.1445-5994.1985.tb04048.x
   Heath CJ, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx234
   Hennessey MJ, 2018, AM J TROP MED HYG, V99, P1321, DOI 10.4269/ajtmh.18-0437
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hossain MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006561
   Huits R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196630
   Ikeda N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat0207
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   Jain J, 2017, CLIN INFECT DIS, V65, P133, DOI 10.1093/cid/cix283
   Jin J, 2018, CELL HOST MICROBE, V24, P417, DOI 10.1016/j.chom.2018.07.018
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Kang G, 2018, WORKSH CHIK VACC DEL
   Karonitsch T, 2018, RHEUMATOLOGY, V57, P572, DOI 10.1093/rheumatology/kex426
   Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245
   Amaral JK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030289
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Koeltz A, 2018, EMERG INFECT DIS, V24, P794, DOI 10.3201/eid2404.161536
   Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178
   Kulkarni SP, 2017, EUR J CLIN MICROBIOL, V36, P2475, DOI 10.1007/s10096-017-3087-4
   Kumar A, 2017, J TROP PEDIATRICS, V63, P43, DOI 10.1093/tropej/fmw051
   Kuo SC, 2016, ANTIVIR RES, V134, P89, DOI 10.1016/j.antiviral.2016.07.025
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Langsjoen RM, 2018, MBIO, V9, DOI 10.1128/mBio.02449-17
   Lee WWL, 2015, J VIROL, V89, P7893, DOI 10.1128/JVI.00998-15
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Lim E. X. Y., 2018, VIRUSES, V10, pE86
   Lim SM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01556
   Lokireddy S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-31
   Londhey Vikram, 2016, J Assoc Physicians India, V64, P36
   Long Kristin M, 2015, Curr Trop Med Rep, V2, P13
   Marques CDL, 2017, REV BRAS REUMATOL, V57, pS438, DOI 10.1016/j.rbre.2017.06.004
   Marques CDL, 2017, REV BRAS REUMATOL, V57, pS421, DOI 10.1016/j.rbre.2017.05.006
   Lovett B, 2019, SCIENCE, V364, P894, DOI 10.1126/science.aaw8737
   Lu SH, 2010, J CLIN NURS, V19, P4, DOI 10.1111/j.1365-2702.2009.02945.x
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Marr N, 2014, J IMMUNOL, V192, P948, DOI 10.4049/jimmunol.1302007
   Marti-Carvajal A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179028
   Mathew AJ, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0680-7
   Matusali G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020175
   Maucourant C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020131
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   McCarthy MK, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121100
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Mercado M, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.22.30244
   Mercado M, 2018, J CLIN VIROL, V103, P16, DOI 10.1016/j.jcv.2018.03.009
   Michlmayr D, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177862
   Milligan GN, 2019, VACCINE, V37, P7427, DOI 10.1016/j.vaccine.2018.10.033
   Miner JJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3438
   Molony RD, 2017, SCI SIGNAL, V10, P1, DOI [10.1126/scisignalaan2392, DOI 10.1126/SCISIGNALAAN2392]
   Molony RD, 2018, EXP GERONTOL, V107, P130, DOI 10.1016/j.exger.2017.08.019
   Monge P, 2019, JCR-J CLIN RHEUMATOL, V25, P101, DOI 10.1097/RHU.0000000000000868
   Mylonas AD, 2004, JCR-J CLIN RHEUMATOL, V10, P326, DOI 10.1097/01.rhu.0000147052.11190.36
   Mylonas AD, 2002, MED J AUSTRALIA, V177, P356, DOI 10.5694/j.1326-5377.2002.tb04837.x
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Nayak TK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00786
   Nehmar R, 2018, TRENDS MOL MED, V24, P338, DOI 10.1016/j.molmed.2018.02.001
   Ng LFP, 2017, ANNU REV VIROL, V4, P413, DOI 10.1146/annurev-virology-101416-041808
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Nikitina E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092821
   Noret M, 2012, J INFECT DIS, V206, P455, DOI 10.1093/infdis/jis368
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   O'Neill Scott L, 2018, Gates Open Res, V2, P36, DOI 10.12688/gatesopenres.12844.2
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Paixao ES, 2018, T ROY SOC TROP MED H, V112, P301, DOI 10.1093/trstmh/try063
   Parker D, 2018, CYTOKINE, V107, P130, DOI 10.1016/j.cyto.2018.01.016
   Peters CMM, 2018, J VECTOR DIS, V55, P137, DOI 10.4103/0972-9062.242561
   Phuklia W, 2013, VIRUS RES, V177, P179, DOI 10.1016/j.virusres.2013.08.011
   Pinzon-Redondo H, 2016, PEDIATR INFECT DIS J, V35, P702, DOI 10.1097/INF.0000000000001135
   Sales GMPG, 2018, REV ASSOC MED BRAS, V64, P63, DOI 10.1590/1806-9282.64.01.63
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Powers AM, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00104-16
   Prow NA, 2018, EXPERT REV VACCINES, V17, P925, DOI 10.1080/14760584.2018.1522255
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Prow NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006788
   Pyke AT, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0024-2
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Ramos R, 2018, PEDIATR INFECT DIS J, V37, P94, DOI 10.1097/INF.0000000000001690
   Remenyi R, 2018, J VIROL, V92, DOI [10.1128/JVI.00477-18, 10.1128/jvi.00477-18]
   Freitas ARR, 2018, T ROY SOC TROP MED H, V112, P443, DOI 10.1093/trstmh/try072
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Ritz N, 2015, PEDIATR INFECT DIS J, V34, P789, DOI 10.1097/INF.0000000000000716
   Robert M, 2019, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00364
   Roberts CA, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00571
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Roques P, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050268
   Roques P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.83527
   Rosso F, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12978
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Rudwaleit M, 2000, ANN RHEUM DIS, V59, P311, DOI 10.1136/ard.59.4.311
   Runowska M, 2018, CLIN EXP RHEUMATOL, V36, P494
   Salam N, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5626-z
   Samra JA, 2017, J CHILD NEUROL, V32, P712, DOI 10.1177/0883073817701879
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Shanks GD, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz003
   Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429
   Sharma PK, 2018, EMERG INFECT DIS, V24, P1737, DOI 10.3201/eid2409.180330
   Sharma SK, 2018, INT J RHEUM DIS, V21, P584, DOI 10.1111/1756-185X.13273
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
   Shaw WR, 2019, NAT MICROBIOL, V4, P20, DOI 10.1038/s41564-018-0214-7
   Silva JVJ, 2018, ACTA TROP, V188, P213, DOI 10.1016/j.actatropica.2018.09.003
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Silva MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep32288
   Simarmata D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26097
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Singh J, 2018, TZU CHI MED J, V30, P158, DOI 10.4103/tcmj.tcmj_138_17
   Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005
   Sukkaew A, 2018, J GEN VIROL, V99, P525, DOI 10.1099/jgv.0.001039
   Sutaria RB, 2018, CURR OPIN RHEUMATOL, V30, P256, DOI 10.1097/BOR.0000000000000486
   Tapasvi Puwar, 2010, Dengue Bulletin, V34, P40
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Taylor A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071146
   Teo TH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06227-9
   Teo TH, 2018, EMBO MOL MED, V10, P121, DOI 10.15252/emmm.201707885
   Teo TH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1333
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Thanapati S, 2017, HUM IMMUNOL, V78, P370, DOI 10.1016/j.humimm.2017.02.006
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Ulloa-Padilla JP, 2018, P R HEALTH SCI J, V37, P83
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Wade SM, 2019, ANN RHEUM DIS, V78, P350, DOI 10.1136/annrheumdis-2018-214138
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   WHO-World Health Organization, 2009, GUID PREV CONTR CHIK
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   Yamin R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37448-z
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Zaid A, 2018, ARTHRITIS RHEUMATOL, V70, P484, DOI 10.1002/art.40403
   Zaid A, 2011, ARTHRITIS RHEUM-US, V63, P488, DOI 10.1002/art.30112
   Zhang R, 2018, NATURE, V557, P570, DOI 10.1038/s41586-018-0121-3
   Ziemssen T, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000548
NR 230
TC 6
Z9 6
U1 3
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4790
EI 1759-4804
J9 NAT REV RHEUMATOL
JI Nat. Rev. Rheumatol.
PD OCT
PY 2019
VL 15
IS 10
BP 597
EP 611
DI 10.1038/s41584-019-0276-9
PG 15
WC Rheumatology
SC Rheumatology
GA IZ8DW
UT WOS:000487334300011
PM 31481759
DA 2020-07-08
ER

PT J
AU Thanigaivel, A
   Chanthini, KMP
   Karthi, S
   Vasantha-Srinivasan, P
   Ponsankar, A
   Sivanesh, H
   Stanley-Raja, V
   Shyam-Sundar, N
   Narayanan, KR
   Senthil-Nathan, S
AF Thanigaivel, Annamalai
   Chanthini, Kanagaraj Muthu-Pandian
   Karthi, Sengodan
   Vasantha-Srinivasan, Prabhakaran
   Ponsankar, Athirstam
   Sivanesh, Haridoss
   Stanley-Raja, Vethamonickam
   Shyam-Sundar, Narayanan
   Narayanan, Kilapavoor Raman
   Senthil-Nathan, Sengottayan
TI Toxic effect of essential oil and its compounds isolated from
   Sphaeranthus amaranthoides Burm. f. against dengue mosquito vector Aedes
   aegypti Linn.
SO PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Article
DE Larvicide; Mortality; Enzyme; Repellent; CytP450; Detoxification;
   Photomicrography
ID SPODOPTERA-LITURA FAB.; STEPHENSI LISTON DIPTERA; NONTARGET TOXICITY;
   TOBACCO CUTWORM; EXTRACT; TARGET; REPELLENTS; CULICIDAE; EARTHWORM;
   SUBLETHAL
AB Aedes aegypti is a major mosquito vector that can transfer many deadly diseases such as dengue, chikungunya, Zika, and yellow fever viruses. Due to the developing resistance among the vector populations by the application of chemical insecticides, alternative eco-friendly vector management strategies are being focused. In this aspect, the present study was carried out to evaluate the mosquitocidal potentials of essential oil of Sphaeranthus amaranthoides (EO-Sa). EO-Sa was found to be effective against Ae. aegypti mosquito vector by exhibiting significant larvicidal, adulticidal and repellent activities. GCMS analysis of EO-Sa revealed the presence of Carvone as the major component (peak area of 89.7%). The larvicidal bioassays performed revealed that the second instar larvae were relatively more susceptible (94.32% mortality) to EO-Sa treatments (75 ppm), LC50, 20.38 ppm. The sub lethal treatment concentration (20 ppm) significantly affected the oviposition, fecundity and morphology of Ae. aegypti. At sub lethal treatment concentration, EO-Sa down regulated alpha- and beta carboxylesterase and up regulated the GST and CYP450 level of third and fourth instar larvae. Thus the present results illustrates that EO-Sa can deliver a durable larvicidal, repellent and adulticidal activity against Ae. aegypti in an effective and eco-friendly manner.
C1 [Thanigaivel, Annamalai; Narayanan, Kilapavoor Raman] Sri Paramakalyani Coll, Dept Zool, Tirunelveli 627412, Tamil Nadu, India.
   [Chanthini, Kanagaraj Muthu-Pandian; Karthi, Sengodan; Sivanesh, Haridoss; Stanley-Raja, Vethamonickam; Shyam-Sundar, Narayanan; Senthil-Nathan, Sengottayan] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
   [Vasantha-Srinivasan, Prabhakaran] St Peters Inst Higher Educ & Res, Dept Biotechnol, Chennai 600054, Tamil Nadu, India.
   [Ponsankar, Athirstam] Sri Paramakalyani Coll, Dept Biotechnol, Tirunelveli 627412, Tamil Nadu, India.
RP Senthil-Nathan, S (corresponding author), Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
EM senthil@msuniv.ac.in
FU Department of Science and Technology, Science and Engineering Research
   Board (DST -SERB), New Delhi, India; National Post -Doctoral Fellowship
   [PDF/2016/003987]
FX The project was full financially supported by Department of Science and
   Technology, Science and Engineering Research Board (DST -SERB), New
   Delhi, India, for the grant of National Post -Doctoral Fellowship (File
   No: PDF/2016/003987).
CR Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Chellappandian M, 2018, ENVIRON INT, V113, P214, DOI 10.1016/j.envint.2017.12.038
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   Conti B, 2013, PARASITOL RES, V112, P991, DOI 10.1007/s00436-012-3221-2
   de Carvalho CCCR, 2006, FOOD CHEM, V95, P413, DOI 10.1016/j.foodchem.2005.01.003
   Dinesh-Kumar A, 2018, CHEMOSPHERE, V199, P35, DOI 10.1016/j.chemosphere.2018.01.130
   Dua VK, 2010, INDIAN J MED RES, V131, P434
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Gupta N, 2012, INDIAN J MED RES, V136, P373
   Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t
   HWANG YS, 1982, ENVIRON ENTOMOL, V11, P223, DOI 10.1093/ee/11.1.223
   Kalaivani K, 2012, PARASITOL RES, V110, P1261, DOI 10.1007/s00436-011-2623-x
   Kamaraj C, 2018, ECOTOX ENVIRON SAFE, V161, P221, DOI 10.1016/j.ecoenv.2018.05.062
   Karthi S, 2018, PESTIC BIOCHEM PHYS, V149, P54, DOI 10.1016/j.pestbp.2018.05.009
   Koodalingam A, 2011, ACTA TROP, V118, P27, DOI 10.1016/j.actatropica.2011.01.003
   Laranja AT, 2003, GENET MOL BIOL, V26, P419, DOI 10.1590/S1415-47572003000400004
   Maheswaran R, 2012, PARASITOL RES, V110, P1801, DOI 10.1007/s00436-011-2702-z
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Napoleao TH, 2012, PARASITOL RES, V110, P609, DOI 10.1007/s00436-011-2529-7
   Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Ponsankar A, 2016, ECOTOX ENVIRON SAFE, V133, P260, DOI 10.1016/j.ecoenv.2016.06.043
   Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009
   Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002
   Nathan SS, 2006, BIORESOURCE TECHNOL, V97, P2077, DOI 10.1016/j.biortech.2005.09.034
   Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Somnath De, 2013, Pharmacognosy Journal, V5, P265
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Thanigaivel A, 2018, ENVIRON SCI POLLUT R, V25, P10340, DOI 10.1007/s11356-017-9102-6
   Thanigaivel A, 2017, ARCH INSECT BIOCHEM, V94, DOI 10.1002/arch.21384
   Thanigaivel A, 2017, ECOTOX ENVIRON SAFE, V137, P210, DOI 10.1016/j.ecoenv.2016.11.004
   Thanigaivel A, 2012, PARASITOL RES, V110, P1993, DOI 10.1007/s00436-011-2728-2
   Thanigavelan V., 2012, Journal of Applied Pharmaceutical Science, V2, P95
   Vasantha-Srinivasan P, 2018, J ASIA-PAC ENTOMOL, V21, P1466, DOI 10.1016/j.aspen.2018.10.008
   Vasantha-Srinivasan P, 2017, ECOTOX ENVIRON SAFE, V139, P439, DOI 10.1016/j.ecoenv.2017.01.026
   World Health Organisation, 1981, WHOVBC, V81, P1
   Zibaee Arash, 2014, Archives of Phytopathology and Plant Protection, V47, P2187, DOI 10.1080/03235408.2013.870112
NR 43
TC 2
Z9 2
U1 3
U2 17
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0048-3575
EI 1095-9939
J9 PESTIC BIOCHEM PHYS
JI Pest. Biochem. Physiol.
PD OCT
PY 2019
VL 160
BP 163
EP 170
DI 10.1016/j.pestbp.2019.08.006
PG 8
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA JA1IQ
UT WOS:000487571100019
PM 31519251
DA 2020-07-08
ER

PT J
AU Lin, Y
   Zhang, HJ
   Song, WB
   Si, SY
   Han, YX
   Jiang, JD
AF Lin, Yuan
   Zhang, Hongjuan
   Song, Weibao
   Si, Shuyi
   Han, Yanxing
   Jiang, Jiandong
TI Identification and characterization of Zika virus NS5 RNA-dependent RNA
   polymerase inhibitors
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Zika virus; NS5; RNA-dependent RNA polymerase; Inhibitor
ID NONNUCLEOSIDE INHIBITORS; ACID
AB The current outbreak of Zika virus (ZIKV) is the impetus for novel, safe and efficacious anti-ZIKV agents. ZIKV non-structural protein 5 RNA-dependent RNA polymerase (RdRp) is essential for viral replication and is logically regarded as an attractive drug target. This study used a fluorescence-based polymerase assay to find an anti-infective drug 10-undecenoic acid zinc salt (UA) which could inhibit RdRp activity with a half maximal inhibitory concentration (IC50) of 1.13-1.25 mu M. Molecular docking and site-directed mutagenesis analyses identified D535 as the key amino acid in the interaction between RdRp and UA. Importantly, the surface plasmon resonance assay showed that UA had strong direct binding with ZIKV wild-type RdRp and a relatively weak interaction with D535A-RdRp. As a control, the nucleoside inhibitor sofosbuvir triphosphate (PSI-7409) conferred insensitivity to the fluorescence-based RdRp assay and cannot bind directly with RdRp. Moreover, UA showed anti-ZIKV activity comparable to sofosbuvir. All these results indicate that UA is likely to be a promising lead compound against ZIKV, exhibiting a different mechanism than sofosbuvir. (C) 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
C1 [Lin, Yuan; Zhang, Hongjuan; Song, Weibao; Han, Yanxing; Jiang, Jiandong] Chinese Acad Med Sci, Inst Materia Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China.
   [Lin, Yuan; Zhang, Hongjuan; Song, Weibao; Si, Shuyi; Han, Yanxing; Jiang, Jiandong] Peking Union Med Coll, Beijing, Peoples R China.
   [Si, Shuyi; Jiang, Jiandong] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China.
RP Han, YX; Jiang, JD (corresponding author), Chinese Acad Med Sci, Inst Materia Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China.; Han, YX; Jiang, JD (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Jiang, JD (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China.
EM hanyanxing@imm.ac.cn; jiang.jdong@163.com
FU Zika Special Project of MOST [273-2016]; NSFCNational Natural Science
   Foundation of China [81773784]; Beijing Nova ProgramBeijing Municipal
   Science & Technology Commission [Z181100006218075]; Basic Scientific
   Research Program of CAMS [2018RC350005]; CAMS Major Collaborative
   Innovation Project [2016-I2M-1-011]; Drug Innovation Major Project
   [2018ZX09711001-002-002]
FX This work was supported by the Zika Special Project of MOST (273-2016),
   NSFC (81773784), Beijing Nova Program (Z18110 0 0 06218075), Basic
   Scientific Research Program of CAMS (2018RC350 0 05), CAMS Major
   Collaborative Innovation Project (2016-I2M-1-011) and Drug Innovation
   Major Project (2018ZX09711001-002-002).
CR Bourne N, 1999, ANTIVIR RES, V40, P139, DOI 10.1016/S0166-3542(98)00055-2
   Brayden DJ, 2014, AAPS J, V16, P1064, DOI 10.1208/s12248-014-9634-3
   Cheek MA, 2013, ANTIVIR RES, V98, P144, DOI 10.1016/j.antiviral.2013.02.014
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gorshkov K, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03252
   Helms S, 2006, ALTERN MED REV, V11, P196
   Liu J, 2012, NUCLEOS NUCLEOT NUCL, V31, P277, DOI 10.1080/15257770.2012.658131
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Masmejan S, 2018, EXPERT REV ANTI-INFE, V16, P471, DOI 10.1080/14787210.2018.1483239
   Netzler NE, 2017, ANTIVIR RES, V146, P65, DOI 10.1016/j.antiviral.2017.07.014
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   Rahman VPM, 2005, EUR J MED CHEM, V40, P173, DOI 10.1016/j.ejmech.2004.10.003
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu HT, 2016, ANTIMICROB AGENTS CH, V60, P600, DOI 10.1128/AAC.02203-15
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 20
TC 2
Z9 2
U1 6
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD OCT
PY 2019
VL 54
IS 4
BP 502
EP 506
DI 10.1016/j.ijantimicag.2019.07.010
PG 5
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA IZ3YL
UT WOS:000487021400016
PM 31310806
DA 2020-07-08
ER

PT J
AU Heinz, FX
   Stiasny, K
AF Heinz, Franz X.
   Stiasny, Karin
TI When it is better to stay together
SO NATURE IMMUNOLOGY
LA English
DT Editorial Material
ID ZIKA VIRUS; DENGUE VIRUS; ENHANCEMENT
C1 [Heinz, Franz X.; Stiasny, Karin] Med Univ Vienna, Ctr Virol, Vienna, Austria.
RP Heinz, FX (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.
EM franz.x.heinz@meduniwien.ac.at
OI Stiasny, Karin/0000-0002-1902-8674
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P 27501]
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2018, ANNU REV VIROL, V5, P185, DOI 10.1146/annurev-virology-092917-043300
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19
   Slon-Campos JL, 2019, NAT IMMUNOL, V20, P1291, DOI 10.1038/s41590-019-0477-z
   Snapper CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00598
NR 13
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD OCT
PY 2019
VL 20
IS 10
BP 1266
EP 1268
DI 10.1038/s41590-019-0497-8
PG 4
WC Immunology
SC Immunology
GA IY8AH
UT WOS:000486615900010
PM 31520069
DA 2020-07-08
ER

PT J
AU Slon-Campos, JL
   Dejnirattisai, W
   Jagger, BW
   Lopez-Camacho, C
   Wongwiwat, W
   Durnell, LA
   Winkler, ES
   Chen, RE
   Reyes-Sandoval, A
   Rey, FA
   Diamond, MS
   Mongkolsapaya, J
   Screaton, GR
AF Slon-Campos, Jose Luis
   Dejnirattisai, Wanwisa
   Jagger, Brett W.
   Lopez-Camacho, Cesar
   Wongwiwat, Wiyada
   Durnell, Lorellin A.
   Winkler, Emma S.
   Chen, Rita E.
   Reyes-Sandoval, Arturo
   Rey, Felix A.
   Diamond, Michael S.
   Mongkolsapaya, Juthathip
   Screaton, Gavin R.
TI A protective Zika virus E-dimer-based subunit vaccine engineered to
   abrogate antibody-dependent enhancement of dengue infection
SO NATURE IMMUNOLOGY
LA English
DT Article
ID NEUTRALIZING HUMAN-ANTIBODIES; CROSS-REACTIVITY; STRUCTURAL BASIS; MOUSE
   MODEL; POTENT; EPITOPE
AB Infections with dengue virus (DENV) and Zika virus (ZIKV) can induce cross-reactive antibody responses. Two immunodominant epitopes-one to precursor membrane protein and one to the fusion loop epitope on envelope (E) protein-are recognized by cross-reactive antibodies 1-3 that are not only poorly neutralizing, but can also promote increased viral replication and disease severity via Fcy receptor-mediated infection of myeloid cells-a process termed antibody-dependent enhancement (ADE)(1,4,5). ADE is a significant concern for both ZIKV and DENV vaccines as the induction of poorly neutralizing cross-reactive antibodies may prime an individual for ADE on natural infection. In this report, we describe the design and production of covalently stabilized ZIKV E dimers, which lack precursor membrane protein and do not expose the immunodominant fusion loop epitope. Immunization of mice with ZIKV E dimers induces dimer-specific antibodies, which protect against ZIKV challenge during pregnancy. Importantly, the ZIKV E-dimer-induced response does not cross-react with DENV or induce ADE of DENV infection.
C1 [Slon-Campos, Jose Luis; Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip] Univ Oxford, Nuffield Dept Med, Wellcome Ctr Human Genet, Oxford, England.
   [Jagger, Brett W.; Durnell, Lorellin A.; Winkler, Emma S.; Chen, Rita E.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Lopez-Camacho, Cesar; Reyes-Sandoval, Arturo] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England.
   [Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, Paris, France.
   [Rey, Felix A.] CNRS, Unite Mixte Rech 3569, Paris, France.
   [Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Fac Med,Siriraj Hosp, Bangkok, Thailand.
   [Screaton, Gavin R.] Univ Oxford, Div Med Sci, Oxford, England.
   [Jagger, Brett W.] Western Michigan Univ, Dept Med, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA.
RP Mongkolsapaya, J (corresponding author), Univ Oxford, Nuffield Dept Med, Wellcome Ctr Human Genet, Oxford, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Fac Med,Siriraj Hosp, Bangkok, Thailand.; Screaton, GR (corresponding author), Univ Oxford, Div Med Sci, Oxford, England.
EM jmongkol@well.ox.ac.uk; gavin.screaton@medsci.ox.ac.uk
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Reyes-Sandoval,
   Arturo/0000-0002-2648-1696; Screaton, Gavin/0000-0002-3549-4309
FU Wellcome TrustWellcome Trust [203224/Z/16/Z, 095541/A/11/Z]; National
   Institute for Health Research Biomedical Research Centre Funding
   SchemeNational Institute for Health Research (NIHR); Medical Research
   Council Newton fund (UK-Thailand joint initiative of infectious diseases
   grant) [MR/R020957/1]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI073755, R01 AI127828, R01 HD091218, T32 AI007172]; UK
   Department of Health and Social Care [972216, 971557]; French
   Government's Programme d'Investissements d'Avenir (Labex Integrative
   Biology of Emerging Infectious Diseases grant)French National Research
   Agency (ANR) [ANR-10-LABX-62IBEID 4E AAP]
FX This work was supported by the Wellcome Trust (collaborative grant
   203224/Z/16/Z to G.R.S. and J.M.), National Institute for Health
   Research Biomedical Research Centre Funding Scheme (to G.R.S.), Medical
   Research Council Newton fund (UK-Thailand joint initiative of infectious
   diseases grant MR/R020957/1 to J.M.), National Institutes of Health
   (grants R01 AI073755, R01 AI127828 and R01 HD091218 to M.S.D., and grant
   T32 AI007172 to B.W.J.), UK Department of Health and Social Care
   (projects 972216 and 971557 to A. R.-S.) and French Government's
   Programme d'Investissements d'Avenir (Labex Integrative Biology of
   Emerging Infectious Diseases grant ANR-10-LABX-62IBEID 4E AAP to
   F.A.R.). G.R.S. is supported as a Wellcome Trust Senior Investigator
   (grant 095541/A/11/Z). We thank Y.C.Kim and B.D. Jimenez for technical
   assistance.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Bailey MJ, 2019, J VIROL, V93, DOI 10.1128/JVI.00405-19
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Lopez-Camacho C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040322
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Petris G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096700
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 53
TC 6
Z9 6
U1 3
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD OCT
PY 2019
VL 20
IS 10
BP 1291
EP +
DI 10.1038/s41590-019-0477-z
PG 10
WC Immunology
SC Immunology
GA IY8AH
UT WOS:000486615900013
PM 31477918
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Carr, M
   Gonzalez, G
   Martinelli, A
   Wastika, CE
   Ito, K
   Orba, Y
   Sasaki, M
   Hall, WW
   Sawa, H
AF Carr, Michael
   Gonzalez, Gabriel
   Martinelli, Axel
   Wastika, Christida E.
   Ito, Kimihito
   Orba, Yasuko
   Sasaki, Michihito
   Hall, William W.
   Sawa, Hirofumi
TI Upregulated expression of the antioxidant sestrin 2 identified by
   transcriptomic analysis of Japanese encephalitis virus-infected SH-SY5Y
   neuroblastoma cells
SO VIRUS GENES
LA English
DT Article
DE Japanese encephalitis virus; Neuron; RNA-Seq; Sestrin; xCT antiporter
ID SUBSTANTIA-NIGRA; PREDOMINANT INVOLVEMENT; ALZHEIMERS-DISEASE; PROTEIN;
   STRESS; GROWTH; TARGET; MTOR; PARKINSONISM; AUTOPHAGY
AB Japanese encephalitis virus (JEV) exerts a profound burden of viral encephalitis. We have investigated the differentially expressed transcripts in the neuronal transcriptome during JEV infection by RNA sequencing (RNA-Seq) of virus-infected SH-SY5Y human neuroblastoma cells. Gene ontology analysis revealed significant enrichment from two main pathways: endoplasmic reticulum (ER)-nucleus signaling (P value: 5.75E-18; false discovery rate [FDR] 3.11E-15) and the ER unfolded protein response (P value: 7.58E-18; FDR 3.11E-15). qPCR validation showed significant upregulation and differential expression (P < 0.01) of ER stress-signaling transcripts (SESN2, TRIB3, DDIT3, DDIT4, XBP1, and ATF4) at 24 h post-infection for both low (LN) and high (HN) neurovirulence JEV strains. Immunoblot analysis following JEV infection of SH-SY5Y cells showed an increase in levels of SESN2 protein following JEV infection. Similarly, Zika virus (MR766) infection of SH-SY5Y showed a titer-dependent increase in ER stress-signaling transcripts; however, this was absent or diminished for DDIT4 and ATF4, respectively, suggestive of differences in the induction of stress-response transcripts between flaviviruses. Interestingly, SLC7A11 and SLC3A2 mRNA were also both deregulated in JEV-infected SH-SY5Y cells and encode the two constituent subunits of the plasma membrane xCT amino acid antiporter that relieves oxidative stress by export of glutamate and import of cystine. Infection of SH-SY5Y and HEK293T cells by the JEV HN strain Sw/Mie/40/2004 lead to significant upregulation of the SLC7A11 mRNA to levels comparable to DDIT3. Our findings suggest upregulation of antioxidants including SESN2 and, also, the xCT antiporter occurs to counteract the oxidative stress elicited by JEV infection.
C1 [Carr, Michael; Martinelli, Axel; Hall, William W.; Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.
   [Carr, Michael; Hall, William W.] Univ Coll Dublin, Sch Med, Natl Virus Reference Lab, Dublin 4, Ireland.
   [Gonzalez, Gabriel; Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.
   [Wastika, Christida E.; Orba, Yasuko; Sasaki, Michihito; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.
   [Hall, William W.; Sawa, Hirofumi] Global Virus Network, Baltimore, MD 21201 USA.
RP Carr, M (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.; Carr, M (corresponding author), Univ Coll Dublin, Sch Med, Natl Virus Reference Lab, Dublin 4, Ireland.
EM michael.carr@ucd.ie
RI Ito, Kimihito/E-9975-2012; Sawa, Hirofumi/F-6954-2012
OI Ito, Kimihito/0000-0003-4986-1795; Carr, Michael/0000-0003-0011-6209
FU Japanese Society for the Promotion of Science (JSPS/KAKENHI) of Japan
   [16K08803]; Ministry of Education, Culture, Science, Sports and
   Technology (MEXT) of JapanMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT) [16H06429, 16H06431, 16K21723];
   Ministry of Education, Culture, Sports, Science and TechnologyMinistry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT);
   Ministry of Health, Labour and Welfare, Japan (MEXT)/JSPS KAKENHI
   [16H05805]
FX We are extremely grateful to Dr. Tomohiko Takashi from the National
   Institute of Infectious Diseases, Tokyo for the kind gift of the JEV
   strains and to Dr. Takashi Kimura (Hokkaido University) for rabbit
   anti-JEV hyperimmune sera. This study was supported in part by a grant
   to Dr. Michael Carr from the Japanese Society for the Promotion of
   Science (JSPS/KAKENHI) of Japan (16K08803). This study was also
   supported in part by grants to Professor Hirofumi Sawa for Scientific
   Research on Innovative Areas from the Ministry of Education, Culture,
   Science, Sports and Technology (MEXT) of Japan (16H06429, 16H06431,
   16K21723), grants from the Ministry of Education, Culture, Sports,
   Science and Technology; the Ministry of Health, Labour and Welfare,
   Japan (MEXT)/JSPS KAKENHI (16H05805).
CR Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569
   Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113
   DESAI A, 1995, ACTA NEUROPATHOL, V89, P368, DOI 10.1007/BF00309631
   Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643
   German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007
   Giffin L, 2014, J VIROL, V88, P9429, DOI 10.1128/JVI.00511-14
   Gupta N, 2010, VIRUS RES, V147, P107, DOI 10.1016/j.virusres.2009.10.018
   Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011
   Jauhiainen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033208
   JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510
   Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081
   Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507
   Kitada T, 1998, NATURE, V392, P605
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19102-2
   Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Lewerenz J, 2014, ANTIOXID REDOX SIGN, V20, P2907, DOI 10.1089/ars.2013.5455
   Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391
   Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214
   Lin D, 2018, GENE, V647, P244, DOI 10.1016/j.gene.2018.01.023
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498
   McLaughlin T, 2018, ADV EXP MED BIOL, V1074, P421, DOI 10.1007/978-3-319-75402-4_52
   Mukherjee S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.394
   Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   Nerome R, 2007, J GEN VIROL, V88, P2762, DOI 10.1099/vir.0.82941-0
   Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117
   Ogata A, 2000, NEUROLOGY, V55, P602, DOI 10.1212/WNL.55.4.602
   Pal B, 2018, CELL MOL LIFE SCI
   Pasha M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3296294
   Pradhan S, 1999, NEUROLOGY, V53, P1781, DOI 10.1212/WNL.53.8.1781
   Rai N, 2016, J ALZHEIMERS DIS, V54, P1147, DOI 10.3233/JAD-160479
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rosato PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005028
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]
   Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792
   Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074
   Singh Simendra, 2012, J Exp Ther Oncol, V9, P303
   Slodzinski H, 2009, CLIN NEUROPATHOL, V28, P333, DOI 10.2379/NPX08162
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Soontornniyomkij V, 2012, J NEUROIMMUNE PHARM, V7, P579, DOI 10.1007/s11481-012-9357-0
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Takayama J, 2015, JAPANESE ENCEPHALITI
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tran SC, 2016, J VIROL, V90, P7231, DOI 10.1128/JVI.00326-16
   Trottier MD, 2005, VIROLOGY, V333, P215, DOI 10.1016/j.virol.2005.01.009
   Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016
   Yamaguchi Y, 2011, J GEN VIROL, V92, P1601, DOI 10.1099/vir.0.031237-0
   Yin ZD, 2015, AM J TROP MED HYG, V92, P1125, DOI 10.4269/ajtmh.14-0148
   Zhou DX, 2013, J MOL NEUROSCI, V51, P967, DOI 10.1007/s12031-013-0081-x
   Zhou Y, 2014, J NEUROSCI, V34, P13472, DOI 10.1523/JNEUROSCI.2282-14.2014
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 64
TC 0
Z9 0
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD OCT
PY 2019
VL 55
IS 5
BP 630
EP 642
DI 10.1007/s11262-019-01683-x
PG 13
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA IY2LR
UT WOS:000486222300007
PM 31292858
DA 2020-07-08
ER

PT J
AU Ishida, K
   Goto, S
   Ishimura, M
   Amanuma, M
   Hara, Y
   Suzuki, R
   Katoh, K
   Morita, E
AF Ishida, Kotaro
   Goto, Simon
   Ishimura, Marina
   Amanuma, Misato
   Hara, Yumiko
   Suzuki, Ryosuke
   Katoh, Kaoru
   Morita, Eiji
TI Functional Correlation between Subcellular Localizations of Japanese
   Encephalitis Virus Capsid Protein and Virus Production
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Japanese encephalitis virus; capsid; flavivirus; lipid droplet;
   nucleolus; virus production
ID N-TERMINAL REGION; DENGUE VIRUS; CORE PROTEIN; NUCLEAR-LOCALIZATION;
   HUMAN ESCRT; ZIKA VIRUS; BINDING; RNA; REPLICATION; ORGANIZATION
AB The flavivirus capsid protein is considered to be essential for the formation of nucleocapsid complexes with viral genomic RNA at the viral replication organelle that appears on the endoplasmic reticulum (ER), as well as for incorporation into virus particles. However, this protein is also detected at the lipid droplet (LD) and nucleolus, and physiological roles of these off-site localizations are still unclear. In this study, we made a series of alanine substitution mutants of Japanese encephalitis virus (JEV) capsid protein that cover all polar and hydrophobic amino acid residues to identify the molecular surfaces required for virus particle formation and for localization at the LD and nucleolus. Five mutants exhibited a defect in the formation of infectious particles, and two of these mutants failed to be incorporated into the subviral particles (SVP). Three mutants lost the ability to localize to the nucleolus, and only a single mutant, with mutations at alpha 2, was unable to localize to the LD. Unlike the cytoplasmic capsid protein, the nucleolar capsid protein was resistant to detergent treatment, and the alpha 2 mutant was hypersensitive to detergent treatment. To scrutinize the relationship between these localizations and viral particle formation, we made eight additional alanine substitution mutants and found that all the mutants that did not localize at the LD or nucleolus failed to form normal viral particles. These results support the functional correlation between LD or nucleolus localization of the flaviviral capsid protein and the formation of infectious viral particles.
   IMPORTANCE This study is the first to report the comprehensive mutagenesis of a flavivirus capsid protein. We assessed the requirement of each molecular surface for infectious viral particle formation as well as for LD and nucleolar localization and found functional relationships between the subcellular localization of the virus capsid protein and infectious virus particle formation. We developed a system to independently assess the packaging of viral RNA and that of the capsid protein and found a molecular surface of the capsid protein that is crucial for packaging of viral RNA but not for packaging of the capsid protein itself. We also characterized the biochemical properties of capsid protein mutants and found that the capsid protein localizes at the nucleolus in a different manner than for its localization to the LD. Our comprehensive alanine-scanning mutagenesis study will aid in the development of antiflavivirus small molecules that can target the flavivirus capsid protein.
C1 [Ishida, Kotaro; Goto, Simon; Ishimura, Marina; Amanuma, Misato; Hara, Yumiko; Morita, Eiji] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Aomori, Japan.
   [Suzuki, Ryosuke] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.
   [Katoh, Kaoru] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.
RP Morita, E (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Aomori, Japan.
EM moritae@hirosaki-u.ac.jp
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23790503,
   26460555, 16H01188, 17H06413]; Health Labor Sciences Research Grant for
   Research on Emerging and Re-emerging Infectious Diseases [12103320]; JST
   CREST, JapanCore Research for Evolutional Science and Technology (CREST)
   [JPMJCR17H4]
FX This research was supported by JSPS KAKENHI (grant numbers 23790503,
   26460555, 16H01188, and 17H06413) and a Health Labor Sciences Research
   Grant for Research on Emerging and Re-emerging Infectious Diseases
   (grant number 12103320). This work was also supported by JST CREST
   (grant number JPMJCR17H4), Japan.
CR Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gromowski GD, 2015, J VIROL, V89, P6328, DOI 10.1128/JVI.00219-15
   Hirai Y, 2013, GENES CELLS, V18, P780, DOI 10.1111/gtc.12077
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   Kofler RM, 2004, P NATL ACAD SCI USA, V101, P1951, DOI 10.1073/pnas.0307145101
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850
   Morita E, 2007, CELL HOST MICROBE, V2, P41, DOI 10.1016/j.chom.2007.06.003
   Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107
   Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Schlick P, 2009, J VIROL, V83, P5581, DOI 10.1128/JVI.02653-08
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Slomnicki LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16952-8
   Su CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003122
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035
   Teoh PG, 2014, J VIROL, V88, P7998, DOI 10.1128/JVI.00940-14
   Tiwary AK, 2017, VIROLOGY, V502, P48, DOI 10.1016/j.virol.2016.12.013
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
NR 45
TC 0
Z9 0
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2019
VL 93
IS 19
AR e00612-19
DI 10.1128/JVI.00612-19
PG 21
WC Virology
SC Virology
GA IX6JL
UT WOS:000485789300016
PM 31315991
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ruszkiewicz, JA
   Tinkov, AA
   Skalny, AV
   Siokas, V
   Dardiotis, E
   Tsatsakis, A
   Bowman, AB
   da Rocha, JBT
   Aschner, M
AF Ruszkiewicz, Joanna A.
   Tinkov, Alexey A.
   Skalny, Anatoly, V
   Siokas, Vasileios
   Dardiotis, Efthimios
   Tsatsakis, Aristidis
   Bowman, Aaron B.
   da Rocha, Joao B. T.
   Aschner, Michael
TI Brain diseases in changing climate
SO ENVIRONMENTAL RESEARCH
LA English
DT Review
DE Climate change; Environment; Health; Brain disease
ID HEPATITIS-A VIRUS; PRIMARY AMEBIC MENINGOENCEPHALITIS;
   HYPERTHERMIA-INDUCED SEIZURES; CENTRAL-NERVOUS-SYSTEM;
   METHYLAMINO-L-ALANINE; HEAT-STRESS; AMBIENT-TEMPERATURE; OXIDATIVE
   STRESS; AIR-POLLUTION; ZIKA VIRUS
AB Climate change is one of the biggest and most urgent challenges for the 21st century. Rising average temperatures and ocean levels, altered precipitation patterns and increased occurrence of extreme weather events affect not only the global landscape and ecosystem, but also human health. Multiple environmental factors influence the onset and severity of human diseases and changing climate may have a great impact on these factors. Climate shifts disrupt the quantity and quality of water, increase environmental pollution, change the distribution of pathogens and severely impacts food production - all of which are important regarding public health. This paper focuses on brain health and provides an overview of climate change impacts on risk factors specific to brain diseases and disorders. We also discuss emerging hazards in brain health due to mitigation and adaptation strategies in response to climate changes.
C1 [Ruszkiewicz, Joanna A.] Univ Konstanz, Dept Biol, Mol Toxicol Grp, Constance, Germany.
   [Tinkov, Alexey A.; Skalny, Anatoly, V] Yaroslavl State Univ, Yaroslavl, Russia.
   [Tinkov, Alexey A.; Skalny, Anatoly, V] IM Sechenov First Moscow State Med Univ, Moscow, Russia.
   [Tinkov, Alexey A.] Russian Acad Sci, Inst Cellular & Intracellular Symbiosis, Orenburg, Russia.
   [Skalny, Anatoly, V] Trace Element Inst UNESCO, Lyon, France.
   [Siokas, Vasileios; Dardiotis, Efthimios] Univ Thessaly, Univ Hosp Larissa, Lab Neurogenet, Dept Neurol, Larisa, Greece.
   [Tsatsakis, Aristidis] Univ Crete, Sch Med, Lab Toxicol, Iraklion 71003, Greece.
   [Bowman, Aaron B.] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA.
   [da Rocha, Joao B. T.] Univ Fed Santa Maria, Dept Biochem, Santa Maria, RS, Brazil.
   [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
RP Aschner, M (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM michael.aschner@einstein.yu.edu
RI da Rocha, Joao Batista Teixeira/S-6813-2016; Tinkov, Alexey/H-5842-2016;
   Skalny, Anatoly/J-3953-2019; Tsatsakis, Aristidis M./H-2890-2013
OI da Rocha, Joao Batista Teixeira/0000-0003-3829-0595; Tinkov,
   Alexey/0000-0003-0348-6192; Skalny, Anatoly/0000-0001-7838-1366;
   Tsatsakis, Aristidis M./0000-0003-3824-2462; Dardiotis,
   Efthimios/0000-0003-2957-641X
FU National Institute of Environmental Health SciencesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [R01ES07331, R01E510563, R01E5020852]
FX This work has been supported by the National Institute of Environmental
   Health Sciences (R01ES07331, R01E510563 and R01E5020852).
CR Alam M, 2011, NEUROSCI LETT, V495, P135, DOI 10.1016/j.neulet.2011.03.056
   Alava JJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31824-5
   Alehan FK, 2004, ANN TROP PAEDIATR, V24, P141, DOI 10.1179/027249304225013411
   Alkishe AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189092
   Allard R, 2011, INT J BIOMETEOROL, V55, P353, DOI 10.1007/s00484-010-0345-x
   Amiel JJ, 2017, ANIM COGN, V20, P117, DOI 10.1007/s10071-016-0993-2
   Andrade V M, 2017, Adv Neurobiol, V18, P227, DOI 10.1007/978-3-319-60189-2_12
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Asad H, 2018, REV ENVIRON HEALTH, V33, P31, DOI 10.1515/reveh-2017-0042
   Azimi F, 2017, GEOSPATIAL HEALTH, V12, P15, DOI 10.4081/gh.2017.478
   Azuma K, 2014, INT J ENVIRON HEAL R, V24, P158, DOI 10.1080/09603123.2013.800964
   Bain AR, 2015, COMPR PHYSIOL, V5, P1345, DOI 10.1002/cphy.c140066
   Bain AR, 2013, J APPL PHYSIOL, V115, P653, DOI 10.1152/japplphysiol.00394.2013
   Beknazarova M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050517
   Bentes AA, 2019, J CLIN VIROL, V116, P49, DOI 10.1016/j.jcv.2019.04.006
   Berry HL, 2018, NAT CLIM CHANGE, V8, P282, DOI 10.1038/s41558-018-0102-4
   Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009
   Bonnet MS, 2012, TOXINS, V4, P1120, DOI 10.3390/toxins4111120
   Booth S, 2005, ENVIRON HEALTH PERSP, V113, P521, DOI 10.1289/ehp.7603
   Bourque F, 2014, INT REV PSYCHIATR, V26, P415, DOI 10.3109/09540261.2014.925851
   Boxall ABA, 2009, ENVIRON HEALTH PERSP, V117, P508, DOI 10.1289/ehp.0800084
   Boyce R, 2016, J INFECT DIS, V214, P1403, DOI 10.1093/infdis/jiw363
   Bronstein J, 2009, ENVIRON HEALTH PERSP, V117, P117, DOI 10.1289/ehp.11702
   Burke RD, 2017, J NEUROCHEM, V142, P162, DOI 10.1111/jnc.14077
   Burke S, 2012, AUTON NEUROSCI-BASIC, V168, P4, DOI 10.1016/j.autneu.2012.02.003
   Burke SEL, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0896-9
   Burrows K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040443
   Caito Samuel, 2015, Handb Clin Neurol, V131, P169, DOI 10.1016/B978-0-444-62627-1.00011-1
   Caminade C, 2019, ANN NY ACAD SCI, V1436, P157, DOI 10.1111/nyas.13950
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Canavan BC, 2019, ACTA TROP, V196, P93, DOI 10.1016/j.actatropica.2019.04.021
   Capewell LG, 2015, J PEDIAT INF DIS SOC, V4, pE68, DOI 10.1093/jpids/piu103
   Carleton TA, 2017, P NATL ACAD SCI USA, V114, P8746, DOI 10.1073/pnas.1701354114
   Carmona-Castro O, 2018, MED VET ENTOMOL, V32, P84, DOI 10.1111/mve.12269
   Carnevale M., 2016, RESOLVING CLIMATE PA, P1
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Cascio WE, 2018, SCI TOTAL ENVIRON, V624, P586, DOI 10.1016/j.scitotenv.2017.12.086
   Cassereau J, 2017, CURR MED CHEM, V24, P2988, DOI 10.2174/0929867324666170526122654
   Chapra SC, 2017, ENVIRON SCI TECHNOL, V51, P8933, DOI 10.1021/acs.est.7b01498
   Chauderlier A, 2017, METHODS MOL BIOL, V1523, P369, DOI 10.1007/978-1-4939-6598-4_25
   Chauhan NR, 2017, NEUROSCIENCE, V358, P79, DOI 10.1016/j.neuroscience.2017.06.023
   Cheng J, 2017, EPIDEMIOL INFECT, V145, P1567, DOI 10.1017/S0950268817000280
   Chernoff N, 2017, J TOXICOL ENV HEAL B, V20, P183, DOI 10.1080/10937404.2017.1297592
   Cizauskas CA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160535
   Codjoe SNA, 2014, INT J ENV RES PUB HE, V11, P6923, DOI 10.3390/ijerph110706923
   Cope JR, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0539-4
   Cope JR, 2015, CLIN INFECT DIS, V60, pE36, DOI 10.1093/cid/civ017
   Costa Lucio G, 2017, Curr Environ Health Rep, V4, P156, DOI 10.1007/s40572-017-0135-2
   Costa LG, 2014, TOXICOL LETT, V230, P282, DOI 10.1016/j.toxlet.2013.11.011
   Costa LG, 2010, NEUROTOXICOLOGY, V31, P409, DOI 10.1016/j.neuro.2010.05.003
   Cramer MN, 2016, AUTON NEUROSCI-BASIC, V196, P3, DOI 10.1016/j.autneu.2016.03.001
   Crandall CG, 2010, ACTA PHYSIOL, V199, P407, DOI 10.1111/j.1748-1716.2010.02119.x
   Daniel M, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00090
   Daoud A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153296
   Dasgupta S, 2018, INT J HYG ENVIR HEAL, V221, P782, DOI 10.1016/j.ijheh.2018.04.003
   Dayananda B, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0002
   de Souza JM, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007122
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   Doherty RM, 2017, ENVIRON HEALTH-GLOB, V16, P33, DOI 10.1186/s12940-017-0325-2
   Domijan AM, 2012, ARH HIG RADA TOKSIKO, V63, P531, DOI 10.2478/10004-1254-63-2012-2239
   Dyregrov A, 2018, EUR J PSYCHOTRAUMATO, V9, DOI 10.1080/20008198.2018.1500823
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   El-Orabi NF, 2011, J THERM BIOL, V36, P49, DOI 10.1016/j.jtherbio.2010.11.002
   Ely Brett R, 2015, Temperature (Austin), V2, P51, DOI 10.4161/23328940.2014.992657
   Escudero-Lourdes C, 2016, NEUROTOXICOLOGY, V53, P223, DOI 10.1016/j.neuro.2016.02.002
   Eun BL, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.348
   Farina Marcelo, 2017, Adv Neurobiol, V18, P267, DOI 10.1007/978-3-319-60189-2_13
   Fountoulakis KN, 2016, ANN GEN PSYCHIATR, V15, DOI 10.1186/s12991-016-0106-2
   Fountoulakis KN, 2016, J AFFECT DISORDERS, V193, P331, DOI 10.1016/j.jad.2016.01.008
   French PW, 2019, NEUROTOX RES, V35, P969, DOI 10.1007/s12640-018-9980-5
   Fritze Jessica G, 2008, Int J Ment Health Syst, V2, P13, DOI 10.1186/1752-4458-2-13
   Gao L, 2016, INT J BIOMETEOROL, V60, P1873, DOI 10.1007/s00484-016-1174-3
   Garg RK, 2019, J STROKE CEREBROVASC, V28, P405, DOI 10.1016/j.jstrokecerebrovasdis.2018.10.011
   Garkowski A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00146
   Garza M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002818
   Ghassabian A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00204
   Gleadow R, 2016, J EXP BOT, V67, P5403, DOI 10.1093/jxb/erw302
   Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221
   Grant KS, 2010, NEUROTOXICOL TERATOL, V32, P132, DOI 10.1016/j.ntt.2009.09.005
   Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101
   Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x
   Gullon P, 2017, ENVIRON INT, V102, P230, DOI 10.1016/j.envint.2017.03.008
   Gustin MS, 2004, J AIR WASTE MANAGE, V54, P320, DOI 10.1080/10473289.2004.10470900
   Hallegatte S, 2017, NAT CLIM CHANGE, V7, P250, DOI 10.1038/NCLIMATE3253
   Han MH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0579-2
   Hanigan IC, 2018, ECOHEALTH, V15, P642, DOI 10.1007/s10393-018-1339-0
   Hanigan IC, 2012, P NATL ACAD SCI USA, V109, P13950, DOI 10.1073/pnas.1112965109
   Hayes K, 2018, INT J MENT HEALTH SY, V12, DOI 10.1186/s13033-018-0210-6
   Hayes MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192887
   Hegazi MA, 2011, PEDIATR INFECT DIS J, V30, P1012, DOI 10.1097/INF.0b013e3182270020
   Hellberg RS, 2016, CRIT REV MICROBIOL, V42, P548, DOI 10.3109/1040841X.2014.972335
   Hermstad Erik, 2010, J Emerg Trauma Shock, V3, P66, DOI 10.4103/0974-2700.58660
   Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695
   Hora R, 2016, METAB BRAIN DIS, V31, P225, DOI 10.1007/s11011-015-9787-5
   Hu WB, 2004, MED J AUSTRALIA, V180, P487, DOI 10.5694/j.1326-5377.2004.tb06041.x
   Hu YA, 2016, ENVIRON POLLUT, V218, P1209, DOI 10.1016/j.envpol.2016.08.077
   Huisman J, 2018, NAT REV MICROBIOL, V16, P471, DOI 10.1038/s41579-018-0040-1
   Hunt RF, 2012, EXP NEUROL, V237, P199, DOI 10.1016/j.expneurol.2012.06.013
   IPCC, 2018, IPCC SPEC REP IMP GL
   Iqbal MS, 2019, SCI TOTAL ENVIRON, V650, P1935, DOI 10.1016/j.scitotenv.2018.09.347
   Ito S, 2006, SCI TOTAL ENVIRON, V368, P397, DOI 10.1016/j.scitotenv.2005.09.044
   Ivanescu L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8560519
   Jiang QJ, 2013, INT J HYPERTHER, V29, P219, DOI 10.3109/02656736.2013.786141
   Jore S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-11
   Kallenborn R, 2012, J ENVIRON MONITOR, V14, P2854, DOI 10.1039/c2em30519d
   Kanekar S, 2015, HIGH ALT MED BIOL, V16, P52, DOI 10.1089/ham.2014.1070
   Kashala-Abotnes E, 2019, BRAIN RES BULL, V145, P87, DOI 10.1016/j.brainresbull.2018.07.001
   Kemble SK, 2012, CLIN INFECT DIS, V54, P805, DOI 10.1093/cid/cir961
   Kennedy J, 1997, PROCEEDINGS OF 1997 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '97), P303, DOI 10.1109/ICEC.1997.592326
   Kiehl J, 2011, SCIENCE, V331, P158, DOI 10.1126/science.1199380
   Kim JA, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00027
   Kinney P., 2018, HLTH REP, DOI [10.1007/s40572-018-0188-x, DOI 10.1007/S40572-018-0188-X]
   Kiyatkin EA, 2005, BRAIN RES REV, V50, P27, DOI 10.1016/j.brainresrev.2005.04.001
   Kiyatkin EA, 2018, HAND CLINIC, V157, P483, DOI 10.1016/B978-0-444-64074-1.00030-6
   Kleinschmidt-DeMasters BK, 2015, BRAIN PATHOL, V25, P625, DOI 10.1111/bpa.12280
   Kozak L, 2019, APPL MICROBIOL BIOT, V103, P1599, DOI 10.1007/s00253-018-09594-x
   Lafferty KD, 2016, F1000RES, V5, pF1000
   LaJoie AS, 2010, DISASTERS, V34, P1031, DOI 10.1111/j.1467-7717.2010.01181.x
   Lake IR, 2017, ENVIRON HEALTH-GLOB, V16, P53, DOI 10.1186/s12940-017-0327-0
   Lambein F., 2019, PLANTA
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Lee H, 2018, ENVIRON INT, V121, P383, DOI 10.1016/j.envint.2018.09.022
   Lee H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44741
   Lee Jung-Ju, 2011, J Epilepsy Res, V1, P27, DOI 10.14581/jer.11005
   Lee W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0324-6
   Leedale J, 2016, GEOSPATIAL HEALTH, V11, P102, DOI 10.4081/gh.2016.393
   LeMonte JJ, 2017, ENVIRON SCI TECHNOL, V51, P5913, DOI 10.1021/acs.est.6b06152
   Leon LR, 2015, COMPR PHYSIOL, V5, P611, DOI 10.1002/cphy.c140017
   Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010
   Levy Karen, 2018, Curr Environ Health Rep, V5, P272, DOI 10.1007/s40572-018-0199-7
   Levy K, 2016, ENVIRON SCI TECHNOL, V50, P4905, DOI 10.1021/acs.est.5b06186
   Li CL, 2018, SCI TOTAL ENVIRON, V622, P493, DOI 10.1016/j.scitotenv.2017.11.326
   Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449
   Li L., 2015, PLOS ONE, V9
   Liu JC, 2016, CLIMATIC CHANGE, V138, P655, DOI 10.1007/s10584-016-1762-6
   Liu XN, 2017, SCI TOTAL ENVIRON, V601, P1298, DOI 10.1016/j.scitotenv.2017.05.020
   Liu YH, 2012, MOL BIOL REP, V39, P3987, DOI 10.1007/s11033-011-1179-2
   Low AJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002727
   Lu YL, 2018, ENVIRON POLLUT, V239, P670, DOI 10.1016/j.envpol.2018.04.016
   Luo YX, 2018, ENVIRON POLLUT, V232, P90, DOI 10.1016/j.envpol.2017.09.021
   Ma P, 2018, SCI TOTAL ENVIRON, V644, P1573, DOI 10.1016/j.scitotenv.2018.07.080
   Macdonald RW, 2005, SCI TOTAL ENVIRON, V342, P5, DOI 10.1016/j.scitotenv.2004.12.059
   Mach K. J., 2019, NATURE
   Mamun MA, 2019, PSYCHIAT RES, V276, P124, DOI 10.1016/j.psychres.2019.05.007
   Mattei Davide, 2019, Curr Nutr Rep, V8, P99, DOI 10.1007/s13668-019-0268-z
   McCreesh N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0617-0
   MCLUSKY DS, 1986, OCEANOGR MAR BIOL, V24, P481
   McMahon C, 2012, VET PARASITOL, V190, P167, DOI 10.1016/j.vetpar.2012.06.016
   Meason B, 2014, HEALTH HUM RIGHTS, V16, P105
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Mendes CS, 2016, CIENC SAUDE COLETIVA, V21, P263, DOI 10.1590/1413-81232015211.03992015
   Meng Q, 2012, INT J HYPERTHER, V28, P24, DOI 10.3109/02656736.2011.631963
   Messina J. P., 2019, NAT MICROBIOL
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Mizoguchi H, 2011, BEHAV BRAIN RES, V218, P190, DOI 10.1016/j.bbr.2010.11.057
   Morand S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01774
   MORIMOTO T, 1995, DEV BRAIN RES, V84, P204, DOI 10.1016/0165-3806(94)00173-W
   Muresanu DF, 2010, ANN NY ACAD SCI, V1199, P15, DOI 10.1111/j.1749-6632.2009.05328.x
   Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P327, DOI 10.1007/978-3-211-98811-4_61
   Myers SS, 2017, ANNU REV PUBL HEALTH, V38, P259, DOI 10.1146/annurev-publhealth-031816-044356
   Myhre O, 2018, TOXICOL APPL PHARM, V354, P196, DOI 10.1016/j.taap.2018.03.015
   Noor R, 2003, NEUROSCI LETT, V349, P130, DOI 10.1016/S0304-3940(03)00802-4
   Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006
   Nunneley SA, 2002, J APPL PHYSIOL, V92, P846, DOI 10.1152/japplphysiol.00072.2001
   Obradovich N, 2018, P NATL ACAD SCI USA, V115, P10953, DOI 10.1073/pnas.1801528115
   Onyango EA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1600-3
   Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051
   Paerl HW, 2018, TOXINS, V10, DOI 10.3390/toxins10020076
   Pallotta MM, 2017, J EXP ZOOL PART B, V328, P360, DOI 10.1002/jez.b.22736
   Paterson RRM, 2011, FOOD RES INT, V44, P2555, DOI 10.1016/j.foodres.2011.05.038
   Paxson C, 2012, SOC SCI MED, V74, P150, DOI 10.1016/j.socscimed.2011.10.004
   Peres TV, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0099-0
   Philipsborn R, 2016, J INFECT DIS, V214, P6, DOI 10.1093/infdis/jiw081
   Pietrzak RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038964
   Pletz J, 2016, TOXICOLOGY, V347, P1, DOI 10.1016/j.tox.2016.02.006
   PLUMLEE KH, 1994, J VET INTERN MED, V8, P49, DOI 10.1111/j.1939-1676.1994.tb03195.x
   Pomara C, 2015, CURR NEUROPHARMACOL, V13, P132, DOI 10.2174/1570159X13666141210221434
   Porojan C, 2016, FOOD ADDIT CONTAM A, V33, P1570, DOI 10.1080/19440049.2016.1217070
   Portier C. J., 2010, HUMAN HLTH PERSPECTI, DOI [10.1289/ehp.1002272, DOI 10.1289/EHP.1002272]
   Postels Douglas G, 2013, Handb Clin Neurol, V114, P91, DOI 10.1016/B978-0-444-53490-3.00006-6
   Purse BV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183583
   Qian SW, 2014, PHYSIOL BEHAV, V128, P99, DOI 10.1016/j.physbeh.2014.01.028
   Qian SW, 2013, BRAIN COGNITION, V83, P121, DOI 10.1016/j.bandc.2013.07.013
   Qu LT, 2007, NEUROBIOL DIS, V27, P320, DOI 10.1016/j.nbd.2007.06.003
   Ramirez C, 1997, NEUROREPORT, V8, P2337, DOI 10.1097/00001756-199707070-00047
   Ramsdell JS, 2008, MAR DRUGS, V6, P262, DOI 10.3390/md20080013
   Ramsdell JS, 2014, MAR DRUGS, V12, P1185, DOI 10.3390/md12031185
   Ratnaseelan AM, 2018, CLIN THER, V40, P903, DOI 10.1016/j.clinthera.2018.05.004
   Ready PD, 2008, REV SCI TECH OIE, V27, P399, DOI 10.20506/rst.27.2.1803
   Riba I, 2004, ENVIRON TOXICOL CHEM, V23, P1100, DOI 10.1897/023-601
   Lopez IR, 2010, ENVIRON SCI POLLUT R, V17, P1519, DOI 10.1007/s11356-010-0338-7
   Rivadeneyra-Dominguez E, 2014, NEUROLOGIA, V29, P517, DOI 10.1016/j.nrl.2013.03.005
   Rohrbach LA, 2009, PSYCHIATRY, V72, P222, DOI 10.1521/psyc.2009.72.3.222
   Rosenberg A, 2018, ENVIRON RES, V164, P539, DOI 10.1016/j.envres.2018.03.017
   Ross EZ, 2012, J APPL PHYSIOL, V112, P748, DOI 10.1152/japplphysiol.00988.2011
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152
   Sato J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211297
   Scheidt J, 2013, INT J BIOMETEOROL, V57, P649, DOI 10.1007/s00484-012-0582-2
   Schiedek D, 2007, MAR POLLUT BULL, V54, P1845, DOI 10.1016/j.marpolbul.2007.09.020
   Schwartz RM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14090957
   Semenza J. C., 2018, FEMS MICROBIOL LETT, V365
   Sergi C, 2019, ACTA TROP, V190, P157, DOI 10.1016/j.actatropica.2018.11.016
   Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x
   Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1
   Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621
   Singh G, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00089
   Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446
   Smith CJ, 2016, AUTON NEUROSCI-BASIC, V196, P25, DOI 10.1016/j.autneu.2016.01.002
   Soneja S, 2016, ENVIRON RES, V149, P216, DOI 10.1016/j.envres.2016.05.021
   Song YJ, 2018, INT J ENV RES PUBLIC, V15
   Squire SA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2111-y
   Sram RJ, 2017, NEUROENDOCRINOL LETT, V38, P389
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Suchomelova L, 2015, NEUROSCIENCE, V305, P209, DOI 10.1016/j.neuroscience.2015.08.006
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Sun G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061157
   Sunyer J, 2019, BASIC CLIN PHARM TOX
   Szekely M, 2018, HAND CLINIC, V156, P377, DOI 10.1016/B978-0-444-63912-7.00023-0
   Taylor VF, 2019, ENVIRON POLLUT, V246, P639, DOI 10.1016/j.envpol.2018.12.064
   Terciolo C, 2018, FOOD CHEM TOXICOL, V121, P701, DOI 10.1016/j.fct.2018.09.034
   Thornton C, 2017, BIOCHEM SOC T, V45, P1067, DOI 10.1042/BST20170017
   Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Tolins M, 2014, ANN GLOB HEALTH, V80, P303, DOI 10.1016/j.aogh.2014.09.005
   Tong S, 2019, ENVIRON RES, V174, P9, DOI 10.1016/j.envres.2019.04.012
   Torres JM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4508-0
   Trombley J, 2017, AM J NURS, V117, P44, DOI 10.1097/01.NAJ.0000515232.51795.fa
   Veenema TG, 2017, J NURS SCHOLARSHIP, V49, P625, DOI 10.1111/jnu.12328
   Velasco J, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0011
   Walker JT, 2018, PERSPECT PUBLIC HEAL, V138, P282, DOI 10.1177/1757913918791198
   Wang DZ, 2008, MAR DRUGS, V6, P349, DOI 10.3390/md20080016
   Wang HP, 2018, PROCEEDINGS OF THE 2018 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'18), P3, DOI 10.1145/3243734.3243749
   Wang P, 2018, ENVIRON INT, V120, P223, DOI 10.1016/j.envint.2018.08.014
   Wang X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001125
   Wang YY, 2011, BRAIN RES, V1417, P87, DOI 10.1016/j.brainres.2011.08.027
   Watkins SM, 2008, MAR DRUGS, V6, P431, DOI [10.3390/md20080021, 10.3390/md6030431]
   Weaver HJ, 2010, TRENDS PARASITOL, V26, P574, DOI 10.1016/j.pt.2010.06.009
   Weiss B, 2012, NEUROTOXICOLOGY, V33, P1410, DOI 10.1016/j.neuro.2012.05.014
   Welch K, 2019, J WATER HEALTH, V17, P179, DOI 10.2166/wh.2018.224
   White MG, 2012, J NEUROPHYSIOL, V108, P2203, DOI 10.1152/jn.00638.2011
   WHO, 2018, COP24 SPEC REP HLTH
   Winneke G, 2011, J NEUROL SCI, V308, P9, DOI 10.1016/j.jns.2011.05.020
   Woodward A., 2019, GLOB TRANSIT, V1, P44, DOI DOI 10.1016/J.GLT.2019.02.001
   Yan C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1432-6
   Yang Y Tony, 2016, Prev Med Rep, V4, P444, DOI 10.1016/j.pmedr.2016.07.011
   Zhang FF, 2016, SCI TOTAL ENVIRON, V563, P1105, DOI 10.1016/j.scitotenv.2016.05.162
   Zhang H., 2017, INT J ENV RES PUBLIC, V14
   Zhang MS, 2019, PEERJ, V7, DOI 10.7717/peerj.7018
   Zhou YB, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0156-3
   Zhu GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006021
   Zlotnik A, 2010, ANESTH ANALG, V111, P1497, DOI 10.1213/ANE.0b013e3181fc0112
NR 253
TC 3
Z9 3
U1 12
U2 46
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0013-9351
EI 1096-0953
J9 ENVIRON RES
JI Environ. Res.
PD OCT
PY 2019
VL 177
AR 108637
DI 10.1016/j.envres.2019.108637
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA IW0IL
UT WOS:000484645500025
PM 31416010
DA 2020-07-08
ER

PT J
AU Vliet, SMF
   Dasgupta, S
   Sparks, NRL
   Kirkwood, JS
   Vollaro, A
   Hur, M
   zur Nieden, NI
   Volz, DC
AF Vliet, Sara M. F.
   Dasgupta, Subham
   Sparks, Nicole R. L.
   Kirkwood, Jay S.
   Vollaro, Alyssa
   Hur, Manhoi
   zur Nieden, Nicole, I
   Volz, David C.
TI Maternal-to-zygotic transition as a potential target for niclosamide
   during early embryogenesis
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Zebrafish; Maternal-to-zygotic transition; Embryonic development;
   Niclosamide
ID ANTHELMINTIC DRUG NICLOSAMIDE; ZIKA VIRUS; ZEBRAFISH; IDENTIFICATION;
   CANCER; CELL; ORGANIZATION; RESPIRATION; INHIBITORS; INSIGHTS
AB Niclosamide is an antihelminthic drug used worldwide for the treatment of tapeworm infections. Recent drug repurposing screens have highlighted the broad bioactivity of niclosamide across diverse mechanisms of action. As a result, niclosamide is being evaluated for a range of alternative drug-repurposing applications, including the treatment of cancer, bacterial infections, and Zika virus. As new applications of niclosamide will require non-oral delivery routes that may lead to exposure in utero, it is important to understand the mechanism of niclosamide toxicity during early stages of embryonic development. Previously, we showed that niclosamide induces a concentration-dependent delay in epiboly progression in the absence of effects on oxidative phosphorylation - a well-established target for niclosamide. Therefore, the overall objective of this study was to further examine the mechanism of niclosamide-induced epiboly delay during zebrafish embryogenesis. Based on this study, we found that (1) niclosamide exposure during early zebrafish embryogenesis resulted in a decrease in yolk sac integrity with a concomitant decrease in the presence of yolk sac actin networks and increase in cell size; (2) within whole embryos, niclosamide exposure did not alter non-polar metabolites and lipids, but significantly altered amino acids specific to aminoacyl-tRNA biosynthesis; (3) niclosamide significantly altered transcripts related to translation, transcription, and mRNA processing pathways; and (4) niclosamide did not significantly alter levels of rRNA and tRNA. Overall, our findings suggest that niclosamide may be causing a systemic delay in embryonic development by disrupting the translation of maternally-supplied mRNAs, an effect that may be mediated through disruption of aminoacyl-tRNA biosynthesis.
C1 [Vliet, Sara M. F.] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.
   [Vliet, Sara M. F.; Dasgupta, Subham; Volz, David C.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
   [Sparks, Nicole R. L.; zur Nieden, Nicole, I] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA.
   [Kirkwood, Jay S.; Vollaro, Alyssa; Hur, Manhoi] Univ Calif Riverside, Metabol Core Facil, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
RP Volz, DC (corresponding author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
EM david.volz@ucr.edu
RI ; Vliet, Sara/M-1103-2015
OI Hur, Manhoi/0000-0003-4278-3210; Vliet, Sara/0000-0002-7429-0771
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01ES027576,
   T32ES018827]; National Institute of Food and AgricultureUnited States
   Department of Agriculture (USDA)National Institute of Food and
   Agriculture [1009609]
FX This work was supported by the National Institutes of Health
   [R01ES027576 and T32ES018827] and National Institute of Food and
   Agriculture [1009609].
CR Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110
   ABELRAHEEM K, 1980, HYDROBIOLOGIA, V74, P11, DOI 10.1007/BF00009009
   Abrams EW, 2009, CURR OPIN GENET DEV, V19, P396, DOI 10.1016/j.gde.2009.06.002
   ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X
   Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124
   Broeckling CD, 2014, ANAL CHEM, V86, P6812, DOI 10.1021/ac501530d
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677
   Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001
   Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144
   DENNIS G, 2003, GENOME BIOL, V4
   DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005
   Domalaon R, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02574-18
   Duffie R, 2013, CURR TOP DEV BIOL, V104, P293, DOI 10.1016/B978-0-12-416027-9.00009-7
   Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335
   Dutta A, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170063
   ESPINOSAAGUIRRE JJ, 1991, MUTAT RES, V264, P139, DOI 10.1016/0165-7992(91)90131-M
   Gallicano GI, 2001, FRONT BIOSCI-LANDMRK, V6, pD1089, DOI 10.2741/Gallican
   Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Imperi F, 2013, ANTIMICROB AGENTS CH, V57, P996, DOI 10.1128/AAC.01952-12
   Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950
   KANE DA, 1993, DEVELOPMENT, V119, P447
   Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Langley AR, 2014, DEVELOPMENT, V141, P3834, DOI 10.1242/dev.102368
   Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632
   Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl
   Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003
   Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   LIU YJ, 2019, CELLS-BASEL, V8, DOI DOI 10.3390/CELLS8030248
   Lu DY, 2016, XENOBIOTICA, V46, P1, DOI 10.3109/00498254.2015.1047812
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Mook RA, 2019, BIOORG MED CHEM LETT, V29, P317, DOI 10.1016/j.bmcl.2018.11.022
   Newton PT, 2019, BIOCHEM J, V476, P779, DOI 10.1042/BCJ20190020
   Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290
   Prather GR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140236
   Putzer H., 2013, RNA
   Rajendran V, 2018, INT J BIOL MACROMOL, V111, P400, DOI 10.1016/j.ijbiomac.2017.12.157
   Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z
   Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105
   Sha QQ, 2019, BIOL REPROD, V101, P579, DOI 10.1093/biolre/ioz012
   Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016
   SOLNICAKREZEL L, 1994, DEVELOPMENT, V120, P2443
   Suliman MA, 2016, INT J MOL MED, V38, P776, DOI 10.3892/ijmm.2016.2689
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699
   Tharmalingam N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22037-x
   United States Environmental Protection Agency, 1999, PA738F99013
   Tran UT, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0244-y
   Vliet SM, 2018, TOXICOL SCI, V166, P306, DOI 10.1093/toxsci/kfy214
   Vliet SM, 2017, TOXICOL APPL PHARM, V329, P241, DOI 10.1016/j.taap.2017.06.011
   WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yartseva V, 2015, CURR TOP DEV BIOL, V113, P191, DOI 10.1016/bs.ctdb.2015.07.020
   YORKE RE, 1974, Z PARASITENKD, V45, P1, DOI 10.1007/BF00636524
NR 59
TC 3
Z9 3
U1 3
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD OCT 1
PY 2019
VL 380
AR UNSP 114699
DI 10.1016/j.taap.2019.114699
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA IW0IR
UT WOS:000484646100016
PM 31398420
DA 2020-07-08
ER

PT J
AU Loiola, LMD
   Batista, M
   Capeletti, LB
   Mondo, GB
   Rosa, RSM
   Marques, RE
   Bajgelman, MC
   Cardoso, MB
AF Loiola, Livia M. D.
   Batista, Marina
   Capeletti, Larissa B.
   Mondo, Gabriela B.
   Rosa, Rhubia S. M.
   Marques, Rafael E.
   Bajgelman, Marcio C.
   Cardoso, Mateus B.
TI Shielding and stealth effects of zwitterion moieties in
   double-functionalized silica nanoparticles
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Silica nanoparticles; Double-functionalization; Zwitterion; Mammalian
   cell; Bacterium; Zika virus; Shielding effect
ID SURFACE FUNCTIONALIZATION; PROTEIN ADSORPTION; SIZE; VIRUS; CHEMISTRY;
   DELIVERY; CELLS; AMINO; ASSAY; SHAPE
AB Surface functionalization of silica nanoparticles (SiO(2)NPs) has been considered as a promising strategy to develop target-specific nanostructures. However, finding a chemical functionalization that can be used as an active targeting moiety while preserving the nanoparticles colloidal stability in biological fluids is still challenging. We present here a dual surface modification strategy for SiO(2)NPs where a zwitterion (ZW) and a biologically active group (BAG) (amino, mercapto or carboxylic functionalities) are simultaneously grafted on the nanoparticles' surface. The rationale behind this strategy is to generate colloidally stable nanoparticles and avoid the nonspecific protein adsorption due to ZW groups insertion, while the effective interaction with biosystems is guaranteed by the BAGs presence. The biological efficacy was tested against VERO cells, E. coli bacteria and Zika viruses and a similar trend was observed for all tested particles. The desirable "stealth property" to prevent nonspecific protein adhesion also generated a ZW shielding effect of the BAG functionality hindering their proper interaction and activity in cells, bacteria and viruses. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Loiola, Livia M. D.; Batista, Marina; Capeletti, Larissa B.; Mondo, Gabriela B.; Cardoso, Mateus B.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Nanotechnol Natl Lab LNNano, BR-13083970 Campinas, SP, Brazil.
   [Capeletti, Larissa B.; Mondo, Gabriela B.; Cardoso, Mateus B.] Univ Estadual Campinas, UNICAMP, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
   [Rosa, Rhubia S. M.; Marques, Rafael E.; Bajgelman, Marcio C.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.
RP Cardoso, MB (corresponding author), Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Nanotechnol Natl Lab LNNano, BR-13083970 Campinas, SP, Brazil.; Cardoso, MB (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM cardosomb@lnnano.cnpem.br
RI Marques, Rafael Elias/R-4890-2016
OI Marques, Rafael Elias/0000-0002-6949-0947
FU Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [15/25406-5, 16/16905-0, 16/21598-0,
   17/01167-7, 17/06692-2, 17/09203-2]; CNPqNational Council for Scientific
   and Technological Development (CNPq); Decit [440379-2016-4,
   130767-2016-1]; CapesCAPES
FX The authors would like to acknowledge the financial support of the Sao
   Paulo Research Foundation - FAPESP (processes 15/25406-5, 16/16905-0,
   16/21598-0, 17/01167-7, 17/06692-2 and 17/09203-2), CNPq, Capes and
   Decit (processes 440379-2016-4 and 130767-2016-1). The authors also
   thank LME and LCS labs in LNNano - CNPEM for the use of electron
   microscopy and atomic force microcopy facilities.
CR de Oliveira JFA, 2018, ACS APPL MATER INTER, V10, P41917, DOI 10.1021/acsami.8b12351
   de Oliveira JFA, 2017, NANOMEDICINE-UK, V12, P2587, DOI 10.2217/nnm-2017-0273
   Almeida JPM, 2011, NANOMEDICINE-UK, V6, P815, DOI [10.2217/NNM.11.79, 10.2217/nnm.11.79]
   [Anonymous], TUNING SURFACE PROPE, P1
   Bagwe RP, 2006, LANGMUIR, V22, P4357, DOI 10.1021/la052797j
   Beyleveld G, 2013, ANTIVIR RES, V100, P120, DOI 10.1016/j.antiviral.2013.07.018
   BOGUSH GH, 1988, J NON-CRYST SOLIDS, V104, P95, DOI 10.1016/0022-3093(88)90187-1
   Bouchmella K., 2018, NANOMEDICINE, P1743
   Capeletti LB, 2018, MICRO NANO TECHNOL, P115, DOI 10.1016/B978-0-12-814156-4.00008-2
   Capeletti LB, 2014, LANGMUIR, V30, P7456, DOI 10.1021/la4046435
   Cauda V, 2009, J AM CHEM SOC, V131, P11361, DOI 10.1021/ja809346n
   Chen LQ, 2015, CHEM RES TOXICOL, V28, P501, DOI 10.1021/tx500479m
   Curtis C, 2018, COLLOID SURFACE B, V170, P673, DOI 10.1016/j.colsurfb.2018.06.050
   de Oliveira LF, 2017, J BRAZIL CHEM SOC, V28, P1715, DOI 10.21577/0103-5053.20170017
   de Oliveira LF, 2012, J MATER CHEM, V22, P22851, DOI 10.1039/c2jm34899c
   Silva JMDE, 2016, ACS APPL MATER INTER, V8, P16564, DOI 10.1021/acsami.6b03342
   Dobo DG, 2017, J MOL STRUCT, V1140, P83, DOI 10.1016/j.molstruc.2016.11.043
   Emer M, 2017, J MATER CHEM B, V5, P8052, DOI 10.1039/c7tb01744h
   Estephan ZG, 2011, LANGMUIR, V27, P6794, DOI 10.1021/la200227b
   Estupinan D, 2016, NANOSCALE, V8, P3019, DOI 10.1039/c5nr08258g
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gomes MC, 2016, J INNOV OPT HEAL SCI, V9, DOI 10.1142/S1793545816300056
   Hadjidemetriou M, 2017, NAT NANOTECHNOL, V12, P288, DOI 10.1038/nnano.2017.61
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   He YJ, 2017, J BIOMATER APPL, V32, P524, DOI 10.1177/0885328217724638
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Higaki Y, 2017, LANGMUIR, V33, P8404, DOI 10.1021/acs.langmuir.7b01935
   Hu FL, 2018, ACTA BIOMATER, V72, P239, DOI 10.1016/j.actbio.2018.03.038
   Jia GW, 2009, LANGMUIR, V25, P3196, DOI 10.1021/la803737c
   Jin Q, 2014, COLLOID SURFACE B, V124, P80, DOI 10.1016/j.colsurfb.2014.07.013
   Joglekar M, 2013, RSC ADV, V3, P2454, DOI 10.1039/c2ra22264g
   Khatoon S, 2016, ACTA BIOMATER, V40, P282, DOI 10.1016/j.actbio.2016.04.011
   Khung YL, 2015, ADV COLLOID INTERFAC, V226, P166, DOI 10.1016/j.cis.2015.10.009
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Lehman SE, 2016, LANGMUIR, V32, P731, DOI 10.1021/acs.langmuir.5b03997
   Liberman A, 2014, SURF SCI REP, V69, P132, DOI 10.1016/j.surfrep.2014.07.001
   Lin YS, 2010, J AM CHEM SOC, V132, P4834, DOI 10.1021/ja910846q
   Ma NN, 2013, J NANOSCI NANOTECHNO, V13, P6485, DOI 10.1166/jnn.2013.7525
   Ma ZF, 2014, ACS APPL MATER INTER, V6, P2431, DOI 10.1021/am404860q
   Manrique-Rincon AJ, 2018, J BIOTECHNOL, V284, P11, DOI 10.1016/j.jbiotec.2018.07.029
   Martinez DST, 2015, EUR J INORG CHEM, P4595, DOI 10.1002/ejic.201500573
   MIKLAVIC SJ, 1993, CHEM PHYS LETT, V210, P25, DOI 10.1016/0009-2614(93)89094-X
   Moller K, 2007, J MATER CHEM, V17, P624, DOI 10.1039/b611931j
   Mondini S, 2015, LANGMUIR, V31, P7381, DOI 10.1021/acs.langmuir.5b01496
   Mout R, 2012, CHEM SOC REV, V41, P2539, DOI 10.1039/c2cs15294k
   Moyano DF, 2014, ACS NANO, V8, P6748, DOI 10.1021/nn5006478
   Otsuka H, 2012, ADV DRUG DELIVER REV, V64, P246, DOI 10.1016/j.addr.2012.09.022
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Paula AJ, 2012, J BRAZIL CHEM SOC, V23, P1807, DOI 10.1590/S0103-50532012005000048
   Picco AS, 2018, NANOMEDICINE-UK, V13, P179, DOI 10.2217/nnm-2017-0280
   Rosen JE, 2011, LANGMUIR, V27, P10507, DOI 10.1021/la201940r
   Safavi-Sohi R, 2016, ACS APPL MATER INTER, V8, P22808, DOI 10.1021/acsami.6b05099
   Saha K, 2014, MATER HORIZONS, V1, P102, DOI 10.1039/c3mh00075c
   Shahabi S, 2015, ACS APPL MATER INTER, V7, P13821, DOI 10.1021/acsami.5b01900
   Sola-Rabada A, 2018, LANGMUIR, V34, P8255, DOI 10.1021/acs.langmuir.8b00874
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Stolnik S, 2012, ADV DRUG DELIVER REV, V64, P290, DOI 10.1016/j.addr.2012.09.029
   Sun JT, 2012, MACROMOL RAPID COMM, V33, P811, DOI 10.1002/marc.201100876
   Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181
   Tsai CP, 2009, J MATER CHEM, V19, P5737, DOI 10.1039/b905158a
   Wu LX, 2010, ACS APPL MATER INTER, V2, P2781, DOI 10.1021/am1004249
   Xie M, 2013, COLLOID SURFACE B, V110, P138, DOI 10.1016/j.colsurfb.2013.04.009
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu F, 2006, J THERM ANAL CALORIM, V83, P187, DOI 10.1007/s10973-005-6969-0
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhou ZK, 2010, ACS NANO, V4, P5003, DOI 10.1021/nn100578b
NR 67
TC 3
Z9 3
U1 8
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD OCT 1
PY 2019
VL 553
BP 540
EP 548
DI 10.1016/j.jcis.2019.06.044
PG 9
WC Chemistry, Physical
SC Chemistry
GA IU3BT
UT WOS:000483454400055
PM 31234127
DA 2020-07-08
ER

PT J
AU Maeki, T
   Tajima, S
   Ikeda, M
   Kato, F
   Taniguchi, S
   Nakayama, E
   Takasaki, T
   Lim, CK
   Saijo, M
AF Maeki, Takahiro
   Tajima, Shigeru
   Ikeda, Makiko
   Kato, Fumihiro
   Taniguchi, Satoshi
   Nakayama, Eri
   Takasaki, Tomohiko
   Lim, Chang-Kweng
   Saijo, Masayuki
TI Analysis of cross-reactivity between flaviviruses with sera of patients
   with Japanese encephalitis showed the importance of neutralization tests
   for the diagnosis of Japanese encephalitis
SO JOURNAL OF INFECTION AND CHEMOTHERAPY
LA English
DT Article
DE Japanese encephalitis; Cross-reactivity; Flavivirus; ELISA;
   Neutralization test
ID WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; INFECTION; OUTBREAK; AREA
AB Japanese encephalitis (JE) is one of the most important viral encephalitis in Asia. JE is caused by the Japanese encephalitis virus (JEV), which belongs to the genus Flavivirus, family Flaviviridae. The diagnosis of JE is usually based on serological assays, and it has been reported that cross-reactivity between flaviviruses has complicated the interpretations of results from serological assays. Therefore, analysis of the cross-reactivity is an important subject for serological diagnosis of JE and other diseases caused by flaviviruses. In the present study, the cross-reactivity of the sera of patients with JE to other flaviviruses was analyzed using enzyme-linked immunosorbent assay (ELISA) and neutralization tests. Sixteen serum samples were collected from patients with JE and were tested for: i) IgM antibody against West Nile virus (WNV), dengue virus (DENV), zika virus (ZIKV), and tick-borne encephalitis virus (TBEV) using IgM-ELISA, ii) IgG antibody against DENV and TBEV using IgG-ELISA, and iii) neutralization tests with DENV 1 -4, ZIKV, TBEV, and WNV. Out of the 16 samples tested using ELISA, 11 and 14 samples were positive for IgM and IgG, respectively, against at least one of the other flaviviruses. In neutralization tests, neutralizing potency against DENV, ZIKV, or TBEV was not detected in any samples. Although 13 samples showed neutralizing potency against WNV, their neutralizing antibody titers were equal to or less than one-eighth of those against JEV. These results show that neutralization tests are more specific than ELISA, indicating the importance of the neutralization tests in the diagnosis of JE. (C) 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
C1 [Maeki, Takahiro; Tajima, Shigeru; Ikeda, Makiko; Kato, Fumihiro; Taniguchi, Satoshi; Nakayama, Eri; Lim, Chang-Kweng; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Takasaki, Tomohiko] Kanagawa Prefectural Inst Publ Hlth, 1-3-1 Shimomachiya, Chigasaki, Kanagawa 2530087, Japan.
RP Maeki, T (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
EM tomaeki@nih.go.jp
OI Shigeru, Tajima/0000-0002-1981-9062; Saijo, Masayuki/0000-0001-5458-7298
FU Research Program on Emerging and Re-emering Infectious Diseases of the
   Japan Agency for Medical Research and Development (AMED)
   [JP19fk0108035j0030]; Health and Labor Sciences Research Grant from the
   Ministry of Health, Labour and Welfare of Japan
   [H28-Shiko-Gyosei-Ippan-007]; KAKENHI from Japan Society for the
   Promotion of ScienceMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18K15472]
FX This work was supported by the Research Program on Emerging and
   Re-emering Infectious Diseases of the Japan Agency for Medical Research
   and Development (AMED) [Grant Number JP19fk0108035j0030]; the Health and
   Labor Sciences Research Grant from the Ministry of Health, Labour and
   Welfare of Japan [H28-Shiko-Gyosei-Ippan-007], and by KAKENHI from Japan
   Society for the Promotion of Science [18K15472].
CR Alkadhi H, 2000, NEURORADIOLOGY, V42, P753, DOI 10.1007/s002340000396
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Davis LE, 2008, NEUROL CLIN, V26, P727, DOI 10.1016/j.ncl.2008.03.012
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hegde NR, 2017, HUM VACC IMMUNOTHER, V13, P1320, DOI 10.1080/21645515.2017.1285472
   Ito M, 2010, JPN J INFECT DIS, V63, P181
   Kato F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21582-9
   Kitchen A, 2011, P NATL ACAD SCI USA, V108, P238, DOI 10.1073/pnas.1011090108
   Kuczera D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0548-9
   Li XL, 2013, VECTOR-BORNE ZOONOT, V13, P131, DOI 10.1089/vbz.2012.0995
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Maeki T, 2018, JPN J INFECT DIS, V71, P360, DOI 10.7883/yoken.JJID.2018.126
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Petropoulou KA, 2005, AM J NEURORADIOL, V26, P1986
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Rawal A, 2006, DIAGN CYTOPATHOL, V34, P127, DOI 10.1002/dc.20410
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Sakai M, 2014, J GEN VIROL, V95, P823, DOI 10.1099/vir.0.060046-0
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Tajima S, 2015, J GEN VIROL, V96, P2661, DOI 10.1099/vir.0.000213
   Tajima Y, 2018, INTERNAL MED, V57, P873, DOI 10.2169/internalmedicine.8437-16
   Takashima I, 1997, J CLIN MICROBIOL, V35, P1943, DOI 10.1128/JCM.35.8.1943-1947.1997
   Yamaguchi H, 2018, INFECT AGENTS SURVEI, V39, P46
   Yoshii K, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.69
   Yoshii K, 2011, J VET MED SCI, V73, P409, DOI 10.1292/jvms.10-0350
NR 29
TC 3
Z9 3
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1341-321X
EI 1437-7780
J9 J INFECT CHEMOTHER
JI J. Infect. Chemother.
PD OCT
PY 2019
VL 25
IS 10
BP 786
EP 790
DI 10.1016/j.jiac.2019.04.003
PG 5
WC Infectious Diseases; Pharmacology & Pharmacy
SC Infectious Diseases; Pharmacology & Pharmacy
GA IS5UA
UT WOS:000482216800008
PM 31105002
OA Other Gold
DA 2020-07-08
ER

PT J
AU Watanabe, Y
   Bowden, TA
   Wilson, IA
   Crispin, M
AF Watanabe, Yasunori
   Bowden, Thomas A.
   Wilson, Ian A.
   Crispin, Max
TI Exploitation of glycosylation in enveloped virus pathobiology
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Virus-host interactions; Glycosylation; Virus; Glycoprotein; Structure;
   Glycan shielding
ID N-LINKED GLYCOSYLATION; MANNOSE-BINDING LECTIN; INFLUENZA-A VIRUS;
   RESPIRATORY SYNDROME CORONAVIRUS; SURFACTANT PROTEIN-D; HEPATITIS-C
   VIRUS; BROADLY NEUTRALIZING ANTIBODIES; NEWCASTLE-DISEASE VIRUS; HUMAN
   DENDRITIC CELLS; BLOOD GROUP ANTIGENS
AB Glycosylation is a ubiquitous post-translational modification responsible for a multitude of crucial biological roles. As obligate parasites, viruses exploit host-cell machinery to glycosylate their own proteins during replication. Viral envelope proteins from a variety of human pathogens including HIV-1, influenza virus, Lassa virus, SARS, Zika virus, dengue virus, and Ebola virus have evolved to be extensively glycosylated. These host-cell derived glycans facilitate diverse structural and functional roles during the viral life-cycle, ranging from immune evasion by glycan shielding to enhancement of immune cell infection. In this review, we highlight the imperative and auxiliary roles glycans play, and how specific oligosaccharide structures facilitate these functions during viral pathogenesis. We discuss the growing efforts to exploit viral glycobiology in the development of anti-viral vaccines and therapies.
C1 [Watanabe, Yasunori; Crispin, Max] Univ Southampton, Sch Biol Sci, Southampton SO17 1BJ, Hants, England.
   [Watanabe, Yasunori; Crispin, Max] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England.
   [Watanabe, Yasunori; Bowden, Thomas A.] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.
   [Watanabe, Yasunori] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.
   [Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
   [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
RP Crispin, M (corresponding author), Univ Southampton, Sch Biol Sci, Southampton SO17 1BJ, Hants, England.; Crispin, M (corresponding author), Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England.
EM max.crispin@soton.ac.uk
OI Crispin, Max/0000-0002-1072-2694
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MR/L009528/1]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R56 AI127371]; Bill
   and Melinda Gates FoundationGates Foundation [OPP1196345]; Bill and
   Melinda Gates Foundation through the Collaboration for AIDS Discovery
   [OPP1084519, OPP1115782]; Scripps Center for HIV/AIDS Vaccine Immunology
   and Immunogen Discovery (CHAVI-ID) [1UM1AI100663]; European Union's
   Horizon 2020 for Research & Innovation program [681137]; 
   [203141/Z/16/Z]
FX The Wellcome Centre for Human Genetics is supported by grant
   203141/Z/16/Z. We thank the Medical Research Council (MR/L009528/1 to
   T.A.B.), the NIH (R56 AI127371 to I.A.W.), the Bill and Melinda Gates
   Foundation (grant OPP1196345 to I.A.W.), the International AIDS Vaccine
   Initiative, the Bill and Melinda Gates Foundation through the
   Collaboration for AIDS Discovery (grants OPP1084519 and OPP1115782 to
   M.C.), and the Scripps Center for HIV/AIDS Vaccine Immunology and
   Immunogen Discovery (CHAVI-ID) (1UM1AI100663 to M.C.). This project has
   received funding from the European Union's Horizon 2020 for Research &
   Innovation program under grant agreement No. 681137 (to M.C.).
CR Acciani M, 2017, J VIROL, V91, DOI 10.1128/JVI.00574-17
   Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006
   Alonzi DS, 2017, BIOCHEM SOC T, V45, P571, DOI 10.1042/BST20160182
   Altgarde N, 2015, J BIOL CHEM, V290, P21473, DOI 10.1074/jbc.M115.637363
   An YM, 2015, J PROTEOME RES, V14, P3957, DOI 10.1021/acs.jproteome.5b00416
   ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615
   Antonopoulos A, 2011, BIOCHEM SOC T, V39, P1334, DOI 10.1042/BST0391334
   Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090
   Auriti C, 2017, J IMMUNOL RES, DOI 10.1155/2017/7045630
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021
   Bagdonaite I, 2016, J BIOL CHEM, V291, P12014, DOI 10.1074/jbc.M116.721746
   Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784
   Baize S, 2004, J IMMUNOL, V172, P2861, DOI 10.4049/jimmunol.172.5.2861
   BAUM LG, 1990, ACTA HISTOCHEM, P35
   Bayer K, 2016, J VIROL, V90, P10558, DOI 10.1128/JVI.01615-16
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Behrens AJ, 2017, CURR OPIN STRUC BIOL, V44, P125, DOI 10.1016/j.sbi.2017.03.008
   Behrens AJ, 2017, J VIROL, V91, DOI 10.1128/JVI.01894-16
   Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058
   Benne CA, 1997, EUR J IMMUNOL, V27, P886, DOI 10.1002/eji.1830270413
   Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044
   Biering SB, 2012, J VIROL, V86, P11991, DOI 10.1128/JVI.01304-12
   Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058
   Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008
   Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011
   Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521
   Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039
   Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435
   Bowden TA, 2009, J VIROL, V83, P8259, DOI 10.1128/JVI.00761-09
   Bradel-Tretheway BG, 2015, J VIROL, V89, P7235, DOI 10.1128/JVI.00773-15
   Branco LM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-306
   Branco LM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-147
   Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1
   Bukreyev A, 2008, J VIROL, V82, P12191, DOI 10.1128/JVI.01604-08
   Burton DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a030262
   Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182
   Cao LW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06121-4
   Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954
   Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079
   Chang JH, 2013, ANTIVIR RES, V98, P432, DOI 10.1016/j.antiviral.2013.03.023
   Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200
   Chen L, 2013, J VIROL, V87, P4118, DOI 10.1128/JVI.03476-12
   Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Cherry J. L., 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1001
   Chuang GY, 2019, STRUCTURE, V27, P196, DOI 10.1016/j.str.2018.10.007
   Cohen-Dvashi H, 2015, J VIROL, V89, P7584, DOI 10.1128/JVI.00651-15
   Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002
   Cook JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003258
   Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14
   Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t
   Cormier EG, 2004, P NATL ACAD SCI USA, V101, P14067, DOI 10.1073/pnas.0405695101
   Crennell S, 2000, NAT STRUCT BIOL, V7, P1068
   Crispin M, 2018, ANNU REV BIOPHYS, V47, P499, DOI 10.1146/annurev-biophys-060414-034156
   Crispin M, 2015, CURR OPIN VIROL, V11, P63, DOI 10.1016/j.coviro.2015.02.002
   Crispin M, 2014, J VIROL, V88, P10244, DOI 10.1128/JVI.01662-14
   Crispin M, 2014, J PROTEOME RES, V13, P1702, DOI 10.1021/pr401162k
   Crispin MDM, 2004, FEBS LETT, V566, P270, DOI 10.1016/j.febslet.2004.04.045
   Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703
   Crowe JE, 2019, J INFECT DIS, V219, pS21, DOI 10.1093/infdis/jiz010
   Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108
   Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211
   DATEMA R, 1982, P NATL ACAD SCI-BIOL, V79, P6787, DOI 10.1073/pnas.79.22.6787
   de Groot RJ, 2006, GLYCOCONJUGATE J, V23, P59, DOI 10.1007/s10719-006-5438-8
   de La Vega MA, 2015, VIRAL IMMUNOL, V28, P3, DOI 10.1089/vim.2014.0068
   de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056
   de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Desheva Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196771
   Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051
   Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530
   Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107
   Druar C, 2005, IMMUNOGENETICS, V57, P730, DOI 10.1007/s00251-005-0047-4
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Dubuisson J., 1999, J GEN VIROL, V80, P887, DOI [10.1099/0022-1317-80-4-887, DOI 10.1099/0022-1317-80-4-887]
   Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118
   Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   FLEET GWJ, 1988, FEBS LETT, V237, P128, DOI 10.1016/0014-5793(88)80185-6
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098
   Francois KO, 2011, J BIOL CHEM, V286, P42900, DOI 10.1074/jbc.M111.274456
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Funk CJ, 2012, J GEN VIROL, V93, P494, DOI 10.1099/vir.0.038414-0
   Galili U, 2016, GLYCOBIOLOGY, V26, P1140, DOI 10.1093/glycob/cww088
   Garner OB, 2015, J VIROL, V89, P2520, DOI 10.1128/JVI.02435-14
   Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993
   Gee GV, 2006, GLYCOCONJUGATE J, V23, P19, DOI 10.1007/s10719-006-5434-z
   Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31
   Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7
   Gluschankof P, 1997, VIROLOGY, V230, P125, DOI 10.1006/viro.1997.8453
   Goncalves AR, 2013, J VIROL, V87, P11504, DOI 10.1128/JVI.01893-13
   Gorander S, 2006, CLIN VACCINE IMMUNOL, V13, P633, DOI 10.1128/CVI.00051-06
   Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008
   GRUTERS RA, 1987, NATURE, V330, P74, DOI 10.1038/330074a0
   GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252
   Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784
   Halim A, 2011, P NATL ACAD SCI USA, V108, P11848, DOI 10.1073/pnas.1102664108
   Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2
   Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113
   HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0
   Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156
   Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096
   Hastie KM, 2017, SCIENCE, V356, P923, DOI 10.1126/science.aam7260
   Hebert DN, 2014, NAT CHEM BIOL, V10, P902, DOI 10.1038/nchembio.1651
   Heggelund JE, 2017, CURR OPIN STRUC BIOL, V44, P190, DOI 10.1016/j.sbi.2017.04.001
   Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005
   Hilleman MR, 2004, P NATL ACAD SCI USA, V101, P14560, DOI 10.1073/pnas.0404758101
   Hoebe EK, 2012, VIRAL IMMUNOL, V25, P461, DOI 10.1089/vim.2012.0034
   Hofmann H, 2013, J VIROL, V87, P4384, DOI 10.1128/JVI.02628-12
   Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601
   Hudak JE, 2014, CHEM BIOL, V21, P16, DOI 10.1016/j.chembiol.2013.09.010
   Hussain S, 2015, J ANTIMICROB CHEMOTH, V70, P136, DOI 10.1093/jac/dku349
   Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036
   Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003
   Imberty A, 2008, CHEM-EUR J, V14, P7490, DOI 10.1002/chem.200800700
   Isa P, 2006, GLYCOCONJUGATE J, V23, P27, DOI 10.1007/s10719-006-5435-y
   Israeli H, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006337
   Iversen MB, 2016, NAT IMMUNOL, V17, P150, DOI 10.1038/ni.3319
   Izquierdo-Useros N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004146
   Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480
   Jantti J, 1997, J VIROL, V71, P1162
   Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150
   Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101
   Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Julithe R, 2014, J VIROL, V88, P9049, DOI 10.1128/JVI.01161-14
   Kiappes JL, 2018, ACS CHEM BIOL, V13, P60, DOI 10.1021/acschembio.7b00870
   Kim NY, 2007, XENOTRANSPLANTATION, V14, P104, DOI 10.1111/j.1399-3089.2007.00377.x
   Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200
   Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003
   Kobayashi Y, 2012, J VIROL, V86, P3446, DOI 10.1128/JVI.06147-11
   Kong L, 2015, PROTEINS, V83, P590, DOI 10.1002/prot.24747
   Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19
   KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215
   Kosik I, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006796
   KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733
   Kumlin U, 2008, INFLUENZA OTHER RESP, V2, P147, DOI 10.1111/j.1750-2659.2008.00051.x
   Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029
   Lavie M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00910
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082
   Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56
   Lee JH, 2015, STRUCTURE, V23, P1943, DOI 10.1016/j.str.2015.07.020
   Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614
   Leger P, 2016, TRAFFIC, V17, P639, DOI 10.1111/tra.12393
   LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC
   Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413
   Li S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005418
   Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114
   Liu Y., 2014, PLOS PATHOG, V10, DOI [10.1371/joumal.ppat, DOI 10.1371/JOUMAL.PPAT]
   Loke I, 2016, MOL ASPECTS MED, V51, P31, DOI 10.1016/j.mam.2016.04.004
   Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10
   Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lu J, 2018, EMERG INFECT DIS, V24, P1795, DOI 10.3201/eid2410.171063
   Luo SK, 2015, VIROLOGY, V483, P72, DOI 10.1016/j.virol.2015.04.005
   Luther KB, 2011, J BIOL CHEM, V286, P43701, DOI 10.1074/jbc.M111.309096
   Ma XC, 2018, ELIFE, V7, DOI 10.7554/eLife.34271
   Machiels B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002387
   Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0
   Martinez O, 2011, J INFECT DIS, V204, pS825, DOI 10.1093/infdis/jir295
   Maruyama T, 1999, J INFECT DIS, V179, pS235, DOI 10.1086/514280
   Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004
   Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000
   Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004
   Matsushita M, 1996, MICROBIOL IMMUNOL, V40, P887, DOI 10.1111/j.1348-0421.1996.tb01156.x
   Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x
   McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4
   Medina RA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005996
   Miller A, 2012, J BIOL CHEM, V287, P3930, DOI 10.1074/jbc.M111.320341
   Miller J. L., 2016, PLOS ONE, V11, DOI [10.1371/journalpone.0167018e0167018, DOI 10.1371/JOURNALPONE.0167018E0167018]
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miller JL, 2012, ANTIMICROB AGENTS CH, V56, P6379, DOI 10.1128/AAC.01554-12
   MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065
   Moll M, 2004, J VIROL, V78, P7274, DOI 10.1128/JVI.78.13.7274-7278.2004
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006
   Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Neil SJD, 2005, BLOOD, V105, P4693, DOI 10.1182/blood-2004-11-4267
   Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200
   Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008
   Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73
   Nishikawa I, 2010, INT J MOL SCI, V11, P4992, DOI 10.3390/ijms11124991
   Norden R, 2015, J BIOL CHEM, V290, P5078, DOI 10.1074/jbc.M114.616409
   O'Donnell Christopher D, 2008, Virol Sin, V23, P383, DOI 10.1007/s12250-008-2992-1
   O'Flaherty R, 2018, EXPERT REV PROTEOMIC, V15, P13, DOI 10.1080/14789450.2018.1404907
   Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340
   Ouellet M, 2005, J IMMUNOL, V174, P4120, DOI 10.4049/jimmunol.174.7.4120
   PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159
   Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114
   Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600
   Panico M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32956
   Parsy ML, 2013, J VIROL, V87, P13070, DOI 10.1128/JVI.02298-13
   Pasqual G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002232
   Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW
   PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167
   Peerboom N, 2017, BIOPHYS J, V113, P1223, DOI 10.1016/j.bpj.2017.06.028
   Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256
   PHOENIX I, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/V8050149
   Piacente F, 2017, J BIOL CHEM, V292, P7385, DOI 10.1074/jbc.M117.783217
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Pritchard LK, 2015, J VIROL, V89, P8932, DOI 10.1128/JVI.01190-15
   Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479
   Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017
   Pryce R, 2019, J VIROL, V93, DOI 10.1128/JVI.01048-18
   Radoshitzky SR, 2015, ARCH VIROL, V160, P1851, DOI 10.1007/s00705-015-2418-y
   Regan AD, 2008, J VIROL, V82, P11992, DOI 10.1128/JVI.01094-08
   Ressing ME, 2005, J VIROL, V79, P841, DOI 10.1128/JVI.79.2.841-852.2005
   Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236
   Ritchie G, 2010, RAPID COMMUN MASS SP, V24, P571, DOI 10.1002/rcm.4410
   Ritchie G, 2010, VIROLOGY, V399, P257, DOI 10.1016/j.virol.2009.12.020
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Samal S, 2012, J VIROL, V86, P2501, DOI 10.1128/JVI.06380-11
   Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481
   Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618
   Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033
   SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Seabright GE, 2019, J MOL BIOL, V431, P2223, DOI 10.1016/j.jmb.2019.04.016
   Seymour RM, 2004, P ROY SOC B-BIOL SCI, V271, P1065, DOI 10.1098/rspb.2004.2674
   Shelton H, 2011, J VIROL, V85, P1875, DOI 10.1128/JVI.01822-10
   Shen S, 2016, J GEN VIROL, V97, P988, DOI 10.1099/jgv.0.000404
   Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005
   Shi XH, 2004, J VIROL, V78, P5414, DOI 10.1128/JVI.78.10.5414-5422.2004
   Shi XZ, 2007, CURR DRUG TARGETS, V8, P1116, DOI 10.2174/138945007782151360
   Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a
   Shtyrya YA, 2009, ACTA NATURAE, V1, P26, DOI 10.32607/20758251-2009-1-2-26-32
   Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI200113799
   Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531
   SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779
   Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3
   SODORA DL, 1989, J VIROL, V63, P5184, DOI 10.1128/JVI.63.12.5184-5193.1989
   Sommerstein R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005276
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Spear GT, 2003, IMMUNOLOGY, V110, P80, DOI 10.1046/j.1365-2567.2003.01707.x
   Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R
   St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11
   Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79
   Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027
   Struwe WB, 2018, CELL REP, V24, P1958, DOI 10.1016/j.celrep.2018.07.080
   Sukegawa S, 2018, CELL REP, V22, P786, DOI 10.1016/j.celrep.2017.12.085
   Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294
   Taylor ME, 2011, INTRO GLYCOBIOLOGY
   Thaysen-Andersen M, 2014, BBA-PROTEINS PROTEOM, V1844, P1437, DOI 10.1016/j.bbapap.2014.05.002
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Thompson CP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06228-8
   Tokatlian T, 2019, SCIENCE, V363, P649, DOI 10.1126/science.aat9120
   Trefry JC, 2015, VIRUSES-BASEL, V7, P6739, DOI 10.3390/v7122969
   Van Breedam W, 2014, FEMS MICROBIOL REV, V38, P598, DOI 10.1111/1574-6976.12052
   Varki A., 2015, BIOL FUNCTIONS GLYCA, DOI [10.1101/GLYCOBIOLOGY.3E.007, DOI 10.1101/GLYCOBIOLOGY.3E.007]
   Varki A., 2009, ESSENTIALS OF GLYCOB
   Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07
   von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400
   VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0
   Wagh K, 2018, CELL REP, V25, P893, DOI 10.1016/j.celrep.2018.09.087
   Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373
   Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004
   Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028
   Walls AC, 2016, NAT STRUCT MOL BIOL, V23, P899, DOI 10.1038/nsmb.3293
   Wang LS, 2018, J VIROL, V92, DOI 10.1128/JVI.02002-17
   Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712
   Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14
   Wanzeck K, 2011, AM J RESP CRIT CARE, V183, P767, DOI 10.1164/rccm.201007-1184OC
   Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507
   Watanabe Y, 2018, P NATL ACAD SCI USA, V115, P7320, DOI 10.1073/pnas.1803990115
   Watanabe Y, 2018, ANAL CHEM, V90, P7325, DOI 10.1021/acs.analchem.8b00573
   WAXHAM MN, 1986, J VIROL, V59, P392, DOI 10.1128/JVI.59.2.392-400.1986
   Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799
   Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470
   WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0
   Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
   Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1
   Wu NC, 2017, J MOL BIOL, V429, P2694, DOI 10.1016/j.jmb.2017.06.015
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514
   Xiang Y, 2010, J VIROL, V84, P12265, DOI 10.1128/JVI.01303-10
   Xiang Y, 2016, P NATL ACAD SCI USA, V113, pE7890, DOI 10.1073/pnas.1611213113
   Xiao HP, 2019, MASS SPECTROM REV, V38, P356, DOI 10.1002/mas.21586
   Xiong XL, 2018, J VIROL, V92
   Xu K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005322
   Xu R, 2013, MBIO, V4, DOI 10.1128/mBio.00803-13
   Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430
   Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264
   Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11
   Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004
   Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021
   Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951
   Zeltina A, 2017, P NATL ACAD SCI USA, V114, P7031, DOI 10.1073/pnas.1702127114
   Zeltina A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005390
   Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106
   Zhang S, 2012, PROTEOMICS, V12, P1269, DOI 10.1002/pmic.201100474
   Zhang XJ, 2015, J GEN VIROL, V96, P1248, DOI 10.1099/vir.0.000082
   Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615
   Zhou TQ, 2018, IMMUNITY, V48, P500, DOI 10.1016/j.immuni.2018.02.013
   Zhou YC, 2010, J VIROL, V84, P8753, DOI 10.1128/JVI.00554-10
NR 313
TC 7
Z9 7
U1 14
U2 39
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD OCT
PY 2019
VL 1863
IS 10
BP 1480
EP 1497
DI 10.1016/j.bbagen.2019.05.012
PG 18
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA IQ3SB
UT WOS:000480670300005
PM 31121217
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Alves, RD
   Franco, DL
   Cordeiro, MT
   de Oliveira, EM
   Dutra, RAF
   Sotomayor, MDT
AF Alves, Rafael da Fonseca
   Franco, Diego Leoni
   Cordeiro, Marli Tenorio
   de Oliveira Junior, Ernesto Marques
   Fireman Dutra, Rosa Amalia
   Taboada Sotomayor, Maria Del Pilar
TI Novel electrochemical genosensor for Zika virus based on a
   poly-(3-amino-4-hydroxybenzoic acid)-modified pencil carbon graphite
   electrode
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Zika virus; Pencil graphite; Electrochemical genosensor;
   3-Amino-4-hydroxybenzoic acid polymer
ID ELECTROPOLYMERIZATION; TRANSMISSION; AMINOPHENOL; AMERICA; PURINES; FILM
AB The Zika virus has recently emerged as a major worldwide threat because it induces microencephaly and other brain damage in babies born to infected mothers. Epidemiological monitoring of infection has been hampered by the lack of reliable tests capable of distinguishing between Zika and other Flavivirus infections, especially the dengue virus. The present work describes the electrochemical modification of pencil carbon graphite electrodes with a material derived from 3-amino-4-hydroxybenzoic acid. Solutions were prepared in acid medium and the material formed showed insulating behavior. Optical and electrical data suggested that carboxyl groups did not participate in the reaction mechanism. FT-IR spectra indicated that these groups were retained, enabling the proposal of a mechanism based on the data obtained. The material formed was used for immobilization of the ssDNAzv aminated oligonucleotide. Detection of the hybridization was based on the Delta ip resulting from the higher electrostatic repulsion of [Fe(CN)(6)](3-), caused by the increase of phosphates by addition of the complementary target sequence. The system showed a good linear correlation coefficient (r(2) = 0.997), with satisfactory selectivity and reproducibility, a low limit of detection (25.4 pM), and precision (RSD) of 3.1%, using real samples of human serum enriched with total extract of Zika virus RNA. Tests of the system using the total RNA extracted from dengue virus types 2 and 3 cultures showed little difference in the observed current, hence confirming the specificity of the system. These findings demonstrated the potential of the proposed biosensor.
C1 [Alves, Rafael da Fonseca; Taboada Sotomayor, Maria Del Pilar] State Univ Sao Paulo UNESP, Dept Analyt Chem, Inst Chem, BR-14801970 Araraquara, SP, Brazil.
   [Franco, Diego Leoni] Univ Fed Uberlandia, Inst Quim, Grp Eletroquim Aplicada & Polimeros & Sensores, BR-38700128 Patos De Minas, MG, Brazil.
   [Cordeiro, Marli Tenorio; de Oliveira Junior, Ernesto Marques] Oswaldo Cruz Fiocruz Fdn, Aggeu Magalhaes Inst, Av Prof Moraes Rego S-N,POB 7-472, BR-50670420 Recife, PE, Brazil.
   [Fireman Dutra, Rosa Amalia] Univ Fed Pernambuco, Biomed Engn Lab, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
RP Sotomayor, MDT (corresponding author), State Univ Sao Paulo UNESP, Dept Analyt Chem, Inst Chem, BR-14801970 Araraquara, SP, Brazil.
EM m.sotomayor@unesp.br
RI Alves, Rafael F./P-3427-2018; Franco, Diego L/H-1660-2012; Sotomayor,
   Maria/M-6317-2013
OI Franco, Diego L/0000-0003-4675-971X; Sotomayor,
   Maria/0000-0002-6173-7888
FU Sao Paulo State Research Foundation -Brazil (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2017/07436-0]; Coordination
   for the Improvement of Higher Education Personnel (CAPES)CAPES; National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [440605/2016-4]
FX The authors are grateful for financial support provided by the Sao Paulo
   State Research Foundation -Brazil (FAPESP, grant #2017/07436-0),
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   and the National Council for Scientific and Technological Development
   (CNPq, grant #440605/2016-4).
CR Alves RD, 2017, TALANTA, V165, P69, DOI 10.1016/j.talanta.2016.12.025
   BARBERO C, 1987, ELECTROCHIM ACTA, V32, P693, DOI 10.1016/0013-4686(87)87063-9
   BARBERO C, 1989, J ELECTROANAL CHEM, V263, P333, DOI 10.1016/0022-0728(89)85103-4
   Bonanni A, 2015, TALANTA, V136, P95, DOI 10.1016/j.talanta.2015.01.004
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), 2018, TYP ZIK VIR TESTS ZI
   Cha JH, 2003, BIOSENS BIOELECTRON, V18, P1241, DOI 10.1016/S0956-5663(03)00088-55
   Chen CX, 2013, ELECTROCHIM ACTA, V97, P112, DOI 10.1016/j.electacta.2013.02.138
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Cruz FS, 2017, J ELECTROANAL CHEM, V806, P172, DOI 10.1016/j.jelechem.2017.10.070
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franco DL, 2008, POLYM ENG SCI, V48, P2043, DOI 10.1002/pen.21044
   Franco DL, 2008, MATER CHEM PHYS, V107, P404, DOI 10.1016/j.matchemphys.2007.08.006
   Goncalves D, 2000, J ELECTROANAL CHEM, V487, P90, DOI 10.1016/S0022-0728(00)00151-0
   Guenbour A, 2000, PROG ORG COAT, V38, P121, DOI 10.1016/S0300-9440(00)00085-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamdan N. A., 2012, CURR RES TUBERCULOSI, V4, P1, DOI DOI 10.3923/CRT.2012.1.12
   Hofer U, 2016, NAT REV MICROBIOL, V14, P401, DOI 10.1038/nrmicro.2016.80
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kafka J, 2008, ELECTROCHIM ACTA, V53, P7467, DOI 10.1016/j.electacta.2008.01.031
   Kawaguchi H, 2015, BIORESOURCE TECHNOL, V198, P410, DOI 10.1016/j.biortech.2015.09.024
   KUNIMURA S, 1988, MACROMOLECULES, V21, P894, DOI 10.1021/ma00182a007
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti R. S., 2015, EMERG INFECT DIS, V22, P2015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li LL, 2004, ELECTROANAL, V16, P81, DOI 10.1002/elan.200302921
   Li P, 2018, CELL HOST MICROBE, V24, P875, DOI 10.1016/j.chom.2018.10.011
   Marques ETA, 1998, MOL BIOCHEM PARASIT, V93, P237, DOI 10.1016/S0166-6851(98)00033-4
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miao YQ, 2004, TRENDS BIOTECHNOL, V22, P227, DOI 10.1016/j.tibtech.2004.03.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira RML, 2010, J MATER SCI, V45, P475, DOI 10.1007/s10853-009-3964-z
   Ortega JM, 2000, THIN SOLID FILMS, V371, P28, DOI 10.1016/S0040-6090(00)00980-9
   Pavia G. S., 2010, INTRO SPECTROSCOPY G
   Peng H, 2006, BIOSENS BIOELECTRON, V21, P1727, DOI 10.1016/j.bios.2005.08.011
   Qi H, 2007, TALANTA, V72, P1030, DOI 10.1016/j.talanta.2006.12.032
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Suzuki H, 2006, J BIOL CHEM, V281, P36944, DOI 10.1074/jbc.M608103200
   Tappe D, 2013, EURO SURVEILL, V19
   THENMOZHI G, 2014, INT J ELECTROCHEM, V2014, P1, DOI DOI 10.1155/2014/96161
   Vieira SN, 2006, MACROMOL SYMP, V245, P236, DOI 10.1002/masy.200651333
   VISCHER E, 1948, J BIOL CHEM, V176, P703
   Wang J, 2002, ANAL CHIM ACTA, V469, P63, DOI 10.1016/S0003-2670(01)01399-X
   Wu J, 2005, SENSOR ACTUAT B-CHEM, V104, P43, DOI 10.1016/j.snb.2004.04.097
NR 50
TC 4
Z9 4
U1 7
U2 38
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD OCT 1
PY 2019
VL 296
AR UNSP 126681
DI 10.1016/j.snb.2019.126681
PG 10
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA II6PC
UT WOS:000475314800066
DA 2020-07-08
ER

PT J
AU Faria, AM
   Mazon, T
AF Faria, Aline Macedo
   Mazon, Talita
TI Early diagnosis of Zika infection using a ZnO nanostructures-based rapid
   electrochemical biosensor
SO TALANTA
LA English
DT Article
DE Immunosensor; ZnO; Zika virus; Dengue
ID MEMBRANE ASSOCIATION; VIRUS; ANTIBODIES; URINE; PCR
AB In this work, we report a develop of electrochemical immunosensor based on ZnO nanostructures immobilized with ZIKV-NS1 antibody on Printed Circuit Board (PCB). ZnO nanostructures were grown on PCB by chemical bath deposition (CDB) and characterized by SEM. ZIKV-NS1 antibody was immobilized on the ZnO nanostructures surface via cystamine and glutaraldehyde. The samples were characterized by Immunofluorescence Confocal Microscopy and FTIR to identify the immobilization of the antibody to the sensor board. The analytical responses of the immunosensor were evaluated by Cyclic Voltammetry (CV). The biosensor developed here allows rapid detection of Zika virus in undiluted urine, without cross reactive with DENV-NS1 antigen, with linear range 0.1 ng mL(-1) to 100 ng mL(-1). The limit of detection is lower than 1.00 pg mL(-1). The biosensor is portable, cost-effectiveness, and simple to use, which makes it ideal for point-of-care applications.
C1 [Faria, Aline Macedo; Mazon, Talita] CTI, Ctr Tecnol Informacao Renato Archer, Rod D Pedro 1,KM 143-6, BR-13069901 Campinas, SP, Brazil.
RP Mazon, T (corresponding author), CTI, Ctr Tecnol Informacao Renato Archer, Rod D Pedro 1,KM 143-6, BR-13069901 Campinas, SP, Brazil.
EM talita.mazon@cti.gov.br
RI Mazon, Talita/E-3705-2012
OI Mazon, Talita/0000-0003-2491-079X
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [301855/2016-1]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [CEPID -CDMF 2013/07296-2]
FX This work was financially supported by CNPq (301855/2016-1) and FAPESP
   (CEPID -CDMF 2013/07296-2) by the financial support. The authors thank
   LME/LNNano -Brazilian Nanotechnology National Laboratory/CNPEM/MCTI by
   the support in SEM images. We thank the staff of the Electronic
   Packaging from CTI for the support on fabrication our homemade
   bare-sensor board. We also thank the staff of the Life Sciences Core
   Facility (LaCTAD) from State University of Campinas (UNICAMP), for the
   Confocal Microscopy analysis. In particular, the authors are grateful to
   Dr. Jose Butori Lopes de Faria (Renal Pathophysiology Laboratory,
   Investigation on Diabetes Complications, Faculty of Medical Sciences,
   State University of Campinas -UNICAMP) for his technical and scientific
   assistance.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   ANNO Y, 1995, SENSOR ACTUAT B-CHEM, V25, P623, DOI 10.1016/0925-4005(95)85137-2
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bhattacharya M, 2011, SENSOR ACTUAT B-CHEM, V155, P67, DOI 10.1016/j.snb.2010.11.025
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Casale TB, 2018, J ALLERGY CLIN IMMUN, V141, P482, DOI 10.1016/j.jaci.2017.11.029
   CDC, GUID US LAB TEST ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Gasparotto G, 2017, MAT SCI ENG C-MATER, V76, P1240, DOI 10.1016/j.msec.2017.02.031
   Gonzalez-Chavarri J, 2018, SENSOR ACTUAT B-CHEM, V255, P1244, DOI 10.1016/j.snb.2017.08.094
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lee-Lewandrowski E, 2013, J HOSP ADM, V2, P125
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836
   Rui Q, 2010, ANAL CHIM ACTA, V670, P57, DOI 10.1016/j.aca.2010.04.065
   Sassolas A, 2012, BIOTECHNOL ADV, V30, P489, DOI 10.1016/j.biotechadv.2011.09.003
   Segneanu A.E., 2012, ORGANIC COMPOUNDS FT
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Sharma S, 2016, ESSAYS BIOCHEM, V60, P9, DOI 10.1042/EBC20150002
   Silva MMS, 2014, TALANTA, V128, P505, DOI 10.1016/j.talanta.2014.06.009
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Vessalli BA, 2017, J ALLOY COMPD, V696, P996, DOI 10.1016/j.jallcom.2016.12.075
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   World Health Organization, ZIK VIR DIS DIAGN
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 32
TC 2
Z9 2
U1 12
U2 64
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD OCT 1
PY 2019
VL 203
BP 153
EP 160
DI 10.1016/j.talanta.2019.04.080
PG 8
WC Chemistry, Analytical
SC Chemistry
GA IH2IT
UT WOS:000474319100020
PM 31202320
DA 2020-07-08
ER

PT J
AU Corzo-Gomez, J
   Garcia-Cordero, J
   Gomez, AEM
   Bernal-Siria, K
   Namorado-Tonix, K
   Gutierrez-Castaneda, B
   Cedillo-Barron, L
AF Corzo-Gomez, Josselin
   Garcia-Cordero, Julio
   Montes Gomez, Alfredo E.
   Bernal-Siria, Karen
   Namorado-Tonix, Karime
   Gutierrez-Castaneda, Benito
   Cedillo-Barron, Leticia
TI Expression and purification of domain III proteins from Dengue and Zika
   viruses
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE Dengue virus; Zika virus; Recombinant proteins; E protein; Specific
   antibodies cross-reactivity; Immune response
ID ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; EPITOPES
AB The envelope (E) protein from Dengue and Zika viruses comprises three functional and structural domains (DI, DII, and DIII). Domain III induces most of the neutralizing antibodies and, as such, is considered as having the highest antigenic potential for the evaluation of population-level surveillance and for detecting past infections in both Dengue and Zika patients. The present study aimed to clone and express recombinant proteins of domain III from Dengue virus serotype 2 and from Zika virus in a prokaryotic system, as well as evaluate their immunogenicity and cross-reactivity. Both antigens were successfully purified and their antigenicity was assessed in mice. The antibodies elicited by domain III of Zika and Dengue virus antigens recognized specifically the native proteins in infected cells. Furthermore, the antigens showed a more specific immunogenic response than that of domain III proteins from Dengue virus. The generated recombinant proteins can be potentially used in subunit vaccines or for surveillance studies.
C1 [Corzo-Gomez, Josselin; Garcia-Cordero, Julio; Montes Gomez, Alfredo E.; Bernal-Siria, Karen; Namorado-Tonix, Karime; Cedillo-Barron, Leticia] CINVESTAV IPN, Dept Biomed Mol, Av IPN 2508 Col, Mexico City 07360, DF, Mexico.
   [Gutierrez-Castaneda, Benito] Univ Nacl Autonoma Mexico, Fac Estudios Super Itztacala, Immunol Dept UMF, Av Barrios 1, Tlalnepantla 54090, Edo De Mexico, Mexico.
RP Cedillo-Barron, L (corresponding author), CINVESTAV IPN, Dept Biomed Mol, Av IPN 2508 Col, Mexico City 07360, DF, Mexico.
EM lcedillo@cinvestav.mx
FU National Council for Science and Technology (CONACyT)Consejo Nacional de
   Ciencia y Tecnologia (CONACyT) [FONSECO 2014-1-233347 LCB]
FX This work was supported by the National Council for Science and
   Technology (CONACyT) Grant FONSECO 2014-1-233347 LCB.
CR Coconi-Linares N, 2013, VACCINE, V31, P2366, DOI 10.1016/j.vaccine.2013.03.009
   Montes-Gomez AE, 2017, ACTA TROP, V171, P233, DOI 10.1016/j.actatropica.2017.04.006
   Frei JC, 2018, J VIROL, V92, DOI [10.1128/JVI.01023-18, 10.1128/jvi.01023-18]
   Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349
   Gileadi O, 2017, METHODS MOL BIOL, V1586, P3, DOI 10.1007/978-1-4939-6887-9_1
   Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Jia B, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160196
   Kim MY, 2017, PROTEIN EXPRES PURIF, V139, P57, DOI 10.1016/j.pep.2016.06.006
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li HB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01268
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yeliseev A, 2007, PROTEIN EXPRES PURIF, V53, P153, DOI 10.1016/j.pep.2006.12.003
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 27
TC 0
Z9 0
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD OCT
PY 2019
VL 162
BP 38
EP 43
DI 10.1016/j.pep.2019.05.005
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA IF3MU
UT WOS:000472985700006
PM 31112759
DA 2020-07-08
ER

PT J
AU Paiva, MHS
   Barbosa, RMR
   Santos, SA
   Silva, NM
   Paula, MB
   Ayres, CFJ
   Leal, WS
AF Paiva, Marcelo H. S.
   Barbosa, Rosangela M. R.
   Santos, Suzane A.
   Silva, Norma M.
   Paula, Marcia B.
   Ayres, Constancia F. J.
   Leal, Walter S.
TI An unsettling explanation for the failure of skatole-baited ovitraps to
   capture Culex mosquitoes
SO INSECT SCIENCE
LA English
DT Article
DE Culex quinquefasciatus; Culex nigripalpus; dengue; oviposition
   attractant; skatole; West Nile virus; Zika
ID LOUIS-ENCEPHALITIS-VIRUS; HOST-FEEDING PATTERNS; DIPTERA-CULICIDAE;
   LYMPHATIC FILARIASIS; PHLEBOTOMINE SANDFLIES; NIGRIPALPUS DIPTERA;
   THEOBALD DIPTERA; SAO-PAULO; QUINQUEFASCIATUS; STATE
AB Culex mosquitoes are primarily found in temperate and tropical regions worldwide where they play a crucial role as main vectors of filarial worms and arboviruses. In Recife, a northeast city in Brazil, high densities of Culex quinquefasciatus are often found in association with human populated areas. In marked contrast to another part of the city, field tests conducted in the neighborhood of Sitio dos Pintos showed that trapping of mosquitoes in skatole-baited ovitraps did not differ significantly from captures in control (water) traps. Thus, classical and molecular taxonomic approaches were used to analyze the Culex species circulating in Sitio dos Pintos. Results obtained from both approaches agreed on the cocirculation of Culex quinquefasciatus and Culex nigripalpus in three different areas of this neighborhood. What was initially considered as an unexpected failure of this lure turned out to be a more unsettling problem, that is, the first report in Recife of Culex nigripalpus, a vector of Venezuelan equine encephalitisvirus and West Nile virus. Unplanned urbanization processes close to remnants of the Atlantic forest, such as observed in Sitio dos Pintos, may have contributed to the introduction of Cx. nigripalpus in urban areas.
C1 [Paiva, Marcelo H. S.; Barbosa, Rosangela M. R.; Santos, Suzane A.; Ayres, Constancia F. J.] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Entomol, Ave Prof Moraes Rego, Recife, PE, Brazil.
   [Paiva, Marcelo H. S.] Univ Fed Pernambuco, Ctr Acad Agreste, Caruaru, PE, Brazil.
   [Silva, Norma M.] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil.
   [Paula, Marcia B.] Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, SP, Brazil.
   [Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
RP Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
EM wsleal@ucdavis.edu
RI Barbosa, Rosangela/AAC-3339-2020; Ayres, Constancia/AAQ-3448-2020
OI Barbosa, Rosangela/0000-0002-1171-598X; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [407475/2012-5]; Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco [APQ-2141-4.00/12 PPSUS-FACEPE]; National Institute
   of Allergy and Infectious Diseases of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI095514, R21AI128931]
FX We would like to thank the NPT-PDTIS platform from Instituto Aggeu
   Magalhaes-FIOCRUZ for performing the nucleotide sequencing. This work
   was supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), under award 407475/2012-5; Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco, under award
   APQ-2141-4.00/12 PPSUS-FACEPE; and the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health, under award
   R01AI095514 and R21AI128931.
CR Aguiar-Santos AM, 2013, J PEDIAT-BRAZIL, V89, P250, DOI 10.1016/j.jped.2012.11.003
   Alencar J, 2005, NEOTROP ENTOMOL, V34, P681, DOI 10.1590/S1519-566X2005000400020
   ANDERSON RA, 1995, J MED ENTOMOL, V32, P705, DOI 10.1093/jmedent/32.5.705
   Aragao NC, 2010, REV SOC BRAS MED TRO, V43, P458, DOI 10.1590/S0037-86822010000400024
   Balbino VQ, 2005, ANN TROP MED PARASIT, V99, P683, DOI 10.1179/136485905X65116
   Christensen HA, 1996, AM J TROP MED HYG, V55, P202, DOI 10.4269/ajtmh.1996.55.202
   Dantas-Torres F, 2010, REV SOC BRAS MED TRO, V43, P733, DOI 10.1590/S0037-86822010000600028
   de Albuquerque C M, 2000, Rev Saude Publica, V34, P314
   Demari-Silva B, 2011, J MED ENTOMOL, V48, P272, DOI 10.1603/ME09293
   Fontes G, 2005, REV SOC BRAS MED TRO, V38, P131, DOI 10.1590/S0037-86822005000200001
   Fontes G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-272
   Forattini OP., 2002, CULICIDOLOGIA MED
   Freitas H, 2008, REV SOC BRAS MED TRO, V41, P212, DOI 10.1590/S0037-86822008000200018
   Gomes AC, 2003, J VECTOR ECOL, V28, P74
   Gomez A, 2008, EMERG INFECT DIS, V14, P962, DOI 10.3201/eid1406.070352
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Laporta GZ, 2008, REV BRAS ENTOMOL, V52, P663, DOI 10.1590/S0085-56262008000400019
   Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457
   Lourenco-de-Oliveira R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P479
   Mendez W, 2001, J MED ENTOMOL, V38, P813, DOI 10.1603/0022-2585-38.6.813
   NAYAR JK, 1986, AM J TROP MED HYG, V35, P1296, DOI 10.4269/ajtmh.1986.35.1296
   Olagbemiro TO, 2004, J CHEM ECOL, V30, P965, DOI 10.1023/B:JOEC.0000028461.86243.19
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Pauvolid-Correa A, 2010, MEM I OSWALDO CRUZ, V105, P829, DOI 10.1590/S0074-02762010000600017
   REGIS L, 1995, MEM I OSWALDO CRUZ, V90, P115, DOI 10.1590/S0074-02761995000100022
   Regis L, 2000, T ROY SOC TROP MED H, V94, P488, DOI 10.1016/S0035-9203(00)90061-0
   Barbosa RMR, 2011, MEM I OSWALDO CRUZ, V106, P451, DOI 10.1590/S0074-02762011000400011
   Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621
   Rudbeck L, 1998, BIOTECHNIQUES, V25, P588, DOI 10.2144/98254bm09
   Rutledge CR, 2003, J MED ENTOMOL, V40, P253, DOI 10.1603/0022-2585-40.3.253
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Samuel PP, 2004, J MED ENTOMOL, V41, P442, DOI 10.1603/0022-2585-41.3.442
   Shroyer D. A., 1991, Journal of the Florida Mosquito Control Association, V62, P69
   Silva DF, 2005, REV SOC BRAS MED TRO, V38, P264, DOI 10.1590/S0037-86822005000300013
   Sneath P.H.A., 1973, NUMERICAL TAXONOMY P
   Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2
   Wang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047051
NR 40
TC 0
Z9 0
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1672-9609
EI 1744-7917
J9 INSECT SCI
JI Insect Sci.
PD OCT
PY 2019
VL 26
IS 5
BP 873
EP 880
DI 10.1111/1744-7917.12578
PG 8
WC Entomology
SC Entomology
GA IC5EV
UT WOS:000470991300008
PM 29442435
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wei, WJ
   Shi, B
   Guan, X
   Ma, JY
   Wang, YC
   Liu, J
AF Wei, Wen-Juan
   Shi, Bei
   Guan, Xin
   Ma, Jing-Yun
   Wang, Ya-Chen
   Liu, Jing
TI Mapping theme trends and knowledge structures for human neural stem
   cells: a quantitative and co-word biclustering analysis for the
   2013-2018 period
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; human neural stem cells; PubMed; bibliometric
   analysis; biclustering analysis; co-word analysis; strategic diagram
   analysis; social network analysis; hot research topics; mapping theme
   trends; knowledge structures; neural regeneration
ID HIPPOCAMPAL NEUROGENESIS; NEURONS; GENERATION; EXPRESSION; GROWTH;
   INJURY
AB Neural stem cells, which are capable of multi-potential differentiation and self-renewal, have recently been shown to have clinical potential for repairing central nervous system tissue damage. However, the theme trends and knowledge structures for human neural stem cells have not yet been studied bibliometrically. In this study, we retrieved 2742 articles from the PubMed database from 2013 to 2018 using "Neural Stem Cells" as the retrieval word. Co-word analysis was conducted to statistically quantify the characteristics and popular themes of human neural stem cell-related studies. Bibliographic data matrices were generated with the Bibliographic Item Co-Occurrence Matrix Builder. We identified 78 high-frequency Medical Subject I leading (MeSH) terms. A visual matrix was built with the repeated bisection method in gCLUTO software. A social network analysis network was generated with Ucinet 6.0 software and GraphPad Prism 5 software. The analyses demonstrated that in the 6-year period, hot topics were clustered into five categories. As suggested by the constructed strategic diagram, studies related to cytology and physiology were well-developed, whereas those related to neural stem cell applications, tissue engineering, metabolism and cell signaling, and neural stem cell pathology and virology remained immature. Neural stem cell therapy for stroke and Parkinson's disease, the genetics of microRNAs and brain neoplasms, as well as neuroprotective agents, Zika virus, Notch receptor, neural crest and embryonic stem cells were identified as emerging hot spots. These undeveloped themes and popular topics are potential points of focus for new studies on human neural stem cells.
C1 [Wei, Wen-Juan; Guan, Xin; Ma, Jing-Yun; Wang, Ya-Chen; Liu, Jing] Dalian Med Univ, Affiliated Hosp 1, Stem Cell Clin Res Ctr, Dalian, Liaoning, Peoples R China.
   [Wei, Wen-Juan; Guan, Xin; Ma, Jing-Yun; Wang, Ya-Chen; Liu, Jing] Dalian Med Univ, Affiliated Hosp 1, Natl Joint Engn Lab, Dalian, Liaoning, Peoples R China.
   [Shi, Bei] China Med Univ, Dept Physiol, Shenyang, Liaoning, Peoples R China.
RP Liu, J (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Stem Cell Clin Res Ctr, Dalian, Liaoning, Peoples R China.; Liu, J (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Natl Joint Engn Lab, Dalian, Liaoning, Peoples R China.
EM liujing.dlrmc@hotmail.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81471308]; Stem Cell Clinical Research Project in
   China [CMR-20161129-1003]; Innovation Technology Funding of Dalian in
   China [2018J11CY025]
FX This study was supported by the National Natural Science Foundation of
   China, No. 81471308 (to JL); the Stem Cell Clinical Research Project in
   China, No. CMR-20161129-1003 (to JL); the Innovation Technology Funding
   of Dalian in China, No. 2018J11CY025 (to JL). The funding sources had no
   role in manuscript conception and design, data analysis or
   interpretation, paper writing or deciding to submit this paper for
   publication.
CR Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365
   Adams KV, 2018, PROG NEUROBIOL, V170, P2, DOI 10.1016/j.pneurobio.2018.06.005
   Beclin C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35729
   Begum AN, 2015, STEM CELL RES, V15, P731, DOI 10.1016/j.scr.2015.10.014
   Bergstrom T, 2012, UPSALA J MED SCI, V117, P132, DOI 10.3109/03009734.2012.665096
   Bhagat R, 2018, CELL DEATH DIFFER, V25, P1837, DOI 10.1038/s41418-018-0163-y
   Bian S, 2013, CURR OPIN NEUROBIOL, V23, P928, DOI 10.1016/j.conb.2013.08.002
   Boese AC, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0913-2
   Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015
   CALLON M, 1991, SCIENTOMETRICS, V22, P155, DOI 10.1007/BF02019280
   D'Aiuto L, 2014, ORGANOGENESIS, V10, P365, DOI 10.1080/15476278.2015.1011921
   Donohue JC, 1974, UNDERSTANDING SCI LI, P101
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044
   Ferreira AC, 2018, NEUROSCI BIOBEHAV R, V95, P73, DOI 10.1016/j.neubiorev.2018.09.014
   Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364
   Gkikas D, 2017, CELL MOL LIFE SCI, V74, P4097, DOI 10.1007/s00018-017-2571-4
   HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710
   Hong Y, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0403-5
   Howe JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177661
   Viedma-Del-Jesus MI, 2011, PSYCHOPHYSIOLOGY, V48, P1029, DOI 10.1111/j.1469-8986.2011.01171.x
   Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X
   Kanojia D, 2015, STEM CELLS, V33, P2985, DOI 10.1002/stem.2109
   Knobloch M, 2017, CURR OPIN NEUROBIOL, V42, P45, DOI 10.1016/j.conb.2016.11.006
   Li F, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3326
   Li HY, 2009, J ALTERN COMPLEM MED, V15, P779, DOI 10.1089/acm.2008.0594
   Li ZQ, 2016, STEM CELL REP, V7, P483, DOI 10.1016/j.stemcr.2016.07.013
   Liu Y, 2015, INT J CLIN EXP PATHO, V8, P3835
   Ludwig PE, 2018, NEURAL REGEN RES, V13, P7, DOI 10.4103/1673-5374.224361
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Metz MZ, 2013, STEM CELL TRANSL MED, V2, P983, DOI 10.5966/sctm.2012-0177
   Mooney R, 2018, STEM CELL TRANSL MED, V7, P740, DOI 10.1002/sctm.18-0003
   Navarro Quiroz E, 2018, CELL, V7, pE75
   Portnow J, 2017, CLIN CANCER RES, V23, P2951, DOI 10.1158/1078-0432.CCR-16-1518
   Pourabdolhossein F, 2017, GLIA, V65, P756, DOI 10.1002/glia.23124
   Radhakrishnan B, 2016, J EXP NEUROSCI, V10, P101, DOI 10.4137/JEN.S32843
   Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657
   Rasmussen M, 2004, 04021 CSEUMN TR
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002
   Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Song J, 2016, YONSEI MED J, V57, P1461, DOI 10.3349/ymj.2016.57.6.1461
   Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975
   Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002
   Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5
   Tsan YC, 2016, STEM CELL RES, V17, P238, DOI 10.1016/j.scr.2016.07.003
   Umeda K, 2016, ONCOL LETT, V11, P856, DOI 10.3892/ol.2015.3928
   Velasco I, 2014, STEM CELLS, V32, P2811, DOI 10.1002/stem.1782
   Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689
   Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237
   Wang J, 2018, ZHONGGUO ZUZHI GONGC, V22, P3381
   Yao Q, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-26
   Yin ZM, 2012, NEURAL REGEN RES, V7, P2624, DOI 10.3969/j.issn.1673-5374.2012.33.008
   Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616
   Zhang CC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-52
NR 56
TC 1
Z9 1
U1 4
U2 37
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD OCT
PY 2019
VL 14
IS 10
BP 1823
EP 1832
AR PMID 31169201
DI 10.4103/1673-5374.257535
PG 10
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA IC3YT
UT WOS:000470900400030
PM 31169201
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giordano, BV
   Gasparotto, A
   Liang, P
   Nelder, MP
   Russell, C
   Hunter, FF
AF Giordano, B. V.
   Gasparotto, A.
   Liang, P.
   Nelder, M. P.
   Russell, C.
   Hunter, F. F.
TI Discovery of an Aedes (Stegomyia) albopictus population and first
   records of Aedes (Stegomyia) aegypti in Canada
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; invasive species; new record; range
   expansion; vector
ID UNITED-STATES; DIPTERA; MOSQUITOS; CULICIDAE; VIRUS; CHECKLIST; ONTARIO
AB A population of Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae), a vector of chikungunya, dengue, yellow fever, and Zika and West Nile viruses, has been detected in Windsor, Ontario, Canada from 2016 onwards. Here, we describe its seasonal distribution, as well as the various aquatic habitats from which this species was collected and its larval co-habitation. We collected immatures from tires, treeholes, extruded polystyrene foam containers, discarded plastic cups, old recycling bins and oviposition traps. Aedes albopictus larvae were collected with Aedes japonicus (Theobald), Anopheles punctipennis (Say), Culex pipiens Linnaeus, Ochlerotatus hendersoni (Cockerell), Ochlerotatus triseriatus (Say) and Orthopodomyia signifera (Coquillett). Adult female and male specimens were collected from Biogents sentinel traps (Biogents AG, Regensburg, Germany), as well as Centers for Disease Control and Prevention miniature light traps (CDC, Atlanta, GA, U.S.A.), and also as they alighted on the investigators. Peak adult collections occurred in September during epidemiological week 37. We also collected Aedes (Stegomyia) aegypti (Linnaeus), a new record for Canada, in 2016 and from two new collection sites in 2017. The 2017 collections were 3.5 km north and 19.4 km south of the index site. The present study adds to the increasing number of studies reporting range expansions of these mosquito species.
C1 [Giordano, B. V.; Liang, P.; Hunter, F. F.] Brock Univ, Ctr Vector Borne Dis, St Catharines, ON, Canada.
   [Giordano, B. V.; Liang, P.; Hunter, F. F.] Brock Univ, Ctr Biotechnol, St Catharines, ON, Canada.
   [Giordano, B. V.; Gasparotto, A.; Hunter, F. F.] Entomogen Inc, St Catharines, ON, Canada.
   [Liang, P.; Hunter, F. F.] Brock Univ, Dept Biol Sci, 1812 Sir Isaac Brock Way, St Catharines, ON L2R 1T3, Canada.
   [Nelder, M. P.; Russell, C.] Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis Unit, Toronto, ON, Canada.
RP Hunter, FF (corresponding author), Brock Univ, Dept Biol Sci, 1812 Sir Isaac Brock Way, St Catharines, ON L2R 1T3, Canada.
EM fhunter@brocku.ca
CR Armstrong PM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005623
   BONNET DD, 1946, AM J TROP MED, V26, P465, DOI 10.4269/ajtmh.1946.s1-26.465
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CHRISTOPHERS SR, 1960, AEDES AEGYPTI YELLOW
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   EADS RB, 1972, MOSQ NEWS, V32, P113
   Elliott K.A., 1988, FOREST CHRON, V74, P850
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Farajollahi A, 2012, J AM MOSQUITO CONTR, V28, P237, DOI 10.2987/12-6229R.1
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1
   Government of Canada, 2017, HIST CLIM DAT
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Madon MB, 2003, J AM MOSQUITO CONTR, V19, P297
   Michigan Department of Health and Human Services, 2017, MICH DIS MAPP
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314
   Nayar JK, 1999, J MED ENTOMOL, V36, P441, DOI 10.1093/jmedent/36.4.441
   Nelson M.J., 1986, AEDES AEGYPTI BIOL E
   Ohio Department of Health, 2017, ZOON DIS PROGR
   Public Health Ontario, 2019, W NIL VIR DAT VECT B
   REITER P, 1984, MOSQ NEWS, V44, P396
   Richards N.R., 1949, SOIL SURVEY ESSEX CO, V11
   Sanchez-Vargas I, 2019, INSECTS, V10, DOI 10.3390/insects10020039
   Snow Keith, 2002, Biologist (London), V49, P49
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Thielman A, 2006, J MED ENTOMOL, V43, P138, DOI 10.1603/0022-2585(2006)043[0138:EOOJDC]2.0.CO;2
   Thielman A., 2007, CANADIAN J ARTHROPOD, P4, DOI 10.3752/cjai.2007.04
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 36
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD MAR
PY 2020
VL 34
IS 1
BP 10
EP 16
DI 10.1111/mve.12408
EA SEP 2019
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA KH2NY
UT WOS:000488154200001
PM 31566765
DA 2020-07-08
ER

PT J
AU Beachboard, DC
   Park, M
   Vijayan, M
   Snider, DL
   Fernando, DJ
   Williams, GD
   Stanley, S
   McFadden, MJ
   Horner, SM
AF Beachboard, Dia C.
   Park, Moonhee
   Vijayan, Madhuvanthi
   Snider, Daltry L.
   Fernando, Dillon J.
   Williams, Graham D.
   Stanley, Sydney
   McFadden, Michael J.
   Horner, Stacy M.
TI The small GTPase RAB1B promotes antiviral innate immunity by interacting
   with TNF receptor?associated factor 3 (TRAF3)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE interferon; innate immunity; RNA virus; flavivirus; antiviral agent;
   MAVS; RAB1B; TRAF3
ID INTERFERON REGULATORY FACTOR-3; RIG-I; ENDOPLASMIC-RETICULUM; UBIQUITIN
   LIGASE; BETA PROMOTER; ACTIVATION; RESPONSES; TBK1; RECOGNITION;
   AUTOPHAGY
AB Innate immune detection of viral nucleic acids during viral infection activates a signaling cascade that induces type I and type III IFNs as well as other cytokines, to generate an antiviral response. This signaling is initiated by pattern recognition receptors, such as the RNA helicase retinoic acid-inducible gene I (RIG-I), that sense viral RNA. These sensors then interact with the adaptor protein mitochondrial antiviral signaling protein (MAVS), which recruits additional signaling proteins, including TNF receptor?associated factor 3 (TRAF3) and TANK-binding kinase 1 (TBK1), to form a signaling complex that activates IFN regulatory factor 3 (IRF3) for transcriptional induction of type I IFNs. Here, using several immunological and biochemical approaches in multiple human cell types, we show that the GTPase-trafficking protein RAB1B up-regulates RIG-I pathway signaling and thereby promotes IFN-? induction and the antiviral response. We observed that RAB1B overexpression increases RIG-I?mediated signaling to IFN-? and that RAB1B deletion reduces signaling of this pathway. Additionally, loss of RAB1B dampened the antiviral response, indicated by enhanced Zika virus infection of cells depleted of RAB1B. Importantly, we identified the mechanism of RAB1B action in the antiviral response, finding that it forms a protein complex with TRAF3 to facilitate the interaction of TRAF3 with mitochondrial antiviral signaling protein. We conclude that RAB1B regulates TRAF3 and promotes the formation of innate immune signaling complexes in response to nucleic acid sensing during RNA virus infection.
C1 [Beachboard, Dia C.; Park, Moonhee; Vijayan, Madhuvanthi; Snider, Daltry L.; Fernando, Dillon J.; Williams, Graham D.; Stanley, Sydney; McFadden, Michael J.; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 213 Res Dr,Box 3053 DUMC, Durham, NC 27710 USA.
   [Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
RP Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 213 Res Dr,Box 3053 DUMC, Durham, NC 27710 USA.
EM stacy.horner@duke.edu
OI McFadden, Michael/0000-0003-0303-6968; Stanley,
   Sydney/0000-0001-6386-2415; Williams, Graham/0000-0003-3387-4356;
   Horner, Stacy/0000-0002-9351-7409
FU NIAID, National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [K22 AI100935]; NCI,
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [T32-CA009111]; American Cancer SocietyAmerican Cancer
   Society [131321-PF-17-188-01-MPC]; Burroughs Wellcome FundBurroughs
   Wellcome Fund [1016810]; Duke Bridge Award
FX This work was supported by NIAID, National Institutes of Health Grant
   K22 AI100935 (to S. M. H.) and NCI, National Institutes of Health Grant
   T32-CA009111 (to D. C. B.). This work was also supported by American
   Cancer Society Postdoctoral Fellowship 131321-PF-17-188-01-MPC (to
   D.C.B.), Burroughs Wellcome Fund Grant 1016810 (to S. M. H), and a Duke
   Bridge Award (to S. M. H.). The authors declare that they have no
   conflicts of interest with the contents of this article. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392
   Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625
   Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240
   Cantell K, 1981, Methods Enzymol, V78, P29
   Chiang C, 2017, TRENDS IMMUNOL, V38, P39, DOI 10.1016/j.it.2016.10.008
   Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Fang R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006720
   Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921
   Fredericksen B, 2002, VIRAL IMMUNOL, V15, P29, DOI 10.1089/088282402317340215
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Galvez T, 2012, CELL, V151, P234, DOI 10.1016/j.cell.2012.09.013
   Gillingham AK, 2014, DEV CELL, V31, P358, DOI 10.1016/j.devcel.2014.10.007
   Horner SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117963
   Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108
   Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010
   Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009
   Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112
   Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792
   Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   McFadden MJ, 2017, CURR OPIN VIROL, V22, P36, DOI 10.1016/j.coviro.2016.11.012
   Miao YX, 2017, CELL HOST MICROBE, V22, P330, DOI 10.1016/j.chom.2017.08.002
   Miao YX, 2016, IMMUNITY, V45, P94, DOI 10.1016/j.immuni.2016.06.023
   Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008
   Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200
   Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2
   PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31
   Pourcelot M, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0292-z
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Rustagi A, 2013, METHODS, V59, P225, DOI 10.1016/j.ymeth.2012.05.011
   Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847
   Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Takahama M, 2017, CELL REP, V20, P2944, DOI 10.1016/j.celrep.2017.08.085
   van Zuylen WJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002747
   Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044
   Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107
   Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027
   Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674
NR 54
TC 2
Z9 2
U1 2
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 27
PY 2019
VL 294
IS 39
BP 14231
EP 14240
DI 10.1074/jbc.RA119.007917
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JQ9HH
UT WOS:000499248200007
PM 31375559
DA 2020-07-08
ER

PT J
AU Ayala-Nunez, NV
   Follain, G
   Delalande, F
   Hirschler, A
   Partiot, E
   Hale, GL
   Bollweg, BC
   Roels, J
   Chazal, M
   Bakoa, F
   Carocci, M
   Bourdoulous, S
   Faklaris, O
   Zaki, SR
   Eckly, A
   Uring-Lambert, B
   Doussau, F
   Cianferani, S
   Carapito, C
   Jacobs, FMJ
   Jouvenet, N
   Goetz, JG
   Gaudin, R
AF Ayala-Nunez, Nilda Vanesa
   Follain, Gautier
   Delalande, Franois
   Hirschler, Aurlie
   Partiot, Emma
   Hale, Gillian L.
   Bollweg, Brigid C.
   Roels, Judith
   Chazal, Maxime
   Bakoa, Florian
   Carocci, Margot
   Bourdoulous, Sandrine
   Faklaris, Orestis
   Zaki, Sherif R.
   Eckly, Anita
   Uring-Lambert, Batrice
   Doussau, Frdric
   Cianferani, Sarah
   Carapito, Christine
   Jacobs, Frank M. J.
   Jouvenet, Nolwenn
   Goetz, Jacky G.
   Gaudin, Raphael
TI Zika virus enhances monocyte adhesion and transmigration favoring viral
   dissemination to neural cells
SO NATURE COMMUNICATIONS
LA English
DT Article
ID HUMAN ENDOTHELIAL-CELLS; BLOOD-BRAIN-BARRIER; TROJAN HORSE; INFECTION;
   EXTRAVASATION; REPLICATION; PERSISTENCE; ACTIVATION; ORGANOIDS; SOFTWARE
AB Zika virus (ZIKV) invades and persists in the central nervous system (CNS), causing severe neurological diseases. However the virus journey, from the bloodstream to tissues through a mature endothelium, remains unclear. Here, we show that ZIKV-infected monocytes represent suitable carriers for viral dissemination to the CNS using human primary monocytes, cerebral organoids derived from embryonic stem cells, organotypic mouse cerebellar slices, a xenotypic human-zebrafish model, and human fetus brain samples. We find that ZIKV-exposed monocytes exhibit higher expression of adhesion molecules, and higher abilities to attach onto the vessel wall and transmigrate across endothelia. This phenotype is associated to enhanced monocyte-mediated ZIKV dissemination to neural cells. Together, our data show that ZIKV manipulates the monocyte adhesive properties and enhances monocyte transmigration and viral dissemination to neural cells. Monocyte transmigration may represent an important mechanism required for viral tissue invasion and persistence that could be specifically targeted for therapeutic intervention.
C1 [Ayala-Nunez, Nilda Vanesa; Partiot, Emma; Gaudin, Raphael] Univ Montpellier, CNRS, IRIM, F-34293 Montpellier, France.
   [Ayala-Nunez, Nilda Vanesa; Gaudin, Raphael] Univ Strasbourg, INSERM, F-67000 Strasbourg, France.
   [Follain, Gautier; Goetz, Jacky G.] INSERM U1109, F-67000 Strasbourg, France.
   [Follain, Gautier; Goetz, Jacky G.] FMTS, F-67000 Strasbourg, France.
   [Delalande, Franois; Hirschler, Aurlie; Cianferani, Sarah; Carapito, Christine] Univ Strasbourg, ECPM, CNRS, Lab Spectrometrie Masse Bioorgan,IPHC,UMR 7178, F-67087 Strasbourg, France.
   [Hale, Gillian L.; Bollweg, Brigid C.; Zaki, Sherif R.] Ctr Dis Control & Prevent, NCEZID, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, 1600 Clifton Rd NE,MS G32, Atlanta, GA 30329 USA.
   [Roels, Judith; Jacobs, Frank M. J.] Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.
   [Chazal, Maxime; Bakoa, Florian; Jouvenet, Nolwenn] Inst Pasteur, Virol Dept, CNRS UMR3569, Viral Genom & Vaccinat Unit, F-75015 Paris, France.
   [Carocci, Margot; Eckly, Anita] Univ Strasbourg, INSERM, EFS Grand Est, BPPS UMR 51255,FMTS, F-67000 Strasbourg, France.
   [Bourdoulous, Sandrine] Univ Paris 05, CNRS UMR8104, Inst Cochin, INSERM U1016, Paris, France.
   [Faklaris, Orestis] CNRS UMS 3426, MRI Core Facil, Biocampus, F-34293 Montpellier, France.
   [Uring-Lambert, Batrice] Hop Univ Strasbourg, Lab Cent Immunol, F-67000 Strasbourg, France.
   [Doussau, Frdric] Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integratives, F-67000 Strasbourg, France.
RP Gaudin, R (corresponding author), Univ Montpellier, CNRS, IRIM, F-34293 Montpellier, France.; Gaudin, R (corresponding author), Univ Strasbourg, INSERM, F-67000 Strasbourg, France.
EM raphael.gaudin@irim.cnrs.fr
RI ; Jacobs, Frank/O-1809-2014
OI CHAZAL, Maxime/0000-0002-3144-5032; GOETZ, Jacky/0000-0003-2842-8116;
   Ayala Nunez, Nilda Vanesa/0000-0001-8401-8723; Jacobs,
   Frank/0000-0003-4423-1479; gaudin, raphael/0000-0002-8558-8143;
   jouvenet, nolwenn/0000-0001-6103-6048
FU French National Research AgencyFrench National Research Agency (ANR)
   [ANR-10INBS-04]; French State via the French National Research Agency
   (ANR) as part of the program Investissements d'avenir (IdEx Universite
   de Strasbourg)French National Research Agency (ANR); ATIPAVENIR starting
   grant; European UnionEuropean Union (EU) [PCOFUND-GA-2013609102]; French
   Agency for Research on AIDS and Viral Hepatitis (ANRS)ANRSFrench
   National Research Agency (ANR); Plan Cancer (OptoMetaTrap); Ligue contre
   le CancerLigue nationale contre le cancer; Idex Attractivites
   (University of Strasbourg); INSERMInstitut National de la Sante et de la
   Recherche Medicale (Inserm); French Proteomic Infrastructure (ProFI)
   [ANR-10-INBS-08-03]; ANRT (Association Nationale de la Recherche et de
   la Technologie)French National Research Agency (ANR); Agence Nationale
   pour la RechercheFrench National Research Agency (ANR)
   [ANR-16-CE15-002501]; Centre National de la Recherche Scientifique
   (CNRS)Centre National de la Recherche Scientifique (CNRS); Institut
   Pasteur; University of Strasbourg
FX We thank Dr. Philippe Benaroch for his critical reading of our study,
   Lucie Klughertz for her technical support, and Dr. Camille Ducloy for
   her helpful insights on flow cytometry techniques. We acknowledge the
   imaging facility MRI, a member of the national infrastructure
   France-BioImaging supported by the French National Research Agency
   (ANR-10INBS-04, Investissements d'avenir). This work has received
   funding from the French State via the French National Research Agency
   (ANR) as part of the program Investissements d'avenir (IdEx Universite
   de Strasbourg) to RG. This work was supported by an ATIPAVENIR starting
   grant to RG. The research leading to these results has received funding
   from the People Program (Marie Curie Actions) of the European Union's
   Seventh Framework Program (FP7/2007-2013) under REA grant agreement no.
   PCOFUND-GA-2013609102, through the PRESTIGE program coordinated by
   Campus France, and from the French Agency for Research on AIDS and Viral
   Hepatitis (ANRS), both attributed to NVAN. Experiments conducted by G.F.
   and J.G.G. were funded by Plan Cancer (OptoMetaTrap), Ligue contre le
   Cancer, Idex Attractivites (University of Strasbourg), and by
   institutional funds from INSERM and University of Strasbourg. G.F. was
   supported by a doctoral fellowship from Ligue Contre le Cancer. Mass
   spectrometry experiments were supported by the French Proteomic
   Infrastructure (ProFI; ANR-10-INBS-08-03). F.B. is a recipient of a PhD
   grant provided by ANRT (Association Nationale de la Recherche et de la
   Technologie). N.J. is funded by Agence Nationale pour la Recherche
   (ANR-16-CE15-002501), Centre National de la Recherche Scientifique
   (CNRS), and Institut Pasteur. CDC contributions to this paper written
   and edited by G.L.H. and B.C.B. in their private capacity. No official
   support or endorsement by the Centers for Disease Control and
   Prevention, Department of Health and Human Services is intended, nor
   should be inferred. All authors read, provided feedback, and approved
   the paper. The findings and conclusions in this report are those of the
   authors and do not necessarily represent the official position of the
   Centers for Disease Control and Prevention. The following reagent was
   obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID,
   NIH: HIV-1 NL4-3 AD8 Infectious Molecular Clone (pNL(AD8)) from Dr. Eric
   O. Freed (cat#11346).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Antoine TE, 2014, ZEBRAFISH, V11, P17, DOI 10.1089/zeb.2013.0920
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Benjamin DC, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3647-0
   Bergmann S, 2018, NAT PROTOC, V13, P2827, DOI 10.1038/s41596-018-0066-x
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068
   Carapito C, 2014, PROTEOMICS, V14, P1014, DOI 10.1002/pmic.201300415
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Chou YY, 2016, J VIROL, V90, P4494, DOI 10.1128/JVI.00103-16
   Coulter ME, 2018, CELL REP, V24, P973, DOI 10.1016/j.celrep.2018.06.100
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936
   Doussau F, 2017, EXPERT OPIN DRUG DIS, V12, P1011, DOI 10.1080/17460441.2017.1356285
   Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33
   Faraco G, 2017, J MOL MED, V95, P1143, DOI 10.1007/s00109-017-1573-x
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051
   Follain G, 2018, DEV CELL, V45, P33, DOI 10.1016/j.devcel.2018.02.015
   Follain Gautier, 2018, Methods Mol Biol, V1749, P195, DOI 10.1007/978-1-4939-7701-7_15
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995
   Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147
   Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421
   Ginhoux F, 2018, NAT NEUROSCI, V21, P897, DOI 10.1038/s41593-018-0176-3
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Lancaster MA, 2018, NAT BIOTECHNOL, V36, P407, DOI 10.1038/nbt.4133
   Laval K, 2015, J VIROL, V89, P10912, DOI 10.1128/JVI.01589-15
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li ZL, 2016, ACTA PHARMACOL SIN, V37, P1121, DOI 10.1038/aps.2016.59
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Palha N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003619
   Passoni G, 2017, DIS MODEL MECH, V10, P847, DOI 10.1242/dmm.029231
   Paul AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04839-7
   Paul CD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38186-y
   PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tiong V, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02747
   Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Weksler BB, 2005, FASEB J, V19, P1872
   Wieczorek Samuel, 2019, Methods Mol Biol, V1959, P225, DOI 10.1007/978-1-4939-9164-8_15
   Wieczorek S, 2017, BIOINFORMATICS, V33, P135, DOI 10.1093/bioinformatics/btw580
   Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394
   Wioland L, 2015, CELL MICROBIOL, V17, P369, DOI 10.1111/cmi.12373
   Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293
   Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435
   Yoshikawa FSY, 2019, J INFECT DIS, V220, P32, DOI 10.1093/infdis/jiz075
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoshida H, 2000, BLOOD, V96, P234, DOI 10.1182/blood.V96.1.234.013k06_234_241
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 81
TC 2
Z9 2
U1 3
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 27
PY 2019
VL 10
AR 4430
DI 10.1038/s41467-019-12408-x
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JB0HL
UT WOS:000488233300010
PM 31562326
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Si, LL
   Meng, Y
   Tian, F
   Li, WH
   Zou, P
   Wang, Q
   Xu, W
   Wang, YZ
   Xia, MJ
   Hu, JY
   Jiang, SB
   Lu, L
AF Si, Lulu
   Meng, Yu
   Tian, Fang
   Li, Weihua
   Zou, Peng
   Wang, Qian
   Xu, Wei
   Wang, Yuzhu
   Xia, Minjie
   Hu, Jingying
   Jiang, Shibo
   Lu, Lu
TI A Peptide-Based Virus Inactivator Protects Male Mice Against Zika
   Virus-Induced Damage of Testicular Tissue
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE inactivator; peptide; Zika virus; testicular tissue damage; sperm
ID BLOOD-TESTIS BARRIER; SEXUAL TRANSMISSION; INFECTION; SEMEN;
   NEUTRALIZATION; PERSISTENCE; MECHANISM; ANTIBODY
AB Zika virus (ZIKV) was a re-emerging arbovirus associated with Guillain-Barre Syndrome in adult and congenital Zika syndrome in fetus and infant. Although ZIKV was mainly transmitted by mosquito bites, many sexual transmission cases have been reported since the outbreak in 2015. ZIKV can persist in testis and semen for a long time, causing testicular tissue damage and reducing sperm quality. However, no drug has been approved for prevention or treatment of ZIKV infection, especially infection in male testicular tissue. Previously reported peptide Z2 could inactivate ZIKV, inhibiting ZIKV infection in vitro and in vivo. Importantly, Z2 could inhibit vertical transmission of ZIKV in pregnant mice, reducing ZIKV infection in fetus. Here we showed that intraperitoneally administered Z2 could also be distributed to testis and epididymis, resulting in the reduction of ZIKV RNA copies in testicular tissue and protection of testis and epididymis against ZIKV-induced pathological damage and poor sperm quality in type I interferon receptor-deficient A129 mice. Thus, Z2, a ZIKV inactivator, could serve as an antiviral agent for treatment of ZIKV infection and attenuation of ZIKV-induced testicular tissue damage.
C1 [Si, Lulu; Meng, Yu; Zou, Peng; Wang, Qian; Xu, Wei; Jiang, Shibo; Lu, Lu] Fudan Univ, Key Lab Med Mol Virol MOE NHC CAMS, Sch Basic Med Sci, Shanghai, Peoples R China.
   [Si, Lulu; Meng, Yu; Zou, Peng; Wang, Qian; Xu, Wei; Jiang, Shibo; Lu, Lu] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   [Tian, Fang; Li, Weihua; Wang, Yuzhu; Xia, Minjie; Hu, Jingying; Jiang, Shibo] Fudan Univ, NHC Key Lab Reprod Regulat, Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China.
   [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
RP Jiang, SB; Lu, L (corresponding author), Fudan Univ, Key Lab Med Mol Virol MOE NHC CAMS, Sch Basic Med Sci, Shanghai, Peoples R China.; Jiang, SB; Lu, L (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Hu, JY; Jiang, SB (corresponding author), Fudan Univ, NHC Key Lab Reprod Regulat, Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China.; Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
EM hujingying@aliyun.com; shibojiang@fudan.edu.cn; lul@fudan.edu.cn
RI Lu, Lu/K-7070-2014
OI Lu, Lu/0000-0002-2255-0391
FU National Megaprojects of China for Major Infectious Diseases
   [2018ZX10301403]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81661128041, 81672019, 81822045,
   81630090, 81701998, 81703571]; Sanming Project of Medicine in Shenzhen;
   National Key Research and Development Program of China [2016YFC1000905];
   Shanghai Municipal Science and Technology Committee [18431900200]
FX This work was supported by the National Megaprojects of China for Major
   Infectious Diseases (2018ZX10301403 to LL), the National Natural Science
   Foundation of China (81661128041, 81672019, and 81822045 to LL; 81630090
   to SJ; 81701998 to QW; and 81703571 to WX), the Sanming Project of
   Medicine in Shenzhen (to SJ), the National Key Research and Development
   Program of China (2016YFC1000905), and the Shanghai Municipal Science
   and Technology Committee (18431900200).
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   de La Vega MA, 2019, J INFECT DIS, V219, P365, DOI 10.1093/infdis/jiy336
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Gao GF, 2018, CELL, V172, P1157, DOI 10.1016/j.cell.2018.02.025
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989
   Gorshkov K, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03252
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Knee RA, 2005, BIOL REPROD, V73, P688, DOI 10.1095/biolreprod.105.041079
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Nelson EJ, 2019, J COMMUN HEALTH, V44, P377, DOI 10.1007/s10900-018-0594-x
   Peixoto HM, 2019, T ROY SOC TROP MED H, V113, P252, DOI 10.1093/trstmh/trz010
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Strange DP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0080-7
   Su LL, 2011, J ENDOCRINOL, V208, P207, DOI 10.1677/JOE-10-0363
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang L, 2019, CELL REP, V26, P3360, DOI 10.1016/j.celrep.2019.02.062
   Wei XD, 2018, ONCOTARGET, V9, P1542, DOI 10.18632/oncotarget.23457
   Xia S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4580
   Yarrington Christina D, 2019, Fertil Res Pract, V5, P1, DOI 10.1186/s40738-018-0053-5
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 54
TC 1
Z9 1
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 27
PY 2019
VL 10
AR 2250
DI 10.3389/fmicb.2019.02250
PG 13
WC Microbiology
SC Microbiology
GA JA7LX
UT WOS:000488026200001
PM 31611865
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Amaral, P
   de Carvalho, LR
   Rocha, TAH
   da Silva, NC
   Vissoci, JRN
AF Amaral, Pedro
   de Carvalho, Lucas Resende
   Hernandes Rocha, Thiago Augusto
   da Silva, Nubia Cristina
   Nickenig Vissoci, Joao Ricardo
TI Geospatial modeling of microcephaly and zika virus spread patterns in
   Brazil
SO PLOS ONE
LA English
DT Article
ID HEALTH
AB Microcephaly and Zika Virus infection (ZIKV) were declared Public Health Emergencies of International Concern by the World Health Organization in 2016. Brazil was considered the epicenter of the outbreak. However, the occurrence of both ZIKV and microcephaly in Brazil was not evenly distributed across the country. To better understand this phenomenon, we investigate regional characteristics at the municipal level that can be associated with the incidence of microcephaly, our response variable, and its relationship with ZIKV and other predictors. All epidemiological data in this study was provided by the Ministry of Health official database (DATASUS). Microcephaly was only confirmed after birth and the diagnostic was made regardless of the mother's ZIKV status. Using exploratory spatial data analysis and spatial autoregressive Tobit models, our results show that microcephaly incidence is significantly, at 95% confidence level, related not only to ZIKV, but also to access to primary care, population size, gross national product, mobility and environmental attributes of the municipalities. There is also a significant spatial autocorrelation of the dependent variable. The results indicate that municipalities that show a high incidence of microcephaly tend to be clustered in space and that incidence of microcephaly varies considerably across regions when correlated only with ZIKV, i.e. that ZIKV alone cannot explain the differences in microcephaly across regions and their correlation is mediated by regional attributes.
C1 [Amaral, Pedro; de Carvalho, Lucas Resende] Univ Fed Minas Gerais, Ctr Dev & Reg Planning, CEDEPLAR UFMG, Belo Horizonte, MG, Brazil.
   [Hernandes Rocha, Thiago Augusto] PAHO WHO, Brasilia, DF, Brazil.
   [Hernandes Rocha, Thiago Augusto; da Silva, Nubia Cristina] Univ Fed Minas Gerais, Ctr Higher Studies & Res Adm, CEPEAD UFMG, Belo Horizonte, MG, Brazil.
   [Nickenig Vissoci, Joao Ricardo] Duke Univ, Duke Sch Med, Dept Surg, Div Emergency Med, Durham, NC USA.
RP Amaral, P (corresponding author), Univ Fed Minas Gerais, Ctr Dev & Reg Planning, CEDEPLAR UFMG, Belo Horizonte, MG, Brazil.
EM pedroamaral@cedeplar.ufmg.br
RI Carvalho, Lucas/AAB-7031-2019
OI Carvalho, Lucas/0000-0002-3618-3967
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX This research was funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brazil. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amaral PV, 2014, PAP REG SCI, V93, DOI 10.1111/pirs.12034
   Amemiya T., 1985, ADV ECONOMETRICS
   Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brasil-SINAN/SUS. Ministry of Health, 2019, SUST INF AGR NOT SI
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   ESRI, 2014, ARCGIS DESKT
   European Centre for Disease Prevention and Control, 2017, CURR ZIK TRANSM WORL
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gelman A., 1995, BAYESIAN DATA ANAL
   IBGE, 2013, PROD INT BRUT MUN
   IBGE, 2016, EST POP
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Kesrouani A, 2001, EARLY HUM DEV, V63, P79, DOI 10.1016/S0378-3782(01)00123-2
   Laguardia J, 2004, EPIDEMIOL SERV SAUDE, V13, P135, DOI DOI 10.5123/S1679-49742004000300002
   LeSage J, 2009, STAT TEXTB MONOGR, P1
   LOWRES N, 2019, PLOS MED, V16, DOI DOI 10.1371/JOURNAL.PMED.1002755
   Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3
   Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, P1
   ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Ribeiro LC de Q, 2013, IBEU MUNICIPAL INDIC
   TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382
   Vissoci JRN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006392
   Wilhelm S, 2013, R J, V5, P130
   World Health Organization, 2016, ZIK VIR COMPL PUBL H
   Xavier DR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00186615, 10.1590/0102-311x00186615]
NR 29
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2019
VL 14
IS 9
AR e0222668
DI 10.1371/journal.pone.0222668
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LM6FU
UT WOS:000532345500027
PM 31557165
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira, AS
   Gazolla, PAR
   Oliveira, AFCD
   Pereira, WL
   Viol, LCD
   Maia, AFD
   Santos, EG
   da Silva, IEP
   Mendes, TAD
   da Silva, AM
   Dias, RS
   da Silva, CC
   Poleto, MD
   Teixeira, RR
   de Paula, SO
AF de Oliveira, Andre S.
   Gazolla, Poliana A. R.
   Oliveira, Ana Flavia C. da S.
   Pereira, Wagner L.
   Viol, Livia C. de S.
   Maia, Angelica F. da S.
   Santos, Edjon G.
   da Silva, Italo E. P.
   de Oliveira Mendes, Tiago A.
   da Silva, Adalberto M.
   Dias, Roberto S.
   da Silva, Cynthia C.
   Poleto, Marcelo D.
   Teixeira, Robson R.
   de Paula, Sergio O.
TI Discovery of novel West Nile Virus protease inhibitor based on
   isobenzonafuranone and triazolic derivatives of eugenol and
   indan-1,3-dione scaffolds
SO PLOS ONE
LA English
DT Article
ID HUMAN-PAPILLOMAVIRUS TYPE-11; SMALL-MOLECULE INHIBITORS; DENGUE VIRUS;
   MEDICINAL CHEMISTRY; ESSENTIAL OIL; ANTIPLATELET ACTIVITY; FLAVIVIRAL
   PROTEASES; NS2B-NS3 PROTEASE; NS3 PROTEIN; ZIKA
AB The West Nile Virus (WNV) NS2B-NS3 protease is an attractive target for the development of therapeutics against this arboviral pathogen. In the present investigation, the screening of a small library of fifty-eight synthetic compounds against the NS2-NB3 protease of WNV is described. The following groups of compounds were evaluated: 3-(2-aryl-2-oxoethyl)isobenzofuran-1(3H)-ones; eugenol derivatives bearing 1,2,3-triazolic functionalities; and indan-1,3-diones with 1,2,3-triazolic functionalities. The most promising of these was a eugenol derivative, namely 4-(3-(4-allyl-2-methoxyphenoxy)-propyl)-1-(2-bromobenzyl)-1H-1,2,3-triazole (35), which inhibited the protease with IC50 of 6.86 mu mol L-1. Enzyme kinetic assays showed that this derivative of eugenol presents competitive inhibition behaviour. Molecular docking calculations predicted a recognition pattern involving the residues His(51) and Ser(135), which are members of the catalytic triad of the WNV NS2B-NS3 protease.
C1 [de Oliveira, Andre S.; Oliveira, Ana Flavia C. da S.; Santos, Edjon G.; da Silva, Italo E. P.; Dias, Roberto S.; da Silva, Cynthia C.; Poleto, Marcelo D.; de Paula, Sergio O.] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.
   [de Oliveira, Andre S.; Gazolla, Poliana A. R.; Oliveira, Ana Flavia C. da S.; Pereira, Wagner L.; Viol, Livia C. de S.; Maia, Angelica F. da S.] Inst Fed Educ Ciencia & Tecnol Norte Minas Gerais, Fazenda Biribiri, MG, Brazil.
   [de Oliveira Mendes, Tiago A.] Univ Fed Vicosa, Dept Bioquim Biol Mol, Vicosa, MG, Brazil.
   [da Silva, Adalberto M.; Teixeira, Robson R.] Univ Fed Vicosa, Dept Quim, Vicosa, MG, Brazil.
   [da Silva, Adalberto M.] Inst Fed Educ Ciencia & Tecnol Catarinense, Araquari, SC, Brazil.
RP de Paula, SO (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.; Teixeira, RR (corresponding author), Univ Fed Vicosa, Dept Quim, Vicosa, MG, Brazil.
EM robsonr.teixeira@ufv.br; depaula@ufv.br
OI Teixeira, Robson R/0000-0003-3181-1108; Poleto,
   Marcelo/0000-0001-9210-690X; Silva, Italo/0000-0003-0579-8157
FU Instituto Federal de Educacao, Ciencia e Tecnologia do Norte de Minas
   Gerais (IFNMG); Fundacao de Amparo a Pesquisa Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)National
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The following authors of this paper received scholarships during this
   research: ASO and AFCSO from the Instituto Federal de Educacao, Ciencia
   e Tecnologia do Norte de Minas Gerais (IFNMG - www.ifnmg.edu.br); EGS,
   IEPS and AMS from the Fundacao de Amparo a Pesquisa Estado de Minas
   Gerais (FAPEMIG - www.fapemig.br); RSD, TAOM and SOP from the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ
   -www.memoria.cnpq.br); PARG, WLP, LCSV and AFSM from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES
   -www.capes.gov.br).The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   [Anonymous], 2016, LIGPREP SR
   Aravapalli S, 2012, BIOORGAN MED CHEM, V20, P4140, DOI 10.1016/j.bmc.2012.04.055
   Artico M, 1998, J MED CHEM, V41, P3948, DOI 10.1021/jm9707232
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028
   Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Benencia F, 2000, PHYTOTHER RES, V14, P495, DOI 10.1002/1099-1573(200011)14:7&lt;495::AID-PTR650&gt;3.0.CO;2-8
   Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293
   Bhakat S, 2014, EUR J MED CHEM, V87, P677, DOI 10.1016/j.ejmech.2014.10.010
   Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0
   Borgati TF, 2013, J BRAZIL CHEM SOC, V24, P953, DOI 10.5935/0103-5053.20130121
   Cardozo JAB-F, 2005, REV COLOMB CIENC QUI, V34, P69
   Moreira FJC, 2016, WATER RESOUR IRRIG M, V5, P9
   Chaskopoulou A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1736-6
   Chaskopoulou A, 2013, VECTOR-BORNE ZOONOT, V13, P723, DOI 10.1089/vbz.2012.1176
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Dai JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061026
   Daniel AN, 2009, REV BRAS FARMACOGN, V19, P212, DOI 10.1590/S0102-695X2009000200006
   Davidson W, 2004, ANAL CHEM, V76, P2095, DOI 10.1021/ac035335o
   de Oliveira AS, 2014, J BRAZIL CHEM SOC, V25, P1759, DOI 10.5935/0103-5053.20140057
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FLATAU E, 1981, ISRAEL J MED SCI, V17, P1057
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Fujisawa S, 2016, Adv Exp Med Biol, V929, P45
   Goudreau N, 2007, BIOORGAN MED CHEM, V15, P2690, DOI 10.1016/j.bmc.2007.01.036
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Huang XZ, 2012, MOLECULES, V17, P4219, DOI 10.3390/molecules17044219
   Islamuddin M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005011
   Khalilzadeh E, 2016, RES PHARM SCI, V11, P293, DOI 10.4103/1735-5362.189297
   Kildea MA, 2004, AQUACULTURE, V232, P265, DOI 10.1016/S0044-8486(03)00483-6
   Kleinschmidt-DeMasters BK, 2015, BRAIN PATHOL, V25, P625, DOI 10.1111/bpa.12280
   Kurian R., 2006, Indian Journal of Pharmacology, V38, P341
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lionnet L, 2010, PHYTOTHER RES, V24, P1645, DOI 10.1002/ptr.3174
   Liu YY, 2003, BIOCHEMISTRY-US, V42, P8862, DOI 10.1021/bi034661v
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma FF, 2012, J THROMB THROMBOLYS, V33, P64, DOI 10.1007/s11239-011-0647-9
   Mahadlek J, 2010, J MET MAT MINER, V20, P159
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Ohkubo T, 1997, J DENT RES, V76, P848, DOI 10.1177/00220345970760040501
   Oliveira AFCD, 2018, EUR J MED CHEM, V149, P98, DOI 10.1016/j.ejmech.2018.02.037
   Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081
   Park SH, 2011, ARCH PHARM RES, V34, P501, DOI 10.1007/s12272-011-0320-z
   Peng Y, 2004, J CARDIOVASC PHARM, V43, P876, DOI 10.1097/00005344-200406000-00018
   Perrin D.D., 1988, PURIFICATION LAB CHE
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Schrodinger, 2016, GLID
   Schrodinger, 2016, SCHRODINGER RELEASE
   Schrodinger, 2016, MAESTR
   Serkedjieva J, 1999, J ETHNOPHARMACOL, V64, P59, DOI 10.1016/S0378-8741(98)00095-6
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Strobel G, 2002, PHYTOCHEMISTRY, V60, P179, DOI 10.1016/S0031-9422(02)00062-6
   Tanaka S, 2004, CONTACT DERMATITIS, V51, P288, DOI 10.1111/j.0105-1873.2004.00446.x
   Teixeira RR, 2013, MOLECULES, V18, P1881, DOI 10.3390/molecules18021881
   Teo KF, 1997, J GEN VIROL, V78, P337, DOI 10.1099/0022-1317-78-2-337
   Tiew KC, 2012, BIOORGAN MED CHEM, V20, P1213, DOI 10.1016/j.bmc.2011.12.047
   Timiri AK, 2016, EUR J MED CHEM, V117, P125, DOI 10.1016/j.ejmech.2016.04.008
   Tragoolpua Y, 2007, PHYTOTHER RES, V21, P1153, DOI 10.1002/ptr.2226
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yang H, 2007, BIOORG MED CHEM LETT, V17, P5210, DOI 10.1016/j.bmcl.2007.06.082
   Yoakim C, 2003, BIOORG MED CHEM LETT, V13, P2539, DOI 10.1016/S0960-894X(03)00510-9
   Yoganathan K, 2003, J NAT PROD, V66, P1116, DOI 10.1021/np030146m
NR 72
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2019
VL 14
IS 9
AR e0223017
DI 10.1371/journal.pone.0223017
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LM6FU
UT WOS:000532345500060
PM 31557229
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ramos, W
   Luna, M
   Alarcon, T
   Jimenez, G
   Diaz, J
   Calderon, M
   Gutierrez, EL
AF Ramos, Willy
   Luna, Miguel
   Alarcon, Tania
   Jimenez, Gerardo
   Diaz, Jesus
   Calderon, Maria
   Gutierrez, Ericson L.
TI Cutaneous Manifestations of Zika in Peru
SO JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
LA English
DT Article
DE Zika virus infection; arboviruses; skin rash; Peru
ID PRURITIC URTICARIAL PAPULES; VIRUS; EXANTHEMA; CHIKUNGUNYA; INFECTION;
   PLAQUES
AB This article aims to describe the cutaneous manifestations observed in the Zika epidemic in Peru during 2016 and 2017, as well as discuss the potential differential diagnoses. During the outbreak, the main reason for seeking medical advice was the development of a pruriginous maculopapular rash with a marked papular component, which started on the chest and later generalized to the rest of the body. Similar manifestations were noted in adults, children, and pregnant women. Other manifestations such as conjunctivitis, edema, or petechiae on the palate were rare. We suggest that in areas that are endemic for arboviral infections, in the differential diagnosis of a rash one must consider infections such as dengue, Zika, or chikungunya viruses. In nonendemic areas, the diagnosis is more difficult, as the rash may result from other viral infections not transmitted by arthropods and/or reactive or inflammatory diseases (urticaria, atopic dermatitis, systemic lupus erythematosus). We recommend that primary care health personnel are trained in the recognition of the mucocutaneous lesions caused by Zika virus infection, which could contribute to the identification of suspicious cases, particularly pregnant women.
C1 [Ramos, Willy] Minist Hlth, Natl Ctr Epidemiol Control & Prevent Dis, Lima, Peru.
   [Ramos, Willy] Natl Univ San Marcos, Inst Clin Res, Lima, Peru.
   [Luna, Miguel; Alarcon, Tania] Reg Hlth Dept Ica, Epidemiol Off, Ica, Peru.
   [Jimenez, Gerardo; Diaz, Jesus] Santo Toribio de Mogrovejo Univ, Chiclayo, Peru.
   [Calderon, Maria] HAMPI Consultoria Salud, Lima, Peru.
   [Gutierrez, Ericson L.] Peruvian Natl Inst Hlth, Lima, Peru.
   [Gutierrez, Ericson L.] Univ San Martin de Porres, Fac Human Med, Lima, Peru.
RP Gutierrez, EL (corresponding author), Inst Nacl Salud, Ctr Nacl Salud Publ, Calle Capac Yupanqui 1400, Lima 11, Peru.
EM eringunza@yahoo.es
RI Ramos, Willy/AAA-3747-2020
OI Ramos, Willy/0000-0003-1599-7811; Gutierrez, Ericson/0000-0003-4725-6284
CR Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636
   Aletti M, 2016, PRESSE MED, V45, P939, DOI 10.1016/j.lpm.2016.06.003
   [Anonymous], 2016, 125MINSA2016CDCINS N
   Bandyopadhyay Debabrata, 2010, Indian J Dermatol, V55, P64, DOI 10.4103/0019-5154.60356
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhat Ramesh M, 2011, Indian J Dermatol, V56, P290, DOI 10.4103/0019-5154.82483
   Brasil P, 2016, LANCET INFECT DIS, V16, P866, DOI 10.1016/S1473-3099(16)30117-7
   Centro Nacional de Epidemiologia Prevencion y Control de Enfermedades del Ministerio de Salud del Peru, SAL SIT SAL
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   Cordel N, 2017, JAMA DERMATOL, V153, P326, DOI 10.1001/jamadermatol.2016.5442
   Cosano-Quero A, 2018, ACTAS DERMO-SIFILOGR, V109, pE13, DOI 10.1016/j.ad.2017.02.021
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Direccion General de Epidemiologia, 2016, AL EP AE DEBE 001 20
   Edupuganti S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx133
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Farahnik B, 2016, J AM ACAD DERMATOL, V74, P1286, DOI 10.1016/j.jaad.2016.02.1232
   Ghazeeri G, 2012, INT J DERMATOL, V51, P1047, DOI 10.1111/j.1365-4632.2011.05203.x
   Giugliano E, 2012, J OBSTET GYNAECOL, V32, P301, DOI 10.3109/01443615.2011.652704
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Lee J, 2016, J KOREAN MED SCI, V31, P331, DOI 10.3346/jkms.2016.31.3.331
   Mateo S., 2017, B EPIDEMIOL LIMA, V26, P844
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Organizacion Mundial de la Salud, 2015, ENF VIR ZIK DEF PROV
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Palma-Pinedo Helen, 2016, Rev. perú. med. exp. salud publica, V33, P13, DOI 10.17843/rpmesp.2016.331.1900
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Riyaz N, 2010, INDIAN J DERMATOL VE, V76, P671, DOI 10.4103/0378-6323.72466
   Seetharam KA, 2012, INDIAN PEDIATR, V49, P51, DOI 10.1007/s13312-012-0007-7
   Singh RK, 2016, DERMATOL ONLINE J, V22
   Troncoso A, 2016, ASIAN PAC J TROP BIO, V6, P520, DOI 10.1016/j.apjtb.2016.04.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zheng N C, 2016, Zhonghua Yi Xue Za Zhi, V96, P3666, DOI 10.3760/cma.j.issn.0376-2491.2016.45.012
NR 35
TC 2
Z9 2
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1203-4754
EI 1615-7109
J9 J CUTAN MED SURG
JI J. Cutan. Med. Surg.
PD JAN
PY 2020
VL 24
IS 1
BP 33
EP 40
AR UNSP 1203475419878160
DI 10.1177/1203475419878160
EA SEP 2019
PG 8
WC Dermatology
SC Dermatology
GA KG6LZ
UT WOS:000489866900001
PM 31556723
DA 2020-07-08
ER

PT J
AU Lwande, OW
   Obanda, V
   Lindstrom, A
   Ahlm, C
   Evander, M
   Naslund, J
   Bucht, G
AF Lwande, Olivia Wesula
   Obanda, Vincent
   Lindstrom, Anders
   Ahlm, Clas
   Evander, Magnus
   Naslund, Jonas
   Bucht, Goran
TI Globe-Trotting Aedes aegypti and Aedes albopictus: Risk Factors for
   Arbovirus Pandemics
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE mosquitoes; arboviruses; vector control; pandemic risk
ID DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; INSECTICIDE-RESISTANCE; INVASIVE
   MOSQUITOS; STEGOMYIA AEGYPTI; SKUSE DIPTERA; UNITED-STATES; ZIKA VIRUS;
   DENGUE; VECTOR
AB Introduction: Two species of Aedes (Ae.) mosquitoes (Ae. aegypti and Ae. albopictus) are primary vectors for emerging arboviruses that are a significant threat to public health and economic burden worldwide. Distribution of these vectors and the associated arboviruses, such as dengue virus, chikungunya virus, yellow fever virus, and Zika virus, was for a long time restricted by geographical, ecological, and biological factors. Presently, arbovirus emergence and dispersion are more rapid and geographically widespread, largely due to expansion of the range for these two mosquitoes that have exploited the global transportation network, land perturbation, and failure to contain the mosquito population coupled with enhanced vector competence. Ae. aegypti and Ae. albopictus may also sustain transmission between humans without having to depend on their natural reservoir forest cycles due to arthropod adaptation to urbanization. Currently, there is no single strategy that is adequate to control these vectors, especially when managing arbovirus outbreaks. Objective: This review aimed at presenting the characteristics and abilities of Ae. aegypti and Ae. albopictus, which can drive a global public health risk, and suggests strategies for prevention and control. Methods: This review presents the geographic range, reproduction and ecology, vector competence, genetic evolution, and biological and chemical control of these two mosquito species and how they have changed and developed over time combined with factors that may drive pandemics and mitigation measures. Conclusion: We suggest that more efforts should be geared toward the development of a concerted multidisciplinary approach.
C1 [Lwande, Olivia Wesula; Evander, Magnus] Umea Univ, Dept Clin Microbiol, Virol Sect, S-90185 Umea, Sweden.
   [Lwande, Olivia Wesula; Obanda, Vincent] Consortium Epidemiol & Ecol CEER Africa, Nairobi, Kenya.
   [Lwande, Olivia Wesula; Ahlm, Clas; Evander, Magnus] Sweden Univ, Umea Univ, Arctic Res Ctr, Umea, Sweden.
   [Obanda, Vincent] Kenya Wildlife Serv, Vet Serv Dept, Nairobi, Kenya.
   [Lindstrom, Anders] Natl Vet Inst, Uppsala, Sweden.
   [Ahlm, Clas] Umea Univ, Dept Clin Microbiol, Infect & Immunol Sect, Umea, Sweden.
   [Naslund, Jonas; Bucht, Goran] Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden.
RP Lwande, OW (corresponding author), Umea Univ, Dept Clin Microbiol, Virol Sect, S-90185 Umea, Sweden.
EM olivia.lwande@umu.se
RI Evander, Magnus/AAF-5665-2019
OI Evander, Magnus/0000-0001-6034-4807
FU Swedish Defence Research Agency [A495718]; Swedish Research Council
   FormasSwedish Research CouncilSwedish Research Council Formas
   [221-2014-1556]
FX This work was supported by the Swedish Defence Research Agency, project
   A495718, and Swedish Research Council Formas (grant no. 221-2014-1556).
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Almeida APG, 2007, EUROSURVEILLANCE, V12, P6
   ARCTANDER P, 1995, P ROY SOC B-BIOL SCI, V262, P13, DOI 10.1098/rspb.1995.0170
   Avise J.C., 1994, MOL MARKERS NATURAL, P511, DOI DOI 10.1007/978-1-4615-2381-9
   Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291
   Barrera R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2596-4
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Besansky NJ, 1997, GENETICS, V147, P1817
   Bohart R, 1950, P CALIF MOSQ CONTROL, V18, P22
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   BURTON GEORGE J., 1964, MOSQUITO NEWS, V24, P200
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P617
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Chung HN, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey103
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Derraik JGB, 2006, J MED ENTOMOL, V43, P1, DOI 10.1603/0022-2585(2006)043[0001:ASFIAD]2.0.CO;2
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duncombe J, 2013, GEOSPATIAL HEALTH, V8, P255, DOI 10.4081/gh.2013.71
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Engdahl C, 2014, MOL ECOL RESOUR, V14, P478, DOI 10.1111/1755-0998.12202
   Entwistle J, 2014, URBAN INSECT PESTS: SUSTAINABLE MANAGEMENT STRATEGIES, P23, DOI 10.1079/9781780642758.0023
   ENTWISTLE P. F., 1964, Proceedings. Conf. Mirids, Nigeria, 1964., P9
   Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   FLYNN A. D., 1964, MOSQUITO NEWS, V24, P118
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P533, DOI 10.1016/S0035-9203(97)90013-4
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   FOX I, 1961, B WORLD HEALTH ORGAN, V24, P489
   Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   HALSTEAD SB, 1966, B WORLD HEALTH ORGAN, V35, P3
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Helmersson E, 2013, MOL IDENTIFICATION M
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   HOLSTEIN M, 1967, B WORLD HEALTH ORGAN, V36, P541
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Hudson RR, 2003, EVOLUTION, V57, P182
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   KLASSEN W, 1964, CAN J GENET CYTOL, V6, P61, DOI 10.1139/g64-009
   Knols BGJ, 2007, AM J TROP MED HYG, V77, P232, DOI 10.4269/ajtmh.2007.77.232
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   LARSEN JR, 1971, AM J TROP MED HYG, V20, P754, DOI 10.4269/ajtmh.1971.20.754
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lounibos LP, 2016, J MED ENTOMOL, V53, P1385, DOI 10.1093/jme/tjw122
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   LWANDE OW, 2015, PRECIS MED, V2, pE604, DOI DOI 10.14800/pm.604
   Martinez-Ibarra JA, 2002, BIOCONTROL, V47, P481, DOI 10.1023/A:1015691831489
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x
   Nimmo DD, 2015, OUTLOOKS PEST MANAGE, V26, P207
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   Papa A, 2011, CLIN MICROBIOL INFEC, V17, P1176, DOI 10.1111/j.1469-0691.2010.03438.x
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rios L, 2011, USITC PUBL, VEENY-319
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P443
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Saliternik Z, 1958, P NJ MOSQ EXTERM ASS, V45, P70
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Scholte E, 2009, EUROSURVEILLANCE, V15, P1817
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Seixas G, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3081-4
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Subramaniam TSS, 2012, BIOTECHNOL J, V7, P1323, DOI 10.1002/biot.201200282
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   van den Hurk AF, 2018, TROP MED INFECT DIS, V3
   Van Kleef E, 2010, GEOGRAPHIC DISTRIBUT, P1
   de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wallace H, 2013, GENETICALLY MODIFIED
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Womack M., 1993, WING BEATS, V5, P4
   Xia H, 2018, VIROL SIN, V33, P5, DOI 10.1007/s12250-018-0002-9
NR 107
TC 2
Z9 2
U1 7
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD FEB 1
PY 2020
VL 20
IS 2
BP 71
EP 81
DI 10.1089/vbz.2019.2486
EA SEP 2019
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KK1CH
UT WOS:000488218500001
PM 31556813
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ramos-Soriano, J
   Reina, JJ
   Illescas, BM
   de la Cruz, N
   Rodriguez-Perez, L
   Lasala, F
   Rojo, J
   Delgado, R
   Martin, N
AF Ramos-Soriano, Javier
   Reina, Jose J.
   Illescas, Beatriz M.
   de la Cruz, Noelia
   Rodriguez-Perez, Laura
   Lasala, Fatima
   Rojo, Javier
   Delgado, Rafael
   Martin, Nazario
TI Synthesis of Highly Efficient Multivalent Disaccharide/[60]Fullerene
   Nanoballs for Emergent Viruses
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID CARBOHYDRATE-RECOGNITION DOMAIN; GIANT GLYCOSIDASE INHIBITORS; DC-SIGN;
   EBOLA-VIRUS; CLICK CHEMISTRY; DENGUE VIRUS; CYCLOADDITION;
   GLYCOSYLATION; INFECTION; AFFINITY
AB After the last epidemic of the Zika virus (ZIKV) in Brazil that peaked in 2016, growing evidence has been demonstrated of the link between this teratogenic flavivirus and microcephaly cases. However, no vaccine or antiviral drug has been approved yet. ZIKV and Dengue viruses (DENV) entry to the host cell takes place through several receptors, including dendritic cell-specific intercellular adhesion molecule3-grabbing nonintegrin (DC-SIGN), so that the blockade of this receptor through multivalent glycoconjugates supposes a promising biological target to inhibit the infection process. In order to get enhanced multivalency in biocompatible systems, tridecafullerenes appended with up to 360 1,2-mannobiosides have been synthesized using a strain-promoted cycloaddition of azides to alkynes (SPAAC) strategy. These systems have been tested against ZIKV and DENV infection, showing an outstanding activity in the picomolar range.
C1 [Ramos-Soriano, Javier; Illescas, Beatriz M.; Rodriguez-Perez, Laura; Martin, Nazario] Univ Complutense, Fac Quim, Dept Quim Organ, E-28040 Madrid, Spain.
   [Ramos-Soriano, Javier; Reina, Jose J.; de la Cruz, Noelia; Rojo, Javier] Univ Seville, CSIC, Inst Invest Quim, Glycosyst Lab, Av Americo Vespucio 49, Seville 41092, Spain.
   [Lasala, Fatima; Delgado, Rafael] Inst Invest Hosp, Lab Microbiol Mol, 12 Octubre Imasl2, Madrid 28041, Spain.
   [Martin, Nazario] IMDEA Nanosci, Campus Cantoblanco, Madrid 28049, Spain.
   [Reina, Jose J.] Univ Santiago de Compostela, Singular Res Ctr Chem Biol & Mol Mat CIQUS, Organ Chem Dept, Santiago De Compostela 15782, Spain.
RP Illescas, BM; Martin, N (corresponding author), Univ Complutense, Fac Quim, Dept Quim Organ, E-28040 Madrid, Spain.; Rojo, J (corresponding author), Univ Seville, CSIC, Inst Invest Quim, Glycosyst Lab, Av Americo Vespucio 49, Seville 41092, Spain.; Delgado, R (corresponding author), Inst Invest Hosp, Lab Microbiol Mol, 12 Octubre Imasl2, Madrid 28041, Spain.; Martin, N (corresponding author), IMDEA Nanosci, Campus Cantoblanco, Madrid 28049, Spain.
EM beti@ucm.es; javier.rojo@iiq.csic.es; rafael.delgado@salud.madrid.org;
   nazmar@quim.ucm.es
RI Beatriz, Illescas/K-3700-2014; Rojo, Javier/A-2801-2015; Ramos-Soriano,
   Javier/O-7429-2017; Martin, Nazario/B-4329-2008; Reina, Jose
   Juan/A-8444-2018; Delgado, Rafael/C-4910-2016
OI Beatriz, Illescas/0000-0002-4727-8291; Rojo, Javier/0000-0003-3173-3437;
   Ramos-Soriano, Javier/0000-0002-3054-0679; Martin,
   Nazario/0000-0002-5355-1477; Reina, Jose Juan/0000-0001-7936-4250;
   Delgado, Rafael/0000-0002-6912-4736
FU European Research CouncilEuropean Research Council (ERC)
   [ERC2012-ADG_20120216]; European CommissionEuropean Commission Joint
   Research Centre [VIRUSCAN FETPROACT-2016:731868]; Ministerio de Economia
   y Competitividad (MINECO) of Spain [CTQ201784327-P, CTQ2017-83531-R,
   CTQ2014-52328-P, CTQ2017-86265-P]; Instituto de Salud Carlos III
   (ISCIII)Instituto de Salud Carlos III [FIS PI1400708, PI1801007]
FX Financial support by the European Research Council (ERC2012-ADG_20120216
   (Chirallcarbon)), European Commission (VIRUSCAN FETPROACT-2016:731868
   -Horizon 2020 Framework Programme), Ministerio de Economia y
   Competitividad (MINECO) of Spain (projects CTQ201784327-P,
   CTQ2017-83531-R, CTQ2014-52328-P, and CTQ2017-86265-P), and Instituto de
   Salud Carlos III (ISCIII) (FIS PI1400708 and PI1801007) is acknowledged.
CR Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228
   Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f
   Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002
   Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Bhatia S, 2016, J AM CHEM SOC, V138, P8654, DOI 10.1021/jacs.5b12950
   Buffet K, 2015, ORG BIOMOL CHEM, V13, P6482, DOI 10.1039/c5ob00689a
   Cecioni S, 2015, CHEM REV, V115, P525, DOI 10.1021/cr500303t
   Chabre YM, 2010, ADV CARBOHYD CHEM BI, V63, P165, DOI 10.1016/S0065-2318(10)63006-5
   Ciampi S, 2007, LANGMUIR, V23, P9320, DOI 10.1021/la701035g
   Compain P, 2010, ANGEW CHEM, V122, P5889
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Durka M, 2011, CHEM COMMUN, V47, P1321, DOI 10.1039/c0cc04468g
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200
   Flos MA, 2016, CHEM-EUR J, V22, P11450, DOI 10.1002/chem.201601673
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hartmann M, 2012, CHEM-EUR J, V18, P6485, DOI 10.1002/chem.201104069
   Hirsch A, 1999, TOP CURR CHEM, V199, P1
   Illescas BM, 2017, J AM CHEM SOC, V139, P6018, DOI 10.1021/jacs.7b01683
   Imai Y, 2012, CHEM-ASIAN J, V7, P97, DOI 10.1002/asia.201100586
   Imberty A, 2008, CHEM-EUR J, V14, P7490, DOI 10.1002/chem.200800700
   Blanco JLJ, 2017, J DRUG DELIV SCI TEC, V42, P18, DOI 10.1016/j.jddst.2017.03.012
   Kanfar N, 2015, ORG BIOMOL CHEM, V13, P9894, DOI 10.1039/c5ob01405k
   Luczkowiak J, 2013, BIOMACROMOLECULES, V14, P431, DOI 10.1021/bm3016658
   Ludtke A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43776
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Munoz A, 2016, NAT CHEM, V8, P50, DOI [10.1038/NCHEM.2387, 10.1038/nchem.2387]
   Nierengarten I, 2015, CHEM REC, V15, P31, DOI 10.1002/tcr.201402081
   Nierengarten JF, 2018, CHEM-EUR J, V24, P2483, DOI 10.1002/chem.201705600
   Nierengarten JF, 2017, CHEM COMMUN, V53, P11855, DOI 10.1039/c7cc07479d
   Nierengarten JF, 2010, CHEM COMMUN, V46, P3860, DOI 10.1039/c0cc00034e
   Ornelas C, 2010, J AM CHEM SOC, V132, P3923, DOI 10.1021/ja910581d
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Ramos-Soriano J, 2017, ORG BIOMOL CHEM, V15, P8877, DOI 10.1039/c7ob02286g
   Ramos-Soriano J, 2016, CHEM COMMUN, V52, P10544, DOI 10.1039/c6cc05484f
   Reichardt NC, 2016, CHEM COMMUN, V52, P13430, DOI 10.1039/c6cc04445j
   Reina JJ, 2016, ORG BIOMOL CHEM, V14, P2873, DOI 10.1039/c6ob00083e
   Ribeiro-Viana R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2302
   Rodriguez-Perez L, 2018, J AM CHEM SOC, V140, P9891, DOI 10.1021/jacs.8b03847
   Roy R, 2003, TRENDS GLYCOSCI GLYC, V15, P291, DOI 10.4052/tigg.15.291
   Roy Rene, 2002, J Biotechnol, V90, P291
   Sanchez-Navarro M, 2011, CHEM-EUR J, V17, P766, DOI 10.1002/chem.201002816
   Sigwalt D, 2016, EUR J ORG CHEM, V2016, P2882, DOI 10.1002/ejoc.201600439
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thepaut M, 2013, J AM CHEM SOC, V135, P2518, DOI 10.1021/ja3053305
   Trinh TMN, 2017, J MATER CHEM B, V5, P6546, DOI 10.1039/c7tb01052d
   Tikad A, 2016, CHEM-EUR J, V22, P13147, DOI 10.1002/chem.201602190
   Varga N, 2014, BIOMATERIALS, V35, P4175, DOI 10.1016/j.biomaterials.2014.01.014
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
NR 55
TC 3
Z9 3
U1 19
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD SEP 25
PY 2019
VL 141
IS 38
BP 15403
EP 15412
DI 10.1021/jacs.9b08003
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA JB1LR
UT WOS:000488322500052
PM 31469952
DA 2020-07-08
ER

PT J
AU Khan, S
   Lew, I
   Wu, F
   Fritts, L
   Fontaine, KA
   Tomar, S
   Trapecar, M
   Shehata, HM
   Ott, M
   Miller, CJ
   Sanjabi, S
AF Khan, Shahzada
   Lew, Irene
   Wu, Frank
   Fritts, Linda
   Fontaine, Krystal A.
   Tomar, Sakshi
   Trapecar, Martin
   Shehata, Hesham M.
   Ott, Melanie
   Miller, Christopher J.
   Sanjabi, Shomyseh
TI Low expression of RNA sensors impacts Zika virus infection in the lower
   female reproductive tract
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SEXUAL TRANSMISSION; IMMUNE-RESPONSES; MOUSE MODEL; MICE; PROGESTERONE;
   PROTECTION; PREGNANCY; HORMONES; VAGINA; BRAIN
AB Innate immune responses to Zika virus (ZIKV) are dampened in the lower female reproductive tract (LFRT) compared to other tissues, but the mechanism that underlies this vulnerability is poorly understood. Using tissues from uninfected and vaginally ZIKV-infected macaques and mice, we show that low basal expression of RNA-sensing pattern recognition receptors (PRRs), or their co-receptors, in the LFRT contributes to high viral replication in this tissue. In the LFRT, ZIKV sensing provides limited protection against viral replication, and the sensors are also minimally induced after vaginal infection. While IFN alpha/beta receptor signaling offers minimal protection in the LFRT, it is required to prevent dissemination of ZIKV to other tissues, including the upper FRT. Our findings support a role for RNA-sensing PRRs in the dampened innate immunity against ZIKV in the LFRT compared to other tissues and underlie potential implications for systemic dissemination upon heterosexual transmission of ZIKV in women.
C1 [Khan, Shahzada; Lew, Irene; Wu, Frank; Fontaine, Krystal A.; Tomar, Sakshi; Trapecar, Martin; Shehata, Hesham M.; Ott, Melanie; Sanjabi, Shomyseh] Gladstone Inst, Virol & Immunol, San Francisco, CA 94158 USA.
   [Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.
   [Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Sanjabi, Shomyseh] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
   [Sanjabi, Shomyseh] Genentech Inc, San Francisco, CA 94080 USA.
RP Sanjabi, S (corresponding author), Gladstone Inst, Virol & Immunol, San Francisco, CA 94158 USA.; Sanjabi, S (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Sanjabi, S (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.
EM sanjabi.shomyseh@gene.com
RI Tomar, Sakshi/AAL-6766-2020; Trapecar, Martin/AAL-5800-2020
OI Tomar, Sakshi/0000-0001-5994-4178; Trapecar, Martin/0000-0002-0860-8948;
   khan, shahzada/0000-0003-2975-6621
FU Gladstone InstitutesUniversity of California System; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [DP2 AI112244, R01 AI097552, R21 OD023818, P30 AI027763]; National
   Center for Research Resources GrantUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [RR18928]
FX This work was supported by support from the Gladstone Institutes and an
   NIH DP2 AI112244 to S.S., NIH R01 AI097552 to M.O., and NIH R21 OD023818
   to C.J.M. This publication was made possible with help from the
   UCSF-Gladstone CFAR, an NIH funded program (P30 AI027763) supporting
   Gladstone's flow core and NIH S10 RR028962 and the James B. Pendleton
   Charitable Trust for the FACSAria cell sorter. The Gladstone Institutes
   received support for its animal care facility from a National Center for
   Research Resources Grant RR18928.
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Calla NEQ, 2016, MUCOSAL IMMUNOL, V9, P1571, DOI 10.1038/mi.2016.22
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Chen Q, 2016, NAT REV GENET, V17, P733, DOI 10.1038/nrg.2016.106
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deruaz M, 2015, IMMUNOL CELL BIOL, V93, P347, DOI 10.1038/icb.2015.20
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108
   Iversen MB, 2016, NAT IMMUNOL, V17, P150, DOI 10.1038/ni.3319
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836
   Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0
   Kumamoto Y, 2012, CURR OPIN IMMUNOL, V24, P411, DOI 10.1016/j.coi.2012.05.006
   Lasarte S, 2016, J INFECT DIS, V213, P476, DOI 10.1093/infdis/jiv402
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338
   Martinez L. E., 2017, PREPRINT, DOI [10.1101/128876v1, DOI 10.1101/128876V1]
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   MCCORMACK JT, 1974, J ENDOCRINOL, V62, P101, DOI 10.1677/joe.0.0620101
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Milligan GN, 1999, J VIROL, V73, P6380, DOI 10.1128/JVI.73.8.6380-6386.1999
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Seavey MM, 2009, VACCINE, V27, P2342, DOI 10.1016/j.vaccine.2009.02.025
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Sonoda Y, 1998, J IMMUNOL, V160, P6159
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Trapecar M, 2018, MUCOSAL IMMUNOL, V11, P1158, DOI 10.1038/s41385-018-0009-4
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Vink AS, 2018, TRENDS CARDIOVAS MED, V28, P64, DOI 10.1016/j.tcm.2017.07.012
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347
   Wang W, 2018, NATURE COMMUNICATION, V106, P1
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Yang Y, 2016, CELL RES, V26, P288, DOI 10.1038/cr.2016.16
   Yao XD, 2007, J REPROD IMMUNOL, V75, P106, DOI 10.1016/j.jri.2007.04.008
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 67
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 25
PY 2019
VL 10
AR 4344
DI 10.1038/s41467-019-12371-7
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JA1OF
UT WOS:000487585600005
PM 31554802
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tran, TV
   Nguyen, BV
   Nguyen, TTP
   Tran, TT
   Pham, KG
   Le, QB
   Do, BN
   Pham, HN
   Nguyen, CV
   Van, DPH
   Ha, V
   Doan, THT
   Le, HQ
AF Tran, Tien, V
   Nguyen, Ba, V
   Nguyen, Thao T. P.
   Tran, Tung T.
   Pham, Khanh G.
   Le, Quang B.
   Do, Binh N.
   Pham, Hung N.
   Nguyen, Chuyen, V
   Van, Duong P. H.
   Ha, Van T.
   Doan, Trang H. T.
   Le, Hoa Q.
TI Development of a highly sensitive magneto-enzyme lateral flow
   immunoassay for dengue NS1 detection
SO PEERJ
LA English
DT Article
DE Dengue virus; NS1 protein; Magnetic lateral flow immunoassay; Signal
   amplification; Rapid method
ID LINKED-IMMUNOSORBENT-ASSAY; BACILLUS-ANTHRACIS SPORES; RAPID DETECTION;
   EARLY-DIAGNOSIS; PROTEIN NS1; ANTIGEN; VIRUS; SEROTYPE; FEVER; TESTS
AB Background: Dengue infection represents a global health issue of growing importance. Dengue non-structural protein 1 (NS1) plays a central role in the early detection of the disease. The most common method for NS1 detection is testing by lateral flow immunoassays (LFIAs) with varying sensitivity. In this study, we present a highly sensitive magneto-enzyme LFIA for prompt diagnosis of dengue.
   Methods: We have demonstrated the development of a magneto-enzyme LFIA combining super-paramagnetic nanoparticles as labels and Biotin-Streptavidin signal amplification strategy to detect dengue NS1. Factors affecting the test performance including antibody pair, super-paramagnetic nanoparticle size, nitrocellulose membrane type, amounts of detection and capture antibodies, and amounts of Streptavidin-polyHRP were optimized. Analytical sensitivity and cross-reactivity were determined. Clinical performance of the novel assay was evaluated using a panel of 120 clinical sera.
   Results: This newly developed assay could detect NS1 of all four serotypes of dengue virus (DENV). The limit of detection (LOD) was found to be as low as 0.25 ng ml(-1) for DENV-1 and DENV-3, 0.1 ng ml(-1) for DENV-2, and 1.0 ng ml(-1) for DENV-4. The LOD for DENV-2 was a 50-fold improvement over the best values previously reported. There was an absence of cross-reactivity with Zika NS1, Hepatitis B virus, Hepatitis C virus, and Japanese encephalitis virus. The sensitivity and specificity of the novel assay were 100% when tested on clinical samples.
   Conclusions: We have successfully developed a magneto-enzyme LFIA, allowing rapid and highly sensitive detection of dengue NS1, which is essential for proper management of patients infected with DENV.
C1 [Tran, Tien, V; Nguyen, Ba, V; Pham, Khanh G.; Le, Quang B.; Do, Binh N.; Pham, Hung N.; Nguyen, Chuyen, V] Mil Med Univ, Hanoi, Vietnam.
   [Nguyen, Thao T. P.; Tran, Tung T.; Doan, Trang H. T.; Le, Hoa Q.] Hanoi Univ Sci & Technol, Sch Biotechnol & Food Technol, Hanoi, Vietnam.
   [Van, Duong P. H.] Nguyen Hue High Sch Gifted Students, Hanoi, Vietnam.
   [Ha, Van T.] Hanoi Amsterdam High Sch Gifted Students, Hanoi, Vietnam.
RP Le, HQ (corresponding author), Hanoi Univ Sci & Technol, Sch Biotechnol & Food Technol, Hanoi, Vietnam.
EM hoa.lequang@hust.edu.vn
RI Binh, Nhu/AAL-3339-2020
OI Binh, Nhu/0000-0002-1377-3921
FU Ministry of Science and Technology of Vietnam [06/2014/HD-NDT]
FX This research was funded by the Ministry of Science and Technology of
   Vietnam (grant no. 06/2014/HD-NDT). There was no additional external
   funding received for this study. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   [Anonymous], 2017, SUPERMAG MULTITUBE S
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Cho IH, 2013, ANAL BIOANAL CHEM, V405, P3313, DOI 10.1007/s00216-013-6742-3
   Datta S, 2010, INDIAN J MED MICROBI, V28, P107, DOI 10.4103/0255-0857.62484
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Huang WC, 2018, J NANOSCI NANOTECHNO, V18, P7190, DOI 10.1166/jnn.2018.16020
   Jacinto MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186782
   Kassim FM, 2011, SE ASIAN J TROP MED, V42, P562
   Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661
   Kumar S, 2018, BIOMICROFLUIDICS, V12, DOI 10.1063/1.5035113
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Linares EM, 2012, J IMMUNOL METHODS, V375, P264, DOI 10.1016/j.jim.2011.11.003
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Najioullah F, 2011, DIAGN MICR INFEC DIS, V69, P172, DOI 10.1016/j.diagmicrobio.2010.09.021
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Posthuma-Trumpie GA, 2008, ANAL BIOANAL CHEM, V392, P1215, DOI 10.1007/s00216-008-2362-8
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Vicente CR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1668-y
   Wang DB, 2015, BIOSENS BIOELECTRON, V67, P608, DOI 10.1016/j.bios.2014.09.067
   Wang DB, 2013, BIOSENS BIOELECTRON, V42, P661, DOI 10.1016/j.bios.2012.10.088
   Wang YY, 2009, MAT SCI ENG C-BIO S, V29, P714, DOI 10.1016/j.msec.2009.01.011
   World Health Organization, 2019, DENG SEV DENG
   Wu J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061286
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zainah S, 2009, J VIROL METHODS, V155, P157, DOI 10.1016/j.jviromet.2008.10.016
   Zherdev AV, 2018, RAPID TEST ADV FORMA, P10, DOI [10.5772/intechopen.76926, DOI 10.5772/INTECHOPEN.76926]
NR 36
TC 0
Z9 0
U1 3
U2 6
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD SEP 25
PY 2019
VL 7
AR e7779
DI 10.7717/peerj.7779
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JA1MQ
UT WOS:000487581500014
PM 31579630
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, XM
   Yang, JY
   Pu, Q
   Peng, XY
   Xu, LL
   Liu, SP
AF Li, Xuemei
   Yang, Jinyu
   Pu, Qian
   Peng, Xinyue
   Xu, Lili
   Liu, Shiping
TI Serine hydroxymethyltransferase controls blood-meal digestion in the
   midgut of Aedes aegypti mosquitoes
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Serine hydroxymethyltransferase; Digestive enzyme;
   Midgut; Blood meal
ID TRYPSIN-LIKE; PROTEASE INHIBITOR; GENE-EXPRESSION; YELLOW-FEVER; ZIKA
   VIRUS; DENGUE; TRANSMISSION; CHYMOTRYPSIN; CLONING; VECTOR
AB Background Female Aedes aegypti mosquitoes are vectors of arboviruses that cause diverse diseases of public health significance. Blood protein digestion by midgut proteases provides anautogenous mosquitoes with the nutrients essential for oocyte maturation and egg production. Midgut-specific miR-1174 affects the functions of the midgut through its target gene serine hydroxymethyltransferase (SHMT). However, less is known about SHMT-regulated processes in blood digestion by mosquitoes. Methods RNAi of SHMT was realized by injection of the double-stranded RNA at 16 h post-eclosion. The expression of SHMT at mRNA level and protein level was assayed by real-time PCR and Western blotting, respectively. Statistical analyses were performed with GraphPad7 using Student's t-test. Results Here, we confirmed that digestion of blood was inhibited in SHMT RNAi-silenced female A. aegypti mosquitoes. Evidence is also presented that all SHMT-depleted female mosquitoes lost their flight ability and died within 48 h of a blood meal. Furthermore, most examined digestive enzymes responded differently in their transcriptional expression to RNAi depletion of SHMT, with some downregulated, some upregulated and some remaining stable. Phylogenetic analysis showed that transcriptional expression responses to SHMT silence were largely unrelated to the sequence similarity between these enzymes. Conclusions Overall, this research shows that SHMT was expressed at a low level in the midgut of Aedes aegypti mosquitoes, but blood-meal digestion was inhibited when SHMT was silenced. Transcriptional expressions of different digestive enzymes were affected in response to SHMT depletion, suggesting that SHMT is required for the blood-meal digestion in the midgut and targeting SHMT could provide an effective strategy for vector mosquito population control.
C1 [Li, Xuemei; Yang, Jinyu; Pu, Qian; Peng, Xinyue; Xu, Lili; Liu, Shiping] Southwest Univ, State Key Lab Silkworm Genome Biol, Biol Sci Res Ctr, Chongqing 400715, Peoples R China.
   [Yang, Jinyu] Southwest Univ, Coll Biotechnol, Chongqing 400715, Peoples R China.
   [Liu, Shiping] China West Normal Univ, Coll Life Sci, Nanchong 637002, Peoples R China.
RP Liu, SP (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Biol Sci Res Ctr, Chongqing 400715, Peoples R China.
EM lsp98668@163.com
RI Liu, Shiping/W-2577-2019
OI Liu, Shiping/0000-0002-2917-0172
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31571334]; State Key Programme of National Natural
   Science of China [31530071]; Chongqing Basic and Frontier Research
   Programme [cstc2014jcyjA00025]
FX This work was supported by grants from the National Natural Science
   Foundation of China (31571334), State Key Programme of National Natural
   Science of China (31530071) and Chongqing Basic and Frontier Research
   Programme (cstc2014jcyjA00025).
CR Anderson DD, 2012, J BIOL CHEM, V287, P7051, DOI 10.1074/jbc.M111.333120
   Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   BARILLASMURY C, 1991, INSECT BIOCHEM, V21, P825, DOI 10.1016/0020-1790(91)90089-W
   BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bian GW, 2008, INSECT BIOCHEM MOLEC, V38, P190, DOI 10.1016/j.ibmb.2007.10.008
   Blow DM, 1997, TRENDS BIOCHEM SCI, V22, P405, DOI 10.1016/S0968-0004(97)01115-8
   Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721
   Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003
   Briegel H, 2003, J VECTOR ECOL, V28, P1
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FELIX CR, 1991, INSECT BIOCHEM, V21, P197, DOI 10.1016/0020-1790(91)90050-O
   Ferreira-de-Lima VH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2643-9
   GARROW TA, 1993, J BIOL CHEM, V268, P11910
   Giardina G, 2018, FEBS J, V285, P3238, DOI 10.1111/febs.14610
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006
   Jiang QJ, 1997, INSECT BIOCHEM MOLEC, V27, P283, DOI 10.1016/S0965-1748(97)00001-5
   Kalhok S.E., 1993, Insect Molecular Biology, V2, P71, DOI 10.1111/j.1365-2583.1993.tb00127.x
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Liu BY, 2019, CURR BIOL, V29, P1187, DOI 10.1016/j.cub.2019.02.021
   Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111
   Misselbeck K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00854-w
   Mourya DT, 2018, INDIAN J MED RES, V147, P88, DOI 10.4103/ijmr.IJMR_1142_17
   Ngoagouni C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2101-0
   Nonaka H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08833-7
   Noriega FG, 1996, INSECT MOL BIOL, V5, P25, DOI 10.1111/j.1365-2583.1996.tb00037.x
   Noriega FG, 2002, J INSECT PHYSIOL, V48, P205, DOI 10.1016/S0022-1910(01)00165-2
   Perry C, 2005, J BIOL CHEM, V280, P396, DOI [10.1074/jbc.M412914200, 10.1074/jbc.M410467200]
   Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P163, DOI 10.1016/S0965-1748(02)00187-X
   Rascon AA, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-43
   Renwick SB, 1998, STRUCTURE, V6, P1105, DOI 10.1016/S0969-2126(98)00112-9
   Saboia-Vahia L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-253
   Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3
   Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017
   Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786
   Soares TS, 2018, BIOCHIMIE, V144, P160, DOI 10.1016/j.biochi.2017.11.005
   Szebenyi DME, 2004, BIOCHEMISTRY-US, V43, P6865, DOI 10.1021/bi049791y
   Torquato RJS, 2017, ACTA CRYSTALLOGR F, V73, P469, DOI 10.1107/S2053230X17010007
   Tramonti A, 2018, BIOCHEMISTRY-US, V57, P6984, DOI 10.1021/acs.biochem.8b01074
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x
   Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114
   Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085
   Winkler F, 2017, G3-GENES GENOM GENET, V7, P2305, DOI 10.1534/g3.117.043133
   Wu DD, 2009, MOL BIOL EVOL, V26, P2333, DOI 10.1093/molbev/msp139
NR 51
TC 0
Z9 0
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 24
PY 2019
VL 12
IS 1
AR 460
DI 10.1186/s13071-019-3714-2
PG 15
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JA1SJ
UT WOS:000487597200003
PM 31551071
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brito, L
   Ambrogi, I
   Diniz, D
AF Brito, Luciana
   Ambrogi, Ilana
   Diniz, Debora
TI Zika and Reproductive Rights: Women's Perceptions at Public Health
   Services
SO INTERNATIONAL JOURNAL OF SEXUAL HEALTH
LA English
DT Meeting Abstract
DE Zika; Brazil; Sexual and Reproductive Health
C1 [Brito, Luciana; Ambrogi, Ilana] Anis Inst Bioeth, Brasilia, DF, Brazil.
   [Diniz, Debora] Planned Parenthood Federat Western Hemisphere Reg, New York, NY USA.
FU UNDP/UNFPA/UNICEF/WHO/World Bank Human Reproduction Program (HRP)
FX UNDP/UNFPA/UNICEF/WHO/World Bank Human Reproduction Program (HRP)
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1931-7611
EI 1931-762X
J9 INT J SEX HEALTH
JI Int. J. Sex. Health
PD SEP 23
PY 2019
VL 31
SU 1
BP A182
EP A183
PG 2
WC Psychology, Clinical; Public, Environmental & Occupational Health;
   Social Sciences, Interdisciplinary
SC Psychology; Public, Environmental & Occupational Health; Social Sciences
   - Other Topics
GA JC5RK
UT WOS:000489340400328
DA 2020-07-08
ER

PT J
AU Casazza, RL
   Lazear, HM
   Miner, JJ
AF Casazza, Rebecca L.
   Lazear, Helen M.
   Miner, Jonathan J.
TI Protective and Pathogenic Effects of Interferon Signaling During
   Pregnancy
SO VIRAL IMMUNOLOGY
LA English
DT Article
DE Zika virus; pregnancy; interferons; systemic lupus erythematosus
ID ZIKA VIRUS CAUSES; I-INTERFERON; III INTERFERON; GENE-EXPRESSION;
   LUPUS-ERYTHEMATOSUS; MOUSE MODEL; INFECTION; GAMMA; EVOLUTION; MICE
AB Immune regulation at the maternal-fetal interface is complex due to conflicting immunological objectives: protection of the fetus from maternal pathogens and prevention of immune-mediated rejection of the semiallogeneic fetus and placenta. Interferon (IFN) signaling plays an important role in restricting congenital infections as well as in the physiology of healthy pregnancies. In this review, we discuss the antiviral and pathogenic effects of type I IFN (IFN-alpha, IFN-beta), type II IFN (IFN-gamma), and type III IFN (IFN-lambda) during pregnancy, with an emphasis on mouse and non-human primate models of congenital Zika virus infection. In the context of these animal model systems, we examine the role of IFN signaling during healthy pregnancy. Finally, we review mechanisms by which dysregulated type I IFN responses contribute to poor pregnancy outcomes in humans with autoimmune disease, including interferonopathies and systemic lupus erythematosus.
C1 [Casazza, Rebecca L.; Lazear, Helen M.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Miner, Jonathan J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Miner, Jonathan J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Miner, Jonathan J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Lazear, HM (corresponding author), Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Miner, JJ (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
EM helen.lazear@med.unc.edu; jonathan.miner@wustl.edu
FU  [R01 AI39512];  [K08 AR070918];  [R01 AI143982];  [T32 AI007419]
FX Research in the authors' laboratories is supported, in part, by R01
   AI39512 (H.M.L.) and K08 AR070918 (J.J.M.), and R01 AI143982 (J.J.M.).
   R.L.C. is supported by T32 AI007419.
CR Agbayani G, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13068
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alspach E, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028480
   Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114
   Andrade D, 2015, ARTHRITIS RHEUMATOL, V67, P977, DOI 10.1002/art.39029
   Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493
   Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100
   Bayer A, 2018, PLACENTA, V61, P33, DOI 10.1016/j.placenta.2017.11.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080
   Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Buchrieser J, 2019, SCIENCE, V365, P176, DOI 10.1126/science.aaw7733
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Cappelletti M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91288
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Davidson S, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0748-y
   de Rijk EPCT, 2008, TOXICOL PATHOL, V36, p108S, DOI 10.1177/0192623308326095
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Demers A, 2014, J LEUKOCYTE BIOL, V96, P1101, DOI 10.1189/jlb.3A0214-088RRR
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ealy AD, 2017, REPRODUCTION, V154, pF1, DOI 10.1530/REP-17-0292
   ESWARAN K, 1985, AM J OBSTET GYNECOL, V151, P751, DOI 10.1016/0002-9378(85)90510-1
   Ezashi T, 2017, REPRODUCTION, V154, pF21, DOI 10.1530/REP-17-0330
   Fritz Melinda, 2005, J Perinatol, V25, P552, DOI 10.1038/sj.jp.7211342
   Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Gaynor LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00467
   Geisert RD, 2015, ADV ANAT EMBRYOL CEL, V216, P137, DOI 10.1007/978-3-319-15856-3_8
   GOBLE MM, 1993, AM J CARDIOL, V71, P94, DOI 10.1016/0002-9149(93)90717-Q
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Hansen TR, 2017, REPRODUCTION, V154, pF45, DOI 10.1530/REP-17-0315
   Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hong S, 2019, J EXP MED, V216, P1154, DOI 10.1084/jem.20190185
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   Kashiwagi A, 2007, ENDOCRINOLOGY, V148, P4173, DOI 10.1210/en.2007-0268
   KEPHART DC, 1981, J INVEST DERMATOL, V77, P331, DOI 10.1111/1523-1747.ep12482531
   Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681
   Kim S, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-22
   Krause CD, 2015, CYTOKINE, V76, P480, DOI 10.1016/j.cyto.2015.07.019
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625
   Luksch H, 2019, J ALLERGY CLIN IMMUN, V144, P254, DOI 10.1016/j.jaci.2019.01.044
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mathew DJ, 2016, REPRODUCTION, V151, pR111, DOI 10.1530/REP-16-0047
   Mesev EV, 2019, NAT MICROBIOL, V4, P914, DOI 10.1038/s41564-019-0421-x
   Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2014, RHEUM DIS CLIN N AM, V40, P51, DOI 10.1016/j.rdc.2013.10.003
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353
   Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Niewold TR, 2008, ARTHRITIS RHEUM, V58, P541, DOI 10.1002/art.23191
   Niikura M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185392
   Odendall C, 2017, J IMMUNOL, V199, P3270, DOI 10.4049/jimmunol.1700250
   Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915
   Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   PAULESU L, 1994, J REPROD IMMUNOL, V27, P37, DOI 10.1016/0165-0378(94)90013-2
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Platt JS, 1998, J LEUKOCYTE BIOL, V64, P393
   Prokunina-Olsson L, 2019, J INTERF CYTOK RES, V39, P599, DOI 10.1089/jir.2019.0043
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746
   Roberts RM, 2016, REPRODUCTION, V152, pR179, DOI 10.1530/REP-16-0325
   Rossi M, 2017, P NATL ACAD SCI USA, V114, P4987, DOI 10.1073/pnas.1621447114
   Sanchez JM, 2018, REPROD DOMEST ANIM, V53, P20, DOI 10.1111/rda.13297
   Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033
   Sang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112378
   Schoggins JW, 2019, ANNU REV VIROL, V6, P567, DOI 10.1146/annurev-virology-092818-015756
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Senegas A, 2009, INT J PARASITOL, V39, P481, DOI 10.1016/j.ijpara.2008.08.009
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   SHIMIZU T, 1988, PEDIATR CARDIOL, V9, P121, DOI 10.1007/BF02083711
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192
   YAMAMOTO Y, 1992, J REPROD FERTIL, V95, P559, DOI 10.1530/jrf.0.0950559
   Yan N, 2017, J INTERF CYTOK RES, V37, P198, DOI 10.1089/jir.2016.0086
   Yockey LJ, 2018, IMMUNITY, V49, P397, DOI 10.1016/j.immuni.2018.07.017
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zani A, 2019, IFITMS INHIBIT CELL, DOI [10.1101/713032, DOI 10.1101/713032]
   Zhou JZ, 2018, TRENDS IMMUNOL, V39, P355, DOI 10.1016/j.it.2018.02.006
NR 121
TC 1
Z9 1
U1 1
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD FEB 1
PY 2020
VL 33
IS 1
BP 3
EP 11
DI 10.1089/vim.2019.0076
EA SEP 2019
PG 9
WC Immunology; Virology
SC Immunology; Virology
GA KF2KV
UT WOS:000487274000001
PM 31545139
DA 2020-07-08
ER

PT J
AU Perez-Guzman, EX
   Pantoja, P
   Serrano-Collazo, C
   Hassert, MA
   Ortiz-Rosa, A
   Rodriguez, IV
   Giavedoni, L
   Hodara, V
   Parodi, L
   Cruz, L
   Arana, T
   White, LJ
   Martinez, MI
   Weiskopf, D
   Brien, JD
   de Silva, A
   Pinto, AK
   Sariol, CA
AF Perez-Guzman, Erick X.
   Pantoja, Petraleigh
   Serrano-Collazo, Crisanta
   Hassert, Mariah A.
   Ortiz-Rosa, Alexandra
   Rodriguez, Idia, V
   Giavedoni, Luis
   Hodara, Vida
   Parodi, Laura
   Cruz, Lorna
   Arana, Teresa
   White, Laura J.
   Martinez, Melween, I
   Weiskopf, Daniela
   Brien, James D.
   de Silva, Aravinda
   Pinto, Amelia K.
   Sariol, Carlos A.
TI Time elapsed between Zika and dengue virus infections affects antibody
   and T cell responses
SO NATURE COMMUNICATIONS
LA English
DT Article
ID DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; CROSS-REACTIVITY; MACAQUES;
   PATHOGENESIS; PROTECTION; IMMUNITY; RHESUS; BRAZIL
AB Zika virus (ZIKV) and dengue virus (DENV) are co-endemic in many parts of the world, but the impact of ZIKV infection on subsequent DENV infection is not well understood. Here we show in rhesus macaques that the time elapsed after ZIKV infection affects the immune response to DENV infection. We show that previous ZIKV exposure increases the magnitude of the antibody and T cell responses against DENV. The time interval between ZIKV and subsequent DENV infection further affects the immune response. A mid-convalescent period of 10 months after ZIKV infection results in higher and more durable antibody and T cell responses to DENV infection than a short period of 2 months. In contrast, previous ZIKV infection does not affect DENV viremia or pro-inflammatory status. Collectively, we find no evidence of a detrimental effect of ZIKV immunity in a subsequent DENV infection. This supports the implementation of ZIKV vaccines that could also boost immunity against future DENV epidemics.
C1 [Perez-Guzman, Erick X.; Pantoja, Petraleigh; Serrano-Collazo, Crisanta; Cruz, Lorna; Arana, Teresa; Martinez, Melween, I; Sariol, Carlos A.] Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.
   [Pantoja, Petraleigh; Rodriguez, Idia, V; Cruz, Lorna; Arana, Teresa; Martinez, Melween, I; Sariol, Carlos A.] Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00936 USA.
   [Pantoja, Petraleigh; Rodriguez, Idia, V; Cruz, Lorna; Arana, Teresa; Martinez, Melween, I; Sariol, Carlos A.] Univ Puerto Rico, Anim Resources Ctr, Med Sci Campus, San Juan, PR 00936 USA.
   [Hassert, Mariah A.; Brien, James D.; Pinto, Amelia K.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA.
   [Ortiz-Rosa, Alexandra] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.
   [Giavedoni, Luis; Hodara, Vida; Parodi, Laura] Texas Biomed Res Inst, San Antonio, TX USA.
   [White, Laura J.; de Silva, Aravinda] Univ North Carolina Chapel Hill, Dept Microbiol, Chapel Hill, NC USA.
   [White, Laura J.; de Silva, Aravinda] Univ North Carolina Chapel Hill, Dept Immunol, Chapel Hill, NC USA.
   [Weiskopf, Daniela] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Sariol, Carlos A.] Univ Puerto Rico, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA.
   [Perez-Guzman, Erick X.] Takeda Vaccines Inc, Cambridge, MA USA.
RP Sariol, CA (corresponding author), Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.; Sariol, CA (corresponding author), Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00936 USA.; Sariol, CA (corresponding author), Univ Puerto Rico, Anim Resources Ctr, Med Sci Campus, San Juan, PR 00936 USA.; Sariol, CA (corresponding author), Univ Puerto Rico, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA.
EM carlos.sariol@upr.edu
OI Brien, James/0000-0002-1670-8041; Ortiz-Rosa,
   Alexandra/0000-0002-2846-3029
FU [2 P40 OD012217];  [2U42OD021458-15];  [K22AI104794];  [P51OD011133]; 
   [HHSN272201400045C];  [R25GM061838]
FX We thank all the staff of the Caribbean Primate Research Center and
   Animal Resources Center for their continuous support with the sample
   collection, schedule, and monitoring of the animals. Authors recognize
   the support provided by Dr. Elmer Rodriguez reviewing the statistics.
   This work was supported by the following grants: 2 P40 OD012217 and
   2U42OD021458-15 to C.A.S. and M.I.M., K22AI104794 to J.D.B., P51OD011133
   (L.G.), HHSN272201400045C to D.W., and R25GM061838 to E.X.P.-G.
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Arien KK, 2018, LANCET GLOB HEALTH, V6, pE494, DOI 10.1016/S2214-109X(18)30122-0
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1590-z
   Borges MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196311
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Gutierrez-Lopez R, 2019, EMERG INFECT DIS, V25, P346, DOI 10.3201/eid2502.171123
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kanthaswamy S, 2016, J AM ASSOC LAB ANIM, V55, P147
   Katzelnick LC, 2018, CURR OPIN VIROL, V29, P51, DOI 10.1016/j.coviro.2018.03.004
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Khurram M, 2014, J INFECT PUBLIC HEAL, V7, P489, DOI 10.1016/j.jiph.2014.05.005
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Knudsen ML, 2014, J VIROL, V88, P12438, DOI 10.1128/JVI.02223-14
   Koraka P, 2007, MICROBES INFECT, V9, P940, DOI 10.1016/j.micinf.2007.03.012
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Meyer C, 2015, METHODS MOL BIOL, V1343, P65, DOI 10.1007/978-1-4939-2963-4_6
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE495, DOI 10.1016/S2214-109X(18)30123-2
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323
   Serrano-Collazo C., 2019, BIORXIV, DOI [10.1101/625293, DOI 10.1101/625293]
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Solimini AG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34664-5
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Symonds EM, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007639
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   White LJ, 2013, J VIROL, V87, P3409, DOI 10.1128/JVI.02298-12
   Wijeratne DT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006540
NR 66
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 20
PY 2019
VL 10
AR 4316
DI 10.1038/s41467-019-12295-2
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IZ3OS
UT WOS:000486995600003
PM 31541110
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira, DN
   Lima, EO
   Melo, CFOR
   Delafiori, J
   Guerreiro, TM
   Rodrigues, RGM
   Morishita, KN
   Silveira, C
   Muraro, SP
   de Souza, GF
   Vieira, A
   Silva, A
   Batista, RF
   Doriqui, MJR
   Sousa, PS
   Milanez, GP
   Proenca-Modena, JL
   Cavalcanti, DP
   Catharino, RR
AF de Oliveira, Diogo N.
   Lima, Estela O.
   Melo, Carlos F. O. R.
   Delafiori, Jeany
   Guerreiro, Tatiane M.
   Rodrigues, Rafael G. M.
   Morishita, Karen N.
   Silveira, Cynthia
   Muraro, Stefanie Primon
   de Souza, Gabriela Fabiano
   Vieira, Aline
   Silva, Antonio
   Batista, Rosangela F.
   Doriqui, Maria J. R.
   Sousa, Patricia S.
   Milanez, Guilherme P.
   Proenca-Modena, Jose L.
   Cavalcanti, Denise P.
   Catharino, Rodrigo R.
TI Inflammation markers in the saliva of infants born from Zika-infected
   mothers: exploring potential mechanisms of microcephaly during fetal
   development
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PPAR-GAMMA; VIRUS; ACTIVATION
AB Zika virus (ZIKV) has emerged as one of the most medically relevant viral infections of the past decades; the devastating effects of this virus over the developing brain are a major matter of concern during pregnancy. Although the connection with congenital malformations are well documented, the mechanisms by which ZIKV reach the central nervous system (CNS) and the causes of impaired cortical growth in affected fetuses need to be better addressed. We performed a non-invasive, meta bolomicsbased screening of saliva from infants with congenital Zika syndrome (CZS), born from mothers that were infected with ZIKV during pregnancy. We were able to identify three biomarkers that suggest that this population suffered from an important inflammatory process; with the detection of mediators associated with glial activation, we propose that microcephaly is a product of immune response to the virus, as well as excitotoxicity mechanisms, which remain ongoing even after birth.
C1 [de Oliveira, Diogo N.; Lima, Estela O.; Melo, Carlos F. O. R.; Delafiori, Jeany; Guerreiro, Tatiane M.; Rodrigues, Rafael G. M.; Morishita, Karen N.; Catharino, Rodrigo R.] Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
   [Silveira, Cynthia; Cavalcanti, Denise P.] Univ Estadual Campinas, Sch Med Sci, Med Genet Dept, Campinas, SP, Brazil.
   [Muraro, Stefanie Primon; de Souza, Gabriela Fabiano; Vieira, Aline; Milanez, Guilherme P.; Proenca-Modena, Jose L.] Univ Estadual Campinas, Biol Inst, Dept Genet Evolut Microbiol & Immunol, Emerging Viruses Study Lab, Campinas, SP, Brazil.
   [Silva, Antonio; Batista, Rosangela F.; Doriqui, Maria J. R.; Sousa, Patricia S.] Univ Fed Maranhao, Publ Hlth Dept, Sao Luis, Brazil.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
EM rrc@g.unicamp.br
RI Silveira, Cynthia/AAE-4080-2019; Batista, Rosangela Fernandes
   Lucena/G-6808-2016; de Oliveira, Diogo Noin/C-3939-2013; Lima,
   Estela/W-5105-2019; Silva, Antonio/B-5410-2009; Proenca-Modena, Jose
   Luiz/C-8231-2014; Muraro, Stefanie/M-6705-2013
OI Batista, Rosangela Fernandes Lucena/0000-0002-1529-0165; de Oliveira,
   Diogo Noin/0000-0002-2725-476X; Lima, Estela/0000-0003-0479-0364; Silva,
   Antonio/0000-0003-4968-5138; Proenca-Modena, Jose
   Luiz/0000-0002-4996-3153; Melo, Carlos/0000-0003-0334-1065; Muraro,
   Stefanie/0000-0002-5105-6659
FU Brazilian Ministry of Health (Plano Nacional de Enfrentamento ao Aedes
   aegypti e a Microcefalia [Brazilian Plan for Fighting Aedes aegypti and
   Microcephaly]) [88887.137889/2017-00, 88882.305824/2013-01];
   CAPES/MECCAPESSpanish Government [14/2016]; CNPq/MCTI [14/2016];
   Decit/SCTIE/MS/FNDCT [14/2016]; Coordination for the Improvement of
   Higher Level Personnel (CAPES)CAPES [PNPD: 1578388, PROEX: 1489740]; Sao
   Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [11/50400-0, 18/14657-5, 16/17066-2,
   18/03321-6]; OCRC (Obesity Comorbidities Research Center) CEPID: CMPO
   -Centro Multidisciplinar de Pesquisa em Obesidade e Doencas Associadas,
   under FAPESP [13/07607-8]
FX DNO would like to thank the Brazilian Ministry of Health (Plano Nacional
   de Enfrentamento ao Aedes aegypti e a Microcefalia [Brazilian Plan for
   Fighting Aedes aegypti and Microcephaly]) for the fellowship under
   process No. 88887.137889/2017-00 and PNPD No. 88882.305824/2013-01. DPC,
   JLPM and RRC thank CAPES/MEC, CNPq/MCTI and Decit/SCTIE/MS/FNDCT for
   grant No. 14/2016. Our group thanks the Coordination for the Improvement
   of Higher Level Personnel (CAPES) for the fellowships from EOL (PNPD:
   1578388) and TMG (PROEX: 1489740). Finally, we acknowledge the Sao Paulo
   Research Foundation (FAPESP, Process Nos. 11/50400-0 and 18/14657-5 for
   RRC, and 16/17066-2 and 18/03321-6 for CFORM), as well as the financial
   support provided by the OCRC (Obesity Comorbidities Research Center)
   CEPID: CMPO -Centro Multidisciplinar de Pesquisa em Obesidade e Doencas
   Associadas, under FAPESP number 13/07607-8.
CR Amer RK, 2003, NEUROSCIENCE, V116, P935, DOI 10.1016/S0306-4522(02)00764-9
   An Y, 2014, J INFLAMM RES, V7, P57, DOI 10.2147/JIR.S63205
   Arruza L, 2016, PEDIATR RES, V79, P401, DOI 10.1038/pr.2015.87
   Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046/j.1460-9568.2000.00110.x
   Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Douda DN, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/520871
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Ferreira JN, 2013, ORGANOGENESIS, V9, P199, DOI 10.4161/org.25224
   Huan T., 2018, J ALZHEIMERS DIS, P1
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x
   Lima ED, 2018, J MASS SPECTROM, V53, P257, DOI 10.1002/jms.4058
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muraro SP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32576-y
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Camara-Lemarroy CR, 2012, SCI WORLD J, DOI 10.1100/2012/168953
   Sapkota S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00296
   Schuler-Faccini L., 2015, MMWR MORBIDITY MORTA
   Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Velandia M. L., 2012, VIRAL GENOMES MOL ST
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 38
TC 1
Z9 1
U1 2
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 20
PY 2019
VL 9
AR 13606
DI 10.1038/s41598-019-49796-5
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IZ3RD
UT WOS:000487002100001
PM 31541139
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xu, S
   Ci, YL
   Wang, LJ
   Yang, Y
   Zhang, LL
   Xu, CM
   Qin, CF
   Shi, L
AF Xu, Shan
   Ci, Yali
   Wang, Leijie
   Yang, Yang
   Zhang, Leiliang
   Xu, Caimin
   Qin, Chengfeng
   Shi, Lei
TI Zika virus NS3 is a canonical RNA helicase stimulated by NS5 RNA
   polymerase
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN-3 NS3; DNA UNWINDING ACTIVITY;
   KINETIC-ANALYSIS; SERINE-PROTEASE; HCVNS3 HELICASE; DENGUE; DOMAIN;
   TYPE-2; REPLICATION
AB Zika virus is a positive single-strand RNA virus whose replication involved RNA unwinding and synthesis. ZIKV NS3 contains a helicase domain, but its enzymatic activity is not fully characterized. Here, we established a dsRNA unwinding assay based on the FRET effect to study the helicase activity of ZIKV NS3, which provided kinetic information in real time. We found that ZIKV NS3 specifically unwound dsRNA/dsDNA with a 3' overhang in the 3' to 5' direction. The RNA unwinding ability of NS3 significantly decreased when the duplex was longer than 18 base pairs. The helicase activity of NS3 depends on ATP hydrolysis and binding to RNA. Mutations in the ATP binding region or the RNA binding region of NS3 impair its helicase activity, thus blocking viral replication in the cell. Furthermore, we showed that ZIKV NS5 interacted with NS3 and stimulated its helicase activity. Disrupting NS3-NS5 interaction resulted in a defect in viral replication, revealing the tight coupling of RNA unwinding and synthesis. We suggest that NS3 helicase activity is stimulated by NS5; thus, viral replication can be carried out efficiently. Our work provides a molecular mechanism of ZIKV NS3 unwinding and novel insights into ZIKV replication.
C1 [Xu, Shan; Ci, Yali; Wang, Leijie; Yang, Yang; Xu, Caimin; Shi, Lei] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China.
   [Xu, Shan; Ci, Yali; Wang, Leijie; Yang, Yang; Xu, Caimin; Shi, Lei] Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.
   [Xu, Shan; Ci, Yali; Wang, Leijie; Yang, Yang; Xu, Caimin; Shi, Lei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China.
   [Zhang, Leiliang] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing, Peoples R China.
   [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
RP Shi, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China.; Shi, L (corresponding author), Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.; Shi, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China.
EM shilei@ibms.pumc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81788101, 81622028, 31470813]; 1000 Talents Plan
   Youth program; CAMS Innovation Fund for Medical Sciences (CIFMS)
   [2016-I2M-3-020]; Chinese Academy of Medical Sciences [2016ZX310192,
   2016RC310037, 2016RC310031]; CAMS Innovation Fund for Medical Sciences
FX National Natural Science Foundation of China [81788101, 81622028,
   31470813], 1000 Talents Plan Youth program (to L.S.); CAMS Innovation
   Fund for Medical Sciences (CIFMS) [2016-I2M-3-020]; Chinese Academy of
   Medical Sciences [2016ZX310192, 2016RC310037, 2016RC310031]. Funding for
   open access charge: National Natural Science Foundation of China; CAMS
   Innovation Fund for Medical Sciences.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Brand C, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1437
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Duffy Erin E, 2016, Curr Protoc Chem Biol, V8, P234, DOI 10.1002/cpch.12
   Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023
   Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331
   Fontanet A, 2016, LANCET, V387, P2600, DOI 10.1016/S0140-6736(16)30773-5
   Garcia-Garcia C, 2015, SCIENCE, V348, P1486, DOI 10.1126/science.aaa5089
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007
   Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008
   Jennings TA, 2009, J BIOL CHEM, V284, P4806, DOI 10.1074/jbc.M805540200
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102
   Lim SM, 2013, J VIROL METHODS, V194, P146, DOI 10.1016/j.jviromet.2013.07.050
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006
   Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130
   Ozes A, 2014, NAT PROTOC, V9, P1645, DOI 10.1038/nprot.2014.112
   Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168
   Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200
   Porter DJT, 1998, J BIOL CHEM, V273, P14247, DOI 10.1074/jbc.273.23.14247
   Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Rajagopal V, 2008, J MOL BIOL, V376, P69, DOI 10.1016/j.jmb.2007.10.070
   Reynolds KA, 2015, BIOCHEMISTRY-US, V54, P4248, DOI 10.1021/acs.biochem.5b00214
   Rosales-Leon L, 2007, J MOL GRAPH MODEL, V25, P585, DOI 10.1016/j.jmgm.2006.04.001
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011
   Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200
   Sladewski TE, 2011, MOL MICROBIOL, V80, P524, DOI 10.1111/j.1365-2958.2011.07590.x
   Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Teramoto T, 2017, J BIOL CHEM, V292, P9465, DOI [10.1074/jbc.M117.775643, 10.1074/jbc.m117.775643]
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 61
TC 6
Z9 6
U1 2
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD SEP 19
PY 2019
VL 47
IS 16
BP 8693
EP 8707
DI 10.1093/nar/gkz650
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JE3EN
UT WOS:000490576900032
PM 31361901
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sornjai, W
   Ramphan, S
   Wikan, N
   Auewarakul, P
   Smith, DR
AF Sornjai, Wannapa
   Ramphan, Suwipa
   Wikan, Nitwara
   Auewarakul, Prasert
   Smith, Duncan R.
TI High correlation between Zika virus NS1 antibodies and neutralizing
   antibodies in selected serum samples from normal healthy Thais
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TEMBUSU VIRUS; MONOCLONAL-ANTIBODIES; DENGUE INFECTION; PROTEIN NS1;
   ACUTE-PHASE; MOSQUITOS; TRAVELERS; THAILAND; ANTIGEN; BIOLOGY
AB Despite the widespread presence of the mosquito transmitted Zika virus (ZIKV) over much of Southeast Asia, the number of reported cases remains low. One possibility is that residents in Southeast Asia are immunologically protected, although the nature of any such protection remains unclear. This study sought to investigate the presence of antibodies directed to ZIKV NS1 protein in a selected sub-set of samples from a well characterized cohort of serum samples from normal, healthy Thais that had been previously characterized for the presence of neutralizing antibodies to ZIKV, DENV 1-4, and JEV. Because of similarities in molecular weight between the flavivirus E and NS1 proteins, an immunoblot system was established in which the NS1 antigen was not denatured, allowing detection of the dimer form of NS1, distinctly clear from the migration position of the E and NS1 monomer proteins. The results showed that antibodies to ZIKV NS1 protein were only detected in samples with ZIKV neutralizing antibodies (27/30 samples), and no sample (0/30) with a ZIKV plaque reduction neutralization test (PRNT)(90) < 20 showed evidence of anti-ZIKV NS1 antibodies. The high correlation between the presence of ZIKV NS1 antibodies and ZIKV PRNT suggests that immunological protection against ZIKV infection in Thailand arises from prior exposure to ZIKV, and not through cross neutralization.
C1 [Sornjai, Wannapa; Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Dept Microbiol, Fac Med, Bangkok, Thailand.
   [Sornjai, Wannapa; Ramphan, Suwipa; Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand.
EM duncan_r_smith@hotmail.com
FU National Science and Technology Development Agency [P-16-50685,
   FDA-CO-2559-1569-TH]; Thailand Research FundThailand Research Fund (TRF)
   [IRN60W0002, IRN5802PHDW03, IRN58W0002]; Mahidol University [IRN58W0002,
   BRG6080006]; Mahidol University Post-Doctoral Fellowship
FX D.R.S. is supported by the National Science and Technology Development
   Agency (P-16-50685 and FDA-CO-2559-1569-TH) and the Thailand Research
   Fund and Mahidol University (BRG6080006 and IRN58W0002). P.A. is
   supported by the Thailand Research Fund (IRN60W0002). S.R. is supported
   by a scholarship from the Thailand Research Fund (IRN5802PHDW03 under
   IRN58W0002). W.S. was supported by a Mahidol University Post-Doctoral
   Fellowship. The funders had no role in the design or interpretation of
   this work, or in the decision to submit for publication.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fortuna C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2320-1
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050
   Jaaskelainen AJ, 2019, J VIROL METHODS, V263, P68, DOI 10.1016/j.jviromet.2018.10.011
   Khongwichit S, 2018, MICROBES INFECT, V20, P670, DOI 10.1016/j.micinf.2018.01.007
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Konishi E, 2009, VACCINE, V27, P7053, DOI 10.1016/j.vaccine.2009.09.064
   Lan Phan Trong, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindholm DA, 2017, AM J TROP MED HYG, V96, P903, DOI 10.4269/ajtmh.16-0635
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Nitatpattana N, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.00121-18, 10.1128/genomea.00121-18]
   O'Guinn ML, 2013, AM J TROP MED HYG, V89, P1023, DOI 10.4269/ajtmh.13-0160
   Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Polwiang S, 2016, TRAVEL MED INFECT DI, V14, P398, DOI 10.1016/j.tmaid.2016.06.002
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   PONGPAIROJ S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P647
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Sornjai W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35643-6
   Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P193, DOI 10.1111/tbed.12085
   Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708
   WHO, 2007, GUID PLAQ RED NEUTR
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zhang W, 2017, J GEN VIROL, V98, P2413, DOI 10.1099/jgv.0.000908
NR 49
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 18
PY 2019
VL 9
AR 13498
DI 10.1038/s41598-019-49569-0
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IY4QY
UT WOS:000486379300003
PM 31534148
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leda, AR
   Bertrand, L
   Andras, IE
   El-Hage, N
   Nair, M
   Toborek, M
AF Leda, Ana Rachel
   Bertrand, Luc
   Andras, Ibolya Edit
   El-Hage, Nazira
   Nair, Madhavan
   Toborek, Michal
TI Selective Disruption of the Blood-Brain Barrier by Zika Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; blood-brain barrier; endothelial cells; tight junctions;
   neuroinfection
ID ENDOTHELIAL-CELLS; SEXUAL TRANSMISSION; HIV-1; INFECTION; MECHANISMS;
   OCCLUDIN; ENCEPHALITIS; PATHOGENESIS; EXPRESSION; PROTECTION
AB The blood-brain barrier (BBB) selectively regulates the cellular exchange of macromolecules between the circulation and the central nervous system (CNS). Here, we hypothesize that Zika virus (ZIKV) infects the brain via a disrupted BBB and altered expression of tight junction (TJ) proteins, which are structural components of the BBB. To assess this hypothesis, in vitro and in vivo studies were performed using three different strains of ZIKV: Honduras (ZIKV-H), Puerto Rico (ZIKV-PR), and Uganda (ZIKV-U). Primary human brain microvascular endothelial cells (BMECs) were productively infected by all studied ZIKV strains at MOI 0.01, and were analyzed by plaque assay, immunofluorescence for NS1 protein, and qRT-PCR at 2 and 6 days post-infection (dpi). Compared to mock-infected controls, expression level of ZO-1 was significantly upregulated in ZIKV-H-infected BMECs, while occludin and claudin-5 levels were significantly downregulated in BMECs infected by all three studied viral strains. Interestingly, BMEC permeability was not disturbed by ZIKV infection, even in the presence of a very high viral load (MOI 10). All studied ZIKV strains productively infected wild-type C57BL/J mice after intravenous infection with 10(7) PFU. Viral load was detected in the plasma, spleen, and brain from 1 to 8 dpi. Peak brain infection was observed at 2 dpi; therefore, TJ protein expression was assessed at this time point. Claudin-5 was significantly downregulated in ZIKV-U-infected animals and the BBB integrity was significantly disturbed in ZIKV-H-infected animals. Our results suggest that ZIKV penetrates the brain parenchyma early after infection with concurrent alterations of TJ protein expression and disruption of the BBB permeability in a strain-dependent manner.
C1 [Leda, Ana Rachel; Bertrand, Luc; Andras, Ibolya Edit; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.
   [El-Hage, Nazira; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol & Nanomed, Miami, FL 33199 USA.
RP Leda, AR; Toborek, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.
EM aleda@miami.edu; mtoborek@med.miami.edu
OI Leda, Ana/0000-0003-0276-0487
FU Florida Department of Health [7ZK09]
FX This work was supported by the Florida Department of Health, Grant
   #7ZK09.
CR Andras IE, 2017, MOL CELL NEUROSCI, V79, P12, DOI 10.1016/j.mcn.2016.12.006
   Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115
   Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bertrand L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10046-x
   Bertrand L, 2019, BRAIN, V142, P502, DOI 10.1093/brain/awy339
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cain MD, 2017, J NEUROIMMUNOL, V308, P118, DOI 10.1016/j.jneuroim.2017.04.008
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cho HJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00410
   Crema A, 2015, CURR DRUG TARGETS, V16, P757, DOI 10.2174/1389450116666150213111603
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Diop F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206093
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fahey E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01426
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991
   Kim JH, 2016, COMP IMMUNOL MICROB, V48, P22, DOI 10.1016/j.cimid.2016.07.007
   Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee YW, 2004, CARDIOVASC RES, V63, P139, DOI 10.1016/j.cardiores.2004.03.006
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liao X, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0680-1
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08
   Lodermeyer V, 2018, J VIROL, V92, DOI 10.1128/JVI.00226-18
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   McRae M, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1143543
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nau R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00138
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Palus M, 2017, VIROLOGY, V507, P110, DOI 10.1016/j.virol.2017.04.012
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Park M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34111
   Park M, 2013, J BIOL CHEM, V288, P33324, DOI 10.1074/jbc.M113.483487
   Pu H, 2005, J CEREBR BLOOD F MET, V25, P1325, DOI 10.1038/sj.jcbfm.9600125
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0
   Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008
   Siddiqui MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135875
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TOBOREK M, 1995, ATHEROSCLEROSIS, V117, P179, DOI 10.1016/0021-9150(95)05568-H
   Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012
NR 72
TC 1
Z9 1
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 18
PY 2019
VL 10
AR 2158
DI 10.3389/fmicb.2019.02158
PG 14
WC Microbiology
SC Microbiology
GA IY4TD
UT WOS:000486385000003
PM 31620112
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goertz, GP
   van Bree, JWM
   Hiralal, A
   Fernhout, BM
   Steffens, C
   Boeren, S
   Visser, TM
   Vogels, CBF
   Abbo, SR
   Fros, JJ
   Koenraadt, CJM
   van Oers, MM
   Pijlman, GP
AF Goertz, Giel P.
   van Bree, Joyce W. M.
   Hiralal, Anwar
   Fernhout, Bas M.
   Steffens, Carmen
   Boeren, Sjef
   Visser, Tessa M.
   Vogels, Chantal B. F.
   Abbo, Sandra R.
   Fros, Jelke J.
   Koenraadt, Constantianus J. M.
   van Oers, Monique M.
   Pijlman, Gorben P.
TI Subgenomic flavivirus RNA binds the mosquito DEAD/H-box helicase ME31B
   and determines Zika virus transmission by Aedes aegypti
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; subgenomic flavivirus RNA; Aedes aegypti; RNA-affinity
   purification; transmission
ID WEST-NILE; DENGUE VIRUS; 3'-UNTRANSLATED REGION; ARBOVIRUS INFECTION;
   ATAXIN-2 PROTEIN; P-BODY; TRANSLATION; INTERFERENCE; CELLS; DDX6
AB Zika virus (ZIKV) is an arthropod-borne flavivirus predominantly transmitted by Aedes aegypti mosquitoes and poses a global human health threat. All flaviviruses, including those that exclusively replicate in mosquitoes, produce a highly abundant, noncoding subgenomic flavivirus RNA (sfRNA) in infected cells, which implies an important function of sfRNA during mosquito infection. Currently, the role of sfRNA in flavivirus transmission by mosquitoes is not well understood. Here, we demonstrate that an sfRNA-deficient ZIKV (ZIKV Delta SF1) replicates similar to wild-type ZIKV in mosquito cell culture but is severely attenuated in transmission by Ae. aegypti after an infectious blood meal, with 5% saliva-positive mosquitoes for ZIKV Delta SF1 vs. 31% for ZIKV. Furthermore, viral titers in the mosquito saliva were lower for ZIKV Delta SF1 as compared to ZIKV. Comparison of mosquito infection via infectious blood meals and intrathoracic injections showed that sfRNA is important for ZIKV to overcome the mosquito midgut barrier and to promote virus accumulation in the saliva. Next-generation sequencing of infected mosquitoes showed that viral small-interfering RNAs were elevated upon ZIKV Delta SF1 as compared to ZIKV infection. RNA-affinity purification followed by mass spectrometry analysis uncovered that sfRNA specifically interacts with a specific set of Ae. aegypti proteins that are normally associated with RNA turnover and protein translation. The DEAD/H-box helicase ME31B showed the highest affinity for sfRNA and displayed antiviral activity against. ZIKV in Ae. aegypti cells. Based on these results, we present a mechanistic model in which sfRNA sequesters ME31B to promote flavivirus replication and virion production to facilitate transmission by mosquitoes.
C1 [Goertz, Giel P.; van Bree, Joyce W. M.; Hiralal, Anwar; Fernhout, Bas M.; Steffens, Carmen; Abbo, Sandra R.; Fros, Jelke J.; van Oers, Monique M.; Pijlman, Gorben P.] Wageningen Univ & Res, Lab Virol, NL-6708 PB Wageningen, Netherlands.
   [Boeren, Sjef] Wageningen Univ & Res, Lab Biochem, NL-6708 WE Wageningen, Netherlands.
   [Visser, Tessa M.; Vogels, Chantal B. F.; Koenraadt, Constantianus J. M.] Wageningen Univ & Res, Lab Entomol, NL-6708 PB Wageningen, Netherlands.
   [Vogels, Chantal B. F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
RP Pijlman, GP (corresponding author), Wageningen Univ & Res, Lab Virol, NL-6708 PB Wageningen, Netherlands.
EM gorben.pijlman@wur.nl
RI Fros, Jelke/AAN-5110-2020
OI Vogels, Chantal/0000-0003-0027-6480; Visser, Tessa/0000-0003-0899-7450
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Andrews S, FASTQC QUALITY CONTR
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Charley PA, 2014, CURR OPIN VIROL, V9, P14, DOI 10.1016/j.coviro.2014.09.001
   Chen YS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201250
   Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goertz GP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030271
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lee J, 2017, MOL CELL, V66, P129, DOI 10.1016/j.molcel.2017.03.004
   Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956
   Lim C, 2013, SCIENCE, V340, P875, DOI 10.1126/science.1234785
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108
   McIntyre W, 2018, NUCLEIC ACIDS RES, V46, P5776, DOI 10.1093/nar/gky029
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Olmo RP, 2018, NAT MICROBIOL, V3, P1385, DOI 10.1038/s41564-018-0268-6
   Ostareck DH, 2014, WIRES RNA, V5, P659, DOI 10.1002/wrna.1237
   Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Poblete-Duran N., 2016, VIRUSES, V8, P1
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Standart N, 2018, TRENDS GENET, V34, P612, DOI 10.1016/j.tig.2018.05.005
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WHO, 2017, GLOB VECT CONTR RESP, P41
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yang F, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-17, 10.1186/1743-422X-8-492]
   Yeh SC, 2018, DNA CELL BIOL, V37, P154, DOI 10.1089/dna.2017.4059
   Zhang Y, 2013, SCIENCE, V340, P879, DOI 10.1126/science.1234746
NR 67
TC 3
Z9 3
U1 6
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 17
PY 2019
VL 116
IS 38
BP 19136
EP 19144
DI 10.1073/pnas.1905617116
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IY4UL
UT WOS:000486388400060
PM 31488709
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Haqshenas, G
   Doerig, C
AF Haqshenas, Gholamreza
   Doerig, Christian
TI Targeting of host cell receptor tyrosine kinases by intracellular
   pathogens
SO SCIENCE SIGNALING
LA English
DT Review
ID GROWTH-FACTOR RECEPTOR; C VIRUS ENTRY; ZIKA VIRUS;
   LISTERIA-MONOCYTOGENES; PLASMODIUM-FALCIPARUM; ENDOTHELIAL-CELLS; DENGUE
   VIRUS; PROTEIN; ACTIVATION; AXL
AB Intracellular pathogens use complex and tightly regulated processes to enter host cells. Upon initial interactions with signaling proteins at the surface of target cells, intracellular microbes activate and co-opt specific host signaling pathways that mediate cell surface-cytosol communications to facilitate pathogen internalization. Here, we discuss the roles of host receptor tyrosine kinases (RTKs) in the establishment of productive infections by major intracellular pathogens. We evaluate the gaps in the current understanding of this process and propose a comprehensive approach for assessing the role of host cell signaling in the biology of intracellular microorganisms and viruses. We also discuss RTK-targeting strategies for the treatment of various infections.
C1 [Haqshenas, Gholamreza; Doerig, Christian] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun, Clayton, Vic 3800, Australia.
   [Haqshenas, Gholamreza; Doerig, Christian] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.
   [Doerig, Christian] RMIT Univ, Sch Hlth & Biomed Sci, Ctr Chron Infect & Inflammatory Dis, Bundoora, Vic 3083, Australia.
RP Haqshenas, G; Doerig, C (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun, Clayton, Vic 3800, Australia.; Haqshenas, G; Doerig, C (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.; Doerig, C (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Ctr Chron Infect & Inflammatory Dis, Bundoora, Vic 3083, Australia.
EM gholamreza.haqshenas@monash.edu; christian.doerig@rmit.edu.au
OI Doerig, Christian/0000-0002-3188-094X; Haqshenas,
   Gholamreza/0000-0003-1559-5046
FU Australian Centre for HIV and Hepatitis Virology Research (ACH2);
   Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia
FX This research project was supported by grants from the Australian Centre
   for HIV and Hepatitis Virology Research (ACH2) and the Australian
   National Health and Medical Research Council.
CR Abu-Thuraia A, 2015, MOL CELL BIOL, V35, P76, DOI 10.1128/MCB.00764-14
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314
   Bhalla M, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00689-18
   Bhalla M, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00087-17
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bierne H, 2002, J CELL SCI, V115, P3357
   Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11
   Bonazzi M, 2006, FEBS LETT, V580, P2962, DOI 10.1016/j.febslet.2006.04.010
   Boulant S, 2015, VIRUSES-BASEL, V7, P2794, DOI 10.3390/v7062747
   Carrolo M, 2003, NAT MED, V9, P1363, DOI 10.1038/nm947
   Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Chi SS, 2011, J BIOL CHEM, V286, P35196, DOI 10.1074/jbc.M111.247577
   Cossart P, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016972
   de Carvalho TMU, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00106
   Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12
   Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540
   Drayman N, 2013, CELL HOST MICROBE, V14, P63, DOI 10.1016/j.chom.2013.05.005
   Drolia R, 2018, CELL HOST MICROBE, V23, P470, DOI 10.1016/j.chom.2018.03.004
   Duangkhae P, 2018, J INVEST DERMATOL, V138, P618, DOI 10.1016/j.jid.2017.10.018
   Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099
   Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Galluzzi L, 2018, CELL, V173, DOI 10.1016/j.cell.2018.03.015
   Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012
   Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459
   Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011
   Haqshenas G, 2019, CELL REP, V26, P529, DOI 10.1016/j.celrep.2018.12.068
   Haqshenas G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15158
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Ho J, 2017, TRENDS MICROBIOL, V25, P942, DOI 10.1016/j.tim.2017.04.009
   Hsu ACY, 2015, AM J RESP CRIT CARE, V191, P1012, DOI 10.1164/rccm.201501-0188OC
   Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748
   Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kedzierski L, 2017, ELIFE, V6, DOI 10.7554/eLife.20444
   Kim JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002285
   Kirkegaard K, 2017, P NATL ACAD SCI USA, V114, P6653, DOI 10.1073/pnas.1707142114
   Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699
   Krause-Gruszczynska M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-32
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kumar B, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110305
   Kumar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30490
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011
   Limonta D., 2019, J INFECT DIS
   Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341
   McKnight KL, 2017, P NATL ACAD SCI USA, V114, P6587, DOI 10.1073/pnas.1619519114
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155
   Meyer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09012
   Miaczynska M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009035
   Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325
   Mohr EL, 2015, ANTIVIR RES, V120, P40, DOI 10.1016/j.antiviral.2015.05.003
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037
   Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027
   Oppliger J, 2016, J VIROL, V90, P6412, DOI 10.1128/JVI.00257-16
   Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556
   Penberthy KK, 2016, IMMUNOL REV, V269, P44, DOI 10.1111/imr.12376
   Prudencio M, 2013, CURR PHARM DESIGN, V19, P290, DOI 10.2174/138161213804070276
   Radoshevich L, 2018, NAT REV MICROBIOL, V16, P32, DOI 10.1038/nrmicro.2017.126
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006
   Roskoski R, 2019, PHARMACOL RES, V144, P19, DOI 10.1016/j.phrs.2019.03.006
   Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252
   Sarukhanyan E, 2018, ACS OMEGA, V3, P5281, DOI 10.1021/acsomega.8b00223
   Schor S, 2018, ACS INFECT DIS, V4, P88, DOI 10.1021/acsinfecdis.7b00268
   Schoumacher M, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0579-4
   Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078
   Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16
   Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0
   Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003
   Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808
   Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008
   Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209
   Srivastava A, 2016, CURR OPIN VIROL, V21, P75, DOI 10.1016/j.coviro.2016.08.003
   Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519
   Tham TN, 2010, INFECT IMMUN, V78, P204, DOI 10.1128/IAI.00661-09
   Ueki IF, 2013, J EXP MED, V210, P1929, DOI 10.1084/jem.20121401
   Van Ngo H, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12768
   Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001
   Vouri M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.66
   Vrijens P, 2019, J GEN VIROL, V100, P583, DOI 10.1099/jgv.0.001235
   Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351
   Wang R, 2016, BIOCHEM BIOPH RES CO, V475, P230, DOI 10.1016/j.bbrc.2016.05.084
   Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818
   Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79
   Weinkauf C, 2011, INFECT IMMUN, V79, P4081, DOI 10.1128/IAI.05403-11
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wiedemann A, 2016, FASEB J, V30, P4180, DOI 10.1096/fj.201600701R
   Wiedemann A, 2012, J BIOL CHEM, V287, P31148, DOI 10.1074/jbc.M112.392134
   Wu SY, 2019, NAT CELL BIOL, V21, P1027, DOI 10.1038/s41556-019-0352-z
   Wu YQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006281
   Xu QQ, 2016, FUTURE MICROBIOL, V11, P1227, DOI 10.2217/fmb-2016-0002
   Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003
   Zheng K, 2014, MBIO, V5, DOI 10.1128/mBio.00958-13
   Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109
   Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80
   Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006
   Zuccala ES, 2016, SCI REP-UK, V6, DOI 10.1038/srep19766
NR 107
TC 4
Z9 4
U1 1
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD SEP 17
PY 2019
VL 12
IS 599
AR eaau9894
DI 10.1126/scisignal.aau9894
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA IY4UE
UT WOS:000486387700001
PM 31530732
OA Bronze
DA 2020-07-08
ER

PT J
AU Clapham, H
AF Clapham, Hannah
TI Determinants of Zika Transmission and Control
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika; vaccine development; transmission route; epidemiology; health
   economics
ID VIRUS; SEMEN
C1 [Clapham, Hannah] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
RP Clapham, H (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England.
EM hannah.clapham@ndm.ox.ac.uk
FU Wellcome TrustWellcome Trust [089276/B/09/7]
FX The author is funded by the Wellcome Trust (grant number 089276/B/09/7).
CR [Anonymous], 2016, TARG PROD PROF BETT
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Pan American Health Organization, OPS OMS EP AL UPD
   ProMED, PROMED SOAS S AS ZIK
   Shoukat A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1091-x
   Wellcome Trust, RES IS HELP KIDS GRO
   WHO, ZIK VIR COMPL 2016 P
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   World Health Organization, WHO VACC PIP TRACK
NR 14
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 15
PY 2019
VL 220
IS 6
BP 917
EP 919
DI 10.1093/infdis/jiy691
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9CF
UT WOS:000490985400001
PM 30544174
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bartsch, SM
   Asti, L
   Cox, SN
   Durham, DP
   Randall, S
   Hotez, PJ
   Galvani, AP
   Lee, BY
AF Bartsch, Sarah M.
   Asti, Lindsey
   Cox, Sarah N.
   Durham, David P.
   Randall, Samuel
   Hotez, Peter J.
   Galvani, Alison P.
   Lee, Bruce Y.
TI What Is the Value of Different Zika Vaccination Strategies to Prevent
   and Mitigate Zika Outbreaks?
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; cost-effectiveness; vaccine
ID MALARIA VACCINE; VIRUS; EFFICACY; DENGUE
AB Background. While the 2015-2016 Zika epidemics prompted accelerated vaccine development, decision makers need to know the potential economic value of vaccination strategies.
   Methods. We developed models of Honduras, Brazil, and Puerto Rico, simulated targeting different populations for Zika vaccination (women of childbearing age, school-aged children, young adults, and everyone) and then introduced various Zika outbreaks. Sensitivity analyses varied vaccine characteristics.
   Results. With a 2% attack rate ($5 vaccination), compared to no vaccination, vaccinating women of childbearing age cost $314-$1664 per case averted ($790-$4221/disability-adjusted life-year [DALY] averted) in Honduras, and saved $847-$1644/case averted in Brazil, and $3648-$4177/case averted in Puerto Rico, varying with vaccination coverage and efficacy (societal perspective). Vaccinating school-aged children cost $718-$1849/case averted (<=$5002/DALY averted) in Honduras, saved $819-$1609/case averted in Brazil, and saved $3823-$4360/case averted in Puerto Rico. Vaccinating young adults cost $310-$1666/case averted ($731-$4017/DALY averted) in Honduras, saved $953-$1703/case averted in Brazil, and saved $3857-$4372/case averted in Puerto Rico. Vaccinating everyone averted more cases but cost more, decreasing cost savings per case averted. Vaccination resulted in more cost savings and better outcomes at higher attack rates.
   Conclusions. When considering transmission, while vaccinating everyone naturally averted the most cases, specifically targeting women of childbearing age or young adults was the most cost-effective.
C1 [Bartsch, Sarah M.; Asti, Lindsey; Cox, Sarah N.; Randall, Samuel; Lee, Bruce Y.] Johns Hopkins Bloomberg Sch Publ Hlth, GOPC, Baltimore, MD USA.
   [Bartsch, Sarah M.; Asti, Lindsey; Cox, Sarah N.; Randall, Samuel; Lee, Bruce Y.] Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Profess & Operat Res PHICOR, Baltimore, MD USA.
   [Durham, David P.; Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA.
   [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
RP Lee, BY (corresponding author), Johns Hopkins Univ, 615 N Wolfe St,Rm W3501, Baltimore, MD 21205 USA.
EM brucelee@jhu.edu
FU Bill & Melinda Gates FoundationGates Foundation [OPP1139051]; Instituto
   Carlos Slim de la Salud; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U01 GM087719, U01 GM105627, U54HD070725, U01 HD086861]; Agency
   for Healthcare Research and QualityUnited States Department of Health &
   Human ServicesAgency for Healthcare Research & Quality [R01HS023317]; US
   Agency for International DevelopmentUnited States Agency for
   International Development (USAID) [AID-OAA-A-15-00064]
FX This work was supported by the Bill & Melinda Gates Foundation (Award
   Number OPP1139051); Instituto Carlos Slim de la Salud; the National
   Institutes of Health (grant numbers U01 GM087719, U01 GM105627,
   U54HD070725, U01 HD086861); the Agency for Healthcare Research and
   Quality (grant number R01HS023317); and the US Agency for International
   Development (grant number AID-OAA-A-15-00064).
CR Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685
   Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1
   Barreto Mauricio L., 2006, J. Pediatr. (Rio J.), V82, ps45, DOI 10.1590/S0021-75572006000400006
   Centers for Disease Control and Prevention, 2005, SEAS INFL VACC EFF
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Durham DP, 2018, ANN INTERN MED, V168, P621, DOI 10.7326/M17-0641
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Lee BY, 2010, VACCINE, V28, P2806, DOI 10.1016/j.vaccine.2009.09.047
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Macciocchi D, 2016, NEW MICROBIOL, V39, P287
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Rodrigues MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0703-y
   Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   *WHO, CHOOS INT AR COST EF
   WORLD BANK, 2016, WORLD DEV IND 1960 2
   World Bank, 2015, UPD INC CLASS
NR 27
TC 3
Z9 3
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 15
PY 2019
VL 220
IS 6
BP 920
EP 931
DI 10.1093/infdis/jiy688
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9CF
UT WOS:000490985400002
PM 30544164
OA Bronze
DA 2020-07-08
ER

PT J
AU Rosenberg, ES
   Doyle, K
   Munoz-Jordan, JL
   Klein, L
   Adams, L
   Lozier, M
   Weiss, K
   Sharp, TM
   Paz-Bailey, G
AF Rosenberg, Eli S.
   Doyle, Kate
   Munoz-Jordan, Jorge L.
   Klein, Liore
   Adams, Laura
   Lozier, Matthew
   Weiss, Kevin
   Sharp, Tyler M.
   Paz-Bailey, Gabriela
TI Prevalence and Incidence of Zika Virus Infection Among Household
   Contacts of Patients With Zika Virus Disease, Puerto Rico, 2016-2017
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; arbovirus; household transmission; sexual transmission
ID MALE SEXUAL TRANSMISSION; OUTBREAK
AB Background. Little is known about the prevalence or incidence of Zika virus (ZIKV) infection in settings affected by the 20152016 Zika pandemic and associated risk factors. We assessed these factors among household contacts of patients with ZIKV disease enrolled in a cohort study in Puerto Rico during 2016-2017.
   Methods. Household contacts of index case patients completed a questionnaire and gave specimens for real-time polymerase chain reaction (RT-PCR) and immunoglobulin M enzyme-linked immunosorbent assay testing to detect ZIKV infection. We measured the prevalence of ZIKV infection among contacts and associated individual and household factors, examined sexual transmission using a sexual-networks approach, and assessed incident infection among initially uninfected household contacts 2-4 months later.
   Results. Of 366 contacts, 34.4% had evidence of ZIKV infection at enrollment, including 11.2% by RT-PCR. Having open doors and windows that were either screened (prevalence ratio [PR], 2.1 [95% confidence interval {CI}, 1.2-3.6]) or unscreened (PR, 2.5 [95% CI, 1.5-4.1]) was associated with increased prevalence. Sexual partners were more likely to both be RT-PCR positive relative to other relationships (odds ratio, 2.2 [95% CI, 1.1-4.5]). At follow-up, 6.1% of contacts had evidence of incident infection.
   Conclusions. This study identified sexual contact as a risk factor for ZIKV infection. Persons living with ZIKV-infected individuals should be a focus of public health efforts.
C1 [Rosenberg, Eli S.] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY 12144 USA.
   [Doyle, Kate] Ctr Dis Control & Prevent, Natl Ctr HIVAIDS Viral Hepatitis Sexually Transmi, Atlanta, GA USA.
   [Munoz-Jordan, Jorge L.; Adams, Laura; Lozier, Matthew; Sharp, Tyler M.; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, San Juan, PR USA.
   [Klein, Liore] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Weiss, Kevin] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth Emory, Atlanta, GA 30322 USA.
RP Rosenberg, ES (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY 12144 USA.
EM erosenberg2@albany.edu
RI Weiss, Kevin/AAI-8250-2020
OI Weiss, Kevin/0000-0001-9669-8236
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA
FX This study was supported by the CDC.
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bloch D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005075
   Burger-Calderon R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006518
   Centers for Disease Control and Prevention, CLIN GUID HEALTHC PR
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DIGGLE P. J, 2002, ANAL LONGITUDINAL DA
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   HOLMES K, 2008, SEXUALLY TRANSMITTED
   Kenny DA, 2006, DYADIC DATA ANAL
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   KORN EL, 1999, ANAL HLTH SURVEYS
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   US Food and Drug Administration, 2016, ZIK VIR EM US AUTH Z
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   WHO, 2016, PREV SEX TRANSM ZIK
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 33
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 15
PY 2019
VL 220
IS 6
BP 932
EP 939
DI 10.1093/infdis/jiy689
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9CF
UT WOS:000490985400003
PM 30544195
OA Bronze
DA 2020-07-08
ER

PT J
AU Steinmetz, M
   Lima, D
   Viana, AG
   Fujiwara, ST
   Pessoa, CA
   Etto, RM
   Wohnrath, K
AF Steinmetz, Marines
   Lima, Dhesmon
   Viana, Adriano Goncalves
   Fujiwara, Sergio Toshio
   Pessoa, Christiana Andrade
   Etto, Rafael Mazer
   Wohnrath, Karen
TI A sensitive label-free impedimetric DNA biosensor based on
   silsesquioxane-functionalized gold nanoparticles for Zika Virus
   detection
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE ZIKV diagnosis; Impedimetric biosensor; Gold nanoparticles;
   Silsesquioxane
ID BEHAVIOR; METAL; ACID
AB Zika virus (ZIKV) has recently become a global health challenge due to its rapid geographical expansion, since it is associated with serious neurological anomalies such as Guillain-Barre syndrome and microcephaly. Currently, the techniques for ZIKV diagnosis require labor-intensive, expensive and lengthy tests using sophisticated equipment. Moreover, false-positive or false-negative results can occur. In the present work, a DNA biosensor to detect ZIKV in real human serum samples was developed using an oxidized glassy carbon electrode (ox-GCE) modified with silsesquioxane-functionalized gold nanoparticles (AuNPs-SiPy). This nanohybrid was characterized by UV-Vis, FTIR and Raman spectroscopies, DLS, and XRD. The conditions for the immobilization of a ZIKV ssDNA probe on the electrode surface (ox-GCE-[AuNPs-SiPy]) were optimized by univariate and multivariate analysis. The optimized biosensor was characterized by CV, EIS and AFM experiments. The ZIKV target recognition was based on the variation of the charge transfer resistance (Delta R-ct) of the redox marker ([Fe(CN)(6)](3-/4-)) used and the roughness (R-q) of the electrode surface. The proposed biosensor presented a LOD of 0.82 pmol L-1, with a linear range of 1.0 x10(-12) - 1.0 x10(-6) mol L-1. Moreover, the reported device showed a suitable stability and satisfactory sensitivity and selectivity to quantify ZIKV in human serum samples, which suggests its promising clinical applications for the early diagnosis of ZIKV-associated pathologies.
C1 [Steinmetz, Marines; Lima, Dhesmon; Viana, Adriano Goncalves; Fujiwara, Sergio Toshio; Pessoa, Christiana Andrade; Etto, Rafael Mazer; Wohnrath, Karen] Univ Estadual Ponta Grossa, Dept Chem, Ave Gen Carlos Cavalcanti 4748, BR-84030900 Ponta Grosso, Parana, Brazil.
RP Wohnrath, K (corresponding author), Univ Estadual Ponta Grossa, Dept Chem, Ave Gen Carlos Cavalcanti 4748, BR-84030900 Ponta Grosso, Parana, Brazil.
EM karen.woh@gmail.com
RI Wohnrath, Karen/AAF-2999-2019; Etto, Rafael Mazer/K-9367-2015
OI Wohnrath, Karen/0000-0002-3606-9275; Etto, Rafael
   Mazer/0000-0001-5138-7418; Goncalves Viana, Adriano/0000-0002-9978-8058
FU Brazilian governmental agency Fundacao Araucaria (FASESA) [073/2016 - CP
   04/2016]
FX The authors are grateful for financial support (grant and scholarship)
   from the Brazilian governmental agency Fundacao Araucaria (FASESA, grant
   number 073/2016 - CP 04/2016). We are also grateful to the Multi-User
   Laboratory Complex (C-Labmu/UEPG) and the to State University of Ponta
   Grossa (UEPG). We thank Cristiane Andrea Erdmann for the X -Rays
   analysis and Prof. R. T. Boere (University of Lethbridge, AB, Canada)
   for the helpful suggestions on the final text. We also thank Microbial
   Molecular Biology Laboratory (LABMOM/UEPG) team for technical support.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Alex S, 2015, J NANOSCI NANOTECHNO, V15, P1869, DOI 10.1166/jnn.2015.9718
   Alfaya R. V. S., 1998, PROCESSO PREPARACAO
   Amorim L., 2019, ZIKA VIRUS, P163, DOI [10.1007/978-3-319-94436-4, DOI 10.1007/978-3-319-94436-4]
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Austin LA, 2014, ARCH TOXICOL, V88, P1391, DOI 10.1007/s00204-014-1245-3
   Bard A.J., 2001, ELECTROCHEMICAL METH
   Benvidi A, 2015, SENSOR ACTUAT B-CHEM, V207, P673, DOI 10.1016/j.snb.2014.10.043
   Brett C.M.A., 1993, ELECTROCHEMISTRY PRI
   Burke LD, 1997, GOLD BULL, V30, P43, DOI 10.1007/BF03214756
   Cai H, 2001, J ELECTROANAL CHEM, V510, P78, DOI 10.1016/S0022-0728(01)00548-4
   Calaca GN, 2017, ELECTROCHIM ACTA, V249, P104, DOI 10.1016/j.electacta.2017.07.185
   Chao J, 2016, BIOSENS BIOELECTRON, V76, P68, DOI 10.1016/j.bios.2015.07.007
   da Silva PS, 2014, J HAZARD MATER, V273, P70, DOI 10.1016/j.jhazmat.2014.03.032
   Martinez JD, 2019, DERMATOL CLIN, V37, P95, DOI 10.1016/j.det.2018.07.008
   de Menezes EW, 2012, J SOLID STATE ELECTR, V16, P3703, DOI 10.1007/s10008-012-1782-8
   Dekanski A, 2001, CARBON, V39, P1195, DOI 10.1016/S0008-6223(00)00228-1
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Dinckaya E, 2011, BIOSENS BIOELECTRON, V26, P3806, DOI 10.1016/j.bios.2011.02.038
   Dowell S. D, 2017, PLOS NEGLECTED TROP, V11, P1, DOI [10.1371/journal.pntd.0005704, DOI 10.1371/JOURNAL.PNTD.0005704]
   Goncalves R, 2017, INT J ELECTROCHEM SC, V12, P1983, DOI 10.20964/2017.03.44
   de Castro ACH, 2018, J SOLID STATE ELECTR, V22, P2339, DOI 10.1007/s10008-018-3940-0
   Huang Y, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102375
   Jarocka U, 2014, BIOSENS BIOELECTRON, V55, P301, DOI 10.1016/j.bios.2013.12.030
   Kaushik A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28035-3
   Kumarasamy J, 2018, NANOSCALE, V10, P1196, DOI 10.1039/c7nr06952a
   Liu SF, 2010, BIOELECTROCHEMISTRY, V79, P37, DOI 10.1016/j.bioelechem.2009.10.005
   Mashhadizadeh MH, 2016, MAT SCI ENG C-MATER, V59, P773, DOI 10.1016/j.msec.2015.10.082
   Faria HAM, 2019, BIOSENS BIOELECTRON, V131, P149, DOI 10.1016/j.bios.2019.02.018
   Mossanha R, 2017, SENSOR ACTUAT B-CHEM, V252, P747, DOI 10.1016/j.snb.2017.06.001
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nic M, 1997, COMPENDIUM CHEM TERM, DOI [10.1351/goldbook, DOI 10.1351/GOLDBOOK]
   Oliveira DA, 2018, ANAL BIOCHEM, V549, P157, DOI 10.1016/j.ab.2018.03.023
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rafique B, 2019, SENSOR REV, V39, P34, DOI 10.1108/SR-08-2017-0156
   Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Tancharoen C, 2019, ACS SENSORS, V4, P69, DOI 10.1021/acssensors.8b00885
   Tian B, 2018, ACS SENSORS, V3, P1093, DOI 10.1021/acssensors.8b00048
   Wang L, 2017, BIOSENS BIOELECTRON, V87, P646, DOI 10.1016/j.bios.2016.09.006
   Wang Y, 2013, PHYS CHEM CHEM PHYS, V15, P3133, DOI [10.1039/c3xp44615h, 10.1039/c3cp44615h]
   Xie BP, 2018, SENSOR ACTUAT B-CHEM, V254, P1133, DOI 10.1016/j.snb.2017.06.085
   Zhang N., 2016, CELL STEM CELL, V19, P120, DOI [10.1016/j.stem.2016.04.017, DOI 10.1016/J.STEM.2016.04.017]
NR 44
TC 7
Z9 7
U1 19
U2 52
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD SEP 15
PY 2019
VL 141
AR UNSP 111351
DI 10.1016/j.bios.2019.111351
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA IY1DW
UT WOS:000486132800016
PM 31176113
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI CDC Clarification on Diagnostic Testing for Individuals Who Could Have
   Either Dengue or Zika
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 15
PY 2019
VL 69
IS 6
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IY9KD
UT WOS:000486711400005
DA 2020-07-08
ER

PT J
AU da Silva, EF
   de Araujo, JX
AF da Silva-Junior, Edeildo Ferreira
   de Araujo-Junior, Joao Xavier
TI Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West
   Nile, and Zika flaviviruses
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Review
DE Flavivirus; Dengue; West Nile; Zika; Peptides; Peptidomimetics
ID VIRUS NS2B/NS3 PROTEASE; ANGIOTENSIN-CONVERTING ENZYME; YELLOW-FEVER
   VIRUS; SERINE-PROTEASE; NS3 PROTEASE; SUBSTRATE-SPECIFICITY;
   NONSTRUCTURAL PROTEIN; SYNTHETIC PEPTIDES; BIOLOGICAL EVALUATION;
   MEDICINAL CHEMISTRY
AB Currently, more than 70 flaviviruses were identified and reported in the literature, whose Dengue (DENV), Zika (ZIKV), and West Nile (WNV) viruses have been responsible for millions of cases of infections worldwide, mainly in developing countries. These viruses are transmitted by the bite of mosquitoes from genus Aedes, or Culex and, in some cases, Stegomyia. Despite numerous efforts to identify a selective, safe, and effective antiviral agent, there is no currently approved drug for the treatment of flaviviral infections. Then, current pharmacological therapy has the objective to treat the clinical symptoms. Various peptidomimetics and peptide-derivatives have been synthesized and evaluated against several biological targets from flaviviruses with different applications, such as diagnosis, E protein inhibitors, entry inhibitors, virucidal inhibitors, and also viral replication inhibitors. Flaviviral replication depends on the NS3(pro) that is completely activated when it is complexed to its cofactor, NS2B; forming a viral enzymatic complex. The development of NS2B-NS3(pro) inhibitors is considered a challenging work due to its active site is shallow and open-pocket. In this work, we report all advances involving peptidomimetics, peptide-derived, and peptide-hybrids found in the literature. In sense, we discuss the influence of different functional groups in the activity and selectivity. Moreover, the first inhibitors reported in the literature as covalent ligands, comprising two basic residues followed by an electrophilic moiety that binds to the catalytic serine (Ser(135)-O-) are also discussed in details, such as trifluoromethyl ketones, aldehydes, and boronic acids. Furthermore, it is presented the influence of introducing transition metals, providing metallo-peptide inhibitors; and cyclization of linear peptides, generating cyclic and macrocyclic peptide inhibitors. Finally, we provide the most accurate state of the art found in the literature, which can be utilized to design new and effective antiviral agents.
C1 [da Silva-Junior, Edeildo Ferreira; de Araujo-Junior, Joao Xavier] Univ Fed Alagoas, Pharmaceut Sci Inst, Lab Med Chem, Maceio, Brazil.
RP da Silva, EF (corresponding author), Univ Fed Alagoas, Pharmaceut Sci Inst, Lab Med Chem, Maceio, Brazil.
EM edeildo.junior@esenfar.ufal.br
RI SILVA-JUNIOR, EDEILDO/S-3896-2019
OI SILVA-JUNIOR, EDEILDO/0000-0002-1527-4501
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil
   (CAPES)CAPES [001]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brazil (CAPES) - Finance Code 001. Also, the
   authors would like to give thanks to the National Council for Scientific
   and Technological Development (CNPq) - Brazil.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Alagarasu K, 2017, PEPTIDES, V92, P23, DOI 10.1016/j.peptides.2017.04.002
   Amir-Hassan A, 2017, J MOL GRAPH MODEL, V74, P273, DOI 10.1016/j.jmgm.2017.03.010
   Ang MJY, 2014, PEPTIDES, V52, P49, DOI 10.1016/j.peptides.2013.12.002
   Arranz-Gibert P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24517-6
   Au JS, 2014, CLIN PHARMACOL THER, V95, P78, DOI 10.1038/clpt.2013.206
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Becker GL, 2010, J MED CHEM, V53, P1067, DOI 10.1021/jm9012455
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107
   Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   CHOREV M, 1995, TRENDS BIOTECHNOL, V13, P438, DOI 10.1016/S0167-7799(00)88999-4
   Chu JJH, 2015, ANTIVIR RES, V118, P68, DOI 10.1016/j.antiviral.2015.03.010
   Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029
   Martinez JD, 2019, DERMATOL CLIN, V37, P95, DOI 10.1016/j.det.2018.07.008
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424
   De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010
   Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006
   Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   Gibbs AC, 2018, BIOCHEMISTRY-US, V57, P1591, DOI 10.1021/acs.biochem.7b01127
   Gokhale NH, 2005, CHEM COMMUN, P5916, DOI 10.1039/b511081e
   Gomes B, 2018, BIOTECHNOL ADV, V36, P415, DOI 10.1016/j.biotechadv.2018.01.004
   Gruba N, 2018, ACS MED CHEM LETT, V9, P1025, DOI 10.1021/acsmedchemlett.8b00316
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gustafsson D, 2004, NAT REV DRUG DISCOV, V3, P649, DOI 10.1038/nrd1466
   Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x
   Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n
   John AM, 2019, VIRUS RES, V260, P142, DOI 10.1016/j.virusres.2018.11.016
   Joyner JC, 2013, CHEM COMMUN, V49, P2118, DOI 10.1039/c3cc38977d
   Joyner JC, 2012, J AM CHEM SOC, V134, P3396, DOI 10.1021/ja208791f
   Joyner JC, 2011, J AM CHEM SOC, V133, P15613, DOI 10.1021/ja2052599
   Joyner JC, 2011, J AM CHEM SOC, V133, P9912, DOI 10.1021/ja203057z
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Kautner I, 1997, J PEDIATR-US, V131, P516, DOI 10.1016/S0022-3476(97)70054-4
   Khumthong R, 2003, PROTEIN PEPTIDE LETT, V10, P19, DOI 10.2174/0929866033408228
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim HA, 2013, EUR J MED CHEM, V62, P199, DOI 10.1016/j.ejmech.2012.12.043
   Lim HA, 2011, EUR J MED CHEM, V46, P3130, DOI 10.1016/j.ejmech.2011.04.055
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Lin KH, 2017, J VIROL, V91, DOI 10.1128/JVI.00045-17
   Lin KH, 2016, ACS INFECT DIS, V2, P734, DOI 10.1021/acsinfecdis.6b00131
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Majerova T, 2019, BIOCHIMIE, V166, P132, DOI 10.1016/j.biochi.2019.05.004
   Matsson P, 2016, ADV DRUG DELIVER REV, V101, P42, DOI 10.1016/j.addr.2016.03.013
   Monteiro JMC, 2018, VIROLOGY, V514, P79, DOI 10.1016/j.virol.2017.11.009
   Mueller NH, 2007, INT J BIOCHEM CELL B, V39, P606, DOI 10.1016/j.biocel.2006.10.025
   Murgue B, 2010, MICROBES INFECT, V12, P113, DOI 10.1016/j.micinf.2009.11.006
   Murugan SB, 2016, ASIAN PAC J TROP MED, V9, P910, DOI 10.1016/j.apjtm.2016.07.020
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Nedumpully-Govindan P, 2016, J CHEM INF MODEL, V56, P1042, DOI 10.1021/acs.jcim.5b00303
   Nicholson CO, 2011, ANTIVIR RES, V89, P71, DOI 10.1016/j.antiviral.2010.11.008
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Nitsche C, 2011, BIOORGAN MED CHEM, V19, P7318, DOI 10.1016/j.bmc.2011.10.061
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Nutho B, 2019, J PHYS CHEM B, V123, P2889, DOI 10.1021/acs.jpcb.9b02157
   Passioura T, 2014, ANNU REV BIOCHEM, V83, P727, DOI 10.1146/annurev-biochem-060713-035456
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pinkham AM, 2018, CHEM COMMUN, V54, P12357, DOI 10.1039/c8cc07448h
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Prusis P, 2008, BIOORGAN MED CHEM, V16, P9369, DOI 10.1016/j.bmc.2008.08.081
   Prusis P, 2013, BIOCHEM BIOPH RES CO, V434, P767, DOI 10.1016/j.bbrc.2013.03.139
   Qadir A, 2018, EUR J MED CHEM, V156, P444, DOI 10.1016/j.ejmech.2018.07.014
   Rai R, 2017, BIOLOGICALS, V49, P81, DOI 10.1016/j.biologicals.2017.08.005
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rocha RP, 2014, VIRUS RES, V188, P122, DOI 10.1016/j.virusres.2014.04.009
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Shartouny JR, 2019, SEMIN CELL DEV BIOL, V88, P147, DOI 10.1016/j.semcdb.2018.03.001
   Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Silva-Junior EF, 2018, VECTOR BORNE DIS TRE, P1
   Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v
   Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Su XC, 2009, FEBS J, V276, P4244, DOI 10.1111/j.1742-4658.2009.07132.x
   Sylte I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200237
   Takagi Y, 2017, BIOORG MED CHEM LETT, V27, P3586, DOI 10.1016/j.bmcl.2017.05.027
   Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003
   Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002
   Vazquez S, 2002, VACCINE, V20, P1823, DOI 10.1016/S0264-410X(01)00515-1
   Venkatraman S, 2009, J MED CHEM, V52, P336, DOI 10.1021/jm800940u
   Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r
   Wang SB, 2016, VIROLOGY, V498, P116, DOI 10.1016/j.virol.2016.08.013
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Weng ZB, 2017, EUR J MED CHEM, V125, P751, DOI 10.1016/j.ejmech.2016.09.063
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   World Health Organization, 2019, DENG SEV DENG
   Xu SQ, 2012, J MED CHEM, V55, P6881, DOI 10.1021/jm300655h
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Zhou GC, 2013, BIOORG MED CHEM LETT, V23, P6549, DOI 10.1016/j.bmcl.2013.10.071
   Zhu TC, 2018, ANAL BIOCHEM, V556, P112, DOI 10.1016/j.ab.2018.06.030
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zuo ZL, 2009, J VIROL, V83, P1060, DOI 10.1128/JVI.01325-08
NR 124
TC 4
Z9 4
U1 7
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD SEP 15
PY 2019
VL 27
IS 18
BP 3963
EP 3978
DI 10.1016/j.bmc.2019.07.038
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA IT4QM
UT WOS:000482845600001
PM 31351847
DA 2020-07-08
ER

PT J
AU Ngo, AM
   Shurtleff, MJ
   Popova, KD
   Kulsuptrakul, J
   Weissman, JS
   Puschnik, AS
AF Ngo, Ashley M.
   Shurtleff, Matthew J.
   Popova, Katerina D.
   Kulsuptrakul, Jessie
   Weissman, Jonathan S.
   Puschnik, Andreas S.
TI The ER membrane protein complex is required to ensure correct topology
   and stable expression of flavivirus polyproteins
SO ELIFE
LA English
DT Article
ID DENGUE VIRUS; ENDOPLASMIC-RETICULUM; ZIKA VIRUS; SCREEN; JUNCTIONS;
   NETWORKS; CLEAVAGE; STRESS; NS4B
AB Flaviviruses translate their genomes as multi-pass transmembrane proteins at the endoplasmic reticulum ( ER) membrane. Here, we show that the ER membrane protein complex (EMC) is indispensable for the expression of viral polyproteins. We demonstrated that EMC was essential for accurate folding and post-translational stability rather than translation efficiency. Specifically, we revealed degradation of NS4A-NS4B, a region rich in transmembrane domains, in absence of EMC. Orthogonally, by serial passaging of virus on EMC-deficient cells, we identified two non-synonymous point mutations in NS4A and NS4B, which rescued viral replication. Finally, we showed a physical interaction between EMC and viral NS4B and that the NS4A-4B region adopts an aberrant topology in the absence of the EMC leading to degradation. Together, our data highlight how flaviviruses hijack the EMC for transmembrane protein biogenesis to achieve optimal expression of their polyproteins, which reinforces a role for the EMC in stabilizing challenging transmembrane proteins during synthesis.
C1 [Ngo, Ashley M.; Kulsuptrakul, Jessie; Puschnik, Andreas S.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.
   [Shurtleff, Matthew J.; Popova, Katerina D.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.
   [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.
RP Puschnik, AS (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.
EM andreas.puschnik@czbiohub.org
OI Puschnik, Andreas/0000-0002-9605-9458; Kulsuptrakul,
   Jessie/0000-0003-3881-4686
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute; Helen
   Hay Whitney Foundation
FX Howard Hughes Medical Institute Jonathan S Weissman; Helen Hay Whitney
   Foundation Matthew J Shurtleff; The funders had no role in study design,
   data collection and interpretation, or the decision to submit the work
   for publication.
CR Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Beaucourt S, 2014, CURR OPIN VIROL, V8, P10, DOI 10.1016/j.coviro.2014.04.011
   Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936
   Buentzel J, 2017, METHODS MOL BIOL, V1595, P221, DOI 10.1007/978-1-4939-6937-1_21
   CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Chitwood PJ, 2019, TRENDS CELL BIOL, V29, P371, DOI 10.1016/j.tcb.2019.01.007
   Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Coelho JPL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08632-0
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18909-3
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Plaszczyca A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007736
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Volkmar N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223453
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
NR 38
TC 1
Z9 1
U1 1
U2 2
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD SEP 13
PY 2019
VL 8
AR e48469
DI 10.7554/eLife.48469
PG 23
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA JA3QS
UT WOS:000487740200001
PM 31516121
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, L
   Lacko, LA
   Zhou, T
   Tomoiaga, D
   Hurtado, R
   Zhang, T
   Sevilla, A
   Zhong, A
   Mason, CE
   Noggle, S
   Evans, T
   Stuhlmann, H
   Schwartz, RE
   Chen, SB
AF Tan, Lei
   Lacko, Lauretta A.
   Zhou, Ting
   Tomoiaga, Delia
   Hurtado, Romulo
   Zhang, Tuo
   Sevilla, Ana
   Zhong, Aaron
   Mason, Christopher E.
   Noggle, Scott
   Evans, Todd
   Stuhlmann, Heidi
   Schwartz, Robert E.
   Chen, Shuibing
TI Pre- and peri-implantation Zika virus infection impairs fetal
   development by targeting trophectoderm cells
SO NATURE COMMUNICATIONS
LA English
DT Article
ID BROAD-SPECTRUM; SLINGSHOT 1; TROPHOBLAST; DENGUE; DIFFERENTIATION;
   EXPRESSION; PROTECTION; PLACENTA; BRAIN
AB Zika virus (ZIKV) infection results in an increased risk of spontaneous abortion and poor intrauterine growth although the underlying mechanisms remain undetermined. Little is known about the impact of ZIKV infection during the earliest stages of pregnancy, at pre- and peri-implantation, because most current ZIKV pregnancy studies have focused on post-implantation stages. Here, we demonstrate that trophectoderm cells of pre-implantation human and mouse embryos can be infected with ZIKV, and propagate virus causing neural progenitor cell death. These findings are corroborated by the dose-dependent nature of ZIKV susceptibility of hESC-derived trophectoderm cells. Single blastocyst RNA-seq reveals key transcriptional changes upon ZIKV infection, including nervous system development, prior to commitment to the neural lineage. The pregnancy rate of mice is >50% lower in pre-implantation infection than infection at E4.5, demonstrating that pre-implantation ZIKV infection leads to miscarriage. Cumulatively, these data elucidate a previously unappreciated association of pre- and peri-implantation ZIKV infection and microcephaly.
C1 [Tan, Lei; Lacko, Lauretta A.; Zhou, Ting; Hurtado, Romulo; Evans, Todd; Chen, Shuibing] Weill Cornell Med Coll, Dept Surg, 1300 York Ave, New York, NY 10065 USA.
   [Lacko, Lauretta A.; Stuhlmann, Heidi] Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA.
   [Zhou, Ting; Zhong, Aaron] Sloan Kettering Inst, Ctr Stem Cell Biol & Dev Biol Program, SKI Stem Cell Res Facil, 1275 York Ave, New York, NY 10065 USA.
   [Tomoiaga, Delia; Mason, Christopher E.; Schwartz, Robert E.] Weill Cornell Med Coll, Physiol Biophys & Syst Biol, 1300 York Ave, New York, NY 10065 USA.
   [Zhang, Tuo] Weill Cornell Med Coll, Genom Resources Core Facil, 1300 York Ave, New York, NY 10065 USA.
   [Sevilla, Ana; Noggle, Scott] New York Stem Cell Fdn, 619 W 54th St, New York, NY 10019 USA.
   [Sevilla, Ana] Univ Barcelona, Fac Biol, Dept Physiol Cellular Biol & Immunol, Diagonal 643, E-08028 Barcelona, Spain.
RP Chen, SB (corresponding author), Weill Cornell Med Coll, Dept Surg, 1300 York Ave, New York, NY 10065 USA.; Stuhlmann, H (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA.; Schwartz, RE (corresponding author), Weill Cornell Med Coll, Physiol Biophys & Syst Biol, 1300 York Ave, New York, NY 10065 USA.
EM hes2011@med.cornell.edu; res2025@med.cornell.edu;
   shc2034@med.cornell.edu
OI tan, lei/0000-0002-8473-4911; Noggle, Scott/0000-0002-0374-2240; Zhang,
   Tuo/0000-0001-5396-918X
FU FFPI program at Weill Cornell; NYSTEM [C029156]; NICHDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [F32 HD096810-01]; NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [DP3DK111907-01, R01 DK116075-01, R01 DK119667-01, 1R01NS099270,
   1R21DK116171, 1R01MH117406, P01HD067244, R01ES021006, 1K08DK101754,
   1R03DK117252]; WorldQuant Foundation; Ramon y Cajal contractSpanish
   Government [RYC-2016-19962]; Spanish Ministry of Economy and Innovation
   (MINECO); Agencia Estatal de Investigacion (AEI); European Development
   Regional Fund (FEDER) [PGC2018-098626-B100]; Merck FoundationMerck &
   Company
FX S.C. is funded by NIH (DP3DK111907-01, R01 DK116075-01, R01 DK119667-01,
   1R01NS099270). T.Z. is funded by a FFPI program at Weill Cornell. This
   study was also supported by a Shared Facility contract to T.E. and S.C.
   from NYSTEM (C029156). L.L. is funded by NICHD (F32 HD096810-01). R.H.
   is funded by NIH (1R21DK116171). C.E.M. is funded by the WorldQuant
   Foundation and NIH (1R01MH117406, P01HD067244, and R01ES021006). R.E.S.
   was funded by NIH (1K08DK101754 and 1R03DK117252). A.S. is a recipient
   of a Ramon y Cajal contract (RYC-2016-19962). A.S. is also supported by
   the Spanish Ministry of Economy and Innovation (MINECO) and Agencia
   Estatal de Investigacion (AEI), the European Development Regional Fund
   (FEDER, PGC2018-098626-B100) and the Merck Foundation. We are also very
   grateful for technical support provided by Harold S. Ralph in the Cell
   Screening Core Facility at Weill Cornell Medical College, NY.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Arumugasaamy N, 2018, ANN BIOMED ENG, V46, P1963, DOI 10.1007/s10439-018-2090-y
   Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106
   Bayer A, 2018, PLACENTA, V61, P33, DOI 10.1016/j.placenta.2017.11.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   CATTERALL JR, 1987, INFECT IMMUN, V55, P1635, DOI 10.1128/IAI.55.7.1635-1640.1987
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Choma MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140404
   Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Feng LL, 2016, CELL REP, V15, P2063, DOI 10.1016/j.celrep.2016.04.066
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844
   Li YC, 2013, DEVELOPMENT, V140, P3965, DOI 10.1242/dev.092155
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Poulain S, 2017, METHODS MOL BIOL, V1543, P57, DOI 10.1007/978-1-4939-6716-2_4
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Razanskas R, 2010, ARCH VIROL, V155, P247, DOI 10.1007/s00705-009-0561-z
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253
   Stephenson EL, 2007, REGEN MED, V2, P349, DOI 10.2217/17460751.2.4.349
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xiang YF, 2014, VIROLOGY, V449, P88, DOI 10.1016/j.virol.2013.11.011
   Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761
   Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zheng K, 2014, VIRUS RES, V188, P32, DOI 10.1016/j.virusres.2014.03.016
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 62
TC 2
Z9 2
U1 3
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 13
PY 2019
VL 10
AR 4155
DI 10.1038/s41467-019-12063-2
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IX4WA
UT WOS:000485685200001
PM 31519912
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shaw, R
   Baker, E
   Jie, CF
   Adamian, S
   Andres, S
   Bachelor, B
   Hodges, F
   Mittra, T
   Viloria, AR
AF Shaw, Rebecca
   Baker, Elizabeth
   Jie, Chunfa
   Adamian, Shant
   Andres, Sarah
   Bachelor, Brooke
   Hodges, Fiona
   Mittra, Tricia
   Viloria, Anny Rodriquez
TI Zika virus knowledge, contraception use, and lessons learned from a
   Dominican Republic pilot study
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Charlas; Congenital Zika syndrome; Contraception; Dominican Republic;
   Family planning; Sexual transmission; Zika virus knowledge
ID PUERTO-RICO; ACCESS
AB Objective To assess knowledge of the Zika virus (ZIKV), use of contraceptives, and sources of health information in rural communities in the Dominican Republic. Methods Over 4 days in March 2017, a research team traveled to four rural communities in the Dominican Republic to provide healthcare services. Overall, 90 men and women consented to a voluntary verbal 12-question survey. Results Of the participants, 55% were not certain whether ZIKV is transmitted sexually; 75% of participants were either not sure or thought ZIKV was not present in their community. Charlas (informal discussions led by community health workers) were cited as the most common source for public health information. Prevalence of contraceptive use was 26.6% hormonal and 1.1% long-acting reversible contraception (LARC); 30.0% cited no use of contraception. Conclusion Significant deficits in ZIKV knowledge, underutilization of LARCs, and socioeconomic factors exist that constrain the application of WHO recommendations for preventing ZIKV infection. Additional and more robust surveys are needed to assess public health education and interventions, critical for disease prevention in communities facing current and future epidemics.
C1 [Shaw, Rebecca] Des Moines Univ, Dept Specialty Med, Div Obstet & Gynecol, Des Moines, IA USA.
   [Baker, Elizabeth] Des Moines Univ, Dept Publ Hlth, Coll Hlth Sci, Des Moines, IA USA.
   [Jie, Chunfa] Des Moines Univ, Off Res, Des Moines, IA USA.
   [Adamian, Shant; Andres, Sarah; Bachelor, Brooke; Hodges, Fiona; Mittra, Tricia] Des Moines Univ, Coll Osteopath Med, Des Moines, IA USA.
   [Viloria, Anny Rodriquez] Monte Cristi, Timmy Global Hlth, Monte Cristi, Dominican Rep.
RP Shaw, R (corresponding author), Des Moines Univ, Dept Specialty Med, Des Moines, IA 50312 USA.
EM Rebecca.Shaw@dmu.edu
CR Ali M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0283-8
   Centers for Disease Control and Prevention, ZIK VIR PROT YOURS O
   Centers for Disease Control and Prevention, 2018, PREV UN PREGN ZIK VI
   Delet J, 2018, EUR J OBSTET GYN R B, V222, P70, DOI 10.1016/j.ejogrb.2018.01.010
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nadia L, 2017, MMWR MORB MORTAL WKL
   Pan American Health Organization, 2017, ZIK EP REP DOM REP
   Sedgh G, 2016, UNMET NEED CONTRACEP
   Shaw R, 2017, INT J GYNECOL OBSTET, V139, P370, DOI 10.1002/ijgo.12258
   Southwell BG, 2018, EMERG INFECT DIS, V24, P938, DOI 10.3201/eid2405.171570
   Timmy Global Health, OUR COMM MONT CRIST
   Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6
   World Health Organization, ZIK VIR FACT SHEET
   World Health Organization, 2016, KNOWL ATT PRACT SURV
NR 16
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD DEC
PY 2019
VL 147
IS 3
BP 313
EP 318
DI 10.1002/ijgo.12957
EA SEP 2019
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JI7KQ
UT WOS:000485406300001
PM 31479162
DA 2020-07-08
ER

PT J
AU Hayashida, E
   Ling, ZL
   Ashhurst, TM
   Viengkhou, B
   Jung, SR
   Songkhunawej, P
   West, PK
   King, NJC
   Hofer, MJ
AF Hayashida, Emina
   Ling, Zheng Lung
   Ashhurst, Thomas M.
   Viengkhou, Barney
   Jung, So Ri
   Songkhunawej, Pattama
   West, Phillip K.
   King, Nicholas J. C.
   Hofer, Markus J.
TI Zika virus encephalitis in immunocompetent mice is dominated by innate
   immune cells and does not require T or B cells
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article
DE Zika virus; Microglia; Monocyte; Neutrophil; Encephalitis; Innate
   immunity; Type I interferon; Adaptive immunity
ID GUILLAIN-BARRE-SYNDROME; GENE-EXPRESSION; MURINE MODEL; MOUSE MODEL;
   INFECTION; BRAIN; VISUALIZATION; INTERFERONS; MECHANISMS; RECEPTORS
AB Background Until the end of the twentieth century, Zika virus (ZIKV) was thought to cause a mostly mild, self-limiting disease in humans. However, as the geographic distribution of ZIKV has shifted, so too has its pathogenicity. Modern-day ZIKV infection is now known to cause encephalitis, acute disseminated encephalomyelitis, and Guillain-Barre syndrome in otherwise healthy adults. Nevertheless, the underlying pathogenetic mechanisms responsible for this shift in virulence remain unclear. Methods Here, we investigated the contribution of the innate versus the adaptive immune response using a new mouse model involving intracranial infection of adult immunocompetent mice with a moderately low dose of ZIKV MR766. To determine the contribution of type I interferons (IFN-Is) and adaptive immune cells, we also studied mice deficient for the IFN-I receptor 1 (Ifnar1(-/-)) and recombination-activating gene 1 (Rag1(-/-)). Results We show that intracranial infection with ZIKV resulted in lethal encephalitis. In wild-type mice, ZIKV remained restricted predominantly to the central nervous system (CNS) and infected neurons, whereas astrocytes and microglia were spared. Histological and molecular analysis revealed prominent activation of resident microglia and infiltrating monocytes that were accompanied by an expression of pro-inflammatory cytokines. The disease was independent of T and B cells. Importantly, unlike peripheral infection, IFN-Is modulated but did not protect from infection and lethal disease. Lack of IFN-I signaling resulted in spread of the virus, generalized inflammatory changes, and accelerated disease onset. Conclusions Using intracranial infection of immunocompetent wild-type mice with ZIKV, we demonstrate that in contrast to the peripheral immune system, the CNS is susceptible to infection and responds to ZIKV by initiating an antiviral immune response. This response is dominated by resident microglia and infiltrating monocytes and macrophages but does not require T or B cells. Unlike in the periphery, IFN-Is in the CNS cannot prevent the establishment of infection. Our findings show that ZIKV encephalitis in mice is dependent on the innate immune response, and adaptive immune cells play at most a minor role in disease pathogenesis.
C1 [Hayashida, Emina; Viengkhou, Barney; Jung, So Ri; Songkhunawej, Pattama; West, Phillip K.; Hofer, Markus J.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.
   [Hayashida, Emina; Viengkhou, Barney; Jung, So Ri; Songkhunawej, Pattama; West, Phillip K.; Hofer, Markus J.] Univ Sydney, Bosch Inst, Sydney, NSW, Australia.
   [Ling, Zheng Lung; Ashhurst, Thomas M.; King, Nicholas J. C.] Univ Sydney, Discipline Pathol, Marie Bashir Inst Infect Dis & Biosecur, Bosch Inst,Charles Perkins Ctr,Sch Med Sci, Sydney, NSW, Australia.
   [Ashhurst, Thomas M.; King, Nicholas J. C.] Univ Sydney, Sydney Cytometry Facil, Sydney, NSW, Australia.
   [Ashhurst, Thomas M.; King, Nicholas J. C.] Centenary Inst, Sydney, NSW, Australia.
   [Hofer, Markus J.] Univ Sydney, Sch Life & Environm Sci, Mol Biosci Bldg,Maze Crescent G08, Sydney, NSW 2006, Australia.
RP Hofer, MJ (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.; Hofer, MJ (corresponding author), Univ Sydney, Bosch Inst, Sydney, NSW, Australia.; Hofer, MJ (corresponding author), Univ Sydney, Sch Life & Environm Sci, Mol Biosci Bldg,Maze Crescent G08, Sydney, NSW 2006, Australia.
EM makus.hofer@sydney.edu.au
RI ; Hofer, Markus/C-3688-2013
OI Jung, So Ri/0000-0003-1611-7644; King, Nicholas Jonathan
   Cole/0000-0002-3877-9772; Hofer, Markus/0000-0001-5111-3978; Ashhurst,
   Thomas/0000-0001-7269-7773
FU Marie Bashir Institute for Infectious Diseases and Biosecurity at The
   University of Sydney
FX This work was funded by a seed funding grant from the Marie Bashir
   Institute for Infectious Diseases and Biosecurity at The University of
   Sydney to Markus J. Hofer.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594
   Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421
   Getts DR, 2007, J NEUROCHEM, V103, P1019, DOI 10.1111/j.1471-4159.2007.04798.x
   Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hofer MJ, 2012, J VIROL, V86, P6932, DOI 10.1128/JVI.07147-11
   Hofer MJ, 2008, VIRAL IMMUNOL, V21, P425, DOI 10.1089/vim.2008.0057
   Hofer U, 2016, NAT REV MICROBIOL, V14, P401, DOI 10.1038/nrmicro.2016.80
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Iwami K, 2012, J NEUROSURG, V116, P630, DOI 10.3171/2011.10.JNS11852
   King NJC, 2017, TRENDS MICROBIOL, V25, P701, DOI 10.1016/j.tim.2017.05.005
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Ousman SS, 2005, METH MOLEC MED, V116, P115
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166
   Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   van der Maaten L, 2014, J MACH LEARN RES, V15, P3221
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 66
TC 0
Z9 0
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD SEP 11
PY 2019
VL 16
IS 1
AR 177
DI 10.1186/s12974-019-1566-5
PG 15
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA IW8LU
UT WOS:000485246500001
PM 31511023
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rothan, HA
   Arora, K
   Natekar, JP
   Strate, PG
   Brinton, MA
   Kumar, M
AF Rothan, Hussin A.
   Arora, Komal
   Natekar, Janhavi P.
   Strate, Philip G.
   Brinton, Margo A.
   Kumar, Mukesh
TI Z-DNA-Binding Protein 1 Is Critical for Controlling Virus Replication
   and Survival in West Nile Virus Encephalitis
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE West Nile virus; flavivirus; Zika virus; Z-DNA-binding protein 1;
   DNA-dependent activator of IFN-regulatory factors; host-pathogen
   interaction; virus replication
ID ZIKA VIRUS; DAI DLM-1/ZBP1; CELL-DEATH; PATHOGENESIS; INHIBITION;
   INFECTION; NECROSIS; LETHAL; RIPK3; MICE
AB West Nile virus (WNV), a neurotropic flavivirus, is the leading cause of viral encephalitis in the United States. Recently, Zika virus (ZIKV) infections have caused serious neurological diseases and birth defects, specifically Guillain-Barre syndrome and microcephaly. Z-DNA binding protein 1 (ZBP1) is a cytoplasmic sensor that that has been shown to play a significant role in initiating a robust immune response. We previously reported that WNV and ZIKV infections induce dramatic up-regulation of ZBP1 in mouse brains as well as in infected primary mouse cells. Herein, we show the critical role of ZBP1 in restricting the pathogenesis of WNV and ZIKV infections. Deletion of ZBP1 resulted in significantly higher morbidity and mortality after infection with a pathogenic WNV NY99 strain in mice. No mortality was observed in wild-type (WT) mice infected with the non-pathogenic WNV strain, Eg101. Interestingly, infection of ZBP1(-/-) mice with WNV Eg101 was lethal resulting in 100% mortality, suggesting that ZBP1 is required for survival after WNV infection. Viremia and brain viral load were significantly higher in ZBP1(-/-) mice compared to WT mice. In addition, protein levels of interferon (IFN)-alpha, and inflammatory cytokines and chemokines were significantly higher in the serum and brains of infected ZBP1(-/-) mice compared to the WT mice. Primary mouse cortical neurons and mouse embryonic fibroblasts (MEFs) derived from ZBP1(-/-) mice produced higher virus titers compared to WT cells after infection with WNV NY99 and WNV Eg101. Similarly, neurons and MEFs lacking ZBP1 exhibited significantly enhanced replication of PRVABC59 (Asian) and MR766 (African) ZIKV compared to WT cells. The knockout of ZBP1 function in MEFs inhibited ZBP1-dependent virus-induced cell death. In conclusion, these data reveal that ZBP1 restricts WNV and ZIKV production in mouse cells and is required for survival of a peripheral WNV infection in mice.
C1 [Rothan, Hussin A.; Arora, Komal; Natekar, Janhavi P.; Strate, Philip G.; Brinton, Margo A.; Kumar, Mukesh] Georgia State Univ, Dept Biol, Coll Arts & Sci, Atlanta, GA 30302 USA.
RP Kumar, M (corresponding author), Georgia State Univ, Dept Biol, Coll Arts & Sci, Atlanta, GA 30302 USA.
EM mkumar8@gsu.edu
RI Kumar, Mukesh/N-8814-2015
OI Kumar, Mukesh/0000-0003-0970-4875
FU National Institute of Neurological Disorders and StrokeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R21NS099838]; Office of the Director, National Institutes of Health and
   Institutional fundsUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21OD024896]
FX This work was supported by a grant (R21NS099838) from National Institute
   of Neurological Disorders and Stroke and a grant (R21OD024896) from the
   Office of the Director, National Institutes of Health and Institutional
   funds.
CR Azouz F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020162
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Costa F, 2018, LANCET INFECT DIS, V18, P236, DOI 10.1016/S1473-3099(17)30697-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017
   Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011
   DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Durkin ME, 2013, BIO PROTOC, V3, pe908, DOI DOI 10.21769/BioProtoc.908
   Forest KH, 2018, J NEUROCHEM, V144, P201, DOI 10.1111/jnc.14257
   Guo HY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0868-3
   Ha SC, 2006, BBA-PROTEINS PROTEOM, V1764, P320, DOI 10.1016/j.bbapap.2005.12.012
   da Cruz LCH, 2018, AM J NEURORADIOL, V39, P1967, DOI 10.3174/ajnr.A5649
   Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282
   Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100
   Koehler H, 2017, P NATL ACAD SCI USA, V114, P11506, DOI 10.1073/pnas.1700999114
   Krause K, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00259
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Kumar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26350
   Kumar M, 2014, VIRUSES-BASEL, V6, P2328, DOI 10.3390/v6062328
   Kumar M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-80
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044682
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Orozco S, 2017, IMMUNOL REV, V277, P102, DOI 10.1111/imr.12536
   Pham TH, 2013, J VIROL, V87, P3076, DOI 10.1128/JVI.02860-12
   Pittman KJ, 2016, INFECT IMMUN, V84, P3063, DOI 10.1128/IAI.00511-16
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761
   Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205
   Sridharan H, 2017, EMBO REP, V18, P1429, DOI 10.15252/embr.201743947
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014
   Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI 10.1016/j.chom.2012.01.016
   Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154
   Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111
   Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105
NR 43
TC 2
Z9 2
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 11
PY 2019
VL 10
AR 2089
DI 10.3389/fmicb.2019.02089
PG 10
WC Microbiology
SC Microbiology
GA IW7IN
UT WOS:000485160900001
PM 31572318
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, YP
   Zhang, YK
   Liu, ZY
   Cheng, ML
   Ma, JF
   Wang, Y
   Qin, CF
   Fang, XY
AF Zhang, Yupeng
   Zhang, Yikan
   Liu, Zhong-Yu
   Cheng, Meng-Li
   Ma, Junfeng
   Wang, Yan
   Qin, Cheng-Feng
   Fang, Xianyang
TI Long non-coding subgenomic flavivirus RNAs have extended 3D structures
   and are flexible in solution
SO EMBO REPORTS
LA English
DT Article; Early Access
DE 3D structure; computational modeling; long non-coding RNA; small angle
   X-ray scattering; subgenomic flavivirus RNA
ID X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; PSEUDOKNOT STRUCTURE;
   STEM-LOOP; SECONDARY; RESOLUTION; CLASSIFICATION; PATHOGENESIS;
   RESISTANT; RECEPTOR
AB Most mosquito-borne flaviviruses, including Zika virus (ZIKV), Dengue virus (DENV), and West Nile virus (WNV), produce long non-coding subgenomic RNAs (sfRNAs) in infected cells that link to pathogenicity and immune evasion. Until now, the structural characterization of these lncRNAs remains limited. Here, we studied the 3D structures of individual and combined subdomains of sfRNAs, and visualized the accessible 3D conformational spaces of complete sfRNAs from DENV2, ZIKV, and WNV by small angle X-ray scattering (SAXS) and computational modeling. The individual xrRNA1s and xrRNA2s adopt similar structures in solution as the crystal structure of ZIKV xrRNA1, and all xrRNA1-2s form compact structures with reduced flexibility. While the DB12 of DENV2 is extended, the DB12s of ZIKV and WNV are compact due to the formation of intertwined double pseudoknots. All 3 ' stem-loops (3 ' SLs) share similar rod-like structures. Complete sfRNAs are extended and sample a large conformational space in solution. Our work not only provides structural insight into the function of flavivirus sfRNAs, but also highlights strategies of visualizing other lncRNAs in solution by SAXS and computational methods.
C1 [Zhang, Yupeng; Zhang, Yikan; Ma, Junfeng; Wang, Yan; Fang, Xianyang] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China.
   [Liu, Zhong-Yu; Cheng, Meng-Li; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Liu, Zhong-Yu] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Liu, Zhong-Yu] Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou, Guangdong, Peoples R China.
RP Fang, XY (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
EM qincf@bmi.ac.cn; fargxy@tsinghua.edu.cn
OI Fang, Xianyang/0000-0001-9432-9736
FU DOE Office of ScienceUnited States Department of Energy (DOE)
   [DE-AC02-06CH11357]; National Key Research and Development Project of
   China [2016YFA0500700, 2016YFD0500304, 2018ZX09711003]; China Youth
   1000-Talent Program of the State Council of China; Tsinghua University
   Initiative Scientific Research Program; Beijing Advanced Innovation
   Center for Structural Biology; Tsinghua-Peking Joint Center for Life
   Sciences; National Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81522025, 81621005, 31770190]
FX This research used resources of the Advanced Photon Source, a U.S.
   Department of Energy (DOE) Office of Science User Facility operated for
   the DOE Office of Science by Argonne National Laboratory under Contract
   No. DE-AC02-06CH11357. We thank Dr. Xiaobing Zuo at the beamline
   12-ID-B, Advanced Photon Source, Argonne National Laboratory and the
   staffs of beamline BL19U2 at National Facility for Protein Science
   Shanghai (NFPS), and Shanghai Synchrotron Radiation Facility, Shanghai,
   People's Republic of China for assistance during data collection. This
   work was supported by grants from the National Key Research and
   Development Project of China (2016YFA0500700), the China Youth
   1000-Talent Program of the State Council of China, Tsinghua University
   Initiative Scientific Research Program, the Beijing Advanced Innovation
   Center for Structural Biology, the Tsinghua-Peking Joint Center for Life
   Sciences to X. F., and the National Key Research and Development Project
   of China (2016YFD0500304, 2018ZX09711003), and the National Natural
   Science Foundation of China (No. 81522025, 81621005, 31770190) to C. F.
   Q.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Bailor MH, 2011, CURR OPIN STRUC BIOL, V21, P296, DOI 10.1016/j.sbi.2011.03.009
   Bermejo GA, 2016, STRUCTURE, V24, P806, DOI 10.1016/j.str.2016.03.007
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   Blythe AJ, 2016, BBA-GENE REGUL MECH, V1859, P46, DOI 10.1016/j.bbagrm.2015.08.009
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Charley PA, 2016, VIRUS RES, V212, P70, DOI 10.1016/j.virusres.2015.09.009
   Cheng CY, 2015, METHOD ENZYMOL, V553, P35, DOI 10.1016/bs.mie.2014.10.051
   Chillon I, 2015, METHOD ENZYMOL, V558, P3, DOI 10.1016/bs.mie.2015.01.008
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009
   Fang XY, 2017, BIOCHEMISTRY-US, V56, P3549, DOI 10.1021/acs.biochem.7b00284
   Fang XY, 2015, CURR OPIN STRUC BIOL, V30, P147, DOI 10.1016/j.sbi.2015.02.010
   Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008
   Fernandez-Sanles A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00546
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Fortes P, 2016, VIRUS RES, V212, P1, DOI 10.1016/j.virusres.2015.10.002
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gortz GP, 2015, CELL HOST MICROBE, V18, P133, DOI 10.1016/j.chom.2015.07.009
   Hermann T, 2016, WIRES RNA, V7, P726, DOI 10.1002/wrna.1373
   Jones CP, 2014, P NATL ACAD SCI USA, V111, P3395, DOI 10.1073/pnas.1319658111
   Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Liu F, 2017, NAT CHEM BIOL, V13, P282, DOI [10.1038/NCHEMBIO.2272, 10.1038/nchembio.2272]
   Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   McFadden EJ, 2016, BIOCHEMISTRY-US, V55, P1615, DOI 10.1021/acs.biochem.5b01141
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Nogales E, 2016, CURR OPIN STRUC BIOL, V40, P120, DOI 10.1016/j.sbi.2016.09.009
   Novikova IV, 2013, INT J MOL SCI, V14, P23672, DOI 10.3390/ijms141223672
   Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030
   Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Ostareck DH, 2014, WIRES RNA, V5, P659, DOI 10.1002/wrna.1237
   Perard J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2611
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070
   Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638
   Reyes FE, 2014, METHOD ENZYMOL, V549, P235, DOI 10.1016/B978-0-12-801122-5.00011-8
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320
   Sanbonmatsu KY, 2016, BBA-GENE REGUL MECH, V1859, P41, DOI 10.1016/j.bbagrm.2015.09.011
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Schwieters CD, 2014, PROG NUCL MAG RES SP, V80, P1, DOI 10.1016/j.pnmrs.2014.03.001
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao SC, 2016, CELL, V167, P1229, DOI 10.1016/j.cell.2016.10.046
   Shi PY, 1996, BIOCHEMISTRY-US, V35, P4222, DOI 10.1021/bi952398v
   Somarowthu S, 2016, J MOL BIOL, V428, P736, DOI 10.1016/j.jmb.2015.11.011
   Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Sztuba-Solinska J, 2017, NUCLEIC ACIDS RES, V45, P6805, DOI 10.1093/nar/gkx241
   Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115
   Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249
   Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zuo XB, 2006, P NATL ACAD SCI USA, V103, P3534, DOI 10.1073/pnas.0600022103
NR 80
TC 1
Z9 1
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
AR e47016
DI 10.15252/embr.201847016
EA SEP 2019
PG 20
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA IX8CL
UT WOS:000485912500001
PM 31502753
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Evans, BR
   Kotsakiozi, P
   Costa-da-Silva, AL
   Ioshino, RS
   Garziera, L
   Pedrosa, MC
   Malavasi, A
   Virginio, JF
   Capurro, ML
   Powell, JR
AF Evans, Benjamin R.
   Kotsakiozi, Panayiota
   Costa-da-Silva, Andre Luis
   Ioshino, Rafaella Sayuri
   Garziera, Luiza
   Pedrosa, Michele C.
   Malavasi, Aldo
   Virginio, Jair F.
   Capurro, Margareth L.
   Powell, Jeffrey R.
TI Transgenic Aedes aegypti Mosquitoes Transfer Genes into a Natural
   Population
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PACKAGE
AB In an attempt to control the mosquito-borne diseases yellow fever, dengue, chikungunya, and Zika fevers, a strain of transgenically modified Aedes aegypti mosquitoes containing a dominant lethal gene has been developed by a commercial company, Oxitec Ltd. If lethality is complete, releasing this strain should only reduce population size and not affect the genetics of the target populations. Approximately 450 thousand males of this strain were released each week for 27 months in Jacobina, Bahia, Brazil. We genotyped the release strain and the target Jacobina population before releases began for >21,000 single nucleotide polymorphisms (SNPs). Genetic sampling from the target population six, 12, and 27-30 months after releases commenced provides clear evidence that portions of the transgenic strain genome have been incorporated into the target population. Evidently, rare viable hybrid offspring between the release strain and the Jacobina population are sufficiently robust to be able to reproduce in nature. The release strain was developed using a strain originally from Cuba, then outcrossed to a Mexican population. Thus, Jacobina Ae. aegypti are now a mix of three populations. It is unclear how this may affect disease transmission or affect other efforts to control these dangerous vectors. These results highlight the importance of having in place a genetic monitoring program during such releases to detect un-anticipated outcomes.
C1 [Evans, Benjamin R.; Kotsakiozi, Panayiota; Powell, Jeffrey R.] Yale Univ, 21 Sachem St, New Haven, CT 06520 USA.
   [Costa-da-Silva, Andre Luis; Ioshino, Rafaella Sayuri; Pedrosa, Michele C.; Capurro, Margareth L.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508000 Sao Paulo, SP, Brazil.
   [Costa-da-Silva, Andre Luis; Ioshino, Rafaella Sayuri; Garziera, Luiza; Pedrosa, Michele C.; Capurro, Margareth L.] INCT EM, Rio De Janeiro, RJ, Brazil.
   [Pedrosa, Michele C.; Malavasi, Aldo; Virginio, Jair F.] Moscamed Brasil, Loteamento Ctr Ind Sao Francisco 9 It 15, BR-48908000 Juazeiro, BA, Brazil.
RP Powell, JR (corresponding author), Yale Univ, 21 Sachem St, New Haven, CT 06520 USA.
EM jeffrey.powell@yale.edu
RI Costa-Da-Silva, Andre Luis/J-8913-2019
OI Costa-Da-Silva, Andre Luis/0000-0002-7615-7376
FU U.S. National Institute of Allergies and Infectious Diseases [UO1
   AI115595]; Science Without Borders Fellowship from the Brazilian
   National Government
FX Financial support was provided by grants from the U.S. National
   Institute of Allergies and Infectious Diseases, UO1 AI115595, JRP,
   Principal Investigator. BRE was a training fellow on NIH 5T32AI007404.
   JRP was a recipient of a Science Without Borders Fellowship from the
   Brazilian National Government.
CR Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382
   Garziera L, 2017, ENTOMOL EXP APPL, V164, P327, DOI 10.1111/eea.12618
   Gompert Z, 2010, MOL ECOL RESOUR, V10, P378, DOI 10.1111/j.1755-0998.2009.02733.x
   Harris A, 2002, NATURE BIOTCH, V30, P828
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Powell JR, 2018, INSECTS, V9, DOI 10.3390/insects9040139
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Romano CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070318
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
NR 16
TC 11
Z9 11
U1 11
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 10
PY 2019
VL 9
AR 13047
DI 10.1038/s41598-019-49660-6
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW4ZJ
UT WOS:000484988100021
PM 31506595
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hill, SR
   Ghaninia, M
   Ignell, R
AF Hill, Sharon R.
   Ghaninia, Majid
   Ignell, Rickard
TI Blood Meal Induced Regulation o f Gene Expression in the Maxillary
   Palps, a Chemosensory Organ of the Mosquito Aedes aegypti
SO FRONTIERS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE chemosensory; mosquito; transcriptome; host seeking; blood feeding;
   resting
ID HOST-SEEKING BEHAVIOR; ODORANT-BINDING-PROTEINS; REAL-TIME PCR;
   ANOPHELES-GAMBIAE; CARBON-DIOXIDE; ELECTROPHYSIOLOGICAL RESPONSES;
   ANTENNAL TRANSCRIPTOME; OLFACTORY RECEPTORS; MOLECULAR-BASIS;
   GAIN-CONTROL
AB Background: Aedes aegypti is a prominent and highly competent vector of several arboviral diseases, including dengue, yellow fever, and Zika. Behaviors associated with reproductive feeding, both pre- and post-blood meal, directly influence disease transmission capacity. Odors mediate host seeking pre-blood meal, while post-blood meal females are refractory to host odors for at least 24 h. During this time, flight activity is substantially reduced. Two key host odors, carbon dioxide and (R)-1 -octen-3-ol, are detected by the maxillary palps in mosquitoes. In the search for future vector control tools, the identification of genes that are regulated in the maxillary palps between host seeking and 24 h post-blood meal may provide an informative pool of targets.
   Results: The blood meal-induced regulation of chemosensory, neuromodulatory, and other signal transduction genes was investigated in the maxillary palps of 24 h post-blood fed Ae. aegypti females, 6 days after emergence, and compared to host-seeking females of the same age using a transcriptomic approach. Genes-of-interest implicated in the behavioral switch from host seeking to post-blood meal quiescence were identified from multiple gene families investigated: odorant receptors, ionotropic receptors, pickpocket receptors, transient receptor potential receptors, odorant binding proteins, chemosensory proteins, neuromodulators, and their receptors, as well as constituents of second messenger signaling pathways. Reflecting the change in transcript abundance of families involved in CO2 signaling, the neural sensitivity to this key kairomone compound was found to decrease in blood fed mosquitoes compare with their on-blood fed counter parts.
   Conclusions: Sensory-associated gene expression is regulated in the maxillary palps of Ae. aegypti females in response to blood feeding. The concerted regulation of multiple genes within the sensory pathways of the maxillary palps likely play a key role in modulating the behavioral changes observed post-blood meal. Future functional characterization of the proteins generated by the genes-of-interest identified in this study may provide both a better understanding of the regulation of gonotrophic feeding and a pool of potential targets for vector control strategies.
C1 [Hill, Sharon R.; Ignell, Rickard] Swedish Univ Agr Sci, Dept Plant Protect Biol, Chem Ecol, Dis Vector Grp, Alnarp, Sweden.
   [Ghaninia, Majid] Arizona State Univ, Sch Life Sci, Tempe, AZ USA.
   [Ghaninia, Majid] Gorgan Univ Agr Sci & Nat Resources, Dept Plant Protect, Div Entomol, Gorgan, Golestan, Iran.
RP Hill, SR (corresponding author), Swedish Univ Agr Sci, Dept Plant Protect Biol, Chem Ecol, Dis Vector Grp, Alnarp, Sweden.
EM sharon.hill@slu.se
RI Hill, Sharon Rose/A-5121-2008
OI Hill, Sharon Rose/0000-0002-6474-0214
FU Swedish Research Council FormasSwedish Research CouncilSwedish Research
   Council Formas; Linnaeus initiative Insect Chemical Ecology, Ethology
   and Evolution IC-E3 (Formas)Swedish Research Council Formas; Linnaeus
   initiative Insect Chemical Ecology, Ethology and Evolution IC-E3
   ((Swedish University of Agricultural Sciences)
FX This work was funded by The Swedish Research Council Formas and
   supported by the Linnaeus initiative Insect Chemical Ecology, Ethology
   and Evolution IC-E3 (Formas and Swedish University of Agricultural
   Sciences). The funding body has had no role in the design of the study
   and collection, analysis, and interpretation of data, or in writing the
   manuscript.
CR Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042
   Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002
   Badsha F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049848
   Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328
   Benton R, 2015, TRENDS ECOL EVOL, V30, P590, DOI 10.1016/j.tree.2015.07.009
   Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001
   Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x
   Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x
   Bohbot JD, 2014, INSECT BIOCHEM MOLEC, V48, P29, DOI 10.1016/j.ibmb.2014.02.007
   Bohbot JD, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00039
   Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105
   Bohbot JD, 2010, ECOL CONT VECTOR-BOR, V2, P17
   Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042
   BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   Christ P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188243
   Cook JI, 2011, B ENTOMOL RES, V101, P541, DOI 10.1017/S0007485311000162
   Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064
   Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5
   DAVIS EE, 1984, J INSECT PHYSIOL, V30, P211, DOI 10.1016/0022-1910(84)90005-2
   Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186
   Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121
   Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618
   Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x
   Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087
   Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029
   Getahun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058889
   GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475
   Guo YM, 2014, CELL REP, V9, P1183, DOI 10.1016/j.celrep.2014.10.020
   Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015
   Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a
   Hill SR, 2015, INSECT MOL BIOL, V24, P491, DOI 10.1111/imb.12176
   Jiang XC, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew015
   Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105
   Johnson WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032878
   Joseph RM, 2015, TRENDS GENET, V31, P683, DOI 10.1016/j.tig.2015.09.005
   Jung JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13444
   Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859
   Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848
   Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067
   Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107
   Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801
   KLOWDEN MJ, 1987, J INSECT PHYSIOL, V33, P689, DOI 10.1016/0022-1910(87)90052-7
   Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298
   Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016
   Larter NK, 2016, ELIFE, V5, DOI 10.7554/eLife.20242
   Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635
   Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062
   Majeed S, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170189
   Majeed S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160467
   Majeed S, 2014, J EXP BIOL, V217, P598, DOI 10.1242/jeb.092718
   Manoharan M, 2013, GENOME BIOL EVOL, V5, P163, DOI 10.1093/gbe/evs131
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   Mayoral JG, 2010, PEPTIDES, V31, P442, DOI 10.1016/j.peptides.2009.04.013
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   MCIVER S, 1970, CAN J ZOOLOG, V48, P293, DOI 10.1139/z70-048
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   Mescher MC, 2017, CURR OPIN INSECT SCI, V20, pV, DOI 10.1016/j.cois.2017.04.003
   Moll P., 2014, NAT METHODS, V11, pi, DOI [10.1038/nmeth.f.376, DOI 10.1038/NMETH.F.376]
   Montell C, 2016, ADV INSECT PHYSIOL, V51, P293, DOI 10.1016/bs.aiip.2016.04.007
   Mysore K, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-9
   Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015
   Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003
   Ohno H, 2017, ELIFE, V6, DOI 10.7554/eLife.28877
   Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864
   Omondi BA, 2015, J EXP BIOL, V218, P2482, DOI 10.1242/jeb.116798
   Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071
   Paterson GI, 2011, ELECTRON J HEALTH IN, V6
   Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229
   Pitts RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40297
   Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110
   Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003
   Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005
   Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850
   Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2
   Shakeel M, 2018, BIOTECHNOL LETT, V40, P227, DOI 10.1007/s10529-017-2465-4
   Siju KP, 2008, ARTHROPOD STRUCT DEV, V37, P248, DOI 10.1016/j.asd.2007.12.001
   Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010
   Sparks JT, 2014, INSECT BIOCHEM MOLEC, V48, P8, DOI 10.1016/j.ibmb.2014.02.004
   Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3
   Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133
   Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131
   Taparia T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3779-2
   Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1
   VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0
   Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481
   Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5
   Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007
   Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229
   Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107
   Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861
   Xu PX, 2013, J INSECT PHYSIOL, V59, P961, DOI 10.1016/j.jinsphys.2013.07.004
   Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010
   Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005
   Younus F, 2014, INSECT BIOCHEM MOLEC, V53, P30, DOI 10.1016/j.ibmb.2014.07.003
   Zelle KM, 2013, G3-GENES GENOM GENET, V3, P441, DOI 10.1534/g3.112.005272
   Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x
NR 103
TC 0
Z9 0
U1 4
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-701X
J9 FRONT ECOL EVOL
JI Front. Ecol. Evol.
PD SEP 10
PY 2019
VL 7
AR 336
DI 10.3389/fevo.2019.00336
PG 17
WC Ecology
SC Environmental Sciences & Ecology
GA IW5KB
UT WOS:000485016200001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU da Costa, MP
   Leite, FCL
AF da Costa, Michelli Pereira
   Lima Leite, Fernando Cesar
TI Factors influencing research data communication on Zika virus: a
   grounded theory
SO JOURNAL OF DOCUMENTATION
LA English
DT Article
DE Research data; Scientific communication; Open data; Data sharing; Open
   science; Academic culture; Data communication
ID RESEARCH DATA-MANAGEMENT; TRANSMISSION; INFORMATION; POLICIES
AB Purpose The purpose of this paper is to propose a theoretical model to illustrate factors influencing research data communication on diseases caused by the Zika virus. Design/methodology/approach The grounded theory methodology was adopted. For data collection, interviews were conducted with 13 Brazilian researchers involved with the Zika virus theme. Data analysis was performed using the open, axial and selective coding processes, according to the principles of the grounded theory. Findings Based on data collection and analysis, seven theoretical categories representing intervening factors in Zika virus research data communication were identified. The emerging theory showed the centrality of researchers' expectations for acknowledgment and reward, influenced by the aspects of research funding and academic culture. Three factors involved in the macro processes of research data communication: data use, data production and data sharing. In the use and production processes, factors related to collaboration figured most strongly. In the production and sharing processes, the factors regarding data processing and the use of research data repositories were more pronounced. Finally, data sharing, and the possibility of reusing data are directly affected by the social context of Zika virus disease as an emerging disease. Originality/value The study presents a theory developed systematically to explain the phenomenon of communication of research data on Zika virus. The theory presents a set of intervening factors of the process of communication of research data and discusses the factors in light of the fundamentals of information science.
C1 [da Costa, Michelli Pereira; Lima Leite, Fernando Cesar] Univ Brasilia, Fac Informat Sci, Brasilia, DF, Brazil.
RP da Costa, MP (corresponding author), Univ Brasilia, Fac Informat Sci, Brasilia, DF, Brazil.
EM michellicosta11@gmail.com
RI Leite, Fernando/F-9578-2010
OI Leite, Fernando/0000-0003-1998-2385
CR [Anonymous], 2015, PROTOCOLO VIGILANCIA
   Associated Press, 2016, ASS PRESS
   Bond CS, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2435
   Boulton G., 2013, DECADA ACESSO ABERTO, P239
   Brase J., 2009, INFORM SERVICES USE, V29
   Bruniera-Oliveira R.B.O., 2014, TEMPUS ACTAS SAUDE C, V8, P75
   Carmo Eduardo Hage, 2008, Estud. av., V22, P19, DOI 10.1590/S0103-40142008000300003
   Chaves M.R.O., 2015, NEWSLAB, V132
   Childs S., 2004, New Review of Information Networking, V10, P131, DOI 10.1080/13614570500053866
   Cox A., 2012, UPSKILLING LIAISON L
   Dallmeier-Tiessen Suenje, 2014, New Review of Information Networking, V19, P16, DOI 10.1080/13614576.2014.883936
   Douglass K, 2014, J ASSOC INF SCI TECH, V65, P251, DOI 10.1002/asi.22988
   Dye C., 2016, B WHO, V2
   Fecher B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118053
   Gardner W, 2004, INFORM SOC, V20, P141, DOI 10.1080/01972240490423067
   Garvey W. D., 1979, COMMUNICATION ESSENC
   Gezelter D, 2009, WHAT EXACTLY IS OPEN
   Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x
   Hey Tony, 2008, SCI COLLABORATION IN, P15
   Higman R, 2015, PROGRAM-ELECTRON LIB, V49, P364, DOI 10.1108/PROG-01-2015-0005
   Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679
   Jameson E, 2016, WESTERN HIST QUART, V47, P1, DOI 10.1093/whq/whv041
   Knight G, 2015, PROGRAM-ELECTRON LIB, V49, P424, DOI 10.1108/PROG-01-2015-0011
   Lopez F., 2015, WORKSH DAT CIENT INT
   Losoff B., 2009, ISSUES SCI TECHNOLOG, V59
   Melero R, 2014, REV ESP DOC CIENT, V37, DOI 10.3989/redc.2014.4.1154
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Institutes of Health, 2003, NIH DAT SHAR POL IMP
   Oms, 2009, REG SAN INT
   RUTTENBERG S, 1994, J ATMOS TERR PHYS, V56, P865, DOI 10.1016/0021-9169(94)90148-1
   Sankoh O, 2011, LANCET, V378, P401, DOI 10.1016/S0140-6736(11)61211-7
   SANTOS J. J., 2015, REV MINISTERIO PUBLI, P21
   Sondergaard TF, 2003, J DOC, V59, P278, DOI 10.1108/00220410310472509
   Strauss A., 2008, PESQUISA QUALITATIVA
   Sturges P, 2015, J ASSOC INF SCI TECH, V66, P2445, DOI 10.1002/asi.23336
   Thompson CA, 2014, COLL RES LIBR, V75, P842, DOI 10.5860/crl.75.6.842
   VASCONCELOS PFD, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9
   Whitmire AL, 2015, PROGRAM-ELECTRON LIB, V49, P382, DOI 10.1108/PROG-02-2015-0017
   Whitmire E, 2002, J AM SOC INF SCI TEC, V53, P631, DOI 10.1002/asi.10123
   WHO, 2017, ZIK RESP FUND
   WHO, 2016, LAT ZIK SIT REP
   Whyte A., 2011, INT J DIGITAL CURATI, V6, P199, DOI DOI 10.2218/IJDC.V6IL.182
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   ZATZ M, 2000, SAO PAULO PERSPECT, V14, P47
NR 47
TC 1
Z9 1
U1 4
U2 23
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0022-0418
EI 1758-7379
J9 J DOC
JI J. Doc.
PD SEP 9
PY 2019
VL 75
IS 5
BP 910
EP 926
DI 10.1108/JD-05-2018-0071
PG 17
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA IW9GI
UT WOS:000485301100001
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ren, JH
   Lee, Y
   Kotak, AP
   Johnson, ME
AF Ren, Jinhong
   Lee, Hyun
   Kotak, Alpa
   Johnson, Michael E.
TI MD simulations reveal alternate conformations of the oxyanion hole in
   the Zika virus NS2B/NS3 protease
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE accelerated molecular dynamics simulation; conventional molecular
   dynamics simulation; NS2B; NS3 protease; oxyanion hole; Zika virus
ID MOLECULAR-DYNAMICS; NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; BINDING;
   IDENTIFICATION; STABILIZATION; ACTIVATION
AB Recent crystallography studies have shown that the binding site oxyanion hole plays an important role in inhibitor binding, but can exist in two conformations (active/inactive). We have undertaken molecular dynamics (MD) calculations to better understand oxyanion hole dynamics and thermodynamics. We find that the Zika virus (ZIKV) NS2B/NS3 protease maintains a stable closed conformation over multiple 100-ns conventional MD simulations in both the presence and absence of inhibitors. The S1, S2, and S3 pockets are stable as well. However, in two of eight simulations, the A132-G133 peptide bond in the binding pocket of S1' spontaneously flips to form a 3(10)-helix that corresponds to the inactive conformation of the oxyanion hole, and then maintains this conformation until the end of the 100-ns conventional MD simulations without inversion of the flip. This conformational change affects the S1' pocket in ZIKV NS2B/NS3 protease active site, which is important for small molecule binding. The simulation results provide evidence at the atomic level that the inactive conformation of the oxyanion hole is more favored energetically when no specific interactions are formed between substrate/inhibitor and oxyanion hole residues. Interestingly, however, transition between the active and inactive conformation of the oxyanion hole can be observed by boosting the valley potential in accelerated MD simulations. This supports a proposed induced-fit mechanism of ZIKV NS2B/NS3 protease from computational methods and provides useful direction to enhance inhibitor binding predictions in structure-based drug design.
C1 [Ren, Jinhong; Lee, Hyun; Kotak, Alpa; Johnson, Michael E.] Univ Illinois, Ctr Biomol Sci, Chicago, IL 60607 USA.
   [Lee, Hyun] Univ Illinois, Res Resource Ctr Biophys Core, Chicago, IL 60607 USA.
   [Lee, Hyun; Johnson, Michael E.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.
   [Kotak, Alpa; Johnson, Michael E.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RP Ren, JH; Johnson, ME (corresponding author), Univ Illinois, Ctr Biomol Sci, Chicago, IL 60607 USA.
EM jhren@uic.edu; mjohnson@uic.edu
RI Johnson, Michael E/F-5141-2013
OI Johnson, Michael E/0000-0002-8246-4081; Lee, Hyun/0000-0003-2570-8120
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P41-GM103311]
FX cMD and aMD simulations were performed on the Extreme highperformance
   computing cluster in the UIC Academic Computing and Communications
   Center. We thank UIC ACCC providing us with access. We also thank
   ChemAxon for providing access to JChem for Excel. Molecular graphics and
   analyses were performed with UCSF Chimera, developed by the Resource for
   Biocomputing, Visualization, and Informatics at the University of
   California, San Francisco, with support from NIH P41-GM103311.
CR Barrette-Ng IH, 2002, J BIOL CHEM, V277, P39960, DOI 10.1074/jbc.M206978200
   BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Case D. A., 2014, AMBER 14
   Chappell KJ, 2005, J BIOL CHEM, V280, P2896, DOI 10.1074/jbc.M409931200
   Chaudhuri R, 2011, J MOL BIOL, V414, P272, DOI 10.1016/j.jmb.2011.09.030
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   desAlmeida H, 2013, PLOS ONE, V8
   Ekonomiuk D, 2009, PROTEIN SCI, V18, P1003, DOI 10.1002/pro.110
   Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656
   Hilgenfeld R, 2018, ADV EXP MED BIOL, V1062, P131, DOI 10.1007/978-981-10-8727-1_10
   Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508
   Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Salaemae W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-68
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu YC, 2003, J AM CHEM SOC, V125, P11340, DOI 10.1021/ja029775t
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zuo ZL, 2009, J VIROL, V83, P1060, DOI 10.1128/JVI.01325-08
NR 37
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD FEB
PY 2020
VL 88
IS 2
BP 345
EP 354
DI 10.1002/prot.25809
EA SEP 2019
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA JZ7RC
UT WOS:000485525600001
PM 31461176
DA 2020-07-08
ER

PT J
AU Fisher, ML
   Levine, JF
   Guy, JS
   Mochizuki, H
   Breen, M
   Schal, C
   Watson, DW
AF Fisher, Michael L.
   Levine, Jay F.
   Guy, James S.
   Mochizuki, Hiroyuki
   Breen, Matthew
   Schal, Coby
   Watson, David W.
TI Lack of influence by endosymbiont Wolbachia on virus titer in the common
   bed bug, Cimex lectularius
SO PARASITES & VECTORS
LA English
DT Article
DE Cimex lectularius; Wolbachia; Endosymbiont; Cimicidae; Virus
   suppression; ssRNA
ID HEPATITIS-B VIRUS; AEDES-AEGYPTI; DENGUE VIRUS; FELINE CALICIVIRUS;
   DROSOPHILA-MELANOGASTER; PERITROPHIC MATRIX; GUT MICROBIOTA;
   TRANSMISSION; ACTIVATION; INFECTION
AB Background The common bed bug, Cimex lectularius, is an obligatory blood-feeding ectoparasite that requires a blood meal to molt and produce eggs. Their frequent biting to obtain blood meals and intimate association with humans increase the potential for disease transmission. However, despite more than 100 years of inquiry into bed bugs as potential disease vectors, they still have not been conclusively linked to any pathogen or disease. This ecological niche is extraordinarily rare, given that nearly every other blood-feeding arthropod is associated with some type of human or zoonotic disease. Bed bugs rely on the bacteria Wolbachia as an obligate endosymbiont to biosynthesize B vitamins, since they acquire a nutritionally deficient diet, but it is unknown if Wolbachia confers additional benefits to its bed bug host. In some insects, Wolbachia induces resistance to viruses such as Dengue, Chikungunya, West Nile, Drosophila C and Zika, and primes the insect immune system in other blood-feeding insects. Wolbachia might have evolved a similar role in its mutualistic association with the bed bug. In this study, we evaluated the influence of Wolbachia on virus replication within C. lectularius. Methods We used feline calicivirus as a model pathogen. We fed 40 bed bugs from an established line of Wolbachia-cured and a line of Wolbachia-positive C. lectularius a virus-laden blood meal, and quantified the amount of virus over five time intervals post-feeding. The antibiotic rifampicin was used to cure bed bugs of Wolbachia. Results There was a significant effect of time post-feeding, as the amount of virus declined by similar to 90% over 10 days in both groups, but no significant difference in virus titer was observed between the Wolbachia-positive and Wolbachia-cured groups. Conclusions These findings suggest that other mechanisms are involved in virus suppression within bed bugs, independent of the influence of Wolbachia, and our conclusions underscore the need for future research.
C1 [Fisher, Michael L.; Schal, Coby; Watson, David W.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA.
   [Fisher, Michael L.] US Navy Med Serv Corps, Raleigh, NC 27616 USA.
   [Mochizuki, Hiroyuki; Breen, Matthew] North Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC USA.
   [Levine, Jay F.] North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC USA.
   [Guy, James S.] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27607 USA.
RP Fisher, ML (corresponding author), US Navy Med Serv Corps, Raleigh, NC 27616 USA.
EM ento4life@gmail.com
RI Schal, Coby/A-8717-2010
OI Schal, Coby/0000-0001-7195-6358; Guy, James/0000-0003-0350-7934
FU US Department of Housing and Urban Development Healthy Homes Program
   [NCHHU0017-13]; Alfred P. Sloan FoundationAlfred P. Sloan Foundation
   [2013-5-35 MBE]; Blanton J. Whitmire Endowment; WM Keck Center for
   Behavioral Biology; Department of Entomology and Plant Pathology at
   North Carolina State University; W. M. Keck FoundationW.M. Keck
   Foundation
FX This work was funded in part by grants from the US Department of Housing
   and Urban Development Healthy Homes Program (NCHHU0017-13) and the
   Alfred P. Sloan Foundation (2013-5-35 MBE), the Blanton J. Whitmire
   Endowment, WM Keck Center for Behavioral Biology, and the Department of
   Entomology and Plant Pathology, all at North Carolina State University.
   This study was funded by W. M. Keck Foundation (2016scholarship).
CR Adelman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003462
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011
   Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06
   Bai XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016336
   Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144
   Benoit JB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10165
   Bidawid S, 2003, J VIROL METHODS, V107, P163, DOI 10.1016/S0166-0934(02)00214-8
   Blow JA, 2001, J MED ENTOMOL, V38, P694, DOI 10.1603/0022-2585-38.5.694
   Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286
   Brown CR, 2005, J VECTOR ECOL, V30, P137
   Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005
   BURTON GJ, 1963, PUBLIC HEALTH REP, V78, P513, DOI 10.2307/4591852
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102
   DeVries ZC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192462
   Doggett SL, 2018, ADV BIOL MANAGEMENT, P117
   Doggett SL, 2018, ADVANCES IN THE BIOL
   Douglas A. E., 2013, INSECTS STRUCTURE FU, P46
   Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822
   Edwards MJ, 2000, J INSECT PHYSIOL, V46, P1313, DOI 10.1016/S0022-1910(00)00053-6
   Fisher ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29682-2
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010
   Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405
   Gordon JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10807
   Harrison JF, 2001, ANNU REV ENTOMOL, V46, P221, DOI 10.1146/annurev.ento.46.1.221
   Henzel A, 2012, BRAZ J MICROBIOL, V43, P560, DOI 10.1590/S1517-83822012000200017
   Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Johnson KN, 2015, CURR OPIN INSECT SCI, V8, P97, DOI 10.1016/j.cois.2015.01.008
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   JUPP PG, 1987, AIDS, V1, P171
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Koganemaru R, 2013, PESTIC BIOCHEM PHYS, V106, P190, DOI 10.1016/j.pestbp.2013.01.001
   Lai O, 2016, ARCH DERMATOL RES, V308, P531, DOI 10.1007/s00403-016-1661-8
   LAKE P, 1968, J INSECT PHYSIOL, V14, P543, DOI 10.1016/0022-1910(68)90070-X
   LEE KM, 1973, INFECT IMMUN, V7, P678, DOI 10.1128/IAI.7.4.678-679.1973
   Leulmi H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003789
   Lilly DG, 2016, INSECTS, V7, DOI 10.3390/insects7040074
   Lilly DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153302
   Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moriyama M, 2015, MBIO, V6, DOI 10.1128/mBio.01732-15
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Nikoh N, 2014, P NATL ACAD SCI USA, V111, P10257, DOI 10.1073/pnas.1409284111
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Peters W, 2012, PERITROPHIC MEMBRANE
   Raab RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0117805
   Ratcliffe NA, 2004, VECTOR IMMUNITY MICR, P199
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913
   Romero A, 2016, J MED ENTOMOL, V53, P727, DOI 10.1093/jme/tjv253
   RUSH WA, 1980, ANN ENTOMOL SOC AM, V73, P315, DOI 10.1093/aesa/73.3.315
   Saenz VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073661
   Sakamoto JM, 2006, J MED ENTOMOL, V43, P696, DOI 10.1603/0022-2585(2006)43[696:GDOWII]2.0.CO;2
   Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483
   Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042.abs
   Shaw AE, 2012, J VIROL, V86, P9015, DOI 10.1128/JVI.00131-12
   Sicard M, 2014, ENVIRON MICROBIOL, V16, P3583, DOI 10.1111/1462-2920.12573
   Sierras A, 2017, PEST MANAG SCI, V73, P521, DOI 10.1002/ps.4464
   Silverman AL, 2001, AM J GASTROENTEROL, V96, P2194, DOI 10.1111/j.1572-0241.2001.03955.x
   Skelton E, 2016, J MED ENTOMOL, V53, P401, DOI 10.1093/jme/tjv235
   Steelman CD, 2008, J AGR URBAN ENTOMOL, V25, P41, DOI 10.3954/1523-5475-25.1.41
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   USINGER R, 1966, MONOGRAPH CIMICIDAE
   van Tol S, 2016, ADV INSECT PHYSIOL, V51, P243, DOI 10.1016/bs.aiip.2016.04.006
   Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001
   Weiss BL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003318
   Wong ZS, 2016, J GEN VIROL, V97, P1446, DOI 10.1099/jgv.0.000456
   Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430
   Ye YH, 2017, J INVERTEBR PATHOL, V143, P18, DOI 10.1016/j.jip.2016.11.011
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
NR 77
TC 0
Z9 0
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 9
PY 2019
VL 12
IS 1
AR 436
DI 10.1186/s13071-019-3694-2
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IW3XS
UT WOS:000484915600001
PM 31500667
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bradt, V
   Malafa, S
   von Braun, A
   Jarmer, J
   Tsouchnikas, G
   Medits, I
   Wanke, K
   Karrer, U
   Stiasny, K
   Heinz, FX
AF Bradt, Victoria
   Malafa, Stefan
   von Braun, Amrei
   Jarmer, Johanna
   Tsouchnikas, Georgios
   Medits, Iris
   Wanke, Kerstin
   Karrer, Urs
   Stiasny, Karin
   Heinz, Franz X.
TI Pre-existing yellow fever immunity impairs and modulates the antibody
   response to tick-borne encephalitis vaccination
SO NPJ VACCINES
LA English
DT Article
ID ORIGINAL ANTIGENIC SIN; ZIKA VIRUS; HEMAGGLUTINATION-INHIBITION;
   MEDIATED NEUTRALIZATION; BIOLOGY; FLAVIVIRUSES; INFECTION; LESSONS;
   TESTS
AB Flaviviruses have an increasing global impact as arthropod-transmitted human pathogens, exemplified by Zika, dengue, yellow fever (YF), West Nile, Japanese encephalitis, and tick-borne encephalitis (TBE) viruses. Since all flaviviruses are antigenically related, they are prone to phenomena of immunological memory ('original antigenic sin'), which can modulate immune responses in the course of sequential infections and/or vaccinations. In our study, we analyzed the influence of pre-existing YF vaccine-derived immunity on the antibody response to TBE vaccination. By comparing samples from YF pre-vaccinated and flavivirus-naive individuals, we show that YF immunity not only caused a significant impairment of the neutralizing antibody response to TBE vaccination but also a reduction of the specific TBE virus neutralizing activities (NT/ELISA-titer ratios). Our results point to a possible negative effect of pre-existing cross-reactive immunity on the outcome of flavivirus vaccination that may also pertain to other combinations of sequential flavivirus infections and/or vaccinations.
C1 [Bradt, Victoria; Malafa, Stefan; Jarmer, Johanna; Tsouchnikas, Georgios; Medits, Iris; Stiasny, Karin; Heinz, Franz X.] Med Univ Vienna, Ctr Virol, Vienna, Austria.
   [von Braun, Amrei; Wanke, Kerstin; Karrer, Urs] Univ Hosp Zurich, Dept Med, Div Infect Dis, Zurich, Switzerland.
   [von Braun, Amrei] Univ Hosp Leipzig, Dept Med, Leipzig, Germany.
   [Jarmer, Johanna] Boehringer Ingelhe RCV GmbH & Co KG, Vienna, Austria.
   [Tsouchnikas, Georgios] Hookipa Pharma, Vienna, Austria.
   [Wanke, Kerstin] Novartis, Rotkreuz, Switzerland.
   [Karrer, Urs] Cantonal Hosp Winterthur, Dept Med, Winterthur, Switzerland.
RP Stiasny, K; Heinz, FX (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.
EM karin.stiasny@meduniwien.ac.at; franz.x.heinz@meduniwien.ac.at
OI Stiasny, Karin/0000-0002-1902-8674; Malafa, Stefan/0000-0002-0222-9832
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P25265-B21,
   P27501-B21, P29928-B30]; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [PP0033-110737]; Promedica Foundation (Chur,
   Switzerland); Baxter Healthcare Inc. (Austria)
FX We thank Ted Pierson and Kimberly Dowd (National Institute of Allergy
   and Infectious Diseases, National Institutes of Health, Bethesda, MD,
   USA) for providing the subgenomic WNV replicon plasmid. We thank Jutta
   Hutecek, Cornelia Hell, Angelika Berger, Andrea Reiter, Lea Haberli,
   Walter Holzer and Silvia Schwodiauer for their excellent technical
   assistance. F.X.H. and K.S. acknowledge support from the Austrian
   Science Fund FWF (F.X.H.: grants P25265-B21, P27501-B21; K.S.: grant
   P29928-B30) and U.K. from the Swiss National Science Foundation (grant
   PP0033-110737) and the Promedica Foundation (Chur, Switzerland). U.K.
   was supported by an unrestricted educational grant from Baxter
   Healthcare Inc. (Austria), the manufacturer of the TBE vaccine used.
   Neither the National Science Funds nor Baxter and its representatives
   had a role in study design, data collection, analysis and
   interpretation, or the decision to submit the work for publication. The
   analyses were approved by the ethics committees of the University
   Hospital of Zurich and the Medical University of Vienna, respectively.
CR Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522
   [Anonymous], 2011, Wkly Epidemiol Rec, V86, P241
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Cobey S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0235
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2018, ANNU REV VIROL, V5, P185, DOI 10.1146/annurev-virology-092917-043300
   Duehr J, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00011-18, 10.1128/mspheredirect.00011-18]
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0
   Halstead S. B., 2018, PLOTKINS VACCINES
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Holzmann H, 1996, J MED VIROL, V48, P102, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;102::AID-JMV16&gt;3.0.CO;2-I
   Hombach J., 2018, PLOTKINS VACCINES
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103
   KAYSER M, 1985, J MED VIROL, V17, P35, DOI 10.1002/jmv.1890170106
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Monto AS, 2017, J INFECT DIS, V215, P1782, DOI 10.1093/infdis/jix173
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Park MS, 2016, IMMUNE NETW, V16, P261, DOI 10.4110/in.2016.16.5.261
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Plotkin S. A., 2018, PLOTKINS VACCINES
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2018, CELL, V172, P1319, DOI 10.1016/j.cell.2018.02.054
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sage PT, 2015, TRENDS IMMUNOL, V36, P410, DOI 10.1016/j.it.2015.05.005
   Schuller E, 2008, VACCINE, V26, P6151, DOI 10.1016/j.vaccine.2008.08.056
   Staples J. E., 2018, PLOTKINS VACCINES
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Tsai W.-Y., 2018, J VIROL, V92
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
   Wang TT, 2018, CURR OPIN IMMUNOL, V53, P124, DOI 10.1016/j.coi.2018.04.026
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Zarnitsyna VI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0248
   Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10
NR 53
TC 5
Z9 5
U1 0
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD SEP 6
PY 2019
VL 4
AR 38
DI 10.1038/s41541-019-0133-5
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IZ3UR
UT WOS:000487011500001
PM 31508246
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fathi, A
   Dahlke, C
   Addo, MM
AF Fathi, Anahita
   Dahlke, Christine
   Addo, Marylyn M.
TI Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint
   priority pathogens
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE rVSV; vesicular stomatitis virus; vector vaccine; V920; VSV-EBOV; Ebola
   virus; Marburg virus; Lassa virus; Nipah virus; emerging infections
ID PROTECTS NONHUMAN-PRIMATES; EBOLA-VIRUS; RVSV-ZEBOV; HEMORRHAGIC-FEVER;
   LETHAL CHALLENGE; DOUBLE-BLIND; ZIKA VIRUS; POSTEXPOSURE PROTECTION;
   QUESTIONABLE EFFICACY; SINGLE IMMUNIZATION
AB The devastating Ebola virus (EBOV) outbreak in West Africa in 2013-2016 has flagged the need for the timely development of vaccines for high-threat pathogens. To be better prepared for new epidemics, the WHO has compiled a list of priority pathogens that are likely to cause future outbreaks and for which R&D efforts are, therefore, paramount (R&D Blueprint: ). To this end, the detailed characterization of vaccine platforms is needed. The vesicular stomatitis virus (VSV) has been established as a robust vaccine vector backbone for infectious diseases for well over a decade. The recent clinical trials testing the vaccine candidate VSV-EBOV against EBOV disease now have added a substantial amount of clinical data and suggest VSV to be an ideal vaccine vector candidate for outbreak pathogens. In this review, we discuss insights gained from the clinical VSV-EBOV vaccine trials as well as from animal studies investigating vaccine candidates for Blueprint pathogens.
C1 Univ Med Ctr Hamburg Eppendorf, Dept Med, Div Infect Dis, Hamburg, Germany.
   Bernhard Nocht Inst Trop Med, Dept Clin Immunol Infect Dis, Hamburg, Germany.
   German Ctr Infect Res, Hamburg, Germany.
RP Addo, MM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Div Infect Dis, Martinistr 52, D-20246 Hamburg, Germany.
EM m.addo@uke.de
OI Addo, Marylyn/0000-0003-2836-9224; Fathi, Anahita/0000-0002-9351-9471
FU German Center for Infection Research (DZIF, Clinical Leave Stipend)
FX This work has been supported by the German Center for Infection Research
   (DZIF, Clinical Leave Stipend for AF).
CR Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Agnandji ST, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002402
   [Anonymous], 2017, MARBURG VIRUS DIS
   Arnemo M, 2016, J INFECT DIS, V213, P930, DOI 10.1093/infdis/jiv532
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Branswell H., EBOLA VACCINE WILL B
   Brown KS, 2011, J VIROL, V85, P12781, DOI 10.1128/JVI.00794-11
   Caluwaerts S, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0429-8
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Chattopadhyay A, 2013, J VIROL, V87, P395, DOI 10.1128/JVI.01860-12
   Chattopadhyay A, 2011, J VIROL, V85, P2004, DOI 10.1128/JVI.01852-10
   Clarke DK, 2007, J VIROL, V81, P2056, DOI 10.1128/JVI.01911-06
   Clarke DK, 2016, VACCINE, V34, P6597, DOI 10.1016/j.vaccine.2016.06.071
   Coller BAG, 2017, VACCINE, V35, P4465, DOI 10.1016/j.vaccine.2017.05.097
   Cross RW, 2018, NAT REV DRUG DISCOV, V17, P413, DOI 10.1038/nrd.2017.251
   Daddario-DiCaprio KM, 2006, J VIROL, V80, P9659, DOI 10.1128/JVI.00959-06
   Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2
   Dahlke C, 2017, EBIOMEDICINE, V19, P107, DOI 10.1016/j.ebiom.2017.03.045
   DeBuysscher BL, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.2
   DeBuysscher BL, 2014, VACCINE, V32, P2637, DOI 10.1016/j.vaccine.2014.02.087
   Dong FF, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-018-0096-y
   Elizaga ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202753
   ElSherif MS, 2017, CMAJ, V189, P819, DOI [10.1503/cmaj.171389, DOI 10.1503/CMAJ.171389]
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Falzarano D, 2011, J INFECT DIS, V204, pS1082, DOI 10.1093/infdis/jir350
   Farooq F, 2016, SCI REP-UK, V6, DOI 10.1038/srep27944
   Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002
   Fischer WA, 2018, LANCET INFECT DIS, V18, pE183, DOI 10.1016/S1473-3099(17)30677-1
   Fuchs JD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv082
   Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Geisbert TW, 2008, J VIROL, V82, P5664, DOI 10.1128/JVI.00456-08
   Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349
   Geisbert TW, 2010, EMERG INFECT DIS, V16, P1119, DOI 10.3201/eid1607.100159
   Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690
   Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09
   Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082
   Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225
   Geisbert TW, 2005, PLOS MED, V2, P537, DOI 10.1371/journal.pmed.0020183
   Goldstein T, 2018, NAT MICROBIOL, V3, P1084, DOI 10.1038/s41564-018-0227-2
   Gross L, 2018, INT J INFECT DIS, V74, P83, DOI 10.1016/j.ijid.2018.06.022
   Gsell PS, 2017, LANCET INFECT DIS, V17, P1276, DOI 10.1016/S1473-3099(17)30541-8
   Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298
   Halperin SA, 2017, J INFECT DIS, V215, P1789, DOI 10.1093/infdis/jix189
   Haug CJ, 2018, NEW ENGL J MED, V378, P2353, DOI 10.1056/NEJMp1806978
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Heppner DG, 2017, LANCET INFECT DIS, V17, P854, DOI 10.1016/S1473-3099(17)30313-4
   Huttner A, 2018, LANCET INFECT DIS, V18, P738, DOI 10.1016/S1473-3099(18)30165-8
   Huttner A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1701
   Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1
   Iyer AV, 2009, VACCINE, V27, P893, DOI 10.1016/j.vaccine.2008.11.087
   Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258
   Jones SM, 2007, J INFECT DIS, V196, pS404, DOI 10.1086/520591
   Juan-Giner A, 2018, VACCINE, VS0264-410X, P31246
   Kafetzopoulou LE, 2019, SCIENCE, V363, P74, DOI 10.1126/science.aau9343
   Kapadia SU, 2008, VIROLOGY, V376, P165, DOI 10.1016/j.virol.2008.03.002
   Kapadia SU, 2005, VIROLOGY, V340, P174, DOI 10.1016/j.virol.2005.06.016
   Kasereka MC, 2019, VACCINE, V37, P2174, DOI 10.1016/j.vaccine.2019.03.004
   Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067
   Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x
   Lai LL, 2015, JAMA-J AM MED ASSOC, V313, P1249, DOI 10.1001/jama.2015.1995
   Lauretti F, 2016, HUM VACC IMMUNOTHER, V12, P2327, DOI 10.1080/21645515.2016.1183857
   LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Liu RQ, 2018, ANTIVIR RES, V150, P30, DOI 10.1016/j.antiviral.2017.12.007
   Liu X, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1137-3
   Lo MK, 2014, ANTIVIR RES, V101, P26, DOI 10.1016/j.antiviral.2013.10.012
   Locher S, 2018, J GEN VIROL, V99, P866, DOI 10.1099/jgv.0.001085
   Longini IM, 2018, LANCET, V391, P1021, DOI 10.1016/S0140-6736(18)30559-2
   Marzi A, 2019, BIODRUGS, V33, P9, DOI 10.1007/s40259-018-0329-7
   Marzi A, 2016, J INFECT DIS, V214, pS360, DOI 10.1093/infdis/jiw218
   Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920
   Marzi A, 2015, EMERG INFECT DIS, V21, P305, DOI 10.3201/eid2102.141649
   Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110
   Matassov D, 2018, J VIROL, V92, DOI 10.1128/JVI.01190-17
   Matassov D, 2015, J INFECT DIS, V212, pS443, DOI 10.1093/infdis/jiv316
   McGettigan JP, 2001, J VIROL, V75, P8724, DOI 10.1128/JVI.75.18.8724-8732.2001
   Menicucci AR, 2019, MBIO, V10, DOI 10.1128/mBio.00597-19
   Metzger WG, 2018, LANCET, V391, P1021, DOI 10.1016/S0140-6736(18)30560-9
   Ministere de la Sante RD du C, 2019, EBOLA RDC EV RIP EP
   Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428
   Mire CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094355
   Mire CE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002600
   Modjarrad K, 2016, NAT MED, V22, P701, DOI 10.1038/nm.4131
   Monath Thomas P, 2019, Vaccine X, V1, P100009, DOI 10.1016/j.jvacx.2019.100009
   Nachbagauer R, 2019, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.03122, DOI 10.3389/FIMMU.2018.03122]
   Nigeria Center for Disease Control (NCDC), 2019, 2019 LASSA FEV OUTBR
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Plotkin SA, 2017, HUM VACC IMMUNOTHER, V13, P2755, DOI 10.1080/21645515.2017.1306615
   Plummer FA, 2017, CAN MED ASSOC J, V189, pE1326, DOI 10.1503/cmaj.170704
   Poetsch JH, 2019, J INFECT DIS, V219, P556, DOI 10.1093/infdis/jiy565
   Prescott J, 2015, VACCINE, V33, P2823, DOI 10.1016/j.vaccine.2015.03.089
   Prescott J, 2014, VIRUSES-BASEL, V6, P516, DOI 10.3390/v6020516
   Profectus Biosciences, 2017, PROF BIOSC AW NIH CO
   Profectus Biosciences, 2018, CEPI AW CONTR WORTH
   Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547
   RDC, 2019, EBOLA RDC EV RIP EP
   Rechtien A, 2017, CELL REP, V20, P2251, DOI 10.1016/j.celrep.2017.08.023
   Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216
   Reynolds P, 2017, VIRUS GENES, V53, P501, DOI 10.1007/s11262-017-1455-x
   Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999
   Rodriguez SE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44210-6
   Rose J, 1987, THABDOVIRUSES, P129
   Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2
   Rose NF, 2000, J VIROL, V74, P10903, DOI 10.1128/JVI.74.23.10903-10910.2000
   Ruibal P, 2016, NATURE, V533, P100, DOI 10.1038/nature17949
   Safronetz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003736
   Samai M, 2018, J INFECT DIS, V6, P217
   Shi XD, 2019, VIROL SIN, V34, P106, DOI 10.1007/s12250-019-00083-7
   Stein DR, 2019, EMERG INFECT DIS, V25, P1563, DOI 10.3201/eid2508.190281
   Stein DR, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0104-x
   The PREVENT Working Group, PREGN WOM VACC EM EP
   Tsuda Y, 2011, J INFECT DIS, V204, pS1090, DOI 10.1093/infdis/jir379
   van den Pol AN, 2017, J VIROL, V91, DOI 10.1128/JVI.02154-16
   Warner BM, 2018, DRUG DES DEV THER, V12, P2519, DOI 10.2147/DDDT.S147276
   WHO, WHO RES DEV BLUEPR 2
   WHO, 2015, WHO PUBL LIST TOP EM
   WHO, 2019, PREL RES EFF RVSV ZE
   WHO, WHO DIR GEN SUMM OUT
   WHO, 2018, EB VIR DIS DEM REP C
   Widdowson MA, 2016, MMWR-MORBID MORTAL W, V65, P98, DOI 10.15585/mmwr.su6503a14
   Wong KK, 2016, CLIN INFECT DIS, V63, P376, DOI 10.1093/cid/ciw256
   Woolsey C, 2018, J INFECT DIS, V218, pS582, DOI 10.1093/infdis/jiy293
   World Health Organization, 2019, STRAT ADV GROUP EXP
   World Health Organization, 2017, METH PRIOR SEV EM DI
   World Health Organization, 10 THREATS GLOB HLTH
   Yan Q, 2016, VACCINE, V34, P4196, DOI 10.1016/j.vaccine.2016.06.058
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zemp F, 2018, BIOTECHNOL GENET ENG, V34, P122, DOI 10.1080/02648725.2018.1474320
NR 130
TC 2
Z9 2
U1 2
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD OCT 3
PY 2019
VL 15
IS 10
BP 2269
EP 2285
DI 10.1080/21645515.2019.1649532
EA SEP 2019
PG 17
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA JG2QG
UT WOS:000485714200001
PM 31368826
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rohde, BB
   Staunton, KM
   Zeak, NC
   Beebe, N
   Snoad, N
   Bondarenco, A
   Liddington, C
   Anderson, JA
   Xiang, W
   Mankin, RW
   Ritchie, SA
AF Rohde, Barukh B.
   Staunton, Kyran M.
   Zeak, Nicholas C.
   Beebe, Nigel
   Snoad, Nigel
   Bondarenco, Artiom
   Liddington, Catherine
   Anderson, Jason A.
   Xiang, Wei
   Mankin, Richard W.
   Ritchie, Scott A.
TI Waterproof, low-cost, long-battery-life sound trap for surveillance of
   male Aedes aegypti for rear-and-release mosquito control programmes
SO PARASITES & VECTORS
LA English
DT Article
DE Vector control; Gravid Aedes Trap; Female wingbeat
ID DIPTERA-CULICIDAE; VIBRATIONS; CAPTURE; FEVER; SONG
AB BackgroundSterile male rear-and-release programmes are of growing interest for controlling Aedes aegypti, including use an incompatible insect technique (IIT) to suppress transmission of dengue, Zika, and other viruses. Under IIT, males infected with Wolbachia are released into the suppression area to induce cytoplasmic incompatibility in uninfected populations. These and similar mosquito-release programmes require cost-effective field surveys of both sexes to optimize the locations, timing, and quantity of releases. Unfortunately, traps that sample male Ae. aegypti effectively are expensive and usually require mains power. Recently, an electronic lure was developed that attracts males using a 484 Hz sinusoidal tone mimicking the female wingbeat frequencies, broadcast in a 120 s on/off cycle. When deployed in commercially available gravid Aedes traps (GATs), the new combination, sound-GAT (SGAT), captures both males and females effectively. Given its success, there is interest in optimizing SGAT to reduce cost and power usage while maximizing catch rates.MethodsOptions considered in this study included use of a smaller, lower-power microcontroller (Tiny) with either the original or a lower-cost speaker (lcS). A 30s on/off cycle was tested in addition to the original 120s cycle to minimize the potential that the longer cycle induced habituation. The original SGAT was compared against other traps incorporating the Tiny-based lures for mosquito capture in a large semi-field cage. The catch rates in waterproofed versions of this trap were then compared with catch rates in standard [BG-Sentinel 2 (BGS 2); Biogents AG, Regensburg, Germany] traps during an IIT field study in the Innisfail region of Queensland, Australia in 2017.ResultsThe system with a low-power microcontroller and low-cost speaker playing a 30s tone (Tiny-lcS-30s) caught the highest proportion of males. The mean proportions of males caught in a semi-field cage were not significantly different among the original design and the four low-power, low-cost versions of the SGAT. During the IIT field study, the waterproofed version of the highest-rated, Tiny-lcS-30s SGAT captured male Ae. aegypti at similar rates as co-located BGS-2 traps.ConclusionsPower- and cost-optimized, waterproofed versions of male Ae. aegypti acoustic lures in GATs are now available for field use in areas with sterile male mosquito rear-and-release programmes.
C1 [Rohde, Barukh B.; Zeak, Nicholas C.] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL 32611 USA.
   [Rohde, Barukh B.; Staunton, Kyran M.; Zeak, Nicholas C.; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Australia.
   [Rohde, Barukh B.; Staunton, Kyran M.; Zeak, Nicholas C.; Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia.
   [Beebe, Nigel; Liddington, Catherine; Anderson, Jason A.] CSIRO, Hlth & Biosecur, Brisbane, Qld, Australia.
   [Beebe, Nigel] Univ Queensland, Fac Sci, Sch Biol Sci, Brisbane, Qld, Australia.
   [Snoad, Nigel] Verily Life Sci, 259 East Grand Ave, San Francisco, CA 94080 USA.
   [Bondarenco, Artiom] CSIRO, Land & Water, Brisbane, Qld, Australia.
   [Xiang, Wei] James Cook Univ, Coll Sci & Engn, Cairns, Qld 4878, Australia.
   [Mankin, Richard W.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
RP Rohde, BB (corresponding author), Univ Florida, Dept Elect & Comp Engn, Gainesville, FL 32611 USA.; Rohde, BB (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Australia.; Rohde, BB (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia.; Mankin, RW (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
EM barukh94-work@yahoo.com; Richard.Mankin@ars.usda.gov
RI Mankin, R. W./AAC-6588-2019; Beebe, Nigel/C-5610-2008
OI Mankin, R. W./0000-0003-3369-8110; Staunton, Kyran/0000-0001-6812-3320;
   Beebe, Nigel/0000-0003-2877-0691
FU National Science FoundationNational Science Foundation (NSF)
   [DGE-1315138, DGE-1842473]; National Health and Medical Research
   CouncilNational Health and Medical Research Council of Australia
   [1044698]
FX This material is based on work supported by the National Science
   Foundation Graduate Research Fellowship Programme to BBR under Grant No.
   DGE-1315138 and DGE-1842473 and an international travel allowance
   through the Graduate Research Opportunities Worldwide (GROW). Any
   opinions, findings, and conclusions or recommendations expressed in this
   material are those of the author(s) and do not necessarily reflect the
   views of the National Science Foundation.; This work was also funded by
   a National Health and Medical Research Council Senior Research
   Fellowship (1044698) to SAR.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Balestrino F, 2016, ACTA TROP, V164, P448, DOI 10.1016/j.actatropica.2016.09.002
   BELTON P, 1994, J AM MOSQUITO CONTR, V10, P297
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BIDLINGMAYER WL, 1994, J AM MOSQUITO CONTR, V10, P272
   Cator LJ, 2011, J MED ENTOMOL, V48, P941, DOI 10.1603/ME11019
   Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541
   CHARLWOOD JD, 1980, PHYSIOL ENTOMOL, V5, P315, DOI 10.1111/j.1365-3032.1980.tb00241.x
   Davis AK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0018
   Dillman AR, 2014, ENVIRON ENTOMOL, V43, P146, DOI 10.1603/EN13152
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Engel JE, 1999, J EXP BIOL, V202, P2797
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Gopfert MC, 1999, J EXP BIOL, V202, P2727
   Jakhete SS, 2017, J MED ENTOMOL, V54, P1415, DOI 10.1093/jme/tjx074
   Jamora E. M. M., 2018, Annals of Tropical Research, V40, P15
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johnson BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201709
   Johnson BJ, 2016, J MED ENTOMOL, V53, P245, DOI 10.1093/jme/tjv165
   Kaindoa E. W., 2017, Wellcome Open Research, V2, P88, DOI 10.12688/wellcomeopenres.12458.1
   Mankin R. W., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127001
   Mankin RW, 2004, J ECON ENTOMOL, V97, P1299, DOI 10.1603/0022-0493-97.4.1299
   Mulberry G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179133
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritchie SA, 2017, J INFECT DIS, V215, pS103, DOI 10.1093/infdis/jiw575
   Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suman DS, 2019, PARASITOL RES, V118, P743, DOI 10.1007/s00436-019-06228-7
   Swale DR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006259
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Wijnands M, 2016, THESIS
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 34
TC 1
Z9 1
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 6
PY 2019
VL 12
IS 1
AR 417
DI 10.1186/s13071-019-3647-9
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IW5ZI
UT WOS:000485056300001
PM 31488182
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Nkomo, D
AF Nkomo, Dion
TI The translation and adaptation of Alice's Adventures in Wonderland into
   isiNdebele
SO SOUTHERN AFRICAN LINGUISTICS AND APPLIED LANGUAGE STUDIES
LA English
DT Article
AB This article reflects on the translation of Lewis Carroll's Alice's Adventures in Wonderland into the isiNdebele language of Zimbabwe. The isiNdebele translation, Insumansumane zika-Alice, is one of the numerous translations produced towards the 150th commemorative exhibition of Carroll's legacy following the publication of Wonderland in 1865. The translations resulted in Wonderland becoming one of the most translated English novels, thereby vindicating the 'universal-child hypothesis' propounded by Warren Weaver in an earlier appraisal of Wonderland translations fifty years earlier. Weaver regarded the translation of Wonderland as a measure of the popularity of the text among children, who are arguably fascinated by Alice, with whom they are assumed to identify. This article problematises this argument in the light of most translations being initiated by non-mother-tongue speakers of target languages. It is argued that Alice's worldwide appeal should not be taken for granted as a universal one, partly because of her particular identity, which is different from the diverse target readers. Therefore, the question of whether Alice can really become African reflects on the domestication approach that was adopted by the isiNdebele translator, among others. Special attention is paid to proper nouns and other complex features characterising Carroll's language usage.
C1 [Nkomo, Dion] Rhodes Univ, African Language Studies, Sch Languages & Literatures, Makhanda Grahamstown, South Africa.
RP Nkomo, D (corresponding author), Rhodes Univ, African Language Studies, Sch Languages & Literatures, Makhanda Grahamstown, South Africa.
EM d.nkomo@ru.ac.za
OI Nkomo, Dion/0000-0002-0277-6828
CR alvarez R, 1996, TRANSLATION POWER SU, V8
   Alvstad C, 2010, HDB TRANSLATION STUD, V1, P22
   [Anonymous], 2015, WISDOM, V4, P15
   Bassnett S, 1990, TRANSLATION REWRITIN, pvii
   Bassnett Susan, 1996, TRANSLATION POWER SU, P10
   Carroll L., 2015, INSUMANSUMANE ZIKA A
   Carroll Lewis, 2015, ALICES ADVENTURES WO
   CATFORD J. C., 1965, LINGUISTIC THEORY TR
   Cohen MN., 2015, ALICE WORLD WONDERLA, V1, P51
   Delabastita D., 2011, HDB TRANSLATION STUD, V1, P69, DOI [10.1075/hts.2.lit2, DOI 10.1075/HTS.2.LIT2]
   Franco Aixela Javier, 1996, TRANSLATION POWER SU, P52
   Goodacre S., 2015, ALICE WORLD WONDERLA, V1, P99
   Hadjivayanis I., 2015, ALICE WORLD WONDERLA, V1, P567
   Jones FR., 2011, HDB TRANSLATION STUD, V1, P117, DOI [10.1075/hts.2.poe1, DOI 10.1075/HTS.2.POE1]
   Koskinen K., 2011, HDB TRANSLATION STUD, V2, P54, DOI DOI 10.1075/HTS.2.INS1
   Lefevere A., 1992, TRANSLATION REWRITIN
   Lindseth J., 2015, NEW COUNTRY PLAYS ST, V1, P21
   Lindseth Jon, 2015, ALICE WORLD WONDERLA, V1, P127
   Lindseth Jon, 2015, ALICE WORLD WONDERLA
   Meschonnic H., 2011, ETHICS POLITICS TRAN, DOI [10.1075/btl.91, DOI 10.1075/BTL.91]
   Mhlabi SJ., 2000, SIZWE ELIKANTULO IQO
   Mnkandla PN., 1974, ABASEGUSWINI LEZOTHA
   Mtuze P., 2003, SO AFRICAN LINGUISTI, V21, P141, DOI [10.2989/16073610309486337, DOI 10.2989/16073610309486337]
   Nida E., 1969, THEORY PRACTICE TRAN
   Nida E. A., 1964, SCI TRANSLATING
   Nord C, 2003, META, V48, P182, DOI 10.7202/006966ar
   Nyota S, 2015, ALICE WORLD WONDERLA, V1, P539
   O'Sullivan E., 2015, ALICE WORLD WONDERLA, V1, P29
   Venuti L., 2008, TRANSLATORS INVISIBI
   Vid Natalija, 2008, ELOPE ENGLISH LANGUA, V5, P217, DOI [10.4312/elope.5.1-2.217-227, DOI 10.4312/ELOPE.5.1-2.217-227]
   Wakeling E., 2015, ALICE WORLD WONDERLA, V1, P80
   Weaver Warren, 1964, ALICE MANY TONGUES T
NR 32
TC 0
Z9 0
U1 2
U2 3
PU NATL INQUIRY SERVICES CENTRE PTY LTD
PI GRAHAMSTOWN
PA 19 WORCESTER STREET, PO BOX 377, GRAHAMSTOWN 6140, SOUTH AFRICA
SN 1607-3614
EI 1727-9461
J9 SO AFR LINGUIST APPL
JI South. Afr. Linguist. Appl. Lang.
PD SEP 6
PY 2019
VL 37
IS 2
BP 130
EP 141
DI 10.2989/16073614.2019.1617175
PG 12
WC Linguistics; Language & Linguistics
SC Linguistics
GA IY0WZ
UT WOS:000486114900004
DA 2020-07-08
ER

PT J
AU Lasso, G
   Mayer, SV
   Winkelmann, ER
   Chu, T
   Elliot, O
   Patino-Galindo, JA
   Park, K
   Rabadan, R
   Honig, B
   Shapira, SD
AF Lasso, Gorka
   Mayer, Sandra V.
   Winkelmann, Evandro R.
   Chu, Tim
   Elliot, Oliver
   Patino-Galindo, Juan Angel
   Park, Kernyu
   Rabadan, Raul
   Honig, Barry
   Shapira, Sagi D.
TI A Structure-Informed Atlas of Human-Virus Interactions
SO CELL
LA English
DT Article
ID CELL NUCLEAR ANTIGEN; EPSTEIN-BARR-VIRUS; PROTEIN-PROTEIN INTERACTIONS;
   INTEGRATED APPROACH; BINDING-PROTEINS; DNA-REPLICATION; GENE ONTOLOGY;
   EBOLA-VIRUS; EXPRESSION; E7
AB While knowledge of protein-protein interactions (PPIs) is critical for understanding virus-host relationships, limitations on the scalability of high-throughput methods have hampered their identification beyond a number of well-studied viruses. Here, we implement an in silico computational framework (pathogen host interactome prediction using structure similarity [P-HIPSTer]) that employs structural information to predict similar to 282,000 pan viral-human PPIs with an experimental validation rate of similar to 76%. In addition to rediscovering known biology, P-HIPSTer has yielded a series of new findings: the discovery of shared and unique machinery employed across human-infecting viruses, a likely role for ZIKV-ESR1 interactions in modulating viral replication, the identification of PPIs that discriminate between human papilloma viruses (HPVs) with high and low oncogenic potential, and a structure-enabled history of evolutionary selective pressure imposed on the human proteome. Further, P-HIPSTer enables discovery of previously unappreciated cellular circuits that act on human-infecting viruses and provides insight into experimentally intractable viruses.
C1 [Lasso, Gorka; Mayer, Sandra V.; Winkelmann, Evandro R.; Chu, Tim; Elliot, Oliver; Patino-Galindo, Juan Angel; Rabadan, Raul; Honig, Barry; Shapira, Sagi D.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA.
   [Lasso, Gorka; Mayer, Sandra V.; Winkelmann, Evandro R.; Shapira, Sagi D.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10032 USA.
   [Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.
   [Park, Kernyu; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY USA.
   [Honig, Barry] Columbia Univ, Zuckerman Mind Brain Behav Inst, Med Ctr, New York, NY 10032 USA.
   [Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Med Ctr, New York, NY 10032 USA.
RP Honig, B; Shapira, SD (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA.; Shapira, SD (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10032 USA.; Honig, B (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.; Honig, B (corresponding author), Columbia Univ, Zuckerman Mind Brain Behav Inst, Med Ctr, New York, NY 10032 USA.; Honig, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, Med Ctr, New York, NY 10032 USA.
EM bh6@columbia.edu; ss4197@columbia.edu
OI Lasso Cabrera, Gorka/0000-0001-5355-323X; Rabadan,
   Raul/0000-0001-7946-9255
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5R01GM109018-05, 5U54CA209997-03,
   5R01GM030518-38, 5R01GM117591, S10OD012351, S10OD021764]
FX We thank Jose Ignacio Garzon and Donald Petrey for their technical
   support. This work was funded by NIH grants 5R01GM109018-05 and
   5U54CA209997-03 to S.D.S., 5R01GM030518-38 to B.H., 5R01GM117591 to
   R.R., and equipment grants S10OD012351 and S10OD021764 to the Department
   of Systems Biology.
CR Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130
   Acland A, 2013, NUCLEIC ACIDS RES, V41, pD8, DOI 10.1093/nar/gks1189
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Artaza-Irigaray C, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0125-x
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971
   Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698
   Batra J, 2018, CELL, V175, P1917, DOI 10.1016/j.cell.2018.08.044
   Belinky Frida, 2015, Database (Oxford), V2015, DOI 10.1093/database/bav006
   Ben-Ari Fuchs S, 2016, OMICS, V20, P139, DOI 10.1089/omi.2015.0168
   Berg M, 1997, J VIROL, V71, P3853, DOI 10.1128/JVI.71.5.3853-3863.1997
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Branca M, 2007, EUR J OBSTET GYN R B, V130, P223, DOI 10.1016/j.ejogrb.2006.10.007
   Budhu A, 2007, CARCINOGENESIS, V28, P1552, DOI 10.1093/carcin/bgm075
   Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107
   Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235
   Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240
   Butt AQ, 2014, J BIOL CHEM, V289, P25474, DOI 10.1074/jbc.A112.367490
   Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104
   Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348
   Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-249
   Chen SJ, 2014, AM J PHYSIOL-GASTR L, V306, pG394, DOI 10.1152/ajpgi.00328.2013
   Chen TS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004248
   Chen YF, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006762
   Chojnacki M, 2018, NUCLEIC ACIDS RES, V46, P229, DOI 10.1093/nar/gkx1103
   Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648
   Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007
   Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522
   Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026
   de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66
   de Chassey B, 2013, EMBO REP, V14, P938, DOI 10.1038/embor.2013.130
   DietrichGoetz W, 1997, P NATL ACAD SCI USA, V94, P163, DOI 10.1073/pnas.94.1.163
   Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047
   Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083
   Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071
   Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367
   Emmott E, 2017, MOL CELL PROTEOMICS, V16, pS215, DOI 10.1074/mcp.M116.062448
   Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469
   Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   Frank E, 2016, WEKA WORKBENCH ONLIN
   Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090
   Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200
   Garamszegi S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003778
   Garzon JI, 2016, ELIFE, V5, DOI 10.7554/eLife.18715
   Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111
   Germain MA, 2014, MOL CELL PROTEOMICS, V13, P184, DOI 10.1074/mcp.M113.030155
   Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grinstein E, 2002, J EXP MED, V196, P1067, DOI 10.1084/jem.20011053
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Halehalli RR, 2015, BIOINFORMATICS, V31, P1025, DOI 10.1093/bioinformatics/btu763
   Hall M., 1999, THESIS
   Hallast P, 2016, GENOME RES, V26, P427, DOI 10.1101/gr.198754.115
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han XG, 2015, MOL CELLS, V38, P112, DOI [10.14348/molcells.2015.02101, 10.14348/molcells.2015.2101]
   Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488
   IARC, 2019, AG CLASS IARC MON, V1-123
   Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719
   Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Kajitani N, 2015, BIOMOLECULES, V5, P758, DOI 10.3390/biom5020758
   Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015
   Kasprzyk A, 2011, DATABASE, V2011, DOI DOI 10.1093/DATABASE/BAR049
   Katzenellenbogen RA, 2010, J VIROL, V84, P12934, DOI 10.1128/JVI.01377-10
   Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886
   Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092
   Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Li XZ, 2013, NUCLEIC ACIDS RES, V41, P10488, DOI 10.1093/nar/gkt803
   Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006
   Loytynoja A, 2014, METHODS MOL BIOL, V1079, P155, DOI 10.1007/978-1-62703-646-7_10
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Luck K, 2017, TRENDS BIOCHEM SCI, V42, P342, DOI 10.1016/j.tibs.2017.02.006
   Ma YJ, 2017, CELL HOST MICROBE, V21, P580, DOI 10.1016/j.chom.2017.04.005
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129
   MELENDY T, 1995, J VIROL, V69, P7857, DOI 10.1128/JVI.69.12.7857-7867.1995
   Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066
   Mirabello L, 2017, CELL, V170, P1164, DOI 10.1016/j.cell.2017.08.001
   MOHR IJ, 1990, SCIENCE, V250, P1694, DOI 10.1126/science.2176744
   Muller N, 2006, TRAFFIC, V7, P849, DOI 10.1111/j.1600-0854.2006.00426.x
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nicod C, 2017, CURR OPIN MICROBIOL, V39, P7, DOI 10.1016/j.mib.2017.07.005
   Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7
   Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0
   Pang CL, 2014, ONCOGENE, V33, P4039, DOI 10.1038/onc.2013.426
   Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550
   Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pietsch EC, 2008, CANCER BIOL THER, V7, P1916, DOI 10.4161/cbt.7.12.7169
   Plaza JJG, 2016, INTRACTABLE RARE DIS, V5, P90, DOI 10.5582/irdr.2016.01008
   Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619
   Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028
   Raman R, 2016, CURR OPIN STRUC BIOL, V40, P153, DOI 10.1016/j.sbi.2016.10.003
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/nmeth.1818, 10.1038/NMETH.1818]
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707
   Rose AS, 2018, BIOINFORMATICS, V34, P3755, DOI 10.1093/bioinformatics/bty419
   Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun HZ, 2017, GENE CHROMOSOME CANC, V56, P598, DOI 10.1002/gcc.22463
   Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TANNER J, 1988, J VIROL, V62, P4452, DOI 10.1128/JVI.62.12.4452-4464.1988
   Tjalma WA, 2001, EUR J OBSTET GYN R B, V97, P223, DOI 10.1016/S0301-2115(00)00541-8
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Tsuchiya N, 1998, J BIOCHEM-TOKYO, V123, P499
   Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804
   Van den Broeke Celine, 2014, Small GTPases, V5, pe28318, DOI 10.4161/sgtp.28318
   Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893
   von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750
   Warnes GR, 2016, GPLOTS VARIOUS R PRO
   White EA, 2017, CELL, V170, P1057, DOI 10.1016/j.cell.2017.08.033
   Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865
   Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973
   Yang AS, 2000, J MOL BIOL, V301, P691, DOI 10.1006/jmbi.2000.3975
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503
NR 144
TC 4
Z9 5
U1 5
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD SEP 5
PY 2019
VL 178
IS 6
BP 1526
EP +
DI 10.1016/j.cell.2019.08.005
PG 32
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA IV0QF
UT WOS:000483983000023
PM 31474372
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Cuba's untold Zika outbreak uncovered
SO NATURE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD SEP 5
PY 2019
VL 573
IS 7772
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IV0KI
UT WOS:000483967700004
DA 2020-07-08
ER

PT J
AU Figueiredo, CP
   Barros-Aragao, FGQ
   Neris, RLS
   Frost, PS
   Soares, C
   Souza, INO
   Zeidler, JD
   Zamberlan, DC
   de Sousa, VL
   Souza, AS
   Guimaraes, ALA
   Bellio, M
   de Souza, JM
   Alves-Leon, SV
   Neves, GA
   Paula-Neto, HA
   Castro, NG
   De Felice, FG
   Assuncao-Miranda, I
   Clarke, JR
   Da Poian, AT
   Ferreira, ST
AF Figueiredo, Claudia P.
   Barros-Aragao, Fernanda G. Q.
   Neris, Romulo L. S.
   Frost, Paula S.
   Soares, Carolina
   Souza, Isis N. O.
   Zeidler, Julianna D.
   Zamberlan, Daniele C.
   de Sousa, Virginia L.
   Souza, Amanda S.
   Guimaraes, Andre Luis A.
   Bellio, Maria
   de Souza, Jorge Marcondes
   Alves-Leon, Soniza V.
   Neves, Gilda A.
   Paula-Neto, Heitor A.
   Castro, Newton G.
   De Felice, Fernanda G.
   Assuncao-Miranda, Iranaia
   Clarke, Julia R.
   Da Poian, Andrea T.
   Ferreira, Sergio T.
TI Zika virus replicates in adult human brain tissue and impairs synapses
   and memory in mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; A-BETA OLIGOMERS; ACTIVATION; INFECTION;
   COMPLICATIONS; MICROGLIA; EPIDEMIC; DISEASE; IMPACT
AB Neurological complications affecting the central nervous system have been reported in adult patients infected by Zika virus (ZIKV) but the underlying mechanisms remain unknown. Here, we report that ZIKV replicates in human and mouse adult brain tissue, targeting mature neurons. ZIKV preferentially targets memory-related brain regions, inhibits hippocampal long-term potentiation and induces memory impairment in adult mice. TNF-alpha upregulation, microgliosis and upregulation of complement system proteins, C1q and C3, are induced by ZIKV infection. Microglia are found to engulf hippocampal presynaptic terminals during acute infection. Neutralization of TNF-alpha signaling, blockage of microglial activation or of C1q/C3 prevent synapse and memory impairment in ZIKV-infected mice. Results suggest that ZIKV induces synapse and memory dysfunction via aberrant activation of TNF-alpha, microglia and complement. Our findings establish a mechanism by which ZIKV affects the adult brain, and point to the need of evaluating cognitive deficits as a potential comorbidity in ZIKV-infected adults.
C1 [Figueiredo, Claudia P.; Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Souza, Isis N. O.; Zamberlan, Daniele C.; de Sousa, Virginia L.; Guimaraes, Andre Luis A.; Paula-Neto, Heitor A.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Barros-Aragao, Fernanda G. Q.; Frost, Paula S.; Soares, Carolina; Neves, Gilda A.; Castro, Newton G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Bellio, Maria; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Zeidler, Julianna D.; De Felice, Fernanda G.; Da Poian, Andrea T.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Souza, Amanda S.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [de Souza, Jorge Marcondes; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Alves-Leon, Soniza V.] Queens Univ, Fed Univ Rio de Janeiro State, Grad Program Neurol, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.
   [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada.
RP Figueiredo, CP (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM claudia@pharma.ufrj.br; dapoian@bioqmed.ufrj.br;
   ferreira@bioqmed.ufrj.br
RI Castro, Newton G/C-3263-2009; de Oliveira Souza, Isis Nem/AAA-3423-2019;
   Neves, Gilda A./K-7573-2012; Clarke, Julia/AAF-9434-2019; BELLIO,
   MARIA/N-8525-2018
OI Castro, Newton G/0000-0001-9570-7428; de Oliveira Souza, Isis
   Nem/0000-0002-0335-2541; Neves, Gilda A./0000-0002-7027-3851; Gomes de
   Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; BELLIO,
   MARIA/0000-0002-3360-2740; Souza, Amanda/0000-0002-7561-8150; da Silva
   Frost, Paula/0000-0002-3814-999X; Zeidler, Julianna
   D./0000-0003-3168-1518
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alves-Leon SV, 2019, MULT SCLER J, V25, P427, DOI 10.1177/1352458518781992
   Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017
   Bido-Medina R, 2018, ANN CLIN TRANSL NEUR, V5, P752, DOI 10.1002/acn3.575
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Ennaceur A, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.223
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Ferreira J, 2005, PAIN, V117, P171, DOI 10.1016/j.pain.2005.06.001
   Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013
   Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gonzalez-Dunia D, 2000, J VIROL, V74, P3441, DOI 10.1128/JVI.74.8.3441-3448.2000
   Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14
   Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54
   Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Mamik MK, 2016, J NEUROSCI, V36, P10683, DOI 10.1523/JNEUROSCI.1287-16.2016
   Matheus FC, 2016, MOL NEUROBIOL, V53, P3891, DOI 10.1007/s12035-015-9330-z
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Piacentini R, 2015, SCI REP-UK, V5, DOI 10.1038/srep15444
   Presumey J, 2017, ADV IMMUNOL, V135, P53, DOI 10.1016/bs.ai.2017.06.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Report S, 2017, ZIK VIR MICR GUILL B
   Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047
   Ronca SE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00959
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Souza INO, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020060
   STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14
   Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
NR 59
TC 6
Z9 6
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 5
PY 2019
VL 10
AR 3890
DI 10.1038/s41467-019-11866-7
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IU9SV
UT WOS:000483921700001
PM 31488835
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maness, NJ
   Schouest, B
   Singapuri, A
   Dennis, M
   Gilbert, MH
   Bohm, RP
   Schiro, F
   Aye, PP
   Baker, K
   Van Rompay, KKA
   Lackner, AA
   Bonaldo, MC
   Blair, RV
   Permar, SR
   Coffey, LL
   Panganiban, AT
   Magnani, D
AF Maness, Nicholas J.
   Schouest, Blake
   Singapuri, Anil
   Dennis, Maria
   Gilbert, Margaret H.
   Bohm, Rudolf P.
   Schiro, Faith
   Aye, Pyone P.
   Baker, Kate
   Van Rompay, Koen K. A.
   Lackner, Andrew A.
   Bonaldo, Myrna C.
   Blair, Robert V.
   Permar, Sallie R.
   Coffey, Lark L.
   Panganiban, Antonito T.
   Magnani, Diogo
TI Postnatal Zika virus infection of nonhuman primate infants born to
   mothers infected with homologous Brazilian Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MATERNAL DENGUE ANTIBODIES; VACCINE; TRANSMISSION; CELLS; TEMPERAMENT;
   PERSISTENCE; IMMUNITY; MEASLES; BRAIN
AB Recent data in a nonhuman primate model showed that infants postnatally infected with Zika virus (ZIKV) were acutely susceptible to high viremia and neurological damage, suggesting the window of vulnerability extends beyond gestation. In this pilot study, we addressed the susceptibility of two infant rhesus macaques born healthy to dams infected with Zika virus during pregnancy. Passively acquired neutralizing antibody titers dropped below detection limits between 2 and 3 months of age, while binding antibodies remained detectable until viral infection at 5 months. Acute serum viremia was comparatively lower than adults infected with the same Brazilian isolate of ZIKV (n = 11 pregnant females, 4 males, and 4 non-pregnant females). Virus was never detected in cerebrospinal fluid nor in neural tissues at necropsy two weeks after infection. However, viral RNA was detected in lymph nodes, confirming some tissue dissemination. Though protection was not absolute and our study lacks an important comparison with postnatally infected infants born to naive dams, our data suggest infants born healthy to infected mothers may harbor a modest but important level of protection from postnatally acquired ZIKV for several months after birth, an encouraging result given the potentially severe infection outcomes of this population.
C1 [Maness, Nicholas J.; Panganiban, Antonito T.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.
   [Maness, Nicholas J.; Schouest, Blake; Gilbert, Margaret H.; Bohm, Rudolf P.; Schiro, Faith; Aye, Pyone P.; Baker, Kate; Lackner, Andrew A.; Blair, Robert V.; Panganiban, Antonito T.] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.
   [Schouest, Blake] Tulane Univ, Sch Med, Biomed Sci Training Program, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Singapuri, Anil; Van Rompay, Koen K. A.; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Dennis, Maria; Permar, Sallie R.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA.
   [Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA USA.
   [Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Permar, Sallie R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA.
   [Magnani, Diogo] Univ Massachusetts, Sch Med, MassBiol, Boston, MA 02125 USA.
RP Maness, NJ (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.; Maness, NJ (corresponding author), Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.
EM nmaness@tulane.edu
OI Van Rompay, Koen/0000-0002-7375-1337; Magnani,
   Diogo/0000-0002-1773-2406; Schouest, Blake/0000-0002-9602-2364
FU Bill and Melinda Gates FoundationGates Foundation [OPP1152818]; National
   Institute of Health ORIP/OD [P51OD011104]; NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P30AI073961]; National Institute of Allergy and Infectious
   DiseaseUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R21AI132677, 1P01AI132132]
FX This work was supported by the Bill and Melinda Gates Foundation
   (OPP1152818) and the National Institute of Health ORIP/OD P51OD011104 to
   the Tulane National Primate Research Center and NIH grant P30AI073961 to
   the Miami Center for AIDS Research (CFAR). Support to the Duke Human
   Vaccine Institute was provided by the National Institute of Allergy and
   Infectious Disease (1R21AI132677, 1P01AI132132). The funders had no role
   in study design.
CR Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199
   ALS H, 1977, J ABNORM CHILD PSYCH, V5, P215, DOI 10.1007/BF00913693
   [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Asturias EJ, 2018, JAMA PEDIATR, V172, P624, DOI 10.1001/jamapediatrics.2018.0921
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bayley N., 1993, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRAZELTON T B, 1973, Clinical Obstetrics and Gynecology, V16, P361, DOI 10.1097/00003081-197303000-00020
   Camargos VN, 2019, EBIOMEDICINE, V44, P516, DOI 10.1016/j.ebiom.2019.05.014
   CHAMPOUX M, 1994, LAB ANIM SCI, V44, P351
   DICK GWA, 1952, J HYG-CAMBRIDGE, V50, P376, DOI 10.1017/S0022172400019653
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Hickman HD, 2016, TRENDS MOL MED, V22, P639, DOI 10.1016/j.molmed.2016.06.004
   Jacob JA, 2016, JAMA-J AM MED ASSOC, V315, P1097, DOI 10.1001/jama.2016.1219
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Leineweber B, 2004, PEDIATR INFECT DIS J, V23, P361, DOI 10.1097/00006454-200404000-00019
   Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Milligan C, 2015, CELL HOST MICROBE, V17, P500, DOI 10.1016/j.chom.2015.03.002
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Odorizzi PM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat6176
   Pengsaa K, 2011, PEDIATR INFECT DIS J, V30, P897, DOI 10.1097/INF.0b013e31821f07f6
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Quintana-Domeque C, 2018, ECON HUM BIOL, V30, P14, DOI 10.1016/j.ehb.2018.04.003
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   SCHNEIDER ML, 1992, INFANT BEHAV DEV, V15, P155, DOI 10.1016/0163-6383(92)80021-L
   SCHNEIDER ML, 1992, INFANT BEHAV DEV, V15, P389, DOI 10.1016/0163-6383(92)80009-J
   SCHNEIDER ML, 1991, AM J PRIMATOL, V25, P137, DOI 10.1002/ajp.1350250302
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115
   Van Den Ende C, 2017, EXPERT REV VACCINES, V16, P811, DOI 10.1080/14760584.2017.1338568
   van Panhuis WG, 2011, AM J TROP MED HYG, V85, P355, DOI 10.4269/ajtmh.2011.11-0125
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 57
TC 1
Z9 1
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 5
PY 2019
VL 9
AR 12802
DI 10.1038/s41598-019-49209-7
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IU9SF
UT WOS:000483920000014
PM 31488856
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Haglin, K
   Chapman, D
   Motta, M
   Kahan, D
AF Haglin, Kathryn
   Chapman, Daniel
   Motta, Matthew
   Kahan, Dan
TI How Localized Outbreaks and Changes in Media Coverage Affect Zika
   Attitudes in National and Local Contexts
SO HEALTH COMMUNICATION
LA English
DT Article; Early Access
ID COMMUNICATION; VIRUS; TRANSMISSION; FLORIDA; SARS
AB Public opinion researchers often find changing attitudes about pressing public health issues to be a difficult task and even when attitudes do change, behaviors often do not. However, salient real-world events have the ability to bring public health crises to the fore in unique ways. To assess the impact of localized public health events on individuals' self-reported behavior, this paper examines Floridians' intentions to take preventative measures against the Zika virus before and after the first locally transmit- ted case of Zika emerged in Florida. We find that local and national media coverage of Zika increased significantly following its first transmission in the U.S. Critically, we also find that Floridians surveyed after this increase in media coverage were more likely to pay attention to Zika-related news, and self-report intentions to take protective action against the virus. These results suggest that behavioral intentions can shift as health threats become more proximate.
C1 [Haglin, Kathryn] Univ Minnesota, Dept Hist Polit Sci & Int Studies, 306 Cina Hall,1123 Univ Dr, Duluth, MN 55812 USA.
   [Chapman, Daniel] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.
   [Motta, Matthew] Oklahoma State Univ, Dept Polit Sci, Stillwater, OK 74078 USA.
   [Kahan, Dan] Yale Univ, Yale Law Sch, New Haven, CT 06520 USA.
RP Haglin, K (corresponding author), Univ Minnesota, Dept Hist Polit Sci & Int Studies, 306 Cina Hall,1123 Univ Dr, Duluth, MN 55812 USA.
EM khaglin@d.umn.edu
RI Motta, Matthew/J-7262-2019
OI Motta, Matthew/0000-0002-2824-6833
CR Bergeron SL, 2005, EMERG INFECT DIS, V11, P732, DOI 10.3201/eid1105.040512
   Betancourt M, 2017, SHAPE WEAKLY INFORM
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Calonico S, 2017, STATA J, V17, P372, DOI 10.1177/1536867X1701700208
   Chan MPS, 2018, J PUBLIC HEALTH-UK, V40, P776, DOI 10.1093/pubmed/fdy085
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Gelman A., 2013, BAYESIAN DATA ANAL
   Gelman A., 2006, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942
   Gelman A, 2019, J BUS ECON STAT, V37, P447, DOI 10.1080/07350015.2017.1366909
   Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2
   Haglin K, 2017, RES POLITICS, V4, DOI 10.1177/2053168017716547
   Hall Jamieson K., 2017, OXFORD HDB SCI SCI C
   Hilgard J, 2017, SCI COMMUN, V39, P548, DOI 10.1177/1075547017719075
   Jerit J, 2019, HEALTH COMMUN, V34, P1816, DOI 10.1080/10410236.2018.1536949
   Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Liu R. S., 2007, COMP MATH MATH PHYS, V8, P153, DOI DOI 10.1080/17486700701425870
   Lupia A., 1998, DEMOCRATIC DILEMMA C
   Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2
   Ophir Y, 2020, HEALTH COMMUN, V35, P35, DOI 10.1080/10410236.2018.1536958
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Skovron C., 2015, AM J POLIT SCI, V59, P1
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Snyder LB, 2004, J HEALTH COMMUN, V9, P71, DOI 10.1080/10810730490271548
   Snyder LB, 2002, LEA COMMUN SER, P357
   Tchuenche JM, 2012, ISRN BIOMATHEMATICS, DOI [10.5402/2012/581274, DOI 10.5402/2012/581274]
   Watanabe S, 2010, J MACH LEARN RES, V11, P3571
   Winneg KM, 2018, RISK ANAL, V38, P2546, DOI 10.1111/risa.13010
   Wood T, 2018, POLITICAL BEHAV, DOI [10.1007/s11109-018-9443-y, DOI 10.1007/S11109-018-9443-Y]
   Zaller J.R., 1992, NATURE ORIGINS MASS
   Zimicki S, 2002, LEA COMMUN SER, P197
NR 33
TC 0
Z9 0
U1 5
U2 6
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1041-0236
EI 1532-7027
J9 HEALTH COMMUN
JI Health Commun.
DI 10.1080/10410236.2019.1662556
EA SEP 2019
PG 12
WC Communication; Health Policy & Services
SC Communication; Health Care Sciences & Services
GA IW1ZG
UT WOS:000484770400001
PM 31475575
DA 2020-07-08
ER

PT J
AU Fiaz, M
   Martinez, LC
   Plata-Rueda, A
   Goncalves, WG
   de Souza, DLL
   Cossolin, JFS
   Carvalho, PEGR
   Martins, GF
   Serrao, JE
AF Fiaz, Muhammad
   Martinez, Luis Carlos
   Plata-Rueda, Angelica
   Goncalves, Wagner Gonzaga
   Lino de Souza, Debora Linhares
   Silva Cossolin, Jamile Fernanda
   Gomes Rodrigues Carvalho, Paulo Eduardo
   Martins, Gustavo Ferreira
   Serrao, Jose Eduardo
TI Pyriproxyfen, a juvenile hormone analog, damages midgut cells and
   interferes with behaviors of Aedes aegypti larvae
SO PEERJ
LA English
DT Article
DE Autophagy; Aedes aegypti; Ultrastructure; Juvenile Hormone; Locomotory
   behavior
ID ORGANOPHOSPHORUS FLAME RETARDANTS; REGENERATIVE CELLS; YELLOW-FEVER;
   ZIKA VIRUS; LABORATORY ASSESSMENT; RISK-ASSESSMENT; ESSENTIAL OILS;
   GLOBAL RISK; DENGUE; ALBOPICTUS
AB Juvenile hormone analogs (JHA) are known to interfere with growth and biosynthesis of insects with potential for insecticide action. However, there has been comparatively few data on morphological effects of JHA on insect organs. To determine pyriproxyfen effects on Aedes aegypti larvae, we conducted toxicity, behavioral bioassays and assessed ultrastructural effects of pyriproxyfen on midgut cells. A. aegypti larvae were exposed in aqueous solution of pyriproxyfen LC50 concentrations and evaluated for 24 h. This study fulfilled the toxic prevalence of pyriproxyfen to A. aegypti larvae (LC50 = 8.2 mg L-1). Behavioral observations confirmed that pyriproxyfen treatment significantly changes swimming behavior of larvae, limiting its displacement and speed. The pyriproxyfen causes remarkable histopathological and cytotoxic alterations in the midgut of larvae. Histopathological study reveals presence of cytoplasmic vacuolization and damage to brush border of the digestive cells. The main salient lesions of cytotoxic effects are occurrence of cell debris released into the midgut lumen, cytoplasm rich in lipid droplets, autophagosomes, disorganized microvilli and deformed mitochondria. Data suggest that pyriproxyfen can be used to help to control and eradicate this insect vector.
C1 [Fiaz, Muhammad; Plata-Rueda, Angelica] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.
   [Martinez, Luis Carlos; Goncalves, Wagner Gonzaga; Lino de Souza, Debora Linhares; Silva Cossolin, Jamile Fernanda; Gomes Rodrigues Carvalho, Paulo Eduardo; Martins, Gustavo Ferreira; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.
RP Fiaz, M (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.; Serrao, JE (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.
EM muhammad.fiaz@ufv.br; jeserrao@ufv.br
RI Martins, Gustavo Ferreira/AAL-7744-2020; Martinez, Luis
   Carlos/H-4495-2013; Rueda, Angelica Plata/H-4519-2013; Fiaz,
   Muhammad/P-4513-2017
OI Martins, Gustavo Ferreira/0000-0003-0614-8551; Martinez, Luis
   Carlos/0000-0001-7741-2984; Rueda, Angelica Plata/0000-0002-2114-8237;
   Serrao, Jose Eduardo/0000-0002-0477-4252; Cossolin,
   Jamile/0000-0001-8608-1726; Fiaz, Muhammad/0000-0001-7666-9147
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq) [305165/2013-5]; World Academy of Sciences TWAS (Italy);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES
   (Brazil)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   FAPEMIG (Brazil)Minas Gerais State Research Foundation (FAPEMIG); Nucleo
   de Microscopia e Microanalise of Universidade Federal de Vicosa
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico CNPq (Brazil) (305165/2013-5), The World
   Academy of Sciences TWAS (Italy), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior CAPES (Brazil), Fundacao de Amparo a Pesquisa
   do Estado de Minas Gerais FAPEMIG (Brazil) and Nucleo de Microscopia e
   Microanalise of Universidade Federal de Vicosa. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alberts B., 2014, MOL BIOL CELL
   Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8
   Barbosa PRR, 2018, ECOTOX ENVIRON SAFE, V147, P963, DOI 10.1016/j.ecoenv.2017.09.021
   BARSON G, 1992, J STORED PROD RES, V28, P161, DOI 10.1016/0022-474X(92)90036-P
   Boyer S, 2018, ASIA-PAC J PUBLIC HE, V30, P158, DOI 10.1177/1010539517753876
   Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200
   Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cao ZG, 2014, ENVIRON SCI TECHNOL, V48, P8839, DOI 10.1021/es501224b
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Catae AF, 2018, ECOTOXICOLOGY, V27, P109, DOI 10.1007/s10646-017-1874-4
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200
   Chung HW, 2009, ANAL BIOANAL CHEM, V395, P2325, DOI 10.1007/s00216-009-3139-4
   Costa AA, 2018, J MED ENTOMOL, V55, P1098, DOI 10.1093/jme/tjy086
   Costa MS, 2014, TOXINS, V6, P1169, DOI 10.3390/toxins6041169
   Cristale J, 2013, ENVIRON POLLUT, V179, P194, DOI 10.1016/j.envpol.2013.04.001
   Dettloff M, 2001, CELL TISSUE RES, V306, P449, DOI 10.1007/s00441-001-0468-9
   Ding JJ, 2015, SCI TOTAL ENVIRON, V538, P959, DOI 10.1016/j.scitotenv.2015.08.101
   Engstrom-Ost J, 2004, J FISH BIOL, V65, P251, DOI 10.1111/j.0022-1112.2004.00448.x
   Eulaers I, 2014, SCI TOTAL ENVIRON, V478, P48, DOI 10.1016/j.scitotenv.2014.01.051
   Fang ML, 2013, ENVIRON SCI TECHNOL, V47, P4449, DOI 10.1021/es400032v
   Fernandes KM, 2015, MED VET ENTOMOL, V29, P245, DOI 10.1111/mve.12122
   Fernandes KM, 2014, PARASITOL INT, V63, P506, DOI 10.1016/j.parint.2014.01.004
   Fialho MDCQ, 2009, ANN ENTOMOL SOC AM, V102, P119
   Fiaz M, 2018, CHEMOSPHERE, V212, P337, DOI 10.1016/j.chemosphere.2018.08.088
   Fiaz M, 2018, ECOTOX ENVIRON SAFE, V156, P1, DOI 10.1016/j.ecoenv.2018.02.080
   Finney DJ, 1964, PROBIT ANAL
   Forkpah C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091180
   Foster Woodbridge A., 2002, P203, DOI 10.1016/B978-012510451-7/50014-1
   Gaban C.R.G., 2015, J MOSQ RES, V5, P1, DOI DOI 10.5376/JMR.2015.05.0021
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Goellner E, 2018, PEST MANAG SCI, V74, P1013, DOI 10.1002/ps.4803
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Gross AD, 2017, MED VET ENTOMOL, V31, P55, DOI 10.1111/mve.12197
   Gutierrez Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152383
   Hemanga Hazarika, 2018, International Journal of Mosquito Research, V5, P51
   Henne WM, 2018, EMBO J, V37, DOI 10.15252/embj.201898947
   Hu MY, 2014, MAR POLLUT BULL, V86, P569, DOI 10.1016/j.marpolbul.2014.06.009
   Hustedt J, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2105-2
   Invest J., 2008, P 6 INT C URB PESTS, P239
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Janssens L, 2012, AQUAT TOXICOL, V110, P91, DOI 10.1016/j.aquatox.2011.12.019
   Jaspers VLB, 2011, ENVIRON INT, V37, P1349, DOI 10.1016/j.envint.2011.06.004
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Kumar RSS, 2013, ENVIRON SCI POLLUT R, V20, P2593, DOI 10.1007/s11356-012-1161-0
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Liu J, 2018, CHEMOSPHERE, V208, P366, DOI 10.1016/j.chemosphere.2018.05.179
   Maharajan K, 2018, AQUAT TOXICOL, V196, P132, DOI 10.1016/j.aquatox.2018.01.010
   Makinen MSE, 2009, ENVIRON SCI TECHNOL, V43, P941, DOI 10.1021/es802593t
   Mangia C, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3020-4
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Maricopa County Environmental Services, 2006, LIF INF AED AEG MOSQ
   Marriel NB, 2016, ACTA TROP, V158, P88, DOI 10.1016/j.actatropica.2016.02.021
   Martinez LC, 2018, CHEMOSPHERE, V212, P629, DOI 10.1016/j.chemosphere.2018.08.134
   Martinez LC, 2018, PROTOPLASMA, V255, P1693, DOI 10.1007/s00709-018-1261-x
   Martins GF, 2006, MICRON, V37, P161, DOI 10.1016/j.micron.2005.07.003
   Meng QW, 2018, J ASIA-PAC ENTOMOL, V21, P466, DOI 10.1016/j.aspen.2018.02.011
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mizouchi S, 2015, CHEMOSPHERE, V123, P17, DOI 10.1016/j.chemosphere.2014.11.028
   Mordue (Luntz) A. Jennifer, 2000, Anais da Sociedade Entomologica do Brasil, V29, P615, DOI 10.1590/S0301-80592000000400001
   Mullen L, 2003, INSECT BIOCHEM MOLEC, V33, P661, DOI 10.1016/S0965-1748(03)00045-6
   Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010
   Nardi JB, 2012, J MORPHOL, V273, P1010, DOI 10.1002/jmor.20038
   Nardi JB, 2010, J INSECT PHYSIOL, V56, P296, DOI 10.1016/j.jinsphys.2009.11.001
   Oo SZM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2603-9
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Prophiro JS, 2011, REV SOC BRAS MED TRO, V44, P300, DOI [10.1590/s0037-86822011005000025, 10.1590/S0037-86822011005000025]
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Rost-Roszkowska MM, 2010, FOLIA BIOL-KRAKOW, V58, P209, DOI 10.3409/fb58_3-4.209-216
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Salehzadeh A, 2002, PEST MANAG SCI, V58, P268, DOI 10.1002/ps.449
   SCHAEFER CH, 1991, J AM MOSQUITO CONTR, V7, P409
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Silva IMA, 2018, PEST MANAG SCI, V74, P1001, DOI 10.1002/ps.4801
   Smagghe G, 2003, J APPL ENTOMOL, V127, P167, DOI 10.1046/j.1439-0418.2003.00727.x
   Aguiar RWS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116765
   STEELE JE, 1982, INSECT BIOCHEM, V12, P131, DOI 10.1016/0020-1790(82)90001-4
   STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0
   Suman DS, 2018, PEST MANAG SCI, V74, P885, DOI 10.1002/ps.4780
   Tan XX, 2016, SCI TOTAL ENVIRON, V544, P77, DOI 10.1016/j.scitotenv.2015.11.089
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tuten HC, 2016, J AM MOSQUITO CONTR, V32, P55, DOI 10.2987/moco-32-01-55-58.1
   Rocha LLV, 2014, FOLIA BIOL-KRAKOW, V62, P259, DOI 10.3409/fb62_3.259
   Vasantha-Srinivasan P, 2018, ENVIRON SCI POLLUT R, V25, P10434, DOI 10.1007/s11356-017-9714-x
   Verheggen F, 2007, J CHEM ECOL, V33, P525, DOI 10.1007/s10886-006-9236-3
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Watson E, 1996, J STORED PROD RES, V32, P59, DOI 10.1016/0022-474X(95)00033-4
   WHO Pesticide Evaluation Scheme (WHOPES), 2000, REP 4 WHOPES WORK GR
   World Health Organization, 2016, WORLD HLTH STAT 2016
   World Health Organization, 2015, EPIDEMIOLOGICAL WEEK
   World Health Organization, 2017, EPIDEMIOLOGICAL WEEK
   Yang FX, 2014, ENVIRON SCI TECHNOL, V48, P63, DOI 10.1021/es403186z
   Yang ZX, 2017, COMP BIOCHEM PHYS B, V204, P35, DOI 10.1016/j.cbpb.2016.11.003
NR 98
TC 2
Z9 2
U1 1
U2 3
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD SEP 4
PY 2019
VL 7
AR e7489
DI 10.7717/peerj.7489
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IU6UQ
UT WOS:000483721600001
PM 31534837
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Scolari, F
   Casiraghi, M
   Bonizzoni, M
AF Scolari, Francesca
   Casiraghi, Maurizio
   Bonizzoni, Mariangela
TI Aedes spp. and Their Microbiota: A Review
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE symbiosis; bacterial community; breeding sites; Aedes spp.; vector
   control
ID WEST NILE VIRUS; BACTERIAL COMMUNITY COMPOSITION; VECTOR COMPETENCE;
   DIPTERA-CULICIDAE; ANOPHELES-GAMBIAE; MIDGUT BACTERIA; AEGYPTI DIPTERA;
   GUT MICROBIOTA; ARBOVIRUS TRANSMISSION; ALBOPICTUS MOSQUITOS
AB Aedes spp. are a major public health concern due to their ability to be efficient vectors of dengue, Chikungunya, Zika, and other arboviruses. With limited vaccines available and no effective therapeutic treatments against arboviruses, the control of Aedes spp. populations is currently the only strategy to prevent disease transmission. Host-associated microbes (i.e., microbiota) recently emerged as a promising field to be explored for novel environmentally friendly vector control strategies. In particular, gut microbiota is revealing its impact on multiple aspects of Aedes spp. biology, including vector competence, thus being a promising target for manipulation. Here we describe the technological advances, which are currently expanding our understanding of microbiota composition, abundance, variability, and function in the two main arboviral vectors, the mosquitoes Aedes aegypti and Aedes albopictus. Aedes spp. microbiota is described in light of its tight connections with the environment, with which mosquitoes interact during their various developmental stages. Unraveling the dynamic interactions among the ecology of the habitat, the mosquito and the microbiota have the potential to uncover novel physiological interdependencies and provide a novel perspective for mosquito control.
C1 [Scolari, Francesca; Bonizzoni, Mariangela] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
   [Casiraghi, Maurizio] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.
RP Bonizzoni, M (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
EM mariangela.bonizzoni@unipv.it
RI Scolari, Francesca/L-9233-2015
OI Scolari, Francesca/0000-0003-3085-9038
FU European Research Council Consolidator Grant (ERC-CoG) under the
   European Union's Horizon 2020 Programme [ERC-CoG 682394]; Italian
   Ministry of Education, University and Research FARE-MIUR project
   [R1623HZAH5]; Human Frontier Science Program Research GrantHuman
   Frontier Science Program [RGP0007/2017]; Italian Ministry of Education,
   University and Research (MIUR): Dipartimenti Eccellenza Program
   (2018-2022) Department of Biology and Biotechnology "L. Spallanzani",
   University of Pavia
FX This research was funded by a European Research Council Consolidator
   Grant (ERC-CoG) under the European Union's Horizon 2020 Programme (Grant
   Number ERC-CoG 682394) to MB, the Italian Ministry of Education,
   University and Research FARE-MIUR project R1623HZAH5 to MB, the Human
   Frontier Science Program Research Grant RGP0007/2017 to MB, and the
   Italian Ministry of Education, University and Research (MIUR):
   Dipartimenti Eccellenza Program (2018-2022) Department of Biology and
   Biotechnology "L. Spallanzani", University of Pavia.
CR Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Anglero-Rodriguez YI, 2017, ELIFE, V6, DOI 10.7554/eLife.28844
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762
   Atoni E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010030
   Audsley MD, 2018, MOL ECOL, V27, P297, DOI 10.1111/mec.14436
   Audsley MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005426
   Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   BENZON GL, 1988, J MED ENTOMOL, V25, P158, DOI 10.1093/jmedent/25.3.158
   Bernalier A, 1996, ARCH MICROBIOL, V166, P176, DOI 10.1007/s002030050373
   Bishop-Lilly KA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000878
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Blumberg BJ, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P335
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bongio NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143541
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bozic J, 2017, ENV MICROBIOL REP, V9, P642, DOI 10.1111/1758-2229.12569
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95
   Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486
   Bruno A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02557
   Bruno A, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.421
   Bruno A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44350
   Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2
   Canali M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040444
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8
   Carissimo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153881
   Carvajal T., 2018, BIORXIV
   Chandler JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00185
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Charan SS, 2016, MED VET ENTOMOL, V30, P264, DOI 10.1111/mve.12173
   Charan SS, 2013, PARASITOL RES, V112, P2627, DOI 10.1007/s00436-013-3428-x
   Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015
   Cholleti H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162751
   Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2
   Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   Clemens A. N., 1992, BIOL MOSQUITOES DEV, V1
   Clements A. N., 2000, BIOL MOSQUITOES, V2
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Correa MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07014-2
   Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10
   Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x
   da Costa GL, 1998, J BASIC MICROB, V38, P343, DOI 10.1002/(SICI)1521-4028(199811)38:5/6&lt;343::AID-
   Dada N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20367-4
   Dada N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-391
   David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238
   DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219
   Deng SQ, 2019, J PEST SCI, V92, P781, DOI 10.1007/s10340-019-01081-0
   Dharne M, 2006, J BIOSCIENCES, V31, P293, DOI 10.1007/BF02704100
   Diaz-Sanchez S, 2018, INSECT MOL BIOL, V27, P847, DOI 10.1111/imb.12526
   Dickson LB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2780-1
   Dickson LB, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700585
   Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   Dorigatti I, 2018, TRENDS PARASITOL, V34, P102, DOI 10.1016/j.pt.2017.11.002
   Duguma D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0475-8
   Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27
   Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109
   Eren AM, 2015, ISME J, V9, P90, DOI 10.1038/ismej.2014.97
   Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Fouda M. A., 2001, Journal of the Egyptian Society of Parasitology, V31, P767
   Frants T G, 1986, Nauchnye Doki Vyss Shkoly Biol Nauki, P94
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frey KG, 2016, EVOL BIOINFORM, V12, P1, DOI 10.4137/EBO.S38518
   Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10
   Gaio AD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-105
   Garza-Hernandez JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002013
   Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921
   Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029
   Gloria-Soria A, 2018, J MED ENTOMOL, V55, P1354, DOI 10.1093/jme/tjy084
   Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371
   Greub G, 2012, CLIN MICROBIOL INFEC, V18, P1157, DOI 10.1111/1469-0691.12032
   Grubaugh ND, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003628
   Guegan M, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy188
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011
   Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hall-Mendelin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058026
   HASSELSCHWERT D, 1988, GREAT LAKES ENTOMOL, V21, P163
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hegde S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02160
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Hillyer JF, 2005, CELL MICROBIOL, V7, P39, DOI 10.1111/j.1462-5822.2004.00430.x
   Hortnagl P, 2010, FEMS MICROBIOL ECOL, V73, P458, DOI 10.1111/j.1574-6941.2010.00904.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Husseneder C, 2009, ANN ENTOMOL SOC AM, V102, P498, DOI 10.1603/008.102.0321
   Jackrel SL, 2017, MOL ECOL RESOUR, V17, P931, DOI 10.1111/1755-0998.12645
   Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513
   Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218
   Junqueira ACM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16353-x
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Kamal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210122
   Kaufman MG, 1999, APPL ENVIRON MICROB, V65, P2661
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Koneman EW, 1992, COLOR ATLAS TXB DIAG
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Lagier JC, 2018, NAT REV MICROBIOL, V16, P540, DOI 10.1038/s41579-018-0041-0
   LANG CA, 1972, J NUTR, V102, P1057
   Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008
   Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005
   Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372
   Luxananil P, 2001, J BIOSCI BIOENG, V92, P342, DOI 10.1016/S1389-1723(01)80237-1
   Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Mancini MV, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1266-9
   Mancini MV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1427-3
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Martin E, 2018, ENVIRON MICROBIOL, V20, P1064, DOI 10.1111/1462-2920.14044
   Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   Minard G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194521
   Minard G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00059
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Minard G, 2013, FEMS MICROBIOL ECOL, V83, P63, DOI 10.1111/j.1574-6941.2012.01455.x
   Mishra Nalini, 2018, International Journal of Mosquito Research, V5, P1
   Mohanty I, 2016, J VECTOR DIS, V53, P199
   Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29
   Moncayo AC, 2005, J MED ENTOMOL, V42, P939, DOI 10.1603/0022-2585(2005)042[0939:MPMSFA]2.0.CO;2
   Montagna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117439
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moro CV, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-70
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muturi EJ, 2016, MOL ECOL, V25, P4075, DOI 10.1111/mec.13741
   Muturi EJ, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiy213
   Muturi EJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005377
   Muturi EJ, 2016, ACTA TROP, V164, P54, DOI 10.1016/j.actatropica.2016.08.018
   Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579
   O'Neill SL, 2018, ADV EXP MED BIOL, V1062, P355, DOI 10.1007/978-981-10-8727-1_24
   Ohlund P, 2019, VIRUS GENES, V55, P127, DOI 10.1007/s11262-018-01629-9
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Onchuru TO, 2016, INT J TROP INSECT SC, V36, P146, DOI 10.1017/S1742758416000096
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x
   Patel JB, 2001, MOL DIAGN, V6, P313, DOI 10.1054/modi.2001.29158
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-8
   Pichler V, 2018, PEST MANAG SCI, V74, P1319, DOI 10.1002/ps.4840
   Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691
   Pollock J, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02627-17
   Ponnusamy L, 2008, MICROB ECOL, V56, P593, DOI 10.1007/s00248-008-9379-6
   Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Rosso F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34640-z
   Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656
   Saldana MA, 2017, MEM I OSWALDO CRUZ, V112, P81, DOI 10.1590/0074-02760160373
   Saraiva RG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006443
   Saraiva RG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24296-0
   Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109
   Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011
   Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207
   Sharma P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-235
   Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107
   Shi CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129845
   Shi M, 2018, VIRUS RES, V243, P83, DOI 10.1016/j.virusres.2017.10.016
   Short SM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005677
   Singh R, 2012, INDIAN J MED RES, V136, P671
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Stefanini I, 2018, YEAST, V35, P315, DOI 10.1002/yea.3309
   Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222
   Strand MR, 2018, CURR OPIN INSECT SCI, V28, P59, DOI 10.1016/j.cois.2018.05.008
   Swei A, 2017, ISME J, V11, P813, DOI 10.1038/ismej.2016.152
   Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x
   Tan TY, 2016, MED MYCOL, V54, P471, DOI 10.1093/mmy/myv114
   Tandina F, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1776-y
   Tchioffo MT, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01500
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2
   Terenius O, 2012, FEMS MICROBIOL ECOL, V80, P556, DOI 10.1111/j.1574-6941.2012.01317.x
   THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991
   Thongsripong P, 2018, ECOL EVOL, V8, P1352, DOI 10.1002/ece3.3676
   Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841
   Valzania L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006638
   Vazquez-Martinez MG, 2002, J MED ENTOMOL, V39, P825, DOI 10.1603/0022-2585-39.6.825
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang SB, 2017, ARTHROPOD VECTOR: CONTROLLER OF DISEASE TRANSMISSION, VOL 1: VECTOR MICROBIOME AND INNATE IMMUNITY OF ARTHROPODS, P219, DOI 10.1016/B978-0-12-805350-8.00013-1
   Wang XM, 2018, MOL ECOL, V27, P2972, DOI 10.1111/mec.14732
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
   Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wu P, 2019, CELL HOST MICROBE, V25, P101, DOI 10.1016/j.chom.2018.11.004
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Xia H, 2018, VIROL SIN, V33, P59, DOI 10.1007/s12250-018-0015-4
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Yadav KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167409
   Yadav KK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1252-0
   Yamao T, 2009, ARCH VIROL, V154, P153, DOI 10.1007/s00705-008-0285-5
   Ye YH, 2016, AM J TROP MED HYG, V94, P812, DOI 10.4269/ajtmh.15-0801
   Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x
   Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x
   Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388
NR 222
TC 6
Z9 6
U1 3
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 4
PY 2019
VL 10
AR 2036
DI 10.3389/fmicb.2019.02036
PG 19
WC Microbiology
SC Microbiology
GA IU7EL
UT WOS:000483747100001
PM 31551973
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tian, SH
   Wu, Q
   Zhou, B
   Choi, MY
   Ding, B
   Yang, W
   Dong, M
AF Tian, Songhai
   Wu, Quan
   Zhou, Bo
   Choi, Mei Yuk
   Ding, Bo
   Yang, Wei
   Dong, Min
TI Proteomic Analysis Identifies Membrane Proteins Dependent on the ER
   Membrane Protein Complex
SO CELL REPORTS
LA English
DT Article
ID ZIKA VIRUS; TRANSMEMBRANE; MUTATIONS; RECEPTORS; INSERTION; DENGUE
AB The endoplasmic reticulum (ER) membrane protein complex (EMC) is a key contributor to biogenesis and membrane integration of transmembrane proteins, but our understanding of its mechanisms and the range of EMC-dependent proteins remains incomplete. Here, we carried out an unbiased mass spectrometry (MS)-based quantitative proteomic analysis comparing membrane proteins in EMC-deficient cells to wild-type (WT) cells and identified 36 EMC-dependent membrane proteins and 171 EMC-independent membrane proteins. Of these, six EMC-dependent and six EMC-independent proteins were further independently validated. We found that a common feature among EMC-dependent proteins is that they contain transmembrane domains (TMDs) with polar and/or charged residues. Mutagenesis studies demonstrate that EMC dependency can be converted in cells by removing or introducing polar and/or charged residues within TMDs. Our studies expand the list of validated EMC-dependent and EMC-independent proteins and suggest that the EMC is involved in handling TMDs with residues challenging for membrane integration.
C1 [Tian, Songhai; Wu, Quan; Dong, Min] Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA.
   [Tian, Songhai; Wu, Quan; Dong, Min] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA.
   [Tian, Songhai; Wu, Quan; Dong, Min] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.
   [Wu, Quan] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp 1, Cent Lab,Med Res Ctr, Hefei 230001, Anhui, Peoples R China.
   [Zhou, Bo; Yang, Wei] Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA.
   [Zhou, Bo; Yang, Wei] Cedars Sinai Med Ctr, Dept Biomed Sci, Samuel Oschin Comprehens Canc Inst, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA.
   [Choi, Mei Yuk] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.
   [Choi, Mei Yuk] Harvard Med Sch, Boston, MA 02115 USA.
   [Ding, Bo] Bonacept LLC, San Diego, CA 92122 USA.
RP Dong, M (corresponding author), Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA.; Dong, M (corresponding author), Harvard Med Sch, Dept Surg, Boston, MA 02115 USA.; Dong, M (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.
EM min.dong@childrens.harvard.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01NS080833, R01AI132387, R01AI139087,
   R21NS106159, P30DK034854]; Intelligence Advanced Research Projects
   Activity (IARPA) [W911NF-17-2-0089]; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [81572255]; Boston
   Children's Hospital Intellectual and Developmental Disabilities Research
   Center [P30HD18655]; Burroughs Wellcome FundBurroughs Wellcome Fund
FX We thank members of the Dong lab, Dr. A. Kruse (Harvard Medical School),
   and Dr. T. Rapoport (Harvard Medical School) for discussion. This study
   was partially supported by grants from NIH (R01NS080833, R01AI132387,
   R01AI139087, and R21NS106159) and Intelligence Advanced Research
   Projects Activity (IARPA; W911NF-17-2-0089) to M.D., and by the National
   Natural Science Foundation of China to Q.W. (81572255). M.D. also
   acknowledges support from the NIH-funded Harvard Digestive Disease
   Center (P30DK034854) and Boston Children's Hospital Intellectual and
   Developmental Disabilities Research Center (P30HD18655). M.D. holds the
   Investigator in the Pathogenesis of Infectious Disease award from the
   Burroughs Wellcome Fund.
CR Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006
   Bagchi P, 2016, ELIFE, V5, DOI 10.7554/eLife.21470
   Chitwood PJ, 2019, TRENDS CELL BIOL, V29, P371, DOI 10.1016/j.tcb.2019.01.007
   Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Coelho JPL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08632-0
   Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Harel T, 2016, AM J HUM GENET, V98, P562, DOI 10.1016/j.ajhg.2016.01.011
   Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969
   Li YJ, 2013, AUTOPHAGY, V9, P150, DOI 10.4161/auto.22742
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611
   Qu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32007
   Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schlebach JP, 2015, J MEMBRANE BIOL, V248, P371, DOI 10.1007/s00232-014-9726-0
   Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125
   Shen X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.408
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Tang XF, 2017, J CLIN INVEST, V127, P4314, DOI 10.1172/JCI94152
   Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799
   Tian SH, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006951
   Volkmar N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223453
   Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.2
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 33
TC 2
Z9 2
U1 1
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 3
PY 2019
VL 28
IS 10
BP 2517
EP +
DI 10.1016/j.celrep.2019.08.006
PG 15
WC Cell Biology
SC Cell Biology
GA IV6KL
UT WOS:000484377200006
PM 31484065
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Hassan, AO
   Dmitriev, IP
   Kashentseva, EA
   Zhao, HY
   Brough, DE
   Fremont, DH
   Curiel, DT
   Diamond, MS
AF Hassan, Ahmed O.
   Dmitriev, Igor P.
   Kashentseva, Elena A.
   Zhao, Haiyan
   Brough, Douglas E.
   Fremont, Daved H.
   Curiel, David T.
   Diamond, Michael S.
TI A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable
   Immunity and Confers Protection in Pregnancy
SO CELL REPORTS
LA English
DT Article
ID ANTIBODY-MEDIATED NEUTRALIZATION; STRUCTURAL BASIS; DENGUE VIRUS;
   PLASMA-CELLS; DOUBLE-BLIND; DNA VACCINE; MOUSE MODEL; B-CELLS;
   INFECTION; VECTORS
AB The teratogenic potential of Zika virus (ZIKV) has made the development of an effective vaccine a global health priority. Here, we generate two gorilla adenovirus-based ZIKV vaccines that encode for pre-membrane (prM) and envelope (E) proteins (GAd-Zvp) or prM and the ectodomain of E protein (GAd-Eecto). Both vaccines induce humoral and cell-mediated immune responses and prevent lethality after ZIKV challenge in mice. Protection is antibody dependent, CD8(+) T cell independent, and for GAd-Eecto requires the complement component C1q. Immunization of GAd-Zvp induces antibodies against a key neutralizing epitope on domain III of E protein and confers durable protection as evidenced by memory B and long-lived plasma cell responses and challenge studies 9 months later. In two models of ZIKV infection during pregnancy, GAd-Zvp prevents maternal-to-fetal transmission. The gorilla adenovirus-based vaccine platform encoding full-length prM and E genes is a promising candidate for preventing congenital ZIKV syndrome and possibly infection by other flaviviruses.
C1 [Hassan, Ahmed O.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Dmitriev, Igor P.; Kashentseva, Elena A.; Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA.
   [Zhao, Haiyan; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Brough, Douglas E.] 20358 Seneca Meadows Pkwy, Germantown, MD 20876 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019; Hassan, Ahmed/AAG-3491-2019
OI Diamond, Michael/0000-0002-8791-3165; 
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 HD091218, R21
   AI131254]
FX This work was supported by grants from the NIH (R01 AI073755, R01
   HD091218 to M.S.D.; R21 AI131254 to D.T.C. and M.S.D.).
CR Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005
   Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brough DE, 2015, MOL THER, V23, pS23, DOI 10.1016/S1525-0016(16)33657-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gall JGD, 2007, MOL BIOTECHNOL, V35, P263, DOI 10.1007/BF02686012
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J
   Johnson TR, 2014, MOL THER, V22, P196, DOI 10.1038/mt.2013.142
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312
   Liu XY, 2018, 2018 4TH INTERNATIONAL CONFERENCE ON INDUSTRIAL AND BUSINESS ENGINEERING (ICIBE 2018), P29, DOI 10.1145/3288155.3288174
   Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   McVey D, 2013, VIROLOGY, V444, P119, DOI 10.1016/j.virol.2013.05.041
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Metz SW, 2016, METHODS MOL BIOL, V1426, P297, DOI 10.1007/978-1-4939-3618-2_27
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nurnberger C, 2019, J VIROL, V93, DOI 10.1128/JVI.01485-18
   Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rodriguez-Limas WA, 2013, CURR OPIN BIOTECH, V24, P1089, DOI 10.1016/j.copbio.2013.02.008
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wold WSM, 2013, CURR GENE THER, V13, P421
   Xiang ZQ, 2006, EMERG INFECT DIS, V12, P1596, DOI 10.3201/eid1210.060078
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 103
TC 2
Z9 2
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 3
PY 2019
VL 28
IS 10
BP 2634
EP +
DI 10.1016/j.celrep.2019.08.005
PG 17
WC Cell Biology
SC Cell Biology
GA IV6KL
UT WOS:000484377200015
PM 31484074
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Luetke, M
   Omodior, O
   Nelson, EJ
AF Luetke, Maya
   Omodior, Oghenekaro
   Nelson, Erik J.
TI Zika knowledge and prevention practices among US travelers: a large
   cross-sectional survey study
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika virus; Zika knowledge; Zika prevention; Personal protective
   behaviors; Sexual transmission
ID HEALTH-CARE STUDENTS; VIRUS-DISEASE; SEXUAL TRANSMISSION; WORKERS
   KNOWLEDGE; EPIDEMIOLOGY; ASSOCIATION; INFECTION; ATTITUDES; AMERICA;
   CITIES
AB Background The aim of this study was to investigate what factors predict knowledge about Zika transmission, symptomology, and treatment among U.S. travelers and, additionally, to evaluate how Zika knowledge influences the adoption of personal protective behaviors. Methods Data were collected as part of a cross-sectional survey study using a probability-based internet panel of U.S. travelers in June 2017. We ran logistic regression models of factors predicting Zika knowledge (high vs. low) and of knowledge predicting adoption of personal protective measures. Results We found that traveling to a Zika endemic country and travelers' gender were both significantly predictive of higher Zika knowledge (odds ratio (OR): 1.48, 95% confidence interval (CI): 1.14-1.93 and OR: 1.44, 95% CI: 1.08-1.92), adjusting for age, race, education, income, and trip purpose. Additionally, among travelers to Zika endemic countries, individuals with higher Zika knowledge had significantly higher odds of engaging in preventive behaviors compared to those with lower knowledge. However, few travelers knew about the sexual transmission of Zika and adopted sexual prevention measures. Conclusions Our findings suggest that there are gaps in knowledge about the risks and transmission of Zika and travelers with low knowledge are less likely to engage in the appropriate prevention methods. Significantly, few U.S. travelers have knowledge of the sexual transmission of Zika and, accordingly, there is less overall engagement with prevention measures for this transmission mechanism than for vector-borne transmission.
C1 [Luetke, Maya; Nelson, Erik J.] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1025 E 7th St,Suite 111, Bloomington, IN 47405 USA.
   [Omodior, Oghenekaro] Indiana Univ, Sch Publ Hlth, Dept Recreat Pk & Tourism Studies, Bloomington, IN USA.
RP Luetke, M (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1025 E 7th St,Suite 111, Bloomington, IN 47405 USA.
EM luetke@iu.edu
RI Luetke, Maya/AAK-5915-2020
OI Luetke, Maya/0000-0001-6793-245X
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Bhat S, 2017, OBSTET GYNECOL, V129, p135S, DOI 10.1097/01.AOG.0000514681.98545.97
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cantrell MA, 2007, J ADV NURS, V60, P544, DOI 10.1111/j.1365-2648.2007.04448.x
   Centers for Disease Control and Prevention (CDC), ZIK VIR PREV
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fraiz LD, 2018, VACCINE, V36, P165, DOI 10.1016/j.vaccine.2017.11.021
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Gushulak BD, 2004, CLIN INFECT DIS, V38, P1742, DOI 10.1086/421268
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hays RD, 2015, BEHAV RES METHODS, V47, P685, DOI 10.3758/s13428-015-0617-9
   Heen Miliaikeala S. J., 2014, CTR CRIME JUSTICE PO, V1, P1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lantz PM, 2016, MILBANK Q, V94, P51, DOI 10.1111/1468-0009.12181
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Michael GC, 2017, S AFR FAM PRACT, V59, P148, DOI 10.1080/20786190.2017.1313484
   Miller A, 2017, PRESIDENT'S KITCHEN CABINET: THE STORY OF AFRICAN AMERICANS WHO HAVE FED OUR FIRST FAMILIES, FROM THE WASHINGTONS TO THE OBAMAS, P92
   Moore KS, 2016, JNP-J NURSE PRACT, V12, P697, DOI 10.1016/j.nurpra.2016.09.012
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson EJ, 2019, J COMMUN HEALTH, V44, P377, DOI 10.1007/s10900-018-0594-x
   Pan American Health Organization and World Health Organization, 2017, ZIK EP REP US
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Qualtrics, 2017, QUALTR SOFTW
   R Core Team, 2017, R LANG ENV STAT COMP
   Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68
   Ryan ET, 2000, NEW ENGL J MED, V342, P1716, DOI 10.1056/NEJM200006083422306
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   SAS Institute Inc, 2014, SAS SOFTW 9 4
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Shartzer A, 2016, WOMEN REPROD AGE LAC, P20
   U.S. Census Bureau, AM COMM SURV ACS
   United Nations World Tourism Organization, 2017, UNWTO TOUR HIGHL 201
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WHO Antibacterial Agents, 2017, ANT AG CLIN DEV AN A, P1
   Wilson Mary E, 2004, J Agromedicine, V9, P161
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2017, ZIKA VIR ZIKV CLASS, P2
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
NR 43
TC 0
Z9 0
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD SEP 3
PY 2019
VL 19
IS 1
AR 1217
DI 10.1186/s12889-019-7533-3
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IU7GE
UT WOS:000483751600003
PM 31481059
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Montecillo-Aguado, MR
   Montes-Gomez, AE
   Garcia-Cordero, J
   Corzo-Gomez, J
   Vivanco-Cid, H
   Mellado-Sanchez, G
   Munoz-Medina, JE
   Gutierrez-Castaneda, B
   Santos-Argumedo, L
   Gonzalez-Bonilla, C
   Cedillo-Barron, L
AF Montecillo-Aguado, Mayra R.
   Montes-Gomez, Alfredo E.
   Garcia-Cordero, Julio
   Corzo-Gomez, Josselin
   Vivanco-Cid, Hector
   Mellado-Sanchez, Gabriela
   Esteban Munoz-Medina, J.
   Gutierrez-Castaneda, Benito
   Santos-Argumedo, Leopoldo
   Gonzalez-Bonilla, Cesar
   Cedillo-Barron, Leticia
TI Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus
   Antibodies against Zika Virus: A Study in the Mexican Population
SO JOURNAL OF IMMUNOLOGY RESEARCH
LA English
DT Article
ID IMMUNE-RESPONSE; INFECTION; TRANSMISSION; GLYCOPROTEIN; BIND
AB Zika virus (ZIKV), an emerging mosquito-borne flavivirus, has quickly spread in many regions around the world where dengue virus (DENV) is endemic. This represents a major health concern, given the high homology between these two viruses, which can result in cross-reactivity. The aim of this study was to determine the cross-reacting antibody response of the IgM and IgG classes against the recombinant envelope protein of ZIKV (rE-ZIKV) in sera from patients with acute-phase infection of different clinical forms of dengue, i.e., dengue fever (DF) and dengue hemorrhagic fever (DHF) (before the arrival of ZIKV in Mexico 2010), as well as acute-phase sera of ZIKV patients, together with the implications in neutralization and antibody-dependent enhancement. Differences in IgM responses were observed in a number of DF and DHF patients whose sera cross-reacted with the rE-ZIK antigen, with 42% recognition between acute-phase DHF and ZIKV but 27% recognition between DF and ZIKV. Regarding IgG antibodies, 71.5% from the DF group showed cross-reactivity to rE-ZIKV in contrast with 50% and only 25% of DHF and ZIKV serum samples, respectively, which specifically recognized the homologous antigen. The DHF group showed more enhancement of ZIKV infection of FCR gamma-expressing cells compared to the DF group. Furthermore, the DHF group also showed a higher cross-neutralizing ability than that of DF. This is the first report where DF and DHF serum samples were evaluated for cross-reactivity against Zika protein and ZIKV. Furthermore, DENV serum samples cross-protect against ZIKV through neutralizing antibodies but at the same time mediate antibody-dependent enhancement in the sequential ZIKV infection.
C1 [Montecillo-Aguado, Mayra R.; Montes-Gomez, Alfredo E.; Garcia-Cordero, Julio; Corzo-Gomez, Josselin; Santos-Argumedo, Leopoldo; Cedillo-Barron, Leticia] CINVESTAV, IPN, Dept Biomed Mol, Av IPN 2508 Col San Pedro Zacatenco, Mexico City, DF, Mexico.
   [Vivanco-Cid, Hector] Univ Veracruzana, Inst Invest Medicobiol, Lab Multidisciplinario Ciencias Biomed, Xalapa, Veracruz, Mexico.
   [Mellado-Sanchez, Gabriela] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Unidad Desarrollo Invest Bioproc, Mexico City, DF, Mexico.
   [Esteban Munoz-Medina, J.] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Lab Cent Epidemiol, Mexico City, DF, Mexico.
   [Gutierrez-Castaneda, Benito] Univ Nacl Autonoma Mexico, UMF Fac Estudios Super Iztacala, Dept Inmunol, Av Barrios 1, Tlalnepantla, Edo De Mexico, Mexico.
   [Gonzalez-Bonilla, Cesar] Inst Mexicano Seguro Social, Coordinac Vigilancia Epidemiol, Lab Cent Epidemiol, Mexico City, DF, Mexico.
RP Cedillo-Barron, L (corresponding author), CINVESTAV, IPN, Dept Biomed Mol, Av IPN 2508 Col San Pedro Zacatenco, Mexico City, DF, Mexico.
EM lcedillo@cinvestav.mx
RI Mellado-Sanchez, Gabriela/I-7638-2013
OI Mellado-Sanchez, Gabriela/0000-0002-8299-5958; Munoz Medina, Jose
   Esteban/0000-0002-1289-4457
FU CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT); National
   Council for Science and Technology (CONACYT)Consejo Nacional de Ciencia
   y Tecnologia (CONACyT) [FONSEC0 2014-1-233347]; National Council for
   Science and Technology (CONACYT) through Fronteras de la Ciencia
   [2015-02-1192]; National Council for Science and Technology (CONACYT)
   through Ciencia Basica SEP-CONACYT [256235]
FX MRMA, AMG, and JCG received postgraduate fellowships from CONACYT.
   Additionally, JGC, HVC, GMS, JEMM, BGC, LSA, CGB, and LCB are members of
   the National System of Researchers, SNI. This work was supported by the
   National Council for Science and Technology (CONACYT) through Grants
   FONSEC0 2014-1-233347 to LCB, Fronteras de la Ciencia 2015-02-1192 to
   HVC, and Ciencia Basica SEP-CONACYT 256235 to HVC.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Montes-Gomez AE, 2017, ACTA TROP, V171, P233, DOI 10.1016/j.actatropica.2017.04.006
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Konishi E, 2010, J VIROL METHODS, V163, P360, DOI 10.1016/j.jviromet.2009.10.026
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Leon-Juarez M, 2013, APMIS, V121, P848, DOI 10.1111/apm.12044
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Mellado-Sanchez G, 2005, VIRAL IMMUNOL, V18, P709, DOI 10.1089/vim.2005.18.709
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   *WHO, 1997, DENG HEM FEV DIAGN T
   Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 2
Z9 2
U1 2
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-8861
EI 2314-7156
J9 J IMMUNOL RES
JI J Immunol. Res.
PD SEP 2
PY 2019
VL 2019
AR 7239347
DI 10.1155/2019/7239347
PG 14
WC Immunology
SC Immunology
GA IY5AT
UT WOS:000486404800001
PM 31565661
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rowinska-Zyrek, M
   Wiech, A
   Watly, J
   Wieczorek, R
   Witkowska, D
   Ozyhar, A
   Orlowski, M
AF Rowinska-Zyrek, Magdalena
   Wiech, Anna
   Watly, Joanna
   Wieczorek, Robert
   Witkowska, Danuta
   Ozyhar, Andrzej
   Orlowski, Marek
TI Copper(II)-Binding Induces a Unique Polyproline Type II Helical
   Structure within the Ion-Binding Segment in the Intrinsically Disordered
   F-Domain of Ecdysteroid Receptor from Aedes aegypti
SO INORGANIC CHEMISTRY
LA English
DT Article
ID N-TERMINAL DOMAIN; ANDROGEN RECEPTOR; AB-INITIO; PROTEINS;
   TRANSACTIVATION; CONFORMATION; ACID; PROLINE; AF1; COMPLEXES
AB Reproduction of the dominant vector of Zika and dengue diseases, Aedes aegypti mosquito, is controlled by an active heterodimer complex composed of the 20-hydroxyecdysone receptor (EcR) and ultraspiracle protein. Although A. aegypti EcR shares the structural and functional organization with other nuclear receptors, its C-terminus has an additional long F domain (AaFEcR). Recently, we showed that the full length AaFEcR is intrinsically disordered with the ability to specifically bind divalent metal ions. Here, we describe the details of the exhaustive structural and thermodynamic properties of Zn2+- and Cu2+-complexes with the AaFEcR domain, based on peptide models of its two putative metal binding sites (Ac-HGPHPHPHG-NH2 and Ac-QQLTPNQQQHQQQHSQLQQVHANGS-NH2). Unexpectedly, only in the presence of increasing concentrations of Cu2+ ions, the Ac-HGPHPHPHG-NH2 peptide gained a metal ion-induced poly-L-proline type II helical structure, which is unique for members of the family of nuclear receptors.
C1 [Rowinska-Zyrek, Magdalena; Watly, Joanna; Wieczorek, Robert] Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland.
   [Wiech, Anna; Ozyhar, Andrzej; Orlowski, Marek] Wroclaw Univ Sci & Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland.
   [Witkowska, Danuta] Publ Higher Med Profess Sch Opole, Katowicka 68, PL-45060 Opole, Poland.
RP Rowinska-Zyrek, M (corresponding author), Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland.; Orlowski, M (corresponding author), Wroclaw Univ Sci & Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland.
EM magdalena.rowinska-zyrek@chem.uni.wroc.pl; marek.orlowski@pwr.edu.pl
RI Witkowska, Danuta/K-4147-2016
OI Orlowski, Marek/0000-0003-1282-2282; Witkowska,
   Danuta/0000-0002-6346-7543; OZYHAR, Andrzej/0000-0002-5874-784X;
   Wieczorek, Robert/0000-0003-3711-8961; Rowinska-Zyrek,
   Magdalena/0000-0002-0425-1128
FU National Science Centre [UMO-2017/26/E/ST5/00364]; Polish Ministry of
   Science and Higher EducationMinistry of Science and Higher Education,
   Poland
FX The work was supported by the National Science Centre
   (UM0-2017/26/E/ST5/00364) and by a statutory activity subsidy from the
   Polish Ministry of Science and Higher Education for the Faculty of
   Chemistry of Wroclaw University of Science and Technology. We are
   grateful to Michal Szumiriski for painting the Aedes aegypti mosquito
   for the table of contents graphic.
CR Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018
   Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4
   Arao Y, 2018, J BIOL CHEM, V293, P8495, DOI 10.1074/jbc.RA117.001212
   ARENA G, 1976, THERMOCHIM ACTA, V16, P315, DOI 10.1016/0040-6031(76)80024-X
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bianchetti L, 2018, BBA-GEN SUBJECTS, V1862, P1810, DOI 10.1016/j.bbagen.2018.04.022
   Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X
   Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b
   Chiera NM, 2013, METALLOMICS, V5, P214, DOI 10.1039/c3mt20166j
   CHO WL, 1995, INSECT BIOCHEM MOLEC, V25, P19, DOI 10.1016/0965-1748(94)00045-J
   DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699
   Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042
   Dziedzic-Letka A, 2011, PROTEINS, V79, P376, DOI 10.1002/prot.22887
   Frisch M. J., 2016, GAUSSIAN 09 REVISION
   Gans P, 2000, TALANTA, V51, P33, DOI 10.1016/S0039-9140(99)00245-3
   GANS P, 1985, J CHEM SOC DALTON, P1195, DOI 10.1039/dt9850001195
   Garapati S, 2018, J BIOL INORG CHEM, V23, P1255, DOI 10.1007/s00775-018-1612-2
   Gemayel R, 2015, MOL CELL, V59, P615, DOI 10.1016/j.molcel.2015.07.003
   GRAN G, 1950, ACTA CHEM SCAND, V4, P559, DOI 10.3891/acta.chem.scand.04-0559
   Gumienna-Kontecka E, 2000, J CHEM SOC DALTON, P4201, DOI 10.1039/b004432f
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hecel A, 2019, INORG CHEM, V58, P5932, DOI 10.1021/acs.inorgchem.9b00265
   Hicks JM, 2004, PROTEINS, V55, P330, DOI 10.1002/prot.10630
   Huang KY, 2019, J PHYS CHEM B, V123, P138, DOI 10.1021/acs.jpcb.8b10864
   Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.3.CO;2-V
   JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045
   Kay BK, 2000, FASEB J, V14, P231
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Kowalik-Jankowska T., 2007, METAL IONS LIFE SCI, V2, P63
   Krasowski MD, 2008, J PROTEOME RES, V7, P4359, DOI 10.1021/pr8003024
   Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101
   Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p
   Kumar R, 2013, J BIOL CHEM, V288, P30285, DOI 10.1074/jbc.M113.491787
   Kumar R, 2009, STEROIDS, V74, P877, DOI 10.1016/j.steroids.2009.07.012
   Latajka Z, 1999, PHYS CHEM CHEM PHYS, V1, P2441
   Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872
   Ma K, 2003, BIOPOLYMERS, V70, P297, DOI 10.1002/bip.10477
   MAKAROV AA, 1975, DOKL AKAD NAUK SSSR+, V225, P1434
   Makowska J, 2006, P NATL ACAD SCI USA, V103, P1744, DOI 10.1073/pnas.0510549103
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McEwan I. J, 2015, NUCL RECEPTORS STRUC, P1, DOI [10.1007/978-3-319-18729-7, DOI 10.1007/978-3-319-18729-7]
   Nocula-Lugowska M, 2009, PROTEINS, V76, P291, DOI 10.1002/prot.22342
   Patel SR, 2015, MOL CELL ENDOCRINOL, V418, P298, DOI 10.1016/j.mce.2015.07.009
   Pettit L. D., 1992, CHEM INFORM, V23, P5
   Pettit L. D., 2006, CHEM INT NEWSMAGAZIN, V56, P14
   Pieprzyk J, 2014, BBA-PROTEINS PROTEOM, V1844, P1153, DOI 10.1016/j.bbapap.2014.03.010
   Ranieri-Raggi M, 2014, BIOMOLECULES, V4, P474, DOI 10.3390/biom4020474
   Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200
   Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656
   SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047
   Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a
   SILIGARDI G, 1995, BIOPOLYMERS, V37, P281, DOI 10.1002/bip.360370406
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200
   Watly J, 2018, INORG CHIM ACTA, V472, P119, DOI 10.1016/j.ica.2017.06.053
   Wiech A, 2019, J STEROID BIOCHEM, V186, P42, DOI 10.1016/j.jsbmb.2018.09.008
   Wierzejewska M, 2003, CHEM PHYS, V287, P169, DOI 10.1016/S0301-0104(02)00989-8
   WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249
   Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003
NR 60
TC 0
Z9 0
U1 2
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0020-1669
EI 1520-510X
J9 INORG CHEM
JI Inorg. Chem.
PD SEP 2
PY 2019
VL 58
IS 17
BP 11782
EP 11792
DI 10.1021/acs.inorgchem.9b01826
PG 11
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA IV1VI
UT WOS:000484066500054
PM 31433630
DA 2020-07-08
ER

PT J
AU Akhtar, M
   Kraemer, MUG
   Gardner, LM
AF Akhtar, Mahmood
   Kraemer, Moritz U. G.
   Gardner, Lauren M.
TI A dynamic neural network model for predicting risk of Zika in real time
SO BMC MEDICINE
LA English
DT Article
DE Zika; Epidemic risk prediction; Dynamic neural network
ID VIRUS OUTBREAK; DENGUE SURVEILLANCE; SOUTH-PACIFIC; TRANSMISSION;
   FORECAST; SYSTEM; IMPACT; SPREAD; ISLAND
AB Background In 2015, the Zika virus spread from Brazil throughout the Americas, posing an unprecedented challenge to the public health community. During the epidemic, international public health officials lacked reliable predictions of the outbreak's expected geographic scale and prevalence of cases, and were therefore unable to plan and allocate surveillance resources in a timely and effective manner. Methods In this work, we present a dynamic neural network model to predict the geographic spread of outbreaks in real time. The modeling framework is flexible in three main dimensions (i) selection of the chosen risk indicator, i.e., case counts or incidence rate; (ii) risk classification scheme, which defines the high-risk group based on a relative or absolute threshold; and (iii) prediction forecast window (1 up to 12 weeks). The proposed model can be applied dynamically throughout the course of an outbreak to identify the regions expected to be at greatest risk in the future. Results The model is applied to the recent Zika epidemic in the Americas at a weekly temporal resolution and country spatial resolution, using epidemiological data, passenger air travel volumes, and vector habitat suitability, socioeconomic, and population data for all affected countries and territories in the Americas. The model performance is quantitatively evaluated based on the predictive accuracy of the model. We show that the model can accurately predict the geographic expansion of Zika in the Americas with the overall average accuracy remaining above 85% even for prediction windows of up to 12 weeks. Conclusions Sensitivity analysis illustrated the model performance to be robust across a range of features. Critically, the model performed consistently well at various stages throughout the course of the outbreak, indicating its potential value at any time during an epidemic. The predictive capability was superior for shorter forecast windows and geographically isolated locations that are predominantly connected via air travel. The highly flexible nature of the proposed modeling framework enables policy makers to develop and plan vector control programs and case surveillance strategies which can be tailored to a range of objectives and resource constraints.
C1 [Akhtar, Mahmood; Gardner, Lauren M.] UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW, Australia.
   [Akhtar, Mahmood] UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Grp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA 02115 USA.
   [Gardner, Lauren M.] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA.
RP Gardner, LM (corresponding author), UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW, Australia.; Gardner, LM (corresponding author), Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA.
EM l.gardner@jhu.edu
OI Gardner, Lauren/0000-0003-1083-3850
CR Aburas HM, 2010, EXPERT SYST APPL, V37, P4256, DOI 10.1016/j.eswa.2009.11.077
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Martinez-Bello DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005696
   Ahmadi Shukrullah, 2018, J PUBLIC HLTH EMERGE, V2, P20, DOI [10.21037/jphe.2018.05.02, DOI 10.21037/JPHE.2018.05.02]
   Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258
   Anggraeni W., 2016, 2016 INT C INF COMM
   Baquero OS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195065
   Beltran JD, 2018, DH '18: PROCEEDINGS OF THE 2018 INTERNATIONAL CONFERENCE ON DIGITAL HEALTH, P90, DOI 10.1145/3194658.3194683
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boussaada Z, 2018, ENERGIES, V11, DOI 10.3390/en11030620
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CHEN S, 1990, INT J CONTROL, V51, P1191, DOI 10.1080/00207179008934126
   Chen YR, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1108-5
   Cheong YL, 2014, SPAT SPATIO-TEMPORAL, V10, P75, DOI 10.1016/j.sste.2014.05.002
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cortes F, 2018, ACTA TROP, V182, P190, DOI 10.1016/j.actatropica.2018.03.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Earnest A, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/758674
   European Centre for Disease Prevention and Control, 2017, VECT CONTR FOC AED A
   Faisal T, 2012, J MED SYST, V36, P661, DOI 10.1007/s10916-010-9532-x
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gardner LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/103679
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guo P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005973
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Jiang D, 2018, ACTA TROP, V185, P391, DOI 10.1016/j.actatropica.2018.06.021
   Johansson MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33707
   Kiskin IOB, ARXIV170505180
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lauer SA, 2018, P NATL ACAD SCI USA, V115, pE2175, DOI 10.1073/pnas.1714457115
   Laureano-Rosario Abdiel E, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3010005
   LEONTARITIS IJ, 1985, INT J CONTROL, V41, P303, DOI 10.1080/0020718508961129
   Li QX, 2018, ACTA TROP, V183, P8, DOI 10.1016/j.actatropica.2018.03.026
   Liu KK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006318
   Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Marques-Toledo CD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005729
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Morsy S, 2018, EPIDEMIOL INFECT, V146, P1625, DOI [10.1017/S0950268818002078, 10.1017/s0950268818002078]
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Narendra K S, 1990, IEEE Trans Neural Netw, V1, P4, DOI 10.1109/72.80202
   NGUYEN T, 2013, IEEE IJCNN
   Nishanthi PHM, 2014, INT J COMPUTER APPL, V101, P1
   PAHO, 2017, COUNTR TERR AUT TRAN
   Pan American Health Organization / World Health Organization, 2017, REG ZIK EP UPD AM AU
   Pdnn S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166806
   Pigott DM, 2017, LANCET, V390, P2662, DOI 10.1016/S0140-6736(17)32092-5
   Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688
   Rehman NA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501215
   Sanchez-Ortiz A, 2017, INT CONF ELECTR COMM
   Scavuzzo JM, 2017, 2017 XVII WORKSHOP ON INFORMATION PROCESSING AND CONTROL (RPIC)
   Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9
   Shi Y, 2016, ENVIRON HEALTH PERSP, V124, P1369, DOI 10.1289/ehp.1509981
   Siegelmann HT, 1997, IEEE T SYST MAN CY B, V27, P208, DOI 10.1109/3477.558801
   Siriyasatien P, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1034-5
   Tatem AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1489, DOI 10.1098/rspb.2007.0148
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsungnan L, 1995, LEARNING LONG TERM D, P23
   U. S. Bureau of Economic Analysis, GDP STAT
   Wahba G, 1990, SOC IND APPL MATH, P177
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   WHO, WHO WORLD HLTH STAT
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   World Bank Open Data, 2016, POPULATION DENSITY P
   World Health Organization (WHO)/Pan American Health Organization (PAHO), 2017, PLISA HLTH IND PLATF
   WorldBank, INT COMP PROGR DAT G
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhu GG, 2018, SCI TOTAL ENVIRON, V622, P252, DOI 10.1016/j.scitotenv.2017.11.314
   Zhu GH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004633
NR 83
TC 1
Z9 1
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD SEP 2
PY 2019
VL 17
IS 1
AR 171
DI 10.1186/s12916-019-1389-3
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA IU5TB
UT WOS:000483649100001
PM 31474220
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maucourant, C
   Queiroz, GAN
   Samri, A
   Grassi, MFR
   Yssel, H
   Vieillard, V
AF Maucourant, Christopher
   Queiroz, Gabriel Andrade Nonato
   Samri, Assia
   Grassi, Maria Fernanda Rios
   Yssel, Hans
   Vieillard, Vincent
TI Zika virus in the eye of the cytokine storm
SO EUROPEAN CYTOKINE NETWORK
LA English
DT Review
DE Zika virus; Flavivirus; Cytokines; Chemokines; Microcephaly;
   Guillain-Barre syndrome
ID INTERFERON-STIMULATED GENES; DENGUE VIRUS; INFECTION; MONOCYTES;
   MACROPHAGES; ACTIVATION; RECEPTORS; PREGNANCY; OUTBREAK; PROTEIN
AB Zika virus (ZIKV) is an emerging arbovirus that causes a mosquito-borne disease. Although infection with ZIKV generally leads to mild disease, its recent emergence in the Americas has been associated with an increase in the development of the Guillain-Barre syndrome in adults, as well as with neurological complications, in particular congenital microcephaly, in new-borns. Over the five past years, through the combined efforts of the scientific community, comprehensive remarkable progress aimed at deciphering the clinical, virological, physiopathological, and immunological features of ZIKV infection. This review highlights some of the most recent advances in our understanding of the role of cytokines and chemokines in ZIKV infection, and discusses potential links to pathogenesis.
C1 [Maucourant, Christopher; Samri, Assia; Yssel, Hans; Vieillard, Vincent] Univ Paris 06, Sorbonne Univ, Ctr Immunol & Malad Infect CIMI Paris, CNRS,ERL8255,INSERM,UPMC,U1135, Paris, France.
   [Queiroz, Gabriel Andrade Nonato; Grassi, Maria Fernanda Rios] IGM Oswaldo Cruz Fdn FIOCRUZ, Adv Lab Publ Hlth, Rua Waldemar Falcao 121, Salvador, Bahia, Brazil.
   [Queiroz, Gabriel Andrade Nonato; Grassi, Maria Fernanda Rios] Bahiana Sch Med & Publ Hlth, Salvador, Bahia, Brazil.
RP Vieillard, V (corresponding author), Univ Paris 06, Sorbonne Univ, Ctr Immunol & Malad Infect CIMI Paris, CNRS,ERL8255,INSERM,UPMC,U1135, Paris, France.
EM vincent.vieillard@sorbonne-universite.fr
FU EU Horizon 2020 ZIKAlliance Program [734548]
FX This study was supported by the EU Horizon 2020 ZIKAlliance Program
   (grant agreement no. 734548).
CR [Anonymous], 2016, WHO DIR GEN SUMM OUT
   [Anonymous], 2016, WHO STAT 1 M INT HLT
   [Anonymous], 2016, WHO EM PREP RESP GUI
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chiang S, 2013, MUSCLE NERVE, V48, P320, DOI 10.1002/mus.23829
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diop F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206093
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faas MM, 2017, PLACENTA, V56, P44, DOI 10.1016/j.placenta.2017.03.001
   Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x
   Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grip O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005263
   Halstead SB, ANTIBODY FC LINKING
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Malmberg KJ, 2012, EUR J IMMUNOL, V42, P3141, DOI 10.1002/eji.201243050
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Maucourant C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020131
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nyati KK, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/758639
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Peng J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21025-5
   Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499
   Petitdemange C, 2015, J ALLERGY CLIN IMMUN, V135, P846, DOI 10.1016/j.jaci.2015.01.039
   Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   SAITO S, 1993, INT IMMUNOL, V5, P559, DOI 10.1093/intimm/5.5.559
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tarin JJ, 2002, HUM REPROD, V17, P2243, DOI 10.1093/humrep/17.9.2243
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687
   Wang Y, 2017, EXPERT OPIN THER TAR, V21, P103, DOI 10.1080/14728222.2017.1258402
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Zhang MJ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-3
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
NR 87
TC 0
Z9 0
U1 2
U2 2
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
EI 1952-4005
J9 EUR CYTOKINE NETW
JI Eur. Cytokine Netw.
PD SEP
PY 2019
VL 30
IS 3
BP 74
EP 81
DI 10.1684/ecn.2019.0433
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA KS2KD
UT WOS:000518138300001
PM 31957701
DA 2020-07-08
ER

PT J
AU Riley, LE
   Heine, RP
   Oduyebo, T
AF Riley, Laura E.
   Heine, R. Phillips
   Oduyebo, Titilope
CA Immunization Infect Dis Public
TI Management of Patients in the Context of Zika Virus
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; US TERRITORIES; INFECTION;
   PREGNANCY; FETUSES; ULTRASOUND; INFANTS
AB Zika virus is a flavivirus with the potential to cause serious adverse pregnancy and infant outcomes. Although rates of Zika virus infection have decreased in the United States, obstetrician-gynecologists and other health care providers should continue to assess their patients for potential exposure based on travel or sexual history and test symptomatic patients with possible exposure and pregnant women with ongoing exposure regardless of symptoms in accordance with the Centers for Disease Control and Prevention recommendations. Pregnant women and those planning a pregnancy should talk to their health care providers about potential risks before traveling to an area where current or past Zika virus transmission has occurred. Testing recommendations for pregnant women with possible Zika virus exposure differ based on the presence or absence of symptoms of Zika virus infection and the circumstances of possible exposure. If obstetrician-gynecologists or other health care providers identify a patient who has possibly been exposed to the Zika virus and may require testing, they should contact their local or state health department for assistance. Consultation with a maternal-fetal medicine specialist or an infectious disease specialist with expertise in the management of infectious diseases in pregnancy may be useful for pregnant women with possible maternal Zika virus infection or concerning fetal findings. Zika virus identification and follow-up care of infants born to women with possible exposure to Zika virus during pregnancy are critical and can ensure that appropriate intervention services are available to affected infants. Obstetrician-gynecologists and other obstetric care providers should have a system to ensure relevant information regarding a woman's Zika infection status is communicated to pediatric care providers.
RI Heine, R. Phillips/AAR-1189-2020
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, QUEST ZIK
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   World Health Organisation Guideline, 2016, GUID INF FEED AR ZIK
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
NR 22
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD SEP
PY 2019
VL 134
IS 3
BP E64
EP E70
DI 10.1097/AOG.0000000000003399
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KK5LL
UT WOS:000512783100001
OA Bronze
DA 2020-07-08
ER

PT J
AU Pinchoff, J
   Serino, A
   Merritt, AP
   Hunter, G
   Silva, M
   Parikh, P
   Hewett, PC
AF Pinchoff, Jessie
   Serino, Arianna
   Merritt, Alice Payne
   Hunter, Gabrielle
   Silva, Martha
   Parikh, Priya
   Hewett, Paul C.
TI Evidence-Based Process for Prioritizing Positive Behaviors for
   Promotion: Zika Prevention in Latin America and the Caribbean and
   Applicability to Future Health Emergency Responses
SO GLOBAL HEALTH-SCIENCE AND PRACTICE
LA English
DT Article
ID VIRUS-INFECTION; EL-PROGRESO; PREGNANCY; IMPACT
AB Since the 2015 Zika outbreak in Latin America and the Caribbean, a plethora of behavior change messages have been promoted to reduce Zika transmission. One year after the United States Agency for International Development (USAID) initiated its Zika response, more than 30 variants of preventive behaviors were being promoted. This situation challenged social and behavior change (SBC) programming efforts that require a coordinated response and agreed upon set of focus behaviors to be effective. To support USAID implementing partners in harmonizing prevention efforts to reduce Zika infection, we developed an evidence-based process to identify behaviors with the highest potential to reduce Zika infection and transmission. We compiled a full list of behaviors and selected the most promising for a full evidence review. The review included systematic keyword searches on Google Scholar, extraction of all relevant published articles on Aedes-borne diseases between 2012 and 2018, review of seminal papers, and review of gray literature. We examined articles to determine each behavior's potential effectiveness in preventing Zika transmission or reducing the Aedes aegypti population. We also developed assessment criteria to delineate the ease with which the target population could adopt each behavior, including: (1) required frequency; (2) feasibility of the behavior; and (3) accessibility and cost of the necessary materials in the setting. These behaviors were refined through a consensus-building process with USAID's Zika implementing partners, considering contextual factors. The resulting 7 evidence-based preventive behaviors have high potential to strengthen SBC programming's impact in USAID's Zika response: (1) apply mosquito repellent, (2) use condoms during pregnancy, (3) remove standing water, (4) cover water storage containers, (5) clean/remove mosquito eggs from water containers, (6) seek antenatal care, and (7) seek family planning counseling. This case study documents a flexible process that can be adapted to inform the prioritization of behaviors when there is limited evidence available, as during many emergency responses.
C1 [Pinchoff, Jessie; Hewett, Paul C.] Populat Council, 1230 York Ave, New York, NY 10021 USA.
   [Serino, Arianna] US Agcy Int Dev, Washington, DC 20523 USA.
   [Merritt, Alice Payne; Hunter, Gabrielle; Parikh, Priya] Johns Hopkins Ctr Commun Programs, Baltimore, MD USA.
   [Silva, Martha] Tulane Univ, New Orleans, LA 70118 USA.
RP Pinchoff, J (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.
EM jpinchoff@popcouncil.org
FU United States Agency for International Development (USAID)United States
   Agency for International Development (USAID) [AID-OAA-A-17-00018]
FX Breakthrough-RESEARCH is made possible by the generous support of the
   American people through the United States Agency for International
   Development (USAID) under the terms of cooperative agreement no.
   AID-OAA-A-17-00018.
CR Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z
   Andraud M, 2013, MATH BIOSCI, V244, P22, DOI 10.1016/j.mbs.2013.04.001
   [Anonymous], SEX TRANSM PREV
   [Anonymous], 2016, RISK COMM COMM ENG Z
   [Anonymous], SBCC EMERGENCY PREPA
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, P3, DOI DOI 10.1371/J0URNAL.PNTD.0004551
   Centers for Disease Control and Prevention, CONG ZIK SYNDR OTH B
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   Fernandez EA, 1998, ACTA TROP, V70, P171, DOI 10.1016/S0001-706X(98)00033-3
   FERNANDEZ EA, 1992, DENGUE WORLDWIDE PRO, P279
   Fraiz LD, 2018, VACCINE, V36, P165, DOI 10.1016/j.vaccine.2017.11.021
   Garcia-Betancourt T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129054
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Leontsini E., 2004, Dengue Bulletin, V28, P22
   LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   Morales-Perez A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4293-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Phuanukoonnon S, 2005, TROP MED INT HEALTH, V10, P755, DOI 10.1111/j.1365-3156.2005.01452.x
   PIOTROW PT, 1997, HLTH COMMUNICATION L
   PONS JA, 2002, CIENC SOC, V27, P73
   Population Services International (PSI), 2013, CENTR AM 2013 MAP ST
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Rao R, 2017, OBSTET GYNECOL, V129, P1098, DOI 10.1097/AOG.0000000000002049
   Paumgartten FJR, 2016, VIGIL SANIT DEBATE, V4, P97, DOI 10.3395/2317-269x.00736
   Rosenberg ES, 2017, AM SOC TROP MED HYG
   Tran HP, 2012, AM J TROP MED HYG, V87, P631, DOI 10.4269/ajtmh.2012.12-0335
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization (WHO), 2013, DENGUE B, V36
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
   World Health Organization (WHO), 2017, SEX TRANSM ZIK VIR C
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Zorrilla Carmen D, 2016, Obstet Gynecol Int J, V5, DOI 10.15406/ogij.2016.05.00180
NR 38
TC 0
Z9 0
U1 2
U2 2
PU US AGENCY INT DEVELOPMENT-USAID
PI BALTIMORE
PA US AGENCY INT DEVELOPMENT-USAID, BALTIMORE, MD 00000 USA
SN 2169-575X
J9 GLOB HEALTH-SCI PRAC
JI Glob. Health
PD SEP
PY 2019
VL 7
IS 3
BP 404
EP 417
DI 10.9745/GHSP-D-19-00188
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JY5XX
UT WOS:000504488700006
PM 31558597
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stone, M
   Bakkour, S
   Deng, XT
   Lam, S
   Gao, K
   Linnen, JM
   Munoz-Jordan, JL
   Hecht, LS
   Sabino, E
   Busch, MP
AF Stone, Mars
   Bakkour, Sonia
   Deng, Xutao
   Lam, Sally
   Gao, Kui
   Linnen, Jeffrey M.
   Munoz-Jordan, Jorge L.
   Hecht, Leonie-Sophie
   Sabino, Ester
   Busch, Michael P.
TI Analytical Performance of Donor NAT Screening and Real-Time PCR
   Diagnostic Assays for Detection of Zika Virus RNA
SO TRANSFUSION
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Blood-Banks (AABB)
CY OCT 19-22, 2019
CL San Antonio, TX
SP Amer Assoc Blood Banks
C1 [Stone, Mars; Bakkour, Sonia; Deng, Xutao; Busch, Michael P.] Vitalant Res Inst, San Francisco, CA USA.
   [Lam, Sally] Hlth Sci Author, Singapore, Singapore.
   [Gao, Kui; Linnen, Jeffrey M.] Grifols Diagnost Solut Inc, Emeryville, CA USA.
   [Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Hecht, Leonie-Sophie] Altona Diagnost GmbH, Hamburg, Germany.
   [Sabino, Ester] Univ Sao Paulo, Sao Paulo, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2019
VL 59
SU 3
SI SI
MA OA3-ST2-15
BP 10A
EP 11A
PG 2
WC Hematology
SC Hematology
GA JW1NS
UT WOS:000502826600008
DA 2020-07-08
ER

PT J
AU Stone, M
   Simmons, G
   Lu, K
   Dave, H
   Singh, I
   Montoya, M
   Harris, E
   Ananta, JS
   Wu, GP
   Busch, MP
AF Stone, Mars
   Simmons, Graham
   Lu, Kai
   Dave, Honey
   Singh, Inderdeep
   Montoya, Magelda
   Harris, Eva
   Ananta, Jeyarama S.
   Wu, Guoping
   Busch, Michael P.
TI Dynamics of ZIKV Seroreactivity in Viremic Blood Donors
SO TRANSFUSION
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Blood-Banks (AABB)
CY OCT 19-22, 2019
CL San Antonio, TX
SP Amer Assoc Blood Banks
C1 [Stone, Mars; Lu, Kai; Dave, Honey; Singh, Inderdeep; Busch, Michael P.] Vitalant Res Inst, San Francisco, CA USA.
   [Simmons, Graham] Blood Syst Res Inst, San Francisco, CA USA.
   [Montoya, Magelda; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Ananta, Jeyarama S.] Nirmidas Biotech Inc, Palo Alto, CA USA.
   [Wu, Guoping] BioTechne, Minneapolis, MN USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2019
VL 59
SU 3
SI SI
MA OA4-ST2-15
BP 11A
EP 11A
PG 1
WC Hematology
SC Hematology
GA JW1NS
UT WOS:000502826600009
DA 2020-07-08
ER

PT J
AU Saa, P
   Chiu, C
   Grimm, K
   Yu, GX
   Benjamin, RJ
   Susan, LC
   Stramer, SL
AF Saa, Paula
   Chiu, Charles
   Grimm, Kacie
   Yu, Guixia
   Benjamin, Richard J.
   Susan, Laurence Corash
   Stramer, Susan L.
TI Acute Zika Virus Infection in an Asymptomatic Blood Donor at the Onset
   of the Puerto Rico Epidemic
SO TRANSFUSION
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Blood-Banks (AABB)
CY OCT 19-22, 2019
CL San Antonio, TX
SP Amer Assoc Blood Banks
C1 [Saa, Paula; Grimm, Kacie; Stramer, Susan L.] Amer Red Cross, Washington, DC 20006 USA.
   [Chiu, Charles; Yu, Guixia] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Benjamin, Richard J.; Susan, Laurence Corash] Cerus Corp, Concord, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2019
VL 59
SU 3
SI SI
MA OA1-MN2-15
BP 26A
EP 26A
PG 1
WC Hematology
SC Hematology
GA JW1NS
UT WOS:000502826600046
DA 2020-07-08
ER

PT J
AU Fedyk, CG
   Shahin, G
   Cap, AP
AF Fedyk, Chriselda G.
   Shahin, George
   Cap, Andrew P.
TI Screening of Donated Blood Products for Zika Virus in US Armed Services
   Blood Program Donors
SO TRANSFUSION
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Blood-Banks (AABB)
CY OCT 19-22, 2019
CL San Antonio, TX
SP Amer Assoc Blood Banks
C1 [Fedyk, Chriselda G.; Cap, Andrew P.] US Army, Inst Surg Res, Ft Sam Houston, TX 78234 USA.
   [Shahin, George] San Antonio Mil Med Ctr, San Antonio, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2019
VL 59
SU 3
SI SI
MA P-BB-41
BP 54A
EP 55A
PG 2
WC Hematology
SC Hematology
GA JW1NS
UT WOS:000502826600116
DA 2020-07-08
ER

PT J
AU Staunton, KM
   Usher, L
   Prachar, T
   Ritchie, SA
   Snoad, N
   Johnson, BJ
AF Staunton, Kyran M.
   Usher, Lili
   Prachar, Tim
   Ritchie, Scott A.
   Snoad, Nigel
   Johnson, Brian J.
TI A NOVEL METHODOLOGY FOR RECORDING WING BEAT FREQUENCIES OF UNTETHERED
   MALE AND FEMALE AEDES AEGYPTI
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; dengue; wing beat frequency; Wolbachia; Zika
ID FLIGHT-TONE; DIPTERA-CULICIDAE; HARMONIC CONVERGENCE; ANOPHELES-GAMBIAE;
   ACOUSTIC-SIGNALS; PUERTO-RICO; BODY-SIZE; TEMPERATURE; INSECTS;
   POPULATIONS
AB Aedes aegypti is a vector of many significant arboviruses worldwide, including dengue, Zika, chikungunya, and yellow fever viruses. With vector control methodology pivoting toward rearing and releasing large numbers of insects for either population suppression or virus-blocking, economical remote (sentinel) surveillance methods for release tracking become increasingly necessary. Recent steps in this direction include advances in optical sensors that identify and classify insects based on their wing beat frequency (WBF). As these traps are being developed, there is a strong need to better understand the environmental and biological factors influencing mosquito WBFs. Here, we developed new untethered-subject methodology to detect changes in WBFs of male and female Ae. aegypti. This new methodology involves directing an ultrasonic transducer at a free-flying subject and measuring the Doppler shift of the reflected ultrasonic continuous wave signal. This system's utility was assessed by determining its ability to confirm previous reports on the effect of temperature, body size, and age on the WBFs generated from acoustic or optical-based experiments. The presented ultrasonic method successfully detected expected trends for each factor for both male and female Ae. aegypti without the need for subject manipulation and potential impediment of natural flight dynamics due to tethering. As a result, this ultrasonic methodology provides a new method for understanding the environmental and physiological determinants of male and female WBFs that can inform the design of remote mosquito surveillance systems.
C1 [Staunton, Kyran M.; Usher, Lili; Ritchie, Scott A.; Johnson, Brian J.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.
   [Staunton, Kyran M.; Usher, Lili; Ritchie, Scott A.; Johnson, Brian J.] James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
   [Prachar, Tim; Snoad, Nigel] Verily Life Sci, 259 East Grand Ave, San Francisco, CA 94080 USA.
RP Staunton, KM (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.; Staunton, KM (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
OI Staunton, Kyran/0000-0001-6812-3320
CR Aldersley A, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1007
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Arthur BJ, 2014, J ACOUST SOC AM, V135, P933, DOI 10.1121/1.4861233
   Balestrino F, 2016, ACTA TROP, V164, P448, DOI 10.1016/j.actatropica.2016.09.002
   Batista GE, 2011, 2011 10 INT C MACH L
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   BROGDON WG, 1994, J MED ENTOMOL, V31, P700, DOI 10.1093/jmedent/31.5.700
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cator LJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1914-6
   Cator LJ, 2011, ANIM BEHAV, V82, P627, DOI 10.1016/j.anbehav.2011.07.013
   Cator LJ, 2011, J MED ENTOMOL, V48, P941, DOI 10.1603/ME11019
   Cator LJ, 2010, BEHAV ECOL, V21, P1033, DOI 10.1093/beheco/arq087
   Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541
   Chen YP, 2014, J INSECT BEHAV, V27, P657, DOI 10.1007/s10905-014-9454-4
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Costello RA, 1974, THESIS
   de Silva P, 2015, ANIM BEHAV, V103, P45, DOI 10.1016/j.anbehav.2015.02.002
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   FULL RJ, 1990, J EXP BIOL, V148, P129
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Johnson BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201709
   Johnson BJ, 2016, J MED ENTOMOL, V53, P245, DOI 10.1093/jme/tjv165
   MOORE A, 1986, J ECON ENTOMOL, V79, P1703, DOI 10.1093/jee/79.6.1703
   Mukundarajan H, 2017, ELIFE, V6, DOI 10.7554/eLife.27854
   Potamitis I, 2015, IEEE SENS J, V15, P4621, DOI 10.1109/JSEN.2015.2424924
   Raman DR, 2007, T ASABE, V50, P1481, DOI 10.13031/2013.23606
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P719, DOI 10.1016/0022-1910(68)90230-8
   ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P1251, DOI 10.1016/0022-1910(68)90018-8
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SOTAVALTA O, 1952, NATURE, V170, P1057, DOI 10.1038/1701057a0
   Stone CM, 2013, J MED ENTOMOL, V50, P723, DOI 10.1603/ME13023
   Tischner H., 1955, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V1954, P453
   Tripet F, 2004, J MED ENTOMOL, V41, P375, DOI 10.1603/0022-2585-41.3.375
   UNWIN DM, 1984, PHYSIOL ENTOMOL, V9, P115, DOI 10.1111/j.1365-3032.1984.tb00687.x
   Villarreal SM, 2017, J MED ENTOMOL, V54, P1116, DOI 10.1093/jme/tjx079
   Wang R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01616-4
   Wekesa JW, 1998, PHYSIOL ENTOMOL, V23, P289, DOI 10.1046/j.1365-3032.1998.233087.x
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
NR 42
TC 0
Z9 0
U1 0
U2 0
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2019
VL 35
IS 3
BP 169
EP 177
DI 10.2987/18-6799.1
PG 9
WC Entomology
SC Entomology
GA JT2EY
UT WOS:000500810200002
PM 31647706
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Obregon, JA
   Ximenez, MA
   Villalobos, EE
   de Valdez, MRW
AF Obregon, Joel A.
   Ximenez, Michelle A.
   Villalobos, Estefany E.
   de Valdez, Megan R. Wise
TI VECTOR MOSQUITO SURVEILLANCE USING CENTERS FOR DISEASE CONTROL AND
   PREVENTION AUTOCIDAL GRAVID OVITRAPS IN SAN ANTONIO, TEXAS
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Culex quinquefasciatus; geographic
   distribution; urban
ID WEST NILE VIRUS; AEDES-AEGYPTI; BORNE DISEASE; BG-SENTINEL; TRAP; URBAN;
   DENGUE; OVIPOSITION; RISK
AB Mosquito surveillance in large urban areas of the southern USA that border Mexico has become increasingly important due to recent transmission of Zika virus and chikungunya virus in the Americas as well as the continued threat of dengue and West Nile viruses. The vectors of these viruses, Aedes aegypti, Ae. albopictus, and Culex quinquefasciatus, co-occur in residential areas, requiring vector control entities to deploy several different trap types, often expensive and labor-intensive, to surveil these ecologically different species. We evaluated the use of a single trap type, the US Centers for Disease Control and Prevention autocidal gravid ovitraps (AGOs), to monitor all 3 vector species across residential neighborhoods in San Antonio, TX, over 12 wk (epiweeks 24-35). Mosquito abundance was highest early in our surveillance period (epiweek 25) and was driven largely by Cx. quinquefasciatus. The AGOs collected significantly more Cx. quinquefasciatus than both Aedes species, with more Ae. aegypti collected than Ae. albopictus. The average number of Ae. aegypti captured per trap was consistent across most neighborhoods except for 2 areas where one had significantly the highest and the other with the lowest mosquitoes collected per trap. The average number of Ae. albopictus captured per trap varied with no clear pattern, and Cx. quinquefasciatus were trapped most often near forested hill country neighborhoods. These results indicate that AGOs are appropriate for detecting and tracking the relative abundance of Ae. aegypti, Ae. albopictus, and Cx. quinquefasciatus across a large and diverse urban landscape over time and therefore may be an inexpensive and streamlined option for vector surveillance programs in large cities.
C1 [Obregon, Joel A.; Ximenez, Michelle A.; Villalobos, Estefany E.; de Valdez, Megan R. Wise] Texas A&M Univ San Antonio, Dept Sci & Math, Program Biol, One Univ Way, San Antonio, TX 78224 USA.
RP de Valdez, MRW (corresponding author), Texas A&M Univ San Antonio, Dept Sci & Math, Program Biol, One Univ Way, San Antonio, TX 78224 USA.
FU US Department of Energy by Lawrence Livermore National LaboratoryUnited
   States Department of Energy (DOE) [DE-AC52-07NA27344]; City of San
   Antonio Metropolitan Health District
FX We thank Gilberto Felix and Roberto Barrera for providing the CDC AGOs.
   We also thank the summer field team of undergraduate researchers: Ariana
   Alvarez, Jessica Buitron, Joshua Darden, Trina Fenning, Jonathan
   Hernandez, Alejandra Moya, and Crystal Serrano. We also thank Gabriel
   Hamer for advice on residential field collections. This research was
   supported, in part, by the US Department of Energy by Lawrence Livermore
   National Laboratory under contract DE-AC52-07NA27344 and the City of San
   Antonio Metropolitan Health District.
CR Barrera R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2596-4
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P358, DOI 10.2987/13-6343.1
   BURKETT-CADENA N. D., 2013, MOSQUITOES SE UNITED
   Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x
   Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1
   Cilek JE, 2017, J AM MOSQUITO CONTR, V33, P103, DOI 10.2987/16-6628.1
   City of San Antonio, 2018, HISTORIC DISTRICTS S
   Clements A. N, 1999, BIOL MOSQUITOES VOLU, V2
   Cornel Anthony J, 2016, F1000Res, V5, P194, DOI 10.12688/f1000research.8107.2
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   de Valdez MRW, 2017, J VECTOR ECOL, V42, P184, DOI 10.1111/jvec.12254
   Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Florida R., 2015, SEGREGATED CITY GEOG
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Griffith G. E., 2007, ECOREGIONS OF TEXAS
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Leisnham PT, 2014, PLOS ONE, V9
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   ROZEBOOM LE, 1973, J MED ENTOMOL, V10, P397, DOI 10.1093/jmedent/10.4.397
   Sivagnaname N, 2012, INDIAN J MED RES, V136, P739
   Tedesco C, 2010, HEALTH PLACE, V16, P1188, DOI 10.1016/j.healthplace.2010.08.003
   TEMPELIS CH, 1970, AM J TROP MED HYG, V19, P335, DOI 10.4269/ajtmh.1970.19.335
   TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543
   United States Census Bureau, 2019, FAST GROW CIT PRIM S
   United States Census Bureau, 2019, US CENS BUR QUICK FA
   Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1
   Weather Underground, 2018, WEATH S CIT SAN ANT
   Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003
   Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2
NR 37
TC 0
Z9 0
U1 1
U2 1
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2019
VL 35
IS 3
BP 178
EP 185
DI 10.2987/18-6809.1
PG 8
WC Entomology
SC Entomology
GA JT2EY
UT WOS:000500810200003
PM 31647715
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Garcia-Luna, SM
   Chaves, LF
   Juarez, JG
   Bolling, BG
   Rodriguez, A
   Presas, YE
   Mutebi, JP
   Weaver, SC
   Badillo-Vargas, IE
   Hamer, GL
   Qualls, WA
AF Garcia-Luna, Selene M.
   Fernando Chaves, Luis
   Juarez, Jose G.
   Bolling, Bethany G.
   Rodriguez, Arturo
   Presas, Ysaias E.
   Mutebi, John-Paul
   Weaver, Scott C.
   Badillo-Vargas, Ismael E.
   Hamer, Gabriel L.
   Qualls, Whitney A.
TI FROM SURVEILLANCE TO CONTROL: EVALUATION OF A LARVICIDE INTERVENTION
   AGAINST AEDES AEGYPTI IN BROWNSVILLE, TEXAS
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Field evaluation; larvicide; mosquito abundance; surveillance; wide-area
   larvicide
ID PIPIENS-QUINQUEFASCIATUS SAY; SEASONAL-CHANGES; POPULATION; CULICIDAE;
   DIPTERA
AB South Texas is recognized as a potential area for the emergence and re-emergence of mosquito-borne diseases due to recent circulation of Zika, chikungunya, and dengue viruses. During 2017, high Aedes aegypti abundance found in the city of Brownsville, TX, in combination with the previous year's local transmission of Zika virus, triggered the activation of the Texas Department of State Health Services Emergency Mosquito Control Contingency Contract. A contract with the Clarke Environmental and Mosquito Control was a response to control Ae. aegypti, using a ground-based wide-area larvicide spray (WALS (TM)) containing Bacillus thuringiensis israelensis. The WALS application was evaluated through a field-based bioassay and by comparing surveillance data pre- and post-WALS application. The WALS application bioassay demonstrated that the larvicide was effective up to 60 m into the target properties. Additionally, the number of Ae. aegypti captured in traps decreased in the WALS intervention areas compared with the untreated control areas, with an estimated 29% control.
C1 [Garcia-Luna, Selene M.; Juarez, Jose G.; Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Fernando Chaves, Luis] Inst Costarricense Invest & Ensenanza Nutr & Salu, Tres Rios 42250, Cartago, Costa Rica.
   [Bolling, Bethany G.] Texas Dept State Hlth Serv, Arbovirus Entomol Lab, Austin, TX 78756 USA.
   [Rodriguez, Arturo; Presas, Ysaias E.] City Brownsville Publ Hlth Dept, Brownsville, TX 78520 USA.
   [Mutebi, John-Paul] Ctr Dis Control & Prevent CDC, Div Vector Borne Dis, Arbovirus Dis Branch, Ft Collins, CO 80521 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Badillo-Vargas, Ismael E.] Texas A&M AgriLife Res, Dept Entomol, Weslaco, TX 78596 USA.
   [Qualls, Whitney A.] Texas Dept State Hlth Serv, Zoonosis Control Branch, Austin, TX 78756 USA.
   [Garcia-Luna, Selene M.; Juarez, Jose G.; Bolling, Bethany G.; Rodriguez, Arturo; Presas, Ysaias E.; Weaver, Scott C.; Badillo-Vargas, Ismael E.; Hamer, Gabriel L.; Qualls, Whitney A.] Univ Texas Med Branch, Western Gulf Ctr Excellence Vector Borne Dis, Galveston, TX 77755 USA.
RP Qualls, WA (corresponding author), Texas Dept State Hlth Serv, Zoonosis Control Branch, Austin, TX 78756 USA.; Qualls, WA (corresponding author), Univ Texas Med Branch, Western Gulf Ctr Excellence Vector Borne Dis, Galveston, TX 77755 USA.
OI Juarez Valdez, Jose/0000-0002-0583-478X; Garcia-Luna, Selene
   M./0000-0001-8420-5078
FU Centers for Disease Control and Prevention (CDC)United States Department
   of Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK000512]
FX This work was supported by Cooperative Agreement (grant number
   U01CK000512), funded by the Centers for Disease Control and Prevention
   (CDC). Its contents are solely the responsibility of the authors and do
   not necessarily represent the official views of the CDC or the TDSHS.
CR Chaves LF, 2011, B ENTOMOL RES, V101, P633, DOI 10.1017/S0007485310000519
   Chaves LF, 2011, J APPL ENTOMOL, V135, P611, DOI 10.1111/j.1439-0418.2010.01580.x
   Clarke, 2019, BUFFALO TURBINE
   Clarke, 2019, EMERGENCY NATURAL DI
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   HAYES J, 1980, J MED ENTOMOL, V17, P63, DOI 10.1093/jmedent/17.1.63
   HAYES J, 1975, J MED ENTOMOL, V12, P299, DOI 10.1093/jmedent/12.3.299
   HAYES J, 1975, J MED ENTOMOL, V12, P167, DOI 10.1093/jmedent/12.2.167
   Hotez PJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005581
   Nguyen AT, 2012, J MED ENTOMOL, V49, P1328, DOI 10.1603/ME12090
   Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897
   Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031
   USCB [United States Census Bureau], 2018, QUICKFACTS
   WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510
NR 14
TC 0
Z9 0
U1 0
U2 0
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2019
VL 35
IS 3
BP 233
EP 237
DI 10.2987/19-6858.1
PG 5
WC Entomology
SC Entomology
GA JT2EY
UT WOS:000500810200014
PM 31647710
OA Bronze
DA 2020-07-08
ER

PT J
AU Abdul-Ghani, R
   Mahdy, MAK
   Al-Eryani, SMA
   Fouque, F
   Lenhart, AE
   Alkwri, A
   Al-Mikhlafi, AM
   Wilke, ABB
   Thabet, AAQ
   Beier, JC
AF Abdul-Ghani, Rashad
   Mahdy, Mohammed A. K.
   Al-Eryani, Samira M. A.
   Fouque, Florence
   Lenhart, Audrey E.
   Alkwri, Abdulsamad
   Al-Mikhlafi, Abdulsalam M.
   Wilke, Andre B. B.
   Thabet, Ahmed A. Q.
   Beier, John C.
TI Impact of population displacement and forced movements on the
   transmission and outbreaks of Aedes-borne viral diseases: Dengue as a
   model
SO ACTA TROPICA
LA English
DT Review
DE Population displacement; Human forced movement; Aedes-borne disease;
   Dengue
ID PUBLIC-HEALTH PROBLEM; HEMORRHAGIC-FEVER; NORTH QUEENSLAND; CHIKUNGUNYA
   VIRUS; EPIDEMIC DENGUE; ZIKA VIRUS; MOLECULAR EPIDEMIOLOGY; CONCURRENT
   ISOLATION; EMERGENCE; TYPE-2
AB Population displacement and other forced movement patterns following natural disasters, armed conflicts or due to socioeconomic reasons contribute to the global emergence of Aedes-borne viral disease epidemics. In particular, dengue epidemiology is critically affected by situations of displacement and forced movement patterns, particularly within and across borders. In this respect, waves of human movements have been a major driver for the changing epidemiology and outbreaks of the disease on local, regional and global scales. Both emerging dengue autochthonous transmission and outbreaks in countries known to be non-endemic and co-circulation and hyperendemicity with multiple dengue virus serotypes have led to the emergence of severe disease forms such as dengue hemorrhagic fever and dengue shock syndrome. This paper reviews the emergence of dengue outbreaks driven by population displacement and forced movements following natural disasters and conflicts within the context of regional and sub-regional groupings.
C1 [Abdul-Ghani, Rashad; Mahdy, Mohammed A. K.; Al-Eryani, Samira M. A.; Al-Mikhlafi, Abdulsalam M.] Sanaa Univ, Fac Med & Hlth Sci, Dept Parasitol, Sanaa, Yemen.
   [Abdul-Ghani, Rashad; Mahdy, Mohammed A. K.] Univ Sci & Technol, Fac Med & Hlth Sci, Trop Dis Res Ctr, Sanaa, Yemen.
   [Fouque, Florence] WHO, UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.
   [Lenhart, Audrey E.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis, Atlanta, GA USA.
   [Lenhart, Audrey E.] US Ctr Dis Control & Prevent, Malaria Entomol Branch, Atlanta, GA USA.
   [Alkwri, Abdulsamad] Minist Publ Hlth & Populat, Integrated Vector Management Unit, Natl Malaria Control Programme, Sanaa, Yemen.
   [Wilke, Andre B. B.; Beier, John C.] Miller Sch Med, Univ Miami, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Thabet, Ahmed A. Q.] WHO Off, Neglected Trop Dis & Pandem Influenza Preparednes, Sanaa, Yemen.
   [Al-Eryani, Samira M. A.] WHO, Reg Off Eastern Mediterranean, Cairo, Egypt.
RP Abdul-Ghani, R (corresponding author), Sanaa Univ, Fac Med & Hlth Sci, Dept Parasitol, Sanaa, Yemen.
EM rashadqb@yahoo.com
RI Wilke, Andre B B/J-9973-2014; Abdul-Ghani, Rashad/N-3289-2013; Mahdy,
   Mohammed/C-1187-2010
OI Wilke, Andre B B/0000-0002-6629-7666; Abdul-Ghani,
   Rashad/0000-0001-7181-1108; Mahdy, Mohammed/0000-0002-8340-5219;
   Lenhart, Audrey/0000-0002-9156-4228
FU World Health OrganizationWorld Health Organization [001]
CR Falcon-Lezama JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172313
   Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Ali A, 2013, INT J INFECT DIS, V17, pE518, DOI 10.1016/j.ijid.2013.01.007
   Amarasinghe A, 2012, T ROY SOC TROP MED H, V106, P1, DOI 10.1016/j.trstmh.2011.08.014
   [Anonymous], 2016, LANCET, V387, P1348, DOI 10.1016/S0140-6736(16)30116-7
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosa HK, 2014, INT J INFECT DIS, V21, P3, DOI 10.1016/j.ijid.2014.03.412
   BOTROS BAM, 1989, J MED VIROL, V29, P79, DOI 10.1002/jmv.1890290202
   Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0
   Carballo M, 2008, FORCED MIGRATION, V31, P32
   CAREY DE, 1971, LANCET, V1, P105
   Center for Disease Control and Prevention (CDC), 2014, DENG EP
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10
   Chaparro PE, 2014, REV PANAM SALUD PUBL, V36, P197
   Chastel C, 2009, B ACAD NAT MED PARIS, V193, P485, DOI 10.1016/S0001-4079(19)32598-1
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   CHUNGUE E, 1995, J GEN VIROL, V76, P1877, DOI 10.1099/0022-1317-76-7-1877
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Gautret P., 2010, EUROSURVEILLANCE, V15, P152
   Gill J, 2000, EMERG INFECT DIS, V6, P30
   Gjenero-Margan I, 2011, EURO SURVEILL, V16
   Gorlick B., 2007, ENV DISPLACED PERSON
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Griffiths M, 1997, Commun Dis Intell, V21, P33
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler D J, 1987, P R Health Sci J, V6, P107
   Gubler D.J., 1997, DENGUE DENGUE HAEMOR, P1
   GUBLER DJ, 1993, INFECT AGENT DIS, V2, P383
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guimaraes MHE, 2012, ECOL SOC, V17, DOI 10.5751/ES-05318-170338
   Guzman M G, 1984, Bull Pan Am Health Organ, V18, P213
   Guzman Maria, 2004, Expert Rev Vaccines, V3, P511, DOI 10.1586/14760584.3.5.511
   GUZMAN MG, 1995, AM J TROP MED HYG, V52, P241, DOI 10.4269/ajtmh.1995.52.241
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P635, DOI 10.4269/ajtmh.1980.29.635
   Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292
   HAMMON WM, 1964, AM J TROP MED HYG, V13, P629, DOI 10.4269/ajtmh.1964.13.629
   HAMMON WM, 1973, AM J TROP MED HYG, V22, P82, DOI 10.4269/ajtmh.1973.22.82
   HAMMON WM, 1960, T ASSOC AM PHYSICIAN, V73, P140
   Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1
   Hanna J., 1995, Communicable Diseases Intelligence, V19, P447
   Hanna JN, 2006, AUST NZ J PUBL HEAL, V30, P220, DOI 10.1111/j.1467-842X.2006.tb00861.x
   Hanna JN, 2009, COMMUN DIS INTELL, V33, P32
   Hanna JN, 1998, MED J AUSTRALIA, V168, P221, DOI 10.5694/j.1326-5377.1998.tb140134.x
   Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Hotta S., 2000, Japanese Journal of Tropical Medicine and Hygiene, V28, P369
   Huang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081887
   IRIN, 2010, COT IVO YELL FEV DEN
   Jelinek T, 2009, EURO SURVEILL, V14
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Kanesa-thasan N, 1998, EMERG INFECT DIS, V4, P299, DOI 10.3201/eid0402.980220
   KANESATHASAN N, 1994, LANCET, V343, P678, DOI 10.1016/S0140-6736(94)92678-6
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Khan NA, 2008, ACTA TROP, V105, P39, DOI 10.1016/j.actatropica.2007.09.005
   Kimura R., 1943, NIPPON IGAKU, V3344, P1378
   Kitchener S, 2002, J TRAVEL MED, V9, P180, DOI 10.2310/7060.2002.24234
   Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]
   Kouri G, 1986, Bull Pan Am Health Organ, V20, P24
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   LopezVelez R, 1996, EUR J CLIN MICROBIOL, V15, P823, DOI 10.1007/BF01701528
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mackenzie JS, 1999, EMERG INFECT DIS, V5, P1, DOI 10.3201/eid0501.990101
   Mears E.G., 1929, GREECE TODAY AFTERMA
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Moise IK, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2833-5
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   NEFF JM, 1967, AM J EPIDEMIOL, V86, P162, DOI 10.1093/oxfordjournals.aje.a120722
   Nisii C., 2010, EURO SURVEILL, V15
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Pan American Health Organization, 1979, 1977 P WORKSH MONT B
   Pan American Health Organization WHO, 2007, NUMB REP CAS DENG DE
   PAPAEVANGELOU G, 1977, J TROP MED HYG, V80, P46
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Rawlings JA, 1998, AM J TROP MED HYG, V59, P95, DOI 10.4269/ajtmh.1998.59.95
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Ritchie S., 1995, Communicable Diseases Intelligence, V19, P366
   Rivera-Osorio P, 2011, J CLIN MICROBIOL, V49, P3370, DOI 10.1128/JCM.00950-11
   ROBINSON M C, 1956, Cent Afr J Med, V2, P394
   Roesel TR, 2005, NEW ENGL J MED, V353, P2512
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Seet RCS, 2005, J CLIN VIROL, V33, P336, DOI 10.1016/j.jcv.2005.03.002
   Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775
   SHARP TW, 1995, AM J TROP MED HYG, V53, P89, DOI 10.4269/ajtmh.1995.53.89
   Shin DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074904
   Shortus M, 2016, WEST PAC SURVEILL RE, V7, P38, DOI 10.5365/wpsar.2015.6.3.004
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Snow GE, 2014, AM J TROP MED HYG, V91, P1203, DOI 10.4269/ajtmh.14-0132
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Strauss EG, 2008, VIRUSES HUMAN DIS
   Teichmam D, 1999, EUR J CLIN MICROBIOL, V18, P310, DOI 10.1007/s100960050285
   THEILER M, 1960, P SOC EXP BIOL MED, V103, P244, DOI 10.3181/00379727-103-25474
   Thonnon J, 1999, B SOC PATHOL EXOT, V92, P79
   TRENT DW, 1983, VIROLOGY, V128, P271, DOI 10.1016/0042-6822(83)90255-6
   Trofa AF, 1997, JAMA-J AM MED ASSOC, V277, P1546, DOI 10.1001/jama.277.19.1546
   Tsuzuki A, 2014, TROP BIOMED, V31, P698
   United Nations High Commissioner for Refugees, 2016, TOT INT DISPL PERS
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Vazquez-Prokopec GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-68
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2014, QUEST ANSW DENG VACC
   Yonetani M., 2016, WMO B, V65, P1
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zaki A, 2008, TROP MED INT HEALTH, V13, P584, DOI 10.1111/j.1365-3156.2008.02037.x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
NR 137
TC 1
Z9 1
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2019
VL 197
AR UNSP 105066
DI 10.1016/j.actatropica.2019.105066
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JS3AU
UT WOS:000500182400038
PM 31226251
DA 2020-07-08
ER

PT J
AU Lima, MED
   Bachur, TPR
   Aragao, GF
AF de Sousa Lima, Matheus Eugenio
   Rodrigues Bachur, Tatiana Paschoalette
   Aragao, Gislei Frota
TI Guillain-Barre syndrome and its correlation with dengue, Zika and
   chikungunya viruses infection based on a literature review of reported
   cases in Brazil
SO ACTA TROPICA
LA English
DT Review
DE Guillain-Barre syndrome; Zika virus; Dengue fever; Chikungunya
ID COLOMBIA; DISEASE
AB Guillain-Barre syndrome (GBS) is one of the main neurologic manifestations of arboviruses, especially Zika virus infection. As known, the prevalence of these diseases is high, so the risk of having an increase on GBS is relevant. The study purposes making a comparative survey between the involvement of dengue, Zika and chikungunya infections in the development of the GBS in Brazil, as well as search in literature resemblances and distinctions between beforehand reported cases. It was performed an electronic search in online databases, with articles published between the years of 2004-2018. A total of 729 articles about the proposed search were found, and 10 were selected according to inclusion and exclusion criteria. The medium age found in Brazilian studies was 429. The time lapse for the neurological symptoms manifest was 6,5-11 days. Facial palsy, paresthesia and member weakness were the main symptoms related. Pediatric cases are rare. There are many studies that implicated the association of GBS and arboviruses and point it to one of the main neurological manifestation of these infections. More research and consistent data are needed to clarify unanswered questions and guide public health measures.
C1 [de Sousa Lima, Matheus Eugenio; Rodrigues Bachur, Tatiana Paschoalette; Aragao, Gislei Frota] Univ Estadual Ceara, Curso Med, Campus Itaperi,Av Dr Silas Munguba 1700, BR-60714903 Fortaleza, Ceara, Brazil.
   [Aragao, Gislei Frota] Univ Fed Ceara, Fac Med, Nucleo Pesquisa & Desenvolvimento Med, Campus Porangabussu,Rua Cel Nunes de Melo 1000, BR-60430275 Fortaleza, Ceara, Brazil.
RP Aragao, GF (corresponding author), Univ Fed Ceara, Fac Med, Nucleo Pesquisa & Desenvolvimento Med, Campus Porangabussu,Rua Cel Nunes de Melo 1000, BR-60430275 Fortaleza, Ceara, Brazil.
EM matheus.eugenio@aluno.uece.br; tatiana.bachur@uece.br;
   gislei.frota@uece.br
CR Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Braunwald F., 2008, HARRISON MED INTERNA, VI, DOI [10.1111/j.1445-5994.2008.01837.x, DOI 10.1111/J.1445-5994.2008.01837.X]
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Vieira MADES, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759022, 10.1590/S1678-9946201759022]
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Estofolete CF, 2019, J INFECT PUBLIC HEAL, V12, P178, DOI 10.1016/j.jiph.2018.09.007
   Fragoso YD, 2016, ARQ NEURO-PSIQUIAT, V74, P1039, DOI [10.1590/0004-282X20160161, 10.1590/0004-282x20160161]
   Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009
   Leao JC, 2018, ORAL DIS, V24, P233, DOI 10.1111/odi.12777
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pastula DM, 2017, J NEUROL SCI, V372, P350, DOI 10.1016/j.jns.2016.08.064
   Proenca-Modena J.L., 2018, MICROBES INFECT, VS128604579, DOI [10.1016/j.micinf.2018.02.008.30052-2, DOI 10.1016/J.MICINF.2018.02.008.30052-2]
   Rodriguez Y, 2018, CELL MOL IMMUNOL, V15, P547, DOI 10.1038/cmi.2017.142
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Soares CN, 2008, ARQ NEURO-PSIQUIAT, V66, P234, DOI 10.1590/S0004-282X2008000200018
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   Uncini A, 2018, EUR J NEUROL, V25, P644, DOI 10.1111/ene.13552
   Veronesi R., 2005, TRATADO INFECTOLOGIA
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
NR 31
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2019
VL 197
AR UNSP 105064
DI 10.1016/j.actatropica.2019.105064
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JS3AU
UT WOS:000500182400035
PM 31220435
DA 2020-07-08
ER

PT J
AU dos Reis, IC
   Gibson, G
   Ayllon, T
   Tavares, AD
   de Araujo, JMG
   Monteiro, ED
   Aguiar, AR
   de Oliveira, JV
   de Paiva, AAP
   Pereira, HWB
   Monteiro, JD
   Carvalho, MS
   Sabroza, PC
   Honorio, NA
   Siqueira, AS
   Nobre, AD
   de Almeida, AS
   da Silva, BB
   Camara, DCP
   Silva, DRX
   Barroso, E
   Praca, HLF
   Albuquerque, HG
   dos Santos, JPC
   Pereira, LHV
   Alves, MB
   Mayrink, MC
   Bruno, PRD
   Erbisti, RS
   Simoes, TC
   de Matos, VP
   Vanlerberghe, V
AF dos Reis, Izabel Cristina
   Gibson, Gerusa
   Ayllon, Tania
   Tavares, Alessandre de Medeiros
   Galvao de Araujo, Joselio Maria
   Monteiro, Elias da Silva
   Aguiar, Amanda Rodrigues
   de Oliveira, Josinaldo Vital
   Pereira de Paiva, Anne Aline
   Bezerra Pereira, Hannaly Wana
   Monteiro, Joelma Dantas
   Carvalho, Marilia Sa
   Sabroza, Paulo Chagastelles
   Honorio, Nildimar Alves
   Siqueira, Alexandre San Pedro
   Nobre, Aline de Araujo
   de Almeida, Andrea Sobral
   da Silva, Bianca Borges
   Portela Camara, Daniel Cardoso
   Xavier Silva, Diego Ricardo
   Barroso, Elaine
   Ferreira Praca, Heitor Levy
   Albuquerque, Hermano Gomes
   Caldas dos Santos, Jefferson Pereira
   Vouga Pereira, Leandro Henrique
   Alves, Mariane Branco
   Mayrink, Manoel Caetano
   de Abreu Bruno, Paulo Roberto
   Erbisti, Rafael Santos
   Simoes, Taynana Cesar
   de Matos, Vanderlei Pascoal
   Vanlerberghe, Veerle
CA ARBOALVO Network
TI Entomo-virological surveillance strategy for dengue, Zika and
   chikungunya arboviruses in field-caught Aedes mosquitoes in an endemic
   urban area of the Northeast of Brazil
SO ACTA TROPICA
LA English
DT Article
DE Entomo-virological surveillance; Arboviruses; Aedes spp.; DENV-3;
   Key-sites
ID RIO-DE-JANEIRO; GRANDE-DO-NORTE; AEGYPTI DIPTERA; ALBOPICTUS SKUSE;
   VIRUS DETECTION; STATE; CULICIDAE; IDENTIFICATION; TRANSMISSION;
   OUTBREAK
AB Aedes spp. are considered the main vectors of dengue (DENV), Zika (ZIKV) and chikungunya (CHIKV) viruses in the world. Arbovirus detection in Aedes mosquitoes can alert authorities to possible outbreaks, reducing the impact of these diseases. The purpose of this study was to perform an operational strategy for virological surveillance of DENV, ZIKV and CHIKV in adult Aedes aegypti and Aedes albopictus mosquitoes captured at different key-sites in an endemic urban area of the Northeast Region of Brazil, with the prospect of discussing its role as part of an alert system for outbreaks in critical areas. Residential and non-residential premises located in areas of recent of transmission of these arboviruses were selected for adult mosquito collection in the rainy season (July) of 2018. A total of 1068 adult mosquitoes were collected: 946 Culex quinquefasciatus (88.6%), 118 Ae. aegypti (11.0%), two Ae. albopictus (0.2%) and two Aedes taeniorhynchus (0.2%). Among the premises surveyed, recycling points (N= 48, 40.7%), municipal schools (N= 36, 30.5%) and junkyards (N= 31, 26.2%) were the places with the highest frequency of adult Ae. aegypti. Health units (including primary health care facilities and one hospital) (N= 23; 19.5%) together with residential premises (N= 11; 9.3%) presented the lowest frequencies. Total RNAs of the samples were extracted from Aedes mosquitoes and a nested reverse transcription (RT) polymerase chain reaction (PCR) assay for detecting and typing DENV, ZIKV and CHIKV was performed. From the 37 Aedes spp. pools analyzed (35 Ae. aegypti, one Ae. albopictus and one Ae. taeniorhynchus), seven were positive for DENV-3, including three pools containing Ae. aegypti females, one containing an Ae. aegypti engorged female and three comprised of Ae. aegypti males. The positive pools were composed of mosquitoes collected in public schools, health units, junkyards, recycling points and residential premises. Our findings reinforce the importance of continuous virological surveillance in Aedes mosquitoes, as a useful tool for detecting arboviruses circulation in vulnerable areas, even in low infestation seasons.
C1 [dos Reis, Izabel Cristina; Honorio, Nildimar Alves] Fiocruz MS, Fundacao Oswald Cruz, LATHEMA, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [dos Reis, Izabel Cristina; Ayllon, Tania; Honorio, Nildimar Alves] Fiocruz MS, Fundacao Oswaldo Cruz, Nosmove, Nucl Operac Sentinela Mosquitos Vetores, Rio De Janeiro, RJ, Brazil.
   [Gibson, Gerusa] Univ Fed Rio de Janeiro, IESC, Av Horatio de Macedo S-N,Cidade Univ, Rio De Janeiro, Brazil.
   [Tavares, Alessandre de Medeiros; Monteiro, Elias da Silva; Aguiar, Amanda Rodrigues; de Oliveira, Josinaldo Vital] Secretaria Municipal Saude Natal, Ctr Controle Zoonoses, Natal, RN, Brazil.
   [Galvao de Araujo, Joselio Maria; Pereira de Paiva, Anne Aline; Bezerra Pereira, Hannaly Wana; Monteiro, Joelma Dantas] Univ Fed Rio Grande do Norte, UFRN, Lab Biol Mol Doencas Infecciosas & Canc, Natal, RN, Brazil.
   [Galvao de Araujo, Joselio Maria; Monteiro, Joelma Dantas] Univ Fed Rio Grande do Norte, Inst Med Trop, Lab Virol, UFRN, Natal, RN, Brazil.
   [Carvalho, Marilia Sa] Fiocruz MS, Fundacao Oswaldo Cruz, Programa Comp Cient PROCC, Rio De Janeiro, RJ, Brazil.
   [Sabroza, Paulo Chagastelles] Fiocruz MS, Fundacao Oswaldo Cruz, ENSP, Rio De Janeiro, RJ, Brazil.
RP Gibson, G; Honorio, NA (corresponding author), Univ Fed Rio de Janeiro, IESC, Av Horatio de Macedo S-N,Cidade Univ, Rio De Janeiro, Brazil.
EM gibson.gerusa@iesc.ufrj.br; honorio@ioc.fiocruz.br
RI CARVALHO, MARILIA/AAD-8283-2020; Santiago, Tania Ayllon/B-2543-2019;
   Araujo, Joselio M G/B-5502-2013
OI CARVALHO, MARILIA/0000-0002-9566-0284; Santiago, Tania
   Ayllon/0000-0002-1195-5078; Araujo, Joselio M G/0000-0003-3548-2786
FU ARBOALVO Project [TED 90/2016]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPqNational Council for Scientific and
   Technological Development (CNPq) [404904/2016-5]
FX This work was supported by the ARBOALVO Project (TED 90/2016) and the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
   (grant nr. 404904/2016-5).
CR Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Barbosa IR, 2017, EPIDEMIOL SERV SAUDE, V26, P629, DOI 10.5123/S1679-49742017000300020
   Barbosa IR, 2012, EPIDEMIOL SERV SAUDE, V21, P149, DOI 10.5123/S1679-49742012000100015
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Barroso A.V., 2003, MAPEANDO QUALIDADE V
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Branco MSD, 2015, TROP MED INT HEALTH, V20, P1707, DOI 10.1111/tmi.12612
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   Choochote Wej, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P745
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Farraudiere L, 2017, REV PANAM SALUD PUBL, V41
   Favaro EA, 2013, REV SAUDE PUBL, V47, P588, DOI 10.1590/S0034-8910.2013047004506
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Lagrotta MT, 2008, CAD SAUDE PUBLICA, V24, P70, DOI 10.1590/S0102-311X2008000100007
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Ferreira-de-Lima VH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2643-9
   Gomes AD, 2008, EPIDEMIOL SERV SAUDE, V17, P293
   Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Honorio NA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040353
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Huerta H, 2017, T ROY SOC TROP MED H, V111, P328, DOI 10.1093/trstmh/trx056
   IBGE, 2010, CENS DEM 2010
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   Lau SM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2091-y
   Lau SM, 2015, TROP MED INT HEALTH, V20, P1271, DOI 10.1111/tmi.12555
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   Macedo GA, 2013, T ROY SOC TROP MED H, V107, P141, DOI 10.1093/trstmh/trs091
   Pessanha JEM, 2011, REV SOC BRAS MED TRO, V44
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Medronho RD, 2008, CAD SAUDE PUBLICA, V24, P949
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Pinheiro VCS, 2005, MEM I OSWALDO CRUZ, V100, P833, DOI 10.1590/S0074-02762005000800003
   Reis I.C., 2010, ACTA TROP, V114, P37, DOI [10.1016/j.actatropica.2010.01, DOI 10.1016/J.ACTATROPICA.2010.01]
   Resendes A.P.C., 2009, REV SAUDE PUBL, V44, P274
   Secretaria Municipal de Saude de Natal-Rio Grande do Norte, 2018, SECR MUN SAUD NAT RI
   SEMURB, 2012, CONH MELH SEU BAIRR
   SESAP, 2018, SESAP B EP ARB MON C
   SHROYER DA, 1990, J AM MOSQUITO CONTR, V6, P312
   Sivan A, 2016, ACTA TROP, V156, P122, DOI 10.1016/j.actatropica.2016.01.015
   SMS- Natal, 2019, SMS NAT B ENT ARB, V11
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Thavara U, 2009, SE ASIAN J TROP MED, V40, P951
   Thenmozhi V, 2005, TROP MED INT HEALTH, V10, P187, DOI 10.1111/j.1365-3156.2004.01360.x
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Waldman E.A., 2007, EPIDEMIOL SERV SAUDE, V16, P73
NR 58
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2019
VL 197
AR UNSP 105061
DI 10.1016/j.actatropica.2019.105061
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JS3AU
UT WOS:000500182400032
PM 31194961
DA 2020-07-08
ER

PT J
AU Katz, I
   Gilburd, B
   Shovman, O
AF Katz, Itai
   Gilburd, Boris
   Shovman, Ora
TI Zika autoimmunity and Guillain-Barre syndrome
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE autoantibodies; autoimmunity; Guillain-Barre syndrome; molecular
   mimicry; zika virus
ID MOLECULAR MIMICRY; VIRUS; DISEASES; EPIDEMIOLOGY
AB Purpose of review To summarize the recent data regarding Guillain-Barre syndrome (GBS) as an autoimmune disorder following infection with Zika virus (ZIKV) infection, including the proposed pathogenic mechanisms and the role of autoantibodies. Recent findings The loss of self-tolerance that leads to autoimmune diseases is a multifactorial process that may be illustrated as 'the mosaic of autoimmunity'. Infectious agents may contribute to the development of autoimmunity by several proposed mechanisms. One of the central mechanisms is molecular mimicry, which is also the most plausible mechanism in the case of ZIKV-induced autoimmune disorders. A recent meta-analysis found a low prevalence of GBS associated with ZIKV infection. Nevertheless, the estimated cost of illness for patients with GBS associated with ZIKV are tremendous and exceed 4.7 million dollars per year in Brazil alone. Currently, there is sufficient data to indicate that ZIKV infection is one of many triggers and factors that may contribute to the development GBS. Thus, it is advised to evaluate and determine ZIKV exposure and infection in the management of potential GBS patients.
C1 [Katz, Itai; Gilburd, Boris; Shovman, Ora] Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Hashomer, Israel.
   [Katz, Itai; Gilburd, Boris; Shovman, Ora] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
RP Katz, I (corresponding author), Tel Aviv Univ, Zabludowicz Ctr Autoimmune Dis, Sheba Med Ctr, IL-5265601 Tel Hashomer, Israel.
EM itaikatz1@mail.tau.ac.il
CR Amital H, 2006, SEMIN ARTHRITIS RHEU, V35, P341, DOI 10.1016/j.semarthrit.2005.09.002
   Anaya JM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00139
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Brannagan TH, 2003, J NEUROL SCI, V208, P39, DOI 10.1016/S0022-510X(02)00418-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Guilherme L, 2006, AUTOIMMUNITY, V39, P31, DOI 10.1080/08916930500484674
   Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005
   Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Lucchese G, 2016, AUTOIMMUN REV, V15, P854, DOI 10.1016/j.autrev.2016.04.003
   McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Peixoto HM, 2019, T ROY SOC TROP MED H, V113, P252, DOI 10.1093/trstmh/trz010
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piliero PJ, 2003, CLIN INFECT DIS, V36, pE111, DOI 10.1086/368311
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Rojas M, 2018, J AUTOIMMUN, V95, P100, DOI 10.1016/j.jaut.2018.10.012
   Shapira Y, 2012, CLIN REV ALLERG IMMU, V42, P154, DOI 10.1007/s12016-010-8241-z
   Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724
   Wang LF, 2015, J INTERN MED, V278, P369, DOI 10.1111/joim.12395
   Watad A, 2017, J AUTOIMMUN, V82, P13, DOI 10.1016/j.jaut.2017.06.001
   WILLISON HJ, 1993, J NEUROL NEUROSUR PS, V56, P204, DOI 10.1136/jnnp.56.2.204
   Wiwanitkit V, 2016, AUTOIMMUN REV, V15, P855, DOI 10.1016/j.autrev.2016.04.002
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 27
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD SEP
PY 2019
VL 31
IS 5
BP 484
EP 487
DI 10.1097/BOR.0000000000000629
PG 4
WC Rheumatology
SC Rheumatology
GA JT7EN
UT WOS:000501148600010
PM 31246623
DA 2020-07-08
ER

PT J
AU Dubankova, A
   Boura, E
AF Dubankova, Anna
   Boura, Evzen
TI Structure of the yellow fever NS5 protein reveals conserved drug targets
   shared among flaviviruses
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE RNA; Polymerase; Crystal structure; Flavivirus; Yellow fever; Drug
   design
ID ZIKA-VIRUS NS5; CRYSTAL-STRUCTURE; FEATURES
AB Yellow fever virus (YFV) is responsible for devastating outbreaks of Yellow fever (YF) in humans and is associated with high mortality rates. Recent large epidemics and epizootics and exponential increases in the numbers of YF cases in humans and non-human primates highlight the increasing threat YFV poses, despite the availability of an effective YFV vaccine. YFV is the first human virus discovered, but the structures of several of the viral proteins remain poorly understood. Here we report the structure of the full-length NS5 protein, a key enzyme for the replication of flaviviruses that contains both a methyltransferase domain and an RNA dependent RNA polymerase domain, at 3.1 angstrom resolution. The viral polymerase adopts right-hand fold, demonstrating the similarities of the Yellow fever, Dengue and Zika polymerases. Together this data suggests NS5 as a prime and ideal target for the design of pan-flavivirus inhibitors.
C1 [Dubankova, Anna; Boura, Evzen] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610 6, Czech Republic.
RP Boura, E (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610 6, Czech Republic.
EM boura@uochb.cas.cz
RI ; Dubankova, Anna/M-6168-2017
OI Boura, Evzen/0000-0002-9652-4065; Dubankova, Anna/0000-0002-1181-1867
FU European Regional Development Fund; OP RDE; Project: "Chemical biology
   for drugging undruggable targets (ChemBioDrug)"
   [CZ.02.1.01/0.0/0.0/16_019/0000729]; Academy of Sciences Czech
   RepublicCzech Academy of SciencesCzech Republic Government [RVO:
   61388963]
FX The work was supported from European Regional Development Fund; OP RDE;
   Project: "Chemical biology for drugging undruggable targets
   (ChemBioDrug)" (No. CZ.02.1.01/0.0/0.0/16_019/0000729) and by the
   Academy of Sciences Czech Republic (RVO: 61388963).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841
   Blake LE, 2014, MBIO, V5, DOI 10.1128/mBio.01253-14
   Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653
   Byszewska M, 2014, RNA BIOL, V11, P1597, DOI 10.1080/15476286.2015.1004955
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Dubankova A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17621-6
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferrero DS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007656
   Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272
   Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   Monaghan AJ, 2018, CLIMATIC CHANGE, V146, P487, DOI 10.1007/s10584-016-1679-0
   Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Reed W, 1900, Public Health Pap Rep, V26, P37
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rusanov T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35511-3
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Selisko B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020059
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 48
TC 5
Z9 5
U1 2
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD SEP
PY 2019
VL 169
AR 104536
DI 10.1016/j.antiviral.2019.104536
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9KI
UT WOS:000499934800002
PM 31202975
DA 2020-07-08
ER

PT J
AU Zhang, SN
   Yi, CH
   Li, CF
   Zhang, F
   Peng, JJ
   Wang, Q
   Liu, XL
   Ye, XM
   Li, PC
   Wu, M
   Yan, QH
   Guo, WJ
   Niu, XF
   Feng, LQ
   Pan, WQ
   Chen, L
   Qu, LB
AF Zhang, Shengnan
   Yi, Changhua
   Li, Chufang
   Zhang, Fan
   Peng, Jiaojiao
   Wang, Qian
   Liu, Xinglong
   Ye, Xianmiao
   Li, Pingchao
   Wu, Min
   Yan, Qihong
   Guo, Wenjing
   Niu, Xuefeng
   Feng, Liqiang
   Pan, Weiqi
   Chen, Ling
   Qu, Linbing
TI Chloroquine inhibits endosomal viral RNA release and autophagy-dependent
   viral replication and effectively prevents maternal to fetal
   transmission of Zika virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Chloroquine; Zika virus; Viral RNA release; Autophagy
ID INFECTION; MOUSE; DRUG; TISSUE; CELLS
AB Zika virus (ZIKV) infection can cause neonatal microcephaly and neurological disorders. Currently, there is no designated drug for treating ZIKV infection and preventing neonatal microcephaly. In this study, we evaluated the effect of chloroquine, an anti-malaria drug, in ZIKV infected cells and mouse models. Chloroquine significantly inhibited ZIKV infection in multiple mammalian cell lines. Chloroquine treatment significantly improved the survival of ZIKV-infected 1-day old suckling SCID Beige mice and reduced viremia in adult SCID Beige mice. Importantly, chloroquine protected the fetus from maternal infection by reducing placenta to fetus viral transmission. We found that chloroquine exerts at least two mechanisms in protecting against ZIKV infection: 1) inhibiting endosomal disassembly of the internalized virus and thus reducing the release of viral RNA to the cytoplasm for replication; 2) inhibiting ZIKV RNA replication through blocking ZIKV induced autophagy. Our study suggests that chloroquine treatment warrants to be considered as a mitigation strategy for treating ZIKV infection and preventing ZIKV-associated microcephaly in pregnant women.
C1 [Zhang, Shengnan] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China.
   [Zhang, Shengnan; Yi, Changhua; Zhang, Fan; Wang, Qian; Liu, Xinglong; Ye, Xianmiao; Li, Pingchao; Wu, Min; Yan, Qihong; Guo, Wenjing; Feng, Liqiang; Chen, Ling; Qu, Linbing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Lab Computat Biomed, Guangzhou, Guangdong, Peoples R China.
   [Li, Chufang; Peng, Jiaojiao; Niu, Xuefeng; Pan, Weiqi; Chen, Ling] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, State Key Labs Resp Dis, Guangzhou, Guangdong, Peoples R China.
   [Li, Chufang; Peng, Jiaojiao; Niu, Xuefeng; Pan, Weiqi; Chen, Ling] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.
RP Chen, L; Qu, LB (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China.
EM chen_ling@gibh.ac.cn; qu_linbing@gibh.ac.cn
FU Guangdong Science and Technology Department [2016A020250001]; Guangzhou
   Health Care and Cooperative Innovation Major Project [201704020229];
   State Key Laboratory of Respiratory Disease
FX We thank Qingqing Wang and Zhi Wang for technical support. This work was
   supported by the grant from Guangdong Science and Technology Department
   (No. 2016A020250001), and the Guangzhou Health Care and Cooperative
   Innovation Major Project (No. 201704020229), and the Open Fund from the
   State Key Laboratory of Respiratory Disease.
CR ADELUSI SA, 1982, J PHARM PHARMACOL, V34, P733, DOI 10.1111/j.2042-7158.1982.tb06211.x
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111
   BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gorshkov K, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03252
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hsieh SC, 2014, J BIOL CHEM, V289, P33149, DOI 10.1074/jbc.M114.610428
   Kitchen LW, 2006, CLIN INFECT DIS, V43, P67, DOI 10.1086/504873
   Law I, 2008, BRIT J CLIN PHARMACO, V65, P674, DOI 10.1111/j.1365-2125.2008.03111.x
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   PERCY DH, 1993, LAB ANIM SCI, V43, P127
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   PRASAD RN, 1987, IMMUNOL CELL BIOL, V65, P211, DOI 10.1038/icb.1987.23
   PULLMAN TN, 1948, J CLIN INVEST, V27, P46, DOI 10.1172/JCI101970
   Qin XS, 2014, TOHOKU J EXP MED, V234, P271, DOI 10.1620/tjem.234.271
   Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045
   RODER J, 1979, NATURE, V278, P451, DOI 10.1038/278451a0
   Said A, 2014, J IMMUNOL, V193, P6135, DOI 10.4049/jimmunol.1303276
   Savarino A, 2001, AIDS, V15, P2221, DOI 10.1097/00002030-200111230-00002
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Sperber K, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-9
   Sweiti H, 2017, CURR THER RES CLIN E, V84, P10, DOI 10.1016/j.curtheres.2017.01.007
   Villegas L, 2007, TROP MED INT HEALTH, V12, P209, DOI [10.1111/j.1365-3165.2006.01778.x, 10.1111/j.1365-3156.2006.01778.x]
   Winslow GM, 1998, INFECT IMMUN, V66, P3892, DOI 10.1128/IAI.66.8.3892-3899.1998
NR 39
TC 4
Z9 6
U1 12
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD SEP
PY 2019
VL 169
AR 104547
DI 10.1016/j.antiviral.2019.104547
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA JR9KI
UT WOS:000499934800011
PM 31251958
DA 2020-07-08
ER

PT J
AU Chang, J
   Lee, HY
   Seong, MW
   Kim, MN
   Sung, H
AF Chang, Jeonghyun
   Lee, Hye-Young
   Seong, Moon-Woo
   Kim, Mi-Na
   Sung, Heungsup
TI EXTERNAL QUALITY ASSESSMENT OF MOLECULAR DIAGNOSTICS FOR ZIKA VIRUS AND
   MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IN KOREA
SO SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Article
DE external quality assessment; Middle East respiratory syndrome
   coronavirus; quality control; Zika virus; Korea
ID INACTIVATION
AB In Korea since August 2016, molecular tests for Zika virus and Middle East respiratory syndrome coronavirus (MERS-CoV) have been extended for use in non-governmental medical institutions to prepare for potential emergence of these viruses. The study evaluated reliability of Zika virus and MERS-CoV molecular tests performed by non-governmental medical laboratories. In December 2016, information on participation in a Zika virus and MERS-CoV external quality assessment (EQA) was sent to 36 laboratories performing molecular tests for these viruses. Sensitivity and specificity were tested using five samples of Zika virus and 12 samples of MERS-CoV, each containing a different viral load. Thirty-three laboratories returned their EQA results for Zika virus and 25 for MERS-CoV. For Zika virus assay, 73% of participating laboratories tested both serum and urine samples, and for MERS-CoV, 92% tested lower, or both upper and lower, respiratory tract specimens. There was one false-positive result from Zika virus tests. MERS-CoV EQA results were 96% correct except for one outlier. EQA samples for Zika virus and MERS-CoV tests showed good homogeneity and stability for up to 72 hours at 4 degrees C and eight weeks at -70 degrees C. Although there is still room for improvement with respect to outliers and false-positive results, EQA of Zika virus and MERS-CoV molecular tests in Korea revealed good assay performance. The EQA method used in the study will help laboratories cope with assays of other new pathogens.
C1 [Chang, Jeonghyun; Lee, Hye-Young; Kim, Mi-Na; Sung, Heungsup] Univ Ulsan, Dept Lab Med, Coll Med, Asan Med Ctr, Seoul, South Korea.
   [Seong, Moon-Woo] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Lab Med, Coll Med, Seoul, South Korea.
RP Sung, H (corresponding author), Asan Med Ctr, Dept Lab Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.; Sung, H (corresponding author), Univ Ulsan, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM sung@amc.seoul.kr
FU Korean Center for Disease Control and Prevention; Bio and Medical
   Technology Development Program of the National Research Foundation
   (NRF), Korea; Korean government (MSIP) [NRF-2016M3A9B6918715]; Korean
   government (MOHW)Korean Government [NRF-2016M3A9B6918715]
FX The work was supported by the Korean Center for Disease Control and
   Prevention and the Bio and Medical Technology Development Program of the
   National Research Foundation (NRF), Korea and funded by the Korean
   government (MSIP and MOHW, grant number NRF-2016M3A9B6918715).
CR Abubakar I, 2016, INFECT DIS EPIDEMIOL
   [Anonymous], 2015, SAF TRANSP MAN DOM I
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Kim KH, 2017, J HOSP INFECT, V95, P207, DOI 10.1016/j.jhin.2016.10.008
   Korea Centers for Disease Control and Prevention (KCDC), 2016, GUID MOL DIAGN MIDDL
   Korea Centers for Disease Control and Prevention (KCDC), 2018, PUBL HLTH WEEKL REP
   Leclercq I, 2014, INFLUENZA OTHER RESP, V8, P585, DOI 10.1111/irv.12261
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Pas SD, 2015, J CLIN VIROL, V69, P81, DOI 10.1016/j.jcv.2015.05.022
   Seong MW, 2016, ANN LAB MED, V36, P230, DOI 10.3343/alm.2016.36.3.230
   TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074
NR 14
TC 0
Z9 0
U1 0
U2 0
PU SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION
PI BANGKOK
PA SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND
SN 0125-1562
J9 SE ASIAN J TROP MED
JI Southeast Asian J. Trop. Med. Public Health
PD SEP
PY 2019
VL 50
IS 5
BP 840
EP 847
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
GA JP5MD
UT WOS:000498307700006
DA 2020-07-08
ER

PT J
AU Ferreira, MDL
   Fernandes, DA
   Nunes, FC
   Teles, YCF
   Rolim, YM
   da Silva, CM
   de Albuquerque, JBL
   Agra, MD
   de Souza, MDV
AF Leite Ferreira, Maria Denise
   Fernandes, Diegina A.
   Nunes, Fabiola C.
   Teles, Yanna C. F.
   Rolim, Yngred M.
   da Silva, Camila Macaubas
   de Albuquerque, Janderson B. L.
   Agra, Maria de Fatima
   de Souza, Maria de F., V
TI Phytochemical study of Waltheria viscosissima and evaluation of its
   larvicidal activity against Aedes aegypti
SO REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
LA English
DT Article
DE Sterculiaceae; Phytochemical study; Antioxidant activity; Larvicidal
   assay; Aedes aegypti
ID ANTIOXIDANT ACTIVITY; CHEMICAL-CONSTITUENTS; QUINOLINE ALKALOIDS;
   ANOPHELES-STEPHENSI; OVICIDAL ACTIVITY; MALARIAL VECTOR; DENGUE VECTOR;
   IN-VITRO; DIPTERA; EXTRACTS
AB The species Waltheria viscosissima A.St.-Hil, Malvaceae, which is known as 'malva-branca', is traditionally used in the Brazilian northeast for the treatment of coughs. This research looks towards reporting the isolation of phytoconstituents of W. viscosissima, as well as the quantification of its phenolics, total flavonoid content, and free radical scavenging potential, along with an evaluation of its larvicidal activity against Aedes aegypti larvae. Chromatographic techniques were used to isolate the compounds and a structural elucidation was performed by 1D and 2D NMR. The quantification of total phenolics and flavonoids and the DPPHtadical scavenging activity was determined through spectrophotometric methods. Consequently, the phytochemical investigation led to the identification of fourteen compounds from the aerial parts of the W viscosissima: steroids, triterpenes, alkaloids, and eight flavonoids previously reported in the literature. The quantification of compounds showed that the aerial parts extract possessed high concentration of flavonoids, while the roots extract were rich in other phenolic compounds. At the DPPHfree radical scavenging assay, the roots extract presented EC50 = 77.32 +/- 4.37 mu g/ml and the aerial parts extracts showed EC50 = 118.10 +/- 1.21 mu g/ml. W. viscosissima roots extract showed the most potent larvicidal activity against Ae. aegypti (LC50 = 4.78 mg/ml), with the potential of being used in effective and economically viable preparations that can be catered for domestic use towards controlling the vector insect of severe diseases, such as dengue and Zika. (C) 2019 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Farmacognosia.
C1 [Leite Ferreira, Maria Denise; Fernandes, Diegina A.; de Souza, Maria de F., V] Univ Fed Paraiba, Ctr Ciencias Saude, Posgrad Prod Nat & Sintet Bioativos, Joao Pessoa, Paraiba, Brazil.
   [Rolim, Yngred M.; de Souza, Maria de F., V] Univ Fed Paraiba, Ctr Ciencias Saude, Posgrad Desenvolvimento & Inovacao Tecnol Medicam, Joao Pessoa, Paraiba, Brazil.
   [Teles, Yanna C. F.; da Silva, Camila Macaubas] Univ Fed Paraiba, Ctr Ciencias Agr, Dept Quim & Fis, Areia, PB, Brazil.
   [de Albuquerque, Janderson B. L.] Univ Fed Paraiba, Ctr Ciencias Saude, Dept Ciencias Farmaceut, Joao Pessoa, Paraiba, Brazil.
   [Nunes, Fabiola C.; Agra, Maria de Fatima] Univ Fed Paraiba, Ctr Biotecnol, Joao Pessoa, Paraiba, Brazil.
RP de Souza, MDV (corresponding author), Univ Fed Paraiba, Ctr Ciencias Saude, Posgrad Prod Nat & Sintet Bioativos, Joao Pessoa, Paraiba, Brazil.; de Souza, MDV (corresponding author), Univ Fed Paraiba, Ctr Ciencias Saude, Posgrad Desenvolvimento & Inovacao Tecnol Medicam, Joao Pessoa, Paraiba, Brazil.
EM mfvanderlei@ltf.ufpb.br
RI de Fatima Agra, Maria/I-3395-2012; Teles, Yanna Carolina
   Ferreira/AAH-2135-2019; Agra, Maria/B-7244-2014
OI Teles, Yanna Carolina Ferreira/0000-0001-9409-3727; ferreira,
   maria/0000-0001-8156-3443; Fernandes, Diegina/0000-0001-6120-761X; Agra,
   Maria/0000-0002-8888-0975; Silva, Camila/0000-0003-1710-0342
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES [001]
FX The authors would like to thank the CNPq for financial support, CAPES
   -Finance Code 001 and the Multiuser Analytical Central Laboratory
   (LMCA-UFPB) for obtaining the spectra, and the Center of Biotechnology
   (BIOTEC-UFPB) for assistance in the biological assay.
CR Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014
   Al Muqarrabun LMR, 2015, EUR J MED CHEM, V92, P514, DOI 10.1016/j.ejmech.2015.01.026
   Alakurtti S, 2010, J ANTIBIOT, V63, P123, DOI 10.1038/ja.2010.2
   Silveira CEA, 2017, ACTA BOT BRAS, V31, P597, DOI 10.1590/0102-33062017abb0159
   Barbosa E, 2007, J ETHNOPHARMACOL, V109, P552, DOI 10.1016/j.jep.2006.09.009
   Bremer B, 2009, BOT J LINN SOC, V161, P105, DOI 10.1111/j.1095-8339.2009.00996.x
   Caridade TNS, 2018, BIOCHEM SYST ECOL, V80, P81, DOI 10.1016/j.bse.2018.07.003
   Castillo RM, 2017, J AM MOSQUITO CONTR, V33, P25, DOI 10.2987/16-6585.1
   Chaves OS, 2017, MOLECULES, V22, DOI 10.3390/molecules22010094
   Correa M.P., 1974, DICIONARIO PLANTAS U, P44
   Cretton S, 2016, J NAT PROD, V79, P300, DOI 10.1021/acs.jnatprod.5b00896
   Cretton S, 2015, FITOTERAPIA, V105, P55, DOI 10.1016/j.fitote.2015.06.007
   Cretton S, 2014, J NAT PROD, V77, P2304, DOI 10.1021/np5006554
   Cuong L.C.V., 2015, VIETNAM J CHEM, V53, P94
   da Costa DA, 2009, QUIM NOVA, V32, P48, DOI 10.1590/S0100-40422009000100009
   da Costa FJ, 2008, QUIM NOVA, V31, P1691, DOI 10.1590/S0100-40422008000700017
   da Cunha SSL, 2014, REV BIOTEMAS, V27, P79, DOI [10.5007/2175-7925.2014v27n2p79, DOI 10.5007/2175-7925.2014v27n2p79]
   de Almeida JGL, 2008, MAGN RESON CHEM, V46, P103, DOI 10.1002/mrc.2138
   Dixit P, 2011, BIOORG MED CHEM LETT, V21, P4617, DOI 10.1016/j.bmcl.2011.05.087
   Silva DAE, 2006, QUIM NOVA, V29, P1250, DOI 10.1590/S0100-40422006000600020
   Esteves G., 2015, WALTHERIA LISTA ESPE
   Fernandes D.A., 2018, ANAIS ELETRONICOS
   de Oliveira AMF, 2012, ANTIOXIDANTS-BASEL, V1, P33, DOI 10.3390/antiox1010033
   Fernandes DA, 2018, MOLECULES, V23, DOI 10.3390/molecules23112784
   Gomes RA, 2011, QUIM NOVA, V34, P1385, DOI 10.1590/S0100-40422011000800016
   Govindarajan M, 2008, EUR REV MED PHARMACO, V12, P299
   Govindarajan M, 2008, PARASITOL RES, V103, P691, DOI 10.1007/s00436-008-1032-2
   Govindarajan M, 2008, PARASITOL RES, V102, P289, DOI 10.1007/s00436-007-0761-y
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P691, DOI 10.1016/S1995-7645(10)60167-8
   Gressler V, 2008, PHYTOCHEMISTRY, V69, P994, DOI 10.1016/j.phytochem.2007.10.018
   Guarda C, 2016, INTERCIENCIA, V41, P243
   Gulcin I, 2004, FOOD CHEM, V87, P393, DOI 10.1016/j.foodchem.2003.12.008
   Harini R., 2012, Journal of Pharmacy Research, V5, P707
   Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572
   He M, 2016, FITOTERAPIA, V115, P74, DOI 10.1016/j.fitote.2016.09.011
   Herrera-Calderon O., 2016, Asian Pacific Journal of Tropical Disease, V6, P1000, DOI 10.1016/S2222-1808(16)61172-6
   Hoelzel SCSM, 2005, PHYTOCHEMISTRY, V66, P1163, DOI 10.1016/j.phytochem.2005.03.019
   Hou Z., 2017, FOOD FUNCT, V7
   Kwon HC, 2011, BIOMOL THER, V19, P90, DOI 10.4062/biomolther.2011.19.1.090
   Lakshmi KV, 2018, PLANT SCI TODAY, V5, P167, DOI 10.14719/pst.2018.5.4.407
   Li T, 2012, BRAIN RES, V1433, P80, DOI 10.1016/j.brainres.2011.11.045
   Lima MMC, 2009, PLANTA MED, V75, P335, DOI 10.1055/s-0028-1112215
   Maciel JKS, 2016, MOLECULES, V21, DOI 10.3390/molecules21010011
   Monteillier A, 2017, J ETHNOPHARMACOL, V203, P214, DOI 10.1016/j.jep.2017.03.048
   Mundo J, 2017, BIOMED PHARMACOTHER, V94, P129, DOI 10.1016/j.biopha.2017.07.061
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   NIRAIMATHI S, 2010, INT J CURR RES, V11, P034
   Nour A.H., 2012, SCI RES ESSAYS, V7, P2810, DOI DOI 10.5897/SRE12.133
   Oliveira GL, 2013, AN ACAD BRAS CIENC, V85, P1227, DOI 10.1590/0001-3765201391011
   Oliveira PV, 2010, PARASITOL RES, V107, P403, DOI 10.1007/s00436-010-1880-4
   Orhan N, 2009, PHARMACOGN MAG, V5, P309
   Pushpalatha E., 1999, J APPL ENTOMOL, V123, P258
   Ravikumar S., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS143
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Santiago G.M.P., 2005, Rev. bras. farmacogn., V15, P187, DOI 10.1590/S0102-695X2005000300003
   Santos D.B., 2015, THESIS, P73
   Santos E.A., 2012, EVID-BASED COMPL ALT, V1, P1, DOI [DOI 10.1155/2012/846583, 10.1155/2012/846583]
   Simoes C.M.O., 2010, FARMACOGNOSIA PLANTA, P1104
   Singh P. A., 2016, Asian Pacific Journal of Tropical Disease, V6, P75
   Soares FP, 1998, MAGN RESON CHEM, V36, P608, DOI 10.1002/(SICI)1097-458X(199808)36:8<608::AID-OMR335>3.3.CO;2-B
   Sumroiphon Suchada, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P123
   Tao XF, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070418
   Teles YCF, 2016, NAT PROD RES, V30, P1880, DOI 10.1080/14786419.2015.1081196
   Teles YCF, 2015, MOLECULES, V20, P20161, DOI 10.3390/molecules201119685
   Tennyson Samuel, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1842
   Vasques CAR, 1999, PHYTOTHER RES, V13, P312, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;312::AID-PTR432&gt;3.0.CO;2-Z
   Veeramani P., 2016, PHARM LETT, V8, P299
   Veni Thangapandi, 2017, J Parasit Dis, V41, P693, DOI 10.1007/s12639-016-0869-z
   Xiao P, 2017, ONCOL LETT, V14, P5989, DOI 10.3892/ol.2017.6945
   Yang SJ, 2015, EUR J MED CHEM, V96, P58, DOI 10.1016/j.ejmech.2015.04.006
   Yougbare-Ziebrou M. N., 2016, J APPL PHARM SCI, V6, P124, DOI DOI 10.7324/JAPS.2016.60219
   Zhang ZJ, 2015, FREE RADICAL BIO MED, V84, P331, DOI 10.1016/j.freeradbiomed.2015.02.030
   Zongo F, 2013, J ETHNOPHARMACOL, V148, P14, DOI 10.1016/j.jep.2013.03.080
NR 73
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA FARMACOGNOSIA
PI CURITIBA-PR
PA C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO
   MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL
SN 0102-695X
J9 REV BRAS FARMACOGN
JI Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.
PD SEP-OCT
PY 2019
VL 29
IS 5
BP 582
EP 590
DI 10.1016/j.bjp.2019.05.008
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JK7KG
UT WOS:000495019200004
OA Other Gold
DA 2020-07-08
ER

PT J
AU Gallichotte, EN
   Young, EF
   Baric, TJ
   Yount, BL
   Metz, SW
   Begley, MC
   de Silva, AM
   Baric, RS
AF Gallichotte, Emily N.
   Young, Ellen F.
   Baric, Thomas J.
   Yount, Boyd L.
   Metz, Stefan W.
   Begley, Matthew C.
   de Silva, Aravinda M.
   Baric, Ralph S.
TI Role of Zika Virus Envelope Protein Domain III as a Target of Human
   Neutralizing Antibodies
SO MBIO
LA English
DT Article
DE Zika virus; chimeric virus; epitope; neutralizing antibodies
ID INFECTION
AB Zika virus (ZIKV) is a flavivirus that is structurally highly similar to the related viruses, dengue virus (DENV), West Nile virus, and yellow fever virus. ZIKV causes an acute infection that often results in mild symptoms but that can cause severe disease in rare instances. Following infection, individuals mount an adaptive immune response, composed of antibodies (Abs) that target the envelope (E) glycoprotein of ZIKV, which covers the surface of the virus. Groups have studied monoclonal antibodies and polyclonal immune sera isolated from individuals who recovered from natural ZIKV infections. Some of these antibodies bind to domain III of E (EDIII), but the functional importance of these antibodies is unknown. In this study, we aimed to determine if EDIII is a major target of the potent serum neutralizing antibodies present in people after ZIKV infection. By generating a chimeric virus containing ZIKV EDIII in a DENV4 virus backbone, our data show a minor role of EDIII-targeting antibodies in human polyclonal neutralization. These results reveal that while monoclonal antibody (MAb) studies are informative in identifying individual antibody epitopes, they can overestimate the importance of epitopes contained within EDIII as targets of serum neutralizing antibodies. Additionally, these results argue that the major target of human ZIKV neutralizing antibodies resides elsewhere in E; however, further studies are needed to assess the epitope specificity of the neutralizing response at the population level. Identification of the major epitopes on the envelope of ZIKV recognized by serum neutralizing antibodies is critical for understanding protective immunity following natural infection and for guiding the design and evaluation of vaccines.
   IMPORTANCE Zika virus is a flavivirus that was recently introduced to Latin America, where it caused a massive epidemic. Individuals infected with ZIKV generate an immune response composed of antibodies which bind to the envelope (E) protein. These anti-E antibodies are critical in protecting individuals from subsequent infection. Multiple groups have found that many ZIKV antibodies bind to domain III of E (EDIII), suggesting that this region is an important target of neutralizing antibodies. Here, we generated a chimeric virus containing ZIKV EDIII in a dengue virus backbone to measure ZIKV EDIII-specific antibody responses. We found that while polyclonal ZIKV immune serum contains antibodies targeting EDIII, they constitute only a small fraction of the total population of antibodies that neutralize ZIKV. Further studies are needed to define the main targets on the viral envelope recognized by human neutralizing antibodies, which is critical for guiding the development of ZIKV vaccines.
C1 [Gallichotte, Emily N.; Young, Ellen F.; Baric, Thomas J.; Yount, Boyd L.; Begley, Matthew C.; Baric, Ralph S.] Univ North Carolina Chapel Hill, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Metz, Stefan W.; de Silva, Aravinda M.; Baric, Ralph S.] Univ North Carolina Chapel Hill, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27516 USA.
RP Gallichotte, EN; Baric, RS (corresponding author), Univ North Carolina Chapel Hill, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.; Baric, RS (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27516 USA.
EM egallich@email.unc.edu; rbaric@email.unc.edu
RI Metz, Stefan/J-1974-2019
OI Metz, Stefan/0000-0002-9249-2844; Begley, Matthew/0000-0003-4852-7656
FU U.S. National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01 AI107731, R01 AI125198, P01 AI106695, U19
   AI109761]; T32 NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI007419]
FX This research was supported by U.S. National Institute of Allergy and
   Infectious Diseases (NIAID) grants R01 AI107731 and R01 AI125198
   (principal investigator [PI], A.M.D.S.), P01 AI106695 (PI, E. Harris),
   and U19 AI109761 (R.S.B.). E.N.G. was supported by T32 NIH Training
   Grant AI007419.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Collins MH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124588
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dinnon KH, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007212
   Gallichotte EN, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006934
   Gallichotte EN, 2017, J INFECT DIS, V216, P1196, DOI 10.1093/infdis/jix473
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   McAuley AJ, 2016, J VIROL, V90, P4757, DOI 10.1128/JVI.02861-15
   Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071
   Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Tripathi NK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01919
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
NR 25
TC 2
Z9 2
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2019
VL 10
IS 5
AR e01485-19
DI 10.1128/mBio.01485-19
PG 6
WC Microbiology
SC Microbiology
GA JJ1JB
UT WOS:000493915800014
PM 31530669
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marques, ETA
   Drexler, JF
AF Marques, Ernesto T. A.
   Drexler, Jan Felix
TI Complex Scenario of Homotypic and Heterotypic Zika Virus Immune
   Enhancement
SO MBIO
LA English
DT Letter
DE Zika virus; antibody-dependent enhancement; congenital malformation;
   outbreak
C1 [Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Marques, Ernesto T. A.] Fundacao Oswaldo Cruz MS, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Humbold Univ Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Berlin Inst Hlth, Berlin, Germany.
   [Drexler, Jan Felix] Charite Univ Med Berlin, German Ctr Infect Res DAB, Berlin, Germany.
RP Drexler, JF (corresponding author), Charite Univ Med Berlin, Inst Virol, Berlin, Germany.; Drexler, JF (corresponding author), Free Univ Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Humbold Univ Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Drexler, JF (corresponding author), Charite Univ Med Berlin, German Ctr Infect Res DAB, Berlin, Germany.
EM felix.drexler@charite.de
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
FU European Union's Horizon 2020 research and innovation program through
   the ZIKAlliance project [734548]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation program through the ZIKAlliance project (grant agreement
   734548).
CR Castanha PMS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007246
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lum FM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20305-4
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
NR 13
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2019
VL 10
IS 5
AR e01849-19
DI 10.1128/mBio.01849-19
PG 2
WC Microbiology
SC Microbiology
GA JJ1JB
UT WOS:000493915800002
PM 31481385
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rosenfeld, AB
   Warren, AL
   Racaniello, VR
AF Rosenfeld, Amy B.
   Warren, Audrey L.
   Racaniello, Vincent R.
TI Neurotropism of Enterovirus D68 Isolates Is Independent of Sialic Acid
   and Is Not a Recently Acquired Phenotype
SO MBIO
LA English
DT Article
DE acute flaccid myelitis; astrocyte; enterovirus; neuron; neurotropism;
   picornavirus
ID ACUTE FLACCID PARALYSIS; WEST-NILE-VIRUS; ALPHA/BETA-INTERFERON
   RESPONSE; CENTRAL-NERVOUS-SYSTEM; ZIKA VIRUS; SLICE CULTURES;
   RESPIRATORY ILLNESS; GENE-EXPRESSION; TISSUE TROPISM; INFECTION
AB Acute flaccid myelitis (AFM) is a rare but serious illness of the nervous system, specifically affecting the gray matter of the spinal cord, motor-controlling regions of the brain, and cranial nerves. Most cases of AFM are pathogen associated, typically with poliovirus and enterovirus infections, and occur in children under the age of 6 years. Enterovirus D68 (EV-D68) was first isolated from children with pneumonia in 1962, but an association with AFM was not observed until the 2014 outbreak. Organotypic mouse brain slice cultures generated from postnatal day 1 to 10 mice and adult ifnar knockout mice were used to determine if neurotropism of EV-D68 is shared among virus isolates. All isolates replicated in organotypic mouse brain slice cultures, and three isolates replicated in primary murine astrocyte cultures. All four EV-D68 isolates examined caused paralysis and death in adult ifnar knockout mice. In contrast, no viral disease was observed after intracranial inoculation of wild-type mice. Six of the seven EV-D68 isolates, including two from 1962 and four from the 2014 outbreak, replicated in induced human neurons, and all of the isolates replicated in induced human astrocytes. Furthermore, a putative viral receptor, sialic acid, is not required for neurotropism of EV-D68, as viruses replicated within neurons and astrocytes independent of binding to sialic acid. These observations demonstrate that EV-D68 is neurotropic independent of its genetic lineage and can infect both neurons and astrocytes and that neurotropism is not a recently acquired characteristic as has been suggested. Furthermore, the results show that in mice the innate immune response is critical for restricting EV-D68 disease.
   IMPORTANCE Since 2014, numerous outbreaks of childhood infections with enterovirus D68 (EV-D68) have occurred worldwide. Most infections are associated with flulike symptoms, but paralysis may develop in young children. It has been suggested that infection only with recent viral isolates can cause paralysis. To address the hypothesis that EV-D68 has recently acquired neurotropism, murine organotypic brain slice cultures, induced human motor neurons and astrocytes, and mice lacking the alpha/beta interferon receptor were infected with multiple virus isolates. All EV-D68 isolates, from 1962 to the present, can infect neural cells, astrocytes, and neurons. Furthermore, our results show that sialic acid binding does not play a role in EV-D68 neuropathogenesis. The study of EV-D68 infection in organotypic brain slice cultures, induced motor neurons, and astrocytes will allow for the elucidation of the mechanism by which the virus infection causes disease.
C1 [Rosenfeld, Amy B.; Warren, Audrey L.; Racaniello, Vincent R.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10027 USA.
RP Racaniello, VR (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10027 USA.
EM vrr1@columbia.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI121944]
FX This work was supported by the National Institutes of Health (grant
   AI121944).
CR Abe Y, 2012, J VIROL, V86, P185, DOI 10.1128/JVI.05245-11
   Aliabadi N, 2016, EMERG INFECT DIS, V22, P1387, DOI 10.3201/eid2208.151949
   Ayscue P, 2014, MMWR-MORBID MORTAL W, V63, P903
   Baggen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11256-z
   Baggen J, 2018, P NATL ACAD SCI USA, V115, P397, DOI 10.1073/pnas.1713284115
   Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113
   BAHR BA, 1994, MOL BRAIN RES, V26, P277, DOI 10.1016/0169-328X(94)90100-7
   Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brown BA, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.01201-14
   Brown DM, 2018, MBIO, V9, DOI 10.1128/mBio.01954-18
   Carabalona A, 2016, NAT NEUROSCI, V19, P253, DOI 10.1038/nn.4213
   Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105
   Crone M, 2016, J CHILD NEUROL, V31, P409, DOI 10.1177/0883073815596613
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Das T, 2015, J GEN VIROL, V96, P294, DOI 10.1099/vir.0.071175-0
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Doobin DJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12551
   Du J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144208
   Dyrdak R, 2015, INFECT DIS-NOR, V47, P734, DOI 10.3109/23744235.2015.1047402
   Esposito S, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0678-0
   Essaidi-Laziosi M, 2018, J ALLERGY CLIN IMMUN, V141, P2074, DOI 10.1016/j.jaci.2017.07.018
   Feng M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00192
   FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069
   Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3
   Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957
   Helfferich J, 2017, EUR J PAEDIATR NEURO, V21, P594, DOI 10.1016/j.ejpn.2017.02.001
   Hixon AM, 2019, J VIROL, V93, DOI 10.1128/JVI.00578-19
   Hixon AM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006199
   Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086
   Hurst BL, 2019, VIROLOGY, V526, P146, DOI 10.1016/j.virol.2018.10.014
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Hutter-Schmid Bianca, 2015, Front Cell Dev Biol, V3, P52, DOI 10.3389/fcell.2015.00052
   Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005
   Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13
   Kauder SE, 2004, J CLIN INVEST, V113, P1743, DOI 10.1172/JCI200421323
   Khan Feras, 2015, Emerg Med Clin North Am, V33, pe19
   Khetsuriani N, 2006, MMWR SURVEILL SUMM, V55, P1
   Knoester M, 2017, EMERG INFECT DIS, V23, P140, DOI 10.3201/eid2301.161313
   Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1
   LAMONICA N, 1986, J VIROL, V57, P515, DOI 10.1128/JVI.57.2.515-525.1986
   Levy A, 2015, J CLIN VIROL, V69, P117, DOI 10.1016/j.jcv.2015.06.079
   Lipton HL, 2006, GLYCOCONJUGATE J, V23, P39, DOI 10.1007/s10719-006-5436-x
   Lipton HL, 2005, VIRUS RES, V111, P214, DOI 10.1016/j.virusres.2005.04.010
   Liu Y, 2018, P NATL ACAD SCI USA, V115, pE12209, DOI 10.1073/pnas.1803347115
   Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865
   Liu Y, 2015, SCIENCE, V347, P71, DOI 10.1126/science.1261962
   Maloney JA, 2015, AM J NEURORADIOL, V36, P245, DOI 10.3174/ajnr.A4188
   Messacar K, 2016, ANN NEUROL, V80, P326, DOI 10.1002/ana.24730
   Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0
   Midgley CM, 2015, LANCET RESP MED, V3, P879, DOI 10.1016/S2213-2600(15)00335-5
   Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798
   Midgley SE, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.17.21105
   Mizuno T, 1999, BRAIN RES, V849, P58, DOI 10.1016/S0006-8993(99)01984-8
   Morens DM, 2019, MBIO, V10, DOI 10.1128/mBio.00521-19
   Morrey JD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010033
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   New York State Department of Health, 2018, NYS DEP HLTH CONF CA
   Ng TFF, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01350-16
   Nokhbeh MR, 2005, J VIROL, V79, P7087, DOI 10.1128/JVI.79.11.7087-7094.2005
   Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P901
   Patel MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163926
   Pfeiffer HC, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21062
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Rajput C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121882
   REN R, 1992, J VIROL, V66, P296, DOI 10.1128/JVI.66.1.296-304.1992
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Royston L, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006962
   SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tan Y, 2016, J VIROL, V90, P1997, DOI 10.1128/JVI.02418-15
   Tokarz R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-288
   Tsunoda I, 2009, J NEUROVIROL, V15, P81, DOI 10.1080/13550280802380563
   van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06
   Wei W, 2016, CELL HOST MICROBE, V20, P631, DOI 10.1016/j.chom.2016.09.013
   Weil M, 2017, J CLIN VIROL, V86, P52, DOI 10.1016/j.jcv.2016.11.013
   Welsch JC, 2019, J VIROL, V93, DOI 10.1128/JVI.00618-19
   Yip CCY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051065
   Yoder JA, 2017, J EMERG MED, V53, pE19, DOI 10.1016/j.jemermed.2017.03.020
   Yoshikawa T, 2006, J VIROL, V80, P4313, DOI 10.1128/JVI.80.9.4313-4325.2006
   Zhang TG, 2016, BIOMED ENVIRON SCI, V29, P675, DOI 10.3967/bes2016.089
   Zhang Y, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew015
   Zheng HW, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050104
NR 85
TC 3
Z9 3
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2019
VL 10
IS 5
AR e02370-19
DI 10.1128/mBio.02370-19
PG 16
WC Microbiology
SC Microbiology
GA JJ1JB
UT WOS:000493915800094
PM 31641090
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shim, BS
   Choe, H
AF Shim, Byoung-Shik
   Choe, Hyeryun
TI Reply to Marques and Drexler, "Complex Scenario of Homotypic and
   Heterotypic Zika Virus Immune Enhancement"
SO MBIO
LA English
DT Letter
DE Zika virus; antibody-dependent enhancement; homotypic
C1 [Shim, Byoung-Shik; Choe, Hyeryun] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.
RP Choe, H (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.
EM hchoe@scripps.edu
CR Marques ETA, 2019, MBIO, V10, DOI 10.1128/mBio.01849-19
   Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19
NR 2
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2019
VL 10
IS 5
AR e02073-19
DI 10.1128/mBio.02073-19
PG 1
WC Microbiology
SC Microbiology
GA JJ1JB
UT WOS:000493915800004
PM 31481388
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, XW
   Xie, XP
   Xia, HJ
   Zou, J
   Huang, LF
   Popov, VL
   Chen, XW
   Shi, PY
AF Zhang, Xianwen
   Xie, Xuping
   Xia, Hongjie
   Zou, Jing
   Huang, Linfen
   Popov, Vsevolod L.
   Chen, Xinwen
   Shi, Pei-Yong
TI Zika Virus NS2A-Mediated Virion Assembly
SO MBIO
LA English
DT Article
DE Zika; flavivirus; virus assembly
ID VIRAL-RNA REPLICATION; NONSTRUCTURAL PROTEIN NS2A; DENGUE VIRUS;
   3-DIMENSIONAL ARCHITECTURE; ULTRASTRUCTURAL CHARACTERIZATION; SIGNAL
   PEPTIDE; CLEAVAGE; LOCALIZATION; MUTAGENESIS; INHIBITION
AB The flavivirus virion consists of an envelope outer layer, formed by envelope (E) and membrane (M) proteins on a lipid bilayer, and an internal core, formed by capsid (C) protein and genomic RNA. The molecular mechanism of flavivirus assembly is not well understood. Here, we show that Zika virus (ZIKV) NS2A protein recruits genomic RNA, the structural protein prM/E complex, and the NS2B/NS3 protease complex to the virion assembly site and orchestrates virus morphogenesis. Coimmunoprecipitation analysis showed that ZIKV NS2A binds to prM, E, NS2B, and NS3 (but not C, NS4B, or NS5) in a viral RNA-independent manner, whereas prM/E complex does not interact with NS2B/NS3 complex. Remarkably, a single-amino-acid mutation (E103A) of NS2A impairs its binding to prM/E and NS2B/NS3 and abolishes virus production, demonstrating the indispensable role of NS2A/prM/E and NS2A/NS2B/NS3 interactions in virion assembly. In addition, RNA-protein pulldown analysis identified a stem-loop RNA from the 3' untranslated region (UTR) of the viral genome as an "RNA recruitment signal" for ZIKV assembly. The 3' UTR RNA binds to a cytoplasmic loop of NS2A protein. Mutations of two positively charged residues (R96A and R102A) from the cytoplasmic loop reduce NS2A binding to viral RNA, leading to a complete loss of virion assembly. Collectively, our results support a virion assembly model in which NS2A recruits viral NS2B/NS3 protease and structural C-prM-E polyprotein to the virion assembly site; once the C-prM-E polyprotein has been processed, NS2A presents viral RNA to the structural proteins for virion assembly.
   IMPORTANCE ZIKV is a recently emerged mosquito-borne flavivirus that can cause devastating congenital Zika syndrome in pregnant women and Guillain-Barre syndrome in adults. The molecular mechanism of ZIKV virion assembly is largely unknown. Here, we report that ZIKV NS2A plays a central role in recruiting viral RNA, structural protein prM/E, and viral NS2B/NS3 protease to the virion assembly site and orchestrating virion morphogenesis. One mutation that impairs these interactions does not significantly affect viral RNA replication but selectively abolishes virion assembly, demonstrating the specific role of these interactions in virus morphogenesis. We also show that the 3' UTR of ZIKV RNA may serve as a "recruitment signal" through binding to NS2A to enter the virion assembly site. Following a coordinated cleavage of C-prM-E at the virion assembly site, NS2A may present the viral RNA to C protein for nucleocapsid formation followed by envelopment with prM/E proteins. The results have provided new insights into flavivirus virion assembly.
C1 [Zhang, Xianwen; Xie, Xuping; Xia, Hongjie; Zou, Jing; Huang, Linfen; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Zhang, Xianwen; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.
   [Zhang, Xianwen; Chen, Xinwen] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Popov, Vsevolod L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Popov, Vsevolod L.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect Immun, Galveston, TX 77555 USA.
   [Chen, Xinwen] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Xie, XP; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Chen, XW (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.; Chen, XW (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect Immun, Galveston, TX 77555 USA.; Chen, XW (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
EM xuxie@utmb.edu; chenxw@wh.iov.cn; peshi@utmb.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI142759, AI127744, AI136126]; Kleberg
   Foundation; John S. Dunn Foundation; Amon G. Carter Foundation; Gilson
   Longenbaugh Foundation; Summerfield Robert Foundation
FX P.-Y.S. was supported by NIH grants AI142759, AI127744, and AI136126 and
   awards from the Kleberg Foundation, John S. Dunn Foundation, Amon G.
   Carter Foundation, Gilson Longenbaugh Foundation, and Summerfield Robert
   Foundation.
CR Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li XD, 2016, J VIROL, V90, P5735, DOI 10.1128/JVI.00340-16
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Nemesio H, 2014, J PHYS CHEM B, V118, P10142, DOI 10.1021/jp504911r
   Ng IHW, 2019, ACS INFECT DIS, V5, P932, DOI 10.1021/acsinfecdis.8b00373
   Nugent CI, 1999, J VIROL, V73, P427, DOI 10.1128/JVI.73.1.427-435.1999
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01002-18
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Vossmann S, 2015, J VIROL, V89, P4951, DOI 10.1128/JVI.03351-14
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu RH, 2015, J VIROL, V89, P4281, DOI 10.1128/JVI.03011-14
   Xi XF, 2016, J BIOTECHNOL, V223, P8, DOI 10.1016/j.jbiotec.2016.02.025
   Xie X, CELL HOST MICROBE
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xie XP, 2014, VIROLOGY, V450, P250, DOI 10.1016/j.virol.2013.12.025
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XW, 2019, EMERG MICROBES INFEC, V8, P585, DOI 10.1080/22221751.2019.1598291
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 50
TC 7
Z9 7
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2019
VL 10
IS 5
AR e02375-19
DI 10.1128/mBio.02375-19
PG 21
WC Microbiology
SC Microbiology
GA JJ1JB
UT WOS:000493915800105
PM 31662457
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chan, MPS
   Farhadloo, M
   Winneg, K
   Jamieson, KH
   Albarracin, D
AF Chan, Man-pui Sally
   Farhadloo, Mohsen
   Winneg, Kenneth
   Jamieson, Kathleen Hall
   Albarracin, Dolores
TI Sources affecting knowledge and behavior responses to the Zika virus in
   US households with current pregnancy, intended pregnancy and a high
   probability of unintended pregnancy (vol 40, pg 776, 2017)
SO JOURNAL OF PUBLIC HEALTH
LA English
DT Correction
C1 [Winneg, Kenneth] Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
RP Winneg, K (corresponding author), Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
CR Chan MPS, 2018, J PUBLIC HEALTH-UK, V40, P776, DOI 10.1093/pubmed/fdy085
NR 1
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1741-3842
EI 1741-3850
J9 J PUBLIC HEALTH-UK
JI J. Public Health
PD SEP
PY 2019
VL 41
IS 3
BP 649
EP 649
DI 10.1093/pubmed/fdy146
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JI6FY
UT WOS:000493564400042
PM 30107555
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Albuquerque, MSV
   Lyra, TM
   Melo, APL
   Valongueiro, SA
   Araujo, TVB
   Pimentel, C
   Moreira, MCN
   Mendes, CHF
   Nascimento, M
   Kuper, H
   Penn-Kekana, L
AF Albuquerque, Maria S., V
   Lyra, Tereza M.
   Melo, Ana P. L.
   Valongueiro, Sandra A.
   Araujo, Thalia V. B.
   Pimentel, Camila
   Moreira, Martha C. N.
   Mendes, Corina H. F.
   Nascimento, Marcos
   Kuper, Hannah
   Penn-Kekana, Loveday
TI Access to healthcare for children with Congenital Zika Syndrome in
   Brazil: perspectives of mothers and health professionals
SO HEALTH POLICY AND PLANNING
LA English
DT Article
DE Access; health system; Zika; disability
ID SYSTEM; COMMUNICATION; UNIVERSAL; POLICY
AB The Congenital Zika Syndrome (CZS) epidemic took place in Brazil between 2015 and 2017 and led to the emergence of at least 3194 children born with CZS. We explored access to healthcare services and activities in the Unified Health Service (Sistema Unico de Saude: SUS) from the perspective of mothers of children with CZS and professionals in the Public Healthcare Network. We carried out a qualitative, exploratory study, using semi-structured interviews, in two Brazilian states-Pernambuco, which was the epicentre of the epidemic in Brazil, and Rio de Janeiro, where the epidemic was less intense. The mothers and health professionals reported that healthcare provision was insufficient and fragmented and there were problems with follow-up care. There was a lack of co-ordination and an absence of communication between the various specialized services and between different levels of the health system. We also noted a public-private mixture in access to healthcare services, resulting from a segmented system and related to inequality of access. High reported household expenditure is an expression of the phenomenon of underfunding of the public system. The challenges that mothers and health professionals reported exposes contradictions in the health system which, although universal, does not guarantee equitable and comprehensive care. Other gaps were revealed through the outbreak. The epidemic provided visibility regarding
C1 [Albuquerque, Maria S., V] Univ Fed Pernambuco, Dept Social Med, Ave Rui Barbosa 716, BR-20021140 Rio De Janeiro, Brazil.
   [Lyra, Tereza M.; Melo, Ana P. L.; Pimentel, Camila] FIOCRUZ PE, Aggeu Magalhaes Inst, Av Prof Moraes Rego S-N,Campus UFPE, BR-50740465 Recife, PE, Brazil.
   [Lyra, Tereza M.] Univ Pernambuco, Fac Med, Publ Hlth Dept, Ave Rui Barbosa 716, BR-20021140 Rio De Janeiro, RJ, Brazil.
   [Melo, Ana P. L.] Univ Fed Pernambuco, Ave Rui Barbosa 716, BR-20021140 Rio De Janeiro, RJ, Brazil.
   [Valongueiro, Sandra A.; Araujo, Thalia V. B.] Univ Fed Pernambuco, Postgrad Programme Publ Hlth, Ave Rui Barbosa 716, BR-20021140 Rio De Janeiro, RJ, Brazil.
   [Moreira, Martha C. N.; Mendes, Corina H. F.; Nascimento, Marcos] Fiocruz MS, Children & Adolescents Hlth Fernandes Figueira, Natl Inst Women, Ave Rui Barbosa 716, BR-20021140 Rio De Janeiro, RJ, Brazil.
   [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Clin Res Dept, Kepple St, London WC1E 7HT, England.
   [Penn-Kekana, Loveday] London Sch Hyg & Trop Med, Epidemiol & Publ Hlth, Maternal & Neonatal Hlth Grp, Kepple St, London WC1E 7HT, England.
RP Penn-Kekana, L (corresponding author), London Sch Hyg & Trop Med, Epidemiol & Publ Hlth, Maternal & Neonatal Hlth Grp, Kepple St, London WC1E 7HT, England.
EM loveday.penn-kekana@lshtm.ac.uk
RI Moreira, Martha Cristina Nunes/AAQ-5567-2020
FU Wellcome TrustWellcome Trust [205377/Z/16/Z, MC_PC_15088]; UK's
   Department for International Development [205377/Z/16/Z]; Wellcome
   Trust's Enhancing Research Activity in Epidemic Situations programme
   [107779/Z/15/Z, ER1505, ER1601]; European Union's Horizon 2020 research
   and innovation program under ZikaPLAN grant [734584]; Medical Research
   Council on behalf of the Newton Fund [MC_PC_15088]; Secretaria de
   Vigilancia em Saude/Ministerio da Saude de Brasil Resposta a Emergencia
   em Saude Publica Zika virus e Microcefalia [837058/2016]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Ni'vel SuperiorCAPES; Departamento de
   Ciencia e Tecnologia [440839/2016-5]
FX We would like to thank the mothers, other family members and health
   professionals who gave their precious provided the information for this
   article. This work was supported by the: Wellcome Trust & the UK's
   Department for International Development (205377/Z/16/Z to LCR;
   https://wellcome.ac.uk/); the Wellcome Trust's Enhancing Research
   Activity in Epidemic Situations programme (107779/Z/15/Z; with ER1505 &
   ER1601 to RAAX); the European Union's Horizon 2020 research and
   innovation program (https://ec.europa.eu/programmes/horizon2020/) under
   ZikaPLAN grant agreement No. 734584 (https://zikaplan.tghn.org/); the
   Medical Research Council on behalf of the Newton Fund and the Wellcome
   Trust (MC_PC_15088 to LCR; https://mrc.ukri.org/); Secretaria de
   Vigilancia em Saude/Ministerio da Saude de Brasil Resposta a Emergencia
   em Saude Publica Zika virus e Microcefalia (837058/2016 to RAAX); the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, the
   Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior
   (http://www.capes.gov.br/); & the Departamento de Ciencia e Tecnologia
   (http://rebrats.saude.gov.br/noticias/59DECIT) for Prevencao e Combate
   ao virus Zika I (440839/2016-5 to RAAX). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALBUQUERQUE MSV, 2014, SAUDE DEBATE, V38, P182, DOI DOI 10.5935/0103-1104.2014S014
   ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brunhara FCRP, 1998, CADERNOS PSICOLOGIA, V9, P31
   Campos TD, 2018, INT J GENOMICS, DOI 10.1155/2018/6941735
   Viana LAC, 2011, CAD SAUDE PUBLICA, V27, pS298, DOI 10.1590/S0102-311X2011001400016
   Cunha GT, 2011, SAUDE SOC-SAO PAULO, V20, P961, DOI 10.1590/S0104-12902011000400013
   Coriolano-Marinus MWD, 2014, SAUDE SOC-SAO PAULO, V23, P1356, DOI 10.1590/S0104-12902014000400019
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz SG, 2017, REPROD HEALTH MATTER, V25, P21, DOI 10.1080/09688080.2017.1397442
   DONABEDIAN A, 1973, ASPECTS MED CARE ADM
   Donabedian A., 2003, INTRO QUALITY ASSURA
   Miranda GMD, 2017, SAUDE SOC-SAO PAULO, V26, P329, DOI [10.1590/S0104-12902017168321, 10.1590/s0104-12902017168321]
   Fekete MC, 1996, ESTUDO ACESSIBILIDAD
   Gerschman S., 2010, GESTAO SUS AMBITO ES, P69
   Giovanella L, 2017, POLITICAS SAUDE BRAS, P493
   Giovanella L, 2018, CIENC SAUDE COLETIVA, V23, P1763, DOI 10.1590/1413-81232018236.05562018
   Governo de Pernambuco, 2018, RED ASS AOS PAC SIND, P1
   Governo do Estado do Rio de Janeiro, 2016, 001 SEASDHRJ SESRJ G, P1
   Instituto Brasileiro de Geografia e Estatistica/IBGE, 2015, BRAS GRAND REG UN FE, P105
   Julio F., 1985, CONCEPTO MED ACCESIB, P443
   Kuper Hannah, 2018, Wellcome Open Res, V3, P127, DOI 10.12688/wellcomeopenres.14838.1
   Lesser J, 2016, ESTUD AV-SAO PAULO, V30, P167, DOI DOI 10.1590/S0103-40142016.30880012
   Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18
   Lowy I, 2017, AM J PUBLIC HEALTH, V107, P517, DOI 10.2105/AJPH.2017.303652
   Marques Rosa Maria, 2012, Econ. soc., V21, P345, DOI 10.1590/S0104-06182012000200005
   Marshall C., 2011, DESIGNING QUALITATIV
   McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836
   Mendes E, 2009, REDES ATENCAO SAUDE
   MINAYO M.C. S., 2010, DESAFIO CONHECIMENTO
   Ministerio da Saude, 2018, B EPIDEMIOLOGICO
   Moreira MCN, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00075718
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001
   PINHEIRO R., 2005, CONSTRUCAO SOCIAL DE
   Rossi P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00194316
   Secretaria de Estado de Saude Rio de Janeiro, 2016, 001 SEASDHRJ SESRJ S
   Silva ACR, 2017, REV ANTHR, V28, P223
   Terraza Núñez Rebeca, 2006, Gac Sanit, V20, P485
   Tesser CD, 2017, CIENC SAUDE COLETIVA, V22, P941, DOI 10.1590/1413-81232017223.18842016
   Thiede M, 2008, CAD SAUDE PUBLICA, V24, P1168, DOI 10.1590/S0102-311X2008000500025
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190
   Vargas I, 2015, HEALTH POLICY PLANN, V30, P705, DOI 10.1093/heapol/czu048
   de Albuquerque MDV, 2013, SAUDE SOC-SAO PAULO, V22, P223, DOI 10.1590/S0104-12902013000100020
   World Bank, 2018, WORLD DEV IND
NR 46
TC 3
Z9 3
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1080
EI 1460-2237
J9 HEALTH POLICY PLANN
JI Health Policy Plan.
PD SEP
PY 2019
VL 34
IS 7
BP 499
EP 507
DI 10.1093/heapol/czz059
PG 9
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA JH8TX
UT WOS:000493041600003
PM 31369667
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Herber, S
   Silva, AA
   Sanseverino, MTV
   Friedrich, L
   Ranieri, TMS
   Favreto, C
   Fraga, LR
   Terra, AP
   Schwartz, IVD
   Schuler-Faccini, L
AF Herber, Silvani
   Silva, Andre A.
   Sanseverino, Maria Teresa, V
   Friedrich, Luciana
   Ranieri, Tani M. S.
   Favreto, Catia
   Fraga, Lucas R.
   Terra, Anna P.
   Schwartz, Ida V. D.
   Schuler-Faccini, Lavinia
TI Prevalence and causes of congenital microcephaly in the absence of a
   Zika virus outbreak in southern Brazil
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Microcephaly; ZIKV; Congenital infection
ID SURVEILLANCE; INFECTION
AB Objective: The aim of this study was to identify the causes of congenital microcephaly in Rio Grande do Sul, a state in southern Brazil, where no ZIKV outbreak was detected, from December 2015 to December 2016, which was the period when ZIKV infection was at its peak in northeast Brazil.
   Methods: This was a cross-sectional study where all notifications of congenital microcephaly in the state of Rio Grande do Sul were included for analysis. Evaluation of cases followed the guidelines of the Brazilian Ministry of Health. Dysmorphological and neurological evaluations were performed by a specialized team, and genetic tests and neuroimaging were performed when clinically indicated. STORCH infections were diagnosed using standard tests. ZIKV infection was diagnosed through maternal serum RT-PCR and/or neuroimaging associated with clinical/epidemiological criteria.
   Results: From 153 744 registered live births in the study period, 148 cases were notified, but 90 (60.8%) of those were later excluded as "non-confirmed" microcephaly. In the 58 confirmed cases of microcephaly (prevalence = 3.8/10 000 live births), congenital infections (syphilis, toxoplasmosis, cytomegalovirus, and ZIKV) constituted the predominant etiology (50.0%), followed by isolated CNS (15.5%), and genetic syndromes (10.3%). Congenital ZIKV syndrome (CZS) with typical phenotype was diagnosed in three cases (5.2% of alt confirmed microcephaly cases or 10.4% of all congenital infections).
   Conclusion: In Rio Grande do Sul, where no outbreak of ZIKV infection was recorded, congenital infections were the leading cause of congenital microcephaly, and the attributable risk for CZS in the etiology of microcephaly was 5.2%. (C) 2018 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [Herber, Silvani; Schwartz, Ida V. D.] Univ Fed Rio Grande do Sul, Programa Posgrad Med Ciencias Med, Porto Alegre, RS, Brazil.
   [Silva, Andre A.] Univ Vale Taquari UNIVATES, Fac Med, Lajeado, RS, Brazil.
   [Silva, Andre A.; Sanseverino, Maria Teresa, V; Fraga, Lucas R.; Schuler-Faccini, Lavinia] Sistema Nacl Informacao Agentes Teratogenico SIAT, Porto Alegre, RS, Brazil.
   [Sanseverino, Maria Teresa, V; Terra, Anna P.; Schwartz, Ida V. D.; Schuler-Faccini, Lavinia] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil.
   [Sanseverino, Maria Teresa, V] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Fac Med, Porto Alegre, RS, Brazil.
   [Friedrich, Luciana] Univ Fed Rio Grande do Sul, Serv Pediat, Porto Alegre, RS, Brazil.
   [Fraga, Lucas R.; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.
   [Schuler-Faccini, Lavinia] Inst Nacl Ciencia & Tecnol Genet Med Populac INaG, Porto Alegre, RS, Brazil.
   [Sanseverino, Maria Teresa, V; Schwartz, Ida V. D.; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.
   [Ranieri, Tani M. S.; Favreto, Catia] CEVS, Secretaria Saude Estado Rio Grande do Sul SES RS, Porto Alegre, RS, Brazil.
RP Schuler-Faccini, L (corresponding author), Sistema Nacl Informacao Agentes Teratogenico SIAT, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (corresponding author), Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (corresponding author), Inst Nacl Ciencia & Tecnol Genet Med Populac INaG, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.
EM lavinia.faccini@ufrgs.br
RI SCHULER-FACCINI, LAVINIA/C-8309-2013; Schwartz, Ida/M-1422-2015
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Schwartz,
   Ida/0000-0002-7933-6687
FU Fundo de Incentivo a Pesquisa de Eventos do Hospital de Clinicas de
   Porto Alegre (FIPE-HCPA); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX This work was funded by the Fundo de Incentivo a Pesquisa de Eventos do
   Hospital de Clinicas de Porto Alegre (FIPE-HCPA) and the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR [Anonymous], 2016, PROT VIG RESP OC MIC
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dhoti IM, 2017, BMJ, V359
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ribeiro IG, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-49742018000100002
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Vitlar J, 2014, LANCET, V384, P857
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 17
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD SEP-OCT
PY 2019
VL 95
IS 5
BP 600
EP 606
DI 10.1016/j.jped.2018.05.013
PG 7
WC Pediatrics
SC Pediatrics
GA JI3VU
UT WOS:000493397800014
PM 31340900
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carabali, M
   Harper, S
   Lima-Neto, A
   Caprara, A
   Restrepo, BN
   Kaufman, JS
AF Carabali, M.
   Harper, S.
   Lima-Neto, A.
   Caprara, A.
   Restrepo, B. N.
   Kaufman, J. S.
TI SOCIOECONOMIC INEQUALITIES IN ARBOVIRAL DISEASES IN LATIN AMERICA:
   ESTIMATING AND DECOMPOSING THE INDEX OF INEQUALITY FOR DENGUE, ZIKA AND
   CHIKUNGUNYA IN COLOMBIA AND BRAZIL
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Carabali, M.; Harper, S.; Kaufman, J. S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
   [Lima-Neto, A.] Fortaleza Hlth Secretariat SMS Fortaleza, Fortaleza, Ceara, Brazil.
   [Lima-Neto, A.] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil.
   [Caprara, A.] Univ State Ceara UECE, Fortaleza, CE, Brazil.
   [Restrepo, B. N.] Univ CES, Inst Med Trop, Medellin, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP
PY 2019
VL 113
SU 1
SI SI
MA 107
BP S42
EP S43
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JH9CH
UT WOS:000493064400108
DA 2020-07-08
ER

PT J
AU Jabeen, A
   Ikram, A
   Ansari, JA
   Khan, MA
AF Jabeen, A.
   Ikram, A.
   Ansari, J. A.
   Khan, M. A.
TI MOSQUITO ALERT PAKISTAN - A TOOL FOR SURVEILLANCE AND MONITORING OF
   MALARIA, DENGUE, CHIKUNGUNYA ZIKA AND WEST NILE DISEASE VECTORS
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Jabeen, A.; Ikram, A.; Ansari, J. A.; Khan, M. A.] Natl Inst Hlth, Field Epidemiol & Dis Surveillance Div, Islamabad, Pakistan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP
PY 2019
VL 113
SU 1
SI SI
MA P048
BP S110
EP S111
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JH9CH
UT WOS:000493064400278
DA 2020-07-08
ER

PT J
AU La Corte, R
   Jesus, MCS
   Batista, MVA
   Chagas, RDO
   Storti-de-Melo, LM
AF La Corte, R.
   Jesus, M. C. S.
   Batista, M. V. A.
   Chagas, R. D. O.
   Storti-de-Melo, L. M.
TI SILENT CIRCULATION OF ZIKA VIRUS IN THE STATE OF SERGIPE, NORTHEAST OF
   BRAZIL
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [La Corte, R.] Univ Fed Sergipe, Dept Morfol, Sao Cristovao, Brazil.
   [La Corte, R.; Jesus, M. C. S.; Batista, M. V. A.; Storti-de-Melo, L. M.] Univ Fed Sergipe, Programa Posgrad Biol Parasitaria, Sao Cristovao, Brazil.
   [Batista, M. V. A.; Storti-de-Melo, L. M.] Univ Fed Sergipe, Dept Biol, Sao Cristovao, Brazil.
   [Chagas, R. D. O.] Univ Fed Sergipe, Dept Med, Sao Cristovao, Brazil.
RI Santos, Roseli LC/F-1735-2015
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP
PY 2019
VL 113
SU 1
SI SI
MA 023
BP S10
EP S10
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JH9CH
UT WOS:000493064400024
DA 2020-07-08
ER

PT J
AU Parodi, P
   Bellino, S
   Albonico, M
   Maraglino, F
   Rizzo, C
AF Parodi, P.
   Bellino, S.
   Albonico, M.
   Maraglino, F.
   Rizzo, C.
TI EVALUATION OF RISK COMMUNICATION ON ZIKA VIRUS TRANSMISSION IN ITALY
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Parodi, P.; Maraglino, F.] Minist Hlth, Rome, Italy.
   [Bellino, S.] Natl Inst Hlth, Dept Infect Dis, Rome, Italy.
   [Albonico, M.] S Cuore Hosp, Ctr Trop Dis, Negrar, Italy.
   [Rizzo, C.] Pediat Hosp Bambino Gesu, Rome, Italy.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP
PY 2019
VL 113
SU 1
SI SI
MA P086
BP S121
EP S122
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JH9CH
UT WOS:000493064400306
DA 2020-07-08
ER

PT J
AU Soriano-Arandes, A
   Sulleiro, E
   Rodo, C
   Frick, MA
   Rando, A
   Suy, A
   Espiau, M
   Martin-Nalda, A
   Pumarola, T
   Soler-Palacin, P
AF Soriano-Arandes, A.
   Sulleiro, E.
   Rodo, C.
   Frick, M. A.
   Rando, A.
   Suy, A.
   Espiau, M.
   Martin-Nalda, A.
   Pumarola, T.
   Soler-Palacin, P.
TI THE CHALLENGE OF THE LABORATORY DIAGNOSIS IN A CONFIRMED CONGENITAL ZIKA
   VIRUS SYNDROME IN UTERO: A CASE REPORT
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Soriano-Arandes, A.; Frick, M. A.; Espiau, M.; Martin-Nalda, A.; Soler-Palacin, P.] Hosp Univ Vall dHebron, Paediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain.
   [Sulleiro, E.; Rando, A.; Pumarola, T.] Hosp Univ Vall dHebron, Dept Microbiol, Barcelona, Spain.
   [Rodo, C.; Suy, A.] Hosp Univ Vall dHebron, Dept Obstet, Barcelona, Spain.
RI Arandes, Antonio Soriano/Q-3348-2016
OI Arandes, Antonio Soriano/0000-0001-9613-7228
CR Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 1
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP
PY 2019
VL 113
SU 1
SI SI
MA 197
BP S79
EP S80
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JH9CH
UT WOS:000493064400198
DA 2020-07-08
ER

PT J
AU Tapia, L
   Delgadillo, M
   Paulino-Ramirez, R
AF Tapia, L.
   Delgadillo, M.
   Paulino-Ramirez, R.
TI GEOSPATIAL DISTRIBUTION OF CHIKUNGUNYA AND ZIKA VIRUS OUTBREAKS IN THE
   DOMINICAN REPUBLIC: TWO SIDES OF THE SAME COIN?
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Tapia, L.; Paulino-Ramirez, R.] Univ Iberoamer, Inst Trop Med & Global Hlth, Santo Domingo, Dominican Rep.
   [Delgadillo, M.] Univ Iberoamer, Sch Med, Santo Domingo, Dominican Rep.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP
PY 2019
VL 113
SU 1
SI SI
MA P320
BP S196
EP S196
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JH9CH
UT WOS:000493064400487
DA 2020-07-08
ER

PT J
AU Li, WT
   Wu, CC
   Tu, YC
   Huang, WH
   Chang, HW
   Pang, VF
   Jeng, CR
   Liu, CH
AF Li, Wen-Ta
   Wu, Chih-Ching
   Tu, Yang-Chang
   Huang, Wei-Hsiang
   Chang, Hui-Wei
   Pang, Victor Fei
   Jeng, Chian-Ren
   Liu, Chen-Hsuan
TI Concurrent leukoencephalomyelitis and polyneuritis in a Maltese terrier:
   resembling combined central and peripheral demyelination in humans
SO JOURNAL OF VETERINARY MEDICAL SCIENCE
LA English
DT Article
DE autoimmune; canine; combined central and peripheral demyelination
   (CCPD); leukoencephalomyelitis; polyneuritis
ID TOXOPLASMA-GONDII; PCR ASSAY; HLA-DR; DOGS; ENCEPHALITIS; EXPRESSION;
   INFECTION; DIAGNOSIS
AB A one-year-old male Maltese terrier presented with mild ataxia and disorientation for 4 months. Over time, clinical signs progressed from paraparesis to non-ambulatory tetraparesis, voice change and dysphagia. Histological examination revealed concurrent leukoencephalomyelitis and polyneuritis. Infectious etiologies, including dengue, Japanese encephalitis, Zika, canine distemper, pseudorabies, rabies, toxoplasmosis, neosporosis, leishmaniasis, and encephalitozoonosis, were ruled out by PCR and/or immunohistochemical (IHC) staining. IHC tested on neurological tissues highlighted a heterogeneous population of infiltrating T and B lymphocytes admixed macrophages. Therefore, this case was diagnosed with current leukoencephalomyelitis and polyneuritis, resembling combined central and peripheral demyelination (CCPD), an autoimmune inflammatory demyelinating disease affecting both the CNS and PNS in humans.
C1 [Li, Wen-Ta; Huang, Wei-Hsiang; Chang, Hui-Wei; Pang, Victor Fei; Jeng, Chian-Ren; Liu, Chen-Hsuan] Natl Taiwan Univ, Grad Inst Mol & Comparat Pathobiol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
   [Wu, Chih-Ching] Natl Taiwan Univ, Sch Vet Med, Grad Inst Vet Clin Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
   [Tu, Yang-Chang] Council Agr, Anim Hlth Res Inst, Epidemiol Div, 376 Zhongzheng Rd, New Taipei 251, Taiwan.
   [Li, Wen-Ta] Fishhead Labs LLC, 5658 SE Pine Ave, Stuart, FL 34997 USA.
RP Li, WT; Liu, CH (corresponding author), Natl Taiwan Univ, Grad Inst Mol & Comparat Pathobiol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.; Li, WT (corresponding author), Fishhead Labs LLC, 5658 SE Pine Ave, Stuart, FL 34997 USA.
EM heerolee1104@gmail.com; chhsuliu@ntu.edu.tw
RI Li, Wen-Ta/H-3718-2017
OI Li, Wen-Ta/0000-0002-4181-249X
CR Alldinger S, 1996, ACTA NEUROPATHOL, V92, P273, DOI 10.1007/s004010050518
   Cantile C, 2016, JUBB KENNEDY PALMERS, V1, P250, DOI DOI 10.1016/B978-0-7020-5317-7.00004-7>
   Caplan Louis R, 2012, Handb Clin Neurol, V103, P147, DOI 10.1016/B978-0-444-51892-7.00008-5
   Cortese A, 2016, J NEUROL SCI, V363, P182, DOI 10.1016/j.jns.2016.02.022
   Cramer SD, 2011, J VET DIAGN INVEST, V23, P915, DOI 10.1177/1040638711416628
   Hernandez RC, 2017, NEUROLOGIA, V32, P547, DOI 10.1016/j.nrl.2015.12.017
   Fairley RA, 2015, NEW ZEAL VET J, V63, P117, DOI 10.1080/00480169.2014.955068
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Frisk AL, 1999, J CLIN MICROBIOL, V37, P3634, DOI 10.1128/JCM.37.11.3634-3643.1999
   Hartlehnert M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12744-2
   Hayman DTS, 2011, J VIROL METHODS, V177, P87, DOI 10.1016/j.jviromet.2011.07.002
   Hester JD, 2002, MOL CELL PROBE, V16, P435, DOI 10.1006/mcpr.2002.0442
   Hill DE, 2006, VET PARASITOL, V141, P9, DOI 10.1016/j.vetpar.2006.05.008
   Katchanov J, 2004, J NEUROL NEUROSUR PS, V75, P1784, DOI 10.1136/jnnp.2004.037572
   Kira J. I., 2018, NEUROCHEM INT
   Klehmet J, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00724
   Leite RS, 2010, VET PARASITOL, V170, P201, DOI 10.1016/j.vetpar.2010.02.020
   Meyer zu Horste G., 2011, PLOS ONE, V6
   Muller N, 1996, J CLIN MICROBIOL, V34, P2850
   Ogata H, 2016, J NEUROL NEUROSUR PS, V87, P29, DOI 10.1136/jnnp-2014-309831
   Santhosh SR, 2007, J VIROL METHODS, V143, P73, DOI 10.1016/j.jviromet.2007.02.011
   Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   STYREN SD, 1990, EXP NEUROL, V110, P93, DOI 10.1016/0014-4886(90)90054-V
   Tajima Y, 2018, INTERNAL MED, V57, P867, DOI 10.2169/internalmedicine.7153-16
   Terzo E, 2012, VET RADIOL ULTRASOUN, V53, P636, DOI 10.1111/j.1740-8261.2012.01963.x
   Thomas Alissa A, 2014, J Clin Neuromuscul Dis, V15, P112, DOI 10.1097/CND.0000000000000025
   Vandevelde M., 2012, MANUAL VET NEUROPATH
   YONG VW, 1991, J NEUROPATH EXP NEUR, V50, P16, DOI 10.1097/00005072-199101000-00002
NR 29
TC 0
Z9 0
U1 0
U2 0
PU JAPAN SOC VET SCI
PI TOKYO
PA UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN
SN 0916-7250
EI 1347-7439
J9 J VET MED SCI
JI J. Vet. Med. Sci.
PD SEP
PY 2019
VL 81
IS 9
BP 1373
EP 1378
DI 10.1292/jvms.18-0696
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA JH5YK
UT WOS:000492845000023
PM 31366813
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mains, JW
   Kelly, PH
   Dobson, KL
   Petrie, WD
   Dobson, SL
AF Mains, James W.
   Kelly, Patrick H.
   Dobson, Karen L.
   Petrie, William D.
   Dobson, Stephen L.
TI Localized Control of Aedes aegypti (Diptera: Culicidae) in Miami, FL,
   via Inundative Releases of Wolbachia-Infected Male Mosquitoes
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE sterile insect technique; biological control; dengue; Zika; incompatible
   insect technique
ID DAILY SURVIVAL RATES; RIO-DE-JANEIRO; CYTOPLASMIC INCOMPATIBILITY;
   DISPERSAL; ENDOSYMBIONTS; RECAPTURE; INVASION; VECTOR
AB As part of the response to autochthonous Zika transmission in the United States, the City of South Miami implemented a 6-mo period in which Wolbachia-infected WB1 Aedes aegypti (L.) males were released into an similar to 170-acre area. Intracellular Wolbachia bacteria infections in Ae. aegypti cause early embryonic arrest (known as cytoplasmic incompatibility [CI]) and egg hatch failure, and inundative introductions have been suggested as a potential control tool. Throughout the release period, the Ae. aegypti population was monitored within both the release area and an equivalent area that did not receive WB1 male releases. The results show a significant reduction in egg hatch at the area receiving WB1 males, which is consistent with expectations for CI. Similarly, the number of Ae. aegypti was significantly reduced at the area receiving WB1 males, relative to the untreated area. The observed population reduction and results encourage additional work and replication of the Wolbachia biopesticide approach against Ae. aegypti, as an additional tool to be integrated with existing control tools for the control of this medically important vector and nuisance pest.
C1 [Mains, James W.; Dobson, Karen L.; Dobson, Stephen L.] MosquitoMate Inc, 2520 Regency Rd, Lexington, KY 40503 USA.
   [Kelly, Patrick H.] Uniformed Serv Univ Hlth Sci, Dept Preventat Med & Biometr, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
   [Petrie, William D.] Dept Solid Waste Management, Mosquito Control Div, Miami Dade Cty, 8901 NW 58th St, Miami, FL 33178 USA.
RP Dobson, SL (corresponding author), MosquitoMate Inc, 2520 Regency Rd, Lexington, KY 40503 USA.
EM sdobson@mosquitomate.com
RI Dobson, Stephen/E-5853-2010
OI Dobson, Stephen/0000-0001-5486-8225
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   ANAMAN KA, 1994, PREV VET MED, V20, P79, DOI 10.1016/0167-5877(94)90109-0
   [Anonymous], J MED ENTOMOL, V22, P190
   Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Dyck VA, 2005, STERILE INSECT TECHN
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567
   Gloria-Soria A, 2018, J MED ENTOMOL, V55, P1354, DOI 10.1093/jme/tjy084
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5
   Lloyd A.M., 2018, FLORIDA MOSQUITO CON
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Mains J. W, 2012, ENDOSYMBIONT WOLBACH
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   MORRIS CD, 1991, J AM MOSQUITO CONTR, V7, P608
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699
   Slatko BE, 2014, MOL BIOCHEM PARASIT, V195, P88, DOI 10.1016/j.molbiopara.2014.07.004
   Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031
   Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139
   White D. J., 1985, BIONOMICS ANTHROPOPH
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0
NR 31
TC 5
Z9 5
U1 9
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2019
VL 56
IS 5
BP 1296
EP 1303
DI 10.1093/jme/tjz051
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4OS
UT WOS:000492054500019
PM 31008514
DA 2020-07-08
ER

PT J
AU Liebman, KA
   Billeter, SA
   Yoshimizu, MH
   Yang, F
   Metzger, ME
   Schildhauer, S
   Payne, R
   Pakingan, MJ
   Hu, RJ
   Kramer, V
   Padgett, KA
AF Liebman, Kelly A.
   Billeter, Sarah A.
   Yoshimizu, Melissa Hardstone
   Yang, Fan
   Metzger, Marco E.
   Schildhauer, Samuel
   Payne, Robert
   Pakingan, Mary Joyce
   Hu, Renjie
   Kramer, Vicki
   Padgett, Kerry A.
TI Identification of Molecular Determinants of Resistance to Pyrethroid
   Insecticides in Aedes aegypti (Diptera: Culicidae) Populations in
   California, USA
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; insecticide resistance; California; knockdown resistance
ID ZIKA VIRUS; DENGUE; TRANSMISSION; CHIKUNGUNYA; ALBOPICTUS; FLORIDA
AB The first breeding populations of Aedes aegypti (Linnaeus) were identified in California in 2013, and have since been detected in 13 counties. Recent studies suggest two introductions likely occurred, with genetically distinct populations in the central and southern regions of the state. Given the threat of dengue, chikungunya, and Zika virus transmission, it is imperative to understand if these populations harbor genes that could confer resistance to pyrethrin-based insecticides, known as pyrethroids, the most commonly used class of adulticides in the state. In 2017, the California Department of Public Health initiated a pesticide resistance screening program for Ae. aegypti to assess the presence of specific mutations on the sodium channel gene (V1016I and F1534C) associated with knockdown resistance to pyrethroids. Mosquitoes collected between 2015 and 2017 from 11 counties were screened for mutations using real-time polymerase chain reaction assays. Results revealed distinctly different resistance profiles between the central and southern regions. The central population displayed nearly fixed resistant mutations at both loci, whereas the southern population was more variable. The relative proportion of resistant alleles observed in sampled mosquitoes collected in southern California increased each year from 2015 through 2017, indicating potential increases in resistance across this region. The presence of these mutations indicates that these mosquitoes may be predisposed to surviving pyrethroid treatments. Additional biological and biochemical assays will help better elucidate the mechanisms underlying insecticide resistance in California Ae. aegypti and prompt the use of pesticides that are most effective at controlling these mosquitoes.
C1 [Liebman, Kelly A.; Yoshimizu, Melissa Hardstone; Yang, Fan; Schildhauer, Samuel; Payne, Robert; Pakingan, Mary Joyce; Padgett, Kerry A.] Calif Dept Publ Hlth, Vector Borne Dis Sect, Infect Dis Branch, 850 Marina Bay Pkwy, Richmond, CA USA.
   [Liebman, Kelly A.] Marin Sonoma Mosquito & Vector Control Dist, 595 Helman Lane, Cotati, CA USA.
   [Billeter, Sarah A.; Metzger, Marco E.; Hu, Renjie] Calif Dept Publ Hlth, Infect Dis Branch, Vector Borne Dis Sect, 2151 Convent Ctr Way,Suite 226, Ontario, CA USA.
   [Kramer, Vicki] Calif Dept Publ Hlth, Infect Dis Branch, Vector Borne Dis Sect, 1600 Capital Ave, Sacramento, CA USA.
RP Padgett, KA (corresponding author), Calif Dept Publ Hlth, Vector Borne Dis Sect, Infect Dis Branch, 850 Marina Bay Pkwy, Richmond, CA USA.
EM Kerry.Padgett@cdph.ca.gov
OI Schildhauer, Samuel/0000-0001-7139-1086
FU Epidemiology & Laboratory Capacity - Centers for Disease Control and
   Prevention [6 NU50CK000410-05]
FX We thank Jaron Smith and Nicholas Ledesma for laboratory support of this
   project, Allyx Nicolici for her assistance with the maps, and the Powell
   laboratory at Yale University for providing mosquito DNA. This work
   would not have been possible without the continued cooperation of
   several vector control agencies in California, including Consolidated
   Mosquito Abatement District, Coachella Valley Mosquito and Vector
   Control District, Delano Mosquito Abatement District, Delta Vector
   Control District, Fresno Mosquito and Vector Control District,Greater
   Los Angeles County Vector Control District, Kern Mosquito and Vector
   Control District, Long Beach Vector Control Program, Madera County
   Mosquito and Vector Control District, Merced County Mosquito Abatement
   District, Northwest Mosquito and Vector Control District, Orange County
   Mosquito and Vector Control Program, Riverside County Environmental
   Health Vector Control Program, San Bernardino County Mosquito and Vector
   Control Program, San Diego County Department of Environmental Health
   Vector Control Program, San Gabriel Valley Mosquito and Vector Control
   Program, Tulare Mosquito Abatement District, and West Valley Mosquito
   and Vector Control District. This publication was supported by the
   Epidemiology & Laboratory Capacity Cooperative Agreement Number 6
   NU50CK000410-05, funded by the Centers for Disease Control and
   Prevention. Its contents are solely the responsibility of the authors
   and do not necessarily represent the official views of the Centers for
   Disease Control and Prevention or the Department of Health and Human
   Services.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CDC, 2018, EST RANG AED AEG AED
   CDPH, 2018, AED AEG AED ALB MOSQ
   Cornel Anthony J, 2016, F1000Res, V5, P194, DOI 10.12688/f1000research.8107.2
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Metzger ME, 2017, J MED ENTOMOL, V54, P533, DOI 10.1093/jme/tjw237
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Porse CC, 2018, EMERG INFECT DIS, V24, P1626, DOI 10.3201/eid2409.180203
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7
   Team R.D.C, 2016, R LANG ENV STAT COMP
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3
   WHO, 2014, MAL WORLD REP 2013
   World Health Organization, 2016, ZIK VIR SIT REP
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Yoshimizu M. H, 2016, P MOSQ VECTOR CONTRO, V84, P153
NR 31
TC 1
Z9 1
U1 3
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2019
VL 56
IS 5
BP 1353
EP 1358
DI 10.1093/jme/tjz076
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4OS
UT WOS:000492054500027
PM 31121042
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ben Ayed, W
   Amraoui, F
   M'ghirbi, Y
   Schaffner, F
   Rhaim, A
   Failloux, AB
   Bouattour, A
AF Ben Ayed, Wiem
   Amraoui, Fadila
   M'ghirbi, Youmna
   Schaffner, Francis
   Rhaim, Adel
   Failloux, Anna-Bella
   Bouattour, Ali
TI A Survey of Aedes (Diptera: Culicidae) Mosquitoes in Tunisia and the
   Potential Role of Aedes detritus and Aedes caspius in the Transmission
   of Zika Virus
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes; ecology; Tunisia; Zika virus; vector competence
ID OCHLEROTATUS-DETRITUS; PREVALENCE; ALBOPICTUS; AUTOGENY; DENSITY;
   MOROCCO; PALLAS
AB The present study aimed to update the list of Aedes mosquito species occurring in Tunisia and to test the vector competence of Aedes (Ochlerotatus) caspius (Pallas) and Ae. (Ochlerotatus) detritus (Haliday), the locally most abundant and widespread species, to transmit Zika virus (ZIKV). In 2017-2018, mosquito larvae were collected from 39 different larval habitats in seven bioclimatic zones of Tunisia. The salinity and pH of each breeding site were measured. The survey revealed the presence of 10 Aedes species in Tunisia: Ae. (Stegomyia) albopictus (Skuse), Ae. (Ochlerotatus) berlandi (Seguy), Ae. caspius, Ae. detritus, Ae. (Finlaya) echinus (Edwards), Ae. (Finlaya) geniculatus (Olivier), Ae. (Acartomyia) mariae (Sergent and Sergent), Ae. (Ochlerotatus) pulcritarsis (Rondani), Ae. (Aedimorphus) vexans (Meigen), and Ae. (Fredwardsius) vittatus (Bigot). Of these 10 species, Ae. caspius and Ae. detritus were the most abundant in Tunisia. Aedes detritus and Ae. caspius larvae were reared until the imago stage under insectary conditions to test autogeny. The study showed that Ae. detritus is autogenous and stenogamous and Ae. caspius, anautogenous and eurygamous. Finally, the collected strains of these two species were experimentally infected with the Asian genotype of ZIKV, originally isolated from a patient in April 2014 in New Caledonia, to test their vector competence. Neither of these species was able to transmit ZIKV at 7 and 14 d postexposure. Further investigations are needed to test the competence of other Tunisian mosquito species that may be associated with ZIKV transmission.
C1 [Ben Ayed, Wiem; M'ghirbi, Youmna; Rhaim, Adel; Bouattour, Ali] Inst Pasteur, Med Entomol, Lab Epidemiol & Vet Microbiol, 13 Pl Pasteur,BP 74, Tunis 1002, Tunisia.
   [Amraoui, Fadila; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
   [Schaffner, Francis] Univ Zurich, Inst Parasitol, Swiss Natl Ctr Vector Entomol, Zurich, Switzerland.
RP Bouattour, A (corresponding author), Inst Pasteur, Med Entomol, Lab Epidemiol & Vet Microbiol, 13 Pl Pasteur,BP 74, Tunis 1002, Tunisia.
EM ali.bouattour@pasteur.tn
OI Schaffner, Francis/0000-0001-9166-7617
FU World Health OrganizationWorld Health Organization
   [EMDCD1611541-2017/700724, EMDCD 1611541-2017/707590]; VectorNet;
   European Centre for Disease Prevention and Control (ECDC); European Food
   Safety Authority (EFSA) [OC/EFSA/AHAW/2013/02]
FX We thank Pei-Shi Yen, Laurence Mousson, and Marie Vazeille from Institut
   Pasteur of Paris for technical help and Fatma Khrouf and Marwa Beji from
   Institut Pasteur of Tunis for field help. We also warmly thank Tran Minh
   Nhu Nguyen from the WHO Regional Office for the Eastern Mediterranean.
   This study was supported by World Health Organization (contract numbers:
   of Vec Zika Med and Mos-Envi projects
   respectivelyEMDCD1611541-2017/700724 and EMDCD 1611541-2017/707590) and
   VectorNet and its funding agencies the European Centre for Disease
   Prevention and Control (ECDC) and the European Food Safety Authority
   (EFSA) (contract number OC/EFSA/AHAW/2013/02). A.B., A.B.F., and Y.M.
   conceived and designed the study. W.B.A., A.R., A.B., and F.S. collected
   mosquitoes species. W.B.A. and F.A. performed the experiments and
   analyzed the data. W.B.A., A.B.F., A.B., and F.S. contributed to writing
   and critically revised the manuscript. All authors read and approved the
   final manuscript. The Institute Pasteur animal facility has received
   accreditation from the French Ministry of Agriculture to perform
   experiments on live animals in compliance with the French and European
   regulations on care and protection of laboratory animals. This study was
   approved by the Institutional Animal Care and Use Committee (IACUC) at
   the Institut Pasteur of Paris and by the Bio Medical Ethic Committee
   (BMEC) at the Institut Pasteur of Tunis (file 2016/23/I/LR11IPT03/V1).
   We have no competing interests.
CR AHMED AM, 2011, J INSECT SCI, V11
   Ahmed AM, 2013, INSECT SCI, V20, P472, DOI 10.1111/j.1744-7917.2012.01544.x
   ALBANESE M, 1971, Rivista di Parassitologia, V32, P137
   Amraoui F, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006997
   BARDO V., 1959, JOUR HYG EPIDEMIOL MICROBIOL AND IMMUNOL, V3, P264
   Beadle LC, 1939, J EXP BIOL, V16, P346
   Beji M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2265-7
   Benallal KE, 2016, ACTA TROP, V164, P411, DOI 10.1016/j.actatropica.2016.09.027
   Bennouna A, 2017, MED VET ENTOMOL, V31, P102, DOI 10.1111/mve.12194
   Blagrove MSC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1739-3
   Bouattour A., 2019, J MED ENTOMOL
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brengues C, 2014, INFECT GENET EVOL, V28, P676, DOI 10.1016/j.meegid.2014.07.010
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Brunhes J., 2000, CULICIDAE AFRIQUE ME
   Callot J., 1938, ARCH I PASTEUR TUNIS, V272, P133
   CHINAEV P. P., 1964, ZOOL ZH, V43, P939
   Colas-Belcour J., 1931, ARCH I PASTEUR TUNIS, V1, P66
   COLUZZI M, 1974, Rivista di Parassitologia, V35, P321
   Ferreira CAC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0760-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   El Kaim B., 1972, B SOC SCI NAT PHYS, V52, P3
   Engelman F., 1970, PHYSL INSECT REPROD, V44
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   GABINAUD A, 1975, Annales de Parasitologie Humaine et Comparee, V50, P123
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Handaq N., 1995, THESIS
   Hassain K., 2002, THESIS
   HOLSTEIN M, 1967, B WORLD HEALTH ORGAN, V36, P541
   JOUBERT L, 1967, Bulletin de l'Academie Veterinaire de France, V40, P315
   JUMINER B., 1964, Arch. Inst. Pasteur Tunis, V41, P23
   Krida G, 2012, ANN SOC ENTOMOL FR, V48, P18, DOI 10.1080/00379271.2012.10697748
   Lafri Ismail, 2014, Bulletin de la Societe Zoologique de France, V139, P257
   LAMBERT M, 1990, ANN SOC ENTOMOL FR, V26, P381
   Li R, 2017, RADIOL INFECT DIS, V4, P88, DOI [10.1016/j.jrid.2017.01.002, DOI 10.1016/J.JRID.2017.01.002]
   Lothrop B.B., 1988, Proceedings and Papers of the Annual Conference of the California Mosquito and Vector Control Association Inc., V56, P139
   MAROLI M, 1973, Rivista di Parassitologia, V34, P219
   MARSHALL JF, 1938, BRIT MOSQUITOES, P341
   Moussiegt O., 1983, DOCUMENT EID, V47, P3
   Moussiegt O., 1990, DOC EID, V58, P21
   Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009
   Natvig L., 1948, CULLCINI NOR ENTOMOL, V1, P567
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   OMEARA GF, 1973, SCIENCE, V180, P1291, DOI 10.1126/science.180.4092.1291
   OMEARA GF, 1979, INT J INVER REP DEV, V1, P253
   PAPIEROK B, 1975, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V13, P47
   PASTEUR N, 1978, ANN PARASIT HUM COMP, V53, P761, DOI 10.1051/parasite/1978536761
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   RAGEAU J, 1967, CAH ORSTOM EM, V5, P263
   REISEN WK, 1977, ANN ENTOMOL SOC AM, V70, P988, DOI 10.1093/aesa/70.6.988
   Ribeiro H., 1988, Actas do Congresso Iberico de Entomologia, V3, P233
   Rioux J. A., 1998, Parassitologia (Rome), V40, P353
   RIOUX J-A, 1975, Annales de Parasitologie Humaine et Comparee, V50, P131
   RIOUX JA, 1958, CULICIDES MIDI MEDIT
   SENEVET GEORGES, 1963, ARCH INST PASTEUR ALGERIE, V41, P115
   Sinegre G., 1974, THESIS
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Tandina F, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3045-8
   Trari B, 2017, J VECTOR ECOL, V42, P94, DOI 10.1111/jvec.12243
   Turell MJ, 1996, AM J TROP MED HYG, V54, P136, DOI 10.4269/ajtmh.1996.54.136
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   VERMEIL C., 1953, BULL SOC PATH EXOT, V46, P338
NR 64
TC 0
Z9 0
U1 4
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2019
VL 56
IS 5
BP 1377
EP 1383
DI 10.1093/jme/tjz067
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JG4OS
UT WOS:000492054500030
PM 31121045
DA 2020-07-08
ER

PT J
AU Baker, AT
   Mundy, RM
   Davies, JA
   Rizkallah, PJ
   Parker, AL
AF Baker, Alexander T.
   Mundy, Rosie M.
   Davies, James A.
   Rizkallah, Pierre J.
   Parker, Alan L.
TI Human adenovirus type 26 uses sialic acid-bearing glycans as a primary
   cell entry receptor
SO SCIENCE ADVANCES
LA English
DT Article
ID FIBER; INFECTIONS; VACCINE; BINDING; DOMAIN
AB Adenoviruses are clinically important agents. They cause respiratory distress, gastroenteritis, and epidemic keratoconjunctivitis. As non-enveloped, double-stranded DNA viruses, they are easily manipulated, making them popular vectors for therapeutic applications, including vaccines. Species D adenovirus type 26 (HAdV-D26) is both a cause of EKC and other diseases and a promising vaccine vector. HAdV-D26-derived vaccines are under investigation as protective platforms against HIV, Zika, and respiratory syncytial virus infections and are in phase 3 clinical trials for Ebola. We recently demonstrated that HAdV-D26 does not use CD46 or Desmoglein-2 as entry receptors, while the putative interaction with coxsackie and adenovirus receptor is low affinity and unlikely to represent the primary cell receptor. Here, we establish sialic acid as a primary entry receptor used by HAdV-D26. We demonstrate that removal of cell surface sialic acid inhibits HAdV-D26 infection, and provide a high-resolution crystal structure of HAdV-D26 fiber-knob in complex with sialic acid.
C1 [Baker, Alexander T.; Mundy, Rosie M.; Davies, James A.; Parker, Alan L.] Cardiff Univ, Sch Med, Div Canc & Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.
   [Rizkallah, Pierre J.] Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.
RP Parker, AL (corresponding author), Cardiff Univ, Sch Med, Div Canc & Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.
EM parkeral@cardiff.ac.uk
RI Baker, Alexander Thomas/AAC-5345-2019; Parker, Alan L/B-8187-2009;
   Rizkallah, Pierre J/A-5367-2012; Baker, Alexander/AAC-5273-2019
OI Baker, Alexander Thomas/0000-0001-8232-0531; Parker, Alan
   L/0000-0002-9302-1761; Rizkallah, Pierre J/0000-0002-9290-0369; Davies,
   James/0000-0003-3569-4500; Mundy, Rosie/0000-0003-3493-1084
FU Tenovus Cancer Care PhD studentship [PhD2015/L13]; Ludo Frevel
   Crystallography Scholarship from the International Centre for
   Diffraction Data (ICDD); Cancer Research UK Biotherapeutics Drug
   Discovery Project Award [C52915/A23946]; Cardiff Universities Research
   Opportunities Placement (CUROP); Higher Education Funding Council for
   WalesHigher Education Funding Council for England
FX A.T.B. was supported by a Tenovus Cancer Care PhD studentship to A.L.P.
   (project reference PhD2015/L13) and the Ludo Frevel Crystallography
   Scholarship from the International Centre for Diffraction Data (ICDD).
   J.A.D. was supported by a Cancer Research UK Biotherapeutics Drug
   Discovery Project Award to A.L.P. (project reference C52915/A23946).
   R.M.M. was supported by the Cardiff Universities Research Opportunities
   Placement (CUROP). A.L.P. and P.J.R. were funded by the Higher Education
   Funding Council for Wales.
CR Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06
   Al Qurashi YMA, 2012, J MED VIROL, V84, P1157, DOI 10.1002/jmv.23331
   Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91
   Aoki K., 2017, J CLIN OPHTHALMOL EY, V1, P1013
   Aoki Koki, 2002, International Ophthalmology Clinics, V42, P49
   Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714
   Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000
   Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000
   Arnberg N, 2002, J VIROL, V76, P8834, DOI 10.1128/JVI.76.17.8834-8841.2002
   Baker AT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08599-y
   Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/S0140-6736(18)31364-3, 10.1016/s0140-6736(18)31364-3]
   Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004
   CHANDRA N, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11050395
   Civljak R, 2019, J MED VIROL, V91, P1202, DOI 10.1002/jmv.25437
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Dakin RS, 2015, HUM GENE THER, V26, P312, DOI 10.1089/hum.2015.019
   Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952
   Garcia-Zalisnak D, 2018, EYE CONTACT LENS, V44, pS1, DOI 10.1097/ICL.0000000000000226
   HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992
   Huang GH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110781, 10.137]
   Huang S, 1999, J VIROL, V73, P2798, DOI 10.1128/JVI.73.4.2798-2802.1999
   International Committee on Taxonomy of Viruses, 1995, ARCH VIROLOGY S
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kaneko H, 2009, J GEN VIROL, V90, P1471, DOI 10.1099/vir.0.009225-0
   Khanal S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010030
   Killerby ME, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz017
   Lenman A, 2018, P NATL ACAD SCI USA, V115, pE4264, DOI 10.1073/pnas.1716900115
   Lenman A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004657
   Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13
   Majhen D, 2014, HUM GENE THER, V25, P301, DOI 10.1089/hum.2013.235
   Matsuura K, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-018-1025-6
   Nestic D, 2019, J VIROL, V93, DOI 10.1128/JVI.01474-18
   Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267
   NORRIS SH, 1989, AM J NEPHROL, V9, P101, DOI 10.1159/000167945
   Pauly M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-25
   Potter RN, 2012, EMERG INFECT DIS, V18, P507, DOI 10.3201/eid1803.111238
   Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020
   Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200
   Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Singh AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139339
   Spjut S, 2011, ANGEW CHEM INT EDIT, V50, P6519, DOI 10.1002/anie.201101559
   Stanton RJ, 2008, BIOTECHNIQUES, V45, P659, DOI 10.2144/000112993
   SWENSON PD, 1995, J CLIN MICROBIOL, V33, P2728, DOI 10.1128/JCM.33.10.2728-2731.1995
   Uusi-Kerttula H, 2016, ONCOTARGET, V7, P27926, DOI 10.18632/oncotarget.8545
   Uusi-Kerttula H, 2015, VIRUSES-BASEL, V7, P6009, DOI 10.3390/v7112923
   Uusi-Kerttula H, 2015, HUM GENE THER, V26, P320, DOI 10.1089/hum.2015.015
   Vassal-Stermann E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09220-y
   Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773
   Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635
   Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Yu XD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602670
   Zhou XH, 2012, INVEST OPHTH VIS SCI, V53, P2804, DOI 10.1167/iovs.12-9656
NR 56
TC 2
Z9 3
U1 1
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD SEP
PY 2019
VL 5
IS 9
AR eaax3567
DI 10.1126/sciadv.aax3567
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JF1DW
UT WOS:000491128800017
PM 31517055
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Denis, J
   Attoumani, S
   Gravier, P
   Tenebray, B
   Garnier, A
   Briolant, S
   de Laval, F
   Chastres, V
   Grard, G
   Leparc-Goffart, I
   Coutard, B
   Badaut, C
AF Denis, Jessica
   Attoumani, Sarah
   Gravier, Patrick
   Tenebray, Bernard
   Garnier, Annabelle
   Briolant, Sebastien
   de Laval, Franck
   Chastres, Veronique
   Grard, Gilda
   Leparc-Goffart, Isabelle
   Coutard, Bruno
   Badaut, Cyril
TI High specificity and sensitivity of Zika EDIII-based ELISA diagnosis
   highlighted by a large human reference panel
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS-INFECTION; FRENCH-POLYNESIA;
   HUMAN-ANTIBODIES; SEROPREVALENCE; TRANSMISSION; OUTBREAK
AB Background Zika virus (ZIKV) and Dengue virus (DENV) are often co-endemic. The high protein-sequence homology of flaviviruses renders IgG induced by and directed against them highly cross-reactive against their antigen(s), as observed on a large set of sera, leading to poorly reliable sero-diagnosis. Methods We selected Domain III of the ZIKV Envelope (ZEDIII) sequence, which is virus specific. This recombinant domain was expressed and purified for the specific detection of ZEDIII-induced IgG by ELISA from ZIKV-RT-PCR-positive, ZIKV-IgM-positive, flavivirus-positive but ZIKV-negative, or flavivirus-negative sera. We also assessed the reactivity of ZEDIII-specific human antibodies against EDIII of DENV serotype 4 (D4EDIII) as a specific control. Sera from ZEDIII-immunized mice were also tested. Results Cross-reactivity of IgG from 5,600 sera against total inactivated DENV or ZIKV was high (71.0% [69.1; 72.2]), whereas the specificity and sensitivity calculated using a representative cohort (242 sera) reached 90% [84.0; 95.8] and 92% [84.5; 99.5], respectively, using a ZEDIII-based ELISA. Moreover, purified human IgG against D2EDIII or D4EDIII did not bind to ZEDIII and we observed no D4EDIII reactivity with ZIKV-induced mouse polyclonal IgGs. Conclusions We developed a ZEDIII-based ELISA that can discriminate between past or current DENV and ZIKV infections, allowing the detection of a serological scar from other flaviviruses. This could be used to confirm exposure of pregnant women or to follow the spread of an endemic disease.
   Author summary The serological detection of Zika virus (ZIKV) is a challenge, as ZIKV infection generally leads to an immune response with a high level of cross reactivity against related viruses, such as Dengue virus. Although seroneutralization assays are the gold-standard to address specificity, a rapid and cost-effective detection assay with good specificity and sensitivity could be used for first-line screening. We used a large cohort to define a set of human reference sera to validate an ELISA based on a recombinant ZIKV antigen. The assay showed 90% specificity and 92% sensitivity, providing a good basis for the development of diagnostic assays. Characterization of both DENV-EDIII-purified human and murine IgG induced by ZIKV infection or ZEDIII, respectively, confirmed the good specificity of the antigen.
C1 [Denis, Jessica; Garnier, Annabelle; Badaut, Cyril] Inst Rech Biomed Armees, Unite Biotherapies Antiinfect & Immun, 1 Pl Gen Valerie Andre,BP73, Bretigny Sur Orge, France.
   [Denis, Jessica; Gravier, Patrick; Tenebray, Bernard; Grard, Gilda; Leparc-Goffart, Isabelle; Badaut, Cyril] Ctr Natl Reference Arbovirus, Inst Rech Biomed Armees, Unite Arbovirol HIA Laveran, Marseille, France.
   [Attoumani, Sarah; Coutard, Bruno] Aix Marseille Univ, AFMB, CNRS, UMR 7257, Case 932 163, Ave Luminy, Marseille, France.
   [Attoumani, Sarah; Gravier, Patrick; Tenebray, Bernard; Grard, Gilda; Leparc-Goffart, Isabelle; Coutard, Bruno] Aix Marseille Univ, IHU Mediterrane Infect, UVE, INSERM 1207,IRD 190, Marseille, France.
   [Briolant, Sebastien] Inst Rech Biomed Armees, Dept Malad Infect, Unite Parasitol & Entomol, Marseille, France.
   [Briolant, Sebastien] Aix Marseille Univ, AP HM, Vecteurs Infect Trop & Mediterraneennes VITROME, IHU Mediterrane Infect,IRD,SSA,UMR, Marseille, France.
   [de Laval, Franck] Ctr Epidemiol & Sante Publ Armees, Serv Sante Armees, Marseille, France.
   [de Laval, Franck] Aix Marseille Univ, INSERM, SESSTIM, Marseille, France.
   [Chastres, Veronique] Inst Rech Biomed Armees, Dept Neurosci & Sci Cognit, Unite Percept, 1 Pl Gen Valerie Andre,BP73, Bretigny Sur Orge, France.
RP Badaut, C (corresponding author), Inst Rech Biomed Armees, Unite Biotherapies Antiinfect & Immun, 1 Pl Gen Valerie Andre,BP73, Bretigny Sur Orge, France.; Badaut, C (corresponding author), Ctr Natl Reference Arbovirus, Inst Rech Biomed Armees, Unite Arbovirol HIA Laveran, Marseille, France.
EM cbadaut@gmail.com
OI Badaut, Cyril/0000-0002-0064-6384
FU European Union's Horizon 2020 Research and Innovation Programme, under
   ZIKAlliance [734548]; European Virus Archive goes global (EVAg) project
   [653316]; Service de Santedes Armees, Biomedef [PDH-2-NRBC-2-B2-205,
   PDH-2-NRBC-2-B-2111]; Direction Generale de l'Armement
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme, under ZIKAlliance Grant Agreement no.
   734548, as well as by the European Virus Archive goes global (EVAg)
   project, under Grant Agreement no. 653316, and partially funded by the
   Direction Generale de l'Armement and the Service de Santedes Armees,
   Biomedef PDH-2-NRBC-2-B2-205 and PDH-2-NRBC-2-B-2111. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beck C, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007162
   Beck C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/678084
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Laval F, 2018, J CLIN VIROL, V109, P57, DOI 10.1016/j.jcv.2018.09.015
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Henderson AD, 578211 BIORXIV, DOI [10.1101/578211, DOI 10.1101/578211]
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lantez V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000936
   Matheus S, 2019, EMERG INFECT DIS, V25, P1153, DOI 10.3201/eid2506.180361
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   WHO (World Health Organization) report, 2016, NEUR SYNDR CONG AN
   World Health Organization, 2016, WHOZIKVLAB161
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 38
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007747
DI 10.1371/journal.pntd.0007747
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100048
PM 31539394
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kuper, H
   Moreira, ME
   de Araujo, TVB
   Valongueiro, S
   Fernandes, S
   Pinto, M
   Lyra, TM
AF Kuper, Hannah
   Lopes Moreira, Maria Elisabeth
   Barreto de Araujo, Thalia Velho
   Valongueiro, Sandra
   Fernandes, Silke
   Pinto, Marcia
   Lyra, Tereza Maciel
TI The association of depression, anxiety, and stress with caring for a
   child with Congenital Zika Syndrome in Brazil; Results of a
   cross-sectional study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID QUALITY-OF-LIFE; CEREBRAL-PALSY; MOTHERS; NEWBORNS; HEALTH
AB Author summary The 2015 Zika epidemic in Brazil gained international attention with the birth of thousands of babies with severe adverse outcomes, collectively called "Congenital Zika Syndrome" (CZS). Parenting a child with disabilities can be extremely stressful, and in other settings is linked to depression, anxiety and other mental health conditions. However, these associations have not been fully explored in the context of CZS in Brazil. We conducted a cross-sectional study in Rio de Janeiro and Recife, two cities in Brazil. We identified 163 caregivers (mostly the mother) of a child with CZS, and 324 caregivers of children of similar ages, but without obvious disabilities. The caregivers were asked a series of questions to gauge whether they were experiencing depression, anxiety or stress. We found that a high proportion of the mothers reported experiencing severe or extremely severe levels of depression (18%), anxiety (27%) and stress (36%). Levels of depression and anxiety were even higher for mothers of children with CZS compared to mothers of unaffected children, especially for those mothers with low social support and those living in Rio de Janeiro.
   Background Zika virus (ZIKV) infection in pregnancy can cause microcephaly and a wide spectrum of severe adverse outcomes, collectively called "Congenital Zika Syndrome" (CZS). Parenting a child with disabilities can have adverse mental health impacts, but these associations have not been fully explored in the context of CZS in Brazil. Methodology/Principal findings A cross-sectional study was undertaken in Recife and Rio de Janeiro, including 163 caregivers of a child with CZS (cases) and 324 caregivers with an unaffected child (comparison subjects), identified from existing studies. The primary caregiver, almost always the mother, was interviewed using a structured questionnaire to collect information on: depression, anxiety, and stress (Depression, Anxiety, and Stress Scale-DASS-21), social support (Medical Outcomes Study Social Support Scale-MOS-SSS), and socio-demographic data. Data was collected May 2017-January 2018. Ethical standards were adhered to throughout the research. A high proportion of mothers reported experiencing severe or extremely severe levels of depression (18%), anxiety (27%) and stress (36%). Mothers of children with CZS were more likely to experience symptoms of depression, anxiety andstress, compared to mothers of comparison children. These associations were more apparent among mothers living in Rio de Janeiro. These differences were reduced after adjustment for socio-economic status and social support. Among mothers of children with CZS, low social support was linked to higher levels of depression, anxiety and stress, but there was no association with socio-economic status.
C1 [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Clin Res Dept, London, England.
   [Lopes Moreira, Maria Elisabeth; Pinto, Marcia] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Barreto de Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Postgrad Programme Publ Hlth, Recife, PE, Brazil.
   [Fernandes, Silke] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England.
   [Lyra, Tereza Maciel] FIOCRUZ PE, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Lyra, Tereza Maciel] Univ Pernambuco, Fac Med, Recife, PE, Brazil.
RP Kuper, H (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Clin Res Dept, London, England.
EM Hannah.kuper@lshtm.ac.uk
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU Wellcome TrustWellcome Trust [MC_PC_15088]; UK's Department for
   International Development [205377/Z/16/Z]; Wellcome Trust's Enhancing
   Research Activity in Epidemic Situations programme [107779/Z/15/Z,
   ER1505, ER1601]; European Union's Horizon 2020 research and innovation
   program under ZikaPLAN grant [734584]; Medical Research Council on
   behalf of the Newton Fund; Secretaria de Vigilancia em Saude/Ministerio
   da Sau'de de Brasil Resposta a Emergencia em Saude Publica - Zika virus
   e Microcefalia [837058/2016]; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES; Departamento de Ciencia e Tecnologia
   [440839/2016-5]
FX This work was supported by the: Wellcome Trust & the UK's Department for
   International Development (205377/Z/16/Z to LCR;
   https://wellcome.ac.uk/); the Wellcome Trust's Enhancing Research
   Activity in Epidemic Situations programme (107779/Z/15/Z; with ER1505 &
   ER1601 to RAAX); the European Union's Horizon 2020 research and
   innovation program (https://ec.europa.eu/programmes/horizon2020/) under
   ZikaPLAN grant agreement No. 734584 (https://zikaplan.tghn.org/); the
   Medical Research Council on behalf of the Newton Fund and the Wellcome
   Trust (MC_PC_15088 to LCR; https://mrc.ukri.org/); Secretaria de
   Vigilancia em Saude/Ministerio da Sau ' de de Brasil Resposta a
   Emergencia em Saude Publica - Zika virus e Microcefalia (837058/2016 to
   RAAX); the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br/); & the Departamento de Ciencia e
   Tecnologia (http://rebrats.saude.gov.br/noticias/59DECIT) for Prevencao
   e Combate ao virus Zika I (440839/2016-5 to RAAX). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR [Anonymous], 2018, MONITORAMENTO INTEGR
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Barcelos RS, 2019, INJURY PREV, V25, P222, DOI 10.1136/injuryprev-2017-042641
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Vignola RCB, 2014, J AFFECT DISORDERS, V155, P104, DOI 10.1016/j.jad.2013.10.031
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bromley J, 2004, AUTISM, V8, P409, DOI 10.1177/1362361304047224
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   DiGiacomo M, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0668-3
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Eccleston C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009660.pub3
   Oliveira SJGD, 2017, ARCH WOMEN MENT HLTH, V20, P473, DOI 10.1007/s00737-017-0724-y
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Kuper H, 2018, WELLCOME OPEN RES, V3
   Kupferberg A, 2016, NEUROSCI BIOBEHAV R, V69, P313, DOI 10.1016/j.neubiorev.2016.07.002
   Lindo EJ, 2016, FAM RELAT, V65, P207, DOI 10.1111/fare.12185
   Lovibond SH, 1995, MANUAL DEPRESSION AN
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Osborn DPJ, 2001, WESTERN J MED, V175, P329, DOI 10.1136/ewjm.175.5.329
   Pesquisa ABdEd, CRIT CLASS EC BRAS 2
   Pinquart M, 2018, STRESS HEALTH, V34, P197, DOI 10.1002/smi.2780
   Singer GHS, 2006, AM J MENT RETARD, V111, P155, DOI 10.1352/0895-8017(2006)111[155:MOCSOD]2.0.CO;2
   Soares A, 2012, SUPPORT CARE CANCER, V20, P1895, DOI 10.1007/s00520-011-1292-8
   Stabile M, 2012, FUTURE CHILD, V22, P65
   Tilahun D, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1383-9
   Unsal-Delialioglu S, 2009, INT J REHABIL RES, V32, P199, DOI 10.1097/MRR.0b013e32832607b6
   Yilmaz H, 2013, EUR J PHYS REHAB MED, V49, P823
NR 27
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007768
DI 10.1371/journal.pntd.0007768
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100021
PM 31568478
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Maiga, H
   Mamai, W
   Somda, NSB
   Konczal, A
   Wallner, T
   Herranz, GS
   Herrero, RA
   Yamada, H
   Bouyer, J
AF Maiega, Hamidou
   Mamai, Wadaka
   Somda, Nanwintoum Severin Bimbile
   Konczal, Anna
   Wallner, Thomas
   Herranz, Gustavo Salvador
   Herrero, Rafael Argiles
   Yamada, Hanano
   Bouyer, Jeremy
TI Reducing the cost and assessing the performance of a novel adult
   mass-rearing cage for the dengue, chikungunya, yellow fever and Zika
   vector, Aedes aegypti (Linnaeus)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ARABIENSIS DIPTERA-CULICIDAE; BODY-SIZE; ALBOPICTUS DIPTERA;
   OVIPOSITION; POPULATIONS; SURVIVAL; RESERVES; MALES; WATER; DIET
AB Author summary Dengue, among other arboviral infections, is a neglected disease and a major health issue that is re-emerging in tropical countries due to the poor efficacy of conventional vector control methods. Therefore, there is a growing need for more sustainable techniques to control Aedes mosquito species, while reducing the dependence on insecticides. The sterile insect technique, which relies on the mass-production of sterile males, can be used as part of area- wide integrated pest management (AW-IPM) programmes to reduce the vector population below the disease transmission threshold. Therefore, innovations in mosquito mass-rearing techniques including the development of low-cost adult holding cages are essential in the quest to promote an economical and logistically efficient mass -rearing system for the vectors of dengue, chikungunya, yellow fever and Zika diseases.
   Introduction The widespread emergence of resistance to insecticides used to control adult Aedes mosquitoes has made traditional control strategies inadequate for the reduction of various vector populations. Therefore, complementary vector control methods, such as the Sterile Insect Technique, are needed to enhance existing efforts. The technique relies on the rearing and release of large numbers of sterile males, and the development of efficient and standardized mass-rearing procedures and tools is essential for its application against medically important mosquitoes. Methods In the effort to reduce the cost of the rearing process, a prototype low-cost plexiglass mass-rearing cage has been developed and tested for egg production and egg hatch rate in comparison to the current Food and Agriculture Organization/International Atomic Energy Agency (FAO/IAEA) stainless-steel cage. Additionally, an adult-index was validated and used as a proxy to estimate the mosquito survival rates by counting the number of male and female mosquitoes that were resting within each of the 6 squares at a given point of time each day in the cage. Results The study has shown that the prototype mass-rearing cage is cheap and is as efficient as the FAO/IAEA stainless-steel cage in terms of egg production, with even better overall egg hatch rate. The mean numbers of eggs per cage, after seven cycles of blood feeding and egg collection, were 969,789 +/- 138,101 and 779,970 +/- 123,042, corresponding to 81 +/- 11 and 65 +/- 10 eggs per female over her lifespan, in the prototype and the stainless-steel-mass-rearing cages, respectively. The longevity of adult male and female mosquitoes was not affected by cage type and, the adult-index could be considered as an appropriate proxy for survival. Moreover, the mass-rearing cage prototype is easy to handle and transport and improves economic and logistic efficiency. Conclusion The low-cost mass-rearing prototype cage can be recommended to produce Ae. aegypti in the context of rear and release techniques. The proposed adult-index can be used as a quick proxy of mosquito survival rates in mass-rearing settings.
C1 [Maiega, Hamidou; Mamai, Wadaka; Somda, Nanwintoum Severin Bimbile; Konczal, Anna; Wallner, Thomas; Herrero, Rafael Argiles; Yamada, Hanano; Bouyer, Jeremy] IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.
   [Maiega, Hamidou; Somda, Nanwintoum Severin Bimbile] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso.
   [Mamai, Wadaka] Inst Rech Agr Dev, Yaounde, Cameroon.
   [Herranz, Gustavo Salvador] Univ CEU Cardenal Herrera, Tech Sch Design Architecture & Engn, Valencia, Spain.
RP Maiga, H (corresponding author), IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.; Maiga, H (corresponding author), Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso.
EM h.maiga@iaea.org
RI Bouyer, Jeremy/AAK-7370-2020; Mamai, Wadaka/R-2764-2019; MAIGA,
   Hamidou/AAR-3023-2020
OI Bouyer, Jeremy/0000-0002-1913-416X; MAIGA, Hamidou/0000-0001-8662-4700;
   Bimbile Somda, Nanwintoum Severin/0000-0002-3546-3078
FU United States of America
FX The research presented in this paper was partially funded by the United
   States of America under the grant to the IAEA entitled: Surge expansion
   for the sterile insect technique to control mosquito populations that
   transmit the Zika virus. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allan SA, 1998, J MED ENTOMOL, V35, P943, DOI 10.1093/jmedent/35.6.943
   Balestrino F, 2014, J MED ENTOMOL, V51, P155, DOI 10.1603/ME13130
   Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914
   Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839
   Burnham KP, 2003, MODEL SELECTION MULT
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Chadee DD, 2009, ACTA TROP, V111, P279, DOI 10.1016/j.actatropica.2009.05.012
   CHAMBERS DL, 1977, ANNU REV ENTOMOL, V22, P289, DOI 10.1146/annurev.en.22.010177.001445
   CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401
   Damiens D, 2013, J MED ENTOMOL, V50, P336, DOI 10.1603/ME12212
   Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dogan M, 2016, ACTA TROP, V159, P62, DOI 10.1016/j.actatropica.2016.03.032
   Dyck VA, 2005, STERILE INSECT TECHN
   FAO/IAEA, 2018, GUID MASS REAR AED M
   FAO/IAEA, 2017, GUID ROUT COL MAINT, P18
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567
   Gerberg EJ, 1970, MANUAL MOSQUITO REAR
   Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209
   Gomes AD, 2006, REV SOC BRAS MED TRO, V39, P327, DOI 10.1590/S0037-86822006000400002
   HIEN D S, 1976, Acta Parasitologica Polonica, V24, P37
   Huang J, 2018, J MED ENTOMOL, V55, P801, DOI 10.1093/jme/tjy059
   HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006
   JUDSON CHARLES L., 1960, ANN ENT SOC AMER, V53, P688, DOI 10.1093/aesa/53.5.688
   KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902
   Levy-Blitchtein S, 2016, ASIAN PAC J TROP MED, V9, P997, DOI 10.1016/j.apjtm.2016.07.030
   Maiga H, 2017, ENTOMOL EXP APPL, V164, P269, DOI 10.1111/eea.12614
   Maiga H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1119-7
   Maiga H, 2014, ACTA TROP, V132, pS102, DOI 10.1016/j.actatropica.2013.08.018
   Maiga H, 2012, J VECTOR ECOL, V37, P289, DOI 10.1111/j.1948-7134.2012.00230.x
   Mamai W, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1685-3
   MILLER DR, 1973, J THEOR BIOL, V42, P263, DOI 10.1016/0022-5193(73)90089-1
   R Development CORE TEAM R, 2008, R LANG ENV STAT COMP
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   de Abreu FVS, 2015, MEM I OSWALDO CRUZ, V110, P669, DOI 10.1590/0074-02760140490
   STEINWASCHER K, 1984, AM MIDL NAT, V112, P76, DOI 10.2307/2425459
   Villarreal SM, 2018, J INSECT PHYSIOL, V108, P1, DOI 10.1016/j.jinsphys.2018.05.001
   Wermelinger ED, 2015, REV SOC BRAS MED TRO, V48, P770, DOI 10.1590/0037-8682-0087-2015
   World Health Organization, 2017, GLOB VECT CONT RESP
   Zhang DJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2750-7
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2
NR 46
TC 3
Z9 3
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007775
DI 10.1371/journal.pntd.0007775
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100026
PM 31553724
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paixao, ES
   Rodrigues, MS
   Cardim, LL
   Oliveira, JF
   Catharina, LC
   Costa, MDN
   Barreto, ML
   Rodrigues, LC
   Smeeth, L
   Andrade, RFS
   Oliveira, WK
   Teixeira, MG
AF Paixao, Enny S.
   Rodrigues, Moreno S.
   Cardim, Luciana L.
   Oliveira, Juliane F.
   Catharina, L. C.
   Costa, Maria da Conceicao N.
   Barreto, Mauricio L.
   Rodrigues, Laura C.
   Smeeth, Liam
   Andrade, Roberto F. S.
   Oliveira, Wanderson K.
   Teixeira, Maria Gloria
TI Impact evaluation of Zika epidemic on congenital anomalies registration
   in Brazil: An interrupted time series analysis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BIRTH-DEFECTS SURVEILLANCE; CERTIFICATES; INFORMATION; RELIABILITY
AB This study aimed to assess the impact of the Zika epidemic on the registration of birth defects in Brazil. We used an interrupted time series analysis design to identify changes in the trends in the registration of congenital anomalies. We obtained monthly data from Brazilian Live Birth Information System and used two outcome definitions: 1) rate of congenital malformation of the brain and eye (likely to be affected by Zika and its complications) 2) rate of congenital malformation not related to the brain or eye unlikely to be causally affected by Zika. The period between maternal infection with Zika and diagnosis of congenital abnormality attributable to the infection is around six months. We therefore used September 2015 as the interruption point in the time series, six months following March 2015 when cases of Zika started to increase. For the purposes of this analysis, we considered the period from January 2010 to September 2015 to be "pre-Zika event," and the period from just after September 2015 to December 2017 to be "post-Zika event." We found that immediately after the interruption point, there was a great increase in the notification rate of congenital anomalies of 14.9/10,000 live births in the brain and eye group and of 5.2/10,000 live births in the group not related with brain or eye malformations. This increase in reporting was in all regions of the country (except in the South) and especially in the Northeast. In the period "post-Zika event", unlike the brain and eye group which showed a monthly decrease, the group without brain or eye malformations showed a slow but significant increase (relative to the pre-Zika trend) of 0.2/10,000 live births. These findings suggest an overall improvement in the registration of birth malformations, including malformations that were not attributed to Zika, during and after the Zika epidemic.
   Author summary Zika can be characterized as one of the most significant emerging arboviruses. The Zika epidemic in Brazil and the subsequent increase in the number of serious brain anomalies, such as microcephaly, has demonstrated the importance of analysing the impact of Zika infection on the rate of congenital anomalies in an affected population. From the analysis of the monthly data on the Live Birth Information System, the authors found that immediately after the Zika event there was a large increase in the notification rate of congenital anomalies reported as a complication of which infection (malformations of brain and eye) and also an increase in the rate of congenital malformations not related with Zika. This growth was seen throughout the country as a whole and in all regions (except in the South), especially in the Northeast where the infection rates were the highest. In the period post-Zika event, the group not related with brain or eye malformation there was an increase in the monthly notification rate while in the brain and eye group there was a decrease in the monthly notification rate. These findings suggest an overall growing awareness of health professionals to improve the registration of birth malformations trigged by the Zika epidemic.
C1 [Paixao, Enny S.; Rodrigues, Moreno S.; Cardim, Luciana L.; Oliveira, Juliane F.; Catharina, L. C.; Barreto, Mauricio L.; Andrade, Roberto F. S.] Fiocruz MS, Ctr Integracao Dados & Conhecimentos Saude, Ctr Pesquisas Goncalo Muniz, Salvador, BA, Brazil.
   [Paixao, Enny S.; Rodrigues, Laura C.; Smeeth, Liam; Teixeira, Maria Gloria] London Sch Hyg & Trop Med, Epidemiol & Populat Hlth, London, England.
   [Costa, Maria da Conceicao N.; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Andrade, Roberto F. S.] Univ Fed Bahia, Inst Fis, Salvador, BA, Brazil.
   [Oliveira, Wanderson K.] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
RP Paixao, ES (corresponding author), Fiocruz MS, Ctr Integracao Dados & Conhecimentos Saude, Ctr Pesquisas Goncalo Muniz, Salvador, BA, Brazil.; Paixao, ES (corresponding author), London Sch Hyg & Trop Med, Epidemiol & Populat Hlth, London, England.
EM enny.cruz@lshtm.ac.uk
RI Oliveira, Wanderson/AAF-5182-2019; Fonseca de Oliveira,
   Juliane/W-6438-2018
OI Oliveira, Wanderson/0000-0002-9662-1930; Rodrigues,
   Moreno/0000-0002-1594-2311; Fonseca de Oliveira,
   Juliane/0000-0002-7167-8754
FU Wellcome TrustWellcome Trust [213589/Z/18/Z]
FX ESP is funded by the Wellcome Trust (grant number 213589/Z/18/Z). The
   funders had no role in study design, analysis, decision to publish or
   preparation of the manuscript.
CR Almeida Geremias A.L.a, 2009, REV BRAS EPIDEMIOL, V12, P1, DOI DOI 10.1590/S1415-790X2009000100007
   [Anonymous], 2015, FINAL REPORT ECLAMC
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bonilha ED, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/s1679-49742018000100011, 10.5123/S1679-49742018000100011]
   Boyd PA, 2005, BMJ-BRIT MED J, V330, P27, DOI 10.1136/bmj.38300.665301.3A
   Brasil. Ministerio da Saude, MIN SAUD DECL FIM EM
   Brasil. Ministerio da Saude, 2013, COORD GER INF AN EP, V24
   Pavao ALB, 2017, REV SOC BRAS MED TRO, V50, P450, DOI 10.1590/0037-8682-0506-2016
   Broussard CS, 2018, PEDIATRICS, V141, pS146, DOI 10.1542/peds.2017-2038C
   Butler D., 2016, NAT NEWS EXPLAI 0321
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Correa-Villasenor A, 2003, BIRTH DEFECTS RES A, V67, P610, DOI 10.1002/bdra.10110
   de Oliveira MM, 2015, EPIDEMIOL SERV SAUDE, V24, P629, DOI 10.5123/S1679-49742015000400005
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabriel Guilherme Paiva, 2014, Rev. paul. pediatr., V32, P183, DOI 10.1590/0103-0582201432306
   Guerra FAR, 2008, CAD SAUDE PUBLICA, V24, P438, DOI [10.1590/S0102-311X2008000200023, 10.1590/S0102-311X2008000100014]
   Hamer DH, 2019, J TRAVEL MED, DOI [10.1093/jtm/taz012, DOI 10.1093/JTM/TAZ01230753689]
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208
   Luquetti DV, 2009, CAD SAUDE PUBLICA, V25, P1721, DOI 10.1590/S0102-311X2009000800008
   Ministerio da Saude (BR), 2012, RED INT INF SAUD IND
   Nhoncanse GC, 2012, CIENC SAUDE COLETIVA, V17, P955, DOI 10.1590/S1413-81232012000400017
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tanner JP, 2010, BIRTH DEFECTS RES A, V88, P1017, DOI 10.1002/bdra.20718
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Watkins ML, 1996, AM J PUBLIC HEALTH, V86, P731, DOI 10.2105/AJPH.86.5.731
   Watts AG, 2018, J TRAVEL MED, V25, DOI [10.1093/jtm/tay132, DOI 10.1093/JTM/TAY13230476232, 10.1093/jtm/tay132 30476232]
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
NR 29
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007721
DI 10.1371/journal.pntd.0007721
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100006
PM 31545803
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Proesmans, S
   Katshongo, F
   Milambu, J
   Fungula, B
   Mavoko, HM
   Ahuka-Mundeke, S
   da Luz, RI
   Van Esbroeck, M
   Arien, KK
   Cnops, L
   De Smet, B
   Lutumba, P
   Van Geertruyden, JP
   Vanlerberghe, V
AF Proesmans, Sam
   Katshongo, Freddy
   Milambu, John
   Fungula, Blaise
   Muhindo Mavoko, Hypolite
   Ahuka-Mundeke, Steve
   Inocencio da Luz, Raquel
   Van Esbroeck, Marjan
   Arien, Kevin K.
   Cnops, Lieselotte
   De Smet, Birgit
   Lutumba, Pascal
   Van Geertruyden, Jean-Pierre
   Vanlerberghe, Veerle
TI Dengue and chikungunya among outpatients with acute undifferentiated
   fever in Kinshasa, Democratic Republic of Congo: A cross-sectional study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS-INFECTIONS; YELLOW-FEVER; MALARIA; SEROPREVALENCE; IDENTIFICATION;
   SURVEILLANCE; RESURGENCE; EPIDEMIC; TANZANIA; SPREAD
AB Background Pathogens causing acute fever, with the exception of malaria, remain largely unidentified in sub-Saharan Africa, given the local unavailability of diagnostic tests and the broad differential diagnosis. Methodology We conducted a cross-sectional study including outpatient acute undifferentiated fever in both children and adults, between November 2015 and June 2016 in Kinshasa, Democratic Republic of Congo. Serological and molecular diagnostic tests for selected arboviral infections were performed on blood, including PCR, NS1-RDT, ELISA and IFA for acute, and ELISA and IFA for past infections. Results Investigation among 342 patients, aged 2 to 68 years (mean age of 21 years), with acute undifferentiated fever (having no clear focus of infection) revealed 19 (8.1%) acute dengue-caused by DENV-1 and/or DENV-2 -and 2 (0.9%) acute chikungunya infections. Furthermore, 30.2% and 26.4% of participants had been infected in the past with dengue and chikungunya, respectively. We found no evidence of acute Zika nor yellow fever virus infections. 45.3% of patients tested positive on malaria Rapid Diagnostic Test, 87.7% received antimalarial treatment and 64.3% received antibacterial treatment. Discussion Chikungunya outbreaks have been reported in the study area in the past, so the high seroprevalence is not surprising. However, scarce evidence exists on dengue transmission in Kinshasa and based on our data, circulation is more important than previously reported. Furthermore, our study shows that the prescription of antibiotics, both antibacterial and antimalarial drugs, is rampant. Studies like this one, elucidating the causes of acute fever, may lead to a more considerate and rigorous use of antibiotics. This will not only stem the ever-increasing problem of antimicrobial resistance, but will-ultimately and hopefully-improve the clinical care of outpatients in low-resource settings.
   Author summary Malaria remains one of the most important causes of fever in sub-Saharan Africa. However, its share is declining, since the diagnosis and treatment of malaria have improved significantly over the years. Hence leading to an increase in the number of patients presenting with non-malarial fever. Often, obvious clinical signs and symptoms like cough or diarrhea are absent, probing the question: "What causes the fever?" Previous studies have shown that the burden of arboviral infections-like dengue and chikungunya-in sub-Saharan Africa is underestimated, which is why we screened for four common arboviral infections in patients presenting with 'undifferentiated fever' at an outpatient clinic in suburban Kinshasa, Democratic Republic of Congo. Among the patients tested, we found that one in ten presented with an acute arboviral infection and that almost one in three patients had been infected in the past. These findings suggest that clinicians should think about arboviral infections more often, thereby refraining from the prescription of antibiotics, a practice increasingly problematic given the global rise of antimicrobial resistance.
C1 [Proesmans, Sam; Muhindo Mavoko, Hypolite; Arien, Kevin K.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Antwerp, Belgium.
   [Katshongo, Freddy] Inst Super Tech Med, Kinshasa, DEM REP CONGO.
   [Milambu, John; Fungula, Blaise] Ctr Hosp Lisungi, Kinshasa, DEM REP CONGO.
   [Muhindo Mavoko, Hypolite; Ahuka-Mundeke, Steve; Lutumba, Pascal] Univ Kinshasa, Kinshasa, DEM REP CONGO.
   [Ahuka-Mundeke, Steve; Lutumba, Pascal] Inst Natl Res Biomed, Kinshasa, DEM REP CONGO.
   [Inocencio da Luz, Raquel; Van Esbroeck, Marjan; Arien, Kevin K.; Cnops, Lieselotte; De Smet, Birgit; Vanlerberghe, Veerle] Inst Trop Med, Antwerp, Belgium.
RP Proesmans, S (corresponding author), Univ Antwerp, Antwerp, Belgium.
EM sam.proesmans@gmail.com
RI ; Van geertruyden, Jean-Pierre/K-6425-2014
OI Cnops, Lieselotte/0000-0003-0658-1291; Proesmans,
   Sam/0000-0002-1246-5118; Van geertruyden,
   Jean-Pierre/0000-0001-5006-6364; Van Esbroeck,
   Marjan/0000-0002-7294-6319
FU Institute of Tropical Medicine; Belgian development cooperation; Vlaamse
   Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking
   (VLIR-UOS) [ZRDC2014MP083]
FX This study was co-funded by the framework agreement between the
   Institute of Tropical Medicine and the Belgian development cooperation
   (https://www.itg.be/E/cooperation) to VV and Vlaamse Interuniversitaire
   Raad - Universitaire Ontwikkelingssamenwerking
   (https://www.vliruos.be/en) (VLIR-UOS, Grant reference ZRDC2014MP083) to
   JPVG. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Barbazan P, 2002, MICROBES INFECT, V4, P699, DOI 10.1016/S1286-4579(02)01589-7
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Carabali M, 2017, INT J INFECT DIS, V58, P27, DOI 10.1016/j.ijid.2017.02.016
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x
   Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
   D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482
   D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107
   D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240
   Dariano DF, 2017, AM J TROP MED HYG, V97, P1151, DOI 10.4269/ajtmh.16-0798
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128
   Dhanoa A, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-017-0384-1
   Franco L, 2010, EURO SURVEILL, V15
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Gibney KB, 2012, AM J TROP MED HYG, V87, P1112, DOI 10.4269/ajtmh.2012.12-0182
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Grossi-Soyster EN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005998
   Hopkins H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1054
   Ido E, 2016, ANN AFRICAN MED, V10
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Leslie T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095002
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Makiala-Mandanda S, 2018, VECTOR-BORNE ZOONOT, V18, P364, DOI 10.1089/vbz.2017.2176
   Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764
   Mavoko H, 2017, INT J TROPICAL MED P, V7, P7
   Mavoko HM, 2017, LANCET GLOB HEALTH, V5, pE60, DOI 10.1016/S2214-109X(16)30236-4
   Mbanzulu KM, 2017, INT J INFECT DIS, V57, P32, DOI 10.1016/j.ijid.2017.01.016
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Mugabe VA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192110
   Mumba D, 2018, AM J TROP MED HYG, DOI [10.4269/ajtmh.18-0156, DOI 10.4269/AJTMH.18-015629988000]
   Ntamabyaliro NY, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2332-3
   Nur YA, 1999, AM J TROP MED HYG, V61, P885, DOI 10.4269/ajtmh.1999.61.885
   Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168
   Pezzi L, 2019, ANTIVIR RES, V166, P66, DOI 10.1016/j.antiviral.2019.03.009
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497
   Sharp TM, 2015, EMERG INFECT DIS, V21, P1311, DOI 10.3201/eid2108.150368
   Sierra B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006220
   Tsegaye MM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5726-9
   Vairo F, 2012, INT J INFECT DIS, V16, pE44, DOI 10.1016/j.ijid.2011.09.018
   Van Den Bossche D, 2015, EPIDEMIOL INFECT, V143, P2227, DOI 10.1017/S0950268814000685
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   Ward T, 2017, TROP MED INT HEALTH, V22, P960, DOI 10.1111/tmi.12903
   WHO, 2018, WORLD MAL REP 2018
   World Health Organization, 2017, WORLD MAL REP 2017
NR 57
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007047
DI 10.1371/journal.pntd.0007047
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100012
PM 31487279
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rivera-Correa, J
   de Siqueira, IC
   Mota, S
   do Rosario, MS
   de Jesus, PAP
   Alcantara, LCJ
   Ernst, JD
   Rodriguez, A
AF Rivera-Correa, Juan
   de Siqueira, Isadora Cristina
   Mota, Sabrina
   do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Junior Alcantara, Luiz Carlos
   Ernst, Joel D.
   Rodriguez, Ana
TI Anti-ganglioside antibodies in patients with Zika virus
   infection-associated Guillain-Barre Syndrome in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; CAMPYLOBACTER-JEJUNI; AUTOIMMUNITY; AUTOANTIBODIES;
   OUTBREAK; AMERICA
AB Author summary Zika virus infection can trigger the development of Guillain Barre syndrome (GBS), a neurological autoimmune disorder mediated by antibodies recognizing gangliosides in nerve membranes. Mechanisms such as molecular mimicry have been identified as a cause for GBS development in certain infections, such as Campylobacter jejuni, but the broad self reactivity observed during GBS suggests a role for alternative mechanisms. Our finding that Zika patients with GBS present higher levels of anti-ganglioside antibodies compared to uncomplicated Zika patients in Brazil points to these auto-antibodies as a trigger for GBS in these patients. These findings further support infection-induced autoantibodies as a factor contributing to GBS development, adding novel mechanisms for GBS development beyond molecular mimicry.
   Zika virus infection is associated with the development of Guillain-Barre syndrome (GBS), a neurological autoimmune disorder caused by immune recognition of gangliosides and other components at nerve membranes. Using a high-throughput ELISA, we have analyzed the anti-glycolipid antibody profile, including gangliosides, of plasma samples from patients with Zika infections associated or not with GBS in Salvador, Brazil. We have observed that Zika patients that develop GBS present higher levels of anti-ganglioside antibodies when compared to Zika patients without GBS. We also observed that a broad repertoire of gangliosides was targeted by both IgM and IgG anti-self antibodies in these patients. Since Zika virus infects neurons, which contain membrane gangliosides, antigen presentation of these infected cells may trigger the observed autoimmune anti-ganglioside antibodies suggesting direct infection-induced autoantibodies as a cause leading to GBS development. Collectively, our results establish a link between anti-ganglioside antibodies and Zika-associated GBS in patients.
C1 [Rivera-Correa, Juan; Mota, Sabrina; Ernst, Joel D.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
   [de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Pereira de Jesus, Pedro Antonio] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos] Fundaco Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Ernst, Joel D.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.
RP Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
EM ana.rodriguez@nyumc.org
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; do Rosario,
   Mateus/0000-0001-7404-6392; Ernst, Joel/0000-0001-9951-6207; Rodriguez,
   Ana/0000-0002-0060-3405; Alcantara, Luiz/0000-0002-6769-9931;
   Rivera-Correa, Juan/0000-0003-4822-0005
FU New York University School of Medicine Internal Funds
FX AR and JRC received funding for this project from New York University
   School of Medicine Internal Funds. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Arroyo-Avila M, 2017, AM J TROP MED HYG, V96, P916, DOI 10.4269/ajtmh.16-0890
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   do Rosario M, 2018, INT J INFECT DIS, V73, P49, DOI 10.1016/j.ijid.2018.04.3534
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flodstrom-Tullberg M, 2003, MICROBES INFECT, V5, P911, DOI 10.1016/S1286-4579(03)00161-8
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Koga M, 2015, J NEUROL, V262, P1954, DOI 10.1007/s00415-015-7806-4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Leuchten N, 2018, ARTHRIT CARE RES, V70, P428, DOI 10.1002/acr.23292
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Nico D, 2018, FRONT MED-LAUSANNE, V5, DOI [10.3389/fmed.2018.00025, 10.3389/fmed2018.00025]
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Ravindranath MH, 2005, ANN NY ACAD SCI, V1050, P229, DOI 10.1196/annals.1313.024
   Rinaldi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082337
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Steiner I, 2005, EUR J NEUROL, V12, P331, DOI 10.1111/j.1468-1331.2005.01126.x
   Tanay A, 2017, CURR OPIN RHEUMATOL, V29, P389, DOI 10.1097/BOR.0000000000000396
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Van Der Meche F. G. A., 1995, Annals of Neurology, V37, pS14
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
NR 37
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007695
DI 10.1371/journal.pntd.0007695
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100033
PM 31527907
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Halstead, SB
AF Halstead, Scott B.
TI Travelling arboviruses: A historical perspective
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Chikungunya; Arboviruses; Perspective
ID CHIKUNGUNYA VIRUS-INFECTION; SYLVATIC DENGUE VIRUS; ZIKA VIRUS;
   YELLOW-FEVER; PROTEIN NS1; THAILAND; ENHANCEMENT; DISEASE; EMERGENCE;
   PROSPECTS
AB Chikungunya, dengue, yellow fever and Zika viruses share many attributes. All are complex and widespread zoonoses of subhuman primates that have made successful transitions to the urban Aedes aegypti transmission cycle. More important, they have an established record of travelling, having moved from their place of origin hundreds of years ago, sometimes repeatedly. Understanding their epidemiology requires a knowledge of past behaviors including unexplained restraints to their travel. This is a review of mechanisms that may contribute to invasiveness and pathogenicity of these important human pathogens.
C1 [Halstead, Scott B.] Uniformed Serv Univ Hlth Sci, 5824 Edson Lane N, Bethesda, MD 20852 USA.
RP Halstead, SB (corresponding author), Uniformed Serv Univ Hlth Sci, 5824 Edson Lane N, Bethesda, MD 20852 USA.
EM halsteads@erols.cm
CR Althouse BM, 2014, VIROLOGY, V452, P237, DOI 10.1016/j.virol.2014.01.015
   ANDERSON CR, 1956, SCIENCE, V124, P224, DOI 10.1126/science.124.3214.224
   ANDERSON CR, 1965, CURR SCI INDIA, V34, P579
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Bylon D, 1780, VERHANDELUNGEN VANHE, V2, P17
   CAREY DE, 1969, T ROY SOC TROP MED H, V63, P434, DOI 10.1016/0035-9203(69)90030-3
   Chen J, 2016, BIOSCI TRENDS, V10, P158, DOI 10.5582/bst.2016.01051
   Christie J, 1872, Br Med J, V1, P577
   Christie James, 1881, Glasgow Med J, V16, P161
   Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139
   Eckert J, 1993, Trans Stud Coll Physicians Phila, V15, P31
   Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P972, DOI 10.4269/ajtmh.1969.18.972
   HALSTEAD SB, 1965, YALE J BIOL MED, V37, P434
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P1022, DOI 10.4269/ajtmh.1969.18.1022
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997
   HALSTEAD SB, 1966, B WORLD HEALTH ORGAN, V35, P3
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2018, HUM VACC IMMUNOTHER, V14, P2158, DOI 10.1080/21645515.2018.1445448
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hare FE, 1898, AUSTR MED GAZ, V17, P98
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Morillon M, 2002, EUROPEAN ANTHR ASS B, P211
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Nisalak A, 1998, INT C EM INF DIS 8 1
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Powell JR, 2018, BIOSCIENCE, V68, P854, DOI 10.1093/biosci/biy119
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   RAO T. R., 1966, Science and Culture, V32, P215
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE495, DOI 10.1016/S2214-109X(18)30123-2
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   RUSH B, 1789, MED INQUIRIES OBSERV, P89
   Sabin AB, 1952, VIRAL RICKETTSIAL IN, P556
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SARKAR J. K., 1966, INDIAN J PATHOL BACTERIOL, V9, P123
   SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1
   Simo FBN, 2019, PUBLIC HEALTH, V166, P79, DOI 10.1016/j.puhe.2018.09.027
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Martelli CMT, 2011, AM J TROP MED HYG, V85, P732, DOI 10.4269/ajtmh.2011.11-0067
   Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10
   Vasilakis N, 2008, EMERG INFECT DIS, V14, P502, DOI 10.3201/eid1403.070843
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wilder-Smith A, 2019, LANCET INFECT DIS, V19, pE31, DOI 10.1016/S1473-3099(18)30494-8
   Yacoub S, 2015, LANCET, V385, P102, DOI 10.1016/S0140-6736(15)60417-2
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 63
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2019
VL 31
AR UNSP 101471
DI 10.1016/j.tmaid.2019.101471
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JF2RB
UT WOS:000491232000025
PM 31472285
DA 2020-07-08
ER

PT J
AU Zambrano, LI
   Rodriguez, E
   Espinoza-Salvado, IA
   Rodriguez-Morales, AJ
AF Zambrano, Lysien I.
   Rodriguez, Edith
   Alfonso Espinoza-Salvado, Ivan
   Rodriguez-Morales, Alfonso J.
TI Dengue in Honduras and the Americas: The epidemics are back!
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
DE Dengue; Severe dengue; Arbovirus; Chikungunya; Zika; Travelers;
   Epidemic; Honduras; Latin America
ID ZIKA VIRUS; CHIKUNGUNYA; TRAVELER
C1 [Zambrano, Lysien I.] Univ Nacl Autonoma Honduras, Sch Med Sci, Dept Morphol Sci, Tegucigalpa, Honduras.
   [Zambrano, Lysien I.] Univ Fed Sao Paulo, Escola Paulista Med UNIFESP EPM, Dept Physiol, Cardiovasc Div, Sao Paulo, Brazil.
   [Zambrano, Lysien I.; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Rodriguez, Edith] Secretaria Salud, Unidad Vigilancia Salud, Tegucigalpa, Honduras.
   [Alfonso Espinoza-Salvado, Ivan] Univ Nacl Autonoma Honduras, Fac Ciencias Med, Unidad Invest Cient, Tegucigalpa, Honduras.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Pan Amer Assoc Infect Dis API, Comm Travel Med, Panama City, Panama.
RP Rodriguez-Morales, AJ (corresponding author), Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI Zambrano, Lysien Ivania/N-8843-2015
OI Zambrano, Lysien Ivania/0000-0001-9002-5807
CR Dubrocq G, 2017, J PEDIATR INFECT DIS, V6, pE158, DOI 10.1093/jpids/pix048
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   PAHO, 2019, DENG 25 JUN 2019 EP
   PAHO, 2019, HLTH INF PLATF AM PL
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Parker C, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132399
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Pezzi L, 2019, ANTIVIR RES, V166, P66, DOI 10.1016/j.antiviral.2019.03.009
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Zambrano LI, 2012, TROP BIOMED, V29, P499
   Zambrano LI, 2019, TRAVEL MED INFECT DI, V31, DOI 10.1016/j.tmaid.2019.01.017
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
NR 15
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2019
VL 31
AR UNSP 101456
DI 10.1016/j.tmaid.2019.07.012
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JF2RB
UT WOS:000491232000009
PM 31326532
DA 2020-07-08
ER

PT J
AU Zambrano, LI
   Vasquez-Bonilla, WO
   Fuentes-Barahona, IC
   da Silva, JC
   Valle-Reconco, JA
   Medina, MT
   England, JD
   Sanchez-Duque, JA
   Rodriguez-Morales, AJ
AF Zambrano, Lysien, I
   Vasquez-Bonilla, Walter O.
   Fuentes-Barahona, Itzel Carolina
   da Silva, Jose Claudio
   Valle-Reconco, Jorge Alberto
   Medina, Marco Tulio
   England, John D.
   Sanchez-Duque, Jorge A.
   Rodriguez-Morales, Alfonso J.
TI Spatial distribution of Zika in Honduras during 2016-2017 using
   geographic information systems (GIS) - Implications for public health
   and travel medicine
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus (ZIKV); Geographical information systems (GIS); Public
   health; Travelers; Arboviruses; Infectious diseases epidemiology;
   Honduras
ID OUTBREAK IMPLICATIONS; MAPPING ZIKA; CHIKUNGUNYA; DENGUE; VIRUS;
   COLOMBIA; COINFECTION; FEVER; MUNICIPALITIES; EPIDEMIOLOGY
AB Background: Zika virus (ZIKV) infection has significantly affected Latin America in 2015-2017. Most studies have been reported from Brazil and Colombia, and only a few from Central America. For these reasons, we analyzed the incidence, incidence rates and evolution of cases in Honduras from 2016 to 2017.
   Methods: Using epidemiological weeks (EW) surveillance data on the ZIKV epidemics in Honduras, we estimated incidence rates (cases/100,000 population), and developed maps at national, departmental and municipal levels.
   Results: From 1 January 2016 to 31 December 2017, a total of 32,607 cases of ZIKV were reported (98.5% in 2016 for an incidence rate of 36.85 cases/100,000 pop; 1% confirmed by RT-PCR). The highest peak was reached on the EW 6 degrees, 2016 (2559 cases; 29.34 cases/100,000 pop). The department with the highest number of cases and incidence rate was Cortes (13,128 cases, 791.08 cases/100,000 pop in 2016).
   Discussion: The pattern and evolution of ZIKV infection in Honduras have been similar to that which occurred for chikungunya in 2015. As previously reported, infection with chikungunya involved predominantly the central and capital area of the country, reaching incidences there > 750 cases/100,000 pop. Studies using geographical information systems linked with clinical disease characteristics are necessary to attain accurate epidemiological data for public health systems. Such information is also useful for assessment of risk for travelers who visit specific areas in a destination country.
C1 [Zambrano, Lysien, I] Univ Nacl Autonoma Honduras, Sch Med, Dept Morphol Sci, Sci, Tegucigalpa, Honduras.
   [Zambrano, Lysien, I] Univ Fed Sao Paulo, Dept Physiol, Cardiovasc Div, UNIFESP,EPM, Sao Paulo, Brazil.
   [Zambrano, Lysien, I; Medina, Marco Tulio; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Vasquez-Bonilla, Walter O.; Fuentes-Barahona, Itzel Carolina; Valle-Reconco, Jorge Alberto; Medina, Marco Tulio] Univ Nacl Autonoma Honduras, Sch Med Sci, Tegucigalpa, Honduras.
   [Fuentes-Barahona, Itzel Carolina] Hosp Escuela Tegucigalpa, Dept Gynecol & Obstet, Tegucigalpa, Honduras.
   [da Silva, Jose Claudio] Ctr Univ CESMAC, Maceio, Alagoas, Brazil.
   [da Silva, Jose Claudio] State Univ Hlth Sci Alagoas UNCISAL, Alagoas, Brazil.
   [Medina, Marco Tulio; England, John D.] World Federat Neurol Zika Working Grp, London SW6 3JA, England.
   [England, John D.] Louisiana State Univ Hlth Sci, Dept Neurol, New Orleans, LA USA.
   [Sanchez-Duque, Jorge A.; Rodriguez-Morales, Alfonso J.] UTP, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Asociac Panamer Infectol, Comm Travel Med, Panama City, Panama.
   [Rodriguez-Morales, Alfonso J.] UniFranz, Med Sch, Fac Hlth Sci, Cochabamba, Bolivia.
RP Rodriguez-Morales, AJ (corresponding author), Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI da Silva, Jose Claudio/D-8731-2016; Zambrano, Lysien/R-5628-2019
OI da Silva, Jose Claudio/0000-0003-3749-2822; Zambrano,
   Lysien/0000-0001-9002-5807; Medina, Marco Tulio/0000-0003-0469-054X;
   Vasquez Bonilla, Walter Oqueli/0000-0003-1372-8933; Fuentes Barahona,
   Itzel Carolina/0000-0002-9995-2276; Sanchez Duque, Jorge
   Andres/0000-0002-8913-7729
FU Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia [5-15-5
   [2015-2017]]
FX Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia. This
   study is part of the project "Desarrollo de Mapas Epidemiologicos a
   traves de Sistemas de Informacion Geografica para la Caracterizacion
   Geografica de Enfermedades Infecciosas y Tropicales en el Eje Cafetero
   de Colombia" (Code 5-15-5 [2015-2017]), Universidad Tecnologica de
   Pereira, Pereira, Risaralda, Colombia. Training on GIS for A. J.
   Rodriguez-Morales was funded by Universidad Tecnologica de Pereira,
   Pereira, Risaralda, Colombia.
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Alvarado-Arnez LE, 2018, TRAVEL MED INFECT DI, V25, P1, DOI 10.1016/j.tmaid.2018.06.014
   Martinez-Vega RA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2055-4
   Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Bangert M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0288-0
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Brissett DI, 2018, AM J TROP MED HYG, V99, P211, DOI 10.4269/ajtmh.18-0014
   Brooks T, 2017, EMERG INFECT DIS, V23, P1360, DOI 10.3201/eid2308.161944
   Buekens P, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0200-6
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   de Magalhaes-Barbosa MC, 2017, TRAVEL MED INFECT DI, V16, P52, DOI 10.1016/j.tmaid.2017.03.009
   De Pijper CA, 2019, TRAVEL MED INFECT DI, V27, P119, DOI 10.1016/j.tmaid.2018.09.009
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duman-Scheel M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201075
   England JD, 2017, WORLD NEUROL, V32, P13
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Figueroa M, 1982, Bull Pan Am Health Organ, V16, P130
   Gray D, 2019, GLOB PUBLIC HEALTH, V14, P9, DOI 10.1080/17441692.2018.1471146
   Jaramillo-Martinez GA, 2018, J INFECT PUBLIC HEAL, V11, P145, DOI 10.1016/j.jiph.2017.03.001
   Long D, 2016, J EMERG MED, V50, P832, DOI 10.1016/j.jemermed.2016.03.033
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Mesa Despaigne Arelis, 2013, MEDISAN, V17, P3001
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Nicoletti L, 2008, EMERG INFECT DIS, V14, P177, DOI 10.3201/eid1401.070618
   Noor R, 2018, J INFECT PUBLIC HEAL, V11, P611, DOI 10.1016/j.jiph.2018.04.007
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Pachar MR, 2018, AM J TROP MED HYG, V99, P1318, DOI 10.4269/ajtmh.18-0261
   Pan American Health Organization; World Health Organization, 2018, ZIK CAS CONG SYNDR A
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Perich MJ, 2001, J AM MOSQUITO CONTR, V17, P221
   Quintero-Herrera LL, 2015, J INFECT PUBLIC HEAL, V8, P291, DOI 10.1016/j.jiph.2014.11.005
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Rodriguez-Morales AJ, 2017, J PREVENT EPIDEMIOL, V3, pe01, DOI [10.15171/jpe.2018.01, DOI 10.15171/JPE.2018.01]
   Rodriguez-Morales AJ, 2018, CURRENT TOPICS ZIKA, DOI [10.5772/intechopen.72571, DOI 10.5772/INTECHOPEN.72571]
   Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI, V25, P20, DOI 10.1016/j.tmaid.2018.06.006
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rosales A, 2017, INT J HEALTH GOV, V22, P83, DOI 10.1108/IJHG-11-2016-0053
   Sanchez-Duque JA, 2018, CURRENT TOPICS ZIKA, DOI [10.5772/intechopen.77180, DOI 10.5772/INTECHOPEN.77180]
   Chaves TDS, 2018, TRAVEL MED INFECT DI, V23, P1, DOI 10.1016/j.tmaid.2018.05.001
   Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002
   Villamil-Gomez WE, 2017, J INFECT PUBLIC HEAL, V10, P133, DOI 10.1016/j.jiph.2016.02.003
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
   Zambrano LI, 2012, TROP BIOMED, V29, P499
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 61
TC 2
Z9 2
U1 8
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2019
VL 31
AR UNSP 101382
DI 10.1016/j.tmaid.2019.01.017
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA JF2RB
UT WOS:000491232000022
PM 30721779
DA 2020-07-08
ER

PT J
AU Coudray, M
   Kiplagat, S
   Madhivanan, P
AF Coudray, Makella
   Kiplagat, Sandra
   Madhivanan, Purnima
TI Does Zika Virus Lead to Microcephaly in Organoids?
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
C1 [Coudray, Makella; Kiplagat, Sandra] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol, Miami, FL 33199 USA.
   [Madhivanan, Purnima] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, 1295 N Martin Ave,POB 245209, Tucson, AZ 85724 USA.
RP Coudray, M (corresponding author), Robert Stempel Coll Publ Hlth, Dept Epidemiol, AHC 5,11200 SW 8th St, Miami, FL 33199 USA.
EM mcoud001@fiu.edu
RI Madhivanan, Purnima/AAH-4849-2019
OI Madhivanan, Purnima/0000-0001-7818-3394; Coudray,
   Makella/0000-0002-5906-3220
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R15AI28714-01]
FX M. C. and P. M. were supported by the NIH (grant number R15AI28714-01).
CR Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Sutarjono B, 2019, J INFECT DIS, V219, P734, DOI 10.1093/infdis/jiy572
NR 2
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2019
VL 220
IS 5
BP 913
EP 913
DI 10.1093/infdis/jiz215
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9BS
UT WOS:000490984100017
PM 31028387
DA 2020-07-08
ER

PT J
AU Sutarjono, B
AF Sutarjono, Bayu
TI Does Zika Virus Lead to Microcephaly in Organoids? Reply
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
C1 [Sutarjono, Bayu] Saba Univ, Sch Med, 27 Jackson Rd, Devens, MA 01434 USA.
RP Sutarjono, B (corresponding author), Saba Univ, Sch Med, 27 Jackson Rd, Devens, MA 01434 USA.
CR Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010
   Choate P., 2011, HUFFPOST
   Coudray M, 2019, J INFECT DIS, V220, P913, DOI 10.1093/infdis/jiz215
   Garmendia CA, 2019, JAMA INTERN MED, V179, P582, DOI 10.1001/jamainternmed.2018.7661
   Kelly Jacalyn, 2014, EJIFCC, V25, P227
   Osborne J, 2010, SCIENCE, V328, P1354
   Sutarjono B, 2019, J INFECT DIS, V219, P734, DOI 10.1093/infdis/jiy572
   Tomkins A, 2017, P NATL ACAD SCI USA, V114, P12708, DOI 10.1073/pnas.1707323114
NR 8
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2019
VL 220
IS 5
BP 913
EP 915
DI 10.1093/infdis/jiz216
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9BS
UT WOS:000490984100018
PM 31028397
DA 2020-07-08
ER

PT J
AU Perafan-Ledezma, AL
   Martinez-Duenas, WA
AF Lorena Perafan-Ledezma, Astrid
   Andres Martinez-Duenas, William
TI Knowledge, perceptions and practices regarding Zika virus of university
   students in northern Colombia (Santa Marta, 2016)
SO DUAZARY
LA English
DT Article
DE Zika Virus; ZIKV; Infectious disease vectors; Vector Borne Disease; VBD;
   knowledge; Colombia
ID AEDES-AEGYPTI; ATTITUDES; TRANSMISSION; INFECTION; PREVALENCE; VACCINES;
   DISEASE; WOMEN
AB This study focuses on the knowledge, perceptions and practices of 171 university students regarding Zika virus and its vector in Santa Marta (Colombia) in 2016. A survey was conducted, and the answers about causative agent and mode of transmission were classified into three levels of knowledge. Altogether, 32.1% of the students stated that they had suffered from Zika. A total of 60% stated that they knew what the disease was; however, only 29.2% knew what the causative agent was, and 45.6% knew the mode of transmission. Regarding the level of knowledge, only 14.6% knew the causative agent and the mode of transmission (Level 2). In general, the students recognize the symptoms of Zika virus, and 53.8% of them consider Zika to be very serious. More than half of them believe that they, the community, and the government are responsible for controlling the vector. Even though more than half the students know the most important strategies to control the vector, they do not apply them; the reasons for this might be their everyday habits, the lack of organization in their communities, a deficient public health system, and climate change. It is recommended to implement permanent strategies for vector control that take into account the sociocultural characteristics of at-risk populations.
C1 [Lorena Perafan-Ledezma, Astrid; Andres Martinez-Duenas, William] Univ Magdalena, Santa Marta, Colombia.
RP Perafan-Ledezma, AL (corresponding author), Univ Magdalena, Santa Marta, Colombia.
EM aperafan@unimagdalena.edu.co; wmartinez@unimagdalena.edu.co
RI Martinez-Duenas, William Andres/I-9857-2014
OI Martinez-Duenas, William Andres/0000-0003-0921-1149
FU Magdalena University (Colombia)
FX We particularly thank Doctor Victor Hugo Lozano, expert in Infectiology
   at the National Institute of Cancerology (Mexico) and professor
   Alexander Salazar from the Medicine Program at the Magdalena University
   for reviewing this manuscript. This project was supportted by the
   Magdalena University (Colombia).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Alcaldia Distrital de Santa Marta, 2012, PLAN DES 2012 2015
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bombino Y, 2002, EVALUACION RAPIDA NI, V11, P2006
   Burgos-Munoz SJ, 2018, EUR J OBSTET GYN R B, V228, P255, DOI 10.1016/j.ejogrb.2018.07.017
   Cáceres-Manrique Flor de María, 2009, Rev. salud pública, V11, P27
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Camacho-Rodriguez D, 2018, DUAZARY, V15, P81, DOI 10.21676/2389783X.2500
   Casapulla SL, 2018, AIMS PUBLIC HEALTH, V5, P49, DOI 10.3934/publichealth.2018.1.49
   Castañeda Oneida, 2011, Rev. salud pública, V13, P514
   Castañeda-Porras Oneida, 2017, Revista médica Risaralda, V23, P14
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Cofre F, 2016, REV CHIL INFECTOL, V33, P96, DOI 10.4067/S0716-10182016000100018
   DANE, 2005, B CENS GEN 2005 PERF
   Dhar-Chowdhury P, 2016, AM J TROP MED HYG, V94, P1223, DOI 10.4269/ajtmh.15-0639
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Egedus VL, 2014, REV BIOL TROP, V62, P859
   Fajardo P, 2001, Rev Panam Salud Publica, V10, P161, DOI 10.1590/S1020-49892001000900003
   SantoDomingo AF, 2016, ECOHEALTH, V13, P687, DOI 10.1007/s10393-016-1165-1
   Fraiz LD, 2018, VACCINE, V36, P165, DOI 10.1016/j.vaccine.2017.11.021
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Heitzinger Kristen, 2018, Prev Med Rep, V10, P20, DOI 10.1016/j.pmedr.2018.01.002
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Ibrahim Nahla Khamis Ragab, 2009, J Infect Public Health, V2, P30, DOI 10.1016/j.jiph.2009.01.004
   IDEAM, 1999, CART CLIM MED MENS A
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   INS, 2016, B EP SEM SEM EP NUM
   INS, 2015, B EP SEM SEM EP, V40
   INS, 2016, B EP SEM SEM EP, V43
   Jaramillo Ramirez G. I., 2017, The Open Public Health Journal, V10, P80, DOI 10.2174/1874944501710010080
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kirkby K, 2013, T ROY SOC TROP MED H, V107, P110, DOI 10.1093/trstmh/trs015
   LLinas PR, 2014, JANGWA PANA, V13, P118, DOI [10.21676/16574923.1375, DOI 10.21676/16574923.1375]
   Maestre-Serrano Ronald, 2015, Rev. salud pública, V17, P738, DOI 10.15446/rsap.v17n5.35345
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Minsalud, 2011, DIAGN SIT SAL SANT M
   MinSalud e INS, 2015, 043 MINSALUD INS
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   OMS, 2016, WHOZIKVMOC161 OMS
   OMS, 2016, ZIK STRAT RESP FRAM
   OPS OMS, 2015, AL EP SINDR NEUR AN
   Pacheco BA, 2013, INT CONF COGN INFO, P51, DOI 10.1109/CogInfoCom.2013.6719302
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Perafan-Ledezma AL, 2017, JANGWA PANA, V16, P27, DOI [10.21676/16574923.2020, DOI 10.21676/16574923.2020]
   Pineda G Francy, 2005, Rev. salud pública, V7, P339, DOI 10.1590/s0124-00642005000300009
   Plaster AN, 2018, J COMMUN HEALTH, V43, P647, DOI 10.1007/s10900-017-0463-z
   Pooransingh S, 2018, PUBLIC HEALTH, V165, P146, DOI 10.1016/j.puhe.2018.09.025
   Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Rodríguez-Morales Alfonso J., 2016, Infect., V20, P59, DOI 10.1016/j.infect.2016.02.001
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Statistical Program R Core Team, 2013, R LANG ENV STAT COMP
   Suarez R, 2009, CAD SAUDE PUBLICA, V25, pS104, DOI 10.1590/S0102-311X2009001300010
   Teich A, 2018, DIAGN MICR INFEC DIS, V92, P315, DOI 10.1016/j.diagmicrobio.2018.07.003
   Troncoso A, 2016, ASIAN PAC J TROP BIO, V6, P520, DOI 10.1016/j.apjtb.2016.04.004
   UNGRD e IDEAM, 2015, INF TECN AV PLAN NAC
   Wong LP, 2017, J COMMUN HEALTH, V42, P854, DOI 10.1007/s10900-017-0326-7
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 0
Z9 0
U1 0
U2 1
PU UNIV MAGDALENA
PI SANTA MARTA
PA CARRERA 32 NO 22-08, SECTOR SAN PEDRO ALEJANDRO, SANTA MARTA, MAGDALENA
   00000, COLOMBIA
SN 1794-5992
EI 2389-783X
J9 DUAZARY
JI Duazary
PD SEP-DEC
PY 2019
VL 16
IS 3
BP 7
EP 24
DI 10.21676/2389783X.2964
PG 18
WC Medicine, General & Internal
SC General & Internal Medicine
GA JD9HU
UT WOS:000490299300003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mascini, M
   Dikici, E
   Manueco, MR
   Perez-Erviti, JA
   Deo, SK
   Compagnone, D
   Wang, J
   Pingarron, JM
   Daunert, S
AF Mascini, Marcello
   Dikici, Emre
   Manueco, Marta Robles
   Perez-Erviti, Julio A.
   Deo, Sapna K.
   Compagnone, Dario
   Wang, Joseph
   Pingarron, Jose M.
   Daunert, Sylvia
TI Computationally Designed Peptides for Zika Virus Detection: An
   Incremental Construction Approach
SO BIOMOLECULES
LA English
DT Article
DE virtual screening; molecular modelling; peptides; Zika virus; Dengue
   virus; antibody mimetics; ELISA
ID SOLID-PHASE EXTRACTION; CONFORMER GENERATION; STRUCTURAL BASIS; APTAMER;
   DENGUE; ANTIBODIES; DIAGNOSIS
AB Herein, and in contrast to current production of anti-Zika virus antibodies, we propose a semi-combinatorial virtual strategy to select short peptides as biomimetic antibodies/binding agents for the detection of intact Zika virus (ZIKV) particles. The virtual approach was based on generating different docking cycles of tetra, penta, hexa, and heptapeptide libraries by maximizing the discrimination between the amino acid motif in the ZIKV and dengue virus (DENV) envelope protein glycosylation site. Eight peptides, two for each length (tetra, penta, hexa, and heptapeptide) were then synthesized and tested vs. intact ZIKV particles by using a direct enzyme linked immunosorbent assay (ELISA). As a reference, we employed a well-established anti-ZIKV antibody, the antibody 4G2. Three peptide-based assays had good detection limits with dynamic range starting from 10(5) copies/mL of intact ZIKV particles; this was one order magnitude lower than the other peptides or antibodies. These three peptides showed slight cross-reactivity against the three serotypes of DENV (DENV-1, -2, and -3) at a concentration of 10(6) copies/mL of intact virus particles, but the discrimination between the DENV and ZIKV was lost when the coating concentration was increased to 10(7) copies/mL of the virus. The sensitivity of the peptides was tested in the presence of two biological matrices, serum and urine diluted 1:10 and 1:1, respectively. The detection limits decreased about one order of magnitude for ZIKV detection in serum or urine, albeit still having for two of the three peptides tested a distinct analytical signal starting from 10(6) copies/mL, the concentration of ZIKV in acute infection.
C1 [Mascini, Marcello; Pingarron, Jose M.] Univ Complutense Madrid, Fac Chem, Dept Analyt Chem, Ciudad Univ S-N, E-28040 Madrid, Spain.
   [Mascini, Marcello; Compagnone, Dario] Univ Teramo, Fac Biosci & Technol Food Agr & Environm, I-64100 Teramo, Italy.
   [Dikici, Emre; Manueco, Marta Robles; Deo, Sapna K.; Daunert, Sylvia] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.
   [Dikici, Emre; Deo, Sapna K.; Daunert, Sylvia] Univ Miami, Dr JT Macdonald Fdn Biomed Nanotechnol Inst, Miami, FL 33136 USA.
   [Perez-Erviti, Julio A.] Univ Havana, Fac Biol, Ctr Prot Studies, Havana 10400, Cuba.
   [Wang, Joseph] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
   [Daunert, Sylvia] Univ Miami, Clin & Translat Sci Inst, Miami, FL 33136 USA.
RP Mascini, M (corresponding author), Univ Complutense Madrid, Fac Chem, Dept Analyt Chem, Ciudad Univ S-N, E-28040 Madrid, Spain.; Mascini, M (corresponding author), Univ Teramo, Fac Biosci & Technol Food Agr & Environm, I-64100 Teramo, Italy.; Daunert, S (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.; Daunert, S (corresponding author), Univ Miami, Dr JT Macdonald Fdn Biomed Nanotechnol Inst, Miami, FL 33136 USA.; Daunert, S (corresponding author), Univ Miami, Clin & Translat Sci Inst, Miami, FL 33136 USA.
EM mmascini@unite.it; edikici@med.miami.edu; mroblesma@gmail.com;
   japerviti@gmail.com; sdeo@med.miami.edu; dcompagnone@unite.it;
   josephwang@eng.ucsd.edu; pingarro@ucm.es; sdaunert@med.miami.edu
RI ; mascini, marcello/C-5339-2008
OI Compagnone, Dario/0000-0001-7849-8943; mascini,
   marcello/0000-0003-2508-5680
FU European UnionEuropean Union (EU) [656687]; National Institutes of
   Health, NIGMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM047915, R01GM127706]; Florida Department
   of Health-United States [7ZK01]
FX This work has received funding from the European Union's Horizon 2020
   Research and Innovation programme under the Marie Sklodowska-Curie grant
   agreement No 656687. S. Daunert and S. Deo would like to thank the
   National Institutes of Health, NIGMS (R01GM047915, R01GM127706). This
   work was also supported by the Florida Department of Health-United
   States, under Research Grant 7ZK01 to S. Daunert and S. Deo.
CR Acebes S, 2016, ACS CATAL, V6, P1624, DOI 10.1021/acscatal.6b00028
   [Anonymous], 2012, OMEGA VERS 2 4 6
   [Anonymous], 2012, VIDA VERS 4 1 1
   [Anonymous], 2018, PYMOL MOL GRAPHICS S
   [Anonymous], 2012, SZYBKI VERS 1 5 7
   [Anonymous], 2012, OEDOCKING VERS 3 0 0
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bunker A, 2016, BBA-BIOMEMBRANES, V1858, P2334, DOI 10.1016/j.bbamem.2016.02.025
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Kim DTH, 2018, THERANOSTICS, V8, P3629, DOI 10.7150/thno.25955
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Gong Pi-Chang, 2010, Yichuan, V32, P548, DOI 10.3724/SP.J.1005.2010.00548
   Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k
   Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x
   Heffron AS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006903
   Hwang HJ, 2017, BIOSENS BIOELECTRON, V87, P164, DOI 10.1016/j.bios.2016.08.031
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelley BP, 2015, J CHEM INF MODEL, V55, P1771, DOI 10.1021/acs.jcim.5b00142
   Li FQ, 2019, ANAL CHIM ACTA, V1051, P1, DOI 10.1016/j.aca.2018.10.058
   Lin SC, 2016, J CHROMATOGR A, V1446, P34, DOI 10.1016/j.chroma.2016.04.016
   Macalino SJY, 2015, ARCH PHARM RES, V38, P1686, DOI 10.1007/s12272-015-0640-5
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mascini M, 2019, BIOSENS BIOELECTRON, V123, P124, DOI 10.1016/j.bios.2018.07.028
   Mascini M, 2017, TALANTA, V167, P126, DOI 10.1016/j.talanta.2017.01.072
   Michaeli A, 2018, J IMMUNOL, V201, P3383, DOI 10.4049/jimmunol.1800380
   Palzkill T.G., 2013, J CLIN MICROBIOLO, V51, P1803
   Pawley DC, 2019, ACS OMEGA, V4, P6808, DOI 10.1021/acsomega.9b00374
   Perez G, 2013, J CHEM-NY, DOI 10.1155/2013/491827
   Pichon V, 2015, ANAL BIOANAL CHEM, V407, P681, DOI 10.1007/s00216-014-8129-5
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Singh P, 2016, J MED CHEM, V59, P3920, DOI 10.1021/acs.jmedchem.6b00134
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stobiecka M, 2015, CHEM PAP, V69, P62, DOI 10.1515/chempap-2015-0026
   Tambunan USF, 2016, J TEKNOL, V78, P95
   Tang TT, 2016, TALANTA, V146, P55, DOI 10.1016/j.talanta.2015.08.023
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xu K, 2018, NAT MED, V24, P857, DOI 10.1038/s41591-018-0042-6
   Yu XW, 2017, ANNU REV ANAL CHEM, V10, P293, DOI 10.1146/annurev-anchem-061516-045205
   Yuan SG, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1298
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 45
TC 1
Z9 1
U1 4
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD SEP
PY 2019
VL 9
IS 9
AR 498
DI 10.3390/biom9090498
PG 21
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JC2JH
UT WOS:000489102800110
PM 31533374
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cimini, E
   Sacchi, A
   De Minicis, S
   Bordoni, V
   Casetti, R
   Grassi, G
   Colavita, F
   Castilletti, C
   Capobianchi, MR
   Ippolito, G
   Desimio, MG
   Doria, M
   Agrati, C
AF Cimini, Eleonora
   Sacchi, Alessandra
   De Minicis, Sara
   Bordoni, Veronica
   Casetti, Rita
   Grassi, Germana
   Colavita, Francesca
   Castilletti, Concetta
   Capobianchi, Maria Rosaria
   Ippolito, Giuseppe
   Desimio, Maria Giovanna
   Doria, Margherita
   Agrati, Chiara
TI V delta 2 T-Cells Kill ZIKV-Infected Cells by NKG2D-Mediated
   Cytotoxicity
SO MICROORGANISMS
LA English
DT Article
DE ZIKV; innate immunity; V62 T-cells; antiviral activity; NKG2D;
   cytotoxicity; perforin
ID VIRUS-INFECTION; GAMMA; NKG2D; LIGANDS; ACTIVATION; RESPONSES; RECEPTOR;
   MICA
AB An expansion of effector/activated V delta 2 T-cells was recently described in acute Zika virus (ZIKV)-infected patients, but their role in the protective immune response was not clarified. The aim of this study was to define the antiviral activity of V delta 2 T-cells against ZIKV-infected cells. The V delta 2 T-cells expansion and their cytotoxic activity against ZIKV-infected cells were tested in vitro and analyzed by RT-PCR and flow cytometry. We found that ZIKV infection was able to induce V delta 2 T-cells expansion and sensitized A549 cells to V delta 2-mediated killing. Indeed, expanded V delta 2 T-cells killed ZIKV-infected cells through degranulation and perforin release. Moreover, ZIKV infection was able to increase the expression on A549 cells of NKG2D ligands (NKG2DLs), namely MICA, MICB, and ULBP2, at both the mRNA and protein levels, suggesting the possible involvement of these molecules in the recognition by NKG2D-expressing V delta 2 T-cells. Indeed, the killing of ZIKV-infected cells by expanded V delta 2 T-cells was mediated by NKG2D/NKG2DL interaction as NKG2D neutralization abrogated V delta 2 cytotoxicity. Our data showed a strong antiviral activity of V delta 2 T-cells against ZIKV-infected cells, suggesting their involvement in the protective immune response. Other studies are necessary to investigate whether the lack of V delta 2 T-cells expansion in vivo may be associated with disease complications.
C1 [Cimini, Eleonora; Sacchi, Alessandra; De Minicis, Sara; Bordoni, Veronica; Casetti, Rita; Grassi, Germana; Agrati, Chiara] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Immunol & Pharmacol Lab, Via Portuense 292, I-00149 Rome, Italy.
   [Colavita, Francesca; Castilletti, Concetta; Capobianchi, Maria Rosaria] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Virol Lab, Via Portuense 292, I-00149 Rome, Italy.
   [Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Sci Direct, Via Portuense 292, I-00149 Rome, Italy.
   [Desimio, Maria Giovanna; Doria, Margherita] Bambino Gesu Pediat Hosp, Div Immunol & Infect Dis, Acad Dept Pediat, IRCCS, Piazza St Onofrio 4, I-00165 Rome, Italy.
RP Agrati, C (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Immunol & Pharmacol Lab, Via Portuense 292, I-00149 Rome, Italy.
EM eleonora.cimini@inmi.it; alessandra.sacchi@inmi.it; demsara@hotmail.it;
   veronica.bordoni@inmi.it; rita.casetti@inmi.it; germana.grassi@inmi.it;
   francesca.colavita@inmi.it; concetta.castilletti@inmi.it;
   maria.capobianchi@inmi.it; giuseppe.ippolito@inmi.it;
   mariagiovanna.dsm@gmail.com; doria@uniroma2.it; chiara.agrati@inmi.it
RI Desimio, Maria Giovanna/AAA-7541-2020
FU Italian Ministry of HealthMinistry of Health, Italy [RF-2016-02364155,
   GR-2016-02362110, RF-2016-02363642]
FX This work was supported by fundings from the Italian Ministry of Health
   to INMI L Spallanzani-IRCCS (Ricerca Finalizzata RF-2016-02364155;
   Giovani Ricercatori GR-2016-02362110; Ricerca Corrente-Linea1) and to
   Bambino Gesu Children's Hospital-IRCCS (Ricerca Finalizzata
   RF-2016-02363642).
CR Agrati C, 2016, NEW MICROBIOL, V39, P139
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727
   Bessoles S, 2011, EUR J IMMUNOL, V41, P1619, DOI 10.1002/eji.201041230
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Poccia F, 2006, J INFECT DIS, V193, P1244, DOI 10.1086/502975
   Poccia F, 2005, MICROBES INFECT, V7, P518, DOI 10.1016/j.micinf.2004.12.009
   Poggi A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00575
   Prager I, 2019, J EXP MED, V216, P2113, DOI 10.1084/jem.20181454
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951
   Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simoes AE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00929
   Sivori S, 2019, CELL MOL IMMUNOL, V16, P430, DOI 10.1038/s41423-019-0206-4
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0
   Tsai CY, 2015, J IMMUNOL, V194, P3890, DOI 10.4049/jimmunol.1303343
   Wang LS, 2001, J IMMUNOL, V167, P6195, DOI 10.4049/jimmunol.167.11.6195
   Wrobel P, 2007, SCAND J IMMUNOL, V66, P320, DOI 10.1111/j.1365-3083.2007.01963.x
   Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730
   Yao Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172625
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 43
TC 0
Z9 0
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD SEP
PY 2019
VL 7
IS 9
AR 350
DI 10.3390/microorganisms7090350
PG 13
WC Microbiology
SC Microbiology
GA JC2UF
UT WOS:000489131300077
PM 31547470
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Annamalai, AS
   Pattnaik, A
   Sahoo, BR
   Guinn, ZP
   Bullard, BL
   Weaver, EA
   Steffen, D
   Natarajan, SK
   Petro, TM
   Pattnaik, AK
AF Annamalai, Arun S.
   Pattnaik, Aryamav
   Sahoo, Bikash R.
   Guinn, Zack P.
   Bullard, Brianna L.
   Weaver, Eric A.
   Steffen, David
   Natarajan, Sathish Kumar
   Petro, Thomas M.
   Pattnaik, Asit K.
TI An Attenuated Zika Virus Encoding Non-Glycosylated Envelope (E) and
   Non-Structural Protein 1 (NS1) Confers Complete Protection against
   Lethal Challenge in a Mouse Model
SO VACCINES
LA English
DT Article
DE Zika virus; NS1 protein; glycosylation; attenuation; vaccine candidate
ID N-LINKED GLYCOSYLATION; TICK-BORNE ENCEPHALITIS; VACCINE PRODUCTION;
   GLYCOPROTEIN NS1; DNA VACCINE; CELLS; ANTIBODY; RNA; PATHOGENESIS;
   MUTATIONS
AB Zika virus (ZIKV), a mosquito-transmitted flavivirus, emerged in the last decade causing serious human diseases, including congenital microcephaly in newborns and Guillain-Barre syndrome in adults. Although many vaccine platforms are at various stages of development, no licensed vaccines are currently available. Previously, we described a mutant MR766 ZIKV (m2MR) bearing an E protein mutation (N154A) that prevented its glycosylation, resulting in attenuation and defective neuroinvasion. To further attenuate m2MR for its potential use as a live viral vaccine, we incorporated additional mutations into m2MR by substituting the asparagine residues in the glycosylation sites (N130 and N207) of NS1 with alanine residues. Examination of pathogenic properties revealed that the virus (m5MR) carrying mutations in E (N154A) and NS1 (N130A and N207A) was fully attenuated with no disease signs in infected mice, inducing high levels of humoral and cell-mediated immune responses, and protecting mice from subsequent lethal virus challenge. Furthermore, passive transfer of sera from m5MR-infected mice into naive animals resulted in complete protection from lethal challenge. The immune sera from m5MR-infected animals neutralized both African and Asian lineage viruses equally well, suggesting that m5MR virus could be developed as a potentially broad live virus vaccine candidate.
C1 [Annamalai, Arun S.; Pattnaik, Aryamav; Sahoo, Bikash R.; Steffen, David; Pattnaik, Asit K.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.
   [Annamalai, Arun S.; Pattnaik, Aryamav; Sahoo, Bikash R.; Bullard, Brianna L.; Weaver, Eric A.; Natarajan, Sathish Kumar; Petro, Thomas M.; Pattnaik, Asit K.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.
   [Guinn, Zack P.; Petro, Thomas M.] Univ Nebraska Med Ctr, Dept Oral Biol, Lincoln, NE 68583 USA.
   [Bullard, Brianna L.; Weaver, Eric A.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.
   [Natarajan, Sathish Kumar] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68583 USA.
RP Pattnaik, AK (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.; Pattnaik, AK (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.
EM tiger05009@gmail.com; aryamavpattnaik@ymail.com; bsahoo@huskers.unl.edu;
   zack.guinn@huskers.unl.edu; bbullard@huskers.unl.edu; eweaver2@unl.edu;
   dsteffen1@unl.edu; snatarajan2@unl.edu; tpetro@unmc.edu;
   apattnaik2@unl.edu
RI Annamalai, Arun Saravanakumar/AAB-7352-2020; Pattnaik, Asit
   K./X-1531-2019
OI Annamalai, Arun Saravanakumar/0000-0002-4892-4291; Pattnaik, Asit
   K./0000-0002-9581-6787; Steffen, David/0000-0002-5166-2296; Natarajan,
   Sathish kumar/0000-0001-7491-8592; Bullard, Brianna/0000-0002-6702-0079;
   Pattnaik, Aryamav/0000-0002-8325-2216; Petro, Thomas/0000-0002-6163-4854
FU University of Nebraska-Lincoln
FX The research was supported in part by funds from the University of
   Nebraska-Lincoln.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Bailey MJ, 2019, MBIO, V10, DOI [10.1128/mBio.02861-18, 10.1128/mbio.02861-18]
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Bullard BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35755-z
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   Chen HW, 2014, J GEN VIROL, V95, P1983, DOI 10.1099/vir.0.067280-0
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   CROOKS AJ, 1990, J CHROMATOGR, V502, P59, DOI 10.1016/S0021-9673(01)89563-7
   Dai LP, 2018, SUBCELL BIOCHEM, V88, P147, DOI 10.1007/978-981-10-8456-0_7
   DALGARNO L, 1986, J MOL BIOL, V187, P309, DOI 10.1016/0022-2836(86)90435-3
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   FLAMAND M, 1992, VIROLOGY, V191, P826, DOI 10.1016/0042-6822(92)90258-Q
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Genzel Y, 2015, BIOTECHNOL J, V10, P728, DOI 10.1002/biot.201400388
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Khou C, 2017, INTERVIROLOGY, V60, P8, DOI 10.1159/000479966
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Lindenbach B.D., 2013, FLAVIVIRIDAE
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   PLETNEV AG, 1993, J VIROL, V67, P4956, DOI 10.1128/JVI.67.8.4956-4963.1993
   Pryor MJ, 1998, J GEN VIROL, V79, P2631, DOI 10.1099/0022-1317-79-11-2631
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   WESTAWAY EG, 1987, ARCH VIROL, V94, P215, DOI 10.1007/BF01310715
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yap SSL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01415
NR 75
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD SEP
PY 2019
VL 7
IS 3
AR 112
DI 10.3390/vaccines7030112
PG 21
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JA6WH
UT WOS:000487982000031
PM 31547297
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cabral-Miranda, G
   Lim, SM
   Mohsen, MO
   Pobelov, IV
   Roesti, ES
   Heath, MD
   Skinner, MA
   Kramer, ME
   Martina, BEE
   Bachmann, MF
AF Cabral-Miranda, Gustavo
   Lim, Stephanie M.
   Mohsen, Mona O.
   Pobelov, Ilya, V
   Roesti, Elisa S.
   Heath, Matthew D.
   Skinner, Murray A.
   Kramer, Matthias E.
   Martina, Byron E. E.
   Bachmann, Martin F.
TI Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized
   VLPs Induces Neutralizing Antibodies without Causing Enhancement of
   Dengue Virus Infection
SO VACCINES
LA English
DT Article
DE vaccine; Zika virus; envelop (E) protein domain III (EDIII); virus like
   particles (VLPs); dioleoyl phosphatidylserine (DOPS)
ID DEPENDENT ENHANCEMENT; FLAVIVIRUS INFECTION; CROSS-REACTIVITY;
   STRUCTURAL BASIS; IMMUNE-RESPONSE; CHALLENGE; VACCINES; BINDING; RNA
AB Zika virus (ZIKV) is a flavivirus similar to Dengue virus (DENV) in terms of transmission and clinical manifestations, and usually both viruses are found to co-circulate. ZIKV is usually transmitted by mosquitoes bites, but may also be transmitted by blood transfusion, via the maternal-foetal route, and sexually. After 2015, when the most extensive outbreak of ZIKV had occurred in Brazil and subsequently spread throughout the rest of South America, it became evident that ZIKV infection during the first trimester of pregnancy was associated with microcephaly and other neurological complications in newborns. As a result, the development of a vaccine against ZIKV became an urgent goal. A major issue with DENV vaccines, and therefore likely also with ZIKV vaccines, is the induction of antibodies that fail to neutralize the virus properly and cause antibody-dependent enhancement (ADE) of the infection instead. It has previously been shown that antibodies against the third domain of the envelope protein (EDIII) induces optimally neutralizing antibodies with no evidence for ADE for other viral strains. Therefore, we generated a ZIKV vaccine based on the EDIII domain displayed on the immunologically optimized Cucumber mosaic virus (CuMVtt) derived virus-like particles (VLPs) formulated in dioleoyl phosphatidylserine (DOPS) as adjuvant. The vaccine induced high levels of specific IgG after a single injection. The antibodies were able to neutralise ZIKV without enhancing infection by DENV in vitro. Thus, the here described vaccine based on EDIII displayed on VLPs was able to stimulate production of antibodies specifically neutralizing ZIKV without potentially enhancing disease caused by DENV.
C1 [Cabral-Miranda, Gustavo; Mohsen, Mona O.; Bachmann, Martin F.] Univ Oxford, Ctr Cellular & Mol Physiol, Jenner Inst, Nuffield Dept Med, Oxford OX1 2JD, England.
   [Cabral-Miranda, Gustavo; Mohsen, Mona O.; Roesti, Elisa S.; Bachmann, Martin F.] Univ Bern, Inselspital, RIA, Immunol, CH-3010 Bern, Switzerland.
   [Lim, Stephanie M.; Martina, Byron E. E.] Artemis Biosupport, NL-2629 Delft, Netherlands.
   [Pobelov, Ilya, V] Univ Bern, Dept Chem & Biochem, CH-3010 Bern, Switzerland.
   [Heath, Matthew D.; Skinner, Murray A.; Kramer, Matthias E.] Bencard Adjuvant Syst, Worthing BN14 8SA, England.
   [Martina, Byron E. E.] Erasmus MC, Dept Virosci, NL-3015 GD Rotterdam, Netherlands.
RP Cabral-Miranda, G; Bachmann, MF (corresponding author), Univ Oxford, Ctr Cellular & Mol Physiol, Jenner Inst, Nuffield Dept Med, Oxford OX1 2JD, England.; Cabral-Miranda, G; Bachmann, MF (corresponding author), Univ Bern, Inselspital, RIA, Immunol, CH-3010 Bern, Switzerland.
EM gcabral.miranda@gmail.com; martin.bachmann@me.com
RI de Miranda, Gustavo Cabral/AAH-5494-2019
OI Kramer, Matthias/0000-0002-3740-4733
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_ 149925, 310030_ 185114]; Bencard Adjuvant Systems (a
   division of Allergy Therapeutics Plc) [R43086/CN001]
FX This research was funded by The Swiss National Science Foundation (Grant
   31003A_ 149925 and Grant 310030_ 185114) and Bencard Adjuvant Systems (a
   division of Allergy Therapeutics Plc) (R43086/CN001).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ahlborg N, 2000, INFECT IMMUN, V68, P2102, DOI 10.1128/IAI.68.4.2102-2109.2000
   [Anonymous], 2016, WHO 1 M INT HLTH REG
   Avirutnan P, 2011, MBIO, V2, DOI 10.1128/mBio.00276-11
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Berry A.R., 2004, U.S. Patent, Patent No. [8,765,721 B2, 8765721]
   Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949
   Cabral-Miranda Gustavo, 2018, Diseases, V6, DOI 10.3390/diseases6040107
   Cabral-Miranda G, 2018, BIOSENS BIOELECTRON, V113, P101, DOI 10.1016/j.bios.2018.04.058
   Cabral-Miranda G, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5020010
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dixon M, 2007, ALLERGY, V62, P456
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Dumoulin A, 2008, J CLIN MICROBIOL, V46, P3104, DOI 10.1128/JCM.01294-08
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP PREP
   Fiorentino DG, 2016, CURR OBSTET GYNECOL, V5, P234, DOI 10.1007/s13669-016-0171-1
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Gallichotte EN, 2018, CELL REP, V25, P1214, DOI 10.1016/j.celrep.2018.10.006
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huber RG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09391-8
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Krueger CC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00736
   Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Mohsen MO, 2017, SEMIN IMMUNOL, V34, P123, DOI 10.1016/j.smim.2017.08.014
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Perez O, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00407
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Suppiah J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006817
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wei KF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45505
   WHO, ZIK VIR
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Zabel F, 2014, J IMMUNOL, V192, P5499, DOI 10.4049/jimmunol.1400065
   Zeltins A, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0030-8
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 56
TC 6
Z9 6
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD SEP
PY 2019
VL 7
IS 3
AR 72
DI 10.3390/vaccines7030072
PG 14
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JA6WH
UT WOS:000487982000043
PM 31340594
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Frumence, E
   Viranaicken, W
   Gadea, G
   Despres, P
AF Frumence, Etienne
   Viranaicken, Wildriss
   Gadea, Gilles
   Despres, Philippe
TI A GFP Reporter MR766-Based Flow Cytometry Neutralization Test for Rapid
   Detection of Zika Virus-Neutralizing Antibodies in Serum Specimens
SO VACCINES
LA English
DT Article
DE arbovirus; Zika virus; GFP reporter ZIKV; flow cytometry; neutralization
   test; mouse immune sera; humoral immune response; virus neutralizing
   antibodies; plaque-reduction neutralization test; flow cytometry
   neutralization test
ID GUIDELINES; EPIDEMIC
AB Zika virus (ZIKV) is an emerging arthropod-borne virus of major public health concern. ZIKV infection is responsible for congenital Zika disease and other neurological defects. Antibody-mediated virus neutralization is an essential component of protective antiviral immunity against ZIKV. In the present study, we assessed whether our GFP reporter ZIKV derived from African viral strain MR766 could be useful for the development of a flow cytometry neutralization test (FNT), as an alternative to the conventional plaque-reduction neutralization test (PRNT). To improve the efficacy of GFP-expressing MR766, we selected virus variant MR766(GFP) showing a high level of GFP signal in infected cells. A MR766(GFP)-based FNT was assayed with immune sera from adult mice that received ZIKBeHMR-2. The chimeric ZIKV clone ZIKBeHMR-2 comprises the structural protein region of epidemic strain BeH819015 into MR766 backbone. We reported that adult mice inoculated with ZIKBeHMR-2 developed high levels of neutralizing anti-ZIKV antibodies. Comparative analysis between MR766(GFP)-based FNT and conventional PRNT was performed using mouse anti-ZIKBeHMR-2 immune sera. Indistinguishable neutralization patterns were observed when compared with PRNT50 and FNT50. We consider that the newly developed MR766(GFP)-based FNT is a valid format for measuring ZIKV-neutralizing antibodies in serum specimens.
C1 [Frumence, Etienne; Viranaicken, Wildriss; Gadea, Gilles; Despres, Philippe] Univ La Reunion, INSERM U1187, CNRS UMR 9192,Plateforme Technol CYROI, IRD UMR 249,Unite Mixte Proc Infectieux Milieu In, F-97491 Sainte Clotilde, La Reunion, France.
RP Despres, P (corresponding author), Univ La Reunion, INSERM U1187, CNRS UMR 9192,Plateforme Technol CYROI, IRD UMR 249,Unite Mixte Proc Infectieux Milieu In, F-97491 Sainte Clotilde, La Reunion, France.
EM philippe.despres@univ-reunion.fr
FU INSERM transfert; POE FEDER of the Conseil Regional de La Reunion
   (ZIKAlert program) [SYNERGIE RE00001902]; FEDER Region Reunion-La
   Reunion University [SYNERGIE RE0012406]
FX This research was funded by INSERM transfert (ZIKALIVax program) and POE
   FEDER 2014-20 of the Conseil Regional de La Reunion (ZIKAlert program,
   No SYNERGIE RE00001902). EF received funding from FEDER Region
   Reunion-La Reunion University (ZIKALIVax 2.0 program, No SYNERGIE
   RE0012406).
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Clain E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081860
   Clain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29183-2
   El Kalamouni C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010002
   Frumence E, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7020055
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Haddad JG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102382
   Koishi AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006342
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Runge-Ranzinger S, 2019, TROP MED INT HEALTH, V24, P523, DOI 10.1111/tmi.13216
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Smith AJ, 2018, LAB ANIM-UK, V52, P135, DOI 10.1177/0023677217724823
   Vanwalscappel B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071574
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 23
TC 3
Z9 3
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD SEP
PY 2019
VL 7
IS 3
AR 66
DI 10.3390/vaccines7030066
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JA6WH
UT WOS:000487982000056
PM 31315283
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, L
   Collins, ND
   Widen, SG
   Davis, EH
   Kaiser, JA
   White, MM
   Greenberg, MB
   Barrett, ADT
   Bourne, N
   Sarathy, VV
AF Li, Li
   Collins, Natalie D.
   Widen, Steven G.
   Davis, Emily H.
   Kaiser, Jaclyn A.
   White, Mellodee M.
   Greenberg, M. Banks
   Barrett, Alan D. T.
   Bourne, Nigel
   Sarathy, Vanessa V.
TI Attenuation of Zika Virus by Passage in Human HeLa Cells
SO VACCINES
LA English
DT Article
DE Zika virus; attenuation; flavivirus; HeLa cells; Zika virus prM; Zika
   virus NS1
ID JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; VIRULENCE; PROTEIN;
   STRAIN; NS1; DETERMINANTS; VARIANTS; EPIDEMIC
AB Zika virus (ZIKV) is a mosquito-borne Flavivirus. Previous studies have shown that mosquito-transmitted flaviviruses, including yellow fever, Japanese encephalitis, and West Nile viruses, could be attenuated by serial passaging in human HeLa cells. Therefore, it was hypothesized that wild-type ZIKV would also be attenuated after HeLa cell passaging. A human isolate from the recent ZIKV epidemic was subjected to serial HeLa cell passaging, resulting in attenuated in vitro replication in both Vero and A549 cells. Additionally, infection of AG129 mice with 10 plaque forming units (pfu) of wild-type ZIKV led to viremia and mortality at 12 days, whereas infection with 10(3) pfu of HeLa-passage 6 (P6) ZIKV led to lower viremia, significant delay in mortality (median survival: 23 days), and increased cytokine and chemokine responses. Genomic sequencing of HeLa-passaged virus identified two amino acid substitutions as early as HeLa-P3: pre-membrane E87K and nonstructural protein 1 R103K. Furthermore, both substitutions were present in virus harvested from HeLa-P6-infected animal tissue. Together, these data show that, similarly to other mosquito-borne flaviviruses, ZIKV is attenuated following passaging in HeLa cells. This strategy can be used to improve understanding of substitutions that contribute to attenuation of ZIKV and be applied to vaccine development across multiple platforms.
C1 [Li, Li; Davis, Emily H.; Barrett, Alan D. T.; Sarathy, Vanessa V.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Collins, Natalie D.; Kaiser, Jaclyn A.; Bourne, Nigel] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Collins, Natalie D.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Widen, Steven G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [White, Mellodee M.; Greenberg, M. Banks; Bourne, Nigel] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.; Bourne, Nigel; Sarathy, Vanessa V.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.; Bourne, Nigel; Sarathy, Vanessa V.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Sarathy, VV (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Sarathy, VV (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Sarathy, VV (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM vvsarath@utmb.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI 129844, T32 AI 7526-16];
   University of Texas Medical Branch Sealy Institute for Vaccine Sciences
FX J.A.K. was funded in part by NIH T32 AI 7526-16. E.H.D. was supported by
   a predoctoral fellowship from the University of Texas Medical Branch
   Sealy Institute for Vaccine Sciences. A.D.T.B. was supported in part by
   NIH R21 AI 129844.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   BARRETT ADT, 1990, J GEN VIROL, V71, P2301, DOI 10.1099/0022-1317-71-10-2301
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   CAO JX, 1995, J GEN VIROL, V76, P2757, DOI 10.1099/0022-1317-76-11-2757
   Collins ND, 2019, EMERG MICROBES INFEC, V8, P1126, DOI 10.1080/22221751.2019.1645572
   Collins ND, 2018, MBIO, V9, DOI 10.1128/mBio.01871-18
   de Wispelaere M, 2016, J VIROL, V90, P2676, DOI 10.1128/JVI.01176-15
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dunster LM, 1999, VIROLOGY, V261, P309, DOI 10.1006/viro.1999.9873
   DUNSTER LM, 1990, J GEN VIROL, V71, P601, DOI 10.1099/0022-1317-71-3-601
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Gromowski GD, 2015, J VIROL, V89, P6328, DOI 10.1128/JVI.00219-15
   HARDY FM, 1963, J INFECT DIS, V113, P9, DOI 10.1093/infdis/113.1.9
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Kaiser JA, 2017, FUTURE VIROL, V12, P283, DOI 10.2217/fvl-2016-0141
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   MILLER BR, 1988, ACTA VIROL, V32, P227
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Plaszczyca A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007736
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shrivastava S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34147-7
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 33
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD SEP
PY 2019
VL 7
IS 3
AR 93
DI 10.3390/vaccines7030093
PG 16
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JA6WH
UT WOS:000487982000011
PM 31434319
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhong, ZF
   Catani, JPP
   Mc Cafferty, S
   Couck, L
   Van Den Broeck, W
   Gorle, N
   Vandenbroucke, RE
   Devriendt, B
   Ulbert, S
   Cnops, L
   Michels, J
   Arien, KK
   Sanders, NN
AF Zhong, Zifu
   Catani, Joao Paulo Portela
   Mc Cafferty, Sean
   Couck, Liesbeth
   Van Den Broeck, Wim
   Gorle, Nina
   Vandenbroucke, Roosmarijn E.
   Devriendt, Bert
   Ulbert, Sebastian
   Cnops, Lieselotte
   Michels, Johan
   Arien, Kevin K.
   Sanders, Niek N.
TI Immunogenicity and Protection Efficacy of a Naked Self-Replicating
   mRNA-Based Zika Virus Vaccine
SO VACCINES
LA English
DT Article
DE self-replicating mRNA; Zika virus vaccine; type I interferon response;
   IFNAR1 knockout mice
ID DELIVERY; EXPRESSION; ELECTROPORATION; INDUCTION; IMMUNITY
AB To combat emerging infectious diseases like Zika virus (ZIKV), synthetic messenger RNAs (mRNAs) encoding viral antigens are very attractive as they allow a rapid, generic, and flexible production of vaccines. In this work, we engineered a self-replicating mRNA (sr-mRNA) vaccine encoding the pre-membrane and envelope (prM-E) glycoproteins of ZIKV. Intradermal electroporation of as few as 1 mu g of this mRNA-based ZIKV vaccine induced potent humoral and cellular immune responses in BALB/c and especially IFNAR1(-/-) C57BL/6 mice, resulting in a complete protection of the latter mice against ZIKV infection. In wild-type C57BL/6 mice, the vaccine resulted in very low seroconversion rates and antibody titers. The potency of the vaccine was inversely related to the dose of mRNA used in wild-type BALB/c or C57BL/6 mice, as robust type I interferon (IFN) response was determined in a reporter mice model (IFN-beta(+/Delta beta-luc)). We further investigated the inability of the sr-prM-E-mRNA ZIKV vaccine to raise antibodies in wild-type C57BL/6 mice and found indications that type I IFNs elicited by this naked sr-mRNA vaccine might directly impede the induction of a robust humoral response. Therefore, we assume that the efficacy of sr-mRNA vaccines after intradermal electroporation might be increased by strategies that temper their inherent innate immunogenicity.
C1 [Zhong, Zifu; Catani, Joao Paulo Portela; Mc Cafferty, Sean; Sanders, Niek N.] Univ Ghent, Lab Gene Therapy, Dept Nutr Genet & Ethol, Fac Vet Med, Heidestr 19, B-9820 Heidestraat, Belgium.
   [Catani, Joao Paulo Portela; Mc Cafferty, Sean; Sanders, Niek N.] Univ Ghent, Canc Res Inst CRIG, B-9000 Ghent, Belgium.
   [Couck, Liesbeth; Van Den Broeck, Wim] Univ Ghent, Fac Vet Med, Dept Morphol, Salisburylaan 133, B-9820 Merelbeke, Belgium.
   [Gorle, Nina; Vandenbroucke, Roosmarijn E.] Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Barriers Inflammat Lab, Technol Pk Zwijnaarde 71, B-9052 Zwijnaarde, Belgium.
   [Vandenbroucke, Roosmarijn E.] VIB, VIB Ctr Inflammat Res, Technol Pk Zwijnaarde 71, B-9052 Zwijnaarde, Belgium.
   [Devriendt, Bert] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Lab Immunol, Salisburylaan 133, B-9820 Merelbeke, Belgium.
   [Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Perlickstr 1, D-04103 Leipzig, Germany.
   [Cnops, Lieselotte] Inst Trop Med, Dept Clin Sci, Unit Neglected Trop Dis, B-2000 Antwerp, Belgium.
   [Michels, Johan; Arien, Kevin K.] Inst Trop Med, Virol Unit, B-2000 Antwerp, Belgium.
   [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, B-2000 Antwerp, Belgium.
RP Sanders, NN (corresponding author), Univ Ghent, Lab Gene Therapy, Dept Nutr Genet & Ethol, Fac Vet Med, Heidestr 19, B-9820 Heidestraat, Belgium.; Sanders, NN (corresponding author), Univ Ghent, Canc Res Inst CRIG, B-9000 Ghent, Belgium.
EM niek.Sanders@ugent.be
RI Van den Broeck, Wim/B-5526-2009; Vandenbroucke, Roosmarijn/B-9419-2009
OI Van den Broeck, Wim/0000-0001-6683-5658; Vandenbroucke,
   Roosmarijn/0000-0002-8327-620X; Mc Cafferty, Sean/0000-0003-2506-680X;
   Cnops, Lieselotte/0000-0003-0658-1291; Devriendt,
   Bert/0000-0002-3222-8769
FU (GOA) found of Ghent University [BOF2015/GOA/031]; China Scholarship
   Council (CSC)China Scholarship Council [201607650018]; European Union's
   Horizon 2020 research and innovation program ZikaPLAN [734584]; Research
   Foundation Flanders (F.W.O.-Vlaanderen)FWO
FX This work was supported by the concerted research action (GOA) found of
   Ghent University (BOF2015/GOA/031), Z.Z. acknowledges the funding from
   China Scholarship Council (CSC) (201607650018). K.K.A is supported by
   the European Union's Horizon 2020 research and innovation program
   ZikaPLAN (grant agreement no. 734584). B.D. holds a postdoctoral grant
   from the Research Foundation Flanders (F.W.O.-Vlaanderen).
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051
   Aramaki Y, 1999, FEBS LETT, V460, P472, DOI 10.1016/S0014-5793(99)01386-1
   Bertacchini C., 2017, HDB ELECTROPORATION, P1
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000
   Cu Y, 2013, VACCINES, V1, P367, DOI 10.3390/vaccines1030367
   Darville T, 2001, INFECT IMMUN, V69, P7419, DOI 10.1128/IAI.69.12.7419-7424.2001
   De Beuckelaer A, 2016, MOL THER, V24, P2012, DOI 10.1038/mt.2016.161
   Denies S, 2014, J CONTROL RELEASE, V187, P175, DOI 10.1016/j.jconrel.2014.05.045
   Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351
   Doukas J, 2011, VACCINE, V29, P5443, DOI 10.1016/j.vaccine.2011.05.060
   Erasmus JH, 2018, MOL THER, V26, P2507, DOI 10.1016/j.ymthe.2018.07.010
   Fallet B, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6817
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109
   Giese M., 2016, INTRO MOL VACCINOLOG, P233
   Guan S, 2017, GENE THER, V24, P133, DOI 10.1038/gt.2017.5
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Houser KV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206837
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Laidlaw BJ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1836
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledgerwood JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125914
   Leyman B, 2018, MOL PHARMACEUT, V15, P377, DOI 10.1021/acs.molpharmaceut.7b00722
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277
   Liu MA, 2005, ADV GENET, V55, P25, DOI 10.1016/S0065-2660(05)55002-8
   Ljungberg K, 2015, EXPERT REV VACCINES, V14, P177, DOI 10.1586/14760584.2015.965690
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Moreno-Madrinan MJ, 2018, EMERG INFECT DIS, V24, P821, DOI 10.3201/eid2405.171609
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pepini T, 2017, J IMMUNOL, V198, P4012, DOI 10.4049/jimmunol.1601877
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Reichmuth AM, 2016, THER DELIV, V7, P319, DOI 10.4155/tde-2016-0006
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sammicheli S, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6789
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Yun CH, 2016, BIOL PHARM BULL, V39, P1338, DOI 10.1248/bpb.b16-00264
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zhong ZF, 2018, NANO TODAY, V23, P16, DOI 10.1016/j.nantod.2018.10.005
NR 58
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD SEP
PY 2019
VL 7
IS 3
AR 96
DI 10.3390/vaccines7030096
PG 17
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JA6WH
UT WOS:000487982000003
PM 31450775
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barbosa, MHD
   de Magalhaes-Barbosa, MC
   Robaina, JR
   Prata-Barbosa, A
   de Lima, MADT
   da Cunha, AJLA
AF de Magalhaes Barbosa, Maria Helena
   Clara de Magalhaes-Barbosa, Maria
   Robaina, Jaqueline Rodrigues
   Prata-Barbosa, Arnaldo
   de Melo Tavares de Lima, Marco Antonio
   Ledo Alves da Cunha, Antonio Jose
TI Auditory findings associated with Zika virus infection: an integrative
   review
SO BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY
LA English
DT Review
DE Zika virus infection; Hearing disorders; Hearing toss
ID SENSORINEURAL HEARING-LOSS; UPDATE INTERIM GUIDANCE; IDENTIFIED
   CHILDREN; UNITED-STATES; INFANTS; OUTCOMES; BRAZIL; GUIDELINES;
   MANAGEMENT; BIRTH
AB Introduction: Possible associations between Zika virus infection and hearing loss were observed during the epidemic in the Americas.
   Objective: To describe the auditory alterations, pathogenesis and recommendations for follow- up in individuals with prenatal or acquired Zika virus infection.
   Methods: Bibliographic research conducted in March/2018-April/2019 at the main available databases. Article selection, data extraction and quality evaluation were carried out by two independent reviewers. Studies containing auditory evaluation of patients with congenital or acquired Zika virus infection; and/or hypotheses or evidences on the pathophysiology of auditory impairment associated with Zika virus; and/or recommendations on screening and follow-up of patients with auditory impairment by Zika virus were included.
   Results: A total of 27 articles were selected. Sensorineural and transient hearing loss were reported in six adults with acquired Zika virus infection. Of the 962 studied children, 482 had microcephaly and 145 had diagnostic confirmation of Zika virus; 515 of the 624 children with auditory evaluation performed only screening tests with otoacoustic emissions testing and/or automated click-stimuli auditory brainstem response testing. Studies in prenatally exposed children were very heterogeneous and great variations in the frequency of altered otoacoustic emissions and automated click-stimuli auditory brainstem response occurred across the studies. Altered otoacoustic emissions varied from 0% to 75%, while altered automated click-stimuli auditory brainstem response varied from 0% to 29.2%. Sensorineural, retrocochtear or central origin impairment could not be ruled out. One study with infected mice found no microscopic damage to cochlear hair cells. Studies on the pathogenesis of auditory changes in humans are limited to hypotheses and recommendations still include points of controversy.
   Conclusion: The available data are still insufficient to understand the full spectrum of the involvement of the auditory organs by Zika virus, the pathogenesis of this involvement or even to confirm the causal association between auditory involvement and virus infection. The screening and follow-up recommendations still present points of controversy. (C) 2019 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.
C1 [de Magalhaes Barbosa, Maria Helena] Univ Fed Rio de Janeiro, Programa Posgrad, Fac Med, Rio de Janeiro, RJ, Brazil.
   [Clara de Magalhaes-Barbosa, Maria; Robaina, Jaqueline Rodrigues; Prata-Barbosa, Arnaldo] Inst DOr Pesquisa & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo; Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Maternidade Escola, Rio de Janeiro, RJ, Brazil.
   [de Melo Tavares de Lima, Marco Antonio] Univ Fed Rio de Janeiro, HUCFF, Dept Otorrinolaringol & Oftalmol, Rio de Janeiro, RJ, Brazil.
   [Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Rio de Janeiro, RJ, Brazil.
RP Barbosa, MHD (corresponding author), Univ Fed Rio de Janeiro, Programa Posgrad, Fac Med, Rio de Janeiro, RJ, Brazil.
EM mariahelena_barbosa@yahoo.com.br
RI ; Barbosa, Arnaldo Prata/B-2212-2009
OI de Magalhaes-Barbosa, Maria Clara/0000-0003-0959-0775; de Melo Tavares
   de Lima, Marco Antonio/0000-0002-4703-4940; Ledo Alves da Cunha, Antonio
   Jose/0000-0003-3592-1849; Barbosa, Arnaldo Prata/0000-0002-4726-9782
CR Abramov DM, 2018, NEUROLOGY, V90, pE606, DOI 10.1212/WNL.0000000000004974
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   [Anonymous], STUD QUAL ASS TOOLS
   Besnard M, 2016, EURO SURVEILL, V21
   Borja A., 2017, Revista de Ciencias Medicas e Biologicas, V16, P271, DOI 10.9771/cmbio.v16i3.24387
   Brasil. Ministerio da Saade Secretaria de Atencao a Saade BM da S, 2015, PROT AT SAUD RESP OC, V1
   Brown ED, 2009, INT J PEDIATR OTORHI, V73, P707, DOI 10.1016/j.ijporl.2009.01.012
   Calle-Giraldo JP, 2019, PEDIATR INFECT DIS J, V38, P735, DOI [10.1097/INF.0000000000002307, 10.1097/inf.0000000000002307]
   Chao CK, 2012, OTOLARYNG HEAD NECK, V146, P259, DOI 10.1177/0194599811429271
   Ching TYC, 2015, AM J AUDIOL, V24, P345, DOI 10.1044/2015_AJA-15-0007
   Ching TYC, 2013, EAR HEARING, V34, P535, DOI 10.1097/AUD.0b013e3182857718
   Cleto Thais Lira, 2016, Pediatr Neurol, V65, pe1, DOI 10.1016/j.pediatrneurol.2016.08.011
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   de Carvalho Leal Mariana, 2019, Top Magn Reson Imaging, V28, P19, DOI 10.1097/RMR.0000000000000191
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Fandino-Cardenas M, 2018, J TROP PEDIATRICS, P1
   Ribeiro BNF, 2015, INT J SURG CASE REP, V8, P38, DOI 10.1016/j.ijscr.2014.10.057
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gely-Rojas L, 2018, P R HEALTH SCI J, V37, pS73
   Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173
   Gu VC, 2014, INT J PROJ MANAG, V32, P1170, DOI 10.1016/j.ijproman.2013.12.003
   Julander JG, 2018, SCI REP, V8, P1
   Lage MLC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030309
   Leal M de C, 2016, BRAZ J OTORHINOLAR, V30, P1
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Aguayo-Albasini JL, 2014, CIR ESPAN, V92, P82, DOI 10.1016/j.ciresp.2013.08.002
   Martins OR, 2017, AUDIOL COMMUN RES, V22, P1
   Matas Carla Gentile, 2010, Pró-Fono R. Atual. Cient., V22, P269, DOI 10.1590/S0104-56872010000300019
   Mittal R, 2018, JAMA OTOLARYNGOL, V144, P3, DOI 10.1001/jamaoto.2017.1798
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Peloggia A, 2018, INT J GYNECOL OBSTET, V143, P277, DOI 10.1002/ijgo.12663
   Leite RFP, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000400002, 10.5123/s1679-49742018000400002]
   Racicot K, 2017, TRENDS MOL MED, V23, P778, DOI 10.1016/j.molmed.2017.07.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riley DS, 2017, J CLIN EPIDEMIOL, V89, P218, DOI 10.1016/j.jclinepi.2017.04.026
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Salviz M, 2013, OTOL NEUROTOL, V34, P1165, DOI 10.1097/MAO.0b013e31828297b6
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Seetoo K, 2013, MMWR-MORBID MORTAL W, V62, P226
   Silva MFA de A, 2017, 2 C BRAS CIENC SAUD
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stika CJ, 2015, EARLY HUM DEV, V91, P47, DOI 10.1016/j.earlhumdev.2014.11.005
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Teissier N, 2016, EUR ANN OTORHINOLARY, V133, P413, DOI 10.1016/j.anorl.2016.03.004
   Torre P, 2015, AIDS CARE, V27, P1037, DOI 10.1080/09540121.2015.1021746
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   von Elm E, 2007, BMJ-BRIT MED J, V335, P806
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Westerberg BD, 2008, INT J PEDIATR OTORHI, V72, P931, DOI 10.1016/j.ijporl.2008.03.001
   Witayathawornwong P, 2012, SE ASIAN J TROP MED, V43, P62
NR 57
TC 1
Z9 1
U1 1
U2 1
PU ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL
PI SAO PAULO
PA AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL
SN 1808-8694
EI 1808-8686
J9 BRAZ J OTORHINOLAR
JI Braz. J. Otorhinolaryngol.
PD SEP-OCT
PY 2019
VL 85
IS 5
BP 642
EP 663
DI 10.1016/j.bjorl.2019.05.002
PG 22
WC Otorhinolaryngology
SC Otorhinolaryngology
GA JC1VI
UT WOS:000489065400016
PM 31296482
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Castro-Jorge, LA
   de Carvalho, RVH
   Klein, TM
   Hiroki, CH
   Lopes, AH
   Guimaraes, RM
   Fumagalli, MJ
   Floriano, VG
   Agostinho, MR
   Slhessarenko, RD
   Ramalho, FS
   Cunha, TM
   Cunha, FQ
   Fonseca, BAL
   Zamboni, DS
AF de Castro-Jorge, Luiza A.
   de Carvalho, Renan V. H.
   Klein, Taline M.
   Hiroki, Carlos H.
   Lopes, Alexandre H.
   Guimaraes, Rafaela M.
   Fumagalli, Marcilio Jorge
   Floriano, Vitor G.
   Agostinho, Mayara R.
   Slhessarenko, Renata Dezengrini
   Ramalho, Fernando Silva
   Cunha, Thiago M.
   Cunha, Fernando Q.
   Fonseca, Benedito A. L.
   Zamboni, Dario S.
TI The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus
SO PLOS PATHOGENS
LA English
DT Article
ID CHIKUNGUNYA VIRUS; DISEASE; ACTIVATION; INNATE; RECOGNITION; CASPASE-11;
   MECHANISM; INFECTION; OUTBREAK; SLOTHS
AB Author summary Viruses transmitted by mosquitoes have recently received huge attention from the media because the epidemics caused by Zika and chikungunya virus rapidly spread to new areas and infected a large number of individuals. Mayaro is a virus transmitted by mosquitoes that circulates in the Caribbean and tropical regions of Latin America. It causes a highly inflammatory disease, called Mayaro fever, and acute disease is often followed by a prolonged arthralgia mediated by chronic inflammation that can last months or years. The spread of Mayaro to urban areas is a major concern by the authorities, given that the virus has potential to cause an epidemic if spread in high-risk areas. Thus, understanding the mechanisms related to the pathogenesis of this infectious agent would be of great value to treat and prevent the disease. Here, we established an adult mouse model of Mayaro infection and demonstrated that the virus activates the NLRP3 inflammasome, which is important to regulate this viral disease. Our study provides molecular targets for a future treatment of Mayaro fever and provides an experimental model to understand the pathology caused by this emerging viral pathogen.
   Mayaro virus (MAYV) is an arbovirus that circulates in Latin America and is emerging as a potential threat to public health. Infected individuals develop Mayaro fever, a severe inflammatory disease characterized by high fever, rash, arthralgia, myalgia and headache. The disease is often associated with a prolonged arthralgia mediated by a chronic inflammation that can last months. Although the immune response against other arboviruses, such as chikungunya virus (CHIKV), dengue virus (DENV) and Zika virus (ZIKV), has been extensively studied, little is known about the pathogenesis of MAYV infection. In this study, we established models of MAYV infection in macrophages and in mice and found that MAYV can replicate in bone marrow-derived macrophages and robustly induce expression of inflammasome proteins, such as NLRP3, ASC, AIM2, and Caspase-1 (CASP1). Infection performed in macrophages derived from Nlrp3(-/-), Aim2(-/-), Asc(-/-)and Casp1/11(-/-)mice indicate that the NLRP3, but not AIM2 inflammasome is essential for production of inflammatory cytokines, such as IL-1 beta. We also determined that MAYV triggers NLRP3 inflammasome activation by inducing reactive oxygen species (ROS) and potassium efflux. In vivo infections performed in inflammasome-deficient mice indicate that NLRP3 is involved with footpad swelling, inflammation and pain, establishing a role of the NLRP3 inflammasome in the MAYV pathogenesis. Accordingly, we detected higher levels of caspase1-p20, IL-1 beta and IL-18 in the serum of MAYV-infected patients as compared to healthy individuals, supporting the participation of the NLRP3-inflammasome during MAYV infection in humans.
C1 [de Castro-Jorge, Luiza A.; de Carvalho, Renan V. H.; Zamboni, Dario S.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil.
   [Klein, Taline M.; Fumagalli, Marcilio Jorge; Floriano, Vitor G.; Agostinho, Mayara R.; Fonseca, Benedito A. L.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Ribeirao Preto, Brazil.
   [Hiroki, Carlos H.; Lopes, Alexandre H.; Guimaraes, Rafaela M.; Cunha, Thiago M.; Cunha, Fernando Q.] Univ Sao Paulo, Sch Med Ribeirao Preto, Ctr Res Inflammatory Dis, Dept Pharmacol, Ribeirao Preto, Brazil.
   [Slhessarenko, Renata Dezengrini] Univ Fed Mato Grosso, Sch Med, Cuiaba, Brazil.
   [Ramalho, Fernando Silva] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, Brazil.
RP Zamboni, DS (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil.
EM dszamboni@fmrp.usp.br
RI Ramalho, Fernando Silva/G-3817-2012; Zamboni, Dario S/D-3024-2012;
   Cunha, Thiago M/B-7729-2012; de Carvalho, Renan V. H./AAC-7673-2019
OI Ramalho, Fernando Silva/0000-0002-7529-466X; Zamboni, Dario
   S/0000-0002-7856-7512; Cunha, Thiago M/0000-0003-1084-0065; de Carvalho,
   Renan V. H./0000-0001-5740-0652; Hiroki, Carlos/0000-0002-1343-5957
FU PEW; INCTV/CNPqNational Council for Scientific and Technological
   Development (CNPq); CNPqNational Council for Scientific and
   Technological Development (CNPq) [401577/2014-7, 445881/2014-3];
   FAEPA/FMRP; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2013/08216-2, 2014/04684-4]
FX This work was supported by grants from PEW, INCTV/CNPq, CNPq (Grants
   401577/2014-7 and 445881/2014-3), FAEPA/FMRP and FAPESP (Grants
   2013/08216-2 and 2014/04684-4). RVHC, LACG, and TMK were supported by
   fellowships from FAPESP. DSZ, TMC, BALF, and FQC are Research Fellows
   from CNPq. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005
   Esposito DLA, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01372-15
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Bancroft JD, 1996, THEORY PRACTICE HIST
   Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58
   Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005
   Chen RB, 2018, J GEN VIROL, V99, P761, DOI 10.1099/jgv.0.001072
   Chen WQ, 2017, NAT MICROBIOL, V2, P1435, DOI 10.1038/s41564-017-0015-4
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018
   de Carvalho RNVH, 2019, J LEUKOCYTE BIOL, V106, P631, DOI 10.1002/JLB.MA1118-471R
   de Carvalho RVH, 2019, CELL REP, V26, P429, DOI 10.1016/j.celrep.2018.12.047
   de Souza Costa MC, 2018, ACTA TROP, DOI 10.1016/j.actatropica.2018.12.01930552880
   Ekchariyawat P, 2015, INFECT GENET EVOL, V32, P401, DOI 10.1016/j.meegid.2015.03.025
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Fumagalli MJ, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01892-18
   Fumagalli MJ, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1028-1
   Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004
   Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   de Carvalho RVH, 2015, CYTOKINE, V76, P545, DOI 10.1016/j.cyto.2015.01.025
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667
   Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857
   Jia M, 2017, MOL PAIN, V13, DOI 10.1177/1744806917719804
   Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107
   Juarez D, 2013, J VIROL METHODS, V187, P185, DOI 10.1016/j.jviromet.2012.09.026
   Kagan C, 2016, PERSPECT BIOL, V33, P395, DOI 10.1038/nbt.312125395297
   Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475
   Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lee WWL, 2015, J VIROL, V89, P7955, DOI [10.1128/JVI.00909-1525995257, DOI 10.1128/JVI.00909-1525995257]
   Leroy EM, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/J0URNAL.PPAT.100226821966274
   Lima DS, 2017, J IMMUNOL, V199, P2055, DOI 10.4049/jimmunol.1700258
   Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007
   Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515
   Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Maucourant C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020131
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392
   Medlin S, 2016, J WILDLIFE DIS, V52, P883, DOI 10.7589/2015-02-040
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446
   Pabinger Stephan, 2014, Biomol Detect Quantif, V1, P23
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10
   Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046
   Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864
   Sant'Anna MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26955
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   SEYMOUR C, 1983, AM J TROP MED HYG, V32, P854, DOI 10.4269/ajtmh.1983.32.854
   Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1
   Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004
   Tate MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27912
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Thanapati S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00895
   Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wang WB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006123
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
   Yogarajah T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05589-2
NR 72
TC 6
Z9 6
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD SEP
PY 2019
VL 15
IS 9
AR e1007934
DI 10.1371/journal.ppat.1007934
PG 27
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA JB8SE
UT WOS:000488845000037
PM 31479495
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Beamish, E
   Tabard-Cossa, V
   Godin, M
AF Beamish, Eric
   Tabard-Cossa, Vincent
   Godin, Michel
TI Programmable DNA Nanoswitch Sensing with Solid-State Nanopores
SO ACS SENSORS
LA English
DT Article
DE solid-state nanopore; nanoswitch; DNA origami; molecular topology
   sensing; dose-response; biomarker detection; single-molecule sensing
ID CONFIGURATIONS; CARRIERS
AB Sensing performance of solid-state nanopores is limited by the fast kinetics of small molecular targets. To address this challenge, we translate the presence of a small target to a large conformational change of a long polymer. In this work, we explore the performance of solid-state nanopores for sensing the conformational states of molecular nanoswitches assembled using the principles of DNA origami. These programmable single-molecule switches show great potential in molecular diagnostics and long-term information storage. We investigate the translocation properties of linear and looped nanoswitch topologies using nanopores fabricated in thin membranes, ultimately comparing the performance of our nanopore platform for detecting the presence of a DNA analogue to a sequence found in a Zika virus biomarker gene with that of conventional gel electrophoresis. We found that our system provides a high-throughput method for quantifying several target concentrations within an order of magnitude by sensing only several hundred molecules using electronics of moderate bandwidth that are conventionally used in nanopore sensing systems.
C1 [Beamish, Eric; Tabard-Cossa, Vincent; Godin, Michel] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.
   [Godin, Michel] Univ Ottawa, Ottawa Carleton Inst Biomed Engn, Ottawa, ON K1N 6N5, Canada.
   [Godin, Michel] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
RP Godin, M (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.; Godin, M (corresponding author), Univ Ottawa, Ottawa Carleton Inst Biomed Engn, Ottawa, ON K1N 6N5, Canada.; Godin, M (corresponding author), Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
EM michel.godin@uottawa.ca
RI Tabard-Cossa, Vincent/M-5202-2013
OI Tabard-Cossa, Vincent/0000-0003-4375-717X; Godin,
   Michel/0000-0002-9360-0675
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada;
   Ontario Early Research Award program; Canada Foundation for Innovation
   (CFI)Canada Foundation for Innovation
FX This work was supported by funding from the Natural Sciences and
   Engineering Research Council of Canada (NSERC), the Ontario Early
   Research Award program, and the Canada Foundation for Innovation (CFI).
   The authors would also like to recognize Dr. Wesley Wong of the Wyss
   Institute at Harvard University for helpful discussions regarding
   nanoswitch design and characterization.
CR Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745
   Beamish E, 2017, ACS SENSORS, V2, P1814, DOI 10.1021/acssensors.7b00628
   Beamish E, 2013, JOVE-J VIS EXP, DOI 10.3791/51081
   Beamish E, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/40/405301
   Bell NAW, 2015, J AM CHEM SOC, V137, P2035, DOI 10.1021/ja512521w
   Bornholt J., 2017, DNA BASED ARCH STORA, P637
   Chandrasekaran A. R, 2018, BIORXIV
   Chandrasekaran AR, 2017, NUCLEIC ACIDS RES, V45, P11459, DOI 10.1093/nar/gkx777
   Chandrasekaran AR, 2017, J NANOMATER, V2017, DOI 10.1155/2017/2820619
   Chandrasekaran AR, 2016, ACS SENSORS, V1, P120, DOI 10.1021/acssensors.5b00178
   Chandrasekaran AR, 2016, CHEMBIOCHEM, V17, P1081, DOI 10.1002/cbic.201600038
   Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081
   Forstater JH, 2016, ANAL CHEM, V88, P11900, DOI 10.1021/acs.analchem.6b03725
   Halvorsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044212
   He YH, 2011, ACS NANO, V5, P8391, DOI 10.1021/nn203186c
   Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0
   Karau P, 2018, ACS SENSORS, V3, P1308, DOI 10.1021/acssensors.8b00165
   Kong JL, 2017, CHEM COMMUN, V53, P436, DOI 10.1039/c6cc08621g
   Koussa MA, 2015, NAT METHODS, V12, P123, DOI 10.1038/nmeth.3209
   Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880
   Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965
   Liu JF, 2011, ACS NANO, V5, P2240, DOI 10.1021/nn1035075
   Mitov MI, 2009, ELECTROPHORESIS, V30, P848, DOI 10.1002/elps.200800583
   Morin TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154426
   Plesa C, 2015, NANO LETT, V15, P732, DOI 10.1021/nl504375c
   Raillon C, 2012, NANOSCALE, V4, P4916, DOI 10.1039/c2nr30951c
   Restrepo-Perez L, 2018, NAT NANOTECHNOL, V13, P786, DOI 10.1038/s41565-018-0236-6
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Shi WQ, 2017, ANAL CHEM, V89, P157, DOI 10.1021/acs.analchem.6b04260
   Sze JYY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01584-3
   Tahvildari R, 2015, LAB CHIP, V15, P1407, DOI 10.1039/c4lc01366b
   Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010
   Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/NNANO.2009.379, 10.1038/nnano.2009.379]
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Ying YL, 2017, SCI CHINA CHEM, V60, P1187, DOI 10.1007/s11426-017-9082-5
NR 35
TC 3
Z9 3
U1 1
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD SEP
PY 2019
VL 4
IS 9
BP 2458
EP 2464
DI 10.1021/acssensors.9b01053
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA JB2YH
UT WOS:000488424100031
PM 31449750
DA 2020-07-08
ER

PT J
AU Kempster, SL
   Dougall, T
   Morris, C
   Gonzalez-Escobar, G
   Almond, N
   Anderson, R
AF Kempster, Sarah L.
   Dougall, Thomas
   Morris, Clare
   Gonzalez-Escobar, Gabriel
   Almond, Neil
   Anderson, Rob
TI Utility of reference materials for Zika Virus nucleic acid testing
SO BIOLOGICALS
LA English
DT Article
DE Zika virus; PCR; Molecular virus diagnostics; NAT
ID MOLECULAR-DETECTION; INACTIVATION; NAT; PCR
AB The emergence of Zika virus (ZIKV) in the Americas has resulted in increased nucleic acid amplification testing (NAT) of clinical samples and blood donations. New molecular diagnostic assays have been developed resulting in a corollary requirement for ZIKV reference material. To address this we have produced and calibrated two African lineage ZIKV reference materials: a highly concentrated secondary standard (NIBSC: 16/110) and a lower concentration external quality control (QC) reagent (NIBSC: 16/124) and compared their performance in three ZIKV NAT assays in relation with the First International Standard (IS) for Zika Virus NAT assays (PEI: 11468/16). In summary the African lineage ZIKV reference materials were detected by all three assays. The ZIKV lineage did not affect the performance of the secondary standard. The external QC reagent (16/124) was detected by all three assays highlighting its suitability for use as a low positive control to monitor assay performance on a regular basis. The relative potency of 16/110 to the IS was 5.49E + 06IU/mL (95% CI: 1.46E + 06-2.06E+07) and 16/124 to 16/110 was 8.36E+03 (95% CI: 7.83E + 03-8.92E+03). The global availability of African lineage ZIKV reference materials will facilitate standardization of ZIKV molecular diagnostic assays between and within laboratories whilst preserving the IS.
C1 [Kempster, Sarah L.; Dougall, Thomas; Morris, Clare; Almond, Neil; Anderson, Rob] NIBSC, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
   [Gonzalez-Escobar, Gabriel] Caribbean Publ Hlth Agcy CARPHA, 16-18 Jamaica Bvd,Federat Pk, Port Of Spain, Trinidad Tobago.
RP Kempster, SL (corresponding author), NIBSC, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
EM sarah.kempster@nibsc.org
OI kempster, sarah/0000-0002-4309-1489
FU Department of Health & Social Care, UK
FX We would like to acknowledge NCPV for providing ZIKV strains, CARPHA for
   contributing clinical samples and Dr Alain Kohl at the University of
   Glasgow for providing the isolate Brazil/PE243/2015. We would also like
   to acknowledge Dr Mark Page and James Ashall of NIBSC for coordinating
   and collecting samples from CARPHA. This work was funded by the
   Department of Health & Social Care, UK.
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   [Anonymous], COMBISTATS V5 0 E
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Baylis SA, 2015, TRANSFUS MED HEMOTH, V42, P211, DOI 10.1159/000435872
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   NOWAK T, 1993, DEV BIOL STAND, V81, P169
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Saldanha J, 1999, VOX SANG, V76, P149, DOI 10.1046/j.1423-0410.1999.7630149.x
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Thompson KAS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-257
   WESTGARD JO, 1981, CLIN CHEM, V27, P493
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1045-1056
EI 1095-8320
J9 BIOLOGICALS
JI Biologicals
PD SEP
PY 2019
VL 61
BP 55
EP 60
DI 10.1016/j.biologicals.2019.06.007
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
GA JA8YV
UT WOS:000488138100009
PM 31277902
OA Other Gold
DA 2020-07-08
ER

PT J
AU Carolino, AT
   Gomes, SA
   Teodoro, TBP
   Mattoso, TC
   Samuels, RI
AF Carolino, Aline Teixeira
   Gomes, Simone Azevedo
   Pontes Teodoro, Thais Bercot
   Mattoso, Thalles Cardoso
   Samuels, Richard Ian
TI Aedes aegypti Pupae are Highly Susceptible to Infection by Metarhizium
   anisopliae Blastospores
SO JOURNAL OF PURE AND APPLIED MICROBIOLOGY
LA English
DT Article
DE Virulence; Fungus; Vector; Biological control; Pupa; Dengue
ID BIOLOGICAL-CONTROL; BASSIANA
AB The mosquito Aedes aegypti vectors arboviruses such as urban yellow fever, dengue, chikungunya and Zika. Reducing the vector population is still the most effective method to decrease the spread of arboviruses. Fungi are the main natural disease agents of insects. The present study compared the virulence of conidia and blastospores of the entomopathogenic fungus Metarhizium anisopliae against A. aegypti pupae. The pupae were obtained by collecting eggs using "ovitraps" deployed in an urban environment. M. anisopliae conidia were produced using solid media and blastospores were produced by inoculating conidia in liquid culture. Blastospores were more virulent against pupae than conidia, and no pupae survived twenty-four hours after exposure to this type of propagule. Large quantities of mucilage were produced by the blastospores in the presence of the pupae. Exposure of pupae to conidial suspensions resulted in 57% survival at 24h and 23% at 48h. A proportion of the adults, which emerged from pupae exposed to conidia, succumbed to infection. This is the first study to demonstrates the infection of A. aegypti pupae by the entomopathogenic fungus M. anisopliae, showing that this stage of development can also be targeted by biological control agents.
C1 [Carolino, Aline Teixeira; Gomes, Simone Azevedo; Pontes Teodoro, Thais Bercot; Samuels, Richard Ian] State Univ North Fluminense, Dept Entomol & Plant Pathol, Alberto Lamego Ave 2000,Parque California, Campos Dos Goytacazes, RJ, Brazil.
   [Mattoso, Thalles Cardoso] Univ Fed Roraima, Dept Crop Sci, Boa Vista, Roraima, Brazil.
RP Samuels, RI (corresponding author), State Univ North Fluminense, Dept Entomol & Plant Pathol, Alberto Lamego Ave 2000,Parque California, Campos Dos Goytacazes, RJ, Brazil.
EM richardiansamuels@gmail.com
OI Teixeira Carolino, Aline/0000-0001-5240-5171
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/201.345/2016, E-26/203.066/2016,
   E-26/201.336/2016]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [431766/2016-9]
FX FAPERJ : E-26/201.345/2016; E-26/203.066/2016; E-26/201.336/2016. CNPq:
   431766/2016-9.
CR Alkhaibari AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005715
   Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brazilian Ministry of Health, MON CAS DENG FEBR CH
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   Carolino AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-198
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   Gomes SA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1280-9
   Greenfield BPJ, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140193
   Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031
   Holder DJ, 2005, APPL ENVIRON MICROB, V71, P5260, DOI 10.1128/AEM.71.9.5260-5266.2005
   Jaronski ST, 1997, MEM ENTOMOL SOC CAN, P225, DOI 10.4039/entm129171225-1
   Kim JJ, 2012, BIOCONTROL SCI TECHN, V22, P319, DOI 10.1080/09583157.2012.656580
   Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Luz C, 2008, MEM I OSWALDO CRUZ, V103, P214, DOI 10.1590/S0074-02762008000200016
   Mitraka E, 2013, PATHOG GLOB HEALTH, V107, P305, DOI 10.1179/2047773213Y.0000000106
   Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06
   STLEGER RJ, 1987, J GEN MICROBIOL, V133, P1371
   WHO, GLOB VECT CONTR RESP
   Wondji CS, 2008, TROP MED INT HEALTH, V13, P548, DOI 10.1111/j.1365-3156.2008.02033.x
   Zhang J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01445
NR 22
TC 0
Z9 0
U1 0
U2 2
PU DR M N KHAN
PI BHOPAL
PA 54, NEAR POST OFFICE, THANA ST, BHOPAL, SHAHJAHANABAD 462 001, INDIA
SN 0973-7510
EI 2581-690X
J9 J PURE APPL MICROBIO
JI J. Pure Appl. Microbiol.
PD SEP
PY 2019
VL 13
IS 3
BP 1629
EP 1634
DI 10.22207/JPAM.13.3.36
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA JB5LF
UT WOS:000488603700036
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Azar, SR
   Weaver, SC
AF Azar, Sasha R.
   Weaver, Scott C.
TI Vector Competence: What Has Zika Virus Taught Us?
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; mosquitoes; vector competence; arbovirus; Aedes aegypti;
   Flaviviruses
ID AEDES-AEGYPTI DIPTERA; INSECT-SPECIFIC VIRUSES; EQUINE ENCEPHALOMYELITIS
   VIRUS; BLOOD-FEEDING PATTERNS; WEST-NILE-VIRUS; CULEX-TARSALIS; EILAT
   VIRUS; HOST-RANGE; ENCEPHALITIS-VIRUS; DENGUE VIRUS
AB The unprecedented outbreak of Zika virus (ZIKV) infection in the Americas from 2015 to 2017 prompted the publication of a large body of vector competence data in a relatively short period of time. Although differences in vector competence as a result of disparities in mosquito populations and viral strains are to be expected, the limited competence of many populations of the urban mosquito vector, Aedes aegypti, from the Americas (when its susceptibility is viewed relative to other circulating/reemerging mosquito-borne viruses such as dengue (DENV), yellow fever (YFV), and chikungunya viruses (CHIKV)) has proven a paradox for the field. This has been further complicated by the lack of standardization in the methodologies utilized in laboratory vector competence experiments, precluding meta-analyses of this large data set. As the calls for the standardization of such studies continue to grow in number, it is critical to examine the elements of vector competence experimental design. Herein, we review the various techniques and considerations intrinsic to vector competence studies, with respect to contemporary findings for ZIKV, as well as historical findings for other arboviruses, and discuss potential avenues of standardization going forward.
C1 [Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, 300 Univ Blvd, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, 300 Univ Blvd, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, 300 Univ Blvd, Galveston, TX 77555 USA.
RP Azar, SR; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 300 Univ Blvd, Galveston, TX 77555 USA.; Azar, SR; Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Translat Sci, 300 Univ Blvd, Galveston, TX 77555 USA.; Azar, SR; Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, 300 Univ Blvd, Galveston, TX 77555 USA.
EM srazar@utmb.edu; sweaver@utmb.edu
RI Weaver, Scott/D-6490-2011
OI Weaver, Scott/0000-0001-8016-8556; Azar, Sasha/0000-0002-9182-216X
FU McLaughlin Endowment
FX This work was funded by a predoctoral fellowship through the McLaughlin
   Endowment (S.R.A.).
CR Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Amuzu HE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0853-y
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Armstrong P.M., SUCESSIVE BLOODMEALS, DOI [10.1101/246306, DOI 10.1101/246306]
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   AZAR SR, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/v10110661
   Baidaliuk A, 2019, J VIROL, V93, DOI 10.1128/JVI.00705-19
   Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brault AC, 2002, J VIROL, V76, P6387, DOI 10.1128/JVI.76.12.6387-6392.2002
   Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101
   Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cavicchioli R, 2019, NAT REV MICROBIOL, V17, P569, DOI 10.1038/s41579-019-0222-5
   Chepkorir E, 2014, INT J INFECT DIS, V21, P3, DOI 10.1016/j.ijid.2014.03.413
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2015, J INFECT DIS, V212, P1177, DOI 10.1093/infdis/jiv174
   Chuchuy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23401-7
   Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dick G.W.A., 1952, T R SOC TROP MED HYG, V46, P12, DOI [10.1016/0035-9203(52)90042-4, DOI 10.1016/0035-9203(52)90042-4]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dickson LB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2780-1
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   Duggal NK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003262
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   GARGAN TP, 1983, AM J TROP MED HYG, V32, P1154, DOI 10.4269/ajtmh.1983.32.1154
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Gloria-Soria A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1506
   Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Hall-Mendelin S, 2018, VECTOR-BORNE ZOONOT, V18, P317, DOI 10.1089/vbz.2017.2232
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hegde S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02160
   Huang YJS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00022
   Huang YJS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182386
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Knox TB, 2003, J MED ENTOMOL, V40, P950, DOI 10.1603/0022-2585-40.6.950
   Kong WL, 2018, MICROB PATHOGENESIS, V114, P476, DOI 10.1016/j.micpath.2017.12.031
   KONISHI E, 1989, J MED ENTOMOL, V26, P535, DOI 10.1093/jmedent/26.6.535
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   KRAMER LD, 1981, AM J TROP MED HYG, V30, P190, DOI 10.4269/ajtmh.1981.30.190
   KRAMER LD, 1976, AM J TROP MED HYG, V25, P336, DOI 10.4269/ajtmh.1976.25.336
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Lindh E, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy321
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Long KC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007116
   Lord CC, 2006, J MED ENTOMOL, V43, P623, DOI 10.1603/0022-2585(2006)43[623:RBHVAV]2.0.CO;2
   LORENZ L, 1984, AM J TROP MED HYG, V33, P690, DOI 10.4269/ajtmh.1984.33.690
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   MACDONALD G, 1961, PUBLIC HEALTH REP, V76, P753, DOI 10.2307/4591271
   Mahmood F, 2004, J AM MOSQUITO CONTR, V20, P277
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   MEYER RP, 1983, AM J TROP MED HYG, V32, P305, DOI 10.4269/ajtmh.1983.32.305
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MILLER BR, 1987, T ROY SOC TROP MED H, V81, P1011, DOI 10.1016/0035-9203(87)90381-6
   Morrison AC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007090
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Nasar F, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0595-2
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   Ohlund P, 2019, VIRUS GENES, V55, P127, DOI 10.1007/s11262-018-01629-9
   PAULSON SL, 1989, MED VET ENTOMOL, V3, P113, DOI 10.1111/j.1365-2915.1989.tb00485.x
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Perez-Guzman E.X., TIME ELAPSED ZIKA DE, DOI [10.1101/621094, DOI 10.1101/621094]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Prudhomme J, 2019, EMERG MICROBES INFEC, V8, P962, DOI 10.1080/22221751.2019.1634489
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Reynolds ES, 2017, COMPARATIVE MED, V67, P232
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Romano D, 2018, ACTA TROP, V183, P43, DOI 10.1016/j.actatropica.2018.04.009
   Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, ADV VIRUS RES, V98, P119, DOI 10.1016/bs.aivir.2016.10.001
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   TURELL MJ, 1988, AM J TROP MED HYG, V39, P597, DOI 10.4269/ajtmh.1988.39.597
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Vloet RPM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006145
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   WEAVER SC, 1993, J MED ENTOMOL, V30, P391, DOI 10.1093/jmedent/30.2.391
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wilson AJ, 2018, CURR OPIN INSECT SCI, V28, P105, DOI 10.1016/j.cois.2018.05.007
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yang CF, 2014, ACTA TROP, V130, P17, DOI 10.1016/j.actatropica.2013.10.013
NR 174
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD SEP
PY 2019
VL 11
IS 9
AR 867
DI 10.3390/v11090867
PG 24
WC Virology
SC Virology
GA JA6OT
UT WOS:000487962400107
PM 31533267
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Scaturro, P
   Kastner, AL
   Pichlmair, A
AF Scaturro, Pietro
   Kastner, Anna Lena
   Pichlmair, Andreas
TI Chasing Intracellular Zika Virus Using Proteomics
SO VIRUSES-BASEL
LA English
DT Review
DE flaviviruses; Zika virus; proteomics; interactome; AP-LC-MS; MS;
   phosphoproteomics; Label-free Quatification; arboviruses; DENV; WNV
ID CRISPR SCREEN; EBOLA-VIRUS; DENGUE; PROTEIN; REVEALS; GENOME;
   REPLICATION; DEPENDENCY; NS4B; PHOSPHORYLATION
AB Flaviviruses are the most medically relevant group of arboviruses causing a wide range of diseases in humans and are associated with high mortality and morbidity, as such posing a major health concern. Viruses belonging to this family can be endemic (e.g., dengue virus), but can also cause fulminant outbreaks (e.g., West Nile virus, Japanese encephalitis virus and Zika virus). Intense research efforts in the past decades uncovered shared fundamental strategies used by flaviviruses to successfully replicate in their respective hosts. However, the distinct features contributing to the specific host and tissue tropism as well as the pathological outcomes unique to each individual flavivirus are still largely elusive. The profound footprint of individual viruses on their respective hosts can be investigated using novel technologies in the field of proteomics that have rapidly developed over the last decade. An unprecedented sensitivity and throughput of mass spectrometers, combined with the development of new sample preparation and bioinformatics analysis methods, have made the systematic investigation of virus-host interactions possible. Furthermore, the ability to assess dynamic alterations in protein abundances, protein turnover rates and post-translational modifications occurring in infected cells now offer the unique possibility to unravel complex viral perturbations induced in the infected host. In this review, we discuss the most recent contributions of mass spectrometry-based proteomic approaches in flavivirus biology with a special focus on Zika virus, and their basic and translational potential and implications in understanding and characterizing host responses to arboviral infections.
C1 [Scaturro, Pietro; Kastner, Anna Lena; Pichlmair, Andreas] Tech Univ Munich, Inst Virol, Sch Med, Schneckenburgerstr 8, D-81675 Munich, Germany.
   [Pichlmair, Andreas] German Ctr Infect Res DZIF, Munich Partner Site, D-81675 Munich, Germany.
RP Scaturro, P; Pichlmair, A (corresponding author), Tech Univ Munich, Inst Virol, Sch Med, Schneckenburgerstr 8, D-81675 Munich, Germany.; Pichlmair, A (corresponding author), German Ctr Infect Res DZIF, Munich Partner Site, D-81675 Munich, Germany.
EM pietro.scaturro@tum.de; lena.kastner@tum.de; andreas.pichlmair@tum.de
OI Pichlmair, Andreas/0000-0002-0166-1367
FU European Research Council (ERC)European Research Council (ERC) [817798];
   Volkswagen StiftungVolkswagen; German Research FoundationGerman Research
   Foundation (DFG) [PI 1084/2, PI 1084/3, PI 1084/4, PI 1084/5, TRR179
   TP11, TRR237 A07]
FX This research was supported by the European Research Council (ERC
   consolidator grant number ERC-CoG ProDAP, 817798), the Volkswagen
   Stiftung and the German Research Foundation (grant numbers PI 1084/2, PI
   1084/3, PI 1084/4, PI 1084/5, TRR179 TP11, TRR237 A07).
CR Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Batra J, 2018, CELL, V175, P1917, DOI 10.1016/j.cell.2018.08.044
   Beltran PMJ, 2016, CELL SYST, V3, P361, DOI 10.1016/j.cels.2016.08.012
   Beys-da-Silva WO, 2019, MOL NEUROBIOL, V56, P4708, DOI 10.1007/s12035-018-1417-x
   Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Charley PA, 2014, CURR OPIN VIROL, V9, P14, DOI 10.1016/j.coviro.2014.09.001
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Chiu HP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007166
   Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Dechtawewat T, 2016, BBA-PROTEINS PROTEOM, V1864, P1270, DOI 10.1016/j.bbapap.2016.04.008
   Dukhovny A, 2019, J VIROL, V93, DOI 10.1128/JVI.00211-19
   Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Fontaine KA, 2018, MBIO, V9, DOI [10.1128/mBio.02126-18, 10.1128/mbio.02126-18]
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   Hammack C, 2019, J VIROL, V93, DOI 10.1128/JVI.00638-19
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053
   Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kovanich D, 2019, J PROTEOME RES, V18, P3203, DOI 10.1021/acs.jproteome.9b00318
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li H, 2009, STEM CELLS, V27, P1244, DOI 10.1002/stem.55
   Li MMH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006145
   Li MH, 2019, NAT MICROBIOL, V4, P985, DOI 10.1038/s41564-019-0375-z
   Li Y, 2019, P NATL ACAD SCI USA, V116, P9527, DOI 10.1073/pnas.1900867116
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Liu Y, 2019, AUTOPHAGY, V15, P174, DOI 10.1080/15548627.2018.1528813
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morimura R, 2013, DEV NEUROBIOL, V73, P911, DOI 10.1002/dneu.22117
   Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285
   Ooi YS, 2019, NAT MICROBIOL, V4, P2369, DOI 10.1038/s41564-019-0518-2
   Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Plaszczyca A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007736
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rebsamen M, 2013, TRENDS IMMUNOL, V34, P610, DOI 10.1016/j.it.2013.05.002
   Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rosa-Fernandes L, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00064
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Sinitcyn P, 2018, ANNU REV BIOMED DA S, V1, P207, DOI 10.1146/annurev-biodatasci-080917-013516
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Xu XH, 2014, CELL RES, V24, P576, DOI 10.1038/cr.2014.33
   Yang C, 2018, J VIROL, V92, DOI 10.1128/JVI.01042-18
   Ye J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf5132
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zhang B, 2019, MOL CELL PROTEOMICS, V18, pS1, DOI 10.1074/mcp.E119.001693
   Zhang H, 2015, J PROTEOME RES, V14, P5157, DOI 10.1021/acs.jproteome.5b00424
   Zhang JS, 2018, CELL HOST MICROBE, V23, P819, DOI 10.1016/j.chom.2018.05.005
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 82
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD SEP
PY 2019
VL 11
IS 9
AR 878
DI 10.3390/v11090878
PG 17
WC Virology
SC Virology
GA JA6OT
UT WOS:000487962400096
PM 31546825
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schwarz, ER
   Pozor, MA
   Pu, RY
   Barr, KL
   Beachboard, SE
   MacLachlan, NJ
   Prakoso, D
   Long, MT
AF Schwarz, Erika R.
   Pozor, Malgorzata A.
   Pu, Ruiyu
   Barr, Kelli L.
   Beachboard, Sarah E.
   MacLachlan, N. James
   Prakoso, Dhani
   Long, Maureen T.
TI Experimental Infection of Pregnant Female Sheep with Zika Virus During
   Early Gestation
SO VIRUSES-BASEL
LA English
DT Article
DE Zika Virus; ZIKV; ovine; sheep; animal model; vertical transmission;
   pregnancy
ID IN-OVINE FETUSES; CONGENITAL-MALFORMATIONS; BLOOD; DISEASE; ONTOGENY;
   OUTCOMES; GROWTH; TRANSMISSION; TERRITORIES; MONOCYTES
AB Zika virus (ZIKV) is a vertically and sexually transmissible virus resulting in severe congenital malformation. The goal of this study was to develop an ovine model of ZIKV infection. Between 28-35 days gestation (DG), four pregnant animals were infected with two doses of 6 x 10(6) PFU of ZIKV; four control animals received PBS. Animals were evaluated for 45 days (D) post-infection (PI) and necropsies were performed. Viral RNA was detected in infected ewe peripheral blood mononuclear cells (PBMC) during the first week PI; however, all fluids and tissues were negative upon culture. Anti-ZIKV IgM (1:400) and neutralizing antibodies were detected in all infected animals. Clinical disease, virus, or ZIKV antibodies were not detected in control ewes. After two weeks PI, fetal loss occurred in two infected animals, and at necropsy, three infected animals had placental petechiation and ecchymosis and one had hydramnion. Fetal morphometrics revealed smaller cranial circumference to crown-rump length ratios (p < 0.001) and relative brain weights (p = 0.038) in fetuses of infected animals compared with control fetuses. Immunophenotyping indicated an increase in B cells (p = 0.012) in infected sheep. Additionally, in vitro experiments using both adult and fetal cell lines demonstrated that ovine cells are highly permissive to ZIKV infection. In conclusion, ZIKV infection of pregnant sheep results in a change in fetal growth and gestational outcomes.
C1 [Schwarz, Erika R.; Pu, Ruiyu; Beachboard, Sarah E.; Prakoso, Dhani; Long, Maureen T.] Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA.
   [Pozor, Malgorzata A.] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32611 USA.
   [Barr, Kelli L.] Baylor Univ, Coll Arts & Sci, Dept Biol, Waco, TX 76798 USA.
   [MacLachlan, N. James] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
RP Long, MT (corresponding author), Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA.
EM longm@ufl.edu
RI Barr, Kelli L./I-7508-2019
OI Barr, Kelli L./0000-0001-7943-7181; Schwarz, Erika/0000-0002-6641-6063
FU Fern-Audette Endowment [F00832]; University of Florida Graduate School
   Fellowship;  [734857]
FX This work was supported by funding provided by ZikAction: Preparedness,
   research and action network on maternal-paediatric axes of ZIKV
   infection in Latin America and the Caribbean, Grant Agreement Number
   734857. Additional funding was provided by the Fern-Audette Endowment
   (grant number F00832). Graduate student support was provided by a
   University of Florida Graduate School Fellowship.
CR ABELLA N, 1994, RES VET SCI, V57, P163, DOI 10.1016/0034-5288(94)90053-1
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Anthony RV, 2003, REPRODUCTION, P183
   Barbera A, 1995, AM J OBSTET GYNECOL, V173, P1765, DOI 10.1016/0002-9378(95)90424-7
   Barr KL, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00186
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021
   Barry JS, 2008, SEMIN PERINATOL, V32, P225, DOI 10.1053/j.semperi.2007.11.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burns P, 2015, JOVE-J VIS EXP, DOI 10.3791/52581
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   CHUNG SI, 1990, VET MICROBIOL, V21, P297, DOI 10.1016/0378-1135(90)90001-C
   COETZER JAW, 1977, ONDERSTEPOORT J VET, V44, P205
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   El-Mandrawy SAM, 2018, J APPL ANIM RES, V46, P1073, DOI 10.1080/09712119.2018.1461629
   ENRIGHT FM, 1980, AM J VET RES, V41, P224
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Frasch Martin G, 2018, Neurosci Biobehav Rev, DOI 10.1016/j.neubiorev.2018.05.026
   Frasch Martin G, 2018, Methods Mol Biol, V1781, P353, DOI 10.1007/978-1-4939-7828-1_19
   Ghesquiere L, 2019, ACTA OBSTET GYN SCAN, V98, P433, DOI 10.1111/aogs.13515
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Herry CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153515
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Khan E, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00020
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larruskain A, 2013, VIRUSES-BASEL, V5, P2043, DOI 10.3390/v5082043
   Leiser R, 1997, MICROSC RES TECHNIQ, V38, P76
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Long MT, 2006, J VET INTERN MED, V20, P608, DOI 10.1892/0891-6640(2006)20[608:DPOTEI]2.0.CO;2
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   PARSONSON IM, 1981, AM J TROP MED HYG, V30, P660, DOI 10.4269/ajtmh.1981.30.660
   PARSONSON IM, 1988, J COMP PATHOL, V99, P215, DOI 10.1016/0021-9975(88)90073-4
   PELLEGRINI V, 1993, VACCINE, V11, P383, DOI 10.1016/0264-410X(93)90204-B
   Peperkamp NH, 2015, VET PATHOL, V52, P1057, DOI 10.1177/0300985814560231
   Poskin A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0260-6
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rio DC, 2010, COLD SPRING HARB PRO, V2010, P5439, DOI DOI 10.1101/PDB.PROT5439
   Roland L, 2014, J VET DIAGN INVEST, V26, P592, DOI 10.1177/1040638714546490
   SAWYER M, 1978, AM J VET RES, V39, P643
   Seino KK, 2007, CLIN VACCINE IMMUNOL, V14, P1465, DOI 10.1128/CVI.00249-07
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Stegeman J.H.J., 1974, BIJDR DIERKD, V44, P72
   Steven D.H., 1975, ANATOMY PLACENTAL BA
   Stonestreet BS, 1996, AM J PHYSIOL-REG I, V271, pR1594
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106
   van der Sluijs M, 2011, VET MICROBIOL, V149, P113, DOI 10.1016/j.vetmic.2010.11.002
   van der Sluijs MTW, 2013, VACCINE, V31, P3726, DOI 10.1016/j.vaccine.2013.05.087
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Worwa G, 2009, VET REC, V164, P499, DOI 10.1136/vr.164.16.499
   Yasri S, 2018, AM J OBSTET GYNECOL, V219, P514, DOI 10.1016/j.ajog.2018.07.009
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 79
TC 2
Z9 2
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD SEP
PY 2019
VL 11
IS 9
AR 795
DI 10.3390/v11090795
PG 19
WC Virology
SC Virology
GA JA6OT
UT WOS:000487962400036
PM 31470560
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Koo, B
   Choi, B
   Park, H
   Yoon, KJ
AF Koo, Bonsang
   Choi, Baekgyu
   Park, Hoewon
   Yoon, Ki-Jun
TI Past, Present, and Future of Brain Organoid Technology
SO MOLECULES AND CELLS
LA English
DT Review
DE brain disorder; brain organoid; neurodevelopment; pluripotent stem cell;
   three-dimensional culture
ID PLURIPOTENT STEM-CELLS; MAMMALIAN CORTICAL NEUROGENESIS; ZIKA
   VIRUS-INFECTION; NEURAL PROGENITORS; CEREBRAL ORGANOIDS; ANIMAL-MODELS;
   IN-VITRO; DIFFERENTIATION; HETEROGENEITY; GLIOBLASTOMA
AB Brain organoids are an exciting new technology with the potential to significantly change our understanding of the development and disorders of the human brain. With step-by-step differentiation protocols, three-dimensional neural tissues are self-organized from pluripotent stem cells, and recapitulate the major millstones of human brain development in vitro. Recent studies have shown that brain organoids can mimic the spatiotemporal dynamicity of neurogenesis, the formation of regional neural circuitry, and the integration of glial cells into a neural network. This suggests that brain organoids could serve as a representative model system to study the human brain. In this review, we will overview the development of brain organoid technology, its current progress and applications, and future prospects of this technology.
C1 [Koo, Bonsang; Choi, Baekgyu; Park, Hoewon; Yoon, Ki-Jun] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.
RP Yoon, KJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.
EM kijunyoon@kaist.ac.kr
OI Yoon, Ki-Jun/0000-0003-2985-2541
FU National Research Foundation of Korea (NRF) - Korean Ministry of
   Science, ICT, and Future Planning (MSIP) [NRF-2018R1A5A1024261,
   NRF-2019R1C1C1006600, NRF-2017M3C7A1047654]; Korea Advanced Institute of
   Science and Technology [G04180031, N10190012, N11190243, N11190053]
FX This work was supported by National Research Foundation of Korea (NRF)
   grants (NRF-2018R1A5A1024261, NRF-2019R1C1C1006600, NRF-2017M3C7A1047654
   to K.-J.Y.) funded by the Korean Ministry of Science, ICT, and Future
   Planning (MSIP), and grants funded by Korea Advanced Institute of
   Science and Technology (G04180031, N10190012, N11190243, N11190053).
CR Bian S, 2018, NAT METHODS, V15, P631, DOI 10.1038/s41592-018-0070-7
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Buchanan M, 2018, NAT PHYS, V14, P634, DOI 10.1038/s41567-018-0200-2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Charras G, 2018, CURR BIOL, V28, pR445, DOI 10.1016/j.cub.2018.02.003
   Choi YH, 2019, MOL CELLS, V42, P189, DOI 10.14348/molcells.2019.2446
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Czerniecki SM, 2018, CELL STEM CELL, V22, P929, DOI 10.1016/j.stem.2018.04.022
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287
   Grebenyuk S, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00039
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Karzbrun E., 2019, BIOENGINEERING, V6, pE9
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kim H, 2019, STEM CELL REP, V12, P518, DOI 10.1016/j.stemcr.2019.01.020
   Kim J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020124
   Kopper O, 2019, NAT MED, V25, P838, DOI 10.1038/s41591-019-0422-6
   Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Levitt P, 2015, NEUROPSYCHOPHARMACOL, V40, P1, DOI 10.1038/npp.2014.237
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008
   Linkous A, 2019, CELL REP, V26, P3203, DOI 10.1016/j.celrep.2019.02.063
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Marton RM, 2019, NAT NEUROSCI, V22, P484, DOI 10.1038/s41593-018-0316-9
   Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Ogawa J, 2018, CELL REP, V23, P1220, DOI 10.1016/j.celrep.2018.03.105
   Oh Y, 2019, MOL CELLS, V42, P200, DOI 10.14348/molcells.2019.2439
   Ormel PR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06684-2
   Park SE, 2019, SCIENCE, V364, P960, DOI 10.1126/science.aaw7894
   Pasca AM, 2019, NAT MED, V25, P784, DOI 10.1038/s41591-019-0436-0
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Plummer S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38130-0
   Qian XY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166074
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Raslan AA, 2013, GENES GENOM, V35, P425, DOI 10.1007/s13258-013-0116-2
   Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Schafer ST, 2019, NAT NEUROSCI, V22, P243, DOI 10.1038/s41593-018-0295-x
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Trujillo CA, 2019, CELL STEM CELL, V25, P558, DOI 10.1016/j.stem.2019.08.002
   Tung TC, 1944, J ANAT, V78, P52
   Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x
   Vijayavenkataraman S, 2018, ADV DRUG DELIVER REV, V132, P296, DOI 10.1016/j.addr.2018.07.004
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Werner S, 2017, CURR OPIN CELL BIOL, V44, P102, DOI 10.1016/j.ceb.2016.09.002
   Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204
   Wimmer RA, 2019, NATURE, V565, P505, DOI 10.1038/s41586-018-0858-8
   Xia Y, 2014, NAT PROTOC, V9, P2693, DOI 10.1038/nprot.2014.182
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
   Yang HHN, 2018, CELL STEM CELL, V23, P882, DOI 10.1016/j.stem.2018.09.016
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
   Yoon SJ, 2019, NAT METHODS, V16, P75, DOI 10.1038/s41592-018-0255-0
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   ZWILLING EDGAR, 1960, NATL CANCER INST MONOGR, V2, P19
NR 94
TC 3
Z9 3
U1 6
U2 12
PU KOREAN SOC MOLECULAR & CELLULAR  BIOLOGY
PI SEOUL
PA 635-4, YUCKSAM-DONG, GANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1016-8478
EI 0219-1032
J9 MOL CELLS
JI Mol. Cells
PD SEP
PY 2019
VL 42
IS 9
BP 617
EP 627
DI 10.14348/molcells.2019.0162
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA JA9XO
UT WOS:000488204700001
PM 31564073
DA 2020-07-08
ER

PT J
AU Rothan, HA
   Kumar, M
AF Rothan, Hussin A.
   Kumar, Mukesh
TI Role of Endoplasmic Reticulum-Associated Proteins in Flavivirus
   Replication and Assembly Complexes
SO PATHOGENS
LA English
DT Review
DE flavivirus; virus replication complex; endoplasmic reticulum; host
   factors
ID ADP-RIBOSYLATION FACTORS; DENGUE VIRUS; ZIKA VIRUS; 3-DIMENSIONAL
   ARCHITECTURE; METHYLTRANSFERASE DOMAIN; SERINE-PROTEASE; SIGNAL PEPTIDE;
   IN-VITRO; NS3; HELICASE
AB Flavivirus replication in host cells requires the formation of replication and assembly complexes on the cytoplasmic side of the endoplasmic reticulum (ER) membrane. These complexes consist of an ER membrane, viral proteins, and host proteins. Genome-wide investigations have identified a number of ER multiprotein complexes as vital factors for flavivirus replication. The detailed mechanisms of the role of ER complexes in flavivirus replication are still largely elusive. This review highlights the fact that the ER multiprotein complexes are crucial for the formation of flavivirus replication and assembly complexes, and the ER complexes could be considered as a target for developing successful broad-spectrum anti-flavivirus drugs.
C1 [Rothan, Hussin A.; Kumar, Mukesh] Georgia State Univ, Dept Biol, Coll Arts & Sci, POB 4010, Atlanta, GA 30303 USA.
RP Rothan, HA; Kumar, M (corresponding author), Georgia State Univ, Dept Biol, Coll Arts & Sci, POB 4010, Atlanta, GA 30303 USA.
EM hrothan@gsu.edu; mkumar8@gsu.edu
RI Kumar, Mukesh/AAI-1046-2019; Kumar, Mukesh/N-8814-2015
OI Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875;
   ROTHAN, HUSSIN/0000-0002-7300-6388
FU National Institute of Neurological Disorders and StrokeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R21NS099838]; Office of the Director, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21OD024896]
FX This work was supported by a grant (R21NS099838) from National Institute
   of Neurological Disorders and Stroke, grant (R21OD024896) from the
   Office of the Director, National Institutes of Health and Institutional
   funds.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561
   Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cai YP, 2005, MOL BRAIN RES, V138, P236, DOI 10.1016/j.molbrainres.2005.04.020
   CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Diekmann H, 2005, MOL BIOL EVOL, V22, P1635, DOI 10.1093/molbev/msi158
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Farhat R, 2016, CELL MICROBIOL, V18, P1121, DOI 10.1111/cmi.12572
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Hampton RY, 1996, MOL BIOL CELL, V7, P2029
   Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005
   Isken O, 2019, J VIROL, V93, DOI 10.1128/JVI.01714-18
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Jung J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11386
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kobayashi S, 2016, J BIOL CHEM, V291, P6559, DOI 10.1074/jbc.M115.712760
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579
   Kume H, 2009, NEUROPATH APPL NEURO, V35, P178, DOI 10.1111/j.1365-2990.2008.00974.x
   Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18909-3
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li MY, 2015, CELL REP, V10, P1496, DOI 10.1016/j.celrep.2015.02.021
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194
   Luo DH, 2008, ACTA CRYSTALLOGR A, V64, pC135, DOI 10.1107/S0108767308095664
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933
   Nain M, 2017, J VIROL, V91, DOI [10.1128/JVI.02274-16, 10.1128/jvi.02274-16]
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Rice C M, 1990, Southeast Asian J Trop Med Public Health, V21, P670
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10
   Rothan HA, 2019, ANTIVIR RES, V171, DOI 10.1016/j.antiviral.2019.104590
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Rothan HA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-314
   Rothan HA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251482
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Ruan JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47532-7
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   YAMSHCHIKOV VF, 1993, VIROLOGY, V192, P38, DOI 10.1006/viro.1993.1006
   YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994
   Yi ZG, 2012, J VIROL, V86, P11815, DOI 10.1128/JVI.01022-12
   Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XW, 2019, EMERG MICROBES INFEC, V8, P585, DOI 10.1080/22221751.2019.1598291
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 91
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD SEP
PY 2019
VL 8
IS 3
AR 148
DI 10.3390/pathogens8030148
PG 10
WC Microbiology
SC Microbiology
GA JA7EF
UT WOS:000488003600022
PM 31547236
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baz, M
   Boivin, G
AF Baz, Mariana
   Boivin, Guy
TI Antiviral Agents in Development for Zika Virus Infections
SO PHARMACEUTICALS
LA English
DT Review
DE Zika virus; antiviral agents; small molecules; virus targets; host
   targets; repurposing; pre-clinical studies
ID WEST-NILE-VIRUS; NONSTRUCTURAL PROTEIN NS3; SMALL-MOLECULE INHIBITORS;
   BROAD-SPECTRUM; DENGUE VIRUS; IN-VITRO; SERINE-PROTEASE; NS2B-NS3
   PROTEASE; STRUCTURAL BASIS; APPROVED DRUGS
AB In 1947, Zika virus (ZIKV), a mosquito-borne flavivirus was identified in Uganda and subsequently spread to Asia and the Pacific regions. In 2015, it was introduced in Brazil causing an important social and sanitary alarm due to its increased virulence and rapid dissemination. Importantly, ZIKV infections have been associated with severe neurological complications such as Guillain-Barre syndrome and microcephaly in fetuses and newborns. Although enormous efforts were made by investigators in the development of effective countermeasures against ZIKV, there is still no approved specific antiviral drug for the treatment of ZIKV infections. Herein, we review several anti ZIKV candidates including drugs targeting both the virus (structural proteins and enzymes) and cellular elements.
C1 [Baz, Mariana; Boivin, Guy] CHU Quebec, Res Ctr Infect Dis, Quebec City, PQ G1V 4G2, Canada.
   Univ Laval, Quebec City, PQ G1V 4G2, Canada.
RP Baz, M; Boivin, G (corresponding author), CHU Quebec, Res Ctr Infect Dis, Quebec City, PQ G1V 4G2, Canada.
EM Mariana.Baz@crchudequebec.ulaval.ca; Guy.Boivin@crchul.ulaval.ca
CR Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723
   Al-Bari MAA, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.293
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030
   BABA M, 1993, ANTIVIR RES, V20, P223, DOI 10.1016/0166-3542(93)90022-B
   Bahramsoltani R, 2016, EXPERT REV ANTI-INFE, V14, P57, DOI 10.1586/14787210.2016.1120670
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Batista MN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010049
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BioCryst Pharmaceuticals Inc, BIOCRYSTS PARTN SHIN
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Ellenbecker M, 2014, ANTIMICROB AGENTS CH, V58, P7405, DOI 10.1128/AAC.03595-14
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483
   Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6
   Haddad JG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102382
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015
   HAMILL RL, 1973, J ANTIBIOT, V26, P463, DOI 10.7164/antibiotics.26.463
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuo SC, 2016, ANTIVIR RES, V134, P89, DOI 10.1016/j.antiviral.2016.07.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   LEVY M, 1991, AM J PERINAT, V8, P174, DOI 10.1055/s-2007-999371
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mangia A, 2014, DIGEST LIVER DIS, V46, pS179, DOI 10.1016/j.dld.2014.09.026
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Niu XF, 2019, EMERG MICROBES INFEC, V8, P749, DOI 10.1080/22221751.2019.1614885
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Ren PJ, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.60
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Robert-Gero M., 1989, NATO ASI SERIES A, V171
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarkey JP, 2007, J NEUROCHEM, V100, P1265, DOI 10.1111/j.1471-4159.2006.04309.x
   SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   TAKEGAMI T, 1995, VIRUS GENES, V9, P105, DOI 10.1007/BF01702653
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Wang YX, 2014, ANTIVIR RES, V103, P1, DOI 10.1016/j.antiviral.2013.12.008
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851
   Wu YH, 2016, WORLD J GASTROENTERO, V22, P188, DOI 10.3748/wjg.v22.i1.188
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang J, 2016, ACS CHEM BIOL, V11, P583, DOI 10.1021/acschembio.5b00812
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 105
TC 5
Z9 6
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD SEP
PY 2019
VL 12
IS 3
AR UNSP 101
DI 10.3390/ph12030101
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JA6IF
UT WOS:000487945400025
PM 31261947
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodrigues, AM
   Silva, AAS
   Pinto, CCC
   dos Santos, DL
   de Freitas, JCC
   Martins, VEP
   de Morais, SM
AF Rodrigues, Alzeir Machado
   Sousa Silva, Antonio Adailson
   Carneiro Pinto, Cleonilda Claita
   dos Santos, Dayanne Lima
   Carneiro de Freitas, Jose Claudio
   Pessoa Martins, Victor Emanuel
   de Morais, Selene Maia
TI Larvicidal and Enzymatic Inhibition Effects of Annona Muricata Seed
   Extract and Main Constituent Annonacin against Aedes Aegypti and Aedes
   Albopictus (Diptera: Culicidae)
SO PHARMACEUTICALS
LA English
DT Article
DE Aedes; larvicidal; botanicals; annonacin
ID ESSENTIAL OILS; MOSQUITO VECTORS; PLANT-EXTRACTS; ACETOGENINS; EFFICACY;
   LARVAE
AB The mosquitoes Aedes aegypti and Aedes albopictus are vectors of arboviruses that cause dengue, zika and chikungunya. Bioactive compounds from plants are environmentally sustainable alternatives to control these vectors and thus the arboviruses transmitted by them. The present study evaluated the larvicidal activity of an acetogenin-rich fraction (ACERF) and its main constituent annonacin obtained from Annona muricata seeds on Ae. aegypti and Ae. albopictus. The larvicidal assays were performed using different concentrations to calculate the LC50 and LC90 values observed 24 h after exposure to the treatment. Annonacin was more active against Ae. aegypti (LC50 2.65 mu g center dot mL(-1)) in comparison with Ae. albopictus (LC50 8.34 mu g center dot mL(-1)). In contrast, the acetogenin-rich fraction was more active against Ae. albopictus (LC50 3.41 mu g center dot mL(-1)) than Ae. aegypti (LC50 12.41 mu g center dot mL(-1)). ACERF and annonacin treated larvae of Ae. aegypti and Ae. albopictus showed significant differences in the inhibition of their metabolic enzymes when compared to untreated larvae. The results demonstrate the relevant larvicidal action of the acetogenin-rich fraction and annonacin showing the potential to develop new products for the control of Ae. aegypti and Ae. albopictus.
C1 [Rodrigues, Alzeir Machado] Inst Fed Educ Ciencia & Tecnol, Dept Ensino Ciencias & Formacao Professores, Ave Almirante Barroso 1155, BR-66093020 Belem, Para, Brazil.
   [Rodrigues, Alzeir Machado; Carneiro Pinto, Cleonilda Claita] Univ Estadual Ceara, RENORBIO, Programa Posgrad Biotecnol, Ave Doutor Silas Munguba 1700, BR-60741000 Fortaleza, Ceara, Brazil.
   [Sousa Silva, Antonio Adailson] Univ Fed Ceara, Programa Posgrad Farmacol, Rua Coronel Nunes de Melo 1127, BR-60430275 Fortaleza, Ceara, Brazil.
   [dos Santos, Dayanne Lima] Univ Estadual Ceara, Lab Quim Prod Nat, Ave Doutor Silas Munguba 1700, BR-60741000 Fortaleza, Ceara, Brazil.
   [Carneiro de Freitas, Jose Claudio] Vertrauen Diag, Ave Washington Soares 655, BR-60810000 Fortaleza, Ceara, Brazil.
   [Pessoa Martins, Victor Emanuel] Univ Integracao Int Lusofonia Afrobrasileira Unil, Inst Ciencias Exatas & Nat, Campus Auroras,Rua Jose Franco de Oliveira S-N, BR-62790970 Redencao, Ceara, Brazil.
   [de Morais, Selene Maia] Univ Estadual Ceara, Dept Quim, Ave Doutor Silas Munguba 1700, BR-60741000 Fortaleza, Ceara, Brazil.
RP Rodrigues, AM (corresponding author), Inst Fed Educ Ciencia & Tecnol, Dept Ensino Ciencias & Formacao Professores, Ave Almirante Barroso 1155, BR-66093020 Belem, Para, Brazil.; Rodrigues, AM (corresponding author), Univ Estadual Ceara, RENORBIO, Programa Posgrad Biotecnol, Ave Doutor Silas Munguba 1700, BR-60741000 Fortaleza, Ceara, Brazil.; de Morais, SM (corresponding author), Univ Estadual Ceara, Dept Quim, Ave Doutor Silas Munguba 1700, BR-60741000 Fortaleza, Ceara, Brazil.
EM alzeir.rodrigues@ifpa.edu.br; selene.morais@uece.br
RI Rodrigues, Alzeir Machado/AAE-5318-2019
OI Rodrigues, Alzeir Machado/0000-0002-8968-9611
FU Funcap; CNPqNational Council for Scientific and Technological
   Development (CNPq) [3781047/2017, 837577/2016]
FX The authors thank the governmental agencies Funcap and CNPq by the
   financial support of a research project Ref. Proc. No 3781047/2017,
   Agreement 837577/2016, Calling 01/2017-Program for the
   SUS-PPSUS-Funcap-Decit/ACTIE/MS-CNPq.
CR Ali SI, 2018, PARASITOL INT, V67, P781, DOI 10.1016/j.parint.2018.08.005
   Avula B, 2018, J PHARMACEUT BIOMED, V159, P548, DOI 10.1016/j.jpba.2018.07.030
   Bento EB, 2018, SAUDI J BIOL SCI, V25, P609, DOI 10.1016/j.sjbs.2016.01.024
   Bonneau N, 2015, J CHROMATOGR B, V1004, P46, DOI 10.1016/j.jchromb.2015.09.039
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Coria-Tellez AV, 2018, ARAB J CHEM, V11, P662, DOI 10.1016/j.arabjc.2016.01.004
   Costa MD, 2018, PHYSIOL MOL PLANT P, V101, P172, DOI 10.1016/j.pmpp.2017.04.001
   da Silva VC, 2006, REV SAUDE PUBL, V40, P1106, DOI [10.1590/S0034-89102006000700021, 10.1590/s0034-89102006000700021]
   de Mendonca FAC, 2005, FITOTERAPIA, V76, P629, DOI 10.1016/j.fitote.2005.06.013
   de Morals SM, 2007, BIOCHEM SYST ECOL, V35, P670, DOI 10.1016/j.bse.2007.05.002
   de Omena MC, 2007, BIORESOURCE TECHNOL, V98, P2549, DOI 10.1016/j.biortech.2006.09.040
   Fujiwara GM, 2017, ECOTOX ENVIRON SAFE, V139, P238, DOI 10.1016/j.ecoenv.2017.01.046
   He K, 1997, PESTIC SCI, V49, P372, DOI 10.1002/(SICI)1096-9063(199704)49:4&lt;372::AID-PS543&gt;3.0.CO;2-K
   Karunaratne SHPP, 2013, PESTIC BIOCHEM PHYS, V107, P98, DOI 10.1016/j.pestbp.2013.05.011
   Kempraj V, 2011, PESTIC BIOCHEM PHYS, V100, P82, DOI 10.1016/j.pestbp.2011.02.009
   Koodalingam A, 2011, ACTA TROP, V118, P27, DOI 10.1016/j.actatropica.2011.01.003
   Kumar Sarita, 2012, Asian Pacific Journal of Tropical Disease, V2, P395, DOI 10.1016/S2222-1808(12)60086-3
   Cavalca PAM, 2010, BRAZ ARCH BIOL TECHN, V53, P835, DOI 10.1590/S1516-89132010000400012
   Mendes LA, 2017, IND CROP PROD, V108, P684, DOI 10.1016/j.indcrop.2017.07.034
   Mohankumar TK, 2016, J ARTHROPOD-BORNE DI, V10, P305
   Oliveira AEMFM, 2017, SUSTAIN CHEM PHARM, V6, P1, DOI 10.1016/j.scp.2017.06.001
   Park HM, 2011, J MED ENTOMOL, V48, P405, DOI 10.1603/ME10108
   Martins VEP, 2006, REV SAUDE PUBL, V40, P737, DOI 10.1590/s0034-89102006000500027
   Pezzi M, 2019, SAUDI J BIOL SCI, V26, P1112, DOI 10.1016/j.sjbs.2018.03.011
   Piplani M, 2019, EXP PARASITOL, V199, P92, DOI 10.1016/j.exppara.2019.02.014
   Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6
   Ravichandran Ramanibai, 2016, Asian Pacific Journal of Tropical Disease, V6, P741, DOI 10.1016/S2222-1808(16)61121-0
   Ribeiro LD, 2013, J STORED PROD RES, V55, P6, DOI 10.1016/j.jspr.2013.06.001
   Rieser MJ, 1996, J NAT PROD, V59, P100, DOI 10.1021/np960037q
   Rodriguez-Cavallo E, 2019, J KING SAUD UNIV SCI, V31, P464, DOI 10.1016/j.jksus.2018.04.019
   Roduan MRM, 2017, BIOMED PHARMACOTHER, V94, P481, DOI 10.1016/j.biopha.2017.07.133
   Rueda AG, 2018, REV BRAS ENTOMOL, V62, P112, DOI 10.1016/j.rbe.2018.01.004
   Santos LMM, 2017, PHYSIOL MOL PLANT P, V100, P35, DOI 10.1016/j.pmpp.2017.05.008
   Shamsi T. N., 2018, Acta Ecologica Sinica - International Journal, V38, P325, DOI 10.1016/j.chnaes.2018.01.002
   de Oliveira APS, 2016, PROCESS BIOCHEM, V51, P1683, DOI 10.1016/j.procbio.2016.06.026
   Subramaniam J, 2012, SAUDI J BIOL SCI, V19, P503, DOI 10.1016/j.sjbs.2012.07.003
   Sun S, 2017, TETRAHEDRON LETT, V58, P1895, DOI 10.1016/j.tetlet.2017.04.016
   Suryawanshi RK, 2015, PESTIC BIOCHEM PHYS, V123, P49, DOI 10.1016/j.pestbp.2015.01.018
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Warikoo Radhika, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P152, DOI 10.1016/S2221-1691(11)60211-6
   WHO, 2005, GUID LAB FIELD TEST
   Yu KX, 2015, ASIAN PAC J TROP MED, V8, P981, DOI 10.1016/j.apjtm.2015.11.011
NR 42
TC 1
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD SEP
PY 2019
VL 12
IS 3
AR UNSP 112
DI 10.3390/ph12030112
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JA6IF
UT WOS:000487945400004
PM 31357557
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saiz, JC
AF Saiz, Juan-Carlos
TI Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go
SO PHARMACEUTICALS
LA English
DT Review
DE Zika virus; vaccines; direct acting antivirals (DAAs); host acting
   antivirals (HAAs)
ID NEUTRALIZING IMMUNE-RESPONSES; SPECTRUM ANTIVIRAL COMPOUND;
   SMALL-MOLECULE INHIBITORS; INFECTION IN-VITRO; FDA-APPROVED DRUG;
   VIRUS-INFECTION; BROAD-SPECTRUM; NS2B-NS3 PROTEASE; DENGUE VIRUS; DNA
   VACCINE
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that spread throughout the American continent in 2015 causing considerable worldwide social and health alarm due to its association with ocular lesions and microcephaly in newborns, and Guillain-Barre syndrome (GBS) cases in adults. Nowadays, no licensed vaccines or antivirals are available against ZIKV, and thus, in this very short time, the scientific community has conducted enormous efforts to develop vaccines and antivirals. So that, different platforms (purified inactivated and live attenuated viruses, DNA and RNA nucleic acid based candidates, virus-like particles, subunit elements, and recombinant viruses) have been evaluated as vaccine candidates. Overall, these vaccines have shown the induction of vigorous humoral and cellular responses, the decrease of viremia and viral RNA levels in natural target organs, the prevention of vertical and sexual transmission, as well as that of ZIKV-associated malformations, and the protection of experimental animal models. Some of these vaccine candidates have already been assayed in clinical trials. Likewise, the search for antivirals have also been the focus of recent investigations, with dozens of compounds tested in cell culture and a few in animal models. Both direct acting antivirals (DAAs), directed to viral structural proteins and enzymes, and host acting antivirals (HAAs), directed to cellular factors affecting all steps of the viral life cycle (binding, entry, fusion, transcription, translation, replication, maturation, and egress), have been evaluated. It is expected that this huge collaborative effort will produce affordable and effective therapeutic and prophylactic tools to combat ZIKV and other related still unknown or nowadays neglected flaviviruses. Here, a comprehensive overview of the advances made in the development of therapeutic measures against ZIKV and the questions that still have to be faced are summarized.
C1 [Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
RP Saiz, JC (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
EM jcsaiz@inia.es
OI Saiz, Juan-Carlos/0000-0001-8269-5544
FU Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria,
   INIAInstituto de Investigacion Agropecuaria (INIA)
   [E-RTA2017-00003-C02-01]
FX This research was funded by the Instituto Nacional de Investigacion y
   Tecnologia Agraria y Alimentaria, INIA (E-RTA2017-00003-C02-01).
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Alves MP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110593
   Arbuckle JH, 2017, MBIO, V8, DOI [10.1128/mBio.01141-17, 10.1128/mbio.01141-17]
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Baldwin WR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34735-7
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bassi MR, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00380-18, 10.1128/aac.00380-18]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   BECK S, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/v11040338
   Bernatchez JA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040365
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Bullard BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35755-z
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Cannalire R, 2019, ANTIVIR RES, V167, P6, DOI 10.1016/j.antiviral.2019.03.004
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Chung DH, 2016, ANTIMICROB AGENTS CH, V60, P4552, DOI 10.1128/AAC.00282-16
   Clain E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081860
   Clain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29183-2
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Coronado MA, 2018, ANTIVIR RES, V160, P118, DOI 10.1016/j.antiviral.2018.10.019
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Carvalho OV, 2017, INT J ANTIMICROB AG, V50, P718, DOI 10.1016/j.ijantimicag.2017.08.016
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   de Mello CPP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01983-17
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durham DP, 2018, ANN INTERN MED, V168, P621, DOI 10.7326/M17-0641
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Francese R, 2019, ANTIVIR RES, V163, P29, DOI 10.1016/j.antiviral.2019.01.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Nicolas O, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01206-18
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Giel-Moloney M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31375-9
   Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Huang SM, 2019, J COLLOID INTERF SCI, V542, P198, DOI 10.1016/j.jcis.2019.02.010
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Ji ZL, 2018, VIROL SIN, V33, P545, DOI 10.1007/s12250-018-0068-4
   de Oya NJ, 2019, EMERG MICROBES INFEC, V8, P624, DOI 10.1080/22221751.2019.1604084
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kaner J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0194-4
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kottkamp AC, 2019, J VIROL, V93, DOI [10.1128/JVI.00389-19, 10.1128/jvi.00389-19]
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kum DB, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0092-2
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Lee JL, 2019, ANTIVIR RES, V167, P13, DOI 10.1016/j.antiviral.2019.04.003
   Lei J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122678
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li FF, 2019, J BIOL CHEM, V294, P182, DOI 10.1074/jbc.RA118.005015
   Li PC, 2019, ACS INFECT DIS, V5, P460, DOI 10.1021/acsinfecdis.8b00322
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lian WL, 2018, ACS INFECT DIS, V4, P1395, DOI 10.1021/acsinfecdis.8b00127
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lin SC, 2019, INT J ANTIMICROB AG, V54, P80, DOI 10.1016/j.ijantimicag.2019.03.017
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martin-Acebes MA, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020097
   Martin-Acebes MA, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030369
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Mazzon M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020176
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Medina LO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02464
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, pIV, DOI 10.1016/j.coviro.2014.08.002
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nazerai L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010029
   Neris RLS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27855-7
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Nurnberger C, 2019, J VIROL, V93, DOI 10.1128/JVI.01485-18
   Palanichamy K, 2019, J MED CHEM, V62, P4110, DOI 10.1021/acs.jmedchem.9b00142
   Pan T, 2018, J VIROL, V92, DOI [10.1128/JVI.01018-18, 10.1128/jvi.01018-18]
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Park JG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00718
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Perez P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35724-6
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Pitts J, 2019, ANTIVIR RES, V164, P147, DOI 10.1016/j.antiviral.2019.02.008
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Pryke KM, 2017, MBIO, V8, DOI [10.1128/mBio.00452-17, 10.1128/mbio.00452-17]
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Raekiansyah M, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0072-7
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rocker AE, 2018, ANTIVIR RES, V152, P26, DOI 10.1016/j.antiviral.2018.02.003
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Russo RR, 2019, ARCH VIROL, V164, P1159, DOI 10.1007/s00705-019-04172-6
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarkey JP, 2007, J NEUROCHEM, V100, P1265, DOI 10.1111/j.1471-4159.2006.04309.x
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Taguwa S, 2019, CELL REP, V26, P906, DOI 10.1016/j.celrep.2018.12.095
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Touret F, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0161-7
   Tricarico PM, 2019, INFLAMMOPHARMACOLOGY, V27, P621, DOI 10.1007/s10787-018-0517-6
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024
   Wang HB, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0013-6
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang R, 2018, VACCINE, V36, P3522, DOI 10.1016/j.vaccine.2018.04.051
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, HIST ZIK VIR
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Willard KA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010020
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang CF, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0191-1
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   YANG SNY, 2019, CELLS-BASEL, V8, DOI DOI 10.3390/cells8030281
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu XL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0572-7
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 223
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD SEP
PY 2019
VL 12
IS 3
AR UNSP 127
DI 10.3390/ph12030127
PG 29
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JA6IF
UT WOS:000487945400032
PM 31480297
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zamoner, LOB
   Aragao-Leoneti, V
   Carvalho, I
AF Zamoner, Luis O. B.
   Aragao-Leoneti, Valquiria
   Carvalho, Ivone
TI Iminosugars: Effects of Stereochemistry, Ring Size, and N-Substituents
   on Glucosidase Activities
SO PHARMACEUTICALS
LA English
DT Article
DE iminosugars; polyhydroxypiperidines; polyhydroxyazepanes; glucosidase
   inhibition; miglustat; miglitol
ID ALPHA-GLUCOSIDASE; GLUCOCEREBROSIDASE INHIBITORS; GLYCOSIDASE
   INHIBITORS; POTENTIAL INHIBITORS; LIBRARY GENERATION; IN-VITRO;
   1-DEOXYNOJIRIMYCIN; DERIVATIVES; ALKYL; DEOXYNOJIRIMYCIN
AB N-substituted iminosugar analogues are potent inhibitors of glucosidases and glycosyltransferases with broad therapeutic applications, such as treatment of diabetes and Gaucher disease, immunosuppressive activities, and antibacterial and antiviral effects against HIV, HPV, hepatitis C, bovine diarrhea (BVDV), Ebola (EBOV) and Marburg viruses (MARV), influenza, Zika, and dengue virus. Based on our previous work on functionalized isomeric 1,5-dideoxy-1,5-imino-D-gulitol (L-gulo-piperidines, with inverted configuration at C-2 and C-5 in respect to glucose or deoxynojirimycin (DNJ)) and 1,6-dideoxy-1,6-imino-D-mannitol (D-manno-azepane derivatives) cores N-linked to different sites of glucopyranose units, we continue our studies on these alternative iminosugars bearing simple N-alkyl chains instead of glucose to understand if these easily accessed scaffolds could preserve the inhibition profile of the corresponding glucose-based N-alkyl derivatives as DNJ cores found in miglustat and miglitol drugs. Thus, a small library of iminosugars (14 compounds) displaying different stereochemistry, ring size, and N-substitutions was successfully synthesized from a common precursor, D-mannitol, by utilizing an S(N)2 aminocyclization reaction via two isomeric bis-epoxides. The evaluation of the prospective inhibitors on glucosidases revealed that merely D-gluco-piperidine (miglitol, 41a) and L-ido-azepane (41b) DNJ-derivatives bearing the N-hydroxylethyl group showed inhibition towards alpha-glucosidase with IC50 41 mu M and 138 mu M, respectively, using DNJ as reference (IC50 134 mu M). On the other hand, beta-glucosidase inhibition was achieved for glucose-inverted configuration (C-2 and C-5) derivatives, as novel L-gulo-piperidine (27a) and D-manno-azepane (27b), preserving the N-butyl chain, with IC50 109 and 184 mu M, respectively, comparable to miglustat with the same N-butyl substituent (40a, IC50 172 mu M). Interestingly, the seven-membered ring L-ido-azepane (40b) displayed near twice the activity (IC50 80 mu M) of the corresponding D-gluco-piperidine miglustat drug (40a). Furthermore, besides alpha-glucosidase inhibition, both miglitol (41a) and L-ido-azepane (41b) proved to be the strongest beta-glucosidase inhibitors of the series with IC50 of 4 mu M.
C1 [Zamoner, Luis O. B.; Aragao-Leoneti, Valquiria; Carvalho, Ivone] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Av Cafe S-N, BR-14040903 Ribeirao Preto, Brazil.
RP Carvalho, I (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Av Cafe S-N, BR-14040903 Ribeirao Preto, Brazil.
EM carronal@usp.br
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/00910-6];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [503709/2011-5]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)CAPES
FX This research was funded by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP), grant number 2007/00910-6, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq),), grant number
   503709/2011-5, and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES).
CR Alonzi DS, 2017, BIOCHEM SOC T, V45, P571, DOI 10.1042/BST20160182
   Alonzi DS, 2009, TETRAHEDRON-ASYMMETR, V20, P897, DOI 10.1016/j.tetasy.2009.03.007
   Aragao-Leoneti V, 2013, TETRAHEDRON LETT, V54, P1087, DOI 10.1016/j.tetlet.2012.12.062
   ASANO N, 1994, CARBOHYD RES, V258, P255, DOI 10.1016/0008-6215(94)84091-1
   ASANO N, 1994, J MED CHEM, V37, P3701, DOI 10.1021/jm00048a006
   Asano N., 2015, CARBOHYDRATE CHEM ST, P279, DOI [10.1142/9781783267200_0011, DOI 10.1142/9781783267200_0011]
   Bras NF, 2014, EXPERT OPIN THER PAT, V24, P857, DOI 10.1517/13543776.2014.916280
   Campo VL, 2013, SPR CARB CH, V39, P181, DOI 10.1039/9781849737173-00181
   Cendret V, 2015, ORG BIOMOL CHEM, V13, P10734, DOI 10.1039/c5ob01526j
   Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011
   Collins P., 1995, MONOSACCHARIDES THEI, P37
   Compain P, 2001, BIOORGAN MED CHEM, V9, P3077, DOI 10.1016/S0968-0896(01)00176-6
   de Melo EB, 2006, TETRAHEDRON, V62, P10277, DOI 10.1016/j.tet.2006.08.055
   Desire J, 2014, ORG BIOMOL CHEM, V12, P8977, DOI 10.1039/c4ob00325j
   Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f
   FOWLER PA, 1994, J CHEM SOC PERK T 1, P2229, DOI 10.1039/p19940002229
   Gao K, 2016, MOLECULES, V21, DOI 10.3390/molecules21111600
   Hines JV, 1999, BIOORG MED CHEM LETT, V9, P1255, DOI 10.1016/S0960-894X(99)00175-4
   Home G, 2011, DRUG DISCOV TODAY, V16, P107, DOI 10.1016/j.drudis.2010.08.017
   Jacob JR, 2007, J MICROBIOL, V45, P431
   Jakobsen P, 2001, BIOORGAN MED CHEM, V9, P733, DOI 10.1016/S0968-0896(00)00291-1
   JUNG ME, 1977, J ORG CHEM, V42, P3761, DOI 10.1021/jo00443a033
   JURCZAK J, 1987, CARBOHYD RES, V164, P493, DOI 10.1016/0008-6215(87)80154-4
   Kasai K., 2001, Jpn. Kokai Tokkyo Koho JP, Patent No. [2001002648 A, 2001002648]
   Lee RE, 1999, TETRAHEDRON LETT, V40, P8689, DOI 10.1016/S0040-4039(99)01844-4
   LeMerrer Y, 1997, BIOORGAN MED CHEM, V5, P519, DOI 10.1016/S0968-0896(96)00266-0
   Li HQ, 2008, CHEMBIOCHEM, V9, P253, DOI 10.1002/cbic.200700496
   Miller JL, 2018, ADV EXP MED BIOL, V1062, P277, DOI 10.1007/978-981-10-8727-1_20
   Miller JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167018
   Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]
   Ouzounov S, 2002, ANTIVIR RES, V55, P425, DOI 10.1016/S0166-3542(02)00075-X
   Parmeggiani C, 2015, CHEMBIOCHEM, V16, P2054, DOI 10.1002/cbic.201500292
   POITOUT L, 1994, TETRAHEDRON LETT, V35, P3293, DOI 10.1016/S0040-4039(00)76888-2
   Qian XH, 1996, BIOORGAN MED CHEM, V4, P2055, DOI 10.1016/S0968-0896(96)00218-0
   ROBINSON KM, 1991, DIABETES, V40, P825, DOI 10.2337/diabetes.40.7.825
   Rosenbloom Barry E., 2013, Critical Reviews in Oncogenesis, V18, P163
   Sayce A.C., 2010, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0004524/1-22
   Schuster M, 2001, BIOORG MED CHEM LETT, V11, P1809, DOI 10.1016/S0960-894X(01)00282-7
   Shih TL, 2011, CARBOHYD RES, V346, P183, DOI 10.1016/j.carres.2010.11.014
   Sorbera LA, 2003, DRUG FUTURE, V28, P229, DOI 10.1358/dof.2003.028.03.723080
   Taghzouti H, 2015, BIOORG CHEM, V58, P11, DOI 10.1016/j.bioorg.2014.11.003
   TAN A, 1991, J BIOL CHEM, V266, P14504
   Trapero A, 2013, FUTURE MED CHEM, V5, P573, DOI [10.4155/fmc.13.14, 10.4155/FMC.13.14]
   Treston A.M., 2017, PCT Int. App. WO, Patent No. [2017201052 A1, 2017201052]
   Tyrrell BE, 2017, CRIT REV MICROBIOL, V43, P521, DOI 10.1080/1040841X.2016.1242868
   VANDENBROEK LAGM, 1994, RECL TRAV CHIM PAY B, V113, P507
   Wadood A, 2018, INT J BIOL MACROMOL, V111, P82, DOI 10.1016/j.ijbiomac.2017.12.148
   Warfield K., 2014, PCT Int. App. WO, Patent No. [2014143999 A1, 2014143999]
   Warfield KL, 2017, ANTIVIR RES, V138, P22, DOI 10.1016/j.antiviral.2016.11.019
   Wetherill LF, 2018, ANTIVIR RES, V158, P113, DOI 10.1016/j.antiviral.2018.08.005
   Wilkinson BL, 2010, AUST J CHEM, V63, P821, DOI 10.1071/CH09426
   Yang XM, 2015, ORG BIOMOL CHEM, V13, P9364, DOI 10.1039/c5ob01278c
   YOSHIKUNI Y, 1989, CHEM PHARM BULL, V37, P106
   Zamoner LOB, 2016, CARBOHYD RES, V429, P29, DOI 10.1016/j.carres.2016.04.020
   Zhang ZX, 2011, TETRAHEDRON LETT, V52, P3802, DOI 10.1016/j.tetlet.2011.05.063
NR 55
TC 1
Z9 1
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD SEP
PY 2019
VL 12
IS 3
AR UNSP 108
DI 10.3390/ph12030108
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA JA6IF
UT WOS:000487945400034
PM 31336868
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Suganya, S
   Ishwarya, R
   Jayakumar, R
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Al-anbr, MN
   Vaseeharan, B
AF Suganya, S.
   Ishwarya, R.
   Jayakumar, R.
   Govindarajan, M.
   Alharbi, N. S.
   Kadaikunnan, S.
   Khaled, J. M.
   Al-anbr, M. N.
   Vaseeharan, B.
TI New insecticides and antimicrobials derived from Sargassum wightii and
   Halimeda gracillis seaweeds: Toxicity against mosquito vectors and
   antibiofilm activity against microbial pathogens
SO SOUTH AFRICAN JOURNAL OF BOTANY
LA English
DT Article
DE Arbovirus; Halimeda gracilis; Sargassum wightii; Larvicides; Pesticides;
   Zika virus
ID ECO-FRIENDLY LARVICIDES; ANTIOXIDANT ACTIVITY; AEDES-AEGYPTI;
   CULEX-QUINQUEFASCIATUS; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL ACTIVITY;
   LIPID-PEROXIDATION; ZNO NANOPARTICLES; BIOFILM FORMATION;
   NATURAL-PRODUCTS
AB Phytochemicals derived from seaweeds offer a novel source of compounds to develop new insecticides and antimicrobials. In the present study, two seaweed species, the brown Sargassum wightii and the green Halimeda gracilis, were investigated. Extracts were obtained using five solvents of varying polarity (acetone, chloroform, methanol, ethanol, and water). The total phenolic content, total flavonoid content and the antioxidant activities of the extracts were estimated. The ethanol extract from S. wightii exhibited more potent antioxidant activity compared to that of the H. gracilis extracts. The ethanol extract from S. wightii possessed higher values of total phenolics, flavonoids, and antioxidant activity compared to those of the H. gracillis ethanol extract. The total phenolic and flavonoid content for ethanol extracts of S. wightii and H. gracillis was 5.5 mg gallic acid equivalent (GAE)/g, 3.8 mg GAE/g, 10 mg quercetin equivalent (QE)/g, and 8.3 mg QE/g, respectively. The total antioxidant activity of the seaweed extracts was 47 mg ascorbic acid equivalent (AAE)/g for S. wightii and 35.9 mg AAE/g for H. gracilis. Additionally, the bioactive compounds present in these seaweeds were characterized by FTIR spectroscopy and GC-MS analysis, and the antimicrobial activity of these extracts was then tested against the biofilm formation capabilities of three pathogenic Gram-negative bacteria. The ethanol extracts from S. wightii and H. gracillis presented the highest inhibitory effect with up to a 40-75% significant reduction in biofilm formation by Gram-negative bacteria. Finally, their insecticidal potential was assessed against late third instar larvae of malaria vectors (Anopheles stephensi), dengue and Zika virus vectors (Aedes aegypti), and the Japanese encephalitis vector (Culex tritaeniorhynchus). LC50 values estimated for the S. wightii ethanol extract were lower than 50 ppm against all tested mosquito species. Light microscopy revealed that morphological changes were triggered upon exposure to seaweed extracts. Overall, the present study sheds light on the relevant bioactivity of phytochemicals obtained from two widespread seaweeds, suggesting the possibility that these seaweeds can be used to develop novel and biodegradable pesticides and also antimicrobial drugs that can be used to inhibit the development of microbial biofilms. (C) 2019 SAAB. Published by Elsevier B.V. All rights reserved.
C1 [Suganya, S.; Ishwarya, R.; Vaseeharan, B.] Alagappa Univ, Nanobiosci & Nanopharmacol Div, Biomat & Biotechnol Anim Hlth Lab, Dept Anim Hlth & Management, Sci Block 6th Floor, Karaikkudi 630004, Tamil Nadu, India.
   [Jayakumar, R.] Cent Marine Fisheries Res Inst, Mandapam Reg Ctr, Mandapam, Tamil Nadu, India.
   [Govindarajan, M.] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Govindarajan, M.] Govt Coll Women, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
   [Alharbi, N. S.; Kadaikunnan, S.; Khaled, J. M.; Al-anbr, M. N.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Nanobiosci & Nanopharmacol Div, Biomat & Biotechnol Anim Hlth Lab, Dept Anim Hlth & Management, Sci Block 6th Floor, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI /L-2836-2013; Alharbi, Naiyf S/B-9402-2019
OI /0000-0001-7018-5379; 
FU Council of Scientific and Industrial Research (CSIR), New Delhi,
   IndiaCouncil of Scientific & Industrial Research (CSIR) - India [9/688
   (0030)/18 EMR - I]; Deanship of Scientific Research at King Saud
   UniversityDeanship of Scientific Research at King Saud University
   [RG-1438-091]
FX RI gratefully acknowledges the Council of Scientific and Industrial
   Research (CSIR), New Delhi, India, for the financial assistance rendered
   [ref: 9/688 (0030)/18 EMR - I]. The authors extend their appreciation to
   the Deanship of Scientific Research at King Saud University for funding
   this work through Research Group No. RG-1438-091. The authors thank the
   Deanship of Scientific Research and RSSU at King Saud University for
   their technical support.
CR Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Al-Mehmadi R. M., 2010, Journal of King Saud University Science, V22, P77, DOI 10.1016/j.jksus.2010.02.004
   Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002
   Ali M. Syed, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P570, DOI 10.1016/S2221-1691(12)60099-9
   Anuradha V., 2015, J TROP DIS, V4, P191
   Arulpriya P., 2010, CHEM SINICA, V1, P73
   Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Chakraborty K, 2015, J FOOD SCI TECH MYS, V52, P1924, DOI 10.1007/s13197-013-1189-2
   Chakraborty K, 2010, FOOD CHEM, V122, P31, DOI 10.1016/j.foodchem.2010.02.012
   Chakraborty K, 2010, FOOD CHEM, V119, P1399, DOI 10.1016/j.foodchem.2009.09.019
   Chang HY, 2007, BOT STUD, V48, P407
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Cox S., 2010, International Food Research Journal, V17, P205
   Devi KP, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-38
   El-Din SMM, 2016, J TAIBAH UNIV SCI, V10, P471, DOI 10.1016/j.jtusci.2015.06.004
   Fernando IPS, 2017, ALGAE-SEOUL, V32, P75, DOI 10.4490/algae.2017.32.12.1
   Ganesan P, 2008, BIORESOURCE TECHNOL, V99, P2717, DOI 10.1016/j.biortech.2007.07.005
   Gonzalez del Val A, 2001, Int Microbiol, V4, P35
   Gopinath K, 2016, MICROB PATHOGENESIS, V101, P1, DOI 10.1016/j.micpath.2016.10.011
   Govindarajan M, 2005, Trop Biomed, V22, P1
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0
   Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987
   Gupta S, 2011, TRENDS FOOD SCI TECH, V22, P315, DOI 10.1016/j.tifs.2011.03.011
   Gusmao DS, 2002, MEM I OSWALDO CRUZ, V97, P371, DOI 10.1590/S0074-02762002000300017
   Heo SJ, 2005, BIORESOURCE TECHNOL, V96, P1613, DOI 10.1016/j.biortech.2004.07.013
   HORNSEY IS, 1985, BRIT PHYCOL J, V20, P21, DOI 10.1080/00071618500650041
   Indu H, 2013, INT J PHARM PHARM SC, V5, P474
   Jimenez-Escrig A, 2001, J SCI FOOD AGR, V81, P530, DOI 10.1002/jsfa.842
   Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022
   Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kannan S., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P341
   Kolanjinathan K, 2009, EUR REV MED PHARMACO, V13, P173
   Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750
   LEKAMEERA R, 2008, AFR J FOOD SCI, V2, P126
   Lizana J.A., 2013, HIGH SCH STUDENTS AG, P43
   Luo J, 2016, DRUG DES DEV THER, V10, DOI 10.2147/DDDT.S97221
   Madhiyazhagan P, 2017, J APPL PHYCOL, V29, P649, DOI 10.1007/s10811-016-0953-x
   Malaikozhundan B, 2016, BIOCATAL AGR BIOTECH, V8, P189, DOI 10.1016/j.bcab.2016.09.007
   Manivannan K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P114, DOI 10.1016/S2221-1691(11)60007-5
   Mathivanan T, 2010, J VECTOR DIS, V47, P178
   Meenakshi S., 2009, GLOBAL J PHARM, V3, P59
   Miquel S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00592
   Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k
   Nagai T., 2003, J ALGAL BIOMASS UTIL, V1, P29
   Nakayama R, 1999, J AM OIL CHEM SOC, V76, P649, DOI 10.1007/s11746-999-0017-3
   Namasivayam SKR, 2013, GLOBAL J MED RES, V13, P1
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   Poonguzhali TV, 2012, INT J CURR SCI, V4, P163
   Raghu K.L., 2011, ASIAN J EXP BIOL SCI, V2, P58
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649
   de Souza MCR, 2007, J APPL PHYCOL, V19, P153, DOI 10.1007/s10811-006-9121-z
   Roginsky V, 2005, FOOD CHEM, V92, P235, DOI 10.1016/j.foodchem.2004.08.004
   Sarojini Y., 2012, Der Pharma Chemica, V4, P1481
   Sasidharan S, 2010, NEW BIOTECHNOL, V27, P390, DOI 10.1016/j.nbt.2010.02.002
   Savithramma N., 2011, Journal of Chemical and Pharmaceutical Research, V3, P28
   Selvin J, 2004, HYDROBIOLOGIA, V513, P231, DOI 10.1023/B:hydr.0000018183.92410.21
   Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008
   Siriwardhana N, 2003, FOOD SCI TECHNOL INT, V9, P339, DOI 10.1177/1082013203039014
   Smit AJ, 2004, J APPL PHYCOL, V16, P245, DOI 10.1023/B:JAPH.0000047783.36600.ef
   Souza BWS, 2011, J AGR FOOD CHEM, V59, P5589, DOI 10.1021/jf200999n
   Sugihara N, 1999, FREE RADICAL BIO MED, V27, P1313, DOI 10.1016/S0891-5849(99)00167-7
   Taubes G, 2000, SCIENCE, V290, P434, DOI 10.1126/science.290.5491.434
   THANGAM TS, 1988, INDIAN J MED RES, V88, P35
   Thanigaivel S, 2015, AQUACULTURE, V443, P56, DOI 10.1016/j.aquaculture.2015.03.010
   Tuney Inci, 2006, Turkish Journal of Biology, V30, P171
   VALENTINA J, 2015, INT J MOSQ RES A, V2, P54
   Vallinayagam K., 2009, GLOBAL J PHARM, V3, P50
   Vaseeharan B, 2010, LETT APPL MICROBIOL, V50, P352, DOI 10.1111/j.1472-765X.2010.02799.x
   Vijayakumar S, 2017, MICROB PATHOGENESIS, V102, P173, DOI 10.1016/j.micpath.2016.11.029
   Wang BG, 2009, FOOD CHEM, V113, P1101, DOI 10.1016/j.foodchem.2008.08.078
   WHO, 2005, WHOCDSWHOPESGCDPP13
   YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007
   Yu KX, 2015, ASIAN PAC J TROP MED, V8, P981, DOI 10.1016/j.apjtm.2015.11.011
   Zakaria ZA, 2014, J ETHNOPHARMACOL, V151, P1184, DOI 10.1016/j.jep.2013.12.045
   Zubia M, 2009, FOOD CHEM, V116, P693, DOI 10.1016/j.foodchem.2009.03.025
NR 90
TC 2
Z9 2
U1 9
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0254-6299
EI 1727-9321
J9 S AFR J BOT
JI S. Afr. J. Bot.
PD SEP
PY 2019
VL 125
BP 466
EP 480
DI 10.1016/j.sajb.2019.08.006
PG 15
WC Plant Sciences
SC Plant Sciences
GA JA9UU
UT WOS:000488195200055
DA 2020-07-08
ER

PT J
AU Martinez-Lopez, A
   Persaud, M
   Chavez, MP
   Zhang, HJ
   Rong, LJ
   Liu, SF
   Wang, TT
   Sarafianos, SG
   Diaz-Griffero, F
AF Martinez-Lopez, Alicia
   Persaud, Mirjana
   Chavez, Maritza Puray
   Zhang, Hongjie
   Rong, Lijun
   Liu, Shufeng
   Wang, Tony T.
   Sarafianos, Stefan G.
   Diaz-Griffero, Felipe
TI Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika
   virus
SO EBIOMEDICINE
LA English
DT Article
DE Zika; Glycosylated diphyllin; Fusion; Endosomal; pH; Ifnar1(-/-)
ID V-ATPASE INHIBITOR; PH-DEPENDENT FUSION; FDA-APPROVED DRUG;
   SENDAI-VIRUS; SEXUAL TRANSMISSION; CELL-FUSION; MOUSE MODEL; WEST-NILE;
   INFECTION; BIOLOGY
AB Background: Flaviviruses such as Zika cause sporadic pandemic outbreaks worldwide. There is an urgent need for anti-Zika virus (ZIKV) drugs to prevent mother-to-child transmission of ZIKV, new infections in high-risk populations, and the infection of medical personnel in ZIKV-affected areas.
   Methods: Here, we showed that the small molecule 6-deoxyglucose-diphyllin (DGP) exhibited anti-ZIKV activity both in vitro and in vivo. DGP potently blocked ZIKV infection across all human and monkey cell lines tested. DGP also displayed broad-spectrum antiviral activity against other flaviviruses. Remarkably, DGP prevented ZIKV-induced mortality in mice lacking the type I interferon receptor (Ifnar1(-/-)). Cellular and virological experiments showed that DGP blocked ZIKV at a pre-fusion step or during fusion, which prevented the delivery of viral contents into the cytosol of the target cell. Mechanistic studies revealed that DGP prevented the acidification of endosomal/lysosomal compartments in target cells, thus inhibiting ZIKV fusion with cellular membranes and infection.
   Findings: These investigations revealed that DGP inhibits ZIKV infection in vitro and in vivo.
   Interpretation: The small molecule DGP has great potential for preclinical studies and the ability to inhibit ZIKV infection in humans. (c) 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Martinez-Lopez, Alicia; Persaud, Mirjana; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.
   [Chavez, Maritza Puray; Sarafianos, Stefan G.] Emory Univ, Lab Biochem Pharmacol, Atlanta, GA 30322 USA.
   [Zhang, Hongjie] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, 7 Baptist Univ Rd, Hong Kong, Peoples R China.
   [Rong, Lijun] Univ Illinois, Coll Med, Microbiol & Immunol, Chicago, IL 60612 USA.
   [Liu, Shufeng; Wang, Tony T.] Ctr Biol Evaluat & Res Food & Drug Adm, Div Viral Prod, Lab Vector Borne Viral Dis, Silver Spring, MD 20903 USA.
RP Diaz-Griffero, F (corresponding author), Albert Einstein Coll Med, 1301 Morris Pk,Price Ctr 501, New York, NY 10461 USA.
EM felipe.diaz-griffero@einstein.yu.edu
FU Albert Einstein College of Medicine
FX This work was supported by the Albert Einstein College of Medicine.
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BOUSSE T, 1994, VIROLOGY, V204, P506, DOI 10.1006/viro.1994.1564
   Bradfute SB, 2012, VIRUSES-BASEL, V4, P1477, DOI 10.3390/v4091477
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Chen HJ, 2018, ONCOL REP, V39, P921, DOI 10.3892/or.2018.6191
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faisca P, 2007, RES VET SCI, V82, P115, DOI 10.1016/j.rvsc.2006.03.009
   Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272
   Garg Tarun K., 2004, BMC Pharmacology, V4, P6, DOI 10.1186/1471-2210-4-6
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Ladner J. T, 2016, GENOME ANNOUNC, V4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Makar S, 2019, EUR J MED CHEM, V161, P252, DOI 10.1016/j.ejmech.2018.10.018
   Martinez-Lopez A, 2018, MOL IMMUNOL, V101, P450, DOI 10.1016/j.molimm.2018.08.005
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nandy A, 2016, CURR COMPUT-AID DRUG, V12, P87, DOI 10.2174/1573409912666160401115812
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Puray-Chavez M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01693-z
   RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, P6, DOI DOI 10.1128/AAC.00411-17.E00411-17
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   SCHEID A, 1974, VIROLOGY, V57, P475, DOI 10.1016/0042-6822(74)90187-1
   Shen WD, 2011, EUR J PHARMACOL, V667, P330, DOI 10.1016/j.ejphar.2011.05.042
   Shi DK, 2012, EUR J MED CHEM, V47, P424, DOI 10.1016/j.ejmech.2011.11.011
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sorensen MG, 2007, J BONE MINER RES, V22, P1640, DOI 10.1359/JBMR.070613
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Susplugas S, 2005, J NAT PROD, V68, P734, DOI 10.1021/np050028u
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thome MP, 2016, J CELL SCI, V129, P4622, DOI 10.1242/jcs.195057
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   VOROVITCH MF, 1991, ARCH VIROL, V118, P133, DOI 10.1007/BF01311309
   Wagner AM, 2003, COMPARATIVE MED, V53, P173
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   Zhang HJ, 2017, J NAT PROD, V80, P1798, DOI 10.1021/acs.jnatprod.7b00004
   Zhao Y, 2012, ARCH PHARM, V345, P622, DOI 10.1002/ardp.201200035
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 76
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD SEP
PY 2019
VL 47
BP 269
EP 283
DI 10.1016/j.ebiom.2019.08.060
PG 15
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA IZ3HR
UT WOS:000486976200038
PM 31501074
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ochoa, JH
   Sosa-Olavarria, A
   Quiroga, H
   Sepulveda, W
AF Ochoa, Jose Hector
   Sosa-Olavarria, Alberto
   Quiroga, Hector
   Sepulveda, Waldo
TI Sonographic Detection of Seizure-Like Activity in Fetuses with
   Congenital Infection: Report of Three Cases and Review of the Literature
SO FETAL DIAGNOSIS AND THERAPY
LA English
DT Review
DE Fetal seizures; Seizure-like activity; Zika virus; Toxoplasmosis; Fetal
   cerebral lesions; Abnormal fetal movements; Prenatal ultrasound
ID FETAL MOTOR BEHAVIOR; PRENATAL-DIAGNOSIS; MOVEMENTS; EMERGENCE
AB Fetal seizure is a very rare prenatal finding and associated with an almost invariably poor outcome, the most common causes being hypoxic-ischemic encephalopathy, congenital anomalies of either the central nervous system (CNS) or musculoskeletal system, and metabolic disorders. The prenatal detection of seizure-like activity in fetuses with congenital infection has not been previously reported. In this report, we describe 3 cases of seizures in fetuses with congenital infection including Zika virus (n = 2) and toxoplasmosis (n = 1). All 3 fetuses had associated CNS abnormalities and the perinatal outcome was uniformly poor. This report suggests that for fetuses with proven congenital infections an extended and targeted sonographic examination may be helpful in -detecting associated fetal seizures that may even worsen the neonatal outcome.
C1 [Ochoa, Jose Hector] Prenatal Diag Ctr, DIAGNUS, 9 Julio 726,X5000EMP, Cordoba, Province Of Cor, Argentina.
   [Sosa-Olavarria, Alberto] Univ Carabobo, Valencia, Venezuela.
   [Quiroga, Hector] Ctr Profes Rosancar, Barquisimeto, Venezuela.
   [Sepulveda, Waldo] Maternal Fetal Diagnost Ctr, FETALMED, Fetal Imaging Unit, Santiago, Chile.
RP Ochoa, JH (corresponding author), Prenatal Diag Ctr, DIAGNUS, 9 Julio 726,X5000EMP, Cordoba, Province Of Cor, Argentina.
EM josehochoa.cba@gmail.com
FU Sociedad Profesional de Medicina Fetal "Fetalmed" Ltda., Chile
FX W.S. was supported by an unrestricted research grant from the Sociedad
   Profesional de Medicina Fetal "Fetalmed" Ltda., Chile.
CR BEJSOVEC M, 1967, ARCH DIS CHILD, V42, P201, DOI 10.1136/adc.42.222.201
   Darin N, 2016, AM J HUM GENET, V99, P1325, DOI 10.1016/j.ajhg.2016.10.011
   De Vries JIP, 2007, ULTRASOUND OBST GYN, V29, P590, DOI 10.1002/uog.3917
   de Vries J, 2008, BJOG-INT J OBSTET GY, V115, DOI 10.1111/j.1471-0528.2007.01573.x
   DEVRIES JIP, 1985, EARLY HUM DEV, V12, P99, DOI 10.1016/0378-3782(85)90174-4
   DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0
   DUPLESSIS AJ, 1993, J CHILD NEUROL, V8, P164, DOI 10.1177/088307389300800210
   Hayat TTA, 2018, AM J NEURORADIOL, V39, P1519, DOI 10.3174/ajnr.A5694
   Hobson EE, 2005, EUR J PEDIATR, V164, P655, DOI 10.1007/s00431-005-1729-5
   Jung E, 2008, J KOREAN MED SCI, V23, P906, DOI 10.3346/jkms.2008.23.5.906
   Keogh JM, 2000, ACTA OBSTET GYN SCAN, V79, P787, DOI 10.1034/j.1600-0412.2000.079009787.x
   McNally MA, 2016, PEDIATR NEUROL, V64, P87, DOI 10.1016/j.pediatrneurol.2016.08.003
   Patel MS, 2006, AM J MED GENET A, V140A, P594, DOI 10.1002/ajmg.a.31095
   PRECHTL HFR, 1990, EARLY HUM DEV, V23, P151, DOI 10.1016/0378-3782(90)90011-7
   ROODENBURG PJ, 1991, EARLY HUM DEV, V25, P19, DOI 10.1016/0378-3782(91)90203-F
   Ruiz A, 2008, MOL GENET METAB, V93, P216, DOI 10.1016/j.ymgme.2007.10.003
   Sheizaf B, 2007, ULTRASOUND OBST GYN, V30, P1007, DOI 10.1002/uog.5153
   SIVAL DA, 1993, EARLY HUM DEV, V34, P13, DOI 10.1016/0378-3782(93)90036-T
   SIVAL DA, 1992, EARLY HUM DEV, V28, P119, DOI 10.1016/0378-3782(92)90107-R
   Usta IM, 2007, BJOG-INT J OBSTET GY, V114, P1031, DOI 10.1111/j.1471-0528.2007.01398.x
   Westgate JA, 1999, AM J OBSTET GYNECOL, V181, P765, DOI 10.1016/S0002-9378(99)70532-6
NR 21
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-3837
EI 1421-9964
J9 FETAL DIAGN THER
JI Fetal Diagn. Ther.
PD SEP
PY 2019
VL 46
IS 3
BP 207
EP 216
DI 10.1159/000500023
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IZ4BK
UT WOS:000487029100009
PM 31352447
DA 2020-07-08
ER

PT J
AU Laurent-Simpson, A
   Lo, CC
AF Laurent-Simpson, Andrea
   Lo, Celia C.
TI Risk society online: Zika virus, social media and distrust in the
   Centers for Disease Control and Prevention
SO SOCIOLOGY OF HEALTH & ILLNESS
LA English
DT Article
DE Zika; social construction; risk society; emerging infectious disease;
   trust; public health communication; social media
ID EMERGING INFECTIOUS-DISEASES; WEST NILE VIRUS; MEDICALIZATION; SCIENCE;
   EBOLA; FLU; COMMUNICATION; CONSTRUCTION; ILLNESSES; SUPPORT
AB While social construction of illness research has examined the redefinition of medically defined illness as non-illness by laypersons, nothing has considered this process alongside emerging infectious diseases (EIDs). Using Gidden's notion of modern risk society and distrust in expert authority, this paper examines how social media posts construct Zika virus as nonhazardous while displaying a distrust in research and prevention. Using qualitative content analysis, we examine 801 posts on the Centers for Disease Control and Prevention's (CDC) Facebook page to highlight the interplay between risk, the social construction of Zika and trust in experts. Three themes are discussed, including Zika: (i) as legitimate public health threat; (ii) as product of CDC corruption and (iii) used to question medical expertise. We find the latter two themes supportive of Gidden's focus on risk and distrust in expert authority and discuss the danger of constructing EIDs as products of corrupt expert authority on public health social media platforms.
C1 [Laurent-Simpson, Andrea] Southern Methodist Univ, Dept Sociol, POB 750192, Dallas, TX 75205 USA.
   [Lo, Celia C.] Texas Womans Univ, Dept Sociol, Denton, TX 76204 USA.
RP Laurent-Simpson, A (corresponding author), Southern Methodist Univ, Dept Sociol, POB 750192, Dallas, TX 75205 USA.
EM alaurentsimpson@mail.smu.edu
OI Laurent-Simpson, Andrea/0000-0002-7261-9860
CR Allum N, 2008, PUBLIC UNDERST SCI, V17, P35, DOI 10.1177/0963662506070159
   Anderson JG, 2017, J FAM NURS, V23, P34, DOI 10.1177/1074840716681289
   Bar-Lev S, 2008, QUAL HEALTH RES, V18, P509, DOI 10.1177/1049732307311680
   Barker KK, 2008, J HEALTH SOC BEHAV, V49, P20, DOI 10.1177/002214650804900103
   Beck U., 1997, POLITICS RISK SOC, P9
   Beck U., 1992, RISK SOC NEW MODERNI
   Berger P., 1966, SOCIAL CONSTRUCTION
   BROWN P, 1995, J HEALTH SOC BEHAV, V35, P34, DOI 10.2307/2626956
   Charmaz K., 2006, CONSTRUCTING GROUNDE
   Chien YJ, 2013, SOCIOL HEALTH ILL, V35, P213, DOI 10.1111/j.1467-9566.2012.01534.x
   CONRAD P, 1992, ANNU REV SOCIOL, V18, P209, DOI 10.1146/annurev.so.18.080192.001233
   Conrad P, 2010, HDB MED SOCIOLOGY
   Conrad P, 2016, HEALTH-LONDON, V20, P22, DOI 10.1177/1363459315611941
   Conrad P, 2010, CULTURE, BODIES AND THE SOCIOLOGY OF HEALTH, P107
   Conrad P, 2010, J HEALTH SOC BEHAV, V51, pS67, DOI 10.1177/0022146510383495
   Cottle S, 1998, EUR J COMMUN, V13, P5, DOI 10.1177/0267323198013001001
   Davis M, 2014, SOCIOL INQ, V84, P499, DOI 10.1111/soin.12058
   Dingwall R, 2013, SOCIOL HEALTH ILL, V35, P167, DOI 10.1111/1467-9566.12019
   Dredze M, 2016, AM J PREV MED, V50, P550, DOI 10.1016/j.amepre.2015.10.002
   Duggan M., 2015, SOCIAL MEDIA UPDATE
   Dumit J, 2006, SOC SCI MED, V62, P577, DOI 10.1016/j.socscimed.2005.06.018
   Eisenberg L, 1977, Cult Med Psychiatry, V1, P9, DOI 10.1007/BF00114808
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   French M, 2013, SOCIOL HEALTH ILL, V35, P174, DOI 10.1111/j.1467-9566.2012.01536.x
   Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225
   Gesser-Edelsburg A, 2014, DISASTER MED PUBLIC, V8, P158, DOI 10.1017/dmp.2014.27
   Giddens A., 2013, CONSEQUENCES MODERNI
   Giddens A., 2011, RUNAWAY WORLD
   Gieryn TF, 1999, CULTURAL BOUNDARIES
   Gislason MK, 2013, SOCIOL HEALTH ILL, V35, P188, DOI 10.1111/j.1467-9566.2012.01535.x
   Glaser B.G., 2009, DISCOVERY GROUNDED T
   Gottfried J., 2016, NEWS USE SOCIAL MEDI
   Hacking I., 1999, SOCIAL CONSTRUCTION
   Halfmann D, 2012, HEALTH, V16, P186, DOI 10.1177/1363459311403947
   Hall Stuart, 1973, CULTURE MEDIA LANGUA, P128, DOI DOI 10.1007/BF00986815
   Heldman AB, 2013, PUBLIC HEALTH REV, V35, DOI 10.1007/BF03391698
   Holmes BJ, 2008, HEALTH RISK SOC, V10, P349, DOI 10.1080/13698570802166431
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Mira JJ, 2015, EUR J PUBLIC HEALTH, V25, P188, DOI 10.1093/eurpub/cku237
   Joffe H, 2002, SOC SCI MED, V54, P955, DOI 10.1016/S0277-9536(01)00068-5
   Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604
   Joffe H, 2011, PSYCHOL HEALTH, V26, P667, DOI 10.1080/08870441003763238
   Kodjak A., 2016, C ENDS SPAT AGREES F
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Lee WS, 2018, J CHIN SOC MECH ENG, V39, P1
   Liu BF, 2015, J APPL COMMUN RES, V43, P44, DOI 10.1080/00909882.2014.982685
   Marken G.A., 2009, PUBLIC RELAT Q, V52, P9
   McCormick S, 2013, SOCIOL HEALTH ILL, V35, P268, DOI 10.1111/1467-9566.12002
   Mechanic D, 1996, MILBANK Q, V74, P171, DOI 10.2307/3350245
   Mesch GS, 2013, SOCIOL HEALTH ILL, V35, P325, DOI 10.1111/j.1467-9566.2012.01500.x
   Nerlich B, 2007, SOCIOL HEALTH ILL, V29, P46, DOI 10.1111/j.1467-9566.2007.00517.x
   Nielson J., 2006, PARTICIPATION INEQUA
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Shapin S., 2007, HDB SCI TECHNOLOGY S
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Sherlaw W, 2013, SOCIOL HEALTH ILL, V35, P332, DOI 10.1111/j.1467-9566.2012.01525.x
   Statista, 2017, NUMB INT US WORLDW 2
   Statista, 2018, INT US FREQ AD US JA
   Sun LH, 2017, WASHINGTON POST
   The National Academies of Sciences Engineering and Medicine, 2015, TRUST CONF INT LIF S
   Ungar S, 1998, BRIT J SOCIOL, V49, P36, DOI 10.2307/591262
   Ungar S, 2008, SCI COMMUN, V29, P472, DOI 10.1177/1075547008316219
   vansMierlo T., 2014, J MED INTERNET RES, V16, pe33
   WHO, 2018, DIS OUTBR YEAR
NR 66
TC 0
Z9 0
U1 7
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-9889
EI 1467-9566
J9 SOCIOL HEALTH ILL
JI Sociol. Health Ill.
PD SEP
PY 2019
VL 41
IS 7
BP 1270
EP 1288
DI 10.1111/1467-9566.12924
PG 19
WC Public, Environmental & Occupational Health; Social Sciences,
   Biomedical; Sociology
SC Public, Environmental & Occupational Health; Biomedical Social Sciences;
   Sociology
GA IZ2ZM
UT WOS:000486954400005
PM 31025389
DA 2020-07-08
ER

PT J
AU Zulu, MZ
   Martinez, FO
   Gordon, S
   Gray, CM
AF Zulu, Michael Z.
   Martinez, Fernando O.
   Gordon, Siamon
   Gray, Clive M.
TI The Elusive Role of Placental Macrophages: The Hofbauer Cell
SO JOURNAL OF INNATE IMMUNITY
LA English
DT Review
DE Placenta; Macrophages; Hofbauer cells; Human immunodeficiency virus;
   ZIKA
ID GESTATIONAL DIABETES-MELLITUS; MATERNAL HIV-INFECTION; TO-CHILD
   TRANSMISSION; ZIKA VIRUS; HUMAN CYTOMEGALOVIRUS; ALTERNATIVE ACTIVATION;
   INFLAMMATORY RESPONSE; VERTICAL TRANSMISSION; CD163 EXPRESSION;
   CHORIONIC VILLI
AB In this review, we discuss the often overlooked tissue-resident fetal macrophages, Hofbauer cells, which are found within the chorionic villi of the human placenta. Hofbauer cells have been shown to have a phenotype associated with regulatory and anti-inflammatory functions. They are thought to play a crucial role in the regulation of pregnancy and in the maintenance of a homeostatic environment that is crucial for fetal development. Even though the numbers of these macrophages are some of the most abundant immune cells in the human placenta, which are sustained throughout pregnancy, there are very few studies that have identified their origin, their phenotype, and functions and why they are maintained throughout gestation. It is not yet understood how Hofbauer cells may change in function throughout normal pregnancy, and especially in those complicated by maternal gestational diabetes, preeclampsia, and viral infections, such as Zika, cytomegalovirus, and human immunodeficiency virus. We review what is known about the origin of these macrophages and explore how common complications of pregnancy dysregulate these cells leading to adverse birth outcomes in humans. Our synthesis sheds light on areas for human studies that can further define these innate regulatory cells.
C1 [Zulu, Michael Z.; Gray, Clive M.] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Inst Infect Dis & Mol Med,Div Immunol, Cape Town, South Africa.
   [Martinez, Fernando O.] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England.
   [Gordon, Siamon] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan.
   [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.
   [Gray, Clive M.] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa.
RP Gray, CM (corresponding author), Univ Cape Town, Dept Pathol, Div Immunol, Inst Infect Dis & Mol Med, Anzio Rd,Level 3,Falmouth Bldg, ZA-7925 Cape Town, South Africa.
EM clive.gray@uct.ac.za
OI Martinez Estrada, Fernando O/0000-0003-0908-9366; Zulu,
   Michael/0000-0002-3203-7866
FU Newton Fund Biomedical Sciences Exchange PhD Studentship; South African
   National Research Foundation (NRF) scholarship; Canadian Africa
   Prevention Trials (CAPT) network scholarship
FX M.Z.Z. was a recipient of the Newton Fund Biomedical Sciences Exchange
   PhD Studentship, a South African National Research Foundation (NRF)
   scholarship and a Canadian Africa Prevention Trials (CAPT) network
   scholarship.
CR Al-Husaini AM, 2009, J PERINATOL, V29, P331, DOI 10.1038/jp.2008.187
   Araujo JR, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0569-y
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908
   Ben Amara A, 2013, J IMMUNOL, V191, P5501, DOI 10.4049/jimmunol.1300988
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Bracci R, 2003, BIOL NEONATE, V83, P85, DOI 10.1159/000067956
   BRIGHT NA, 1994, J ANAT, V184, P297
   Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Castellucci M, 2000, HUM REPROD UPDATE, V6, P485, DOI 10.1093/humupd/6.5.485
   CASTELLUCCI M, 1980, CELL TISSUE RES, V210, P235
   Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553
   Czikk MJ, 2011, CLIN MICROBIOL INFEC, V17, P1304, DOI 10.1111/j.1469-0691.2011.03574.x
   De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Emery VC, 2001, J CLIN PATHOL, V54, P84, DOI 10.1136/jcp.54.2.84
   ENDERS AC, 1970, ANAT REC, V167, P231, DOI 10.1002/ar.1091670211
   Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003
   Fayyad AM, 2005, EARLY HUM DEV, V81, P865, DOI 10.1016/j.earlhumdev.2005.09.005
   Ferrante CJ, 2013, INFLAMMATION, V36, P921, DOI 10.1007/s10753-013-9621-3
   FOX H, 1967, J PATHOL BACTERIOL, V93, P710, DOI 10.1002/path.1700930239
   Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034
   Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024
   GOLDSTEIN J, 1988, AM J PATHOL, V133, P648
   Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Hiden U, 2006, DIABETOLOGIA, V49, P123, DOI 10.1007/s00125-005-0054-x
   Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486
   Hung TH, 2006, PLACENTA, V27, P996, DOI 10.1016/j.placenta.2005.11.002
   IBANEZ CE, 1991, J VIROL, V65, P6581, DOI 10.1128/JVI.65.12.6581-6588.1991
   Jawerbaum A, 2006, CURR MED CHEM, V13, P2127, DOI 10.2174/092986706777935302
   JENSEN TS, 1995, APMIS, V103, P433, DOI 10.1111/j.1699-0463.1995.tb01129.x
   Joerink M, 2011, PLACENTA, V32, P380, DOI 10.1016/j.placenta.2011.02.003
   Johnson EL, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19385
   Johnson EL, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-101
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Katabuchi H, 2014, PLACENTA, V35, pA2, DOI 10.1016/j.placenta.2014.08.004
   KAUFMANN P, 1977, CELL TISSUE RES, V177, P105
   Kawamura H, 2015, PLACENTA, V36, pA10, DOI 10.1016/j.placenta.2015.07.170
   Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   KLIKS S, 1990, AIDS RES HUM RETROV, V6, P993, DOI 10.1089/aid.1990.6.993
   Koi H, 2001, ANN NY ACAD SCI, V943, P148, DOI 10.1111/j.1749-6632.2001.tb03798.x
   Krausgruber T, 2010, CYTOKINE, V52, P44, DOI 10.1016/j.cyto.2010.07.185
   LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A
   Lilleri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059863
   Lissauer D, 2016, BJOG-INT J OBSTET GY, V123, P1258, DOI 10.1111/1471-0528.14071
   Loegl J, 2016, REPRODUCTION, V152, P447, DOI 10.1530/REP-16-0159
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   MACIEJEWSKI JP, 1993, VIROLOGY, V195, P327, DOI 10.1006/viro.1993.1383
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mattar R, 2004, EUR J OBSTET GYN R B, V117, P240, DOI 10.1016/j.ejogrb.2004.04.014
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320
   Mendelson M, 1996, J GEN VIROL, V77, P3099, DOI 10.1099/0022-1317-77-12-3099
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   MOSKALEWSKI S, 1975, BIOL NEONATE, V26, P268
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962
   Naidoo M, 2016, SOUTH AFR J INFECT D, V31, P25, DOI 10.1080/23120053.2016.1118838
   Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090
   Newell ML, 1998, AIDS, V12, P831, DOI 10.1097/00002030-199808000-00004
   Ning F, 2016, AM J REPROD IMMUNOL, V75, P298, DOI 10.1111/aji.12477
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Przybyl L, 2016, CIRC RES, V119, P55, DOI 10.1161/CIRCRESAHA.116.308304
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951
   Redline RW, 2012, SEMIN FETAL NEONAT M, V17, P20, DOI 10.1016/j.siny.2011.08.003
   Reyes L, 2017, RESULTS PROBL CELL D, V62, P45, DOI 10.1007/978-3-319-54090-0_3
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Romagnani P, 2000, EUR CYTOKINE NETW, V11, P510
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   RUSSELL P, 1980, PLACENTA, V1, P227, DOI 10.1016/S0143-4004(80)80005-1
   SAJI F, 1994, PLACENTA, V15, P453, DOI 10.1016/S0143-4004(05)80415-1
   Schliefsteiner C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00888
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Selkov SA, 2013, PLACENTA, V34, P836, DOI 10.1016/j.placenta.2013.05.007
   Simister NE, 1998, VACCINE, V16, P1451, DOI 10.1016/S0264-410X(98)00107-8
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586
   Sisino G, 2013, BBA-MOL BASIS DIS, V1832, P1959, DOI 10.1016/j.bbadis.2013.07.009
   STAGNO S, 1982, Clinical Obstetrics and Gynecology, V25, P563, DOI 10.1097/00003081-198209000-00014
   Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130
   Svensson-Arvelund J, 2015, AM J REPROD IMMUNOL, V74, P100, DOI 10.1111/aji.12357
   Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536
   TAKAHASHI K, 1991, J LEUKOCYTE BIOL, V50, P57
   Tang ZH, 2013, ENDOCRINOLOGY, V154, P471, DOI 10.1210/en.2012-1575
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   Tarique AA, 2015, AM J RESP CELL MOL, V53, P676, DOI 10.1165/rcmb.2015-0012OC
   TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059
   Teasdale CA, 2011, BMJ CLIN EVID, V2011
   Tooke L, 2016, PREGNANCY HYPERTENS, V6, P266, DOI 10.1016/j.preghy.2016.04.006
   Toti P, 2011, AM J REPROD IMMUNOL, V65, P470, DOI 10.1111/j.1600-0897.2010.00927.x
   VACEK Z, 1970, Folia Morphologica (Prague), V18, P1
   VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845
   Vinnars MTN, 2008, PLACENTA, V29, pA48
   Vinnars MTN, 2010, PEDIATR DEVEL PATHOL, V13, P300, DOI 10.2350/09-03-0632-OA.1
   Wedi COO, 2016, LANCET HIV, V3, pE33, DOI 10.1016/S2352-3018(15)00207-6
   Weisblum Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01296-17
   Weisblum Y, 2015, VIROLOGY, V485, P289, DOI 10.1016/j.virol.2015.06.023
   Weisblum Y, 2014, SEMIN IMMUNOPATHOL, V36, P615, DOI 10.1007/s00281-014-0449-1
   Wetzka B, 1997, HUM REPROD, V12, P847, DOI 10.1093/humrep/12.4.847
   Yang SW, 2017, J REPROD IMMUNOL, V124, P30, DOI 10.1016/j.jri.2017.09.012
   Yona S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00328
   Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445
   Yu J, 2013, J HUAZHONG U SCI-MED, V33, P725, DOI 10.1007/s11596-013-1187-7
   Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 122
TC 4
Z9 4
U1 6
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1662-811X
EI 1662-8128
J9 J INNATE IMMUN
JI J. Innate Immun.
PD SEP
PY 2019
VL 11
IS 6
BP 447
EP 456
DI 10.1159/000497416
PG 10
WC Immunology
SC Immunology
GA IX8PR
UT WOS:000485950300002
PM 30970346
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lopez, JFV
   Velilla, PA
   Urcuqui-Inchima, S
AF Valdes Lopez, Juan Felipe
   Andrea Velilla, Paula
   Urcuqui-Inchima, Silvio
TI Chikungunya Virus and Zika Virus, Two Different Viruses Examined with a
   Common Aim: Role of Pattern Recognition Receptors on the Inflammatory
   Response
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Review
DE PRRs; CHIKV; ZIKV; inflammation and arbovirus
ID INNATE IMMUNE-RESPONSE; NOD-LIKE RECEPTORS; RIG-I; ANTIVIRAL RESPONSES;
   INFECTION; RNA; ACTIVATION; PROTEIN; REPLICATION; DISEASE
AB Chikungunya virus (CHIKV) and Zika virus (ZIKV) are 2 reemerging arboviruses that have been the focus of public health institutions worldwide, since the last decades and following a spate of outbreaks in tropical and subtropical areas. The disease caused by both viruses manifests itself first as an acute stage of severe inflammation into the infected tissues, which later progresses to arthritis and chronic polyarthralgia in the case of CHIKV or congenital microcephaly and neurological disorders such as Guillain-Barre syndrome in the case of ZIKV. This review aims to summarize on current knowledge of the role of different pattern recognition receptors that leads to an elevated production and secretion of antiviral response (interferon) and severe inflammation in response to CHIKV and ZIKV infection.
C1 [Valdes Lopez, Juan Felipe; Andrea Velilla, Paula; Urcuqui-Inchima, Silvio] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Calle 70 52-21, Medellin 050010, Colombia.
RP Urcuqui-Inchima, S (corresponding author), Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Calle 70 52-21, Medellin 050010, Colombia.
EM silvio.urcuqui@udea.edu.co
FU COLCIENCIAS from Colombia [111574455028]; CODI Universidad de Antioquia,
   UdeA [2017-16389]
FX This study was supported by COLCIENCIAS, Grant no. 111574455028 from
   Colombia and the CODI (Acta No. 2017-16389) Universidad de Antioquia,
   UdeA. The authors thank Anne-Lise Haenni for reading the article and for
   her constructive and valuable comments. The funders played no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the article.
CR Abraham R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075854
   Ahola T, 1997, J VIROL, V71, P392, DOI 10.1128/JVI.71.1.392-397.1997
   Akhrymuk I, 2016, VIROLOGY, V487, P230, DOI 10.1016/j.virol.2015.09.023
   Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brickley EB, 2018, LANCET CHILD ADOLESC, V2, P162, DOI 10.1016/S2352-4642(18)30021-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Chen WQ, 2017, NAT MICROBIOL, V2, P1435, DOI 10.1038/s41564-017-0015-4
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309
   Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405
   de Sousa JR, 2018, CYTOKINE, V111, P255, DOI 10.1016/j.cyto.2018.08.008
   de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Dutta SK, 2017, VIROLOGY, V511, P207, DOI 10.1016/j.virol.2017.08.009
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Ekchariyawat P, 2015, INFECT GENET EVOL, V32, P401, DOI 10.1016/j.meegid.2015.03.025
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001
   Gasque P, 2015, VECTOR-BORNE ZOONOT, V15, P241, DOI 10.1089/vbz.2014.1710
   Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19
   Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590
   Goupil Brad A, 2016, Open Rheumatol J, V10, P129, DOI 10.2174/1874312901610010129
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Her ZS, 2015, EMBO MOL MED, V7, P24, DOI 10.15252/emmm.201404459
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P1, DOI 10.1146/annurev.immunol.20.080801.102422
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Kim YJ, 2018, BRIT J MATH STAT PSY, V71, P1, DOI 10.1111/bmsp.12103
   Kim YK, 2016, YONSEI MED J, V57, P5, DOI 10.3349/ymj.2016.57.1.5
   Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2
   Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lassig C, 2017, J BIOL CHEM, V292, P9000, DOI 10.1074/jbc.R117.788398
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0
   Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113
   Li YG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-114
   Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Lustig Y, 2016, EUROSURVEILLANCE, V30, P21
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Motta V, 2015, PHYSIOL REV, V95, P149, DOI 10.1152/physrev.00009.2014
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nakaya Y, 2017, MBIO, V8, DOI 10.1128/mBio.00944-17
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   PAHO/WHO, 2015, ZIK EPID AL
   Petitdemange C, 2015, J ALLERGY CLIN IMMUN, V135, P846, DOI 10.1016/j.jaci.2015.01.039
   Phuklia W, 2013, VIRUS RES, V177, P179, DOI 10.1016/j.virusres.2013.08.011
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001
   Pirher N, 2017, IMMUNOL LETT, V189, P55, DOI 10.1016/j.imlet.2017.03.019
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Priya R, 2014, VIRUS RES, V189, P194, DOI 10.1016/j.virusres.2014.05.010
   Priya R, 2013, INFECT GENET EVOL, V20, P396, DOI 10.1016/j.meegid.2013.09.030
   Puiprom O, 2013, INFECT GENET EVOL, V17, P210, DOI 10.1016/j.meegid.2013.04.005
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   RESTREPO JARAMILLO BERTA NELLY, 2014, CES Med., V28, P313
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09
   Rolph MS, 2015, LANCET INFECT DIS, V15, P1007, DOI 10.1016/S1473-3099(15)00231-5
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Shuaib W, 2016, AM J MED, V879, DOI 10.1016/j.amjmed.2016.02.027
   Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880
   Solanki BS, 2007, INT J CLIN PRACT, V61, P1941, DOI 10.1111/j.1742-1241.2007.01329.x
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Tang BL, 2012, CELL MICROBIOL, V14, P1354, DOI 10.1111/j.1462-5822.2012.01825.x
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Vasiljeva L, 2000, J BIOL CHEM, V275, P17281, DOI 10.1074/jbc.M910340199
   Venugopalan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111305
   Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Waymouth HE, 2013, SEMIN ARTHRITIS RHEU, V43, P273, DOI 10.1016/j.semarthrit.2013.03.003
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Werneke SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002322
   White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Orhanisation, 2016, IHR EM COMM ZIK VIR
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia H, 2018, NATURE COMMUNICATION, V9, P1, DOI DOI 10.1038/S41467-017-02816-2
   Zaid A, 2018, ARTHRITIS RHEUMATOL, V70, P484, DOI 10.1002/art.40403
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zhang X, 2018, APPL THERM ENG, V130, P1, DOI 10.1016/j.applthermaleng.2017.10.092
   Zheng Y, 2018, PROCEEDINGS OF 2018 1ST IEEE INTERNATIONAL CONFERENCE ON HOT INFORMATION-CENTRIC NETWORKING (HOTICN 2018), P18, DOI 10.1109/HOTICN.2018.8606041
NR 138
TC 1
Z9 1
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1079-9907
EI 1557-7465
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD SEP 1
PY 2019
VL 39
IS 9
BP 507
EP 521
DI 10.1089/jir.2019.0058
PG 15
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA IW9DY
UT WOS:000485294800001
PM 31090481
DA 2020-07-08
ER

PT J
AU Oliveira, LG
   Peron, JPS
AF Oliveira, Lilian G.
   Schatzmann Peron, Jean Pierre
TI Viral receptors for flaviviruses: Not only gatekeepers
SO JOURNAL OF LEUKOCYTE BIOLOGY
LA English
DT Review
DE viral entry receptors; Flavivirus; TAM; TIM; integrins
ID ZIKA VIRUS-INFECTION; DENGUE-VIRUS; PHOSPHATIDYLSERINE RECEPTORS;
   ENDOTHELIAL-CELLS; TAM RECEPTORS; AXL; ENTRY; PROTEIN; ENDOCYTOSIS;
   INTEGRINS
AB Arboviruses have been a huge threat for human health since the discovery of yellow fever virus in 1901. Arboviruses are arthropod born viruses, mainly transmitted by mosquitoes and ticks, responsible for more than thousands of deaths annually. The Flavivirideae family is probably the most clinically relevant, as it is composed of very important agents, such as dengue, yellow fever, West Nile, Japanese encephalitis, and, recently, Zika virus. Intriguingly, despite their structural and genomic similarities, flaviviruses may cause conditions ranging from mild infections with fever, cutaneous rash, and headache, to very severe cases, such as hemorrhagic fever, encephalitis, Guillain-Barre syndrome, and microcephaly. These differences may greatly rely on viral burden, tissue tropism, and mechanisms of immune evasion that may depend on both viral and host genetic factors. Unfortunately, very little is known about the biology of these factors, and how they orchestrate these differences. In this context, viral structural proteins and host cellular receptors may have a great relevance, as their interaction dictates not only viral tissue tropism, but also a plethora on intracellular mechanisms that may greatly account for either failure or success of infection. A great number of viral receptors have been described so far, although there is still a huge gap in understanding their overall role during infection. Here we discuss some important aspects triggered after the interaction of flaviviruses and host membrane receptors, and how they change the overall outcome of the infection.
C1 [Oliveira, Lilian G.] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Neuroimmune Interact Lab, Sao Paulo, Brazil.
   [Schatzmann Peron, Jean Pierre] Univ Sao Paulo, Sch Med, Immunopathol & Alergy PostGrad Program, Sao Paulo, Brazil.
   [Schatzmann Peron, Jean Pierre] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
RP Peron, JPS (corresponding author), Av Prof Lineu Prestes,1730 Lab 232 ICBIV, BR-05508000 Sao Paulo, SP, Brazil.
EM jeanpierre@usp.br
OI Peron, Jean Pierre/0000-0003-1638-8866; Oliveira,
   Lilian/0000-0002-5676-4443
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Best SM, 2013, CELL HOST MICROBE, V14, P117, DOI 10.1016/j.chom.2013.07.014
   Brasil P., 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004636
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cossart P, 2014, COLD SPRING HARB PER, V6, P8, DOI DOI 10.1101/CSHPERSPECT.A016972
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005048
   Encinas JA, 2000, CURR OPIN IMMUNOL, V12, P691, DOI 10.1016/S0952-7915(00)00164-3
   Fan WC, 2017, RES VET SCI, V111, P67, DOI 10.1016/j.rvsc.2016.12.007
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gonsalves WI, 2013, MAYO CLIN PROC, V88, P495, DOI 10.1016/j.mayocp.2013.03.006
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6
   Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280
   Hastings AK, 2019, ISCIENCE, V13, P339, DOI 10.1016/j.isci.2019.03.003
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   HENSELEIT U, 1990, BIOCHIM BIOPHYS ACTA, V1029, P127, DOI 10.1016/0005-2736(90)90445-T
   Higuera A, 2019, ACTA TROP, V190, P99, DOI 10.1016/j.actatropica.2018.11.010
   Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508
   Huang MT, 2015, EUR J IMMUNOL, V45, P1696, DOI 10.1002/eji.201445239
   Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446
   Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234
   Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lullo ED, 2016, STEM CELLS, P1, DOI [10.1016/j.stem.2016.03.012, DOI 10.1016/J.STEM.2016.03.012]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manninen A, 2002, J EXP MED, V195, P1023, DOI 10.1084/jem.20012039
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Meister M, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.47
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Niu JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110630
   Note AA, 1900, PUBLIC HLTH PAP REP, V26, P37
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Polonio CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0131-x
   Prieto AL, 1999, BRAIN RES, V816, P646, DOI 10.1016/S0006-8993(98)01159-7
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rusanov T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35511-3
   Sanlioglu S, 2000, J VIROL, V74, P9184, DOI 10.1128/JVI.74.19.9184-9196.2000
   Schmidt K, 2013, J GEN VIROL, V94, P1723, DOI 10.1099/vir.0.052613-0
   Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635
   Sharma NR, 2010, J VIROL, V84, P4366, DOI 10.1128/JVI.01940-09
   Soto-Acosta R, 2018, ELIFE, V2007, P1
   Wan SW, 2012, J CELL BIOCHEM, V113, P1681, DOI 10.1002/jcb.24037
   Wang H, 2005, J HISTOCHEM, V53
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156
   Yuan S, 2015, PROTEIN CELL, V6, P814, DOI 10.1007/s13238-015-0220-y
   Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051
   Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271
   Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x
NR 74
TC 1
Z9 1
U1 5
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0741-5400
EI 1938-3673
J9 J LEUKOCYTE BIOL
JI J. Leukoc. Biol.
PD SEP
PY 2019
VL 106
IS 3
SI SI
BP 695
EP 701
DI 10.1002/JLB.MR1118-460R
PG 7
WC Cell Biology; Hematology; Immunology
SC Cell Biology; Hematology; Immunology
GA IW9CY
UT WOS:000485292100019
PM 31063609
DA 2020-07-08
ER

PT J
AU Paige, AS
   Bellamy, SK
   Alto, BW
   Dean, CL
   Yee, DA
AF Paige, Andrew S.
   Bellamy, Shawna K.
   Alto, Barry W.
   Dean, Catherine L.
   Yee, Donald A.
TI Linking nutrient stoichiometry to Zika virus transmission in a mosquito
SO OECOLOGIA
LA English
DT Article
DE Nutrition; Ontogeny; Infection; Zika virus
ID AEDES-TRISERIATUS DIPTERA; LA-CROSSE VIRUS; BODY-SIZE; DETRITUS TYPE;
   HOST-SEEKING; IMMUNE FUNCTION; INFECTION; AEGYPTI; LARVAL; COMPETITION
AB Food quality and quantity serve as the basis for cycling of key chemical elements in trophic interactions; yet the role of nutrient stoichiometry in shaping host-pathogen interactions is under appreciated. Most of the emergent mosquito-borne viruses affecting human health are transmitted by mosquitoes that inhabit container systems during their immature stages, where allochthonous input of detritus serves as the basal nutrients. Quantity and type of detritus (animal and plant) were manipulated in microcosms containing newly hatched Aedes aegypti mosquito larvae. Adult mosquitoes derived from these microcosms were allowed to ingest Zika virus-infected blood and then tested for disseminated infection, transmission, and total nutrients (percent carbon, percent nitrogen, ratio of carbon to nitrogen). Treatments lacking high-quality animal (insect) detritus significantly delayed development. Survivorship to adulthood was closely associated with the amount of insect detritus present. Insect detritus was positively correlated with percent nitrogen, which affected Zika virus infection. Disseminated infection and transmission decreased with increasing insect detritus and percent nitrogen. We provide the first definitive evidence linking nutrient stoichiometry to arbovirus infection and transmission in a mosquito using a model system of invasive Ae. aegypti and emergent Zika virus.
C1 [Paige, Andrew S.] New Coll Florida, Sarasota, FL 34243 USA.
   [Bellamy, Shawna K.] Univ Florida, Inst Food & Agr Sci, Florida Med Entomol Lab, Entomol & Nematol Dept, Vero Beach, FL 32962 USA.
   [Alto, Barry W.] Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
   [Dean, Catherine L.; Yee, Donald A.] Univ Southern Mississippi, Sch Biol Environm & Earth Sci, Hattiesburg, MS 39406 USA.
RP Alto, BW (corresponding author), Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
EM andrew.paige15@ncf.edu; shawnakbellamy@ufl.edu; bwalto@ufl.edu;
   Catherine.Dean@usm.edu; Donald.Yee@usm.edu
CR Aalto SL, 2015, TRENDS PARASITOL, V31, P333, DOI 10.1016/j.pt.2015.04.005
   Alto BW, 2012, MED VET ENTOMOL, V26, P396, DOI 10.1111/j.1365-2915.2012.01010.x
   Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688
   Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501
   Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209
   Araujo MD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-261
   Bara J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126703
   Beldomenico PM, 2010, TRENDS ECOL EVOL, V25, P21, DOI 10.1016/j.tree.2009.06.015
   Borer ET, 2016, ANNU REV PHYTOPATHOL, V54, P397, DOI 10.1146/annurev-phyto-080615-095959
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   CARPENTER SR, 1983, ECOLOGY, V64, P219, DOI 10.2307/1937068
   Clements AN, 2012, BIOL MOSQUITOES TRAN
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Cornet S, 2014, J ANIM ECOL, V83, P256, DOI 10.1111/1365-2656.12113
   Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x
   Frost PC, 2008, J ANIM ECOL, V77, P1265, DOI 10.1111/j.1365-2656.2008.01438.x
   Green BS, 2005, MAR ECOL PROG SER, V289, P263, DOI 10.3354/meps289263
   Grill CP, 1996, J ANIM ECOL, V65, P63, DOI 10.2307/5700
   GRIMSTAD PR, 1984, J MED ENTOMOL, V21, P249, DOI 10.1093/jmedent/21.3.249
   GRIMSTAD PR, 1991, J MED ENTOMOL, V28, P378, DOI 10.1093/jmedent/28.3.378
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Haramis L, 1985, P S, P431
   Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218
   Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014
   Howick VM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-56
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Kauffman E, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2542
   Kingsolver JG, 2011, INTEGR COMP BIOL, V51, P719, DOI 10.1093/icb/icr015
   Kling LJ, 2007, J VECTOR ECOL, V32, P207, DOI 10.3376/1081-1710(2007)32[207:LMCIDV]2.0.CO;2
   KLOWDEN MJ, 1986, J INSECT PHYSIOL, V32, P479, DOI 10.1016/0022-1910(86)90009-0
   Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x
   Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385
   LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535
   McCann S, 2009, J VECTOR ECOL, V34, P174, DOI [10.1111/j.1948-7134.2009.00024.x, 10.3376/038.034.0202]
   McCormick MI, 2008, P 11 INT COR REEF S
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x
   NASCI RS, 1991, J MED ENTOMOL, V28, P522, DOI 10.1093/jmedent/28.4.522
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   PATRICAN LA, 1985, J MED ENTOMOL, V22, P604, DOI 10.1093/jmedent/22.6.604
   PAULSON SL, 1991, J AM MOSQUITO CONTR, V7, P170
   STEINWASCHER K, 1982, ENVIRON ENTOMOL, V11, P150, DOI 10.1093/ee/11.1.150
   Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639
   Telang A, 2012, MED VET ENTOMOL, V26, P271, DOI 10.1111/j.1365-2915.2011.00993.x
   TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176
   Vantaux A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36778
   Vantaux A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1514-5
   Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550
   Winters AE, 2012, ECOL ENTOMOL, V37, P56, DOI 10.1111/j.1365-2311.2011.01337.x
   Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
   Yee DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133734
   Yee DA, 2012, OECOLOGIA, V169, P511, DOI 10.1007/s00442-011-2209-4
   Zhang S., 1993, ARBOVIRUS RES AUST, V6, P44
NR 57
TC 1
Z9 1
U1 2
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0029-8549
EI 1432-1939
J9 OECOLOGIA
JI Oecologia
PD SEP
PY 2019
VL 191
IS 1
BP 1
EP 10
DI 10.1007/s00442-019-04429-6
PG 10
WC Ecology
SC Environmental Sciences & Ecology
GA IW4NJ
UT WOS:000484956600001
PM 31227906
DA 2020-07-08
ER

PT J
AU Kowalski, TW
   Dupont, AD
   Rengel, BD
   Sgarioni, E
   Gomes, JD
   Fraga, LR
   Schuler-Faccini, L
   Vianna, FSL
AF Kowalski, Thayne Woycinck
   Dupont, Agata de Vargas
   Rengel, Bruna Duarte
   Sgarioni, Eduarda
   Gomes, Julia do Amaral
   Fraga, Lucas Rosa
   Schuler-Faccini, Lavinia
   Luiz Vianna, Fernanda Sales
TI Assembling systems biology, embryo development and teratogenesis: What
   do we know so far and where to go next?
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Review
DE Network; Birth defects; Teratogen STITCH database; Interactome;
   Congenital anomalies; Malformation; Thalidomide; Zika
ID ADVERSE OUTCOME PATHWAYS; BISPHENOL-A EXPOSURE; HEART DEVELOPMENT;
   RETINOIC ACID; INTERACTION NETWORKS; PRENATAL COCAINE; NEURAL-TUBE;
   THALIDOMIDE; EXPRESSION; GENES
AB The recognition of molecular mechanisms of a teratogen can provide insights to understand its embryopathy, and later to plan strategies for the prevention of new exposures. In this context, experimental research is the most invested approach. Despite its relevance, these assays require financial and time investment. Hence, the evaluation of such mechanisms through systems biology rise as an alternative for this conventional methodology. Systems biology is an integrative field that connects experimental and computational analyses, assembling interaction networks between genes, proteins, and even teratogens. It is a valid strategy to generate new hypotheses, that can later be confirmed in experimental assays. Here, we present a literature review of the application of systems biology in embryo development and teratogenesis studies. We provide a glance at the data available in public databases, and evaluate common mechanisms between different teratogens. Finally, we discuss the advantages of using this strategy in future teratogenesis researches.
C1 [Kowalski, Thayne Woycinck; Rengel, Bruna Duarte; Gomes, Julia do Amaral; Schuler-Faccini, Lavinia; Luiz Vianna, Fernanda Sales] Univ Fed Rio Grande do Sul, PPGBM, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil.
   [Kowalski, Thayne Woycinck; Dupont, Agata de Vargas; Rengel, Bruna Duarte; Sgarioni, Eduarda; Gomes, Julia do Amaral; Schuler-Faccini, Lavinia; Luiz Vianna, Fernanda Sales] Univ Fed Rio Grande do Sul, Genet Dept, Lab Med Genet & Evolut, Porto Alegre, RS, Brazil.
   [Kowalski, Thayne Woycinck; Dupont, Agata de Vargas; Rengel, Bruna Duarte; Gomes, Julia do Amaral; Luiz Vianna, Fernanda Sales] Hosp Clin Porto Alegre, Ctr Expt Res, Lab Genom Med, Av Ramiro Barcelos 2350, Porto Alegre, RS, Brazil.
   [Kowalski, Thayne Woycinck; Gomes, Julia do Amaral; Schuler-Faccini, Lavinia; Luiz Vianna, Fernanda Sales] INAGEMP, Natl Inst Med Populat Genet, Porto Alegre, RS, Brazil.
   [Kowalski, Thayne Woycinck; Rengel, Bruna Duarte; Gomes, Julia do Amaral; Fraga, Lucas Rosa; Schuler-Faccini, Lavinia; Luiz Vianna, Fernanda Sales] Hosp Clin Porto Alegre, SIAT, Sistema Nacl Informacao Agentes Teratogen, Porto Alegre, RS, Brazil.
   [Fraga, Lucas Rosa] Univ Fed Rio Grande do Sul, Inst Hlth Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil.
   [Luiz Vianna, Fernanda Sales] Hosp Clin Porto Alegre, GPPG, Grp Postgrad Res, Porto Alegre, RS, Brazil.
RP Kowalski, TW; Vianna, FSL (corresponding author), Hosp Clin Porto Alegre, Ctr Expt Res, Lab Genom Med, Av Ramiro Barcelos 2350, Porto Alegre, RS, Brazil.
EM tkowalski@hcpa.edu.br; fvianna@hcpa.edu.br
RI Kowalski, Thayne/AAQ-1439-2020; SCHULER-FACCINI, LAVINIA/C-8309-2013;
   Fraga, Lucas/L-1538-2015
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Kowalski,
   Thayne/0000-0001-5799-2272
FU INAGEMP (National Institute of Population Medical Genetics)
   [CNPq573993/2008-4, 465549/2014-4, FAPERGS17/2551.0000521-0]; INAGEMP
   (National Institute of Population Medical Genetics, CAPES); National
   Council of Scientific and Technologic Development (CNPq)National Council
   for Scientific and Technological Development (CNPq) [156158/2018-3,
   423249/2016-9, 312993/2017-0]
FX We deeply thank Professor Mariana Recamonde-Mendoza for the scientific
   support. The authors would like to acknowledge the financial support:
   INAGEMP (National Institute of Population Medical Genetics; Grant
   CNPq573993/2008-4, 465549/2014-4, FAPERGS17/2551.0000521-0 and CAPES)
   and National Council of Scientific and Technologic Development (CNPq);
   Grant 156158/2018-3, 423249/2016-9, and 312993/2017-0.
CR Ahand D, 2017, EXP EYE RES, V156, P22, DOI 10.1016/j.exer.2016.03.010
   Andersen TA, 2014, CELL MOL LIFE SCI, V71, P1327, DOI 10.1007/s00018-013-1430-1
   Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34
   Bal-Price A, 2017, PHARMACOL THERAPEUT, V179, P84, DOI 10.1016/j.pharmthera.2017.05.006
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Benavides VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035213
   Berenguer M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35681-0
   Brahma R, 2018, VIRAL IMMUNOL, V31, P321, DOI 10.1089/vim.2017.0116
   Cassina M, 2012, REPROD TOXICOL, V34, P186, DOI 10.1016/j.reprotox.2012.05.004
   Cassina T, 2017, MINERVA ANESTESIOL, V83, P1236, DOI 10.23736/S0375-9393.17.12317-5
   Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932
   Daemmrich A, 2002, SOC HIST MED, V15, P137, DOI 10.1093/shm/15.1.137
   De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208
   De Santis M, 2004, EUR J OBSTET GYN R B, V117, P10, DOI 10.1016/j.ejogrb.2004.04.022
   Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757
   Ferrazzi F, 2015, THROMB HAEMOSTASIS, V113, P522, DOI 10.1160/TH14-06-0483
   Gao XG, 2015, DATA BRIEF, V4, P199, DOI 10.1016/j.dib.2015.05.014
   Giavini E, 2012, REPROD TOXICOL, V34, P180, DOI 10.1016/j.reprotox.2012.05.003
   Grunert M, 2016, CARDIOVASC RES, V112, P464, DOI 10.1093/cvr/cvw195
   Hansen JM, 2004, ANTIOXID REDOX SIGN, V6, P1, DOI 10.1089/152308604771978291
   Hood Leroy, 2008, Briefings in Functional Genomics & Proteomics, V7, P239, DOI 10.1093/bfgp/eln027
   Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Ji ZW, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5958321
   Jones KL, 2010, AM J MED GENET A, V152A, P2731, DOI 10.1002/ajmg.a.33675
   JONES KL, 1973, LANCET, V1, P1267
   Karen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024954
   Khodiyar VK, 2011, DEV BIOL, V354, P9, DOI 10.1016/j.ydbio.2011.03.011
   Kleiber ML, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-6
   Knapen D, 2018, ENVIRON TOXICOL CHEM, V37, P1723, DOI 10.1002/etc.4125
   Kowalski TW, 2017, REPROD TOXICOL, V70, P133, DOI 10.1016/j.reprotox.2017.01.012
   Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315
   Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795
   Kultima K, 2004, ENVIRON HEALTH PERSP, V112, P1225, DOI 10.1289/txg.7034
   Lachke SA, 2010, WIRES SYST BIOL MED, V2, P305, DOI 10.1002/wsbm.59
   Lage K, 2012, P NATL ACAD SCI USA, V109, P14035, DOI 10.1073/pnas.1210730109
   Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885
   Lee WJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8932583
   Leist M, 2017, ARCH TOXICOL, V91, P3477, DOI 10.1007/s00204-017-2045-3
   LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303
   LENZ W, 1962, ARCH ENVIRON HEALTH, V5, P100
   Leung MCK, 2016, ENVIRON HEALTH PERSP, V124, P1050, DOI 10.1289/ehp.1510385
   Mazzu-Nascimento T, 2017, GENET MOL BIOL, V40, P387, DOI [10.1590/1678-4685-GMB-2016-0179, 10.1590/1678-4685-gmb-2016-0179]
   MCBRIDE WG, 1961, LANCET, V2, P1358
   McCulloch AD, 2005, ANN NY ACAD SCI, V1047, P283, DOI 10.1196/annals.1341.025
   Menegola E, 2001, ALCOHOL, V23, P35, DOI 10.1016/S0741-8329(00)00132-4
   Mitchell ES, 2003, EXP NEUROL, V182, P64, DOI 10.1016/S0014-4886(03)00026-8
   Moni MA, 2017, J INFECT DIS, V216, P703, DOI 10.1093/infdis/jix327
   Nassogne MC, 1997, J NEUROCHEM, V68, P2442
   Novikova SI, 2005, NEUROTOXICOL TERATOL, V27, P3, DOI 10.1016/j.ntt.2004.08.004
   Obiol-Pardo C, 2011, J CHEM INF MODEL, V51, P483, DOI 10.1021/ci100423z
   Okada A, 2005, BIRTH DEFECTS RES A, V73, P229, DOI 10.1002/bdra.20131
   Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5
   Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492
   Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020
   Saili KS, 2013, REPROD TOXICOL, V38, P89, DOI 10.1016/j.reprotox.2013.03.009
   Saili KS, 2012, TOXICOLOGY, V291, P83, DOI 10.1016/j.tox.2011.11.001
   Schuler-Faccini L., 2011, MANUAL TERATOGENESE
   Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220
   Smith LM, 2016, BIRTH DEFECTS RES C, V108, P142, DOI 10.1002/bdrc.21131
   SMITHELLS RW, 1992, J MED GENET, V29, P716, DOI 10.1136/jmg.29.10.716
   Snider J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156351
   SOMERS GF, 1960, BRIT J PHARM CHEMOTH, V15, P111, DOI 10.1111/j.1476-5381.1960.tb01217.x
   Sperling SR, 2011, CARDIOVASC RES, V91, P269, DOI 10.1093/cvr/cvr126
   Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277
   Tavassoly I, 2018, ESSAYS BIOCHEM, V62, P487, DOI 10.1042/EBC20180003
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Tonk ECM, 2015, REPROD TOXICOL, V55, P104, DOI 10.1016/j.reprotox.2014.10.008
   Torchinsky A, 2010, J REPROD IMMUNOL, V85, P76, DOI 10.1016/j.jri.2010.01.003
   Vargesson N, 2009, BIOESSAYS, V31, P1327, DOI 10.1002/bies.200900103
   Velez-Ruiz NJ, 2015, DRUG SAFETY, V38, P271, DOI 10.1007/s40264-015-0269-9
   Villeneuve DL, 2018, ENVIRON TOXICOL CHEM, V37, P1734, DOI 10.1002/etc.4124
   WILSON J G, 1959, J Chronic Dis, V10, P111, DOI 10.1016/0021-9681(59)90026-8
   Wilson J. G., 1973, ENV BIRTH DEFECTS
   Zeidan-Chulia F, 2013, NEUROMOL MED, V15, P364, DOI 10.1007/s12017-013-8224-3
   Zhao Y, 2010, MOL PSYCHIATR, V15, P286, DOI 10.1038/mp.2009.51
NR 78
TC 1
Z9 1
U1 2
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD SEP
PY 2019
VL 88
BP 67
EP 75
DI 10.1016/j.reprotox.2019.07.015
PG 9
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA IW9TI
UT WOS:000485336200007
PM 31362043
DA 2020-07-08
ER

PT J
AU Jenkins, B
   Eller, M
AF Jenkins, Bronwyn
   Eller, Michael
TI A case study of CGRP receptor blockade in New Daily Persistent Headache
   secondary to Zika Virus
SO CEPHALALGIA
LA English
DT Meeting Abstract
CT 19th International Headache Congress of International-Headache-Society
CY SEP 05-08, 2019
CL Dublin, IRELAND
SP Int Headache Soc
C1 [Jenkins, Bronwyn] Royal North Shore Hosp, Sydney, NSW, Australia.
   [Eller, Michael] Monash Med Ctr, Melbourne, Vic, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0333-1024
EI 1468-2982
J9 CEPHALALGIA
JI Cephalalgia
PD SEP
PY 2019
VL 39
SU 1
SI SI
MA IHC-PO-460
BP 316
EP 316
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IV9MO
UT WOS:000484588200496
DA 2020-07-08
ER

PT J
AU Khurshid, Z
   Zafar, M
   Khan, E
   Mali, M
   Latif, M
AF Khurshid, Zohaib
   Zafar, Muhammad
   Khan, Erum
   Mali, Maria
   Latif, Muhammad
TI Human saliva can be a diagnostic tool for Zika virus detection
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE Saliva; Proteins; Zika infection; Biomarkers
ID INFECTION; OUTBREAK; RNA; DNA; PEPTIDES; TRAVELER; ISLAND
AB Zika virus (ZIKV), an Aedes mosquito-borne flavivirus, has captured public health attention worldwide. Initially, the virus was reported in Africa and Asia. However, the outbreak of ZIKV in Brazil and the United States of America demonstrated the global health risk. Symptoms of ZIKV infection vary from mild fever, rash, and joint pain to an apparent increase in microcephaly in infants and severe manifestations including Guillain-Barre syndrome in adults. Such consequences led to enormous health challenges, and consequently the World Health Organization declared a global health emergency. This review incorporates all aspects of ZIKV that could significantly impact human health, including epidemiology, clinical presentation, possible complications, cutting-edge therapeutic management of ZIKV infection, and latest developments in ZIKV diagnosis, particularly the value of human saliva as a diagnostic fluid. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Khurshid, Zohaib] King Faisal Univ, Coll Dent, Dept Prosthodont & Dent Implantol, Al Hufuf, Saudi Arabia.
   [Zafar, Muhammad] Taibah Univ, Coll Dent, Dept Dent Mat, Medina Munawwarah, Saudi Arabia.
   [Zafar, Muhammad] Riphah Int Univ, Islamic Int Dent Coll, Dept Dent Mat, Islamabad, Pakistan.
   [Khan, Erum] Liaquat Univ Med & Hlth Sci, Dept Oral Pathol, Jamshoro, Pakistan.
   [Mali, Maria] Riphah Int Univ, Islamic Int Dent Coll, Dept Orthodont, Coll Dent, Islamabad, Pakistan.
   [Latif, Muhammad] Taibah Univ, CGID, Medina Munawwarah, Saudi Arabia.
RP Zafar, M (corresponding author), Taibah Univ, Coll Dent, Dept Dent Mat, Medina Munawwarah, Saudi Arabia.
EM drzohaibkhurshid@gmail.com; MZAFAR@taibahu.edu.sa;
   erumkhan_2010@icloud.com; drmariahmali@gmail.com; latifmayo@kaist.ac.kr
RI Zafar, Muhammad S/N-2800-2014; Khurshid, Zohaib/K-9314-2015; Latif,
   Muhammad/D-1335-2018
OI Zafar, Muhammad S/0000-0002-5157-7067; Khurshid,
   Zohaib/0000-0001-7998-7335; Latif, Muhammad/0000-0003-4858-3324
CR Amado FML, 2013, CLIN BIOCHEM, V46, P506, DOI 10.1016/j.clinbiochem.2012.10.024
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen M, 1997, J CLIN MICROBIOL, V35, P973, DOI 10.1128/JCM.35.4.973-975.1997
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hofman LF, 2001, J NUTR, V131, p1621S
   Inami T, 2000, J CLIN MICROBIOL, V38, P2407
   Khan RS, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7030039
   Khurshid Z, 2016, SAUDI PHARM J, V24, P515, DOI 10.1016/j.jsps.2015.02.015
   Khurshid Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060846
   Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Singh Shikha, 2015, J Oral Biol Craniofac Res, V5, P59, DOI 10.1016/j.jobcr.2015.05.001
   Siqueira WL, 2008, J DENT RES, V87, P445, DOI 10.1177/154405910808700508
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Speicher DJ, 2015, DIAGN MICR INFEC DIS, V82, P120, DOI 10.1016/j.diagmicrobio.2015.02.013
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Zhang J, 2016, J TRAVEL MED, V23, P606
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 40
TC 7
Z9 7
U1 2
U2 6
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD SEP-OCT
PY 2019
VL 12
IS 5
BP 601
EP 604
DI 10.1016/j.jiph.2019.05.004
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IW0UL
UT WOS:000484679000001
PM 31129010
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Williams, F
   Oke, A
   Zachary, I
AF Williams, F.
   Oke, A.
   Zachary, I.
TI Public health delivery in the information age: the role of informatics
   and technology
SO PERSPECTIVES IN PUBLIC HEALTH
LA English
DT Review
DE public health; public health informatics; informatics; information
   technology; management information system
ID SYNDROMIC SURVEILLANCE; OUTBREAK DETECTION; SYSTEM; PREPAREDNESS;
   ALGORITHMS; FRAMEWORK; MODEL; FIELD
AB Aim: Public health systems have embraced health informatics and information technology as a potential transformational tool to improve real-time surveillance systems, communication, and sharing of information among various agencies. Global pandemic outbreaks like Zika and Ebola were quickly controlled due to electronic surveillance systems enabling efficient information access and exchange. However, there is the need for a more robust technology to enhance adequate epidemic forecasting, data sharing, and effective communication. The purpose of this review was to examine the use of informatics and information technology tools and its impact on public health delivery. Method: Investigators searched six electronic databases. These were MEDLINE, Cumulative Index to Nursing and Allied Health Literature (CINAHL) Complete, Cochrane Database of Systematic Reviews, COMPENDEX, Scopus, and Academic Search Premier from January 2000 to 31 March 2016. Results: A total of 60 articles met the eligibility criteria for inclusion. These studies were organized into three areas as (1) definition of the term public health informatics; (2) type of public health surveillance systems and implications for public health; and (3) electronic surveillance systems functionality, capability, training, and challenges. Our analysis revealed that due to the growing expectations to provide real-time response and population-centered evidence-based public health in this information-driven age there has been a surge in informatics and information technology adoption. Education and training programs are now available to equip public health students and professionals with skills in public health informatics. However, obstacles including interoperability, data standardization, privacy, and technology transfer persist. Conclusion: Re-engineering the delivery of public health is necessary to meet the demands of the 21(st) century and beyond. To meet this expectation, public health must invest in workforce development and capacity through education and training in informatics.
C1 [Williams, F.] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Gateway Bldg,533N,7201 Wisconsin Ave, Bethesda, MD 20814 USA.
   [Oke, A.] East Tennessee State Univ, Dept Hlth Serv Management & Policy, Coll Publ Hlth, Johnson City, TN 37614 USA.
   [Zachary, I.] Univ Missouri, Sch Med, Dept Hlth Management & Informat, Columbia, MO USA.
RP Williams, F (corresponding author), Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Gateway Bldg,533N,7201 Wisconsin Ave, Bethesda, MD 20814 USA.
EM Faustine.Williams@nih.gov
FU Division of Intramural Research, National Institute on Minority Health
   and Health Disparities, National Institutes of Health
FX Dr. Williams' effort is supported in part by the Division of Intramural
   Research, National Institute on Minority Health and Health Disparities,
   National Institutes of Health.
CR America IoMCoQoHCi, 2001, CROSSING QUALITY CHA
   Anderson GF, 2006, HEALTH AFFAIR, V25, P819, DOI 10.1377/hlthaff.25.3.819
   Bell BP, 2016, MMWR-MORBID MORTAL W, V65, P4, DOI 10.15585/mmwr.su6503a2
   Berndt DJ, 2003, INTELLIGENCE SECURIT, P322
   Boom JA, 2007, PEDIATRICS, V119, P1213, DOI 10.1542/peds.2006-3251
   Bradley Colleen A, 2005, MMWR Suppl, V54, P11
   Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013
   Brittain J M, 2000, Health Libr Rev, V17, P117, DOI 10.1046/j.1365-2532.2000.00279.x
   Buckeridge David L, 2004, MMWR Suppl, V53, P137
   Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007
   Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231
   Castillo-Salgado C, 2010, EPIDEMIOL REV, V32, P93, DOI 10.1093/epirev/mxq008
   Centers for Disease Control Prevention, 2009, PUBL HLTH PREP STREN
   Coiera E, 2007, Yearb Med Inform, P11
   Derby Mary P, 2005, MMWR Suppl, V54, P35
   Disease Control Priorities Project, 2008, PUBL HLTH SURV BEST
   Doyle Timothy J, 2005, BMC Med Inform Decis Mak, V5, P27, DOI 10.1186/1472-6947-5-27
   Duchin JS, 2016, DISASTER MED PUBLIC, V10, P298, DOI 10.1017/dmp.2016.26
   Edmunds Margo, 2014, EGEMS (Wash DC), V2, P1156, DOI 10.13063/2327-9214.1156
   Espino JU, 2004, STUD HEALTH TECHNOL, V107, P1192
   Fan C, 2010, CAN J PUBLIC HEALTH, V101, P459, DOI 10.1007/BF03403964
   Fan SH, 2010, CAN J PUBLIC HEALTH, V101, P454, DOI 10.1007/BF03403963
   Flamand C, 2014, J AM MED INFORM ASSN, V21, P232, DOI 10.1136/amiajnl-2013-002348
   Flamand C, 2011, STUD HEALTH TECHNOL, V169, P629, DOI 10.3233/978-1-60750-806-9-629
   Fricker Jr RD, 2006, CHANCE, V19, P4, DOI DOI 10.1080/09332480.2006.10722809
   FRIEDE A, 1995, ANNU REV PUBL HEALTH, V16, P239
   Graber JM, 2007, PUBLIC HEALTH REP, V122, P145, DOI 10.1177/003335490712200203
   Hanrahan LP, 2004, ENVIRON HEALTH PERSP, V112, P1434, DOI 10.1289/ehp.7150
   Heffernan Richard, 2004, MMWR Suppl, V53, P23
   Heisey-Grove DM, 2011, PUBLIC HEALTH REP, V126, P13, DOI 10.1177/003335491112600105
   Henao OL, 2015, EMERG INFECT DIS, V21, P1529, DOI 10.3201/eid2109.150581
   Hope K, 2006, J EPIDEMIOL COMMUN H, V60, P374, DOI 10.1136/jech.2005.035337
   Hovenga Evelyn Johanna Sophia, 2008, Texto contexto - enferm., V17, P158, DOI 10.1590/S0104-07072008000100018
   Hughes HE, 2016, EPIDEMIOL INFECT, V144, P1052, DOI 10.1017/S0950268815002125
   Hurt-Mullen Kathy J, 2005, MMWR Suppl, V54, P141
   Hutwagner L, 2003, J URBAN HEALTH, V80, pI89
   International Society for Disease Surveillance, TOOLS SYST SURV TOOL
   Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14
   Karras Bryant Thomas, 2002, J Public Health Manag Pract, V8, P37
   Kateh F, 2015, MMWR-MORBID MORTAL W, V64, P188
   Klingler C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4200-4
   Koo D, 2001, J AM MED INFORM ASSN, V8, P585, DOI 10.1136/jamia.2001.0080585
   Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253
   Kukafka R, 2007, J BIOMED INFORM, V40, P365, DOI 10.1016/j.jbi.2007.07.005
   Kukafka R, 2005, HEALTH PROMOT PRACT, V6, P23, DOI 10.1177/1524839904270389
   Kulldorff Martin, 2004, MMWR Suppl, V53, P144
   Lewis SH, 2011, J PUBLIC HEALTH MAN, V17, P248, DOI 10.1097/PHH.0b013e3181f9eeda
   Liang HG, 2004, INT J MED INFORM, V73, P675, DOI 10.1016/j.ijmedinf.2004.05.010
   Lober William B, 2004, MMWR Suppl, V53, P203
   Lombardo Joseph S, 2004, MMWR Suppl, V53, P159
   Lumpkin JR, 2003, HIST SIGNIFICANCE IN
   Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356
   McHugh M, 2004, HEALTH AFFAIR, V23, P201, DOI 10.1377/hlthaff.23.3.201
   McKinney WP, 2005, PUBLIC HEALTH REP, V120, P42, DOI 10.1177/00333549051200S109
   Mirhaji P, 2009, JALA-J LAB AUTOM, V14, P157, DOI 10.1016/j.jala.2009.02.007
   Mnatsakanyan ZR, 2008, J HOPKINS APL TECH D, V27, P332
   Naumova Elena N, 2005, MMWR Suppl, V54, P77
   Norris A.C., 2000, HLTH INFORM J, V6, P189
   Office of Disease Prevention and Health Promotion, HLTH PEOPL 2020 GLOB
   Organisation for Economic Co operation and Development, 2010, IMPR VAL HLTH CAR ME
   Ortega JAA, 2010, 1 ACM INT HLTH INF S
   Reeder B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-116
   Reis Ben Y, 2003, BMC Med Inform Decis Mak, V3, P2, DOI 10.1186/1472-6947-3-2
   Sandt CH, 2006, J CLIN MICROBIOL, V44, P3208, DOI 10.1128/JCM.01404-06
   Savel T, 2010, INT J MED INFORM, V79, P523, DOI 10.1016/j.ijmedinf.2010.04.002
   Savel Thomas G, 2012, MMWR Suppl, V61, P20
   Scotch M, 2008, J AM MED INFORM ASSN, V15, P783, DOI 10.1197/jamia.M2731
   Shea DA, 2003, 32152 R6 C RES SERV
   Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134
   Siegrist David, 2004, MMWR Suppl, V53, P152
   Sosin DM, 2003, J URBAN HEALTH, V80, pI8
   Stoto MA, 2006, STAT METHODS COUNTER, P141
   Surjan G, 2006, COMPUT BIOL MED, V36, P802, DOI 10.1016/j.compbiomed.2005.07.003
   Tang PC, 2002, J AM MED INFORM ASSN, V9, P123, DOI 10.1197/jamia.M1051
   Tokars JI, 2009, EMERG INFECT DIS, V15, P533, DOI 10.3201/eid1504.080616
   Tomines Alan, 2013, EGEMS (Wash DC), V1, P1019, DOI 10.13063/2327-9214.1019
   Uscher-Pines L, 2009, DISASTER MED PUBLIC, V3, pS29, DOI 10.1097/DMP.0b013e31819f4483
   Wagner Michael M, 2004, MMWR Suppl, V53, P28
   Wagner Michael M, 2004, MMWR Suppl, V53, P40
   Widdowson MA, 2016, MMWR-MORBID MORTAL W, V65, P98, DOI 10.15585/mmwr.su6503a14
   Williams F, 2008, INT J INFORM MANAGE, V28, P503, DOI 10.1016/j.ijinfomgt.2008.01.016
   Williams Faustine, 2008, Inform Prim Care, V16, P139
   Wilson JM, 2008, J AM MED INFORM ASSN, V15, P158, DOI 10.1197/jamia.M2558
   Winslow CEA, 1920, SCIENCE, V51, P23, DOI 10.1126/science.51.1306.23
   World Health Organization (WHO), 2006, COMM DIS SURV RESP S
   Xue Y., 2004, J INFORM TECHNOL THE, V6, P41
   Yan P, 2008, ANNU REV INFORM SCI, V42, P425
   Yasnoff W A, 2000, J Public Health Manag Pract, V6, P67
   Yasnoff WA, 2001, J AM MED INFORM ASSN, V8, P535, DOI 10.1136/jamia.2001.0080535
   Yih W Katherine, 2004, MMWR Suppl, V53, P43
   Yih WK, 2010, PUBLIC HEALTH REP, V125, P111, DOI 10.1177/003335491012500115
NR 91
TC 0
Z9 0
U1 8
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1757-9139
EI 1757-9147
J9 PERSPECT PUBLIC HEAL
JI Perspect. Public Health
PD SEP
PY 2019
VL 139
IS 5
BP 236
EP 254
DI 10.1177/1757913918802308
PG 19
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IV6TR
UT WOS:000484401200010
PM 30758258
DA 2020-07-08
ER

PT J
AU Al-Tawfiq, JA
   Memish, ZA
AF Al-Tawfiq, Jaffar A.
   Memish, Ziad A.
TI The Hajj 2019 Vaccine Requirements and Possible New Challenges
SO JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH
LA English
DT Article
DE Hajj; pilgrimage; mass gathering; vaccine requirements; Saudi Arabia
ID VIRAL RESPIRATORY-INFECTIONS; W135 MENINGOCOCCAL DISEASE; INFLUENZA-LIKE
   ILLNESS; MASS GATHERINGS; MIDDLE-EAST; MERS-COV; ELECTROPHORETIC
   TYPE-37; SYNDROME CORONAVIRUS; MEASLES OUTBREAK; SEROGROUP W135
AB Each year millions of pilgrims perform the annual Hajj from more than 180 countries around the world. This is one of the largest mass gathering events and may result in the occurrence and spread of infectious diseases. As such, there are mandatory vaccinations for the pilgrims such as meningococcal vaccines. The 2019 annual Hajj will take place during August 8-13, 2019. Thus, we review the recommended and mandated vaccinations for the 2019 Hajj and Umrah. The mandatory vaccines required to secure the visa include the quadrivalent meningococcal vaccine for all pilgrims, while yellow fever, and poliomyelitis vaccines are required for pilgrims coming from countries endemic or with disease activity. The recommended vaccines are influenza, pneumococcal, in addition to full compliance with basic vaccines for all pilgrims against diphtheria, tetanus, pertussis, polio, measles, and mumps. It is imperative to continue surveillance for the spread of antimicrobial resistance and occurrence of all infectious diseases causing outbreaks across the globe in the last year, like Zika virus, MDR-Typhoid, Nipah, Ebola, cholera, chikungunya and Middle East Respiratory Syndrome Coronavirus. (C) 2019 Atlantis Press International B.V.
C1 [Al-Tawfiq, Jaffar A.] Johns Hopkins Aramco Healthcare, Infect Dis Sect, Specialty Med Dept, Dhahran, Saudi Arabia.
   [Al-Tawfiq, Jaffar A.] Indiana Univ, Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46204 USA.
   [Al-Tawfiq, Jaffar A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Dept Med, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Prince Mohammed Bin Abdulaziz Hosp PMAH, Dept Med, Infect Dis Div, Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
RP Al-Tawfiq, JA (corresponding author), Johns Hopkins Aramco Healthcare, Infect Dis Sect, Specialty Med Dept, Dhahran, Saudi Arabia.; Al-Tawfiq, JA (corresponding author), Indiana Univ, Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46204 USA.; Al-Tawfiq, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.
EM jaffar.tawfiq@jhah.com
CR Aberle JH, 2015, EMERG INFECT DIS, V21, P726, DOI 10.3201/eid2104.141745
   Aguilera JF, 2002, EMERG INFECT DIS, V8, P761, DOI 10.3201/eid0808.010422
   Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8
   Al-Tawfiq JA, 2015, CLIN MICROBIOL INFEC, V21, P109, DOI [10.1016/j.cmi.2015.02.008, 10.1016/j.cmi.2014.11.013, 10.1016/j.cmi.2014.07.005]
   Al-Tawfiq JA, 2013, E MEDITERR HEALTH J, V19, pS48
   Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6
   Al-Tawfiq JA, 2018, TRAVEL MED INFECT DI, V23, P6, DOI 10.1016/j.tmaid.2018.04.007
   Al-Tawfiq JA, 2017, TRAVEL MED INFECT DI, V19, P2, DOI 10.1016/j.tmaid.2017.10.005
   Al-Tawfiq JA, 2016, ANN AM THORAC SOC, V13, P759, DOI 10.1513/AnnalsATS.201511-772FR
   Al-Tawfiq JA, 2016, HUM VACC IMMUNOTHER, V12, P326, DOI 10.1080/21645515.2015.1058456
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001
   Al-Tawfiq JA, 2014, TRAVEL MED INFECT DI, V12, P422, DOI 10.1016/j.tmaid.2014.06.007
   Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, V26, P725, DOI 10.1016/j.idc.2012.05.005
   Al-Tawfiq JA, 2010, J TRAVEL MED, V17, P3, DOI 10.1111/j.1708-8305.2010.00448.x
   Alborzi A, 2008, East Mediterr Health J, V14, P277
   Alborzi A, 2009, J TRAVEL MED, V16, P239, DOI 10.1111/j.1708-8305.2009.00301.x
   Alfelali M, 2016, HUM VACC IMMUNOTHER, V12, P709, DOI 10.1080/21645515.2015.1085144
   Alfelali M, 2015, VACCINE, V33, P2562, DOI 10.1016/j.vaccine.2015.04.006
   AlGahtani YM, 1995, EPIDEMIOL INFECT, V115, P399, DOI 10.1017/S0950268800058556
   Annan A, 2015, TROP MED INT HEALTH, V20, P807, DOI 10.1111/tmi.12482
   [Anonymous], POL TOD
   Ashshi A, 2014, J INFECT DEV COUNTR, V8, P1169, DOI 10.3855/jidc.4204
   Atabani SF, 2016, INT J INFECT DIS, V47, P10, DOI 10.1016/j.ijid.2016.04.016
   Baharoon S, 2009, TRAVEL MED INFECT DI, V7, P247, DOI 10.1016/j.tmaid.2008.09.002
   Barasheed Osamah, 2014, Virologica Sinica, V29, P364, DOI 10.1007/s12250-014-3507-x
   Barasheed Osamah, 2014, Infectious Disorders - Drug Targets, V14, P110
   Benkouiten S, 2014, EMERG INFECT DIS, V20, P1821, DOI 10.3201/eid2011.140600
   Borrow R, 2009, TRAVEL MED INFECT DI, V7, P219, DOI 10.1016/j.tmaid.2009.05.003
   CARLSON A, 2019, J TRANSPLANT, V19, P2134, DOI DOI 10.1111/AJT.15479
   Chen TH, 2010, PEDIATR INFECT DIS J, V29, P794, DOI 10.1097/INF.0b013e3181dbaacf
   Dull PM, 2005, J INFECT DIS, V191, P33, DOI 10.1086/425927
   Edouard S, 2018, VACCINE, V36, P7415, DOI 10.1016/j.vaccine.2018.09.017
   Elachola H, 2018, TRAVEL MED INFECT DI, V25, P3, DOI 10.1016/j.tmaid.2018.08.003
   Elachola H, 2015, INT J INFECT DIS, V40, P133, DOI 10.1016/j.ijid.2015.10.003
   Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608
   Gautret P, 2013, CLIN MICROBIOL INFEC, V19, pE315, DOI 10.1111/1469-0691.12174
   Gautret P, 2016, INT J INFECT DIS, V47, P46, DOI 10.1016/j.ijid.2016.03.007
   Gautret P, 2015, TRAVEL MED INFECT DI, V13, P159, DOI 10.1016/j.tmaid.2015.02.005
   Gautret P, 2014, EMERG INFECT DIS, V20, P728, DOI 10.3201/eid2004.131708
   Gautret P, 2016, INT J INFECT DIS, V47, P83, DOI 10.1016/j.ijid.2016.01.013
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P92, DOI 10.1016/j.tmaid.2015.12.008
   Griffiths K, 2016, TRAVEL MED INFECT DI, V14, P414, DOI 10.1016/j.tmaid.2016.05.002
   Issack MI, 2002, EMERG INFECT DIS, V8, P332
   Kandeel A, 2011, EMERG INFECT DIS, V17, P1266, DOI 10.3201/eid1707.101484
   Lingappa JR, 2003, EMERG INFECT DIS, V9, P665
   Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395
   Mahase E, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1810
   Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414
   McDonald R, 2019, AM J TRANSPLANT, V19, P2131, DOI 10.1111/ajt.15478
   Memish Z, 2013, EURO SURVEILL, V18
   Memish ZA, 2003, INT J ANTIMICROB AG, V21, P96, DOI 10.1016/S0924-8579(02)00364-3
   Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403
   Memish ZA, 2017, VACCINE, V35, P2473, DOI 10.1016/j.vaccine.2017.03.027
   Memish ZA, 2014, TRAVEL MED INFECT DI, V12, P415, DOI 10.1016/j.tmaid.2014.09.003
   Memish ZA, 2014, J INFECT DIS, V210, P1067, DOI 10.1093/infdis/jiu150
   Memish ZA, 2014, INT J INFECT DIS, V25, P186, DOI 10.1016/j.ijid.2014.06.003
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Memish ZA, 2013, LANCET GLOB HEALTH, V1, pE331, DOI 10.1016/S2214-109X(13)70079-2
   Memish ZA, 2012, J TRAVEL MED, V19, P15, DOI 10.1111/j.1708-8305.2011.00575.x
   Moattari A, 2012, INFLUENZA OTHER RESP, V6, pe77, DOI 10.1111/j.1750-2659.2012.00380.x
   MOORE PS, 1989, LANCET, V2, P260
   Mushtaq A, 2015, TRAVEL MED INFECT DI, V13, P360, DOI 10.1016/j.tmaid.2015.06.004
   NOVELLI VM, 1987, LANCET, V2, P863
   Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775
   Patel M, 2019, AM J TRANSPLANT, V19, P2127, DOI 10.1111/ajt.15477
   Pfaff G, 2010, EURO SURVEILL, V15
   ProMed, 2013, NOV COR E MED 03 SAU
   Rashid H, 2008, Emerg Health Threats J, V1, pe2, DOI 10.3134/ehtj.08.002
   Rashid H, 2008, CLIN MICROBIOL INFEC, V14, P569, DOI 10.1111/j.1469-0691.2008.01987.x
   Rashid Harunor, 2007, Travel Med Infect Dis, V5, P310, DOI 10.1016/j.tmaid.2007.07.006
   Refaey S, 2017, INFLUENZA OTHER RESP, V11, P57, DOI 10.1111/irv.12429
   Shibl A, 2013, E MEDITERR HEALTH J, V19, P389
   Sridhar S, 2015, TRAVEL MED INFECT DI, V13, P106, DOI 10.1016/j.tmaid.2014.11.006
   Wilder-Smith A, 2003, EMERG INFECT DIS, V9, P734
   Wilder-Smith A, 2003, CLIN INFECT DIS, V36, P679, DOI 10.1086/367858
   Wilder-Smith A, 2002, BMJ-BRIT MED J, V325, P365, DOI 10.1136/bmj.325.7360.365
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   World Health Organization, 2016, COUNTR RISK YELL FEV
   World Health Organization, 2016, NEW YELL FEV VACC RE
   Ziyaeyan M, 2012, INFLUENZA OTHER RESP, V6, pe80, DOI 10.1111/j.1750-2659.2012.00381.x
NR 80
TC 0
Z9 0
U1 2
U2 2
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAUMIERE, PARIS, 75019, FRANCE
SN 2210-6006
EI 2210-6014
J9 J EPIDEMIOL GLOB HEA
JI J. Epidemiol. Glob. Health
PD SEP
PY 2019
VL 9
IS 3
BP 147
EP 152
DI 10.2991/jegh.k.190705.001
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IV6ZY
UT WOS:000484417500001
PM 31529930
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Blume, S
AF Blume, Stuart
TI Zika: From the Brazilian Backlands to Global Threat
SO ISIS
LA English
DT Book Review
C1 [Blume, Stuart] Univ Amsterdam, Sci & Technol Studies, Amsterdam, Netherlands.
RP Blume, S (corresponding author), Univ Amsterdam, Sci & Technol Studies, Amsterdam, Netherlands.
CR DINIZ D, 2016, ZIKA BRAZILIAN BACKL
NR 1
TC 0
Z9 0
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0021-1753
EI 1545-6994
J9 ISIS
JI Isis
PD SEP 1
PY 2019
VL 110
IS 3
BP 658
EP 660
PG 3
WC History & Philosophy Of Science
SC History & Philosophy of Science
GA IU7VX
UT WOS:000483792500077
DA 2020-07-08
ER

PT J
AU Zappas, MP
   Whitely, C
   Carter, S
AF Zappas, Michelle P.
   Whitely, Candice
   Carter, Sarah
TI Global Travel: What to Know Before They Go
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Article
DE immunizations; infectious disease; malaria chemoprophylaxis; pretravel
   consultation; travel
ID IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; ZIKA VIRUS; RECOMMENDATIONS
AB The pretravel consultation presents an opportunity for nurse practitioners to promote the health and safety of individual patients and the communities to which they return. Nurse practitioners are responsible for education regarding disease transmission and avoiding illness and for providing immunotherapy and chemoprophylaxis to the traveler. Providers must establish duration, location, and motivation for travel, the patient's health status, and the living arrangements while away, all of which determine whether special actions are required. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Zappas, Michelle P.; Whitely, Candice] Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Dept Nursing, Los Angeles, CA 90089 USA.
   [Carter, Sarah] Univ Louisville, Sch Nursing, Louisville, KY 40292 USA.
RP Zappas, MP (corresponding author), Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Dept Nursing, Los Angeles, CA 90089 USA.
EM zappas@usc.edu
OI Whitely, Candice/0000-0003-3558-0108
CR Alpern JD, 2016, MED CLIN N AM, V100, P303, DOI 10.1016/j.mcna.2015.08.019
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Brophy J, 2015, Can Commun Dis Rep, V41, P89
   Chen LH, CDC YELLOW BOOK HLTH
   Giddings SL, 2016, MED CLIN N AM, V100, P317, DOI 10.1016/j.mcna.2015.08.017
   Griffen PM, CDC YELLOW BOOK HLTH
   Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1
   Hill SL, CDC YELLOW BOOK HLTH
   International Air Transportation Authority, MED MAN
   Judd MC, CDC YELLOW BOOK HLTH
   Kamata K, 2017, J GEN FAM MED, V18, P52, DOI 10.1002/jgf2.39
   Kamata K, 2017, J GEN FAM MED, V18, P114, DOI 10.1002/jgf2.40
   Kotton C, CDC YELLOW BOOK HLTH
   Kroger AT, CDC YELLOW BOOK HLTH
   Laurent BS, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1950-5
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Morof D, CDC YELLOW BOOK HLTH
   Mosquera A, 2015, PUBLIC HEALTH NURS, V32, P550, DOI 10.1111/phn.12217
   Mutebi J, CDC YELLOW BOOK HLTH
   Ocan M, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0780-z
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Reyes NL, CDC YELLOW BOOK HLTH
   Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI 10.1093/cid/cit684
   Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647
   United States Department of Commerce, US RES TRAV INT DEST
   Uribe C., CDC YELLOW BOOK HLTH
   US Food and Drug Administration, HIGHL PRESCR INF
   Walker XJ, 2015, J TRAVEL MED, V22, P403, DOI 10.1111/jtm.12237
   Williamson J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2153
   World Health Organization, 2017, WORLD MAL REP 2017
NR 31
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD SEP
PY 2019
VL 15
IS 8
BP 544
EP 549
DI 10.1016/j.nurpra.2019.02.020
PG 6
WC Nursing
SC Nursing
GA IV0JN
UT WOS:000483965600018
DA 2020-07-08
ER

PT J
AU Li, T
   Mbala-Kingebeni, P
   Naccache, SN
   Theze, J
   Bouquet, J
   Federman, S
   Somasekar, S
   Yu, GX
   Sanchez-San Martin, C
   Achari, A
   Schneider, BS
   Rimoin, AW
   Rambaut, A
   Nsio, J
   Mulembakani, P
   Ahuka-Mundeke, S
   Kapetshi, J
   Pybus, OG
   Muyembe-Tamfum, JJ
   Chiu, CY
AF Li, Tony
   Mbala-Kingebeni, Placide
   Naccache, Samia N.
   Theze, Julien
   Bouquet, Jerome
   Federman, Scot
   Somasekar, Sneha
   Yu, Guixia
   Sanchez-San Martin, Claudia
   Achari, Asmeeta
   Schneider, Bradley S.
   Rimoin, Anne W.
   Rambaut, Andrew
   Nsio, Justus
   Mulembakani, Prime
   Ahuka-Mundeke, Steve
   Kapetshi, Jimmy
   Pybus, Oliver G.
   Muyembe-Tamfum, Jean-Jacques
   Chiu, Charles Y.
TI Metagenomic Next-Generation Sequencing of the 2014 Ebola Virus Disease
   Outbreak in the Democratic Republic of the Congo
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE 2014 Boende outbreak; Orungo virus; coinfection; Ebola virus; molecular
   clock analysis; next-generation sequencing; pathogen discovery;
   phylogenetic analysis; viral genome assembly; viral metagenomics
ID REAL-TIME; INFECTION; IDENTIFICATION; SAMPLES; BAHIA; ZIKA
AB We applied metagenomic next-generation sequencing (mNGS) to detect Zaire Ebola virus (EBOV) and other potential pathogens from whole-blood samples from 70 patients with suspected Ebola hemorrhagic fever during a 2014 outbreak in Boende, Democratic Republic of the Congo (DRC) and correlated these findings with clinical symptoms. Twenty of 31 patients (64.5%) tested in Kinshasa, DRC, were EBOV positive by quantitative reverse transcriptase PCR (qRT-PCR). Despite partial degradation of sample RNA during shipping and handling, mNGS followed by EBOV-specific capture probe enrichment in a U.S. genomics laboratory identified EBOV reads in 22 of 70 samples (31.4%) versus in 21 of 70 (30.0%) EBOV-positive samples by repeat qRT-PCR (overall concordance = 87.1%). Reads from Plasmodium falciparum (malaria) were detected in 21 patients, of which at least 9 (42.9%) were coinfected with EBOV. Other positive viral detections included hepatitis B virus (n = 2), human pegivirus 1 (n = 2), Epstein-Barr virus (n = 9), and Orungo virus (n = 1), a virus in the Reoviridae family. The patient with Orungo virus infection presented with an acute febrile illness and died rapidly from massive hemorrhage and dehydration. Although the patient's blood sample was negative by EBOV qRT-PCR testing, identification of viral reads by mNGS confirmed the presence of EBOV coinfection. In total, 9 new EBOV genomes (3 complete genomes, and an additional 6 >= 50% complete) were assembled. Relaxed molecular clock phylogenetic analysis demonstrated a molecular evolutionary rate for the Boende strain 4 to 10x slower than that of other Ebola lineages. These results demonstrate the utility of mNGS in broad-based pathogen detection and outbreak surveillance.
C1 [Li, Tony; Naccache, Samia N.; Bouquet, Jerome; Federman, Scot; Somasekar, Sneha; Yu, Guixia; Sanchez-San Martin, Claudia; Achari, Asmeeta; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Li, Tony; Naccache, Samia N.; Bouquet, Jerome; Federman, Scot; Somasekar, Sneha; Yu, Guixia; Sanchez-San Martin, Claudia; Achari, Asmeeta; Chiu, Charles Y.] Univ Calif San Francisco, UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.
   [Mbala-Kingebeni, Placide; Mulembakani, Prime; Ahuka-Mundeke, Steve; Kapetshi, Jimmy; Muyembe-Tamfum, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Schneider, Bradley S.] Etiologic Inc, San Francisco, CA USA.
   [Rimoin, Anne W.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Nsio, Justus] Minist Publ Hlth, Kinshasa, DEM REP CONGO.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA.
EM Charles.chiu@ucsf.edu
RI Pybus, Oliver g/B-2640-2012; Rambaut, Andrew/B-2481-2009
OI Pybus, Oliver g/0000-0002-8797-2667; Rambaut,
   Andrew/0000-0003-4337-3707; Schneider, Bradley S/0000-0001-7642-0018
FU Abbott Laboratories, Inc.Abbott Laboratories; NIH grant from National
   Heart, Lung, and Blood Institute [R01HL105704]; National Institute of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R21/R33AI120977];
   European Research Council under the European Commission Seventh
   Framework Program (FP7/2007-2013)/European Research Council
   [614725-PATHPHYLODYN]; Oxford Martin School; Wellcome Trust core
   awardWellcome Trust [203141/Z]
FX This work was funded by Abbott Laboratories, Inc. (to C.Y.C.), NIH grant
   R01HL105704 from the National Heart, Lung, and Blood Institute (to
   C.Y.C.), and R21/R33AI120977 from the National Institute of Allergy and
   Infectious Diseases (to C.Y.C.). This work was also supported in part by
   the European Research Council under the European Commission Seventh
   Framework Program (FP7/2007-2013)/European Research Council grant
   agreement 614725-PATHPHYLODYN, the Oxford Martin School, and the
   Wellcome Trust core award (203141/Z to O.G.P.).; C.Y.C. is the director
   of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) and
   receives research support from Abbott Laboratories, Inc. The other
   authors declare no competing interests.
CR Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506
   CDC, 2018, CAS COUNTS 2014 2016
   Chowell G, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002057
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Wit E, 2016, EMERG INFECT DIS, V22, P323, DOI 10.3201/eid2202.151656
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   FAMILUSI JB, 1972, CLIN PEDIATR, V11, P272, DOI 10.1177/000992287201100509
   Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381
   Grolla A, 2012, ZOONOSES PUBLIC HLTH, V59, P151, DOI 10.1111/j.1863-2378.2012.01477.x
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hidalgo J, 2017, J CRIT CARE, V42, P366, DOI 10.1016/j.jcrc.2017.11.006
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Lam TTY, 2015, J VIROL, V89, P10130, DOI 10.1128/JVI.01226-15
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Luk KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141723
   Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099
   Martinez MJ, 2015, INFECT DIS THER, V4, P365, DOI 10.1007/s40121-015-0079-5
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Relova Damarys, 2018, Vet Sci, V5, DOI 10.3390/vetsci5010019
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Somasekar S, 2017, CLIN INFECT DIS, V65, P1477, DOI 10.1093/cid/cix596
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tang LSY, 2018, JAMA-J AM MED ASSOC, V319, P1802, DOI 10.1001/jama.2018.3795
   Ternak G, 2003, LANCET INFECT DIS, V3, P271, DOI 10.1016/S1473-3099(03)00603-0
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636
   Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6
   Waxman M, 2017, LANCET INFECT DIS, V17, P654, DOI 10.1016/S1473-3099(17)30112-3
NR 38
TC 2
Z9 2
U1 2
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD SEP
PY 2019
VL 57
IS 9
AR e00827-19
DI 10.1128/JCM.00827-19
PG 13
WC Microbiology
SC Microbiology
GA IU5GK
UT WOS:000483614700032
PM 31315955
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Milora, KA
   Rall, GF
AF Milora, Katelynn A.
   Rall, Glenn F.
TI Interferon Control Of Neurotropic Viral Infections
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID CENTRAL-NERVOUS-SYSTEM; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8 T-CELLS;
   BRAIN-BARRIER DISRUPTION; SINDBIS-VIRUS; CLONAL EXPANSION;
   IMMUNE-RESPONSES; TIGHT JUNCTIONS; ZIKA-VIRUS; GAMMA
AB Interferons (IFNs) comprise a pleiotropic family of signaling molecules that are often the first line of defense against viral infection. Inflammatory responses induced by IFN are generally well tolerated during peripheral infections; yet, the same degree of inflammation during infection of the central nervous system (CNS) could be catastrophic. Thus, IFN responses must be modified within the CNS to ensure host survival. In this review, we discuss emerging principles highlighting unique aspects of antiviral effects of IFN protection following neurotropic viral infection, chiefly using new techniques in rodent models. Evaluation of these unique responses provides insights into how the immune system eradicates or controls pathogens, while avoiding host damage. Defining these principles may have direct impact on the development of novel clinical approaches.
C1 [Milora, Katelynn A.; Rall, Glenn F.] Fox Chase Canc Ctr, Program Blood Cell Dev & Funct, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
RP Rall, GF (corresponding author), Fox Chase Canc Ctr, Program Blood Cell Dev & Funct, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
EM Glenn.Rall@fccc.edu
FU  [T32 NS007180-36];  [R01 NS060701];  [R21 NS099788];  [5P30CA006927-53]
FX We would like to thank Riley M. Williams and Christine M. Matullo for
   contributions in reviewing this work. Katelynn A. Milora and Glenn F.
   Rall wrote this review. All illustrations were created by Katelynn A.
   Milora using Adobe Illustrator. This was work supported by T32
   NS007180-36 (KAM), R01 NS060701 (GFR), R21 NS099788 (GFR), a gift from
   the F.M. Kirby Foundation, and Cancer Center Support Grant
   5P30CA006927-53.
CR Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521
   Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Baker DG, 1998, CLIN MICROBIOL REV, V11, P231, DOI 10.1128/CMR.11.2.231
   Barkhouse DA, 2015, J VIROL, V89, P312, DOI 10.1128/JVI.01572-14
   Baxter VK, 2016, J GEN VIROL, V97, P2908, DOI 10.1099/jgv.0.000613
   Bender SJ, 2010, J NEUROIMMUNE PHARM, V5, P336, DOI 10.1007/s11481-010-9202-2
   Berger JR, 1998, ANN NEUROL, V44, P341, DOI 10.1002/ana.410440309
   Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107
   Bleau C, 2015, J VIROL, V89, P9896, DOI 10.1128/JVI.01501-15
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Burdeinick-Kerr R, 2007, J VIROL, V81, P5628, DOI 10.1128/JVI.01152-06
   Byrnes AP, 2000, J VIROL, V74, P3905, DOI 10.1128/JVI.74.8.3905-3908.2000
   Cain MD, 2017, J NEUROIMMUNOL, V308, P118, DOI 10.1016/j.jneuroim.2017.04.008
   Campbell HK, 2017, EXP CELL RES, V358, P39, DOI 10.1016/j.yexcr.2017.03.061
   Cavanaugh SE, 2015, J NEUROIMMUNOL, V279, P11, DOI 10.1016/j.jneuroim.2014.12.012
   Chai QQ, 2014, J VIROL, V88, P4698, DOI 10.1128/JVI.03149-13
   Chauhan VS, 2010, VIROLOGY, V400, P187, DOI 10.1016/j.virol.2010.01.025
   Chhatbar C, 2018, CELL REP, V25, P118, DOI 10.1016/j.celrep.2018.09.003
   Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796
   Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Delbue S, 2012, J CELL PHYSIOL, V227, P3511, DOI 10.1002/jcp.24051
   Ding JW, 1997, J VIROL, V71, P9223, DOI 10.1128/JVI.71.12.9223-9230.1997
   Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114
   Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045
   Fantetti KN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0571-1
   Faul EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001016
   Furr SR, 2008, J NEUROVIROL, V14, P503, DOI 10.1080/13550280802337217
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   GRIFFIN DE, 1976, J INFECT DIS, V133, P456, DOI 10.1093/infdis/133.4.456
   Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038
   Holzmann H, 2003, VACCINE, V21, pS36, DOI 10.1016/S0264-410X(02)00819-8
   Hooper DC, 2000, FASEB J, V14, P691
   Hwang M, 2018, J VIROL, V92, DOI 10.1128/JVI.01901-17
   Iijima N, 2016, NATURE, V533, P552, DOI 10.1038/nature17979
   Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748
   Itzhaki R. F., 2018, FRONT AGING NEUROSCI, P10
   Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203
   JACKSON AC, 1987, LAB INVEST, V56, P418
   Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6
   Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kak Gunjan, 2018, BioMolecular Concepts, V9, P64, DOI 10.1515/bmc-2018-0007
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9
   Lamers SL, 2011, INFECT GENET EVOL, V11, P31, DOI 10.1016/j.meegid.2010.10.016
   Laterra JKR, 1999, BASIC NEUROCHEMISTRY
   Lauterbach H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-53
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Miller KD, 2016, NAT REV NEUROSCI, V17, P766, DOI 10.1038/nrn.2016.140
   Mlera L, 2018, J NEUROVIROL, V24, P75, DOI 10.1007/s13365-017-0596-y
   MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0
   Nair S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003999
   Nayak D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003395
   Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602
   O'Donnell LA, 2015, J NEUROCHEM, V135, P309, DOI 10.1111/jnc.13250
   O'Donnell LA, 2012, J IMMUNOL, V188, P1915, DOI 10.4049/jimmunol.1101356
   Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004
   Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pfefferkorn C, 2016, J VIROL, V90, P2031, DOI 10.1128/JVI.02979-15
   Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1
   Richards MH, 2015, GLIA, V63, P441, DOI 10.1002/glia.22763
   Richner M, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01038
   Rua R, 2018, TRENDS MOL MED, V24, P542, DOI 10.1016/j.molmed.2018.04.003
   Solomos AC, 2016, ACS CHEM NEUROSCI, V7, P435, DOI 10.1021/acschemneuro.5b00336
   TARDIEU M, 1982, ACTA NEUROPATHOL, V58, P168, DOI 10.1007/BF00690797
   Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214
   Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746
   van den Pol AN, 2014, J VIROL, V88, P3695, DOI 10.1128/JVI.03509-13
   Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003
   Wang ZW, 2005, J VIROL, V79, P12554, DOI 10.1128/JVI.79.19.12554-12565.2005
   Weerasuriya A, 2011, METHODS MOL BIOL, V686, P149, DOI 10.1007/978-1-60761-938-3_6
   Wells AI, 2018, TRENDS IMMUNOL, V39, P848, DOI 10.1016/j.it.2018.08.008
   Wilcox DR, 2016, MBIO, V7, DOI 10.1128/mBio.00437-16
   Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Ye L, 2019, NAT REV IMMUNOL, V19, P614, DOI 10.1038/s41577-019-0182-z
NR 88
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
EI 1471-4981
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD SEP
PY 2019
VL 40
IS 9
BP 842
EP 856
DI 10.1016/j.it.2019.07.005
PG 15
WC Immunology
SC Immunology
GA IU9XI
UT WOS:000483933500007
PM 31439415
DA 2020-07-08
ER

PT J
AU Ketkar, H
   Yang, L
   Wormser, GP
   Wang, PH
AF Ketkar, Harshada
   Yang, Long
   Wormser, Gary P.
   Wang, Penghua
TI Lack of efficacy of ivermectin for prevention of a lethal Zika virus
   infection in a murine system
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Ivermectin; Mouse model; Treatment
ID INHIBITOR; REPLICATION
AB The antihelminthic drug ivermectin has been demonstrated to have antiviral activity against the Zika virus and other arboviruses in in vitro studies. The effectiveness of ivermectin for Zika virus infection, however, has never been studied in an animal model. In this study, ivermectin was found to be ineffective for prevention of a lethal infection with the Senegal strain of Zika virus in Ifnar1 knockout mice. In view of several study limitations, evaluation of ivermectin's anti-Zika virus activity in other animal models and against other Zika virus strains would be desirable. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Ketkar, Harshada; Yang, Long; Wang, Penghua] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
   [Wormser, Gary P.] New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA.
RP Wormser, GP (corresponding author), New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA.
EM gwormser@nymc.edu
RI wang, Penghua/AAL-4011-2020
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI132526]
FX This study was in part supported by the National Institutes of Health
   grant R01AI132526 to P.W.
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   [Anonymous], 2010, VANC PACK INS
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Chiu S. H. L., 1989, Ivermectin and abamectin., P131
   Conole J, 2003, CONTEMP TOP LAB ANIM, V42, P42
   Croci R, 2016, INT J BIOMATER, DOI 10.1155/2016/8043983
   Crump A, 2017, J ANTIBIOT, V70, P495, DOI 10.1038/ja.2017.11
   Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002401382731
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
NR 15
TC 3
Z9 3
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD SEP
PY 2019
VL 95
IS 1
BP 38
EP 40
DI 10.1016/j.diagmicrobio.2019.03.012
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IU2RH
UT WOS:000483427000009
PM 31097261
DA 2020-07-08
ER

PT J
AU Gilbert-Jaramillo, J
   Garcez, P
   James, W
   Molnar, Z
   Clarke, K
AF Gilbert-Jaramillo, Javier
   Garcez, Patricia
   James, William
   Molnar, Zoltan
   Clarke, Kieran
TI The potential contribution of impaired brain glucose metabolism to
   congenital Zika syndrome
SO JOURNAL OF ANATOMY
LA English
DT Article; Proceedings Paper
CT Summer Meeting of the Anatomical-Society
CY JUN 23-25, 2018
CL St Johns Coll, Oxford, ENGLAND
SP Anat Soc
HO St Johns Coll
DE congenital Zika syndrome; diet; glucose; ketone bodies; metabolism;
   microcephaly; Zika virus
ID UNFOLDED PROTEIN RESPONSE; VIRUS-INFECTION; KETOGENIC-DIET; DENGUE
   VIRUS; KETONE-BODY; NEUROLOGICAL DISORDERS; ENERGY-METABOLISM;
   BIRTH-DEFECTS; FATTY-ACIDS; MOUSE MODEL
AB The Zika virus (ZIKV) became a major worldwide public concern in 2015 due to the congenital syndrome which presents the highest risk during the first trimester of pregnancy and includes microcephaly and eye malformations. Several cellular, genetic and molecular studies have shown alterations in metabolic pathways, endoplasmic reticulum (ER) stress, immunity and dysregulation of RNA and energy metabolism both in vivo and in vitro. Here we summarise the main metabolic complications, with a particular focus on the possibility that brain energy metabolism is altered following ZIKV infection, contributing to developmental abnormalities. Brain energetic failure has been implicated in neurological conditions such as autism disorder and epilepsy, as well as in metabolic diseases with severe neurodevelopmental complications such as Glut-1 deficiency syndrome. Therefore, these energetic alterations are of wide-ranging interest as they might be directly implicated in congenital ZIKV syndrome. Data showing increased glycolysis during ZIKV infection, presumably required for viral replication, might support the idea that the virus can cause energetic stress in the developing brain cells. Consequences may include neuroinflammation, cell cycle dysregulation and cell death. Ketone bodies are non-glycolytic brain fuels that are produced during neonatal life, starvation or fasting, ingestion of high-fat low-carbohydrate diets, and following supplementation with ketone esters. We propose that dietary ketones might alter the course of the disease and could even provide some degree of prevention of ZIKV-associated abnormalities and potentially related neurological conditions characterised by brain glucose impairment.
C1 [Gilbert-Jaramillo, Javier; Molnar, Zoltan; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England.
   [Garcez, Patricia] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [James, William] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.
RP Gilbert-Jaramillo, J (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England.
EM javier.gilbertjaramillo@dpag.ox.ac.uk
RI Garcez, Patricia/F-8026-2012; Molnar, Zoltan/J-7281-2012; james,
   william/H-4289-2013
OI Garcez, Patricia/0000-0002-9107-1335; Molnar,
   Zoltan/0000-0002-6852-6004; james, william/0000-0002-2506-1198; Gilbert,
   Javier/0000-0003-1268-2304
FU Medical Research CouncilMedical Research Council UK (MRC) [G0900901,
   MR/N026039/1, MC_PC_15102]
CR Adachi Y, 2014, NEUROPEDIATRICS, V45, P93, DOI 10.1055/s-0033-1360483
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Augustin K, 2018, LANCET NEUROL, V17, P84, DOI 10.1016/S1474-4422(17)30408-8
   Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
   Bae HR, 2016, ONCOTARGET, V7, P66444, DOI 10.18632/oncotarget.12119
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Blonz ER, 2016, LANCET INFECT DIS, V16, P642, DOI 10.1016/S1473-3099(16)30062-7
   BOUGNERES PF, 1986, J CLIN INVEST, V77, P42, DOI 10.1172/JCI112299
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031
   Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810
   Camberos-Luna L, 2016, NEUROCHEM RES, V41, P600, DOI 10.1007/s11064-015-1700-4
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castro MA, 2007, J NEUROCHEM, V102, P773, DOI 10.1111/j.1471-4159.2007.04631.x
   Castro MA, 2008, PFLUG ARCH EUR J PHY, V457, P519, DOI 10.1007/s00424-008-0526-1
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369
   Covarrubias-Pinto A, 2015, INT J MOL SCI, V16, P28194, DOI 10.3390/ijms161226095
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Devraj K, 2011, J NEUROSCI RES, V89, P1913, DOI 10.1002/jnr.22738
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Evans JD, 2011, VIRAL IMMUNOL, V24, P253, DOI 10.1089/vim.2010.0126
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Falkowska A, 2015, INT J MOL SCI, V16, P25959, DOI 10.3390/ijms161125939
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7
   Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126
   Gebre Y, 2016, ASIAN PAC J TROP BIO, V6, P815, DOI 10.1016/j.apjtb.2016.08.008
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Grabacka M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122093
   Gustafsson J, 2009, INDIAN J MED RES, V130, P618
   Hay William W Jr, 2006, Trans Am Clin Climatol Assoc, V117, P321
   HAY WW, 1990, AM J PHYSIOL, V258, pR569
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hofmann K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11103-5
   Holme AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117084
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Cornejo VH, 2013, IUBMB LIFE, V65, P962, DOI 10.1002/iub.1224
   Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jensen PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200
   Jimena Barbeito A, 2018, EXPLORING BRAIN PHEN, P18
   Jordan TX, 2016, CURR OPIN VIROL, V19, P7, DOI 10.1016/j.coviro.2016.05.007
   Jurcovicova J, 2014, Endocr Regul, V48, P35
   Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Klepper J, 2005, NEUROPEDIATRICS, V36, P302, DOI 10.1055/s-2005-872843
   Klepper J, 2004, PROSTAG LEUKOTR ESS, V70, P321, DOI 10.1016/j.plefa.2003.07.004
   Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x
   Kono H, 2004, AM J PHYSIOL-GASTR L, V286, pG1081, DOI 10.1152/ajpgi.00457.2003
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Foll C, 2016, AM J PHYSIOL-REG I, V310, pR1186, DOI 10.1152/ajpregu.00113.2016
   Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18909-3
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0042-1
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019
   Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967
   Lombardo MV, 2018, MOL PSYCHIATR, V23, P1001, DOI 10.1038/mp.2017.15
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065
   Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471
   MAHER F, 1991, Molecular and Cellular Neuroscience, V2, P351, DOI 10.1016/1044-7431(91)90066-W
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musa-Veloso K, 2002, AM J CLIN NUTR, V76, P65
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Owen OE, 2005, BIOCHEM MOL BIOL EDU, V33, P246, DOI 10.1002/bmb.2005.49403304246
   OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Panov A, 2014, BIOMED RES INT, DOI 10.1155/2014/472459
   Payne J, 1997, GLIA, V21, P327, DOI 10.1002/(SICI)1098-1136(199711)21:3<327::AID-GLIA7>3.0.CO;2-1
   PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C
   Rhyu HS, 2014, J EXERC REHABIL, V10, P326, DOI 10.12965/jer.140160
   Rick AM, 2017, LANCET GLOB HEALTH, V5, P16
   Romano A, 2017, INT J BIOCHEM CELL B, V84, P40, DOI 10.1016/j.biocel.2016.12.015
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schneider H, 2003, PLACENTA, V24, P27, DOI 10.1053/plac.2002.0869
   Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128
   Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shi YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21894-w
   Soejima E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191147
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stolp Helen, 2012, Front Psychiatry, V3, P50, DOI 10.3389/fpsyt.2012.00050
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang MX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14152
   Thevenet J, 2016, FASEB J, V30, P1913, DOI 10.1096/fj.201500182
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Tongluan N, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0685-9
   Tracey TJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00010
   Uncini A, 2018, EUR J NEUROL, V25, P644, DOI 10.1111/ene.13552
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Verma R, 2011, ANN INDIAN ACAD NEUR, V14, P272, DOI 10.4103/0972-2327.91946
   Vidali S, 2015, INT J BIOCHEM CELL B, V63, P55, DOI 10.1016/j.biocel.2015.01.022
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Xia C, 2016, J VIROL, V90, P2403, DOI 10.1128/JVI.02749-15
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002
   Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 169
TC 0
Z9 0
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8782
EI 1469-7580
J9 J ANAT
JI J. Anat.
PD SEP
PY 2019
VL 235
IS 3
SI SI
BP 468
EP 480
DI 10.1111/joa.12959
PG 13
WC Anatomy & Morphology
SC Anatomy & Morphology
GA IS8VE
UT WOS:000482426800004
PM 30793304
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Baidaliuk, A
   Miot, EF
   Lequime, S
   Moltini-Conclois, I
   Delaigue, F
   Dabo, S
   Dickson, LB
   Aubry, F
   Merkling, SH
   Cao-Lormeau, VM
   Lambrechts, L
AF Baidaliuk, Artem
   Miot, Elliott F.
   Lequime, Sebastian
   Moltini-Conclois, Isabelle
   Delaigue, Fanny
   Dabo, Stephanie
   Dickson, Laura B.
   Aubry, Fabien
   Merkling, Sarah H.
   Cao-Lormeau, Van-Mai
   Lambrechts, Louis
TI Cell-Fusing Agent Virus Reduces Arbovirus Dissemination in Aedes aegypti
   Mosquitoes In Vivo
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Aedes aegypti; arbovirus; coinfection; insect-specific virus;
   superinfection; viral interference
ID INFECTION; TRANSMISSION; FLAVIVIRUS; SEQUENCE; DISCOVERY; ALIGNMENT
AB Aedes aegypti mosquitoes are the main vectors of arthropod-borne viruses (arboviruses) of public health significance, such as the flaviviruses dengue virus (DENV) and Zika virus (ZIKV). Mosquitoes are also the natural hosts of a wide range of viruses that are insect specific, raising the question of their influence on arbovirus transmission in nature. Cell-fusing agent virus (CFAV) was the first described insect-specific flavivirus, initially discovered in an A. aegypti cell line and subsequently detected in natural A. aegypti populations. It was recently shown that DENV and the CFAV strain isolated from the A. aegypti cell line have mutually beneficial interactions in mosquito cells in culture. However, whether natural strains of CFAV and DENV interact in live mosquitoes is unknown. Using a wild-type CFAV isolate recently derived from Thai A. aegypti mosquitoes, we found that CFAV negatively interferes with both DENV type 1 and ZIKV in vitro and in vivo. For both arboviruses, prior infection by CFAV reduced the dissemination titer in mosquito head tissues. Our results indicate that the interactions observed between arboviruses and the CFAV strain derived from the cell line might not be a relevant model of the viral interference that we observed in vivo. Overall, our study supports the hypothesis that insect-specific flaviviruses may contribute to reduce the transmission of human-pathogenic flaviviruses.
   IMPORTANCE The mosquito Aedes aegypti carries several arthropod-borne viruses (arboviruses) that are pathogenic to humans, including dengue and Zika viruses. Interestingly, A. aegypti is also naturally infected with insect-only viruses, such as cell-fusing agent virus. Although interactions between cell-fusing agent virus and dengue virus have been documented in mosquito cells in culture, whether wild strains of cell-fusing agent virus interfere with arbovirus transmission by live mosquitoes was unknown. We used an experimental approach to demonstrate that cell-fusing agent virus infection reduces the propagation of dengue and Zika viruses in A. aegypti mosquitoes. These results support the idea that insect-only viruses in nature can modulate the ability of mosquitoes to carry arboviruses of medical significance and that they could possibly be manipulated to reduce arbovirus transmission.
C1 [Baidaliuk, Artem; Miot, Elliott F.; Lequime, Sebastian; Moltini-Conclois, Isabelle; Delaigue, Fanny; Dabo, Stephanie; Dickson, Laura B.; Aubry, Fabien; Merkling, Sarah H.; Lambrechts, Louis] CNRS, Inst Pasteur, UMR2000, Insect Virus Interact Unit, Paris, France.
   [Baidaliuk, Artem; Miot, Elliott F.] Sorbonne Univ, Coll Doctoral, Paris, France.
   [Miot, Elliott F.] Inst Pasteur Laos, Med Entomol & Vector Borne Dis Unit, Viangchan, Laos.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Lequime, Sebastian] Rega Inst, Lab Clin & Epidemiol Virol, Dept Microbiol & Immunol, Leuven, Belgium.
RP Lambrechts, L (corresponding author), CNRS, Inst Pasteur, UMR2000, Insect Virus Interact Unit, Paris, France.
EM louis.lambrechts@pasteur.fr
RI Lequime, Sebastian/E-9380-2011; Cao-Lormeau, Van-Mai/H-4879-2018
OI Lequime, Sebastian/0000-0002-3140-0651; Baidaliuk,
   Artem/0000-0002-8351-1142; Cao-Lormeau, Van-Mai/0000-0001-5606-7480
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR16-CE35-0004-01, ANR-17-ERC2-0016-01]; French Government's
   Investissement d'Avenir program Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious DiseasesFrench National Research Agency
   (ANR) [ANR-10-LABX-62-IBEID]; European Union's Horizon 2020 research and
   innovation program under ZikaPLAN grant [734584]; City of Paris
   Emergence(s) Program in Biomedical ResearchRegion Ile-de-France
FX This work was supported by the Agence Nationale de la Recherche (grants
   ANR16-CE35-0004-01 and ANR-17-ERC2-0016-01), the French Government's
   Investissement d'Avenir program Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID),
   the European Union's Horizon 2020 research and innovation program under
   ZikaPLAN grant agreement no. 734584, and the City of Paris Emergence(s)
   Program in Biomedical Research.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amuzu HE, 2018, ECOL EVOL, V8, P5441, DOI 10.1002/ece3.4066
   Contreras-Gutierrez MA, 2017, AM J TROP MED HYG, V97, P299, DOI 10.4269/ajtmh.16-0987
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Espinoza-Gomez F, 2011, ARCH VIROL, V156, P1263, DOI 10.1007/s00705-011-0967-2
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033
   Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Fujita R, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00736
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goertz GP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030271
   Halbach R, 2017, CURR OPIN INSECT SCI, V22, P16, DOI 10.1016/j.cois.2017.05.004
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025
   Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kihara Y, 2007, J VIROL METHODS, V146, P372, DOI 10.1016/j.jviromet.2007.07.008
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex031
   Lutomiah JJL, 2007, J INSECT SCI, V7
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ohlund P, 2019, VIRUS GENES, V55, P127, DOI 10.1007/s11262-018-01629-9
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Weger-Lucarelli J, 2018, VIROLOGY, V521, P175, DOI 10.1016/j.virol.2018.06.007
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
NR 46
TC 8
Z9 8
U1 5
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2019
VL 93
IS 18
AR e00705-19
DI 10.1128/JVI.00705-19
PG 17
WC Virology
SC Virology
GA IU2RK
UT WOS:000483427300017
PM 31243123
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, MMH
   Aguilar, EG
   Michailidis, E
   Pabon, J
   Park, P
   Wu, XF
   de Jong, YP
   Schneider, WM
   Molina, H
   Rice, CM
   MacDonald, MR
AF Li, Melody M. H.
   Aguilar, Eduardo G.
   Michailidis, Eleftherios
   Pabon, Jonathan
   Park, Paul
   Wu, Xianfang
   de Jong, Ype P.
   Schneider, William M.
   Molina, Henrik
   Rice, Charles M.
   MacDonald, Margaret R.
TI Characterization of Novel Splice Variants of Zinc Finger Antiviral
   Protein (ZAP)
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Ebola virus; PARP13; ZAP; alphavirus; alternative splice variants;
   hepatitis B virus; interferon
ID VIRAL MESSENGER-RNAS; ROSS RIVER VIRUS; CHIKUNGUNYA VIRUS; RIG-I; GENE;
   REPLICATION; ACTIVATION; INHIBITION; INFECTION; IDENTIFICATION
AB Given the unprecedented scale of the recent Ebola and Zika viral epidemics, it is crucial to understand the biology of host factors with broad antiviral action in order to develop novel therapeutic approaches. Here, we look into one such factor: zinc finger antiviral protein (ZAP) inhibits a variety of RNA and DNA viruses. Alternative splicing results in two isoforms that differ at their C termini: ZAPL (long) encodes a poly(ADP-ribose) polymerase (PARP)-like domain that is missing in ZAPS (short). Previously, it has been shown that ZAPL is more antiviral than ZAPS, while the latter is more induced by interferon (IFN). In this study, we discovered and confirmed the expression of two additional splice variants of human ZAP: ZAPXL (extralong) and ZAPM (medium). We also found two haplotypes of human ZAP. Since ZAPL and ZAPS have differential activities, we hypothesize that all four ZAP isoforms have evolved to mediate distinct antiviral and/or cellular functions. By taking a gene-knockout-and-reconstitution approach, we have characterized the antiviral, translational inhibition, and IFN activation activities of individual ZAP isoforms. Our work demonstrates that ZAPL and ZAPXL are more active against alphaviruses and hepatitis B virus (HBV) than ZAPS and ZAPM and elucidates the effects of splice variants on the action of a broad-spectrum antiviral factor.
   IMPORTANCE ZAP is an IFN-induced host factor that can inhibit a wide range of viruses, and there is great interest in fully characterizing its antiviral mechanism. This is the first study that defines the antiviral capacities of individual ZAP isoforms in the absence of endogenous ZAP expression and, hence, cross talk with other isoforms. Our data demonstrate that ZAP is expressed as four different forms: ZAPS, ZAPM, ZAPL, and ZAPXL. The longer ZAP isoforms better inhibit alphaviruses and HBV, while all isoforms equally inhibit Ebola virus transcription and replication. In addition, there is no difference in the abilities of ZAP isoforms to enhance the induction of type I IFN expression. Our results show that the full spectrum of ZAP activities can change depending on the virus target and the relative levels of basal expression and induction by IFN or infection.
C1 [Li, Melody M. H.; Aguilar, Eduardo G.; Michailidis, Eleftherios; Pabon, Jonathan; Park, Paul; Wu, Xianfang; de Jong, Ype P.; Schneider, William M.; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA.
   [de Jong, Ype P.] Weill Cornell Med, Div Gastroenterol & Lepatol, New York, NY USA.
   [Li, Melody M. H.] Univ Calif Los Angeles, David E Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
RP Li, MMH; MacDonald, MR (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.; Li, MMH (corresponding author), Univ Calif Los Angeles, David E Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
EM ManHingLi@mednet.ucla.edu; macdonm@rockefeller.edu
OI wu, xianfang/0000-0002-2995-935X; Michailidis,
   Eleftherios/0000-0002-9907-4346
FU Rockefeller University Women & Science postdoctoral fellowship; National
   Institutes of Health (NIH) fellowshipsUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [F31AI138409,
   F32DK107164, F32DK095666]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI091707,
   R01AI143295, R01AI114873]; Robertson Foundation
FX The work was supported in part by a Rockefeller University Women &
   Science postdoctoral fellowship (to M.M.H.L.); National Institutes of
   Health (NIH) fellowships F31AI138409 (to E.G.A.), F32DK107164 (to E.M.),
   and F32DK095666 (to W.M.S.); NIH supplement fellowship R01AI091707 (to
   J.P.); NIH grants R01AI091707 and R01AI143295 (to C.M.R.); NIH grant
   R01AI114873 (to M.R.M.); a Robertson Foundation grant (to E.M.); and
   anonymous donors.
CR Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X
   Baril M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003416
   Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107
   Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003
   Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x
   Bunkenborg J, 2010, PROTEOMICS, V10, P3040, DOI 10.1002/pmic.201000103
   Charron G, 2013, P NATL ACAD SCI USA, V110, P11085, DOI 10.1073/pnas.1302564110
   Chiu HP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007166
   Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297
   Doitsh G, 2004, MOL CELL BIOL, V24, P1799, DOI 10.1128/MCB.24.4.1799-1808.2004
   Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002
   Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004
   Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104
   Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963
   Honda M, 2000, GASTROENTEROLOGY, V118, P152, DOI 10.1016/S0016-5085(00)70424-0
   Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113
   Karki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037398
   Katoh M, 2003, INT J ONCOL, V23, P541
   Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009
   KUHN RJ, 1991, VIROLOGY, V182, P430, DOI 10.1016/0042-6822(91)90584-X
   Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011
   Law LMJ, 2010, J VIROL, V84, P4504, DOI 10.1128/JVI.02018-09
   Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110
   Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015
   Li MMH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006145
   Li MMH, 2015, TRENDS CELL BIOL, V25, P320, DOI 10.1016/j.tcb.2015.02.001
   Li M, 2015, ANTIVIR RES, V123, P50, DOI 10.1016/j.antiviral.2015.09.001
   Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113
   Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000
   Liu CH, 2015, P NATL ACAD SCI USA, V112, P14048, DOI 10.1073/pnas.1509745112
   Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06
   Muhlberger E, 1999, J VIROL, V73, P2333
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022
   Sun L, 2012, J BIOL CHEM, V287, P22882, DOI 10.1074/jbc.M111.306373
   Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039
   Wang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039159
   Zheng XJ, 2017, J VIROL, V91, DOI [10.1128/JVI.00088-17, 10.1128/jvi.00088-17]
   Zhu YP, 2012, EMBO J, V31, P4236, DOI 10.1038/emboj.2012.271
   Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108
NR 52
TC 4
Z9 4
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2019
VL 93
IS 18
AR e00715-19
DI 10.1128/JVI.00715-19
PG 17
WC Virology
SC Virology
GA IU2RK
UT WOS:000483427300019
PM 31118263
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Xu, H
   Cheng, M
   Chi, XJ
   Liu, XY
   Zhou, J
   Lin, TL
   Yang, W
AF Xu, Hua
   Cheng, Min
   Chi, Xiaojing
   Liu, Xiuying
   Zhou, Jia
   Lin, Tianli
   Yang, Wei
TI High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key
   Host Regulatory Factor in Zika Virus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE cytokine; MLK3; URMC-099; ZIKV
ID SMALL-MOLECULE INHIBITORS; BROAD-SPECTRUM; HUMAN BRAIN; ACTIVATION;
   DRUGS
AB The Zika virus (ZIKV) life cycle involves multiple steps and requires interactions with host factors. However, the inability to systematically identify host regulatory factors for ZIKV has hampered antiviral development and our understanding of pathogenicity. Here, using a bioactive compound library with 2,659 small molecules, we applied a high-throughput and imaging-based screen to identify host factors that modulate ZIKV infection. The screen yielded hundreds of hits that markedly inhibited or potentiated ZIKV infection in SNB-19 glioblastoma cells. Among the hits, URMC-099, a mixed-lineage kinase 3 (MLK3) inhibitor, significantly facilitated ZIKV replication in both SNB-19 cells and the neonatal mouse brain. Using gene silencing and overexpression, we further confirmed that MLK3 was a host restriction factor against ZIKV. Mechanistically, MLK3 negatively regulated ZIKV replication through induction of the inflammatory cytokines interleukin-6 (IL-6), IL-8, tumor necrosis factor alpha (TNF-alpha), and monocyte chemoattractant protein 1 (MCP-1) but did not modulate host interferon-related pathways. Importantly, ZIKV activated the MLK3/MKK7/Jun N-terminal protein kinase (JNK) pathway in both SNB-19 cells and neonatal mouse brain. Together, these findings reveal a critical role for MLK3 in regulating ZIKV infection and facilitate the development of anti-ZIKV therapeutics by providing a number of screening hits.
   IMPORTANCE Zika fever, an infectious disease caused by the Zika virus (ZIKV), normally results in mild symptoms. Severe infection can cause Guillain-Barre syndrome in adults and birth defects, including microcephaly, in newborns. Although ZIKV was first identified in Uganda in 1947 in rhesus monkeys, a widespread epidemic of ZIKV infection in South and Central America in 2015 and 2016 raised major concerns. To date, there is no vaccine or specific medicine for ZIKV. The significance of our research is the systematic discovery of small molecule candidates that modulate ZIKV infection, which will allow the development of antiviral therapeutics. In addition, we identified MLK3, a key mediator of host signaling pathways that can be activated during ZIKV infection and limits virus replication by inducing multiple inflammatory cytokines. These findings broaden our understanding of ZIKV pathogenesis.
C1 [Xu, Hua; Cheng, Min; Chi, Xiaojing; Liu, Xiuying; Zhou, Jia; Lin, Tianli; Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing, Peoples R China.
   [Xu, Hua; Cheng, Min; Chi, Xiaojing; Liu, Xiuying; Zhou, Jia; Lin, Tianli; Yang, Wei] Peking Union Med Coll, Beijing, Peoples R China.
RP Yang, W (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing, Peoples R China.; Yang, W (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.
EM wyang@ipb.pumc.edu.cn
RI Zhou, Jia/AAG-7370-2020
OI Xu, Hua/0000-0001-8470-5558
FU CAMS Initiative for Innovative Medicine [2016-I2M-3-020]; National Basic
   Research Program of ChinaNational Basic Research Program of China
   [2015CB554301]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81672030, 81871667]; National
   Science and Technology Major Project [2017ZX10304402-001-013]
FX This work was supported by the CAMS Initiative for Innovative Medicine
   (grant no. 2016-I2M-3-020), the National Basic Research Program of China
   (grant no. 2015CB554301), the National Natural Science Foundation of
   China (grant no. 81672030 and 81871667), and the National Science and
   Technology Major Project (grant no. 2017ZX10304402-001-013).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Desmet EA, 2010, VIROLOGY, V400, P224, DOI 10.1016/j.virol.2010.02.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Goodfellow VS, 2013, J MED CHEM, V56, P8032, DOI 10.1021/jm401094t
   Hartkamp J, 1999, CANCER RES, V59, P2195
   Hehner SP, 2000, MOL CELL BIOL, V20, P2556, DOI 10.1128/MCB.20.7.2556-2568.2000
   Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002
   Ibrahim SH, 2016, HEPATOLOGY, V63, P731, DOI 10.1002/hep.28252
   ING YL, 1994, ONCOGENE, V9, P1745
   Kant S, 2011, GENE DEV, V25, P2069, DOI 10.1101/gad.17224711
   Komatsu T, 2000, J VIROL, V74, P2477, DOI 10.1128/JVI.74.5.2477-2480.2000
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Li X, 2016, ANTIVIR RES, V131, P26, DOI 10.1016/j.antiviral.2016.04.006
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557
   MATTOLI S, 1992, CHEST, V101, pS27, DOI 10.1378/chest.101.3.27S
   McKenzie BA, 2015, NEURO-ONCOLOGY, V17, P1086, DOI 10.1093/neuonc/nou359
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morimoto K, 2011, J ALZHEIMERS DIS, V25, P59, DOI 10.3233/JAD-2011-101815
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sahu U, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.27
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shi WF, 2013, BRAZ J INFECT DIS, V17, P410, DOI 10.1016/j.bjid.2012.11.009
   Sun Yan, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1820
   Tang RX, 2012, WORLD J GASTROENTERO, V18, P1485, DOI 10.3748/wjg.v18.i13.1485
   Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 44
TC 1
Z9 1
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2019
VL 93
IS 18
AR e00758-19
DI 10.1128/JVI.00758-19
PG 16
WC Virology
SC Virology
GA IU2RK
UT WOS:000483427300020
PM 31270223
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Yau, WL
   Nguyen-Dinh, V
   Larsson, E
   Lindqvist, R
   Overby, AK
   Lundmark, R
AF Yau, Wai-Lok
   Van Nguyen-Dinh
   Larsson, Elin
   Lindqvist, Richard
   Overby, Anna K.
   Lundmark, Richard
TI Model System for the Formation of Tick-Borne Encephalitis Virus
   Replication Compartments without Viral RNA Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Flaviviridae; Flp-In cell line; NS4B; flavivirus; replication
   compartment; replication vesicles; tick-borne encephalitis virus
ID ZIKA VIRUS; 3-DIMENSIONAL ARCHITECTURE; PROTEIN; LOCALIZATION;
   CONSTRUCTION; ASSOCIATION; REPLICONS; INFECTION; VESICLES
AB Flavivirus is a positive-sense, single-stranded RNA viral genus, with members causing severe diseases in humans such as tick-borne encephalitis, yellow fever, and dengue fever. Flaviviruses are known to cause remodeling of intracellular membranes into small cavities, where replication of the viral RNA takes place. Nonstructural (NS) proteins are not part of the virus coat and are thought to participate in the formation of these viral replication compartments (RCs). Here, we used tick-borne encephalitis virus (TBEV) as a model for the flaviviruses and developed a stable human cell line in which the expression of NS proteins can be induced without viral RNA replication. The model system described provides a novel and benign tool for studies of the viral components under controlled expression levels. We show that the expression of six NS proteins is sufficient to induce infection-like dilation of the endoplasmic reticulum (ER) and the formation of RC-like membrane invaginations. The NS proteins form a membrane-associated complex in the ER, and electron tomography reveals that the dilated areas of the ER are closely associated with lipid droplets and mitochondria. We propose that the NS proteins drive the remodeling of ER membranes and that viral RNA, RNA replication, viral polymerase, and TBEV structural proteins are not required.
   IMPORTANCE TBEV infection causes a broad spectrum of symptoms, ranging from mild fever to severe encephalitis. Similar to other flaviviruses, TBEV exploits intracellular membranes to build RCs for viral replication. The viral NS proteins have been suggested to be involved in this process; however, the mechanism of RC formation and the roles of individual NS proteins remain unclear. To study how TBEV induces membrane remodeling, we developed an inducible stable cell system expressing the TBEV NS polyprotein in the absence of viral RNA replication. Using this system, we were able to reproduce RC-like vesicles that resembled the RCs formed in flavivirus-infected cells, in terms of morphology and size. This cell system is a robust tool to facilitate studies of flavivirus RC formation and is an ideal model for the screening of antiviral agents at a lower biosafety level.
C1 [Yau, Wai-Lok; Van Nguyen-Dinh; Lundmark, Richard] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.
   [Yau, Wai-Lok; Van Nguyen-Dinh; Lindqvist, Richard; Overby, Anna K.; Lundmark, Richard] Umea Univ, Mol Infect Med Sweden, Umea, Sweden.
   [Larsson, Elin; Lundmark, Richard] Umea Univ, Dept Integrat Med Biol, Umea, Sweden.
   [Lindqvist, Richard; Overby, Anna K.] Umea Univ, Dept Clin Microbiol, Sect Virol, Umea, Sweden.
   [Van Nguyen-Dinh] Philipps Univ Marburg, Inst Virol, Marburg, Germany.
RP Lundmark, R (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.; Lundmark, R (corresponding author), Umea Univ, Mol Infect Med Sweden, Umea, Sweden.; Lundmark, R (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.
EM richard.lundmark@umu.se
OI Lundmark, Richard/0000-0001-9104-724X; Overby Wernstedt,
   Anna/0000-0001-6553-0940
FU Swedish Research CouncilSwedish Research Council [Dnr 2017-04028, Dnr
   2018-05851, VR-RFI 2016-00968]; Umea Centre for Microbial Research;
   Laboratory for Molecular Infection Medicine Sweden
FX This work was supported by the Swedish Research Council (grants Dnr
   2017-04028 and Dnr 2018-05851), the Umea Centre for Microbial Research
   (W.-L. Yau and V. Nguyen-Dinh), and the Laboratory for Molecular
   Infection Medicine Sweden (A. K. Overby and R. Lundmark). The
   Biochemical Imaging Center Umea and the Umea Core Facility for Electron
   Microscopy received funding from the Swedish Research Council (grant
   VR-RFI 2016-00968).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561
   Asghar N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39265
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao XL, 2015, J VIROL, V89, P6184, DOI 10.1128/JVI.00401-15
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hoenninger VM, 2008, VIROLOGY, V377, P419, DOI 10.1016/j.virol.2008.04.035
   Hrnjakovic Cvjetkovic Ivana, 2016, Med Pregl, V69, P93
   Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003
   Kallio K, 2013, J VIROL, V87, P9125, DOI 10.1128/JVI.00660-13
   Kato F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050122
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Kummerer BM, 2018, ADV EXP MED BIOL, V1062, P165, DOI 10.1007/978-981-10-8727-1_12
   Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Lindquist L, 2014, HAND CLINIC, V123, P531, DOI 10.1016/B978-0-444-53488-0.00025-0
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Mackenzie JM, 2001, VIROLOGY, V279, P161, DOI 10.1006/viro.2000.0691
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miorin L, 2008, VIROLOGY, V379, P64, DOI 10.1016/j.virol.2008.06.025
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   NIEDRIG M, 1994, ACTA VIROL, V38, P141
   Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Panayiotou C, 2018, J VIROL, V92, DOI 10.1128/JVI.00501-18
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Senigl F, 2006, INTERVIROLOGY, V49, P239, DOI 10.1159/000091471
   Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365
   Spuul P, 2011, J VIROL, V85, P4739, DOI 10.1128/JVI.00085-11
   Wang JJ, 1997, VIROLOGY, V238, P30, DOI 10.1006/viro.1997.8791
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wigerius M, 2010, MOL CELL NEUROSCI, V44, P260, DOI 10.1016/j.mcn.2010.03.012
   Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368
   Yu L, 2017, VIROLOGY, V506, P130, DOI 10.1016/j.virol.2017.03.016
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 47
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2019
VL 93
IS 18
AR e00292-19
DI 10.1128/JVI.00292-19
PG 16
WC Virology
SC Virology
GA IU2RK
UT WOS:000483427300003
PM 31243132
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pezzi, M
   Zamberlan, F
   Chicca, M
   Leis, M
AF Pezzi, Marco
   Zamberlan, Francesco
   Chicca, Milvia
   Leis, Marilena
TI Evaluation of larvicidal activity of esters of 4-mercapto-2-butenoic
   acid against Aedes albopictus (Diptera: Culicidae)
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Mosquito; Larvicidal; Bioassay; Sulphur; Alkyl chain; Wittig synthesis
ID LEAF ESSENTIAL OILS; ZIKA VIRUS; WITTIG REACTION; COMPONENTS; SPREADS;
   AEGYPTI; SKUSE
AB Aedes albopictus (Skuse) (Diptera: Culicidae), an aggressive and annoying vector of several arbovirus including Chikungunya and Zika, is a serious health problem worldwide. Control of this mosquito is difficult because of high adaptability, egg resistance to dehydration and ability to exploit many man-made microhabitats. The most effective strategy appears the control of larval population. Based on previous data showing a larvicidal effect of plant extracts containing sulfhydryl and isothiocyanate compounds, we evaluated by bioassays the toxicity of three synthetic esters of 4-mercapto-2-butenoic acid on larvae of A. albopictus in comparison to cypermethrin. Among the compounds tested, the most effective was n-octyl 4-mercapto-2-butenoate, about 5 times more effective than ethyl 4-mercaptobut-2-enoate and about 20 times more effective than menthyl 4-mercaptobut-2-enoate. We advance the hypothesis that the larvicidal properties of n-octyl 4-mercapto-2-butenoate are due to its hydrophobic alkyl chain, longer than that of the other two compounds. This chain confers to the molecule the ability to spread on water surface and interfere with larval respiration. The larvicidal activity of n-octyl 4-mercapto-2-butenoate against A. albopictus appears interesting and may be developed after toxicological evaluation on vertebrates and humans, and environmental toxicity tests in compliance with WHO and ECDC rules. (C) 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Pezzi, Marco; Chicca, Milvia; Leis, Marilena] Univ Ferrara, Dept Life Sci & Biotechnol, Via Luigi Borsari 46, I-44121 Ferrara, Italy.
   [Zamberlan, Francesco] Univ Lincoln, Sch Chem, Lincoln LN6 7TS, England.
RP Pezzi, M (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Via Luigi Borsari 46, I-44121 Ferrara, Italy.
EM marco.pezzi@unife.it
RI Zamberlan, Francesco/F-2674-2014
OI Zamberlan, Francesco/0000-0003-1120-2276
FU Public Health Service of Region Emilia-Romagna [CTB-PROG-ZT-2016 AUSL
   Cesena]; Municipality of Ferrara [COFE2015]
FX The authors owe thanks to Dr. Giovanna Azzini and Dr. Michele Donegatti
   (University Library System, Ferrara) for valuable help in providing
   bibliographic references. The authors also thank the Centro Agricoltura
   Ambiente "Giorgio Nicoli" in Crevalcore (Bologna, Italy) for providing
   the mosquito eggs used in bioassays and Professor Simonetta Benetti for
   useful suggestions about the manuscript. This research was funded by the
   Public Health Service of Region Emilia-Romagna (CTB-PROG-ZT-2016 AUSL
   Cesena) and by the Municipality of Ferrara (COFE2015). The manuscript is
   dedicated to the loving memory of Mrs. Eugenia Dragoni.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   ADHAMI J, 1987, REV MJEKESORE, V1, P13
   Becker N., 1993, BACILLUS THURINGIENS, P146
   Benelli G, 2017, PARASITOL RES, V116, P1175, DOI 10.1007/s00436-017-5395-0
   Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P457, DOI 10.1016/j.biortech.2008.02.030
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318
   Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010
   ECDC WHO, 2007, MISS REP  CHIK IT JO, P1
   Estrada-Franco J. G., 1995, 42 PAHO, V42, P1
   European Centre for Disease Control and Prevention (ECDC), 2016, AED ALB CURR KNOWN D
   European Centre for Disease Control and Prevention (ECDC), 2016, RAP RISK ASS ZIK VIR, P1
   European Centre for Disease Control and Prevention (ECDC), 2012, TECHN REP GUID SURV, P1
   Favre H. A, 2014, NOM ORG CHEM IUPAC R
   Finney D.T., 1971, PROBIT ANAL
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   LeOraSoftware, 2002, POLO PC US GUID PROB
   Madon MB, 2002, J VECTOR ECOL, V27, P149
   Mitchell C. J., 1995, Parassitologia (Rome), V37, P109
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   POMMER H, 1977, ANGEW CHEM INT EDIT, V16, P423, DOI 10.1002/anie.197704233
   Rahuman AA, 2008, PARASITOL RES, V102, P981, DOI 10.1007/s00436-007-0864-5
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Robiette R, 2006, J AM CHEM SOC, V128, P2394, DOI 10.1021/ja056650q
   Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Skuse F. A. A., 1895, Indian Museum Notes, Viii, P20
   Tedeschi P, 2011, J ENVIRON SCI HEAL B, V46, P486, DOI 10.1080/03601234.2011.583868
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
NR 43
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD SEP
PY 2019
VL 26
IS 6
BP 1112
EP 1116
DI 10.1016/j.sjbs.2018.03.011
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA IU1WF
UT WOS:000483366900004
PM 31516337
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Werner, SL
   Banda, BK
   Burnsides, CL
   Stuber, AJ
AF Werner, Sandra Lee
   Banda, Bhanu Kirthi
   Burnsides, Christopher Lee
   Stuber, Alexander James
TI Zoonosis: Update on Existing and Emerging Vector-Borne Illnesses in the
   USA
SO CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS
LA English
DT Article
DE Zoonosis; Tick; Mosquito; Zika; Lyme; Vector-borne
ID ZIKA VIRUS-INFECTION; UNITED-STATES; SURVEILLANCE; TRANSMISSION;
   CHIKUNGUNYA; TULAREMIA; MOSQUITOS; DEATH; TIME; DOXYCYCLINE
AB Purpose of review This review describes mosquito- and tick-borne diseases found in the Western Hemisphere. It focuses on emerging diseases and recent geographic shifts in the presence of disease vectors. Recent Findings Mosquito and tick vectors have become more widespread as environmental conditions have become more favorable. Zika recently has emerged as a concern for fetal anomalies. West Nile Virus has become widespread. Lyme disease and other tick-borne diseases are more prevalent in areas previously inhospitable to these ticks. Healthcare providers must consider the possibility of mosquito- and tick-borne diseases in broader geographic areas and council patients traveling to endemic areas on precautions against these diseases. Treatment for suspected cases of serious tick-borne illnesses should not be delayed pending culture results.
C1 [Werner, Sandra Lee; Banda, Bhanu Kirthi; Burnsides, Christopher Lee; Stuber, Alexander James] Metrohlth Med Ctr, Dept Emergency Med, MetroHlth Cleveland Clin CWRU Emergency Med Resid, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.
RP Werner, SL (corresponding author), Metrohlth Med Ctr, Dept Emergency Med, MetroHlth Cleveland Clin CWRU Emergency Med Resid, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.
EM swerner@metrohealth.org; Bbanda1@metrohealth.org;
   Cburnsides1@metrohealth.org; astuber@metrohealth.org
CR Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   [Anonymous], 2018, CLIN LAB DIAGN ROCK
   [Anonymous], 2016, DIAGN MAN TICKB RICK
   [Anonymous], 2019, EP STAT ROCK MOUNT S
   [Anonymous], TULAREMIA
   [Anonymous], 2018, DIAGN TEST LYM DIS
   [Anonymous], 2019, PUBL HLTH OFF ROCK M
   Bakken JS, 2015, INFECT DIS CLIN N AM, V29, P341, DOI 10.1016/j.idc.2015.02.007
   Barbour AG, 2018, MICROBIOLOGY PATHOGE
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barton Behravesh C, 2015, AAP NEWS
   Beard C B, 2016, IMPACTS CLIMATE CHAN
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Biggs H, 2016, MORB MORTAL WKLY REP, V65
   Burkhalter KL, 2017, EMERG INFECT DIS, V23, P680, DOI 10.3201/eid2304.161772
   CDC, 2018, BABESIOSIS
   Cdc. gov, 2017, LYM DIS LYM DIS
   Centers for Disease Control, BOURB VIR
   Centers for Disease Control, HEARTL VIR
   Centers for Disease Control, POW VIR
   Centers for Disease Control, STARI LYM
   Centers for Disease Control, 2018, TICK BORN REL FEV
   Centers for Disease Control and Prevention, 2016, SEL TICKB DIS REP CD
   Centers for Disease Control and Prevention, AN
   Centers for Disease Control and Prevention, 2016, MMWR, V65
   Centers for Disease Control and Prevention, W NIL VIR STAT MAPS
   Centers for Disease Control and Prevention, 2018, W NIL VIR THER REV L
   Centres for Disease Control and Prevention, DENGUE
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chen J, 2015, MECH SYST SIGNAL PR, V64-65, P58, DOI 10.1016/j.ymssp.2015.02.027
   Cross R, 2016, EXPERT OPIN DRUG SAF, V15, P367, DOI 10.1517/14740338.2016.1133584
   De Leon SA, 2019, POSTGRAD MED, V131, P138, DOI 10.1080/00325481.2019.1558910
   Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763
   Dessau RB, 2018, CLIN MICROBIOL INFEC, V24, P118, DOI 10.1016/j.cmi.2017.08.025
   Diuk-Wasser MA, 2016, TRENDS PARASITOL, V32, P30, DOI 10.1016/j.pt.2015.09.008
   Domachowske J, 2019, INTRO CLIN INFECT DI
   Dora EG, 2019, VACCINE, V37, P3146, DOI 10.1016/j.vaccine.2019.04.069
   Dumic I, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/5719081
   Dworkin MS, 2008, INFECT DIS CLIN N AM, V22, P449, DOI 10.1016/j.idc.2008.03.006
   Eggo RM, 2018, EMERG INFECT DIS, V24, P127, DOI 10.3201/eid2401.170482
   Engel J, 2007, REVISION NATL SURVEI
   Fatmi SS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00342
   Feder HM, 2011, CLIN INFECT DIS, V53, pE142, DOI 10.1093/cid/cir553
   Fernandes JN, 2018, TRENDS PARASITOL, V34, P359, DOI 10.1016/j.pt.2018.01.005
   Fida M, 2018, OPEN FORUM INFECT DI, V5
   Frost HM, 2017, EMERG INFECT DIS, V23, P1384, DOI 10.3201/eid2308.161971
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   Guarner J, 2019, SEMIN DIAGN PATHOL, V36, P170, DOI 10.1053/j.semdp.2019.04.009
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Heitman KN, 2016, AM J TROP MED HYG, V94, P52, DOI 10.4269/ajtmh.15-0540
   Herwaldt BL, 2003, EMERG INFECT DIS, V9, P184
   Howard A, 2018, EMERG INFECT DIS, V24, P625, DOI 10.3201/eid2404.171545
   Hu L, 2018, LYME DIS SYMPTOMS DI
   Jones JM, 2015, MMWR-MORBID MORTAL W, V64, P651
   Kamal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210122
   Kendra JA, 2018, J BIOL CHEM, V293, P17536, DOI 10.1074/jbc.RA118.005606
   Kosoy OI, 2015, EMERG INFECT DIS, V21, P760, DOI 10.3201/eid2105.150150
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P1260, DOI 10.3201/eid2308.170479
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   KUEHN BM, 2018, JAMA-J AM MED ASSOC, V319, P332, DOI DOI 10.1001/JAMA.2017.20802
   Leeflang MMG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1468-4
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Liu LE, 2017, DISASTER MED PUBLIC, V11, P290, DOI 10.1017/dmp.2016.144
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Masters EJ, 2003, ARCH INTERN MED, V163, P769, DOI 10.1001/archinte.163.7.769
   Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013
   Moreno-Madrinan MJ, 2018, EMERG INFECT DIS, V24, P821, DOI 10.3201/eid2405.171609
   Muehlenbachs A, 2014, CLIN INFECT DIS, V59, P845, DOI 10.1093/cid/ciu434
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919
   Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125
   Nasserie T, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz028
   Nurnberger C, 2019, J VIROL, V93, DOI 10.1128/JVI.01485-18
   Patel K, 2018, CLIN INFECT DIS
   Pedati C, 2015, MMWR-MORBID MORTAL W, V64, DOI 10.15585/mmwr.mm6447a4
   Pena F, 2019, EMERG INFECT DIS, V25, P247, DOI 10.3201/eid2502.181054
   Penn RL, 2019, TULAREMIA CLIN MANIF
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Powers AM, 2010, HUNTERS TROPICAL MED
   Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714
   Regan JJ, 2015, CLIN INFECT DIS, V60, P1659, DOI 10.1093/cid/civ116
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Savage HM, 2016, J MED ENTOMOL, V53, P607, DOI 10.1093/jme/tjw028
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Sexton D, 2017, UPTODATE
   Sexton DJ, 2017, SO TICK ASS RASH ILL
   Sexton DJ, 2018, HUMAN EHRLICHIOSIS A
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Todd SR, 2015, J PEDIATR-US, V166, P1246, DOI 10.1016/j.jpeds.2015.02.015
   US Department of Health and Human Services Public Health Services Centers for Disease Control, 2013, W NIL VIR US GUID SU
   Wahnich A, 2018, EMERG INFECT DIS, V24, P827, DOI 10.3201/eid2405.170764
   Ward CE, 2018, PEDIATR EMERG CARE, V34, P510, DOI 10.1097/PEC.0000000000001529
   Ward SJ, 2018, TRANSFUSION, V58, P1916, DOI 10.1111/trf.14912
   Waterman SH, 2015, AM J TROP MED HYG, V92, P996, DOI 10.4269/ajtmh.14-0016
   World Health Organization, ZIK VIR FACT SHEET
   World Health Organization (WHO), 2017, VECT BORN DIS FACT S
   Wormser GP, 2005, CLIN INFECT DIS, V40, P423, DOI 10.1086/427289
   Yeung MW, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2637-9
   Zhan Y, 2019, VACCINE, V37, P2122, DOI 10.1016/j.vaccine.2019.02.063
   Zientek J, 2014, J PEDIATR-US, V164, P416, DOI 10.1016/j.jpeds.2013.10.008
   Zimmer A, 2018, BABESIOSIS
NR 109
TC 0
Z9 0
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2167-4884
J9 CURR EMERG HOSP ME R
JI Curr. Emerg. Hosp. Med. Rep.
PD SEP
PY 2019
VL 7
IS 3
BP 91
EP 106
DI 10.1007/s40138-019-00189-y
PG 16
WC Emergency Medicine
SC Emergency Medicine
GA IT5GD
UT WOS:000482889600006
PM 32288973
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Dimopoulos, G
AF Dimopoulos, George
TI Combining Sterile and Incompatible Insect Techniques for Aedes
   albopictus Suppression
SO TRENDS IN PARASITOLOGY
LA English
DT Editorial Material
ID ZIKA
AB Traditional control strategies are failing to contain Aedes albopictus as an emerging major vector for dengue. A combination of approaches (Zheng et al., Nature, 2019) involving an artificial triple Wolbachia superinfection and low dose irradiation enabled mass production of adult sterile males for release. The resulting suppression of field populations suggests feasibility for area-wide vector control.
C1 [Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
RP Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
EM gdrropo@ju.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI141532,
   R01AI122743, R21AI131574]; Bloomberg Philanthropies
FX G. D. was supported by National Institutes of Health grants R01AI141532,
   R01AI122743, and R21AI131574, and Bloomberg Philanthropies. We thank
   Deborah McClelland for editorial assistance.
CR Angelini P., 2008, Parassitologia (Rome), V50, P97
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Valle D, 2019, MEM I O CRUZ, V114
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
NR 8
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD SEP
PY 2019
VL 35
IS 9
BP 671
EP 673
DI 10.1016/j.pt.2019.07.006
PG 3
WC Parasitology
SC Parasitology
GA IT1OV
UT WOS:000482616500003
PM 31375435
DA 2020-07-08
ER

PT J
AU McDonald, EM
   Duggal, NK
   Delorey, MJ
   Oksanish, J
   Ritter, JM
   Brault, AC
AF McDonald, Erin M.
   Duggal, Nisha K.
   Delorey, Mark J.
   Oksanish, James
   Ritter, Jana M.
   Brault, Aaron C.
TI Duration of seminal Zika viral RNA shedding in immunocompetent mice
   inoculated with Asian and African genotype viruses
SO VIROLOGY
LA English
DT Article
DE Zika virus; Pathogenesis; Mouse model; Sexual transmission
ID SEXUAL TRANSMISSION; INFECTION; SEMEN; PROTECTION
AB Prior to the emergence of Asian genotype Zika virus (ZIKV) in the Western hemisphere, sexual transmission in humans was documented. Sexual transmission by African genotype ZIKVs has not been assessed in laboratory animal models, due to rapid and high mortality rates of immunodeficient mice following inoculation. To overcome these limitations, immunocompetent C5781/6 mice were used to longitudinally assess Asian and African genotype ZIKV sexual transmission potential. Furthermore, to determine if enhanced pathogenesis of African genotype ZIKVs is due to structural determinants, PRVABC59 prM/E was replaced with African MR766 prM/E (chimeric ZIKV). The African genotype and chimeric ZIKV elicited greater pathogenic effects in the male reproductive tract and generated higher viremias. Yet, the duration, magnitude and efficiency of seminal shedding of infectious virus and viral RNA were similar between chimeric-, African and Asian genotype ZIKV-inoculated mice. These data show that increased male reproductive tract pathology does not increase sexual transmission potential.
C1 [McDonald, Erin M.; Duggal, Nisha K.; Delorey, Mark J.; Oksanish, James; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Ritter, Jana M.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA.
   [Duggal, Nisha K.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
RP Brault, AC (corresponding author), 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM abrault@cdc.gov
OI Brault, Aaron/0000-0001-5801-3021
CR Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Clancy CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33528-2
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Diagne MM, 2017, ONE HEALTH-AMSTERDAM, V3, P23, DOI 10.1016/j.onehlt.2017.02.001
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   McDonald EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006691
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Palladino MA, 2007, BIOL REPROD, V76, P958, DOI 10.1095/biolreprod.106.059410
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Zanoni I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01661
   Zhu W., 1950, J IMMUNOL, V194, P4825, DOI [10.4049/j.immunol.1402706, DOI 10.4049/J.IMMUNOL.1402706]
NR 40
TC 0
Z9 0
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2019
VL 535
BP 1
EP 10
DI 10.1016/j.virol.2019.06.010
PG 10
WC Virology
SC Virology
GA IT6TJ
UT WOS:000483007400001
PM 31254742
OA Other Gold
DA 2020-07-08
ER

PT J
AU Chuong, C
   Bates, TA
   Weger-Lucarelli, J
AF Chuong, Christina
   Bates, Tyler A.
   Weger-Lucarelli, James
TI Infectious cDNA clones of two strains of Mayaro virus for studies on
   viral pathogenesis and vaccine development
SO VIROLOGY
LA English
DT Article
DE Alphavirus; Mayaro virus; Infectious clones
AB Mayaro virus (MAYV; family Togaviridae, genus Alphavirus) is an emerging global threat that can cause severe clinical manifestations similar to Zika, dengue, and chikungunya viruses. Currently, there is a lack of molecular tools to enable a better understanding of the transmission and pathogenesis of MAYV. Here, we detail the development and characterization of infectious clones of two strains of MAYV that produce infectious virus and replicate in mammalian and mosquito cells similarly to wild-type virus. Additionally, clone-derived viruses produced identical infection rates and phenotypes in CD-1 mice compared to the parental strains. This infectious clone system will provide a resource to the research community to analyze MAYV genetic determinants of virulence, determine vector competence, and develop vaccines.
C1 [Chuong, Christina; Bates, Tyler A.; Weger-Lucarelli, James] Virginia Tech, VA MD Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
RP Weger-Lucarelli, J (corresponding author), Virginia Tech, VA MD Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
EM weger@vt.edu
FU DARPA's PREventing EMerging Pathogenic Threats (PREEMPT) program
FX This work was partially supported by funding from DARPA's PREventing
   EMerging Pathogenic Threats (PREEMPT) program.
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Levi LI, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7050133
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Ryman KD, 2007, J VIROL, V81, P3563, DOI 10.1128/JVI.02494-06
   Steel JJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-356
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weger-Lucarelli J, 2016, J VIROL, V90, P2418, DOI 10.1128/JVI.02792-15
   Weger-Lucarelli J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004163
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
NR 14
TC 3
Z9 3
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2019
VL 535
BP 227
EP 231
DI 10.1016/j.virol.2019.07.013
PG 5
WC Virology
SC Virology
GA IT6TJ
UT WOS:000483007400023
PM 31325837
DA 2020-07-08
ER

PT J
AU Li, WJ
   Li, N
   Dai, SY
   Hou, GQ
   Guo, KL
   Chen, XZ
   Yi, CH
   Liu, WY
   Deng, F
   Wu, YS
   Cao, X
AF Li, Wenjiao
   Li, Ning
   Dai, Shiyu
   Hou, Guoqing
   Guo, Kanglin
   Chen, Xuanzuo
   Yi, Changhua
   Liu, Weiyong
   Deng, Fei
   Wu, Yaosong
   Cao, Xuan
TI Zika virus circumvents host innate immunity by targeting the adaptor
   proteins MAVS and MITA
SO FASEB JOURNAL
LA English
DT Article
DE ZIKV; immune evasion; IFN-beta
ID ANTIVIRAL SIGNALING PROTEIN; UBIQUITINATION; DEGRADATION; COMPLEX; GENES
AB Recently, Zika virus (ZIKV) has generated extraordinary concern because of its severe neurotoxicity. Disturbingly, there is no vaccine or specific drug to prevent or treat the diseases caused by ZIKV infection. Thus, it is extremely urgent to characterize the pathogenesis of ZIKV. It has been documented that ZIKV can evade antiviral responses of host cells. Here, we demonstrate that ZIKV strain SZ-WIV01 down-regulates the production of type I IFN and IFN-stimulated genes along with the expression of mitochondrial antiviral signaling protein (MAVS) and mediator of IFN regulatory factor 3 activation (MITA). In the mechanism, ZIKV nonstructural (NS) 3 and NS2B3 negatively regulate IFN-related retinoic acid-inducible gene I-like receptor signaling pathway by targeting MAVS and MITA, respectively. Overexpression of ZIKV NS3 and NS2B3 dramatically inhibits expression of IFN-beta. ZIKV NS3 interacts with MAVS, and NS2B3 interacts with MITA, which catalyzes K48-linked polyubiquitination of MAVS and MITA for degradation. Further investigations suggest that ZIKV NS2B3 impairs polyinosinic:polycytidylic acid-triggered K63-linked polyubiquitination of MITA, thereby subverting the activation of downstream sensors. Our study reveals an undiscovered mechanism for ZIKV to escape the innate immune response, providing new insights into clinical study of vaccines or effective drugs.-Li, W., Li, N., Dai, S., Hou, G., Guo, K., Chen, X., Yi, C., Liu, W., Deng, F., Wu, Y., Cao, X. Zika virus circumvents host innate immunity by targeting the adaptor proteins MAVS and MITA.
C1 [Li, Wenjiao; Hou, Guoqing; Guo, Kanglin; Chen, Xuanzuo; Cao, Xuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Hangkong Rd 13, Wuhan 430030, Hubei, Peoples R China.
   [Liu, Weiyong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Clin Lab, Wuhan, Hubei, Peoples R China.
   [Li, Ning; Wu, Yaosong] Henan Univ Tradit Chinese Med, Sch Basic Med, Inst Canc Mol Mech & Drug Targets, Zhengzhou, Henan, Peoples R China.
   [Dai, Shiyu; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.
   [Yi, Changhua] Chinese Acad Sci, State Key Lab Resp Dis, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.
RP Cao, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Hangkong Rd 13, Wuhan 430030, Hubei, Peoples R China.; Wu, YS (corresponding author), Henan Univ Tradit Chinese Med, Inst Canc Mol Mech & Drug Targets, Jinshuidong Rd 156, Zhengzhou 450046, Henan, Peoples R China.
EM 178028972@qq.com; caoxuanwhu@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31571431, 31771541, 81503490]; Natural Science
   Foundation of Hubei Province of ChinaNatural Science Foundation of Hubei
   Province [2016CFA053]; Intergovernmental Special Program of State Key
   Research and Development Plan from the Ministry of Science and
   Technology of China [2016YFE0113500]; National Mega Project on Major
   Infectious Diseases Prevention [2017ZX10103005-007]
FX The authors thank Dr. Hong-Bing Shu (Wuhan University, Wuhan, China) for
   providing the plasmid pRK-Flag-MITA/TBK1/IRF3/IRF3-5D and Dr. Hong-Bo
   Zhou (Huazhong Agricultural University, Wuhan, China) for providing the
   IFN-beta luciferase reporter plasmid (pIFN-beta-luci) and Renilla
   luciferase reporter plasmid (pRL-TK) as gifts. This work was supported
   by the National Natural Science Foundation of China (31571431, 31771541,
   81503490), the Natural Science Foundation of Hubei Province of China
   (2016CFA053), the Intergovernmental Special Program of State Key
   Research and Development Plan from the Ministry of Science and
   Technology of China (2016YFE0113500), and the National Mega Project on
   Major Infectious Diseases Prevention (2017ZX10103005-007). The authors
   declare no conflicts of interest.
CR Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923
   Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Ebner P, 2017, CRIT REV BIOCHEM MOL, V52, P425, DOI 10.1080/10409238.2017.1325829
   Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011
   Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Jin SH, 2017, MOL CELL, V68, P308, DOI 10.1016/j.molcel.2017.09.005
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102
   Liu BY, 2017, NAT IMMUNOL, V18, P214, DOI 10.1038/ni.3641
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Ma JZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01350
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Pan Y, 2014, J IMMUNOL, V192, P4758, DOI 10.4049/jimmunol.1302632
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753
   Sun H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15534
   Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith A., 2018, J TRAVEL MED, V25, P1, DOI DOI 10.1093/JTM/TAY057
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xing JJ, 2018, J IMMUNOL, V201, P183, DOI 10.4049/jimmunol.1701569
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhang HL, 2017, J VIROL, V91, DOI [10.1128/jvi.02396-16, 10.1128/JVI.02396-16]
   Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
   Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748
NR 50
TC 1
Z9 1
U1 1
U2 9
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD SEP
PY 2019
VL 33
IS 9
BP 9929
EP 9944
DI 10.1096/fj.201900260R
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA IS5TA
UT WOS:000482214200019
PM 31180720
OA Bronze
DA 2020-07-08
ER

PT J
AU Ebranati, E
   Veo, C
   Carta, V
   Percivalle, E
   Rovida, F
   Frati, ER
   Amendola, A
   Ciccozzi, M
   Tanzi, E
   Galli, M
   Baldanti, F
   Zehender, G
AF Ebranati, Erika
   Veo, Carla
   Carta, Valentina
   Percivalle, Elena
   Rovida, Francesca
   Frati, Elena Rosanna
   Amendola, Antonella
   Ciccozzi, Massimo
   Tanzi, Elisabetta
   Galli, Massimo
   Baldanti, Fausto
   Zehender, Gianguglielmo
TI Time-scaled phylogeography of complete Zika virus genomes using discrete
   and continuous space diffusion models
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Continuous phylogeography; Sourveillance; Phylodynamics
ID RIO-DE-JANEIRO; AEDES-AEGYPTI MOSQUITOS; MOSAIC STRUCTURE;
   RECOMBINATION; TRANSMISSION; EMERGENCE; OUTBREAK; HISTORY; DYNAMICS;
   PATIENT
AB Zika virus (ZIKV), a vector-borne infectious agent that has recently been associated with neurological diseases and congenital microcephaly, was first reported in the Western hemisphere in early 2015.
   A number of authors have reconstructed its epidemiological history using advanced phylogenetic approaches, and the majority of Zika phylogeography studies have used discrete diffusion models. Continuous space diffusion models make it possible to infer the possible origin of the virus in real space by reconstructing its ancestral location on the basis of geographical coordinates deduced from the latitude and longitude of the sampling locations. We analysed all the ZIKV complete genome isolates whose sampling times and localities were available in public databases at the time the study began, using a Bayesian approach for discrete and continuous phylogeographic reconstruction.
   The discrete phylogeographic analysis suggested that ZIKV emerged to become endemic/epidemic in the first decade of the 1900s in the Ugandan rainforests, and then reached Western Africa and Asia between the 1930s and 1950s. After a long period of about 40 years, it spread to the Pacific islands and reached Brazil from French Polynesia. Continuous phylogeography of the American epidemic showed that the virus entered in north-eastern Brazil in late 2012 and started to spread in early 2013 from two high probability regions: one corresponding to the entire north-east Brazil and the second surrounding the city of Rio de Janeiro, in a mainly northwesterly direction to Central America, the north-western countries of south America and the Caribbean islands. Our data suggest its cryptic circulation in both French Polynesia and Brazil, thus raising questions about the mechanisms underlying its undetected persistence in the absence of a known animal reservoir, and underline the importance of continuous diffusion models in making more reliable phylogeographic reconstructions of emerging viruses.
C1 [Ebranati, Erika; Veo, Carla; Carta, Valentina; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.
   [Ebranati, Erika; Veo, Carla; Frati, Elena Rosanna; Amendola, Antonella; Tanzi, Elisabetta; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, CRC Coordinated Res Ctr EpiSoMI, Milan, Italy.
   [Percivalle, Elena; Rovida, Francesca; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy.
   [Frati, Elena Rosanna; Amendola, Antonella; Tanzi, Elisabetta] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
RP Zehender, G (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.
EM gianguglielmo.zehender@unimi.it
RI Rovida, Francesca/K-7984-2016; Baldanti, Fausto/J-4924-2018; percivalle,
   elena/K-7994-2016
OI Rovida, Francesca/0000-0003-2345-2790; Baldanti,
   Fausto/0000-0002-3358-8969; percivalle, elena/0000-0002-3355-1410;
   Frati, Elena/0000-0001-7021-2525; VEO, CARLA/0000-0002-2724-5871
FU "NANOMAX" Bandiera project (2013-2015) - Italian Ministry for Education,
   University and Research [G42I12000180005]; Lombardy Region; Ministero
   della Salute, Ricerca Corrente Fondazione Istituto Di Ricovero e Cura a.
   Carattere Scientifico Policlinico San Matteo [80206]
FX This work was partially financed by the "NANOMAX" Bandiera project.;
   (2013-2015) funded by Italian Ministry for Education, University and
   Research (grant number G42I12000180005) to GZ.; This study was also
   partially supported by funds from Lombardy Region and grant from.; the
   Ministero della Salute, Ricerca Corrente Fondazione Istituto Di Ricovero
   e Cura a.; Carattere Scientifico Policlinico San Matteo, grant no. 80206
   to EP.
CR Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082
   Bloomquist EW, 2010, TRENDS ECOL EVOL, V25, P626, DOI 10.1016/j.tree.2010.08.010
   Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874
   Boskova V, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex044
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Calvez E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006637
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Han JF, 2016, J INFECTION, V73, P87, DOI 10.1016/j.jinf.2016.04.011
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lana RM, 2014, ACTA TROP, V129, P25, DOI 10.1016/j.actatropica.2013.07.025
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Liang D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176710
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin D. P., 2015, VIR EVOL, V1
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Moreira-Soto A., 2018, MSPHERE, V3
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Olawoyin O, 2018, INFECT DIS MODEL, V3, P331, DOI 10.1016/j.idm.2018.11.003
   Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   SMITH JM, 1992, J MOL EVOL, V34, P126
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zehender G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179679
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 61
TC 1
Z9 1
U1 3
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2019
VL 73
BP 33
EP 43
DI 10.1016/j.meegid.2019.04.006
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA IS3ZE
UT WOS:000482092100006
PM 30974264
DA 2020-07-08
ER

PT J
AU Munnink, BBO
   Kik, M
   de Bruijn, ND
   Kohl, R
   van der Linden, A
   Reusken, CBEM
   Koopmans, M
AF Munnink, B. B. Oude
   Kik, M.
   de Bruijn, N. D.
   Kohl, R.
   van der Linden, A.
   Reusken, C. B. E. M.
   Koopmans, M.
TI Towards high quality real-time whole genome sequencing during outbreaks
   using Usutu virus as example
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Nanopore; Sequencing; USUV; Arboviruses
ID STRAINS; ALGORITHM; ALIGNMENT; SEARCH
AB Recently, protocols for amplicon based whole genome sequencing using Nanopore technology have been described for Ebola virus, Zika virus, yellow fever virus and West Nile virus. However, there is some debate regarding reliability of sequencing using this technology, which is important for applications beyond diagnosis such as linking lineages to outbreaks, tracking transmission pathways and pockets of circulation, or mapping specific markers. To our knowledge, no in depth analyses of the required read coverage to compensate for the error profile in Nanopore sequencing have been described. Here, we describe the validation of a protocol for whole genome sequencing of USUV using Nanopore sequencing by direct comparison to Illumina sequencing. To that point we selected brain tissue samples with high viral loads, typical for birds which died from USUV infection. We conclude that the low-cost MinION Nanopore sequencing platform can be used for characterization and tracking of Usutu virus outbreaks.
C1 [Munnink, B. B. Oude; Kohl, R.; van der Linden, A.; Reusken, C. B. E. M.; Koopmans, M.] ErasmusMC, Dept Virosci, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Rotterdam, Netherlands.
   [Kik, M.] Univ Utrecht, Vet Pathol Ctr, Utrecht, Netherlands.
   [de Bruijn, N. D.] GD Anim Hlth, Deventer, Netherlands.
   [Reusken, C. B. E. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.
RP Koopmans, M (corresponding author), ErasmusMC, Dept Virosci, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Rotterdam, Netherlands.
EM m.koopmans@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312
FU European UnionEuropean Union (EU) [643476]; ZonMW Eco-Alert Project
FX This work has received funding from the European Union's Horizon 2020
   Research and Innovation Programme under grant agreement No. 643476
   (COMPARE) and by the ZonMW Eco-Alert Project.
CR Aberle SW, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.43.1800545
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Benson DA, 2010, NUCLEIC ACIDS RES, V38, pD46, DOI 10.1093/nar/gkp1024
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bushnell B., 2019, BBMAP DOWNLOAD
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Calzolari M, 2017, INFECT GENET EVOL, V51, P255, DOI 10.1016/j.meegid.2017.03.022
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Eiden M, 2018, INFECT GENET EVOL, V61, P151, DOI 10.1016/j.meegid.2018.03.020
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Faria NR, 2018, BIORXIV, DOI [10.1101/299842, DOI 10.1101/299842]
   Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Grubaugh N. D., 2007, AMPLICONBASED SEQUEN, DOI [10.1101/383513, DOI 10.1101/383513]
   Hargitai R, 2016, ARCH VIROL, V161, P1033, DOI 10.1007/s00705-015-2732-4
   Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133
   Hubalek Z, 2014, TRANSBOUND EMERG DIS, V61, P273, DOI 10.1111/tbed.12025
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lesho E., 2016, CHALLENGES IMPLEMENT, DOI [10.1371/journal.pone.0155770, DOI 10.1371/JOURNAL.PONE.0155770]
   Lightbody G, 2019, BRIEF BIOINFORM, V20, P1795, DOI 10.1093/bib/bby051
   Luhken R, 2017, EMERG INFECT DIS, V23, P1991, DOI 10.3201/eid2312.171257
   Magi A, 2017, BRIEF BIOINFORM, V18, P940, DOI 10.1093/bib/bbw077
   Nikolay B, 2014, J VIROL METHODS, V197, P51, DOI 10.1016/j.jviromet.2013.08.039
   Pauli G, 2014, TRANSFUS MED HEMOTH, V41, P73, DOI 10.1159/000357106
   PECORARI M, 2009, EURO SURVEILL, V14
   Qiu SF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13617
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rijks J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.45.30391
   Saiz J.C., 2017, VIRUS ADAPT TREAT, V9, P27, DOI [10.2147/VAAT.S123619, DOI 10.2147/VAAT.S123619]
   Siddle KJ, 2018, NEW ENGL J MED, V379, P1745, DOI 10.1056/NEJMoa1804498
   Sieg M, 2017, VECTOR-BORNE ZOONOT, V17, P662, DOI 10.1089/vbz.2016.2096
   Tamas B, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.72
   Van Nimwegen K. J. M., 2016, COST ANAL NEXT GENER, DOI [10.1373/clinchem.2016.258632, DOI 10.1373/CLINCHEM.2016.258632]
   Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205
   Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   WILLIAMS MC, 1964, ANN TROP MED PARASIT, V58, P367, DOI 10.1080/00034983.1964.11686258
NR 45
TC 2
Z9 2
U1 2
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2019
VL 73
BP 49
EP 54
DI 10.1016/j.meegid.2019.04.015
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA IS3ZE
UT WOS:000482092100008
PM 31014969
DA 2020-07-08
ER

PT J
AU Connery, AK
   Colbert, AM
   Lamb, MM
   Hernandez, S
   Martinez, MA
   Bauer, D
   Arroyave, P
   El Sahly, HM
   Paniagua-Avila, A
   Calvimontes, M
   Bolanos, GA
   Olson, D
   Asturias, EJ
   Munoz, FM
AF Connery, Amy K.
   Colbert, Alison M.
   Lamb, Molly M.
   Hernandez, Sara
   Martinez, Maria Alejandra
   Bauer, Desiree
   Arroyave, Paola
   El Sahly, Hana M.
   Paniagua-Avila, Alejandra
   Calvimontes, Mirella
   Bolanos, Guillermo Antonio
   Olson, Daniel
   Asturias, Edwin J.
   Munoz, Flor M.
TI Receptive language skills among young children in rural Guatemala: The
   relationship between the Test de Vocabulario en Imagenes Peabody and a
   translated and adapted version of the Mullen Scales of Early Learning
SO CHILD CARE HEALTH AND DEVELOPMENT
LA English
DT Article
DE assessment; development; Guatemala; language; young children
ID COGNITIVE-DEVELOPMENT; CHILDHOOD; GRADIENTS; POVERTY; WEALTH; HEALTH
AB Background Children in low- and lower middle income countries (LMICs) often have poorer language skills compared with children from high-income countries. Limited availability of culturally and linguistically appropriate assessment measures in LMICs, especially for young children, can hinder early identification and prevention efforts. Here, we describe receptive language (RL) skills among young children in rural Guatemala and report on the validity of a translated and culturally adapted developmental measure of RL. Methods Children (n = 157; m = 53.6 months, range = 42-68 months) enrolled in a prospective cohort study of postnatally acquired Zika virus infection were administered the Test de Vocabulario en Imagenes Peabody (TVIP) and the RL scale from a translated and adapted version of the Mullen Scales of Early Learning (MSEL). Performance on the TVIP was compared with the Latin American normative sample. Correlational analysis examined the relationship between performance on the TVIP and the MSEL-RL. Results Mean scores were significantly below the normative sample mean on the TVIP, t(126) = -11.04, p d = 1.00. Performance on the TVIP among children who passed the practice items (n = 127) was significantly positively associated with performance on the MSEL-RL (r = .50, p < .001), but not significantly associated with age or gender. Older age (p < .0001) and female gender (p = .018) were associated with passing the TVIP practice items. Conclusions Delays in RL vocabulary were identified among young children in rural Guatemala on the TVIP. The association between scores on the TVIP and the RL scale of the MSEL provides preliminary support for the construct validity of this translated and adapted version of the MSEL.
C1 [Connery, Amy K.; Colbert, Alison M.; Olson, Daniel; Asturias, Edwin J.] Childrens Hosp Colorado, Aurora, CO USA.
   [Connery, Amy K.; Colbert, Alison M.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA.
   [Lamb, Molly M.] Colorado Sch Publ Hlth, Ctr Global Hlth, Aurora, CO USA.
   [Lamb, Molly M.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA.
   [Hernandez, Sara; Martinez, Maria Alejandra; Bauer, Desiree; Arroyave, Paola; Paniagua-Avila, Alejandra; Calvimontes, Mirella; Bolanos, Guillermo Antonio] Fdn Salud Integral Guatemaltecos, Ctr Human Dev, Retalhuleu, Guatemala.
   [El Sahly, Hana M.; Munoz, Flor M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Olson, Daniel; Asturias, Edwin J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.
   [Munoz, Flor M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
RP Connery, AK (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Childrens Hosp Colorado, Aurora, CO 80309 USA.
EM amy.connery@childrenscolorado.org
OI Connery, Amy/0000-0002-8595-8167
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [HHSN272201300015I]
CR Asturias EJ, 2015, ADV PEDIATR, V63, P357
   Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293
   Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b
   Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7
   Bodeau-Livinec F, 2019, BRAIN RES BULL, V145, P129, DOI 10.1016/j.brainresbull.2018.04.001
   Boivin MJ, 2013, J PEDIATR-US, V163, P1409, DOI 10.1016/j.jpeds.2013.06.055
   Boivin MJ, 2009, PROG BRAIN RES, V178, P113, DOI 10.1016/S0079-6123(09)17808-1
   Bornman J, 2018, S AFR J COMMUN DISOR, V65, DOI 10.4102/sajcd.v65i1.571
   Bornman J, 2010, J POLICY PRACT INTEL, V7, P111, DOI 10.1111/j.1741-1130.2010.00254.x
   Cassepp-Borges V, 2010, INSTRUMENTACAO PSICO, P506
   Chernoff MC, 2018, J PEDIAT INF DIS-GER, V13, P185, DOI 10.1055/s-0038-1637020
   Connery AK, 2019, AM J TROP MED HYG, V100, P438, DOI 10.4269/ajtmh.18-0713
   Dunn L.M., 1986, TEST VOCABULARIO IMA
   Erkut S, 2010, CHILD DEV PERSPECT, V4, P19, DOI 10.1111/j.1750-8606.2009.00111.x
   Fernald LC, 2017, TOOLKIT MEASURING EA
   Fernald LCH, 2011, DEVELOPMENTAL SCI, V14, P832, DOI 10.1111/j.1467-7687.2010.01032.x
   Fischer VJ, 2014, J HEALTH POPUL NUTR, V32, P314
   Fryer RG, 2004, REV ECON STAT, V86, P447, DOI 10.1162/003465304323031049
   Gudmundsson E, 2009, NORD PSYCHOL, V61, P29, DOI 10.1027/1901-2276.61.2.29
   Hagan J. F., 2008, AM ACAD PEDIAT, V116, P241, DOI [10.1007/s00340-013-5682-0, DOI 10.1007/S00340-013-5682-0]
   Hamadani JD, 2014, PEDIATRICS, V134, pE1001, DOI 10.1542/peds.2014-0694
   Hambleton R.K., 2004, ADAPTING ED PSYCHOL, P3, DOI DOI 10.4324/9781410611758
   Hambleton RK, 1999, J APPL TEST TECHNOL, V53, P1689
   Heckman JJ, 2007, REV AGR ECON, V29, P446, DOI 10.1111/j.1467-9353.2007.00359.x
   Holding P, 2018, APPL NEUROPSYCH-CHIL, V7, P1, DOI 10.1080/21622965.2016.1206823
   Koura KG, 2013, J DEV BEHAV PEDIATR, V34, P486, DOI 10.1097/DBP.0b013e31829d211c
   McCoy DC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002034
   Mitchell JM, 2018, S AFR J PSYCHOL, V48, P434, DOI 10.1177/0081246317741822
   Mullen EM, 1995, MULLEN SCALES EARLY
   Nelson CA, 2015, TRENDS COGN SCI, V19, P424, DOI 10.1016/j.tics.2015.05.008
   Olson D, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx049
   Paxson C. H., 2005, ECUADOR ROLES WEALTH, DOI [10.2139/ssrn.753548, DOI 10.2139/SSRN.753548]
   Paxson C, 2007, J HUM RESOUR, V42, P49, DOI 10.3368/jhr.XLII.1.49
   Pena ED, 2007, CHILD DEV, V78, P1255, DOI 10.1111/j.1467-8624.2007.01064.x
   Pitt MB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3939
   Romski M, 2018, AM J SPEECH-LANG PAT, V27, P602, DOI 10.1044/2017_AJSLP-17-0035
   Rubio-Codina M, 2015, J HUM RESOUR, V50, P464, DOI 10.3368/jhr.50.2.464
   Schady N, 2015, J HUM RESOUR, V50, P446, DOI 10.3368/jhr.50.2.446
   Segretin MS, 2016, NEW DIR CHILD ADOLES, V152, P9, DOI 10.1002/cad.20162
   Van de Vijver F., 2005, ADAPTING ED PSYCHOL, P51, DOI [10.4324/9781410611758, DOI 10.4324/9781410611758]
   Weber A, 2017, CHILD DEV, V88, P1513, DOI 10.1111/cdev.12882
   Wehby GL, 2013, SOC SCI MED, V78, P86, DOI 10.1016/j.socscimed.2012.11.038
NR 42
TC 1
Z9 1
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1862
EI 1365-2214
J9 CHILD CARE HLTH DEV
JI Child Care Health Dev.
PD SEP
PY 2019
VL 45
IS 5
BP 702
EP 708
DI 10.1111/cch.12702
PG 7
WC Psychology, Developmental; Pediatrics
SC Psychology; Pediatrics
GA IR5BS
UT WOS:000481448600011
PM 31270836
DA 2020-07-08
ER

PT J
AU Dinh, TC
   Bac, ND
   Minh, LB
   Ngoc, VTN
   Pham, VH
   Vo, HL
   Tien, NLB
   Thanh, VV
   Tao, Y
   Show, PL
   Chu, DT
AF Thien Chu Dinh
   Nguyen Duy Bac
   Le Bui Minh
   Vo Truong Nhu Ngoc
   Van-Huy Pham
   Hoang-Long Vo
   Nguyen Le Bao Tien
   Vo Van Thanh
   Tao, Yang
   Show, Pau Loke
   Dinh-Toi Chu
TI Zika virus in Vietnam, Laos, and Cambodia: are there health risks for
   travelers?
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus infection; Travelers; Zika virus-infected travelers; Vietnam;
   Laos; Cambodia
ID DENGUE VIRUS; INFECTION; ENHANCEMENT; EPIDEMIOLOGY; DIAGNOSTICS;
   DISEASE; STRAIN
AB Vietnam, Laos, and Cambodia have reported first cases of Zika virus (ZIKV) infection since 2010 (Cambodia) and 2016 (Vietnam and Laos). One case of ZIKV-related microcephaly was recognized among a hundred infected cases in these areas, raising a great concern about the health risk related to this virus infection. At least 5 cases of ZIKV infection among travelers to Vietnam, Laos, and Cambodia were recorded. It is noticeable that ZIKV in these areas can cause birth defects. This work aims to discuss the current epidemics of ZIKV in Vietnam, Laos, and Cambodia and update the infection risk of ZIKV for travelers to these areas.
C1 [Thien Chu Dinh] Duy Tan Univ, Inst Res & Dev, 03 QuangTrung, Danang, Vietnam.
   [Nguyen Duy Bac] Vietnam Mil Med Univ, Hanoi, Vietnam.
   [Le Bui Minh] Nguyen Tat Thanh Univ, NTT Hitech Inst, 300A Nguyen Tat Thanh St,Ward 13,Dist 4, Ho Chi Minh City, Vietnam.
   [Vo Truong Nhu Ngoc; Dinh-Toi Chu] Hanoi Med Univ, Sch Odonto Stomatol, Hanoi, Vietnam.
   [Van-Huy Pham] Ton Duc Thang Univ, Fac Informat Technol, AI Lab, Ho Chi Minh City, Vietnam.
   [Hoang-Long Vo] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.
   [Nguyen Le Bao Tien; Vo Van Thanh] Viet Duc Hosp, Inst Orthopaed & Trauma Surg, Hanoi, Vietnam.
   [Tao, Yang] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095 8, Jiangsu, Peoples R China.
   [Show, Pau Loke] Univ Nottingham Malaysia Campus, Fac Engn, Dept Chem & Environm Engn, JalanBroga, Semenyih 43500, Selangor Darul, Malaysia.
   [Dinh-Toi Chu] Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam.
RP Chu, DT (corresponding author), Hanoi Med Univ, Sch Odonto Stomatol, Hanoi, Vietnam.; Pham, VH (corresponding author), Ton Duc Thang Univ, Fac Informat Technol, AI Lab, Ho Chi Minh City, Vietnam.; Chu, DT (corresponding author), Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam.
EM phamvanhuy@tdtu.edu.vn; chudinhtoi.hnue@gmail.com
RI Pham, Van-Huy/D-1474-2019; Show, Pau Loke/A-7953-2015; Vo,
   Hoang-Long/R-1975-2019; Chu, Dinh Toi/I-7414-2019
OI Pham, Van-Huy/0000-0001-9907-4066; Show, Pau Loke/0000-0002-0913-5409;
   Vo, Hoang-Long/0000-0001-5992-875X; Chu, Dinh Toi/0000-0002-4596-2022
CR [Anonymous], 2016, VECT CONTR OP FRAM Z
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cambodia Ministry of tourism, 2016, TOUR STAT REP YEAR 2
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Chu DT, 2017, EUR J CLIN MICROBIOL, V36, P2041, DOI 10.1007/s10096-017-3030-8
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Goorhuis A, 2016, LANCET INFECT DIS, V16, P1204, DOI 10.1016/S1473-3099(16)30316-4
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003575
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Silva JVJ, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759021, 10.1590/s1678-9946201759021]
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Khongwichit S, 2018, ZIKA VIRUS THAILAND
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lan Phan Trong, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Ministry of Information CaT Tourism Development Department, 2016, STAT REP TOUR LAOS 2
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   ProMED- mail, 2019, PROMED MAIL
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Vietnam General Statistics Office, 2016, INT TRAV VIETN DEC W
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, 2018, ZIK VIR COMPL QUEST
   WHO, 2018, ZIK VIR
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 55
TC 3
Z9 3
U1 3
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD SEP
PY 2019
VL 38
IS 9
BP 1585
EP 1590
DI 10.1007/s10096-019-03563-6
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IR9IQ
UT WOS:000481757500002
PM 31044332
DA 2020-07-08
ER

PT J
AU Henrique, MO
   Neto, LS
   Assis, JB
   Barros, MS
   Capurro, ML
   Lepique, AP
   Fonseca, DM
   Sa-Nunes, A
AF Henrique, Maressa O.
   Neto, Leila S.
   Assis, Josiane B.
   Barros, Michele S.
   Capurro, Margareth L.
   Lepique, Ana P.
   Fonseca, Denise M.
   Sa-Nunes, Anderson
TI Evaluation of inflammatory skin infiltrate following Aedes aegypti bites
   in sensitized and non-sensitized mice reveals saliva-dependent and
   immune-dependent phenotypes
SO IMMUNOLOGY
LA English
DT Article
DE Aedes aegypti; eosinophils; IL-5; inflammation; mosquito bites; saliva
ID DELAYED-TYPE HYPERSENSITIVITY; YELLOW-FEVER MOSQUITO;
   TUMOR-NECROSIS-FACTOR; BALB/C MICE; MOUSE MODEL; GUINEA-PIGS; ZIKA
   VIRUS; B-CELLS; RESPONSES; FLOW
AB During probing and blood feeding, haematophagous mosquitoes inoculate a mixture of salivary molecules into their vertebrate hosts' skin. In addition to the anti-haemostatic and immunomodulatory activities, mosquito saliva also triggers acute inflammatory reactions, especially in sensitized hosts. Here, we characterize the oedema and the cellular infiltrate following Aedes aegypti mosquito bites in the skin of sensitized and non-sensitized BALB/c mice by flow cytometry. Ae. aegypti bites induced an increased oedema in the ears of both non-sensitized and salivary gland extract- (SGE-)sensitized mice, peaking at 6 hr and 24 hr after exposure, respectively. The quantification of the total cell number in the ears revealed that the cellular recruitment was more robust in SGE-sensitized mice than in non-sensitized mice, and the histological evaluation confirmed these findings. The immunophenotyping performed by flow cytometry revealed that mosquito bites were able to produce complex changes in cell populations present in the ears of non-sensitized and SGE-sensitized mice. When compared with steady-state ears, the leucocyte populations significantly recruited to the skin after mosquito bites in non-sensitized and sensitized mice were eosinophils, neutrophils, monocytes, inflammatory monocytes, mast cells, B-cells and CD4(+) T-cells, each one with its specific kinetics. The changes in the absolute number of cells suggested two cell recruitment profiles: (i) a saliva-dependent migration; and (ii) a migration dependent on the immune status of the host. These findings suggest that mosquito bites influence the skin microenvironment by inducing differential cell migration, which is dependent on the degree of host sensitization to salivary molecules.
C1 [Henrique, Maressa O.; Neto, Leila S.; Assis, Josiane B.; Barros, Michele S.; Sa-Nunes, Anderson] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunol Expt, BR-05508900 Sao Paulo, SP, Brazil.
   [Capurro, Margareth L.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Lab Mosquitos Geneticamente Modificados, Sao Paulo, SP, Brazil.
   [Capurro, Margareth L.; Sa-Nunes, Anderson] Conselho Nacl Desenvolvimento Cient & Tecnol INCT, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil.
   [Lepique, Ana P.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunomodulacao, Sao Paulo, SP, Brazil.
   [Fonseca, Denise M.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunol Mucosas, BR-05508900 Sao Paulo, SP, Brazil.
RP Fonseca, DM; Sa-Nunes, A (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunol Expt, BR-05508900 Sao Paulo, SP, Brazil.; Fonseca, DM; Sa-Nunes, A (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Lab Imunol Mucosas, BR-05508900 Sao Paulo, SP, Brazil.
EM denisefonseca@usp.br; sanunes@usp.br
RI Sa-Nunes, Anderson/D-8667-2012
OI Sa-Nunes, Anderson/0000-0002-1859-4973; Henrique, Maressa de
   Oliveira/0000-0001-7914-3116
CR Abdel-Hamid Yousrya M., 2006, Journal of the Egyptian Society of Parasitology, V36, P937
   Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]
   Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594
   Anderson JM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01784
   Ashraf MI, 2015, CYTOKINE, V76, P375, DOI 10.1016/j.cyto.2015.09.013
   ASKENASE PW, 1983, J IMMUNOL, V131, P2687
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barros MS, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3487-7
   Barros MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155454
   Belkaid Y, 2000, P NATL ACAD SCI USA, V97, P6704, DOI 10.1073/pnas.97.12.6704
   Belkaid Y, 1996, J IMMUNOL METHODS, V199, P5, DOI 10.1016/S0022-1759(96)00117-2
   Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441
   BISSONNETTE EY, 1993, PARASITE IMMUNOL, V15, P27, DOI 10.1111/j.1365-3024.1993.tb00569.x
   Bizzarro B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-329
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bos J, 2004, SKIN IMMUNE SYSTEM C, P840
   Bosio CF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003196
   BOWLES VM, 1992, VET PARASITOL, V44, P151, DOI 10.1016/0304-4017(92)90153-Z
   BOYCOTT A. E., 1928, UNIV COLL HOSPITAL MAG [LONDON], V13, P200
   BROWN SJ, 1980, EXP PARASITOL, V49, P303, DOI 10.1016/0014-4894(80)90067-3
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Calvo E, 2007, J BIOL CHEM, V282, P2051
   Calvo E, 2011, J BIOL CHEM, V286, P27998, DOI 10.1074/jbc.M111.247924
   Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106
   Castelli E, 2008, AM J DERMATOPATH, V30, P241, DOI 10.1097/DAD.0b013e3181676b60
   CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138
   CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694
   Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177
   Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955
   Christophers SR, 1960, AEDES AEGYPTI L YELL
   Cochez PM, 2016, EUR J IMMUNOL, V46, P1449, DOI 10.1002/eji.201546070
   Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932
   Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   ECDC, 2016, AED AEG FACTSH EXP, P10
   Egbuniwe LU, 2015, TRENDS IMMUNOL, V36, P102, DOI 10.1016/j.it.2014.12.006
   Engler R J, 2001, Curr Opin Allergy Clin Immunol, V1, P349
   FEINGOLD BF, 1968, ANNU REV ENTOMOL, V13, P137, DOI 10.1146/annurev.en.13.010168.001033
   Fettelschoss-Gabriel A, 2018, J ALLERGY CLIN IMMUN, V142, P1194, DOI 10.1016/j.jaci.2018.01.041
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   FRENCH FE, 1972, EXP PARASITOL, V32, P175, DOI 10.1016/0014-4894(72)90022-7
   FRENCH FE, 1971, J PARASITOL, V57, P396, DOI 10.2307/3278051
   GOLDMAN L, 1952, AM J TROP MED HYG, V1, P514, DOI 10.4269/ajtmh.1952.1.514
   Gordon R. M., 1922, Annals of Tropical Medicine and Parasitology, V16, P229
   GROSS TL, 1985, VET PATHOL, V22, P78, DOI 10.1177/030098588502200112
   Harbach R, 2018, MOSQUITO TAXONOMIC I, P16
   Harbach Ralph E., 2007, European Mosquito Bulletin, V23, P1
   Harbach RE, 2007, ZOOTAXA, P591
   HUDSON A, 1960, SCIENCE, V131, P1730, DOI 10.1126/science.131.3415.1730
   JAMES AA, 1991, PARASITOL TODAY, V7, P267, DOI 10.1016/0169-4758(91)90092-3
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   JOHNSTON CM, 1985, INT J PARASITOL, V15, P621, DOI 10.1016/0020-7519(85)90007-4
   Karppinen A, 1996, CLIN EXP ALLERGY, V26, P703, DOI 10.1111/j.1365-2222.1996.tb00597.x
   Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802
   KILLBY VA, 1967, AM J TROP MED HYG, V16, P374, DOI 10.4269/ajtmh.1967.16.374
   KRINSKY WL, 1982, EXP PARASITOL, V53, P381, DOI 10.1016/0014-4894(82)90081-9
   Kulthanan K, 2010, J DERMATOL, V37, P1025, DOI 10.1111/j.1346-8138.2010.00958.x
   Kvistborg P, 2015, IMMUNITY, V42, P591, DOI 10.1016/j.immuni.2015.04.006
   LARRIVEE DH, 1964, EXP PARASITOL, V15, P491, DOI 10.1016/0014-4894(64)90042-6
   Lin HL, 2009, J FORMOS MED ASSOC, V108, P964, DOI 10.1016/S0929-6646(10)60010-1
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003
   Maciel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110551
   MBOW ML, 1994, IMMUNOLOGY, V82, P596
   McKIEL J. A., 1959, Canadian Journal of Zoology, V37, P341, DOI 10.1139/z59-038
   MELLANBY K, 1946, NATURE, V158, P554, DOI 10.1038/158554c0
   Moon PD, 2016, INT IMMUNOPHARMACOL, V38, P420, DOI 10.1016/j.intimp.2016.06.019
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622
   Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646
   Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P498, DOI 10.1016/S0091-6749(98)70357-4
   Peng ZK, 2002, J ALLERGY CLIN IMMUN, V110, P816, DOI 10.1067/mai.2002.128736
   Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Pohin M, 2016, EUR J IMMUNOL, V46, P1737, DOI 10.1002/eji.201546216
   Rathore APS, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180087
   REUNALA T, 1994, ANN MED, V26, P301, DOI 10.3109/07853899409147906
   RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335
   Robbertse L, 2018, TICKS TICK-BORNE DIS, V9, P976, DOI 10.1016/j.ttbdis.2018.03.034
   ROCKWELL EM, 1952, J INVEST DERMATOL, V19, P137, DOI 10.1038/jid.1952.78
   Rogerio AP, 2010, PHARMACOL RES, V62, P298, DOI 10.1016/j.phrs.2010.04.005
   Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56
   Sales-Campos H, 2015, INT IMMUNOPHARMACOL, V26, P13, DOI 10.1016/j.intimp.2015.03.002
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171
   Schneider BS, 2011, VECTOR-BORNE ZOONOT, V11, P423, DOI 10.1089/vbz.2010.0120
   Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857
   Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94
   Simons FER, 1999, J ALLERGY CLIN IMMUN, V104, P705, DOI 10.1016/S0091-6749(99)70348-9
   STREILEIN JW, 1983, J INVEST DERMATOL, V80, pS12, DOI 10.1111/1523-1747.ep12536743
   TATCHELL RJ, 1970, SCIENCE, V167, P1002, DOI 10.1126/science.167.3920.1002
   Teixeira C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002781
   Watanabe RMO, 2010, BIOCHIMIE, V92, P933, DOI 10.1016/j.biochi.2010.03.024
   Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030
   WILSON AB, 1965, INT ARCH ALLER A IMM, V26, P294, DOI 10.1159/000229580
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 96
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD SEP
PY 2019
VL 158
IS 1
BP 47
EP 59
DI 10.1111/imm.13096
PG 13
WC Immunology
SC Immunology
GA IS0CW
UT WOS:000481815800005
PM 31315156
OA Bronze
DA 2020-07-08
ER

PT J
AU Venturi, G
   Fortuna, C
   Alves, RM
   Paschoal, AGPD
   da Silva, PJ
   Remoli, ME
   Benedetti, E
   Amendola, A
   Batista, ED
   Gama, DVN
   Barros, DH
   Fiorentini, C
   Rezza, G
   Chagas, JRLP
AF Venturi, Giulietta
   Fortuna, Claudia
   Alves, Rita Maria
   Passos do Prado Paschoal, Ana Gabriela
   da Silva Junior, Pedro Jose
   Remoli, Maria Elena
   Benedetti, Eleonora
   Amendola, Antonello
   Batista, Everton da Silva
   Novais Gama, Deijamile Virginia
   Barros, Davi Hasselmann
   Fiorentini, Cristiano
   Rezza, Giovanni
   Leite Primo Chagas, Janeusa Rita
TI Epidemiological and clinical suspicion of congenital Zika virus
   infection: Serological findings in mothers and children from Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE congenital infection; diagnosis; flavivirus; microcephaly;
   neutralization test; serological tests
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; CROSS-REACTIVITY;
   PREGNANT-WOMEN; DENGUE VIRUS; OUTBREAK; CHIKUNGUNYA; INFANTS; BLOOD;
   PATHOGENESIS
AB The emergence of Zika virus in the Americas has caused an increase of babies born with microcephaly or other neurological malformations. The differential diagnosis of Zika infection, particularly serological diagnosis, is an important but complex issue. In this study, we describe clinical manifestations of 94 suspected cases of congenital Zika from Bahia state, Brazil, and the results of serological tests performed on children and/or their mothers at an average of 71 days after birth. Anti-Zika immunoglobulin M (IgM) antibodies were detected in 44.4% and in 7.1% of samples from mothers and children, respectively. Nearly all the IgM, and 92% of immunoglobulin G positive results were confirmed by neutralization test. Zika specific neutralizing antibodies were detected in as much as 90.4% of the cases. Moreover, dengue specific neutralizing antibodies were detected in 79.0% of Zika seropositive mothers. In conclusion, Zika IgM negative results should be considered with caution, due to a possible rapid loss of sensitivity after birth, while the NS1-based Zika IgM enzyme-linked immunosorbent assay test we have used has demonstrated to be highly specific. In a high percentage of cases, Zika specific neutralizing antibodies were detected, which are indicative of a past Zika infection, probably occurred during pregnancy in this population.
C1 [Venturi, Giulietta; Fortuna, Claudia; Remoli, Maria Elena; Benedetti, Eleonora; Amendola, Antonello; Fiorentini, Cristiano; Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Alves, Rita Maria; Passos do Prado Paschoal, Ana Gabriela; Novais Gama, Deijamile Virginia; Leite Primo Chagas, Janeusa Rita] S Antonio Obras Sociais Irma Dulce Hosp HSA OSID, Pediat Neurol Serv, Salvador, BA, Brazil.
   [da Silva Junior, Pedro Jose; Batista, Everton da Silva; Barros, Davi Hasselmann; Leite Primo Chagas, Janeusa Rita] Univ Salvador UNIFACS, Neurol Pediat, Salvador, BA, Brazil.
RP Venturi, G (corresponding author), Ist Super Sanita, Dept Infect Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
EM giulietta.venturi@iss.it
RI Venturi, Giulietta/O-8123-2015
OI Venturi, Giulietta/0000-0002-9078-8350
FU DIAPRO
FX We thank Dr Isadora Cristina de Siqueira, researcher from Advanced
   Public Health laboratory (Laboratorio Avancado de Saude Publica-LASP),
   FIOCRUZ-Bahia, Brazil, who contributed storing the sample specimens. We
   thank the Lecca family, Cagliari, Italy, for their generous contribution
   to the expenses for the shipping of samples. We thank DIAPRO for
   financial support, through the provision of ELISA kits. We thank Dr
   Andrea Cara, Istituto Superiore di Sanita, for making this
   Brazilian-Italian collaboration possible and scientific support.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso C.W., 2017, PLOS NEGLECT TROP D, V11, P1
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Centers for Disease Control and Prevention, ZIK VIR DIS ZIK VIR
   Centers for Disease Control and Prevention, 2016, CDC CONCL ZIK CAUS M
   Centers for Disease Control and Prevention, 2018, MICR OTH BIRTH DEF
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fortuna C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2320-1
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   INTERGROWTH-21st, 2015, INTERGROWTH 21 NEWB
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005262
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004
   Portal do Governo Brasileiro, 2017, SIST INF NASC VIV SI
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 58
TC 0
Z9 0
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2019
VL 91
IS 9
BP 1577
EP 1583
DI 10.1002/jmv.25504
PG 7
WC Virology
SC Virology
GA IR5CL
UT WOS:000481450500001
PM 31090222
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Islam, MS
   Khan, MAAK
   Murad, MW
   Karim, M
   Islam, AMMK
AF Islam, Md Sajedul
   Khan, Md Abdullah-Al-Kamran
   Murad, Md Wahid
   Karim, Marwah
   Islam, Abul Bashar Mir Md Khademul
TI In silico analysis revealed Zika virus miRNAs associated with viral
   pathogenesis through alteration of host genes involved in immune
   response and neurological functions
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE functional annotation; immune response; miRNA; neurological functions;
   pathogenesis; Zika virus
ID MICRORNA; PREDICTION; OUTBREAK; SYSTEM
AB Background The concurrent Zika Virus (ZIKV) outbreaks in the United States and Northeast Brazil have evoked global surveillance. Zika infection has been correlated with severe clinical symptoms, such as microcephaly, Guillain-Barre syndrome, and other congenital brain abnormalities. Recent data suggest that ZIKV predominantly targets neural progenitor cells leading to neurological impairment. Despite the clinical evidence, detailed experimental mechanism of ZIKV neurotropic pathogenesis has not been fully understood yet. Here we hypothesized that ZIKV produces miRNAs, which target essential host genes involved in various cellular pathways facilitating their survival through immune evasion and progression of disease during brain development. Methods From genome sequence information using several bioinformatic tools, we predicted pri-miRNAs, pre-miRNAs, and finally the mature miRNAs produced by ZIKV. We also identified their target genes and performed functional enrichment analysis to identify the biological processes associated with these genes. Finally, we analyzed a publicly available RNA-seq data set to determine the altered expression level of the targeted genes. Results From ZIKV genome sequence, we identified and validated 47 putative novel miRNAs. Functional enrichment of the targeted genes demonstrates the involvement of various biological pathways regulating cellular signaling, neurological functions, cancer, and fetal development. The expression analysis of these genes showed that ZIKV-produced miRNAs downregulate the key genes involved in these pathways, which in turn may lead to impaired brain development. Conclusions Our finding proposes novel ZIKV miRNAs and their targets, which upon experimental validation could help developing new therapeutics to combat ZIKV infection and minimize ZIKV-mediated pathologies.
C1 [Islam, Md Sajedul; Khan, Md Abdullah-Al-Kamran; Murad, Md Wahid; Karim, Marwah; Islam, Abul Bashar Mir Md Khademul] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh.
RP Islam, AMMK (corresponding author), Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh.
EM khademul@du.ac.bd
OI Islam, Md Sajedul/0000-0002-3649-8037; Islam, Abul/0000-0002-7274-0855;
   Khan, Md. Abdullah-Al-Kamran/0000-0002-3484-6333
FU Biotechnology Research Centre (BRC); University of Dhaka Bangladesh;
   University Grants Commission (UGC) BangladeshUniversity Grants
   Commission, India; The World Academy of Sciences (TWAS)
FX We acknowledge research support from Biotechnology Research Centre
   (BRC), University of Dhaka and University Grants Commission (UGC)
   Bangladesh and The World Academy of Sciences (TWAS).
CR [Anonymous], 2017, UT CARC
   [Anonymous], 2018, UT CARC
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, FACTSH HLTH PROF
   Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061
   Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004
   Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106
   Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183
   Herrero J., 2016, DATABASE, V2016
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kincaid RP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003818
   Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Leclercq M, 2013, NUCLEIC ACIDS RES, V41, P7200, DOI 10.1093/nar/gkt466
   Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847
   Nukui M, 2015, J VIROL, V89, P2615, DOI 10.1128/JVI.02007-14
   Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048236
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tav C, 2016, NUCLEIC ACIDS RES, V44, pW181, DOI 10.1093/nar/gkw459
   Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x
   Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251
   World Health Organization, 2016, WHO EXP PRIOR VACC D
   Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422
   Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310
NR 51
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2019
VL 91
IS 9
BP 1584
EP 1594
DI 10.1002/jmv.25505
PG 11
WC Virology
SC Virology
GA IR5CL
UT WOS:000481450500002
PM 31095749
DA 2020-07-08
ER

PT J
AU Tai, WB
   Chen, JW
   Zhao, GY
   Geng, QB
   He, L
   Chen, YH
   Zhou, YS
   Li, F
   Du, LY
AF Tai, Wanbo
   Chen, Jiawei
   Zhao, Guangyu
   Geng, Qibin
   He, Lei
   Chen, Yuehong
   Zhou, Yusen
   Li, Fang
   Du, Lanying
TI Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; domain III; envelope protein; epitope shielding; glycan
   probe; intrinsic limitation of subunit vaccine designs; vaccine efficacy
ID BORNE ENCEPHALITIS-VIRUS; MONOPHOSPHORYL-LIPID-A; ANTIBODY-RESPONSES;
   ALUMINUM-HYDROXIDE; STRUCTURAL BASIS; DNA VACCINE; IMMUNOGENICITY;
   SPECIFICITY; INFECTION; DOMAIN
AB Zika virus (ZIKV) infection in pregnant women can lead to fetal deaths and malformations. We have previously reported that ZIKV envelope protein domain III (EDIII) is a subunit vaccine candidate with cross-neutralization activity; however, like many other subunit vaccines, its efficacy is limited. To improve the efficacy of this subunit vaccine, we identified a nonneutralizing epitope on ZIKV EDIII surrounding residue 375, which is buried in the full-length envelope protein but becomes exposed in recombinant EDIII. We then shielded this epitope with an engineered glycan probe. Compared to the wild-type EDIII, the mutant EDIII induced significantly stronger neutralizing antibodies in three mouse strains and also demonstrated significantly improved efficacy by fully protecting mice, particularly pregnant mice and their fetuses, against high-dose lethal ZIKV challenge. Moreover, the mutant EDIII immune sera significantly enhanced the passive protective efficacy by fully protecting mice against lethal ZIKV challenge; this passive protection was positively associated with neutralizing antibody titers. We further showed that the enhanced efficacy of the mutant EDIII was due to the shielding of the immunodominant nonneutralizing epitope surrounding residue 375, which led to immune refocusing on the neutralizing epitopes. Taken together, the results of this study reveal that an intrinsic limitation of subunit vaccines is their artificially exposed immunodominant nonneutralizing epitopes, which can be overcome through glycan shielding. Additionally, the mutant ZIKV protein generated in this study is a promising subunit vaccine candidate with high efficacy in preventing ZIKV infections in mice.
   IMPORTANCE Viral subunit vaccines generally show low efficacy. In this study, we revealed an intrinsic limitation of subunit vaccine designs: artificially exposed surfaces of subunit vaccines contain epitopes unfavorable for vaccine efficacy. More specifically, we identified an epitope on Zika virus (ZIKV) envelope protein domain III (EDIII) that is buried in the full-length envelope protein but becomes exposed in recombinant EDIII. We further shielded this epitope with a glycan, and the resulting mutant EDIII vaccine demonstrated significantly enhanced efficacy over the wild-type EDIII vaccine in protecting animal models from ZIKV infections. Therefore, the intrinsic limitation of subunit vaccines can be overcome through shielding these artificially exposed unfavorable epitopes. The engineered EDIII vaccine generated in this study is a promising vaccine candidate that can be further developed to battle ZIKV infections.
C1 [Tai, Wanbo; Chen, Jiawei; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
   [Chen, Jiawei; Zhao, Guangyu; He, Lei; Chen, Yuehong; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Geng, Qibin; Li, Fang] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Zhou, Yusen] Zhengzhou Univ, Inst Med & Pharmaceut Sci, Zhengzhou, Henan, Peoples R China.
RP Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.; Li, F (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
EM lifang@umn.edu; ldu@nybc.org
RI Tai, Wanbo/G-3838-2018
OI Tai, Wanbo/0000-0002-9864-8993
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI139092, R21AI137790]; New York
   Blood Center [NYB000475, NYB000486, NYB000552]
FX This study was supported by NIH grants (R01AI139092 and R21AI137790) and
   intramural funds from the New York Blood Center (NYB000475, NYB000486,
   and NYB000552).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Apostolico JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145637
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10
   Cohen J, 2018, SCIENCE, V361, P1055, DOI 10.1126/science.361.6407.1055
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Du LY, 2017, EXPERT REV VACCINES, V16, P951, DOI 10.1080/14760584.2017.1363648
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Garcon N, 2017, HUM VACC IMMUNOTHER, V13, P19, DOI 10.1080/21645515.2016.1225635
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   Hachiya A, 2013, ANTIMICROB AGENTS CH, V57, P4554, DOI 10.1128/AAC.00283-13
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Jiang SB, 2019, CELL MOL IMMUNOL, V16, P96, DOI 10.1038/s41423-018-0043-x
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Ko EJ, 2017, J IMMUNOL, V198, P279, DOI 10.4049/jimmunol.1600173
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kulp DW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01549-6
   Kulp DW, 2013, CURR OPIN VIROL, V3, P322, DOI 10.1016/j.coviro.2013.05.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lin B, 2016, ANTIVIR THER, V21, P595, DOI 10.3851/IMP3044
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Ma CQ, 2014, VACCINE, V32, P6170, DOI 10.1016/j.vaccine.2014.08.086
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moon SH, 2015, VACCINE, V33, P4762, DOI 10.1016/j.vaccine.2015.08.006
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   National Research Council, 2011, GUIDE CARE USE LAB A
   Pantophlet R, 2003, TRENDS MOL MED, V9, P468, DOI 10.1016/j.molmed.2003.09.001
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tai WB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00029
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tai WB, 2017, J VIROL, V91, DOI 10.1128/JVI.01651-16
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Xia S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020487
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhang NR, 2016, CELL MOL IMMUNOL, V13, P180, DOI 10.1038/cmi.2015.03
   Zhang NR, 2014, EXPERT REV VACCINES, V13, P761, DOI 10.1586/14760584.2014.912134
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086573
   Zlatkovic J, 2013, J VIROL, V87, P12187, DOI 10.1128/JVI.01690-13
NR 64
TC 5
Z9 5
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2019
VL 93
IS 17
AR e02187-18
DI 10.1128/JVI.02187-18
PG 16
WC Virology
SC Virology
GA IQ4HQ
UT WOS:000480712100032
PM 31189716
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Calman, F
   Arayici, PP
   Buyukbayraktar, HK
   Karahan, M
   Mustafaeva, Z
   Katsarava, R
AF Calman, Fulya
   Arayici, Pelin Pelit
   Buyukbayraktar, Hatice K.
   Karahan, Mesut
   Mustafaeva, Zeynep
   Katsarava, Ramaz
TI Development of Vaccine Prototype Against Zika Virus Disease of
   Peptide-Loaded PLGA Nanoparticles and Evaluation of Cytotoxicity
SO INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
LA English
DT Article
DE Nanoparticles; Peptide; PLGA; Vaccine; Zika virus; Cytotoxicity
AB Zika virus has recently evolved from an obscure mosquito-borne pathogen to an international public health concern. People with Zika virus disease can have indications including mild fever, skin rash, conjunctivitis, muscle pain, malaise or headache. Effective vaccines are needed for controlling and preventing the disease. In the current study, we aim to design the substructure for vaccine against Zika virus by forming antigenic peptide epitope of the disease. Zika peptide loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles have been fabricated in the present work as a potential artificial vaccine. UV and FT-IR Spectrophotometers and ZetaSizer were used for studying the nanoparticles, and Scanning Electron Microscope was used for morphological examination. The nanoparticles (NPs) yield, encapsulation efficiency, the peptide loading capacity were determined and in vitro release of the peptide was studied. Cytotoxic effects of the various concentrations of Zika peptide, blank PLGA nanoparticles and Zika peptide loaded PLGA nanoparticles on ECV304 human epithelial cells were determined via MTT assay. The present paper could be considered as one of the important steps in the use of nanoparticles for constructing the new generation of vaccination systems.
C1 [Calman, Fulya] Marmara Univ, Inst Pure & Appl Sci, Polymer Sci & Technol Dept, TR-34722 Istanbul, Turkey.
   [Arayici, Pelin Pelit; Buyukbayraktar, Hatice K.; Mustafaeva, Zeynep] Yildiz Tech Univ, Chem & Met Fac, Bioengn Dept, TR-34220 Istanbul, Turkey.
   [Karahan, Mesut] Uskudar Univ, Vocat Sch Hlth Serv, Biomed Devices Dept, TR-34662 Istanbul, Turkey.
   [Katsarava, Ramaz] Agr Univ Georgia, Inst Chem & Mol Engn, Kakha Bendukidze Univ Campus, Tbilisi, Georgia.
RP Karahan, M (corresponding author), Uskudar Univ, Vocat Sch Hlth Serv, Biomed Devices Dept, TR-34662 Istanbul, Turkey.
EM mesut.karahan@uskudar.edu.tr
RI PELIT ARAYICI, PELIN/L-4664-2018
OI PELIT ARAYICI, PELIN/0000-0002-7176-4484; Buyukbayraktar, Hatice
   Kubra/0000-0001-9382-5535; Katsarava, Ramaz/0000-0002-2373-1514
FU Scientific and Technological Research Council of Turkey (TUBITAK)Turkiye
   Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); University Student
   Domestic Research Projects Support Program [2209]
FX The authors wish to thank the Scientific and Technological Research
   Council of Turkey (TUBITAK) for its support and contribution as part of
   the 2209-A University Student Domestic Research Projects Support
   Program.
CR Allahyari M, 2016, HUM VACC IMMUNOTHER, V12, P806, DOI 10.1080/21645515.2015.1102804
   Arasoglu T, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/2/025103
   Arayici PP, 2017, FRESEN ENVIRON BULL, V26, P2752
   Brito C., 2016, LANCET NEUROL, V28, P679, DOI [10.1016/S1474-4422(16)00074-0, DOI 10.1016/S1474-4422(16)00074-0]
   Can F, 2016, BIOTECHNOL ACTA, V9, P7, DOI [10.15407/biotech9.04.007, DOI 10.15407/BIOTECH9.04.007]
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Derman S, 2013, SIGMA J ENG NAT SCI, V31, P107
   Derman S, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0195-2
   Derman S, 2014, FRESEN ENVIRON BULL, V23, P558
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Feczko T, 2011, CHEM ENG PROCESS, V50, P757, DOI 10.1016/j.cep.2011.06.008
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Karahan M, 2017, AKU J SCI ENG, V17, P312, DOI [10.5578/fmbd.53815, DOI 10.5578/FMBD.53815]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Ma WX, 2012, INT J NANOMED, V7, P1475, DOI 10.2147/IJN.S29506
   MILLER JC, 2004, HDB NANOTECHNOLOGY B
   Mustafaeva Z, 2017, BIOTECHNOL ACTA, V10, P52, DOI [10.15407/biotech10.01.052, DOI 10.15407/BIOTECH10.01.052]
   Mustafaeva Z, 2016, SIGMA J ENG NAT SCI, V34, P439
   Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Rao CNR, 2005, CHEM NANOMATERIALS
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Sumer Z, 2011, TURKIYE KLIN J FAM M, V2, P19
   Vandervoort J, 2001, PHARMAZIE, V56, P484
   World Health Organization, 2017, ZIK VIR
   Yilmaz E, 2016, BIOTECHNOL ACTA, V9, P7, DOI [10.15407/biotech9.06.007, DOI 10.15407/BIOTECH9.06.007]
   Yin YS, 2006, J CONTROL RELEASE, V116, P337, DOI 10.1016/j.jconrel.2006.09.015
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
NR 31
TC 0
Z9 0
U1 4
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1573-3149
EI 1573-3904
J9 INT J PEPT RES THER
JI Int. J. Pept. Res. Ther.
PD SEP
PY 2019
VL 25
IS 3
BP 1057
EP 1063
DI 10.1007/s10989-018-9753-2
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IO2ZF
UT WOS:000479249600022
DA 2020-07-08
ER

PT J
AU Basile, AJ
   Ao, JN
   Horiuchi, K
   Semenova, V
   Steward-Clark, E
   Schiffer, J
AF Basile, Alison Jane
   Ao, Jingning
   Horiuchi, Kalanthe
   Semenova, Vera
   Steward-Clark, Evelene
   Schiffer, Jarad
TI Performance of InBios ZIKV Detect (TM) 2.0 IgM Capture ELISA in two
   reference laboratories compared to the original ZIKV Detect (TM) IgM
   Capture ELISA
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika; ELISA; InBios; Version 2.0; IgM
ID LINKED-IMMUNOSORBENT-ASSAY; DENGUE VIRUS; ANTIBODIES; INFECTION; ANTIGEN
AB ZIKV Detect (TM) 2.0 IgM Capture ELISA (InBios International, Seattle, WA) recently replaced the ZIKV Detect (TM) IgM Capture ELISA and a number of significant changes have been made to the original version. This study compares data generated from the ZIKV Detect (TM) 2.0 IgM Capture ELISA, to data generated using the original version of the kit. The same sample sets were used in this comparison, and reference test results for these samples were used to assess sensitivity, specificity, accuracy and concordance of results across two laboratories. Average sensitivity increased from 90.4% to 92.5% with the updated kit where the increase was not statistically different, and specificity increased from 79.5% to 97.4%, a statistically-significant difference. Accuracy of the ZIKV Detect (TM) 2.0 IgM Capture ELISA was 89% compared to 63.9% for the original version of the kit, and agreement across the laboratories increased from 79.5% to 97.4%. With secondary dengue virus infections, specificity increased from 9.3% to 82.6% with the updated kit, primarily due to the change in interpretation criteria that no longer includes "Possible Zika positive."
C1 [Basile, Alison Jane; Horiuchi, Kalanthe] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Ao, Jingning; Semenova, Vera; Steward-Clark, Evelene; Schiffer, Jarad] Ctr Dis Control & Prevent, Div Bacterial Dis, Microbial Pathogenesis & Immune Response Lab, Atlanta, GA USA.
RP Basile, AJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
EM ajj1@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Basile AJ, 2018, J VIROL METHODS, V260, P26, DOI 10.1016/j.jviromet.2018.06.018
   Beaty B. J., 1995, ARBOVIRUSES
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   R Core Team, 2017, LANG ENV STAT COMP
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sloan A, 2018, DIAGN MICR INFEC DIS, V90, P264, DOI 10.1016/j.diagmicrobio.2017.11.018
   TSAI TF, 1987, J CLIN MICROBIOL, V25, P370, DOI 10.1128/JCM.25.2.370-376.1987
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208
NR 15
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD SEP
PY 2019
VL 271
AR 113671
DI 10.1016/j.jviromet.2019.05.011
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA IN9UE
UT WOS:000479023100012
PM 31181219
OA Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Estrela, PFN
   Mendes, GD
   de Oliveira, KG
   Bailao, AM
   Soares, CMD
   Assuncao, NA
   Duarte, GRM
AF Neves Estrela, Paulo Felipe
   Mendes, Geovana de Melo
   de Oliveira, Kezia Gomes
   Bailao, Alexandre Melo
   de Almeida Soares, Celia Maria
   Assuncao, Nilson Antonio
   Mendes Duarte, Gabriela Rodrigues
TI Ten-minute direct detection of Zika virus in serum samples by RT-LAMP
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE RT-LAMP; Zika virus; Molecular diagnosis; Rapid detection; Point-of-care
ID MEDIATED ISOTHERMAL AMPLIFICATION; RAPID DETECTION; ASSAY
AB Zika virus (ZIKV) is a current threat to global health. In most of cases, ZIKV infection has no symptoms; however in some cases, ZIKV can cause paralysis (Guillain-Barre syndrome), and in pregnant women, it can cause birth defects in infants. Rapid and accurate diagnosis can help improve disease control as well as being vital to prenatal care for women living in endemic areas. Molecular diagnostics based on isothermal amplification techniques are an excellent alternative to conventional methods of DNA amplification, such as PCR. Here, we develop and optimized a rapid and sensitive method for direct detection of ZIKV in Serum samples based on RT-LAMP and visual detection. The reaction was thermally controlled with a thermoblock for 10 min at 72 degrees C. The results show that the use of the Bst 3.0 enzyme and an adequate optimization can further reduce the time needed for the RT-LAMP reaction to detect ZIKV. Our results demonstrate that it is possible to detect ZIKV through RT-LAMP directly from a Serum sample, without prior RNA extraction. As little as 10(-3) copies of RNA in a 10 mu L reaction (20 zepto-molar) was detected by RT-LAMP from a panel of 51 Serum samples (16 samples from pregnant women and 35 samples from newborns infected with ZIKV during pregnancy). The RT-LAMP has proven to be a valuable tool for molecular diagnosis of Zika, presenting a great potential for point-of-care applications, especially in developing countries.
C1 [Neves Estrela, Paulo Felipe; Mendes, Geovana de Melo; de Oliveira, Kezia Gomes; Mendes Duarte, Gabriela Rodrigues] Univ Fed Goias, Inst Quim, Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
   [Bailao, Alexandre Melo; de Almeida Soares, Celia Maria] Univ Fed Goias, Inst Ciencias Biol, BR-74690900 Goiania, Go, Brazil.
   [Assuncao, Nilson Antonio] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, BR-04021001 Sao Paulo, SP, Brazil.
RP Duarte, GRM (corresponding author), Univ Fed Goias, Inst Quim, Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
EM gabriela_duarte@ufg.br
RI Duarte, G R M/E-4894-2014; Assuncao, Nilson/B-7926-2012; Bailao,
   Alexandre/H-1272-2013; Assuncao, Nilson/B-2574-2012
OI Duarte, G R M/0000-0003-2039-1750; Bailao,
   Alexandre/0000-0001-7754-4047; Assuncao, Nilson/0000-0002-3747-0415
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [422016/2016-0, 407666/2016-8]; FAPEG [201410267001777,
   INCT-IPH201810267000022];  [MCTIC/FINEP/FNDCT-04.16.0054.01]
FX We are grateful to Prof. Mayana Zatz, Dr. Uira Souto Melo and Danielle
   Zildeana Sousa Furtado, who kindly provided samples from infected
   patients with ZIKV. This study was supported by the CNPq (Grant numbers:
   422016/2016-0, 407666/2016-8), FAPEG (Grant numbers: 201410267001777,
   INCT-IPH201810267000022) and MCTIC/FINEP/FNDCT-04.16.0054.01.
CR Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   de Oliveira KG, 2017, ANAL BIOCHEM, V534, P70, DOI 10.1016/j.ab.2017.07.014
   Gimenez TD, 2017, ANAL METHODS-UK, V9, P2116, DOI [10.1039/C6AY03481K, 10.1039/c6ay03481k]
   Karthik K, 2014, METHODSX, V1, P137, DOI 10.1016/j.mex.2014.08.009
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Liu ZY, 2016, MITOCHONDRIAL DNA A, V27, P2318, DOI 10.3109/19401736.2015.1022762
   Mansuy JM, 2018, DIAGN MICR INFEC DIS, V92, P284, DOI 10.1016/j.diagmicrobio.2018.06.019
   Matheus S, 2017, EMERG INFECT DIS, V23, P1910, DOI 10.3201/eid2311.170337
   Mendes GM, 2019, J BRAZIL CHEM SOC, V30, P1841, DOI 10.21577/0103-5053.20190092
   Mora-Cardenas E, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.10.19
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pianka K, 2017, TECHNOLOGY, V5, P115, DOI 10.1142/S2339547817300025
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Ranjbar R, 2015, IRAN J MICROBIOL, V7, P185
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Subramanian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100596
   Sui X, 2019, PEERJ, V6, DOI 10.7717/peerj.6068
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tsai SM, 2009, J VIROL METHODS, V157, P200, DOI 10.1016/j.jviromet.2009.01.003
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Winkler CW, 2018, IMMUNOLOGY, V153, P443, DOI 10.1111/imm.12883
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zhao JT, 2019, VIRUS GENES, V55, P43, DOI 10.1007/s11262-018-1612-x
NR 29
TC 2
Z9 2
U1 9
U2 24
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD SEP
PY 2019
VL 271
AR 113675
DI 10.1016/j.jviromet.2019.113675
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA IN9UE
UT WOS:000479023100013
PM 31170469
DA 2020-07-08
ER

PT J
AU Maia, LMS
   Bezerra, MCF
   Costa, MCS
   Souza, EM
   Oliveira, MEB
   Ribeiro, ALM
   Miyazaki, RD
   Slhessarenko, RD
AF Maia, L. M. S.
   Bezerra, M. C. F.
   Costa, M. C. S.
   Souza, E. M.
   Oliveira, M. E. B.
   Ribeiro, A. L. M.
   Miyazaki, R. D.
   Slhessarenko, R. D.
TI Natural vertical infection by dengue virus serotype 4, Zika virus and
   Mayaro virus in Aedes (Stegomyia) aegypti and Aedes (Stegomyia)
   albopictus
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE arbovirus; entomology; surveillance; vertical route
ID MATO-GROSSO; TRANSMISSION; DIPTERA; CUIABA; STATE
AB Vertical transmission to progeny ensures the maintenance of arboviruses in their natural vectors. This mechanism is largely reported for dengue virus (DENV) and yellow fever virus (YFV). Few studies have addressed this mechanism for Zika virus (ZIKV), Mayaro virus (MAYV) and other arboviruses. The present study investigated the natural infection rate by arboviruses in 4490 Aedes (Stegomyia) aegypti and 296 Aedes (Stegomyia) albopictus (Diptera: Culicidae) reared from eggs collected with ovitraps in Cuiaba, Mato Grosso State, from February to July, 2017. After viral RNA extraction and reverse transcriptase-polymerase chain reaction protocols for 10 flaviviruses and five alphaviruses, nucleotide sequencing and three passages in C6/36 cells, eight pools of Ae. aegypti positive for DENV-4 genotype II, seven for ZIKV Asian genotype and two for MAYV genotype L were found. In addition, two Ae. albopictus pools were positive for DENV-4 genotype II and two were positive for ZIKV Asian genotype. Infection was confirmed by viral isolation in all positive pools for DENV-4 and for MAYV and in eight of nine for ZIKV. This mechanism may contribute to the spread of arboviruses during epidemics and also to their maintenance in natural vectors during interepidemic periods.
C1 [Maia, L. M. S.; Bezerra, M. C. F.; Costa, M. C. S.; Slhessarenko, R. D.] Univ Fed Mato Grosso UFMT, Virol Lab, Programa Posgrad Ciencias Saude, BR-78060900 Cuiaba, MT, Brazil.
   [Souza, E. M.; Oliveira, M. E. B.; Ribeiro, A. L. M.; Miyazaki, R. D.] Univ Fed Mato Grosso UFMT, Inst Biociencias, Entomol Lab, Cuiaba, Brazil.
RP Slhessarenko, RD (corresponding author), Univ Fed Mato Grosso UFMT, Virol Lab, Programa Posgrad Ciencias Saude, BR-78060900 Cuiaba, MT, Brazil.
EM renatadezengrini@yahoo.com.br
FU CAPESCAPES [001]; DECIT/SCTIE/MS; CNPqNational Council for Scientific
   and Technological Development (CNPq); FAPEMAT/SES-MT grant [214502/2013]
FX The authors are very thankfull to the Leonidas and Maria Deane Institute
   (Fiocruz, Manaus, AM) for nucleotide sequencing. LMSM and MCSC received
   CAPES Master scholarships (code 001). The present study was supported by
   a DECIT/SCTIE/MS, CNPq, FAPEMAT/SES-MT grant (214502/2013). The authors
   declare that they have no conflicts of interest.
CR Balm M.N., 2012, J MED VIROL, V84, P5
   BOSIO CF, 1992, J MED ENTOMOL, V29, P985, DOI 10.1093/jmedent/29.6.985
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   Costa MCD, 2019, ACTA TROP, V190, P395, DOI 10.1016/j.actatropica.2018.12.019
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faye O., 2008, VIROL J, V10, P311
   Forattini O.P., 2002, CULICIDOLOGIA MED, P27
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   HEINEN LBS, 2015, REV INST MED TROP SP, V57, P1
   Jain J, 2016, ACTA TROP, V162, P46, DOI 10.1016/j.actatropica.2016.06.004
   Joshi V., 2002, AM SOC TROPICAL MED, V67, P61
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Long K.C., 2011, AM J TROP MED HYG, V4, P7
   Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030178
   Miyazaki RD, 2009, REV SOC BRAS MED TRO, V42, P392, DOI 10.1590/S0037-86822009000400007
   Mlakar J., 2016, NEW ENGL J MED, V374, P8
   Secretaria Municipal de Saude, 2017, IND INF AED AEG
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Smartt C.T., 2017, J MED ENTOMOL, V0, P1, DOI DOI 10.1093/JME/TJW152
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 24
TC 4
Z9 4
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD SEP
PY 2019
VL 33
IS 3
BP 437
EP 442
DI 10.1111/mve.12369
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA IN4HW
UT WOS:000478636800014
PM 30776139
DA 2020-07-08
ER

PT J
AU Aranda, DF
   Gonzalez-Parra, G
   Benincasa, T
AF Aranda L, Diego F.
   Gonzalez-Parra, Gilberto
   Benincasa, Tommaso
TI Mathematical modeling and numerical simulations of Zika in Colombia
   considering mutation
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Article
DE Zika virus; Nonlinear dynamical systems; Epidemiological models; Global
   stability; Estimation of parameters
ID VIRUS-INFECTION; DISEASE; INFLUENZA; DYNAMICS; SIZE
AB In this paper, we analyze the Zika virus transmission dynamics on human and mosquito populations. Mosquitoes play a role of infectious agents and vector of the Zika virus (ZIKV). In this sense, we set out a mathematical model assuming constant size population for the evolution of the infected humans with ZIKV and analyze its qualitative dynamics. The epidemic threshold parameter R-0 for the extinction of disease is computed. Numerical simulations of the model varying the numerical values of the parameters corroborate the theoretical results regarding R-0. The values of the parameters related to the mathematical model of the Zika epidemic are estimated using real data from Zika prevalence in Colombia for year 2016. We find a R-0 = 0.88 for this particular case which allows us to understand and explain some aspects of the Zika epidemic in Colombia. These results are valuable since they can be compared with Zika epidemics in other countries and from other years, and enrich the knowledge about the dynamics of the spread of Zika virus. (C) 2019 International Association for Mathematics and Computers in Simulation (IMACS). Published by Elsevier B.V. All rights reserved.
C1 [Aranda L, Diego F.; Benincasa, Tommaso] Univ El Bosque, Fac Ciencias, Dept Matemat, Grp Invest SIGNOS, Bogota, Colombia.
   [Gonzalez-Parra, Gilberto] New Mexico Inst Min & Technol, Dept Math, Socorro, NM 87801 USA.
RP Gonzalez-Parra, G (corresponding author), New Mexico Inst Min & Technol, Dept Math, Socorro, NM 87801 USA.
EM Gilberto.GonzalezParra@nmt.edu
OI Gonzalez-Parra, Gilberto/0000-0001-5847-678X
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2017, VIRUS CHIKUNGUNYA SE
   Aranda DF, 2008, COMPUT MATH APPL, V56, P690, DOI 10.1016/j.camwa.2008.01.008
   Aranda DF, 2012, MATH METHOD APPL SCI, V35, P249, DOI 10.1002/mma.1544
   Arenas AJ, 2010, THEOR POPUL BIOL, V77, P227, DOI 10.1016/j.tpb.2010.03.005
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Cardona-Ospina JA, 2015, J CLIN VIROL, V70, P14, DOI 10.1016/j.jcv.2015.07.001
   Castillo-Chavez C, 2012, MATH MODELS POPULATI
   Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023
   Cruz-Pacheco G, 2012, MATH BIOSCI, V237, P49, DOI 10.1016/j.mbs.2012.03.005
   Davison A.C., 1997, BOOTSTRAP METHODS TH, V1
   Departamento Administrativo Nacional de Estadistica, 2005, CENS COL
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552
   Gao  Daozhou, 2016, ARXIV160404008
   Gotz T, 2017, ECOL COMPLEX, V30, P57, DOI 10.1016/j.ecocom.2016.12.010
   Golberg D. E., 1989, GENETIC ALGORITHMS S, V1989
   Gonzalez-Parra G, 2016, J VIROL METHODS, V231, P14, DOI 10.1016/j.jviromet.2016.02.005
   Gonzalez-Parra Gilberto, 2015, Osong Public Health Res Perspect, V6, P288, DOI 10.1016/j.phrp.2015.09.001
   Gonzalez-Parra G, 2014, MATH METHOD APPL SCI, V37, P2218, DOI 10.1002/mma.2968
   Gonzalez-Parra G, 2011, SPAT SPATIO-TEMPORAL, V2, P219, DOI 10.1016/j.sste.2011.05.002
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Isea R., 2016, ARXIV160608233
   Khan MR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41995
   Khan MA, 2018, CHAOS SOLITON FRACT, V108, P205, DOI 10.1016/j.chaos.2018.02.002
   Kincaid D. R., 2002, NUMERICAL ANAL MATH, V2
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Majumder Maimuna S., 2016, JMIR PUBL HLTH SURVE, V2
   Manore C, 2016, SIAM NEWS
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Mpeshe Saul C., 2017, INT J ADV APPL MATH, V4, P14
   Murray J.D., 2002, INTERDISCIPLINARY AP, V17
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Ospina  Juan, 2017, TROP MED INT HLTH
   Press W. H., 1992, NUMERICAL RECIPES AR
   Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358
   Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van den Driessche P, 2008, LECT NOTES MATH, V1945, P159
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zhu  Min, 2018, MATH COMPUT SIMULATI
NR 48
TC 2
Z9 2
U1 3
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4754
EI 1872-7166
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD SEP
PY 2019
VL 163
BP 1
EP 18
DI 10.1016/j.matcom.2019.02.009
PG 18
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA HT9XL
UT WOS:000464925900001
DA 2020-07-08
ER

PT J
AU Fatic, A
   Zhang, N
   Keller, MD
   Hanley, PJ
AF Fatic, Alyssa
   Zhang, Nan
   Keller, Michael D.
   Hanley, Patrick J.
TI The pipeline of antiviral T-cell therapy: what's in the clinic and
   undergoing development
SO TRANSFUSION
LA English
DT Review
ID EPSTEIN-BARR-VIRUS; BK VIRUS; ADENOVIRUS; CYTOMEGALOVIRUS
AB KEY IDEAS
   Virus-specific T cells allow targeting of multiple pathogens in patients after hematopoietic stem cell transplantation and have demonstrated potential efficacy for cytomegalovirus, Epstein-Barr Virus, and adenovirus. Novel targets may include BK virus, JC virus, varicella zoster virus, human herpesvirus 6, Aspergillus, human parainfluenza virus-3, herpes simplex virus Type I, Zika virus, and mycobacteria. Generation of patient-specific products and third-party products may expand feasibility of therapy.
C1 [Fatic, Alyssa; Zhang, Nan; Keller, Michael D.; Hanley, Patrick J.] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Washington, DC 20010 USA.
   [Keller, Michael D.] Ctr Canc & Blood Disorders, Div Allergy & Immunol, Washington, DC USA.
   [Hanley, Patrick J.] Ctr Canc & Blood Disorders, Div Blood & Marrow Transplantat, Washington, DC USA.
   [Keller, Michael D.; Hanley, Patrick J.] George Washington Univ, Washington, DC 20010 USA.
RP Hanley, PJ (corresponding author), George Washington Univ, Ctr Canc & Immunol Res, Ctr Canc & Blood Disorders, Childrens Natl Hlth Syst, 111 Michigan Ave North West, Washington, DC 20010 USA.
EM phanley@childrensnational.org
OI Fatic, Alyssa/0000-0002-7613-5214
FU Children's Cancer Foundation (CCF); Amy Manasevit Award from Be the
   Match/American Society for Transplantation and Cellular Therapy (ASTCT);
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K23-HL136783-01];
   Jeffrey Modell Foundation
FX This work was supported by the Children's Cancer Foundation (CCF), the
   Amy Manasevit Award from Be the Match/American Society for
   Transplantation and Cellular Therapy (ASTCT) to PJH; the National
   Institutes of Health (K23-HL136783-01 to MK), and the Jeffrey Modell
   Foundation.
CR Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Hanajiri R, 2019, CYTOTHERAPY, V19, P30794
   Hanley PJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2546
   Hanley PJ, 2009, BLOOD, V114, P1958, DOI 10.1182/blood-2009-03-213256
   Harris KM, 2019, J ALLER CL IMM-PRACT, V7, P809, DOI 10.1016/j.jaip.2018.10.049
   Hill JA, 2017, BLOOD, V129, P2316, DOI 10.1182/blood-2016-10-748426
   Ma CKK, 2017, CYTOTHERAPY, V19, P107, DOI 10.1016/j.jcyt.2016.09.013
   Ma CKK, 2015, CYTOTHERAPY, V17, P1406, DOI 10.1016/j.jcyt.2015.07.005
   Mclaughlin LP, 2016, CYTOTHERAPY, V18, P1515, DOI 10.1016/j.jcyt.2016.08.010
   Muftuoglu M, 2018, NEW ENGL J MED, V379, P1443, DOI 10.1056/NEJMoa1801540
   Papadopoulou A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008825
   Patel S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00621
   Perruccio K, 2005, BLOOD, V106, P4397, DOI 10.1182/blood-2005-05-1775
   Tzannou I, 2017, J CLIN ONCOL, V35, P3547, DOI [10.1200/jco.2017.73.0655, 10.1200/JCO.2017.73.0655]
NR 14
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JAN
PY 2020
VL 60
IS 1
BP 7
EP 10
DI 10.1111/trf.15501
EA AUG 2019
PG 4
WC Hematology
SC Hematology
GA KB7XP
UT WOS:000484267200001
PM 31469438
DA 2020-07-08
ER

PT J
AU Millan, S
   Diaz, C
   Pardo, DGD
   Guzman, GC
AF Millan, Sonia
   Diaz, Cindy
   David Pardo, David G.
   Castro Guzman, Gabriel
TI Clinical and neurophysiological characteristics of patients with
   Guillain-Barre syndrome at Hospital Universitario San Ignacio, Bogota,
   Colombia between 2009 and 2017
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Article
DE Bogota; Colombia; Guillain-Barre; neurophysiology; peripheral
   polyneuropathy
ID VIRUS; ZIKA
AB Guillain-Barre syndrome (GBS) is the most common acute peripheral polyneuropathy in the world. The estimated incidence in Colombia is 1.2-1.7 cases per 100 000 inhabitants, although during 2016 an increase in the incidence of the disease was documented, apparently associated with an epidemiological peak of the Zika virus. We conducted to describe the clinical and neurophysiological characteristics of adult patients with GBS treated at Hospital Universitario San Ignacio, Bogota, Colombia, between 2009 and 2017. An observational, descriptive, cross-sectional study was designed.
C1 [Millan, Sonia; Diaz, Cindy] Hosp Univ San Ignacio, Dept Neurol, Carrera 7 40-62,Piso 6, Bogota, Colombia.
   [David Pardo, David G.; Castro Guzman, Gabriel] Pontificia Univ Javeriana, Sch Med, Bogota, Colombia.
   [David Pardo, David G.] Pontificia Univ Javeriana, Dept Neurosci & Aging, Bogota, Colombia.
RP Millan, S (corresponding author), Hosp Univ San Ignacio, Dept Neurol, Carrera 7 40-62,Piso 6, Bogota, Colombia.; Millan, S (corresponding author), Pontificia Univ Javeriana, Hosp San Ignacio, Fac Med, Carrera 7 40-62,Piso 6, Bogota, Colombia.
EM snmillan@yahoo.com
CR Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Burns TM, 2008, SEMIN NEUROL, V28, P152, DOI 10.1055/s-2008-1062261
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Donofrio Peter D, 2017, Continuum (Minneap Minn), V23, P1295, DOI 10.1212/CON.0000000000000513
   GB Syndrome, 2014, REV MED SCI, V18, P275
   Hernández-Beltrán Natalia, 2015, Infect., V19, P172, DOI 10.1016/j.infect.2015.01.001
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Jasti AK, 2016, EXPERT REV CLIN IMMU, V12, P1175, DOI 10.1080/1744666X.2016.1193006
   Kusunoki S, 2003, MUSCLE NERVE, V27, P302, DOI 10.1002/mus.10307
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Netto AB, 2011, ANN INDIAN ACAD NEUR, V14, P262, DOI 10.4103/0972-2327.91942
   Palacios E., 1978, GUILLAIN BARRE SYNDR
   Paprocka G, 2010, B VET I PULAWY, V54, P467
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perez JC, 2006, ACTA NEUROL COLOMB, V22, P201
   Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Winer JB, 2014, AUTOIMMUNE DIS, P1
NR 20
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2019
VL 24
IS 3
BP 272
EP 275
DI 10.1111/jns.12345
EA AUG 2019
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IX8KK
UT WOS:000484601100001
PM 31410933
DA 2020-07-08
ER

PT J
AU Valente, AP
   Moraes, AH
AF Valente, Ana Paula
   Moraes, Adolfo Henrique
TI Zika virus proteins at an atomic scale: how does structural biology help
   us to understand and develop vaccines and drugs against Zika virus
   infection?
SO JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
LA English
DT Review
DE Zika virus proteins; structural biology; protein structure; nuclear
   magnetic resonance spectroscopy; protein-antibody interaction;
   protein-small compound interaction
ID DEPENDENT RNA-POLYMERASE; DENGUE VIRUS; CRYSTAL-STRUCTURE; NS2B-NS3
   PROTEASE; CATALYTIC DOMAIN; NS3 HELICASE; HELICASE/NUCLEOSIDE
   TRIPHOSPHATASE; NONNUCLEOSIDE INHIBITORS; BINDING; ANTIBODY
AB In Brazil and in other tropical areas Zika virus infection was directly associated with clinical complications as microcephaly in newborn children whose mothers were infected during pregnancy and the Guillain-Barre syndrome in adults. Recently, research has been focused on developing new vaccines and drug candidates against Zika virus infection since none of those are available. In order to contribute to vaccine and drug development efforts, it becomes important the understanding of the molecular basis of the Zika virus recognition, infection and blockade. To this purpose, it is essential the structural determination of the Zika virus proteins. The genome sequencing of the Zika virus identified ten proteins, being three structural (protein E, protein C and protein prM) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). Together, these proteins are the main targets for drugs and antibody recognition. Here we examine new discoveries on high-resolution structural biology of Zika virus, observing the interactions and functions of its proteins identified via state-of-art structural methodologies as X-ray crystallography, nuclear magnetic resonance spectroscopy and cryogenic electronic microscopy. The aim of the present study is to contribute to the understanding of the structural basis of Zika virus infection at an atomic level and to point out similarities and differences to others flaviviruses
C1 [Valente, Ana Paula] Fed Univ Rio De Janeiro UFRJ, Leopoldo Meis Inst Med Biochem, Natl Ctr Magnet Resonance, Rio De Janeiro, RJ, Brazil.
   [Moraes, Adolfo Henrique] Fed Univ Minas Gerais UFMG, Inst Exact Sci, Dept Chem, Belo Horizonte, MG, Brazil.
RP Moraes, AH (corresponding author), Fed Univ Minas Gerais UFMG, Inst Exact Sci, Dept Chem, Belo Horizonte, MG, Brazil.
EM adolfo.dq.ufmg@gmail.com
RI Moraes, Adolfo/G-3931-2018
OI Moraes, Adolfo/0000-0002-3344-4084
FU Brazilian Innovation and Research Funding Agency (FINEP)
   [MCTI/FINEP/FNDCT 01/2016/01.16.0050.00]; Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [303785/2014-4,
   426265/2016-5]; Foundation of Research Support of the State of Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [202.902/2015]; CNPq through
   Programa Editorial CNPq/CAPES [26/2017, 440954/2017-7]
FX This work was supported by the Brazilian Innovation and Research Funding
   Agency (FINEP - grant MCTI/FINEP/FNDCT 01/2016/01.16.0050.00), by
   Brazilian National Council for Scientific and Technological Development
   (CNPq - grants 303785/2014-4 and 426265/2016-5), and by the Foundation
   of Research Support of the State of Rio de Janeiro (FAPERJ - grant
   202.902/2015). JVATiTD publication is supported by CNPq through Programa
   Editorial CNPq/CAPES (chamada n. 26/2017, processo n. 440954/2017-7).
   Therefore, all articles published by the journal are in part funded by
   this grant.
CR ABADZAPATERO C, 1980, NATURE, V286, P33, DOI 10.1038/286033a0
   Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardelli M, 2015, J MOL RECOGNIT, V28, P393, DOI 10.1002/jmr.2454
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Best SM, 2016, J VIROL
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Chen HL, 2010, BIOPOLYMERS, V94, P331, DOI 10.1002/bip.21371
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665
   Jiang W, 2017, CURR OPIN STRUC BIOL, V46, P122, DOI 10.1016/j.sbi.2017.07.002
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lima MCP, 2016, PHYS CHEM CHEM PHYS, V18, P30288, DOI 10.1039/c6cp03209e
   Linkuviene V, 2016, ANAL BIOCHEM, V515, P61, DOI 10.1016/j.ab.2016.10.005
   Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moraes AH, 2016, J VIROL, V90, P1802, DOI 10.1128/JVI.02314-15
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neumann T, 2007, CURR TOP MED CHEM, V7, P1630, DOI 10.2174/156802607782341073
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Pedotti M, 2011, INT J MOL SCI, V12, P226, DOI 10.3390/ijms12010226
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Simonelli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055561
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H., 2016, NAT STRUCT MOL BIOL, P1
   Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2007, J STRUCT BIOL, V157, P356, DOI 10.1016/j.jsb.2006.09.002
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
NR 90
TC 0
Z9 0
U1 2
U2 7
PU CEVAP-SAO PAULO STATE UNIV-UNESP
PI BOTUCATU
PA CENTER STUDY VENOMS & VENOMOUS, SUA JOSE BARROS, BOTUCATU, SP 18610-307,
   BRAZIL
EI 1678-9199
J9 J VENOM ANIM TOXINS
JI J. Venom. Anim. Toxins Trop. Dis.
PD AUG 29
PY 2019
VL 25
AR e20190013
DI 10.1590/1678-9199-JVATITD-2019-0013
PG 14
WC Toxicology; Tropical Medicine; Zoology
SC Toxicology; Tropical Medicine; Zoology
GA IV8WC
UT WOS:000484544800001
PM 31523227
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Elfiky, AA
AF Elfiky, Abdo A.
TI Novel guanosine derivatives against Zika virus polymerase in silico
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE drug-protein interaction; guanosine derivatives; molecular docking; NS5;
   RNA-dependent RNA polymerase; Zika virus
ID SEMIEMPIRICAL METHODS; CRYSTAL-STRUCTURE; DOCKING; OPTIMIZATION;
   INHIBITORS; PARAMETERS; DYNAMICS; REVEALS; DRUGS; WATER
AB The Zika virus (ZIKV) outbreak, which started in the year 2015, is considered the fastest and most widely spread outbreak reported for this flavivirus. The polymerase domain of the NS5 protein has been targeted in other viral infections and is recognized as a suitable target in ZIKV infection. Different novel modified compounds against ZIKV NS5 have been tested in silico. A few structures have been solved for ZIKV polymerase and deposited in the protein data bank website. Two of these solved structures (with a resolution of less than 1.9 A) are used in this study to test the binding of 74 novel compounds in silico. Molecular docking is used to quantify the binding affinities of ZIKV polymerase and compare it to the hepatitis C virus NS5B. A total of 19 novel compounds revealed results that are either similar to or better than the physiological molecule, guanosine triphosphate. Water molecules are found to facilitate the binding of the compounds to ZIKV RNA-dependent RNA polymerase (RdRp) structures. The presented 19 novel compounds represent good binders to ZIKV RdRp and could be suitable candidates for developing a new and effective anti-ZIKV polymerase nucleotide inhibitor.
C1 [Elfiky, Abdo A.] Cairo Univ, Fac Sci, Biophys Dept, Giza 12613, Egypt.
   [Elfiky, Abdo A.] Abdus Salam Int Ctr Theoret Phys ICTP, Quantitat Life Sci Sect, Str Costiera, Trieste, Italy.
RP Elfiky, AA (corresponding author), Cairo Univ, Fac Sci, Biophys Dept, Giza 12613, Egypt.
EM abdo@sci.cu.edu.eg
RI Mohamed, Abdo/H-3595-2019
OI Mohamed, Abdo/0000-0003-4600-6240
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   [Anonymous], 2017, SCHROD REL 2017 1 MA
   [Anonymous], PYMOL MOL GRAPH SYST
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bellissent-Funel MC, 2016, CHEM REV, V116, P7673, DOI 10.1021/acs.chemrev.5b00664
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elfiky AA, 2019, MED CHEM, V15, P130, DOI 10.2174/1573406414666181015152511
   Elfiky AA, 2017, FUTURE VIROL, V12, P720, DOI 10.2217/fvl-2017-0081
   Elfiky AA, 2018, J MED VIROL, V90, P13, DOI 10.1002/jmv.24934
   Elfiky AA, 2017, FUTURE VIROL, V12, P339, DOI 10.2217/fvl-2017-0027
   Elfiky AA, 2017, J MED VIROL, V89, P1040, DOI 10.1002/jmv.24736
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Elfiky AA, 2016, MED CHEM RES, V25, P1005, DOI 10.1007/s00044-016-1533-y
   Ferrer-Orta C, 2015, VIRUSES-BASEL, V7, P4438, DOI 10.3390/v7082829
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ganesan A, 2017, EXPERT OPIN DRUG DIS, V12, P407, DOI 10.1080/17460441.2017.1291628
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gonzalez-Grande R, 2016, WORLD J GASTROENTERO, V22, P1421, DOI 10.3748/wjg.v22.i4.1421
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Leach A. R., 2001, MOL MODELLING PRINCI
   Levine DM, 1999, STAT MANAGERS USING, V660
   LII JH, 1989, J AM CHEM SOC, V111, P8576, DOI 10.1021/ja00205a003
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mayhoub AS, 2012, BIOORGAN MED CHEM, V20, P3150, DOI 10.1016/j.bmc.2012.03.049
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Muegge I., 2002, VIRTUAL SCREENING AL, P99
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Ojha CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02340
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4
   STEWART JJP, 1991, J COMPUT CHEM, V12, P320, DOI 10.1002/jcc.540120306
   Summers KL, 2012, BIOCHEM BIOPH RES CO, V425, P485, DOI 10.1016/j.bbrc.2012.07.141
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
NR 49
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JAN
PY 2020
VL 92
IS 1
BP 11
EP 16
DI 10.1002/jmv.25573
EA AUG 2019
PG 6
WC Virology
SC Virology
GA JL0TD
UT WOS:000484275300001
PM 31436327
OA Green Published
DA 2020-07-08
ER

PT J
AU Carletti, T
   Zakaria, MK
   Faoro, V
   Reale, L
   Kazungu, Y
   Licastro, D
   Marcello, A
AF Carletti, Tea
   Zakaria, Mohammad Khalid
   Faoro, Valentina
   Reale, Laura
   Kazungu, Yvette
   Licastro, Danilo
   Marcello, Alessandro
TI Viral priming of cell intrinsic innate antiviral signaling by the
   unfolded protein response
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; NILE-VIRUS-INFECTION; IFN-BETA INDUCTION;
   3-DIMENSIONAL ARCHITECTURE; RIG-I; REPLICATION; ATF6; RNA; INHIBITION;
   PATHWAY
AB The innate response to a pathogen is critical in determining the outcome of the infection. However, the interplay of different cellular responses that are activated following viral infection and their contribution to innate antiviral signalling has not been clearly established. This work shows that flaviviruses, including Dengue, Zika, West Nile and Tick-borne encephalitis viruses, activate the unfolded protein response before transcription of interferon regulatory factor 3 induced genes. Infection in conditions of unfolded protein response priming leads to early activation of innate antiviral responses and cell intrinsic inhibition of viral replication, which is interferon regulatory factor 3 dependent. These results demonstrate that the unfolded protein response is not only a physiological reaction of the cell to viral infection, but also synergizes with pattern recognition sensing to mount a potent antiviral response.
C1 [Carletti, Tea; Zakaria, Mohammad Khalid; Faoro, Valentina; Reale, Laura; Kazungu, Yvette; Marcello, Alessandro] ICGEB, Lab Mol Virol, Trieste, Italy.
   [Licastro, Danilo] CBM Scrl, Trieste, Italy.
   [Zakaria, Mohammad Khalid] Pirbright Inst, Ash Rd, Woking GU24 0NF, Surrey, England.
RP Marcello, A (corresponding author), ICGEB, Lab Mol Virol, Trieste, Italy.
EM marcello@icgeb.org
FU Beneficientia Stiftung, Vaduz Lichtenstein; FLAVIPOC project from the
   Regione FVG of Italy; SEVARE project from the Regione FVG of Italy
FX Work on flaviviruses in A.M.'s laboratory is supported by the
   Beneficientia Stiftung, Vaduz Lichtenstein, and by the FLAVIPOC and
   SEVARE projects from the Regione FVG of Italy. We thank Tatjana Avsic -
   Zupanc for the Zika virus obtained through the European Virus Archive
   (EVAg).
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Ambrose RL, 2013, J VIROL, V87, P2206, DOI 10.1128/JVI.02097-12
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Atasheva S, 2014, J VIROL, V88, P2116, DOI 10.1128/JVI.03443-13
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Carletti T, 2017, BIOCHEM BIOPH RES CO, V492, P533, DOI 10.1016/j.bbrc.2017.02.006
   Carlton-Smith C, 2012, J VIROL, V86, P11548, DOI 10.1128/JVI.01773-12
   Cevik RE, 2017, J VIROL, V91, DOI 10.1128/JVI.00880-17
   Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200
   Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011
   Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51
   Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948
   Fusco DN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00240
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831
   Ignatiadis N, 2016, NAT METHODS, V13, P577, DOI [10.1038/NMETH.3885, 10.1038/nmeth.3885]
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meng XZ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006884
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134
   Selinger M, 2017, J GEN VIROL, V98, P2043, DOI 10.1099/jgv.0.000853
   Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yu C, 2013, VIRUS RES, V178, P471, DOI 10.1016/j.virusres.2013.10.012
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 42
TC 5
Z9 5
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 29
PY 2019
VL 10
AR 3889
DI 10.1038/s41467-019-11663-2
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IT6WU
UT WOS:000483017800006
PM 31467282
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Otu, AA
   Udoh, UA
   Ita, OI
   Hicks, JP
   Ukpeh, I
   Walley, J
AF Otu, Akaninyene A.
   Udoh, Ubong A.
   Ita, Okokon I.
   Hicks, Joseph P.
   Ukpeh, Ido
   Walley, John
TI Prevalence of Zika and malaria in patients with fever in secondary
   healthcare facilities in south-eastern Nigeria
SO TROPICAL DOCTOR
LA English
DT Article
DE Zika; malaria; Cross River; fever
ID INFECTIONS; VIRUS; MOSQUITOS
AB We describe the frequency of Zika and malaria among patients presenting with fever to secondary health facilities in Cross River State, Nigeria. Using a cross-sectional, stratified survey design, we randomly selected nine facilities and consecutively recruited 100 participants (aged >= 1 year) who presented with fever. On testing blood samples using Biocan qualitative lateral flow immuno-chromatographic cassettes for Zika IgG and IgM, 10% were seropositive for Zika virus (ZIKV) IgM, 12% for ZIKV IgG and 20% for ZIKV IgM, IgG or both. Following microscopy of thick films stained with Giemsa for malaria parasites, 55% were positive for malaria and 15% were positive for both malaria and ZIKV IgM, IgG or both. A moderately negative association between urban and rural household location and seropositivity for ZIKV IgM or IgG was found on logistic regression. Our results clearly indicate a high rate of probable ZIKV and malaria co-incidence in Cross River State. Given the high risk of serious fetal outcomes following ZIKV infection, further epidemiological research and surveillance systems for ZIKV are clearly required.
C1 [Otu, Akaninyene A.] Univ Calabar, Dept Internal Med, Calabar, Cross River Sta, Nigeria.
   [Udoh, Ubong A.; Ita, Okokon I.] Univ Calabar, Dept Med Microbiol & Parasitol, Calabar, Cross River Sta, Nigeria.
   [Hicks, Joseph P.] Univ Leeds, Leeds Inst Hlth Sci, Nuffield Ctr Int Hlth, Med Stat, Leeds, W Yorkshire, England.
   [Ukpeh, Ido] Univ Calabar, Dept Internal Med, Internal Med, Calabar, Cross River Sta, Nigeria.
   [Walley, John] Univ Leeds, LIHS, Nuffield Ctr Int Hlth & Dev, Int Publ Hlth, Leeds, W Yorkshire, England.
RP Otu, AA (corresponding author), Univ Calabar, Dept Internal Med, Calabar, Cross River Sta, Nigeria.
EM akanotu@yahoo.com
FU AstraZeneca Pharmaceuticals (Pty) LimitedAstraZeneca
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by a research grant provided by AstraZeneca
   Pharmaceuticals (Pty) Limited (https://www.astrazeneca.com/) awarded to
   AAO and UAU. AstraZeneca did not play any role in the study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript. We are grateful to the staff of the various health
   facilities in Cross River State Nigeria who facilitated our recruitment
   of participants.
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   [Anonymous], 2016, DEV ZIK ANT RAP TEST
   Ayorinde AF, 2016, J INFECT PUBLIC HEAL, V9, P52, DOI 10.1016/j.jiph.2015.06.009
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Centre for Disease Control and Prevention, TYP ZIK VIR TESTS
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Eke R. A., 2006, Annals of African Medicine, V5, P42
   Eni EG, 2014, J ACAD IND RES, V2, P472
   Epelboin L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-142
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Ganguly S, 2013, J CLIN MICROBIOL, V51, P1439, DOI 10.1128/JCM.03437-12
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jimenez Corona Maria Eugenia, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053
   Lumley T., 2017, SURVEY ANAL COMPLEX
   Lumley T., 2004, J STAT SOFTW, V9, P1, DOI DOI 10.18637/JSS.V009.I08
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mgbemena IC, 2016, ISSUES BIOL SCI PHAR, V4, P50
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   R Core Team, 2017, R LANG ENV STAT COMP
   RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391
   Roll Back Malaria Partnership, 2005, GLOB STRAT PLAN ROLL
   Smith T, 1999, T ROY SOC TROP MED H, V93, pS59
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496
   Whitley Fund For Nature, CONS END PRIM COMM C
   WHO, 2018, WORLD MAL REP 2018
   WHO, HIST ZIK VIR
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
NR 40
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0049-4755
EI 1758-1133
J9 TROP DOCT
JI Trop. Dr.
PD JAN
PY 2020
VL 50
IS 1
BP 22
EP 30
AR UNSP 0049475519872580
DI 10.1177/0049475519872580
EA AUG 2019
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC1AS
UT WOS:000484497600001
PM 31462185
DA 2020-07-08
ER

PT J
AU Buttner, C
   Heer, M
   Traichel, J
   Schwemmle, M
   Heimrich, B
AF Buettner, Caroline
   Heer, Maxi
   Traichel, Jasmin
   Schwemmle, Martin
   Heimrich, Bernd
TI Zika Virus-Mediated Death of Hippocampal Neurons Is Independent From
   Maturation State
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Article
DE Zika virus; hippocampus; cell death; organotypic slice culture; electron
   microscopy
ID SLICE CULTURES; NEURAL PROGENITORS; DIFFERENTIATION; REPLICATION; BRAIN;
   CELLS; LEADS; MODEL
AB Zika virus (ZIKV) infection of pregnant women and diaplazental transmission to the fetus is linked to the congenital syndrome of microcephaly in newborns. This neuropathology is believed to result from significant death of neuronal progenitor cells (NPC). Here, we examined the fate of neurons in the developing hippocampus, a brain structure which houses neuronal populations of different maturation states. For this purpose, we infected hippocampal slice cultures from immunocompetent newborn mice with ZIKV and monitored changes in hippocampal architecture. In neurons of all hippocampal subfields ZIKV was detected by immunofluorescence labeling and electron microscopy. This includes pyramidal neurons that maturate during the embryonic phase. In the dentate gyrus, ZIKV could be found in the Cajal-Retzius (CR) cells which belong to the earliest born cortical neurons, but also in granule cells that are predominantly generated postnatally. Intriguingly, virus particles were also present in the correctly outgrowing mossy fiber axons of juvenile granule cells, suggesting that viral infection does not impair region- and layer-specific formation of this projection. ZIKV infection of hippocampal tissue was accompanied by both a profound astrocyte reaction indicating tissue injury and a microglia response suggesting phagocytotic activity. Furthermore, depending on the viral load and incubation time, we observed extensive overall neuronal loss in the cultured hippocampal slice cultures. Thus, we conclude ZIKV can replicate in various neuronal populations and trigger neuronal death independent of the maturation state of infected cells.
C1 [Buettner, Caroline; Heer, Maxi; Traichel, Jasmin; Heimrich, Bernd] Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, Ctr Basics NeuroModulat, Freiburg, Germany.
   [Buettner, Caroline; Heer, Maxi; Traichel, Jasmin; Schwemmle, Martin; Heimrich, Bernd] Univ Freiburg, Fac Med, Freiburg, Germany.
   [Schwemmle, Martin] Univ Freiburg, Inst Virol, Med Ctr, Freiburg, Germany.
RP Heimrich, B (corresponding author), Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, Ctr Basics NeuroModulat, Freiburg, Germany.; Schwemmle, M; Heimrich, B (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.; Schwemmle, M (corresponding author), Univ Freiburg, Inst Virol, Med Ctr, Freiburg, Germany.
EM martin.schwemmle@uniklinik-freiburg.de;
   bernd.heimrich@zfn.uni-freiburg.de
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SCHW632/11-2, He1520]
FX This work was supported by the Deutsche Forschungsgemeinschaft
   (SCHW632/11-2 to MS and He1520 to BH).
CR ABBASI J, 2016, PLOS NEGLECT TROP D, V316, P2588, DOI DOI 10.1371/JOURNAL.PNTD.0004682
   BAYER SA, 1990, EXP NEUROL, V107, P48, DOI 10.1016/0014-4886(90)90062-W
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DELRIO JA, 1991, NEUROSCIENCE, V43, P335, DOI 10.1016/0306-4522(91)90298-3
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   FROTSCHER M, 1995, PROG NEUROBIOL, V45, P143, DOI 10.1016/0301-0082(94)00040-O
   FROTSCHER M, 1993, P NATL ACAD SCI USA, V90, P10400, DOI 10.1073/pnas.90.21.10400
   GAHWILER BH, 1984, NEUROSCIENCE, V11, P751, DOI 10.1016/0306-4522(84)90192-1
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HEIMRICH B, 1991, BRAIN RES, V538, P263, DOI 10.1016/0006-8993(91)90438-2
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Mayer D, 2005, J VIROL, V79, P11716, DOI 10.1128/JVI.79.18.11716-11723.2005
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Wu YJ, 2013, P NATL ACAD SCI USA, V110, P1899, DOI 10.1073/pnas.1214939110
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43303-6
   Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263
NR 29
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD AUG 27
PY 2019
VL 13
AR 389
DI 10.3389/fncel.2019.00389
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA IT4PU
UT WOS:000482843800001
PM 31551711
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liang, HB
   Tang, JY
   Liu, ZH
   Liu, YH
   Huang, YY
   Xu, YF
   Hao, P
   Yin, ZN
   Zhong, J
   Ye, LL
   Jin, X
   Wang, HK
AF Liang, Huabin
   Tang, Jinyi
   Liu, Zhihua
   Liu, Yuanhua
   Huang, Yuanyuan
   Xu, Yongfen
   Hao, Pei
   Yin, Zhinan
   Zhong, Jin
   Ye, Lilin
   Jin, Xia
   Wang, Haikun
TI ZIKV infection induces robust Th1-like Tfh cell and long-term protective
   antibody responses in immunocompetent mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID T-CELLS; DIFFERENTIATION; BCL6; IMMUNOGENICITY; SECRETION; PHASE-1;
   SAFETY; ROLES
AB Induction of long-lived antibody responses during infection or vaccination is often essential for subsequent protection, but the relative contributions of T follicular helper (Tfh) cells and T helper 1 (Th1) cells for induction of antigen specific antibody responses to viruses are unclear. Here, we establish an acute Zika virus (ZIKV) infection model in immunocompetent mice, and show that ZIKV infection elicits robust Th1-like Tfh cell and protective antibody responses. While these Th1-like Tfh cells share phenotypic and transcriptomic profiles with both Tfh and Th1 cells, they also have unique surface markers and gene expression characteristics, and are dependent on T-bet for their development. Th1-like Tfh cells, but not Th1 cells, are essential for class switching of ZIKV-specific IgG2c antibodies and maintenance of long-term neutralizing antibody responses. Our study suggests that specific modulation of the Th1-like Tfh cell response during infection or vaccination may augment the induction of antiviral antibody response to ZIKV and other viruses.
C1 [Liang, Huabin; Tang, Jinyi; Liu, Zhihua; Liu, Yuanhua; Huang, Yuanyuan; Xu, Yongfen; Hao, Pei; Zhong, Jin; Jin, Xia; Wang, Haikun] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
   [Liang, Huabin; Tang, Jinyi; Liu, Zhihua; Huang, Yuanyuan; Jin, Xia; Wang, Haikun] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Yin, Zhinan] Jinan Univ, Guangdong Prov Key Lab Mol Immunol & Antibody Eng, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.
   [Ye, Lilin] Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China.
RP Jin, X; Wang, HK (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Jin, X; Wang, HK (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.
EM xjin@ips.ac.cn; hkwang@ips.ac.cn
OI liu, zhihua/0000-0002-8959-2350
FU Strategic Priority Research Program of the Chinese Academy of
   SciencesChinese Academy of Sciences [XDB29040301, XDB29030103]; National
   Key R&D Program of China [2016YFA0502202, 2016YFC1201000]; Ministry of
   Science and Technology of ChinaMinistry of Science and Technology, China
   [2016YFE0133500]; European Union HorisonEuropean Union (EU); Innovation
   Programme under ZIKAlliance [734548]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [31570886]; National Sciences and Technology Major Projects for 'Major
   New Drugs Innovation and Development' [2018ZX09711003-001-004]
FX We thank Dr. H. Tang for kindly providing NKG2D antibody, and Dr. X.Z.
   Liang for kindly providing Ifngr1<SUP>-/-</SUP> mice. This work was
   supported by the following grants: Strategic Priority Research Program
   of the Chinese Academy of Sciences (XDB29040301, X.J.; XDB29030103,
   H.W.), National Key R&D Program of China (2016YFA0502202, H.W., L.Y.;
   2016YFC1201000, X.J), Ministry of Science and Technology of China
   (2016YFE0133500), European Union Horison 2020 Research (X.J., J.Z.) and
   Innovation Programme under ZIKAlliance Grant Agreement 734548 (X.J.,
   H.W., and J.Z.), the National Natural Science Foundation of China
   (31570886, H.W.), and the National Sciences and Technology Major
   Projects for 'Major New Drugs Innovation and Development'
   (2018ZX09711003-001-004, Y.X.).
CR Bautista LE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5566-7
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Fang DF, 2018, J EXP MED, V215, P2705, DOI 10.1084/jem.20180927
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317
   Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870
   King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313
   Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412
   Miyauchi K, 2016, NAT IMMUNOL, V17, P1447, DOI 10.1038/ni.3563
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145
   Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675
   Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012
   Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676
   Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605
   Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890
   Weinstein JS, 2018, J EXP MED, V215, P337, DOI 10.1084/jem.20170457
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002
   Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303
NR 30
TC 2
Z9 2
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 27
PY 2019
VL 10
AR 3859
DI 10.1038/s41467-019-11754-0
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IT2VI
UT WOS:000482711300001
PM 31455769
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mwanga, EP
   Ngowo, HS
   Mapua, SA
   Mmbando, AS
   Kaindoa, EW
   Kifungo, K
   Okumu, FO
AF Mwanga, Emmanuel P.
   Ngowo, Halfan S.
   Mapua, Salum A.
   Mmbando, Arnold S.
   Kaindoa, Emmanuel W.
   Kifungo, Khamis
   Okumu, Fredros O.
TI Evaluation of an ultraviolet LED trap for catching Anopheles and Culex
   mosquitoes in south-eastern Tanzania
SO PARASITES & VECTORS
LA English
DT Article
DE Malaria; An; arabiensis; An; funestus; Culex spp; Mosclean trap; Ifakara
   Health Institute; Light-emitting diodes (LEDs)
ID ADULT AEDES-AEGYPTI; CARBON-DIOXIDE; BG-SENTINEL; LIGHT-TRAP;
   FIELD-EVALUATION; LANDING CATCH; MALARIA; EFFICACY; DIPTERA; POPULATIONS
AB Background Improved surveillance techniques are required to accelerate efforts against major arthropod-borne diseases such as malaria, dengue, filariasis, Zika and yellow-fever. Light-emitting diodes (LEDs) are increasingly used in mosquito traps because they improve energy efficiency and battery longevity relative to incandescent bulbs. This study evaluated the efficacy of a new ultraviolet LED trap (Mosclean) against standard mosquito collection methods. Methods The study was conducted in controlled semi-field settings and in field conditions in rural south-eastern Tanzania. The Mosclean trap was compared to commonly used techniques, namely CDC-light traps, human landing catches (HLCs), BG-Sentinel traps and Suna traps. Results When simultaneously placed inside the same semi-field chamber, the Mosclean trap caught twice as many Anopheles arabiensis as the CDC-light trap, and equal numbers to HLCs. Similar results were obtained when traps were tested individually in the chambers. Under field settings, Mosclean traps caught equal numbers of An. arabiensis and twice as many Culex mosquitoes as CDC-light traps. It was also better at trapping malaria vectors compared to both Suna and BG-Sentinel traps, and was more efficient in collecting mosquitoes indoors than outdoors. The majority of An. arabiensis females caught by Mosclean traps were parous (63.6%) and inseminated (89.8%). In comparison, the females caught by CDC-light traps were 43.9% parous and 92.8% inseminated. Conclusions The UV LED trap (Mosclean trap) was efficacious for sampling Anopheles and Culex mosquitoes. Its efficacy was comparable to and in some instances better than traps commonly used for vector surveillance. The Mosclean trap was more productive in sampling mosquitoes indoors compared to outdoors. The trap can be used indoors near human-occupied nets, or outdoors, in which case additional CO2 improves catches. We conclude that this trap may have potential for mosquito surveillance. However, we recommend additional field tests to validate these findings in multiple settings and to assess the potential of LEDs to attract non-target organisms, especially outdoors.
C1 [Mwanga, Emmanuel P.; Ngowo, Halfan S.; Mapua, Salum A.; Mmbando, Arnold S.; Kaindoa, Emmanuel W.; Kifungo, Khamis; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Morogoro, Tanzania.
   [Ngowo, Halfan S.; Okumu, Fredros O.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.
   [Kaindoa, Emmanuel W.; Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
RP Mwanga, EP (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Morogoro, Tanzania.
EM emwanga@ihi.or.tz
OI Ngowo, Halfan/0000-0003-2789-0261; Mwanga, Emmanuel
   P./0000-0003-1799-3830
FU Wellcome Trust Intermediate Fellowship in Public Health and Tropical
   Medicine grantWellcome Trust [WT102350/Z/13/Z]
FX This work was funded by Wellcome Trust Intermediate Fellowship in Public
   Health and Tropical Medicine grant awarded to FO (Grant Number
   WT102350/Z/13/Z).
CR [Anonymous], 1995, World Health Organ Tech Rep Ser, V857, P1
   Bates D., 2009, PACKAGE LME4 VERSION
   Batista EPA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205358
   Batista EPA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186696
   Biogents, 2019, BG SUN PROF IS SPEC
   BRADY J, 1963, B WORLD HEALTH ORGAN, V29, P147
   Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471
   Burkett DA, 1998, J AM MOSQUITO CONTR, V14, P186
   Canyon DV, 1997, J AM MOSQUITO CONTR, V13, P66
   Cohnstaedt LW, 2008, J AM MOSQUITO CONTR, V24, P331, DOI 10.2987/5619.1
   Costa-Neta BM, 2017, J MED ENTOMOL, V54, P1699, DOI 10.1093/jme/tjx148
   DAVIS JR, 1995, MED VET ENTOMOL, V9, P249, DOI 10.1111/j.1365-2915.1995.tb00130.x
   DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126
   DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Ferguson HM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-158
   GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295
   Govella NJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1513-1
   Govella NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-157
   Hawkes FM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17632-3
   Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257
   Hoel DF, 2007, J VECTOR ECOL, V32, P302, DOI 10.3376/1081-1710(2007)32[302:ROPSFT]2.0.CO;2
   Homan T, 2016, LANCET, V388, P1193, DOI 10.1016/S0140-6736(16)30445-7
   John W, 2019, CDC MINIATURE LIGHT
   Kaindoa EW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177807
   Kaindoa EW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1268-8
   Kim HC, 2017, J MED ENTOMOL, V54, P221, DOI 10.1093/jme/tjw136
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mathenge EM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-7
   Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137
   Mboera L., 2006, TANZAN J HLTH RES, V7, P117
   Mboera L E G, 2005, Tanzan Health Res Bull, V7, P117
   Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595
   Mboera LEG, 2000, MED VET ENTOMOL, V14, P257, DOI 10.1046/j.1365-2915.2000.00239.x
   Mburu MM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2680-7
   McQwin's wholesale, 2019, MOSCL MOSQ TRAP
   Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8
   Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8
   Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160
   Ngowo Halfan S, 2017, Wellcome Open Res, V2, P102, DOI 10.12688/wellcomeopenres.12928.1
   Okumu FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030967
   Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573
   Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951
   Pombi M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0674-7
   R Development Core Team, 2018, R LANG ENV STAT COMP
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   ROSAY B, 1969, MOSQ NEWS, V29, P419
   Seoul Viosys, 2017, MOSCL TRAP
   Sikulu M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-197
   Silva FS, 2016, J MED ENTOMOL, V53, P634, DOI 10.1093/jme/tjw016
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042
   SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126
   Tangena JAA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138735
   Viribright, 2019, VIRIBRIGHT COMP LED
   WHO, 2018, MAL SURV MON EV REF
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Wickham H., 2009, GGPLOT2
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
   World Health Organization, 2015, GLOB TECHN STRAT MAL
   ZAIM M, 1986, J AM MOSQUITO CONTR, V2, P511
NR 62
TC 1
Z9 1
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD AUG 27
PY 2019
VL 12
IS 1
AR 418
DI 10.1186/s13071-019-3673-7
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IT6HI
UT WOS:000482972000002
PM 31455370
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nurtop, E
   Moyen, N
   Dzia-Lepfoundzou, A
   Dimi, Y
   Ninove, L
   Drexler, JF
   Gallian, P
   de Lamballerie, X
   Priet, S
AF Nurtop, Elif
   Moyen, Nanikaly
   Dzia-Lepfoundzou, Amelia
   Dimi, Yannick
   Ninove, Laetitia
   Drexler, Jan Felix
   Gallian, Pierre
   de Lamballerie, Xavier
   Priet, Stephane
TI A Report of Zika Virus Seroprevalence in Republic of the Congo
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Zika virus; seroepidemiology; Africa
AB Zika virus (ZIKV) is an arthropod-borne RNA virus (arbovirus), belonging to the Spondweni serogroup. ZIKV was first described in Africa in 1947 and remained sporadic until Micronesia outbreak in 2007, which was followed by outbreaks in the Pacific Islands, Latin America, and the Caribbean. Subsequent to the epidemics, ZIKV revealed its severity as virus was sexually transmissible, and it was associated with serious fetal and neurological complications. ZIKV originated from Africa; however, little is known about the epidemiology of the virus in African populations. Following a recent study in Cameroon that evidenced low ZIKV epidemiology associated with a presumptive (peri-)sylvatic transmission, we performed a seroepidemiological study in Republic of the Congo, neighbor of Cameroon. To accomplish this, 386 serum specimens from volunteer blood donors collected in 2011 from rural and urban areas of Republic of the Congo were tested with ZIKV-specific methodology; primary screening with anti-NS1 ZIKV IgG ELISA followed by confirmation with cytopathic effect (CPE)-based virus neutralization test (VNT). ZIKV seropositivity was determined as low as 1.8%, varying slightly between urban and rural areas (1.7% and 3.6%). These results demonstrate that the majority of the population of Republic of the Congo is immunologically naive against ZIKV with a presumptive (peri-)sylvatic transmission cycle, which emphasizes the importance of surveillance studies in Africa.
C1 [Nurtop, Elif; Moyen, Nanikaly; Ninove, Laetitia; Gallian, Pierre; de Lamballerie, Xavier; Priet, Stephane] Aix Marseille Univ, IRD 190, Inserm 1207, UVE,IHU Mediterranee Infect, Marseille, France.
   [Dzia-Lepfoundzou, Amelia; Dimi, Yannick] Ctr Natl Transfus Sanguine, Brazzaville, Rep Congo.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Gallian, Pierre] Etab Francais Sang Prov Alpes Cote Azur & Corse E, Lab Virol, Marseille, France.
RP Nurtop, E (corresponding author), Fac Med Timone, 27 Blvd Jean Moulin 13005, F-13385 Marseille 5, France.
EM elif.nurtop@etu.univ-amu.fr
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance grant [734548]; European Union's Horizon 2020 Research and
   Innovation Programme under European Virus Archive EVAg; European
   Union-Horizon 2020 programme [653316]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance grant agreement no.
   734548 and the European Virus Archive EVAg; European Union-Horizon 2020
   programme under grant agreement no. 653316. We thank the GDRI
   GRAVIR-Groupement de Recherche sur les Arthropodes Vecteurs en afrIque
   centRale.
CR Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Kayiwa JT, 2018, J GEN VIROL, V99, P1248, DOI 10.1099/jgv.0.001113
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mathe P, 2018, J CLIN VIROL, V105, P35, DOI 10.1016/j.jcv.2018.05.011
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   PELLISSIER AIME, 1954, BULL SOC PATHOL EXOT, V47, P223
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Saba V, 2018, PLOS NEGLECT TROP D, V12
   Willcox AC, 2018, AM J TROP MED HYG, V99, P756, DOI 10.4269/ajtmh.18-0156
   World Health Organization, 2009, DENG HAEM FEV LAB DI
NR 19
TC 1
Z9 1
U1 2
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JAN 1
PY 2020
VL 20
IS 1
BP 40
EP 42
DI 10.1089/vbz.2019.2466
EA AUG 2019
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KA2WL
UT WOS:000482686600001
PM 31448988
DA 2020-07-08
ER

PT J
AU Mosca, F
   Slawek, P
   Carraher, C
   Roner, M
   Miller, L
   Haky, J
AF Mosca, Francesca
   Slawek, Paul
   Carraher, Charles
   Roner, Michale
   Miller, Lindsey
   Haky, Jerome
TI Synthesis of organotin polymers from the HIV drug lamivudiine (3TC) and
   their ability to inhibit the Zika virus
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT Fall National Meeting and Exposition of the American-Chemical-Society
   (ACS)
CY AUG 25-29, 2019
CL San Diego, CA
SP Amer Chem Soc
C1 [Mosca, Francesca; Slawek, Paul; Carraher, Charles] Florida Atlantic Univ, Dept Chem & Biochem, Parkland, FL USA.
   [Roner, Michale; Miller, Lindsey] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.
   [Haky, Jerome] Florida Atlantic Univ, Boca Raton, FL 33431 USA.
EM fmosca@fau.edu; carraher@fau.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 25
PY 2019
VL 258
MA 313-PMSE
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA LC1AO
UT WOS:000525061504491
DA 2020-07-08
ER

PT J
AU Telehany, S
   Humby, M
   McGee, D
   Jacobs, A
   Rizzo, R
AF Telehany, Stephen
   Humby, Monica
   McGee, Dwight
   Jacobs, Amy
   Rizzo, Robert
TI Identification and characterization of small molecule inhibitors of Zika
   virus glycoprotein E
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT ACS Fall National Meeting and Exposition
CY AUG 25-29, 2019
CL San Diego, CA
SP Amer Chem S oc
C1 [Telehany, Stephen] SUNY Stony Brook, Chem, North Massapequa, NY USA.
   [Humby, Monica; Jacobs, Amy] Univ Buffalo, Jacobs Sch Med, Buffalo, NY USA.
   [McGee, Dwight; Rizzo, Robert] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.
   [Rizzo, Robert] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.
   [Rizzo, Robert] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY 11794 USA.
EM stephentelehany@mail.adelphi.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 25
PY 2019
VL 258
MA 283-COMP
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA LC0YG
UT WOS:000525055504644
DA 2020-07-08
ER

PT J
AU Jimenez, P
   Kestelman, E
   Kestelman, B
   Vizzoni, AG
   Cerbino-Neto, J
   Curi, ALL
AF Jimenez, Paulo
   Kestelman, Eduardo
   Kestelman, Bernardo
   Vizzoni, Alexandre Gomes
   Cerbino-Neto, Jose
   Land Curi, Andre Luiz
TI Multifocal Choroiditis Secondary to Acute Zika Virus Infection
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Letter; Early Access
DE infection; inflammation; multifocal choroiditis; uveitis; Zika
AB Purpose: To describe a case of Acute Zika infection with ocular involvementMethods: Review of clinical recordsResults: Patient presented with sudden blurred vision in both eyes during an acute episode of zika virus infection. Ophthalmological examination revealed clinical picture of multifocal choroiditis in both eyes. Lesions improved and visual acuities returned to normal level without any treatment.Conclusion: Ocular changes in acute Zika virus infection is a rare condition. Patiens may present spontaneous recovery
C1 [Jimenez, Paulo] Oftalmoclin Sao Goncalo, Ctr Oftalmol Ipanema, Dept Ophthalmol, Rio De Janeiro, Brazil.
   [Kestelman, Eduardo] Oftalmoclin Sao Goncalo, Dept Ophthalmol, Sao Goncalo, Brazil.
   [Kestelman, Bernardo] Fac Ciencias Med Santa Casa Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Vizzoni, Alexandre Gomes; Cerbino-Neto, Jose] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas INI, Dept Infect Dis, Rio De Janeiro, Brazil.
   [Land Curi, Andre Luiz] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas INI, Clin Res Lab Infect Dis Ophthalmol, R Otavio Kelly 500 Ap 1502, BR-24220301 Rio De Janeiro, Brazil.
RP Curi, ALL (corresponding author), Fiocruz MS, Natl Inst Infect Dis Evandro Chagas INI, Clin Res Lab Infect Dis Ophthalmol, R Otavio Kelly 500 Ap 1502, BR-24220301 Rio De Janeiro, Brazil.
EM andre.curi@ini.fiocruz.br
RI Neto, Jose Cerbino/P-3713-2018; Vizzoni, Alexandre/A-1524-2016
OI Neto, Jose Cerbino/0000-0001-9254-917X; Vizzoni,
   Alexandre/0000-0003-0004-5084
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Singh Mandeep S, 2018, Am J Ophthalmol Case Rep, V10, P6, DOI 10.1016/j.ajoc.2018.01.023
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 13
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
DI 10.1080/09273948.2019.1651872
EA AUG 2019
PG 4
WC Ophthalmology
SC Ophthalmology
GA JB1NH
UT WOS:000488326700001
PM 31567025
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
   Smith, PG
   Luo, R
   Kelly-Cirino, C
   Curry, D
   Larson, H
   Durbin, A
   Chu, M
   Tharmaphornpilas, P
   Ng, LC
   Sartori, AMC
   Luna, EJA
   Gublerj, DJ
   Espana, G
   Yoon, IK
   Flasche, S
AF Wilder-Smith, A.
   Smith, P. G.
   Luo, R.
   Kelly-Cirino, C.
   Curry, D.
   Larson, H.
   Durbin, A.
   Chu, M.
   Tharmaphornpilas, P.
   Ng, L. C.
   Sartori, A. M. C.
   Luna, E. J. A.
   Gublerj, D. J.
   Espana, G.
   Yoon, I. K.
   Flasche, S.
TI Pre-vaccination screening strategies for the use of the CYD-TDV dengue
   vaccine: A meeting report
SO VACCINE
LA English
DT Article
DE WHO; Rapid diagnostic tests; Dengue; Vaccine hesitancy; Communication;
   Ethics; Brazil; Philippines; National vaccination programmes
ID ZIKA
AB The first licensed dengue vaccine, CYD-TDV (Dengvaxia) is efficacious in seropositive individuals, but increases the risk for severe dengue in seronegative persons about two years after administration of the first dose. For countries considering the introduction of Dengvaxia, WHO recommends a pre-vaccination screening strategy whereby only persons with evidence of a past dengue infection would be vaccinated. Policy-makers need to consider the risk-benefit of vaccination strategies based on such screening tests, the optimal age to introduce the vaccine, communication and implementation strategies. To address these questions, the Global Dengue and Aedes-transmitted diseases Consortium (GDAC) organized a 3-day workshop in January 2019 with country representatives from Asia and Latin America.
   The meeting discussions highlighted many challenges in introducing Dengvaxia, in terms of screening test characteristics, costs of such tests combined with a 3-dose schedule, logistics, achieving high coverage rates, vaccine confidence and communication; more challenges than for any other vaccine introduction programme. A screening test would require a high specificity to minimize individual risk, and at the same time high sensitivity to maximize individual and population benefit. The underlying seroprevalence dependent positive predictive value is the best indicator for an acceptable safety profile of a pre-vaccination screening strategy. The working groups discussed many possible implementation strategies. Addressing the bottlenecks in school-based vaccine introduction for Dengvaxia will also benefit other vaccines such as HPV and booster doses for tetanus and pertussis. Levels of public trust are highly variable and context specific, and understanding of population perceptions and concerns is essential to tailor interventions, monitor and mitigate risks.
C1 [Wilder-Smith, A.; Smith, P. G.; Luo, R.; Larson, H.; Flasche, S.] London Sch Hyg & Trop Med, London, England.
   [Wilder-Smith, A.] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
   [Luo, R.; Kelly-Cirino, C.] Fdn Innovat New Diagnost, Geneva, Switzerland.
   [Curry, D.] GE2P2 Global Fdn, Ctr Vaccine Eth & Policy, Washington, DC USA.
   [Durbin, A.] Johns Hopkins Univ, Baltimore, MD USA.
   [Chu, M.] George Washington Univ, Washington, DC 20052 USA.
   [Tharmaphornpilas, P.] Minist Publ Hlth, Dept Dis Control, Bangkok, Thailand.
   [Ng, L. C.] Natl Environm Agcy, Singapore, Singapore.
   [Sartori, A. M. C.; Luna, E. J. A.] Univ Sao Paolo, Sao Paulo, Brazil.
   [Gublerj, D. J.] Duke NUS Med Sch, Singapore, Singapore.
   [Gublerj, D. J.; Yoon, I. K.] Global Dengue & Aedes Transmitted Dis Consortium, Seoul, South Korea.
   [Espana, G.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Espana, G.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Yoon, I. K.] Int Vaccine Inst, Seoul, South Korea.
RP Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, London, England.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
RI Sartori, Ana Marli Christovam/I-6663-2012
OI Sartori, Ana Marli Christovam/0000-0003-3777-0757; Kelly-Cirino,
   Cassandra/0000-0002-4526-8487
FU Sanofi Pasteur; bioMerieux; Chembio Diagnostic Systems
FX The meeting was financially supported through unrestricted grants by
   Sanofi Pasteur, bioMerieux and Chembio Diagnostic Systems. The funders
   did not play a role in the organization of the workshop, nor in the
   writing of the meeting report.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Angelo KM, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz046
   Arien KK, 2018, LANCET GLOB HEALTH, pe30, DOI [10.1016/52214-109X(18)30295-X, DOI 10.1016/52214-109X(18)30295-X]
   Batchelor T, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay092
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Ceccarelli G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tax080
   Chatterjee P, 2019, LANCET INFECT DIS, V19, P584, DOI 10.1016/S1473-3099(19)30212-9
   Cousins S, 2019, LANCET INFECT DIS, V19, P362, DOI 10.1016/S1473-3099(19)30129-X
   Durrheim DN, 2019, INT J INFECT DIS, V83, P95, DOI 10.1016/j.ijid.2019.04.016
   Espana G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007482
   Flasche S, 2019, LANCET INFECT DIS, V19, P465, DOI 10.1016/S1473-3099(19)30167-7
   Goncalves A, 2017, J INFECT DIS, DOI [10.1093/infdis/jjx678, DOI 10.1093/INFDIS/JJX678]
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Gubler DJ, 2015, VACCINE, V33, P1233, DOI 10.1016/j.vaccine.2015.01.002
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Jaenisch T, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0601-z
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Katzelnick LC, 2018, CURR OPIN VIROL, V29, P51, DOI 10.1016/j.coviro.2018.03.004
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Larson H. J., 2015, PLOS CURRENTS OUTBRE, DOI [10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4, DOI 10.1371/CURRENTS.OUTBREAKS.CE0F6177BC97332602A8E3FE7D7F7CC4]
   Larson HJ, 2018, LANCET, V392, P2244, DOI 10.1016/S0140-6736(18)32608-4
   Larson HJ, 2019, HUM VACC IMMUNOTHER, V15, P625, DOI 10.1080/21645515.2018.1522468
   Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042
   Leong WY, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay080
   Luo R, 2019, CLIN MICROBIOL INFEC, V25, P659, DOI 10.1016/j.cmi.2019.01.002
   Massad E., 2018, J TRAVEL MED, V25, DOI [10.1093/itm/tay091, DOI 10.1093/ITM/TAY091]
   Masyeni S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay061
   Memish ZA, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz041
   Neuberger A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw003
   O'Neill SL, 2018, ADV EXP MED BIOL, V1062, P355, DOI 10.1007/978-981-10-8727-1_24
   Perez-Molina JA, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax035
   Perman S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4168-0
   Rabinowicz S, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax062
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Riddell A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax015
   Ritchie SA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay084
   Rodriguez-Barraquer I, 2019, LANCET INFECT DIS, V19, P132, DOI 10.1016/S1473-3099(18)30799-0
   Sadarangani SP, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax014
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Staehelin C, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz035
   Tan LK, 2019, AM J EPIDEMIOL, V188, P1529, DOI 10.1093/aje/kwz110
   Tomashek KM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006497
   Tustin JL, 2018, JMIR PUBLIC HLTH SUR, V4, P238, DOI 10.2196/publichealth.8921
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Wilder-Smith A, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0656-3
   Wilder-Smith A, 2019, LANCET INFECT DIS, V19, pE31, DOI 10.1016/S1473-3099(18)30494-8
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay057
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2016, J INFECT DIS, V214, P1796, DOI 10.1093/infdis/jiw341
   World Health Organization, 2018, WKLY EPIDEMIOL REC, V93, P457
NR 53
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD AUG 23
PY 2019
VL 37
IS 36
BP 5137
EP 5146
DI 10.1016/j.vaccine.2019.07.016
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IU2PM
UT WOS:000483422300001
PM 31377079
DA 2020-07-08
ER

PT J
AU Guidry, JPD
   Carlyle, KE
   Perrin, PB
   LaRose, JG
   Ryan, M
   Messner, M
AF Guidry, Jeanine P. D.
   Carlyle, Kellie E.
   Perrin, Paul B.
   LaRose, Jessica G.
   Ryan, Mark
   Messner, Marcus
TI A path model of psychosocial constructs predicting future Zika vaccine
   uptake intent
SO VACCINE
LA English
DT Article
DE Zika; Zika vaccine; EPPM; Path modeling
ID HEALTH BELIEF MODEL; HUMAN-PAPILLOMAVIRUS; INFLUENZA VACCINATION; FIT
   INDEXES; VIRUS; ACCEPTABILITY; IMMUNIZATION; HESITANCY; PERCEPTIONS;
   ACCEPTANCE
AB Objective: The recent Zika virus outbreak, while no longer an international public health emergency, is still a serious threat, particularly to pregnant women and babies born to pregnant women infected with the virus. This study examined the predictive effects of psychosocial constructs on self-reported intent to get a future Zika vaccine among women of reproductive age.
   Methods: Data were collected using an online survey with a representative sample of 339 women ages 18-49 from the continental United States. The survey addressed variables originating with the Extended Parallel Processing Model (EPPM) as related to future Zika vaccine uptake intent.
   Results: Three quarters of all respondents reported intention to get a future Zika vaccine. Path modeling revealed a direct effect of perceived susceptibility, self-efficacy, and response efficacy on future Zika vaccine uptake intent, as well as an indirect effect of perceived susceptibility through both self-efficacy and response efficacy. In addition, the final model showed an indirect effect of perceived severity on Zika vaccine uptake intent through self-efficacy and response efficacy and accounted for 54.6% of the variance in vaccination intent.
   Conclusions: These findings have implications for future Zika vaccine promotion campaigns.
   This study confirms the importance of perceived susceptibility, self-efficacy, and response efficacy for use in Zika vaccine uptake campaigns: in addition, when using perceived severity, both self-efficacy and response efficacy should be considered in message design. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Guidry, Jeanine P. D.; Carlyle, Kellie E.; Perrin, Paul B.; LaRose, Jessica G.; Ryan, Mark; Messner, Marcus] Virginia Commonwealth Univ, Richmond, VA 23284 USA.
RP Guidry, JPD (corresponding author), Virginia Commonwealth Univ, Richmond, VA 23284 USA.
EM guidryjd@vcu.edu
RI Perrin, Paul/L-5373-2015
OI Perrin, Paul/0000-0003-2070-215X; Guidry, Jeanine/0000-0002-6903-7464
FU Department of Health Behavior and Policy, Virginia Commonwealth
   University
FX Provided by Department of Health Behavior and Policy, Virginia
   Commonwealth University.
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I., 1985, INTENTIONS ACTIONS T
   Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Bennett KK, 2012, J SOC PSYCHOL, V152, P480, DOI 10.1080/00224545.2011.639408
   BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238
   Betsch C, 2015, P NATL ACAD SCI USA, V112, pE6725, DOI 10.1073/pnas.1516350112
   Betsch C, 2013, HEALTH PSYCHOL, V32, P146, DOI 10.1037/a0027387
   Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048
   Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013
   Byrne BM, 1994, BASIC CONCEPTS APPL
   Cameron KA, 2009, HEALTH COMMUN, V24, P316, DOI 10.1080/10410230902889258
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535
   Chen MF, 2011, J COMMUN HEALTH NURS, V28, P29, DOI 10.1080/07370016.2011.539087
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Ding H, 2011, AM J OBSTET GYNECOL, V204, pS96, DOI 10.1016/j.ajog.2011.03.003
   Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657
   Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fisher BM, 2011, AM J OBSTET GYNECOL, V204, pS107, DOI 10.1016/j.ajog.2011.02.041
   Fridman D, 2011, AM J OBSTET GYNECOL, V204, pS124, DOI 10.1016/j.ajog.2011.04.011
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Gargano LM, 2011, HUM VACCINES, V7, P89, DOI 10.4161/hv.7.1.13460
   Gerend MA, 2012, ANN BEHAV MED, V44, P171, DOI 10.1007/s12160-012-9366-5
   Gorman JR, 2012, VACCINE, V31, P213, DOI 10.1016/j.vaccine.2012.10.064
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Johnson KL, 2017, J COMMUN HEALTH, V42, P522, DOI 10.1007/s10900-016-0284-5
   Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112
   Kenny D. A, 2014, MEASURING MODEL FIT
   Krieger JL, 2013, HEALTH COMMUN, V28, P5, DOI 10.1080/10410236.2012.734914
   Kumar S, 2012, HEALTH EDUC BEHAV, V39, P229, DOI 10.1177/1090198111415105
   Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081
   Lindley MC, 2006, AM J PREV MED, V31, P281, DOI 10.1016/j.amepre.2006.06.025
   Lipsitch M, 2016, SCIENCE, V353, P1094, DOI 10.1126/science.aai8126
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080
   Meyers LS, 2013, APPL MULTIVARIATE RE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mo PKH, 2015, HEALTH EDUC RES, V30, P706, DOI 10.1093/her/cyv038
   Montano D. E., 2015, HLTH BEHAV THEORY RE, P95
   Muhsen K, 2012, VACCINE, V30, P2109, DOI 10.1016/j.vaccine.2012.01.044
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15
   Nan XL, 2012, HEALTH COMMUN, V27, P559, DOI 10.1080/10410236.2011.617243
   NIH, 2017, PHAS 2 ZIK VACC TRIA
   O'Keefe DJ, 2012, HEALTH COMMUN, V27, P776, DOI 10.1080/10410236.2011.640974
   Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013
   Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054
   Shahrabani S, 2012, HEALTH EDUC BEHAV, V39, P612, DOI 10.1177/1090198111427411
   Siu W, 2008, PSYCHOL REP, V102, P539, DOI 10.2466/PR0.102.2.539-550
   Southwell BG, 2018, EMERG INFECT DIS, V24, P938, DOI 10.3201/eid2405.171570
   Stockwell MS, 2011, PUBLIC HEALTH REP, V126, P24, DOI 10.1177/00333549111260S204
   Tabachnick B.G., 2001, USING MULTIVARIATE S
   Teitler-Regev Sharon, 2011, Adv Prev Med, V2011, P353207, DOI 10.4061/2011/353207
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Wei FF, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-18
   Wheldon CW, 2015, J HEALTH PSYCHOL, V20, P427, DOI 10.1177/1359105313502693
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   World Health Organisation, 2011, GLOB PREV AN 2011
   World Health Organization, 2017, ZIK VIR COMPL
   Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018
NR 65
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD AUG 23
PY 2019
VL 37
IS 36
BP 5233
EP 5241
DI 10.1016/j.vaccine.2019.07.064
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IU2PM
UT WOS:000483422300013
PM 31375439
DA 2020-07-08
ER

PT J
AU Brainard, J
AF Brainard, Jeffrey
TI Cuba harbored 'hidden' Zika outbreak
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 23
PY 2019
VL 365
IS 6455
SI SI
BP 726
EP 726
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IS9JH
UT WOS:000482464000004
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Saraf, S
   Gangavarapu, K
   Watts, A
   Tan, AL
   Oidtman, RJ
   Ladner, JT
   Oliveira, G
   Matteson, NL
   Kraemer, MUG
   Vogels, CBF
   Hentoff, A
   Bhatia, D
   Stanek, D
   Scott, B
   Landis, V
   Stryker, I
   Cone, MR
   Kopp, EW
   Cannons, AC
   Heberlein-Larson, L
   White, S
   Gillis, LD
   Ricciardi, MJ
   Kwal, J
   Lichtenberger, PK
   Magnani, DM
   Watkins, DI
   Palacios, G
   Hamer, DH
   Gardner, LM
   Perkins, TA
   Baele, G
   Khan, K
   Morrison, A
   Isern, S
   Michael, SF
   Andersen, KG
AF Grubaugh, Nathan D.
   Saraf, Sharada
   Gangavarapu, Karthik
   Watts, Alexander
   Tan, Amanda L.
   Oidtman, Rachel J.
   Ladner, Jason T.
   Oliveira, Glenn
   Matteson, Nathaniel L.
   Kraemer, Moritz U. G.
   Vogels, Chantal B. F.
   Hentoff, Aaron
   Bhatia, Deepit
   Stanek, Danielle
   Scott, Blake
   Landis, Vanessa
   Stryker, Ian
   Cone, Marshall R.
   Kopp, Edgar W.
   Cannons, Andrew C.
   Heberlein-Larson, Lea
   White, Stephen
   Gillis, Leah D.
   Ricciardi, Michael J.
   Kwal, Jaclyn
   Lichtenberger, Paola K.
   Magnani, Diogo M.
   Watkins, David, I
   Palacios, Gustavo
   Hamer, Davidson H.
   Gardner, Lauren M.
   Perkins, T. Alex
   Baele, Guy
   Khan, Kamran
   Morrison, Andrea
   Isern, Sharon
   Michael, Scott F.
   Andersen, Kristian G.
CA GeoSentinel Surveillance Network
TI Travel Surveillance and Genomics Uncover a Hidden Zika Outbreak during
   the Waning Epidemic
SO CELL
LA English
DT Article
ID ACTIVE COMMUNITY PARTICIPATION; GEOSENTINEL SURVEILLANCE; RETURNED
   TRAVELERS; AEDES-AEGYPTI; VIRUS-DISEASE; TRANSMISSION; DENGUE; CUBA;
   CHIKUNGUNYA; PERFORMANCE
AB The Zika epidemic in the Americas has challenged surveillance and control. As the epidemic appears to be waning, it is unclear whether transmission is still ongoing, which is exacerbated by discrepancies in reporting. To uncover locations with lingering outbreaks, we investigated travel-associated Zika cases to identify transmission not captured by reporting. We uncovered an unreported outbreak in Cuba during 2017, a year after peak transmission in neigh-boring islands. By sequencing Zika virus, we show that the establishment of the virus was delayed by a year and that the ensuing outbreak was sparked by long-lived lineages of Zika virus from other Caribbean islands. Our data suggest that, although mosquito control in Cuba may initially have been effective at mitigating Zika virus transmission, such measures need to be maintained to be effective. Our study highlights how Zika virus may still be ''silently'' spreading and provides a framework for understanding outbreak dynamics.
C1 [Grubaugh, Nathan D.; Vogels, Chantal B. F.; Hentoff, Aaron] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Grubaugh, Nathan D.; Saraf, Sharada; Gangavarapu, Karthik; Oliveira, Glenn; Matteson, Nathaniel L.; Michael, Scott F.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Watts, Alexander; Bhatia, Deepit; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada.
   [Tan, Amanda L.; Isern, Sharon] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA.
   [Tan, Amanda L.; Stryker, Ian; Cone, Marshall R.; Kopp, Edgar W.; Cannons, Andrew C.; Heberlein-Larson, Lea] Florida Dept Hlth, Div Dis Control & Hlth Protect, Bur Publ Hlth Labs, Tampa, FL 33612 USA.
   [Oidtman, Rachel J.; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Oidtman, Rachel J.; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Ladner, Jason T.; Palacios, Gustavo] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA.
   [Ladner, Jason T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA 02115 USA.
   [Stanek, Danielle; Scott, Blake; Landis, Vanessa; Morrison, Andrea] Florida Dept Hlth, Div Dis Control & Hlth Protect, Bur Epidemiol, Tallahassee, FL 32399 USA.
   [White, Stephen; Gillis, Leah D.] Florida Dept Hlth, Div Dis Control & Hlth Protect, Bur Publ Hlth Labs, Miami, FL 33125 USA.
   [Ricciardi, Michael J.; Kwal, Jaclyn; Lichtenberger, Paola K.; Magnani, Diogo M.; Watkins, David, I] Univ Miami, Dept Pathol, Miller Sch Med, Miami, FL 33136 USA.
   [Magnani, Diogo M.] Univ Massachusetts, MassBiol, Med Sch, Boston, MA 02126 USA.
   [Hamer, Davidson H.] Boston Univ, Dept Global Hlth, Sch Publ Hlth, Boston, MA 02118 USA.
   [Hamer, Davidson H.] Boston Med Ctr, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.
   [Gardner, Lauren M.] UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW 2052, Australia.
   [Gardner, Lauren M.] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21287 USA.
   [Baele, Guy] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON M5B 1T8, Canada.
   [Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA 92037 USA.
RP Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Grubaugh, ND; Michael, SF; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.
EM nathan.grubaugh@yale.edu; smichael@fgcu.edu; andersen@scripps.edu
RI Palacios, Gustavo/I-7773-2015; Bhatia, Deepit/AAC-1444-2020; Hamer,
   Davidson/J-2020-2019; Baele, Guy/R-8157-2017
OI Palacios, Gustavo/0000-0001-5062-1938; Hamer,
   Davidson/0000-0002-4700-1495; Vogels, Chantal/0000-0003-0027-6480;
   Baele, Guy/0000-0002-1915-7732; Grubaugh, Nathan/0000-0003-2031-1933;
   Magnani, Diogo/0000-0002-1773-2406
FU Arthur J. Schmitt Leadership Fellowship in Science and Engineering; Eck
   Institute for Global Health Graduate Fellowship; Branco Weiss
   Fellowship-Society in Science; National Institute of Child Health and
   Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD040128]; Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [U50CK00189]; Public Health Agency of Canada; Interne
   Fondsen KU Leuven/Internal Funds KU Leuven [C14/18/094]; RAPID award
   from the National Science Foundation [DEB 1641130]; Defense Advanced
   Research Projects AgencyUnited States Department of DefenseDefense
   Advanced Research Projects Agency (DARPA) [D16AP0014]; NIH NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI099210]; NIH NCATS CTSAUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [UL1TR002550]; NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI135995,
   HHSN272201400048C, R21AI137690]; Ray Thomas Foundation; International
   Society of Travel Medicine; NWO RubiconNetherlands Organization for
   Scientific Research (NWO) [019.181EN. 004]
FX We thank R. Robles-Sikisaka, M. Pauthner, E. Spencer, M. R. Wiley, K.
   Prieto, S. Taylor, and P. Jack for laboratory support and the ECDC for
   graciously providing data regarding travel-associated Zika virus
   infections. The findings and conclusions in this report are those of the
   authors and do not necessarily represent the official position of the US
   Army, CDC, ECDC, or the FL-DOH. R. J. O. received support from the
   Arthur J. Schmitt Leadership Fellowship in Science and Engineering and
   from an Eck Institute for Global Health Graduate Fellowship. M. U. G. K.
   is supported by The Branco Weiss Fellowship-Society in Science,
   administered by the ETH Zurich, and acknowledges funding from a training
   grant from the National Institute of Child Health and Human Development
   (T32HD040128). C. B. F. V. is supported by NWO Rubicon 019.181EN. 004.
   GeoSentinel, the Global Surveillance Network of the International
   Society of Travel Medicine, is supported by a cooperative agreement
   (U50CK00189) from the Centers for Disease Control and Prevention as well
   as the International Society of Travel Medicine and the Public Health
   Agency of Canada. G. B. acknowledges support from the Interne Fondsen KU
   Leuven/Internal Funds KU Leuven under grant agreement C14/18/094. T. A.
   P. received support from a RAPID award from the National Science
   Foundation (DEB 1641130) and a Young Faculty Award from the Defense
   Advanced Research Projects Agency (D16AP0014). S. I. and S. F. M. are
   supported by NIH NIAID R01AI099210. K. G. A. is a Pew Biomedical Scholar
   and is supported by NIH NCATS CTSA UL1TR002550, NIAID contract
   HHSN272201400048C, NIAID R21AI137690, NIAID U19AI135995, and The Ray
   Thomas Foundation.
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   [Anonymous], 2017, REUTERS
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Serrate PCF, 2016, MEDICC REV, V18, P48
   Castro M, 2017, AM J TROP MED HYG, V97, P311, DOI 10.4269/ajtmh.16-0906
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   CDC, 2018, ZIK TRAV INF
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   FL DOH, 2017, SINGL CAS LOC TRANSM
   FL DOH, 2018, MOSQ BORN DIS SURV
   FL DOH, 2017, SEX TRANSM CAS ZIK I
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gorry C, 2016, MEDICC REV, V18, P6
   Grubaugh ND, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1618-7
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   GUL A, 2014, PLOS CURR, V8, DOI DOI 10.3389/FNHUM.2014.00847
   Guzman MG, 2009, LANCET, V374, P1660, DOI 10.1016/S0140-6736(09)61975-9
   Guzman MG, 2005, SCIENCE, V309, P1495, DOI 10.1126/science.1115177
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Hill S. C., 2019, BIORXIV, DOI [10.1101/520437, DOI 10.1101/520437]
   Hobbs N. T., 2015, BAYESIAN MODELS STAT
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004648
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247
   Ladner JT, 2019, NAT MED, V25, P206, DOI 10.1038/s41591-019-0345-2
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   LOURENCO M, 2018, PLOS CURR, V10, DOI DOI 10.3390/V10060327
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   PAHO, 2017, REG ZIK EP UPD AM
   PAHO, 2017, ZIK EP REP CUB
   PAHO, 2017, COUNTR TERR AUT TRAN
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Penton M. J., 2018, YOU PLAN TRAVEL CUBA
   Phumee A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010030
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Reardon S, 2016, NATURE, V536, P257, DOI 10.1038/536257a
   Robles F., 2016, NY TIMES
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Rund S. S. C., 2018, BIORXIV, DOI [10.1101/096875, DOI 10.1101/096875]
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Talevich E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-209
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Vora S., 2016, NY TIMES
   Watts Alexander G, 2018, J Travel Med, V25, DOI 10.1093/jtm/tay132
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 94
TC 6
Z9 6
U1 3
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 22
PY 2019
VL 178
IS 5
BP 1057
EP +
DI 10.1016/j.cell.2019.07.018
PG 26
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA IS5KJ
UT WOS:000482191000006
PM 31442400
OA Green Published
DA 2020-07-08
ER

PT J
AU Harris, M
   Caldwell, JM
   Mordecai, EA
AF Harris, Mallory
   Caldwell, Jamie M.
   Mordecai, Erin A.
TI Climate drives spatial variation in Zika epidemics in Latin America
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE Zika; force of infection; tSIR
ID AEDES-AEGYPTI; DENGUE-FEVER; VIRUS; TEMPERATURE; TRANSMISSION;
   INFECTION; CHIKUNGUNYA; MALARIA; DIPTERA; FORCE
AB Between 2015 and 2017, Zika virus spread rapidly through populations in the Americas with no prior exposure to the disease. Although climate is a known determinant of many Aedes-transmitted diseases, it is currently unclear whether climate was a major driver of the Zika epidemic and how climate might have differentially impacted outbreak intensity across locations within Latin America. Here, we estimated force of infection for Zika over time and across provinces in Latin America using a time-varying susceptible-infectious-recovered model. Climate factors explained less than 5% of the variation in weekly transmission intensity in a spatio-temporal model of force of infection by province over time, suggesting that week to week transmission within provinces may be too stochastic to predict. By contrast, climate and population factors were highly predictive of spatial variation in the presence and intensity of Zika transmission among provinces, with pseudo-R-2 values between 0.33 and 0.60. Temperature, temperature range, rainfall and population size were the most important predictors of where Zika transmission occurred, while rainfall, relative humidity and a nonlinear effect of temperature were the best predictors of Zika intensity and burden. Surprisingly, force of infection was greatest in locations with temperatures near 24 degrees C, much lower than previous estimates from mechanistic models, potentially suggesting that existing vector control programmes and/or prior exposure to other mosquito-borne diseases may have limited transmission in locations most suitable for Aedes aegypti, the main vector of Zika, dengue and chikungunya viruses in Latin America.
C1 [Harris, Mallory] Univ Georgia, Odum Sch Ecol, 140 E Green St, Athens, GA 30602 USA.
   [Caldwell, Jamie M.; Mordecai, Erin A.] Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.
RP Caldwell, JM (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.
EM jamie.sziklay@gmail.com
OI Sziklay, Jamie/0000-0002-6220-918X; Mordecai, Erin/0000-0002-4402-5547
FU National Science Foundation (NSF) Ecology and Evolution of Infectious
   Diseases grantNational Science Foundation (NSF) [DEB1518681]; Research
   Experiences for UndergraduatesNational Science Foundation (NSF);
   NSFNational Science Foundation (NSF) [RAPID 1640780]; Stanford
   University Woods Institute for the Environment Environmental Ventures
   Program; Hellman Faculty Fellowship
FX We received funding from a National Science Foundation (NSF) Ecology and
   Evolution of Infectious Diseases grant (DEB1518681) and a Research
   Experiences for Undergraduates supplement, an NSF Grants for Rapid
   Response Research grant (RAPID 1640780), the Stanford University Woods
   Institute for the Environment Environmental Ventures Program, and the
   Hellman Faculty Fellowship.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, P675
   Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465
   Barton PS, 2004, AUST J ENTOMOL, V43, P16, DOI 10.1111/j.1440-6055.2004.00405.x
   Bi P, 2009, EPIDEMIOL INFECT, V137, P1486, DOI 10.1017/S0950268809002441
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Carran S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005997
   Caudron Q, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1125
   Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003
   CRAGG JG, 1970, CAN J ECONOMICS, V3, P386, DOI 10.2307/133656
   Croissant Y, 2008, J STAT SOFTW, V27, P1
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Eling W., 2001, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V12, P151
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187
   French MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1138-1
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, P1, DOI DOI 10.1371/J0URNAL.PNTD.0006194
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a
   Hafeez S, 2017, SPAT SPATIO-TEMPORAL, V21, P77, DOI 10.1016/j.sste.2017.04.001
   Hernandez-Triana LM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3467-y
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Koenraadt CJM, 2008, J MED ENTOMOL, V45, P28, DOI 10.1603/0022-2585(2008)45[28:FEOROC]2.0.CO;2
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436
   Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141
   Laureano-Rosario AE, 2017, ACTA TROP, V172, P50, DOI 10.1016/j.actatropica.2017.04.017
   Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McFadden D., 1977, 474 YAL U COWL FDN R
   Metcalf CJE, 2011, J R SOC INTERFACE, V8, P369, DOI 10.1098/rsif.2010.0320
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x
   Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146
   Pan American Health Organization/World Health Organization, 2018, ZIK SUSP CONF CAS RE
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Perkins T Alex, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Pomeroy LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136642
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Ryan SJ, 2015, VECTOR-BORNE ZOONOT, V15, P718, DOI 10.1089/vbz.2015.1822
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
NR 63
TC 1
Z9 1
U1 3
U2 8
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD AUG 21
PY 2019
VL 286
IS 1909
AR 20191578
DI 10.1098/rspb.2019.1578
PG 8
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA IU9BR
UT WOS:000483876500009
PM 31455188
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Azlan, A
   Obeidat, SM
   AmirYunus, M
   Azzarn, G
AF Azlan, Azali
   Obeidat, Sattam M.
   AmirYunus, Muhammad
   Azzarn, Ghows
TI Systematic identification and characterization of Aedes aegypti long
   noncoding RNAs (lncRNAs)
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RECONSTRUCTION; EVOLUTION; REVEALS; QUANTIFICATION; TRANSCRIPTOMES; GENE
AB Long noncoding RNAs (lncRNAs) play diverse roles in biological processes. Aedes aegypti (Ae. aegypti), a blood-sucking mosquito, is the principal vector responsible for replication and transmission of arboviruses including dengue, Zika, and Chikungunya virus. Systematic identification and developmental characterisation of Ae. aegypti lncRNAs are still limited. We performed genome-wide identification of lncRNAs, followed by developmental profiling of lncRNA in Ae. aegypti. We identified a total of 4,689 novel lncRNA transcripts, of which 2,064, 2,076, and 549 were intergenic, intronic, and antisense respectively. Ae. aegypti lncRNAs share many characteristics with other species including low expression, low GC content, short in length, and low conservation. Besides, the expression of Ae. aegypti lncRNAs tend to be correlated with neighbouring and antisense protein-coding genes. A subset of lncRNAs shows evidence of maternal inheritance; hence, suggesting potential role of lncRNAs in early-stage embryos. Additionally, lncRNAs show higher tendency to be expressed in developmental and temporal specific manner. The results from this study provide foundation for future investigation on the function of Ae. aegypti lncRNAs.
C1 [Azlan, Azali; Obeidat, Sattam M.; Azzarn, Ghows] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.
   [AmirYunus, Muhammad] Univ Sains Malaysia, Adv Med & Dent Inst, Infect Cluster, George Town 13200, Malaysia.
RP Azzarn, G (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.
EM ghows@usm.my
RI Yunus, Amir M/I-5812-2015; Azzam, Ghows/C-5592-2013
OI Yunus, Amir M/0000-0002-7411-0769; Azzam, Ghows/0000-0001-5352-8675
FU ScienceFund Grant [305/PBIOLOGI/613238]; Universiti Sains Malaysia
   Research University GrantUniversiti Sains Malaysia
   [1001/PBIOLOGI/811320, 1001/PBIOLOGI/8011064]
FX We would like to thank all our collaborators and colleagues for the
   discussion and the work conducted in this lab. This study was funded by
   the ScienceFund Grant (305/PBIOLOGI/613238) and Universiti Sains
   Malaysia Research University Grant (1001/PBIOLOGI/811320 and
   1001/PBIOLOGI/8011064).
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Bohlin J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000057
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonetti Alessandro, 2017, Current Opinion in Systems Biology, V3, P119, DOI 10.1016/j.coisb.2017.04.016
   Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611
   Campbell NM, 2014, J INTERIOR DES, V39, P1
   Canton PE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2240-7
   Chen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23330
   Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72
   Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001
   Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010
   David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174
   Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Etebari K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005069
   Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633
   Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hezroni H, 2015, CELL REP, V11, P1110, DOI 10.1016/j.celrep.2015.04.023
   Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848
   Jenkins AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1507-3
   Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Li YJ, 2017, DESTECH TRANS SOC, P6
   Li YY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00283
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McCorkindale AL, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.175265
   Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144
   Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Tang ZL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43166
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002
   Walker T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-382
   Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006
   Wen KJ, 2016, GENOME RES, V26, P1233, DOI 10.1101/gr.199547.115
   Wu YQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147147
   Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020
NR 46
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 21
PY 2019
VL 9
AR 12147
DI 10.1038/s41598-019-47506-9
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IS2QQ
UT WOS:000481999500001
PM 31434910
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bennett, KL
   Gomez-Martinez, C
   Chin, Y
   Saltonstall, K
   McMillan, WO
   Rovira, JR
   Loaiza, JR
AF Bennett, Kelly L.
   Gomez-Martinez, Carmelo
   Chin, Yamileth
   Saltonstall, Kristin
   Owen McMillan, W.
   Rovira, Jose R.
   Loaiza, Jose R.
TI Dynamics and diversity of bacteria associated with the disease vectors
   Aedes aegypti and Aedes albopictus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUT MICROBIOTA; ZIKA VIRUS; CHIKUNGUNYA VIRUS; MIDGUT BACTERIA; BLOCKS
   DENGUE; WOLBACHIA; MOSQUITO; TRANSMISSION; INFECTION; HOST
AB Aedes aegypti and Aedes albopictus develop in the same aquatic sites where they encounter microorganisms that influence their life history and capacity to transmit human arboviruses. Some bacteria such as Wolbachia are currently being considered for the control of Dengue, Chikungunya and Zika.Yet little is known about the dynamics and diversity of Aedes-associated bacteria, including larval habitat features that shape their tempo-spatial distribution. We applied large-scale 16S rRNA amplicon sequencing to 960 adults and larvae of both Ae. aegypti and Ae. albopictus mosquitoes from 59 sampling sites widely distributed across nine provinces of Panama. We find both species share a limited, yet highly variable core microbiota, reflecting high stochasticity within their oviposition habitats. Despite sharing a large proportion of microbiota, Ae. aegypti harbours higher bacterial diversity than Ae. albopictus, primarily due to rarer bacterial groups at the larval stage. We find significant differences between the bacterial communities of larvae and adult mosquitoes, and among samples from metal and ceramic containers. However, we find little support for geography, water temperature and pH as predictors of bacterial associates. We report a low incidence of natural Wolbachia infection for both Aedes and its geographical distribution. This baseline information provides a foundation for studies on the functions and interactions of Aedes-associated bacteria with consequences for bio-control within Panama.
C1 [Bennett, Kelly L.; Gomez-Martinez, Carmelo; Chin, Yamileth; Saltonstall, Kristin; Owen McMillan, W.; Rovira, Jose R.; Loaiza, Jose R.] Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.
   [Gomez-Martinez, Carmelo; Rovira, Jose R.; Loaiza, Jose R.] Inst Invest Cient & Serv Alta Tecnol, Apartado 0843-01103, Ciudad De Panama, Panama.
   [Loaiza, Jose R.] Univ Panama, Programa Ctr Amer Maestria Entomol, Ciudad De Panama, Panama.
RP Bennett, KL; Loaiza, JR (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.; Loaiza, JR (corresponding author), Inst Invest Cient & Serv Alta Tecnol, Apartado 0843-01103, Ciudad De Panama, Panama.; Loaiza, JR (corresponding author), Univ Panama, Programa Ctr Amer Maestria Entomol, Ciudad De Panama, Panama.
EM BennettK@si.edu; jloaiza@indicasat.org.pa
OI Bennett, Kelly/0000-0003-0330-5275
FU STRI's George E. Burch Fellowship Program; Edward and Jeanne Kashian
   Family Foundation; Secretariat for Science, Technology and Innovation of
   Panama (SENACYT) [IDDS15-047]
FX We are grateful to Panama's Environmental Authority (Mi Ambiente,
   formerly ANAM) for supporting scientific collecting of mosquitoes in
   Panama. We thank the Smithsonian Tropical Research Institute (STRI) for
   administrative support and Instituto de Investigaciones Cientificas y
   Servicios de Alta Tecnologia (INDICASAT) for help in project logistics
   and technical guidance. We would like to thank the members of the
   Mosquito team (i. e., Alejandro Almanza, Elia Barraza, Vanessa Enriquez,
   Marcela Diaz, Evon Magnusson, Kaitlin Driesse and Jaime Cerro), as part
   of JRL research group, for their assistance in mosquito collections
   across Panama. This work was financed in part by STRI's George E. Burch
   Fellowship Program and the Edward and Jeanne Kashian Family Foundation
   to KLB. In addition, the Secretariat for Science, Technology and
   Innovation of Panama (SENACYT), through the research grant IDDS15-047,
   the National System of Investigation (SNI), and the Zika project from
   the government of Panama, supported research activities by JRL.
CR Ahmad NA, 2017, AM J TROP MED HYG, V96, P148, DOI 10.4269/ajtmh.16-0516
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Coon KL, 2017, P NATL ACAD SCI USA, V114, pE5362, DOI 10.1073/pnas.1702983114
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1
   Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x
   Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822
   Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005
   Duguma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072522
   Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025
   Eskildsen GA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194874
   Fouda M. A., 2001, Journal of the Egyptian Society of Parasitology, V31, P767
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105
   Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hegde S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02160
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Jiggins FM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002780
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005
   Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108
   Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005
   Mayoral JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096107
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Minard G, 2013, FEMS MICROBIOL ECOL, V83, P63, DOI 10.1111/j.1574-6941.2012.01455.x
   Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Muturi EJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005377
   Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x
   Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597
   Ponnusamy L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1068-y
   Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827
   R Core Team, 2018, A LANGUAGE AND ENVIR
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96
   Rasgon JL, 2004, J MED ENTOMOL, V41, P255, DOI 10.1603/0022-2585-41.2.255
   Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550
   Rosso F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34640-z
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Rueda LM, 2004, ZOOTAXA, V589, P60
   Schmidt TL, 2018, HEREDITY, V120, P386, DOI 10.1038/s41437-017-0039-9
   TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Tchioffo MT, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01500
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yu JM, 2009, 2009 INTERNATIONAL CONFERENCE ON SUSTAINABLE POWER GENERATION AND SUPPLY, VOLS 1-4, P5, DOI 10.1109/APPEEC.2009.4918260
   Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x
   Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x
   Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388
NR 79
TC 3
Z9 3
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 21
PY 2019
VL 9
AR 12160
DI 10.1038/s41598-019-48414-8
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IS2QQ
UT WOS:000481999500014
PM 31434963
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, HJ
   Hu, YT
   Huang, JH
   Feng, YY
   Zhang, ZL
   Zhong, KH
   Chen, YY
   Wang, Z
   Huang, C
   Yang, H
   Tong, AP
AF Li, Hongjian
   Hu, Yating
   Huang, Jianhan
   Feng, Yunyu
   Zhang, Zongliang
   Zhong, Kunhong
   Chen, Yuyuan
   Wang, Zeng
   Huang, Cheng
   Yang, Hui
   Tong, Aiping
TI Zika virus NS5 protein inhibits cell growth and invasion of glioma
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; NS5; Brain cancer; Glioma cell
ID BRAIN; GLIOBLASTOMA; IDENTIFICATION; INFECTION
AB Glioma is the most common primary brain tumor with high mortality. Given the poor outcomes with standard-of-care treatments, novel treatment strategies are needed. Oncolytic viral therapy for glioma has developed as an exciting therapeutic method in recent years. Zika virus, a member of flavivirus family, has oncolytic activity against glioma cells but the mechanism is unknown. Here, we aimed to determine which viral protein might play a critical role in mitigating glioma cell growth. We examined the tumor suppressor function of four nonstructural proteins NS1, NS3, NS4B and NS5 in human glioma cell line U87. As a result, we found that only NS5 significantly inhibited proliferation, migration and invasion of U87 cells. Moreover, expression of NS5 suppressed tumorigenicity of mouse GL261 glioma cell in vivo. Our findings provide some clues for further exploration of oncolytic Zika virus in the treatment of glioma. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Li, Hongjian; Hu, Yating; Feng, Yunyu; Zhang, Zongliang; Zhong, Kunhong; Chen, Yuyuan; Wang, Zeng; Huang, Cheng; Tong, Aiping] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.
   [Li, Hongjian; Hu, Yating; Feng, Yunyu; Zhang, Zongliang; Zhong, Kunhong; Chen, Yuyuan; Wang, Zeng; Huang, Cheng; Tong, Aiping] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.
   [Li, Hongjian; Hu, Yating; Feng, Yunyu; Zhang, Zongliang; Zhong, Kunhong; Chen, Yuyuan; Wang, Zeng; Huang, Cheng; Tong, Aiping] Collaborat Innovat Ctr, Chengdu 610041, Sichuan, Peoples R China.
   [Huang, Jianhan] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China.
   [Yang, Hui] Sichuan Univ, West China Hosp, Dept Otolaryngol, Chengdu 610041, Sichuan, Peoples R China.
RP Tong, AP (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.; Tong, AP (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.; Tong, AP (corresponding author), Collaborat Innovat Ctr, Chengdu 610041, Sichuan, Peoples R China.; Yang, H (corresponding author), Sichuan Univ, West China Hosp, Dept Otolaryngol, Chengdu 610041, Sichuan, Peoples R China.
EM yh8806@163.com; Aipingtong@scu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31471286, 81772693]; Major Subject of the Science
   and Technology Department of Sichuan Province [2017SZ0015]
FX This work was supported by the National Natural Science Foundation of
   China (31471286 & 81772693) and the Major Subject of the Science and
   Technology Department of Sichuan Province (2017SZ0015)
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287
   Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435
   Foreman PM, 2017, NEUROTHERAPEUTICS, V14, P333, DOI 10.1007/s13311-017-0516-0
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Iannolo G, 2008, CRIT REV ONCOL HEMAT, V66, P42, DOI 10.1016/j.critrevonc.2007.09.004
   Iannolo G, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1499-z
   Jiang Y, 2018, ADV MATER, V30, DOI 10.1002/adma.201800316
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Shackleton M, 2010, SEMIN CANCER BIOL, V20, P85, DOI 10.1016/j.semcancer.2010.04.002
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Singh S, 2004, J PHOTOCH PHOTOBIO B, V77, P45, DOI 10.1016/j.jphotobiol.2004.08.009
   Singh SK, 2003, CANCER RES, V63, P5821
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   Thurmond S., 2018, VIRUSES, P10
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Yan ZQ, 2018, HIGH PERFORMANCE STRUCTURAL MATERIALS, P9, DOI 10.1007/978-981-13-0104-9_2
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 36
TC 1
Z9 1
U1 2
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 20
PY 2019
VL 516
IS 2
BP 515
EP 520
DI 10.1016/j.bbrc.2019.06.064
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA IK4SB
UT WOS:000476575500029
PM 31230744
DA 2020-07-08
ER

PT J
AU Zhang, ZZ
   Rong, L
   Li, YP
AF Zhang, Zhenzhen
   Rong, Liang
   Li, Yi-Ping
TI Flaviviridae Viruses and Oxidative Stress: Implications for Viral
   Pathogenesis
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Review
ID HEPATITIS-C-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; ENDOPLASMIC-RETICULUM
   STRESS; UNFOLDED PROTEIN RESPONSE; IMPAIRS DNA-REPAIR; OXYGEN SPECIES
   ROS; REACTIVE OXYGEN; ZIKA VIRUS; RISK-FACTOR; CELL-DEATH
AB Oxidative stress is induced once the balance of generation and neutralization of reactive oxygen species (ROS) is broken in the cell, and it plays crucial roles in a variety of natural and diseased processes. Infections of Flaviviridae viruses trigger oxidative stress, which affects both the cellular metabolism and the life cycle of the viruses. Oxidative stress associated with specific viral proteins, experimental culture systems, and patient infections, as well as its correlations with the viral pathogenesis attracts much research attention. In this review, we primarily focus on hepatitis C virus (HCV), dengue virus (DENV), Zika virus (ZIKV), Japanese encephalitis virus (JEV), West Nile virus (WNV), and tick-borne encephalitis virus (TBEV) as representatives of Flaviviridae viruses and we summarize the mechanisms involved in the relevance of oxidative stress for virus-associated pathogenesis. We discuss the current understanding of the pathogenic mechanisms of oxidative stress induced by Flaviviridae viruses and highlight the relevance of autophagy and DNA damage in the life cycle of viruses. Understanding the crosstalk between viral infection and oxidative stress-induced molecular events may offer new avenues for antiviral therapeutics.
C1 [Zhang, Zhenzhen; Rong, Liang; Li, Yi-Ping] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China.
   [Zhang, Zhenzhen; Rong, Liang; Li, Yi-Ping] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.
   [Zhang, Zhenzhen; Rong, Liang; Li, Yi-Ping] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.
   [Li, Yi-Ping] Sun Yat Sen Univ, Affiliated Hosp 5, Program Pathobiol, Guangzhou, Guangdong, Peoples R China.
RP Li, YP (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China.; Li, YP (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.; Li, YP (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.; Li, YP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Program Pathobiol, Guangzhou, Guangdong, Peoples R China.
EM lyiping@mail.sysu.edu.cn
RI Li, Yi-Ping/A-4832-2011
OI Li, Yi-Ping/0000-0003-2360-9516; Zhang, Zhenzhen/0000-0002-9885-7453
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31700150, 31470263]; National Basic Research
   Program of ChinaNational Basic Research Program of China [2015CB554301];
   Program for Guangdong Introducing Innovative and Entrepreneurial Teams
   [2016ZT06S252]; Science and Technology Planning Project of Guangdong
   Province [2016A020219003, 2017A050506017]
FX We thank all the researchers whose works have contributed to the topics
   and have been cited in this review paper. Regrettably, we apologize to
   those authors whose excellent work could not be cited due to space
   limitations. This work was supported by the National Natural Science
   Foundation of China (31700150 for ZZ and 31470263 for Y-PL); the
   National Basic Research Program of China (2015CB554301 for Y-PL); the
   Program for Guangdong Introducing Innovative and Entrepreneurial Teams
   (2016ZT06S252 for Y-PL); and the Science and Technology Planning Project
   of Guangdong Province (2016A020219003 and 2017A050506017 for Y-PL).
CR Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07
   Al-alimi AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002711
   Ambrus A, 2015, FREE RADICAL BIO MED, V89, P642, DOI 10.1016/j.freeradbiomed.2015.10.001
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Anticoli S, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6452390
   Asselah T, 2010, J PATHOL, V221, P264, DOI 10.1002/path.2703
   Bartenschlager R, 2018, VIRUS RES, V248, P53, DOI 10.1016/j.virusres.2018.02.016
   Bartolini D, 2018, TRANSL RES, V193, P54, DOI 10.1016/j.trsl.2017.11.007
   Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Bjelakovic G, 2010, ALIMENT PHARM THER, V32, P356, DOI 10.1111/j.1365-2036.2010.04371.x
   Bottino-Rojas V, 2018, J BIOL CHEM, V293, P9053, DOI 10.1074/jbc.RA117.001589
   Boyd JT, 2016, NEUROLOGY, V87, P342, DOI 10.1212/01.wnl.0000489939.73359.c3
   Brault C, 2016, GUT, V65, P144, DOI 10.1136/gutjnl-2014-307904
   Burdette D, 2010, J GEN VIROL, V91, P681, DOI 10.1099/vir.0.014340-0
   Bureau C, 2001, J BIOL CHEM, V276, P23077, DOI 10.1074/jbc.M100698200
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Camini FC, 2017, ARCH VIROL, V162, P907, DOI 10.1007/s00705-016-3187-y
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851
   Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje
   Chen ACH, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1019
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen TH, 2011, VIROLOGY, V410, P410, DOI 10.1016/j.virol.2010.12.013
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Choi J, 2012, FREE RADICAL BIO MED, V52, P1135, DOI 10.1016/j.freeradbiomed.2012.01.008
   Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001
   Choi Y, 2018, NAT REV MICROBIOL, V16, P340, DOI 10.1038/s41579-018-0003-6
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Dandekar A, 2015, METHODS MOL BIOL, V1292, P205, DOI 10.1007/978-1-4939-2522-3_15
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   de Andrade KQ, 2015, INT J MOL SCI, V16, P30269, DOI 10.3390/ijms161226225
   de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671
   DeMaria N, 1996, FREE RADICAL BIO MED, V21, P291, DOI 10.1016/0891-5849(96)00044-5
   Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dreux M, 2011, VIRUSES-BASEL, V3, P1342, DOI 10.3390/v3081342
   Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109
   Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Eslam M, 2011, GUT, V60, P1139, DOI 10.1136/gut.2010.228262
   Esrefoglu M, 2012, HEPAT MON, V12, P160, DOI 10.5812/hepatmon.837
   FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1
   Farinati F, 1999, FREE RADICAL BIO MED, V27, P1284, DOI 10.1016/S0891-5849(99)00161-6
   Fedoreyev SA, 2018, MAR DRUGS, V16, DOI 10.3390/md16120509
   Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150
   Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045
   Gabbay E, 2007, WORLD J GASTROENTERO, V13, P5317, DOI 10.3748/wjg.v13.i40.5317
   Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474
   Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011
   Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391
   Goldstein L, 2019, J NEUROL SCI, V398, P138, DOI 10.1016/j.jns.2019.01.012
   Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Gulli F, 2016, DIGEST LIVER DIS, V48, P927, DOI 10.1016/j.dld.2016.05.013
   Gupta RK, 2014, ASIAN PAC J CANCER P, V15, P4405, DOI 10.7314/APJCP.2014.15.11.4405
   Hall A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070159
   Halstead S.B., 2015, F1000RESEARCH, V4, pF1000, DOI DOI 10.12688/F1000RESEARCH.7024.1
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200
   Hasnain SZ, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1035
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926
   Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892
   Indran IR, 2010, MOL ASPECTS MED, V31, P21, DOI 10.1016/j.mam.2009.12.001
   Indukuri H, 2006, VIROLOGY, V353, P155, DOI 10.1016/j.virol.2006.05.022
   Isaguliants M., 2014, HUMAN VACCINES IMMUN, V9, P2111
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001
   Ivanov AV, 2015, VIRUSES-BASEL, V7, P2745, DOI 10.3390/v7062745
   Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439
   Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957
   Jaiyen Y, 2009, MICROBIOL IMMUNOL, V53, P442, DOI 10.1111/j.1348-0421.2009.00148.x
   Jansons J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030208
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Jiang YF, 2015, GUT, V64, P168, DOI 10.1136/gutjnl-2013-306043
   Kaid C., 2018, CANC RES, V78
   Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474
   Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Khomich OA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080392
   Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152
   Kim N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10631
   Kim SJ, 2014, P NATL ACAD SCI USA, V111, P6413, DOI 10.1073/pnas.1321114111
   Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285
   Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08
   Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200
   Kumar S, 2009, NEUROCHEM INT, V55, P648, DOI 10.1016/j.neuint.2009.06.008
   Kuzmenko YV, 2016, INTERVIROLOGY, V59, P111, DOI 10.1159/000452160
   Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037
   Lee IK, 2015, WORLD J GASTROENTERO, V21, P6872, DOI 10.3748/wjg.v21.i22.6872
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lee YH, 2013, VIRUS RES, V178, P411, DOI 10.1016/j.virusres.2013.09.011
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039
   Li YP, 2012, P NATL ACAD SCI USA, V109, P19757, DOI 10.1073/pnas.1218260109
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liao SL, 2002, NEUROSCI LETT, V324, P133, DOI 10.1016/S0304-3940(02)00236-7
   Lin CC, 2009, CLIN NUTR, V28, P34, DOI 10.1016/j.clnu.2008.09.003
   Lin RJ, 2004, J GEN VIROL, V85, P521, DOI 10.1099/vir.0.19496-0
   Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524
   Lozano-Sepulveda SA, 2015, WORLD J HEPATOL, V7, P2880, DOI 10.4254/wjh.v7.i29.2880
   Lubin JA, 2018, NEUROSURGERY, V82, pE113, DOI 10.1093/neuros/nyy047
   Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548
   Machida K, 2004, J VIROL, V78, P8835, DOI 10.1128/JVI.78.16.8835-8843.2004
   Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06
   Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618
   Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257
   Mahmood S, 2004, ANTIOXID REDOX SIGN, V6, P19, DOI 10.1089/152308604771978318
   Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6
   Marchi S, 2018, CELL CALCIUM, V69, P62, DOI 10.1016/j.ceca.2017.05.003
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Maximova OA, 2018, ANNU REV VIROL, V5, P255, DOI 10.1146/annurev-virology-092917-043439
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Medvedev R, 2017, FREE RADICAL BIO MED, V110, P300, DOI 10.1016/j.freeradbiomed.2017.06.021
   Medvedev R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9012580
   Meissner EG, 2015, HEPATOLOGY, V61, P790, DOI 10.1002/hep.27424
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Mishra MK, 2008, CELL BIOL INT, V32, P1506, DOI 10.1016/j.cellbi.2008.08.020
   Miyazawa T, 2019, IUBMB LIFE, V71, P430, DOI 10.1002/iub.2008
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7
   Nakamura M, 2010, WORLD J GASTROENTERO, V16, P184, DOI 10.3748/wjg.v16.i2.184
   Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021
   Narayanan A, 2014, VIROLOGY, V449, P270, DOI 10.1016/j.virol.2013.11.023
   Nazmi A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000892
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006
   Ozkok A, 2014, WORLD J GASTROENTERO, V20, P7544, DOI 10.3748/wjg.v20.i24.7544
   Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x
   Panieri E, 2013, FREE RADICAL BIO MED, V57, P176, DOI 10.1016/j.freeradbiomed.2012.12.024
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   PETERHANS E, 1979, BIOCHEM BIOPH RES CO, V91, P383, DOI 10.1016/0006-291X(79)90630-2
   Petta S., 2016, GASTROENTEROLOGY, V150
   Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489
   Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pizzino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8416763
   Ploen D, 2015, WORLD J GASTROENTERO, V21, P8492, DOI 10.3748/wjg.v21.i28.8492
   Ramezani A, 2018, J CELL BIOCHEM, V119, P6366, DOI 10.1002/jcb.26897
   Raung SL, 2001, NEUROSCI LETT, V315, P9, DOI 10.1016/S0304-3940(01)02300-X
   Rebbani K, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7425628
   Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452
   Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Roy J, 2017, FASEB J, V31, P3729, DOI 10.1096/fj.201700170R
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035
   Serfaty L, 2009, LIVER INT, V29, P13, DOI 10.1111/j.1478-3231.2008.01952.x
   Shi JY, 2012, ACTA BIOCH BIOPH SIN, V44, P375, DOI 10.1093/abbs/gms010
   Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15
   Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12
   Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Simula MP, 2010, PROTEOM CLIN APPL, V4, P782, DOI 10.1002/prca.201000049
   Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   Smirnova OA, 2016, OXID MED CELL LONGEV, V2016, P10
   Smirnova OA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041219
   Soeur J, 2015, FREE RADICAL BIO MED, V78, P213, DOI 10.1016/j.freeradbiomed.2014.10.510
   Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930
   Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284
   Soundravally R, 2014, INT J INFECT DIS, V18, P68, DOI 10.1016/j.ijid.2013.09.022
   dos Santos RMS, 2008, LIVER INT, V28, P54, DOI 10.1111/j.1478-3231.2007.01599.x
   Srivastava S, 1999, INT J EXP PATHOL, V80, P17, DOI 10.1046/j.1365-2613.1999.00092.x
   Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004
   Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353
   Swarup V, 2008, J ANTIMICROB CHEMOTH, V61, P679, DOI 10.1093/jac/dkm503
   Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002
   Taskoparan M, 2011, HEPATO-GASTROENTEROL, V58, P875
   Terrier B, 2013, AM J CARDIOL, V111, P265, DOI 10.1016/j.amjcard.2012.09.028
   Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375
   Tian YP, 2010, BIOCHEM BIOPH RES CO, V397, P420, DOI 10.1016/j.bbrc.2010.05.108
   Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004
   Tsai HH, 2016, NEUROLOGY, V86, P840, DOI 10.1212/WNL.0000000000002307
   Tseng CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32176
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   Uddin MJ, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00076
   Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   van Pelt JF, 2004, CANCER LETT, V209, P197, DOI 10.1016/j.canlet.2003.11.035
   Vanni E, 2016, DIGEST LIVER DIS, V48, P105, DOI 10.1016/j.dld.2015.10.016
   Vasallo C, 2015, VIRUS RES, V209, P100, DOI 10.1016/j.virusres.2015.03.013
   Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055407
   Wang LY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004764
   Wangensteen KJ, 2016, J VIRAL HEPATITIS, V23, P535, DOI 10.1111/jvh.12517
   Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005
   Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07
   WHO, 2017, GLOB HEP REP 2017 GE
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766
   Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836
   Wong RJ, 2014, DIGEST DIS SCI, V59, P1586, DOI 10.1007/s10620-014-3222-3
   Wu WYY, 2015, J VIRAL HEPATITIS, V22, P784, DOI 10.1111/jvh.12392
   Wu Y, 2011, CLIN EXP DERMATOL, V36, P178, DOI 10.1111/j.1365-2230.2010.03916.x
   Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610
   Yang TC, 2010, MICROBES INFECT, V12, P643, DOI 10.1016/j.micinf.2010.04.007
   Yano M, 2007, ANTIMICROB AGENTS CH, V51, P2016, DOI 10.1128/AAC.01426-06
   Zhang Y, 2014, INT J INFECT DIS, V24, P30, DOI 10.1016/j.ijid.2014.02.011
   Zhang ZZ, 2016, ANTIOXID REDOX SIGN, V25, P609, DOI 10.1089/ars.2016.6634
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zignego AL, 2015, EXPERT REV CLIN IMMU, V11, P15, DOI 10.1586/1744666X.2015.997214
   Zignego AL, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980942
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 229
TC 0
Z9 0
U1 3
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD AUG 19
PY 2019
VL 2019
AR 1409582
DI 10.1155/2019/1409582
PG 17
WC Cell Biology
SC Cell Biology
GA IW0YO
UT WOS:000484691500001
PM 31531178
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lima, MC
   de Mendonca, LR
   Rezende, AM
   Carrera, RM
   Anibal-Silva, CE
   Demers, M
   D'Aiuto, L
   Wood, J
   Chowdari, KV
   Griffiths, M
   Lucena-Araujo, AR
   Barral-Netto, M
   Azevedo, EAN
   Alves, RW
   Farias, PCS
   Marques, ETA
   Castanha, PMS
   Donald, CL
   Kohl, A
   Nimgaonkar, VL
   Franca, RFO
AF Lima, Morganna C.
   de Mendonca, Leila R.
   Rezende, Antonio M.
   Carrera, Raquel M.
   Anibal-Silva, Conceicao E.
   Demers, Matthew
   D'Aiuto, Leonardo
   Wood, Joel
   Chowdari, Kodavali, V
   Griffiths, Michael
   Lucena-Araujo, Antonio R.
   Barral-Netto, Manoel
   Azevedo, Elisa A. N.
   Alves, Renan W.
   Farias, Pablo C. S.
   Marques, Ernesto T. A.
   Castanha, Priscila M. S.
   Donald, Claire L.
   Kohl, Alain
   Nimgaonkar, Vishwajit L.
   Franca, Rafael F. O.
TI The Transcriptional and Protein Profile From Human Infected
   Neuroprogenitor Cells Is Strongly Correlated to Zika Virus Microcephaly
   Cytokines Phenotype Evidencing a Persistent Inflammation in the CNS
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; central nervous system; inflammation; type-I interferon;
   interferonopathy; microcephaly; Zika congenital syndrome and cytokines
ID INTERFERON-ALPHA; NEURAL PROGENITORS; GENE-EXPRESSION; HUMAN BRAIN;
   STEM-CELLS; CXCL10; ASTROCYTES; DIFFERENTIATION; ACTIVATION; EXPOSURE
AB Zika virus (ZIKV) infection during pregnancy is associated with microcephaly, a congenital malformation resulting from neuroinflammation and direct effects of virus replication on the developing central nervous system (CNS). However, the exact changes in the affected CNS remain unknown. Here, we show by transcriptome analysis (at 48 h post-infection) and multiplex immune profiling that human induced-neuroprogenitor stem cells (hiNPCs) respond to ZIKV infection with a strong induction of type-I interferons (IFNs) and several type-I IFNs stimulated genes (ISGs), notably cytokines and the pro-apoptotic chemokines CXCL9 and CXCL10. By comparing the inflammatory profile induced by a ZIKV Brazilian strain with an ancestral strain isolated from Cambodia in 2010, we observed that the response magnitude differs among them. Compared to ZIKV/Cambodia, the experimental infection of hiNPCs with ZIKV/Brazil resulted in a diminished induction of ISGs and lower induction of several cytokines (IFN-alpha, IL-1 alpha/beta, IL-6, IL-8, and IL-15), consequently favoring virus replication. From ZIKV-confirmed infant microcephaly cases, we detected a similar profile characterized by the presence of IFN-alpha, CXCL10, and CXCL9 in cerebrospinal fluid (CSF) samples collected after birth, evidencing a sustained CNS inflammation. Altogether, our data suggest that the CNS may be directly affected due to an unbalanced and chronic local inflammatory response, elicited by ZIKV infection, which contributes to damage to the fetal brain.
C1 [Lima, Morganna C.; de Mendonca, Leila R.; Rezende, Antonio M.; Anibal-Silva, Conceicao E.; Azevedo, Elisa A. N.; Alves, Renan W.; Farias, Pablo C. S.; Marques, Ernesto T. A.; Franca, Rafael F. O.] Fiocruz MS, Oswaldo Cruz Fdn, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Carrera, Raquel M.; Griffiths, Michael] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Demers, Matthew; D'Aiuto, Leonardo; Wood, Joel; Chowdari, Kodavali, V; Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA.
   [Lucena-Araujo, Antonio R.] Fed Univ Pemambuco UFPE, Recife, PE, Brazil.
   [Barral-Netto, Manoel] Fiocruz MS, Oswaldo Cruz Fdn, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Marques, Ernesto T. A.; Castanha, Priscila M. S.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Donald, Claire L.; Kohl, Alain] Univ Glasgow, Ctr Vitus Res, MRC, Glasgow, Lanark, Scotland.
   [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.
RP Franca, RFO (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, Inst Aggeu Magalhaes, Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013; Barral Netto, Manoel/B-3904-2009;
   Rezende, Antonio Mauro/S-2126-2018; CASTANHA, PRISCILA/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Barral Netto,
   Manoel/0000-0002-5823-7903; Rezende, Antonio Mauro/0000-0003-4775-1779;
   Azevedo, Elisa/0000-0002-1774-4095; CASTANHA,
   PRISCILA/0000-0002-1220-5308; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Donald, Claire/0000-0002-4370-0707
FU Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco/FACEPE
   [APQ-0055.2.11/16, APQ-0044.2.11/16]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/CNPqNational Council for
   Scientific and Technological Development (CNPq) [439975/2016-6]; UK
   Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014/8, MR/N017552/1]; Stanley Medical Research Institute
   [07R-1712]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [MH63480, D43 TW009114]; Cura Zika-University of Pittsburgh
FX The research leading to these results received funding from the Fundacao
   de Amparo a Ciencia e Tecnologia de Pernambuco/FACEPE, grant agreement
   nos. APQ-0055.2.11/16 and APQ-0044.2.11/16, and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/CNPq grant agreement
   439975/2016-6 under RF coordination and responsibility. UK Medical
   Research Council Grants MC_UU_12014/8 and MR/N017552/1 under AK's
   coordination. VN received grant support from the Stanley Medical
   Research Institute (07R-1712), National Institutes of Health (MH63480
   and D43 TW009114) and Cura Zika-University of Pittsburgh. The funders
   had no role in study design, data collection, and analysis, decision to
   publish, or preparation of the manuscript.
CR Akwa Y, 1998, J IMMUNOL, V161, P5016
   Asensio VC, 2001, J VIROL, V75, P7067, DOI 10.1128/JVI.75.15.7067-7077.2001
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brahma R, 2018, VIRAL IMMUNOL, V31, P321, DOI 10.1089/vim.2017.0116
   Brito CAA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3313-4
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1
   Castro MAA, 2009, BIOINFORMATICS, V25, P1468, DOI 10.1093/bioinformatics/btp246
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x
   Cuadrado E, 2013, BRAIN, V136, P245, DOI 10.1093/brain/aws321
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Klok MD, 2015, ANN CLIN TRANSL NEUR, V2, P774, DOI 10.1002/acn3.213
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669
   Paz-Bailey G, 2019, NEW ENGL J MED, V380, P198, DOI 10.1056/NEJMc1814416
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Shipley Mackenzie M, 2016, J Vis Exp, P53193, DOI 10.3791/53193
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Sui YJ, 2006, EUR J NEUROSCI, V23, P957, DOI 10.1111/j.1460-9568.2006.04631.x
   Sui YJ, 2004, AM J PATHOL, V164, P1557, DOI 10.1016/S0002-9440(10)63714-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van Heteren JT, 2008, GLIA, V56, P568, DOI 10.1002/glia.20639
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 69
TC 2
Z9 2
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 16
PY 2019
VL 10
AR 1928
DI 10.3389/fimmu.2019.01928
PG 14
WC Immunology
SC Immunology
GA IR4ZR
UT WOS:000481443300001
PM 31474994
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Pereira, JP
   Maykin, MM
   Vasconcelos, Z
   Avvad-Portari, E
   Zin, AA
   Tsui, I
   Brasil, P
   Nielsen-Saines, K
   Moreira, ME
   Gaw, SL
AF Pereira, Jose Paulo, Jr.
   Maykin, Melanie M.
   Vasconcelos, Zilton
   Avvad-Portari, Elyzabeth
   Zin, Andrea A.
   Tsui, Irena
   Brasil, Patricia
   Nielsen-Saines, Karin
   Moreira, Maria E.
   Gaw, Stephanie L.
TI The Role of Amniocentesis in the Diagnosis of Congenital Zika Syndrome
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE ZIKV; TORCH infection; perinatal infection; pregnancy; vertical
   transmission
ID VIRUS-INFECTION; PREGNANCY; FETUSES; BLOOD
AB There are limited data on amniocentesis as a diagnostic tool for congenital Zika syndrome. Here we report on a prospective cohort of 16 women with suspected Zika virus infection in a highly endemic area, and discuss the role of amniocentesis in the prenatal diagnosis of fetal Zika infection.
C1 [Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Avvad-Portari, Elyzabeth; Zin, Andrea A.; Moreira, Maria E.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Maykin, Melanie M.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556,HSE16, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Gaw,
   Stephanie/0000-0003-0891-6964
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K12 HD000849,
   R21AI28697, R21AI129534, R21EY028318]; Queenan Fellowship for Global
   Health; Conselho Nacional de Pesquisa-Brazilian National Research
   Council of the Brazilian Ministry of Health (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Apoio a
   Pesquisa do Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); European Union
   European Horizon 2020 Research and Innovation Programme (Zika-PLAN)
   [734584]
FX This work was supported by the National Institutes of Health (grant
   numbers K12 HD000849 to S.L.G., R21AI28697, R21AI129534, and
   R21EY028318), the Queenan Fellowship for Global Health (to S. L. G.),
   the Conselho Nacional de Pesquisa-Brazilian National Research Council of
   the Brazilian Ministry of Health (CNPq, to M. E. M.); Fundacao de Apoio
   a Pesquisa do Rio de Janeiro (Faperj, to M. E. M); and the European
   Union European Horizon 2020 Research and Innovation Programme (Zika-PLAN
   grant number 734584).
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Besnard M, 2016, EUROSURVEILLANCE, V21, P302
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Herrera K, CASE REP PERINATAL M, V5, P374
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
NR 12
TC 3
Z9 3
U1 3
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2019
VL 69
IS 4
BP 713
EP 716
DI 10.1093/cid/ciz013
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IW7LJ
UT WOS:000485171100021
PM 30624579
OA Green Published
DA 2020-07-08
ER

PT J
AU Bautista, LE
AF Bautista, Leonelo E.
TI Zika virus infection and risk of Guillain-Barre syndrome: A
   meta-analysis
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome; Disease outbreaks; Systematic
   review
ID CASE SERIES; EPIDEMIOLOGY; COLOMBIA; OUTBREAK; COMMON
AB Objective: Findings from studies of the association between Zika virus (ZIKV) infection and Guillain-Barre syndrome (GBS) are inconsistent. I conducted a systematic review and meta-analysis to clarify the nature of this association.
   Methods: I searched PubMed, Scopus, Cochrane, CINAHL, Web of Science, Scielo, and DOAJ for case report, ecological, and analytic studies with "Zika" and "Guillain-Barre syndrome" as keywords, published up to July 1stth 2018. I evaluated if ZIKV infection status influenced the diagnosis of GBS (detection bias) in case-report and analytic studies; assessed if changes in weekly number of cases of ZIKV infection during outbreaks were followed by changes in number of GBS cases 1-8 weeks later; gauged the likelihood of selection, confounding, information, sparse data, and time-dependent bias (i.e. when ZIKV infection was ascertained after GBS onset) in analytic studies; and calculated the average ZIKV-GBS odds ratio (OR) in studies without time-dependent bias.
   Results: In case reports, ZIKV infection prevalence in GBS cases was 2.4 to 25 times higher than expected. Changes in the number of ZIKV-infection cases during outbreaks were not consequentially followed by changes in the number of GBS cases (OR: 1.01; 95% CI: 0.99-1.03). Major biases were likely in all but one analytic study, which showed a non-significant ZIKV-GBS association. The average ZIKV-GBS OR in studies without time-dependent bias was 1.57 (95% CI: 0.86-2.86).
   Interpretation: These findings indicate the available evidence is insufficient to claim ZIKV infection causes GBS. Therefore, stakeholders may want to reconsider current ZIKV-GBS public health and patient care recommendations.
C1 [Bautista, Leonelo E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut St,WARF 703, Madison, WI 53726 USA.
RP Bautista, LE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut St,WARF 703, Madison, WI 53726 USA.
EM lebautista@wisc.edu
CR Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   ASBURY AK, 1990, ANN NEUROL, V27, pS1, DOI 10.1002/ana.410270702
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bautista L. E., 2017, JPHE, DOI [10.21037/jphe.2017.06.05, DOI 10.21037/JPHE.2017.06.05]
   Bautista LE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5566-7
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   da Nobrega MEB, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-49742018000200016
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Direction de la sante. Bureau_de_veillesanitaire Bulletin de Surveillance Sanitaire, BUR VEILL SAN B SURV
   Dirlikov E., 2018, JAMA NEUROL, DOI [10.1001/jamaneuro1.2018.1058May21, DOI 10.1001/JAMANEURO1.2018.1058MAY21]
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Greenland S, 2000, AM J EPIDEMIOL, V151, P531
   Gustafson P., 2010, INT J ENV RES PUBLIC, V7
   Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102
   Hoover KD, 2003, BRIT J PHILOS SCI, V54, P527, DOI 10.1093/bjps/54.4.527
   Hughes R. A. C., 1997, J INFECT DIS S2, V176, DOI [10.1086/513793S92-S8, DOI 10.1086/513793S92-S8]
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   MacCoun R, 2015, NATURE, V526, P187, DOI 10.1038/526187a
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Mitchell M, 2002, ENGAUGE DIGITIZER FR
   MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425
   Nickerson, 1998, REV GEN PSYCHOL, V2, P175, DOI DOI 10.1037/1089-2680.2.2.175
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pan_American_Health_Organization, 2016, GUID ZIK VIR DIS COM
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Williams M, 2016, W INDIAN MED J, V65, P438, DOI 10.7727/wimj.2016.511
   Wilson HL, 2017, J CLIN MICROBIOL, V55, P3104, DOI [10.1128/JCM.00673-17, 10.1128/jcm.00673-17]
   World Health Organization, 2016, SURV ZIK VIR INF MIC
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
NR 50
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD AUG 15
PY 2019
VL 403
BP 99
EP 105
DI 10.1016/j.jns.2019.06.019
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IW0JG
UT WOS:000484647600020
PM 31255970
DA 2020-07-08
ER

PT J
AU Suzuki, K
   Nakayama, EE
   Saito, A
   Egawa, A
   Sato, T
   Phadungsombat, J
   Rahim, R
   Hasan, A
   Iwamoto, H
   Rahman, M
   Shioda, T
AF Suzuki, Keita
   Nakayama, Emi E.
   Saito, Akatsuki
   Egawa, Akio
   Sato, Tairyu
   Phadungsombat, Juthamas
   Rahim, Rummana
   Hasan, Abu
   Iwamoto, Hisahiko
   Rahman, Mizanur
   Shioda, Tatsuo
TI Evaluation of novel rapid detection kits for dengue virus NS1 antigen in
   Dhaka, Bangladesh, in 2017
SO VIROLOGY JOURNAL
LA English
DT Article
DE Dengue; DENV; NS1; IC; POCT; RDT
ID NONSTRUCTURAL PROTEIN-1 NS1; INFECTIONS; DIAGNOSIS; RESPONSES; DISEASE;
   MODEL; IGM
AB Background Dengue virus (DENV) infection is one of the biggest challenges for human health in the world. In addition, a secondary DENV infection sometimes causes dengue hemorrhagic fever (DHF), which frequently leads to death. For this reason, accurate diagnosis record management is useful for prediction of DHF. Therefore, the demand for DENV rapid diagnosis tests (RDTs) is increasing because these tests are easy and rapid to use. However, commercially available RDTs often show low sensitivity for DENV and cross-reactivity against other flaviviruses, especially Zika virus (ZIKV). Methods We developed two types of novel DENV non-structural protein 1 (NS1) detection RDTs, designated TKK-1st and TKK-2nd kits. Specificities of the monoclonal antibodies (MAbs) used in these kits were confirmed by enzyme-linked immuno-sorbent assay (ELISA), dot blot, and western blot using recombinant NS1 proteins and synthetic peptides. For evaluation of sensitivity, specificity, and cross-reactivity of the novel DENV NS1 RDTs, we first used cultured DENV and other flaviviruses, ZIKV and Japanese encephalitis virus (JEV). We then used clinical specimens obtained in Bangladesh in 2017 for further evaluation of kit sensitivity and specificity in comparison with commercially available RDTs. In addition, RNA extracted from sera were used for viral genome sequencing and genotyping. Results Epitopes of three out of four MAbs used in the two novel RDTs were located in amino acid positions 100 to 122 in the NS1 protein, a region that shows low levels of homology with other flaviviruses. Our new kits showed high levels of sensitivity against various serotypes and genotypes of DENV and exhibited high levels of specificity without cross-reactivity against ZIKV and JEV. In clinical specimens, our RDTs showed sensitivities of 96.0% (145/151, TKK-1st kit) and 96.7% (146/151, TKK-2nd kit), and specificities of 98.0% (98/100, TKK-1st kit and TKK-2nd kit). On the other hand, in the case of the commercially available SD Bioline RDT, sensitivity was 83.4% (126/151) and specificity was 99.0% (99/100) against the same clinical specimens. Conclusions Our novel DENV NS1-targeting RDTs demonstrated high levels of sensitivity and lacked cross-reactivity against ZIKV and JEV compared with commercially available RDTs.
C1 [Suzuki, Keita; Nakayama, Emi E.; Saito, Akatsuki; Egawa, Akio; Sato, Tairyu; Shioda, Tatsuo] Osaka Univ, Res Inst Microbial Dis, Dept Viral Infect, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.
   [Suzuki, Keita; Iwamoto, Hisahiko] TANAKA Kikinzoku Kogyo KK, POCT Business Unit, 2-73 Shinmachi, Hiratsuka, Kanagawa 2540076, Japan.
   [Phadungsombat, Juthamas] Mahidol Univ, Mahidol Osaka Ctr Infect Dis, 420-6 Ratchawithi Rd, Bangkok 10400, Thailand.
   [Rahim, Rummana; Hasan, Abu; Rahman, Mizanur] Apollo Hosp Dhaka, Plot 81,Block E, Dhaka 1229, Bangladesh.
RP Shioda, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Viral Infect, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.
EM shioda@biken.osaka-u.ac.jp
OI SAITO, AKATSUKI/0000-0002-2792-4399
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fm0108003]
FX This work was supported by Japan Agency for Medical Research and
   Development (AMED) JP18fm0108003 to TS. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alcala AC, 2016, VIROLOGY, V488, P278, DOI 10.1016/j.virol.2015.11.020
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   [Anonymous], 2019, VACCINE, V37, P4848, DOI 10.1016/j.vaccine.2018.09.063
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Buonora SN, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2306-z
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carter MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003424
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   FALCONAR AKI, 1994, ARCH VIROL, V137, P315, DOI 10.1007/BF01309478
   FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kurosu T, 2010, BIOCHEM BIOPH RES CO, V394, P398, DOI 10.1016/j.bbrc.2010.02.181
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Paul K.K., 2014, HLTH SCI B, V12, P1
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Prado PS, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170433
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Sanchez-Vargas LA, 2014, DIAGN MICR INFEC DIS, V78, P368, DOI 10.1016/j.diagmicrobio.2013.12.019
   Shu PY, 2004, J CLIN MICROBIOL, V42, P2489, DOI 10.1128/JCM.42.6.2489-2494.2004
   Simonnet C, 2017, EUR J CLIN MICROBIOL, V36, P2441, DOI 10.1007/s10096-017-3083-8
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tissera H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004477
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 45
TC 0
Z9 0
U1 2
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD AUG 15
PY 2019
VL 16
IS 1
AR 102
DI 10.1186/s12985-019-1204-y
PG 15
WC Virology
SC Virology
GA IS0VV
UT WOS:000481871600001
PM 31416485
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mills, DM
   Foguel, MV
   Martin, CP
   Trieu, TT
   Kamar, O
   Calvo-Marzal, P
   Kolpashchikov, DM
   Chumbimuni-Torres, KY
AF Mills, Dawn M.
   Foguel, Marcos V.
   Martin, Christopher P.
   Trieu, Tiffany T.
   Kamar, Ola
   Calvo-Marzal, Percy
   Kolpashchikov, Dmitry M.
   Chumbimuni-Torres, Karin Y.
TI Rapid detection of different DNA analytes using a single electrochemical
   sensor
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Multicomponent hybridization probe; Sensors; Electrochemistry; Dengue;
   Zika
ID ZIKA VIRUS; PROTEIN NS1; PROBE; ANTIGEN
AB A unique platform for the detection of two distinct DNA sequences by using one single electrochemical sensor was developed. The sensor consists of a universal stem loop probe attached to a solid surface, and two analyte-specific adaptor strands. These adaptor strands hybridize to a nucleic acid analyte and provide both highly specific recognition and high binding affinity. The universal probe can be regenerated by a simple and quick rinse with urea and water. As a proof of concept, we differentiated long target sequences of Zika (141 nt.) and Dengue (114 nt.) viruses that contain secondary structures. The proposed sensor provides a platform for rapid and cost-efficient detection of potentially any DNA or RNA sequence using a single electrochemical sensor.
C1 [Mills, Dawn M.; Foguel, Marcos V.; Martin, Christopher P.; Trieu, Tiffany T.; Kamar, Ola; Calvo-Marzal, Percy; Kolpashchikov, Dmitry M.; Chumbimuni-Torres, Karin Y.] Univ Cent Florida, Dept Chem, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
   [Kolpashchikov, Dmitry M.] Univ Cent Florida, Burnett Sch Biomed Sci, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
RP Chumbimuni-Torres, KY (corresponding author), Chem Dept, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
EM ChumbimuniTorres@ucf.edu
RI Kolpashchikov, Dmitry/AAO-2777-2020; Foguel, Marcos
   Vinicius/AAD-5767-2020; Kolpashchuikov, Dmitry M./AAE-2085-2019
OI Foguel, Marcos Vinicius/0000-0001-9584-1029; 
FU National Science Foundation - Chemical, Bioengineering, Environmental,
   and Transport Systems (NSF-CBET) [1706802]; Florida Health Department
   grant [7ZK05]; National Science Foundation - Computing and Communication
   Foundations (NSF-CCF) [1117205, 1423219]; National Institute of
   Health-Research Enhancement Award United States [NIHR15AI10388001A1]
FX The authors acknowledge National Science Foundation - Chemical,
   Bioengineering, Environmental, and Transport Systems (NSF-CBET) grant
   number #1706802 and United States. Florida Health Department grant
   #7ZK05. DMK was supported by United States. National Science Foundation
   - Computing and Communication Foundations (NSF-CCF) grants #1117205 and
   1423219 and United States. National Institute of Health-Research
   Enhancement AwardNIHR15AI10388001A1 United States.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Arugula MA, 2014, ANAL CHEM, V86, P119, DOI 10.1021/ac402898j
   Baeumner AJ, 2002, ANAL CHEM, V74, P1442, DOI 10.1021/ac015675e
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carvalhal RT, 2005, ELECTROANAL, V17, P1251, DOI 10.1002/elan.200403224
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gerasimova YV, 2013, BIOSENS BIOELECTRON, V41, P386, DOI 10.1016/j.bios.2012.08.058
   Gerasimova YV, 2010, CHEMBIOCHEM, V11, P1762, DOI 10.1002/cbic.201000287
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gooding JJ, 2002, ELECTROANAL, V14, P1149, DOI 10.1002/1521-4109(200209)14:17<1149::AID-ELAN1149>3.0.CO;2-8
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590
   Mills DM, 2018, BIOSENS BIOELECTRON, V109, P35, DOI 10.1016/j.bios.2018.02.059
   Mills DM, 2017, ELECTROANAL, V29, P873, DOI 10.1002/elan.201600548
   Najioullah F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-164
   Nguyen C, 2011, CHEM-EUR J, V17, P13052, DOI 10.1002/chem.201101987
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Shu PY, 2004, J CLIN MICROBIOL, V42, P2489, DOI 10.1128/JCM.42.6.2489-2494.2004
   Tambo E, 2016, J INFECT PUBLIC HEAL, V9, P240, DOI 10.1016/j.jiph.2016.02.005
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 35
TC 6
Z9 6
U1 14
U2 56
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD AUG 15
PY 2019
VL 293
BP 11
EP 15
DI 10.1016/j.snb.2019.04.149
PG 5
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA HZ7GK
UT WOS:000469021800002
DA 2020-07-08
ER

PT J
AU Batool, K
   Alam, I
   Jin, L
   Xu, J
   Wu, CX
   Wang, JX
   Huang, EJ
   Guan, X
   Yu, XQ
   Zhang, LL
AF Batool, Khadija
   Alam, Intikhab
   Jin, Liang
   Xu, Jin
   Wu, Chenxu
   Wang, Junxiang
   Huang, Enjiong
   Guan, Xiong
   Yu, Xiao-Qiang
   Zhang, Lingling
TI CTLGA9 Interacts with ALP1 and APN Receptors To Modulate Cry11Aa
   Toxicity in Aedes aegypti
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Aedes aegypti; CTLGA9; Bacillus thuringiensis; Cry11Aa; toxicity
ID THURINGIENSIS SUBSP ISRAELENSIS; C-TYPE LECTIN; ALKALINE-PHOSPHATASE;
   CRYSTAL-STRUCTURE; LARVAL MIDGUT; BINDING; PROTEIN; TOXIN; RECOGNITION;
   REVEALS
AB The mosquito Aedes aegypti is associated with the spread of many viral diseases in humans, including Dengue virus (DENVs), Yellow fever virus (YFV), Zika virus (ZIKV), and Chikungunya virus (CHIKV). Bacillus thuringiensis (Bt) is widely used as a biopesticide, which produces Cry toxins for mosquito control. The Cry toxins bind mainly to important receptors, including alkaline phosphatase (ALP) and aminopeptidase-N (APN). This work investigated the function of a C-type lectin, CTLGA9, in A. aegypti in response to Cry toxins. Our results showed by far-western blot and ELISA methods that the CTLTGA9 protein interacted with brush border membrane vesicles (BBMVs) of A. aegypti larvae and with ALP1, APN, and Cry11Aa proteins. Furthermore, molecular docking showed overlapping binding sites in ALP1 and APN for binding to Cry11Aa and CTLGA9. The toxicity assays further demonstrated that CTLGA9 inhibited the larvicidal activity of Cry toxins. According to the results of molecular docking, CTLGA9 may compete with Cry11Aa for binding to ALP1 and APN receptors and thus decreases the mosquitocidal toxicity of Cry11Aa. Our results provide further insights into better understanding the mechanism of Cry toxins and help improve the Cry toxicity for mosquito control.
C1 [Batool, Khadija; Jin, Liang; Xu, Jin; Wu, Chenxu; Wang, Junxiang; Guan, Xiong; Zhang, Lingling] Fujian Agr & Forestry Univ, MOE, State Key Lab Ecol Pest Control Fujian & Taiwan C, Coll Life Sci,Key Lab Biopesticides & Chem Biol, Fuzhou 350002, Fujian, Peoples R China.
   [Alam, Intikhab] Fujian Agr & Forestry Univ, Coll Crop Sci, Minist Educ, Key Lab Genet Breeding & Comprehens Utilizat Crop, Fuzhou 350002, Fujian, Peoples R China.
   [Huang, Enjiong] Fujian Int Travel Healthcare Ctr, Fuzhou 350001, Fujian, Peoples R China.
   [Yu, Xiao-Qiang] Univ Missouri, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.
RP Zhang, LL (corresponding author), Fujian Agr & Forestry Univ, MOE, State Key Lab Ecol Pest Control Fujian & Taiwan C, Coll Life Sci,Key Lab Biopesticides & Chem Biol, Fuzhou 350002, Fujian, Peoples R China.
EM lingling00264@163.com
FU National Program of China [2017YFE0122000, 2017YFE0121700]; foreign
   cooperative project of Fujian province [201810023]; National Institute
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI117808]; Science and Technology
   Project of Fuzhou [2018-G-70]; Open Project Funds of State Key
   Laboratory of Pathogen and Biosecurity [SKLPBS1838]
FX Our work was funded by the National Program of China (2017YFE0122000 and
   2017YFE0121700); the foreign cooperative project of Fujian province
   (201810023); the National Institute of Health (AI117808); Science and
   Technology Project of Fuzhou (2018-G-70); and Open Project Funds of
   State Key Laboratory of Pathogen and Biosecurity (SKLPBS1838).
CR Alto BW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004370
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Ayaad TH, 2015, BRAZ ARCH BIOL TECHN, V58, P905, DOI 10.1590/S1516-89132015060277
   Batool K, 2018, TOXINS, V10, DOI 10.3390/toxins10100390
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006
   Chen JW, 2017, PEPTIDES, V98, P78, DOI 10.1016/j.peptides.2017.05.011
   Chen JW, 2013, INSECT BIOCHEM MOLEC, V43, P1201, DOI 10.1016/j.ibmb.2013.09.007
   Chen JW, 2009, BIOCHEM J, V424, P191, DOI 10.1042/BJ20090730
   Chen JW, 2009, INSECT BIOCHEM MOLEC, V39, P688, DOI 10.1016/j.ibmb.2009.08.003
   CHILCOTT CN, 1988, J GEN MICROBIOL, V134, P2551
   Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998
   DAI SM, 1993, INSECT BIOCHEM MOLEC, V23, P273, DOI 10.1016/0965-1748(93)90008-G
   Devillers J, 2014, SAR QSAR ENVIRON RES, V25, P805, DOI 10.1080/1062936X.2014.958291
   Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R
   DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0
   Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517
   Fernandez LE, 2005, FEBS LETT, V579, P3508, DOI 10.1016/j.febslet.2005.05.032
   Fernandez LE, 2009, BIOCHEMISTRY-US, V48, P8899, DOI 10.1021/bi900979b
   GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Huang YL, 2015, J BIOL CHEM, V290, P21252, DOI 10.1074/jbc.M115.649814
   Hunter FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01248
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Maeda H, 2016, DEV COMP IMMUNOL, V57, P38, DOI 10.1016/j.dci.2015.12.015
   Mayer S, 2017, HISTOCHEM CELL BIOL, V147, P223, DOI 10.1007/s00418-016-1523-7
   Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088
   Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296
   Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102
   Perez C, 2007, CELL MICROBIOL, V9, P2931, DOI 10.1111/j.1462-5822.2007.01007.x
   Pruszynski CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170079
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Rao XJ, 2015, INSECT BIOCHEM MOLEC, V62, P75, DOI 10.1016/j.ibmb.2014.12.006
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x
   WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3
   Yu XQ, 2006, INSECT BIOCHEM MOLEC, V36, P505, DOI 10.1016/j.ibmb.2006.03.010
   Zhan MY, 2016, DEV COMP IMMUNOL, V65, P330, DOI 10.1016/j.dci.2016.08.004
   Zhang LL, 2018, J AGR FOOD CHEM, V66, P13435, DOI 10.1021/acs.jafc.8b04665
   Zhang LL, 2017, J AGR FOOD CHEM, V65, P10884, DOI 10.1021/acs.jafc.7b04427
NR 45
TC 0
Z9 0
U1 1
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD AUG 14
PY 2019
VL 67
IS 32
BP 8896
EP 8904
DI 10.1021/acs.jafc.9b01840
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA IR6QK
UT WOS:000481563600019
PM 31339308
DA 2020-07-08
ER

PT J
AU Liu, T
   Tang, LT
   Tang, H
   Pu, JY
   Gong, ST
   Fang, DY
   Zhang, H
   Li, YP
   Zhu, X
   Wang, WD
   Wu, MH
   Liao, YH
   Li, CL
   Zhou, HB
   Huang, X
AF Liu, Ting
   Tang, Lantian
   Tang, Hui
   Pu, Jieying
   Gong, Sitang
   Fang, Danyun
   Zhang, Hui
   Li, Yi-Ping
   Zhu, Xun
   Wang, Weidong
   Wu, Minhao
   Liao, Yuhui
   Li, Chunling
   Zhou, Haibo
   Huang, Xi
TI Zika Virus Infection Induces Acute Kidney Injury Through Activating
   NLRP3 Inflammasome Via Suppressing Bcl-2
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; acute kidney injury; aquaporins; NLRP3 inflammasome; Bcl-2
ID GELATINASE-ASSOCIATED LIPOCALIN; MOLECULE-1; BIOMARKER; TISSUE; CELLS;
   INHIBITION; PYROPTOSIS; MECHANISM; FAMILY; DOMAIN
AB Zika virus (ZIKV) is a newly emerging flavivirus that broadly exhibits in various bodily tissues and fluids, especially in the brain, and ZIKV infection often causes microcephaly. Previous studies have been reported that ZIKV can infect renal cells and can be detected in the urine samples of infected individuals. However, whether ZIKV infection causes renal diseases and its pathogenic mechanisms remains unknown. Here, we identified that ZIKV infection resulted in acute kidney injury (AKI) in both newborn and adult mouse models by increasing the levels of AKI-related biomarkers [e.g., serum creatinine (Scr), kidney injury molecular-1 (Kim-1), and neutrophil gelatinase-associated lipocalin (NGAL)]. ZIKV infection triggered the inflammatory response and renal cell injury by activating Nod-like receptor 3 (NLRP3) inflammasome and secreting interleukin-1 beta (IL-1 beta). IL-1 beta inhibited aquaporins expression and led to water re-absorption disorder. Furthermore, ZIKV infection induced a decreased expression of B-cell lymphoma-2 (Bcl-2) in the kidney. Overexpression of Bcl-2 attenuated ZIKV-induced NLRP3 inflammasome activation in renal cells and down-regulated PARP/caspase-3-mediated renal apoptosis. Overall, our findings demonstrated that ZIKV infection induced AKI by activating NLRP3 inflammasome and apoptosis through suppressing Bcl-2 expression, which provided potential therapeutic targets for ZIKV-associated renal diseases.
C1 [Liu, Ting; Tang, Lantian; Tang, Hui; Pu, Jieying; Fang, Danyun; Zhang, Hui; Li, Yi-Ping; Zhu, Xun; Wang, Weidong; Wu, Minhao; Liao, Yuhui; Li, Chunling; Huang, Xi] Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Hosp 5, Program Infect & Immun, Zhuhai, Peoples R China.
   [Liu, Ting; Tang, Hui; Pu, Jieying; Gong, Sitang; Wu, Minhao; Huang, Xi] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou Women & Childrens Med Ctr, Program Immunol,Dept Internal Med, Guangzhou, Guangdong, Peoples R China.
   [Liu, Ting; Tang, Hui; Pu, Jieying; Gong, Sitang; Wu, Minhao; Huang, Xi] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Guangzhou, Guangdong, Peoples R China.
   [Zhou, Haibo] Guangzhou Med Univ, Affiliated Hosp 6, Qingyuan, Peoples R China.
RP Li, CL; Huang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Hosp 5, Program Infect & Immun, Zhuhai, Peoples R China.; Huang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou Women & Childrens Med Ctr, Program Immunol,Dept Internal Med, Guangzhou, Guangdong, Peoples R China.; Huang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Guangzhou, Guangdong, Peoples R China.; Zhou, HB (corresponding author), Guangzhou Med Univ, Affiliated Hosp 6, Qingyuan, Peoples R China.
EM lichl3@mail.sysu.edu.cn; haibo_zhou2003@163.com;
   huangxi6@mail.sysu.edu.cn
RI ZHOU, Haibo/M-7373-2017
OI Wang, Weidong/0000-0003-2523-3145
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470877]; National Science and Technology Key
   Projects for Major Infectious Diseases [2017ZX10302301-002]; National
   Key Research and Development Program of China [2016YFC1200105];
   Guangzhou Science and Technology Planning Project [201704020226,
   201604020006]; Guangdong Natural Science FoundationNational Natural
   Science Foundation of Guangdong Province [2015A030311009]
FX This work was supported by grants from National Natural Science
   Foundation of China (31470877), National Science and Technology Key
   Projects for Major Infectious Diseases (2017ZX10302301-002), National
   Key Research and Development Program of China (2016YFC1200105),
   Guangzhou Science and Technology Planning Project (201704020226 and
   201604020006), Guangdong Natural Science Foundation (2015A030311009).
CR Agrelli A, 2019, INFECT GENET EVOL, V69, P22, DOI 10.1016/j.meegid.2019.01.018
   Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900
   Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheema-Dhadli Surinder, 2010, Electrolyte Blood Press, V8, P1, DOI 10.5049/EBP.2010.8.1.1
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Chivero ET, 2017, J NEUROSCI, V37, P3599, DOI 10.1523/JNEUROSCI.3045-16.2017
   Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009
   Diptyanusa A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210360
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106
   Frohlich M, 2016, INT J DEV NEUROSCI, V48, P9, DOI 10.1016/j.ijdevneu.2015.10.004
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008
   Hwang J, 2017, ACS NANO, V11, P9825, DOI 10.1021/acsnano.7b03150
   Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002
   Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135
   Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487
   Khalil MAM, 2012, CLIN KIDNEY J, V5, P390, DOI 10.1093/ckj/sfs117
   Kim SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02563
   Kortenoeven MLA, 2013, J PHYSIOL-LONDON, V591, P2205, DOI 10.1113/jphysiol.2012.250852
   Kuriakose T, 2017, MOL IMMUNOL, V86, P56, DOI 10.1016/j.molimm.2017.01.023
   Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91
   Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534
   Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X
   Mulay SR, 2019, J AM SOC NEPHROL, V30, P1857, DOI 10.1681/ASN.2018121218
   Negash AA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007593
   Novo-Veleiro I, 2019, AGING CLIN EXP RES, V31, P455, DOI 10.1007/s40520-018-1001-2
   Peralta-Aros C, 2017, PEDIATR NEPHROL, V32, P897, DOI 10.1007/s00467-017-3588-5
   Regadas VC, 2018, REV ASSOC MED BRAS, V64, P11, DOI 10.1590/1806-9282.64.01.11
   Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2
   Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166
   Schirmer PL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006416
   Shen JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep34682
   Shyam R, 2017, INDIAN J CRIT CARE M, V21, P740, DOI 10.4103/ijccm.IJCCM_315_17
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458
   Tan XX, 2017, CELL PHYSIOL BIOCHEM, V43, P209, DOI 10.1159/000480340
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tartey S, 2019, IMMUNOLOGY, V156, P329, DOI 10.1111/imm.13046
   Teo SH, 2017, BEST PRACT RES-CLIN, V31, P331, DOI 10.1016/j.bpa.2017.10.003
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662
   Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang WD, 2015, AM J PHYSIOL-RENAL, V308, pF910, DOI 10.1152/ajprenal.00649.2014
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Xu CF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06522-5
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
NR 56
TC 3
Z9 3
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 14
PY 2019
VL 10
AR 1925
DI 10.3389/fimmu.2019.01925
PG 17
WC Immunology
SC Immunology
GA IQ4KS
UT WOS:000480720200001
PM 31474993
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saa, P
   Chiu, C
   Grimm, K
   Yu, GX
   Benjamin, RJ
   Corash, L
   Stramer, SL
AF Saa, Paula
   Chiu, Charles
   Grimm, Kacie
   Yu, Guixia
   Benjamin, Richard J.
   Corash, Laurence
   Stramer, Susan L.
TI Acute Zika virus infection in an asymptomatic blood donor at the onset
   of the Puerto Rico epidemic
SO TRANSFUSION
LA English
DT Article
ID TRANSMISSION
AB BACKGROUND Zika virus (ZIKV) spread to Puerto Rico likely originated from southeastern Brazil approximately 8.5 months earlier than blood donation screening for ZIKV was initiated, but the time of ZIKV introduction in the blood donor population remains unknown. METHODS To better understand when arboviral infections first appeared in the blood donor pool in Puerto Rico, we retrospectively screened for ZIKV RNA (as well as chikungunya [CHIKV] and dengue [DENV] viral RNA) a repository of 1186 linked blood donor and recipient samples collected from February 2015 to May 2016 as an endpoint efficacy measure following the introduction of platelet pathogen reduction (PR). Phylogenetic analysis identified relatedness of donor strain to other circulating strains, and molecular clock analysis identified the estimated time of introduction. RESULTS An asymptomatic donor collected in December 2015 was ZIKV RNA confirmed positive, 4 months BEFORE investigational nucleic acid testing (NAT) implementation in April 2016, coincident and related to the first reported autochthonous cases. No CHIKV RNA or DENV RNA reactives were identified in donors or recipients, and no adverse events were reported from PR use in recipients. Phylogenetic analysis confirmed the molecular relatedness of the donor ZIKV strain to the Puerto Rico lineage likely introduced approximately 4.5 months earlier. CONCLUSION This study identified an asymptomatic ZIKV infection in a blood donor occurring before those previously recognized by blood donation screening. NAT and PR continue to be used as acceptable strategies to prevent transfusion-transmitted arboviral infections worldwide; however, repeated arboviral outbreaks warrant consideration of PR as a more proactive approach.
C1 [Saa, Paula; Grimm, Kacie; Stramer, Susan L.] Amer Red Cross, Sci Affairs, Gaithersburg, MD USA.
   [Chiu, Charles; Yu, Guixia] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA.
   [Chiu, Charles; Yu, Guixia] UCSF, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA.
   [Benjamin, Richard J.; Corash, Laurence] Cerus Corp, Concord, CA USA.
RP Saa, P (corresponding author), Amer Red Cross, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.
EM paula.saa@redcross.org
RI Saa, Paula/AAB-6607-2019
OI Saa, Paula/0000-0001-6077-4532
FU National Institutes of Health (NIH) from the National Heart, Lung, and
   Blood Institute [R01-HL105704]; National Institutes of Health (NIH) from
   the National Institute of Allergy and Infectious Diseases
   [R33-AI129455]; Abbott LaboratoriesAbbott Laboratories; Cerus
   Corporation
FX This study was supported in part by grants from the National Institutes
   of Health (NIH) R01-HL105704 from the National Heart, Lung, and Blood
   Institute; and R33-AI129455 (to CYC) from the National Institute of
   Allergy and Infectious Diseases, and Abbott Laboratories (CYC).
   Laboratory support for this study was provided to the American Red Cross
   by Roche Molecular Diagnostics. The TRUE study and sample repository
   used in this study were funded by Cerus Corporation.
CR cobas Zika, 2017, NUCL AC TEST US COB
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gao K, 2017, VOX SANQUINIS S1, V112, P5
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rico S, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.3844.3844
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Stramer SL, 2019, TRANSFUSION, V59, P1283, DOI 10.1111/trf.15128
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
NR 16
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD OCT
PY 2019
VL 59
IS 10
BP 3164
EP 3170
DI 10.1111/trf.15484
EA AUG 2019
PG 7
WC Hematology
SC Hematology
GA JD3HK
UT WOS:000480946200001
PM 31407817
DA 2020-07-08
ER

PT J
AU Zhang, Z
   Cai, ZN
   Tan, ZY
   Lu, CY
   Jiang, TJ
   Zhang, GH
   Peng, YS
AF Zhang, Zheng
   Cai, Zena
   Tan, Zhiying
   Lu, Congyu
   Jiang, Taijiao
   Zhang, Gaihua
   Peng, Yousong
TI Rapid identification of human-infecting viruses
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE human-infecting virus; machine learning; viral metagenomics; virome
ID ZIKA; EMERGENCE; OUTBREAK
AB Viruses have caused much mortality and morbidity to humans and pose a serious threat to global public health. The virome with the potential of human infection is still far from complete. Novel viruses have been discovered at an unprecedented pace as the rapid development of viral metagenomics. However, there is still a lack of methodology for rapidly identifying novel viruses with the potential of human infection. This study built several machine learning models to discriminate human-infecting viruses from other viruses based on the frequency of k-mers in the viral genomic sequences. The k-nearest neighbor (KNN) model can predict the human-infecting viruses with an accuracy of over 90%. The performance of this KNN model built on the short contigs (>= 1 kb) is comparable to those built on the viral genomes. We used a reported human blood virome to further validate this KNN model with an accuracy of over 80% based on very short raw reads (150 bp). Our work demonstrates a conceptual and generic protocol for the discovery of novel human-infecting viruses in viral metagenomics studies.
C1 [Zhang, Zheng; Cai, Zena; Lu, Congyu; Peng, Yousong] Hunan Univ, Coll Biol, Changsha, Hunan, Peoples R China.
   [Tan, Zhiying] Hunan Univ, Coll Comp Sci & Elect Engn, Changsha, Hunan, Peoples R China.
   [Jiang, Taijiao] Suzhou Inst Syst Med, Suzhou, Peoples R China.
   [Jiang, Taijiao] Chinese Acad Med Sci, Ctr Syst Med, Inst Basic Med Sci, Beijing, Peoples R China.
   [Jiang, Taijiao] Peking Union Med Coll, Beijing, Peoples R China.
   [Zhang, Gaihua] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China.
RP Peng, YS (corresponding author), Hunan Univ, Coll Biol, Changsha, Hunan, Peoples R China.
EM pys2013@hnu.edu.cn
FU National Key Plan for Scientific Research and Development of China
   [2016YFD0500300]; Hunan Provincial Natural Science Foundation of
   ChinaNatural Science Foundation of Hunan Province [2018JJ3039]; Changsha
   Science and Technology Bureau [kq1801040]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [31500126, 31671371]; Chinese Academy of Medical Sciences
   [2016-I2M-1-005]
FX National Key Plan for Scientific Research and Development of China,
   Grant/Award Number: 2016YFD0500300; Hunan Provincial Natural Science
   Foundation of China, Grant/Award Number: 2018JJ3039; Changsha Science
   and Technology Bureau, Grant/Award Number: kq1801040; National Natural
   Science Foundation of China, Grant/Award Number: 31500126 and 31671371;
   Chinese Academy of Medical Sciences, Grant/Award Number: 2016-I2M-1-005
CR Ahlgren NA, 2017, NUCLEIC ACIDS RES, V45, P39, DOI 10.1093/nar/gkw1002
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Alavandi SV, 2012, INDIAN J VIROL, V23, P88, DOI 10.1007/s13337-012-0075-2
   Anderson T, 2019, B WORLD HEALTH ORGAN, V97, P6, DOI 10.2471/BLT.19.020119
   Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008
   Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Chen C., 2004, USING RANDOM FOREST, P1
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048
   European CDC, 2016, ZIK VIR EP AM POT AS
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Garcia-Sastre A, 2014, LANCET, V383, P676, DOI 10.1016/S0140-6736(14)60163-X
   Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Li H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28308-x
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099
   Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Riedel S., 2005, BAYL U MED CTR P
   Rosenberg R, 2015, CELL MOL LIFE SCI, V72, P1115, DOI 10.1007/s00018-014-1785-y
   Shipley Rebecca, 2019, Trop Med Infect Dis, V4, DOI 10.3390/tropicalmed4010031
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560
   Wootton SC, 2011, AM J RESP CRIT CARE, V183, P1698, DOI 10.1164/rccm.201010-1752OC
   Xu BB, 2017, PEERJ, V5, DOI 10.7717/peerj.3579
NR 34
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD NOV
PY 2019
VL 66
IS 6
BP 2517
EP 2522
DI 10.1111/tbed.13314
EA AUG 2019
PG 6
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA JK2PJ
UT WOS:000481500500001
PM 31373773
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Yang, L
   Norris, EJ
   Jiang, SY
   Bernier, UR
   Linthicum, KJ
   Bloomquist, JR
AF Yang, Liu
   Norris, Edmund J.
   Jiang, Shiyao
   Bernier, Ulrich R.
   Linthicum, Kenneth J.
   Bloomquist, Jeffrey R.
TI Reduced effectiveness of repellents in a pyrethroid-resistant strain of
   Aedes aegypti (Diptera: culicidae) and its correlation with olfactory
   sensitivity
SO PEST MANAGEMENT SCIENCE
LA English
DT Article; Early Access
DE cross-resistance; DEET; IR3535; pyrethroids; 2-undecanone; 1-octen-3-ol
ID INSECTICIDE; DENGUE
AB BACKGROUND The mosquito, Aedes aegypti (Diptera: Culicidae), is a vector of dengue fever, zika, chikungunya, and yellow fever viruses, and in many areas possesses significant levels of resistance to pyrethroids. Behavioral performance was assessed in 15, 30, and 60 min exposures in a high throughput vapor phase spatial repellency assay to three contact repellent standards: N,N-diethyl-3-methylbenzamide (DEET), ethyl 3-[acetyl(butyl)amino] propanoate (IR3535), and 2-undecanone, as well as pyrethrum extract, transfluthrin, and metofluthrin in susceptible (Orlando) and a pyrethroid-resistant Puerto Rico strain of Aedes aegypti. Additionally, electroantennographic studies were used to investigate the antennal sensitivities to these compounds in both strains. RESULTS Resistance was found to all tested insect repellents in the Puerto Rico strain of Ae. aegypti. Resistance ratios at the different time points were about 2 for DEET, 3 for 2-undecanone, and 12 for IR3535. Resistance was also observed to pyrethrum extract (similar to 9-fold), transfluthrin (similar to 5-fold), and metofluthrin (similar to 48-fold) in repellent behavioral response. Electrophysiological analysis found decreased antennal sensitivity to all repellents tested, consistent with their behavioral effects. CONCLUSION The reduced sensitivity to these repellents may represent a fitness cost arising from the kdr mutation present in Puerto Rico Aedes aegypti. This work highlights the need for understanding collateral effects from the evolution of pesticide resistance in mosquitoes, and the importance of finding alternative strategies to control resistance development. (c) 2019 Society of Chemical Industry
C1 [Yang, Liu; Norris, Edmund J.; Jiang, Shiyao; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematol, Emerging Pathogens Inst, 2055 Mowry Rd, Gainesville, FL 32610 USA.
   [Bernier, Ulrich R.; Linthicum, Kenneth J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA.
RP Bloomquist, JR (corresponding author), Univ Florida, Dept Entomol & Nematol, Emerging Pathogens Inst, 2055 Mowry Rd, Gainesville, FL 32610 USA.
EM jbquist@epi.ufl.edu
OI yang, liu/0000-0002-0746-3433; Bloomquist, Jeff/0000-0002-9136-4998
FU Department of Defense, Deployed War Fighter Research ProgramUnited
   States Department of Defense [58-6615-4-023, 58-0208-5-001]
FX This project was funded by the Department of Defense, Deployed War
   Fighter Research Program, under USDA Specific Cooperative Agreements
   58-6615-4-023 and 58-0208-5-001 to J.R.B. Drs. Daniel L. Kline and James
   J. Becnel of the USDA CMAVE provided the Orlando and Puerto Rico Ae.
   aegypti mosquitoes, respectively.
CR Agramonte NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005954
   Bibbs CS, 2017, J INTEGR PEST MANAG, V8, DOI 10.1093/jipm/pmx016
   Bowman NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196410
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   CRAMPTON JM, 1994, ANN TROP MED PARASIT, V88, P3, DOI 10.1080/00034983.1994.11812828
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Frances SP, 2005, J AM MOSQUITO CONTR, V21, P1, DOI 10.2987/8756-971X(2005)21[1:RPPAF]2.0.CO;2
   Gautam R, 2017, CURR TOP MED CHEM, V17, P2199, DOI 10.2174/1568026617666170130122921
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   IBM Corp, IBM SPSS STAT WIND V
   Jiang S, 2019, MED VET ENTOMOL, V33, P388, DOI 10.1111/mve.12377
   Kandel Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212693
   Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208
   Lin YH, 2013, PESTIC BIOCHEM PHYS, V107, P266, DOI 10.1016/j.pestbp.2013.08.004
   Liu F, 2013, J INSECT PHYSIOL, V59, P1169, DOI 10.1016/j.jinsphys.2013.08.016
   Mengoni SL, 2018, J ECON ENTOMOL, V111, P836, DOI 10.1093/jee/toy009
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Rapley LP, 2009, AM J TROP MED HYG, V81, P94, DOI 10.4269/ajtmh.2009.81.94
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   Rozendaal J.A., 1997, VECTOR CONTROL METHO
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Sfara V, 2006, MEM I OSWALDO CRUZ, V101, P89, DOI 10.1590/S0074-02762006000100017
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soko W, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0076-7
   Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107
   Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105
   Vassena CV, 2019, J ECON ENTOMOL, V112, P997, DOI 10.1093/jee/toy387
   Wagman JM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003726
   WHO, 2017, DENG SEV DENG
   WHO, 2018, IMM VACC BIOL
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Health Organization, 2011, GLOB INS US VECT BOR
NR 38
TC 3
Z9 3
U1 11
U2 20
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
DI 10.1002/ps.5562
EA AUG 2019
PG 7
WC Agronomy; Entomology
SC Agriculture; Entomology
GA IQ0QK
UT WOS:000480455500001
PM 31338960
DA 2020-07-08
ER

PT J
AU Stolerman, LM
   Maia, PD
   Kutz, JN
AF Stolerman, Lucas M.
   Maia, Pedro D.
   Kutz, J. Nathan
TI Forecasting dengue fever in Brazil: An assessment of climate conditions
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; AEDES-AEGYPTI; TEMPERATURE; VECTOR; TRANSMISSION; VIRUS;
   CULICIDAE; EPIDEMICS; DIPTERA; MODEL
AB Local climate conditions play a major role in the biology of the Aedes aegypti mosquito, the main vector responsible for transmitting dengue, zika, chikungunya and yellow fever in urban centers. For this reason, a detailed assessment of periods in which changes in climate conditions affect the number of human cases may improve the timing of vector-control efforts. In this work, we develop new machine-learning algorithms to analyze climate time series and their connection to the occurrence of dengue epidemic years for seven Brazilian state capitals. Our method explores the impact of two key variables-frequency of precipitation and average temperature-during a wide range of time windows in the annual cycle. Our results indicate that each Brazilian state capital considered has its own climate signatures that correlate with the overall number of human dengue-cases. However, for most of the studied cities, the winter preceding an epidemic year shows a strong predictive power. Understanding such climate contributions to the vector's biology could lead to more accurate prediction models and early warning systems.
C1 [Stolerman, Lucas M.] Fiocruz MS, Programa Comp Cient PROCC, Rio De Janeiro, RJ, Brazil.
   [Stolerman, Lucas M.] IMPA, Rio De Janeiro, RJ, Brazil.
   [Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.
RP Stolerman, LM (corresponding author), Fiocruz MS, Programa Comp Cient PROCC, Rio De Janeiro, RJ, Brazil.; Stolerman, LM (corresponding author), IMPA, Rio De Janeiro, RJ, Brazil.
EM lstolerman@eng.ucsd.edu
OI Stolerman, Lucas/0000-0001-6313-0126
CR Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Bakar A., 2011, EL ENG INF ICEEI 201, P1
   Banu S, 2015, SCI REPORT, P5
   Baquero OS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195065
   Barmak DH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011901
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bishop CM, 2006, MACH LEARN, P128
   Brazilian Ministry of Health, PROM NAT MOB EFF AED
   Brazilian National Institute of Meteorology (INMET), TEMP PREC TIM SER
   Buczak AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002771
   Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555
   Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106
   Choi Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2923-2
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018
   Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Figueredo LTM, 2003, DENGUE B, V27, P25
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Gambhir S., 2019, PRESCREENING SYSTEMS, P69
   Guo P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005973
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Pena-Garcia VH, 2017, ANN GLOB HEALTH, V83, P509, DOI 10.1016/j.aogh.2017.10.011
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Kesorn K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125049
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lana RM, 2014, ACTA TROP, V129, P25, DOI 10.1016/j.actatropica.2013.07.025
   Lana RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190673
   Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560
   Liao CM, 2015, STOCH ENV RES RISK A, V29, P947, DOI 10.1007/s00477-014-0948-6
   Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549
   Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008
   Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933
   Pessanha JEMP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/760951
   Ministry of Health, 2008, EP REP DENG FEV
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Murphy K.P., 2012, MACHINE LEARNING PRO
   Ong J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006587
   Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002581
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rahman D, 2016, IEEE ENER CONV
   Silva FD, 2016, CIENC SAUDE COLETIVA, V21, P641, DOI 10.1590/1413-81232015212.09592015
   Stolerman LM, 2015, SIAM J APPL MATH, V75, P2581, DOI 10.1137/140996148
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tsuda Y, 2001, ENVIRON ENTOMOL, V30, P855, DOI 10.1603/0046-225X-30.5.855
   Valdez L. D., 2017, ARXIV171107164
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
NR 54
TC 0
Z9 0
U1 3
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2019
VL 14
IS 8
AR e0220106
DI 10.1371/journal.pone.0220106
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW5EW
UT WOS:000485002500021
PM 31393908
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tamhankar, M
   Patterson, JL
AF Tamhankar, Manasi
   Patterson, Jean L.
TI Directional entry and release of Zika virus from polarized epithelial
   cells
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Caco-2; Polarized cells; Egress; Permeability
ID HEPARAN-SULFATE; TIGHT JUNCTIONS; DENGUE VIRUS; WEST-NILE; INFECTION;
   PROTEIN; DIFFERENTIATION; TRANSMISSION; TRAFFICKING; BIOLOGY
AB Background Both vector borne and sexual transmission of Zika virus (ZIKV) involve infection of epithelial cells in the initial stages of infection. Epithelial cells are unique in their ability to form polarized monolayers and their barrier function. Cell polarity induces an asymmetry in the epithelial monolayer, which is maintained by tight junctions and specialized sorting machinery. This differential localization can have a potential impact of virus infection. Asymmetrical distribution of a viral receptor can restrict virus entry to a particular membrane while polarized sorting can lead to a directional release of virions. The present study examined the impact of cell polarity on ZIKV infection and release. Methods A polarized Caco-2 cell model we described previously was used to assess ZIKV infection. Transepithelial resistance (TEER) was used to assess epithelial cell polarity, and virus infection was measured by immunofluorescence microscopy and qRT-PCR. Cell permeability was measured using a fluorescein leakage assay. Statistical significance was calculated using one-way ANOVA and significance was set at p < 0.05. Results Using the Caco-2 cell model for polarized epithelial cells, we report that Zika virus preferentially infects polarized cells from the apical route and is released vectorially through the basolateral route. Our data also indicates that release occurs without disruption of cell permeability. Conclusions Our results show that ZIKV has directional infection and egress in a polarized cell system. This mechanism of directional infection may be one of the mechanisms that enables the cross the epithelial barrier effectively without a disruption in cell monolayer integrity. Elucidation of entry and release characteristics of Zika virus in polarized epithelial cells can lead to better understanding of virus dissemination in the host, and can help in developing effective therapeutic interventions.
C1 [Tamhankar, Manasi] Univ Texas San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX USA.
   [Tamhankar, Manasi; Patterson, Jean L.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78227 USA.
RP Patterson, JL (corresponding author), Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78227 USA.
EM mtamhankar@txbiomed.org; jpatters@txbiomed.org
FU internal TBRI funding
FX Work completed at TBRI was supported by internal TBRI funding.
CR Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   BLAU DM, 1995, VIROLOGY, V210, P91, DOI 10.1006/viro.1995.1320
   Blau DM, 1996, SEMIN VIROL, V7, P245, DOI 10.1006/smvy.1996.0031
   Brown PS, 2000, TRAFFIC, V1, P124, DOI 10.1034/j.1600-0854.2000.010205.x
   Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chu JJH, 2002, J GEN VIROL, V83, P2427, DOI 10.1099/0022-1317-83-10-2427
   CLAYSON ET, 1988, MOL CELL BIOL, V8, P3391, DOI 10.1128/MCB.8.8.3391
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005
   Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317
   Duan DS, 1998, HUM GENE THER, V9, P2761, DOI 10.1089/hum.1998.9.18-2761
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Itoh M, 2003, J MAMMARY GLAND BIOL, V8, P449, DOI 10.1023/B:JOMG.0000017431.45314.07
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Lin YJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-39
   Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08
   Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mora R, 2002, J VIROL, V76, P3544, DOI 10.1128/JVI.76.7.3544-3553.2002
   Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071
   Salinas S, 2018, J VIROL, V92, DOI 10.1128/JVI.01546-18
   Salmivirta M, 1998, GLYCOBIOLOGY, V8, P1029, DOI 10.1093/glycob/8.10.1029
   Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123
   Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33
   Stoops EH, 2014, J AM SOC NEPHROL, V25, P1375, DOI 10.1681/ASN.2013080883
   Tafazoli F, 2001, J VIROL, V75, P1540, DOI 10.1128/JVI.75.3.1540-1546.2001
   Tamhankar M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1045-0
   TASHIRO M, 1992, VIROLOGY, V187, P413, DOI 10.1016/0042-6822(92)90443-S
   TUCKER SP, 1993, ADV VIRUS RES, V42, P187, DOI 10.1016/S0065-3527(08)60086-X
   Valenzano MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133926
   Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096957
   Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80
NR 49
TC 2
Z9 2
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD AUG 8
PY 2019
VL 16
IS 1
AR 99
DI 10.1186/s12985-019-1200-2
PG 8
WC Virology
SC Virology
GA IQ1NW
UT WOS:000480518600001
PM 31395061
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lebov, JF
   Arias, JF
   Balmaseda, A
   Britt, W
   Cordero, JF
   Galvao, LA
   Garces, AL
   Hambidge, KM
   Harris, E
   Ko, A
   Krebs, N
   Marques, ETA
   Martinez, AM
   McClure, E
   Miranda, DB
   Moreira, MEL
   Mussi-Pinhata, MM
   Ochoa, TJ
   Osorio, JE
   Scalabrin, DMF
   Schultz-Cherry, S
   Seage, GR
   Stolka, K
   Ugarte-Gil, CA
   Vega, CMV
   Welton, M
   Ximenes, R
   Zorrilla, C
AF Lebov, Jill F.
   Arias, Juan F.
   Balmaseda, Angel
   Britt, William
   Cordero, Jose F.
   Galvao, Luiz Augusto
   Garces, Ana Lucia
   Hambidge, K. Michael
   Harris, Eva
   Ko, Albert
   Krebs, Nancy
   Marques, Ernesto T. A.
   Martinez, Alexander M.
   McClure, Elizabeth
   Miranda-Filho, Democrito B.
   Lopes Moreira, Maria Elisabeth
   Mussi-Pinhata, Marisa M.
   Ochoa, Theresa J.
   Osorio, Jorge E.
   Scalabrin, Deolinda M. F.
   Schultz-Cherry, Stacey
   Seage, George R., III
   Stolka, Kristen
   Augusto Ugarte-Gil, Cesar
   Vega, Carmen Milagros Velez
   Welton, Michael
   Ximenes, Ricardo
   Zorrilla, Carmen
TI International prospective observational cohort study of Zika in infants
   and pregnancy (ZIP study): study protocol
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Zika virus; Pregnancy; Latin America; Microcephaly
ID VIRUS-INFECTION; BIRTH-DEFECTS; CLINICAL-MANIFESTATIONS; EMERGENCE;
   EXPOSURE; FETUSES; HISTORY; UPDATE; STATES; BRAZIL
AB Background Until recently, Zika virus (ZIKV) infections were considered mild and self-limiting. Since 2015, they have been associated with an increase in microcephaly and other birth defects in newborns. While this association has been observed in case reports and epidemiological studies, the nature and extent of the relationship between ZIKV and adverse pregnancy and pediatric health outcomes is not well understood. With the unique opportunity to prospectively explore the full spectrum of issues related to ZIKV exposure during pregnancy, we undertook a multi-country, prospective cohort study to evaluate the association between ZIKV and pregnancy, neonatal, and infant outcomes. Methods At research sites in ZIKV endemic regions of Brazil (4 sites), Colombia, Guatemala, Nicaragua, Puerto Rico (2 sites), and Peru, up to 10,000 pregnant women will be recruited and consented in the first and early second trimesters of pregnancy and then followed through delivery up to 6 weeks post-partum; their infants will be followed until at least 1 year of age. Pregnant women with symptomatic ZIKV infection confirmed by presence of ZIKV RNA and/or IgM for ZIKV will also be enrolled, regardless of gestational age. Participants will be tested monthly for ZIKV infection; additional demographic, physical, laboratory and environmental data will be collected to assess the potential interaction of these variables with ZIKV infection. Delivery outcomes and detailed infant assessments, including physical and neurological outcomes, will be obtained. Discussion With the emergence of ZIKV in the Americas and its association with adverse pregnancy outcomes in this region, a much better understanding of the spectrum of clinical outcomes associated with exposure to ZIKV during pregnancy is needed. This cohort study will provide information about maternal, fetal, and infant outcomes related to ZIKV infection, including congenital ZIKV syndrome, and manifestations that are not detectable at birth but may appear during the first year of life. In addition, the flexibility of the study design has provided an opportunity to modify study parameters in real time to provide rigorous research data to answer the most critical questions about the impact of congenital ZIKV exposure.
C1 [Lebov, Jill F.; McClure, Elizabeth; Stolka, Kristen] RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
   [Arias, Juan F.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.
   [Balmaseda, Angel] Complejo Nacl Salud, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Britt, William] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
   [Cordero, Jose F.; Welton, Michael] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Galvao, Luiz Augusto] Fiocruz MS, Ctr Global Hlth CRIS, Rio De Janeiro, Brazil.
   [Garces, Ana Lucia] Fdn Alimentac & Nutr Cent Amer & Panama INCAP, Guatemala City, Guatemala.
   [Hambidge, K. Michael; Krebs, Nancy] Univ Colorado, Sect Nutr, Pediat, Aurora, CO USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Fiocruz MS, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Martinez, Alexander M.] Imbanaco Med Ctr, Res Inst, Cali, Colombia.
   [Miranda-Filho, Democrito B.] Univ Pernambuco, Programa Posgrad Ciencias Saude PPGCS, Microcephaly Epidem Res Grp, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Mussi-Pinhata, Marisa M.] Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Seage, George R., III] Harvard Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vega, Carmen Milagros Velez] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Ximenes, Ricardo] Univ Fed Pernambuco, Microcephaly Epidem Res Grp, Dept Med Trop, Recife, PE, Brazil.
   [Zorrilla, Carmen] Maternal Infant Studies Ctr CEMI, San Juan, PR USA.
RP Lebov, JF (corresponding author), RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
EM jlebov@rti.org
RI Ko, Albert Icksang/P-2343-2015; Marques, Ernesto T. A/L-4967-2013;
   Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Ugarte-Gil,
   Cesar/E-6074-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Marques, Ernesto T.
   A/0000-0003-3826-9358; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Ugarte-Gil, Cesar/0000-0002-2833-9087;
   Martinez-Blanco, Alexander Maximiliano/0000-0001-5755-1776; McClure,
   Elizabeth/0000-0001-8659-5444; Galvao, Luiz Augusto/0000-0002-3918-0286
FU U.S. National Institute of Child Health and Human Development
   (NICHD)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD); National
   Institute of Allergy and Infectious Diseases (NIAID)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   National Institute of Environmental Health Sciences (NIEHS)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS);
   Fundacao Oswaldo Cruz-Fiocruz, Brazil
FX This study is funded through grants from the U.S. National Institute of
   Child Health and Human Development (NICHD); National Institute of
   Allergy and Infectious Diseases (NIAID); National Institute of
   Environmental Health Sciences (NIEHS); and Fundacao Oswaldo
   Cruz-Fiocruz, Brazil. Representatives from each institution provided
   general support, scientific input, and peer review of the study design,
   protocol, consent forms, data collection forms, and analysis plan.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 33
TC 5
Z9 5
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 7
PY 2019
VL 19
IS 1
AR 282
DI 10.1186/s12884-019-2430-4
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IO2TY
UT WOS:000479235900001
PM 31391005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Espano, E
   Nam, JH
   Song, EJ
   Song, D
   Lee, CK
   Kim, JK
AF Espano, Erica
   Nam, Jeong-Hyun
   Song, Eun-Jung
   Song, Daesub
   Lee, Chong-Kil
   Kim, Jeong-Ki
TI Lipophilic statins inhibit Zika virus production in Vero cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ENTRY; INFECTION; DENGUE; SIMVASTATIN; LIPIDS; DRUG
AB Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family. ZIKV infection has been associated with neurological complications such as microcephaly in newborns and Guillain-Barre syndrome in adults; thus, therapeutic agents are urgently needed. Statins are clinically approved for lowering cholesterol levels to prevent cardiovascular disease but have shown potential as antiviral drugs. In this study, we explored the possibility of utilizing statins as anti-ZIKV drugs. We found that, generally, lipophilic statins (atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, and simvastatin) could reduce ZIKV production in vitro and result in smaller foci of infection. Time-of-drug-addition assay revealed that early treatment with statins is more beneficial than late treatment; however, statins could not completely inhibit the entry stage of ZIKV infection. Furthermore, individual lipophilic statins differed in anti-ZIKV capacity, with fluvastatin being the most efficient at low concentrations. Taken together, this study shows that statins or their derivatives have the potential to be used as anti-ZIKV therapeutic agents.
C1 [Espano, Erica; Nam, Jeong-Hyun; Song, Eun-Jung; Song, Daesub; Kim, Jeong-Ki] Korea Univ, Dept Pharm, Coll Pharm, Sejong 30019, South Korea.
   [Lee, Chong-Kil] Chungbuk Natl Univ, Coll Pharm, Dept Pharm, Cheongju 28160, Chungbuk, South Korea.
RP Kim, JK (corresponding author), Korea Univ, Dept Pharm, Coll Pharm, Sejong 30019, South Korea.; Lee, CK (corresponding author), Chungbuk Natl Univ, Coll Pharm, Dept Pharm, Cheongju 28160, Chungbuk, South Korea.
EM cklee@chungbuk.ac.kr; jkfrancis@korea.ac.kr
OI Lee, Chong-Kil/0000-0001-9070-341X; song, Eun-jung/0000-0002-1495-488X;
   Espano, Erica/0000-0003-1437-9069
FU Korea University [K1715341]; Korea University Sejong Future Research
   Grant [K1826621]
FX This research was supported by Korea University Grant (K1715341) and
   Korea University Sejong Future Research Grant (K1826621).
CR Andrus MR, 2010, SOUTH MED J, V103, P1018, DOI 10.1097/SMJ.0b013e3181f0c6b4
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Bateman BT, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1035
   Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f
   Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butt AA, 2015, HEPATOLOGY, V62, P365, DOI 10.1002/hep.27835
   Chan D, 2017, LANCET NEUROL, V16, P591, DOI 10.1016/S1474-4422(17)30113-8
   Chu CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24248-8
   Das S, 2010, J NEUROCHEM, V115, P537, DOI 10.1111/j.1471-4159.2010.06951.x
   del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Galiullina LF, 2017, BBA-BIOMEMBRANES, V1859, P295, DOI 10.1016/j.bbamem.2016.12.006
   Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Bryan-Marrugo OL, 2016, MOL MED REP, V14, P2155, DOI 10.3892/mmr.2016.5519
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892
   Mason RP, 2005, AM J CARDIOL, V96, p11F, DOI 10.1016/j.amjcard.2005.06.008
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Mehrbod P, 2014, BIOMED RES INT, DOI 10.1155/2014/872370
   Mehrbod P, 2014, INT J MOL MED, V34, P61, DOI 10.3892/ijmm.2014.1761
   Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0
   Moghadasian MH, 1999, LIFE SCI, V65, P1329, DOI 10.1016/S0024-3205(99)00199-X
   Mohamed A. A., 2016, J HEPATOLOGY GASTROI, V2, DOI [10.4172/2475-3181.1000117, DOI 10.4172/2475-3181.1000117]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Roy A, 2015, CELL METAB, V22, P253, DOI 10.1016/j.cmet.2015.05.022
   Shrivastava-Ranjan P, 2018, MBIO, V9, DOI [10.1128/mBio.00660-18, 10.1128/mbio.00660-18]
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Wang Q, 2011, EXP NEUROL, V230, P27, DOI 10.1016/j.expneurol.2010.04.006
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 45
TC 2
Z9 2
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 7
PY 2019
VL 9
AR 11461
DI 10.1038/s41598-019-47956-1
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IN9WF
UT WOS:000479030000033
PM 31391514
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Knowledge and Practice Regarding Zika Virus Infections Among General
   Adults
SO ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat I Med Acad Ctr, Bangkok 10170, Thailand.
   [Wiwanitkit, Viroj] Joseph Ayo Babalola Univ, Ikeji Arakeji, Nigeria.
RP Joob, B (corresponding author), Sanitat I Med Acad Ctr, Bangkok 10170, Thailand.
EM beuyjoob@hotmail.com
CR Chaw LL, 2019, ASIA-PAC J PUBLIC HE, V31, P275, DOI 10.1177/1010539519850023
   Choi JS, 2018, J INFECT PUBLIC HEAL, V11, P840, DOI 10.1016/j.jiph.2018.07.002
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
NR 4
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1010-5395
EI 1941-2479
J9 ASIA-PAC J PUBLIC HE
JI Asia-Pac. J. Public Health
PD SEP
PY 2019
VL 31
IS 6
BP 572
EP 573
AR UNSP 1010539519867183
DI 10.1177/1010539519867183
EA AUG 2019
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JD9NW
UT WOS:000480982300001
PM 31387365
DA 2020-07-08
ER

PT J
AU Harapan, H
   Rajamoorthy, Y
   Utomo, PS
   Anwar, S
   Setiawan, AM
   Alleta, A
   Bambang, A
   Ramadana, MR
   Ikram, I
   Wahyuniati, N
   Maulana, R
   Ichsan, I
   Indah, R
   Wagner, AL
   Kuch, U
   Groneberg, DA
   Rodriguez-Morales, AJ
   Andalas, M
   Muller, R
   Mudatsir, M
   Imrie, A
AF Harapan, Harapan
   Rajamoorthy, Yogambigai
   Utomo, Prattama S.
   Anwar, Samsul
   Setiawan, Abdul M.
   Alleta, Alma
   Bambang, Alfredo
   Ramadana, Muhammad R.
   Ikram, Ikram
   Wahyuniati, Nur
   Maulana, Reza
   Ichsan, Ichsan
   Indah, Rosaria
   Wagner, Abram L.
   Kuch, Ulrich
   Groneberg, David A.
   Rodriguez-Morales, Alfonso J.
   Andalas, Mohd
   Mueller, Ruth
   Mudatsir, Mudatsir
   Imrie, Allison
TI Knowledge and attitude towards pregnancy-related issues of Zika virus
   infection among general practitioners in Indonesia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Knowledge; Attitude; General practitioner; Healthcare worker
ID HEALTH-CARE STUDENTS; CROSS-SECTIONAL SURVEY; WORKERS KNOWLEDGE;
   MEDICAL-STUDENTS; DENGUE VACCINE; ASSOCIATION; PATIENT; BRAZIL; WOMEN;
   SURVEILLANCE
AB Background The aim of this study was to assess the knowledge and attitudes towards pregnancy-related issues of Zika virus (ZIKV) infection among general practitioners (GPs), a frontline healthcare worker group, in Indonesia. Methods A cross-sectional, online survey assessing knowledge and attitudes towards ZIKV infection on multiple-item scales was sent to GPs in the Sumatra and Java islands of Indonesia. The associations between independent factors and either knowledge or attitude were assessed with logistic regressions. The correlation and association between knowledge and attitude were estimated. Results We included 457 (53.7%) out of 850 responses in the analysis. Among these, 304 (66.5%) and 111 (24.2%) respondents had a good knowledge and attitude, respectively. No demographic, workplace, professional development, or experiential characteristics related to ZIKV infection were associated with knowledge. In the multivariate analysis, only contact experience was associated with attitude. There was a significant, positive correlation between knowledge and attitude scores. Conclusions Although knowledge of pregnancy-related complications of ZIKV infection is relatively high among GPs in Indonesia, more than 75% of them had a poor attitude towards pregnancy-related issues of Zika. Strategies for enhancing the capacity of GPs to develop positive attitudes and respond to ZIKV infection are needed.
C1 [Harapan, Harapan; Alleta, Alma; Ramadana, Muhammad R.; Ikram, Ikram; Wahyuniati, Nur; Maulana, Reza; Ichsan, Ichsan; Andalas, Mohd; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Med Res Unit, Banda Aceh, Indonesia.
   [Harapan, Harapan; Ichsan, Ichsan; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia.
   [Harapan, Harapan; Ichsan, Ichsan; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.
   [Harapan, Harapan; Imrie, Allison] Univ Western Australia, Sch Biomed Sci, Nedlands, WA, Australia.
   [Rajamoorthy, Yogambigai] Univ Tunku Abdul Rahman, Kajang, Selangor, Malaysia.
   [Utomo, Prattama S.] Gadjah Mada Univ, Fac Med, Dept Med Educ, Yogyakarta, Indonesia.
   [Anwar, Samsul] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Indonesia.
   [Setiawan, Abdul M.] Maulana Malik Ibrahim State Islamic Univ Malang, Fac Med & Hlth Sci, Dept Microbiol, Malang, Indonesia.
   [Alleta, Alma] Univ Syiah Kuala, Sch Med, Dept Family Med, Banda Aceh, Indonesia.
   [Bambang, Alfredo] Atma Jaya Catholic Univ Indonesia, Sch Med, Dept Microbiol, Jakarta, Indonesia.
   [Indah, Rosaria] Univ Syiah Kuala, Sch Med, Med Educ Unit, Banda Aceh, Indonesia.
   [Indah, Rosaria] Univ Sydney, Fac Arts & Social Sci, Sydney Sch Educ & Social Work, Sydney, NSW, Australia.
   [Wagner, Abram L.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Kuch, Ulrich; Groneberg, David A.; Mueller, Ruth] Goethe Univ, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] IPS Imagenes Diagnost SA, Res Grp Med & Diagnost Images GRIMEID, Pereira, Risaralda, Colombia.
   [Andalas, Mohd] Univ Syiah Kuala, Sch Med, Dept Obstet & Gynecol, Banda Aceh, Indonesia.
   [Mueller, Ruth] Inst Trop Med, Unit Med Entomol, Antwerp, Belgium.
RP Harapan, H; Mudatsir, M (corresponding author), Univ Syiah Kuala, Sch Med, Med Res Unit, Banda Aceh, Indonesia.
EM harapan@unsyiah.ac.id; mudatsir@unsyiah.ac.id
RI Imrie, Allison/AAH-2421-2019; Wagner, Abram/X-6379-2019; Mudatsir,
   Mudatsir/Q-4999-2017; Muller, Ruth/D-2551-2009; Harapan,
   Harapan/I-8741-2016
OI Wagner, Abram/0000-0003-4691-7802; Mudatsir,
   Mudatsir/0000-0002-5643-9384; Ichsan, Ichsan/0000-0002-8903-9977;
   Muller, Ruth/0000-0003-3909-3876; Harapan, Harapan/0000-0001-7630-8413;
   Setiawan, abdul Malik/0000-0002-6913-2007
FU Department of Foreign Affairs and Trade, Australia; NHMRC Centre of
   Research Excellence in Emerging Infectious Diseases (CREID)
   ScholarshipNational Health and Medical Research Council of Australia;
   Federal Ministry of Education and Research under the program "Nationales
   Forschungsnetz Zoonotische Infektionskrankheiten" [01KI1717]; University
   of Western Australia
FX HH is received Australia Awards Scholarship (AAS) from the Department of
   Foreign Affairs and Trade, Australia, Scholarship for International
   Research Fees (SIRF) from The University of Western Australia and NHMRC
   Centre of Research Excellence in Emerging Infectious Diseases (CREID)
   Scholarship. RM, UK and DAG were supported by the Federal Ministry of
   Education and Research under the program "Nationales Forschungsnetz
   Zoonotische Infektionskrankheiten" (01KI1717). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], ZIK VIR
   [Anonymous], 2006, STAND KOMP DOKT IND
   [Anonymous], 2012, STAND KOMP DOKT IND
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Bhat S, 2017, OBSTET GYNECOL, V129, p135S, DOI 10.1097/01.AOG.0000514681.98545.97
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonett DG, 2000, PSYCHOMETRIKA, V65, P23, DOI 10.1007/BF02294183
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cervero RM, 2015, J CONTIN EDUC HEALTH, V35, P131, DOI 10.1002/chp.21290
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Curry CL, 2018, J OBSTET GYNAECOL RE, V44, P503, DOI 10.1111/jog.13533
   Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dhimal M, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0426-3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickson DA, 2017, FERTIL STERIL, V108, pE327, DOI 10.1016/j.fertnstert.2017.07.965
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5577
   Gokce A, 2016, EUR J PUBLIC HEALTH, V26, P452
   Gulland A., 2016, BMJ, V352
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Harapan H, 2019, CLIN EPIDEMIOL GLOB, V7, P542, DOI 10.1016/j.cegh.2018.12.006
   Harapan H, 2019, VACCINE, V37, P1398, DOI 10.1016/j.vaccine.2019.01.062
   Harapan H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110648
   Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Harapan H, 2017, ACTA TROP, V166, P249, DOI 10.1016/j.actatropica.2016.11.035
   Harapan H, 2016, ASIAN PAC J TROP MED, V9, P1092, DOI 10.1016/j.apjtm.2016.07.036
   Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Huang Yu, 2017, JMIR Public Health Surveill, V3, pe81, DOI 10.2196/publichealth.7663
   Ibrahim NK, 2018, J INFECT PUBLIC HEAL, V11, P18, DOI 10.1016/j.jiph.2017.02.015
   Iqbal MZ, 2016, VALUE HEALTH, V19, pA484, DOI 10.1016/j.jval.2016.09.798
   Jaramillo Ramirez GI, 2017, OPEN PUBLIC HLTH J, V10, P80, DOI [10.2174/1874944501710010080, DOI 10.2174/1874944501710010080]
   Khan MU, 2016, VALUE HEALTH, V19, pA423, DOI 10.1016/j.jval.2016.09.445
   Khawar, 2017, ACAD EMERG MED, V24, pS272
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lissauer D, 2016, BJOG-INT J OBSTET GY, V123, P1258, DOI 10.1111/1471-0528.14071
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monajemi A, 2007, MED EDUC, V41, P1166, DOI 10.1111/j.1365-2923.2007.02922.x
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Nicolini D, 2008, INT J MANAG REV, V10, P245, DOI 10.1111/j.1468-2370.2007.00219.x
   Noah Norman, 2008, Epidemiol Infect, V136, P865, DOI 10.1017/S0950268808000733
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Piltci-Loeb R, 2018, AM J PUBLIC HEALTH, V108, P1358, DOI 10.2105/AJPH.2018.304525
   Raman A, 2017, FERTIL STERIL, V108, pE328, DOI 10.1016/j.fertnstert.2017.07.968
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Schmidt HG, 2007, MED EDUC, V41, P1133, DOI 10.1111/j.1365-2923.2007.02915.x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Siraj Amir S, 2017, BMJ Glob Health, V2, pe000309, DOI 10.1136/bmjgh-2017-000309
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Villers MS, 2017, AM J OBSTET GYNECOL, V216, pS206
   Vissoci JRN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006392
   Vogel T., 2016, ATTITUDES ATTITUDE C
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Wong LP, 2017, VACCINE, V35, P5912, DOI 10.1016/j.vaccine.2017.08.074
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization (WHO), ZIK SIT REP
   Yardley S, 2012, MED TEACH, V34, P161, DOI 10.3109/0142159X.2012.643264
   Yung Chee F, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.44b19196298e01f3a6dcd4c09f235fa8
NR 76
TC 2
Z9 2
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD AUG 6
PY 2019
VL 19
IS 1
AR 693
DI 10.1186/s12879-019-4297-4
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA IO0JR
UT WOS:000479065700001
PM 31387537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diniz, D
   Brito, L
   Ambrogi, I
   Tavares, AB
   Ali, M
AF Diniz, Debora
   Brito, Luciana
   Ambrogi, Ilana
   Tavares, Adriano Bueno
   Ali, Moazzam
TI Understanding the sexual and reproductive health needs in Brazil's
   Zika-affected region: placing women at the center of the discussion
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Public Health; Sexual and Reproductive health; Unmet needs;
   Young women; Zika virus
AB Zika is no longer high on the public health agenda. There is a lack of information about Zika infection transmission, prevention, and its effects in Brazil.
C1 [Diniz, Debora] Univ Brasilia, Law Sch Fac, Brasilia, DF, Brazil.
   [Diniz, Debora] Int Planned Parenthood Federat, New York, NY USA.
   [Brito, Luciana; Ambrogi, Ilana] Anis Inst Bioeth, Brasilia, DF, Brazil.
   [Tavares, Adriano Bueno; Ali, Moazzam] WHO, Dept Reprod Hlth & Res RHR, Geneva, Switzerland.
RP Diniz, D (corresponding author), Anis Inst Bioeth, Brasilia, DF, Brazil.
EM d.diniz@anis.org.br
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569
FU  [5149]
FX The authors would like to acknowledge and thank all the young women who
   spared their time in sharing their experiences on sexual and
   reproductive health issues. This study was funded by a large anonymous
   donor under the Grant ID 5149 for Women, Communities, and Health Systems
   in the Context of Zika. The funding sources did not play a role in the
   study design, in the writing of the report, nor in the decision to
   submit the article for publication. This report contains the collective
   views of an international group of experts and does not necessarily
   represent the decisions or the stated policy of WHO.
CR Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   desOliveira WK, 2017, LANCET, V390, P861
   Diniz D, 2017, ZIKA BRAZIL WOMEN CH
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz D, 2017, CIENC SAUDE COLETIVA, V22, P653, DOI 10.1590/1413-81232017222.23812016
   Farias MR, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006176, 10.1590/s1518-8787.2016050006176]
   IPEA Brazil, 2016, DES HUM NAS MACR BRA
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miller A, 2019, ZIKA BRAZILIAN SUPRE
   Ministry of Health Brazil, 2017, OR INT VIG AT SAUD A
   Ministry of Health Brazil, 2019, MIN HLTH EP B, V50
   Ministry of Health Brazil, 2019, EPIDEMIOLOGICAL B, V50
NR 14
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD NOV
PY 2019
VL 147
IS 2
BP 268
EP 270
DI 10.1002/ijgo.12924
EA AUG 2019
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JB1SF
UT WOS:000479484800001
PM 31314905
DA 2020-07-08
ER

PT J
AU Euliano, EM
   Hardcastle, AN
   Victoriano, CM
   Gabella, WE
   Haselton, FR
   Adams, NM
AF Euliano, Erin M.
   Hardcastle, Austin N.
   Victoriano, Christie M.
   Gabella, William E.
   Haselton, Frederick R.
   Adams, Nicholas M.
TI Multiplexed Adaptive RT-PCR Based on L-DNA Hybridization Monitoring for
   the Detection of Zika, Dengue, and Chikungunya RNA
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS; DIAGNOSTICS; OLIGONUCLEOTIDES; INFECTION
AB Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for the molecular diagnosis of many infectious diseases, including RNA viruses, but is generally limited to settings with access to trained personnel and laboratory resources. We have previously reported a fundamentally simpler thermal cycling platform called Adaptive PCR, which dynamically controls thermal cycling conditions during each cycle by optically monitoring the annealing and melting of mirror-image L-DNA surrogates of the PCR primers and targets. In this report, we integrate optically-controlled reverse transcription and single-channel monitoring of L-DNAs to develop a multiplexed Adaptive RT-PCR instrument and assay for the detection of Zika, dengue, and chikungunya virus RNA with high target specific and low limits of detection. The assay is demonstrated to detect as low as 5 copies/reaction of Zika or chikungunya RNA and 50 copies/reaction of dengue RNA. The multiplexed Adaptive RT-PCR instrument is robust and has many of the features required to implement diagnostic assays for RNA viruses in settings that lack traditional laboratory resources.
C1 [Euliano, Erin M.; Hardcastle, Austin N.; Victoriano, Christie M.; Haselton, Frederick R.; Adams, Nicholas M.] Vanderbilt Univ, Dept Biomed Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Gabella, William E.] Vanderbilt Univ, Dept Phys & Astron, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Haselton, Frederick R.] Vanderbilt Univ, Dept Chem, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Haselton, FR; Adams, NM (corresponding author), Vanderbilt Univ, Dept Biomed Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.; Haselton, FR (corresponding author), Vanderbilt Univ, Dept Chem, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM rick.haselton@vanderbilt.edu; n.adams@vanderbilt.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R42HG009470]
FX This work was supported in part by the National Institutes of Health
   Grant Number R42HG009470.
CR Adams NM, 2017, ANAL CHEM, V89, P728, DOI 10.1021/acs.analchem.6b03291
   ANDERSON DJ, 1984, NUCLEOS NUCLEOT, V3, P499, DOI 10.1080/07328318408081285
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Basile K, 2018, EXPERT REV MOL DIAGN, V18, P75, DOI 10.1080/14737159.2018.1419065
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, 2018, CHIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, 2019, ZIK VIR SYMPT TEST T
   Centers for Disease Control and Prevention, 2019, DENG VIR SYMPT TREAT
   Centers for Disease Control and Prevention, 2019, CDC DENV 1 4 REAL TI
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2
   Garbesi A, 1998, NUCLEOS NUCLEOT, V17, P1275, DOI 10.1080/07328319808004239
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Habiyambere V, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002088
   Ke GL, 2012, J AM CHEM SOC, V134, P18908, DOI 10.1021/ja3082439
   Kim Y, 2007, NUCLEIC ACIDS RES, V35, P7279, DOI 10.1093/nar/gkm771
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Land K. J., 2019, UNMET DIAGNOSTICS NE, P1
   Laue T, 1999, J CLIN MICROBIOL, V37, P2543, DOI 10.1128/JCM.37.8.2543-2547.1999
   Leelawong M, 2019, J MOL DIAGN, V21, P623, DOI 10.1016/j.jmoldx.2019.02.004
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Millington Adam L, 2019, Biomol Detect Quantif, V17, P100081, DOI 10.1016/j.bdq.2019.100081
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Saeed M. A., 2015, AFRO EGYPT J INFECT, V5, P189
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Tang YW, 1997, CLIN CHEM, V43, P2021
   Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392
   U. S. Food and Drug Administration, 2019, ZIK VIR EM US ANTH
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Weidemaier K, 2015, FUTURE VIROL, V10, P313, DOI 10.2217/FVL.14.117
   WHO, 2011, RAP IMPL XPERT MTB R
   World Health Organization, 2017, VECT BORN DIS
   World Health Organization, 2019, DENG SEV DENG
   You Y, 2011, BIOPOLYMERS, V95, P472, DOI 10.1002/bip.21615
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zimmers ZA, 2019, ANAL METHODS-UK, V11, P2862, DOI 10.1039/c9ay00584f
NR 36
TC 0
Z9 0
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 6
PY 2019
VL 9
AR 11372
DI 10.1038/s41598-019-47862-6
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IN7LK
UT WOS:000478863700021
PM 31388071
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Agrelli, A
   de Moura, RR
   Crovella, S
   Brandao, LAC
AF Agrelli, Almerinda
   de Moura, Ronald Rodrigues
   Crovella, Sergio
   Cavalcanti Brandao, Lucas Andre
TI Mutational landscape of Zika virus strains worldwide and its structural
   impact on proteins
SO GENE
LA English
DT Article
DE Zika virus; Mutation; Nonsynonymous; Protein C; NS2A; NS3 helicase
ID CRYSTAL-STRUCTURE; FRENCH-POLYNESIA; HELICASE; REPLICATION; EVOLUTION;
   OUTBREAK; TARGETS; GENOME; GENES; NS3
AB Zika virus (ZIKV) has spread globally and has been linked to the onset of microcephaly and other brain abnormalities. The ZIKV genome consists of an similar to 10.7 kb positive-stranded RNA molecule that encodes three structural (C, prM and E) and seven nonstructural (5'-NS1-NS2A-NS2B-NS3-NS4A/2K-NS4B-NS5-3') proteins. In this work, we looked for genetic variants in 485 ZIKV complete genomes from GenBank (NCBI) and performed a computational systematic approach using MAESTROweb server to assess the impact of nonsynonymous mutations in ZIKV proteins (C, M, E, NS1, NS2A, NS2B-NS3 protease, NS3 helicase and NS5). Then, we merged the data and correlated it with the phenotypic reports of ZIKV circulating strains. The sensitivity profile of the proteins showed 96 mutational hotspots. We found 22 relevant mutations in proteins C (180T), NS2A (I34M/T/V, I45V, I80T/V, L113F, A117V, I118V, L128P, V143A, T151A, M199I/V, R207K and L208I) and NS3 helicase (D436G, Y498H, R525K, Q528R and R583K) of the circulating strains. Our analysis exploited the impact of nonsynonymous mutations on ZIKV proteins, their structural and functional insights. The results presented here could advance our current understanding on ZIKV proteins functions and pathogenesis.
C1 [Agrelli, Almerinda; Crovella, Sergio; Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, LIKA, Av Prof Moraes Rego,1235 Cidade Univ, Recife, PE, Brazil.
   [de Moura, Ronald Rodrigues; Crovella, Sergio] Fed Univ Pernambuco UFPE, Dept Genet, Av Prof Moraes Rego,1235 Cidade Univ, Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, Dept Pathol, Av Prof Moraes Rego,1235 Cidade Univ, Recife, PE, Brazil.
RP Agrelli, A (corresponding author), Fed Univ Pernambuco UFPE, LIKA, Av Prof Moraes Rego,1235 Cidade Univ, Recife, PE, Brazil.
EM almerinda.agrelli@ufpe.br; ronald.moura@ufpe.br;
   sergio.crovella@ufpe.br; Iucas.cbrandao@ufpe.br
RI Moura, Ronald/AAE-2318-2020
OI Moura, Ronald/0000-0002-9112-7167; Agrelli,
   Almerinda/0000-0002-9908-742X
FU National Council for the Improvement of Higher Education - Brazil
   (CAPES) [001]; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Department of Science and Technology of the Ministry
   of Health (Decit/SCTIE/MS)
FX This study was financed by the National Council for the Improvement of
   Higher Education - Brazil (CAPES) - Finance Code 001, the National
   Council for Scientific and Technological Development (CNPq) and the
   Department of Science and Technology of the Ministry of Health
   (Decit/SCTIE/MS).
CR Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Capriotti E, 2005, BIOINFORMATICS, V21, P54, DOI 10.1093/bioinformatics/bti1109
   Charif D., 2015, PACKAGE SEQINR R PAC, DOI [10.1093/nar/12.1Part1.121, DOI 10.1093/NAR/12.1PART1.121]
   Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kolde R., 2019, PHEATMAP PRETTY HEAT, P4
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Neuwirth E., 2014, RCOLORBREWER COLORBR
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Phumee A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010030
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Ramharack P, 2017, RSC ADV, V7, P22133, DOI 10.1039/c7ra01376k
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Schuler-Faccini L, 2015, WEEKLY MMWR, V65, P1
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Simon D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120698
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Wu RH, 2015, J VIROL, V89, P4281, DOI 10.1128/JVI.03011-14
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L., 2017, SCIENCE, V88, P11726, DOI [10.1128/JVI.01140-14, DOI 10.1128/JVI.01140-14]
   Yuan L, 2016, GENE, V594, P183, DOI 10.1016/j.gene.2016.08.055
NR 58
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD AUG 5
PY 2019
VL 708
BP 57
EP 62
DI 10.1016/j.gene.2019.05.039
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA IH2LM
UT WOS:000474326300008
PM 31128224
DA 2020-07-08
ER

PT J
AU Bosak, A
   Saraf, N
   Willenberg, A
   Kwan, MWC
   Alto, BW
   Jackson, GW
   Batchelor, RH
   Nguyen-Huu, TD
   Sankarapani, V
   Parks, GD
   Seal, S
   Willenberg, BJ
AF Bosak, Alexander
   Saraf, Nileshi
   Willenberg, Alicia
   Kwan, Michael W. C.
   Alto, Barry W.
   Jackson, George W.
   Batchelor, Robert H.
   Nguyen-Huu, Truong D.
   Sankarapani, Vinoth
   Parks, Griffith D.
   Seal, Sudipta
   Willenberg, Bradley Jay
TI Aptamer-gold nanoparticle conjugates for the colorimetric detection of
   arboviruses and vector mosquito species
SO RSC ADVANCES
LA English
DT Article
ID CHIKUNGUNYA; BIOSENSORS; EVOLUTION; ZIKA
AB The real-time, colorimetric detection of analytes via aptamer-gold nanoparticle technology has proven to be an important, emerging technique within the medical field. Of global health importance, the ability to detect vector mosquito species, such as the Aedes (Ae.) aegypti mosquito, and transmitted arboviruses, such as Zika virus, is paramount to mosquito control and surveillance efforts. Herein, we describe the detection of Ae. aegypti salivary protein for vector identification and the detection of Zika virus to assess mosquito infection status by aptamer-gold nanoparticle conjugates. Key to optimization of these diagnostics were gold nanoparticle capping agents and aptamer degree of labelling (i.e., the amount of aptamers per gold nanoparticle). In the present study, detection was achieved for as little as 10 ng Ae. aegypti salivary protein and 1.0 x 10(5) PFU live Zika virus. These aptamer-gold nanoparticle conjugate diagnostics could one day prove to be useful as deployable nano-based biosensors that provide easy-to-read optical read outs through a straightforward red-to-blue colour change either within a diagnostic solution or atop a card/membrane-based biosensor.
C1 [Bosak, Alexander; Willenberg, Alicia; Kwan, Michael W. C.; Willenberg, Bradley Jay] Univ Cent Florida, Coll Med, Dept Internal Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.
   [Saraf, Nileshi; Seal, Sudipta] Univ Cent Florida, Dept Mat Sci & Engn, Nanosci & Technol Ctr, Adv Mat Proc & Anal Ctr, Orlando, FL 32816 USA.
   [Alto, Barry W.] Univ Florida, IFAS, Florida Med Entomol Lab, Dept Entomol & Nematol, Vero Beach, FL USA.
   [Jackson, George W.; Batchelor, Robert H.; Nguyen-Huu, Truong D.; Sankarapani, Vinoth] Base Pair Biotechnol Inc, 8619 Broadway St,Suite 100, Pearland, TX 77584 USA.
   [Parks, Griffith D.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.
RP Willenberg, BJ (corresponding author), Univ Cent Florida, Coll Med, Dept Internal Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.
EM Bradley.Willenberg@ucf.edu
RI Seal, Sudipta/A-7698-2012
OI Bosak, Alexander/0000-0002-7531-8051; Kwan, Michael/0000-0003-0782-8110
FU Florida Department of Agriculture and Consumer Services (FDACS) [022392,
   023593, 24236]; Pasco County Mosquito Control District
FX Financial support for this project was provided via a grant from the
   Florida Department of Agriculture and Consumer Services (FDACS #022392,
   #023593, #24236). We would also like to acknowledge and thank the
   following people, organizations and agencies for aiding, supporting
   and/or otherwise enabling this project: the University of Central
   Florida College of Medicine (UCF-COM), the UCF-COM Department of
   Internal Medicine, the Florida Coordinating Council on Mosquito Control
   (FCCMC), the USDA-ARS CMAVE, (Gainesville, FL), Daniel Kline, Joyce
   Urban and team (USDA-ARS-CMAVE) for help collecting saliva and salivary
   glands as well as providing work space, adult mosquitoes, mosquito eggs
   and mosquito rearing guidance, Matthew Longo from the Parks Lab for aid
   in the production of purified ZIKV, Dr Darrin Kuystermans and Sanford
   Burnham Prebys Medical Discovery Institute at Lake Nona for recombinant
   protein production, Ryan Dickerson from UCF-COM for helping with artwork
   and Christopher S. Bibbs (Education Specialist, Anastasia Mosquito
   Control District of St. Johns County), Dennis Moore (Director, Pasco
   County Mosquito Control District) and Kelley Deutsch (Orange County
   Mosquito Control) for supporting the project and educating the
   Willenberg Lab on mosquito control.
CR Agnihotri N. P., 2012, INT J SCI RES, P1703
   Aliakbarinodehi N., 2017, SCI REP, V7, P1
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   [Anonymous], 2017, ZIK EP REP
   Hurtado RB, 2016, PHYS LETT A, V380, P2658, DOI 10.1016/j.physleta.2016.05.052
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200
   Cheng AKH, 2007, ANAL CHEM, V79, P5158, DOI 10.1021/ac062214q
   Cheung Y., 2012, DEV APTAMER NANOPART
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Das S, 2012, BIOMATERIALS, V33, P7746, DOI 10.1016/j.biomaterials.2012.07.019
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Javier DJ, 2008, BIOCONJUGATE CHEM, V19, P1309, DOI 10.1021/bc8001248
   Jeon W, 2013, ANAL BIOCHEM, V439, P11, DOI 10.1016/j.ab.2013.03.032
   Katti Kavita K, 2009, Int J Green Nanotechnol Biomed, V1, pB53
   Lee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100847
   Liu J, 2006, NAT PROTOC, V1, P246, DOI 10.1038/nprot.2006.38
   Luo C, 2015, RSC ADV, V5, P10994, DOI 10.1039/c4ra14833a
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Qi ZM, 2004, J PHYS CHEM B, V108, P7006, DOI 10.1021/jp035972i
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Saraf N, 2019, ACS OMEGA, V4, P2234, DOI 10.1021/acsomega.8b03277
   Saraf N, 2018, BIOSENS BIOELECTRON, V117, P40, DOI 10.1016/j.bios.2018.05.031
   Saraf N, 2017, RSC ADV, V7, P49133, DOI 10.1039/c7ra10272k
   Schmitt J, 1997, ADV MATER, V9, P61, DOI 10.1002/adma.19970090114
   Seal S., 1420, 022392 FDACS
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612
   Storhoff JJ, 1998, J AM CHEM SOC, V120, P1959, DOI 10.1021/ja972332i
   Suvarna S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178202
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   White RJ, 2008, LANGMUIR, V24, P10513, DOI 10.1021/la800801v
   Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282
   Zhao WA, 2008, J AM CHEM SOC, V130, P3610, DOI 10.1021/ja710241b
   Zhou WZ, 2014, ANALYST, V139, P2627, DOI 10.1039/c4an00132j
NR 40
TC 1
Z9 1
U1 2
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
EI 2046-2069
J9 RSC ADV
JI RSC Adv.
PD AUG 4
PY 2019
VL 9
IS 41
BP 23752
EP 23763
DI 10.1039/c9ra02089f
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA IN8RK
UT WOS:000478947000036
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Salgueiro, P
   Serrano, C
   Gomes, B
   Alves, J
   Sousa, CA
   Abecasis, A
   Pinto, J
AF Salgueiro, Patricia
   Serrano, Celia
   Gomes, Bruno
   Alves, Joana
   Sousa, Carla A.
   Abecasis, Ana
   Pinto, Joao
TI Phylogeography and invasion history of Aedes aegypti, the Dengue and
   Zika mosquito vector in Cape Verde islands (West Africa)
SO EVOLUTIONARY APPLICATIONS
LA English
DT Article
DE Aedes aegypti; Africa; Cape Verde; Dengue; phylogeography; population
   genetics; vector control; Zika
ID MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; COMPUTER-PROGRAM; YELLOW-FEVER;
   GENETIC-VARIABILITY; RE-IMPLEMENTATION; N-E; SOFTWARE; CULICIDAE;
   PATTERNS
AB Aedes-borne arboviruses have spread globally with outbreaks of vast impact on human populations and health systems. The West African archipelago of Cape Verde had its first outbreak of Dengue in 2009, at the time the largest recorded in Africa, and was one of the few African countries affected by the Zika virus epidemic. Aedes aegypti was the mosquito vector involved in both outbreaks. We performed a phylogeographic and population genetics study of A. aegypti in Cape Verde in order to infer the geographic origin and evolutionary history of this mosquito. These results are discussed with respect to the implications for vector control and prevention of future outbreaks. Mosquitoes captured before and after the Dengue outbreak on the islands of Santiago, Brava, and Fogo were analyzed with two mitochondrial genes COI and ND4, 14 microsatellite loci and five kdr mutations. Genetic variability was comparable to other African populations. Our results suggest that A. aegypti invaded Cape Verde at the beginning of the Holocene from West Africa. Given the historic importance of Cape Verde in the transatlantic trade of the 16th-17th centuries, a possible contribution to the genetic pool of the founding populations in the New World cannot be fully discarded. However, contemporary gene flow with the Americas is likely to be infrequent. No kdr mutations associated with pyrethroid resistance were detected. The implications for vector control and prevention of future outbreaks are discussed.
C1 [Salgueiro, Patricia; Serrano, Celia; Gomes, Bruno; Sousa, Carla A.; Abecasis, Ana; Pinto, Joao] Univ Nova Lisboa, GHTM, IHMT, Rua Junqueira 100, P-1349008 Lisbon, Portugal.
   [Gomes, Bruno] Fundacao Oswaldo Cruz FIOCRUZ, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Alves, Joana] Minist Sat Cabo Verde, Direcao Geral Saude, Inst Nacl Saude Publ, Praia, Cape Verde.
RP Salgueiro, P (corresponding author), Univ Nova Lisboa, GHTM, IHMT, Rua Junqueira 100, P-1349008 Lisbon, Portugal.
EM patsalgueiro@hotmail.com
RI Gomes, Bruno/F-4785-2012; Pinto, Joao/C-2208-2012; Abecasis,
   Ana/B-6295-2009; Sousa, Carla/G-6531-2012; Salgueiro,
   Patricia/B-6410-2012
OI Gomes, Bruno/0000-0003-3877-2359; Pinto, Joao/0000-0001-8572-7708;
   Abecasis, Ana/0000-0002-3903-5265; Sousa, Carla/0000-0002-2386-7577;
   Salgueiro, Patricia/0000-0001-8628-3651
FU Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science
   and Technology [GHTM-UID/Multi/04413/2013, PEst-OE/SAU/LA0018/2011,
   POCI/BIA-BDE/57650/2004, SFRH/BPD/72532/2010]; Horizon 2020 Framework
   Programme [734548 ZIKAlliance]
FX Fundacao para a Ciencia e a Tecnologia, Grant/Award Number:
   GHTM-UID/Multi/04413/2013, PEst-OE/SAU/LA0018/2011,
   POCI/BIA-BDE/57650/2004 and SFRH/BPD/72532/2010; Horizon 2020 Framework
   Programme, Grant/Award Number: Project ID: 734548 ZIKAlliance
CR Alves J, 2010, J VECTOR ECOL, V35, P307, DOI 10.1111/j.1948-7134.2010.00087.x
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434
   Bourne W. R. P., 1955, Ibis, V97, P508, DOI 10.1111/j.1474-919X.1955.tb04981.x
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Carranza S, 2001, P ROY SOC B-BIOL SCI, V268, P1595, DOI 10.1098/rspb.2001.1699
   CDC, 2015, UNV BURD DENG AFR
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   da Costa-Ribeiro MCV, 2007, AM J TROP MED HYG, V77, P303
   desPina A., 2013, BIOECOLOGIA CONTROLO, P13
   Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238
   Diallo M., 2013, T ROY SOC TROP MED H, V102, P493
   Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157
   Donnelly MJ, 1999, HEREDITY, V83, P408, DOI 10.1038/sj.hdy.6885930
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Duarte M. C., 2009, ENCY ISLANDS, P143
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Eskildsen GA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194874
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Franco L, 2010, EUROSURVEILLANCE, V15, P5
   Fu YX, 1997, GENETICS, V147, P915
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Guedes DRD, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex057
   HARPENDING HC, 1994, HUM BIOL, V66, P591
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   HEATWOLE H, 1976, Australian Zoologist, V19, P69
   Huang ZJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-33
   Jaimes-Duenez J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003553
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x
   Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387
   Kotsakiozi P, 2018, ECOL EVOL, V8, P7835, DOI 10.1002/ece3.4278
   Lobban R.A., 2018, CAPE VERDE CRIOULO C
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Lovin DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-590
   Ministry of Health Cape Verde WHO & University of California, 2012, EL MAL CAS STUD 2 MO
   Mitchell C., 2016, PAHO WHO ZIKA CUMULA
   Monteiro M. L., 2016, EVOLUCAO EPIDEMIA ZI
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Morlais I, 2002, DNA SEQUENCE, V13, P123, DOI 10.1080/10425170290030051
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Paduan KD, 2008, J MED ENTOMOL, V45, P59, DOI 10.1603/0022-2585(2008)45[59:MDPAHI]2.0.CO;2
   Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x
   Paupy C, 2008, J MED ENTOMOL, V45, P391, DOI 10.1603/0022-2585(2008)45[391:GFBDAS]2.0.CO;2
   Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074
   Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Pritchard JK, 2000, GENETICS, V155, P945
   Rambaut A., 2017, TRACER VERSION 1 6
   Rambaut A., 2016, FIGTREE VERSION 1 4
   Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Ribeiro H., 1980, OS MOSQUITOS CABO VE, V135
   Ribeiro H., 1995, B SOC PORTUG ENTO S4, V4, P287
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x
   ROGERS AR, 1992, MOL BIOL EVOL, V9, P552
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248
   Russell-Wood A. J. R., 1998, PORTUGUESE EMPIRE 14
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Salgueiro P., 2019, AEDES AEGYPTI MTDNA
   Sang R C, 2001, East Afr Med J, V78, P655
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   Schneider S, 1999, GENETICS, V152, P1079
   Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Stoler J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2025-x
   Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408
   TAJIMA F, 1989, GENETICS, V123, P585
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tandon Neelam, 2000, Dengue Bulletin, V24, P117
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Tavare S., 1986, LECT MATH LIFE SCI, V17, P57
   Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256
   Twerdochlib AL, 2012, REV BRAS ENTOMOL, V56, P249, DOI 10.1590/S0085-56262012005000030
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982
   Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x
   Were F, 2012, PAEDIATR INT CHILD H, V32, P18, DOI 10.1179/2046904712Z.00000000048
   WHO, 2017, WHO ZIK SIT REP
   WHO, 2016, WHO CONF ZIK VIR STR
   WHO, 2009, DENG FEV CAP VERD UP
   Wilder-Smith A, 2016, LANCET INFECT DIS, V16, P629, DOI 10.1016/S1473-3099(16)00076-1
   World Health Organization, 2015, ZIK VIR INF CAP VERD
   World Health Organization (WHO), 2012, DENG SEV DENG
   Yu HJ, 1999, MOL PHYLOGENET EVOL, V13, P556, DOI 10.1006/mpev.1999.0667
NR 104
TC 1
Z9 1
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1752-4571
J9 EVOL APPL
JI Evol. Appl.
PD OCT
PY 2019
VL 12
IS 9
BP 1797
EP 1811
DI 10.1111/eva.12834
EA AUG 2019
PG 15
WC Evolutionary Biology
SC Evolutionary Biology
GA JB9CI
UT WOS:000480213600001
PM 31548858
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tedder, RS
   Dicks, S
   Ijaz, S
   de Souza, NCS
   de Paula, AV
   Levy, F
   Medialdea-Carrera, R
   Levi, JE
   Pannuti, CS
   de Sequeira, PC
   Brown, DWG
   Lumb, IU
AF Tedder, Richard S.
   Dicks, Steve
   Ijaz, Samreen
   Santiago de Souza, Nathalia Caroline
   de Paula, Anderson Vincente
   Levy, Flavia
   Medialdea-Carrera, Raquel
   Levi, Jose Eduardo
   Pannuti, Claudio S.
   de Sequeira, Patricia Carvalho
   Brown, David W. G.
   Lumb, Ines Ushiro
TI Modulated Zika virus NS1 conjugate offers advantages for accurate
   detection of Zika virus specific antibody in double antigen binding and
   Ig capture enzyme immunoassays
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; INFECTION; DISEASE; ASSAY
AB The accurate diagnosis and seroprevalence investigations of Zika virus (ZKV) infections remain complex due to cross reactivity with other flaviviruses. Two assay formats, both using labelled Zika virus NS1 antigen as a revealing agent (a double antigen binding assay, DABA, and an immunoglobulin Ig capture assay, G capture) were initially developed and compared with the indirect EuroimmunZ assay for the detection of anti-Zika antibody. Of 147 pre-Zika period serum samples, 39 (27%) were reactive in the EuroimmunZ or the DABA assays, 28 sera concordantly so. Such false reactivity was influenced by the serotype of Dengue virus (DV) to which individuals had been exposed to. Thus, of sera from patients undergoing secondary Dengue virus infection of known serotype, 91%, 45% and 28% of Dengue virus serotype 2, 3 and 4 respectively were reactive in one or more of the three assays. A novel method of quenching false sero-reactivity was therefore developed for the DABA and G capture assays. Initial addition of a single homologous Dengue virus serotype 3 NS1Ag quench significantly ablated false reactivities in the pre-Zika period sera. An equipotent quadrivalent quench comprising homologous Dengue virus serotypes 1 to 4 NS1Ag was shown to be optimum yet retained sensitivity for the detection of specific anti-Zika antibody. Comparing DABA and G capture assays using quenched and unquenched conjugates in comparison with EuroimmunZ early in the course of PCR-confirmed infection indicated that a significant component of the apparent early anti-ZIKA antibody response is likely to be due to a Zika virus-driven anamnestic anti-Dengue virus response. The increased specificity provided by homologous antigen quenching is likely to provide a significant improvement in sero-diagnostics and to be of clinical value.
C1 [Tedder, Richard S.; Dicks, Steve; Ijaz, Samreen; Brown, David W. G.; Lumb, Ines Ushiro] Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England.
   [Tedder, Richard S.; Dicks, Steve; Lumb, Ines Ushiro] NHS Blood & Transplant, Microbiol Serv, London, England.
   [Tedder, Richard S.] UCL, London, England.
   [Santiago de Souza, Nathalia Caroline; de Paula, Anderson Vincente; Levi, Jose Eduardo; Pannuti, Claudio S.] Univ Sao Paulo, Inst Med Trop, Virol Lab LIM HCFMUSP, Sao Paulo, Brazil.
   [Levy, Flavia; de Sequeira, Patricia Carvalho; Brown, David W. G.] Fiocruz MS, Flavivirus Reference Lab, IOC, Rio De Janeiro, Brazil.
   [Medialdea-Carrera, Raquel] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Tedder, Richard S.] Imperial Coll London, Fac Med, Dept Infect Dis, London, England.
RP Ijaz, S (corresponding author), Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England.
EM samreen.ijaz@phe.gov.uk
OI Ijaz, Samreen/0000-0001-6658-3542; Tedder, Richard/0000-0002-9672-5721;
   Medialdea-Carrera, Raquel/0000-0002-0371-5138
FU Medical Research Council Zika Rapid Response award [MC_PC_15093]; Public
   Health England Pipeline fund [PLF 1819-115/RA]; European Union's horizon
   2020 research and innovation programme [734857]; Zikaction; Zikaplan
   [734584]
FX This work was supported by Medical Research Council Zika Rapid Response
   award (MC_PC_15093) to RST, SI, DWGB, IUL, https://mrc.ukri.org/; Public
   Health England Pipeline fund (PLF 1819-115/RA) to RST, SI,
   https://www.gov.uk/government/organisations/public-health-england. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; We would like to
   thank colleagues in Diasorin for the kind gift of the conjugate diluent.
   DB is partially funded by European Union's horizon 2020 research and
   innovation programme (grant agreement no. 734857), Zikaction and
   Zikaplan consortia (grant agreement 734584). RMC is affiliated to the
   NIHR HPRU in Emerging and Zoonotic Infections at University of Liverpool
   in partnership with PHE, in collaboration with LSHTM.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   BROWN DWG, 1994, BRIT MED J, V308, P1015, DOI 10.1136/bmj.308.6935.1015
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Glynn JR, 2017, LANCET INFECT DIS, V17, P645, DOI 10.1016/S1473-3099(17)30111-1
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mead PS, 2016, NEW ENGL J MED, V378, P1377
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tedder RS, 2018, TRANSFUSION, V58, P1289, DOI 10.1111/trf.14580
NR 19
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 2
PY 2019
VL 14
IS 8
AR e0215708
DI 10.1371/journal.pone.0215708
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW5AR
UT WOS:000484991500001
PM 31374094
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Faustino, AE
   Martins, AS
   Karguth, N
   Artilheiro, V
   Enguita, FJ
   Ricardo, JC
   Santos, NC
   Martins, IC
AF Faustino, Andre E.
   Martins, Ana S.
   Karguth, Nina
   Artilheiro, Vanessa
   Enguita, Francisco J.
   Ricardo, Joana C.
   Santos, Nuno C.
   Martins, Ivo C.
TI Structural and Functional Properties of the Capsid Protein of Dengue and
   Related Flavivirus
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Dengue virus (DENV); capsid protein (C protein); Flavivirus;
   intrinsically disordered protein (IDP); protein-RNA interactions;
   protein-host lipid systems interaction; circular dichroism;
   time-resolved fluorescence anisotropy
ID VIRUS CORE PROTEIN; NUCLEAR-LOCALIZATION SIGNAL; NS1 PROTEIN;
   CONFORMATIONAL STABILITY; CRYSTAL-STRUCTURE; LIPID PROFILE; RNA-BINDING;
   RECOGNITION; PREDICTION; ANTIBODY
AB Dengue, West Nile and Zika, closely related viruses of the Flaviviridae family, are an increasing global threat, due to the expansion of their mosquito vectors. They present a very similar viral particle with an outer lipid bilayer containing two viral proteins and, within it, the nucleocapsid core. This core is composed by the viral RNA complexed with multiple copies of the capsid protein, a crucial structural protein that mediates not only viral assembly, but also encapsidation, by interacting with host lipid systems. The capsid is a homodimeric protein that contains a disordered N-terminal region, an intermediate flexible fold section and a very stable conserved fold region. Since a better understanding of its structure can give light into its biological activity, here, first, we compared and analyzed relevant mosquito-borne Flavivirus capsid protein sequences and their predicted structures. Then, we studied the alternative conformations enabled by the N-terminal region. Finally, using dengue virus capsid protein as main model, we correlated the protein size, thermal stability and function with its structure/dynamics features. The findings suggest that the capsid protein interaction with host lipid systems leads to minor allosteric changes that may modulate the specific binding of the protein to the viral RNA. Such mechanism can be targeted in future drug development strategies, namely by using improved versions of pep14-23, a dengue virus capsid protein peptide inhibitor, previously developed by us. Such knowledge can yield promising advances against Zika, dengue and closely related Flavivirus.
C1 [Faustino, Andre E.; Martins, Ana S.; Karguth, Nina; Artilheiro, Vanessa; Enguita, Francisco J.; Santos, Nuno C.; Martins, Ivo C.] Univ Lisbon, Fac Med, Inst Med Mol, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.
   [Ricardo, Joana C.] Univ Lisbon, Ctr Quim Fis Mol, Inst Super Tecn, P-1049001 Lisbon, Portugal.
   [Faustino, Andre E.] Inst Biol Expt & Tecnol, Apartado 12, P-2780901 Oeiras, Portugal.
   [Ricardo, Joana C.] Czech Acad Sci, Dept Biophys Chem, J Heyrovsky Inst Phys Chem, Dolejskova 3, Prague 18223 8, Czech Republic.
RP Santos, NC; Martins, IC (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.
EM ivomartins@fm.ul.pt; nsantos@fm.ul.pt
RI Enguita, Francisco J./A-2347-2009; Martins, Ana/M-1742-2014
OI Enguita, Francisco J./0000-0002-8072-8557; Martins,
   Ana/0000-0002-4667-3716
FU "Fundacao para a Ciencia e a Tecnologia-Ministerio da Ciencia,
   Tecnologia e Ensino Superior" (FCT-MCTES, Portugal)Portuguese Foundation
   for Science and Technology [PTDC/SAU-ENB/117013/2010]; Calouste
   Gulbenkian Foundation (FCG, Portugal) project Science Frontiers Research
   Prize 2010; FCT-MCTES fellowships [SFRH/BD/77609/2011,
   PD/BD/113698/2015, SFRH/BD/95856/2013]; FCT-MCTES Program "Investigador
   FCT" [IF/00772/2013]; FCT-MCTES Program "Concurso de Estimulo ao Emprego
   Cientifico" [CEECIND/01670/2017]; Fundacao para a Ciencia e a Tecnologia
   (FCT)/ Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES)
   through Fundos do Orcamento de Estado [UID/BIM/50005/2019]
FX This work was supported by "Fundacao para a Ciencia e a
   Tecnologia-Ministerio da Ciencia, Tecnologia e Ensino Superior"
   (FCT-MCTES, Portugal) project PTDC/SAU-ENB/117013/2010, Calouste
   Gulbenkian Foundation (FCG, Portugal) project Science Frontiers Research
   Prize 2010. A.F.F., A.S.M. and J.C.R. also acknowledge FCT-MCTES
   fellowships SFRH/BD/77609/2011, PD/BD/113698/2015 and
   SFRH/BD/95856/2013, respectively. I.C.M. acknowledges FCT-MCTES Programs
   "Investigador FCT" (IF/00772/2013) and "Concurso de Estimulo ao Emprego
   Cientifico" (CEECIND/01670/2017). This work was also supported by
   UID/BIM/50005/2019, project funded by Fundacao para a Ciencia e a
   Tecnologia (FCT)/ Ministerio da Ciencia, Tecnologia e Ensino Superior
   (MCTES) through Fundos do Orcamento de Estado.
CR Allen DL, 1998, PROTEIN SCI, V7, P1262, DOI 10.1002/pro.5560070524
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200
   Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288
   Cho CH, 1999, J PHYS CHEM B, V103, P1991, DOI 10.1021/jp9842953
   DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Durbin AP, 2016, CELL, V166, P1, DOI 10.1016/j.cell.2016.06.036
   Faustino AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37599-z
   Faustino AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10592
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05
   Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Ivanyi-Nagy R, 2012, VIRUS RES, V167, P226, DOI 10.1016/j.virusres.2012.05.003
   Jarvelin AI, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0132-3
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625
   Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06
   Krystkowiak I, 2018, NUCLEIC ACIDS RES, V46, pW235, DOI 10.1093/nar/gky426
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061
   Kumar S, 2008, BIOCHEM J, V415, P275, DOI 10.1042/BJ20071499
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417
   Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x
   Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013
   Martins AS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00008
   Martins AS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01951
   Martins I.C., 2011, International Patent Publication, Patent No. [WO/2012/159187, 2012159187]
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103
   Minde David P, 2013, Intrinsically Disord Proteins, V1, pe26790, DOI 10.4161/idp.26790
   Mok YK, 1996, PROTEIN SCI, V5, P310
   Morando MA, 2019, BIOCHEMISTRY-US, V58, P2488, DOI 10.1021/acs.biochem.9b00194
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Na JH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020381
   NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202
   Niyomrattanakit P, 2006, BIOCHEM J, V397, P203, DOI 10.1042/BJ20051767
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09
   Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200
   SIEVERS F, 2014, CURR PROTOC BIOINFOR, V48, P3, DOI DOI 10.1002/0471250953.BI0313S48
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   SMITH PE, 1994, J MOL BIOL, V236, P629, DOI 10.1006/jmbi.1994.1172
   Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x
   TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409
   Uversky VN, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00010
   Uversky VN, 2014, CHEM REV, V114, P6557, DOI 10.1021/cr500288y
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Zhan CY, 2013, BIOORGAN MED CHEM, V21, P3443, DOI 10.1016/j.bmc.2013.04.035
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 71
TC 4
Z9 4
U1 5
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG 2
PY 2019
VL 20
IS 16
AR 3870
DI 10.3390/ijms20163870
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IV6XM
UT WOS:000484411100027
PM 31398956
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hodge, K
   Kamkaew, M
   Pisitkun, T
   Chimnaronk, S
AF Hodge, Kenneth
   Kamkaew, Maliwan
   Pisitkun, Trairak
   Chimnaronk, Sarin
TI Flavors of Flaviviral RNA Structure: towards an Integrated View of RNA
   Function from Translation through Encapsidation
SO BIOESSAYS
LA English
DT Review
DE Dengue virus (DENV); flaviviruses; host-virus interactions; viral RNA
   genome; untranslated region (UTR); nonstructural protein 5 (NS5);
   RNA-dependent RNA polymerase (RdRp)
ID WEST-NILE-VIRUS; 3 UNTRANSLATED REGION; REPLICATIVE-FORM RNA;
   DOUBLE-STRANDED-RNA; DENGUE-VIRUS; VIRAL-RNA; HEPATITIS-C; GENOME
   CYCLIZATION; 3'-UNTRANSLATED REGION; SECONDARY STRUCTURES
AB For many viruses, RNA is the holder of genetic information and serves as the template for both replication and translation. While host and viral proteins play important roles in viral decision-making, the extent to which viral RNA (vRNA) actively participates in translation and replication might be surprising. Here, the focus is on flaviviruses, which include common human scourges such as dengue, West Nile, and Zika viruses, from an RNA-centric viewpoint. In reviewing more recent findings, an attempt is made to fill knowledge gaps and revisit some canonical views of vRNA structures involved in replication. In particular, alternative views are offered on the nature of the flaviviral promoter and genome cyclization, and the feasibility of refining in vitro-derived models with modern RNA probing and sequencing methods is pointed out. By tracing vRNA structures from translation through encapsidation, a dynamic molecule closely involved in the self-regulation of viral replication is revealed.
C1 [Hodge, Kenneth; Pisitkun, Trairak] Chulalongkorn Univ, Syst Biol Ctr, Res Affairs, Fac Med, 1873 Rama 4 Rd, Bangkok 10330, Thailand.
   [Kamkaew, Maliwan; Chimnaronk, Sarin] Mahidol Univ, Lab RNA Biol, Inst Mol Biosci, Salaya Campus, Salaya 73170, Nakhon Pathom, Thailand.
RP Pisitkun, T (corresponding author), Chulalongkorn Univ, Syst Biol Ctr, Res Affairs, Fac Med, 1873 Rama 4 Rd, Bangkok 10330, Thailand.; Chimnaronk, S (corresponding author), Mahidol Univ, Lab RNA Biol, Inst Mol Biosci, Salaya Campus, Salaya 73170, Nakhon Pathom, Thailand.
EM pisitkut@nhlbi.nih.gov; sarin.chi@mahidol.ac.th
OI Chimnaronk, Sarin/0000-0001-6113-3681
FU Mahidol University, Thailand; Thailand Research Fund (TRF)Thailand
   Research Fund (TRF) [RSA6080066, IRG5780009]; Rachadaphiseksompot Fund
   for Postdoctoral Fellowship, Chulalongkorn University, Thailand
FX The authors thank Dr. David Michael Payne for his useful comments on the
   manuscript. This work was supported by Grants-in-Aids for Research from
   Mahidol University, Thailand, and by grants (RSA6080066 and IRG5780009)
   from the Thailand Research Fund (TRF) to S.C. K.H. is supported by
   Rachadaphiseksompot Fund for Postdoctoral Fellowship, Chulalongkorn
   University, Thailand.
CR Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J
   BALTIMORE D, 1964, P NATL ACAD SCI USA, V51, P450, DOI 10.1073/pnas.51.3.450
   BALTIMORE D, 1964, SCIENCE, V143, P1034, DOI 10.1126/science.143.3610.1034
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Biegel JM, 2017, VIROLOGY, V507, P231, DOI 10.1016/j.virol.2017.04.014
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   Bolten R, 1998, J VIROL, V72, P8578, DOI 10.1128/JVI.72.11.8578-8585.1998
   BOULTON RW, 1977, ARCH VIROL, V55, P201, DOI 10.1007/BF01319906
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Bujalowski PJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00047-17
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003
   de Borba L, 2019, MBIO, V10, DOI 10.1128/mBio.02506-18
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005
   Dethoff EA, 2018, P NATL ACAD SCI USA, V115, P11513, DOI 10.1073/pnas.1716689115
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Egger D, 1996, J VIROL, V70, P8675, DOI 10.1128/JVI.70.12.8675-8683.1996
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   FONG TL, 1991, J CLIN INVEST, V88, P1058, DOI 10.1172/JCI115368
   Friebe P, 2012, VIROLOGY, V422, P346, DOI 10.1016/j.virol.2011.10.025
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293
   Gong YH, 1996, J GEN VIROL, V77, P2729, DOI 10.1099/0022-1317-77-11-2729
   GRANGE T, 1985, FEBS LETT, V188, P159, DOI 10.1016/0014-5793(85)80895-4
   Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hodge K, 2016, J BIOL CHEM, V291, P17437, DOI 10.1074/jbc.M116.724013
   Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034
   HSU MT, 1973, COLD SPRING HARB SYM, V38, P943, DOI 10.1101/SQB.1974.038.01.096
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   Kamkaew M, 2015, PROTEIN EXPRES PURIF, V112, P43, DOI 10.1016/j.pep.2015.04.008
   Khromykh AA, 2003, J VIROL, V77, P10623, DOI 10.1128/JVI.77.19.10623-10629.2003
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Kofler RM, 2006, J VIROL, V80, P4099, DOI 10.1128/JVI.80.8.4099-4113.2006
   Kwok CK, 2015, TRENDS BIOCHEM SCI, V40, P221, DOI 10.1016/j.tibs.2015.02.005
   Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447
   Li P, 2018, CELL HOST MICROBE, V24, P875, DOI 10.1016/j.chom.2018.10.011
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Lott WB, 2013, TRENDS BIOCHEM SCI, V38, P350, DOI 10.1016/j.tibs.2013.04.005
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Mauger DM, 2015, P NATL ACAD SCI USA, V112, P3692, DOI 10.1073/pnas.1416266112
   Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066
   Mizrahi O, 2018, MOL CELL, V72, P862, DOI 10.1016/j.molcel.2018.09.003
   Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708
   Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692
   Narayanan K, 2003, J VIROL, V77, P2922, DOI 10.1128/JVI.77.5.2922-2927.2003
   NOWAK T, 1989, VIROLOGY, V169, P365, DOI 10.1016/0042-6822(89)90162-1
   Oh JW, 2000, J BIOL CHEM, V275, P17710, DOI 10.1074/jbc.M908781199
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   Raviprakash K, 1998, AM J TROP MED HYG, V58, P90, DOI 10.4269/ajtmh.1998.58.90
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894
   SHINDO M, 1994, P NATL ACAD SCI USA, V91, P8719, DOI 10.1073/pnas.91.18.8719
   Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/NMETH.3029, 10.1038/nmeth.3029]
   Slenning BD, 2010, VET PATHOL, V47, P28, DOI 10.1177/0300985809354465
   STOLLAR V, 1967, VIROLOGY, V33, P650, DOI 10.1016/0042-6822(67)90065-7
   Streit JA, 2011, EMERG INFECT DIS, V17, P914, DOI 10.3201/eid1705.101023
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Szymanski MR, 2011, J BIOL CHEM, V286, P33095, DOI 10.1074/jbc.M111.255034
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022
   Tomassini JE, 2003, VIROLOGY, V313, P274, DOI 10.1016/S0042-6822(03)00314-3
   TRENT DW, 1969, J VIROL, V3, P385, DOI 10.1128/JVI.3.4.385-394.1969
   Tyrrell J, 2013, BIOCHEMISTRY-US, V52, P8777, DOI 10.1021/bi401207q
   Uchil PD, 2003, VIROLOGY, V307, P358, DOI 10.1016/S0042-6822(02)00130-7
   Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1978, VIROLOGY, V89, P423, DOI 10.1016/0042-6822(78)90185-X
   WENGLER G, 1981, VIROLOGY, V113, P544, DOI 10.1016/0042-6822(81)90182-3
   WENGLER G, 1986, J GEN VIROL, V67, P1183, DOI 10.1099/0022-1317-67-6-1183
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003
   You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714
   ZEBOVITZ E, 1974, INFECT IMMUN, V10, P204, DOI 10.1128/IAI.10.1.204-211.1974
   Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhang J, 2002, VIROLOGY, V293, P141, DOI 10.1006/viro.2001.1270
   ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V
NR 105
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD AUG
PY 2019
VL 41
IS 8
AR 1900003
DI 10.1002/bies.201900003
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA KG8KY
UT WOS:000510199000002
PM 31210384
OA Green Published
DA 2020-07-08
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   Joshua, Q
   Claro, IM
   Xavier, J
   Hill, SC
   Renato, S
   Paz, P
   Lourenco, J
   Dellicour, S
   Sabino, E
   Loman, NJ
   Naveca, F
   Pybus, OG
   Faria, NR
   Alcantara, LCJ
AF Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Joshua, Quick
   Claro, Ingra Morales
   Xavier Junior, Joilson
   Hill, Sarah C.
   Renato, Souza
   Paz, Paola
   Lourenco, Jose
   Dellicour, Simon
   Sabino, Esther
   Loman, Nicholas J.
   Naveca, Felipe
   Pybus, Oliver G.
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
TI Genomic surveillance of Zika virus transmission in the Amazonas State,
   Brazil
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier Junior, Joilson; Junior Alcantara, Luiz Carlos] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Joshua, Quick; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, Ingra Morales; Sabino, Esther] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Hill, Sarah C.; Lourenco, Jose; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Renato, Souza; Paz, Paola] Univ Fed Rio de Janeiro, Inst Pasteur, Lab Clin & Epidemiol Virol, Rio De Janeiro, Brazil.
   [Dellicour, Simon] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
   [Naveca, Felipe] Fiocruz MS, Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
RI Giovanetti, Marta/AAK-7408-2020; Dellicour, Simon/AAE-9054-2020
OI Dellicour, Simon/0000-0001-9558-1052
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A32
BP S10
EP S10
DI 10.1093/ve/vez002.031
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600033
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Henderson, A
   Hue, S
   Kucharski, A
AF Henderson, A.
   Hue, S.
   Kucharski, A.
TI Using serological and surveillance data to infer the introduction date
   and unobserved transmission dynamics of Zika virus in Fiji 2013-7
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Henderson, A.; Hue, S.; Kucharski, A.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A33
BP S11
EP S11
DI 10.1093/ve/vez002.032
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600034
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martinez, PA
   Diaz, G
   Castillo, EM
   Alvarez, M
   Santana, E
   Serrano, S
   Mederos, D
   Guzman, MG
AF Martinez, P. A.
   Diaz, G.
   Castillo, E. M.
   Alvarez, M.
   Santana, E.
   Serrano, S.
   Mederos, D.
   Guzman, M. G.
TI Molecular characterization of Zika virus in Cuba
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Martinez, P. A.; Diaz, G.; Castillo, E. M.; Alvarez, M.; Santana, E.; Serrano, S.; Mederos, D.; Guzman, M. G.] Pedro Kouri Trop Med Inst IPK, Natl Reference Lab Arboviruses, Havana, Cuba.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A34
BP S11
EP S11
DI 10.1093/ve/vez002.033
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600035
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Clemente, NS
   Rodrigues, M
   Pascalicchio, AP
   Gazeta, RE
   Vedovello, D
   Brickley, EB
   De Almeida, MF
   Passos, SD
AF Clemente, Nuria Sanchez
   Rodrigues, Manoela
   Pascalicchio, Ana Paula
   Gazeta, Rosa Estela
   Vedovello, Danila
   Brickley, Elizabeth B.
   De Almeida, Marcia F.
   Passos, Saulo D.
TI Cohort profile: the Jundiai Zika cohort (JZC), a pregnancy and birth
   cohort in SAo Paulo state, Brazil
SO BMJ OPEN
LA English
DT Article
DE zika virus; flavivirus; congenital infection; pregnancy
ID VIRUS
AB Purpose The Jundiai Zika Cohort (JZC) is a prospective pregnancy and birth cohort setup in the State of SAo Paulo, Brazil, to investigate the epidemic of cases of microcephaly and other neurological disorders, presumed to be associated with Zika virus (ZIKV) infection.
   Participants A total of 748 women with high-risk pregnancies were recruited in the period of March 2016 to August 2017.
   Findings to date Baseline sociodemographic and medical data were collected at recruitment from 737 pregnant women. Biological samples (ie, blood, saliva and urine) were collected from 695 of the pregnant women (94.3%), of whom 53 (7.6%) were ZIKV-positive on subsequent testing by reverse transcription polymerase chain reaction (RT-PCR) in urine. Biological sample (ie, blood, saliva, urine and cerebrospinal fluid) were collected within 10 days of birth from 409 (57.4%) of the liveborn infants, of whom 19 (4.6%) were ZIKV-positive on subsequent testing by RT-PCR in urine. All remaining biological specimens, as well as colostrum, umbilical cord and placental samples, have been stored in a secure biorepository. Antenatal and postnatal imaging studies and neonatal anthropometry were carried out.
   Future plans The JZC provides a unique data set which will continue to be explored to study the effects of pregnancy comorbidities on Zika virus infection during pregnancy, the long-term outcomes of children with congenital Zika infection and how physiotherapy and group interventions can improve outcomes for congenitally-infected children. All women in the cohort have reached the end of their pregnancy and currently the oldest children are 2years old. The study will continue until all the children reach their third birthday (April 2021).
C1 [Clemente, Nuria Sanchez] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London, England.
   [Rodrigues, Manoela] Fac Med Jundiai, Paediat, Jundiai, SP, Brazil.
   [Pascalicchio, Ana Paula; Gazeta, Rosa Estela; Vedovello, Danila; Passos, Saulo D.] Fac Med Jundiai, Jundiai, SP, Brazil.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [De Almeida, Marcia F.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, SP, Brazil.
RP Clemente, NS (corresponding author), London Sch Hyg & Trop Med, Infect Dis Epidemiol, London, England.
EM nuriasanchezclemente@gmail.com
RI Clemente, Nuria Sanchez/AAL-4309-2020
OI Passos, Saulo/0000-0002-0908-2677
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/08578-0]; London School of Hygiene
   and Tropical Medicine [ER1605]; Wellcome TrustWellcome Trust; UK's
   Department for International Development [205377/Z/16/Z]; European
   Union's Horizon 2020 research and innovation program under ZikaPLAN
   grant [734584]; Coordination for the Improvement of Higher Education
   Personnel (CAPES-Brazil)CAPES
FX The Sao Paulo Research Foundation (FAPESP) currently provide core
   funding for the JZC (grant number 2016/08578-0). The London School of
   Hygiene and Tropical Medicine provided initial seed funding (grant
   number ER1605). EBB received funding from the: Wellcome Trust & the UK's
   Department for International Development (205377/Z/16/Z;
   https://wellcome.ac.uk/) and the European Union's Horizon 2020 research
   and innovation program (https://ec.europa.eu/programmes/horizon2020/)
   under ZikaPLAN grant agreement No. 734584 (https://zikaplan.tghn.org/).
   NSC was funded by the Coordination for the Improvement of Higher
   Education Personnel (CAPES-Brazil).S
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brazil Instituto de Geografia e Estatistica Aplicada (IBGE), 2017, POP
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   DATASUS - Departamento de Informatica do SUS, 2015, INF SAUD EST VIT NAS
   de Abreu RL, 2006, MAPA LOCALIZACAO MUN
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Intergrowth-21st, 2018, NEWB BIOM INT 21 STA
   Intergrowth-21st, 2015, INTERGROWTH 21 NEWB
   Kelsey JL, 1996, METHODS OBSERVATIONA
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude (BR), 2018, MON CAS DENG FEBR CH
   Ministerio da Saude (BR), 2015, NOT IMPR MIN SAUD CO
   NIH, 2017, NIH EUN KENN SHRIV N
   PAHO, 2016, ZIK SUSP CONF CAS RE
   Secretaria de Vigilancia em Saude - Ministerio da Saude - Brasil, 2016, B EPIDEMIOLOGICO
   Teixeira JA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5184-4
   UNESCO, 2018, ATL FOR S E RES
   Unidade de Gestao de Promocao da Saude, 2018, PERF PART JUND
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organisation, 2016, HARM ZIKV RES PROT A
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD AUG
PY 2019
VL 9
IS 8
DI 10.1136/bmjopen-2018-027947
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA JV7JK
UT WOS:000502537200140
PM 31455701
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Fandino-Cardenas, M
   Idrovo, AJ
   Velandia, R
   Molina-Franky, J
   Alvarado-Socarras, JL
AF Fandino-Cardenas, Marcela
   Idrovo, Alvaro J.
   Velandia, Roman
   Molina-Franky, Jessica
   Alvarado-Socarras, Jorge L.
TI Zika Virus Infection during Pregnancy and Sensorineural Hearing Loss
   among Children at 3 and 24 Months Post-Partum
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
DE Zika; hearing loss; pregnancy
ID CONGENITAL ZIKA; INFANTS; BRAZIL
AB Objective: The objectives of this study were to describe the findings of the auditory screening in children of mothers with ZIKV during pregnancy or suspicious of congenital ZIKV, and to determine whether hearing loss was in the first 2 years in life, regardless of whether microcephaly was also present.
   Methods: This is a cases report. The information was collected and recorded in a database between January 2016 and April 2018. We perform two auditory tests to 3 and 24 months of life. The study was developed in Aguachica (Cesar, Colombia). It is considered a high-risk area for ZIKV infection. Participants included children of mothers with confirmed ZIKV during pregnancy or suspicious of congenital ZIKV exposure of ZIKV infection during an epidemic period in a tropical area. We defined a positive case according to the epidemiological definition and clinical criteria based on maternal symptoms. However, other children of mothers without clinical signs of Zika were evaluated at the same time. The main outcome was the presence of sensorineural hearing loss.
   Results: The median age in the study group (n = 43) was 3.5 months (rank: 0-6) and the comparison group (n: 23, children of mothers without clinical signs of ZIKV) was 3 months (rank: 0-12). Screening hearing test was done using distortion product otoacustic emissions. At 3 months follow-up, children were evaluated using distortion product otoacustic emissions and automatized auditory brainstem response. None of the patients evaluated in this study were found to have sensorineural hearing loss.
   Conclusions: We did not find hearing loss during the first 2 years in the children whose mother showed Zika during pregnancy. We recommend these children must be assessed to closed because there is a high risk the hearing loss as it usually may occur with CMV.
C1 [Fandino-Cardenas, Marcela; Alvarado-Socarras, Jorge L.] Fdn Cardiovasc Colombia, Dept Pediat, Floridablanca 681004, Colombia.
   [Idrovo, Alvaro J.] Univ Ind Santander, Publ Hlth Dept, Sch Med, Bucaramanga 680002, Santander, Colombia.
   [Velandia, Roman] FBR Biomed, Otolaryngol, Bucaramanga 681004, Colombia.
   [Molina-Franky, Jessica] Univ Boyaca, Sch Med, Tunja 150001, Colombia.
   [Alvarado-Socarras, Jorge L.] Fdn Cardiovasc Colombia, RECOLZIKA Red Colombiana Colaborac Zika, Floridablanca, Santander, Colombia.
RP Alvarado-Socarras, JL (corresponding author), Calle 115 A 23-58, Floridablanca, Santander, Colombia.
EM jorgealso2@yahoo.com
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Socarras JLA, 2016, ARCH ARGENT PEDIATR, V114, pE396
   Alvarado-Socarras JL, 2016, ULTRASOUND OBST GYN, V47, P525, DOI 10.1002/uog.15885
   Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   Arnaoutakis D, 2017, JAMA OTOLARYNGOL, V143, P81, DOI 10.1001/jamaoto.2016.3427
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Frenkel LD, 2016, PEDIATR INFECT DIS J, V35, P1371, DOI 10.1097/INF.0000000000001273
   Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hughes BL, 2016, AM J OBSTET GYNECOL, V214, pB5, DOI 10.1016/j.ajog.2016.02.042
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MC, 2016, BRAZ J OTORHINOLARYN
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Manrique-Hernandez EF, 2017, PUBLIC HEALTH, V143, P14, DOI 10.1016/j.puhe.2016.10.023
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
NR 25
TC 1
Z9 1
U1 3
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD AUG
PY 2019
VL 65
IS 4
BP 328
EP 335
DI 10.1093/tropej/fmy055
PG 8
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA JI5TU
UT WOS:000493530900004
PM 30252119
DA 2020-07-08
ER

PT J
AU Wen, JS
   Shresta, S
AF Wen, Jinsheng
   Shresta, Sujan
TI Antigenic cross-reactivity between Zika and dengue viruses: is it time
   to develop a universal vaccine?
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID T-CELL RESPONSES; ANTIBODY-DEPENDENT ENHANCEMENT; PROTECTIVE ROLE;
   INFECTION; CD4(+); DISEASE; PATHOGENESIS
AB Zika and the four serotypes of dengue are closely related flaviviruses that share a high degree of structural and sequence homology and co-circulate in many regions of the world. Here, we review recent studies investigating antigenic cross-reactivity between the two viruses. We discuss the pathogenic and protective roles of cross-reactive anti-viral antibody and T cell responses, respectively, in modulating the outcome of secondary dengue or Zika infection. Based on recent findings and increased incidence of severe disease in seronegative recipients of the first dengue vaccine to be licensed, we propose that the time has come to focus on developing pan-flavivirus vaccines that protect against Zika and four dengue serotypes by eliciting protective cross-reactive T cell responses while concomitantly reducing production of cross-reactive antibodies that can exacerbate disease.
C1 [Wen, Jinsheng; Shresta, Sujan] La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Wen, Jinsheng; Shresta, Sujan] Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.
   [Wen, Jinsheng] Ningbo Univ, Sch Med, Dept Microbiol, Ningbo 315211, Zhejiang, Peoples R China.
RP Wen, JS; Shresta, S (corresponding author), La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Wen, JS; Shresta, S (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.; Wen, JS (corresponding author), Ningbo Univ, Sch Med, Dept Microbiol, Ningbo 315211, Zhejiang, Peoples R China.
EM wjs78@wmu.edu.cn; sujan@lji.org
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [A1116813, A1140063];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31870159]
FX We would like to thank Anh-Viet Nguyen for making Figure 2. SS is
   supported by grants from the National Institutes of Health (A1116813 and
   A1140063). JW is supported by grant from the National Natural Science
   Foundation of China (31870159).
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Benton DJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02293-16
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chaudhuri AA, 2016, CUREUS, V8, DOI 10.7759/cureus.484
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Control ECfDPa, 2014, RAP RISK ASS ZIK VIR
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grifoni A, 2017, J VIROL, V91
   Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Harenberg A, 2013, HUM VACC IMMUNOTHER, V9, P2317, DOI 10.4161/hv.25562
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
   Lam JH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94500
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rivino L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0526
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   WHO, 2017, ZIK SIT REP ZIK VIR, P1
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 70
TC 4
Z9 4
U1 4
U2 5
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
EI 1879-0372
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD AUG
PY 2019
VL 59
BP 1
EP 8
DI 10.1016/j.coi.2019.02.001
PG 8
WC Immunology
SC Immunology
GA JF8BS
UT WOS:000491610600003
PM 30884384
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Baran, LCP
   da Costa, MF
   Vidal, KS
   Damico, FM
   Barboni, MTS
   Lima, DD
   Franca, VDRD
   Martins, CMG
   Tabares, HS
   Dias, SL
   Silva, LA
   Decleva, D
   Hamer, RD
   Zatz, M
   Bertozzi, APAP
   Gazeta, RE
   Passos, SD
   Ventura, DF
AF Portnoi Baran, Luiz Claudio
   da Costa, Marcelo Fernades
   Vidal, Kallene Summer
   Damico, Francisco Max
   Salgueiro Barboni, Mirella Telles
   Lima, Diego da Silva
   Rodrigues de Matos Franca, Valtenice de Cassia
   Gomes Martins, Cristiane Maria
   Tabares, Heydi Segundo
   Dias, Sarah Leonardo
   Silva, Leonardo Aparecido
   Decleva, Diego
   Hamer, Russell David
   Zatz, Mayana
   Bertozzi, Ana Paula A. P.
   Gazeta, Rosa Estela
   Passos, Saulo Duarte
   Ventura, Dora Fix
TI Alterations in visual acuity and visual development in infants 1-24
   months old either exposed to or infected by Zika virus during gestation,
   with and without microcephaly
SO JOURNAL OF AAPOS
LA English
DT Article
AB PURPOSE To evaluate visual acuity and visual acuity development in children from the state of Sao Paulo, Brazil, who were exposed to the Zika virus (ZIKV) gestationally.
   METHODS Children who had been exposed to ZIKV during gestation and age-matched control subjects received visual acuity and funduscopic examination. ZIKV exposure was confirmed by maternal quantitative polymerase chain reaction testing or serology assay. The ZIKV group was divided into two subgroups: exposed (ZE), with only the mother having confirmed ZIKV infection, and infected (ZI), with confirmed infection. Visual acuity development was compared with prior norms and quantified by measuring visual acuity correlation with age.
   RESULTS A total of 110 children were included: 47 who had been exposed to ZIKV (ZE, 23; ZI, 24) and 63 controls. Abnormal visual acuity was found in 5 of 24 ZI children. Of the 4 children with microcephaly, only 2 had visual acuity loss (only 1 also had abnormal funduscopic findings). There was significant correlation between age and visual acuity in both the control group (R-2 = 0.8; P < 0.0000) and the ZE subgroup (R-2 = 0.6; P < 0.0000). However, visual acuity did not correlate with age in the ZI subgroup (R-2 = 0.04; P = 0.38). Furthermore, the increment in octaves/month was much lower in the ZI subgroup.
   CONCLUSIONS Our data indicate that visual acuity losses only occur in infants who suffered gestational infection, not simply exposure. Lack of correlation between age and visual acuity in the ZI subgroup suggests a slowing of visual development even in the absence of microcephaly. This result may have broad implications for the deleterious effects of ZIKV on the central nervous system.
C1 [Portnoi Baran, Luiz Claudio; da Costa, Marcelo Fernades; Vidal, Kallene Summer; Salgueiro Barboni, Mirella Telles; Lima, Diego da Silva; Rodrigues de Matos Franca, Valtenice de Cassia; Gomes Martins, Cristiane Maria; Tabares, Heydi Segundo; Dias, Sarah Leonardo; Silva, Leonardo Aparecido; Decleva, Diego; Hamer, Russell David; Ventura, Dora Fix] Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, SP, Brazil.
   [Portnoi Baran, Luiz Claudio; da Costa, Marcelo Fernades; Vidal, Kallene Summer; Salgueiro Barboni, Mirella Telles; Lima, Diego da Silva; Gomes Martins, Cristiane Maria; Tabares, Heydi Segundo; Silva, Leonardo Aparecido; Decleva, Diego; Hamer, Russell David; Ventura, Dora Fix] Univ Sao Paulo, Nucleus Neurosci & Behav, Sao Paulo, SP, Brazil.
   [Damico, Francisco Max] Univ Sao Paulo, Coll Med, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Salgueiro Barboni, Mirella Telles] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.
   [Bertozzi, Ana Paula A. P.; Gazeta, Rosa Estela; Passos, Saulo Duarte] Univ Jundiai, Med Sch, Sao Paulo, SP, Brazil.
   [Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cells Ctr, Boca Raton, FL USA.
   [Hamer, Russell David] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA.
RP Baran, LCP (corresponding author), Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, SP, Brazil.; Baran, LCP (corresponding author), Univ Sao Paulo, Nucleus Neurosci & Behav, Sao Paulo, SP, Brazil.
RI Damico, Francisco Max/G-1175-2015
OI Damico, Francisco Max/0000-0002-2594-0336; da Silva Lima,
   Diego/0000-0003-1526-7712; Portnoi Baran, Luiz
   Claudio/0000-0002-6683-0686; Passos, Saulo/0000-0002-0908-2677
CR Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Passos SD, 2016, INF VERT PEL VIR ZIK
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Zin AA, 2018, J AAPOS, V22, P452, DOI 10.1016/j.jaapos.2018.07.352
NR 7
TC 2
Z9 2
U1 2
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD AUG
PY 2019
VL 23
IS 4
BP 215
EP 217
DI 10.1016/j.jaapos.2019.03.005
PG 3
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA JF2HX
UT WOS:000491207600011
PM 31229606
DA 2020-07-08
ER

PT J
AU Capasso, A
   Ompad, DC
   Vieira, DL
   Wilder-Smith, A
   Tozan, Y
AF Capasso, Ariadna
   Ompad, Danielle C.
   Vieira, Dorice L.
   Wilder-Smith, Annelies
   Tozan, Yesim
TI Incidence of Guillain-Barre Syndrome (GBS) in Latin America and the
   Caribbean before and during the 2015-2016 Zika virus epidemic: A
   systematic review and meta-analysis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID QUALITY-OF-LIFE; CLINICAL CHARACTERISTICS; MORTALITY; INFECTION;
   COLOMBIA; CHILDREN; DISEASE; CHIKUNGUNYA; INFLUENZA; DIAGNOSIS
AB Background
   A severe neurological disorder, Guillain-Barre syndrome (GBS) is the leading cause of acute flaccid paralysis. Enhanced surveillance of GBS in Latin America and the Caribbean (LAC) following the 2015-2016 Zika virus (ZIKV) epidemic presents an opportunity to estimate, for the first time, the regional incidence of GBS.
   Methods and findings
   For this systematic review and meta-analysis, we searched nine scientific databases and grey literature from January 1, 1980 to October 1, 2018. Sources with primary data on incident GBS cases in LAC within a well-defined population and timeframe, published in English, Spanish, Portuguese, or French, were included. We calculated the annual GBS incidence rates (IRs) and 95% confidence intervals (CIs) for each source based on published data. Following an assessment of heterogeneity, we used random-effects meta-analysis to calculate the pooled annual IR of GBS. The study is registered with PROSPERO, number CRD42018086659. Of the 6568 initial citation hits, 31 were eligible for inclusion. Background annual GBS IRs in Latin America ranged from 0.40 in Brazil to 2.12/100,000 in Chile. The pooled annual IR in the Caribbean was 1.64 (95% CI 1.29-2.12, I-2<0.01, p = 0.44). During the ZIKV epidemic, GBS IRs ranged from 0.62 in Mexico to 9.35/100,000 in Martinique. GBS increased 2.6 (95% CI 2.3-2.9) times during ZIKV and 1.9 (95% CI 1.1-3.4) times during chikungunya outbreaks over background rates. A limitation of this review is that the studies included employed different methodologies to find and ascertain cases of GBS, which could contribute to IR heterogeneity. In addition, it is important to consider that data on GBS are lacking for many countries in the region.
   Conclusions
   Background IRs of GBS appear to peak during arboviral disease outbreaks. The current review contributes to an understanding of the epidemiology of GBS in the LAC region, which can inform healthcare system planning and preparedness, particularly during arboviral epidemics.
C1 [Capasso, Ariadna; Ompad, Danielle C.; Tozan, Yesim] NYU, NYU Coll Global Publ Hlth, New York, NY 10012 USA.
   [Vieira, Dorice L.] NYU Langone Med Ctr, NYU Sch Med, New York Univ Hlth Sci Lib, New York, NY USA.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Wilder-Smith, Annelies] Univ Umea, Dept Global Hlth & Epidemiol, Umea, Sweden.
RP Tozan, Y (corresponding author), NYU, NYU Coll Global Publ Hlth, New York, NY 10012 USA.
EM tozan@nyu.edu
OI Tozan, Yesim/0000-0001-8997-8897; Vieira, Dorice/0000-0003-4232-9413;
   Capasso, Ariadna/0000-0001-5462-7800
FU European Union's Horizon 2020 research and innovation program ZikaPLAN
   [734584]
FX AWS's participation in this study was partially funded by the European
   Union's Horizon 2020 research and innovation program ZikaPLAN, under
   Grant Agreement No. 734584.
   URL:https://ec.europa.eu/programmes/horizon2020/en. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   [Anonymous], 2016, ASS MAN GUILL BARR S
   Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104
   Benamer HTS, 2014, J NEUROL SCI, V343, P221, DOI 10.1016/j.jns.2014.05.065
   Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x
   Bogliun G, 2002, NEUROL SCI, V23, P113, DOI 10.1007/s100720200036
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carmo E, 2013, VIGILANCIA SALUD SUR
   Codebo O, 2016, REV ARGENTINA SALUD, V7, P38
   Darweesh SKL, 2014, J PERIPHER NERV SYST, V19, P24, DOI 10.1111/jns5.12051
   daSilveira CM, 1997, LANCET, V349, P14, DOI 10.1016/S0140-6736(96)07408-9
   De la O-Pena Daniel, 2015, Rev Med Inst Mex Seguro Soc, V53, P678
   del Carpio-Orantes L, 2018, NEUROLOGIA, DOI [10.33588/rn.6711.2018380, DOI 10.33588/RN.6711.2018380]
   deQuadros CA, 1997, J INFECT DIS, V175, pS37, DOI 10.1093/infdis/175.Supplement_1.S37
   Dias-Tosta E, 2002, ARQ NEURO-PSIQUIAT, V60, P367, DOI 10.1590/S0004-282X2002000300005
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferguson RW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw010
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Hamer DH, 2019, J TRAVEL MED, DOI [10.1093/jtm/taz012, DOI 10.1093/JTM/TAZ01230753689]
   HART DE, 1994, ANN NEUROL, V36, P859, DOI 10.1002/ana.410360609
   Howson CP, 1991, ADVERSE EFFECTS PERT
   Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014
   Instituto Nacional de Salud, 2016, B EP SEM DIR VIG AN
   Ishaque T, 2017, J PERIPHER NERV SYST, V22, P121, DOI 10.1111/jns.12215
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Kogos SC, 2005, J CLIN PSYCHOL MED S, V12, P111, DOI 10.1007/s10880-005-3271-z
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Landaverde JM, 2010, J INFECT DIS, V201, P746, DOI 10.1086/650530
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lee CD, 2011, ANN NEUROL, V70, pS41
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Lindquist L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay006
   Masyeni S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay061
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Molinero MR, 2003, J CHILD NEUROL, V18, P741, DOI 10.1177/08830738030180110801
   Nakayama E, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tax072
   Neuberger A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw003
   Nóbrega Martha Elizabeth Brasil da, 2018, Epidemiol. Serv. Saúde, V27, pe2017039, DOI 10.5123/s1679-49742018000200016
   Nunnez R, 2017, 9 TEPHINET GLOB SCI
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Olive JA, 1997, J INFECT DIS, V175, pS160, DOI 10.1093/infdis/175.Supplement_1.S160
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Pan American Health Organization, 1994, 02514710 PAN AM HLTH
   Pan American Health Organization, 1985, B PAN AM HLTH ORG, V19, P213
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pearce JC, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay009
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Riddell A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax015
   Rivera-Lillo G, 2016, J PERIPHER NERV SYST, V21, P339, DOI 10.1111/jns.12182
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   Rojas JI, 2009, NEUROLOGY, V72, pA451
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Salinas JL, 2017, J NEUROL SCI, V377, P102, DOI 10.1016/j.jns.2017.04.006
   Santos J, 2009, J PERIPHER NERV SYST, V14, P132
   Secretaria de Estado da Saude, 2016, B EPIDEMIOL SEMANAL
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Souza CO, 2018, AM J TROP MED HYG, V98, P586, DOI 10.4269/ajtmh.17-0666
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Suryapranata FST, 2016, AM J TROP MED HYG, V94, P1380, DOI 10.4269/ajtmh.15-0070
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   van Koningsveld R, 2001, NEUROLOGY, V56, P1467, DOI 10.1212/WNL.56.11.1467
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Watts AG, 2018, J TRAVEL MED, V25, DOI [10.1093/jtm/tay132, DOI 10.1093/JTM/TAY13230476232, 10.1093/jtm/tay132 30476232]
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wong AHY, 2014, J NEUROL SCI, V344, P60, DOI 10.1016/j.jns.2014.06.021
NR 84
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2019
VL 13
IS 8
AR e0007622
DI 10.1371/journal.pntd.0007622
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE8DD
UT WOS:000490919400036
PM 31449532
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Danet, L
   Beauclair, G
   Berthet, M
   Moratorio, G
   Gracias, S
   Tangy, F
   Choumet, V
   Jouvenet, N
AF Danet, Lucie
   Beauclair, Guillaume
   Berthet, Michele
   Moratorio, Gonzalo
   Gracias, Segolene
   Tangy, Frederic
   Choumet, Valerie
   Jouvenet, Nolwenn
TI Midgut barriers prevent the replication and dissemination of the yellow
   fever vaccine in Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RNA INTERFERENCE; VIRUS; MOSQUITO; IMMUNITY; LIVE; SUPPRESSION;
   VARIANTS; PROTEIN; STRAIN; ASIBI
AB Background
   To be transmitted to vertebrate hosts via the saliva of their vectors, arthropod-borne viruses have to cross several barriers in the mosquito body, including the midgut infection and escape barriers. Yellow fever virus (YFV) belongs to the genus Flavivirus, which includes human viruses transmitted by Aedes mosquitoes, such as dengue and Zika viruses. The live-attenuated YFV-17D vaccine has been used safely and efficiently on a large scale since the end of World War II. Early studies have shown, using viral titration from salivary glands of infected mosquitoes, that YFV-17D can infect Aedes aegypti midgut, but does not disseminate to other tissues.
   Methodology/Principal findings
   Here, we re-visited this issue using a panel of techniques, such as RT-qPCR, Western blot, immunofluorescence and titration assays. We showed that YFV-17D replication was not efficient in Aedes aegypti midgut, as compared to the clinical isolate YFV-Dakar. Viruses that replicated in the midgut failed to disseminate to secondary organs. When injected into the thorax of mosquitoes, viruses succeeded in replicating into midgut-associated tissues, suggesting that, during natural infection, the block for YFV-17D replication occurs at the basal membrane of the midgut.
   Conclusions/Significance
   The two barriers associated with Ae. aegypti midgut prevent YFV-17D replication. Our study contributes to our basic understanding of vector-pathogen interactions and may also aid in the development of non-transmissible live virus vaccines.
C1 [Danet, Lucie; Beauclair, Guillaume; Gracias, Segolene; Tangy, Frederic; Jouvenet, Nolwenn] Inst Pasteur, CNRS, UMR3569, Viral Genom & Vaccinat Unit, Paris, France.
   [Danet, Lucie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.
   [Berthet, Michele; Choumet, Valerie] Inst Pasteur, Environm & Infect Risks Unit, Paris, France.
   [Moratorio, Gonzalo] Inst Pasteur, CNRS, UMR3569, Viral Populat & Pathogenesis Unit, Paris, France.
   [Moratorio, Gonzalo] Inst Pasteur Montevideo, Lab Inmunovirol, Montevideo, Uruguay.
   [Moratorio, Gonzalo] Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Montevideo, Uruguay.
RP Jouvenet, N (corresponding author), Inst Pasteur, CNRS, UMR3569, Viral Genom & Vaccinat Unit, Paris, France.
EM nolwenn.jouvenet@pasteur.fr
OI jouvenet, nolwenn/0000-0001-6103-6048; Beauclair,
   Guillaume/0000-0001-5323-5987
FU Centre National de la Recherche Scientifique (CNRS)Centre National de la
   Recherche Scientifique (CNRS); Institut Pasteur; EMBO YIP program;
   Universite Paris Diderot PhD fellowship
FX This work was supported by the Centre National de la Recherche
   Scientifique (CNRS) (http://www.cnrs.fr/), Institut Pasteur
   (https://www.pasteur.fr/fr) and the EMBO YIP program
   (http://embo.org/funding-awards/young-investigators).L.D is the
   recipient of a Universite Paris Diderot PhD fellowship
   (https://www.univ-paris-diderot.fr/).The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2018, CLIN DIABETOLOGY, V7, P1, DOI [10.5603/dk.2018.0001, DOI 10.5603/DK.2018.0001]
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Beck A, 2014, J INFECT DIS, V209, P334, DOI 10.1093/infdis/jit546
   Beck AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31085-2
   Bruni D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1552
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   Chin R, 2013, INFECT DIS THER, V2, P145, DOI 10.1007/s40121-013-0018-2
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Mason PW, 2006, VIROLOGY, V351, P432, DOI 10.1016/j.virol.2006.04.003
   Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x
   McElroy KL, 2008, VECTOR-BORNE ZOONOT, V8, P675, DOI 10.1089/vbz.2007.0269
   McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0
   McElroy KL, 2006, AM J TROP MED HYG, V75, P1158, DOI 10.4269/ajtmh.2006.75.1158
   McElroy KL, 2005, J GEN VIROL, V86, P1747, DOI 10.1099/vir.0.80746-0
   MILLER BR, 1988, ACTA VIROL, V32, P227
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Monath TP, 2002, VACCINE, V20, P1004, DOI 10.1016/S0264-410X(01)00457-1
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Olmo RP, 2018, NAT MICROBIOL, V3, P1385, DOI 10.1038/s41564-018-0268-6
   Patterson EI, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey001
   Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Screaton G, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029520
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Smith DR, 2012, INSECT MOL BIOL, V21, P1, DOI 10.1111/j.1365-2583.2011.01098.x
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   WHITMAN LORING, 1939, AMER JOUR TROP MED, V19, P19
NR 50
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2019
VL 13
IS 8
AR e0007299
DI 10.1371/journal.pntd.0007299
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE8DD
UT WOS:000490919400010
PM 31412040
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dong, SZ
   Kang, S
   Dimopoulos, G
AF Dong, Shengzhang
   Kang, Seokyoung
   Dimopoulos, George
TI Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika
   virus activity in Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEXUAL TRANSMISSION; TRANSPORT INHIBITOR; MYCOPHENOLIC-ACID;
   CYCLOSPORINE; REPLICATION; INFECTION; APOPTOSIS; U18666A; TARGETS;
   SCREEN
AB Zika virus (ZIKV), an emerging arbovirus belonging to the genus Flavivirus, is transmitted by Aedes mosquitoes. ZIKV infection can cause microcephaly of newborn babies and Guillain-Barre syndrome in adults. Because no licensed vaccine or specific antiviral treatment is available for ZIKV infection, the most commonly used approach to control the spread of ZIKV is suppression of the mosquito vector population. A novel proposed strategy to block arthropod virus (arbovirus) transmission is based on the chemical inhibition of virus infection in mosquitoes. However, only a few drugs and compounds have been tested with such properties. Here we present a comprehensive screen of 55 FDA-approved anti-flaviviral drugs for potential anti-ZIKV and mosquitocidal activity. Four drugs (auranofin, actinomycin D (Act-D), bortezomib and gemcitabine) were toxic to C6/36 cells, and two drugs (5-fluorouracil and mycophenolic acid (MPA)) significantly reduced ZIKV production in C6/36 cells at 2 mu M and 0.5 mu M, respectively. Three drugs (Act-D, cyclosporin A, ivermectin) exhibited a strong adulticidal activity, and six drugs (U18666A, retinoic acid p-hydroxyanilide (4-HPR), clotrimazole, bortezomib, MPA, imatinib mesylate) significantly suppressed ZIKV infection in mosquito midguts. Some of these FDA-approved drugs may have potential for use for the development of ZIKV transmission-blocking strategies.
C1 [Dong, Shengzhang; Kang, Seokyoung; Dimopoulos, George] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
RP Dimopoulos, G (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
EM gdimopo1@jhu.edu
OI Dong, Shengzhang/0000-0002-8218-4688
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI122743,
   R01AI101431]; Bloomberg Philanthropies
FX The study was supported by grants R01 AI122743 and R01AI101431 from the
   National Institutes of Health, and the Bloomberg Philanthropies. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Carocci M, 2015, ANTIMICROB AGENTS CH, V59, P85, DOI 10.1128/AAC.04177-14
   Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7
   Chaccour C, 2010, J INFECT DIS, V202, P113, DOI 10.1086/653208
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212
   Cohen MH, 2002, CLIN CANCER RES, V8, P935
   Costlow JL, 2017, FINE FOCUS, V3, P11
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deus KM, 2012, J MED ENTOMOL, V49, P356, DOI 10.1603/ME11164
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Dom ZIM, 2018, BRIT J CLIN PHARMACO, V84, P2433, DOI 10.1111/bcp.13704
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Fiolka MJ, 2008, J INVERTEBR PATHOL, V98, P287, DOI 10.1016/j.jip.2008.03.015
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   GOLDBERG IH, 1971, ANNU REV BIOCHEM, V40, P775, DOI 10.1146/annurev.bi.40.070171.004015
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Hill CR, 2014, CLIN PHARMACOKINET, V53, P741, DOI 10.1007/s40262-014-0153-2
   KAHAN BD, 1984, AM J KIDNEY DIS, V3, P444, DOI 10.1016/S0272-6386(84)80009-8
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Khallaayoune K, 2013, ENVIRON ENTOMOL, V42, P1040, DOI 10.1603/EN13119
   Li J, 2006, EUR J MED RES, V11, P139
   Matha V., 1992, Cytobios, V69, P163
   Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x
   Moore MM, 2010, CANCER CHEMOTH PHARM, V66, P845, DOI 10.1007/s00280-009-1228-x
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pitts J, 2019, ANTIVIR RES, V164, P147, DOI 10.1016/j.antiviral.2019.02.008
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Rao RD, 2011, MED ONCOL, V28, pS39, DOI 10.1007/s12032-010-9682-1
   Rezende Vinícius Marcondes, 2013, Rev. Bras. Hematol. Hemoter., V35, P103, DOI 10.5581/1516-8484.20130030
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Samuel W, 2006, J CELL PHYSIOL, V209, P854, DOI 10.1002/jcp.20774
   Scott-Fiorenzano JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1937-z
   Shaw LM, 2007, CLIN J AM SOC NEPHRO, V2, P1062, DOI 10.2215/CJN.03861106
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Simoes ML, 2018, TRENDS PARASITOL, V34, P603, DOI 10.1016/j.pt.2018.04.011
   Sissoko F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214170
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   WEISER J, 1988, J INVERTEBR PATHOL, V51, P92, DOI 10.1016/0022-2011(88)90092-4
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
NR 56
TC 2
Z9 2
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2019
VL 13
IS 8
AR e0007681
DI 10.1371/journal.pntd.0007681
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE8DD
UT WOS:000490919400067
PM 31430351
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, T
   Lopez, CA
   Giuberti, C
   Dennis, ML
   Itell, HL
   Heimsath, HJ
   Webster, HS
   Roark, HK
   de Vargas, PRM
   Hall, A
   Corey, RG
   Swamy, GK
   Dietze, R
   Lazear, HM
   Permar, SR
AF Singh, Tulika
   Lopez, Cesar A.
   Giuberti, Camila
   Dennis, Maria L.
   Itell, Hannah L.
   Heimsath, Holly J.
   Webster, Helen S.
   Roark, Hunter K.
   Mercon de Vargas, Paulo R.
   Hall, Allison
   Corey, Ralph G.
   Swamy, Geeta K.
   Dietze, Reynaldo
   Lazear, Helen M.
   Permar, Sallie R.
TI Efficient transplacental IgG transfer in women infected with Zika virus
   during pregnancy
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB Zika virus (ZIKV) is a newly-identified infectious cause of congenital disease. Transplacental transfer of maternal IgG to the fetus plays an important role in preventing many neonatal infections. However, antibody transfer may also have negative consequences, such as mediating enhancement of flavivirus infections in early life, or trafficking of virus immune complexes to the fetal compartment. ZIKV infection produces placental pathology which could lead to impaired IgG transfer efficiency as occurs in other maternal infections, such as HIV-1 and malaria. In this study, we asked whether ZIKV infection during pregnancy impairs transplacental transfer of IgG. We enrolled pregnant women with fever or rash in a prospective cohort in Vitoria, Brazil during the recent ZIKV epidemic. ZIKV and dengue virus (DENV)-specific IgG, ZIKV and DENV neutralizing antibodies, and routine vaccine antigen-specific IgG were measured in maternal samples collected around delivery and 20 paired cord blood samples. We concluded that 8 of these mothers were infected with ZIKV during pregnancy and 12 were ZIKV-uninfected. The magnitude of flavivirus-specific IgG, neutralizing antibody, and vaccine-elicited IgG were highly correlated between maternal plasma and infant cord blood in both ZIKV-infected and -uninfected mother-infant pairs. Moreover, there was no difference in the magnitude of plasma flavivirus-specific IgG levels between mothers and infants regardless of ZIKV infection status. Our data suggests that maternal ZIKV infection during pregnancy does not impair the efficiency of placental transfer of flavivirus-specific, functional, and vaccine-elicited IgG. These findings have implications for the neonatal outomes of maternal ZIKV infection and optimal administration of antibody-based ZIKV vaccines and therapeutics.
C1 [Singh, Tulika; Dennis, Maria L.; Itell, Hannah L.; Heimsath, Holly J.; Webster, Helen S.; Roark, Hunter K.; Corey, Ralph G.; Permar, Sallie R.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA.
   [Lopez, Cesar A.; Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Giuberti, Camila; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Mercon de Vargas, Paulo R.] Univ Fed Espirito Santo, Dept Pathol, Vitoria, ES, Brazil.
   [Hall, Allison] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
   [Swamy, Geeta K.] Duke Sch Med, Obstet & Gynecol, Durham, NC USA.
   [Dietze, Reynaldo] Univ Nova Lisboa, Global Hlth & Trop Med, Inst Higiene & Med Trop, Lisbon, Portugal.
   [Itell, Hannah L.] Univ Washington, Mol & Cellular Biol PhD Program, Seattle, WA 98195 USA.
RP Permar, SR (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA.; Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
EM helen.lazear@med.unc.edu; sallie.permar@duke.edu
OI Dietze, Reynaldo/0000-0002-6995-8001; Lopez, Cesar/0000-0001-9301-4177
FU Duke Global Health Institute; Duke-NUS Medical School; American Society
   for Reproductive Medicine; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R21 AI132677, T32 CA009111]; University of North Carolina Chapel
   Hill; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   BrasilCAPES [001]; Fundacao de Amparo a Pesquisa do Espi'rito Santo
   [306/2016, 74910132/16]; Duke-Brazil Institute
FX This work was supported by the Duke Global Health Institute* (SRP),
   Duke-NUS Medical School (SRP), the American Society for Reproductive
   Medicine* (SRP), the Duke-Brazil Institute* (TS), the National
   Institutes of Health [R21 AI132677 to SRP; and T32 CA009111 to TS],
   start-up funds from the University of North Carolina Chapel Hill (HML),
   and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (Finance Code 001 to CG). The pregnancy cohort in Brazil was funded by
   UFundacao de Amparo a Pesquisa do Espi ' rito Santo (306/2016 to RD;
   Protocol Financial Support Number: 74910132/16), and led by RD and SRP.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript*. These funding
   sources do not have a number associated with the research award.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2019
VL 13
IS 8
AR e0007648
DI 10.1371/journal.pntd.0007648
PG 26
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE8DD
UT WOS:000490919400052
PM 31449521
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tyson, J
   Tsai, WY
   Tsai, JJ
   Massgard, L
   Stramer, SL
   Lehrer, AT
   Nerurkar, VR
   Wang, WK
AF Tyson, Jasmine
   Tsai, Wen-Yang
   Tsai, Jih-Jin
   Massgard, Ludvig
   Stramer, Susan L.
   Lehrer, Axel T.
   Nerurkar, Vivek R.
   Wang, Wei-Kung
TI A high-throughput and multiplex microsphere immunoassay based on
   non-structural protein 1 can discriminate three flavivirus infections
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS-INFECTION; WEST-NILE-VIRUS; DENGUE VIRUS; CROSS-REACTIVITY;
   UNITED-STATES; ANTIBODIES; ENHANCEMENT; TRANSMISSION; DIAGNOSIS;
   TRAVELERS
AB The explosive spread of Zika virus (ZIKV) and associated complications in flavivirus-endemic regions underscore the need for sensitive and specific serodiagnostic tests to distinguish ZIKV, dengue virus (DENV) and other flavivirus infections. Compared with traditional envelope protein-based assays, several nonstructural protein 1 (NS1)-based assays showed improved specificity, however, none can detect and discriminate three flaviviruses in a single assay. Moreover, secondary DENV infection and ZIKV infection with previous DENV infection, both common in endemic regions, cannot be discriminated. In this study, we developed a high-throughput and multiplex IgG microsphere immunoassay (MIA) using the NS1 proteins of DENV1-DENV4, ZIKV and West Nile virus (WNV) to test samples from reverse-transcription-polymerase-chain reaction-confirmed cases, including primary DENV1, DENV2, DENV3, WNV and ZIKV infections, secondary DENV infection, and ZIKV infection with previous DENV infection. Combination of four DENV NS1 IgG MIAs revealed a sensitivity of 94.3% and specificity of 97.2% to detect DENV infection. The ZIKV and WNV NS1 IgG MIAs had a sensitivity/specificity of 100%/87.9% and 86.1%/78.4%, respectively. A positive correlation was found between the readouts of enzyme-linked immunosorbent assay and MIA for different NS1 tested. Based on the ratio of relative median fluorescence intensity of ZIKV NS1 to DENV1 NS1, the IgG MIA can distinguish ZIKV infection with previous DENV infection and secondary DENV infection with a sensitivity of 88.9-90.0% and specificity of 91.7-100.0%. The multiplex and high-throughput assay could be applied to serodiagnosis and serosurveillance of DENV, ZIKV and WNV infections in endemic regions.
C1 [Tyson, Jasmine; Tsai, Wen-Yang; Lehrer, Axel T.; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.
   [Massgard, Ludvig] Linkoping Univ, Fac Med & Hlth Sci, Linkoping, Sweden.
   [Stramer, Susan L.] Amer Red Cross Sci Support Off, Gaithersburg, MD USA.
RP Wang, WK (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
EM wangwk@hawaii.edu
OI TSAI, JIH-JIN/0000-0003-2226-8916; Wang, Wei-Kung/0000-0002-6670-4663
FU National Institute of Allergy and Infectious Diseases, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI110769-01, R21AI135292-01A1]; National Institute of General
   Medical Sciences, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P30GM114737]; Ministry of Health
   and WelfareMinistry of Health, Labour and Welfare, Japan
   [MOHW108-TDU-B-212-133006]; National Health Research Institute,
   TaiwanNational Health Research Institutes - Taiwan [NHRI-MR-107-PP-38,
   NHRI-108A1-MRCO-0419191]
FX This work was supported by grants R01AI110769-01 (WKW) and
   R21AI135292-01A1 (WKW) from the National Institute of Allergy and
   Infectious Diseases, NIH; P30GM114737 from the National Institute of
   General Medical Sciences, NIH; and MOHW108-TDU-B-212-133006 (JJT) from
   the Ministry of Health and Welfare, NHRI-MR-107-PP-38 (JJT) and
   NHRI-108A1-MRCO-0419191 (JJT) from the National Health Research
   Institute, Taiwan. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], GUID US LAB TEST ZIK
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   Gershman MD, 2017, MMWR-MORBID MORTAL W, V66, P457, DOI 10.15585/mmwr.mm6617e2
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lachmann N, 2013, TRANSFUS MED HEMOTH, V40, P182, DOI 10.1159/000351459
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal SM, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01885-17
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Lynch HE, 2014, J IMMUNOL METHODS, V409, P62, DOI 10.1016/j.jim.2014.04.011
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Namekar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045851
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roberts C, 2014, HUM VACC IMMUNOTHER, V10, P2168, DOI 10.4161/hv.29205
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ronca SE, 2019, EMERG INFECT DIS, V25, P325, DOI 10.3201/eid2502.180765
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Simmons G, 2018, CLIN INFECT DIS, V66, P1181, DOI 10.1093/cid/cix972
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Tsai JJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006879
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Tyson J, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01464-18
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
   Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
NR 60
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2019
VL 13
IS 8
AR e0007649
DI 10.1371/journal.pntd.0007649
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE8DD
UT WOS:000490919400053
PM 31442225
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Caragata, EP
   Tikhe, CV
   Dimopoulos, G
AF Caragata, Eric P.
   Tikhe, Chinmay V.
   Dimopoulos, George
TI Curious entanglements: interactions between mosquitoes, their
   microbiota, and arboviruses
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID WEST NILE VIRUS; MIDGUT BACTERIAL COMMUNITIES; LIFE-SHORTENING
   WOLBACHIA; JAK-STAT PATHWAY; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; DENGUE
   VIRUS; ZIKA VIRUS; INFECTION; HOST
AB Mosquitoes naturally harbor a diverse community of microorganisms that play a crucial role in their biology. Mosquito microbiota interactions are abundant and complex. They can dramatically alter the mosquito immune response, and impede or enhance a mosquito's ability to transmit medically important arboviral pathogens. Yet critically, given the massive public health impact of arboviral disease, few such interactions have been well characterized. In this review, we describe the current state of knowledge of the role of microorganisms in mosquito biology, how microbial-induced changes to mosquito immunity moderate infection with arboviruses, cases of mosquito microbial virus interactions with a defined mechanism, and the molecular interactions that underlie the endosymbiotic bacterium Wolbachia's ability to block virus infection in mosquitoes.
C1 [Caragata, Eric P.; Tikhe, Chinmay V.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
RP Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
EM gdimopo1@jhu.edu
RI Tikhe, Chinmay/J-1040-2019
OI Tikhe, Chinmay/0000-0001-5977-6776
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI141532,
   R01AI122743, R01AI121253, R21AI131574, R21AI136456]; Johns Hopkins
   Malaria Research Institute
FX EPC, CVT, and GD were supported by the National Institutes of Health
   grants R01AI141532, R01AI122743, R01AI121253, R21AI131574 and
   R21AI136456, and a postdoctoral fellowship from the Johns Hopkins
   Malaria Research Institute to CVT.
CR Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x
   Akorli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157529
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Anglero-Rodriguez YI, 2017, ELIFE, V6, DOI 10.7554/eLife.28844
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762
   Asad S, 2018, INSECT BIOCHEM MOLEC, V92, P45, DOI 10.1016/j.ibmb.2017.11.008
   Baldini F, 2018, PARASITES VECTORS, V11
   Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blumberg BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072130
   Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003
   Buck M, 2016, SCI REP, V6
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Champion CJ, 2017, FREE RADICAL BIO MED, V105, P79, DOI 10.1016/j.freeradbiomed.2016.11.031
   Charan SS, 2016, MED VET ENTOMOL, V30, P264, DOI 10.1111/mve.12173
   Charan SS, 2013, PARASITOL RES, V112, P2627, DOI 10.1007/s00436-013-3428-x
   Chayshin AR, 2015, PARASITE VECTORS, V8
   Chen SC, 2015, APPL ENVIRON MICROB, V81, P2233, DOI 10.1128/AEM.03733-14
   Chen TH, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3519158
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136
   Coon KL, 2017, P NATL ACAD SCI USA, V114, pE5362, DOI 10.1073/pnas.1702983114
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Cooper DM, 2009, INSECT BIOCHEM MOLEC, V39, P47, DOI 10.1016/j.ibmb.2008.09.011
   Correa MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07014-2
   Dickson LB, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700585
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Gaio AD, 2011, PARASITES VECTORS, V4
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737
   Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029
   Gomes FM, 2017, P NATL ACAD SCI USA, V114, P12566, DOI 10.1073/pnas.1716181114
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1988, GENETICS, V119, P435
   Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Jeffries Claire L, 2018, Wellcome Open Res, V3, P113, DOI 10.12688/wellcomeopenres.14765.2
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joyce JD, 2011, J MED ENTOMOL, V48, P389, DOI 10.1603/ME09268
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar A, 2018, INSECTS, V9, DOI 10.3390/insects9030095
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Liu K., 2017, J VIROL, V91
   Liu Y, 2014, PLOS PATHOG, V10
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Silva JBL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181678
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moltini-Conclois I, 2018, INSECTS, V9, DOI 10.3390/insects9040193
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moreno-Garcia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133240
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Muturi EJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005377
   Niang EA, 2018, MALARIA J, V17
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pang XJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.23, 10.1038/nmicrobiol.2016.23]
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Ramirez JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8403
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010
   Saraiva RG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006443
   Saraiva RG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24296-0
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200
   Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207
   Sharma A, 2013, ACTA TROP, V128, P41, DOI 10.1016/j.actatropica.2013.06.008
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Short SM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005677
   Simoes ML, 2018, TRENDS PARASITOL, V34, P603, DOI 10.1016/j.pt.2018.04.011
   Skelton E, 2016, J MED ENTOMOL, V53, P401, DOI 10.1093/jme/tjv235
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Tetreau G, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2741-8
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   Valzania L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006638
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   Villegas LM, 2014, MEM I OSWALDO CRUZ, V109, P672, DOI 10.1590/0074-0276140194
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang SB, 2017, SCIENCE, V357, P1399, DOI 10.1126/science.aan5478
   Wang XM, 2018, MOL ECOL, V27, P2972, DOI 10.1111/mec.14732
   Wang Y, 2015, EPL-EUROPHYS LETT, V112, DOI 10.1209/0295-5075/112/50002
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   World Health Organization, 2017, VECT BORN DIS
   Wu P, 2019, CELL HOST MICROBE, V25, P101, DOI 10.1016/j.chom.2018.11.004
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Xiao XP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.20
   Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110
   Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zink SD, 2015, VIRUSES-BASEL, V7, P5619, DOI 10.3390/v7102886
   Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 133
TC 2
Z9 2
U1 5
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD AUG
PY 2019
VL 37
BP 26
EP 36
DI 10.1016/j.coviro.2019.05.005
PG 11
WC Virology
SC Virology
GA JE3XC
UT WOS:000490627200006
PM 31176069
DA 2020-07-08
ER

PT J
AU Breitbach, ME
   Newman, CM
   Dudley, DM
   Stewart, LM
   Aliota, MT
   Koenig, MR
   Shepherd, PM
   Yamamoto, K
   Crooks, CM
   Young, G
   Semler, MR
   Weiler, AM
   Barry, GL
   Heimsath, H
   Mohr, EL
   Eichkoff, J
   Newton, W
   Peterson, E
   Schultz-Darken, N
   Permar, SR
   Dean, H
   Capuano, S
   Osorio, JE
   Friedrich, TC
   O'Connor, DH
AF Breitbach, Meghan E.
   Newman, Christina M.
   Dudley, Dawn M.
   Stewart, Laurel M.
   Aliota, Matthew T.
   Koenig, Michelle R.
   Shepherd, Phoenix M.
   Yamamoto, Keisuke
   Crooks, Chelsea M.
   Young, Ginger
   Semler, Matthew R.
   Weiler, Andrea M.
   Barry, Gabrielle L.
   Heimsath, Holly
   Mohr, Emma L.
   Eichkoff, Jens
   Newton, Wendy
   Peterson, Eric
   Schultz-Darken, Nancy
   Permar, Sallie R.
   Dean, Hansi
   Capuano, Saverio, III
   Osorio, Jorge E.
   Friedrich, Thomas C.
   O'Connor, David H.
TI Primary infection with dengue or Zika virus does not affect the severity
   of heterologous secondary infection in macaques
SO PLOS PATHOGENS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; ENVELOPE GLYCOPROTEIN; RHESUS MACAQUES;
   SHOCK SYNDROME; DISEASE; PATHOGENESIS; IMMUNOPATHOGENESIS; RESPONSES;
   IMMUNITY; MONKEYS
AB Zika virus (ZIKV) and dengue virus (DENV) are genetically and antigenically related flaviviruses that now co-circulate in much of the tropical and subtropical world. The rapid emergence of ZIKV in the Americas in 2015 and 2016, and its recent associations with Guillain-Barre syndrome, birth defects, and fetal loss have led to the hypothesis that DENV infection induces cross-reactive antibodies that influence the severity of secondary ZIKV infections. It has also been proposed that pre-existing ZIKV immunity could affect DENV pathogenesis. We examined outcomes of secondary ZIKV infections in three rhesus and fifteen cynomolgus macaques, as well as secondary DENV-2 infections in three additional rhesus macaques up to a year post-primary ZIKV infection. Although cross-binding antibodies were detected prior to secondary infection for all animals and cross-neutralizing antibodies were detected for some animals, previous DENV or ZIKV infection had no apparent effect on the clinical course of heterotypic secondary infections in these animals. All animals had asymptomatic infections and, when compared to controls, did not have significantly perturbed hematological parameters. Rhesus macaques infected with DENV-2 approximately one year after primary ZIKV infection had higher vRNA loads in plasma when compared with serum vRNA loads from ZIKV-naive animals infected with DENV-2, but a differential effect of sample type could not be ruled out. In cynomolgus macaques, the serotype of primary DENV infection did not affect the outcome of secondary ZIKV infection.
C1 [Breitbach, Meghan E.; Newman, Christina M.; Dudley, Dawn M.; Stewart, Laurel M.; Koenig, Michelle R.; Shepherd, Phoenix M.; Yamamoto, Keisuke; Semler, Matthew R.; O'Connor, David H.] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA.
   [Breitbach, Meghan E.; Newman, Christina M.; Dudley, Dawn M.; Stewart, Laurel M.; Koenig, Michelle R.; Shepherd, Phoenix M.; Yamamoto, Keisuke; Semler, Matthew R.; O'Connor, David H.] Univ Wisconsin, Sch Med & Publ Hlth, Lab Med, Madison, WI 53706 USA.
   [Aliota, Matthew T.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA.
   [Crooks, Chelsea M.; Barry, Gabrielle L.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Young, Ginger; Dean, Hansi] Takeda Vaccines Inc, Madison, WI USA.
   [Weiler, Andrea M.; Newton, Wendy; Peterson, Eric; Schultz-Darken, Nancy; Capuano, Saverio, III] Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Heimsath, Holly; Permar, Sallie R.] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA.
   [Mohr, Emma L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA.
   [Eichkoff, Jens] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA.; O'Connor, DH (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Lab Med, Madison, WI 53706 USA.
EM dhoconno@wisc.edu
OI Aliota, Matthew/0000-0002-6902-9149; Young, Ginger/0000-0003-2403-8188;
   Crooks, Chelsea/0000-0003-3874-4577
FU United States National Institutes of Health National Institute of
   Allergy and Infectious Diseases (NIH/NIAID)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R01
   AI116382, R21 AI131454]
FX This research was funded by grants from the United States National
   Institutes of Health National Institute of Allergy and Infectious
   Diseases (NIH/NIAID) https://www.niaid.nih.gov/: principally award
   number R01 AI116382 (to D.H.O.), secondarily, R21 AI131454 (to M.T.A.).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114
   Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Britto C, 2018, EXPERT OPIN BIOL TH, V18, P1171, DOI 10.1080/14712598.2018.1526277
   Butrapet S, 2006, J VIROL METHODS, V131, P1, DOI 10.1016/j.jviromet.2005.06.019
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cohen J, 2017, SCIENCE, V355, P1362, DOI 10.1126/science.355.6332.1362
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   de-Oliveira-Pinto LM, 2012, MEM I OSWALDO CRUZ, V107, P48, DOI 10.1590/S0074-02762012000100007
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361
   Gardner MB, 2008, ILAR J, V49, P220, DOI 10.1093/ilar.49.2.220
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Harenberg A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004830
   Hickey AC, 2013, AM J TROP MED HYG, V89, P1043, DOI 10.4269/ajtmh.13-0145
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kuczera D, 2018, J INTERF CYTOK RES, V38, P69, DOI 10.1089/jir.2017.0037
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Li MW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193006
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roth A, 2014, EUROSURVEILLANCE, P19
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Silva JVJ, 2018, ACTA TROP, V182, P257, DOI 10.1016/j.actatropica.2018.03.009
   Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1
   Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Torresi J, 2017, HUM VACC IMMUNOTHER, V13, P1059, DOI 10.1080/21645515.2016.1261770
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weatherall D., 2006, USE NONHUMAN PRIMATE
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 72
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD AUG
PY 2019
VL 15
IS 8
AR e1007766
DI 10.1371/journal.ppat.1007766
PG 28
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA JB1LN
UT WOS:000488322100004
PM 31369649
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, A
   Brites, C
   Mochida, G
   Ventura, P
   Fernandes, A
   Lage, ML
   Taguchi, T
   Brandi, I
   Silva, A
   Franceschi, G
   Lucena, P
   Lucena, R
AF Carvalho, Alessandra
   Brites, Carlos
   Mochida, Ganeshwaran
   Ventura, Paloma
   Fernandes, Adriana
   Lage, Maria Lucia
   Taguchi, Thnia
   Brandi, Ivar
   Silva, Alfredo
   Franceschi, Giulia
   Lucena, Pedro
   Lucena, Rita
TI Clinical and neurodevelopmental features in children with cerebral palsy
   and probable congenital Zika
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Zika virus; Cerebral palsy; Neurodevelopment
ID VIRUS-INFECTION; INFANTS; BRAZIL; OUTCOMES; GROWTH; BORN; AGE
AB Objective: To describe the neurological and neurodevelopmental features at 1 year of age in children with cerebral palsy (CP) related to probable congenital Zika (CZ), followed in a referral neurorehabilitation hospital.
   Methods. - Data on 82 children with CP associated with probable CZ, who consecutively attended the neurodevelopmental and neurological assessment around one year of age, were collected. For neurodevelopmental evaluation, Bayley-III Scales of Infant and Toddler Development was used. Descriptive statistical analysis was performed.
   Results: The children were admitted into the rehabilitation program at a young age (mean age: 4.8 months, SD 3.1), followed beyond the first year of life (mean age of follow up: 13.2 months, SD 2.1), born to young mothers (mean age: 28.1 years, SD 5.9), in their first pregnancy (62.2%). The majority had severe congenital microcephaly (62.0%), spastic CP (96.3%), epilepsy (63.4%), absent expected postural reactions (93.2%), abnormal persistence of primitive reflexes (94.7%), and severe neuroimaging abnormalities, predominantly calcifications (97.6%). Extremely low performances on cognitive (95.1%), language (97.6%) and motor (97.6%) developmental composite scores were observed. There was a correlation between the cognitive score with the birth head circumference (HC) (r = 0.3, p = 0.01) and with the follow up HC (r = 0.4, p < 0.01), as well as between the follow up HC with the motor score (r = 0.2, p = 0.03).
   Conclusion: Congenital Zika may be associated with a severe form of CP, mainly bilateral spastic, with a severe global neurodevelopmental impairment and early signs of a poor prognosis for independent walking. Head circumference may be a prognostic marker among those children. These results may help establish goals for the rehabilitation program and identify priority health services. (C) 2019 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Carvalho, Alessandra; Ventura, Paloma; Fernandes, Adriana; Taguchi, Thnia; Brandi, Ivar; Silva, Alfredo] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, Carlos; Lage, Maria Lucia; Franceschi, Giulia; Lucena, Rita] Univ Fed Bahia, Salvador, BA, Brazil.
   [Mochida, Ganeshwaran] Boston Childrens Hosp, Boston, MA USA.
   [Mochida, Ganeshwaran] Harvard Med Sch, Boston, MA 02115 USA.
   [Mochida, Ganeshwaran] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Lucena, Pedro] Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Carvalho, A (corresponding author), SARAH Salvador Hosp, Av Tancredo Neves 2782, BR-41820900 Salvador, BA, Brazil.
EM 13110@sarah.br
OI Lucena, Pedro/0000-0003-1148-7806; Mochida,
   Ganeshwaran/0000-0001-7912-4097
CR Abramov DM, 2018, NEUROLOGY, V90, pE606, DOI 10.1212/WNL.0000000000004974
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BLECK EE, 1975, DEV MED CHILD NEUROL, V17, P18
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Granild-Jensen JB, 2015, DEV MED CHILD NEUROL, V57, P931, DOI 10.1111/dmcn.12760
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lustig Y, 2018, J CLIN VIROL, V99-100, P31, DOI 10.1016/j.jcv.2017.12.007
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Ministerio da Saude, 2018, B EPIDEMIOL, V49, P1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   Pan American Health Organization World Health Organization, 2016, NEUR SYNDR CONG AN Z, V8
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodo C, 2017, CLIN MICROBIOL INFEC, V24, P2017
   Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x
   Rosman NP, 2011, PEDIATRICS, V127, P665, DOI 10.1542/peds.2010-1576
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 35
TC 5
Z9 5
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD AUG
PY 2019
VL 41
IS 7
BP 587
EP 594
DI 10.1016/j.braindev.2019.03.005
PG 8
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA IY1EA
UT WOS:000486133200003
PM 30914212
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, B.
   Wiwanitkit, V.
TI Neurogenic bladder and congenital Zika syndrome
SO JOURNAL OF PEDIATRIC UROLOGY
LA English
DT Letter
C1 [Joob, B.] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, V.] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Monteiro LMC, 2019, J PEDIATR UROL, V15, DOI 10.1016/j.jpurol.2019.04.018
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-5131
EI 1873-4898
J9 J PEDIATR UROL
JI J. Pediatr. Urol
PD AUG
PY 2019
VL 15
IS 4
BP 433
EP 433
DI 10.1016/j.jpurol.2019.06.020
PG 1
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA IY5PG
UT WOS:000486443900062
PM 31331807
OA Bronze
DA 2020-07-08
ER

PT J
AU Monteiro, LMC
   Cruz, GNO
   Monteiro, AC
   Moreira, MEL
AF Costa Monteiro, L. M.
   Cruz, G. N. O.
   Monteiro, A. C.
   Moreira, M. E. L.
TI Comment on the 'Letter to the Editor' related to the article 'Neurogenic
   bladder in the settings of congenital Zika syndrome: a confirmed and
   unknown condition for urologists'
SO JOURNAL OF PEDIATRIC UROLOGY
LA English
DT Letter
C1 [Costa Monteiro, L. M.; Cruz, G. N. O.; Moreira, M. E. L.] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Monteiro, A. C.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA.
RP Monteiro, LMC (corresponding author), Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM luciacostamonteiro@gmail.com
RI Monteiro, Lucia Maria Costa/O-7903-2014; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Monteiro, Lucia Maria Costa/0000-0002-7612-7249; Moreira, Maria
   Elisabeth Lopes/0000-0002-2034-0294
FU MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit [440580/20161]
FX This work was supported by a grant from the
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit (grant number 440580/20161).
CR [Anonymous], 2017, LANCET, V389, P573, DOI 10.1016/S0140-6736(17)30325-2
   Monteiro LMC, 2019, J PEDIATR UROL, V15, DOI 10.1016/j.jpurol.2019.04.018
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Olandoski KP, 2011, CLINICS, V66, P189, DOI 10.1590/S1807-59322011000200002
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-5131
EI 1873-4898
J9 J PEDIATR UROL
JI J. Pediatr. Urol
PD AUG
PY 2019
VL 15
IS 4
BP 434
EP 435
DI 10.1016/j.jpurol.2019.06.021
PG 2
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA IY5PG
UT WOS:000486443900063
PM 31351948
DA 2020-07-08
ER

PT J
AU Brien, JD
   Hassert, M
   Stone, ET
   Geerling, E
   Cruz-Orengo, L
   Pinto, AK
AF Brien, James D.
   Hassert, Mariah
   Stone, E. Taylor
   Geerling, Elizabeth
   Cruz-Orengo, Lillian
   Pinto, Amelia K.
TI Isolation and Quantification of Zika Virus from Multiple Organs in a
   Mouse
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology and Infection; Issue 150; Zika virus; brain; spinal cord;
   kidney; spleen; liver; viral titer; focus forming assay; quantitative
   real-time PCR; foot pad infection
ID ARBOVIRUS INFECTIONS; ANTIBODIES; NEUTRALIZATION; PROTECTION
AB The methods being presented demonstrate laboratory procedures for the isolation of organs from Zika virus infected animals and the quantification of viral load. The purpose of the procedure is to quantify viral titers in peripheral and CNS areas of the mouse at different time points post infection or under different experimental conditions to identify virologic and immunological factors that regulate Zika virus infection. The organ isolation procedures demonstrated allow for both focus forming assay quantification and quantitative PCR assessment of viral titers. The rapid organ isolation techniques are designed for the preservation of virus titer. Viral titer quantification by focus forming assay allows for the rapid throughput assessment of Zika virus. The benefit of the focus forming assay is the assessment of infectious virus, the limitation of this assay is the potential for organ toxicity reducing the limit of detection. Viral titer assessment is combined with quantitative PCR, and using a recombinant RNA copy control viral genome copy number within the organ is assessed with low limit of detection. Overall these techniques provide an accurate rapid high throughput method for the analysis of Zika viral titers in the periphery and CNS of Zika virus infected animals and can be applied to the assessment of viral titers in the organs of animals infected with most pathogens, including Dengue virus.
C1 [Brien, James D.; Hassert, Mariah; Stone, E. Taylor; Geerling, Elizabeth; Pinto, Amelia K.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
   [Cruz-Orengo, Lillian] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA.
RP Pinto, AK (corresponding author), St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
EM amelia.pinto@health.slu.edu
FU Saint Louis University School of Medicine; NIH NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [K22AI104794]; Saint Louis University School
FX Dr. Pinto is funded by a seed grant from the Saint Louis University
   School of Medicine and startup funds from Saint Louis University School
   of Medicine. Dr. Brien is funded by a K22AI104794 early investigator
   award from the NIH NIAID as well a seed grant from the Saint Louis
   University School. For all funded individuals the funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Brien J. D., 2007, THESIS
   Brien J. D., 2013, CURR PROTOC MICROBIO, V31
   Brien JD, 2013, J VIROL, V87, P7747, DOI 10.1128/JVI.00327-13
   Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Pinto AK, 2015, J VIROL, V89, P9465, DOI 10.1128/JVI.00996-15
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 25
TC 0
Z9 0
U1 2
U2 3
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2019
IS 150
AR e59632
DI 10.3791/59632
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IY7QI
UT WOS:000486589800048
PM 31475971
OA Green Published
DA 2020-07-08
ER

PT J
AU Hanajiri, R
   Sani, GM
   Hanley, PJ
   Silveira, CG
   Kallas, EG
   Keller, MD
   Bollard, CM
AF Hanajiri, Ryo
   Sani, Gelina M.
   Hanley, Patrick J.
   Silveira, Cassia G.
   Kallas, Esper G.
   Keller, Michael D.
   Bollard, Catherine M.
TI Generation of Zika virus - specific T cells from seropositive and
   virus-naive donors for potential use as an autologous or "off-the-shelf"
   immunotherapeutic
SO CYTOTHERAPY
LA English
DT Article
DE cord blood; epitope mapping; Good Manufacturing Practice; immunotherapy;
   T lymphocytes; Zika virus
ID GUILLAIN-BARRE-SYNDROME; STEM-CELL; VIRAL-INFECTIONS; BK VIRUS; TARGET;
   BLOOD; ADENOVIRUS; CMV; EBV; LYMPHOCYTES
AB Background: Zika virus (ZIKV) infection can cause severe birth defects in newborns with no effective currently available treatment. Adoptive transfer of virus-specific T cells has proven to be safe and effective for the prevention or treatment of many viral infections, and could represent a novel treatment approach for patients with ZIKV infection. However, extending this strategy to the ZIKV setting has been hampered by limited data on immunogenic T-cell antigens within ZIKV. Hence, we have generated ZIKV-specific T cells and characterized the cellular immune responses against ZIKV antigens. Methods: T-cell products were generated from peripheral blood of ZIKV-exposed donors, ZIKV-naive adult donors and umbilical cord blood by stimulation with pentadecamer (15mer) overlapping peptide libraries spanning four ZIKV polyproteins (C, M, E and NS1) using a Good Manufacturing Practice compliant protocol. Results: We successfully generated T cells targeting ZIKV antigens with clinically relevant numbers. The ex vivo-expanded T cells comprised both CD4(+) and CD8(+) T cells that were able to produce Th1-polarized effector cytokines and kill ZIKV-infected HLA-matched monocytes, confirming functionality of this unique T-cell product as a potential "off-the-shelf" therapeutic. Epitope mapping using peptide arrays identified several novel HLA class I and class II restricted epitopes within NS1 antigen, which is essential for viral replication and immune evasion. Discussion: Our findings demonstrate that it is feasible to generate potent ZIKV-specific T cells from a variety of cell sources including virus naive donors for future clinical use in an "off-the-shelf" setting.
C1 [Hanajiri, Ryo; Sani, Gelina M.; Hanley, Patrick J.; Keller, Michael D.; Bollard, Catherine M.] Childrens Natl Hlth Syst, Ctr Canc & Immunol Res, 111 Michigan Ave NW, Washington, DC 20010 USA.
   [Hanley, Patrick J.; Keller, Michael D.; Bollard, Catherine M.] George Washington Univ, Washington, DC USA.
   [Silveira, Cassia G.; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
   [Keller, Michael D.] Childrens Natl Hlth Syst, Div Allergy & Immunol, Washington, DC USA.
   [Bollard, Catherine M.] Childrens Natl Hlth Syst, Div Blood & Marrow Transplantat, Washington, DC USA.
RP Bollard, CM (corresponding author), Childrens Natl Hlth Syst, Ctr Canc & Immunol Res, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM cbollard@childrensnational.org
FU Be The Match; American Society for Blood and Marrow Transplantation (Amy
   Strelzer Manasevit Award); National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [K23-HL136783-01]; Jeffrey Modell Foundation; Board of Visitors of
   the Children's National Health System
FX This work was supported by grants from Be The Match and the American
   Society for Blood and Marrow Transplantation (Amy Strelzer Manasevit
   Award to P.J.H.), the National Institutes of Health (K23-HL136783-01 to
   M. D. K.), the Jeffrey Modell Foundation and the Board of Visitors of
   the Children's National Health System.
CR Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bollard CM, 2016, BLOOD, V127, P3331, DOI 10.1182/blood-2016-01-628982
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dave H, 2017, MOL THER-METH CLIN D, V5, P13, DOI 10.1016/j.omtm.2017.02.001
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerdemann U, 2013, MOL THER, V21, P2113, DOI 10.1038/mt.2013.151
   Goldszmid RS, 2014, CELL HOST MICROBE, V15, P295, DOI 10.1016/j.chom.2014.02.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   GRIFONI A, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01469-17
   Hanley PJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2546
   Hanley PJ, 2009, BLOOD, V114, P1958, DOI 10.1182/blood-2009-03-213256
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Jurado KA, 2017, NAT MICROBIOL, V2, P1460, DOI 10.1038/s41564-017-0049-7
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leen AM, 2006, NAT MED, V12, P1160, DOI 10.1038/nm1475
   Leen AM, 2013, BLOOD, V121, P5113, DOI 10.1182/blood-2013-02-486324
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Muftuoglu M, 2018, NEW ENGL J MED, V379, P1443, DOI 10.1056/NEJMoa1801540
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neuenhahn M, 2017, LEUKEMIA, V31, P2161, DOI 10.1038/leu.2017.16
   Ngo MC, 2014, J IMMUNOTHER, V37, P193, DOI 10.1097/CJI.0000000000000014
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Papadopoulou A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008825
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Patel S, 2018, MOL THER, V26, P1435, DOI 10.1016/j.ymthe.2018.04.009
   Patel S, 2016, BIOL BLOOD MARROW TR, V22, P536, DOI 10.1016/j.bbmt.2015.12.007
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rana J, 2018, J VIROL, V92, DOI 10.1128/JVI.01174-18
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sutrave G, 2017, CYTOTHERAPY, V19, P1284, DOI 10.1016/j.jcyt.2017.07.012
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tzannou I, 2017, J CLIN ONCOL, V35, P3547, DOI [10.1200/jco.2017.73.0655, 10.1200/JCO.2017.73.0655]
   Weber G, 2013, LEUKEMIA, V27, P1538, DOI 10.1038/leu.2013.66
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xu X, 2016, PLOS CURR, V8, DOI [10.1371/ecurrents.outbreaks.9aa2e1fb61b0f632-f58a098773008c4b, DOI 10.1371/ECURRENTS.OUTBREAKS.9AA2E1FB61B0F632-F58A098773008C4B]
NR 64
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1465-3249
EI 1477-2566
J9 CYTOTHERAPY
JI Cytotherapy
PD AUG
PY 2019
VL 21
IS 8
BP 840
EP 855
DI 10.1016/j.jcyt.2019.06.008
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA IX6HK
UT WOS:000485783700005
PM 31279695
DA 2020-07-08
ER

PT J
AU Kaminski, VD
   Ellwanger, JH
   Chies, JAB
AF Kaminski, Valeria de Lima
   Ellwanger, Joel Henrique
   Bogo Chies, Jose Artur
TI Extracellular vesicles in host-pathogen interactions and immune
   regulation - exosomes as emerging actors in the immunological theater of
   pregnancy
SO HELIYON
LA English
DT Review
DE Exosomes; Extracellular vesicles; Viruses; Bacteria; Fungi; Parasites;
   Prion; Placenta; Maternal-fetal; Gestation; Infection; Vertical
   transmission; Genetics; Immunology; Microbiology
ID HUMAN TROPHOBLAST CELLS; TOLL-LIKE RECEPTOR-2; ANTIGEN-PRESENTING CELLS;
   FAS-LIGAND; HUMAN PLACENTA; T-CELLS; 1ST TRIMESTER; ZIKA VIRUS;
   CYTOMEGALOVIRUS-INFECTION; ORGANELLES PROSTASOMES
AB This review correlates and summarizes the role of the maternal-fetal interface in the immune tolerance of the fetus and the processes that lead to infection avoidance, emphasizing the participation of exosomes and other extra-cellular vesicles in both situations. Exosomes are released into the extracellular medium by several cell types and are excellent carriers of biomolecules. Host-derived exosomes and the transport of pathogen-derived molecules by exosomes impact infections in different ways. The interactions of exosomes with the maternal immune system are pivotal to a favorable gestational outcome. In this review, we highlight the potential role of exosomes in the establishment of an adequate milieu that enables embryo implantation and discuss the participation of exosomes released at the maternal-fetal interface during the establishment of an immune-privileged compartment for fetal development. The placenta is a component where important strategies are used to minimize the risk of infection. To present a contrast, we also discuss possible mechanisms used by pathogens to cross the maternal-fetal interface. We review the processes, mechanisms, and potential consequences of dysregulation in all of the above mentioned phenomena. Basic information about exosomes and their roles in viral immune evasion is also presented. The interactions between extracellular vesicles and bacteria, fungi, parasites and proteinaceous infectious agents are addressed. The discovery of the placental microbiota and the implications of this new microbiota are also discussed, and current proposals that explain fetal/placental colonization by both pathogenic and commensal microbes are addressed. The comprehension of such interactions will help us to understand the immune dynamics of human pregnancy and the mechanisms of immune evasion used by different pathogens.
C1 [Kaminski, Valeria de Lima; Ellwanger, Joel Henrique; Bogo Chies, Jose Artur] Univ Fed Rio Grande do Sul, Dept Genet, Programa Posgrad Genet & Biol Mol, Lab Imunobiol & Imunogenet, Porto Alegre, RS, Brazil.
RP Chies, JAB (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Programa Posgrad Genet & Biol Mol, Lab Imunobiol & Imunogenet, Porto Alegre, RS, Brazil.
EM jabchies@terra.com.br
RI Chies, Jose Artur Bogo/K-9664-2015; Ellwanger, Joel
   Henrique/H-7551-2013; de Lima Kaminski, Valeria/Y-3315-2018
OI Chies, Jose Artur Bogo/0000-0001-7025-0660; Ellwanger, Joel
   Henrique/0000-0002-1040-2738; de Lima Kaminski,
   Valeria/0000-0002-2731-0653
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES,
   Brazil)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq, Brazil)National Council for Scientific and
   Technological Development (CNPq); CAPES (Brazil)CAPES
FX This work was supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES, Brazil) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil). Valeria de Lima Kaminski and
   Joel Henrique Ellwanger received a doctoral scholarship from Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil).
   Currently, Joel Henrique Ellwanger receives a postdoctoral fellowship
   from CAPES (Brazil). Jose Artur Bogo Chies receives a fellowship from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil).
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Abbate JL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004676
   Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599
   Abrahams VM, 2011, J REPROD IMMUNOL, V88, P112, DOI 10.1016/j.jri.2010.12.003
   Abrahams VM, 2004, MOL HUM REPROD, V10, P55, DOI 10.1093/molehr/gah006
   Abrami L, 2013, CELL REP, V5, P986, DOI 10.1016/j.celrep.2013.10.019
   Adams KM, 2007, PLACENTA, V28, P477, DOI 10.1016/j.placenta.2006.08.004
   Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020
   Anderle C, 2008, J REPROD IMMUNOL, V79, P26, DOI 10.1016/j.jri.2008.06.002
   Anderson MR, 2016, NEUROTHERAPEUTICS, V13, P535, DOI 10.1007/s13311-016-0450-6
   Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624
   Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x
   Athman JJ, 2015, J IMMUNOL, V195, P1044, DOI 10.4049/jimmunol.1402894
   Bai X, 2009, PLACENTA, V30, P855, DOI 10.1016/j.placenta.2009.07.006
   Barak S, 2007, J PERIODONTOL, V78, P670, DOI 10.1902/jop.2007.060362
   Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayer A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.060
   Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152
   Bielska E, 2019, CURR OPIN MICROBIOL, V52, P90, DOI 10.1016/j.mib.2019.05.007
   BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0
   Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014
   BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0
   Bromfield JJ, 2014, J ASSIST REPROD GEN, V31, P627, DOI 10.1007/s10815-014-0243-y
   Bu HC, 2019, CHEMBIOCHEM, V20, P451, DOI 10.1002/cbic.201800470
   Canavan TP, 2007, J REPROD IMMUNOL, V74, P46, DOI 10.1016/j.jri.2006.10.004
   CANTLE SJ, 1987, PLACENTA, V8, P221, DOI 10.1016/0143-4004(87)90046-4
   Capmany G, 1996, Mol Hum Reprod, V2, P299, DOI 10.1093/molehr/2.5.299
   Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X
   Chavan AR, 2017, CURR OPIN GENET DEV, V47, P24, DOI 10.1016/j.gde.2017.08.004
   Clark DA, 2005, CHEM IMMUNOL ALLERGY, V89, P36, DOI 10.1159/000087911
   Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249
   Coakley G, 2016, MOL BIOCHEM PARASIT, V208, P33, DOI 10.1016/j.molbiopara.2016.06.003
   Coakley G, 2015, TRENDS PARASITOL, V31, P477, DOI 10.1016/j.pt.2015.06.009
   Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326
   Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338
   Costello MJ, 2007, AM J REPROD IMMUNOL, V57, P67, DOI 10.1111/j.1600-0897.2006.00447.x
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva RP, 2015, SCI REP-UK, V5, DOI 10.1038/srep07763
   De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203
   deGoffau M.C., 2019, NATURE
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001
   Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013
   Ellwanger JH, 2019, TICKS TICK-BORNE DIS, V10, P729, DOI 10.1016/j.ttbdis.2019.03.005
   Ellwanger JH, 2018, BRAZ J INFECT DIS, V22, P76, DOI 10.1016/j.bjid.2017.11.003
   Ellwanger JH, 2017, INFECT GENET EVOL, V53, P146, DOI 10.1016/j.meegid.2017.05.021
   Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003
   Espinoza J, 2006, AM J OBSTET GYNECOL, V194, P630, DOI 10.1016/j.ajog.2005.11.050
   Fan XG, 1997, AM J REPROD IMMUNOL, V37, P359
   Ferguson TA, 2006, IMMUNOL REV, V213, P228, DOI 10.1111/j.1600-065X.2006.00430.x
   Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001
   Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x
   Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Frangsmyr L, 2005, MOL HUM REPROD, V11, P35, DOI 10.1093/molehr/gah129
   Fu BQ, 2014, CELL MOL IMMUNOL, V11, P564, DOI 10.1038/cmi.2014.54
   Gan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029421
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677
   Giri PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002461
   Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100
   Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Hackmon R, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12643
   HAMILTON WJ, 1960, J ANAT, V94, P297
   Hammer A, 2000, J REPROD IMMUNOL, V46, P83, DOI 10.1016/S0165-0378(99)00059-5
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hartmann A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00194
   Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477
   HILL JA, 1995, JAMA-J AM MED ASSOC, V273, P1933, DOI 10.1001/jama.273.24.1933
   Holder B, 2016, TRAFFIC, V17, P168, DOI 10.1111/tra.12352
   HOLMES CH, 1992, EUR J IMMUNOL, V22, P1579, DOI 10.1002/eji.1830220635
   Holmlund U, 2002, IMMUNOLOGY, V107, P145, DOI 10.1046/j.1365-2567.2002.01491.x
   Huang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041219
   Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311
   Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028
   Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100
   Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3
   Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007
   Jodo S, 2000, J IMMUNOL, V165, P5487, DOI 10.4049/jimmunol.165.10.5487
   Joffe LS, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00099-16
   Johansson M, 2004, IMMUNOLOGY, V112, P290, DOI 10.1111/j.1365-2567.2004.01876.x
   Juliano PB, 2006, PLACENTA, V27, P750, DOI 10.1016/j.placenta.2005.07.008
   Kadiu I, 2012, J IMMUNOL, V189, P744, DOI 10.4049/jimmunol.1102244
   Kaminski VD, 2019, INT J IMMUNOGENET, V46, P82, DOI 10.1111/iji.12416
   Kaminski VD, 2018, MOL BIOL REP, V45, P1565, DOI 10.1007/s11033-018-4268-7
   Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I
   Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032
   KELLY RW, 1991, CLIN EXP IMMUNOL, V86, P550
   Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741
   Kim MJ, 2016, KOREAN J PARASITOL, V54, P147, DOI 10.3347/kjp.2016.54.2.147
   Kim YM, 2004, AM J OBSTET GYNECOL, V191, P1346, DOI 10.1016/j.ajog.2004.07.009
   King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M
   Koh YQ, 2014, EUR J OBSTET GYN R B, V175, P129, DOI 10.1016/j.ejogrb.2013.12.032
   Koi H, 2001, ANN NY ACAD SCI, V943, P148, DOI 10.1111/j.1749-6632.2001.tb03798.x
   Krikun G, 2007, HISTOL HISTOPATHOL, V22, P847, DOI 10.14670/HH-22.847
   Kshirsagar SK, 2012, PLACENTA, V33, P982, DOI 10.1016/j.placenta.2012.10.005
   Kudo Y, 2004, J REPROD IMMUNOL, V61, P87, DOI 10.1016/j.jri.2003.11.004
   Kumazaki K, 2004, HUM PATHOL, V35, P47, DOI 10.1016/j.humpath.2003.08.027
   Lai A, 2018, METHODS MOL BIOL, V1710, P131, DOI 10.1007/978-1-4939-7498-6_10
   Lash GE, 2010, PLACENTA, V31, pS87, DOI 10.1016/j.placenta.2009.12.022
   LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101
   Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106
   Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647
   Li YW, 2018, INT J NANOMED, V13, P467, DOI 10.2147/IJN.S151110
   Liu S, 2016, MBIO, V7, DOI 10.1128/mBio.00915-16
   Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146
   Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013
   Ma Y, 2007, PLACENTA, V28, P1024, DOI 10.1016/j.placenta.2007.05.003
   Madison MN, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0102-z
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210
   Makrigiannakis A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061305
   Mantel PY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12727
   Reyes-Ruiz JM, 2019, VIRUS RES, V266, P1, DOI 10.1016/j.virusres.2019.03.015
   Martin R, 2004, TRENDS FOOD SCI TECH, V15, P121, DOI 10.1016/j.tifs.2003.09.010
   Martinez-Garcia EA, 2011, AM J REPROD IMMUNOL, V65, P99, DOI 10.1111/j.1600-0897.2010.00893.x
   Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274
   Martins SD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01792
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2
   Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3
   Meuleman T, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12797
   Michita RT, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01771
   Michita RT, 2016, HUM IMMUNOL, V77, P892, DOI 10.1016/j.humimm.2016.07.004
   Mincheva-Nilsson L, 2000, INT IMMUNOL, V12, P585, DOI 10.1093/intimm/12.5.585
   Mincheva-Nilsson L, 2010, EXPERT REV OBSTET GY, V5, P619, DOI DOI 10.1586/eog.10.43
   Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585
   Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x
   MINCHEVANILSSON L, 1994, J IMMUNOL, V152, P2020
   Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001
   Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886
   Monleon I, 2001, J IMMUNOL, V167, P6736, DOI 10.4049/jimmunol.167.12.6736
   Mor G, 2002, BIOCHEM PHARMACOL, V64, P1305, DOI 10.1016/S0006-2952(02)01267-4
   Mor G, 1998, AM J REPROD IMMUNOL, V40, P89
   Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326
   Nair S, 2018, SEMIN IMMUNOPATHOL, V40, P425, DOI 10.1007/s00281-018-0680-2
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200
   Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272
   Nour AM, 2014, TRENDS CELL BIOL, V24, P449, DOI 10.1016/j.tcb.2014.03.006
   Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461
   Ohshima K, 2001, CLIN EXP IMMUNOL, V123, P481, DOI 10.1046/j.1365-2249.2001.01461.x
   Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068
   Ouyang YS, 2016, PLACENTA, V47, P86, DOI 10.1016/j.placenta.2016.09.008
   Oz HS, 2017, J PEDIAT INF DIS-GER, V12, P202, DOI 10.1055/s-0037-1603942
   Persson G, 2017, IMMUNOGENETICS, V69, P581, DOI 10.1007/s00251-017-0988-4
   Phillips TA, 1999, J IMMUNOL, V162, P6053
   Piccinni MP, 2002, AM J REPROD IMMUNOL, V47, P289, DOI 10.1034/j.1600-0897.2002.01104.x
   Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682
   Pleet ML, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01765
   Pongcharoen S, 2004, PLACENTA, V25, P321, DOI 10.1016/j.placenta.2003.08.020
   PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762
   Raab-Traub N, 2017, NAT REV MICROBIOL, V15, P559, DOI 10.1038/nrmicro.2017.60
   Raghupathy R, 2000, HUM REPROD, V15, P713, DOI 10.1093/humrep/15.3.713
   Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199
   Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991
   Renneberg H, 1997, PROSTATE, V30, P98, DOI 10.1002/(SICI)1097-0045(19970201)30:2<98::AID-PROS5>3.0.CO;2-G
   Rindsjo E, 2007, HUM PATHOL, V38, P468, DOI 10.1016/j.humpath.2006.09.009
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   ROBERTS JM, 1992, IMMUNOLOGY, V75, P202
   Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802
   Robertson SA, 2009, BIOL REPROD, V80, P1036, DOI 10.1095/biolreprod.108.074658
   Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06
   Rodrigues ML, 2014, J PROTEOMICS, V97, P177, DOI 10.1016/j.jprot.2013.04.001
   Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001
   Runic R, 1996, J CLIN ENDOCR METAB, V81, P3119, DOI 10.1210/jc.81.8.3119
   Sabatte J, 2011, MICROBES INFECT, V13, P977, DOI 10.1016/j.micinf.2011.06.005
   Sadeghipour S, 2017, SEMIN CELL DEV BIOL, V67, P91, DOI 10.1016/j.semcdb.2017.03.005
   Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x
   Salomon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098667
   Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seferovic MD, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.04.036
   Shayda Hemmati, 2009, J Reprod Infertil, V10, P177
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shih JC, 2006, HUM REPROD, V21, P1299, DOI 10.1093/humrep/dei489
   Shimoda A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18346
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   SKIBINSKI G, 1992, AM J REPROD IMMUNOL, V28, P97, DOI 10.1111/j.1600-0897.1992.tb00767.x
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith AJ, 2003, TRAFFIC, V4, P302, DOI 10.1034/j.1600-0854.2003.00084.x
   Song H, 2006, CELL IMMUNOL, V239, P22, DOI 10.1016/j.cellimm.2006.03.002
   Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90
   Stenqvist AC, 2013, J IMMUNOL, V191, P5515, DOI 10.4049/jimmunol.1301885
   Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x
   STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0
   Stinson LF, 2017, CRIT REV MICROBIOL, V43, P352, DOI 10.1080/1040841X.2016.1211088
   Surve MV, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005816
   Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536
   Svinarich DM, 1997, AM J REPROD IMMUNOL, V38, P252
   Szempruch AJ, 2016, CELL, V164, P246, DOI 10.1016/j.cell.2015.11.051
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tannetta D, 2017, PLACENTA, V52, P134, DOI 10.1016/j.placenta.2016.11.008
   Tannetta D, 2017, J REPROD IMMUNOL, V119, P98, DOI 10.1016/j.jri.2016.08.008
   Tarazona R, 2011, IMMUNOBIOLOGY, V216, P41, DOI 10.1016/j.imbio.2010.03.002
   Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854
   Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855
   Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   Tong M, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00174
   Tong M, 2016, HUM REPROD, V31, P687, DOI 10.1093/humrep/dew004
   Tripathi P, 2006, TISSUE ANTIGENS, V67, P207, DOI 10.1111/j.1399-0039.2005.00550.x
   Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317
   Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199
   Uckan D, 1997, MOL HUM REPROD, V3, P655, DOI 10.1093/molehr/3.8.655
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   van der Meer A, 2004, MOL HUM REPROD, V10, P189, DOI 10.1093/molehr/gah032
   Vdovikova S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00154
   Vianna P, 2011, MED HYPOTHESES, V77, P188, DOI 10.1016/j.mehy.2011.04.007
   Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347
   von Rango U, 2003, FERTIL STERIL, V79, P1176, DOI 10.1016/S0015-0282(02)04829-X
   Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026
   WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8
   Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z
   Wu HX, 2014, CELL MOL IMMUNOL, V11, P253, DOI 10.1038/cmi.2013.67
   Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066
   Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
   Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005
   Zenclussen AC, 2002, AM J REPROD IMMUNOL, V48, P245, DOI 10.1034/j.1600-0897.2002.01136.x
   Zenclussen AC, 2013, AM J REPROD IMMUNOL, V69, P291, DOI 10.1111/aji.12097
   Zhang WC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00090
   Zhang YW, 2017, SCI REP-UK, V7, DOI [10.1038/srep44269, 10.1038/s41598-017-11514-4]
   Zhou WS, 2019, EMERG MICROBES INFEC, V8, P307, DOI 10.1080/22221751.2019.1578188
NR 236
TC 5
Z9 5
U1 3
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD AUG
PY 2019
VL 5
IS 8
AR e02355
DI 10.1016/j.heliyon.2019.e02355
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IV6PV
UT WOS:000484391200083
PM 31592031
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wasinpiyamongkol, L
   Kanchanaphum, P
AF Wasinpiyamongkol, Ladawan
   Kanchanaphum, Panan
TI Isolating and identifying fungi to determine whether their biological
   properties have the potential to control the population density of
   mosquitoes
SO HELIYON
LA English
DT Article
DE Microbiology; Zoology; Biological control; Entomopathogenic fungi;
   Mosquito
ID CAPPED SELENIUM NANOWIRES; METARHIZIUM-ANISOPLIAE; AEDES-AEGYPTI;
   IN-VITRO; PATHOGENS; TOXICITY; VECTORS; ADULT
AB Mosquitoes transmit diseases such as dengue, chikungunya, Zika, and yellow fever to humans. Biological control methods are required for these insects because they can be environmentally friendlier, safer, and more cost-effective than chemical or physical methods currently available. The aim of this research is to identify fungi found in mosquito breeding containers that have the potential to control the population density of mosquitoes.
   For the identification, water samples were taken from mosquito breeding containers situated in seven districts of Bangkok to obtain pure cultures. Deoxyribonucleic acid (DNA) was extracted from the cultures then sent for sequencing and analyzing. The results show that fourteen strains of fungi were isolated. The most common strain found was Aspergillus spp., which was present in 31 of the 78 fungi samples. The strains Metarhizium anisopliae and Penicilium citrinum were found to be interesting because they may have the potential to act as entomopathogenic fungi. The biological properties of these strains should be further investigated because they could help in the fight against mosquito-borne diseases.
C1 [Wasinpiyamongkol, Ladawan] Rangsit Univ, Fac Sci, Microbiol Unit, Pathum Thani, Thailand.
   [Kanchanaphum, Panan] Rangsit Univ, Fac Sci, Biochem Unit, Pathum Thani, Thailand.
RP Kanchanaphum, P (corresponding author), Rangsit Univ, Fac Sci, Biochem Unit, Pathum Thani, Thailand.
EM panan.k@rsu.ac.th
FU Research Institute of Rangsit University, Thailand [63/2560]
FX This work was supported by a grant from Research Institute of Rangsit
   University, Thailand (Grant no. 63/2560).
CR Abinaya M, 2019, J PHOTOCH PHOTOBIO B, V192, P55, DOI 10.1016/j.jphotobiol.2019.01.009
   Agarwala S. P., 1999, Journal of Communicable Diseases, V31, P193
   AGUDELOSILVA F, 1984, J INVERTEBR PATHOL, V43, P435, DOI 10.1016/0022-2011(84)90094-6
   [Anonymous], 1995, STAND METH EX WAT WA
   BAY EC, 1967, WHO CHRON, V21, P415
   Bellow T. S., 1999, HDB BIOL CONTROL PRI
   Chareonviriyaphap Theeraphap, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P529
   Colin K. C., 2013, IDENTIFICATION PATHO
   Davise H. L., 2002, MED IMPORTANT FUNGI
   Dejene G., 2015, INTERDISCIPL PERSPEC
   Doggett MS, 2000, APPL ENVIRON MICROB, V66, P1249, DOI 10.1128/AEM.66.3.1249-1251.2000
   Dutta P, 2010, J ENVIRON BIOL, V31, P695
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   Forattini O. P., 2002, CULICIDOLOGIA MED ID, V2, p860p
   Frazzon APG, 2000, VET PARASITOL, V94, P117, DOI 10.1016/S0304-4017(00)00368-X
   Haq S., 1992, Indian Journal of Malariology, V29, P113
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI 10.2217/FMB.10.11
   Lichtwardt R. W., 1986, TRICHOMYCETES FUNGAL, p343p
   Lichtwardt R.W., 1986, TRICHOMYCETES FUNGAL
   Lichtwardt RW, 2003, FUNG DIVERS RES SER, V10, P81
   Lichtwardt RW, 2001, TRICHOMYCETES FUNGAL
   Lu Y, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/382742
   Maketon M, 2014, WORLD J MICROB BIOT, V30, P727, DOI 10.1007/s11274-013-1500-4
   Marcombe S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3187-8
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Misra JK, 1998, SYMBIOSIS, V24, P179
   Mnyone LL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-246
   Pereira ED, 2005, NEOTROP ENTOMOL, V34, P325, DOI 10.1590/S1519-566X2005000200022
   Pereira VJ, 2010, WATER RES, V44, P4850, DOI 10.1016/j.watres.2010.07.018
   Piasecka B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003476
   Pitt J. I., 1997, FUNGI FOOD SPOILAGE
   Rekha R, 2019, J TRACE ELEM MED BIO, V51, P191, DOI 10.1016/j.jtemb.2018.10.017
   RIBA G, 1986, J AM MOSQUITO CONTR, V2, P469
   Samson RA, 2004, INTRO FOOD AIRBORNE
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011
   SHARMA V P, 1986, Indian Journal of Malariology, V23, P95
   Smith D Scott, 2010, Perm J, V14, P85
   Tajedin L, 2009, IRAN J ARTHROPOD-BOR, V3, P36
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   Yazhiniprabha M, 2019, J PHOTOCH PHOTOBIO B, V192, P158, DOI 10.1016/j.jphotobiol.2019.01.014
NR 42
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD AUG
PY 2019
VL 5
IS 8
AR e02331
DI 10.1016/j.hcliyon.2019.e02331
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IV6PV
UT WOS:000484391200114
PM 31508522
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Walteros, DM
   Soares, J
   Styczynski, AR
   Abrams, JY
   Galindo-Buitrago, JI
   Acosta-Reyes, J
   Bravo-Ribero, E
   Arteta, ZE
   Solano-Sanchez, A
   Prieto, FE
   Gonzalez-Duarte, M
   Navarro-Lechuga, E
   Salinas, JL
   Belay, ED
   Schonberger, LB
   Damon, IK
   Ospina, ML
   Sejvar, JJ
AF Walteros, Diana M.
   Soares, Jesus
   Styczynski, Ashley R.
   Abrams, Joseph Y.
   Galindo-Buitrago, Jose, I
   Acosta-Reyes, Jorge
   Bravo-Ribero, Elsa
   Arteta, Zuleima E.
   Solano-Sanchez, Alma
   Prieto, Franklyn E.
   Gonzalez-Duarte, Maritza
   Navarro-Lechuga, Edgar
   Salinas, Jorge L.
   Belay, Ermias D.
   Schonberger, Lawrence B.
   Damon, Inger K.
   Ospina, Martha L.
   Sejvar, James J.
TI Long-term outcomes of Guillain-Barre syndrome possibly associated with
   Zika virus infection
SO PLOS ONE
LA English
DT Article
ID QUALITY-OF-LIFE; MORTALITY; VALIDATION; DISABILITY; DEPRESSION;
   EXPERIENCE; PROGNOSIS; DIAGNOSIS; COLOMBIA; ADULTS
AB Background
   This prospective cohort investigation analyzed the long-term functional and neurologic outcomes of patients with Zika virus-associated Guillain-Barre syndrome (GBS) in Barranquilla, Colombia.
   Methods
   Thirty-four Zika virus-associated GBS cases were assessed a median of 17 months following acute GBS illness. We assessed demographics, results of Overall Disability Sum Scores (ODSS), Hughes Disability Score (HDS), Zung Depression Scale (ZDS), and Health Related Quality of Life (HRQL) questionnaires; and compared outcomes indices with a normative sample of neighborhood-selected control subjects in Barranquilla without GBS.
   Results
   Median age at time of acute neurologic onset was 49 years (range, 10-80); 17 (50%) were male. No deaths occurred. At long-term follow-up, 25 (73%) patients had a HDS 0-1, indicating complete / near complete recovery. Among the group, HDS (mean 1.4, range 0-4), ODSS (mean 1.9, range 0-9) and ZDS score (mean 34.4, range 20-56) indicated mild / moderate ongoing disability. Adjusting for age and sex, Zika virus-associated GBS cases were similar to a population comparison group (n = 368) in Barranquilla without GBS in terms of prevalence of physical or mental health complaints, though GBS patients were more likely to have an ODSS of >= 1 (OR 8.8, 95% CI 3.2-24.5) and to suffer from moderate / moderate-severe depression (OR 3.89, 95% CI 1.23-11.17) than the comparison group.
   Conclusions
   Long-term outcomes of Zika virus-associated GBS are consistent with those associated with other antecedent antigenic stimuli in terms of mortality and ongoing long-term morbidity, as published in the literature. Persons with Zika virus-associated GBS more frequently reported disability and depression after approximately one year compared with those without GBS.
C1 [Walteros, Diana M.; Prieto, Franklyn E.; Gonzalez-Duarte, Maritza; Ospina, Martha L.] Inst Nacl Salud, Bogota, Colombia.
   [Soares, Jesus; Abrams, Joseph Y.; Belay, Ermias D.; Schonberger, Lawrence B.; Damon, Inger K.; Sejvar, James J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
   [Styczynski, Ashley R.] Stanford Univ, Dept Infect Dis, Palo Alto, CA 94304 USA.
   [Galindo-Buitrago, Jose, I] TEPHINET Inst Global Hlth, Decatur, GA USA.
   [Acosta-Reyes, Jorge; Navarro-Lechuga, Edgar] Univ Norte, Barranquilla, Colombia.
   [Bravo-Ribero, Elsa; Arteta, Zuleima E.; Solano-Sanchez, Alma] Secretaria Salud Barranquilla, Barranquilla, Colombia.
   [Salinas, Jorge L.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA.
RP Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
EM zea3@cdc.gov
RI Acosta-Reyes, Jorge/D-1906-2011; Galindo-Buitrago, Jose
   Israel/R-1399-2018; Soares, Jesus/D-2992-2016
OI Acosta-Reyes, Jorge/0000-0003-4303-3243; Bravo,
   Elsa/0000-0003-2985-3843; Galindo-Buitrago, Jose
   Israel/0000-0002-3790-6725; Soares, Jesus/0000-0002-8640-8618
CR Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4
   Bernsen RAJAM, 2005, ACTA NEUROL SCAND, V112, P51, DOI 10.1111/j.1600-0404.2005.00429.x
   Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9
   Cheng BC, 2003, J CLIN APHERESIS, V18, P175, DOI 10.1002/jca.10066
   Cheng Q, 2000, EUR J NEUROL, V7, P685, DOI 10.1046/j.1468-1331.2000.00128.x
   Cornblath DR, 2006, HDB CLIN NEUROPHYSIO, V7, P695
   Darweesh SKL, 2014, J PERIPHER NERV SYST, V19, P24, DOI 10.1111/jns5.12051
   Dimachkie MM, 2013, CURR TREAT OPTION NE, V15, P338, DOI 10.1007/s11940-013-0231-z
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dominguez-Moreno R, 2014, REV NEUROLOGIA, V58, P4, DOI 10.33588/rn.5801.2013370
   Farbu E, 2016, CLIN NEUROL NEUROSUR, V141, P33, DOI 10.1016/j.clineuro.2015.12.008
   FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044
   Fletcher DD, 2000, NEUROLOGY, V54, P2311, DOI 10.1212/WNL.54.12.2311
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gupta A, 2010, DISABIL REHABIL, V32, P1897, DOI 10.3109/09638281003734474
   HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   Merkies ISJ, 2006, J NEUROL NEUROSUR PS, V77, P970, DOI 10.1136/jnnp.2005.076174
   Merkies ISJ, 2016, EUR NEUROL, V75, P199, DOI 10.1159/000445347
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Rees JH, 1998, J NEUROL NEUROSUR PS, V64, P74, DOI 10.1136/jnnp.64.1.74
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Soysal A, 2011, ACTA NEUROL SCAND, V123, P181, DOI 10.1111/j.1600-0404.2010.01366.x
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   US Centers for Disease Control and Prevention, 2000, MEASURING HEALTHY DA
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8
   Walling AD, 2013, AM FAM PHYSICIAN, V87, P191
   Wang Y, 2017, ONCOTARGET, V8, P79991, DOI 10.18632/oncotarget.20620
   Wei JCC, 2018, INT J RHEUM DIS, V21, P1443, DOI 10.1111/1756-185X.12973
   Wong AHY, 2014, J NEUROL SCI, V344, P60, DOI 10.1016/j.jns.2014.06.021
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004
NR 40
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 1
PY 2019
VL 14
IS 8
AR e0220049
DI 10.1371/journal.pone.0220049
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW4ZH
UT WOS:000484987900021
PM 31369576
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pardy, RD
   Richer, MJ
AF Pardy, Ryan D.
   Richer, Martin J.
TI Protective to a T: The Role of T Cells during Zika Virus Infection
SO CELLS
LA English
DT Review
DE zika virus; flaviviruses; T cells; host-pathogen interactions
ID DENDRITIC CELLS; I INTERFERON; RESPONSES; IMMUNOPATHOLOGY; BRAIN; MODEL
AB CD4 and CD8 T cells are an important part of the host's capacity to defend itself against viral infections. During flavivirus infections, T cells have been implicated in both protective and pathogenic responses. Given the recent emergence of Zika virus (ZIKV) as a prominent global health threat, the question remains as to how T cells contribute to anti-ZIKV immunity. Furthermore, high homology between ZIKV and other, co-circulating flaviviruses opens the possibility of positive or negative effects of cross-reactivity due to pre-existing immunity. In this review, we will discuss the CD4 and CD8 T cell responses to ZIKV, and the lessons we have learned from both mouse and human infections. In addition, we will consider the possibility of whether T cells, in the context of flavivirus-naive and flavivirus-immune subjects, play a role in promoting ZIKV pathogenesis during infection.
C1 [Pardy, Ryan D.; Richer, Martin J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
   [Pardy, Ryan D.; Richer, Martin J.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada.
RP Richer, MJ (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.; Richer, MJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada.
EM martin.j.richer@mcgill.ca
OI Pardy, Ryan/0000-0002-0024-8888
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [PJT-152903, PJT-162212]; Natural Sciences and
   Engineering Research CouncilNatural Sciences and Engineering Research
   Council of Canada [RGPIN-2016-04713]; Fonds de Recherche du
   Quebec-SanteFonds de la Recherche en Sante du Quebec [32807]; Canada
   Foundation for InnovationCanada Foundation for Innovation; Canadian
   Institutes of Health ResearchCanadian Institutes of Health Research
   (CIHR)
FX The Richer Lab is funded by the Canadian Institutes of Health Research,
   grant number PJT-152903 and PJT-162212; the Natural Sciences and
   Engineering Research Council, grant number RGPIN-2016-04713; Fonds de
   Recherche du Quebec-Sante, grant number 32807; and the Canada Foundation
   for Innovation. R. D. P is supported by the Frederick Banting and
   Charles Best Canada Graduate Scholarships-Doctoral Award from the
   Canadian Institutes of Health Research.
CR Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edupuganti S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx133
   El Sahly HM, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy352
   Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Halstead SB, 2014, ANTIBODY FC: LINKING ADAPTIVE AND INNATE IMMUNITY, P333
   Herrera BB, 2018, MBIO, V9, DOI [10.1128/mBio.00755-18, 10.1128/mbio.00755-18]
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Klenerman P, 1998, NATURE, V394, P482
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pedras-Vasconcelos JA, 2008, J IMMUNOL, V180, P8231, DOI 10.4049/jimmunol.180.12.8231
   Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023
   Schmidt ME, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006810
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Slater J., 2018, INDIA WRESTLES 1 SIG
   Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129
   Swati G., 2018, ZIKA SPREADS RAPIDLY
   Valbon SF, 2016, CYTOKINE, V82, P16, DOI 10.1016/j.cyto.2015.11.013
   Waggoner JJ, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx103
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu YH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006848
NR 66
TC 3
Z9 3
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG
PY 2019
VL 8
IS 8
AR 820
DI 10.3390/cells8080820
PG 11
WC Cell Biology
SC Cell Biology
GA IV8TI
UT WOS:000484537500053
PM 31382545
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Medone, P
   Hernandez-Suarez, CM
AF Medone, Paula
   Hernandez-Suarez, Carlos M.
TI "Swimming mosquitoes': a key stepping stone to prevent Dengue, Zika and
   Chikungunya: an educative experience in Colima, Mexico
SO HEALTH EDUCATION RESEARCH
LA English
DT Article
ID SOCIAL DETERMINANTS; VECTOR CONTROL; AEDES-AEGYPTI; MULTICOUNTRY;
   DYNAMICS; URBAN
AB Dengue, Zika and Chikungunya arboviruses (DZC), mainly transmitted by mosquito Aedes aegypti, are global health public issues affecting 390 million people each year. In most endemic countries, vector control strategies have been focused on reducing breeding sites and adult mosquito populations. Most health communication strategies have pointed out adult mosquito as the main responsible of the transmission, persuading people to eliminate domestic containers. However, it is not clear how should people understand the relationship between adult mosquitoes and water domestic containers. So, the main goal of the present study was to assess the people understanding of this relationship. Results showed that most people associate adult mosquitoes with DZC, but only few could associate swimming larvae with mosquitoes. The unawareness of larva presence leads to an underestimation of risk perception about DZC transmission. In this context, we consider that educative interventions for health promotion, based on meaningful knowledge and social representations arise as long-term strategies to control transmission of vector-borne diseases. Here, we propose innovative health strategies focused on increase the risk perception about swimming larvae, considering social representations, which may be a key stepping stone to increase people adherence to massive campaigns and reducing DZC burden.
C1 [Medone, Paula] Direcc Desarrollo Gest Calidad Educ, Secretaria Educ, Av Gonzalo de Sandoval 760, Los Viboras 28040, Colima, Mexico.
   [Hernandez-Suarez, Carlos M.] Univ Colima, Fac Ciencias, Bernal Diaz del Castillo 340, Col Villas San Sebastian 28040, Colima, Mexico.
RP Medone, P (corresponding author), Direcc Desarrollo Gest Calidad Educ, Secretaria Educ, Av Gonzalo de Sandoval 760, Los Viboras 28040, Colima, Mexico.
EM paulamedone@gmail.com
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Andersson N, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4289-5
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Assis SS, 2014, REV BRAS PESQUI ED C, V13, P25
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonchutima S, 2017, J INFECT PUBLIC HEAL, V10, P836, DOI 10.1016/j.jiph.2017.01.016
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732
   Dans AL, 2018, J CLIN EPIDEMIOL, V95, P137, DOI 10.1016/j.jclinepi.2017.11.019
   Espinoza Gomez F, 2001, Rev Panam Salud Publica, V10, P6, DOI 10.1590/S1020-49892001000700002
   Frank AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005755
   Garelli F, 2017, INTERFACE-BOTUCATU, V21, P35, DOI 10.1590/1807-57622015.0965
   George L. S., 2017, KERALA INT J COMMUN, V4, P962, DOI 10.18203/2394-6040.ijcmph20170984
   Hernandez-Suarez CM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.28026
   Hoyos RC, 2006, REV SAUDE PUBL, V40, P126, DOI 10.1590/S0034-89102006000100020
   Lopez Arellano O, 2008, MED SOCIAL, V3, P323, DOI DOI 10.17162/RCCS.V7I1.992
   Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x
   Madeira Newton G., 2002, Rev. Soc. Bras. Med. Trop., V35, P221, DOI 10.1590/S0037-86822002000300004
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3
   Mendoza-Cano O, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080890
   Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67
   National Institute Of Statistics and Geography (INEGI), 2015, INT SURV TAB DAT
   Pan American Health Organization, HLTH INF PLATF AM
   Rather IA, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00336
   Ritchie SA, 2017, J INFECT DIS, V215, pS103, DOI 10.1093/infdis/jiw575
   SINAVE/ DGE/ Salud, 2016, PREL INF CONF DENG C
   SINAVE/ DGE/ Salud, 2015, PREL INF CONF DENG C
   SINAVE/ DGE/ SALUD/, SPEC SYST DENG EP SU
   Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P10, DOI 10.1179/2046904712Z.00000000047
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   WHO, 2011, COMPR GUID PREV CONT
NR 34
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1153
EI 1465-3648
J9 HEALTH EDUC RES
JI Health Educ. Res.
PD AUG
PY 2019
VL 34
IS 4
BP 389
EP 399
DI 10.1093/her/cyz012
PG 11
WC Education & Educational Research; Public, Environmental & Occupational
   Health
SC Education & Educational Research; Public, Environmental & Occupational
   Health
GA IV6IQ
UT WOS:000484372500003
PM 31329869
DA 2020-07-08
ER

PT J
AU Barbeito, C
   Andres, JB
   Ferreira, J
   Cristofolini, A
   Fiorimanti, M
   Higa, L
   Bellio, M
   Tanuri, A
   Merkis, C
   Cebral, E
   Garcez, P
AF Barbeito, Claudio
   Barbeito Andres, Jimena
   Ferreira, Jessica
   Cristofolini, Andrea
   Fiorimanti, Mariana
   Higa, Luiza
   Bellio, Maria
   Tanuri, Amilcar
   Merkis, Cecilia
   Cebral, Elisa
   Garcez, Patricia
TI MORPHOLOGICAL LESIONS CAUSED BY ZIKV INFECTION IN THE PLACENTA OF
   UNDERNOURISHED MOUSE DAMS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Barbeito, Claudio] Natl Univ La Plata, Fac Vet Sci, Buenos Aires, DF, Argentina.
   [Barbeito, Claudio; Cebral, Elisa] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
   [Barbeito Andres, Jimena] Consejo Nacl Invest Cient & Tecn, Inst Studies Neurosci & Complex Syst Studies, ENyS, Buenos Aires, DF, Argentina.
   [Ferreira, Jessica; Garcez, Patricia] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Cristofolini, Andrea; Fiorimanti, Mariana; Merkis, Cecilia] Natl Univ Rio Cuarto, Fac Agron & Vet Sci, Electron Microscopy Lab, Rio Cuarto, Argentina.
   [Cristofolini, Andrea; Fiorimanti, Mariana] Consejo Nacl Invest Cient & Tecn, Cordoba, Argentina.
   [Higa, Luiza; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Brazil.
   [Bellio, Maria] Univ Fed Rio de Janeiro, Microbiol Inst Paulo de Goes, Rio De Janeiro, Brazil.
   [Cebral, Elisa] Univ Buenos Aires, Inst Biodivers & Expt Biol & Appl IBBEA, CONICET, Dept Biodivers & Expt Biol,Fac Exact & Nat Sci FC, Buenos Aires, DF, Argentina.
RI Barbeito, Claudio/AAM-5227-2020
OI Barbeito, Claudio/0000-0001-9459-138X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P2.5
BP E67
EP E67
DI 10.1016/j.placenta.2019.06.217
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500215
DA 2020-07-08
ER

PT J
AU Braga, S
   Borbely, A
AF Braga, Sefora
   Borbely, Alexandre
TI PREVIOUS ZIKA VIRUS INFECTION IS A RISK-FACTOR TO POSTERIOR PREGNANCY:
   AN EPIDEMIOLOGICAL STUDY IN ALAGOAS STATE, NORTHEASTERN BRAZIL
   (2016-2019)
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Braga, Sefora; Borbely, Alexandre] Univ Fed Alagoas, Inst Hlth & Biol Sci, Cell Biol Lab, Maceio, Brazil.
FU  [06/2016: 60030 000819/2016]
FX PPSUS/Decit/MS/CNPq/SESAU-AL/FAPEAL n.06/2016: 60030 000819/2016
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P1.45
BP E30
EP E31
DI 10.1016/j.placenta.2019.06.102
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500101
DA 2020-07-08
ER

PT J
AU Branco, ACC
   Oliveira, LMDS
   Yoshikawa, FSY
   Pietrobom, AJ
   Neto, AND
   Sato, MN
AF Castelo Branco, Anna Claudia
   da Silva Oliveira, Luanda Mara
   Yamada Yoshikawa, Fabio Seiti
   Pietrobom, Anna Julia
   Duarte Neto, Amaro Nunes
   Sato, Maria Notomi
TI EVALUATION OF HUMAN PLACENTAL VILLI INFLAMMATION VIA TLR4 ACTIVATION
   DURING ZIKA VIRUS INFECTION
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Castelo Branco, Anna Claudia; da Silva Oliveira, Luanda Mara; Yamada Yoshikawa, Fabio Seiti; Pietrobom, Anna Julia; Sato, Maria Notomi] Univ Sao Paulo, Sao Paulo, Brazil.
   [Duarte Neto, Amaro Nunes] Univ Sao Paulo, Clin Hosp, Sao Paulo, Brazil.
RI Sato, Maria N/C-1196-2012
OI Sato, Maria N/0000-0002-7911-1824
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P2.80
BP E92
EP E92
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500290
DA 2020-07-08
ER

PT J
AU Costa, ML
   Nobrega, GD
   Samogim, AP
   Venceslau, EM
   Guida, JPD
   Tavares, AA
   Japecanga, RR
   Amaral, E
   Modena, JLP
AF Costa, Maria Laura
   Nobrega, Guilherme de Moraes
   Samogim, Ana Paula
   Venceslau, Emanuella Meneses
   de Siqueira Guida, Jose Paulo
   Tavares, Arthur Antolini
   Japecanga, Rodolfo Rosa
   Amaral, Eliana
   Proenca Modena, Jose Luiz
TI PLACENTAL CHARACTERIZATION OF ZIKA VIRUS INFECTION DURING 2016 OUTBREAK
   IN CAMPINAS/SP - BRAZIL
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Costa, Maria Laura; Venceslau, Emanuella Meneses; de Siqueira Guida, Jose Paulo; Tavares, Arthur Antolini; Japecanga, Rodolfo Rosa; Amaral, Eliana] Univ Estadual Campinas, CAISM, UNICAMP, Womens Hosp Prof Dr Jose Aristodemo Pinotti, Campinas, SP, Brazil.
   [Nobrega, Guilherme de Moraes; Samogim, Ana Paula; Proenca Modena, Jose Luiz] Univ Estadual Campinas, Inst Biol, UNICAMP, Dept Genet Evolut Microbiol & Immunol, Campinas, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P1.81
BP E42
EP E42
DI 10.1016/j.placenta.2019.06.138
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500137
DA 2020-07-08
ER

PT J
AU Molas, RB
   Ribeiro, MR
   Oliani, DCMV
   Oliani, AH
   Nadkarni, S
   Nogueira, ML
   Moreli, JB
   Oliani, SM
AF Molas, Rafaela Batista
   Ribeiro, Milene Rocha
   Vaz Oliani, Denise C. M.
   Oliani, Antonio Helio
   Nadkarni, Suchita
   Nogueira, Mauricio Lacerda
   Moreli, Jusciele Brogin
   Oliani, Sonia Maria
TI THE INVOLVEMENT OF ANNEXIN A1 IN HUMAN PLACENTAL RESPONSE TO MATERNAL
   ZIKA VIRUS INFECTION
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Molas, Rafaela Batista; Ribeiro, Milene Rocha; Oliani, Sonia Maria] Sao Paulo State Univ UNESP, Dept Biol, Sch Biosci Humanities & Exact Sci, Sao Jose Do Rio Preto, Brazil.
   [Vaz Oliani, Denise C. M.; Oliani, Antonio Helio] Sao Jose do Rio Preto Sch Med FAMERP, Dept Gynecol & Obstet, Sao Jose Do Rio Preto, Brazil.
   [Nadkarni, Suchita] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England.
   [Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Sch Med FAMERP, Dept Dermatol Infect & Parasit Dis, Sao Jose Do Rio Preto, Brazil.
   [Moreli, Jusciele Brogin] Fed Univ Sao Paulo UNIFESP, Postgrad Struct & Funct Biol, Sao Paulo, Brazil.
   [Moreli, Jusciele Brogin] Faceres Sch Med, Sao Jose Do Rio Preto, Brazil.
RI Nogueira, Mauricio L/B-7599-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P1.80
BP E42
EP E42
DI 10.1016/j.placenta.2019.06.137
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500136
DA 2020-07-08
ER

PT J
AU De Freitas, RCM
   Santos, ACM
   De Brito, WI
AF Moraes De Freitas, Rogerio Caixeta
   Magalhaes Santos, Annie Caroline
   De Brito, Wagner Izidoro
TI VERTICAL TRANSMISSION OF ZIKA VIRUS AND PERINATAL MICROCEPHALY
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Moraes De Freitas, Rogerio Caixeta; Magalhaes Santos, Annie Caroline; De Brito, Wagner Izidoro] Univ Hosp Julio Muller, Cuiaba, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P1.74
BP E40
EP E40
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500130
DA 2020-07-08
ER

PT J
AU Rabelo, K
   de Souza, LJ
   Salomao, NG
   Machado, LN
   Pereira, PG
   Portari, EA
   Basilio-de-Oliveira, R
   de Carvalho, JJ
   Paes, MV
AF Rabelo, Kissila
   de Souza, Luiz Jose
   Salomao, Natalia Gedeao
   Machado, Lara Nascentes
   Pereira, Priscila Gomes
   Portari, Elyzabeth Avvad
   Basilio-de-Oliveira, Rodrigo
   de Carvalho, Jorge Jose
   Paes, Marciano Viana
TI ZIKA VIRUS AND PLACENTA: HISTOPATHOLOGICAL INVESTIGATION, INFLAMMATORY
   PROFILE AND ULTRASTRUCTURAL ANALYSIS IN GESTATIONS RESULTING IN CASES OF
   MICROCEPHALY OR NOT
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Rabelo, Kissila; Pereira, Priscila Gomes; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [de Souza, Luiz Jose; Machado, Lara Nascentes] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [Salomao, Natalia Gedeao; Paes, Marciano Viana] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Portari, Elyzabeth Avvad] Inst Fernandes Figueira Fiocruz, Anat Patol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Rodrigo] Univ Fed Estado Rio de Janeiro, Anat Patol, Rio De Janeiro, Brazil.
OI Paes, Marciano/0000-0002-2266-2801; Rabelo, Kissila/0000-0001-7579-7788;
   Carvalho, Jorge/0000-0002-9426-6381
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P1.77
BP E41
EP E41
DI 10.1016/j.placenta.2019.06.134
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500133
DA 2020-07-08
ER

PT J
AU Vota, D
   Paparini, D
   Torti, F
   Merech, F
   Hauk, V
   Giovannoni, F
   Calo, G
   Ramhorst, R
   Garcia, C
   Leiros, CP
AF Vota, Daiana
   Paparini, Daniel
   Torti, Florencia
   Merech, Fatima
   Hauk, Vanesa
   Giovannoni, Federico
   Calo, Guillermina
   Ramhorst, Rosanna
   Garcia, Cybele
   Perez Leiros, Claudia
TI IMPAIRMENT OF FIRST-TRIMESTER TROPHOBLAST CELL FUNCTION BY ZIKV
   INFECTION. ROLE OF VIP IN THE TROPHOBLAST RESPONSE TO THE VIRUS.
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 21-24, 2018
CL Tokyo, JAPAN
SP Int Federat Placenta Assoc
C1 [Vota, Daiana; Paparini, Daniel; Merech, Fatima; Hauk, Vanesa; Calo, Guillermina; Ramhorst, Rosanna; Perez Leiros, Claudia] Univ Buenos Aires, Fac Exactas & Nat IQUIBICEN, Inst Quim Biol, Lab Inmunofarmacol,CONICET, Buenos Aires, DF, Argentina.
   [Torti, Florencia; Giovannoni, Federico; Garcia, Cybele] Univ Buenos Aires, Fac Exactas & Nat IQUIBICEN, Inst Quim Biol, Lab Estrategias Antivirales,CONICET, Buenos Aires, DF, Argentina.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD AUG
PY 2019
VL 83
MA P2.70
BP E89
EP E89
DI 10.1016/j.placenta.2019.06.282
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA IV0WE
UT WOS:000483998500280
DA 2020-07-08
ER

PT J
AU Williams, T
   Farfan, JL
   Mercado, G
   Valle, J
   Abella, A
   Marina, CF
AF Williams, Trevor
   Farfan, Juan L.
   Mercado, Gabriel
   Valle, Javier
   Abella, Antonio
   Marina, Carlos F.
TI Efficacy of Spinosad Granules and Lambda-Cyhalothrin Contrasts with
   Reduced Performance of Temephos for Control of Aedes spp. in Vehicle
   Tires in Veracruz, Mexico
SO INSECTS
LA English
DT Article
DE mosquito; vector control; larvicide; automotive tires; arbovirus; Aedes;
   Culex; Toxorhynchites; oviposition
ID NATURALLY DERIVED INSECTICIDE; AEGYPTI DIPTERA-CULICIDAE; VECTOR
   COMPETENCE; MOSQUITOS DIPTERA; CULEX-PIPIENS; RESISTANCE; ALBOPICTUS;
   TRISERIATUS; POPULATIONS; RELEASE
AB The present study examined the efficacy of lambda-cyhalothrin, pyriproxyfen and granular formulations of spinosad and temephos for the control of mosquito larvae present in experimental tires in Veracruz State, Mexico in the period 2015-2016. Both lambda-cyhalothrin and spinosad granules provided control of larvae and pupae of Aedes aegypti, Ae. albopictus and Culex spp. in used tires in Veracruz State, Mexico, over a 9-12 week period, although numbers of Culex were low. The numbers of Aedes larvae + pupae in pyriproxyfen and temephos-treated tires were slightly less than half of the untreated control tires, probably a result the pupicidal characteristics of pyriproxyfen and possible resistance in the case of temephos. Spinosad was less harmful to predatory Toxorhynchites spp. than lambda-cyhalothrin or temephos. The reduced susceptibility to temephos in Aedes populations was confirmed at five other sites in Veracruz. Public health authorities should consider incorporating spinosad as a larvicide in coastal areas at a high risk of dengue, chikungunya and Zika outbreaks in this region.
C1 [Williams, Trevor; Farfan, Juan L.; Mercado, Gabriel] Inst Ecol AC INECOL, Xalapa 91073, Veracruz, Mexico.
   [Valle, Javier] El Colegio Frontera Sur ECOSUR, Tapachula 30700, Chiapas, Mexico.
   [Abella, Antonio] Univ Nacl Autonoma Mexico, Dept Etol, Fauna Silvestre & Anim Lab FMVZ, Mexico City 04510, DF, Mexico.
   [Marina, Carlos F.] Ctr Reg Invest Salud Publ INSP, Tapachula 30700, Chiapas, Mexico.
RP Williams, T (corresponding author), Inst Ecol AC INECOL, Xalapa 91073, Veracruz, Mexico.
EM trevor.williams@inecol.mx
RI Williams, Trevor/F-1447-2011
OI Williams, Trevor/0000-0003-3414-3440
FU CONACYT-FOSISSS project [2012-180201]; CONACYTConsejo Nacional de
   Ciencia y Tecnologia (CONACyT)
FX This research was funded by CONACYT-FOSISSS project number 2012-180201
   awarded to C. F. M. and an Ayudante de Investigador Nivel III student
   stipend to J.L.F. from CONACYT.
CR Albeny-Simoes D, 2014, OECOLOGIA, V175, P481, DOI 10.1007/s00442-014-2910-1
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Alsobhi A. S., 2016, Asian Pacific Journal of Tropical Disease, V6, P533, DOI 10.1016/S2222-1808(16)61083-6
   [Anonymous], 2008, IARC SCI PUBL, VIX, P1, DOI DOI 10.1007/978-3-642-85851-2
   Antonio GE, 2009, PEST MANAG SCI, V65, P323, DOI 10.1002/ps.1683
   Ardila-Roldan S, 2013, BIOMEDICA, V33, P446, DOI 10.7705/biomedica.v33i3.1534
   Beltran-Silva S. L., 2018, REV MED HOSP GEN MEX, V81, P146, DOI [10.1016/j.hgmx.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   Bond JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187420
   Bond JG, 2004, MED VET ENTOMOL, V18, P50, DOI 10.1111/j.0269-283X.2004.0480.x
   Britch SC, 2018, J AM MOSQUITO CONTR, V34, P58, DOI 10.2987/17-6692.1
   CARPENTER SJ, 1955, MOSQUITOES N AM N ME, P360
   *CDC, W NIL VIR
   CENAPRECE Centro Nacional de Programas Preventivos y Control de Enfermedades, LIST PROD REC COMB I
   Centro Nacional de Programas Preventivos y Control de Enfermedades, LIST PROD REC COMB I
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Chino-Cantor A, 2014, SOUTHWEST ENTOMOL, V39, P601, DOI 10.3958/059.039.0319
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88
   Dennett JA, 2003, J AM MOSQUITO CONTR, V19, P172
   Dias LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173689
   Equihua M, 2017, ACTA TROP, V166, P316, DOI 10.1016/j.actatropica.2016.11.014
   Fernandes KM, 2019, CHEMOSPHERE, V221, P464, DOI 10.1016/j.chemosphere.2019.01.068
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   FOCKS DA, 1980, ENVIRON ENTOMOL, V9, P37, DOI 10.1093/ee/9.1.37
   Fonseca E.O.L., 2019, EPIDEMIOL SERV SAUDE, V28
   Geng CX, 2013, ADV INSECT PHYSIOL, V44, P101, DOI 10.1016/B978-0-12-394389-7.00003-X
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HARAMIS LD, 1984, MOSQ NEWS, V44, P485
   Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859
   Hertlein MB, 2010, J AM MOSQUITO CONTR, V26, P67, DOI 10.2987/09-5936.1
   Instituto Nacional de Estadistica y Geografia, PAN SOC MEX
   Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546
   Kesavaraju B, 2004, ANN ENTOMOL SOC AM, V97, P194, DOI 10.1603/0013-8746(2004)097[0194:DBRTWC]2.0.CO;2
   Khan HAA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-146
   Kling LJ, 2007, J VECTOR ECOL, V32, P207, DOI 10.3376/1081-1710(2007)32[207:LMCIDV]2.0.CO;2
   Lawler SP, 2007, PEST MANAG SCI, V63, P234, DOI 10.1002/ps.1279
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marina CF, 2018, PARASITOL RES, V117, P1941, DOI 10.1007/s00436-018-5891-x
   Marina CF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-55
   Marina CF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-95
   Marina CF, 2011, PEST MANAG SCI, V67, P114, DOI [10.1002/ps.2043, 10.1002/pros.21278]
   Michaelakis A, 2020, PARASITOL INT, V74, DOI 10.1016/j.parint.2019.04.014
   MILLER JE, 1994, J MED ENTOMOL, V31, P114, DOI 10.1093/jmedent/31.1.114
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muller GC, 2010, J MED ENTOMOL, V47, P63, DOI 10.1603/033.047.0108
   Muzari OM, 2014, J MED ENTOMOL, V51, P444, DOI 10.1603/ME13141
   Narahashi T, 1996, PHARMACOL TOXICOL, V79, P1, DOI 10.1111/j.1600-0773.1996.tb00234.x
   Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406
   Nazni W. A., 2009, Dengue Bulletin, V33, P209
   Oetken M., 2004, INT REV CYTOLOGY SUR
   PAULSON SL, 1991, J AM MOSQUITO CONTR, V7, P170
   Perez CM, 2007, J MED ENTOMOL, V44, P631, DOI 10.1603/0022-2585(2007)44[631:SANDIF]2.0.CO;2
   Pettit WJ, 2010, J AM MOSQUITO CONTR, V26, P387, DOI 10.2987/09-5962.1
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   PUMPUNI CB, 1989, J AM MOSQUITO CONTR, V5, P166
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Samuel M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005837
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P398, DOI 10.2987/5697.1
   Seng CM, 2006, J AM MOSQUITO CONTR, V22, P152, DOI 10.2987/8756-971X(2006)22[152:IOAEOA]2.0.CO;2
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   STEFFAN WA, 1981, ANNU REV ENTOMOL, V26, P159, DOI 10.1146/annurev.en.26.010181.001111
   Su TY, 2014, J MED ENTOMOL, V51, P837, DOI 10.1603/ME13134
   Su TY, 2014, J MED ENTOMOL, V51, P421, DOI 10.1603/ME13173
   Sulaiman S, 1999, J VECTOR ECOL, V24, P154
   Sullivan JJ, 2008, J PESTIC SCI, V33, P339, DOI 10.1584/jpestics.R08-02
   Suman DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130499
   Suman DS, 2013, ACTA TROP, V128, P103, DOI 10.1016/j.actatropica.2013.06.025
   Thavara U, 2005, J VECTOR ECOL, V30, P62
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Walter Reed Biosystematics Unit (WRBU), KEYS MED IMP MOSQ SP
   WHO, WHO SPEC EV PUBL HLT
   World Health Organization, 2008, WHOHSEAMR080310
   World Health Organization (WHO) and the Special Programme for Research and Training in Tropical diseases (TDR), DENG GUID DIAGN TREA
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
   Yee DA, 2010, J MED ENTOMOL, V47, P53, DOI 10.1603/033.047.0107
   Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115
NR 79
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4450
J9 INSECTS
JI Insects
PD AUG
PY 2019
VL 10
IS 8
AR 242
DI 10.3390/insects10080242
PG 18
WC Entomology
SC Entomology
GA IT6KP
UT WOS:000482982800037
PM 31390780
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Prasasty, VD
   Grazzolie, K
   Rosmalena, R
   Yazid, F
   Ivan, FX
   Sinaga, E
AF Prasasty, Vivitri Dewi
   Grazzolie, Karel
   Rosmalena, Rosmalena
   Yazid, Fatmawaty
   Ivan, Fransiskus Xaverius
   Sinaga, Ernawati
TI Peptide-Based Subunit Vaccine Design of T- and B-Cells Multi-Epitopes
   against Zika Virus Using Immunoinformatics Approaches
SO MICROORGANISMS
LA English
DT Article
DE Zika virus; peptide vaccine; epitope; immunoinformatics; molecular
   docking; molecular dynamics
ID MHC CLASS-I; ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS;
   MOLECULAR-DYNAMICS; NEURAL-NETWORKS; PROTEIN MODELS; PREDICTION; HLA;
   INFECTION; EVOLUTION
AB The Zika virus disease, also known as Zika fever is an arboviral disease that became epidemic in the Pacific Islands and had spread to 18 territories of the Americas in 2016. Zika virus disease has been linked to several health problems such as microcephaly and the Guillain-Barre syndrome, but to date, there has been no vaccine available for Zika. Problems related to the development of a vaccine include the vaccination target, which covers pregnant women and children, and the antibody dependent enhancement (ADE), which can be caused by non-neutralizing antibodies. The peptide vaccine was chosen as a focus of this study as a safer platform to develop the Zika vaccine. In this study, a collection of Zika proteomes was used to find the best candidates for T- and B-cell epitopes using the immunoinformatics approach. The most promising T-cell epitopes were mapped using the selected human leukocyte antigen (HLA) alleles, and further molecular docking and dynamics studies showed a good peptide-HLA interaction for the best major histocompatibility complex-II (MHC-II) epitope. The most promising B-cell epitopes include four linear peptides predicted to be cross-reactive with T-cells, and conformational epitopes from two proteins accessible by antibodies in their native biological assembly. It is believed that the use of immunoinformatics methods is a promising strategy against the Zika viral infection in designing an efficacious multiepitope vaccine.
C1 [Prasasty, Vivitri Dewi] Atma Jaya Catholic Univ Indonesia, Fac Biotechnol, Jakarta 12930, Indonesia.
   [Grazzolie, Karel; Ivan, Fransiskus Xaverius] Surya Univ, Fac Life Sci, Dept Biol, Tangerang 15143, Banten, Indonesia.
   [Rosmalena, Rosmalena; Yazid, Fatmawaty] Univ Indonesia, Fac Med, Dept Med Chem, Depok 16424, Indonesia.
   [Sinaga, Ernawati] Univ Nas, Fac Biol, Jakarta 12520, Indonesia.
RP Prasasty, VD (corresponding author), Atma Jaya Catholic Univ Indonesia, Fac Biotechnol, Jakarta 12930, Indonesia.
EM vivitri.dewi@atmajaya.ac.id
FU Atma Jaya Catholic University of Indonesia funding scheme; Surya
   University funding scheme; Unversitas Indonesia funding scheme;
   Universitas Nasional funding scheme
FX This research was supported by the Atma Jaya Catholic University of
   Indonesia, Surya University, Unversitas Indonesia and Universitas
   Nasional funding schemes.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Agallou M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00268
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639
   Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y
   [Anonymous], 2017, MON CAS DENG FEBR CH, V48, P1
   Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029
   Badawi MM, 2016, AM J BIOMED RES, V4, P46
   BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916
   Cravo P, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2144-x
   Cunha-Neto E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00640
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Fan QR, 1999, J EXP MED, V190, P113, DOI 10.1084/jem.190.1.113
   Fleischmann G, 2015, J IMMUNOL, V195, P4503, DOI 10.4049/jimmunol.1501515
   FRENCH S, 1983, J MOL EVOL, V19, P171, DOI 10.1007/BF02300754
   GAO XJ, 1992, HUM IMMUNOL, V34, P153, DOI 10.1016/0198-8859(92)90107-X
   Garima Yadav, 2017, Journal of Applied Pharmaceutical Science, V7, P116
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hauser AS, 2016, J CHEM INF MODEL, V56, P188, DOI 10.1021/acs.jcim.5b00234
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z
   Janeway Jr C.A., 2001, IMMUNOBIOLOGY
   Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829
   LaFleur C, 2002, HUM IMMUNOL, V63, P1039, DOI 10.1016/S0198-8859(02)00682-1
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329
   Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Liljeroos L, 2015, J IMMUNOL RES, DOI 10.1155/2015/156241
   Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8
   Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Liu J., 2011, ELS
   Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195
   LODISH H, 2000, MOL CELL BIOL
   Mack SJ, 2000, TISSUE ANTIGENS, V55, P383, DOI 10.1034/j.1399-0039.2000.550501.x
   Mercado ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115619
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x
   Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296
   NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851
   Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329
   Ortiz JF, 2013, GENOME BIOL EVOL, V5, P504, DOI 10.1093/gbe/evt026
   Oyarzn P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-52
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132
   Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pradhan D, 2017, INTERDISCIP SCI, V9, P468, DOI 10.1007/s12539-017-0238-3
   Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012
   Rentzsch R, 2015, BRIEF BIOINFORM, V16, P1045, DOI 10.1093/bib/bbv008
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   ROGNAN D, 1994, BIOCHEMISTRY-US, V33, P11476, DOI 10.1021/bi00204a009
   Roider J, 2014, IMMUNOLOGY, V143, P193, DOI 10.1111/imm.12301
   Saisawang C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193133
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sant'Angelo DB, 2002, EUR J IMMUNOL, V32, P2510, DOI 10.1002/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q
   Schrodinger L.L.C., 2018, PYMOL MOL GRAPHICS S
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Shityakov Sergey, 2014, Adv Appl Bioinform Chem, V7, P23, DOI 10.2147/AABC.S63749
   Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2
   Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001
   Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slenczka W, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0019-2016
   Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003
   Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4
   Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555
   Systemes D, 2016, BIOVIA DISC STUD MOD
   Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803
   Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Westermarck J, 2013, MOL CELL PROTEOMICS, V12, P1752, DOI 10.1074/mcp.R113.027771
   World Health Organization, ZIK SIT REP 5 FEBR 2
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yadav R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060785
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yuliwulandari R, 2009, TISSUE ANTIGENS, V73, P46, DOI 10.1111/j.1399-0039.2008.01178.x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng JF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01384
NR 119
TC 0
Z9 0
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD AUG
PY 2019
VL 7
IS 8
AR 226
DI 10.3390/microorganisms7080226
PG 27
WC Microbiology
SC Microbiology
GA IT6BY
UT WOS:000482956300007
PM 31370224
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ahmed, A
   Siman-Tov, G
   Hall, G
   Bhalla, N
   Narayanan, A
AF Ahmed, Aslaa
   Siman-Tov, Gavriella
   Hall, Grant
   Bhalla, Nishank
   Narayanan, Aarthi
TI Human Antimicrobial Peptides as Therapeutics for Viral Infections
SO VIRUSES-BASEL
LA English
DT Review
DE human antimicrobial peptides; antiviral strategies; defensins;
   cathelicidins; hepcidins; transferrins
ID RESPIRATORY SYNCYTIAL VIRUS; HERPES-SIMPLEX-VIRUS; INFLUENZA-A VIRUS;
   JAPANESE ENCEPHALITIS-VIRUS; ELASTASE-SPECIFIC INHIBITOR; HUMAN
   CATHELICIDIN LL-37; CHRONIC HEPATITIS-C; BETA-DEFENSIN 3; BOVINE
   LACTOFERRIN; IN-VITRO
AB Successful in vivo infection following pathogen entry requires the evasion and subversion of multiple immunological barriers. Antimicrobial peptides (AMPs) are one of the first immune pathways upregulated during infection by multiple pathogens, in multiple organs in vivo. In humans, there are many classes of AMPs exhibiting broad antimicrobial activities, with defensins and the human cathelicidin LL-37 being the best studied examples. Whereas historically the efficacy and therapeutic potential of AMPs against bacterial infection has been the primary focus of research, recent studies have begun to elucidate the antiviral properties of AMPs as well as their role in regulation of inflammation and chemoattraction. AMPs as therapeutic tools seem especially promising against emerging infectious viral pathogens for which no approved vaccines or treatments are currently available, such as dengue virus (DENV) and Zika virus (ZIKV). In this review, we summarize recent studies elucidating the efficacy and diverse mechanisms of action of various classes of AMPs against multiple viral pathogens, as well as the potential use of human AMPs in novel antiviral therapeutic strategies.
C1 [Ahmed, Aslaa; Siman-Tov, Gavriella; Bhalla, Nishank; Narayanan, Aarthi] George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.
   [Hall, Grant] US Mil Acad, West Point, NY 10996 USA.
RP Narayanan, A (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.
EM anaraya1@gmu.edu
OI Hall, Grant/0000-0003-3928-3979
FU Defense Threat Reduction AgencyUnited States Department of
   DefenseDefense Threat Reduction Agency [HDTRA11810041]
FX This work was supported by the Defense Threat Reduction Agency
   (HDTRA11810041).
CR AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195
   Agier J, 2015, CENT EUR J IMMUNOL, V40, P225, DOI 10.5114/ceji.2015.51359
   Ahmed A, 2019, ANTIVIR RES, V164, P61, DOI 10.1016/j.antiviral.2019.02.002
   Alagarasu K, 2017, PEPTIDES, V92, P23, DOI 10.1016/j.peptides.2017.04.002
   Ammendolia MG, 2012, PATHOG GLOB HEALTH, V106, P12, DOI 10.1179/2047773212Y.0000000004
   Armitage AE, 2014, P NATL ACAD SCI USA, V111, P12187, DOI 10.1073/pnas.1402351111
   Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957
   Arnold D, 2002, ANTIVIR RES, V53, P153, DOI 10.1016/S0166-3542(01)00197-8
   Augustyniak D, 2012, CURR PROTEIN PEPT SC, V13, P723, DOI 10.2174/138920312804871139
   Bahar AA, 2013, PHARMACEUTICALS, V6, P1543, DOI 10.3390/ph6121543
   Bandurska K, 2015, BIOFACTORS, V41, P289, DOI 10.1002/biof.1225
   Barcellini W, 2000, J LEUKOCYTE BIOL, V68, P693
   Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333
   Bedoya VI, 2006, AIDS RES HUM RETROV, V22, P897, DOI 10.1089/aid.2006.22.897
   Bergman P, 2007, CURR HIV RES, V5, P410
   Berkhout B, 2002, ANTIVIR RES, V55, P341, DOI 10.1016/S0166-3542(02)00069-4
   Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992
   Biswaro LS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00855
   Bjorn C, 2015, INT J ANTIMICROB AG, V45, P519, DOI 10.1016/j.ijantimicag.2014.12.015
   Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133
   Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103
   Castaneda-Sanchez JI, 2016, INTERVIROLOGY, V59, P8, DOI 10.1159/000446282
   Catania A, 1998, PEPTIDES, V19, P1099, DOI 10.1016/S0196-9781(98)00055-2
   Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948
   Chen JM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091957
   Chennupati SK, 2009, AM J RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261
   Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017
   Currie SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073659
   Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233
   d'Angelo I, 2015, COLLOID SURFACE B, V135, P717, DOI 10.1016/j.colsurfb.2015.08.027
   de la Fuente-Nunez C, 2017, PHARMACOL THERAPEUT, V178, P132, DOI 10.1016/j.pharmthera.2017.04.002
   Dean RE, 2010, PEPTIDES, V31, P1966, DOI 10.1016/j.peptides.2010.07.028
   DEFER MC, 1995, CELL MOL BIOL, V41, P417
   Di Biase AM, 2003, J MED VIROL, V69, P495, DOI 10.1002/jmv.10337
   Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256
   Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322
   Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com
   Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x
   Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049
   Doumas S, 2005, INFECT IMMUN, V73, P1271, DOI 10.1128/IAI.73.3.1271-1274.2005
   Drannik AG, 2013, J VIROL, V87, P7526, DOI 10.1128/JVI.02243-12
   Drobni P, 2004, ANTIVIR RES, V64, P63, DOI 10.1016/S0166-3542(04)00123-8
   EL-Fakharany EM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-199
   Pachon-Ibanez ME, 2017, FEMS MICROBIOL REV, V41, P323, DOI 10.1093/femsre/fux012
   Findlay F, 2016, PATHOG GLOB HEALTH, V110, DOI 10.1080/20477724.2016.1195036
   Furci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045208
   Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300
   Ghosh M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198412
   Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x
   Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z
   Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111
   Grover M, 1997, ACTA PAEDIATR, V86, P315, DOI 10.1111/j.1651-2227.1997.tb08896.x
   Guyot N, 2008, J BIOL CHEM, V283, P32377, DOI 10.1074/jbc.M803707200
   Hara K, 2002, HEPATOL RES, V24, P228, DOI 10.1016/S1386-6346(02)00088-8
   Harcourt Jennifer L, 2016, BMC Res Notes, V9, P11, DOI 10.1186/s13104-015-1836-y
   Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962
   HASEGAWA K, 1994, JPN J MED SCI BIOL, V47, P73, DOI 10.7883/yoken1952.47.73
   Hawley RJ, 2001, ANNU REV MICROBIOL, V55, P235, DOI 10.1146/annurev.micro.55.1.235
   Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658
   He M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00722
   Hiwarkar P, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1980
   Holly MK, 2017, ANNU REV VIROL, V4, P369, DOI 10.1146/annurev-virology-101416-041734
   Honda JR, 2014, J MED MICROBIOL, V63, P997, DOI 10.1099/jmm.0.070888-0
   Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763
   Hsieh IN, 2016, PHARMACEUTICALS, V9, DOI 10.3390/ph9030053
   Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643
   Jadhav NJ, 2020, INT J PEPT RES THER, V26, P547, DOI 10.1007/s10989-019-09861-z
   Jenssen H, 2008, ANTIVIR RES, V79, P192, DOI 10.1016/j.antiviral.2008.03.004
   Jiang Yan, 2012, Antiviral Chemistry & Chemotherapy, V22, P255, DOI 10.3851/IMP2077
   Johansson C, 2007, J VIROL, V81, P954, DOI 10.1128/JVI.01995-06
   Kaito M, 2007, J GASTROEN HEPATOL, V22, P1894, DOI 10.1111/j.1440-1746.2007.04858.x
   King AE, 2009, HUM REPROD, V24, P679, DOI 10.1093/humrep/den452
   Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
   Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200
   Lee CJ, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.3.4
   Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6
   LeMessurier KS, 2016, ANTIVIR RES, V133, P208, DOI 10.1016/j.antiviral.2016.08.013
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Li ST, 2009, MED MICROBIOL IMMUN, V198, P19, DOI 10.1007/s00430-008-0100-7
   Li Songtao, 2008, Wei Sheng Yan Jiu, V37, P196
   Lopez-Gonzalez M, 2018, IMMUNOBIOLOGY, V223, P608, DOI 10.1016/j.imbio.2018.07.006
   Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194
   Mangoni ML, 2016, EXP DERMATOL, V25, P167, DOI 10.1111/exd.12929
   Mansbach JM, 2012, J ALLERGY CLIN IMMUN, V130, P1007, DOI 10.1016/j.jaci.2012.07.044
   Marchetti M, 1999, MED MICROBIOL IMMUN, V187, P199, DOI 10.1007/s004300050093
   Marchetti M, 1998, BIOMETALS, V11, P89, DOI 10.1023/A:1009217709851
   Marchetti M, 1996, ANTIVIR RES, V29, P221, DOI 10.1016/0166-3542(95)00840-3
   Marischen L, 2009, SCAND J IMMUNOL, V70, P547, DOI 10.1111/j.1365-3083.2009.02337.x
   Marr AK, 2009, BIOCHIMIE, V91, P160, DOI 10.1016/j.biochi.2008.05.016
   Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006
   Matsumura T, 2016, HEPATOL RES, V46, P924, DOI 10.1111/hepr.12627
   McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002
   Michels K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004998
   Gonzalez SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131139
   Mistry N, 2007, ANTIVIR RES, V75, P258, DOI 10.1016/j.antiviral.2007.03.012
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mohammadi-Samani S, 2015, PHARM DEV TECHNOL, V20, P385, DOI 10.3109/10837450.2014.882940
   Mulder KCL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00321
   Murphy ME, 2001, J VET MED SCI, V63, P637, DOI 10.1292/jvms.63.637
   Murphy ME, 2000, ARCH VIROL, V145, P1571, DOI 10.1007/s007050070077
   Myhrman E, 2013, APPL MICROBIOL BIOT, V97, P3085, DOI 10.1007/s00253-012-4439-8
   Naafs MA, 2018, BIOMED J SCI TECH RE, V7, P6038, DOI DOI 10.26717/BJSTR.2018.07.001536
   Nagaoka I, 2008, INT IMMUNOL, V20, P543, DOI 10.1093/intimm/dxn012
   Nguyen EK, 2010, J VIROL, V84, P4041, DOI 10.1128/JVI.02471-09
   Ogawa Y, 2013, CELL HOST MICROBE, V13, P77, DOI 10.1016/j.chom.2012.12.002
   Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17
   Pace BT, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5186904
   Park MS, 2018, BIOMOL THER, V26, P242, DOI 10.4062/biomolther.2017.172
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pietrantoni A, 2003, ANTIMICROB AGENTS CH, V47, P2688, DOI 10.1128/AAC.47.8.2688-2691.2003
   Pietrantoni A, 2012, BIOCHEM CELL BIOL, V90, P442, DOI [10.1139/o11-072, 10.1139/O11-072]
   Pietrantoni A, 2010, BIOMETALS, V23, P465, DOI 10.1007/s10534-010-9323-3
   Pifferi M, 2001, PEDIATR PULM, V31, P419, DOI 10.1002/ppul.1069
   Portelli J, 1998, J MED MICROBIOL, V47, P1015, DOI 10.1099/00222615-47-11-1015
   Rodriguez R, 2014, INFECT IMMUN, V82, P745, DOI 10.1128/IAI.00983-13
   Roseanu A, 2006, IUBMB LIFE, V58, P235, DOI 10.1080/15216540600577897
   Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236
   Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691
   Rugeles MT, 2003, AIDS, V17, P481, DOI 10.1097/00002030-200303070-00002
   Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079
   Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027
   Salvini F, 2005, PEDIATR RES, V58, P409, DOI 10.1203/00006450-200508000-00349
   Sano H, 2003, EUR J IMMUNOL, V33, P2894, DOI 10.1002/eji.200324218
   Scala MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10492-x
   Schluesener Hermann Josef, 2012, Front Biosci (Schol Ed), V4, P1375
   Schogler A, 2016, EUR RESPIR J, V47, P520, DOI 10.1183/13993003.00665-2015
   Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041
   Silva JP, 2016, J CONTROL RELEASE, V235, P112, DOI 10.1016/j.jconrel.2016.05.064
   Skott P, 2002, ORAL DIS, V8, P160, DOI 10.1034/j.1601-0825.2002.01807.x
   Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001
   Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959
   Sousa FH, 2017, PEPTIDES, V95, P76, DOI 10.1016/j.peptides.2017.07.013
   Superti F, 1997, MED MICROBIOL IMMUN, V186, P83, DOI 10.1007/s004300050049
   Taha SH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-330
   Tanaka K, 1999, JPN J CANCER RES, V90, P367, DOI 10.1111/j.1349-7006.1999.tb00756.x
   Teng CT, 2002, BIOCHEM CELL BIOL, V80, P7, DOI 10.1139/o01-215
   Tripathi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124706
   Tripathi S, 2014, J LEUKOCYTE BIOL, V96, P931, DOI 10.1189/jlb.4A1113-604RR
   Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0
   Ueno H, 2006, CANCER SCI, V97, P1105, DOI 10.1111/j.1349-7006.2006.00274.x
   Ulaeto DO, 2016, ANTIMICROB AGENTS CH, V60, P1984, DOI 10.1128/AAC.02146-15
   Viani RM, 1999, AIDS, V13, P1273, DOI 10.1097/00002030-199907090-00018
   Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009
   Waarts BL, 2005, VIROLOGY, V333, P284, DOI 10.1016/j.virol.2005.01.010
   Wakabayashi H, 2014, J INFECT CHEMOTHER, V20, P666, DOI 10.1016/j.jiac.2014.08.003
   Walker AP, 2004, GUT, V53, P624, DOI 10.1136/gut.2003.030304
   Wang GS, 2014, PHARMACEUTICALS, V7, P545, DOI 10.3390/ph7050545
   Wang XH, 2013, ANN CLIN LAB SCI, V43, P126
   Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422
   Widegren H, 2011, RESP MED, V105, P997, DOI 10.1016/j.rmed.2010.12.021
   Wiens ME, 2017, MBIO, V8, DOI 10.1128/mBio.02304-16
   Wiens ME, 2015, J VIROL, V89, P2866, DOI 10.1128/JVI.02901-14
   Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200
   Wilson SS, 2016, J VIROL, V90, P5216, DOI 10.1128/JVI.00904-15
   Wong JH, 2011, PEPTIDES, V32, P1117, DOI 10.1016/j.peptides.2011.04.017
   Yamamoto H, 2010, J HEALTH SCI, V56, P613, DOI 10.1248/jhs.56.613
   Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004
   Yen Meng-Hsiu, 2011, Chang Gung Med J, V34, P395
   Yi MY, 1997, J VIROL, V71, P5997, DOI 10.1128/JVI.71.8.5997-6002.1997
   YING QL, 1993, BIOCHEMISTRY-US, V32, P1866, DOI 10.1021/bi00058a021
   Yost SA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01917
   Zuccotti GV, 2006, J INT MED RES, V34, P88, DOI 10.1177/147323000603400111
NR 164
TC 1
Z9 1
U1 3
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD AUG
PY 2019
VL 11
IS 8
AR 704
DI 10.3390/v11080704
PG 26
WC Virology
SC Virology
GA IT6OG
UT WOS:000482993900001
PM 31374901
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Akhras, S
   Herrlein, ML
   Elgner, F
   Holzhauser, T
   Hildt, E
AF Akhras, Sami
   Herrlein, Marie-Luise
   Elgner, Fabian
   Holzhauser, Thomas
   Hildt, Eberhard
TI ZIKV Envelope Domain-Specific Antibodies: Production, Purification and
   Characterization
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; envelope protein; polyclonal antibody; non-;
   weak-neutralizing antibodies; epitopes
ID STRUCTURAL BASIS; VIRUS OUTBREAK; BRAZIL
AB Infection with Zika virus (ZIKV) came first to public attention after it was found to be associated with congenital microcephaly during the outbreak in Brazil (2015-2016). Diagnosis of ZIKV suffers from extensive cross-reactivity with other Flaviviruses, which are circulating in many ZIKV epidemic areas. Due to the fatal outcome of ZIKV infection during pregnancy, detailed knowledge about neutralizing and non-neutralizing epitopes is crucial for the development of robust detection systems of protective antibodies. Therefore, additional information about ZIKV immunogenicity and antibody response is required. In this project, we report the production, purification and characterization of six different polyclonal antibodies against ZIKV envelope (E) protein. The produced antibodies bind to isolated ZIKV E protein as well as to the surface of ZIKV particles, interestingly without being potently neutralizing. Surface plasmon resonance measurement showed that these antibodies bind with high affinity to ZIKV E protein. Epitope mapping revealed that the epitopes are distributed among the three ZIKV E domains with seven binding sites. These identified binding sites overlap only partially with the previously described epitopes recognized by neutralizing antibodies, which is in accordance with their lack of potent neutralizing activity. Additionally, these antibodies showed neither cross-reactivity nor potent neutralizing activity against West Nile virus, a related flavivirus. The gained set of data helps to extend our understanding about the distribution of neutralizing and non-/weak-neutralizing epitopes in ZIKV E protein, and provides a rationale for ZIKV vaccine design and development of robust detection assays for neutralizing antibodies.
C1 [Akhras, Sami; Herrlein, Marie-Luise; Elgner, Fabian; Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Holzhauser, Thomas] Paul Ehrlich Inst, Dept Allergol, D-63225 Langen, Germany.
   [Hildt, Eberhard] German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
RP Hildt, E (corresponding author), Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.; Hildt, E (corresponding author), German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
EM sami.akhras@pei.de; marie-luise.herrlein@pei.de; fabian.elgner@pei.de;
   thomas.holzhauser@pei.de; eberhard.hildt@pei.de
RI Hildt, Eberhard/A-1040-2015
FU Federal Ministry of Health (BMG); LOEWE Center DRUID (Novel Drug Targets
   against Poverty-Related and Neglected Tropical Infectious Diseases);
   European Union's Horizon 2020 research and innovation program [653316]
FX This research was funded by a grant from the Federal Ministry of Health
   (BMG) to E.H. and by a grant from the LOEWE Center DRUID (Novel Drug
   Targets against Poverty-Related and Neglected Tropical Infectious
   Diseases) to E.H. This publication was supported by the European Virus
   Archive goes Global (EVAg) project that has received funding from the
   European Union's Horizon 2020 research and innovation program under
   grant agreement No 653316. Based on this funding, EVAg provided the ZIKV
   Uganda 976 strain.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kuhne Y, 2015, INT ARCH ALLERGY IMM, V166, P213, DOI 10.1159/000381344
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang L, 2019, CELL REP, V26, P3360, DOI 10.1016/j.celrep.2019.02.062
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 27
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD AUG
PY 2019
VL 11
IS 8
AR 748
DI 10.3390/v11080748
PG 23
WC Virology
SC Virology
GA IT6OG
UT WOS:000482993900002
PM 31412626
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Boullis, A
   Cordel, N
   Herrmann-Storck, C
   Vega-Rua, A
AF Boullis, Antoine
   Cordel, Nadege
   Herrmann-Storck, Cecile
   Vega-Rua, Anubis
TI Experimental Assessment of Zika Virus Mechanical Transmission by Aedes
   aegypti
SO VIRUSES-BASEL
LA English
DT Article
DE ZIKV; Aedes aegypti; Arbovirus; Mechanical transmission
ID CHIKUNGUNYA VIRUS; DIPTERA
AB The pandemic emergence of several mosquito-borne viruses highlights the need to understand the different ways in which they can be transmitted by vectors to human hosts. In this study, we evaluated the propensity of Aedes aegypti to transmit mechanically Zika virus (ZIKV) using an experimental design. Mosquitoes were allowed to feed on ZIKV-infected blood and were then rapidly transferred to feed on ZIKV-free blood until they finished their meal. The uninfected blood meals, the mosquito abdomens, as well as the mouthparts dissected from fully and partially engorged mosquitoes were analyzed using RT-qPCR and/or virus titration. All the fully engorged mosquito abdomens were ZIKV-infected, whereas their mouthparts were all ZIKV-negative. Nonetheless, one of the partially engorged mosquitoes carried infectious particles on mouthparts. No infectious virus was found in the receiver blood meals, while viral RNA was detected in 9% of the samples (2/22). Thus, mechanical transmission of ZIKV may sporadically occur via Ae. aegypti bite. However, as the number of virions detected on mouthparts (2 particles) is not sufficient to induce infection in a naive host, our results indicate that mechanical transmission does not impact ZIKV epidemiology.
C1 [Boullis, Antoine; Vega-Rua, Anubis] Inst Pasteur Guadeloupe Lieu Dit Morne Joliviere, Lab Vector Control Res, F-97139 Les Abymes, Guadeloupe, France.
   [Cordel, Nadege] Guadeloupe Univ Hosp, Dermatol & Clin Immunol Unit, F-97159 Pointe A Pitre, Guadeloupe, France.
   [Cordel, Nadege] Normandie Univ, UNIROUEN, INSERM, Unite 1234, F-76000 Rouen, France.
   [Herrmann-Storck, Cecile] Guadeloupe Univ Hosp, Microbiol Lab, F-97159 Pointe A Pitre, Guadeloupe, France.
RP Vega-Rua, A (corresponding author), Inst Pasteur Guadeloupe Lieu Dit Morne Joliviere, Lab Vector Control Res, F-97139 Les Abymes, Guadeloupe, France.
EM anubis.vega-rua@pasteur.fr
OI Boullis, Antoine/0000-0001-8309-5065
FU Programme Operationnel FEDER-Guadeloupe-Conseil Regional [2015-FED-192];
   Horizon 2020 Research and Innovation Framework Programme under
   "ZIKALLIANCE" [734548]; Calmette & Yersin postdoctoral fellowship from
   the Institut Pasteur Department of International Affairs
FX This work has been notably supported by the Programme Operationnel
   FEDER-Guadeloupe-Conseil Regional 2014-2020 (grant 2015-FED-192) and the
   Horizon 2020 Research and Innovation Framework Programme under
   "ZIKALLIANCE" (grant agreement no. 734548). A.B. was financially
   supported by a Calmette & Yersin postdoctoral fellowship from the
   Institut Pasteur Department of International Affairs.
CR Arias-Goeta C, 2014, INFECT GENET EVOL, V24, P116, DOI 10.1016/j.meegid.2014.03.015
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Chihota CM, 2001, EPIDEMIOL INFECT, V126, P317, DOI 10.1017/S0950268801005179
   Cordel N, 2018, BRIT J DERMATOL, V178, pE108, DOI 10.1111/bjd.16096
   Darling AJ, 1998, BIOLOGICALS, V26, P105, DOI 10.1006/biol.1998.0134
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Foil Lane D., 2004, P461
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Hery L, 2019, EMERG MICROBES INFEC, V8, P699, DOI 10.1080/22221751.2019.1615849
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lienard E, 2013, PARASITOL RES, V112, P479, DOI 10.1007/s00436-012-3157-6
   RAO TR, 1968, MOSQ NEWS, V28, P406
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Vazeille M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29564
NR 17
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD AUG
PY 2019
VL 11
IS 8
AR 695
DI 10.3390/v11080695
PG 7
WC Virology
SC Virology
GA IT6OG
UT WOS:000482993900038
PM 31370135
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhou, HZ
   Su, X
   Lin, LL
   Zhang, J
   Qi, Q
   Guo, FF
   Xu, FZ
   Yang, B
AF Zhou, Hongzhuan
   Su, Xia
   Lin, Lulu
   Zhang, Jin
   Qi, Qi
   Guo, Fangfang
   Xu, Fuzhou
   Yang, Bing
TI Inhibitory Effects of Antiviral Drug Candidates on Canine Parvovirus in
   F81 cells
SO VIRUSES-BASEL
LA English
DT Article
DE canine parvovirus; FDA-approved drug library; antiviral inhibitors;
   cytopathic effect (CPE)-based high-throughput screening assay
ID HEPATITIS-B-VIRUS; FDA-APPROVED DRUGS; ZIKA VIRUS; BROAD-SPECTRUM;
   POTENT INHIBITORS; NITAZOXANIDE; IDENTIFICATION; REPLICATION;
   THIAZOLIDES; INFECTION
AB Canine parvovirus (CPV) is a common etiological agent of acute enteritis, which occurs globally in domestic and wild carnivores. Despite the widespread use of inactivated or live attenuated vaccines, the emergence of antigenic variants and the influence of maternal antibodies have raised some concerns regarding the efficacy of commercial vaccines. While no specific antiviral therapy for CPV infection exists, the only treatment option for the infection is supportive therapy based on symptoms. Thus, there is an urgent medical need to develop antiviral therapeutic options to reduce the burden of CPV-related disease. In this study, a cytopathic effect (CPE)-based high-throughput screening assay was used to screen CPV inhibitors from a Food and Drug Administration (FDA)-approved drug library. After two rounds of screening, seven out of 1430 screened drugs were found to have >50% CPE inhibition. Three drugs-Nitazoxanide, Closantel Sodium, and Closantel-with higher anti-CPV effects were further evaluated in F81 cells by absolute PCR quantification and indirect immunofluorescence assay (IFA). The inhibitory effects of all three drugs were dose-dependent. Time of addition assay indicated that the drugs inhibited the early processes of the CPV replication cycle, and the inhibition effects were relatively high within 2 h postinfection. Western blot assay also showed that the three drugs had broad-spectrum antiviral activity against different subspecies of three CPV variants. In addition, antiapoptotic effects were observed within 12 h in Nitazoxanide-treated F81 cells regardless of CPV infection, while Closantel Sodium- or Closantel-treated cells had no pro- or antiapoptotic effects. In conclusion, Nitazoxanide, Closantel Sodium, and Closantel can effectively inhibit different subspecies of CPV. Since the safety profiles of FDA-approved drugs have already been extensively studied, these three drugs can potentially become specific and effective anti-CPV drugs.
C1 [Zhou, Hongzhuan; Su, Xia; Lin, Lulu; Zhang, Jin; Qi, Qi; Guo, Fangfang; Xu, Fuzhou; Yang, Bing] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China.
RP Yang, B (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China.
EM byang111@yeah.net
FU National Key Research and Development Program of China [2016YFD0501001];
   Innovative Capability Project of Beijing Academy of Agriculture and
   Forestry Sciences [KJCX201914]
FX This research was funded by the National Key Research and Development
   Program of China, grant number No. 2016YFD0501001, and Innovative
   Capability Project of Beijing Academy of Agriculture and Forestry
   Sciences, grant number No. KJCX201914.
CR AlAmri MA, 2017, CHEMMEDCHEM, V12, P639, DOI 10.1002/cmdc.201700077
   Ashiru O, 2014, VIROLOGY, V462, P135, DOI 10.1016/j.virol.2014.05.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bragg RF, 2012, JAVMA-J AM VET MED A, V240, P700, DOI 10.2460/javma.240.6.700
   Cao JZ, 2015, ANTIVIR RES, V114, P1, DOI 10.1016/j.antiviral.2014.11.010
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Chang SY, 2016, BIOCHEM BIOPH RES CO, V478, P1594, DOI 10.1016/j.bbrc.2016.08.162
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Cheng H, 2015, J VIROL, V89, P9932, DOI 10.1128/JVI.01337-15
   Doley J, 2014, APPL BIOCHEM BIOTECH, V172, P497, DOI 10.1007/s12010-013-0538-y
   Duque-Garcia Y, 2017, VET MICROBIOL, V201, P56, DOI 10.1016/j.vetmic.2016.12.039
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Gaykwad C, 2018, J VET PHARMACOL THER, V41, P68, DOI 10.1111/jvp.12434
   Goddard A, 2010, VET CLIN N AM-SMALL, V40, P1041, DOI 10.1016/j.cvsm.2010.07.007
   Hickson SE, 2018, VIROLOGY, V518, P398, DOI 10.1016/j.virol.2018.03.023
   Hoelzer K, 2008, J VIROL, V82, P11096, DOI 10.1128/JVI.01003-08
   Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008
   Keeffe EB, 2009, WORLD J GASTROENTERO, V15, P1805, DOI 10.3748/wjg.15.1805
   Kikuchi E, 2015, J AM SOC NEPHROL, V26, P1525, DOI 10.1681/ASN.2014060560
   Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005
   La Frazia S, 2013, J VIROL, V87, P11096, DOI 10.1128/JVI.01213-13
   Lamm CG, 2008, VET CLIN N AM-SMALL, V38, P837, DOI 10.1016/j.cvsm.2008.03.008
   Li YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31074
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liekens S, 2015, ONCOTARGET, V6, P4633, DOI 10.18632/oncotarget.3079
   Liu G, 2017, ACS INFECT DIS, V3, P190, DOI 10.1021/acsinfecdis.6b00209
   Mercorelli B, 2016, CELL CHEM BIOL, V23, P340, DOI 10.1016/j.chembiol.2015.12.012
   Mira F, 2018, TRANSBOUND EMERG DIS, V65, P16, DOI 10.1111/tbed.12747
   Mira F, 2018, INFECT GENET EVOL, V61, P67, DOI 10.1016/j.meegid.2018.03.010
   Miranda C, 2016, J GEN VIROL, V97, P2043, DOI 10.1099/jgv.0.000540
   Perelygina L, 2017, ANTIVIR RES, V147, P58, DOI 10.1016/j.antiviral.2017.09.019
   Rossignol JF, 2009, J BIOL CHEM, V284, P29798, DOI 10.1074/jbc.M109.029470
   Savigny MR, 2010, J VET EMERG CRIT CAR, V20, P132, DOI 10.1111/j.1476-4431.2009.00404.x
   Senkowski W, 2015, MOL CANCER THER, V14, P1504, DOI 10.1158/1535-7163.MCT-14-0792
   Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102
   Shi ZX, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-10
   Siddiq DM, 2011, J INFECTION, V63, P394, DOI 10.1016/j.jinf.2011.08.002
   Stachulski AV, 2011, J MED CHEM, V54, P4119, DOI 10.1021/jm200153p
   Trabattoni D, 2016, SCI REP-UK, V6, DOI 10.1038/srep27148
   van de Klundert MAA, 2016, J VIRAL HEPATITIS, V23, P191, DOI 10.1111/jvh.12479
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Wu Hongchao, 2018, VirusDisease, V29, P113, DOI 10.1007/s13337-018-0427-7
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang YJ, 2016, J BIOMOL SCREEN, V21, P381, DOI 10.1177/1087057115624637
   Zhao ZQ, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0753-1
   Zhou P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175035
   Zhu XY, 2016, ASSAY DRUG DEV TECHN, V14, P282, DOI 10.1089/adt.2015.679
NR 47
TC 0
Z9 0
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD AUG
PY 2019
VL 11
IS 8
AR 742
DI 10.3390/v11080742
PG 14
WC Virology
SC Virology
GA IT6OG
UT WOS:000482993900017
PM 31412574
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fabricio, BF
AF Fabricio, Branca Falabella
TI Discourse circulation in news coverage of the Zika virus outbreak:
   Colonial geopolitics, biomediatization and affect
SO DISCOURSE CONTEXT & MEDIA
LA English
DT Article
DE Discourse circulation; Biomediatization; Affect; Intersectionality;
   (De)colonial thinking
ID COMMUNICABILITY
AB Epidemics like Zika reflect enduring inequalities between and within countries, along with creating international and national discrimination against people from affected regions (Jones, 2007). Colonial practices and discourses get recycled, involving the reperformance of long-standing hierarchies, especially those that are ethnic, racial, and gender-based. In the case of the Zika emergency, these discourses travelled worldwide. In this paper, I explore the performativity of such circulation, by singling out two modes of discourse transit. The first one, termed 'biomedical authority model' by Briggs and Hallin (2016), conceives of health texts as mediatized expandable objects that move as unified static structures, as if they were solid blocks. The second mode, contrastively, displays flowing intensity and potential for change. Inspired by Massumi (2002), I term it 'affective mode'. Upon investigating their performative effects, I delve into the friction between an insidious colonialist-modernist episteme and intensified transformational possibilities. The former projects specific groups as responsible for the spread of Zika. It does so by exploring the intersectionality of gender, race, ethnicity, social class, and nationality. In a rather distinct movement, the latter approaches intersubjectivity as being always intersectionally enacted, thus escaping any kind of causal determinism. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fabricio, Branca Falabella] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
RP Fabricio, BF (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
EM branca.falabella@pq.cnpq.br
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [302935/2017-7]
FX I am grateful to The Brazilian National Research Council (CNPq) for the
   research grant (302935/2017-7) which has made the research reported on
   in this article possible. I am also grateful to the very insightful
   comments made by two critical reviewers and by my colleagues at the
   Federal University of Rio de Janeiro, Luiz Paulo da Moita-Lopes and
   Daniel Nascimento Silva.
CR Amarrillo C. R, 2016, REV CLAM        0923
   Briggs Charles, 2016, MAKING HLTH PUBLIC N
   Briggs CL, 2007, CURR ANTHROPOL, V48, P551, DOI 10.1086/518300
   Briggs CL, 2007, CULT ANTHROPOL, V22, P315, DOI 10.1525/can.2007.22.3.315
   Briggs CL, 2011, LANG COMMUN, V31, P217, DOI 10.1016/j.langcom.2011.03.003
   Briggs CL, 2005, ANNU REV ANTHROPOL, V34, P269, DOI 10.1146/annurev.anthro.34.081804.120618
   Butler J, 1997, EXCITABLE SPEECH POL
   Carr S., 2016, SCALE DISCOURSE DIME
   Crenshaw K., 1994, PUBLIC NATURE PRIVAT, P93, DOI DOI 10.3917/CDGE.039.0051
   Das V, 2007, LIFE AND WORDS: VIOLENCE AND THE DESCENT INTO THE ORDINARY, P1
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   Grosfoguel R, 2011, TRANSMODERNITY J PER, V1, P1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jones R. H., 2007, HLTH RISK COMMUNICAT
   Knapton O, 2017, WORLD C
   Martin-Barbero J., 1987, MEDIOS MEDIACIONES C
   Martin-Barbero J, 2006, GLOB MEDIA COMMUN, V2, P279, DOI 10.1177/1742766506069579
   Massumi B, 2002, PARABLES VIRTUAL MOV
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Quijano Anibal, 2000, J WORLD SYSTEMS RES, V11, P342, DOI DOI 10.5195/JWSR.2000.228
   Silva D. N., 2017, WORKING PAPERS URBAN, V223
   Silva Daniel Nascimento, 2018, LANGUAGE VIOLENCE PR
   Silverstein M, 2003, LANG COMMUN, V23, P193, DOI 10.1016/S0271-5309(03)00013-2
   Silverstein M., 1993, REFLEXIVE LANGUAGE R, P33, DOI DOI 10.1017/CBO9780511621031.004
   Silverstein Michael, 1976, MEANING ANTHR, P11
   Warner Michael, 2005, PUBLICS COUNTERPUBLI
NR 26
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-6958
J9 DISCOURSE CONTEXT ME
JI Discourse Context Media
PD AUG
PY 2019
VL 30
AR UNSP 100289
DI 10.1016/j.dcm.2019.01.002
PG 10
WC Communication
SC Communication
GA IT0DH
UT WOS:000482516400003
DA 2020-07-08
ER

PT J
AU Kandilya, D
   Maskomani, S
   Shyamasundar, S
   Tambyah, PA
   Yng, CS
   Lee, RCH
   Hande, MP
   Mallilankaraman, K
   Chu, JTH
   Dheen, ST
AF Kandilya, Deepika
   Maskomani, Silambarasan
   Shyamasundar, Sukanya
   Tambyah, Paul Anantharajah
   Yng, Chan Shiao
   Lee, Regina Ching Hua
   Hande, Manoor Prakash
   Mallilankaraman, Karthik
   Chu, Justin Tang Hann
   Dheen, S. Thameem
TI Zika virus alters DNA methylation status of genes involved in Hippo
   signaling pathway in human neural progenitor cells
SO EPIGENOMICS
LA English
DT Article
DE DNA methylation; Hippo signaling; human neural progenitor cells;
   microcephaly; RASSF1; stemness and differentiation; YAP/TAZ; Zika virus
ID ORGAN SIZE; YAP; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION; GROWTH;
   CENTROSOME; SIGNATURES; DIVISION; TAZ
AB Aim: This study was aimed to understand if Zika virus (ZIKV) alters the DNA methylome of human neural progenitor cells (hNPCs). Materials & methods: Whole genome DNA methylation profiling was performed using human methylationEPIC array in control and ZIKV infected hNPCs. Results & conclusion: ZIKV infection altered the DNA methylation of several genes such as WWTR1 (TAZ) and RASSF1 of Hippo signaling pathway which regulates organ size during brain development, and decreased the expression of several centrosomal-related microcephaly genes, and genes involved in stemness and differentiation in human neural progenitor cells. Overall, ZIKV downregulated the Hippo signaling pathway genes which perturb the stemness and differentiation process in hNPCs, which could form the basis for ZIKV-induced microcephaly.
C1 [Kandilya, Deepika; Maskomani, Silambarasan; Shyamasundar, Sukanya; Dheen, S. Thameem] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117597, Singapore.
   [Yng, Chan Shiao] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117597, Singapore.
   [Lee, Regina Ching Hua; Chu, Justin Tang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117597, Singapore.
   [Hande, Manoor Prakash; Mallilankaraman, Karthik] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.
RP Dheen, ST (corresponding author), Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore.; Chu, JTH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117597, Singapore.
EM miccjh@nus.edu.sg; antstd@nus.edu.sg
RI MASKOMANI, SILAMBARASAN/V-2927-2017; Hande, M Prakash/B-1645-2008
OI Hande, M Prakash/0000-0002-4511-6256; Chan, Shiao/0000-0002-3530-3023
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Arai Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00384
   Beys-Da-Silva WO, 2018, MOL NEUROBIOL, P1
   Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039
   Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608
   Chavali PL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0468
   Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040
   Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002
   Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020
   Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001
   Hindley CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23208
   Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005
   Imamura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0511
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Kong S, 2019, BIORXIV
   Lavado A, 2013, DEVELOPMENT, V140, P3323, DOI 10.1242/dev.096537
   Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Papaspyropoulos A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02786-5
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramya S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00237
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004
   Sanosaka T, 2017, CELL REP, V20, P2992, DOI 10.1016/j.celrep.2017.08.086
   Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Sukumaran SK, 2017, MOL GENET GENOMICS, V292, P365, DOI 10.1007/s00438-016-1277-x
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303
   Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108
   Zhou ZW, 2013, DNA REPAIR, V12, P645, DOI 10.1016/j.dnarep.2013.04.017
NR 51
TC 3
Z9 3
U1 2
U2 4
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1750-1911
EI 1750-192X
J9 EPIGENOMICS-UK
JI Epigenomics
PD AUG
PY 2019
VL 11
IS 10
BP 1143
EP 1162
DI 10.2217/epi-2018-0180
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA IS8US
UT WOS:000482425600004
PM 31234652
DA 2020-07-08
ER

PT J
AU SteelFisher, GK
   Caporello, H
   Blendon, RJ
   Ben-Porath, EN
   Lubell, K
   Friedman, AL
   Holton, K
   Smith, BJ
   McGowan, E
   Schafer, T
AF SteelFisher, Gillian K.
   Caporello, Hannah
   Blendon, Robert J.
   Ben-Porath, Eran N.
   Lubell, Keri
   Friedman, Allison L.
   Holton, Kelly
   Smith, Belinda J.
   McGowan, Ericka
   Schafer, Thomas
TI Views and Experiences of Travelers from US States to Zika-Affected Areas
SO HEALTH SECURITY
LA English
DT Article
DE Infectious diseases; Risk communication; Travel; Zika
ID UNITED-STATES; PREGNANT-WOMEN; RISK PERCEPTION; PUBLIC RESPONSE; ANTHRAX
   ATTACK; KNOWLEDGE; ATTITUDES; VIRUS; METAANALYSIS; PREVENTION
AB Travelers to areas with Zika virus transmission are at risk of infection and of transmitting the virus after returning home. While protective behaviors during and after travel can reduce these risks, information about traveler practices or underlying views is limited. We examined these issues using data from the first representative poll of travelers from US states to Zika-affected areas, including US territories and Miami, Florida, conducted December 1 to 23, 2016. We analyzed results among all travelers (n = 1,285) and 2 subgroups at risk for pregnancy-related complications: (1) travelers in households where someone was pregnant or considering pregnancy (n = 72), and (2) other travelers of reproductive age (n = 631). We also examined results among those with different levels of awareness and knowledge about Zika virus. Results show that in households where someone was pregnant or considering pregnancy, awareness of Zika in the destination, concern about infection, and adoption of protective behaviors was relatively high. That said, sizable shares of travelers as a whole did not know information about asymptomatic and sexual transmission or post-travel behaviors. Further, concern about getting infected during travel was low among travelers as a whole, including other travelers of reproductive age. Few travelers consistently adopted protective behaviors during or after travel. Even among travelers who were aware of Zika in their destination and knew how to protect themselves, adoption of protective behaviors was only slightly higher. Findings from this poll suggest communications may be more effective if tailored to different levels of true and perceived risk. To address gaps in knowledge about transmission and post-travel protective behaviors, messaging should include facts and acknowledge the complexities of novel information and social context. Consideration should also be given to emphasizing other benefits of Zika protective behaviors or prioritizing behaviors that are most feasible.
C1 [SteelFisher, Gillian K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Global Polling, Harvard Opin Res Program, 677 Huntington Ave,Kresge 446, Boston, MA 02115 USA.
   [Caporello, Hannah] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Harvard Opin Res Program, Boston, MA 02115 USA.
   [Blendon, Robert J.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Publ Hlth, Boston, MA 02115 USA.
   [Blendon, Robert J.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Hlth Policy & Polit Anal, Boston, MA 02115 USA.
   [Blendon, Robert J.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Policy Translat & Leadership Dev, Boston, MA 02115 USA.
   [Ben-Porath, Eran N.] SSRS, Publ Opin Res, Glen Mills, PA USA.
   [Lubell, Keri] Ctr Dis Control & Prevent, Res & Evaluat Team, Emergency Risk Commun Branch, Div Emergency Operat,Ctr Preparedness & Response, Atlanta, GA USA.
   [Friedman, Allison L.; Holton, Kelly] Ctr Dis Control & Prevent, Travelers Hlth Branch, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Smith, Belinda J.] McKing Consulting Corp, Atlanta, GA USA.
   [McGowan, Ericka] Assoc State & Terr Hlth Officials, Infect Dis Preparedness, Arlington, VA USA.
   [Schafer, Thomas] Natl Publ Hlth Informat Coalit, Marietta, GA USA.
RP SteelFisher, GK (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Global Polling, Harvard Opin Res Program, 677 Huntington Ave,Kresge 446, Boston, MA 02115 USA.
EM gsteel@hsph.harvard.edu
CR American Association for Public Opinion Research, ONL PAN
   [Anonymous], SEX TRANSM PREV
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Berenson AB, 2018, AM J TROP MED HYG, V98, P178, DOI 10.4269/ajtmh.17-0595
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Centers for Disease Control and Prevention, ADV PEOPL LIV TRAV S
   Centers for Disease Control and Prevention, ZIK CAS US
   Centers for Disease Control and Prevention, PREV MOSQ BIT
   Centers for Disease Control and Prevention, ADV PEOPL LIV TRAV B
   Dennis B., 2016, WASHINGTON POST
   DiSogra C, 2009, JOINT STAT M JSM AUG
   Fahimi M, 2014, 60 AAPOR ANN C MAY 1
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Fisher GKS, 2015, LANCET INFECT DIS, V15, P1183, DOI 10.1016/S1473-3099(15)00178-4
   FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455
   Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x
   GfK, KNOWLEDGEPANEL METH
   Hamer DH, 2004, J TRAVEL MED, V11, P23, DOI 10.2310/7060.2004.13577
   Harvard Opinion Research Program , 2016, ZIK VIR EL SEAS
   Hays RD, 2015, BEHAV RES METHODS, V47, P685, DOI 10.3758/s13428-015-0617-9
   Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1
   Nelson EJ, 2019, J COMMUN HEALTH, V44, P377, DOI 10.1007/s10900-018-0594-x
   Omodior Oghenekaro, 2018, Prev Med Rep, V12, P336, DOI 10.1016/j.pmedr.2018.10.018
   Parrott R, 1995, DESIGNING HLTH MESSA, P7
   Rainie L, 2016, HALF AM SAY THREATS
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Sallis J.F., 2015, HLTH BEHAV THEORY RE, V5, P43
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Slater M. D., 1995, DESIGNING HLTH MESSA, P186
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   SteelFisher G, 2011, BIOSECUR BIOTERROR, V9, P239, DOI 10.1089/bsp.2011.0005
   SteelFisher GK, 2018, HEALTH SECUR, V16, P108, DOI 10.1089/hs.2017.0068
   SteelFisher GK, 2015, NEW ENGL J MED, V373, P789, DOI 10.1056/NEJMp1506290
   SteelFisher GK, 2012, BIOSECUR BIOTERROR, V10, P401, DOI 10.1089/bsp.2012.0041
   SteelFisher GK, 2011, AM J OBSTET GYNECOL, V204, pS116, DOI 10.1016/j.ajog.2011.02.036
   SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102
   Teich A, 2018, DIAGN MICR INFEC DIS, V92, P315, DOI 10.1016/j.diagmicrobio.2018.07.003
   U. S. Census Bureau, 2000, CURR POP SURV ANN SO
   van Genderen PJJ, 2014, TRAVEL MED INFECT DI, V12, P149, DOI 10.1016/j.tmaid.2013.09.002
   Vielot NA, 2018, AM J TROP MED HYG, V98, P1848, DOI 10.4269/ajtmh.17-0907
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Zimmermann R, 2013, J TRAVEL MED, V20, P3, DOI 10.1111/j.1708-8305.2012.00671.x
NR 44
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD AUG 1
PY 2019
VL 17
IS 4
BP 307
EP 323
DI 10.1089/hs.2019.0008
PG 17
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IS3TO
UT WOS:000482076500006
PM 31433283
DA 2020-07-08
ER

PT J
AU Li, XD
   Zhang, HQ
   Zhang, YN
   Li, JQ
   Wang, Z
   Deng, CL
   Jardim, ACG
   Terzian, ACB
   Nogueira, ML
   Zhang, B
AF Li, Xiaodan
   Zhang, Hongqing
   Zhang, Yanan
   Li, Jiaqi
   Wang, Zhen
   Deng, Chenglin
   Gomes Jardim, Ana Carolina
   Terzian, Ana Carolina B.
   Nogueira, Mauricio Lacerda
   Zhang, Bo
TI Development of a rapid antiviral screening assay based on eGFP reporter
   virus of Mayaro virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Mayaro virus; Reverse genetics; Reporter virus; Antiviral drug discovery
ID CHIKUNGUNYA; REPLICATION; INHIBITION; EXPRESSION; ENTRY; INFECTION;
   RIBAVIRIN; INSERTION; PROTEINS; OUTBREAK
AB Mayaro virus (MAYV) is a neglected mosquito-borne alphavirus that causes illness similar to Chikungunya (CHIKV), Dengue (DENY) and Zika virus (ZIKV). Currently, there is no specific treatment or vaccine against MAYV infection. To develop an efficient antiviral screening assay for MAYV, we constructed the infectious clones of MAYV strain BeAr 20290 and its eGFP reporter virus. The reporter virus exhibited high replication capacity indistinguishable with the wild type MAYV, and was genetically stable within at least five rounds of passages in BHK-21 cell. The expression of eGFP correlated well with the viral replication. Using the known inhibitor ribavirin, we confirmed that the MAYV-eGFP reporter virus could be used for antiviral screening to identify the specific inhibitors against MAYV. Using the MAYV-eGFP based antiviral assay, we found that the compound 6-Azauridine which had antiviral activity against CHIKV and SFV, showed a significant inhibitory effect on MAYV replication.
C1 [Li, Xiaodan; Zhang, Hongqing; Zhang, Yanan; Li, Jiaqi; Wang, Zhen; Deng, Chenglin; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
   [Li, Xiaodan] Hunan Normal Univ, Sch Med, Changsha 410081, Hunan, Peoples R China.
   [Gomes Jardim, Ana Carolina] Univ Fed Uberlandia, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil.
   [Terzian, Ana Carolina B.; Nogueira, Mauricio Lacerda] Sao Jose Do Rio Preto Sch Med FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
RP Zhang, B (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
EM zhangbo@wh.iov.cn
RI Nogueira, Mauricio L/B-7599-2012; Jardim, Ana Carolina Gomes/H-3615-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Jardim, Ana Carolina
   Gomes/0000-0002-6348-7923
FU Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety;
   National Key Research and Development Program of China [2018YFA0507201];
   Key Research Program of the Chinese Academy of SciencesChinese Academy
   of Sciences [ZDRW-ZS-2016-4-2]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81572003]; Wuhan
   Institute of Virology
FX We thank the Core Facility and Technical Support, Wuhan Institute of
   Virology and Wuhan Key Laboratory on Emerging Infectious Diseases and
   Biosafety for helpful supports during the course of the work. This work
   was supported by the National Key Research and Development Program of
   China (2018YFA0507201), the Key Research Program of the Chinese Academy
   of Sciences(ZDRW-ZS-2016-4-2), the National Natural Science Foundation
   of China(81572003).
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Aggarwal M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14753
   Amorim R, 2017, ARCH VIROL, V162, P1577, DOI 10.1007/s00705-017-3261-0
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Bullard-Feibelman KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158923
   Caldas LA, 2018, REV SOC BRAS MED TRO, V51, P584, DOI 10.1590/0037-8682-0235-2018
   Camini FC, 2018, ANTIVIR RES, V158, P8, DOI 10.1016/j.antiviral.2018.07.023
   Carvalho CAM, 2014, VIROLOGY, V452, P297, DOI 10.1016/j.virol.2014.01.022
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Cook E, 2018, METHODS MOL BIOL, V1755, P179, DOI 10.1007/978-1-4939-7724-6_13
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Deng CL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070181
   Esposito D. L, 2015, GENOME ANNOUNC, V3
   Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-108
   Friedrich-Janicke B, 2014, EMERG INFECT DIS, V20, P1255, DOI 10.3201/eid2007.140043
   Gad HH, 2012, VIROLOGY, V434, P27, DOI 10.1016/j.virol.2012.07.019
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Hao Weidong, 2009, V510, P243, DOI 10.1007/978-1-59745-394-3_18
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Kummerer BM, 2012, J GEN VIROL, V93, P1991, DOI 10.1099/vir.0.043752-0
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Phillips AT, 2016, J VIROL, V90, P5785, DOI 10.1128/JVI.03219-15
   Pierro DJ, 2003, INSECT MOL BIOL, V12, P107, DOI 10.1046/j.1365-2583.2003.00392.x
   PUGACHEV KV, 1995, VIROLOGY, V212, P587, DOI 10.1006/viro.1995.1516
   Ralambondrainy M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196757
   Shang BD, 2013, ANTIVIR RES, V97, P198, DOI 10.1016/j.antiviral.2012.12.010
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Sun CQ, 2014, J VIROL, V88, P2035, DOI 10.1128/JVI.02990-13
   Tamberg N, 2007, J GEN VIROL, V88, P1225, DOI 10.1099/vir.0.82436-0
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Vanlandingham DL, 2005, INSECT BIOCHEM MOLEC, V35, P1162, DOI 10.1016/j.ibmb.2005.05.008
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
   Weisshaar M, 2016, J VIROL, V90, P7368, DOI 10.1128/JVI.00898-16
   Zhang ZR, 2017, ACS INFECT DIS, V3, P45, DOI 10.1021/acsinfecdis.6b00116
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 43
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD AUG
PY 2019
VL 168
BP 82
EP 90
DI 10.1016/j.antiviral.2019.05.013
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA IR6PU
UT WOS:000481562000010
PM 31150677
DA 2020-07-08
ER

PT J
AU Larose-Pierre, M
   Carter, C
   Honeywell, MS
AF Larose-Pierre, Margareth
   Carter, Chenita
   Honeywell, Marion S.
TI ZIKV Detect 2.0 IgM Capture ELISA
SO US PHARMACIST
LA English
DT Editorial Material
ID VIRUS; DENGUE
C1 [Larose-Pierre, Margareth; Carter, Chenita; Honeywell, Marion S.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
RP Larose-Pierre, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Mezher M, REGULATORY FOCUS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
NR 11
TC 0
Z9 0
U1 0
U2 0
PU JOBSON PUBLISHING LLC
PI NEW YORK
PA 100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA
SN 0148-4818
EI 2331-3501
J9 US PHARM
JI US Pharm.
PD AUG
PY 2019
VL 44
IS 8
BP 36
EP 38
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IS4GV
UT WOS:000482112500011
DA 2020-07-08
ER

PT J
AU Dukhovny, A
   Lamkiewicz, K
   Chen, Q
   Fricke, M
   Jabrane-Ferrat, N
   Marz, M
   Jung, JU
   Sklan, EH
AF Dukhovny, Anna
   Lamkiewicz, Kevin
   Chen, Qian
   Fricke, Markus
   Jabrane-Ferrat, Nabila
   Marz, Manja
   Jung, Jae U.
   Sklan, Ella H.
TI A CRISPR Activation Screen Identifies Genes That Protect against Zika
   Virus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE CRISPR activation; genome-wide screen; interferon-stimulated genes;
   interferons; Zika virus
ID WEST-NILE-VIRUS; DENGUE VIRUS; TRANSCRIPTIONAL ACTIVATION; CODING
   REGION; ISG12; PHOSPHORYLATION; TRANSLATION; EXPRESSION; APOPTOSIS;
   UTILIZES
AB Zika virus (ZIKV) is an arthropod-borne emerging pathogen causing febrile illness. ZIKV is associated Guillain-Barre syndrome and other neurological complications. Infection during pregnancy is associated with pregnancy complications and developmental and neurological abnormalities collectively defined as congenital Zika syndrome. There is still no vaccine or specific treatment for ZIKV infection. To identify host factors that can rescue cells from ZIKV infection, we used a genome-scale CRISPR activation screen. Our highly ranking hits included a short list of interferon-stimulated genes (ISGs) previously reported to have antiviral activity. Validation of the screen results highlighted interferon lambda 2 (IFN-lambda 2) and interferon alpha-inducible protein 6 (IFI6) as genes providing high levels of protection from ZIKV. Activation of these genes had an effect on an early stage in viral infection. In addition, infected cells expressing single guide RNAs (sgRNAs) for both of these genes displayed lower levels of cell death than did the controls. Furthermore, the identified genes were significantly induced in ZIKV-infected placenta explants. Thus, these results highlight a set of ISGs directly relevant for rescuing cells from ZIKV infection or its associated cell death and substantiate CRISPR activation screens as a tool to identify host factors impeding pathogen infection.
   IMPORTANCE Zika virus (ZIKV) is an emerging vector-borne pathogen causing a febrile disease. ZIKV infection might also trigger Guillain-Barre syndrome, neuropathy, and myelitis. Vertical transmission of ZIKV can cause fetus demise, stillbirth, or severe congenital abnormalities and neurological complications. There is no vaccine or specific antiviral treatment against ZIKV. We used a genome-wide CRISPR activation screen, where genes are activated from their native promoters to identify host cell factors that protect cells from ZIKV infection or associated cell death. The results provide a better understanding of key host factors that protect cells from ZIKV infection and might assist in identifying novel antiviral targets.
C1 [Dukhovny, Anna; Sklan, Ella H.] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.
   [Lamkiewicz, Kevin; Fricke, Markus; Marz, Manja] Friedrich Schiller Univ, RNA Bioinformat & High Throughput Anal, Jena, Germany.
   [Lamkiewicz, Kevin; Marz, Manja] European Virus Bioinformat Ctr, Jena, Germany.
   [Marz, Manja] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.
   [Chen, Qian; Jabrane-Ferrat, Nabila] Toulouse III Univ, CNRS UMR5282, INSERM U1043, Ctr Pathophysiol Toulouse Purpan, Toulouse, France.
   [Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA USA.
RP Sklan, EH (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.
EM sklan@tauex.tau.ac.il
OI Lamkiewicz, Kevin/0000-0002-6375-6441
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI140718]
CR Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657
   Carlin AF, 2017, CELL REP, V21, P1600, DOI 10.1016/j.celrep.2017.10.054
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]
   Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Cheriyath V, 2007, J CLIN INVEST, V117, P3107, DOI 10.1172/JCI31122
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Deng XF, 2017, J VIROL, V91, DOI 10.1128/JVI.01533-17
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004
   Fusco DN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00240
   Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09
   Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029
   Gupta R, 2016, ELIFE, V5, DOI 10.7554/eLife.16432
   Gytz H, 2017, BIOL CELL, V109, P94, DOI 10.1111/boc.201600034
   Heaton BE, 2017, CELL REP, V20, P1503, DOI 10.1016/j.celrep.2017.07.060
   Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004
   Huang JQ, 2014, MOL CELL BIOCHEM, V397, P157, DOI 10.1007/s11010-014-2183-3
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016
   Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18
   Parker N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-8
   Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]
   Qi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132743
   Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1
   Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200
   Smidt KCJ, 2003, BBA-MOL BASIS DIS, V1638, P227, DOI 10.1016/S0925-4439(03)00087-5
   Sobarzo A, 2015, VIRUSES-BASEL, V7, P37, DOI 10.3390/v7010037
   Stern O, 2013, J VIROL, V87, P4080, DOI 10.1128/JVI.01900-12
   Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2
   Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Xue BB, 2016, J VIROL, V90, P6832, DOI 10.1128/JVI.00352-16
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhu JZ, 2010, J IMMUNOL, V184, P5768, DOI 10.4049/jimmunol.0903559
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 56
TC 4
Z9 4
U1 4
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2019
VL 93
IS 16
AR e00211-19
DI 10.1128/JVI.00211-19
PG 16
WC Virology
SC Virology
GA IQ4HJ
UT WOS:000480711400004
PM 31142663
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Eyer, L
   Nougairede, A
   Uhlirova, M
   Driouich, JS
   Zouharova, D
   Valdes, JJ
   Haviernik, J
   Gould, EA
   De Clercq, E
   de Lamballerie, X
   Ruzek, D
AF Eyer, Ludek
   Nougairede, Antoine
   Uhlirova, Marie
   Driouich, Jean-Selim
   Zouharova, Darina
   Valdes, James J.
   Haviernik, Jan
   Gould, Ernest A.
   De Clercq, Erik
   de Lamballerie, Xavier
   Ruzek, Daniel
TI An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis
   Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also
   Attenuates the Virus for Mice
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE BCX4430; galidesivir; attenuation; drug resistance; mutation; tick-borne
   encephalitis virus
ID ZIKA VIRUS; NUCLEOSIDE ANALOG; POLYMERASE; CULTURE; FEVER; DNA
AB The adenosine analogue galidesivir (BCX4430), a broad-spectrum RNA virus inhibitor, has entered a phase 1 clinical safety and pharmacokinetics study in healthy subjects and is under clinical development for treatment of Ebola and yellow fever virus infections. Moreover, galidesivir also inhibits the reproduction of tick-borne encephalitis virus (TBEV) and numerous other medically important flaviviruses. Until now, studies of this antiviral agent have not yielded resistant viruses. Here, we demonstrate that an E460D substitution in the active site of TBEV RNA-dependent RNA polymerase (RdRp) confers resistance to galidesivir in cell culture. Galidesivir-resistant TBEV exhibited no cross-resistance to structurally different antiviral nucleoside analogues, such as 7-deaza-2'-C-methyladenosine, 2'-C-methyladenosine, and 4'-azido-aracytidine. Although the E460D substitution led to only a subtle decrease in viral fitness in cell culture, galidesivir-resistant TBEV was highly attenuated in vivo, with a 100% survival rate and no clinical signs observed in infected mice. Furthermore, no virus was detected in the sera, spleen, or brain of mice inoculated with the galidesivir-resistant TBEV. Our results contribute to understanding the molecular basis of galidesivir antiviral activity, flavivirus resistance to nucleoside inhibitors, and the potential contribution of viral RdRp to flavivirus neurovirulence.
   IMPORTANCE Tick-borne encephalitis virus (TBEV) is a pathogen that causes severe human neuroinfections in Europe and Asia and for which there is currently no specific therapy. We have previously found that galidesivir (BCX4430), a broad-spectrum RNA virus inhibitor, which is under clinical development for treatment of Ebola and yellow fever virus infections, has a strong antiviral effect against TBEV. For any antiviral drug, it is important to generate drug-resistant mutants to understand how the drug works. Here, we produced TBEV mutants resistant to galidesivir and found that the resistance is caused by a single amino acid substitution in an active site of the viral RNA-dependent RNA polymerase, an enzyme which is crucial for replication of the viral RNA genome. Although this substitution led only to a subtle decrease in viral fitness in cell culture, galidesivir-resistant TBEV was highly attenuated in a mouse model. Our results contribute to understanding the molecular basis of galidesivir antiviral activity.
C1 [Eyer, Ludek; Uhlirova, Marie; Zouharova, Darina; Valdes, James J.; Haviernik, Jan; Ruzek, Daniel] Vet Res Inst, Dept Virol, Brno, Czech Republic.
   [Eyer, Ludek; Valdes, James J.; Ruzek, Daniel] Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice, Czech Republic.
   [Nougairede, Antoine; Driouich, Jean-Selim; Gould, Ernest A.; de Lamballerie, Xavier] Aix Marseille Univ, Unite Virus Emergents, IRD 190 Inserm 1207 IHU Mediterranee Infect, Marseille, France.
   [De Clercq, Erik] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium.
RP Ruzek, D (corresponding author), Vet Res Inst, Dept Virol, Brno, Czech Republic.; Ruzek, D (corresponding author), Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice, Czech Republic.
EM ruzekd@paru.cas.cz
RI Driouich, Jean-Selim/T-4625-2019; Ruzek, Daniel/G-9275-2014; Eyer,
   Ludek/U-4883-2018; Valdes, James J/G-9812-2014
OI Driouich, Jean-Selim/0000-0003-2326-2938; Ruzek,
   Daniel/0000-0003-4655-2380; Eyer, Ludek/0000-0001-7761-0702; Valdes,
   James J/0000-0002-0237-8061; De Clercq, Erik/0000-0002-2985-8890
FU Ministry of Education, Youth, and Sports of the Czech RepublicMinistry
   of Education, Youth & Sports - Czech Republic [LTAUSA18016]; Ministry of
   Health of the Czech RepublicMinistry of Health, Czech Republic
   [16-34238A]; Project FIT (Pharmacology, Immunotherapy, Nanotoxicology)
   from the Ministry of Education, Youth, and Sports of the Czech Republic
   [CZ.02.1.01/0.0/0.0/15_003/0000495]; Ministry of Agriculture of the
   Czech RepublicMinistry of Agriculture, Czech Republic [RO0518]
FX This study was supported by a grant from the Ministry of Education,
   Youth, and Sports of the Czech Republic (grant LTAUSA18016) (to L.E.),
   by a grant from the Ministry of Health of the Czech Republic (grant
   16-34238A), and by Project FIT (Pharmacology, Immunotherapy,
   Nanotoxicology; CZ.02.1.01/0.0/0.0/15_003/0000495) from the Ministry of
   Education, Youth, and Sports of the Czech Republic and the Ministry of
   Agriculture of the Czech Republic (RO0518) (both to D.R.).
CR Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Bagaglio S, 2017, DRUGS, V77, P1043, DOI 10.1007/s40265-017-0753-x
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   De Clercq E, 2016, J MED CHEM, V59, P2301, DOI 10.1021/acs.jmedchem.5b01157
   Delang L, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00230-18
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Driouich JS, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0040-2
   Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195
   Eyer L, 2019, BIORXIV, DOI [10.1101/563544, DOI 10.1101/563544]
   Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299
   Eyer L, 2017, J VIROL, V91, DOI 10.1128/JVI.01028-17
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Flint M, 2014, ANTIMICROB AGENTS CH, V58, P3206, DOI 10.1128/AAC.02393-14
   Gammon DB, 2008, J VIROL, V82, P12520, DOI 10.1128/JVI.01528-08
   Groarke JM, 1999, J INFECT DIS, V179, P1538, DOI 10.1086/314758
   HEINZ FX, 1993, APMIS, V101, P735, DOI 10.1111/j.1699-0463.1993.tb00174.x
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Irwin K. K., 2016, VIRUS EVOL, V2, P1
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Julander JG, 2014, ANTIMICROB AGENTS CH, V58, P6607, DOI 10.1128/AAC.03368-14
   Khatun A, 2016, J VIROL, V90, P4454, DOI 10.1128/JVI.02836-15
   KOZUCH O, 1975, ACTA VIROL, V19, P498
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200
   Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262
   POSPISIL L, 1954, Lek List, V9, P3
   Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015
   Ruzek D, 2008, VIROLOGY, V374, P249, DOI 10.1016/j.virol.2008.01.010
   Ruzek D, 2019, ANTIVIR RES, V164, P23, DOI 10.1016/j.antiviral.2019.01.014
   Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Westover JB, 2018, ANTIVIR RES, V156, P38, DOI 10.1016/j.antiviral.2018.05.013
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
NR 38
TC 2
Z9 2
U1 5
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2019
VL 93
IS 16
AR e00367-19
DI 10.1128/JVI.00367-19
PG 13
WC Virology
SC Virology
GA IQ4HJ
UT WOS:000480711400011
PM 31142664
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Whelan, JN
   Li, YZ
   Silverman, RH
   Weiss, SR
AF Whelan, Jillian N.
   Li, Yize
   Silverman, Robert H.
   Weiss, Susan R.
TI Zika Virus Production Is Resistant to RNase L Antiviral Activity
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE RNA; RNase L; Sindbis virus; Zika virus; dengue virus; innate immunity;
   replication factories; viral genome
ID L PATHWAY; MURINE CORONAVIRUS; I INTERFERON; ACTIVATION; REPLICATION;
   APOPTOSIS; CLEAVAGE; ANTAGONISM; EXPRESSION; INFECTION
AB There is currently no knowledge of how the emerging human pathogen Zika virus (ZIKV) interacts with the antiviral endoribonuclease L (RNase L) pathway during infection. Since activation of RNase L during infection typically limits virus production dramatically, we used CRISPR-Cas9 gene editing technology to knockout (KO) targeted host genes involved in the RNase L pathway to evaluate the effects of RNase L on ZIKV infection in human A549 cells. RNase L was activated in response to ZIKV infection, which degraded ZIKV genomic RNA. Surprisingly, despite viral genome reduction, RNase L activity did not reduce ZIKV infectious titers. In contrast, both the flavivirus dengue virus and the alphavirus Sindbis virus replicated to significantly higher titers in RNase L KO cells compared to wild-type (WT) cells. Using MAVS/RNase L double KO cells, we demonstrated that the absence of increased ZIKV production in RNase L KO cells was not due to compensation by enhanced type I interferon transcripts to thus inhibit virus production. Finally, when synthetic double-stranded RNA was detected by OAS3 to induce RNase L antiviral activity prior to ZIKV infection, we observed reduced ZIKV replication factory formation, as well as a 42-fold reduction in virus yield in WT but not RNase L KO cells. This study proposes that ZIKV evades RNase L antiviral activity by generating a viral genome reservoir protected from RNase L cleavage during early infection, allowing for sufficient virus production before RNase L activation is detectable.
   IMPORTANCE With the onset of the 2015 ZIKV outbreak, ZIKV pathogenesis has been of extreme global public health interest, and a better understanding of interactions with the host would provide insight into molecular mechanisms driving the severe neurological outcomes of ZIKV disease. Here is the initial report on the relationship between ZIKV and the host oligoadenylate synthetase-RNase L (OAS-RNase L) system, a potent antiviral pathway effective at restricting replication of diverse viruses. Our study elucidated a unique mechanism whereby ZIKV production is impervious to antiviral RNase L activity, through a mechanism of viral RNA protection that is not mimicked during infection with numerous other RNase L-activating viruses, thus identifying a distinct replication strategy potentially important for ZIKV pathogenesis.
C1 [Whelan, Jillian N.; Li, Yize; Weiss, Susan R.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA.
RP Weiss, SR (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.
EM weisssr@pennmedicine.upenn.edu
RI Whelan, Jillian/AAD-1214-2019; Weiss, Susan/J-8263-2015
OI Whelan, Jillian/0000-0002-2735-2124; Weiss, Susan/0000-0002-8155-4528
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21NS100182, R01AI104887, T32NS007180]
FX This study was supported by NIH grants R21NS100182 (to S.R.W.) and
   R01AI104887 (to S.R.W. and R.H.S.). J.N.W. was supported in part by
   T32NS007180.
CR Aulas A, 2017, J CELL SCI, V130, P927, DOI 10.1242/jcs.199240
   BAGLIONI C, 1984, J VIROL, V52, P865, DOI 10.1128/JVI.52.3.865-871.1984
   Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Birdwell LD, 2016, J VIROL, V90, P3160, DOI 10.1128/JVI.03036-15
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967
   Chakrabarti A, 2015, CELL HOST MICROBE, V17, P466, DOI 10.1016/j.chom.2015.02.010
   Chitrakar A, 2019, P NATL ACAD SCI USA, V116, P2103, DOI 10.1073/pnas.1818363116
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133
   Donovan J, 2017, RNA, V23, P1660, DOI 10.1261/rna.062000.117
   Drappier M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006989
   Drappier M, 2015, CURR OPIN VIROL, V15, P19, DOI 10.1016/j.coviro.2015.07.002
   Foo KY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/427814
   Girardi E, 2013, MBIO, V4, DOI 10.1128/mBio.00698-13
   Goldstein SA, 2017, J VIROL, V91, DOI 10.1128/JVI.02201-16
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/jir.2004.24.664
   Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Li YZ, 2017, ELIFE, V6, DOI 10.7554/eLife.25687
   Li YZ, 2016, J VIROL, V90, P9826, DOI 10.1128/JVI.01423-16
   Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Malathi K, 2014, MBIO, V5, DOI 10.1128/mBio.02012-14
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Sanchez-Tacuba L, 2015, J VIROL, V89, P12145, DOI 10.1128/JVI.01874-15
   Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07
   Silverman RH, 2014, J INTERF CYTOK RES, V34, P455, DOI 10.1089/jir.2014.0007
   Smith JA, 2005, J VIROL, V79, P2240, DOI 10.1128/JVI.79.4.2240-2250.2005
   Suthar MS, 2005, J VIROL, V79, P4219, DOI 10.1128/JVI.79.7.4219-4228.2005
   Tang MF, 2018, BUS STRATEG ENVIRON, V27, P39, DOI 10.1002/bse.1981
   Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351
   Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xiang Y, 2003, CANCER RES, V63, P6795
   Zhang R, 2013, P NATL ACAD SCI USA, V110, P13114, DOI 10.1073/pnas.1306917110
   Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011
   Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355
NR 53
TC 6
Z9 6
U1 1
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2019
VL 93
IS 16
AR e00313-19
DI 10.1128/JVI.00313-19
PG 14
WC Virology
SC Virology
GA IQ4HJ
UT WOS:000480711400007
PM 31142667
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Frey, MT
   Meaney-Delman, D
   Bowen, V
   Yazdy, MM
   Watkins, SM
   Thorpe, PG
   Honein, MA
AF Frey, Meghan T.
   Meaney-Delman, Dana
   Bowen, Virginia
   Yazdy, Mahsa M.
   Watkins, Sharon M.
   Thorpe, Phoebe G.
   Honein, Margaret A.
TI Surveillance for Emerging Threats to Pregnant Women and Infants
SO JOURNAL OF WOMENS HEALTH
LA English
DT Article
DE infectious diseases; emerging threats; pregnant women; infants;
   preparedness
ID BIRTH-DEFECTS; UNITED-STATES; RISK
AB Recent public health emergencies have highlighted the unique vulnerabilities of pregnant women and infants to emerging health threats and the critical role of public health surveillance. Surveillance systems can collect critical data to measure the impact of a disease or disaster and can be used to inform clinical guidance and prevention strategies. These systems can also be tailored to collect data on vulnerable populations, such as pregnant women and their infants. Novel surveillance systems to assess risks and outcomes of pregnant women and infants have been established during public health emergencies but typically cease data collection once the public health response has ended, limiting our ability to collect data to understand longer-term outcomes. State-based birth defects surveillance systems are not available in all states, and no national surveillance system linking pregnancy exposure data to longitudinal outcomes for infants and children exists. In this report, we describe ongoing surveillance efforts to monitor congenital syphilis, Zika virus infection during pregnancy, and neonatal abstinence syndrome. We describe the need and rationale for an ongoing integrated surveillance system to monitor pregnant women and their infants and to detect emerging threats. We also discuss how data collected through this type of system can better position federal, state, and local health departments to more rapidly and comprehensively respond to the next public health emergency.
C1 [Frey, Meghan T.; Meaney-Delman, Dana; Honein, Margaret A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA.
   [Bowen, Virginia] Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.
   [Bowen, Virginia] US PHS, Rockville, MD USA.
   [Yazdy, Mahsa M.] Massachusetts Ctr Birth Defects Res & Prevent, Massachusetts Dept Publ Hlth, Boston, MA USA.
   [Watkins, Sharon M.] Bur Epidemiol, Penn Dept Hlth, Harrisburg, PA USA.
   [Thorpe, Phoebe G.] Ctr Dis Control & Prevent, Off Sci, Atlanta, GA USA.
RP Frey, MT (corresponding author), Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA.
EM mfrey@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Adams DA, 2017, MMWR-MORBID MORTAL W, P64
   Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X
   Broussard CS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.039
   Callaghan WM, 2007, MATERN CHILD HLTH J, V11, P307, DOI 10.1007/s10995-007-0177-4
   Centers for Disease Control and Prevention, 2018, SEX TRANSM DIS SURV
   Centers for Disease Control and Prevention, 2018, PUBL HLTH GRAND ROUN
   Centers for Disease Control and Prevention, 2017, CDC CALL ACT LETS WO
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Council of State and Territorial Epidemiologists (CSTE), 2019, NEON ABST SYNDR STAN
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Crider KS, 2009, ARCH PEDIAT ADOL MED, V163, P978, DOI 10.1001/archpediatrics.2009.188
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Fill MMA, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0562
   Gilboa SM, 2017, BIRTH DEFECTS RES, V109, P372, DOI 10.1002/bdr2.1007
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Haight SC, 2018, MMWR-MORBID MORTAL W, V67, P845, DOI 10.15585/mmwr.mm6731a1
   HOLMES K, 2008, SEXUALLY TRANSMITTED
   Honein MA, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3801
   INGRAHAM N R Jr, 1950, Acta Derm Venereol Suppl (Stockh), V31, P60
   Institute of Medicine, 1988, FUT PUBL HLTH, V88
   Jilani SM, 2019, MMWR-MORBID MORTAL W, V68, P6, DOI 10.15585/mmwr.mm6801a2
   Lind JN, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4131
   Lupo PJ, 2017, BIRTH DEFECTS RES, V109, P1504, DOI 10.1002/bdr2.1145
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Rasmussen SA, 2005, AM J PUBLIC HEALTH, V95, P1942, DOI 10.2105/AJPH.2004.054957
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Senturias Y, 2014, CURR PROB PEDIATR AD, V44, P88, DOI 10.1016/j.cppeds.2013.12.008
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   The Office of the Pennsylvania Governor, 2018, GOV WOLFS DIS DECL H
   Winkelman TNA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3520
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Yazdy MM, 2013, OBSTET GYNECOL, V122, P838, DOI 10.1097/AOG.0b013e3182a6643c
NR 34
TC 2
Z9 2
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-9996
EI 1931-843X
J9 J WOMENS HEALTH
JI J. Womens Health
PD AUG 1
PY 2019
VL 28
IS 8
BP 1031
EP 1036
DI 10.1089/jwh.2019.7943
PG 6
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal; Obstetrics & Gynecology; Women's Studies
SC Public, Environmental & Occupational Health; General & Internal
   Medicine; Obstetrics & Gynecology; Women's Studies
GA IQ2JY
UT WOS:000480576000007
PM 31408424
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Richter, M
   Leuthold, MM
   Graf, D
   Bartenschlager, R
   Klein, CD
AF Richter, Michael
   Leuthold, Mila M.
   Graf, Dominik
   Bartenschlager, Ralf
   Klein, Christian D.
TI Prodrug Activation by a Viral Protease: Evaluating Combretastatin
   Peptide Hybrids To Selectively Target Infected Cells
SO ACS MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Dengue virus; Zika virus; tubulin; combretastatin; serine protease
ID SOLID TUMORS; DENGUE; VIRUS; SEQUENCE; ANALOGS; ENZYMES; BURDEN; FUTURE;
   A4
AB Infections with flaviviruses such as dengue virus (DENV) are prevalent throughout tropical regions worldwide. Replication of these viruses depends on tubulin, a host cell factor that can be targeted to obtain broad-spectrum antiviral agents. Targeting of tubulin does, however, require specific measures to avoid toxic side-effects. Herein, we report the synthesis and biological evaluation of combretastatin peptide hybrids that incorporate the cleavage site of the DENV protease to allow activation of the tubulin ligand within infected cells. The prodrug candidates have no effect on tubulin polymerization in vitro and are 20-2000-fold less toxic than combretastatin A-4. Several of the prodrug candidates were cleaved by the DENV protease in vitro with similar efficiency as the natural viral substrates. Selected compounds were studied in DENV and Zika virus replication assays and had antiviral activity at subcytotoxic concentrations.
C1 [Richter, Michael; Leuthold, Mila M.; Graf, Dominik; Klein, Christian D.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Bartenschlager, Ralf; Klein, Christian D.] German Ctr Infect Res DZIF, Heidelberg Partner Site, Heidelberg, Germany.
RP Klein, CD (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.; Klein, CD (corresponding author), German Ctr Infect Res DZIF, Heidelberg Partner Site, Heidelberg, Germany.
EM c.klein@uni-heidelberg.de
RI ; Bartenschlager, Ralf/L-2582-2015
OI Klein, Christian/0000-0003-3522-9182; Bartenschlager,
   Ralf/0000-0001-5601-9307
CR Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DAVIDSON E, 1975, BIOCHIM BIOPHYS ACTA, V397, P437, DOI 10.1016/0005-2744(75)90133-3
   Foo K. Y, 2015, BIOMED RES INT, V2015, P1
   Gaspari R, 2017, CHEM-US, V2, P102, DOI 10.1016/j.chempr.2016.12.005
   Jaroch K, 2016, PHARMACOL REP, V68, P1266, DOI 10.1016/j.pharep.2016.08.007
   Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162
   Khumthong R, 2003, PROTEIN PEPTIDE LETT, V10, P19, DOI 10.2174/0929866033408228
   Liu TZ, 2017, ACTA BIOMATER, V53, P179, DOI 10.1016/j.actbio.2017.02.001
   MACKOW E, 1987, VIROLOGY, V159, P217, DOI 10.1016/0042-6822(87)90458-2
   Medarde M, 2004, J ENZYM INHIB MED CH, V19, P521, DOI 10.1080/14756360412331280473
   Mikstacka R, 2013, CELL MOL BIOL LETT, V18, P368, DOI 10.2478/s11658-013-0094-z
   Nihei Y, 1999, JPN J CANCER RES, V90, P1016, DOI 10.1111/j.1349-7006.1999.tb00850.x
   Nitsche Christoph, 2013, Methods Mol Biol, V1030, P221, DOI 10.1007/978-1-62703-484-5_18
   Ohsumi K, 1998, J MED CHEM, V41, P3022, DOI 10.1021/jm980101w
   PETTIT GR, 1995, ANTI-CANCER DRUG DES, V10, P299
   Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393
   Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134
   Richter M, 2019, CHEMMEDCHEM, V14, P469, DOI 10.1002/cmdc.201800641
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Steinmetz MO, 2018, TRENDS CELL BIOL, V28, P776, DOI 10.1016/j.tcb.2018.05.001
   Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903
   Weidle UH, 2014, CANCER GENOM PROTEOM, V11, P67
   WITTIG G, 1954, CHEM BER-RECL, V87, P1318, DOI 10.1002/cber.19540870919
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V30, P349
   Yasobu N, 2011, ACS MED CHEM LETT, V2, P348, DOI 10.1021/ml100287y
NR 32
TC 0
Z9 0
U1 3
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-5875
J9 ACS MED CHEM LETT
JI ACS Med. Chem. Lett.
PD AUG
PY 2019
VL 10
IS 8
BP 1115
EP 1121
DI 10.1021/acsmedchemlett.9b00058
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA IQ1HD
UT WOS:000480500000004
PM 31413794
DA 2020-07-08
ER

PT J
AU Moco, ACR
   Guedes, PH
   Flauzino, JMR
   da Silva, HS
   Vieira, JG
   Castro, ACH
   Gomes, EVR
   Tolentino, FM
   Soares, MMCN
   Madurro, JM
   Brito-Madurro, AG
AF Moco, Anna C. R.
   Guedes, Pedro H.
   Flauzino, Jose M. R.
   da Silva, Heliane S.
   Vieira, Jussara G.
   Castro, Ana C. H.
   Gomes, Erica V. R.
   Tolentino, Fernanda M.
   Soares, Marcia M. C. N.
   Madurro, Joao M.
   Brito-Madurro, Ana G.
TI Electrochemical Detection of Zika Virus in Biological Samples: A Step
   for Diagnosis Point-of-care
SO ELECTROANALYSIS
LA English
DT Article
DE genosensor; diagnosis; nanomaterials; polytyramine; Zika virus
ID DNA-SEQUENCE; IMMOBILIZATION; GENOSENSOR; BIOSENSOR
AB This work describes an electrochemical genosensor for detection of genomic RNA of Zika virus in real samples of infected patients, using a new platform based on graphite electrodes modified with electrochemically reduced graphene oxide and polytyramine-conducting polymer. The developed genosensor was suitable for differentiation between samples of healthy and infected patients with Zika virus by differential pulse voltammetry, detecting up to 0.1 fg/mL (1.72 copies/mL), showing good stability (about 60 days), rapid analysis (about 20 min) and potential for filling the lack of practical diagnostic methods for Zika virus.
C1 [Moco, Anna C. R.; Guedes, Pedro H.; Flauzino, Jose M. R.; Vieira, Jussara G.; Castro, Ana C. H.; Brito-Madurro, Ana G.] Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil.
   [da Silva, Heliane S.; Madurro, Joao M.] Univ Fed Uberlandia, Inst Chem, Uberlandia, MG, Brazil.
   [Gomes, Erica V. R.; Tolentino, Fernanda M.; Soares, Marcia M. C. N.] Adolfo Lutz Inst, Reg Lab Sao Jose Rio Do Preto, Sao Jose Rio Do Preto, Brazil.
RP Brito-Madurro, AG (corresponding author), Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil.
EM agbrito@ufu.br
RI Madurro, Ana/AAH-4588-2019; Tolentino, Fernanda Modesto/U-7657-2017;
   Flauzino, Jose/K-7182-2016
OI Tolentino, Fernanda Modesto/0000-0002-2172-6594; Flauzino,
   Jose/0000-0002-0437-4435
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors are grateful for the financial support from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Also, we would
   like to thank teacher Abilio Borghi for the review of the English
   manuscript.
CR Abrahao O, 2013, J MOL STRUCT, V1037, P200, DOI 10.1016/j.molstruc.2012.12.056
   Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Cabral-Miranda G, 2018, BIOSENS BIOELECTRON, V113, P101, DOI 10.1016/j.bios.2018.04.058
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chowdhury AD, 2018, ANAL CHEM, V90, P12464, DOI 10.1021/acs.analchem.8b01802
   Chua CK, 2016, CHEM COMMUN, V52, P72, DOI 10.1039/c5cc08170j
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva JV, 2017, J SOLID STATE ELECTR, V21, P2129, DOI 10.1007/s10008-017-3601-8
   de Castro CM, 2008, J MATER SCI, V43, P475, DOI 10.1007/s10853-007-1880-7
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Ferreira LF, 2011, MATER CHEM PHYS, V129, P46, DOI 10.1016/j.matchemphys.2011.03.053
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Franco DL, 2008, POLYM ENG SCI, V48, P2043, DOI 10.1002/pen.21044
   Castro ACH, 2014, APPL SURF SCI, V314, P273, DOI 10.1016/j.apsusc.2014.06.084
   Kaushik A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28035-3
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Lu C, 2016, LANGMUIR, V32, P10776, DOI 10.1021/acs.langmuir.6b03032
   Mahato K, 2018, BIOSENS BIOELECTRON, V100, P411, DOI 10.1016/j.bios.2017.09.003
   Mazlan NF, 2019, TALANTA, V198, P358, DOI 10.1016/j.talanta.2019.02.036
   Faria HAM, 2019, BIOSENS BIOELECTRON, V131, P149, DOI 10.1016/j.bios.2019.02.018
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Panjan P, 2017, TALANTA, V170, P331, DOI 10.1016/j.talanta.2017.04.011
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Singhal C, 2018, PROCESS BIOCHEM, V74, P35, DOI 10.1016/j.procbio.2018.08.020
   Singhal C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25824-8
   Singhal C, 2017, BIOSENS BIOELECTRON, V97, P75, DOI 10.1016/j.bios.2017.05.047
   Tambo E, 2017, J PARASITE EPIDEMIOL, V2, P50
   Tancharoen C, 2019, ACS SENSORS, V4, P69, DOI 10.1021/acssensors.8b00885
   Tran LD, 2003, SYNTHETIC MET, V139, P251, DOI 10.1016/S0379-6779(03)00131-0
   Vainio EJ, 2018, J GEN VIROL, V99, P17, DOI 10.1099/jgv.0.000985
NR 36
TC 1
Z9 1
U1 10
U2 13
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1040-0397
EI 1521-4109
J9 ELECTROANAL
JI Electroanalysis
PD AUG
PY 2019
VL 31
IS 8
BP 1597
EP 1604
DI 10.1002/elan.201900068
PG 8
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA IO0PO
UT WOS:000479081100022
DA 2020-07-08
ER

PT J
AU Kovanich, D
   Saisawang, C
   Sittipaisankul, P
   Ramphan, S
   Kalpongnukul, N
   Somparn, P
   Pisitkun, T
   Smith, DR
AF Kovanich, Duangnapa
   Saisawang, Chonticha
   Sittipaisankul, Potchaman
   Ramphan, Suwipa
   Kalpongnukul, Nuttiya
   Somparn, Poorichaya
   Pisitkun, Trairak
   Smith, Duncan R.
TI Analysis of the Zika and Japanese Encephalitis Virus NS5 Interactomes
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE flavivirus; nonstructural protein 5; NS5; Japanese encephalitis virus;
   Zika virus
ID PROTEIN PHOSPHATASE 6; DENGUE VIRUS; RNA-SYNTHESIS; REPLICATION;
   COMPLEX; PHOSPHORYLATION; IDENTIFICATION; TRANSCRIPTION; TRANSLATION;
   HELICASE
AB Mosquito-borne flaviviruses, including dengue virus (DENV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV), are major human pathogens. Among the flaviviral proteins, the nonstructural protein 5 (NS5) is the largest, most conserved, and major enzymatic component of the viral replication complex. Disruption of the common key NS5-host protein-protein interactions critical for viral replication could aid in the development of broad-spectrum antiflaviviral therapeutics. Hundreds of NS5 interactors have been identified, but these are mostly DENV-NS5 interactors. To this end, we sought to investigate the JEV- and ZIKV-NS5 interactomes using EGFP immunoprecipitation with label-free quantitative mass spectrometry analysis. We report here a total of 137 NS5 interactors with a significant enrichment of spliceosomal and spliceosomal-associated proteins. The transcription complex Paf1C and phosphatase 6 were identified as common NS5-associated complexes. PAF1 was shown to play opposite roles in JEV and ZIKV infections. Additionally, we validated several NS5 targets and proposed their possible roles in infection. These include lipid-shuttling proteins OSBPL9 and OSBPL11, component of RNAP3 transcription factor TFIIIC, minichromosome maintenance, and cochaperone PAQosome. Mining this data set, our study expands the current interaction landscape of NS5 and uncovers several NS5 targets that are new to flavivirus biology.
C1 [Kovanich, Duangnapa; Saisawang, Chonticha; Sittipaisankul, Potchaman; Ramphan, Suwipa; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand.
   [Kalpongnukul, Nuttiya; Somparn, Poorichaya; Pisitkun, Trairak] Chulalongkorn Univ, Fac Med, Ctr Excellence Syst Biol, Res Affairs, Bangkok, Thailand.
RP Pisitkun, T (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Syst Biol, Res Affairs, Bangkok, Thailand.
EM pisitkut@nhlbi.nih.gov
OI Pisitkun, Trairak/0000-0001-6677-2271
FU Mahidol University; Research Fund for DPST graduates [021/2559];
   Thailand Research FundThailand Research Fund (TRF) [MRG6080085,
   BRG6080006]; Newton Fund [FDS-CO-2561-6820-TH]; Chulalongkorn Academic
   Advancement into its Second Century Project (CUAASC) grant
FX This work was supported by grants from Mahidol University, the Research
   Fund for DPST graduates (021/2559), and the Thailand Research Fund
   (MRG6080085) to D.K. D.R.S. was supported by the Thailand Research Fund
   (BRG6080006) and the Newton Fund as administered by the National Science
   and Technology Development Agency (FDS-CO-2561-6820-TH). T.P. was
   supported by Chulalongkorn Academic Advancement into its Second Century
   Project (CUAASC) grant. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. We thank Atitaya Hitakarun for helping in all aspects of
   experiments involving viruses.
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09
   Bhattacharya D, 2009, VIRUS RES, V141, P101, DOI 10.1016/j.virusres.2009.01.002
   Carpp LN, 2014, MOL CELL PROTEOMICS, V13, P2836, DOI 10.1074/mcp.M114.038984
   Chen Z, 2016, J VIROL, V90, P3722, DOI 10.1128/JVI.03242-15
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dorobantu CM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005185
   Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09
   Dubois J, 2014, MBIO, V5, DOI 10.1128/mBio.00070-14
   Gauthier MS, 2018, ADV EXP MED BIOL, V1106, P25, DOI 10.1007/978-3-030-00737-9_3
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang SP, 2009, ARCH VIROL, V154, P1101, DOI 10.1007/s00705-009-0416-7
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kamoun M, 2013, BIOCHEM BIOPH RES CO, V440, P306, DOI 10.1016/j.bbrc.2013.09.068
   Kao YT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004750
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11
   Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881
   Keating JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-242
   Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Khunchai S, 2012, BIOCHEM BIOPH RES CO, V423, P398, DOI 10.1016/j.bbrc.2012.05.137
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Li C, 2014, VIROLOGY, V449, P70, DOI 10.1016/j.virol.2013.11.008
   Li C, 2013, ANTIVIR RES, V100, P487, DOI 10.1016/j.antiviral.2013.09.002
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94
   Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Male G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8387
   Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892
   Mazeaud C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00595
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Meutiawati F, 2018, ANTIVIR RES, V157, P68, DOI 10.1016/j.antiviral.2018.06.017
   Morais ATS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-205
   Morozova OV, 1997, VIRUS RES, V49, P9, DOI 10.1016/S0168-1702(96)01433-5
   Morwitzer MJ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040372
   Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6
   Pietrangelo A, 2018, CELL MOL LIFE SCI, V75, P3079, DOI 10.1007/s00018-018-2795-y
   Poyomtip T, 2016, J GEN VIROL, V97, P646, DOI 10.1099/jgv.0.000371
   PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993
   Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   SCHNEIDER PA, 1994, J VIROL, V68, P5007, DOI 10.1128/JVI.68.8.5007-5012.1994
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Simmonds P, 2001, VIRUS TAXONOMY, P1003
   SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011
   Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05
   Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839
   Wang HL, 2014, GASTROENTEROLOGY, V146, P1373, DOI 10.1053/j.gastro.2014.02.002
   Wang RYL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-471
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wilusz JE, 2015, WIRES RNA, V6, P453, DOI 10.1002/wrna.1287
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Ye J, 2017, J VIROL, V91, DOI [10.1128/jvi.00039-17, 10.1128/JVI.00039-17]
   Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188
   Yoo NK, 2008, CELL MICROBIOL, V10, P583, DOI 10.1111/j.1462-5822.2007.01047.x
   York A, 2014, J VIROL, V88, P13284, DOI 10.1128/JVI.01813-14
   Ziembik MA, 2017, BIOCHEM SOC T, V45, P693, DOI 10.1042/BST20160169
NR 77
TC 5
Z9 5
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD AUG
PY 2019
VL 18
IS 8
BP 3203
EP 3218
DI 10.1021/acs.jproteome.9b00318
PG 16
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA IP9LE
UT WOS:000480370800020
PM 31199156
DA 2020-07-08
ER

PT J
AU Oboist, U
   Perez, PN
   Villabona-Arenas, CJ
   Theze, J
   Faria, NR
   Lourenco, J
AF Oboist, Uri
   Perez, Pablo N.
   Villabona-Arenas, Christian J.
   Theze, Julien
   Faria, Nuno R.
   Lourenco, Jose
TI MVSE: An R-package that estimates a climate-driven mosquito-borne viral
   suitability index
SO METHODS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE community ecology; community ecological modelling; disease ecology;
   disease ecological modelling; microbial ecology; mosquitoes;
   mosquito-borne Viral Suitability Estimator; viruses
ID AEDES-AEGYPTI; ZIKA VIRUS; JAPANESE ENCEPHALITIS; WEST-NILE; DENGUE;
   TEMPERATURE; CULICIDAE; OUTBREAK; DIPTERA; VECTOR
AB Viruses, such as dengue, Zika, yellow fever and chikungunya, depend on mosquitoes for transmission. Their epidemics typically present periodic patterns, linked to the underlying mosquito population dynamics, which are known to be driven by natural climate fluctuations. Understanding how climate dictates the timing and potential of viral transmission is essential for preparedness of public health systems and design of control strategies. While various alternative approaches have been proposed to estimate local transmission potential of such viruses, few open-source, ready to use and freely available software tools exist. We developed the Mosquito-borne Viral Suitability Estimator (MVSE) software package for the R programming environment. MVSE estimates the index P, a novel suitability index based on a climate-driven mathematical expression for the basic reproductive number of mosquito-borne viruses. By accounting for local humidity and temperature, as well as viral, vector and human priors, the index P can be estimated for specific host and viral species in different regions of the globe. We describe the background theory, empirical support and biological interpretation of the index P. Using real-world examples spanning multiple epidemiological contexts, we further demonstrate MVSE's basic functionality, research and educational potentials.
C1 [Oboist, Uri] Tel Aviv Univ, Sch Publ Hlth, Tel Aviv, Israel.
   [Oboist, Uri] Tel Aviv Univ, Porter Sch Environm & Earth Sci, Tel Aviv, Israel.
   [Perez, Pablo N.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England.
   [Villabona-Arenas, Christian J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London, England.
   [Theze, Julien; Faria, Nuno R.; Lourenco, Jose] Univ Oxford, Dept Zool, Oxford, England.
RP Lourenco, J (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM jose.lourenco@zoo.ox.ac.uk
OI Lourenco, Jose/0000-0002-9318-2581; Villabona Arenas, Christian
   Julian/0000-0001-9928-3968
FU Higher Education Funding Council for EnglandHigher Education Funding
   Council for England [005073]; John Fell Fund, University of Oxford
   [005166]; European Molecular Biology OrganizationEuropean Molecular
   Biology Organization (EMBO); Wellcome TrustWellcome Trust
   [204311/Z/16/Z]; Royal SocietyRoyal Society of London [204311/Z/16/Z];
   H2020 European Research Council [757688]; FP7 Ideas: European Research
   Council [268904, 614725]
FX Higher Education Funding Council for England, Grant/Award Number:
   005073; John Fell Fund, University of Oxford, Grant/Award Number:
   005166; European Molecular Biology Organization; Wellcome Trust and
   Royal Society, Grant/Award Number: 204311/Z/16/Z; H2020 European
   Research Council, Grant/Award Number: ERC-2017-STG and 757688; FP7
   Ideas: European Research Council, Grant/Award Number: 268904 -DIVERSITY
   and 614725 -PATHPHYLODYN
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034651
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dickerson CZ, 2007, EFFECTS TEMPERATURE
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dutta P, 2010, J ENVIRON BIOL, V31, P781
   Ezeakacha N., 2015, THESIS, P131
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS, V8
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92
   Guzzetta G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005918
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, P1
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006284
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Jaenisch Thomas, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2010.140487
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer M. U. G., 2016, LANCET INFECT DIS, V3099, P1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Louren<comma>co J., 2019, MVSE DATA COLLECTION, DOI [10.6084/m9.figshare.c.4485503, DOI 10.6084/M9.FIGSHARE.C.4485503]
   Lourenco J, 2018, EVOL APPL, V11, P516, DOI 10.1111/eva.12554
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lourenco J, 2016, EPIDEMICS-NETH, V16, P40, DOI 10.1016/j.epidem.2016.05.003
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Madeira NG, 2002, MEM I OSWALDO CRUZ, V97, P415, DOI 10.1590/S0074-02762002000300025
   MAGALHAES T, 2017, PLOS NEGLECT TROP D, V26, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Monteiro LCC, 2007, NEOTROP ENTOMOL, V36, P966, DOI 10.1590/S1519-566X2007000600021
   Mordecai E. A., 2017, PLOS NEGLECT TROP D, V11, P1
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oo TT, 2011, TROP BIOMED, V28, P302
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Perez-Guzman Pablo Noel, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.7a6c64436a3085ebba37e5329ba169e6
   ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143
   ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P1251, DOI 10.1016/0022-1910(68)90018-8
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0
   Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Williams CR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000922
   Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yanoviak SP, 2006, ECOL APPL, V16, P1854, DOI 10.1890/1051-0761(2006)016[1854:DAPHAA]2.0.CO;2
   Yasuno M., 1960, POPULATION ENGLISH E, V43, P319
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
NR 78
TC 1
Z9 1
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2041-210X
EI 2041-2096
J9 METHODS ECOL EVOL
JI Methods Ecol. Evol.
PD AUG
PY 2019
VL 10
IS 8
BP 1357
EP 1370
DI 10.1111/2041-210X.13205
PG 14
WC Ecology
SC Environmental Sciences & Ecology
GA IO1AD
UT WOS:000479111100022
PM 32391139
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Muller, WJ
   Mulkey, SB
AF Muller, William J.
   Mulkey, Sarah B.
TI Lessons about early neurodevelopment in children exposed to ZIKV in
   utero
SO NATURE MEDICINE
LA English
DT Editorial Material
ID VIRUS-INFECTION; PREGNANCY OUTCOMES; TERRITORIES; INFANTS; STATES
AB Infants with congenital Zika virus infection are at risk for multiple abnormalities related to impairment in neurodevelopment. Although some findings apparent at birth may resolve with time, infants with no abnormalities apparent at birth may develop problems in early childhood.
C1 [Muller, William J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA.
   [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
   [Mulkey, Sarah B.] Childrens Natl Hlth Syst, Fetal Med Inst, Washington, DC USA.
RP Muller, WJ (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA.
EM wjmuller@northwestern.edu
OI Muller, William J/0000-0001-7690-0695
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 12
TC 0
Z9 0
U1 1
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2019
VL 25
IS 8
BP 1192
EP 1193
DI 10.1038/s41591-019-0540-1
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA IQ0BI
UT WOS:000480414600013
PM 31359000
DA 2020-07-08
ER

PT J
AU Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Vasconcelos, Z
   Gabaglia, CR
   Damasceno, L
   Pone, M
   de Carvalho, LMA
   Pone, SM
   Zin, AA
   Tsui, I
   Salles, TRS
   da Cunha, DC
   Costa, RP
   Malacarne, J
   Reis, AB
   Hasue, RH
   Aizawa, CYP
   Genovesi, FF
   Einspieler, C
   Marschik, PB
   Pereira, JP
   Gaw, SL
   Adachi, K
   Cherry, JD
   Xu, ZH
   Cheng, GH
   Moreira, ME
AF Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Vasconcelos, Zilton
   Gabaglia, Claudia Raja
   Damasceno, Luana
   Pone, Marcos
   Abreu de Carvalho, Liege M.
   Pone, Sheila M.
   Zin, Andrea A.
   Tsui, Irena
   Salles, Tania Regina S.
   da Cunha, Denise Cotrim
   Costa, Roozemerie Pereira
   Malacarne, Jociele
   Reis, Ana Beatriz
   Hasue, Renata Hydee
   Aizawa, Carolina Y. P.
   Genovesi, Fernanda F.
   Einspieler, Christa
   Marschik, Peter B.
   Pereira, Jose Paulo
   Gaw, Stephanie L.
   Adachi, Kristina
   Cherry, James D.
   Xu, Zhiheng
   Cheng, Genhong
   Moreira, Maria Elisabeth
TI Delayed childhood neurodevelopment and neurosensory alterations in the
   second year of life in a prospective cohort of ZIKV-exposed children
SO NATURE MEDICINE
LA English
DT Article
ID INFANT NEUROLOGICAL EXAMINATION; VIRUS-INFECTION; OPHTHALMIC
   MANIFESTATIONS; CEREBRAL-PALSY; BIRTH-DEFECTS; BAYLEY-III; EPIDEMIC;
   OUTCOMES; SEX
AB We report neurodevelopmental outcomes in 216 infants followed since the time of PCR-confirmed maternal Zika virus (ZIKV) infection in pregnancy during the Rio de Janeiro epidemic of 2015-2016 (refs. (1,2)). Neurodevelopment was assessed by Bayley Scales of Infant and Toddler Development, third edition (Bayley-III; cognitive, language and motor domains) in 146 children and through neurodevelopment questionnaires/neurological examinations in 70 remaining children. Complete eye exams (n = 137) and hearing assessments (n = 114) were also performed. Below-average neurodevelopment and/or abnormal eye or hearing assessments were noted in 31.5% of children between 7 and 32 months of age. Among children assessed by Bayley-III, 12% scored below -2 s.d. (score < 70; a score of 100 +/- 2 s.d. is the range) in at least one domain; and 28% scored between -1 and -2 s.d. in any domain (scores < 85-70). Language function was most affected, with 35% of 146 children below average. Improved neurodevelopmental outcomes were noted in female children, term babies, children with normal eye exams and maternal infection later in pregnancy (P = 0.01). We noted resolution of microcephaly with normal neurodevelopment in two of eight children, development of secondary microcephaly in two other children and autism spectrum disorder in three previously healthy children in the second year of life.
C1 [Nielsen-Saines, Karin; Kerin, Tara; Tsui, Irena; Adachi, Kristina; Cherry, James D.; Cheng, Genhong] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Brasil, Patricia; Vasconcelos, Zilton; Damasceno, Luana; Pone, Marcos; Abreu de Carvalho, Liege M.; Pone, Sheila M.; Zin, Andrea A.; Salles, Tania Regina S.; da Cunha, Denise Cotrim; Costa, Roozemerie Pereira; Malacarne, Jociele; Reis, Ana Beatriz; Pereira, Jose Paulo; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, Renata Hydee; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Graz, Austria.
   [Marschik, Peter B.] Univ Med Ctr, Gottingen, Germany.
   [Gaw, Stephanie L.] UCSF Sch Med, San Francisco, CA USA.
   [Xu, Zhiheng] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China.
RP Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.; Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
EM knielsen@mednet.ucla.edu; bebethiff@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Moura Pone,
   Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Vasconcelos, Zilton/0000-0002-2193-2224
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil
   [DECIT/25000.072811/2016-19]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES [001/88887.116627/2016-01]; Brazilian
   National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [CNPq/441098/2016-9, CNPq307282/2017-1]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-18/2015TXB, 239224/E-032018, E-26/202.862/2018]; Fondation
   Christophe e Rodolphe Merieux [734548]; Thrasher Research Fund
   [20164370]; Bill and Melinda gates Foundation Grand Challenges
   ExplorationsGates Foundation [OPP112887]; National Institute of Allergy
   and Infectious Diseases (NIAID) of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI28697, AI1259534-01, AI140718-01];
   National Eye Institute (NEI) of the National Institutes of Health
   [AI129847-01]; United Kingdom's Department for International
   Development; ZikaPlan (Preparedness Latin American Network)
FX This study was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil (DECIT/25000.072811/2016-19, to P.B. and
   M.E.M.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES 001/88887.116627/2016-01 to PB); Brazilian National Council for
   Scientific and Technological Development (CNPq/441098/2016-9 to M.E.M.
   and CNPq307282/2017-1 to P.B.); Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, No. E-18/2015TXB to
   M.E.M., No. 239224/E-032018 to M.E.M. and No. E-26/202.862/2018 to
   P.B.); Fondation Christophe e Rodolphe Merieux to P.B.; ZikAlliance,
   734548 to P.B.; the Thrasher Research Fund (No. 20164370 to K.N.S. and
   K.A.); the Bill and Melinda gates Foundation Grand Challenges
   Explorations (No. OPP112887 to P.B.M.); the National Institute of
   Allergy and Infectious Diseases (NIAID) of the National Institutes of
   Health (No. AI28697 to K.N.S., No. AI1259534-01 to K.N.S. and G.C., No.
   AI140718-01 to K.N.S. and P.B.); the National Eye Institute (NEI) of the
   National Institutes of Health (No. AI129847-01 to K.N.S., I.T. and
   P.B.); the United Kingdom's Department for International Development (to
   M.E.M.); and the ZikaPlan (Preparedness Latin American Network, to
   M.E.M.). We thank the women who enrolled in this study, the Fiocruz Zika
   Field Team who rendered our work possible, and P.F. Augusto and C.B. de
   Souza (Federal University of Sao Paulo), who assisted with
   neurodevelopmental assessments.
CR Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20
   Ballot DE, 2017, INT SCH RES NOTICES, V2017, DOI DOI 10.1155/2017/1631760
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.2307/1126464
   Bayley N, 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cherry JD, 2018, FEIGIN CHERRYS TXB P
   da Cunha RDES, 2016, J PEDIAT-BRAZIL, V92, P136, DOI 10.1016/j.jped.2015.04.004
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jary S, 2011, J PEDIATR-US, V159, P211, DOI 10.1016/j.jpeds.2011.01.037
   Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876
   Romeo DMM, 2008, EUR J PAEDIATR NEURO, V12, P24, DOI 10.1016/j.ejpn.2007.05.006
   Rossetto J. D., 2018, J AAPOS, V22, pe60
   Souza CT, 2010, BRAZ J PHYS THER, V14, P309
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura C. V, 2016, ARQ BRAS OFTALMOL, V79
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vianna P, 2018, NEUROIMMUNOMODULAT, V25, P320, DOI 10.1159/000495660
   Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 39
TC 26
Z9 26
U1 2
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2019
VL 25
IS 8
BP 1213
EP +
DI 10.1038/s41591-019-0496-1
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA IQ0BI
UT WOS:000480414600018
PM 31285631
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Oliveira, KKD
   Caprara, A
AF de Franca Oliveira, Krysne Kelly
   Caprara, Andrea
TI The social face of Aedes control: women take the floor in a suburban
   district of Fortaleza, Brazil
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Dengue; Waste; Poverty areas
ID RIO-DE-JANEIRO; HEALTH-PROMOTION; DENGUE; STATE
AB Aedes aegypti is currently a critical disease agent and is responsible for viruses such as Zika, Chikungunya and Dengue's four serotypes. This mosquito's relevance to the current social body has come to the fore and triggered urgent EcoHealth investigations since this approach aims to articulate different theoretical fields to understand the historical linkages between nature, society and health. Based on an ethnographic premise, this study considered the unequal and unfair conditions that make women's health vulnerable to dengue, analyzing their practices and perceptions about the potential breeding grounds in the public space. A semi-structured interview and participant observation, as well as a field diary, were used to compose the study. The research included the participation of ten women living in the outskirts of Fortaleza, Ceara, Brazil, from January to August 2014. The category "Social inequality, context and practices in the public space" emerged from the content analysis. The narratives revealed that unstable living conditions and evident social inequality might influence in a context permeated by waste, with great potential for dengue's mosquito proliferation.
C1 [de Franca Oliveira, Krysne Kelly; Caprara, Andrea] Univ Estadual Ceara, Av Dr Silas Munguba 1700, BR-60741000 Fortaleza, Ceara, Brazil.
RP Oliveira, KKD (corresponding author), Univ Estadual Ceara, Av Dr Silas Munguba 1700, BR-60741000 Fortaleza, Ceara, Brazil.
EM krysnek13@hotmail.com
RI Caprara, Andrea/F-8399-2012
OI Caprara, Andrea/0000-0003-1972-8205
CR Bardin L., 1977, ANALISE CONTEUDO
   BARONI C.J., 2009, RBAC, V41, P289
   Barrado JCS, 2012, THESIS
   Bento VRS, 2011, THESIS, P173
   Trad LAB, 2012, CIENC SAUDE COLETIVA, V17, P627, DOI 10.1590/S1413-81232012000300008
   BOURDIEU Pierre, 2014, DOMINACAO MASCULINA
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Cáceres-Manrique Flor de María, 2010, Rev. salud pública, V12, P798
   Caprara A, 2008, INTERFACE-BOTUCATU, V12
   Caprara A, 2016, GLOB HEALTH PROMOT, V23, P3, DOI 10.1177/1757975916673964
   Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012
   Carril L, 2006, QUILOMBO FAVELA PERI
   Castellanos Jaime E., 2016, Biomédica, V36, P5
   Cavalcante AMC, 2014, FORTALEZA GERA 5 876
   Cerbini F, 2013, ECOSSAUDE ABORDAGEM, P133
   Charron DF, 2014, INVESTIGACION ECOSAL
   Chiaravalloti Neto Francisco, 2007, Cad. Saúde Pública, V23, P1656, DOI 10.1590/S0102-311X2007000700017
   Chiaravalloti Virgínia Baglini, 2002, Cad. Saúde Pública, V18, P1321, DOI 10.1590/S0102-311X2002000500025
   Chiaravalloti-Neto F, 1998, CAD SAUDE PUBLICA SU, V14, pS101
   Claro Lenita Barreto Lorena, 2004, Cad. Saúde Pública, V20, P1447, DOI 10.1590/S0102-311X2004000600002
   Córdova Bojórquez Gustavo, 2012, Región y sociedad, V24, P119
   Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022
   DE CERTEAU M., 1996, INVENCAO COTIDIANO
   Donalisio M R, 2001, Rev Soc Bras Med Trop, V34, P197, DOI 10.1590/S0037-86822001000200008
   França Elisabeth, 2004, Cad. Saúde Pública, V20, P1334, DOI 10.1590/S0102-311X2004000500028
   Fundacao Oswaldo Cruz (Fiocruz), 2012, REV MAN
   Geertz C, 2008, INTERPRETACAO CULTUR
   Giffin Karen, 2002, Cad Saude Publica, V18 Suppl, P103
   Gonçalves Neto Vicente Silva, 2006, Cad. Saúde Pública, V22, P2191, DOI 10.1590/S0102-311X2006001000025
   Gondim PC, 2013, ECOSSAUDE ABORDAGEM, P111
   HOLSTON James, 2013, CIDADANIA INSURGENTE
   Instituto de pesquisa e estrategia economica do ceara, 2012, COND DOM BAIRR
   Instituto de Pesquisa Economica Aplicada (IPEA), 2009, MUIT MAIS QUE SIMPL
   Lakatos EM, 2011, METODOLOGIA CIENTIFI
   Lenzi M F, 2000, Cad Saude Publica, V16, P851
   Lombardo MA, 2006, MERCATOR-FORTALEZA, V5, P1
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Mafra RLM, 2015, SAUDE SOC-SAO PAULO, V24, P977, DOI 10.1590/S0104-12902015133744
   Ministerio da Saude (MS), 2016, B EPIDEMIOLOGICO, V47
   Miranda MSL, 2013, REV BRAS PROMOC SAUD, V26, P233
   Moura MJ, 2012, MULHER TRAFICO DROGA
   Mucelin Carlos Alberto, 2008, Soc. nat., V20, P111, DOI 10.1590/S1982-45132008000100008
   Mundial da Saude (OMS), PROGR LUCH DENG
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Preteceille E, 2000, DESIGUALDADE POBREZA
   Rêgo Rita de Cássia Franco, 2002, Cad. Saúde Pública, V18, P1583, DOI 10.1590/S0102-311X2002000600012
   Ribeiro AF, 2006, REV SAUDE PUBL, V40, P671, DOI 10.1590/s0034-89102006000500017
   Ribeiro LCQ, 1985, QUE QUESTAO MORADIA
   San Pedro A, 2009, CAD SAUDE PUBLICA, V25, P1937, DOI 10.1590/S0102-311X2009000900008
   Santos Solange Laurentino dos, 2011, Ciênc. saúde coletiva, V16, P1319, DOI 10.1590/S1413-81232011000700066
   Sapag JC, 2007, REV SAUDE PUBL, V41, P139, DOI [10.1590/S0034-89102007000100019, 10.1590/s0034-89102007000100019]
   Secretaria da Saude, 2016, B SEMANAL DENGUE
   Souza VMM, 2012, REV PAN AMAZ SAUDE, V3, P37
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Tavares C., 2003, Ciencia da Informacao, V32, P125
   Tominaga L.K., 2009, DESASTRES NATURAIS C
   Torres Haroldo da Gama, 2003, Estud. av., V17, P97, DOI 10.1590/S0103-40142003000100006
   Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002
   Weihs M, 2013, CIENC SAUDE COLETIVA, V18, P1501, DOI 10.1590/S1413-81232013000500036
NR 59
TC 0
Z9 0
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD AUG
PY 2019
VL 24
IS 8
BP 2983
EP 2991
DI 10.1590/1413-81232018248.21522017
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IN6NO
UT WOS:000478796900020
PM 31389545
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Souza, MA
   da Silva, L
   Macedo, MJF
   Lacerda-Neto, LJ
   dos Santos, MAC
   Coutinho, HDM
   Cunha, FAB
AF de Souza, M. A.
   da Silva, L.
   Macedo, M. J. F.
   Lacerda-Neto, L. J.
   dos Santos, M. A. C.
   Coutinho, H. D. M.
   Cunha, F. A. B.
TI Adulticide and repellent activity of essential oils against Aedes
   aegypti (Diptera: Culicidae) - A review
SO SOUTH AFRICAN JOURNAL OF BOTANY
LA English
DT Review
DE Essential oils; Aedes aegypti; Adulticide; Repellent
ID ANOPHELES-DIRUS PEYTON; RUTACEAE ESSENTIAL OIL; HERBAL ESSENTIAL OILS;
   LARVICIDAL ACTIVITY; CHEMICAL-COMPOSITION; DENGUE-FEVER; PIPER-ADUNCUM;
   MOSQUITO; L.; EFFICACY
AB Aedes aegypti (Ae. aegypti) is responsible for the spread of diseases that compromise public health such as dengue fever, urban yellow fever, chikungunya and zika. Synthetic insecticides are used to control Ae. aegypti, however, this substance use results in vector resistance and environment contamination. Essential oils (OEs) derived from plants are natural alternatives to replace the commercial synthetic insecticides and repellents, since they present components that may be toxic to this vector. This reviewhad as its objective to research the literature surrounding the repellent and adulticide action of essential oils against Ae. aegypti, using electronic research databases (Pubmed, Science Direct and Scielo), to provide an overall view on the plant species used to obtain EOs, the plant parts, extraction methods and analytical techniques used as well as the major components in the EOs. The data showed 16 families, 35 genera and 49 species, with Lamiaceae, Zingiberaceae, Myrtaceae and Rutaceae families being the ones with the most species. Moreover, all plant parts were shown to be used to extract essential oils, especially with hydro-distillation and steam-distillation methods, with Gas Chromatography coupled to Mass Spectrometry (GC-MS) as the main analytical technique. The data revealed the chemical composition of EOs, especially of terpenes. Therefore, essential oils are promising options for the production of natural insecticides due many reasons: they are less harmful to human beings and to the environment; they can be used in association with synthetic insecticides and repellents, reducing the concentration used of the last ones; and can be produced in a perennial manner by producers, using subproducts from the crop industries. By all these reasons, they can be used in insect vector control programs, rather than using synthetic insecticides. (C) 2019 SAAB. Published by Elsevier B.V. All rights reserved.
C1 [de Souza, M. A.; da Silva, L.; Macedo, M. J. F.; Lacerda-Neto, L. J.; dos Santos, M. A. C.; Coutinho, H. D. M.; Cunha, F. A. B.] Reg Univ Cariri, Dept Biol Chem, Crato, CE, Brazil.
RP Coutinho, HDM (corresponding author), Univ Reg Cariri, Urca, Rua Cel Antonio Luis 1161, BR-63105000 Pimenta, Brazil.
EM hdmcoutinho@urca.br
RI ; Coutinho, Henrique/E-1046-2013
OI de Lacerda Neto, Luiz Jardelino/0000-0002-9339-3215; Coutinho,
   Henrique/0000-0002-6634-4207
CR Abu Bakar A, 2012, J ARTHROPOD-BORNE DI, V6, P28
   Ali A, 2013, J MED ENTOMOL, V50, P1267, DOI 10.1603/ME12177
   Costa AA, 2017, J MED ENTOMOL, V54, P670, DOI 10.1093/jme/tjw222
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   [Anonymous], 2015, B EPIDEMIOLOGICO, V46, P1
   Blackwell A, 2003, J R COLL PHYS EDINB, V33, P209
   Carvalho KD, 2016, PARASITOL RES, V115, P3441, DOI 10.1007/s00436-016-5106-2
   Castillo RM, 2017, J AM MOSQUITO CONTR, V33, P25, DOI 10.2987/16-6585.1
   Chaiyasit D, 2006, PARASITOL RES, V99, P715, DOI 10.1007/s00436-006-0232-x
   Champakaew D, 2015, PARASITOL RES, V114, P2187, DOI 10.1007/s00436-015-4409-z
   Chellappandian M, 2018, ENVIRON SCI POLLUT R, V25, P10294, DOI 10.1007/s11356-017-8952-2
   Choochote W, 2007, FITOTERAPIA, V78, P359, DOI 10.1016/j.fitote.2007.02.006
   Choochote W, 2005, J VECTOR ECOL, V30, P302
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Cruz RCD, 2017, J MED ENTOMOL, V54, P985, DOI 10.1093/jme/tjw239
   de Almeida RRP, 2009, CHEM BIODIVERS, V6, P1427, DOI 10.1002/cbdv.200800212
   Demirci B, 2017, SAUDI PHARM J, V25, P703, DOI 10.1016/j.jsps.2016.10.009
   Dolan MC, 2007, J ECON ENTOMOL, V100, P622, DOI 10.1603/0022-0493(2007)100[622:BAOTWE]2.0.CO;2
   GOKULAKRISHNAN J, 2013, ASIAN PAC J TROP DIS, V3, P26, DOI DOI 10.1016/S2222-1808(13)60006-7
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Gu HJ, 2009, J AGR FOOD CHEM, V57, P11127, DOI 10.1021/jf9024486
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Intirach J, 2016, ENVIRON SCI POLLUT R, V23, P23994, DOI 10.1007/s11356-016-7651-8
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Kamsuk K, 2007, PARASITOL RES, V100, P339, DOI 10.1007/s00436-006-0256-2
   Kerdudo A, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201600344
   Kerdudo A, 2016, IND CROP PROD, V89, P295, DOI 10.1016/j.indcrop.2016.04.076
   Khandagle AJ, 2011, PARASITOL RES, V109, P339, DOI 10.1007/s00436-011-2261-3
   Kiran SR, 2007, PARASITOL RES, V101, P413, DOI 10.1007/s00436-007-0485-z
   Kumar Sarita, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P85, DOI 10.1016/S2221-1691(11)60001-4
   Lalthazuali, 2017, PARASITOL RES, V116, P821, DOI 10.1007/s00436-016-5351-4
   Lima RK, 2007, VER FITOS, V3, P14
   Lucia A, 2009, BIORESOURCE TECHNOL, V100, P6083, DOI 10.1016/j.biortech.2009.02.075
   Lukwa N, 2009, TROP BIOMED, V26, P85
   Mamood SNH, 2017, B ENTOMOL RES, V107, P49, DOI 10.1017/S0007485316000614
   Marinho S. C., 2010, THESIS, P127
   Nascimento AMD, 2017, NEOTROP ENTOMOL, V46, P223, DOI 10.1007/s13744-016-0457-z
   Noosidum A, 2014, J VECTOR ECOL, V39, P298, DOI 10.1111/jvec.12104
   Novak RJ, 2005, J AM MOSQUITO CONTR, V21, P7, DOI 10.2987/8756-971X(2005)21[7:NRPEFM]2.0.CO;2
   Oyedele AO, 2002, PHYTOMEDICINE, V9, P259, DOI 10.1078/0944-7113-00120
   Paula J. F. P., 2002, THESIS, P69
   Paula Josiane P., 2004, Acta Farmaceutica Bonaerense, V23, P376
   Phasomkusolsil Siriporn, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS113, DOI 10.1016/S2221-1691(11)60136-6
   Phasomkusolsil S, 2011, SE ASIAN J TROP MED, V42, P1083
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Rajkumar S, 2010, EUR REV MED PHARMACO, V14, P231
   Silva A. L. S., 2012, TEOLOGIA PUBLICA DES, P73
   Silva IMA, 2018, PEST MANAG SCI, V74, P1001, DOI 10.1002/ps.4801
   Simas NK, 2004, QUIM NOVA, V27, P46, DOI 10.1590/S0100-40422004000100009
   SIMOES C. M. O., 2017, FARMACOGNOSIA PRODUT
   Soonwera M, 2017, ASIAN PAC J TROP BIO, V7, P967, DOI 10.1016/j.apjtb.2017.09.019
   Soonwera M, 2015, PARASITOL RES, V114, P4531, DOI 10.1007/s00436-015-4699-1
   Aguiar RWS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116765
   Sritabutra D., 2013, Asian Pacific Journal of Tropical Disease, V3, P271
   Sritabutra Duangkamon, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS124, DOI 10.1016/S2221-1691(11)60138-X
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Tabanca N, 2010, NAT PROD COMMUN, V5, P1409
   Tawatsin A, 2001, J VECTOR ECOL, V26, P76
   Thomas J, 2009, J MED ENTOMOL, V46, P1387, DOI 10.1603/033.046.0619
   Trigg JK, 1996, J AM MOSQUITO CONTR, V12, P329
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Trongtokit Yuwadee, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P325
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   WHO, 2018, DENG SEV DENG
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zoubiri S, 2014, J SAUDI CHEM SOC, V18, P925, DOI 10.1016/j.jscs.2011.11.015
NR 67
TC 1
Z9 1
U1 8
U2 17
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0254-6299
EI 1727-9321
J9 S AFR J BOT
JI S. Afr. J. Bot.
PD AUG
PY 2019
VL 124
BP 160
EP 165
DI 10.1016/j.sajb.2019.05.007
PG 6
WC Plant Sciences
SC Plant Sciences
GA IN4WV
UT WOS:000478678800023
DA 2020-07-08
ER

PT J
AU Mesle, MMI
   Hall, IM
   Christley, RM
   Leach, S
   Read, JM
AF Mesle, Margaux Marie Isabelle
   Hall, Ian Melvyn
   Christley, Robert Matthew
   Leach, Steve
   Read, Jonathan Michael
TI The use and reporting of airline passenger data for infectious disease
   modelling: a systematic review
SO EUROSURVEILLANCE
LA English
DT Review
ID ZIKA VIRUS INTRODUCTION; AIR-TRAVEL; MATHEMATICAL-MODEL; INTERNATIONAL
   SPREAD; RESISTANT-BACTERIA; GEOGRAPHIC SPREAD; HUMAN MOBILITY; GLOBAL
   SPREAD; UNITED-STATES; DENGUE VIRUS
AB Background: A variety of airline passenger data sources are used for modelling the international spread of infectious diseases. Questions exist regarding the suitability and validity of these sources. Aim: We conducted a systematic review to identify the sources of airline passenger data used for these purposes and to assess validation of the data and reproducibility of the methodology. Methods: Articles matching our search criteria and describing a model of the international spread of human infectious disease, parameterised with airline passenger data, were identified. Information regarding type and source of airline passenger data used was collated and the studies' reproducibility assessed. Results: We identified 136 articles. The majority (n = 96) sourced data primarily used by the airline industry. Governmental data sources were used in 30 studies and data published by individual airports in four studies. Validation of passenger data was conducted in only seven studies. No study was found to be fully reproducible, although eight were partially reproducible. Limitations: By limiting the articles to international spread, articles focussed on within-country transmission even if they used relevant data sources were excluded. Authors were not contacted to clarify their methods. Searches were limited to articles in PubMed, Web of Science and Scopus. Conclusion: We recommend greater efforts to assess validity and biases of airline passenger data used for modelling studies, particularly when model outputs are to inform national and international public health policies. We also recommend improving reporting standards and more detailed studies on biases in commercial and open-access data to assess their reproducibility.
C1 [Mesle, Margaux Marie Isabelle; Hall, Ian Melvyn; Christley, Robert Matthew; Leach, Steve; Read, Jonathan Michael] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Mesle, Margaux Marie Isabelle; Christley, Robert Matthew; Read, Jonathan Michael] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Hall, Ian Melvyn] Univ Manchester, Sch Math, Manchester, Lancs, England.
   [Hall, Ian Melvyn; Leach, Steve] Publ Hlth England, Emergency Response Dept, Salisbury, Wilts, England.
   [Hall, Ian Melvyn; Leach, Steve] Kings Coll London, Natl Inst Hlth Res, Hlth Protect Res Unit Emergency Preparedness & Re, London, England.
   [Leach, Steve] Imperial Coll London, Natl Inst Hlth Res, Hlth Protect Res Unit Modelling Methodol, London, England.
   [Read, Jonathan Michael] Univ Lancaster, Lancaster Med Sch, Ctr Hlth Informat Computat & Stat, Lancaster, England.
RP Read, JM (corresponding author), Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.; Read, JM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; Read, JM (corresponding author), Univ Lancaster, Lancaster Med Sch, Ctr Hlth Informat Computat & Stat, Lancaster, England.
EM jonathan.read@lancs.ac.uk
FU National Institute for Health Research Health Protection Research Unit
   (NIHR HPRU) in Emerging and Zoonotic Infections at University of
   Liverpool; Public Health England (PHE); PANDHUB project from the
   European Union Seventh Framework Programme [607433]; Liverpool School of
   Tropical Medicine
FX The research was funded by the National Institute for Health Research
   Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic
   Infections at University of Liverpool in partnership with Public Health
   England (PHE), in collaboration with Liverpool School of Tropical
   Medicine. Margaux Mesle is based at The University of Liverpool. IMH is
   also supported by the PANDHUB project from the European Union Seventh
   Framework Programme under grant agreement no. 607433. The views
   expressed are those of the author(s) and not necessarily those of the
   NHS, the NIHR, the Department of Health or Public Health England. The
   authors would like to thank Dr Caroline Walters for her feedback on
   working drafts of the manuscript.
CR Ajelli M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-190
   Al Hajjar S, 2010, ANN SAUDI MED, V30, P1, DOI 10.4103/0256-4947.59365
   Apenteng OO, 2014, P WORLD C ENG COMP S, VII
   Apolloni A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-176
   Arino J, 2015, ANAL MODELING SPATIA
   Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591
   Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106
   Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45
   Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460
   Bobashev G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003154
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Bowen JT, 2006, GEOGR J, V172, P130, DOI 10.1111/j.1475-4959.2006.00196.x
   Brannen DE, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/8258946
   Brennan S, 2013, P 23 INT JOINT C ART, P2783
   BRIGANTIC RT, 2009, INT J RISK ASSESS MA, V12, P290, DOI DOI 10.HTTPS://D0I.0RG/10.1504/
   Brockmann D, 2007, SARS CASE STUDY EMER
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Brown EBE, 2012, VECTOR-BORNE ZOONOT, V12, P310, DOI 10.1089/vbz.2010.0176
   Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143
   Carias C, 2016, EMERG INFECT DIS, V22, P723, DOI 10.3201/eid2204.150976
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chang CY, 2010, CHINESE SCI BULL, V55, P3030, DOI 10.1007/s11434-010-3180-x
   Cheng Q, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005701
   Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928
   Chong KC, 2014, EPIDEMIOL INFECT, V142, P955, DOI 10.1017/S0950268813002550
   Chong KC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-309
   Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3
   Colizza V, 2006, B MATH BIOL, V68, P1893, DOI 10.1007/s11538-006-9077-9
   Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103
   Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34
   Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028
   Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013
   Colizza V, 2007, CR BIOL, V330, P364, DOI 10.1016/j.crvi.2007.02.014
   Colizza Vittoria, 2008, Biophysical Reviews and Letters, V3, P217, DOI 10.1142/S1793048008000708
   Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212
   Corley CD, 2012, P 1 ACM SIGSPATIAL I, P81, DOI [10.1145/2452516.2452533, DOI 10.1145/2452516.2452533]
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163
   Daniel WB, 2013, MATH BIOSCI, V242, P1, DOI 10.1016/j.mbs.2012.11.002
   Dembele B, 2017, MATH BIOSCI ENG, V14, P95, DOI 10.3934/mbe.2017007
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.28.30572
   Ekdahl K, 2005, J TRAVEL MED, V12, P197, DOI 10.2310/7060.2005.12405
   Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401
   European Centre for Disease Prevention and Control (ECDC), 2015, EP UPD OUTBR EB VIR
   FLAHAULT A, 1994, EUR J EPIDEMIOL, V10, P471, DOI 10.1007/BF01719679
   Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Gardner LM, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw063
   Gardner LM, 2015, TRANSPORT RES REC, P25, DOI 10.3141/2501-04
   Gardner LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/103679
   Gardner LM, 2012, TRANSPORT RES REC, P13, DOI 10.3141/2300-02
   Gautreau A, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/09/L09001
   Gautreau A, 2008, J THEOR BIOL, V251, P509, DOI 10.1016/j.jtbi.2007.12.001
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goedecke DM, 2007, P 2007 WINT SIM C WA
   Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5
   Goncalves B, 2013, SCI REP-UK, V3, DOI 10.1038/srep00810
   Goubar A, 2009, EPIDEMIOL INFECT, V137, P1019, DOI 10.1017/S0950268808001635
   Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Hanvoravongchai P, 2011, SE ASIAN J TROP MED, V42, P1093
   Hatz C, 2009, J TRAVEL MED, V16, P200, DOI 10.1111/j.1708-8305.2009.00334.x
   Hollingsworth TD, 2007, EMERG INFECT DIS, V13, P1288, DOI 10.3201/eid1309.070081
   Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497
   Hosseini P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012763
   Hsu CI, 2010, ACCIDENT ANAL PREV, V42, P93, DOI 10.1016/j.aap.2009.07.004
   Huang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064317
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Hwang GM, 2012, TRAVEL MED INFECT DI, V10, P32, DOI 10.1016/j.tmaid.2011.12.003
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022151
   Kenah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019515
   Kerneis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001478
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Khan Kamran, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.a7b70897ac2fa4f79b59f90d24c860b8
   Khan K, 2013, B WORLD HEALTH ORGAN, V91, P368, DOI 10.2471/BLT.12.114777
   Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9
   Khan K, 2010, CAN MED ASSOC J, V182, P579, DOI 10.1503/cmaj.100093
   Khan K, 2010, J TRAVEL MED, V17, P75, DOI 10.1111/j.1708-8305.2010.00397.x
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Knipl DH, 2013, SIAM J APPL DYN SYST, V12, P1722, DOI 10.1137/130914127
   Lawyer G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1350-4
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lepelletier D, 2011, J TRAVEL MED, V18, P344, DOI 10.1111/j.1708-8305.2011.00547.x
   LONGINI IM, 1988, MATH BIOSCI, V90, P367, DOI 10.1016/0025-5564(88)90075-2
   LONGINI IM, 1986, AM J EPIDEMIOL, V123, P383, DOI 10.1093/oxfordjournals.aje.a114253
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Malone JD, 2009, TRAVEL MED INFECT DI, V7, P181, DOI 10.1016/j.tmaid.2009.02.006
   Mao L, 2015, J TRANSP GEOGR, V48, P52, DOI 10.1016/j.jtrangeo.2015.08.017
   Marcelino Jose, 2012, PLoS Curr, V4, pe4f8c9a2e1fca8, DOI 10.1371/4f8c9a2e1fca8
   Marcelino Jose, 2009, PLOS CURR, DOI [10.1371/currents.RRN1005, DOI 10.1371/CURRENTS.RRN1005]
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964
   Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062
   Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605
   Nah K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1675-z
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   OAG, TRAFF AN FAQS
   Okeke IN, 2001, CLIN INFECT DIS, V33, P364, DOI 10.1086/321877
   Pastore-Piontti A, 2016, MATH STAT MODELING E, DOI [10.1007/978-3-319-40413-4_4, DOI 10.1007/978-3-319-40413-4_4]
   Paul M, 2008, STAT MED, V27, P6250, DOI 10.1002/sim.3440
   Pinsent A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-298
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   Poletto C., 2014, Eurosurveillance, V19, P20824, DOI 10.2807/1560-7917.ES2014.19.23.20824
   Poletto C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1787-5
   Poletto C, 2016, EPIDEMICS-NETH, V15, P1, DOI 10.1016/j.epidem.2015.12.001
   Poletto C, 2013, J THEOR BIOL, V338, P41, DOI 10.1016/j.jtbi.2013.08.032
   Poletto C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00476
   Polwiang S, 2015, J TRAVEL MED, V22, P194, DOI 10.1111/jtm.12193
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Read JM, 2015, LANCET, V385, P23, DOI 10.1016/S0140-6736(14)61894-8
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Ruan SG, 2006, MATH BIOSCI ENG, V3, P205
   RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1
   Saker L., 2004, GLOBALIZATION INFECT
   Sato A, 2015, P 2015 IEEE INT C BI, DOI [10.1109/BigData.2015.7364074, DOI 10.1109/BIGDATA.2015.7364074]
   Schneider CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061911
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Seyler T, 2009, EPIDEMICS-NETH, V1, P175, DOI 10.1016/j.epidem.2009.06.003
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tatem AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1489, DOI 10.1098/rspb.2007.0148
   Tatem AJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-57
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Tuncer N, 2014, INT J CRIT INFR PROT, V7, P27, DOI 10.1016/j.ijcip.2014.02.001
   Urabe CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168127
   Weinberger DM, 2012, AM J EPIDEMIOL, V176, P649, DOI 10.1093/aje/kws140
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004
   Wilder-Smith A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax008
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   Wilson SE, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1039-0
   Xiao L, 2015, 12 P INT C INF SYST
   Yale Law Sch Roundtable Data Code, 2010, COMPUT SCI ENG, V12, P8
   Yoneyama T, 2012, SIMUL-T SOC MOD SIM, V88, P437, DOI [10.1177/003754971140S077, 10.1177/0037549711405077]
NR 152
TC 2
Z9 2
U1 2
U2 5
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 1
PY 2019
VL 24
IS 31
BP 40
EP 57
AR 1800216
DI 10.2807/1560-7917.ES.2019.24.31.1800216
PG 18
WC Infectious Diseases
SC Infectious Diseases
GA IM6GS
UT WOS:000478092000004
PM 31387671
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Magalhaes, T
   Bergren, NA
   Bennett, SL
   Borland, EM
   Hartman, DA
   Lymperopoulos, K
   Sayre, R
   Borlee, BR
   Campbell, CL
   Foy, BD
   Olson, KE
   Blair, CD
   Black, W
   Kading, RC
AF Magalhaes, Tereza
   Bergren, Nicholas A.
   Bennett, Susan L.
   Borland, Erin M.
   Hartman, Daniel A.
   Lymperopoulos, Konstantinos
   Sayre, Richard
   Borlee, Bradley R.
   Campbell, Corey L.
   Foy, Brian D.
   Olson, Kenneth E.
   Blair, Carol D.
   Black, William
   Kading, Rebekah C.
TI Induction of RNA interference to block Zika virus replication and
   transmission in the mosquito Aedes aegypti
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
ID INFECTION; VIREMIA
AB The yellow fever mosquito, Aedes aegypti, serves as the primary vector for epidemic transmission of yellow fever, dengue, Zika (ZIKV), and chikungunya viruses to humans. Control of Ae. aegypti is currently limited to insecticide applications and larval habitat management; however, to combat growing challenges with insecticide resistance, novel genetic approaches for vector population reduction or transmission interruption are being aggressively pursued. The objectives of this study were to assess the ability of the Ae. aegypti antiviral exogenous-small interfering RNA (exo-siRNA) response to inhibit ZIKV infection and transmission, and to identify the optimal RNA interference (RNAi) target region in the ZIKV genome. We accomplished these objectives by in vitro transcription of five long double-stranded RNAs (dsRNAs) from the genome region spanning the NS2B-NS3-NS4A genes, which were the most highly conserved among ZIKV RNA sequences representing both East and West African and Asian-American clades, and evaluation of the ability of these dsRNAs to trigger an effective antiviral exo-siRNA response after intrathoracic injection into Ae. aegypti. In a pilot study, five ZIKV dsRNAs were tested by intrathoracic inoculation of 250 ng dsRNA into groups of approximately 5-day-old mosquitoes. Three days post-inoculation, mosquitoes were provided an infectious blood-meal containing ZIKV strain PRVABC59 (Puerto Rico), MR766 (Uganda), or 41525 (Senegal). On days 7 and 14 post-infection individual whole mosquito bodies were assessed for ZIKV infectious titer by plaque assays. Based on the results of this initial assessment, three dsRNAs were selected for further evaluation of viral loads of matched body and saliva expectorants using a standardized infectious dose of 1 x 10(7) PFU/mL of each ZIKV strain. Fourteen days post-exposure to ZIKV, paired saliva and carcass samples were harvested from individual mosquitoes and assessed for ZIKV RNA load by qRT-PCR. Injection of each of the three dsRNAs resulted in significant inhibition of replication of all three strains of ZIKV in mosquito bodies and saliva. This study lays critical groundwork for pursuing ZIKV transmission-blocking strategies that exploit the Ae. aegypti exo-siRNA response for arbovirus suppression in natural populations.
C1 [Magalhaes, Tereza; Bergren, Nicholas A.; Bennett, Susan L.; Borland, Erin M.; Hartman, Daniel A.; Borlee, Bradley R.; Campbell, Corey L.; Foy, Brian D.; Olson, Kenneth E.; Blair, Carol D.; Black, William; Kading, Rebekah C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.
   [Lymperopoulos, Konstantinos; Sayre, Richard] Pebble Labs USA Inc, Little Fly Div, Los Alamos, NM 87544 USA.
RP Kading, RC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.
EM Tereza.Magalhaes@colostate.edu; Nicholas.Bergren@colostate.edu;
   Susi.Bennett@colostate.edu; Erin.Borland@colostate.edu;
   Daniel.Anthony.Hartman@colostate.edu; klymperopoulos@pebblelabs.com;
   rsayre@pebblelabs.com; Brad.Borlee@colostate.edu;
   Corey.Campbell@colostate.edu; Brian.Foy@colostate.edu;
   Kenneth.Olson@colostate.edu; Carol.Blair@colostate.edu;
   William.Black@colostate.edu; Rebekah.Kading@colostate.edu
RI Magalhaes, Tereza/V-6632-2019; Borland, Erin/K-6607-2019
OI Campbell, Corey L./0000-0002-6384-1259; Borland,
   Erin/0000-0001-8631-9466; Hartman, Daniel/0000-0001-9733-8355
FU Pebble Laboratories, USA [R01 AI130085-02]
FX This project was funded by Pebble Laboratories, USA. Analyses conducted
   to assess sequence conservation among ZIKV isolates was performed under
   NIH R01 AI130085-02, USA.
CR Adalja Amesh, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.1c39ec05a743d41ee39391ed0f2ed8d3
   Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   Cao HF, 2018, HUM GENOMICS, V12
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Sayre R, 2018, Patent, P1, Patent No. [US 2018/0216110 A1, 20180216110]
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Voget S, 2009, IND INFORM TECHNOL, V5
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang SB, 2017, SCIENCE, V357, P1399, DOI 10.1126/science.aan5478
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 37
TC 2
Z9 2
U1 6
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD AUG
PY 2019
VL 111
AR 103169
DI 10.1016/j.ibmb.2019.05.004
PG 10
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA IN5HM
UT WOS:000478706500001
PM 31103782
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Padilla-Ruiz, D
   Mendoza, A
   Alvarez, A
   Baldrich-Gomez, O
   Posso, H
   Campo-Urbina, M
   Parra-Saad, EA
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Padilla-Ruiz, Dionny
   Mendoza, Anibal
   Alvarez, Alvaro
   Baldrich-Gomez, Oldrih
   Posso, Heidi
   Campo-Urbina, Myrna
   Parra-Saad, Edgar A.
   Rodriguez-Morales, Alfonso J.
TI Urinary bladder agenesis and renal hypoplasia potentially related to in
   utero Zika virus infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Birth defects; Urinary bladder; Agenesis; Renal hypoplasia;
   Colombia
AB This case report describes the clinical findings of a 22-year-old pregnant woman with confirmed Zika virus infection, at 16 weeks of gestation, in Sucre, Colombia. Her ultrasound revealed severe oligohydramnios, intrauterine growth restriction, and a complete absence of the urinary bladder of the fetus. The poor prognosis led to the decision to terminate the pregnancy. Autopsy of the fetus revealed severe bilateral renal hypoplasia. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Villamil-Gomez, Wilmer E.; Mendoza, Anibal; Alvarez, Alvaro; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Programa Doctorado Med Trop, SUE Caribe, Barranquilla, Colombia.
   [Padilla-Ruiz, Dionny; Posso, Heidi; Campo-Urbina, Myrna] Univ Metropolitana, Grp Caribe Invest Enfermedades Tipo Infeccioso &, Barranquilla, Atlantico, Colombia.
   [Baldrich-Gomez, Oldrih] Hosp Univ Hernando Moncaleano Perdomo, Gynecol Serv, Neiva, Huila, Colombia.
   [Parra-Saad, Edgar A.] Inst Nacl Salud, Pathol, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] UniFranz, Fac Hlth Sci, Sch Med, Cochabamba, Bolivia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
FU Universidad Metropolitana, Barranquilla, Atlantico, Colombia
FX Universidad Metropolitana, Barranquilla, Atlantico, Colombia.
CR Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   Nazer II, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0396-6
   Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI, V25, P20, DOI 10.1016/j.tmaid.2018.06.006
   Torres JR, 2016, INT J INFECT DIS, V51, P123, DOI 10.1016/j.ijid.2016.09.001
   Valdespino-Vazquez MY, 2019, CLIN INFECT DIS, V68, P903, DOI 10.1093/cid/ciy616
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2019
VL 85
BP 54
EP 56
DI 10.1016/j.ijid.2019.05.021
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA IM4CD
UT WOS:000477941400009
PM 31129423
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Li, L
   He, JA
   Wang, W
   Xia, Y
   Song, L
   Chen, ZH
   Zuo, HZ
   Tan, XP
   Ho, AHP
   Kong, SK
   Loo, JFC
   Li, HW
   Gu, DY
AF Li, Lang
   He, Jian-an
   Wang, Wei
   Xia, Yun
   Song, Li
   Chen, Ze-han
   Zuo, Hang-zhi
   Tan, Xuan-Ping
   Ho, Aaron Ho-Pui
   Kong, Siu-Kai
   Loo, Jacky Fong-Chuen
   Li, Hua-wen
   Gu Dayong
TI Development of a direct reverse-transcription quantitative PCR
   (dirRT-qPCR) assay for clinical Zika diagnosis
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Clinical Zika diagnostics; Direct sample detection; dirRT-qPCR;
   Molecular diagnostics
ID POLYMERASE-CHAIN-REACTION; DIRECT RT-PCR; WHOLE-BLOOD; DNA
   AMPLIFICATION; VIRUS; POLYMORPHISM; SAMPLES; BUFFER
AB Objective: The nucleic acid-based polymerase chain reaction (PCR) assay is commonly applied to detect infection with Zika virus (ZIKV). However, the time-and labor-intensive sample pretreatment required to remove inhibitors that cause false-negative results in clinical samples is impractical for use in resource-limited areas. The aim was to develop a direct reverse-transcription quantitative PCR (dirRT-qPCR) assay for ZIKV diagnosis directly from clinical samples.
   Methods: The combination of inhibitor-tolerant polymerases, polymerase enhancers, and dirRT-qPCR conditions was optimized for various clinical samples including blood and serum. Sensitivity was evaluated with standard DNA spiked in simulated samples. Specificity was evaluated using clinical specimens of other infections such as dengue virus and chikungunya virus.
   Results: High specificity and sensitivity were achieved, and the limit of detection (LOD) of the assay was 9.5 x 10(1) ZIKV RNA copies/reaction. The on-site clinical diagnosis of ZIKV required a 5 mu l sample and the diagnosis could be completed within 2 h.
   Conclusions: This robust dirRT-qPCR assay shows a high potential for point-of-care diagnosis, and the primer-probe combinations can also be extended for other viral detection. It realizes the goal of large-scale on-site screening for viral infections and could be used for early diagnosis and the prevention and control of viral outbreaks. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
C1 [Li, Lang; Song, Li; Chen, Ze-han; Zuo, Hang-zhi; Li, Hua-wen] Guangdong Med Univ, Sch Clin Med 2, Sch Publ Hlth, Dongguan 523808, Peoples R China.
   [Li, Lang; He, Jian-an; Xia, Yun; Song, Li; Gu Dayong] Shenzhen Int Travel Hlth Care Ctr, Shenzhen 518033, Peoples R China.
   [Li, Lang; He, Jian-an; Xia, Yun; Song, Li; Gu Dayong] Shenzhen Acad Inspect & Quarantine, Shenzhen 518033, Peoples R China.
   [Wang, Wei; Gu Dayong] Shenzhen Univ, Hlth Sci Ctr, Affiliated Hosp 1, Dept Lab Med,Shenzhen Peoples Hosp 2, Shenzhen 518035, Peoples R China.
   [Tan, Xuan-Ping] Shenzhen Gene One Biotechnol Co Ltd, Shenzhen 518000, Peoples R China.
   [Ho, Aaron Ho-Pui; Loo, Jacky Fong-Chuen] Chinese Univ Hong Kong, Dept Biomed Engn, Hong Kong, Peoples R China.
   [Kong, Siu-Kai; Loo, Jacky Fong-Chuen] Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Hong Kong, Peoples R China.
RP Li, HW (corresponding author), Guangdong Med Univ, Sch Clin Med 2, Sch Publ Hlth, Dongguan 523808, Peoples R China.; Gu, DY (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Affiliated Hosp 1, Dept Lab Med,Shenzhen Peoples Hosp 2, Shenzhen 518035, Peoples R China.; Loo, JFC (corresponding author), Chinese Univ Hong Kong, Dept Biomed Engn, Hong Kong, Peoples R China.
EM jackyfcloo@cuhk.edu.hk; chineseli@163.com; wanhood@163.com
RI Loo, Jacky FC/D-2769-2015
OI Loo, Jacky FC/0000-0002-0355-8865; li, lang/0000-0001-9233-2632; gu,
   dayong/0000-0002-9547-8474
FU National Key Research and Development Program of China [2018YFC0809200,
   2016YFF0203203]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [K16026]; Guangdong Science and
   Technology Foundation [2017B020210006, 2016A020219005, 20160223];
   Shenzhen Science and Technology Foundation [CKCY20170720100145297,
   JCYJ20160427151920801, JCYJ20170307104024209]; Open project of Key
   Laboratory of Tropical Disease Control of Ministry of Enducation (Sun
   Yat-sen University) [2019kfkt06]
FX This study was supported by the National Key Research and Development
   Program of China (No. 2018YFC0809200, No. 2016YFF0203203), National
   Natural Science Foundation of China (No. K16026), Guangdong Science and
   Technology Foundation (No. 2017B020210006, No. 2016A020219005, No.
   20160223), and Shenzhen Science and Technology Foundation (No.
   CKCY20170720100145297, No. JCYJ20160427151920801, No.
   JCYJ20170307104024209) and Open project of Key Laboratory of Tropical
   Disease Control of Ministry of Enducation (Sun Yat-sen University) (No.
   2019kfkt06).
CR Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345
   Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463, DOI 10.1128/JCM.38.12.4463-4470.2000
   Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001
   Abu Al-Soud W, 1998, APPL ENVIRON MICROB, V64, P3748
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bachofen C, 2013, J VIROL METHODS, V190, P1, DOI 10.1016/j.jviromet.2013.03.015
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bu Y, 2008, ANAL BIOCHEM, V375, P370, DOI 10.1016/j.ab.2008.01.010
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dongyang C, 2018, SCI REP, V8, P1
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jadaon MM, 2009, MED PRIN PRACT, V18, P280, DOI 10.1159/000215724
   Kang K, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-45
   Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055
   KHAN G, 1991, J CLIN PATHOL, V44, P360, DOI 10.1136/jcp.44.5.360
   Nishimura N, 2000, ANN CLIN BIOCHEM, V37, P674, DOI 10.1258/0004563001899726
   Nishimura N, 2010, J VIROL METHODS, V163, P282, DOI 10.1016/j.jviromet.2009.10.011
   PANACCIO M, 1993, NUCLEIC ACIDS RES, V21, P4656, DOI 10.1093/nar/21.19.4656
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Victor ST, 2009, MOL DIAGN THER, V13, P383, DOI 10.2165/11317520-000000000-00000
   WANG JT, 1992, J CLIN MICROBIOL, V30, P750, DOI 10.1128/JCM.30.3.750-753.1992
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Watkins-Riedel T, 2004, CLIN INFECT DIS, V39, P1754, DOI 10.1086/425614
   Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032
   Yang YG, 2007, CLIN CHIM ACTA, V380, P112, DOI 10.1016/j.cca.2007.01.019
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Z, 2010, J MOL DIAGN, V12, P152, DOI 10.2353/jmoldx.2010.090070
NR 35
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2019
VL 85
BP 167
EP 174
DI 10.1016/j.ijid.2019.06.007
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA IM4CD
UT WOS:000477941400031
PM 31202908
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Miyaoka, TY
   Lenhart, S
   Meyer, JFCA
AF Miyaoka, Tiago Yuzo
   Lenhart, Suzanne
   Meyer, Joao F. C. A.
TI Optimal control of vaccination in a vector-borne reaction-diffusion
   model applied to Zika virus
SO JOURNAL OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Zika virus; Optimal control; Vaccination; Partial differential
   equations; Numerical methods
ID PARAMETER-ESTIMATION; SEXUAL TRANSMISSION; SYSTEMS; RABIES
AB Zika virus has acquired worldwide concern after a recent outbreak in Latin America that started in Brazil, with associated neurological conditions such as microcephaly in newborns from infected mothers. The virus is transmitted mainly by Aedes aegypti mosquitoes, but direct (sexual) transmission has been documented. We formulate a reaction diffusion model that considers spatial movement of humans and vectors, with local contact transmission of Zika virus. Vaccination is introduced as a control variable, giving immunity to susceptible humans, in order to characterize an optimal vaccination strategy that minimizes the costs associated with infections and vaccines. The optimal control characterization is obtained in terms of state and adjoint equations. Parameter estimation and numerical simulations are carried out using data for the initial 2015 Zika outbreak in the state of Rio Grande do Norte in Brazil. Several scenarios are considered and analyzed in terms of number of new infections and costs, showing that the optimal control application is successful, significantly reducing these quantities.
C1 [Miyaoka, Tiago Yuzo; Meyer, Joao F. C. A.] Univ Estadual Campinas, Dept Appl Math, IMECC, Campinas, SP, Brazil.
   [Lenhart, Suzanne] Univ Tennessee, Dept Math, Knoxville, TN 37996 USA.
RP Miyaoka, TY (corresponding author), Univ Estadual Campinas, Dept Appl Math, IMECC, Campinas, SP, Brazil.
EM tiagoyuzo@gmail.com; slenhart@utk.edu; joni@ime.unicamp.br
FU CAPESCAPES [88881.134100/2016-01]; National Institute for Mathematical
   and Biological Synthesis - National Science FoundationNational Science
   Foundation (NSF) [DBI-1300426]; University of Tennessee, Knoxville
FX This work was supported by CAPES (Process Number 88881.134100/2016-01)
   and by the National Institute for Mathematical and Biological Synthesis,
   an Institute sponsored by the National Science Foundation through NSF
   Award #DBI-1300426, with additional support from The University of
   Tennessee, Knoxville.
CR Abboubakar H, 2017, J MATH BIOL, V76, P1
   Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Anguelov R, 2017, MATH COMPUT SIMULAT, V133, P47, DOI 10.1016/j.matcom.2015.06.014
   Asano E, 2008, MATH BIOSCI ENG, V5, P219
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Betts John T., 2010, PRACTICAL METHODOP
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo ALA, 2016, J MATH ANAL APPL, V444, P298, DOI 10.1016/j.jmaa.2016.06.037
   De Silva KR, 2017, DISCRETE CONT DYN-B, V22, P1049, DOI 10.3934/dcdsb.2017052
   DOUGLAS J, 1979, SIAM J NUMER ANAL, V16, P503, DOI 10.1137/0716039
   Evans L. C., 1998, PARTIAL DIFFERENTIAL
   Fister R, 1997, HOUSTON J MATH, V23, P341
   Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z
   Gao D, 2016, SCI REP
   Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958
   HACKBUSCH W, 1978, COMPUTING, V20, P229, DOI 10.1007/BF02251947
   Health Office, 2017, RIO GRAND NORT EP B
   Hinze M, 2010, GAMM MITTEILUNGEN, V33, P131, DOI [10.1002/gamm.201010010, DOI 10.1002/GAMM.201010010]
   Hiriart-Urruty J-B, 2016, ADV MATH MODELING OP
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Hughes T.J.R., 2012, FINITE ELEMENT METHO
   Keeling M. J., 2008, MODELING INFECT DIS
   Kon CML, 2016, PROCEEDINGS - 30TH EUROPEAN CONFERENCE ON MODELLING AND SIMULATION ECMS 2016, P93
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839
   Li X, 2012, OPTIMAL CONTROL THEO
   Lions J. L., 1971, OPTIMAL CONTROL SYST
   Lou YJ, 2011, J MATH BIOL, V62, P543, DOI 10.1007/s00285-010-0346-8
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   MIYAOKA T.Y., 2017, TEMA (São Carlos), V18, P253, DOI 10.5540/tema.2017.018.02.0253
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mocenni C, 2011, MATH COMPUT SIMULAT, V81, P2244, DOI 10.1016/j.matcom.2011.05.006
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   MURRAY JD, 2002, MATH BIOL, V2
   Neilan RM, 2011, J MATH ANAL APPL, V378, P603, DOI 10.1016/j.jmaa.2010.12.035
   Neitzel I, 2008, CONTROL CYBERN, V37, P1013
   Oehler E, 2014, EUROSURVEILLANCE
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Powell M.J.D., 2009, NA200906 U CAMBR
   Raimundo SM, 2016, J BIOL SYST, V24, P193, DOI 10.1142/S0218339016500108
   Rodrigues HS, 2014, MATH BIOSCI, V247, P1, DOI 10.1016/j.mbs.2013.10.006
   Soubeyrand S, 2014, POPUL ECOL, V56, P427, DOI 10.1007/s10144-013-0415-0
   Valega-Mackenzie W, 2018, B MATH BIOL, V80, P598, DOI 10.1007/s11538-018-0393-7
   Wang L, 2017, SCI REP
   Zheng B, 2017, J MATH BIOL, V76, P1
NR 50
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0303-6812
EI 1432-1416
J9 J MATH BIOL
JI J. Math. Biol.
PD AUG
PY 2019
VL 79
IS 3
BP 1077
EP 1104
DI 10.1007/s00285-019-01390-z
PG 28
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA IM4QR
UT WOS:000477980100010
PM 31187254
DA 2020-07-08
ER

PT J
AU Keighley, CL
   Skrzypek, HJM
   Wilson, A
   Bonning, MA
   Gilbert, GL
AF Keighley, Caitlin L.
   Skrzypek, Hannah J. M.
   Wilson, Angela
   Bonning, Michael A.
   Gilbert, Gwendolyn L.
TI Infections in pregnancy
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Review
ID PARVOVIRUS B19 INFECTION; HERPES-SIMPLEX-VIRUS; CONGENITAL
   TOXOPLASMOSIS; ZIKA VIRUS; CYTOMEGALOVIRUS-INFECTION; PRENATAL
   TREATMENT; PROSPECTIVE COHORT; RISK; MANAGEMENT; DIAGNOSIS
AB Infections in pregnancy represent a challenging and often under-appreciated area of concern for many specialists and general practitioners and can cause serious sequelae.
   Antenatal status should be highlighted on pathology request forms, as this serves to alert the laboratory of the need to store serum for an extended period. Prior antenatal specimens can be forwarded to other laboratories to enable testing in parallel with the more recent sample.
   Women with a confirmed, potentially vertically transmissible infection should be referred to a specialist with expertise in the management of perinatal infections.
   Cytomegalovirus infection is the most common congenital infection. Women who care for young children are at greater risk of exposure to the virus. Preventive steps including hand hygiene and avoiding contact with children's urine, mucous and saliva are recommended for all pregnant women.
   The incidence of parvovirus B19 infection in pregnancy is unknown. This infection is highly contagious and may result in fetal loss; particularly in the first half of pregnancy, pregnant women should avoid contact with adults or children who may have an infection.
C1 [Keighley, Caitlin L.] NSW Hlth Pathol Ctr Infect Dis & Microbiol, Inst Clin Pathol & Med Res, Sydney, NSW, Australia.
   [Keighley, Caitlin L.] Univ Sydney, Sydney, NSW, Australia.
   [Skrzypek, Hannah J. M.] Mercy Hosp Women, Melbourne, Vic, Australia.
   [Wilson, Angela] Alice Springs Hosp, Alice Springs, NT, Australia.
   [Bonning, Michael A.] GP Synergy, Sydney, NSW, Australia.
   [Bonning, Michael A.] Macquarie Univ, Sydney, NSW, Australia.
   [Gilbert, Gwendolyn L.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Gilbert, Gwendolyn L.] Univ Sydney, Sydney Hlth Eth, Sydney, NSW, Australia.
RP Keighley, CL (corresponding author), NSW Hlth Pathol Ctr Infect Dis & Microbiol, Inst Clin Pathol & Med Res, Sydney, NSW, Australia.; Keighley, CL (corresponding author), Univ Sydney, Sydney, NSW, Australia.
EM Caitlin.Keighley@sydney.edu.au
RI Skrzypek, Hannah/AAG-5947-2019
OI Gilbert, Gwendolyn/0000-0001-7490-6727; Wilson,
   Angela/0000-0003-2776-0635
CR Ahn KH, 2016, J OBSTET GYNAECOL, V36, P563, DOI 10.3109/01443615.2015.1127905
   Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   [Anonymous], 2018, PAN TREATM PREGN WOM
   Australian Technical Advisory Group on Immunisation, 2018, AUSTR IMM HDB
   Bartlett AW, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1938
   Bascietto F, 2018, ULTRASOUND OBST GYN, V52, P569, DOI 10.1002/uog.19092
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Berrebi A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.002
   Bessieres MH, 2001, EUR J OBSTET GYN R B, V94, P37, DOI 10.1016/S0301-2115(00)00300-6
   Best JM, 2007, SEMIN FETAL NEONAT M, V12, P182, DOI 10.1016/j.siny.2007.01.017
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bright A, 2016, COMMUN DIS INTELL, V40, pE7
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Centers for Disease Control and Prevention, 2019, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2018, 10 TIPS PREV INF PRE
   Charlier C, 2017, LANCET INFECT DIS, V17, P510, DOI [10.1016/S1473-3099(16)30521-7, 10.1016/s1473-3099(16)30521-7]
   Chaudhry SA, 2014, CAN FAM PHYSICIAN, V60, P334
   Communicable Diseases Network Australia, 2015, CDNA NAT GUID PUBL H
   CRADOCKWATSON JE, 1981, J HYG-CAMBRIDGE, V87, P147, DOI 10.1017/S0022172400069345
   Azevedo CTD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149938
   Department of Health, 2018, PREGN CAR GUID
   Department of Health, 2018, ZIK VIR INF CLIN PUB
   Department of Health, 2018, CLIN PRACT GUID PREG
   Deverell M, 2017, COMMUN DIS INTELL, V41, pE284
   Enders M, 2010, J CLIN VIROL, V49, P163, DOI 10.1016/j.jcv.2010.07.014
   Faucher B, 2012, J INFECTION, V64, P104, DOI 10.1016/j.jinf.2011.10.008
   Fean WS, 2002, AUST NZ J OBSTET GYN, V42, P347, DOI 10.1111/j.0004-8666.2002.00347.x
   Gilbert G L, 2000, Commun Dis Intell, V24 Suppl, P69
   Gilbert GL, 2002, MED J AUSTRALIA, V176, P229, DOI 10.5694/j.1326-5377.2002.tb04381.x
   Gilbert GL, 2002, AUST NZ J OBSTET GYN, V42, P497, DOI 10.1111/j.0004-8666.2002.00497.x
   Gilbert GL, 1991, INFECT DIS PREGNANCY
   Giorgio Elsa, 2010, J Prenat Med, V4, P63
   Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173
   Goulet V, 2012, CLIN INFECT DIS, V54, P652, DOI 10.1093/cid/cir902
   Gras L, 2005, ACTA PAEDIATR, V94, P1721, DOI 10.1080/08035250500251999
   HAWKES RA, 1993, MED J AUSTRALIA, V159, P159, DOI 10.5694/j.1326-5377.1993.tb137778.x
   Hong FC, 2017, CLIN INFECT DIS, V65, P588, DOI 10.1093/cid/cix371
   Hughes BL, 2016, AM J OBSTET GYNECOL, V214, pB5, DOI 10.1016/j.ajog.2016.02.042
   Hui LS, 2015, PRENATAL DIAG, V35, P1, DOI 10.1002/pd.4497
   Jamil MS, 2017, HIV VIRAL HEPATITIS
   Jayamaha JC, 2012, MED J AUSTRALIA, V196, P443, DOI 10.5694/mja11.11237
   Kagan KO, 2017, ARCH GYNECOL OBSTET, V296, P15, DOI 10.1007/s00404-017-4380-2
   Karunajeewa H, 2001, AUST NZ J OBSTET GYN, V41, P23, DOI 10.1111/j.1479-828X.2001.tb01289.x
   Kelly HA, 2000, EPIDEMIOL INFECT, V124, P449, DOI 10.1017/S0950268899003817
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P175, DOI 10.1111/j.1471-0528.2010.02749.x
   LeBaron CW, 2009, J INFECT DIS, V199, P552, DOI 10.1086/596207
   Leruez-Ville M, 2017, BEST PRACT RES CL OB, V38, P97, DOI 10.1016/j.bpobgyn.2016.10.005
   Loto OM, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/379271
   Madjunkov M, 2017, ARCH GYNECOL OBSTET, V296, P143, DOI 10.1007/s00404-017-4401-1
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mercy Hospital for Women, PLANN YOUR PREGN
   Morshed MG, 2015, CLIN VACCINE IMMUNOL, V22, P137, DOI 10.1128/CVI.00681-14
   Multijurisdicional Syphilis Outbreak Working Group (MJSO) of the Communicable Diseases Network of Australia, 2018, MULT SYPH OUTBR WORK
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   National Health and Medical Research Council, 2018, CLIN PRACT GUID PREG
   National Notifiable Diseases Surveillance System, 2018, NUMB NOT RUB CONG RE
   NSW Department of Primary Industries, 2018, LIST OUTBR INV SUMM
   NSW Food Authority, 2016, FOODS EAT AV PREGN
   Palasanthiran P, 2014, MANAGEMENT PERINATAL
   Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003
   Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pinninti SG, 2014, ARCH DIS CHILD-FETAL, V99, pF240, DOI 10.1136/archdischild-2013-303762
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Pomares C, 2016, J CLIN MICROBIOL, V54, P2448, DOI 10.1128/JCM.00487-16
   Pouillot R, 2012, CLIN INFECT DIS, V54, pS405, DOI 10.1093/cid/cis269
   Public Health Laboratory Network, 2017, LAB CAS DEF DIAGN CO
   Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Robert-Gangneux F, 2014, J INFECTION, V68, pS125, DOI 10.1016/j.jinf.2013.09.023
   Rodis JE, 1998, AM J OBSTET GYNECOL, V179, P985, DOI 10.1016/S0002-9378(98)70203-0
   Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, MAN HEP PREGN
   Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, MATERNAL GROUP B STR
   Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2017, INFL VACC PREGN WOM
   Royal Women's Hospital, HLTH INF A Z FACTS
   Salviz M, 2013, OTOL NEUROTOL, V34, P1165, DOI 10.1097/MAO.0b013e31828297b6
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Sintchenko V, 1999, AUST NZ J MED, V29, P284, DOI 10.1111/j.1445-5994.1999.tb00703.x
   Straface Gianluca, 2012, Infect Dis Obstet Gynecol, V2012, P385697, DOI 10.1155/2012/385697
   Tan HF, 2007, VACCINE, V25, P2630, DOI 10.1016/j.vaccine.2006.12.016
   The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, ROUT ANT ASS ABS PRE
   Thiebaut R, 2007, LANCET, V369, P115
   Trotta M, 2018, INFECTION, V46, P693, DOI 10.1007/s15010-018-1150-4
   Verduin EP, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-77
   Visvanathan K, 2016, GUT, V65, P340, DOI 10.1136/gutjnl-2015-310317
   Ward JS, 2011, MED J AUSTRALIA, V194, P525, DOI 10.5694/j.1326-5377.2011.tb03089.x
   Westhoff GL, 2011, OBSTET GYNECOL SURV, V66, P629, DOI 10.1097/OGX.0b013e31823983ec
   World Health Organization, 2017, INF TRAV VIS ZIK AFF
NR 88
TC 0
Z9 0
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD AUG
PY 2019
VL 211
IS 3
BP 134
EP 141
DI 10.5694/mja2.50261
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA IN5BA
UT WOS:000478689700011
PM 31271467
DA 2020-07-08
ER

PT J
AU Zheng, XY
   Zhang, DJ
   Li, YJ
   Yang, C
   Wu, Y
   Liang, X
   Liang, YK
   Pan, XL
   Hu, LC
   Sun, Q
   Wang, XH
   Wei, YY
   Zhu, J
   Qian, W
   Yan, ZQ
   Parker, AG
   Gilles, JRL
   Bourtzis, K
   Bouyer, J
   Tang, MX
   Zheng, B
   Yu, JS
   Liu, JL
   Zhuang, JJ
   Hu, ZG
   Zhang, MC
   Gong, JT
   Hong, XY
   Zhang, ZB
   Lin, LF
   Liu, QY
   Hu, ZY
   Wu, ZD
   Baton, LA
   Hoffmann, AA
   Xi, ZY
AF Zheng, Xiaoying
   Zhang, Dongjing
   Li, Yongjun
   Yang, Cui
   Wu, Yu
   Liang, Xiao
   Liang, Yongkang
   Pan, Xiaoling
   Hu, Linchao
   Sun, Qiang
   Wang, Xiaohua
   Wei, Yingyang
   Zhu, Jian
   Qian, Wei
   Yan, Ziqiang
   Parker, Andrew G.
   Gilles, Jeremie R. L.
   Bourtzis, Kostas
   Bouyer, Jeremy
   Tang, Moxun
   Zheng, Bo
   Yu, Jianshe
   Liu, Julian
   Zhuang, Jiajia
   Hu, Zhigang
   Zhang, Meichun
   Gong, Jun-Tao
   Hong, Xiao-Yue
   Zhang, Zhoubing
   Lin, Lifeng
   Liu, Qiyong
   Hu, Zhiyong
   Wu, Zhongdao
   Baton, Luke Anthony
   Hoffmann, Ary A.
   Xi, Zhiyong
TI Incompatible and sterile insect techniques combined eliminate mosquitoes
SO NATURE
LA English
DT Article
ID CULEX-PIPIENS-FATIGANS; CYTOPLASMIC INCOMPATIBILITY; WOLBACHIA
   INFECTION; ZIKA VIRUS; DIPTERA; STRAIN; DENGUE; TRANSMISSION;
   INTEGRATION; COMPLEX
AB The radiation-based sterile insect technique (SIT) has successfully suppressed field populations of several insect pest species, but its effect on mosquito vector control has been limited. The related incompatible insect technique (IIT)-which uses sterilization caused by the maternally inherited endosymbiotic bacteria Wolbachia-is a promising alternative, but can be undermined by accidental release of females infected with the same Wolbachia strain as the released males. Here we show that combining incompatible and sterile insect techniques (IIT-SIT) enables near elimination of field populations of the world's most invasive mosquito species, Aedes albopictus. Millions of factory-reared adult males with an artificial triple-Wolbachia infection were released, with prior pupal irradiation of the released mosquitoes to prevent unintentionally released triply infected females from successfully reproducing in the field. This successful field trial demonstrates the feasibility of area-wide application of combined IIT-SIT for mosquito vector control.
C1 [Zheng, Xiaoying; Zhang, Dongjing; Li, Yongjun; Yang, Cui; Wu, Yu; Liang, Yongkang; Hu, Linchao; Sun, Qiang; Zhuang, Jiajia; Zhang, Meichun; Wu, Zhongdao; Xi, Zhiyong] Sun Yat Sen Univ, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Zhongshan Sch Med, Key Lab Trop Dis Control,Minist Educ, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Dongjing; Parker, Andrew G.; Gilles, Jeremie R. L.; Bourtzis, Kostas; Bouyer, Jeremy] Vienna Int Ctr, Insect Pest Control Lab, Joint FAO IAEA Programme Nucl Tech Food & Agr, Vienna, Austria.
   [Li, Yongjun; Yang, Cui; Liang, Yongkang; Wang, Xiaohua; Wei, Yingyang; Zhu, Jian; Qian, Wei; Liu, Julian; Xi, Zhiyong] Guangzhou Wolbaki Biotech Co Ltd, Guangzhou, Guangdong, Peoples R China.
   [Liang, Xiao; Pan, Xiaoling; Sun, Qiang; Baton, Luke Anthony; Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
   [Pan, Xiaoling] Hunan Normal Univ, Sch Med, Changsha, Hunan, Peoples R China.
   [Yan, Ziqiang; Hu, Zhigang; Zhang, Zhoubing] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.
   [Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
   [Zheng, Bo; Yu, Jianshe] Guangzhou Univ, Ctr Appl Math, Coll Math & Informat Sci, Guangzhou, Guangdong, Peoples R China.
   [Gong, Jun-Tao; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.
   [Lin, Lifeng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.
   [Liu, Qiyong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.
   [Hu, Zhiyong] Guangzhou Univ, Lingnan Stat Sci Res Inst, Guangzhou, Guangdong, Peoples R China.
   [Hoffmann, Ary A.] Univ Melbourne, Bio21 Inst, Sch BioSci, Melbourne, Vic, Australia.
RP Xi, ZY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Zhongshan Sch Med, Key Lab Trop Dis Control,Minist Educ, Guangzhou, Guangdong, Peoples R China.; Xi, ZY (corresponding author), Guangzhou Wolbaki Biotech Co Ltd, Guangzhou, Guangdong, Peoples R China.; Xi, ZY (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
EM xizy@msu.edu
RI Hong, Xiao-Yue/AAF-4759-2020; Bouyer, Jeremy/AAK-7370-2020; Hoffmann,
   Ary/R-2972-2019
OI Bouyer, Jeremy/0000-0002-1913-416X; Hoffmann, Ary/0000-0001-9497-7645;
   Baton, Luke/0000-0003-4515-8867; Zhang, Meichun/0000-0002-3134-8099
FU Guangdong Innovative Research Team Program [2011S009]; Scientific and
   Technological Leading Talents of Guangzhou Development District
   [2013L-P116]; Science and Technology Planning Project of Guangdong
   Province [2016A020251001]; Foundation for the NIH through the Grand
   Challenges in Global Health Initiative of the Bill and Melinda Gates
   Foundation; Food and Agricultural Organization (FAO) of the United
   Nations; Food and Agricultural Organization (FAO) of the International
   Atomic Energy Agency (IAEA) Division of Nuclear Techniques in Food and
   Agriculture; IAEA Department of Technical Cooperation [RAS5066, RAS5082,
   D42016, D44002]; 111 ProjectMinistry of Education, China - 111 Project
   [B12003]; Key Project of NNSF of China [11631005]; China Postdoctoral
   Innovation Program [BX20180394]; NJAU-MSU Asia-Hub Project [2017-AH-04];
   NHMRC FellowshipNational Health and Medical Research Council of
   Australia
FX This work was supported by Guangdong Innovative Research Team Program
   (No. 2011S009), Scientific and Technological Leading Talents of
   Guangzhou Development District (No. 2013L-P116), Science and Technology
   Planning Project of Guangdong Province (2016A020251001), a grant from
   the Foundation for the NIH through the Grand Challenges in Global Health
   Initiative of the Bill and Melinda Gates Foundation, the joint Food and
   Agricultural Organization (FAO) of the United Nations and International
   Atomic Energy Agency (IAEA) Division of Nuclear Techniques in Food and
   Agriculture and the IAEA Department of Technical Cooperation (RAS5066,
   RAS5082, D42016 and D44002), the 111 Project (grant no. B12003), Key
   Project of NNSF of China (11631005), China Postdoctoral Innovation
   Program (BX20180394), and a grant-in-aid for joint research (2017-AH-04)
   from the NJAU-MSU Asia-Hub Project. A.A.H. was supported by an NHMRC
   Fellowship. We thank X. Zhou, S. O'Neill, S. L. Dobson, G. Bian and E.
   Walker for their support, suggestions and technical assistance.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   [Anonymous], METHODS ANOPHELES RE
   ARUNACHALAM N, 1985, J MED ENTOMOL, V22, P648, DOI 10.1093/jmedent/22.6.648
   Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38
   Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129
   Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271
   Curtis C. F., 1987, J MED ENTOMOL, V24, P273
   Curtis C. F., 1976, P 15 INT C ENT WASH, P106
   CURTIS CF, 1982, ENTOMOL EXP APPL, V31, P181, DOI 10.1111/j.1570-7458.1982.tb03133.x
   Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2
   Das S., 2007, JOVE-J VIS EXP
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   Dyck VA, 2005, STERILE INSECT TECHN
   FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869
   Fu YQ, 2010, APPL ENVIRON MICROB, V76, P5887, DOI 10.1128/AEM.00218-10
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814
   Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   LAVEN H, 1970, Pakistan Journal of Science, V22, P303
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   McGraw EA, 2001, P ROY SOC B-BIOL SCI, V268, P2565, DOI 10.1098/rspb.2001.1839
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Pal R., 1974, P73
   Sanogo YO, 2004, INSECT MOL BIOL, V13, P365, DOI 10.1111/j.0962-1075.2004.00498.x
   Schmidt TL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006009
   SHARMA VP, 1979, J MED ENTOMOL, V15, P155, DOI 10.1093/jmedent/15.2.155
   Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405
   Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0
   Zhang DJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2750-7
   Zhang DJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2511-z
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zhang MC, 2010, AM J TROP MED HYG, V83, P700, DOI 10.4269/ajtmh.2010.10-0193
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
NR 56
TC 82
Z9 86
U1 41
U2 102
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD AUG 1
PY 2019
VL 572
IS 7767
BP 56
EP +
DI 10.1038/s41586-019-1407-9
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IM5EU
UT WOS:000478017900035
PM 31316207
OA Bronze
DA 2020-07-08
ER

PT J
AU Tate, KM
   Munson, JM
AF Tate, Kinsley M.
   Munson, Jennifer M.
TI Assessing drug response in engineered brain microenvironments
SO BRAIN RESEARCH BULLETIN
LA English
DT Review
DE Microfluidics; Biomaterial scaffolds; Microtissue models;
   Neuro-oncological disease; Neurodegenerative disease; Neurodevelopment
   disorders; in vitro models; Drug screening; Brain microenvironment
ID CEREBRAL ORGANOIDS; INTERSTITIAL FLOW; NEURAL CONSTRUCTS; MODEL;
   PERMEABILITY; CULTURE; DIFFERENTIATION; IDENTIFICATION; XENOGRAFTS;
   SCAFFOLDS
AB Tissue engineered systems are important models for the testing and discovery of therapeutics against a number of diseases. The use of these models in vitro can expand both our understanding of the mechanisms behind disease and allow for higher throughput and personalized modeling of therapeutic response. Over the past decade there has been an explosion of models of neurological disorders that can be used in vitro to study new therapies against devastating neurodegenerative, neurodevelopmental, and neuro-oncological disease. These models span several types of engineered microenvironments which are produced using microfluidic devices, microtissue technology and/or the incorporation of biomaterial scaffolds to model neurological conditions such as; Alzheimer's disease, idiopathic autism, Parkinson's disease, Zika-induced microcephaly and neoplasms. Using engineered brain microenvironments, therapeutics can be tested in more physiologically relevant ways leading to new knowledge of the underlying causes and interactions occurring at the tissue level. However, much is still left to learn and model within these systems to make them truly valuable in the discovery and testing of novel therapies. Here we review the current state of the art of engineered brain microenvironments being used specifically to screen and test new therapeutic strategies and discuss the current benefits and limitations that still exist.
C1 [Tate, Kinsley M.; Munson, Jennifer M.] Virginia Polytech Inst & State Univ, Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.
RP Munson, JM (corresponding author), 349 Kelly Hall,325 Stanger St,MC 0298, Blacksburg, VA 24061 USA.
EM jm4kt@vt.edu
OI Tate, Kinsley/0000-0001-9253-6483
FU NIHR37 [CA222563];  [NIHR37 CA222563]
FX Grant support: NIHR37 CA222563 to JMM.
CR Achyuta AKH, 2013, LAB CHIP, V13, P542, DOI 10.1039/c2lc41033h
   Albritton JL, 2017, DIS MODEL MECH, V10, P3, DOI 10.1242/dmm.025049
   Alonzo LF, 2015, LAB CHIP, V15, P3521, DOI 10.1039/c5lc00507h
   Anastasio TJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00116
   Arifin DY, 2009, J CONTROL RELEASE, V137, P203, DOI 10.1016/j.jconrel.2009.04.013
   Arranz AM, 2019, LANCET NEUROL, V18, P406, DOI 10.1016/S1474-4422(18)30490-3
   Azuaje F, 2017, BRIEF BIOINFORM, V18, P820, DOI 10.1093/bib/bbw065
   Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550
   Bartlett R, 2014, TRANSL ONCOL, V7, P657, DOI 10.1016/j.tranon.2014.10.006
   Ben-David U, 2017, NAT GENET, V49, P1567, DOI 10.1038/ng.3967
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bian S, 2018, NAT METHODS, V15, P748, DOI 10.1038/s41592-018-0118-8
   Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009
   Bischel LL, 2016, J BIOMED MATER RES A, V104, P901, DOI 10.1002/jbm.a.35624
   Booth R, 2014, ANN BIOMED ENG, V42, P2379, DOI 10.1007/s10439-014-1086-5
   Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d
   Bosi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09562
   Brooks E. A., 2018, BIORXIV, DOI [10.1101/408583, DOI 10.1101/408583]
   Carpenter TS, 2014, BIOPHYS J, V107, P630, DOI 10.1016/j.bpj.2014.06.024
   Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075682
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Cornelison RC, 2018, FRONT MATER, V5, DOI 10.3389/fmats.2018.00027
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269
   Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8
   Dai XL, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045005
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898
   Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539
   Fan YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25062
   Fetterly GJ, 2008, CLIN CANCER RES, V14, P5856, DOI 10.1158/1078-0432.CCR-08-1046
   Frampton JP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015002
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gong LL, 2018, ADV MATER, V30, DOI 10.1002/adma.201705684
   Hajiali H, 2018, J MATER CHEM B, V6, P930, DOI 10.1039/c7tb02969a
   Harris AR, 2018, METHODS, V134, P20, DOI 10.1016/j.ymeth.2017.12.010
   Heinrich MA, 2019, ADV MATER, V31, DOI 10.1002/adma.201806590
   Hoshiba T, 2017, J MATER CHEM B, V5, P4322, DOI 10.1039/c7tb00074j
   Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006
   Ivanov DP, 2015, J BIOTECHNOL, V205, P3, DOI 10.1016/j.jbiotec.2015.01.002
   Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024
   Jakobsson A, 2017, NANOMED-NANOTECHNOL, V13, P1563, DOI 10.1016/j.nano.2016.12.023
   Joung D., 2018, ADV FUNCT MATER, V28, P1
   Kingsmore KM, 2016, INTEGR BIOL-UK, V8, P1246, DOI 10.1039/c6ib00167j
   Knight E, 2015, J ANAT, V227, P746, DOI 10.1111/joa.12257
   Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Kurbatova P, 2016, EXP NEUROL, V283, P57, DOI 10.1016/j.expneurol.2016.05.037
   Labour MN, 2016, ACTA BIOMATER, V37, P38, DOI 10.1016/j.actbio.2016.04.001
   Laferla F. M., 2013, ANIMAL MODELS ALZHEI, P1, DOI [10.1101/cshperspecta006320, DOI 10.1101/CSHPERSPECTA006320]
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee H, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/JOURNAL.PONE.0163072
   Li LF, 2016, METHODS, V96, P97, DOI 10.1016/j.ymeth.2015.11.013
   Liao CP, 2016, ONCOTARGET, V7, P61500, DOI 10.18632/oncotarget.11133
   Logsdon DK, 2017, CELL MOL BIOENG, V10, P463, DOI 10.1007/s12195-017-0498-3
   Lozano R, 2015, BIOMATERIALS, V67, P264, DOI 10.1016/j.biomaterials.2015.07.022
   Ma L, 2012, BIOMATERIALS, V33, P4353, DOI 10.1016/j.biomaterials.2012.02.054
   Maoz BM, 2018, NAT BIOTECHNOL, V36, P865, DOI 10.1038/nbt.4226
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838
   Murphy AR, 2017, ACTA BIOMATER, V54, P1, DOI 10.1016/j.actbio.2017.02.046
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Nzou G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25603-5
   Okorji UP, 2016, MOL NEUROBIOL, V53, P6426, DOI 10.1007/s12035-015-9543-1
   Park J, 2015, LAB CHIP, V15, P141, DOI 10.1039/c4lc00962b
   Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741
   Potjewyd G, 2018, TRENDS BIOTECHNOL, V36, P457, DOI 10.1016/j.tibtech.2018.01.003
   Pringsheim T, 2014, NEUROLOGY, V83, P1661, DOI 10.1212/WNL.0000000000000929
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qosa H, 2016, J ALZHEIMERS DIS, V53, P1499, DOI 10.3233/JAD-151179
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Schneider G, 2018, NAT REV DRUG DISCOV, V17, P97, DOI 10.1038/nrd.2017.232
   Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112
   Seidi A, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580756
   Shevelkin AV, 2014, REV NEUROSCIENCE, V25, P177, DOI 10.1515/revneuro-2013-0049
   Son MY, 2017, NEUROPATH APPL NEURO, V43, P584, DOI 10.1111/nan.12396
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stephenson J, 2018, IMMUNOLOGY, V154, P204, DOI 10.1111/imm.12922
   Stylli SS, 2015, J CLIN NEUROSCI, V22, P619, DOI 10.1016/j.jocn.2014.10.013
   Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178
   Taylor AM, 2015, LAB CHIP, V15, P2781, DOI 10.1039/c5lc00503e
   Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777
   Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022
   Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61
   Thomsen LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134765
   Tunesi M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00146
   Uenaka T, 2018, HUM MOL GENET, V27, P3974, DOI 10.1093/hmg/ddy279
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Wang YI, 2017, BIOTECHNOL BIOENG, V114, P184, DOI 10.1002/bit.26045
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Xu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep36670
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yan Y., 2018, TISSUE ENG PART A, V24, DOI [10.1089/ten.TEA.2017.0423.ten.TEA.2017.0423, DOI 10.1089/TEN.TEA.2017.0423.TEN.TEA.2017.0423]
   Yu KKH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193694
   Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103
   Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85
NR 97
TC 2
Z9 2
U1 4
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD AUG
PY 2019
VL 150
SI SI
BP 21
EP 34
DI 10.1016/j.brainresbull.2019.04.027
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA IM1XI
UT WOS:000477784800003
PM 31054318
DA 2020-07-08
ER

PT J
AU Gonzaga, DTG
   Gomes, RSP
   Marra, RKF
   da Silva, FC
   Gomes, MWL
   Ferreira, DE
   Santos, RMA
   Pinto, AMV
   Ratcliffe, NA
   Cirne-Santos, CC
   Barros, CS
   Ferreira, VF
   Paixao, ICNP
AF Gonzaga, Daniel T. G.
   Gomes, Rafaela S. P.
   Marra, Roberta K. F.
   da Silva, Fernando C.
   Gomes, Max W. L.
   Ferreira, Davis E.
   Santos, Raissa M. A.
   Pinto, Ana M., V
   Ratcliffe, Norman Arthur
   Cirne-Santos, Claudio C.
   Barros, Caroline S.
   Ferreira, Vitor F.
   Paixao, Izabel Christina N. P.
TI Inhibition of Zika Virus Replication by Synthetic Bis-Naphthoquinones
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE Zika virus; Flavivirus; arbovirus; antiviral; bis-naphthoquinones
ID IN-VITRO; INFECTION; SCREEN; TYPE-2; DRUGS; RNA
AB Zika virus (ZIKV) is a mosquito-borne pathogen which is a current global public health concern. There are currently no approved vaccines or antivirals against ZIKV infection. Taking into account that naphthoquinones have shown promising antiviral activity, the aim of this study was to describe the screening of two bis-naphthoquinones series against ZIKV. Twenty seven compounds were evaluated against ZIKV using Vero cells. The findings showed that among the compounds analyzed four were promising. Compound 3.3' -((2-nitrophenyl)methylene)bis(2-hydroxynaphthalene-1,4-dione) containing the nitro group at the ortho position showed the best selectivity index, followed by compound 3,3'-(4-chlorophenylmethylene)bis(naphthalene-1,2,4-triyl triacetate) with the chlorophenylmethylene radical. These results demonstrate that these bis-naphthoquinones are largely effective in inhibiting the replication of ZIKV.
C1 [Gonzaga, Daniel T. G.; Marra, Roberta K. F.; da Silva, Fernando C.; Santos, Raissa M. A.; Ferreira, Vitor F.] Univ Fed Fluminense, Inst Quim, BR-24020141 Niteroi, RJ, Brazil.
   [Gonzaga, Daniel T. G.] Ctr Univ Estadual Zona Oeste, Inst Biomed, BR-23070200 Rio De Janeiro, RJ, Brazil.
   [Gomes, Rafaela S. P.; Gomes, Max W. L.; Cirne-Santos, Claudio C.; Barros, Caroline S.; Paixao, Izabel Christina N. P.] Univ Fed Fluminense, Inst Biol, BR-24020141 Niteroi, RJ, Brazil.
   [Ferreira, Davis E.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941599 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis E.] North Carolina State Univ, Dept Mol & Struct Biochem, 120 W Broughton Dr, Raleigh, NC 27607 USA.
   [Pinto, Ana M., V] Univ Fed Fluminense, Unidade Farm, BR-24210130 Niteroi, RJ, Brazil.
   [Ratcliffe, Norman Arthur] Swansea Univ, Coll Sci, Dept Biociences, Swansea SA2 8PP, W Glam, Wales.
RP Ferreira, VF (corresponding author), Univ Fed Fluminense, Inst Quim, BR-24020141 Niteroi, RJ, Brazil.; Paixao, ICNP (corresponding author), Univ Fed Fluminense, Inst Biol, BR-24020141 Niteroi, RJ, Brazil.
EM vitorferreira@id.uff.br; izabeluff@gmail.com
RI Paixao, Izabel/AAM-1668-2020; Pinto, Ana Maria Viana/AAH-2080-2019;
   Barros, Caroline/S-7840-2019; Cirne-Santos, Claudio/T-4009-2019; Paixao,
   Izabel/S-7490-2019; de Carvalho da Silva, Fernando/E-3408-2014
OI Cirne-Santos, Claudio/0000-0001-8376-1830; de Carvalho da Silva,
   Fernando/0000-0002-2042-3778; Barros, Caroline/0000-0002-4678-3093
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); CAPESCAPES
FX The authors thank the Brazilian agencies CNPq, CAPES, and FAPERJ and
   FIOCRUZ for the HRMS. V. F. F., F. C. S. and I. C. N. P. P. are
   recipients of CNPq research fellowships; D. T. G. G., R. K. F. M. and N.
   A. R. received FAPERJ research fellowships. C. C. C. S. thanks to CAPES
   for the Postdoc fellowship and C. S. B. thanks FAPERJ for the Postdoc
   fellowship. The authors would like to acknowledge for the technical
   support of Thereza Elizabeth P. P. Garcia.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   [Anonymous], 2002, GRAPHPAD INST VERS 3
   Azarudeen R. M. S. T., 2016, J CLUST SCI, V20, P359
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brahmachari G, 2015, ACS SUSTAIN CHEM ENG, V3, P2058, DOI 10.1021/acssuschemeng.5b00325
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao S, 2014, CURR ORG CHEM, V18, P70, DOI 10.2174/138527281801140121123221
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheng HY, 2004, J ANTIMICROB CHEMOTH, V53, P577, DOI 10.1093/jac/dkh136
   Crosby IT, 2011, BIOORG MED CHEM LETT, V21, P1644, DOI 10.1016/j.bmcl.2011.01.109
   da Costa ECB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082504
   da Silva FD, 2016, CURR ORG SYNTH, V13, P334, DOI 10.2174/1570179412666150817220343
   de Araujo MV, 2014, MOLECULES, V19, P15180, DOI 10.3390/molecules190915180
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Lieberherr C, 2017, PLANTA MED, V83, P232, DOI 10.1055/s-0042-111825
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira DRM, 2015, J ENZYM INHIB MED CH, V30, P615, DOI 10.3109/14756366.2014.958083
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7
   Ogura Takahiro, 2015, BMC Res Notes, V8, P644, DOI 10.1186/s13104-015-1627-5
   Pinto AMV, 2014, ARCH VIROL, V159, P1827, DOI 10.1007/s00705-014-1989-3
   Pires M. C., 2015, ANTIVIR THER, V21, P507
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Salam AP, 2017, ANN INTERN MED, V166, P725, DOI [10.7326/M16-2530, 10.7326/m16-2530]
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Silva TL, 2016, CHEMELECTROCHEM, V3, P2252, DOI 10.1002/celc.201600504
   Tisseh ZN, 2009, DYES PIGMENTS, V83, P258, DOI 10.1016/j.dyepig.2008.09.003
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 44
TC 1
Z9 1
U1 1
U2 1
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD AUG
PY 2019
VL 30
IS 8
BP 1697
EP 1706
DI 10.21577/0103-5053.20190071
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA IK5IZ
UT WOS:000476620200014
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Krukowski, K
   Rosi, S
AF Krukowski, Karen
   Rosi, Susanna
TI The dark side of antiviral T cell responses
SO NATURE NEUROSCIENCE
LA English
DT Editorial Material
ID INTERFERON-GAMMA
AB Mosquito-borne virus infections, such as West Nile and Zika, have debilitating cognitive effects that persist despite recovery from encephalitis. Garber et al. identify mechanisms by which antiviral T cell persistence after recovery from infection leads to impairments in cognition via virus-specific mediation of microglial synapse elimination.
C1 [Krukowski, Karen; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA.
   [Krukowski, Karen; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.
   [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.
   [Rosi, Susanna] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.
   [Rosi, Susanna] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.
RP Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.
EM susanna.rosi@ucsf.edu
CR Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082
   Chevalier G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002393
   Di Liberto G, 2018, CELL, V175, P458, DOI 10.1016/j.cell.2018.07.049
   Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626
   Garber C, 2019, NAT NEUROSCI, V22, P1276, DOI 10.1038/s41593-019-0427-y
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002
   Kreutzfeldt M, 2013, J EXP MED, V210, P2087, DOI 10.1084/jem.20122143
   Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753
   Liblau RS, 2013, TRENDS NEUROSCI, V36, P315, DOI 10.1016/j.tins.2013.01.008
   Monteiro S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.194
   Readhead B, 2018, NEURON, V99, P64, DOI 10.1016/j.neuron.2018.05.023
   Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295
   Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
NR 15
TC 0
Z9 0
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD AUG
PY 2019
VL 22
IS 8
BP 1199
EP 1200
DI 10.1038/s41593-019-0454-8
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA IL1MZ
UT WOS:000477065500001
PM 31346293
DA 2020-07-08
ER

PT J
AU Garber, C
   Soung, A
   Vollmer, LL
   Kanmogne, M
   Last, A
   Brown, J
   Klein, RS
AF Garber, Charise
   Soung, Allison
   Vollmer, Lauren L.
   Kanmogne, Marlene
   Last, Aisling
   Brown, Jasmine
   Klein, Robyn S.
TI T cells promote microglia-mediated synaptic elimination and cognitive
   dysfunction during recovery from neuropathogenic flaviviruses
SO NATURE NEUROSCIENCE
LA English
DT Article
ID WEST-NILE-VIRUS; CENTRAL-NERVOUS-SYSTEM; INTERFERON-GAMMA; BRAIN;
   INFECTION; EXPRESSION; INJURY; NEUROGENESIS; APOPTOSIS; DYNAMICS
AB T cells clear virus from the CNS and dynamically regulate brain functions, including spatial learning, through cytokine signaling. Here we determined whether hippocampal T cells that persist after recovery from infection with West Nile virus (WNV) or Zika virus (ZIKV) impact hippocampal-dependent learning and memory. Using newly established models of viral encephalitis recovery in adult animals, we show that in mice that have recovered from WNV or ZIKV infection, T cell-derived interferon-gamma (IFN-gamma) signaling in microglia underlies spatial-learning defects via virus-target-specific mechanisms. Following recovery from WNV infection, mice showed presynaptic termini elimination with lack of repair, while for ZIKV, mice showed extensive neuronal apoptosis with loss of postsynaptic termini. Accordingly, animals deficient in CD8(+) T cells or IFN-gamma signaling in microglia demonstrated protection against synapse elimination following WNV infection and decreased neuronal apoptosis with synapse recovery following ZIKV infection. Thus, T cell signaling to microglia drives post-infectious cognitive sequelae that are associated with emerging neurotropic flaviviruses.
C1 [Garber, Charise; Soung, Allison; Vollmer, Lauren L.; Kanmogne, Marlene; Last, Aisling; Brown, Jasmine; Klein, Robyn S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.
   [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.
RP Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA.
EM rklein@wustl.edu
OI Garber, Charise/0000-0001-5270-8500; Soung, Allison/0000-0002-1590-6038
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19 AI083019, R01 NS052632, R01
   AI101400]
FX The authors acknowledge M. Diamond, J. Miner, A. Smith, L. Thackray, and
   K. Funk for helpful discussions and technical support. They also thank
   W. Beatty at the Molecular Microbiology Imaging facility at Washington
   University School of Medicine. This work was supported by NIH grants U19
   AI083019, R01 NS052632, and R01 AI101400 to R.S.K.
CR Borchardt SM, 2010, PUBLIC HEALTH REP, V125, P246, DOI 10.1177/003335491012500213
   Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470
   Canty AJ, 2013, J NEUROSCI, V33, P10374, DOI 10.1523/JNEUROSCI.0254-13.2013
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Durrant DM, 2013, J EXP MED, V210, P503, DOI 10.1084/jem.20121897
   Ebner F, 2013, J IMMUNOL, V191, P5594, DOI 10.4049/jimmunol.1203331
   Eigenbrod T, 2013, J IMMUNOL, V190, P6533, DOI 10.4049/jimmunol.1300324
   Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626
   Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423
   Grebing M, 2016, GLIA, V64, P407, DOI 10.1002/glia.22937
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373
   Kaabinejadian S, 2016, J IMMUNOL, V196, P4263, DOI 10.4049/jimmunol.1501821
   Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002
   Kreutzfeldt M, 2013, J EXP MED, V210, P2087, DOI 10.1084/jem.20122143
   Li L, 2010, J NEUROSCI, V30, P9038, DOI 10.1523/JNEUROSCI.5691-09.2010
   Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Monteiro S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.194
   Murray KO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102953
   Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0
   Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110
   Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   OGATA A, 1991, J VIROL, V65, P880, DOI 10.1128/JVI.65.2.880-886.1991
   Ottum PA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00539
   Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030
   Paz J, 2007, NEUROBIOL AGING, V28, P1446, DOI 10.1016/j.neurobiolaging.2006.06.014
   Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047
   Readhead B, 2018, NEURON, V99, P64, DOI 10.1016/j.neuron.2018.05.023
   Savarin C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0293-9
   Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536
   Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014
   Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Unger MS, 2018, ALZHEIMERS DEMENT, V14, P1022, DOI 10.1016/j.jalz.2018.02.017
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Vilalta A, 2018, FEBS J, V285, P3566, DOI 10.1111/febs.14323
   Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107
   Wang X, 2013, EUR J IMMUNOL, V43, P115, DOI 10.1002/eji.201242679
   Zucker J, 2017, EMERG INFECT DIS, V23, P1047, DOI 10.3201/eid2306.162029
NR 50
TC 5
Z9 5
U1 3
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD AUG
PY 2019
VL 22
IS 8
BP 1276
EP +
DI 10.1038/s41593-019-0427-y
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA IL1MZ
UT WOS:000477065500011
PM 31235930
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Hooftman, A
   O'Neill, LAJ
AF Hooftman, Alexander
   O'Neill, Luke A. J.
TI The Immunomodulatory Potential of the Metabolite Itaconate
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID IMMUNE-RESPONSIVE GENE-1; SUCCINATE-DEHYDROGENASE; ISOCITRATE LYASE;
   ACID; NRF2; UBIQUITINATION; INHIBITION; EXPRESSION; INFECTION; AGENTS
AB The field of immunometabolism has demonstrated that metabolites can lead double lives as immunomodulators. Itaconate is perhaps the best example of such a moonlighting molecule, and has been shown to have multiple anti-inflammatory effects in macrophages. Itaconate is significantly upregulated under inflammatory conditions, and can promote an anti-inflammatory phenotype by reducing oxidative stress and blocking transcriptional responses to lipopolysaccharide (LPS) in murine macrophages. Antibacterial and protumor effects have also been described for itaconate and, most recently, reports have surfaced of its possible modulatory roles during Zika virus infection in murine neurons. We posit here that itaconate is a crucial determinant of innate immune responses, and may potentially be harnessed therapeutically to treat inflammatory diseases.
C1 [Hooftman, Alexander; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.
RP O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.
EM laoneill@tcd.ie
OI Hooftman, Alexander/0000-0002-5412-4012
CR ACKERMANN WW, 1949, P SOC EXP BIOL MED, V72, P1
   Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z
   Baup S., 1836, ANN PHARM, V19, P29
   Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009
   Brennan MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120254
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792
   Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017
   Dominguez-Andres J, 2019, CELL METAB, V29, P211, DOI 10.1016/j.cmet.2018.09.003
   ElAzzouny M, 2017, J BIOL CHEM, V292, P4766, DOI 10.1074/jbc.C117.775270
   Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714
   Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287
   He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488
   Kinoshita K, 1932, ACTA PHYTOCHIM, V5, P271
   Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665
   Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004
   LEE CGL, 1995, IMMUNOGENETICS, V41, P263, DOI 10.1007/BF00172150
   Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538
   Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033
   LOIKE JD, 1993, J IMMUNOL, V150, P1951
   MCFADDEN BA, 1977, J BACTERIOL, V131, P136, DOI 10.1128/JB.131.1.136-144.1977
   Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634
   Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110
   Mills EL, 2018, NATURE, V556, P113, DOI [10.1038/nature25986, 10.1038/s41586-018-0353-2]
   Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064
   Nair S, 2018, J EXP MED, V215, P1035, DOI 10.1084/jem.20180118
   Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408
   Nemeth B, 2016, FASEB J, V30, P286, DOI 10.1096/fj.15-279398
   Olagnier D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05861-7
   Pan J, 2014, ONCOL REP, V32, P1957, DOI 10.3892/or.2014.3474
   Puchalska P, 2018, ISCIENCE, V9, P298, DOI 10.1016/j.isci.2018.10.029
   Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006
   RITTENHOJW, 1974, ARCH BIOCHEM BIOPHYS, V163, P79, DOI DOI 10.1016/0003-9861(74)90456-1
   Ryan DG, 2019, NAT METAB, V1, P16, DOI 10.1038/s42255-018-0014-7
   Sasikaran J, 2014, NAT CHEM BIOL, V10, P371, DOI 10.1038/nchembio.1482
   Shen HY, 2017, CELL, V171, P771, DOI 10.1016/j.cell.2017.09.051
   Shi HZ, 2018, EUR REV MED PHARMACO, V22, P3837, DOI 10.26355/eurrev_201806_15268
   Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m
   Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889
   Sugimoto M, 2012, METABOLOMICS, V8, P624, DOI 10.1007/s11306-011-0353-9
   Turner E, 1841, ELEMENTS CHEM INCLUD
   van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999
   Weiss JM, 2018, J CLIN INVEST, V128, P3794, DOI 10.1172/JCI99169
   WILLIAMS JO, 1971, BIOCHEMISTRY-US, V10, P1384
   Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003
NR 47
TC 8
Z9 8
U1 6
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
EI 1471-4981
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD AUG
PY 2019
VL 40
IS 8
BP 687
EP 698
DI 10.1016/j.it.2019.05.007
PG 12
WC Immunology
SC Immunology
GA IL1NM
UT WOS:000477066800005
PM 31178405
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Caban-Martinez, AJ
   Ajelli, M
   Vasquez, C
   Petrie, W
   Beier, JC
AF Wilke, Andre B. B.
   Caban-Martinez, Alberto J.
   Ajelli, Marco
   Vasquez, Chalmers
   Petrie, William
   Beier, John C.
TI Mosquito Adaptation to the Extreme Habitats of Urban Construction Sites
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID MIAMI-DADE COUNTY; ZIKA VIRUS; AEDES-AEGYPTI; URBANIZATION;
   EPIDEMIOLOGY; TRANSMISSION; KNOWLEDGE; OUTBREAK; WORKERS; FLORIDA
AB The construction industry employs millions of workers in the USA. However, little is known about how environmental disturbances caused by the construction industry impacts vector mosquito ecology and behavior, and whether it is responsible for increasing the abundance of mosquitoes. There is a major scientific gap on how to assess the occupational exposure risk of mosquito biting and arbovirus transmission among outdoor worker populations who spend a disproportionate amount of time working outdoors. In our opinion, it is critical to address how construction workers and the surrounding communities may be geographically and seasonally exposed to vector mosquitoes. Research should identify modifiable worker- and organizational-level factors that improve worksite mosquito-control practices to give insights into future vector-control strategies in urban environments.
C1 [Wilke, Andre B. B.; Caban-Martinez, Alberto J.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Ajelli, Marco] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.
   [Ajelli, Marco] Bruno Kessler Fdn, Trento, Italy.
   [Vasquez, Chalmers; Petrie, William] Miarni Dade Cty Mosquito Control Div, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014; , J/AAG-1499-2019
OI Wilke, Andre B B/0000-0002-6629-7666; , J/0000-0002-5960-1308
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [1U01CK000510-03]
FX This research was supported by the CDC (https://www.cdc.gov/) Grant
   1U01CK000510-03: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program. CDC had no role in the
   design of the study, the collection, analysis, and interpretation of
   data, or in writing the manuscript.
CR Adsul Balkrishna B, 2011, Indian J Occup Environ Med, V15, P29, DOI 10.4103/0019-5278.83001
   Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   BAUMGARTNER DL, 1987, J AM MOSQUITO CONTR, V3, P26
   Bennet F.L, 2016, MANAGEMENT CONSTRUCT
   Brown CA, 2014, INT J SCI TECHNOL RE, V3, P94
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Bureau of Labor Statistics, 2017, EMPL PERS DET IND SE, P230
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Halperin KM, 2004, J SAFETY RES, V35, P141, DOI 10.1016/j.jsr.2003.11.004
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lingard H, 1997, J SAFETY RES, V28, P243, DOI 10.1016/S0022-4375(97)00010-8
   Sampaio AMM, 2009, WASTE MANAGE, V29, P2867, DOI 10.1016/j.wasman.2009.06.017
   McKinlay J. B, 2011, PREPARATION AGING, P87
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE137, DOI 10.1097/JOM.0000000000001039
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919
   Reba M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.34
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Shetty V, 2013, PEST MANAG SCI, V69, P257, DOI 10.1002/ps.3383
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Tserng HP, 2009, AUTOMAT CONSTR, V18, P994, DOI 10.1016/j.autcon.2009.05.005
   United Nations, 2014, WORLD URB PROSP 2014
   Wilke ABB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209625
   Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830
   Zainon N, 2016, PLANN MALAYSIA, V5, P15
NR 43
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD AUG
PY 2019
VL 35
IS 8
BP 607
EP 614
DI 10.1016/j.pt.2019.05.009
PG 8
WC Parasitology
SC Parasitology
GA IL0MF
UT WOS:000476990200006
PM 31230997
OA Other Gold
DA 2020-07-08
ER

PT J
AU Romer, Y
   Valadez-Gonzalez, N
   Contreras-Capetillo, S
   Manrique-Saide, P
   Vazquez-Prokopec, G
   Pavia-Ruz, N
AF Romer, Yamila
   Valadez-Gonzalez, Nina
   Contreras-Capetillo, Silvina
   Manrique-Saide, Pablo
   Vazquez-Prokopec, Gonzalo
   Pavia-Ruz, Norma
TI Zika Virus Infection in Pregnant Women, Yucatan, Mexico
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID EPIDEMIC; OUTBREAK; INFANTS; BRAIN; BIRTH; RNA
AB We report demographic, epidemiologic, and clinical findings for a prospective cohort of pregnant women during the initial phase of Zika virus introduction into Yucatan, Mexico. We monitored 115 pregnant women for signs of active or recent Zika virus infection. The estimated cumulative incidence of Zika virus infection was 0.31 and the ratio of symptomatic to asymptomatic cases was 1.7 (range 1.3-4.0 depending on age group). Exanthema was the most sensitive clinical sign but also the least specific. Conjunctival hyperemia, joint edema, and exanthema were the combination of signs that had the highest specificity but low sensitivity. We did not find evidence of vertical transmission or fetal anomalies, likely because of the low number of pregnant women tested. We also did not find evidence of congenital disease. Our findings emphasize the limited predictive value of clinical features in areas where Zika virus cocirculates with other flaviviruses.
C1 [Romer, Yamila; Vazquez-Prokopec, Gonzalo] Emory Univ, Atlanta, GA 30322 USA.
   [Valadez-Gonzalez, Nina; Contreras-Capetillo, Silvina; Manrique-Saide, Pablo; Pavia-Ruz, Norma] Univ Autonoma Yucatan, Yucatan, Mexico.
RP Romer, Y (corresponding author), Emory Univ, Dept Environm Sci, Math & Sci Ctr, 400 Dowman Dr,5th El Ste E523, Atlanta, GA 30322 USA.
EM yromer@emory.edu
FU Office of Infectious Disease, Bureau for Global Health, US Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID); CDCCentre National de la Recherche Scientifique
   (CNRS)United States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA
FX This research and publication was made possible through support provided
   by the Office of Infectious Disease, Bureau for Global Health, US Agency
   for International Development, under the terms of an Interagency
   Agreement with CDC. The opinions expressed herein are those of the
   author(s) and do not necessarily reflect the views of the US Agency for
   International Development. The recipient of this support was the Yucatan
   Autonomous University and its affiliated Regional Research Center
   "Hideyo Nogushi."
CR Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V530, P399, DOI 10.1038/530398a
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, REV DIAGN TEST ZIK C
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kuivanen S, 2017, J GEN VIROL, V98, P1744, DOI 10.1099/jgv.0.000857
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Contreras-Capetillo SN, 2018, CLIN PEDIATR, V57, P927, DOI 10.1177/0009922817738341
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Pavia-Ruz N, 2018, AM J TROP MED HYG, V98, P1202, DOI 10.4269/ajtmh.17-0382
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2017, LANCET, V390, P824, DOI 10.1016/S0140-6736(17)31478-2
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2016, EM HIST ZIK VIR
   World Health Organization, 2016, ZIK VIR MICR GILL BA
NR 47
TC 0
Z9 0
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2019
VL 25
IS 8
BP 1452
EP 1460
DI 10.3201/eid2508.180915
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IJ5MF
UT WOS:000475946500002
PM 31310215
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Izquierdo-Suzan, M
   Zarate, S
   Torres-Flores, J
   Correa-Morales, F
   Gonzalez-Acosta, C
   Sevilla-Reyes, EE
   Lira, R
   Alcaraz-Estrada, SL
   Yocupicio-Monroy, M
AF Izquierdo-Suzan, Monica
   Zarate, Selene
   Torres-Flores, Jesus
   Correa-Morales, Fabian
   Gonzalez-Acosta, Cassandra
   Sevilla-Reyes, Edgar E.
   Lira, Rosalia
   Alcaraz-Estrada, Sofia L.
   Yocupicio-Monroy, Martha
TI Natural Vertical Transmission of Zika Virus in Larval Aedes aegypti
   Populations, Morelos, Mexico
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID DENGUE VIRUSES; SURVEILLANCE; ACCURATE; BIOLOGY; STATE
AB We characterized natural vertical transmission of Zika virus in pools of Aedes aegypti larvae hatched from eggs collected in Jojutla, Morelos, Mexico. Of the 151 pools analyzed, 17 tested positive for Zika virus RNA; infectious Zika virus was successfully isolated from 1 of the larvae pools (31N) in C6/36 cells. Real-time quantitative PCR and indirect immunofluorescence assays confirmed the identity of the isolate, named Zika virus isolate 31N; plaque assays in Vero cells demonstrated the isolate's infectivity in a mammalian cell line. We obtained the complete genome of Zika virus isolate 31N by next-generation sequencing and identified 3 single-nucleotide variants specific to Zika virus isolate 31N using the meta-CATS tool. These results demonstrate the occurrence of natural vertical transmission of Zika virus in wild Ae. aegypti mosquitoes and suggest that this transmission mode could aid in the spread and maintenance of Zika virus in nature.
C1 [Izquierdo-Suzan, Monica; Zarate, Selene; Yocupicio-Monroy, Martha] Univ Autonoma Ciudad Mexico, Mexico City, DF, Mexico.
   [Torres-Flores, Jesus] Inst Politecn Nacl, Mexico City, DF, Mexico.
   [Correa-Morales, Fabian; Gonzalez-Acosta, Cassandra] Ctr Nacl Programas Prevent & Control Enfermedades, Mexico City, DF, Mexico.
   [Sevilla-Reyes, Edgar E.] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico.
   [Lira, Rosalia] Inst Mexicano Seguro Social, Mexico City, DF, Mexico.
   [Alcaraz-Estrada, Sofia L.] Inst Seguridad & Serv Sociales Trabajadores Estad, Mexico City, DF, Mexico.
RP Yocupicio-Monroy, M (corresponding author), Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, San Lorenzo 290 Col Valle, Mexico City 03100, DF, Mexico.
EM martha.ym1@gmail.com
RI Flores, Jesus Miguel Torres/AAE-2860-2020
OI Lira, Rosalia/0000-0002-6812-9471; Gonzalez Acosta,
   Cassandra/0000-0003-2682-908X; Zarate, Selene/0000-0003-1034-204X;
   Torres Flores, Jesus/0000-0002-2194-521X; Yocupicio-Monroy,
   Martha/0000-0001-7885-5656; Correa Morales, Fabian/0000-0002-6193-1242
FU CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [183448,
   233977, 269826]
FX This work was supported by grants CONACyT 183448, CONACyT 233977, and
   CONACyT 269826.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Direccion General de Epidemiologia SS, 2016, B EPIDEMIOLOGICO
   Edillo FE, 2015, J VECTOR ECOL, V40, P282, DOI 10.1111/jvec.12166
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Gunther J, 2009, J CLIN VIROL, V45, P218, DOI 10.1016/j.jcv.2009.05.007
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x
   Apodaca-Medina AI, 2018, VECTOR-BORNE ZOONOT, V18, P231, DOI 10.1089/vbz.2017.2202
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee HL, 2005, TRANSOVARIAL TRANSMI, P106
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Martinez NE, 2014, J AM MOSQUITO CONTR, V30, P143, DOI 10.2987/14-6402.1
   Pickett BE, 2013, VIROLOGY, V447, P45, DOI 10.1016/j.virol.2013.08.021
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Smartt CT, 2017, MEM I OSWALDO CRUZ, V112, P829, DOI 10.1590/0074-02760170182
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
NR 34
TC 2
Z9 2
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2019
VL 25
IS 8
BP 1477
EP 1484
DI 10.3201/eid2508.181533
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IJ5MF
UT WOS:000475946500005
PM 31310224
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pedroso, C
   Fischer, C
   Feldmann, M
   Sarno, M
   Luz, E
   Moreira-Soto, A
   Cabral, R
   Netto, EM
   Brites, C
   Kummerer, BM
   Drexler, JF
AF Pedroso, Celia
   Fischer, Carlo
   Feldmann, Marie
   Sarno, Manoel
   Luz, Estela
   Moreira-Soto, Andres
   Cabral, Renata
   Netto, Eduardo Martins
   Brites, Carlos
   Kummerer, Beate M.
   Drexler, Jan Felix
TI Cross-Protection of Dengue Virus Infection against Congenital Zika
   Syndrome, Northeastern Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; RIO-DE-JANEIRO; DISEASE; TYPE-3; STATE
AB The Zika virus outbreak in Latin America resulted in congenital malformations, called congenital Zika syndrome (CZS). For unknown reasons, CZS incidence was highest in northeastern Brazil; one potential explanation is that dengue virus (DENV)-mediated immune enhancement may promote CZS development. In contrast, our analyses of historical DENV genomic data refuted the hypothesis that unique genome signatures for northeastern Brazil explain the uneven dispersion of CZS cases. To confirm our findings, we performed serotype-specific DENV neutralization tests in a case-control framework in northeastern Brazil among 29 Zika virus-seropositive mothers of neonates with CZS and 108 Zika virus-seropositive control mothers. Neutralization titers did not differ significantly between groups. In contrast, DENV seroprevalence and median number of neutralized serotypes were significantly lower among the mothers of neonates with CZS. Supported by model analyses, our results suggest that multitypic DENV infection may protect from, rather than enhance, development of CZS.
C1 [Pedroso, Celia; Sarno, Manoel; Luz, Estela; Cabral, Renata; Netto, Eduardo Martins; Brites, Carlos] Univ Fed Bahia, Salvador, BA, Brazil.
   [Fischer, Carlo; Moreira-Soto, Andres; Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany.
   [Fischer, Carlo; Moreira-Soto, Andres; Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Fischer, Carlo; Moreira-Soto, Andres; Drexler, Jan Felix] Humbolt Univ Berlin, Berlin, Germany.
   [Fischer, Carlo; Moreira-Soto, Andres; Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Feldmann, Marie; Kummerer, Beate M.] Univ Bonn, Med Ctr, Bonn, Germany.
   [Kummerer, Beate M.; Drexler, Jan Felix] Sechenov Univ, German Ctr Infect Res, Moscow, Russia.
   [Drexler, Jan Felix] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.
RP Drexler, JF (corresponding author), Charite Univ Med Berlin, Inst Virol, Helmut Ruska Haus Charite Pl 1, D-10098 Berlin, Germany.
EM felix.drexler@charite.de
RI Netto, Eduardo/D-1432-2013
OI Netto, Eduardo/0000-0003-1691-6761; Fischer, Carlo/0000-0001-9163-2406;
   Moreira-Soto, Andres/0000-0002-9224-5157
FU German Centre for Infection Research through the ZIKApath project, an
   intramural funding program at the University of Bonn; European Union's
   Horizon 2020 research and innovation program through the ZIKAlliance
   project [734548]
FX This work was supported by the German Centre for Infection Research
   through the ZIKApath project, an intramural funding program at the
   University of Bonn, and the European Union's Horizon 2020 research and
   innovation program through the ZIKAlliance project (grant agreement no.
   734548). The data used are part of the thesis of M.F.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 1997, Rev Panam Salud Publica, V1, P68
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V530, P399, DOI 10.1038/530398a
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Collins M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.82
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gu LJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191681
   Guzman MG, 2012, INT J INFECT DIS, V16, pE198, DOI 10.1016/j.ijid.2011.09.026
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kurolt IC, 2013, CLIN MICROBIOL INFEC, V19, pE163, DOI 10.1111/1469-0691.12104
   Mayor S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3492
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Moreira-Soto A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00278-18
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320
   Uno N, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0168-0
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
NR 50
TC 12
Z9 12
U1 1
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2019
VL 25
IS 8
BP 1485
EP 1493
DI 10.3201/eid2508.190113
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IJ5MF
UT WOS:000475946500006
PM 31075077
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kama, M
   Aubry, M
   Naivalu, T
   Vanhomwegen, J
   Mariteragi-Helle, T
   Teissier, A
   Paoaafaite, T
   Hue, S
   Hibberd, ML
   Manuguerra, JC
   Christi, K
   Watson, CH
   Nilles, EJ
   Aaskov, J
   Lau, CL
   Musso, D
   Kucharski, AJ
   Cao-Lormeau, VM
AF Kama, Mike
   Aubry, Maite
   Naivalu, Taina
   Vanhomwegen, Jessica
   Mariteragi-Helle, Teheipuaura
   Teissier, Anita
   Paoaafaite, Tuterarii
   Hue, Stephane
   Hibberd, Martin L.
   Manuguerra, Jean-Claude
   Christi, Ketan
   Watson, Conall H.
   Nilles, Eric J.
   Aaskov, John
   Lau, Colleen L.
   Musso, Didier
   Kucharski, Adam J.
   Cao-Lormeau, Van-Mai
TI Sustained Low-Level Transmission of Zika and Chikungunya Viruses after
   Emergence in the Fiji Islands
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB Zika and chikungunya viruses were first detected in Fiji in 2015. Examining surveillance and phylogenetic and serologic data, we found evidence of low-level transmission of Zika and chikungunya viruses during 2013-2017, in contrast to the major outbreaks caused by closely related virus strains in other Pacific Island countries.
C1 [Kama, Mike] Fiji Ctr Communicable Dis Control, Suva, Fiji.
   [Kama, Mike; Naivalu, Taina; Christi, Ketan] Univ South Pacific, Suva, Fiji.
   [Aubry, Maite; Mariteragi-Helle, Teheipuaura; Teissier, Anita; Paoaafaite, Tuterarii; Musso, Didier; Cao-Lormeau, Van-Mai] Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
   [Naivalu, Taina] Fiji Natl Univ, Suva, Fiji.
   [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Pasteur, Paris, France.
   [Hue, Stephane; Hibberd, Martin L.; Watson, Conall H.; Kucharski, Adam J.] London Sch Hyg & Trop Med, London, England.
   [Nilles, Eric J.] World Hlth Org, Suva, Fiji.
   [Nilles, Eric J.] Harvard Med Sch, Boston, MA 02115 USA.
   [Nilles, Eric J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Nilles, Eric J.] Harvard Humanitarian Initiat, Cambridge, MA USA.
   [Aaskov, John] Queensland Univ Technol, Brisbane, Qld, Australia.
   [Lau, Colleen L.] Australian Natl Univ, Canberra, ACT, Australia.
   [Musso, Didier] Aix Marseille Univ, Marseille, France.
RP Cao-Lormeau, VM (corresponding author), Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
EM mlormeau@ilm.pf
RI Musso, Didier/AAO-8178-2020; Lau, Colleen L/F-5974-2012; Musso,
   Didier/P-7809-2016; Cao-Lormeau, Van-Mai/H-4879-2018
OI Musso, Didier/0000-0002-9226-0971; Lau, Colleen L/0000-0001-8288-4169;
   Musso, Didier/0000-0002-9226-0971; Cao-Lormeau,
   Van-Mai/0000-0001-5606-7480; Nilles, Eric/0000-0001-7044-5257; Aubry,
   Maite/0000-0002-9913-5794; Hibberd, Martin/0000-0001-8587-1849
FU French Ministry for Europe and Foreign Affairs (Pacific Fund)
   [06314-09/04/14, 12115-02/09/15, 03016-20/05/16, 04917-19/07/17];
   Embassy of France in the Republic of the Fiji Islands; French
   Government's "Investissement d'Avenir" Program (Labex IBEID)French
   National Research Agency (ANR) [ANR-10-LABX-62-IBEID]; Australia
   National Health and Medical Research Council FellowshipNational Health
   and Medical Research Council of Australia [1109035]; Wellcome
   Trust/Royal Society Sir Henry Dale Fellowship [206250/Z/17/Z]
FX This work was part of ISID-Pacific and R-ZERO Pacific programs funded by
   the French Ministry for Europe and Foreign Affairs (Pacific Fund nos.
   06314-09/04/14, 12115-02/09/15, 03016-20/05/16, and 04917-19/07/17). The
   study also received support from the Embassy of France in the Republic
   of the Fiji Islands. The study was supported by the French Government's
   "Investissement d'Avenir" Program (Labex IBEID no.
   ANR-10-LABX-62-IBEID). C.L.L. was supported by an Australia National
   Health and Medical Research Council Fellowship (grant no. 1109035).
   A.J.K. was supported by a Wellcome Trust/Royal Society Sir Henry Dale
   Fellowship (grant no. 206250/Z/17/Z). The seroprevalence study was part
   of MSc research work by M.K. performed at the University of the South
   Pacific.
CR Australian Government Department of Health, SUMM INF OV ACQ VECT
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Fiji Ministry of Health and Medical Services, FIJ MIN HLTH MED SER
   Fiji Ministry of Health and Medical Services, PEOPL CONT SUPP FIGH
   Fiji Ministry of Health and Medical Services, CHIK AL
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Institute of Environmental Science and Research Limited, 2017, ZIK VIR INF WEEKL RE
   Kucharski AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34848
   Pastula DM, 2017, J NEUROL SCI, V372, P350, DOI 10.1016/j.jns.2016.08.064
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
NR 15
TC 3
Z9 3
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2019
VL 25
IS 8
BP 1535
EP 1538
DI 10.3201/eid2508.180524
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IJ5MF
UT WOS:000475946500012
PM 31310218
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Cardenas, VM
   Paternina-Caicedo, AJ
   Salvatierra, EB
AF Cardenas, Victor M.
   Jose Paternina-Caicedo, Angel
   Benito Salvatierra, Ernesto
TI Underreporting of Fatal Congenital Zika Syndrome, Mexico, 2016-2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VIRUS-INFECTION; PREGNANCY OUTCOMES; TERRITORIES
AB To determine completeness of fatal congenital Zika syndrome reporting in Mexico, we examined data from the Mexican National Institute of Statistics and Geography. We found that an estimated 50% more infants died from microcephaly attributable to congenital Zika syndrome during 2016-2017 than were reported by the existing surveillance system.
C1 [Cardenas, Victor M.] Univ Arkansas Med Sci, Epidemiol, Little Rock, AR 72205 USA.
   [Jose Paternina-Caicedo, Angel] Univ Nacl Colombia, Bogota, Colombia.
   [Benito Salvatierra, Ernesto] Unidad San Cristobal, Chiapas, Mexico.
RP Cardenas, VM (corresponding author), Univ Arkansas Med Sci, Dept Epidemiol, Fay W Boozman Coll Publ Hlth, 4301 West Markham,820, Little Rock, AR 72205 USA.
EM vmcardenas@uams.edu
OI Salvatierra, Benito/0000-0001-5950-7840
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#
   Direccion General de Epidemiologia, CAS CONF AUT ENF VIR
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto Nacional de Estadistica y Geografia, DEF GEN
   Instituto Nacional de Estadistica y Geografia, NAC
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Pan American Health Organization, ZIK CUM CAS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Salud, CAS CONF SINDR CONG
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 15
TC 0
Z9 0
U1 0
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2019
VL 25
IS 8
BP 1560
EP 1562
DI 10.3201/eid2508.190106
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IJ5MF
UT WOS:000475946500018
PM 31310228
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petridou, C
   Bonsall, D
   Ahmed, A
   Roberts, M
   Bell, C
   de Cesare, M
   Bowden, R
   Graham, V
   Bailey, D
   Simpson, A
   Aarons, E
AF Petridou, Christina
   Bonsall, David
   Ahmed, Aleem
   Roberts, Mark
   Bell, Carolyn
   de Cesare, Mariateresa
   Bowden, Rory
   Graham, Victoria
   Bailey, Daniel
   Simpson, Andrew
   Aarons, Emma
TI Prolonged Zika Virus RNA Detection in Semen of Immunosuppressed Patient
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB Zika virus RNA has been detected in semen samples collected <= 370 days after symptom onset. We report unusual persistence of Zika virus RNA in semen, confirmed by sequencing at 515 days after symptom onset and detectable for >900 days, in a patient with immunosuppression.
C1 [Petridou, Christina; Graham, Victoria; Bailey, Daniel; Simpson, Andrew; Aarons, Emma] Publ Hlth England Porton, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.
   [Bonsall, David; de Cesare, Mariateresa; Bowden, Rory] Univ Oxford, Oxford, England.
   [Ahmed, Aleem] Leicester Royal Infirm, Leicester, Leics, England.
   [Roberts, Mark] Worcestershire Royal Hosp, Worcester, MA USA.
   [Bell, Carolyn] South Warwickshire Natl Hlth Syst Fdn Trust, Warwick, England.
RP Petridou, C; Aarons, E (corresponding author), Publ Hlth England Porton, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.
EM christina.petridou@nhs.net; emma.aarons@phe.gov.uk
OI bonsall, david/0000-0003-2187-0550; Bowden, Rory/0000-0001-8596-0366
CR [Anonymous], 2019, WHO GUID PREV SEX TR
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
NR 6
TC 1
Z9 1
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2019
VL 25
IS 8
BP 1598
EP 1600
DI 10.3201/eid2508.181543
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA IJ5MF
UT WOS:000475946500032
PM 31310210
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rothan, HA
   Abdulrahman, AY
   Khazali, AS
   Rashid, NN
   Chong, TT
   Yusof, R
AF Rothan, Hussin A.
   Abdulrahman, Ammar Yasir
   Khazali, Ahmad Suhail
   Rashid, Nurshamimi Nor
   Chong, Teoh Teow
   Yusof, Rohana
TI Carnosine exhibits significant antiviral activity against Dengue and
   Zika virus
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Article
DE antiviral activity; carnosine; dengue virus; dipeptide; NS2B-NS3
   protease; Zika virus
ID INFECTION; IDENTIFICATION; ANTIOXIDANTS; HISTIDINE
AB Dengue virus (DENV) and Zika virus (ZIKV) are flaviviruses transmitted to humans by their common vector, Aedes mosquitoes. DENV infection represents one of the most widely spread mosquito-borne diseases whereas ZIKV infection occasionally re-emerged in the past causing outbreaks. Although there have been considerable advances in understanding the pathophysiology of these viruses, no effective vaccines or antiviral drugs are currently available. In this study, we evaluated the antiviral activity of carnosine, an endogenous dipeptide (beta-alanyl-l-histidine), against DENV serotype 2 (DENV2) and ZIKV infection in human liver cells (Huh7). Computational studies were performed to predict the potential interactions between carnosine and viral proteins. Biochemical and cell-based assays were performed to validate the computational results. Mode-of-inhibition, plaque reduction, and immunostaining assays were performed to determine the antiviral activity of carnosine. Exogenous carnosine showed minimal cytotoxicity in Huh7 cells and rescued the viability of infected cells with EC50 values of 52.3 and 59.5 mu M for DENV2 and ZIKV infection, respectively. Based on the mode-of-inhibition assays, carnosine inhibited DENV2 mainly by inhibiting viral genome replication and interfering with virus entry. Carnosine antiviral activity was verified with immunostaining assay where carnosine treatment diminished viral fluorescence signal. In conclusion, carnosine exhibited significant inhibitory effects against DENV2 and ZIKV replication in human liver cells and could be utilized as a lead peptide for the development of effective and safe antiviral agents against DENV and ZIKV.
C1 [Rothan, Hussin A.] Georgia State Univ, Coll Arts & Sci, Dept Biol, Atlanta, GA 30303 USA.
   [Abdulrahman, Ammar Yasir; Khazali, Ahmad Suhail; Rashid, Nurshamimi Nor; Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.
   [Chong, Teoh Teow] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.
RP Rothan, HA (corresponding author), Georgia State Univ, Coll Arts & Sci, Dept Biol, Atlanta, GA 30303 USA.; Yusof, R (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.
EM hrothan@gsu.edu; rohana@um.edu.my
RI KHAZALI, AHMAD SUHAIL/AAA-7175-2020; TEOH, TEOW CHONG/B-9950-2010;
   Abdulrahman, Ammar Yasir/AAF-9133-2019
OI KHAZALI, AHMAD SUHAIL/0000-0001-8830-441X; 
FU Ministry of Higher Education, MalaysiaMinistry of Education, Malaysia
   [FRGS grant: FP007-2017A]; University of Malaya Postgraduate Research
   Grant (PPP) [PG012-2014B]
CR Abdulrahman AY, 2019, INT J PEPT RES THER, V25, P1659, DOI 10.1007/s10989-019-09808-4
   BABIZHAYEV MA, 1994, BIOCHEM J, V304, P509, DOI 10.1042/bj3040509
   Babizhayev MA, 2012, AM J THER, V19, pE25, DOI 10.1097/MJT.0b013e3181dcf589
   Bae ON, 2013, STROKE, V44, P205, DOI 10.1161/STROKEAHA.112.673954
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chathurangana P, 2016, EUR J PEDIATR, V175, P1459
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   FURUTA S, 1993, DRUG METABOL PHAMACO, V5, P1057, DOI DOI 10.2133/DMPK.8.1057
   GARDNER MLG, 1991, J PHYSIOL-LONDON, V439, P411, DOI 10.1113/jphysiol.1991.sp018673
   Haga A, 2013, J BIOCHEM, V154, P249, DOI 10.1093/jb/mvt041
   Hersh AM, 2017, ANN AM THORAC SOC, V14, P1706, DOI 10.1513/AnnalsATS.201612-988CC
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010
   Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A
   Melhem A, 2005, J CLIN GASTROENTEROL, V39, P737, DOI 10.1097/01.mcg.0000174023.73472.29
   Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Rothan HA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-140
   Rothan HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094561
   Rothan HA, 2014, ARCH VIROL, V159, P711, DOI 10.1007/s00705-013-1880-7
   Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100
   Salaemae W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-68
   Senut MC, 2009, CELL TISSUE RES, V337, P45, DOI 10.1007/s00441-009-0796-8
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Veiga-da-Cunha M, 2014, J BIOL CHEM, V289, P19726, DOI 10.1074/jbc.M114.576579
   World Health Organization, 2018, WKLY EPIDEMIOL REC, V93, P457
NR 32
TC 0
Z9 0
U1 4
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD AUG
PY 2019
VL 25
IS 8
AR UNSP e3196
DI 10.1002/psc.3196
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA IJ5RU
UT WOS:000475961300004
PM 31290226
DA 2020-07-08
ER

PT J
AU Valdez, F
   Salvador, J
   Palermo, PM
   Mohl, JE
   Hanley, KA
   Watts, D
   Llano, M
AF Valdez, Federico
   Salvador, Julienne
   Palermo, Pedro M.
   Mohl, Jonathon E.
   Hanley, Kathryn A.
   Watts, Douglas
   Llano, Manuel
TI Schlafen 11 Restricts Flavivirus Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Schlafen 11; virus restriction factors; flavivirus
ID SYNONYMOUS CODON USAGE; TRANSFER-RNA; PROTEIN-STRUCTURE;
   VIRUS-INFECTION; GENES; MECHANISM; REVEALS; FITNESS; STRESS; SLFN11
AB Schlafen 11 (Slfn11) is an interferon-stimulated gene that controls the synthesis of proteins by regulating tRNA abundance. Likely through this mechanism, Slfn11 has previously been shown to impair human immunodeficiency virus type 1 (HIV-1) infection and the expression of codon-biased open reading frames. Because replication of positive-sense single-stranded RNA [(+)ssRNA] viruses requires the immediate translation of the incoming viral genome, whereas negative-sense single-stranded RNA [(-)ssRNA] viruses carry at infection an RNA replicase that makes multiple translation-competent copies of the incoming viral genome, we reasoned that (-) ssRNA viruses will be more sensitive to the effect of Slfn11 on protein synthesis than (-)ssRNA viruses. To evaluate this hypothesis, we tested the effects of Slfn11 on the replication of a panel of ssRNA viruses in the human glioblastoma cell line A172, which naturally expresses Slfn11. Depletion of Slfn11 significantly increased the replication of (-)ssRNA viruses from the Flavivirus genus, including West Nile virus (WNV), dengue virus (DENV), and Zika virus (ZIKV), but had no significant effect on the replication of the (-)ssRNA viruses vesicular stomatitis virus (VSV) (Rhabdoviridae family) and Rift Valley fever virus (RVFV) (Phenuiviridae family). Quantification of the ratio of genome-containing viral particles to PFU indicated that Slfn11 impairs WNV infectivity. Intriguingly, Slfn11 prevented WNV-induced downregulation of a subset of tRNAs implicated in the translation of 11.8% of the viral polyprotein. Low-abundance tRNAs might promote optimal protein folding and enhance viral infectivity, as previously reported. In summary, this study demonstrates that Slfn11 restricts flavivirus replication by impairing viral infectivity.
   IMPORTANCE We provide evidence that the cellular protein Schlafen 11 (Slfn11) impairs replication of flaviviruses, including West Nile virus (WNV), dengue virus (DENV), and Zika virus (ZIKV). However, replication of single-stranded negative RNA viruses was not affected. Specifically, Slfn11 decreases the infectivity of WNV potentially by preventing virus-induced modifications of the host tRNA repertoire that could lead to enhanced viral protein folding. Furthermore, we demonstrate that Slfn11 is not the limiting factor of this novel broad antiviral pathway.
C1 [Valdez, Federico; Salvador, Julienne; Palermo, Pedro M.; Watts, Douglas; Llano, Manuel] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.
   [Mohl, Jonathon E.] Univ Texas El Paso, Dept Bioinformat, El Paso, TX 79968 USA.
   [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
RP Llano, M (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.
EM mllano@utep.edu
FU National Institute of Minority Health and Health Disparities (NIMHD),
   National Institutes of Health (NIH) [G12MD007592]; Keelung Hong
   fellowship; (RISE program) from the National Institute of General
   Medical Sciences, NIH [5R25GM069621-11]; Research Centers in Minority
   Institutions program grant from the NIMHD, NIH [5G12MD007592]
FX This work was supported in part by a pilot project to M.L. and D.W. from
   grant number G12MD007592 from the National Institute of Minority Health
   and Health Disparities (NIMHD), National Institutes of Health (NIH).
   F.V. was supported by the Keelung Hong fellowship and by grant
   5R25GM069621-11 (RISE program) from the National Institute of General
   Medical Sciences, NIH. We also thank the Biomolecule Analysis, Genomic
   Analysis, and Cytometry, Screening, and Imaging Core Facilities for
   technical help. These core facilities are supported by Research Centers
   in Minority Institutions program grant 5G12MD007592 from the NIMHD, NIH,
   to the Border Biomedical Research Center at The University of Texas at
   El Paso (UTEP).
CR Aragones L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000797
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0
   Clarke P, 2014, MBIO, V5, DOI 10.1128/mBio.00902-14
   Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221
   Elkordy A, 2018, J NEUROCHEM, V146, P560, DOI 10.1111/jnc.14321
   Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043
   Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008
   Garcia-Rivera JA, 2010, J VIROL, V84, P740, DOI 10.1128/JVI.01043-09
   Gardner EE, 2017, CANCER CELL, V31, P286, DOI 10.1016/j.ccell.2017.01.006
   Goffena J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03221-z
   Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022
   Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076
   Li MQ, 2018, NAT STRUCT MOL BIOL, V25, P1047, DOI 10.1038/s41594-018-0142-5
   Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433
   Lim SM, 2013, J VIROL METHODS, V194, P146, DOI 10.1016/j.jviromet.2013.07.050
   Lin YZ, 2016, VIROLOGY, V495, P112, DOI 10.1016/j.virol.2016.04.024
   Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319
   Llano Manuel, 2009, V485, P257, DOI 10.1007/978-1-59745-170-3_18
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Ma XX, 2013, VET RES COMMUN, V37, P243, DOI 10.1007/s11259-013-9564-z
   Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133
   Mesitov MV, 2017, SCI REP-UK, V7, DOI 10.1038/srep46080
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Mu YH, 2016, EMBO REP, V17, P94, DOI 10.15252/embr.201540964
   Pavon-Eternod M, 2013, NUCLEIC ACIDS RES, V41, P1914, DOI 10.1093/nar/gks986
   Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466
   Puck Alexander, 2015, Results Immunol, V5, P23, DOI 10.1016/j.rinim.2015.10.001
   Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035
   Rodrigue N, 2010, P NATL ACAD SCI USA, V107, P4629, DOI 10.1073/pnas.0910915107
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9
   Seong RK, 2017, IMMUNOBIOLOGY, V222, P979, DOI 10.1016/j.imbio.2017.07.002
   Sousa FG, 2015, DNA REPAIR, V28, P107, DOI 10.1016/j.dnarep.2015.01.011
   Stabell AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006066
   Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1
   Tang SW, 2015, CLIN CANCER RES, V21, P4184, DOI 10.1158/1078-0432.CCR-14-2112
   The University of Texas at El Paso, 2018, BIOL SAF MAN
   Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808
   Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031
   Valdez F, 2018, BIORXIV, DOI [10.1101/434563, DOI 10.1101/434563]
   Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106
   Yang JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03544-x
   Zhao F, 2017, NUCLEIC ACIDS RES, V45, P8484, DOI 10.1093/nar/gkx501
   Zhou JH, 2013, INFECT GENET EVOL, V16, P270, DOI 10.1016/j.meegid.2013.02.017
   Zhou M, 2015, MOL MICROBIOL, V97, P974, DOI 10.1111/mmi.13079
NR 51
TC 1
Z9 1
U1 1
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2019
VL 93
IS 15
AR e00104-19
DI 10.1128/JVI.00104-19
PG 19
WC Virology
SC Virology
GA IJ3HA
UT WOS:000475793200003
PM 31118262
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Slathia, PS
   Sharma, P
AF Slathia, Parvez Singh
   Sharma, Preeti
TI A common conserved peptide harboring predicted T and B cell epitopes in
   domain III of envelope protein of Japanese Encephalitis Virus and West
   Nile Virus for potential use in epitope based vaccines
SO COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
DE Flavivirus; Envelope protein; Epitope prediction; Class I MHC; Class II
   MHC
ID I BINDING PEPTIDES; DNA VACCINE; CRYSTAL-STRUCTURE; CROSS-PROTECTION;
   NEURAL-NETWORKS; PEP-FOLD; RESPONSES; DESIGN; SERVER
AB Japanese encephalitis virus (JEV) and West Nile virus (WNV) are two major mosquito borne flaviviruses belonging to same serocomplex. JEV is transmitted by Culex mosquitoes and the reservoir host for the virus is pigs and/or water birds. WNV is also transmitted by Culex mosquitoes and reservoir host in this case is birds. It can also be transmitted through contact with other infected animals, their blood, or other tissues. The envelope protein of these viruses is the major source of epitopes and provides protective immunity. Bioinformatics tools were used to identify conserved epitopes in the envelope protein of these viruses. A conserved peptide "TPV-GRLVTVNPFV" present in both the viruses containing predicted T and B cell epitopes was found. The model of one of the predicted epitope was generated and upon docking it bound in the groove of HLA-A0201 Class I MHC molecule. Further, it was amenable to proteasomal cleavage enhancing its chances of processing by cytosolic pathway. The peptide was found to be non toxic, non allergenic and stable in mammalian cells based on database search. The population coverage was pan world and nearly 70% identity of the peptide was found in the Zika virus envelope protein. The peptide was located in the domain III of envelope protein which is the exposed domain therefore B cell receptors may recognize this peptide easily. The conserved peptide containing T and B cell epitopes can have future application for designing epitope based vaccines for both JEV and WNV.
C1 [Slathia, Parvez Singh; Sharma, Preeti] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Katra, J&K, India.
RP Slathia, PS (corresponding author), Shri Mata Vaishno Devi Univ, Sch Biotechnol, Katra, J&K, India.
EM parvezsingh@gmail.com
OI SLATHIA, PARVEZ SINGH/0000-0002-9064-041X
CR Akhoon BA, 2011, MICROB PATHOGENESIS, V51, P77, DOI 10.1016/j.micpath.2011.01.011
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639
   [Anonymous], 2016, CDC W NILE VIRUS
   Arnon R., 2006, BTI, V18, P10
   Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699
   De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16
   Donnes P, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-25
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Friedrich BM, 2016, VACCINE, V34, P5479, DOI 10.1016/j.vaccine.2016.09.044
   GUPTA S, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0060785
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Jahangiri A, 2011, VACCINE, V29, P6948, DOI 10.1016/j.vaccine.2011.07.040
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Khan MA, 2015, SCAND J IMMUNOL, V82, P25, DOI 10.1111/sji.12302
   Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001
   Kwon WT, 2012, J MICROBIOL BIOTECHN, V22, P1580, DOI 10.4014/jmb.1205.05047
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697
   Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006
   Li SH, 2011, IMMUNOL LETT, V138, P156, DOI 10.1016/j.imlet.2011.04.003
   Liu SLA, 2017, VET MICROBIOL, V198, P51, DOI 10.1016/j.vetmic.2016.12.008
   Lu YJ, 2017, HELMINTHOLOGIA, V54, P275, DOI 10.1515/helm-2017-0041
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Nemeth NM, 2009, AVIAN DIS, V53, P421, DOI 10.1637/8574-010109-Reg.1
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296
   Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097
   Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595
   Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9
   Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116
   Schweitzer BK, 2009, LABMEDICINE, V40, P493, DOI 10.1309/LM5YWS85NJPCWESW
   Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m
   Shinohara N, 2017, T ROY SOC TROP MED H, V111, P393, DOI 10.1093/trstmh/trx071
   Slathia P, 2012, INT J INFECT DIS, V16, pE314, DOI 10.1016/j.ijid.2012.05.1013
   Slathia PS, 2016, INT J INFECT DIS, V53, P149, DOI 10.1016/j.ijid.2016.11.364
   Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419
   Trolle T, 2015, BIOINFORMATICS, V31, P2174, DOI 10.1093/bioinformatics/btv123
   Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
NR 51
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0147-9571
EI 1878-1667
J9 COMP IMMUNOL MICROB
JI Comp. Immunol. Microbiol. Infect. Dis.
PD AUG
PY 2019
VL 65
BP 238
EP 245
DI 10.1016/j.cimid.2019.06.008
PG 8
WC Immunology; Microbiology; Veterinary Sciences
SC Immunology; Microbiology; Veterinary Sciences
GA IH6BL
UT WOS:000474577400039
PM 31300121
DA 2020-07-08
ER

PT J
AU Santana, MB
   Lamas, CC
   Athayde, JG
   Calvet, G
   Moreira, J
   De Lorenzo, A
AF Santana, M. B.
   Lamas, C. C.
   Athayde, J. G.
   Calvet, G.
   Moreira, J.
   De Lorenzo, A.
TI Congenital Zika syndrome: is the heart part of its spectrum?
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Santana, M. B.] Univ Estado Rio De Janeiro, Dept Internal Med, Rio De Janeiro, Brazil.
   [Santana, M. B.] Amer Med City, Cardiointens Care Unit, Rio De Janeiro, Brazil.
   [Santana, M. B.; Lamas, C. C.; Moreira, J.; De Lorenzo, A.] Natl Inst Cardiol, Cardiovasc Res Unit, Rio De Janeiro, Brazil.
   [Lamas, C. C.] Unigranrio Univ, Sch Med, Rio De Janeiro, Brazil.
   [Lamas, C. C.; Calvet, G.; Moreira, J.] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil.
   [Athayde, J. G.] Natl Inst Cardiol, Echocardiog Dept, Rio De Janeiro, Brazil.
RP Lamas, CC (corresponding author), Natl Inst Cardiol, Cardiovasc Res Unit, Rio De Janeiro, Brazil.
EM cristianelamas@gmail.com
RI Calvet, Guilherme/G-6959-2013
OI Calvet, Guilherme/0000-0002-3545-5238
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX We acknowledge Dr Fernanda Fialho, the paediatrician at Instituto
   Nacional do Cerebro Paulo Niemeyer, who helped in the identification of
   patients for inclusion in the study. We would also like to thank all
   case study participants and their mothers who kindly agreed to be
   interviewed for this project. Dr. Moreira is supported by a scholarship
   from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   Brasil (CAPES) e Finance code 001, for his PhD training in Brazil.
CR Angelidou A, 2018, NEONATOLOGY, V113, P177, DOI 10.1159/000484656
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   World Health Organization, STAND PROT PROSP LON
NR 5
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD AUG
PY 2019
VL 25
IS 8
BP 1043
EP 1044
DI 10.1016/j.cmi.2019.03.020
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IF8FV
UT WOS:000473325700026
PM 30922930
DA 2020-07-08
ER

PT J
AU Cagno, V
   Tseligka, ED
   Bettex, Q
   Huang, S
   Constant, S
   Tapparel, C
AF Cagno, V.
   Tseligka, E. D.
   Bettex, Q.
   Huang, S.
   Constant, S.
   Tapparel, C.
TI Growth of Zika virus in human reconstituted respiratory, intestinal,
   vaginal and neural tissues
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Human reconstituted tissues; Tropism; Zika; Shedding; Transmission; Acid
   sensitivity; Intestinal; Respiratory
ID TRANSMISSION
AB Objectives: Zika virus (ZIKV) is mostly mosquito borne but it can also be transmitted via the sexual route and persists in semen for a prolonged time. Moreover, viral RNA has been detected in breast milk, saliva, lacrimal fluids and urine, suggesting other possible transmission routes. The aim of our research is to better define ZIKV tropism.
   Methods: We investigated the tropism of Asian and African strains of ZIKV using human-derived neural, vaginal, intestinal and respiratory tissues.
   Results: Asian and African strains of ZIKV were able to grow in all tissues tested, although with different efficiency (7.3 log RNA copies released apically in vaginal tissues versus 9.8 log RNA copies released in intestinal tissues), without the need for major adaptation.
   Conclusions: Our results underline that ZIKV tropism may be broader than expected in humans and stress the need to better explore all possible virus-shedding sites and transmission routes. (C) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Cagno, V.; Tseligka, E. D.; Bettex, Q.; Tapparel, C.] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.
   [Huang, S.; Constant, S.] Epithelix Sarl, Geneva, Switzerland.
RP Tapparel, C (corresponding author), Univ Geneva, Fac Med, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.
EM caroline.tapparel@unige.ch
RI Cagno, Valeria/AAE-7612-2020
OI Cagno, Valeria/0000-0002-5597-334X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310030_166218]; Fondation Leenaards [4390]
FX This work is supported by the Swiss National Science Foundation (grant
   no. 310030_166218 to CT) and the Fondation Leenaards (grant 4390 to CT).
CR Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Cagno V, 2018, NAT MATER, V17, P195, DOI [10.1038/NMAT5053, 10.1038/nmat5053]
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Essaidi-Laziosi M, 2018, J ALLERGY CLIN IMMUN, V141, P2074, DOI 10.1016/j.jaci.2017.07.018
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Royston L, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006962
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
NR 15
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD AUG
PY 2019
VL 25
IS 8
DI 10.1016/j.cmi.2019.04.016
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA IF8FV
UT WOS:000473325700025
PM 31075547
DA 2020-07-08
ER

PT J
AU Moore, E
   Rodriguez, X
   Fernandez, D
   Griffin, I
   Fermin, ME
   Cap, N
   Zhang, GY
AF Moore, Emily
   Rodriguez, Xeniamaria
   Fernandez, Danielle
   Griffin, Isabel
   Fermin, Manuel E.
   Cap, Natalia
   Zhang, Guoyan
TI Zika Testing Behaviors and Risk Perceptions Among Pregnant Women in
   Miami-Dade County, One Year After Local Transmission
SO MATERNAL AND CHILD HEALTH JOURNAL
LA English
DT Article
DE Zika virus; ZIKV; Pregnant women; Testing; Risk perception; Assessment;
   Risk communication
ID VIRUS OUTBREAK; UNITED-STATES
AB ObjectivesThis study sought to describe the knowledge and perceptions of pregnant women in Miami-Dade County concerning Zika virus (ZIKV) in their community, to characterize their testing behaviors, and to identify any barriers that would keep them from seeking testing.MethodsThe Florida Department of Health in Miami-Dade County partnered with the Healthy Start Coalition of Miami-Dade to administer an assessment survey in eight OBGYN clinics from June to August 2017. The survey captured past ZIKV testing practices, attitudes towards testing, barriers to testing, risk perception of ZIKV in the participants' community, and ZIKV-related knowledge. Descriptive analyses were performed on variables of interest. Chi squared tests examined associations between categorical variables.ResultsA total of 363 participants were included in the analysis. Of these, 203 (55.9%) thought they should be tested for ZIKV, and less than half of the participants reported having been previously tested (152, 41.9%). Participants with some high school education were significantly more likely than those with higher education levels to see ZIKV as a big problem in the community (p=0.0026). There was a significant association (p0.0001) between women who thought that they should be tested, and those who perceived ZIKV to be a medium or big problem in their community.Conclusions for PracticeHealth interventions that focus on increasing ZIKV knowledge should also place greater emphasis on risk communication when targeting the pregnant population. Having a higher risk perception may be more predictive of testing behaviors than having a lack of barriers or a high level of ZIKV-related knowledge.
C1 [Moore, Emily; Rodriguez, Xeniamaria; Fernandez, Danielle; Griffin, Isabel; Zhang, Guoyan] Florida Dept Hlth Miami Dade Cty, Epidemiol Dis Control & Immunizat Serv, 8600 NW 17th St, Miami, FL 33126 USA.
   [Fermin, Manuel E.; Cap, Natalia] Hlth Start Coalit Miami Dade, 701 SW 27th Ave, Miami, FL 33135 USA.
RP Moore, E (corresponding author), Florida Dept Hlth Miami Dade Cty, Epidemiol Dis Control & Immunizat Serv, 8600 NW 17th St, Miami, FL 33126 USA.
EM emily.moore@flhealth.gov
CR Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012
   Guo Fangjian, 2017, Prev Med Rep, V7, P26, DOI 10.1016/j.pmedr.2017.05.003
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ryan P, 2009, CLIN NURSE SPEC, V23, P161, DOI 10.1097/NUR.0b013e3181a42373
NR 13
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1092-7875
EI 1573-6628
J9 MATERN CHILD HLTH J
JI Matern. Child Health J.
PD AUG
PY 2019
VL 23
IS 8
BP 1140
EP 1145
DI 10.1007/s10995-019-02756-x
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IG2LM
UT WOS:000473628700015
PM 31209616
DA 2020-07-08
ER

PT J
AU Wastika, CE
   Sasaki, M
   Yoshii, K
   Anindita, PD
   Hang'ombe, BM
   Mweene, AS
   Kobayashi, S
   Kariwa, H
   Carr, MJ
   Hall, WW
   Eshita, Y
   Orba, Y
   Sawa, H
AF Wastika, Christida E.
   Sasaki, Michihito
   Yoshii, Kentaro
   Anindita, Paulina D.
   Hang'ombe, Bernard M.
   Mweene, Aaron S.
   Kobayashi, Shintaro
   Kariwa, Hiroaki
   Carr, Michael J.
   Hall, William W.
   Eshita, Yuki
   Orba, Yasuko
   Sawa, Hirofumi
TI Serological evidence of Zika virus infection in non-human primates in
   Zambia
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID TRANSMISSION; BORNE; STATE
AB Zika virus (ZIKV) circulation occurs between non-human primates (NHPs) in a sylvatic transmission cycle. To investigate evidence of flavivirus infection in NHPs in Zambia, we performed a plaque reduction neutralization test (PRNT) to quantify neutralizing antibodies. PRNT revealed that sera from NHPs (African green monkeys and baboons) exhibited neutralizing activity against ZIKV (34.4%; 33/96), whereas a PRNT for yellow fever virus using NHP sera showed no neutralization activity. ZIKV genomic RNA was not detected in splenic tissues from NHPs, suggesting that the presence of anti-ZIKV neutralizing antibodies represented resolved infections. Our evidence suggests that ZIKV is maintained in NHP reservoirs in Zambia.
C1 [Wastika, Christida E.; Sasaki, Michihito; Anindita, Paulina D.; Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.
   [Yoshii, Kentaro; Kobayashi, Shintaro; Kariwa, Hiroaki] Hokkaido Univ, Grad Sch Vet Med, Lab Publ Hlth, Kita Ku, N18,W9, Sapporo, Hokkaido 0600818, Japan.
   [Hang'ombe, Bernard M.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, POB 32379, Lusaka 10101, Zambia.
   [Mweene, Aaron S.] Univ Zambia, Sch Vet Med, Dept Dis Control, POB 32379, Lusaka 10101, Zambia.
   [Eshita, Yuki] Hokkaido Univ, Res Ctr Zoonosis Control, Hokudai Ctr Zoonosis Control Zambia, POB 32379, Lusaka 10101, Zambia.
   [Carr, Michael J.] Univ Coll Dublin, Sch Med, Natl Virus Reference Lab, Dublin 4, Ireland.
   [Carr, Michael J.; Hall, William W.; Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.
   [Hall, William W.] Univ Coll Dublin, Sch Med, Ctr Res Infect Dis, Dublin 4, Ireland.
   [Hall, William W.; Sawa, Hirofumi] Global Virus Network, 725 West Lombard St, Baltimore, MD 21201 USA.
   [Hang'ombe, Bernard M.; Mweene, Aaron S.; Sawa, Hirofumi] Univ Zambia, Global Virus Network Affiliate Ctr Excellence, POB 32379, Lusaka 10101, Zambia.
   [Hang'ombe, Bernard M.; Mweene, Aaron S.; Hall, William W.; Sawa, Hirofumi] Africa Ctr Excellence Infect Dis Humans & Anim, POB 32379, Lusaka 10101, Zambia.
RP Sawa, H (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.; Sawa, H (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.; Sawa, H (corresponding author), Global Virus Network, 725 West Lombard St, Baltimore, MD 21201 USA.; Sawa, H (corresponding author), Univ Zambia, Global Virus Network Affiliate Ctr Excellence, POB 32379, Lusaka 10101, Zambia.; Sawa, H (corresponding author), Africa Ctr Excellence Infect Dis Humans & Anim, POB 32379, Lusaka 10101, Zambia.
EM h-sawa@czc.hokudai.ac.jp
RI Sawa, Hirofumi/F-6954-2012
OI Anindita, Paulina Duhita/0000-0001-9885-5813; Carr,
   Michael/0000-0003-0011-6209
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHIMinistry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [JP15K07715, JP16H05805, JP17H03910]; MEXT/JSPS
   KAKENHIMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [JP16H06431, JP16H06429, JP16K21723];
   Japan Initiative for Global Research Network of Infectious Diseases
   (J-GRID) from Japan Agency for Medical Research and Development
   (AMED)Japan Agency for Medical Research and Development (AMED)
   [JP18fm0108008]
FX This study was supported by grants for Scientific Research (C), (B) from
   the Ministry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI
   (JP15K07715, JP16H05805, JP17H03910); and grants for Scientific Research
   on Innovative Areas and International Group from the MEXT/JSPS KAKENHI
   (JP16H06431, JP16H06429, JP16K21723), and the Japan Initiative for
   Global Research Network of Infectious Diseases (J-GRID) from Japan
   Agency for Medical Research and Development (AMED) (JP18fm0108008).
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Babaniyi O, 2016, INT J PUBLIC HLTH EP, V8, P29
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carr M, 2017, ARCH VIROL, V162, P543, DOI 10.1007/s00705-016-3129-8
   Chua CL, 2019, EMERG INFECT DIS, V25, P374, DOI 10.3201/eid2502.180258
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   de Oliveira EF, 2018, TRANSBOUND EMERG DIS, V65, P1094, DOI 10.1111/tbed.12829
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Hallmaier-Wacker LK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.65
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005351
   Moreira-Soto A, 2018, MSPHERE
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45
   Sasaki M, 2013, EMERG INFECT DIS
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Takashima I, 1997, J CLIN MICROBIOL, V35, P1943, DOI 10.1128/JCM.35.8.1943-1947.1997
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 37
TC 1
Z9 1
U1 1
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD AUG
PY 2019
VL 164
IS 8
BP 2165
EP 2170
DI 10.1007/s00705-019-04302-0
PG 6
WC Virology
SC Virology
GA IF1LL
UT WOS:000472840000018
PM 31154511
DA 2020-07-08
ER

PT J
AU Bustamante, FA
   Miro, MP
   Velasquez, ZD
   Molina, L
   Ehrenfeld, P
   Rivera, FJ
   Batiz, LF
AF Bustamante, Felipe A.
   Miro, Maria Paz
   Velasquez, Zahady D.
   Molina, Luis
   Ehrenfeld, Pamela
   Rivera, Francisco J.
   Federico Batiz, Luis
TI Role of adherens junctions and apical-basal polarity of neural
   stem/progenitor cells in the pathogenesis of neurodevelopmental
   disorders: a novel perspective on congenital Zika syndrome
SO TRANSLATIONAL RESEARCH
LA English
DT Review
ID MITOTIC SPINDLE ORIENTATION; TOLL-LIKE RECEPTOR-3; HOP GAIT HYH;
   BETA-CATENIN; VIRUS-INFECTION; N-CADHERIN; STEM-CELLS; RADIAL GLIA;
   ASYMMETRIC DIVISION; ADHESION RECEPTORS
AB Radial glial cells (RGCs) are the neural stem/progenitor cells (NSPCs) that give rise to most of neurons and glial cells that constitute the adult central nervous system. A hallmark of RGCs is their polarization along the apical-basal axis. They extend a long basal process that contacts the pial surface and a short apical process to the ventricular surface. Adherens junctions (AJs) are organized as belt-like structures at the most-apical lateral plasma membrane of the apical processes. These junctional complexes anchor RGCs to each other and allow the recruitment of cytoplasmic proteins that act as apical-basal determinants. It has been proposed that disruption of AJs underlies the onset of different neurodevelopmental disorders. In fact, studies performed in different animal models indicate that loss of function of AJs-related proteins in NSPCs can disrupt cell polarity, imbalance proliferation and/or differentiation rates and increase cell death, which, in turn, lead to disruption of the cytoarchitecture of the ventricular zone, protrusion of non-polarized cells into the ventricles, cortical thinning, and ventriculomegaly/hydrocephalus, among other neuropathological findings. Recent Zika virus (ZIKV) outbreaks and the high comorbidity of ZIKV Infection with congenital neurodevelopmental defects have led to the World Health Organization to declare a public emergency of international concern. Thus, noteworthy advances have been made in clinical and experimental ZIKV research. This review summarizes the current knowledge regarding the function of AJs in normal and pathological corticogenesis and focuses on the neuropathological and cellular mechanisms involved in congenital ZIKV syndrome, highlighting the potential role of cell-to-cell junctions between NSPCs in the etiopathogenesis of such syndrome.
C1 Univ Austral Chile, Fac Med, Inst Anat Histol & Pathol, Lab Dev Neuropathol, Valdivia, Chile.
   Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile.
   Justus Liebig Univ, Biomed Forschungszentrum Seltersberg, Inst Parasitol, Giessen, Germany.
   Univ Austral Chile, Fac Med, Inst Anat Histol & Pathol, Lab Cellular Pathol, Valdivia, Chile.
   Univ San Sebastian, Fac Ciencia, Dept Ciencias Biol & Quim, Puerto Montt, Chile.
   Univ Austral Chile, Fac Med, Inst Anat Histol & Pathol, Lab Stem Cells & Neuroregenerat, Valdivia, Chile.
   Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria.
   Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria.
   [Federico Batiz, Luis] Univ Los Andes, Fac Med, CIB, Santiago, Chile.
RP Batiz, LF (corresponding author), Univ Los Andes, Fac Med, CIB, Santiago, Chile.
EM lbatiz@uandes.cl
RI Rivera, Francisco J./D-7398-2015
OI Rivera, Francisco J./0000-0001-7895-6318; EHRENFELD,
   INGRID/0000-0002-2519-7570; Batiz, Luis Federico/0000-0002-3043-8797
FU Chilean FONDECYT Regular Grant [1141015, 1161787]; Chilean FONDECYT
   Postdoctoral Grant [3130756]; Chilean CONICYT Doctoral Scholarship
   [21160084]
FX The authors acknowledge the support of Carlos Figueroa (UACh), Lara
   Jorge Monteiro and Maria Teresa Valenzuela (UAndes). This work was
   supported in part by Chilean FONDECYT Regular Grant 1141015 (LFB),
   Chilean FONDECYT Regular Grant 1161787 (FJR), Chilean FONDECYT
   Postdoctoral Grant 3130756 (ZDV), and Chilean CONICYT Doctoral
   Scholarship 21160084 (FAB).
CR AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336
   Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170
   Agrawal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069465
   Al-Obaidi MMJ, 2018, ACTA VIROL, V62, P16, DOI 10.4149/av_2018_102
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Arai Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00384
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beattie R, 2017, FEBS LETT, V591, P3993, DOI 10.1002/1873-3468.12906
   Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758
   Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113
   Bizzotto S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00030
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brault V, 2001, DEVELOPMENT, V128, P1253
   BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744
   Carabalona A, 2012, HUM MOL GENET, V21, P1004, DOI 10.1093/hmg/ddr531
   Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302
   Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7
   Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680
   Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599
   Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021
   Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Das RM, 2012, EMBO REP, V13, P448, DOI 10.1038/embor.2012.42
   Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023
   Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld
   Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183
   DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dominguez-Pinos MD, 2005, J NEUROPATH EXP NEUR, V64, P595, DOI 10.1097/01.jnen.0000171648.86718.bb
   Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154
   DUBAND JL, 1988, DEVELOPMENT, V103, P325
   Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Erez N, 2004, EXP CELL RES, V294, P366, DOI 10.1016/j.yexcr.2003.11.033
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Ever L, 2005, CURR OPIN NEUROBIOL, V15, P29, DOI 10.1016/j.conb.2005.01.005
   Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318
   Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Batiz LF, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00501
   Batiz LF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004963
   Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   GADISSEUX JF, 1985, DEV NEUROSCI-BASEL, V7, P12, DOI 10.1159/000112273
   Galaz S, 2005, J CELL PHYSIOL, V205, P86, DOI 10.1002/jcp.20374
   Ganzler-Odenthal SII, 1998, J NEUROSCI, V18, P5415
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gloerich M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13996
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693
   Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399
   Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962
   HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9
   HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489
   Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017
   Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003
   Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005
   Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1
   Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z
   Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330
   Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473
   Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319
   Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Jimenez AJ, 2001, J NEUROPATH EXP NEUR, V60, P1105, DOI 10.1093/jnen/60.11.1105
   JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133
   Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365
   Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014
   KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L
   Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250
   Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008
   Ladran I, 2013, WIRES SYST BIOL MED, V5, P701, DOI 10.1002/wsbm.1239
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219
   Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lian GW, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00099
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Ma XF, 2007, MOL BIOL CELL, V18, P2305, DOI 10.1091/mbc.E07-01-0073
   Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malatesta P, 2008, CELL TISSUE RES, V331, P165, DOI 10.1007/s00441-007-0481-8
   Malicki J, 2003, DEV BIOL, V259, P95, DOI 10.1016/S0012-1606(03)00181-7
   Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139
   Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008
   Miyamoto Y, 2015, CELL ADHES MIGR, V9, P183, DOI 10.1080/19336918.2015.1005466
   Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203
   Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012
   Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632
   Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/j.devcel.2007.07.017
   Nejsum LN, 2009, FRONT BIOSCI-LANDMRK, V14, P1088, DOI 10.2741/3295
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Leary CJ, 2017, CELL REP, V20, P370, DOI 10.1016/j.celrep.2017.06.051
   Oliver C, 2013, J NEUROPATH EXP NEUR, V72, P846, DOI 10.1097/NEN.0b013e3182a2d5fe
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470
   Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218
   Paez P, 2007, J NEUROPATH EXP NEUR, V66, P1082, DOI 10.1097/nen.0b013e31815c1952
   Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406
   Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090
   Peluso JJ, 2000, ENDOCRINE, V12, P295, DOI 10.1385/ENDO:12:3:295
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peyre E, 2012, DEV GROWTH DIFFER, V54, P287, DOI 10.1111/j.1440-169X.2012.01350.x
   Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Puerta-Guardo H, 2013, J VIROL, V87, P7486, DOI 10.1128/JVI.00085-13
   Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443
   Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105
   Rakotomamonjy J, 2017, NEURAL DEV, V12, DOI 10.1186/s13064-017-0085-2
   Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rodriguez EM, 2017, PEDIATR NEUROSURG, V52, P446, DOI 10.1159/000453074
   Rodriguez EM, 2012, BIOL RES, V45, P231, DOI 10.4067/S0716-97602012000300005
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974
   Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339
   Santoni MJ, 2002, TRENDS GENET, V18, P494, DOI 10.1016/S0168-9525(02)02738-5
   Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shewan A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004796
   Simcha I, 2001, MOL BIOL CELL, V12, P1177, DOI 10.1091/mbc.12.4.1177
   Simmonds P., 2012, VIRUS TAXONOMY, P1003
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stenbeck G, 1998, INT J BIOCHEM CELL B, V30, P573, DOI 10.1016/S1357-2725(97)00064-2
   Stocker AM, 2015, CELL ADHES MIGR, V9, P167, DOI 10.1080/19336918.2015.1027478
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Vargas-Hurtado D, 2018, J CELL BIOL, V217, P11, DOI 10.1083/jcb.201712033
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vinci L, 2016, EUR J HISTOCHEM, V60, P13, DOI 10.4081/ejh.2016.2563
   Wagner C, 2003, J NEUROPATH EXP NEUR, V62, P1019, DOI 10.1093/jnen/62.10.1019
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wang X, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007609
   Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025
   WEGIEL J, 2014, ACTA NEUROPATHOL COM, V2
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x
   Werner H, 2017, J OBSTET GYNAECOL CA, V39, P1150, DOI 10.1016/j.jogc.2017.05.013
   Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003
   Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006
   Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005
   Xu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037886
   Yamamoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080356
   Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Yu X, 2000, J CELL SCI, V113, P2139
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4
   Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3
   Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002
NR 226
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1931-5244
EI 1878-1810
J9 TRANSL RES
JI Transl. Res.
PD AUG
PY 2019
VL 210
BP 57
EP 79
DI 10.1016/j.trsl.2019.02.014
PG 23
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA IF3NA
UT WOS:000472986300005
PM 30904442
DA 2020-07-08
ER

PT J
AU Lule-Chavez, AN
   Avila, EE
   Gonzalez-de-la-Vara, LE
   Salas-Marina, MA
   Ibarra, JE
AF Lule-Chavez, A. N.
   Avila, E. E.
   Gonzalez-de-la-Vara, L. E.
   Salas-Marina, M. A.
   Ibarra, J. E.
TI Detrimental Effects of Induced Antibodies on Aedes aegypti Reproduction
SO NEOTROPICAL ENTOMOLOGY
LA English
DT Article
DE Immuno-blocking; fertility; ferritin; transferrin; amino acid
   transporter; acetylcholinesterase
ID ANTI-MOSQUITO ANTIBODIES; AMINO-ACID TRANSPORTER; BLOOD-MEAL;
   ANOPHELES-STEPHENSI; GENE-EXPRESSION; DISEASE VECTORS; CLONING;
   VACCINES; DIPTERA; IDENTIFICATION
AB Aedes aegypti (Linnaeus) (Diptera: Culicidae) is the main vector of viruses causing dengue, chikungunya, Zika, and yellow fever, worldwide. This report focuses on immuno-blocking four critical proteins in the female mosquito when fed on blood containing antibodies against ferritin, transferrin, one amino acid transporter (NAAT1), and acetylcholinesterase (AchE). Peptides from these proteins were selected, synthetized, conjugated to carrier proteins, and used as antigens to immunize New Zealand rabbits. After rabbits were immunized, a minimum of 20 female mosquitos were fed on each rabbit, per replicate. No effect in their viability was observed after blood-feeding; however, the number of infertile females was 20% higher than the control when fed on AchE-immunized rabbits. The oviposition period was significantly longer in females fed on immunized rabbits than those fed on control (non-immunized) rabbits. Fecundity (eggs/female) of treated mosquitoes was significantly reduced (about 50%) in all four treatments, as compared with the control. Fertility (hatched larvae) was also significantly reduced in all four treatments, as compared with the control, being the effect on AchE and transferrin the highest, by reducing hatching between 70 and 80%. Survival to the adult stage of the hatched larvae showed no significant effect, as more than 95% survival was observed in all treatments, including the control. In conclusion, immuno-blocking of these four proteins caused detrimental effects on the mosquito reproduction, being the effect on AchE the most significant.
C1 [Lule-Chavez, A. N.; Gonzalez-de-la-Vara, L. E.; Salas-Marina, M. A.; Ibarra, J. E.] Ctr Invest & Estudios Avanzados IPN, Dept Biotecnol & Bioquim, Irapuato, Gto, Mexico.
   [Avila, E. E.] Univ Guanajuato, Dept Biol, Guanajuato, Gto, Mexico.
RP Ibarra, JE (corresponding author), Ctr Invest & Estudios Avanzados IPN, Dept Biotecnol & Bioquim, Irapuato, Gto, Mexico.
EM jorge.ibarra@cinvestav.mx
RI de la Vara, Luis Gonzalez/J-9119-2012
OI de la Vara, Luis Gonzalez/0000-0003-0275-7202; Salas marina, Miguel
   Angel/0000-0002-4737-2069; Ibarra, Jorge/0000-0002-1013-8260
FU Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [258878]
FX This work was supported by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT, Mexico), project number 258878.
CR Abdeladhim M, 2014, INFECT GENET EVOL, V28, P691, DOI 10.1016/j.meegid.2014.07.028
   ALGER NE, 1972, J ECON ENTOMOL, V65, P165, DOI 10.1093/jee/65.1.165
   Ameku T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006123
   BARTFELD NS, 1990, J BIOL CHEM, V265, P21684
   Billingsley PF, 2008, TRENDS PARASITOL, V24, P396, DOI 10.1016/j.pt.2008.06.003
   BOMFORD AB, 1992, PATHOBIOLOGY, V60, P10, DOI 10.1159/000163691
   Canals M, 1996, TECNOVET, V2, P1
   Carlier PR, 2017, CURR MED CHEM, V24, P2946, DOI 10.2174/0929867324666170206130024
   Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238
   Diallo M, 2016, J INFECT DIS, V214, pS459, DOI 10.1093/infdis/jiw397
   DUNKOV BC, 1995, ARCH INSECT BIOCHEM, V29, P293, DOI 10.1002/arch.940290307
   Evans AM, 2009, J EXP BIOL, V212, P3263, DOI 10.1242/jeb.029553
   Foy Brian D., 2002, American Entomologist, V48, P150
   Harizanova N, 2005, INSECT MOL BIOL, V14, P79, DOI 10.1111/j.1365-2583.2004.00533.x
   HATFIELD PR, 1988, MED VET ENTOMOL, V2, P331, DOI 10.1111/j.1365-2915.1988.tb00205.x
   Heifetz Y, 2014, CURR BIOL, V24, P731, DOI 10.1016/j.cub.2014.02.042
   JACOBSLORENA M, 1995, PARASITOL TODAY, V11, P144, DOI 10.1016/0169-4758(95)80134-0
   Jin XY, 2003, INSECT BIOCHEM MOLEC, V33, P815, DOI 10.1016/S0965-1748(03)00081-X
   JOHNSTON LAY, 1986, INT J PARASITOL, V16, P27, DOI 10.1016/0020-7519(86)90061-5
   Law JH, 2002, BIOCHEM BIOPH RES CO, V292, P1191, DOI 10.1006/bbrc.2001.2015
   McDowell MA, 2015, TRENDS PARASITOL, V31, P363, DOI 10.1016/j.pt.2015.04.011
   Meyers JI, 2017, ARTHROPOD VECTOR: CONTROLLER OF DISEASE TRANSMISSION, VOL 1: VECTOR MICROBIOME AND INNATE IMMUNITY OF ARTHROPODS, P143, DOI 10.1016/B978-0-12-805350-8.00008-8
   Meyers JI, 2015, J EXP BIOL, V218, P1487, DOI 10.1242/jeb.118596
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   RAMASAMY MS, 1988, MED VET ENTOMOL, V2, P87, DOI 10.1111/j.1365-2915.1988.tb00053.x
   Rey JR, 2006, ENY727 U FLOR I FOOD
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427
   Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3
   Shahabuddin M, 1996, INFECT IMMUN, V64, P739, DOI 10.1128/IAI.64.3.739-743.1996
   Shen ZC, 1998, INSECT BIOCHEM MOLEC, V28, P1007, DOI 10.1016/S0965-1748(98)00089-7
   SUTHERLAND GB, 1974, J INSECT PHYSIOL, V20, P655, DOI 10.1016/0022-1910(74)90187-5
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2
   TRAGER WILLIAM, 1939, JOUR PARASITOL, V25, P57, DOI 10.2307/3272160
   Vargas J, 2003, REV PERU EPIDEMIOL, V11, P1
   VAUGHAN JA, 1988, J MED ENTOMOL, V25, P472, DOI 10.1093/jmedent/25.6.472
   VenkatRao V, 2017, ACTA TROP, V168, P21, DOI 10.1016/j.actatropica.2016.12.035
   Villalon JM, 2003, J INSECT PHYSIOL, V49, P891, DOI 10.1016/S0022-1910(03)00135-5
   Wijffels G, 1996, EUR J BIOCHEM, V237, P414, DOI 10.1111/j.1432-1033.1996.0414k.x
   WILLADSEN P, 1989, J IMMUNOL, V143, P1346
   Willadsen P, 2001, VET PARASITOL, V101, P353, DOI 10.1016/S0304-4017(01)00560-X
   Womack M., 1993, WING BEATS, V5, P4
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 43
TC 0
Z9 0
U1 1
U2 11
PU ENTOMOLOGICAL SOC BRASIL
PI LONDRINA,
PA CAIXA POSTAL 481, 86001-970 LONDRINA,, PR, BRAZIL
SN 1519-566X
EI 1678-8052
J9 NEOTROP ENTOMOL
JI Neotrop. Entomol.
PD AUG
PY 2019
VL 48
IS 4
BP 706
EP 716
DI 10.1007/s13744-019-00678-5
PG 11
WC Entomology
SC Entomology
GA IC8CU
UT WOS:000471204700018
PM 30941675
DA 2020-07-08
ER

PT J
AU Le Tyrant, M
   Bley, D
   Leport, C
   Alfandari, S
   Guegan, JF
AF Le Tyrant, Marion
   Bley, Daniel
   Leport, Catherine
   Alfandari, Serge
   Guegan, Jean-Francois
TI Low to medium-low risk perception for dengue, chikungunya and Zika
   outbreaks by infectious diseases physicians in France, Western Europe
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Chikungunya; Dengue; Zika; Infectious diseases physicians; Risk
   perception; Vector-borne disease; Western Europe
ID REUNION ISLAND; VIRUS; FEVER; EPIDEMIC; AMERICA; TRENDS
AB BackgroundMany tropical countries are currently experiencing dengue (DEN), chikungunya (CHIK) and also more recently Zika (ZIKA) epidemics (particularly in Latin America). Although the risk of transmission and spread of these infections in temperate regions remains a controversial issue, vector-borne diseases have been widely reported in the media and have been the focus of preventive strategies by national and international policy-makers and public health authorities. In this context, we wanted to determine the extent of risk perception in infectious diseases (ID) physicians of the current and future risk of arboviral disease introduction, autochthonous case development and epidemic scenarios in France, Western Europe.MethodsTo this aim, we developed an original standardized questionnaire survey which was disseminated by the French Infectious Diseases Society to ID physician members.ResultsWe found that ID physicians perceived the risk of introduction and outbreak development of DEN, CHIK and ZIKA in France to be low to medium-low. Generalized Linear Model(s) identified medical school training, the extent of professional experience, and awareness of the French national plan regarding arboviral infections as significant predictors for lower risk perception among respondents.ConclusionDespite the fact that arboviral diseases are increasingly being imported into France, sometimes resulting in sporadic autochtonous transmission, French ID physicians do not perceive the risk as high. Better communication and education targeting health professionals and citizens will be needed to enhance the effectiveness of the French national plan to prepare against arboviral diseases.
C1 [Le Tyrant, Marion; Bley, Daniel] Univ Nice Sophia Antipolis, Aix Marseille Univ, Avignon Univ, CNRS,UMR ESPACE 7300, F-13545 Aix En Provence, France.
   [Le Tyrant, Marion; Guegan, Jean-Francois] Univ Montpellier, UMR MIVEGEC, Ctr IRD Montpellier, IRD,CNRS, F-34394 Montpellier 5, France.
   [Leport, Catherine] Univ Paris Diderot, Inserm 1137, UMR 1137, 16 Rue Henri Huchard, F-75870 Paris 18, France.
   [Leport, Catherine] AP HP, Mission COREB Natl, F-75004 Paris, France.
   [Alfandari, Serge] Ctr Hosp Tourcoing, Serv Reanimat & Malad Infect, Tourcoing, France.
   [Guegan, Jean-Francois] Univ Montpellier, UMR ASTRE, INRA, Cirad, Campus Int Baillarguet, F-34980 Montpellier, France.
   [Guegan, Jean-Francois] OneHealth Global Res Programme, Int UN Programme FutureEarth, Montreal, PQ, Canada.
RP Guegan, JF (corresponding author), Univ Montpellier, UMR MIVEGEC, Ctr IRD Montpellier, IRD,CNRS, F-34394 Montpellier 5, France.; Guegan, JF (corresponding author), Univ Montpellier, UMR ASTRE, INRA, Cirad, Campus Int Baillarguet, F-34980 Montpellier, France.; Guegan, JF (corresponding author), OneHealth Global Res Programme, Int UN Programme FutureEarth, Montreal, PQ, Canada.
EM marion.letyrant@gmail.com; jean-francois.guegan@cirad.fr
RI Alfandari, Serge/AAF-2022-2020
OI Alfandari, Serge/0000-0002-9672-725X
FU French programme "Investissement d'Avenir" Labex DRIIHMFrench National
   Research Agency (ANR) [ANR-11-LABX-0010]; French programme
   "Investissement d'Avenir" LabEx CEBA [ANR-10-LABX-25-01]; LabEx DRIIHM;
   Institut de Recherche pour le Developpement; Institut national de la
   recherche agronomique; Centre National de la Recherche
   ScientifiqueCentre National de la Recherche Scientifique (CNRS);
   University of Montpellier
FX This study has been financed by two French programmes "Investissement
   d'Avenir" Labex DRIIHM, (ANR-11-LABX-0010) and LabEx CEBA
   (ANR-10-LABX-25-01). Marion Le Tyrant received a 3-years PhD fellowship
   from LabEx DRIIHM. Jean-Francois Guegan is supported by the Institut de
   Recherche pour le Developpement, the Institut national de la recherche
   agronomique, the Centre National de la Recherche Scientifique and
   University of Montpellier. The two LabEx funding bodies did not
   participate to the study design and collection, data analysis and
   interpretation, and in the writing of the paper.
CR Agence regionale de sante - Occitanie, 2018, CAS AUT DENG CONF HE
   [Anonymous], 2018, RESULTATS ACTIVITE A, P97
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Bertrand K, 2015, THESIS
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-2
   Calba C., 2018, Bulletin Epidemiologique Hebdomadaire, P504
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Corrin T, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0061-x
   de Zwart O, 2007, EMERG INFECT DIS, V13, P290, DOI 10.3201/eid1302.060303
   de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2
   Delaunay P, 2012, ANN DERMATOL VENER, V139, P396, DOI 10.1016/j.annder.2011.12.005
   Delfraissy JF, 2016, LANCET, V387, P2183, DOI 10.1016/S0140-6736(16)30059-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fenetrier E, 2013, Bull Soc Pathol Exot, V106, P193, DOI 10.1007/s13149-013-0295-8
   Fontenille D, 2009, DIS VECTOR CONTROL F
   Fox J., 2011, R COMPANION APPL REG
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gardner LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/103679
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gautier A, 2008, ENQUETE NICOLLE 2006
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Gjenero-Margan I, 2011, EURO SURVEILL, V16
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Guegan JF, 2016, MED MALADIES INFECT, V46, P333, DOI 10.1016/j.medmal.2016.05.002
   Handel SA, 2016, TROP DIS TRAVEL MED, V2, P10
   Jelinek T, 2009, EUROSURVEILLANCE, V14, P4
   Kajeguka DC, 2017, TROP MED INT HEALTH, V22, P583, DOI 10.1111/tmi.12863
   Keck F, 2010, MONDE GRIPPE
   LIKERT R, 1932, ARCH PSYCHOL, V22
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Molho S, 2018, B EPIDEMIOL HEBD, V24, P510
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Piccoli S, 1999, MED MALADIES INFECT, V29, p282S, DOI 10.1016/S0399-077X(00)88265-7
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Raude J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002094
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Sante publique France, 2019, CHIK DENG ZIK DONN S
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Setbon M, 2008, MED MALADIES INFECT, V38, pS78, DOI 10.1016/S0399-077X(08)72999-8
   Setbon M, 2011, PREV MED, V52, P178, DOI 10.1016/j.ypmed.2010.11.010
   Setbon M, 2008, POPULATION, V63, P555, DOI 10.3917/popu.803.0555
   Succo T, 2016, BEH, V21, P328
   TABUTEAU D, 2007, TRIBUNES SANTE, V14, P29
   van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575
   Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
   Venables WN, 1999, MODERN APPL STAT S P
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vernazza-Licht N, 2012, SHS WEB C
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Zar J, 2010, BIOSTATISTICAL ANAL
NR 60
TC 0
Z9 0
U1 4
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUL 31
PY 2019
VL 19
AR 1014
DI 10.1186/s12889-019-7317-9
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IM5JC
UT WOS:000478029200001
PM 31366341
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vaux, AGC
   Dallimore, T
   Cull, B
   Schaffner, F
   Strode, C
   Pfluger, V
   Murchie, A
   Rea, I
   Newham, Z
   Mcginley, L
   Catton, M
   Gillingham, EL
   Medlock, JM
AF Vaux, A. G. C.
   Dallimore, T.
   Cull, B.
   Schaffner, F.
   Strode, C.
   Pflueger, V
   Murchie, A.
   Rea, I
   Newham, Z.
   Mcginley, L.
   Catton, M.
   Gillingham, E. L.
   Medlock, J. M.
TI The challenge of invasive mosquito vectors in the UK during 2016-2018: a
   summary of the surveillance and control of Aedes albopictus
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Aedes egg; MALDI-TOF; mosquito;
   mosquito control; mosquito surveillance
ID DIPTERA; AEGYPTI; DENGUE; VIRUS; INFECTION; SEPTEMBER; CULICIDAE;
   SURVIVAL; OUTBREAK; CROATIA
AB Mosquito-borne diseases resulting from the expansion of two key vectors, Aedes aegypti and Aedes albopictus (Diptera: Culicidae), continue to challenge whole regions and continents around the globe. In recent years there have been human cases of disease associated with Chikungunya, dengue and Zika viruses. In Europe, the expansion of Ae. albopictus has resulted in local transmission of Chikungunya and dengue viruses. This paper considers the risk that Ae. aegypti and Ae. albopictus represent for the U.K. and details the results of mosquito surveillance activities. Surveillance was conducted at 34 points of entry, 12 sites serving vehicular traffic and two sites of used tyre importers. The most common native mosquito recorded was Culex pipiens s.l. (Diptera: Culicidae). The invasive mosquito Ae. albopictus was detected on three occasions in southern England (September 2016, July 2017 and July 2018) and subsequent control strategies were conducted. These latest surveillance results demonstrate ongoing incursions of Ae. albopictus into the U.K. via ground vehicular traffic, which can be expected to continue and increase as populations in nearby countries expand, particularly in France, which is the main source of ex-continental traffic.
C1 [Vaux, A. G. C.; Cull, B.; Newham, Z.; Mcginley, L.; Catton, M.; Gillingham, E. L.; Medlock, J. M.] Publ Hlth England, Med Entomol & Zoonoses Ecol Grp, Emergency Response Dept Sci & Technol, Salisbury SP4 0JG, Wilts, England.
   [Dallimore, T.; Strode, C.] Edge Hill Univ, Dept Biol, Ormskirk, England.
   [Schaffner, F.] Francis Schaffner Consultancy, Riehen, Switzerland.
   [Pflueger, V] Mabritec AG, Riehen, Switzerland.
   [Murchie, A.; Rea, I] Agrifood & Biosci Inst, Zool Dept, Belfast, Antrim, North Ireland.
RP Vaux, AGC (corresponding author), Publ Hlth England, Med Entomol & Zoonoses Ecol Grp, Emergency Response Dept Sci & Technol, Salisbury SP4 0JG, Wilts, England.
EM Alexander.Vaux@phe.gov.uk
OI Cull, Benjamin/0000-0001-6814-5669
CR Ashe P., 1991, Proceedings of the Royal Irish Academy Section B Biological Geological and Chemical Science, V91, P21
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Dallimore T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2251-0
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   European Centre for Disease Prevention and Control, 2019, VECT CURR KNOWN DIST
   European Centre for Disease Prevention and Control and European Food Safety Authority, 2012, GUID SURV INV MOSQ E
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Harbach RE, 2017, ZOOKEYS, P119, DOI [10.3897/zookeys.671.12477, 10.3897/zookeys.671.12447]
   Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0
   Kampen H, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.47.30407
   Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5
   Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y
   Kotsakiozi P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2933-2
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   LINLEY JR, 1989, J MED ENTOMOL, V26, P510, DOI 10.1093/jmedent/26.6.510
   Lounibos L.P., 2009, ANN ENTOMOLOGICAL SO, V96, P512
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MEERS PD, 1986, J HYG-CAMBRIDGE, V97, P185, DOI 10.1017/S0022172400064469
   Met Office, 2019, CLIM SUMM
   Metelmann S, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0761
   Osorio HC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040820
   Public Health England, 2019, GUID CHIK
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Schaffner F, 2001, MOUSTIQUES EUROPE LO
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142
   Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2
   Sebesta O, 2012, EUROSURVEILLANCE, V17, P6
   SURTEES G, 1971, B WORLD HEALTH ORGAN, V44, P707
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   Vaux Alexander G.C., 2011, European Mosquito Bulletin, V29, P133
   Venturi G., 2017, EUROSURVEILLANCE, V22
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 1
Z9 1
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD DEC
PY 2019
VL 33
IS 4
BP 443
EP 452
DI 10.1111/mve.12396
EA JUL 2019
PG 10
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA JI7QV
UT WOS:000479384200001
PM 31361038
OA Bronze
DA 2020-07-08
ER

PT J
AU Collins, ND
   Widen, SG
   Li, L
   Swetnam, DM
   Shi, PY
   Tesh, RB
   Sarathy, VV
AF Collins, Natalie D.
   Widen, Steven G.
   Li, Li
   Swetnam, Daniele M.
   Shi, Pei-Yong
   Tesh, Robert B.
   Sarathy, Vanessa V.
TI Inter- and intra-lineage genetic diversity of wild-type Zika viruses
   reveals both common and distinctive nucleotide variants and clusters of
   genomic diversity
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Next generation sequencing; Zika virus; genetic diversity; Zika lineage;
   Shannon entropy
ID PHYLOGENETIC ANALYSIS; MUTATIONS; BIOLOGY; PROTEIN; MODEL
AB Zika virus (ZIKV) strains belong to the East African, West African, and Asian/American phylogenetic lineages. RNA viruses, like ZIKV, exist as populations of genetically-related sequences whose heterogeneity may impact viral fitness, evolution, and virulence. Genetic diversity of representative ZIKVs from each lineage was examined using next generation sequencing (NGS) paired with downstream entropy and single nucleotide variant (SNV) analysis. Comparisons showed that inter-lineage diversity was statistically supported, while intra-lineage diversity. Intra-lineage diversity was significant for East but not West Africa strains. Furthermore, intra-lineage diversity for the Asian/American lineage was not supported for human serum isolates; however, a placenta isolate differed significantly. Relative in the pre-membrane/membrane (prM/M) gene of several ZIKV strains. Additionally, the East African lineage contained a greater number of synonymous SNVs, while a greater number of non-synonymous SNVs were identified for American strains. Further, inter-lineage SNVs were dispersed throughout the genome, whereas intra-lineage non-synonymous SNVs for Asian/American strains clustered within prM/M and NS1 gene. This comprehensive analysis of ZIKV genetic diversity provides a repository of SNV positions across lineages. We posit that increased non-synonymous SNV populations and increased relative genetic diversity of the prM/M and NS1 proteins provides more evidence for their role in ZIKV virulence and fitness.
   [GRAPHICS]
C1 [Collins, Natalie D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Widen, Steven G.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Li, Li; Tesh, Robert B.; Sarathy, Vanessa V.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Swetnam, Daniele M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Sarathy, Vanessa V.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Sarathy, VV (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Sarathy, VV (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM vvsarath@utmb.edu
RI Swetnam, Daniele/AAI-2970-2020
OI Sarathy, Vanessa/0000-0002-1262-2101
FU John Sealy Memorial Research Endowment pilot grant
FX This work was supported by a John Sealy Memorial Research Endowment
   pilot grant to VVS. We thank Jill K. Thompson for assistance with NGS,
   Thomas G. Wood and Alan D.T. Barrett for helpful discussions, and Hilda
   Guzman from the World Reference Center for Emerging Viruses and
   Arboviruses.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, P1
   AZAR SR, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/v10110661
   Beck A, 2014, J INFECT DIS, V209, P334, DOI 10.1093/infdis/jit546
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bray M, 1998, J VIROL, V72, P1647, DOI 10.1128/JVI.72.2.1647-1651.1998
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Collins ND, 2018, MBIO, V9, DOI 10.1128/mBio.01871-18
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Davis CT, 2007, J VIROL, V81, P6111, DOI 10.1128/JVI.02387-06
   de Borba L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001624
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fishman SL, 2009, INFECT GENET EVOL, V9, P1158, DOI 10.1016/j.meegid.2009.07.011
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heinz FX, 2003, ADV VIRUS RES, V59, P63, DOI 10.1016/S0065-3527(03)59003-0
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020157
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miller MA, 2010, 2010 GAT COMP ENV WO
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907
   Nishijima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035052
   Ojha CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208543
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Piccolo SR, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0135-4
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shrivastava S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34147-7
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 56
TC 1
Z9 1
U1 3
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 29
PY 2019
VL 8
IS 1
BP 1126
EP 1138
DI 10.1080/22221751.2019.1645572
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA IM1GA
UT WOS:000477735400001
PM 31355708
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ruan, JJ
   Rothan, HA
   Zhong, YW
   Yan, WJ
   Henderson, MJ
   Chen, FH
   Fang, SY
AF Ruan, Jingjing
   Rothan, Hussin A.
   Zhong, Yongwang
   Yan, Wenjing
   Henderson, Mark J.
   Chen, Feihu
   Fang, Shengyun
TI A small molecule inhibitor of ER-to-cytosol protein dislocation exhibits
   anti-dengue and anti-Zika virus activity
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DRUG TARGET ENGAGEMENT; ENDOPLASMIC-RETICULUM; IN-VITRO; DEGRADATION;
   STRESS; RICIN; UBIQUITIN; TRAFFICKING; CANCER; SCREEN
AB Infection with flaviviruses, such as dengue virus (DENV) and the recently re-emerging Zika virus (ZIKV), represents an increasing global risk. Targeting essential host elements required for flavivirus replication represents an attractive approach for the discovery of antiviral agents. Previous studies have identified several components of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway, a cellular protein quality control process, as host factors crucial for DENV and ZIKV replication. Here, we report that CP26, a small molecule inhibitor of protein dislocation from the ER lumen to the cytosol, which is an essential step for ERAD, has broad-spectrum anti-flavivirus activity. CP26 targets the Hrd1 complex, inhibits ERAD, and induces ER stress. Ricin and cholera toxins are known to hijack the protein dislocation machinery to reach the cytosol, where they exert their cytotoxic effects. CP26 selectively inhibits the activity of cholera toxin but not that of ricin. CP26 exhibits a significant inhibitory activity against both DENV and ZIKV, providing substantial protection to the host cells against virus-induced cell death. This study identified a novel dislocation inhibitor, CP26, that shows potent anti-DENV and anti-ZIKV activity in cells. Furthermore, this study provides the first example of the targeting of host ER dislocation with small molecules to combat flavivirus infection.
C1 [Ruan, Jingjing; Chen, Feihu] Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China.
   [Ruan, Jingjing; Rothan, Hussin A.; Zhong, Yongwang; Yan, Wenjing; Fang, Shengyun] Univ Maryland, Ctr Biomed Engn & Technol, Dept Biochem & Mol Biol, Dept Physiol,Sch Med, Baltimore, MD 21201 USA.
   [Henderson, Mark J.] NIH, Natl Ctr Advancing Translat Sci, Rockville, MD 20850 USA.
   [Rothan, Hussin A.] Georgia State Univ, Coll Arts & Sci, Dept Biol, Atlanta, GA 30303 USA.
RP Chen, FH (corresponding author), Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China.; Fang, SY (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Dept Biochem & Mol Biol, Dept Physiol,Sch Med, Baltimore, MD 21201 USA.
EM cfhchina@qq.com; sfang@som.umaryland.edu
OI Henderson, Mark/0000-0001-8590-7338
FU National Institute of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [UO1GM117175]
FX We would like to thank Dr. Bruce Vogel for comments and editing this
   manuscript. This project was funded by the National Institute of Health,
   USA (UO1GM117175 to S.F.).
CR Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002
   Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586
   Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Byun H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00330
   Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044
   Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932
   Cerezo M, 2016, CANCER CELL, V29, P805, DOI 10.1016/j.ccell.2016.04.013
   Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590
   Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Das B, 2016, CURR OPIN INFECT DIS, V29, P520, DOI 10.1097/QCO.0000000000000306
   Dupzyk A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090242
   Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598
   Fatima K, 2018, J GLOB HEALTH, V8, DOI [10.7189/jogh.08-020312, 10.7189/jogh.08.020312]
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Guichard A, 2013, CELL HOST MICROBE, V14, P294, DOI 10.1016/j.chom.2013.08.001
   Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Inoue T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013250
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Leto DE, 2019, MOL CELL, V73, P377, DOI 10.1016/j.molcel.2018.11.015
   Lewy TG, 2017, YALE J BIOL MED, V90, P291
   Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Martinez NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27834-y
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Melchior WB, 2010, ANAL BIOCHEM, V396, P204, DOI 10.1016/j.ab.2009.09.024
   Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715
   Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606
   Molinari M, 2015, SEMIN CELL DEV BIOL, V41, P70, DOI 10.1016/j.semcdb.2015.05.009
   Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933
   Perera N, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12734
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Ravindran MS, 2016, NAT REV MICROBIOL, V14, P407, DOI 10.1038/nrmicro.2016.60
   Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Rothan HA, 2016, ANTIVIR RES, V127, P50, DOI 10.1016/j.antiviral.2016.01.006
   Rothan HA, 2014, ANTIVIR RES, V108, P173, DOI 10.1016/j.antiviral.2014.05.019
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Sepulveda-Salinas KJ, 2017, CELL STRESS CHAPERON, V22, P799, DOI 10.1007/s12192-017-0810-0
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310
   Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016
   Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742
   Spooner RA, 2015, TOXINS, V7, P49, DOI 10.3390/toxins7010049
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200
   Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780
   Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6
   Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027
   Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546
   Wahome PG, 2012, CURR TOP MICROBIOL, V357, P179, DOI 10.1007/82_2011_177
   Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800
   Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131
   Williams JM, 2016, CURR OPIN CELL BIOL, V41, P51, DOI 10.1016/j.ceb.2016.03.019
   Zhong YW, 2015, BIOCHEM BIOPH RES CO, V458, P424, DOI 10.1016/j.bbrc.2015.01.133
   Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798
   Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906
NR 66
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 29
PY 2019
VL 9
AR 10901
DI 10.1038/s41598-019-47532-7
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IM0TG
UT WOS:000477701800004
PM 31358863
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carlson, CJ
   Mendenhall, E
AF Carlson, Colin J.
   Mendenhall, Emily
TI Preparing for emerging infections means expecting new syndemics
SO LANCET
LA English
DT Letter
ID ZIKA
C1 [Carlson, Colin J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA.
   [Mendenhall, Emily] Georgetown Univ, Sch Foreign Serv, Dept Sci Technol & Foreign Affairs, Washington, DC 20057 USA.
RP Mendenhall, E (corresponding author), Georgetown Univ, Sch Foreign Serv, Dept Sci Technol & Foreign Affairs, Washington, DC 20057 USA.
EM em1061@georgetown.edu
CR Bahia-Oliveira LMG, 2018, SCI MED, V28, DOI 10.15448/1980-6108.2018.2.29527
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Friedman MR, 2015, AIDS, V29, P1087, DOI 10.1097/QAD.0000000000000657
   Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Singer M, 2017, GLOB PUBLIC HEALTH, V12, P1, DOI 10.1080/17441692.2016.1225112
   Tsuyuki K, 2018, CULT HEALTH SEX, V20, P1006, DOI 10.1080/13691058.2017.1406535
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
NR 10
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 27
PY 2019
VL 394
IS 10195
BP 297
EP 297
DI 10.1016/S0140-6736(19)31237-1
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA IL1QD
UT WOS:000477075200017
PM 31354135
OA Bronze
DA 2020-07-08
ER

PT J
AU Beckman, D
   Seelke, A
   Morrison, JH
   Bliss-Moreau, E
AF Beckman, Danielle
   Seelke, Adele
   Morrison, John H.
   Bliss-Moreau, Eliza
TI Novel approaches to study the Zika virus in the brain
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Letter
C1 [Beckman, Danielle; Seelke, Adele; Morrison, John H.; Bliss-Moreau, Eliza] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95626 USA.
   [Seelke, Adele; Bliss-Moreau, Eliza] Univ Calif Davis, Dept Psychol, Davis, CA USA.
   [Morrison, John H.] Univ Calif Davis, Sch Med, Dept Neurol, Davis, CA USA.
RP Bliss-Moreau, E (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95626 USA.
EM eblissmoreau@ucdavis.edu
RI Beckman, Danielle/AAA-1016-2019; Beckman, Danielle/J-5331-2015
OI Beckman, Danielle/0000-0002-9584-4411; Beckman,
   Danielle/0000-0002-9584-4411; Seelke, Adele/0000-0002-2867-0335
FU NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI129479, P51 OD011107]; NINDS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R21 NS104692]
CR Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Daniels BP, 2015, CLIN PHARMACOL THER, V97, P372, DOI 10.1002/cpt.75
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   World Health Organization, 2018, WHO ZIK VIR
NR 9
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0360-4012
EI 1097-4547
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD JAN
PY 2020
VL 98
IS 1
BP 227
EP 228
DI 10.1002/jnr.24499
EA JUL 2019
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA JM0CE
UT WOS:000479486000001
PM 31347721
OA Bronze
DA 2020-07-08
ER

PT J
AU Udenze, D
   Trus, I
   Berube, N
   Gerdts, V
   Karniychuk, U
AF Udenze, Daniel
   Trus, Ivan
   Berube, Nathalie
   Gerdts, Volker
   Karniychuk, Uladzimir
TI The African strain of Zika virus causes more severe in utero infection
   than Asian strain in a porcine fetal transmission model
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika virus; in utero infection; fetus; pig; African strain; Asian
   strain; interferon alpha; cortisol
AB Studies in mice showed that African Zika virus (ZIKV) strains cause more damage in embryos. These studies, however, were limited to the mouse-adapted African MR766 strain or infection at early gestation. Here, we compared infection of Asian and African strains in the fetal pig model at midgestation. Both strains caused fetal infection. ZIKV was detected in placenta, amniotic membrane, amniotic fluid, fetal blood, and brain. The African strain produced more vigorous in utero infection as represented by more efficient virus transmission between siblings, and higher viral loads in fetal organs and membranes. Infection with both strains was associated with reduced fetal brain weight and increased number of placental CD163-positive cells, as well as elevated in utero interferon alpha and cortisol levels. This is the first large animal model study which demonstrated that African strain of ZIKV, with no passage history in experimental animals, can cause persistent infection in fetuses and fetal membranes at midgestation. Our studies also suggest that similar to Asian strains, ZIKV of African lineage might cause silent pathology which is difficult to identify in deceptively healthy fetuses. The findings emphasize the need for further studies to highlight the impact of ZIKV heterogeneity on infection outcomes during pregnancy.
C1 [Udenze, Daniel; Trus, Ivan; Berube, Nathalie; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK S7N 5E3, Canada.
   [Udenze, Daniel; Karniychuk, Uladzimir] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK S7N 2Z4, Canada.
   [Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 5B4, Canada.
RP Karniychuk, U (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK S7N 5E3, Canada.; Karniychuk, U (corresponding author), Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK S7N 2Z4, Canada.; Karniychuk, U (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 5B4, Canada.
EM u.karniychuk@usask.ca
OI Trus, Ivan/0000-0003-2849-5140; Karniychuk,
   Uladzimir/0000-0001-7802-9223
FU Saskatchewan Health Research Foundation [419353]
FX Asian ZIKV strain PRVABC59 was kindly provided by the Division of
   Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort
   Collins, Colorado, USA. We thank VIDO-InterVac animal care technicians
   and veterinarians for the help with animal experiments. Jan Erickson
   made drawings in Figure S1. This work was supported by Saskatchewan
   Health Research Foundation, Establishment Grant 419353. Published as
   VIDO-InterVac manuscript #866.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   ASHDOWN RR, 1967, J ANAT, V101, P269
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Vianna RAD, 2019, J TROP PEDIATRICS, V65, P592, DOI 10.1093/tropej/fmz019
   Derricott H, 2016, AM J PATHOL, V186, P952, DOI 10.1016/j.ajpath.2015.12.010
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamer DH, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz012
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Karniychuk UU, 2009, PLACENTA, V30, P497, DOI 10.1016/j.placenta.2009.03.016
   Karniychuk UU, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-19
   Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Langerak T, 2019, J INFECT DIS, V220, P28, DOI 10.1093/infdis/jiz063
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Majumder Maimuna S, 2018, F1000Res, V7, P159, DOI 10.12688/f1000research.13858.1
   Mathe P, 2018, J CLIN VIROL, V105, P35, DOI 10.1016/j.jcv.2018.05.011
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Novakovic P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0364-7
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Rayner JO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050229
   Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sarkar P, 2008, J NEUROENDOCRINOL, V20, P489, DOI 10.1111/j.1365-2826.2008.01659.x
   Schonkeren D, 2011, AM J PATHOL, V178, P709, DOI 10.1016/j.ajpath.2010.10.011
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Seruyange E, 2018, J MED VIROL, V90, P1290, DOI 10.1002/jmv.25198
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Sherman KE, 2018, JAIDS-J ACQ IMM DEF, V78, pE35, DOI 10.1097/QAI.0000000000001718
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Stanelle-Bertram S, 2018, NAT MICROBIOL, V3, P1161, DOI 10.1038/s41564-018-0236-1
   Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Trus I, 2018, VIRULENCE, V9, P1338, DOI 10.1080/21505594.2018.1504558
   Vanderhaeghe C, 2010, ANIM REPROD SCI, V120, P78, DOI 10.1016/j.anireprosci.2010.02.010
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Yadav PD, 2019, INFECT GENET EVOL, V69, P199, DOI 10.1016/j.meegid.2019.01.026
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 59
TC 9
Z9 9
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 25
PY 2019
VL 8
IS 1
BP 1098
EP 1107
DI 10.1080/22221751.2019.1644967
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA IM1FV
UT WOS:000477734900001
PM 31340725
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nunez, AI
   Talavera, S
   Aranda, C
   Birnberg, L
   Rivas, R
   Pujol, N
   Verdun, M
   Failloux, AB
   Busquets, N
AF Nunez, Ana, I
   Talavera, Sandra
   Aranda, Carles
   Birnberg, Lotty
   Rivas, Raquel
   Pujol, Nuria
   Verdun, Marta
   Failloux, Anna-Bella
   Busquets, Nuria
TI European Aedes caspius mosquitoes are experimentally unable to transmit
   Zika virus
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes caspius; Saliva; Transmission; Arbovirus; Vector competence; Zika
   virus
ID VECTOR COMPETENCE; SUSCEPTIBILITY; ALBOPICTUS; CULEX
AB BackgroundAedes caspius (Pallas, 1771) is a floodwater mosquito species widely distributed in the Western Palaearctic. As an anthropophilic species, its role as an arbovirus vector may be the key for understanding the transmission cycle of certain diseases in Europe such as Zika virus (ZIKV). Concerning vector competence for ZIKV, studies related to Ae. caspius are still scarce. ZIKV is an arbovirus that has provoked a widespread epidemic in the Pacific region (2007-2013) and in the Americas (2015-2016). ZIKV is associated with serious neurological injuries (e.g. microcephaly) and Guillain-Barre syndrome. Due to the ZIKV epidemics in the American continent, some viraemic travellers coming from endemic countries have been reported in Europe. More knowledge is therefore required to define the susceptibility of autochthonous mosquito species such as Ae. caspius for ZIKV in order to improve arbovirus surveillance and control programmes. In the present study, the vector competence of a European population of Ae. caspius was evaluated for two ZIKV lineages, the Suriname ZIKV strain (Asian lineage) and the MR766 ZIKV strain (African I lineage). Females were tested at 7, 14 and 21days post-exposure (dpe) to infectious blood meals. An Ae. aegypti PAEA strain was used as a positive control.ResultsAedes caspius presented low susceptibility to ZIKV infection and the virus was only detected by RT-qPCR in body samples. Low viral loads were detected for the MR766 strain at 7dpe and for the Suriname strain at 14 and 21dpe. Aedes caspius was unable to produce a disseminated infection and virus transmission at any of the tested time points. Using Ae. aegypti PAEA strain, infection, dissemination and transmission rates were calculated for the Suriname ZIKV strain (Asian lineage) at each time point. For the MR766 ZIKV strain (African I lineage), while only infection rates were estimated at each time point, no dissemination or transmission were detected in either species.ConclusionsThe results of the present study reveal that the tested Ae. caspius population has a strong midgut escape barrier that limits the dissemination or transmission of the virus. As such, it seems unlikely that European Ae. caspius mosquitoes could be involved in ZIKV transmission if ZIKV was introduced into Europe. This information may help in designing a better strategy to European surveillance and control programmes for ZIKV.
C1 [Nunez, Ana, I; Talavera, Sandra; Aranda, Carles; Birnberg, Lotty; Rivas, Raquel; Pujol, Nuria; Verdun, Marta; Busquets, Nuria] Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain.
   [Aranda, Carles] Consell Comarcal del Baix Llobregat, Serv Control Mosquits, Barcelona, Spain.
   [Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors Unit, Paris, France.
RP Busquets, N (corresponding author), Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain.
EM nuria.busquets@irta.cat
RI Busquets, Nuria/T-8431-2017
OI Busquets, Nuria/0000-0001-5246-8260
FU CERCA Programme/Generalitat de Catalunya; European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant [734548]
FX This study was funded by CERCA Programme/Generalitat de Catalunya. and
   the European Union's Horizon 2020 Research and Innovation Programme
   under ZIKAlliance Grant Agreement no. 734548.
CR Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266
   Bellini R, 1997, J AM MOSQUITO CONTR, V13, P356
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2018, AM J TROP MED HYG, V99, P417, DOI 10.4269/ajtmh.18-0097
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gutierrez-Lopez R, 2019, EMERG INFECT DIS, V25, P346, DOI 10.3201/eid2502.171123
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li YK, 2017, DNA CELL BIOL, V36, P109, DOI 10.1089/dna.2016.3532
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Millet JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01319
   Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Napp S, 2018, PATHOG GLOB HEALTH, V112, P233, DOI 10.1080/20477724.2018.1483567
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Robert V, 2019, J EUR MOSQ CONTROL A, V37, P1
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Soliman DE, 2016, J MED ENTOMOL, V53, P262, DOI 10.1093/jme/tjv245
   Talavera S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2887-4
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   Veronesi E, 2018, PARASITOL RES, V117, P1925, DOI 10.1007/s00436-018-5886-7
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 44
TC 1
Z9 1
U1 2
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 25
PY 2019
VL 12
AR 363
DI 10.1186/s13071-019-3620-7
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IL9GA
UT WOS:000477592000002
PM 31345269
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Johnson, BB
AF Johnson, Branden B.
TI Americans' Views of Voluntary Protective Actions Against Zika Infection:
   Conceptual and Measurement Issues
SO RISK ANALYSIS
LA English
DT Article
DE Irrelevance; opportunity; Protective Action Decision Model; stage
   theories of behavior change; Zika
ID SELF-GENERATED VALIDITY; FALSE DISCOVERY RATE; RISK PERCEPTIONS; FEAR
   APPEALS; HAZARD; MODEL; ADJUSTMENT; BEHAVIOR; ADOPTION; PREPAREDNESS
AB Understanding factors affecting decisions by people to protect themselves, or not, is critical to designing supportive communications. Here, threat, protective-action, and stakeholder perceptions were evaluated for effects on mainland Americans' behavioral intentions regarding Zika in April 2017, as postulated by the Protective Action Decision Model. Although all three perception types (including a novel resource sufficiency measure) affected intentions, these relationships varied widely depending upon the method used to measure adoption of actions (e.g., total count of all behaviors adopted vs. behavior-specific analyses), the behaviors involved, and whether analysis focused on the full sample or only on people who had a reasonable opportunity to enact the behavior or who believed it relevant to their lives. There was a general contrast between mosquito control actions (removal of mosquito breeding areas and pesticide spraying) and travel-related behaviors (avoiding travel to areas of local transmission of the virus, protecting oneself from mosquito bites after potential exposure, and practicing safe sex after potential exposure). Reported action or inaction during the 2016 mosquito season, and stages of behavior change, were both elicited in January-February 2017; both drove intentions in April 2017 for the upcoming season, although direct and indirect effects varied widely. Collectively these findings present theoretical, measurement, and practical implications for understanding, tracking, and promoting voluntary protective actions against hazards.
C1 [Johnson, Branden B.] Decis Res, 1201 Oak St,Suite 200, Eugene, OR 97401 USA.
RP Johnson, BB (corresponding author), Decis Res, 1201 Oak St,Suite 200, Eugene, OR 97401 USA.
EM branden@decisionresearch.org
OI Johnson, Branden/0000-0003-2264-5419
FU U.S. National Science FoundationNational Science Foundation (NSF)
   [1644853]
FX Marcus Mayorga supervised data collection. Three anonymous reviewers
   provided valuable comments. This material is based on work supported by
   the U.S. National Science Foundation under Grant No. 1644853. The author
   has no conflict of interest.
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I., 1980, UNDERSTANDING ATTITU
   Ajzen I, 1985, ACTION CONTROL COGNI, DOI DOI 10.1007/978-3-642-69746-3_2
   Annenberg Public Policy Center, 2018, ZIK VIR
   Arlikatti S., 2007, INT J MASS EMERGENCI, V25, P218
   Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939
   BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122
   Bandura A, 1996, SELF EFFICACY EXERCI
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7
   Chandon P, 2005, J MARKETING, V69, P1, DOI 10.1509/jmkg.69.2.1.60755
   COTE JA, 1989, ADV CONSUM RES, V16, P105
   Dillon RL, 2014, DECIS ANAL, V11, P27, DOI 10.1287/deca.2013.0286
   Earle T, 2008, INT J GLOBAL ENV ISS, V8, P17, DOI [10.1504/IJGENVI.2008.017257, DOI 10.1504/IJGENVI.2008.017257]
   Earle T.C., 1995, SOCIAL TRUST COSMOPO
   FELDMAN JM, 1988, J APPL PSYCHOL, V73, P421, DOI 10.1037/0021-9010.73.3.421
   Fischoff B., 1980, COGNITIVE PROCESS, P117
   Fishbein M, 2010, PREDICTING CHANGING
   Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012
   Hayes A. F., 2018, INTRO MEDIATION MODE
   Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961
   Heath RL, 2018, RISK ANAL, V38, P333, DOI 10.1111/risa.12845
   Jagiello RD, 2018, RISK ANAL, V38, P2193, DOI 10.1111/risa.13117
   Johnson B. B., 2019, IS THERE COMMO UNPUB
   Johnson BB, 2019, J RISK RES, V22, P346, DOI 10.1080/13669877.2017.1378252
   Johnson BB, 2018, RISK ANAL, V38, P2561, DOI 10.1111/risa.13184
   Kelly BJ, 2016, HEALTH COMMUN, V31, P1284, DOI 10.1080/10410236.2015.1062976
   KIM MS, 1993, COMMUN RES, V20, P331, DOI 10.1177/009365093020003001
   Lindell M.K., 2018, HDB DISASTER RES, P449, DOI DOI 10.1007/978-3-319-63254-4_22
   Lindell Michael, 2013, CITIES RISK LIVING P, P109, DOI DOI 10.1007/978-94-007-6184-1
   Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x
   Lindell MK, 2002, J APPL SOC PSYCHOL, V32, P2377, DOI 10.1111/j.1559-1816.2002.tb01868.x
   Lindell MK, 2000, ENVIRON BEHAV, V32, P461, DOI 10.1177/00139160021972621
   Lindell MK, 2000, RISK ANAL, V20, P13, DOI 10.1111/0272-4332.00002
   Lindell MK, 2004, COMMUNICATING ENV RI
   LINDELL MK, 2000, INT J MASS EMERGENCI, V18, P317
   Mulilis JP, 1997, J APPL SOC PSYCHOL, V27, P1750, DOI 10.1111/j.1559-1816.1997.tb01623.x
   Neuwirth K, 2000, RISK ANAL, V20, P721, DOI 10.1111/0272-4332.205065
   Obenauer J, 2018, EUR J PUBLIC HEALTH, V28, P139, DOI 10.1093/eurpub/ckx092
   Pitch-Loeb R., 2017, PLOS ONE, V12, DOI 10.1371/journal.pone0188666
   Prochaska J. O., 1997, HDB HLTH BEHAV RES, P59
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Sell TK, 2018, RISK ANAL, V38, P2514, DOI 10.1111/risa.12961
   SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x
   Solberg C, 2010, NAT HAZARD EARTH SYS, V10, P1663, DOI 10.5194/nhess-10-1663-2010
   Terpstra T, 2013, ENVIRON BEHAV, V45, P993, DOI 10.1177/0013916512452427
   Tinsley CH, 2012, MANAGE SCI, V58, P1596, DOI 10.1287/mnsc.1120.1517
   US Centers for Disease Control and Prevention (CDC), 2016, CDCS RESP ZIK EST RA
   Wang F, 2018, J RISK RES, V21, P809, DOI 10.1080/13669877.2016.1247377
   Wei H.-L., 2018, INT J MASS EMERGENCI, V36, P52
   WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P235, DOI 10.1037/0278-6133.12.3.235
   WEINSTEIN ND, 1992, HEALTH PSYCHOL, V11, P170, DOI 10.1037/0278-6133.11.3.170
   WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355
   White MP, 2010, RISK ANAL, V30, P1196, DOI 10.1111/j.1539-6924.2010.01407.x
   Wilson RS, 2019, RISK ANAL, V39, P777, DOI 10.1111/risa.13207
   Winneg KM, 2018, RISK ANAL, V38, P2546, DOI 10.1111/risa.13010
   Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   Yang C, 2018, RISK ANAL, V38, P2535, DOI 10.1111/risa.12973
NR 61
TC 0
Z9 0
U1 5
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2019
VL 39
IS 12
BP 2694
EP 2717
DI 10.1111/risa.13378
EA JUL 2019
PG 24
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA JS4CM
UT WOS:000479657200001
PM 31339584
DA 2020-07-08
ER

PT J
AU Wenham, C
   Arevalo, A
   Coast, E
   Correa, S
   Cuellar, K
   Leone, T
   Valongueiro, S
AF Wenham, Clare
   Arevalo, Amaral
   Coast, Ernestina
   Correa, Sonia
   Cuellar, Katherine
   Leone, Tiziana
   Valongueiro, Sandra
TI Zika, abortion and health emergencies: a review of contemporary debates
SO GLOBALIZATION AND HEALTH
LA English
DT Review
DE Zika; Abortion; Health emergencies; Sexual and reproductive health;
   Structural violence; Reproductive rights
ID VIRUS-INFECTION; HUMAN-RIGHTS; PREGNANCY OUTCOMES; TERRITORIES;
   EPIDEMIC; OUTBREAK; MOSQUITO; AMERICA; EBOLA
AB Background: The Zika outbreak provides pertinent case study for considering the impact of health emergencies on abortion decision-making and/or for positioning abortion in global health security debates.
   Main body: This paper provides a baseline of contemporary debates taking place in the intersection of two key health policy areas, and seeks to understand how health emergency preparedness frameworks and the broader global health security infrastructure is prepared to respond to future crises which implicate sexual and reproductive rights. Our paper suggests there are three key themes that emerge from the literature; 1) the lack of consideration of sexual and reproductive health (SRH) services in outbreak response 2) structural inequalities permeate the landscape of health emergencies, epitomised by Zika, and 3) the need for rights based approaches to health.
   Conclusion: Global health security planning and response should specifically include programmatic activity for SRH provision during health emergencies.
C1 [Wenham, Clare] London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England.
   [Arevalo, Amaral] Univ Estado Rio De Janeiro, Inst Med Social, Rua Sao Francisco Xavier 524,Bloco D,7 Andar, BR-20550013 Rio De Janeiro, RJ, Brazil.
   [Coast, Ernestina] London Sch Econ & Polit Sci, Dept Int Dev, Houghton St, London WC2A 2AE, England.
   [Correa, Sonia] ABIA, Sexual Policy Watch, Ave Presidente Vargas 446,13th Floor, BR-20071907 Rio De Janeiro, RJ, Brazil.
   [Cuellar, Katherine] Univ Antioquia, Natl Fac Publ Hlth, Calle 62 52-59, Medellin, Colombia.
   [Valongueiro, Sandra] Univ Fed Pernambuco, Post Grad Programe Publ Hlth, Hosp Clin, Prof Moraes Rego S-N,Bloco E,4 Andar, BR-50670901 Recife, PE, Brazil.
RP Wenham, C (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England.
EM c.wenham@lse.ac.uk
OI Wenham, Clare/0000-0001-5378-3203
FU Wellcome TrustWellcome Trust [210308/Z/18/Z]
FX Funding for this project comes from Wellcome Trust 210308/Z/18/Z,
   Wellcome Trust has had no input into the design, analysis or
   interpretation of this paper.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Ali M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0432-0
   Amarillo Claudia Rivera, 2017, Sex., Salud Soc. (Rio J.), P199, DOI 10.1590/1984-6487.sess.2017.27.11.a
   Anderson Emma Louise., 2015, GENDER HIV RISK NAVI
   [Anonymous], 2017, EM RESP FRAM HUM HLT
   [Anonymous], 2016, SUPREMO TRIBUNAL FED
   Assuncao MS, 2014, SERVICO SOCIAL REV
   Baena de Moraes Lopes MH, 2018, J COMMUN HEALTHC, V11, P62, DOI [10.1080/17538068.2017.1374917, DOI 10.1080/17538068.2017.1374917]
   Barot S, 2017, GUTTMACHER POLICY RE, V20, P1
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carabali M, 2018, GLOB HEALTH RES POL, V3, DOI 10.1186/s41256-018-0069-8
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Center for Reproductive Rights, 2018, UNH VOIC WOM EXP ZIK
   Coast E, 2018, SOC SCI MED, V200, P199, DOI 10.1016/j.socscimed.2018.01.035
   CoLatino G., 2016, DIARIO COLATINO
   Davies SE, 2008, INT AFF, V84, P295, DOI 10.1111/j.1468-2346.2008.00704.x
   Davies SE, 2019, LANCET, V393, P601, DOI 10.1016/S0140-6736(18)32472-3
   Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704
   Davies SE, 2013, INT J HUM RIGHTS, V17, P133, DOI 10.1080/13642987.2012.710840
   de Campos TC, 2017, MED HEALTH CARE PHIL, V20, P443, DOI 10.1007/s11019-016-9739-9
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Diniz D, 2017, CIENC SAUDE COLETIVA, V22, P653, DOI 10.1590/1413-81232017222.23812016
   Dreweke J, 2016, COUNTERING ZIKA GLOB
   El Espectador, 2016, EL ESPECTADOR
   Enemark C, 2007, DIS SECURITY NATURAL
   Galli B, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00031116
   Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4
   Gies H, 2018, RAPE SURVIVOR FACING
   Gobierno de El Salvador, GOB INT ACC COMB VIR
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Guttmacher Institute, 2013, UN PREGN IND AB COL
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hennigan T, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1226
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Johnson C, 2017, J INT POLIT THEORY, V13, P233, DOI 10.1177/1755088217702671
   Lesser Jeffrey, 2016, NACLA REPORT AM, V48, P123, DOI [DOI 10.1080/10714839.2016.1201268, DOI 10.1080/10714839.2016.120168]
   Luna F, 2017, BIOETHICS, V31, P575, DOI 10.1111/bioe.12388
   Lyman M, 2018, INT J GYNECOL OBSTET
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   Mayor S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3492
   McGinn T, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0075-8
   Ministerio de Salud Colombia, 2016, LIN PROV AB CLIN GES
   Ministerio de Salud Colombia, 2016, LIN GEST PLAN CONT F
   Moeller K., 2016, BLOG HUFF POST
   Nunes J, 2016, REV CULTURA POLITICA, P21
   O GLOBO, 2013, GLOBO
   de Albuquerque MDPM, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00069018, 10.1590/0102-311x00069018]
   Prata ARS, 2018, J HUM GROWTH DEV, V28, P77, DOI [10.7322/jhgd.143875, DOI 10.7322/JHGD.143875]
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Reiter P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004769
   Riggirozzi P., 2017, INDEPENDENT
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Rohr Lucia Katharina, 2016, Rev. Bras. Saude Mater. Infant., V16, P447, DOI 10.1590/1806-93042016000400006
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Sedgh G., 2016, LANCET, V39, P16
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shoman H, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-016-0224-2
   Wenham C, 2019, SECUR DIALOGUE, V50, P398, DOI 10.1177/0967010619856458
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 69
TC 2
Z9 2
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1744-8603
J9 GLOBALIZATION HEALTH
JI Global. Health
PD JUL 24
PY 2019
VL 15
AR 49
DI 10.1186/s12992-019-0489-3
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IL0SA
UT WOS:000477009000001
PM 31340836
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Coronado, L
   Rios, L
   Frias, MT
   Amaran, L
   Naranjo, P
   Percedo, MI
   Perera, CL
   Prieto, F
   Fonseca-Rodriguez, O
   Perez, LJ
AF Coronado, Liani
   Rios, Liliam
   Teresa Frias, Maria
   Amaran, Laymara
   Naranjo, Paula
   Irian Percedo, Maria
   Laura Perera, Carmen
   Prieto, Felix
   Fonseca-Rodriguez, Osvaldo
   Perez, Lester J.
TI Positive selection pressure on E2 protein of classical swine fever virus
   drives variations in virulence, pathogenesis and antigenicity:
   Implication for epidemiological surveillance in endemic areas
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE antigenicity; classical swine fever virus; pathogenesis; positive
   selection pressure; surveillance; virulence
ID PORCINE CIRCOVIRUS TYPE-2; MOLECULAR EPIDEMIOLOGY; NEURAL-NETWORKS; CTL
   EPITOPES; ZIKA VIRUS; EVOLUTION; STRAINS; PIGS; PREDICTION; VACCINES
AB Classical swine fever (CSF), caused by CSF virus (CSFV), is considered one of the most important infectious diseases with devasting consequences for the pig industry. Recent reports describe the emergence of new CSFV strains resulting from the action of positive selection pressure, due mainly to the bottleneck effect generated by ineffective vaccination. Even though a decrease in the genetic diversity of the positively selected CSFV strains has been observed by several research groups, there is little information about the effect of this selective force on the virulence degree, antigenicity and pathogenicity of this type of strains. Hence, the aim of the current study was to determine the effect of the positive selection pressure on these three parameters of CSFV strains, emerged as result of the bottleneck effects induced by improper vaccination in a CSF-endemic area. Moreover, the effect of the positively selected strains on the epidemiological surveillance system was assessed. By the combination of in vitro, in vivo and immunoinformatic approaches, we revealed that the action of the positive selection pressure induces a decrease in virulence and alteration in pathogenicity and antigenicity. However, we also noted that the evolutionary process of CSFV, especially in segregated microenvironments, could contribute to the gain-fitness event, restoring the highly virulent pattern of the circulating strains. Besides, we denoted that the presence of low virulent strains selected by bottleneck effect after inefficient vaccination can lead to a relevant challenge for the epidemiological surveillance of CSF, contributing to under-reports of the disease, favouring the perpetuation of the virus in the field. In this study, B-cell and CTL epitopes on the E2 3D-structure model were also identified. Thus, the current study provides novel and significant insights into variation in virulence, pathogenesis and antigenicity experienced by CSFV strains after the positive selection pressure effect.
C1 [Coronado, Liani; Teresa Frias, Maria; Irian Percedo, Maria; Laura Perera, Carmen] OIE Collaborating Ctr Diag & Risk Anal Caribbean, Ctr Nacl Sanidad Agr CENSA, Havana, Cuba.
   [Rios, Liliam] Univ New Brunswick, Fac Med, Reiman Canc Res Lab, St John, NB, Canada.
   [Amaran, Laymara; Prieto, Felix] NLVD, Havana, Cuba.
   [Naranjo, Paula] Vet Med Inst, Havana, Cuba.
   [Fonseca-Rodriguez, Osvaldo] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.
   [Perez, Lester J.] Univ Illinois, Coll Vet Sci, Dept Clin Vet Med, Urbana, IL 61802 USA.
   [Perez, Lester J.] Univ Illinois, Coll Vet Sci, VDL, Urbana, IL 61802 USA.
RP Perez, LJ (corresponding author), Univ Illinois, Coll Vet Sci, Dept Clin Vet Med, Urbana, IL 61802 USA.
EM ljperez@illinois.edu
RI Fonseca-Rodriguez, Osvaldo/AAB-6416-2019; Perez, Lester J./A-1339-2016
OI Fonseca-Rodriguez, Osvaldo/0000-0002-0253-5928; Perez, Lester
   J./0000-0002-5717-5181
FU Program of exotic diseases of Cuba
FX Program of exotic diseases of Cuba
CR Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w
   Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639
   ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441
   Ashraf NM, 2016, INFECT GENET EVOL, V43, P58, DOI 10.1016/j.meegid.2016.05.009
   Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0
   Blome S, 2017, VET MICROBIOL, V206, P10, DOI 10.1016/j.vetmic.2017.01.001
   Blome S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040086
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Coronado L, 2017, VET MICROBIOL, V201, P103, DOI 10.1016/j.vetmic.2017.01.013
   Cummings MJ, 2019, CLIN INFECT DIS, V68, P1118, DOI 10.1093/cid/ciy656
   de Arce HD, 2005, VIRUS RES, V112, P123, DOI 10.1016/j.virusres.2005.03.018
   de Arce HD, 1999, VIRUS RES, V64, P61
   Dhanda SK, 2018, IMMUNOLOGY, V153, P118, DOI 10.1111/imm.12816
   de Arce HD, 2009, VET MICROBIOL, V139, P245, DOI 10.1016/j.vetmic.2009.06.004
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Dikhit MR, 2015, INFECT GENET EVOL, V36, P369, DOI 10.1016/j.meegid.2015.10.012
   Dolz R, 2008, VIROLOGY, V374, P50, DOI 10.1016/j.virol.2007.12.020
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Edwards S, 2000, VET MICROBIOL, V73, P103, DOI 10.1016/S0378-1135(00)00138-3
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011
   Escarmis C, 1999, J MOL BIOL, V285, P495, DOI 10.1006/jmbi.1998.2366
   ESRI, 2009, ARCGIS 9 3 1
   Gao CX, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02524
   Haro ADG, 2018, TRANSBOUND EMERG DIS, V65, P782, DOI 10.1111/tbed.12803
   Hu DF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00085
   Je SH, 2018, EMERG INFECT DIS, V24, P798, DOI 10.3201/eid2404.171319
   Ji W, 2014, INFECT GENET EVOL, V25, P69, DOI 10.1016/j.meegid.2014.04.008
   Perez LJ, 2012, INFECT GENET EVOL, V12, P1405, DOI 10.1016/j.meegid.2012.04.030
   Perez LJ, 2011, J VIROL METHODS, V174, P53, DOI 10.1016/j.jviromet.2011.03.022
   KINJO T, 1968, JPN J VET RES, V16, P128
   KONIG M, 1995, J VIROL, V69, P6479
   Kulldorff M, 2014, SATSCAN V9 3 SOFTWAR
   Lee EC, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006020
   Leifer I, 2013, VIROLOGY, V438, P51, DOI 10.1016/j.virol.2013.01.013
   Li Y, 2013, J VIROL, V87, P9904, DOI 10.1128/JVI.01023-13
   Liu JJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080225
   Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14171
   Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202
   Luo Y, 2017, TRANSBOUND EMERG DIS, V64, P1848, DOI 10.1111/tbed.12581
   Meyers G, 1996, ADV VIRUS RES, V47, P53, DOI 10.1016/S0065-3527(08)60734-4
   Moennig V, 2013, DEV BIOLOGICALS, V135, P167, DOI 10.1159/000178522
   Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0
   Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   OIE M., 2014, CLASSICAL SWINE FEVE, P1
   Peng YS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43566
   Perez L. J., 2009, REV SALUD ANIM, V31, P6
   Perez LJ, 2012, J VIROL METHODS, V179, P233, DOI 10.1016/j.jviromet.2011.11.009
   Perez LJ, 2011, VET MICROBIOL, V151, P245, DOI 10.1016/j.vetmic.2011.03.022
   Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741
   Postel A, 2018, TRANSBOUND EMERG DIS, V65, P248, DOI 10.1111/tbed.12676
   Postel A, 2015, ARCH VIROL, V160, P1435, DOI 10.1007/s00705-015-2407-1
   Postel A, 2013, VET MICROBIOL, V161, P334, DOI 10.1016/j.vetmic.2012.07.045
   Pradhan D, 2017, INTERDISCIP SCI, V9, P468, DOI 10.1007/s12539-017-0238-3
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ren XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126742
   Rios L, 2018, TRANSBOUND EMERG DIS, V65, P963, DOI 10.1111/tbed.12909
   Rios L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18196-y
   Schrodinger L. L. C., 2015, PYMOL MOL GRAPHICS S
   Shen H, 2011, VIRUS GENES, V43, P234, DOI 10.1007/s11262-011-0625-5
   Silva MNF, 2017, ARCH VIROL, V162, P817, DOI 10.1007/s00705-016-3145-8
   Sorensen MR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00701
   Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003
   Stipp SR, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150661
   Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4
   Tamura T, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-47
   Tamura T, 2012, J VIROL, V86, P8602, DOI 10.1128/JVI.00551-12
   Tang FQ, 2008, VIRUS RES, V131, P132, DOI 10.1016/j.virusres.2007.08.015
   Tarradas J, 2014, VIRUS RES, V185, P82, DOI 10.1016/j.virusres.2014.03.004
   TERPSTRA C, 1988, VET MICROBIOL, V16, P123, DOI 10.1016/0378-1135(88)90036-3
   TERPSTRA C, 1984, VET MICROBIOL, V9, P113, DOI 10.1016/0378-1135(84)90026-9
   Topfer A, 2013, VIROLOGY, V438, P14, DOI 10.1016/j.virol.2012.11.020
   Wang JH, 2018, VIRUS RES, V255, P68, DOI 10.1016/j.virusres.2018.06.012
   Wang Qin, 2000, Acta Microbiologica Sinica, V40, P614
   Wang XY, 2016, EXP THER MED, V12, P2439, DOI 10.3892/etm.2016.3636
   Ward M.P., 2007, HOTSPOTS FOCI VET IT, V43, P559
   Weesendorp E, 2009, VET MICROBIOL, V133, P9, DOI 10.1016/j.vetmic.2008.06.008
   WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6
   Xie ZC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007193
   Xing CN, 2019, INFECT GENET EVOL, V68, P212, DOI 10.1016/j.meegid.2018.12.029
   Zhang HL, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1504-2
NR 83
TC 1
Z9 1
U1 3
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD NOV
PY 2019
VL 66
IS 6
BP 2362
EP 2382
DI 10.1111/tbed.13293
EA JUL 2019
PG 21
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA JK2PJ
UT WOS:000477170700001
PM 31306567
DA 2020-07-08
ER

PT J
AU Kareinen, L
   Hepojoki, S
   Huhtamo, E
   Korhonen, EM
   Schmidt-Chanasit, J
   Hedman, K
   Hepojoki, J
   Vapalahti, O
AF Kareinen, Lauri
   Hepojoki, Satu
   Huhtamo, Eili
   Korhonen, Essi M.
   Schmidt-Chanasit, Jonas
   Hedman, Klaus
   Hepojoki, Jussi
   Vapalahti, Olli
TI Immunoassay for serodiagnosis of Zika virus infection based on
   time-resolved Forster resonance energy transfer
SO PLOS ONE
LA English
DT Article
ID OUTBREAK; PROTEIN; IGM
AB Zika virus (ZIKV) is a mosquito-borne pathogen causing a febrile illness with arthralgia, conjunctivitis and rash. The complications include Guillain-Barre syndrome, congenital brain and other abnormalities and miscarriage. The serodiagnosis of ZIKV infection is hampered by cross-reactivity with other members of the Flavivirus family, notably dengue (DENV). This report describes a novel serological platform for the diagnosis of ZIKV infection. The approach utilizes time-resolved Forster resonance energy transfer (TR-FRET) elicited by two chromophore-labeled proteins (a ZIKV antigen and a super-antigen) simultaneously binding to a given antibody molecule. The antigen used in the assay is ZIKV non-structural protein 1 (NS1) and the super-antigen is bacterial protein L. Three assay variants were developed: the first measuring all anti-ZIKV-NS1 antibodies (LFRET), the second measuring IgM and IgA (acute-LFRET) and the third measuring IgG (immunity-LFRET). The assays were evaluated with a panel of samples from clinical ZIKV cases in travelers (n = 25) and seronegative (n = 24) samples. DENV (n = 38), yellow fever (n = 16) and tick-borne-encephalitis (n = 20) seropositive samples were examined for assessment of flavivirus cross-reactivity. The diagnostic sensitivities of the respective LFRET assays were 92%, 100% and 83%, and the diagnostic specificities 88%, 95% and 100% for LFRET, acute-LFRET and immunity-LFRET. Furthermore, we evaluated the assays against a widely-used commercial ELISA. In conclusion, the new FRET-based serological approaches based on NS1 protein are applicable to diagnosing zika virus infections in travelers and differentiating them from other flavivirus infections.
C1 [Kareinen, Lauri; Hepojoki, Satu; Huhtamo, Eili; Korhonen, Essi M.; Hedman, Klaus; Hepojoki, Jussi; Vapalahti, Olli] Univ Helsinki, Dept Virol, Med, Helsinki, Finland.
   [Schmidt-Chanasit, Jonas; Hepojoki, Jussi] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
   [Hedman, Klaus; Vapalahti, Olli] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland.
RP Kareinen, L (corresponding author), Univ Helsinki, Dept Virol, Med, Helsinki, Finland.
EM lauri.kareinen@helsinki.fi
RI ; Hepojoki, Jussi/W-4667-2017
OI Vapalahti, Olli/0000-0003-2270-6824; Kareinen,
   Lauri/0000-0003-2525-7817; Hedman, Klaus/0000-0003-1779-7960; Hepojoki,
   Jussi/0000-0001-5699-214X
FU Business Finland, a public funding agency for research in Finland; Jane
   and Aatos Erkko Foundation; Academy of FinlandAcademy of Finland;
   Finnish Medical Society of Finland; Sigrid Juselius FoundationSigrid
   Juselius Foundation; Finnish Foundation for Clinical Chemistry Research;
   Emil Aaltonen Foundation; Laboratorioldaketieteen edistamissaatio
FX The work was mainly funded by a grant from Business Finland, a public
   funding agency for research in Finland directed by the Finnish Ministry
   of Employment and the Economy (https//v/wvi businessfinland fi/). It was
   further supported by grants from Jane and Aatos Erkko Foundation
   (https//jaes.fi), the Academy of Finland (www.aka.fi), the Finnish
   Medical Society of Finland (https://laaketieteensaatio.fi/) and the
   Sigrid Juselius Foundation (https://sigrdjuselius.fi/).In addition,
   several of the researches had individual grants. JH was supported by a
   grant from the Academy of Finland, SH by grants from the Finnish
   Foundation for Clinical Chemistry Research (https://wm.skicy.fi/) and
   Laboratorioldaketieteen edistamissaatio (https//www.labes.fi/) and EK by
   a grant from the Emil Aaltonen Foundation (https://emilaattonen.fi/).The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ANGERETTI A, 1986, Bollettino dell'Istituto Sieroterapico Milanese, V65, P380
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BJORCK L, 1988, J IMMUNOL, V140, P1194
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hepojoki S, 2015, J CLIN MICROBIOL, V53, P636, DOI 10.1128/JCM.02994-14
   Hepojoki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106432
   Jaaskelainen A, 2003, J CLIN MICROBIOL, V41, P4336, DOI 10.1128/JCM.41.9.4336-4342.2003
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P10
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   OLSON PR, 1976, VOX SANG, V30, P149, DOI 10.1111/j.1423-0410.1976.tb02806.x
   Pan American Health Organization, 2017, ZIK CUM CAS
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Saraheimo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062739
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   TAKATSU K, 1975, J IMMUNOL, V114, P1838
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
NR 26
TC 1
Z9 1
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 23
PY 2019
VL 14
IS 7
AR e0219474
DI 10.1371/journal.pone.0219474
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW4UP
UT WOS:000484975500011
PM 31335898
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Morse, W
   Izenour, K
   McKenzie, B
   Lessard, S
   Zohdy, S
AF Morse, Wayde
   Izenour, Katie
   McKenzie, Benjamin
   Lessard, Sarah
   Zohdy, Sarah
TI Perceptions and practices of mosquito-borne diseases in Alabama - is
   concern where it should be?
SO BMC PUBLIC HEALTH
LA English
DT Article
DE KAP survey; Zika; Chikungunya; West Nile virus; Malaria; Vector control;
   Mosquito ecology
ID INSECTICIDE RESISTANCE; UNITED-STATES; ARBOVIRAL DISEASES;
   AEDES-ALBOPICTUS; VIRUS; TRANSMISSION; EVOLUTION; MALARIA; FEVER
AB BackgroundThe Gulf Coast of the United States is home to mosquito vectors that may spread disease causing pathogens, and environmental conditions that are ideal for the sustained transmission of mosquito-borne pathogens. Understanding public perceptions of mosquito-borne diseases and mosquito prevention strategies is critical for the development of effective vector control strategies and public health interventions. Here, we present a survey conducted in Mobile, Alabama along the Gulf Coast to better understand public perceptions of mosquito-borne diseases, mosquito control activities, and potential risk factors.MethodsUsing Knowledge, Attitude, and Practice (KAPs) assessments, we surveyed populations living in 12 zip codes in Mobile, Alabama using a 7-point Likert scale and frequency assessments. Survey participants were asked about vector control efforts, knowledge of mosquito-borne diseases, and understanding of mosquito ecology and breeding habitats.ResultsOne hundred twenty-six surveys were completed in Mobile, Alabama, revealing that 73% of participants reported being bitten by a mosquito in the last 30days and mosquitoes were frequently seen in their homes. Ninety-four percent of respondents had heard of Zika Virus at the time of the survey, and respondents reported being least familiar with dengue virus and chikungunya virus.ConclusionsChikungunya virus, dengue virus, malaria, West Nile virus, and Zika virus have been documented in the Gulf Coast of the United States. The mosquitoes which vector all of these diseases are presently in the Gulf Coast meaning all five diseases pose a potential risk to human health. The results of this survey emphasize knowledge gaps that public health officials can address to empower the population to reduce their risk of these mosquito-borne diseases. Each species of mosquito has specific preferences for breeding and feeding and there is no one size fits all prevention approach, educating people on the need for a variety of approaches in order to address all species will further empower them to control mosquitoes where they live and further reduce their risk of disease.
C1 [Morse, Wayde; McKenzie, Benjamin; Lessard, Sarah; Zohdy, Sarah] Auburn Univ, Sch Forestry & Wildlife Sci, 602 Duncan Dr, Auburn, AL 36849 USA.
   [Izenour, Katie; Zohdy, Sarah] Auburn Univ, Coll Vet Med, 166 Greene Hall,Pathobiol Rm 161, Auburn, AL 36849 USA.
RP Morse, W (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, 602 Duncan Dr, Auburn, AL 36849 USA.
EM morsewc@auburn.edu
OI Zohdy, Sarah/0000-0001-5316-0567
CR Alabama Public Health, 2019, MOSQ BORN DIS
   Andrews JM, 1949, AM J PUBLIC HEALTH N, V39, P1592, DOI 10.2105/AJPH.39.12.1592-a
   Centers for Disease Control and Prevention, 2018, W NIL VIR WEBP
   Centers for Disease Control and Prevention, 2018, FIN CUM MAPS DAT
   Centers for Disease Control and Prevention, 2018, ARB 2018
   Abramides GC, 2011, T ROY SOC TROP MED H, V105, P281, DOI 10.1016/j.trstmh.2011.01.003
   Christophers R, 1960, AEDES AEGYPTI L YELL
   Curren EJ, 2018, MMWR-MORBID MORTAL W, V67, P1137, DOI 10.15585/mmwr.mm6741a1
   Dillman DA, 2009, SOC SCI RES, V38, P3, DOI 10.1016/j.ssresearch.2008.03.007
   Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148
   Estrada-Franco J. G., 1995, BIOL DIS RELATIONSHI
   FAUST ERNEST CARROLL, 1951, AMER SCIENTIST, V39, P121
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Initiative TPsM, 2018, PRES MAL IN
   Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Levine RS, 2004, J MED ENTOMOL, V41, P607, DOI 10.1603/0022-2585-41.4.607
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Mace KE, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6707a1
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x
   United States Census Bureau, QUICK FACTS MOB COUN
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO, 2018, DENG SEV DENG
   Zohdy S, 2018, J MED ENTOMOL, V55, P1319, DOI 10.1093/jme/tjy050
NR 35
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUL 23
PY 2019
VL 19
AR 987
DI 10.1186/s12889-019-7308-x
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IL1FO
UT WOS:000477044500007
PM 31337359
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rahman, M
   Bekele-Maxwell, K
   Cates, LL
   Banks, HT
   Vaidya, NK
AF Rahman, Munsur
   Bekele-Maxwell, Kidist
   Cates, LeAnna L.
   Banks, H. T.
   Vaidya, Naveen K.
TI Modeling Zika Virus Transmission Dynamics: Parameter Estimates, Disease
   Characteristics, and Prevention
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SENSITIVITY-ANALYSIS; SEXUAL TRANSMISSION; FRENCH-POLYNESIA; OUTBREAK;
   MALARIA; SPREAD; DENGUE
AB Because of limited data, much remains uncertain about parameters related to transmission dynamics of Zika virus (ZIKV). Estimating a large number of parameters from the limited information in data may not provide useful knowledge about the ZIKV. Here, we developed a method that utilizes a mathematical model of ZIKV dynamics and the complex-step derivative approximation technique to identify parameters that can be estimated from the available data. Applying our method to epidemic data from the ZIKV outbreaks in French Polynesia andYap Island, we identified the parameters that can be estimated from these island data. Our results suggest that the parameters that can be estimated from a given data set, as well as the estimated values of those parameters, vary from Island to Island. Our method allowed us to estimate some ZIKV-related parameters with reasonable confidence intervals. We also computed the basic reproduction number to be from 2.03 to 3.20 across islands. Furthermore, using our model, we evaluated potential prevention strategies and found that peak prevalence can be reduced to nearly 10% by reducing mosquito-to-human contact by at least 60% or increasing mosquito death by at least a factor of three of the base case. With these preventions, the final outbreak-size is predicted to be negligible, thereby successfully controlling ZIKV epidemics.
C1 [Rahman, Munsur] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA.
   [Bekele-Maxwell, Kidist; Banks, H. T.] NC State Univ, Ctr Res Sci Computat, Raleigh, NC 27695 USA.
   [Cates, LeAnna L.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
   [Vaidya, Naveen K.] San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA.
   [Vaidya, Naveen K.] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA.
   [Vaidya, Naveen K.] San Diego State Univ, Viral Informat Inst, San Diego, CA 92182 USA.
RP Vaidya, NK (corresponding author), San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA.; Vaidya, NK (corresponding author), San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA.; Vaidya, NK (corresponding author), San Diego State Univ, Viral Informat Inst, San Diego, CA 92182 USA.
EM nvaidya@sdsu.edu
FU NSFNational Science Foundation (NSF) [DMS-1616299, DMS-1836647]; San
   Diego State University; National Institute on Alcohol Abuse and
   AlcoholismUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse
   & Alcoholism (NIAAA) [1R01AA022714-01A1]; Air Force Office of Scientific
   ResearchUnited States Department of DefenseAir Force Office of
   Scientific Research (AFOSR) [AFOSR FA9550-15-1-0298]
FX This work was funded by the NSF grant DMS-1616299 (NKV), DMS-1836647
   (NKV) and the start-up fund from San Diego State University (NKV). This
   research was also supported in part by the National Institute on Alcohol
   Abuse and Alcoholism under grant number 1R01AA022714-01A1, and in part
   by the Air Force Office of Scientific Research under grant number AFOSR
   FA9550-15-1-0298.
CR Akbari S, 2012, B MATH BIOL, V74, P2733, DOI 10.1007/s11538-012-9775-4
   ANDERSON R M, 1991
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2016, CDC EMERGENCY OPERAT
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Banks H, 2015, EURASIAN J MATH COMP, V3, P16
   Banks HT, 2017, Q APPL MATH, V75, P231, DOI 10.1090/qam/1458
   Banks HT, 2016, INVERSE PROBL SCI EN, V24, P127, DOI 10.1080/17415977.2015.1017484
   Banks HT, 2015, J BIOL DYNAM, V9, P172, DOI 10.1080/17513758.2015.1050465
   Banks HT, 2014, INVERSE PROBL SCI EN, V22, P557, DOI 10.1080/17415977.2013.797973
   Banks HT, 2009, TEXTB MATH, P1
   Banks HT, 2018, J INVERSE ILL-POSE P, V26, P423, DOI 10.1515/jiip-2017-0096
   Banks HT, 2014, MONOGR RES NOTES MAT, P1
   Bates D.M., 2007, NONLINEAR REGRESSION
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Housing F. C. o. P. a, 2000, YAP STAT CENS REP
   Keeling M. J., 2011, MODELING INFECT DIS
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, BIORXIV, DOI [10.1101/041913, DOI 10.1101/041913]
   Mallela A, 2016, J COMPUT APPL MATH, V307, P143, DOI 10.1016/j.cam.2016.02.051
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso H.-P. M, 2015, B INFORM SANITAIRES
   Mutua JM, 2015, MATH BIOSCI, V264, P128, DOI 10.1016/j.mbs.2015.03.014
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E, 2014, EURO SURVEILL, V19
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Vaidya NK, 2015, EPIDEMIOL INFECT, V143, P1610, DOI 10.1017/S0950268814002568
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Zhang Q, 2016, BIORXIV, DOI [10.1101/066456, DOI 10.1101/066456]
NR 41
TC 0
Z9 0
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 22
PY 2019
VL 9
AR 10575
DI 10.1038/s41598-019-46218-4
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IK6QR
UT WOS:000476713900039
PM 31332269
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nutho, B
   Mulholland, AJ
   Rungrotmongkol, T
AF Nutho, Bodee
   Mulholland, Adrian J.
   Rungrotmongkol, Thanyada
TI The reaction mechanism of Zika virus NS2B/NS3 serine protease inhibition
   by dipeptidyl aldehyde: a QM/MM study
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; NS3 PROTEASE; PEPTIDE INHIBITORS;
   REACTION BARRIERS; RATIONAL DESIGN; DENGUE; QUANTUM; BINDING;
   TETRAPEPTIDE; MUTAGENESIS
AB Zika virus (ZIKV) infection has become a global public health problem, associated with microcephaly in newborns and Guillain-Barre ' syndrome in adults. Currently, there are no commercially available antiZIKV drugs. The viral protease NS2B/NS3, which is involved in viral replication and maturation, is a potential drug target. Peptidomimetic aldehyde inhibitors bind covalently to the catalytic S135 of the NS3 protease. Here, we apply hybrid quantum mechanics/molecular mechanics (QM/MM) free-energy simulations at the PDDG-PM3/ff14SB level to investigate the inhibition mechanism of the ZIKV protease by a dipeptidyl aldehyde inhibitor (acyl-KR-aldehyde). The results show that proton transfer from the catalytic S135 to H51 occurs in concert with nucleophilic addition on the aldehyde warhead by S135. The anionic covalent complex between the dipeptidyl aldehyde and the ZIKV protease is analogous to the tetrahedral intermediate for substrate hydrolysis. Spontaneous protonation by H51 forms the hemiacetal. In addition, we use correlated ab initio QM/MM potential energy path calculations at levels up to LCCSD(T)/(aug)-cc-pVTZ to obtain accurate potential energy profiles of the reaction, which also support a concerted mechanism. These results provide detailed insight into the mechanism of ZIKV protease inhibition by a peptidyl aldehyde inhibitor, which will guide in the design of inhibitors.
C1 [Nutho, Bodee] Chulalongkorn Univ, Program Biotechnol, Fac Sci, Bangkok 10330, Thailand.
   [Mulholland, Adrian J.] Univ Bristol, Sch Chem, Ctr Computat Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Fac Sci, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Program Bioinformat & Computat Biol, Fac Sci, Bangkok 10330, Thailand.
RP Mulholland, AJ (corresponding author), Univ Bristol, Sch Chem, Ctr Computat Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.; Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Fac Sci, Bangkok 10330, Thailand.; Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Program Bioinformat & Computat Biol, Fac Sci, Bangkok 10330, Thailand.
EM adrian.mulholland@bristol.ac.uk; thanyada.r@chula.ac.th
OI Mulholland, Adrian/0000-0003-1015-4567; Rungrotmongkol,
   Thanyada/0000-0002-7402-3235
FU National Science and Technology Development Agency (NSTDA), Thailand;
   Royal Golden Jubilee PhD ProgramThailand Research Fund (TRF)
   [PHD/0020/2558]; 90th Anniversary of CU (Rachadaphiseksomphot Endowment
   Fund); EPSRCEngineering & Physical Sciences Research Council (EPSRC)
   [EP/M022609/1]
FX This research was supported by Research Chair Grant, the National
   Science and Technology Development Agency (NSTDA), Thailand. B. N. is
   thankful for the Royal Golden Jubilee PhD Program (PHD/0020/2558) for
   PhD scholarship and the 90th Anniversary of CU (Rachadaphiseksomphot
   Endowment Fund) for research funding. A. J. M. thanks EPSRC for support
   (grant number EP/M022609/1).
CR Acevedo O, 2010, ACCOUNTS CHEM RES, V43, P142, DOI 10.1021/ar900171c
   Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m
   Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.10
   Amaro RE, 2018, NAT REV CHEM, V2, DOI 10.1038/s41570-018-0148
   Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486
   Martinez-Gonzalez JA, 2015, ACS CATAL, V5, P246, DOI 10.1021/cs5011162
   ASBOTH B, 1983, BIOCHEMISTRY-US, V22, P117, DOI 10.1021/bi00270a017
   BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v
   Bennie SJ, 2016, J CHEM THEORY COMPUT, V12, P2689, DOI 10.1021/acs.jctc.6b00285
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bistoni G, 2018, J CHEM THEORY COMPUT, V14, P3524, DOI 10.1021/acs.jctc.8b00348
   BLOW DM, 1976, ACCOUNTS CHEM RES, V9, P145, DOI 10.1021/ar50100a004
   BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0
   Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146
   BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Case D. A., 2016, AMBER 16
   CHAMBERS TJ, 1995, J VIROL, V69, P1600, DOI 10.1128/JVI.69.3.1600-1605.1995
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Chu JJH, 2015, ANTIVIR RES, V118, P68, DOI 10.1016/j.antiviral.2015.03.010
   Claeyssens F, 2006, ANGEW CHEM INT EDIT, V45, P6856, DOI 10.1002/anie.200602711
   CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030
   Daniels AD, 2014, ACS CHEM BIOL, V9, P1025, DOI 10.1021/cb500067z
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fox SJ, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3665893
   FRANKFATER A, 1981, BIOCHEMISTRY-US, V20, P5517, DOI 10.1021/bi00522a026
   Goumans TPM, 2009, PHYS CHEM CHEM PHYS, V11, P5431, DOI 10.1039/b816905e
   Grimme S, 2003, J CHEM PHYS, V118, P9095, DOI 10.1063/1.1569242
   Gustafsson D, 2001, THROMB RES, V101, P171, DOI 10.1016/S0049-3848(00)00399-6
   Haldar S, 2018, J CHEM THEORY COMPUT, V14, P6093, DOI 10.1021/acs.jctc.8b00687
   Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672
   Hermann JC, 2009, J PHYS CHEM A, V113, P11984, DOI 10.1021/jp9037254
   Ishida T, 2003, J AM CHEM SOC, V125, P12035, DOI 10.1021/ja021369m
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kaiyawet N, 2015, J CHEM THEORY COMPUT, V11, P713, DOI 10.1021/ct5005033
   Kaiyawet N, 2013, J CHEM INF MODEL, V53, P1315, DOI 10.1021/ci400131y
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Kongkaew S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135575
   KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   KURAMOCHI H, 1979, J BIOCHEM, V86, P1403, DOI 10.1093/oxfordjournals.jbchem.a132657
   Lawan N, 2014, CHEM PHYS LETT, V608, P380, DOI 10.1016/j.cplett.2014.06.010
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Lima MCP, 2016, PHYS CHEM CHEM PHYS, V18, P30288, DOI 10.1039/c6cp03209e
   Lodola A, 2010, J CHEM THEORY COMPUT, V6, P2948, DOI 10.1021/ct100264j
   Lonsdale R, 2012, J CHEM THEORY COMPUT, V8, P4637, DOI 10.1021/ct300329h
   Lonsdale R, 2010, J PHYS CHEM LETT, V1, P3232, DOI 10.1021/jz101279n
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002
   Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a
   Metz S, 2014, WIRES COMPUT MOL SCI, V4, P101, DOI 10.1002/wcms.1163
   Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618
   Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81
   Nemukhin AV, 2004, THEOR CHEM ACC, V111, P36, DOI 10.1007/s00214-003-0556-x
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Nutho B, 2019, J PHYS CHEM B, V123, P2889, DOI 10.1021/acs.jpcb.9b02157
   Peterlin-Masic L, 2001, TETRAHEDRON, V57, P7073, DOI 10.1016/S0040-4020(01)00507-5
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PULAY P, 1983, CHEM PHYS LETT, V100, P151, DOI 10.1016/0009-2614(83)80703-9
   Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103
   Ranaghan KE, 2019, J CHEM INF MODEL, V59, P2063, DOI 10.1021/acs.jcim.8b00940
   Ranaghan KE, 2017, RSC THEOR COMPUT CHE, V9, P377
   Ranaghan KE, 2017, J PHYS CHEM B, V121, P9785, DOI 10.1021/acs.jpcb.7b06892
   Repasky MP, 2002, J COMPUT CHEM, V23, P1601, DOI 10.1002/jcc.10162
   Reuter N, 2000, J PHYS CHEM A, V104, P1720, DOI 10.1021/jp9924124
   Ridder L, 1999, J MOL GRAPH MODEL, V17, P163, DOI 10.1016/S1093-3263(99)00027-3
   Rinaldi S, 2018, ACS CATAL, V8, P5698, DOI 10.1021/acscatal.8b00863
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Rodriguez A, 2007, J PHYS CHEM B, V111, P12909, DOI 10.1021/jp0743469
   Rungrotmongkol T, 2009, PROTEINS, V76, P62, DOI 10.1002/prot.22318
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Schirmeister T, 2016, J AM CHEM SOC, V138, P8332, DOI 10.1021/jacs.6b03052
   Schmidt TC, 2014, CHEMPHYSCHEM, V15, P3226, DOI 10.1002/cphc.201402542
   SCHULTZ RM, 1989, J BIOL CHEM, V264, P1497
   Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9
   Smith W, 1996, J MOL GRAPHICS, V14, P136, DOI 10.1016/S0263-7855(96)00043-4
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   van der Kamp MW, 2013, FEBS J, V280, P3120, DOI 10.1111/febs.12158
   van der Kamp MW, 2010, J PHYS CHEM B, V114, P11303, DOI 10.1021/jp104069t
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   WARSHEL A, 1986, J AM CHEM SOC, V108, P6569, DOI 10.1021/ja00281a021
   WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001
   Warshel A, 2017, RSC THEOR COMPUT CHE, V9, P1
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82
   Werner HJ, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3641642
   Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zhao Y, 2005, DATA MIN KNOWL DISC, V10, P141, DOI 10.1007/s10618-005-0361-3
   Zhou YZ, 2011, CHEM COMMUN, V47, P1577, DOI 10.1039/c0cc04112b
NR 109
TC 1
Z9 1
U1 2
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD JUL 21
PY 2019
VL 21
IS 27
BP 14945
EP 14956
DI 10.1039/c9cp02377a
PG 12
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA IM4MV
UT WOS:000477969700050
PM 31236554
DA 2020-07-08
ER

PT J
AU Ricotta, V
   Yu, YJ
   Clayton, N
   Chuang, YC
   Wang, YT
   Mueller, S
   Levon, K
   Simon, M
   Rafailovich, M
AF Ricotta, Vincent
   Yu, Yingjie
   Clayton, Nicholas
   Chuang, Ya-Chen
   Wang, Yantian
   Mueller, Steffen
   Levon, Kalle
   Simon, Marcia
   Rafailovich, Miriam
TI A chip-based potentiometric sensor for a Zika virus diagnostic using 3D
   surface molecular imprinting
SO ANALYST
LA English
DT Article
ID SEXUAL TRANSMISSION; UNITED-STATES; INFECTION; EMERGENCE
AB The latest Zika virus (ZIKV) pandemic caused great international concern from explosively proliferating throughout the Americas. Currently, there is no vaccine to prevent Zika virus infection and available tests rely on antibodies or RNA. Unfortunately, antibody-based detection systems can result in false positive results and RNA-based detection systems are costly, time-consuming, and impractical for testing in remote regions. In this study, a potential point-of-care (POC) diagnostic system was developed using a chip-based potentiometric sensor to detect Zika virus using a 3D molecular imprinting technique. This chip-based potentiometric sensor system was able to detect 10(-1) PFU mL(-1) ZIKV in a buffered solution under 20 minutes without any sample manipulation. This sensor was tested against Dengue virus at clinical viral loads and showed no sign of cross-reactivity. When tested against human saliva samples containing clinical viral loads, this sensor was able to detect 10 PFU mL(-1) ZIKV among the pool of bio-macromolecules. The high sensitivity and high selectivity demonstrated here proved that this lab-on-a-chip diagnostic has the potential to become a POC detection system for rapid and accurate screening of flaviviruses.
C1 [Ricotta, Vincent; Yu, Yingjie; Clayton, Nicholas; Chuang, Ya-Chen; Wang, Yantian; Rafailovich, Miriam] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
   [Mueller, Steffen] Codagenix Inc, Farmingdale, NY 11735 USA.
   [Levon, Kalle] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA.
   [Simon, Marcia] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.
RP Ricotta, V; Rafailovich, M (corresponding author), SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
EM Vincent.Ricotta35@gmail.com; Miriam.Rafailovich@stonybrook.edu
OI Ricotta, Vincent/0000-0002-5305-7735
FU National Science Foundation (NSF grant INSPIRE) [1344267]
FX We gratefully acknowledge the support of the National Science Foundation
   (NSF grant INSPIRE#1344267). This work was performed in part at the
   Advanced Science Research Center NanoFabrication Facility of the
   Graduate Center at the City University of New York. We would also like
   to acknowledge the Advanced Energy Research and Technology Center for
   access to the ThINC facility at Stony Brook University.
CR [Anonymous], 2016, AM J KIDNEY DIS, V67, pA4
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham A. M., 2016, MMWR-MORBID MORTAL W, P65
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, FACTS MICR
   CDC, 2015, CUM ZIK VIR DIS CAS
   CDC, ZIK GUILL BARR SYNDR
   Chen LY, 2011, SCRIPTA MATER, V65, P17, DOI 10.1016/j.scriptamat.2011.03.025
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Didier M, 2015, EMERG INFECT DIS, V21, P359
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FDA, ZIK VIR EUA INF
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jiang QS, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201700096
   Kaisti M, 2015, IEEE T ELECTRON DEV, V62, P2628, DOI 10.1109/TED.2015.2441878
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mathur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057681
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   PAHO, 2017, REG ZIK EP UPD AM
   PAHO, ZIK CAS CONG SYNDR A
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe I. B., 2016, MMWR-MORBID MORTAL W, P65
   Randviir EP, 2013, ANAL METHODS-UK, V5, P1098, DOI 10.1039/c3ay26476a
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Schnirring L., BRAZIL CONFIRMS BLOO
   Severine M., 2016, EMERG INFECT DIS J, V22, P1691
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tiwari Manjul, 2011, J Nat Sci Biol Med, V2, P53, DOI 10.4103/0976-9668.82322
   ViralZone, FLAV
   Wang YT, 2008, BIOSENS BIOELECTRON, V24, P162, DOI 10.1016/j.bios.2008.04.010
   Wang YT, 2010, SENSOR ACTUAT B-CHEM, V146, P381, DOI 10.1016/j.snb.2010.02.032
   Wang YN, 2018, J MACH LEARN RES, V18, P1
   WHO, WHO FAST TRACK AV DI
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yu YJ, 2016, ANALYST, V141, P5607, DOI 10.1039/c6an01157h
   Yu YJ, 2016, ANALYST, V141, P4424, DOI 10.1039/c6an00375c
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zhang Q, 2015, BIOSENS BIOELECTRON, V72, P100, DOI 10.1016/j.bios.2015.04.084
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhou YX, 2003, CHEM MATER, V15, P2774, DOI 10.1021/cm030060e
NR 68
TC 1
Z9 1
U1 7
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD JUL 21
PY 2019
VL 144
IS 14
BP 4266
EP 4280
DI 10.1039/c9an00580c
PG 15
WC Chemistry, Analytical
SC Chemistry
GA IH6WO
UT WOS:000474643700012
PM 31180088
DA 2020-07-08
ER

PT J
AU Liu, RF
   He, ZJ
   Mei, P
   Xi, JC
   Cao, XD
   Yuan, LH
   Lu, JH
AF Liu, Rong-Fei
   He, Zhen-Jian
   Mei, Peng
   Xi, Jia-Cheng
   Cao, Xu-Dong
   Yuan, Li-Hong
   Lu, Jia-Hai
TI Risk assessment and genomic characterization of Zika virus in China and
   its surrounding areas
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Zika virus; China; Phylogeny; Genetic evolution; Risk assessment
ID EVOLUTION; PROTEIN; EPIDEMIOLOGY; INFECTION; OUTBREAK; MODELS
AB Background: Zika virus (ZIKV) has emerged as a global pathogen causing significant public health concerns. China has reported several imported cases where ZIKV were carried by travelers who frequently travel between China and ZIKV-endemic regions. To fully characterize the ZIKV strains isolated from the cases reported in China and assess the risk of ZIKV transmission in China, comprehensive phylogenetic and genetic analyses were performed both on all ZIKV sequences of China and on a group of scientifically selected ZIKV sequences reported in some of the top interested destinations for Chinese travelers.
   Methods: ZIKV genomic sequences were retrieved from the National Center for Biotechnology Information database through stratified sampling. Recombination event detection, maximum likelihood (ML) phylogenetic analysis, molecular clock analysis, selection pressure analysis, and amino acid substitution analysis were used to reconstruct the epidemiology and molecular transmission of ZIKV.
   Results: The present study investigated 18 ZIKV sequences from China and 70 sequences from 16 selected countries. Recombination events rarely happens in all ZIKV Asian lineage. ZIKV genomes were generally undergone episodic positive selection (17 sites), and only one site was under pervasive positive selection. All ZIKV imported into China were Asian lineage and were assigned into two clusters: Venezuela-origin (cluster A) and Samoa-origin cluster (cluster B) with common ancestor from French Polynesia. The time of most recent common ancestors of Cluster A dated to approximately 2013/11 (95% highest posterior density [HPD]2013/06, 2014/ 03) and cluster B dated to 2014/08 (95% HPD 2014/02, 2015/01). Cluster B is more variable than Cluster A in comparison with other clusters, but no varied site of biological significance was revealed. ZIKV strains in Southeast Asia countries are independent from strains in America epidemics.
   Conclusions: The genetic evolution of ZIKV is conservative. There are two independent introductions of ZIKV into China and China is in danger of autochthonous transmission of ZIKV because of high-risk surrounding areas. Southeast Asia areas have high risk of originating the next large-scale epidemic ZIKV strains.
C1 [Liu, Rong-Fei; He, Zhen-Jian; Mei, Peng; Xi, Jia-Cheng; Lu, Jia-Hai] Sun Yat Sen Univ, Sch Publ Hlth, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
   [He, Zhen-Jian; Lu, Jia-Hai] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.
   [Cao, Xu-Dong] Univ Ottawa, Dept Chem & Biol Engn, Ottawa, ON, Canada.
   [Yuan, Li-Hong] Guangdong Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Guangzhou 510006, Guangdong, Peoples R China.
   [Lu, Jia-Hai] Sun Yat Sen Univ, Hlth Ctr Excellence Res & Training 1, Guangzhou 510080, Guangdong, Peoples R China.
RP Lu, JH (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
EM Lujiahai@mail.sysu.edu.cn
FU Guangdong Provincial Science and Technology Project [2018B020241002,
   2018B020207013]; National Science and Technology Major Project
   [2018ZX10101002]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31872499, 81501744]
FX This study was supported by grants from the Guangdong Provincial Science
   and Technology Project (2018B020241002, 2018B020207013), the National
   Science and Technology Major Project (2018ZX10101002), and the National
   Natural Science Foundation of China (31872499, 81501744).
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Sall AA, 2010, J VIROL, V84, P765, DOI 10.1128/JVI.01738-09
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Tan CH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010044
   Wang BH, 2018, J INFECTION, V76, P106, DOI 10.1016/j.jinf.2017.09.002
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   World Health Organization, 2018, ZIK VIR CLASS TABL
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28890-0
   ZHOU PC, 2017, CHINA INSPECTION AND, DOI DOI 10.1007/978-981-10-4669-8_2
NR 42
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUL 20
PY 2019
VL 132
IS 14
BP 1645
EP 1653
DI 10.1097/CM9.0000000000000317
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA IQ4FC
UT WOS:000480705500002
PM 31268910
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hendrixson, A
   Ojeda, D
   Sasser, JS
   Nadimpally, S
   Foley, EE
   Bhatia, R
AF Hendrixson, Anne
   Ojeda, Diana
   Sasser, Jade S.
   Nadimpally, Sarojini
   Foley, Ellen E.
   Bhatia, Rajani
TI Confronting populationism: Feminist challenges to population control in
   an era of climate change
SO GENDER PLACE AND CULTURE
LA English
DT Article
DE biopopulationism; demopopulationism; geopopulationism; populationism;
   population control
AB In this themed section, we identify three forms of populationism and bring them into conversation, which allows us to mount feminist challenges to present day forms of population control. These interventions are timely and necessary because of the continued prevalence of population control ideology and population alarmism in sustainable development and climate change policy and programs. We issue a direct challenge to scholarship that links population reduction with climate change adaptation and mitigation and the survival of the planet. The introduction provides an overview of our key argument, that seemingly disparate phenomena-technocratic approaches to fertility control, climate change securitization, Zika assemblages, neo-Malthusian articulations of the Anthropocene, and 'climate-smart' agriculture-are entangled with and expressions of demo, geo and biopopulationisms. We employ feminist critiques to contest these manifestations of population control that restrict bodies, reinforce boundaries, and create spaces of exclusion and violence.
C1 [Hendrixson, Anne] Sch Crit Social Inquiry, Populat & Dev Program, Amherst, MA USA.
   [Ojeda, Diana] Inst Estudios Sociales & Culturales, Bogota, Colombia.
   [Sasser, Jade S.] Univ Calif Riverside, Dept Gender & Sexual Studies, Riverside, CA 92521 USA.
   [Nadimpally, Sarojini] Sama Resource Grp Women & Hlth, New Delhi, India.
   [Foley, Ellen E.] Clark Univ, Int Dev & Social Change, Worcester, MA 01610 USA.
   [Bhatia, Rajani] SUNY Albany, Dept Womens Gender & Sexual Studies, Albany, NY 12222 USA.
RP Hendrixson, A (corresponding author), Hampshire Coll, Populat & Dev Program, 893 West St, Amherst, MA 01002 USA.; Hendrixson, A (corresponding author), Hampshire Coll, Sch Crit Social Inquiry, 893 West St, Amherst, MA 01002 USA.
EM ahendrixson@hampshire.edu
FU International Workshop Award from the Antipode Foundation
FX This work was supported by an International Workshop Award from the
   Antipode Foundation.
CR Alves Jaime Ampara, 2018, ANTIBLACK CITY POLIC
   Angus I., 2011, TOO MANY PEOPLE POPU
   Bendix D, 2020, GENDER PLACE CULT, V27, P351, DOI 10.1080/0966369X.2018.1555145
   Bhatia R, 2020, GENDER PLACE CULT, V27, P333, DOI 10.1080/0966369X.2018.1553859
   Bhatia Rajani, 2018, GENDER BIRTH SEX SEL
   Boyce GA, 2020, GENDER PLACE CULT, V27, P394, DOI 10.1080/0966369X.2019.1620698
   Carrington D., 2017, GUARDIAN
   Clarke Adele E, 2018, MAKING KIN NOT POPUL, P1
   Clarke AE, 2003, AM SOCIOL REV, V68, P161, DOI 10.2307/1519765
   Fleming A., 2018, GUARDIAN
   Gaffin SR, 1997, POPUL ENVIRON, V18, P389, DOI 10.1007/BF02208514
   Hartmann B., 2015, Economic and Political Weekly, V50, P10
   Hartmann B., 1995, REPROD RIGHTS WRONGS
   Hartmann B, 2014, GEOPOLITICS, V19, P757, DOI 10.1080/14650045.2013.847433
   Hartmann B, 2010, J INT DEV, V22, P233, DOI 10.1002/jid.1676
   Hartmann Betsy, 2010, GREENWASH NATIVISTS
   Hendrixson A, 2019, DEV CHANGE, V50, P786, DOI 10.1111/dech.12423
   Hickey C., 2016, SOCIAL THEORY PRACTI, V42, P845, DOI DOI 10.5840/soctheorpract201642430
   Inchaustegui Romero T, 2014, SOC ESTADO, V29, P373
   Kissling Frances, 2018, WASHINGTON POST
   Lunstrum E, 2014, ANN ASSOC AM GEOGR, V104, P816, DOI 10.1080/00045608.2014.912545
   Machiyama Kazuyo, 2017, WHORHR1707
   Nadimpally Sarojini, 2016, COMMERCIAL SURROGACY
   O'Neill BC, 2012, LANCET, V380, P157, DOI 10.1016/S0140-6736(12)60958-1
   O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107
   Ojeda D, 2020, GENDER PLACE CULT, V27, P316, DOI 10.1080/0966369X.2018.1553858
   Ojeda Diana, 2018, ROUTLEDGE HDB LATIN, P400
   Ripple William J., 2017, BIOSCIENCE, DOI [10.1093/biosci/bix125/4605229, DOI 10.1093/BIOSCI/BIX125/4605229]
   Ritterbusch AE, 2016, ANN AM ASSOC GEOGR, V106, P422, DOI 10.1080/00045608.2015.1113112
   Rivera-Amarillo C, 2020, GENDER PLACE CULT, V27, P412, DOI 10.1080/0966369X.2018.1555518
   Sasser J, 2018, INFERTILE GROUND POP
   Schultz S., 2015, DISTINKTION SCANDINA, V16, P337, DOI DOI 10.1080/1600910X.2015.1080744
   Shaw A, 2020, GENDER PLACE CULT, V27, P370, DOI 10.1080/0966369X.2019.1609426
   Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374
   The Population and Development Program, 2016, OLD MAPS NEW TERR RE
   UK All Party Parliamentary Group on Population, 2015, DEV REPR HLTH POP DY
   Williams JM, 2017, TERRIT POLIT GOV, V5, P269, DOI 10.1080/21622671.2017.1284021
   Wilson K, 2017, GLOBALIZATIONS, V14, P432, DOI 10.1080/14747731.2016.1275402
   Wynes S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7541
NR 39
TC 1
Z9 1
U1 0
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0966-369X
EI 1360-0524
J9 GENDER PLACE CULT
JI Gend. Place Cult.
PD MAR 3
PY 2020
VL 27
IS 3
BP 307
EP 315
DI 10.1080/0966369X.2019.1639634
EA JUL 2019
PG 9
WC Geography; Women's Studies
SC Geography; Women's Studies
GA KQ7OK
UT WOS:000479520100001
DA 2020-07-08
ER

PT J
AU Fan, JJ
   Cheng, M
   Chi, XJ
   Liu, XY
   Yang, W
AF Fan, Jingjing
   Cheng, Min
   Chi, Xiaojing
   Liu, Xiuying
   Yang, Wei
TI A Human Long Non-coding RNA LncATV Promotes Virus Replication Through
   Restricting RIG-I-Mediated Innate Immunity
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE interferon-regulated lncRNAs; retinoic acid-inducible gene 1; innate
   immune response; hepatitis C virus; Zika virus
ID PATHOGEN RECOGNITION; ANTIVIRAL RESPONSES; SELF; MDA5
AB Pattern recognition receptors sense pathogen components and initiate the host antiviral innate immune response, such as inducing interferons (IFNs). Long non-coding RNAs (lncRNAs) are emerging regulators of multiple biological processes. However, their role in antiviral response, especially through regulating the human innate immune, is largely unexplored. Here we characterized that lncATV, a human specific lncRNA, was up-regulated upon type I/III IFN stimulations and virus infection. LncATV was cytoplasmic localized and relatively high expressed in human monocytes, erythroleukemia cells and hepatoma cells. Notably, lncATV knockdown significantly inhibited the replication of multiple RNA viruses, such as hepatitis C virus, Zika virus, Newcastle disease virus, and Sendai virus. Mechanistically, RIG-I antiviral signaling and IFN effective pathway were enhanced when lncATV expression was knocked down but inhibited by overexpressed lncATV. RNA immunoprecipitation results demonstrated an association between LncATV and RIG-I. Collectively, our findings reveal the functional role of a novel human specific lncATV as a regulatory lncRNA restricting virus associated innate immune response.
C1 [Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing, Peoples R China.
   Peking Union Med Coll, Beijing, Peoples R China.
RP Yang, W (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing, Peoples R China.
EM wyang@ipb.pumc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81871667, 81672030]; CAMS Initiative for Innovative
   Medicine [2016-I2M-3-020]; National Basic Research Program of
   ChinaNational Basic Research Program of China [2015CB554301]; National
   Science and Technology Major Project [2017ZX10304402-001-013]
FX This work was supported by National Natural Science Foundation of China
   (81871667, 81672030); CAMS Initiative for Innovative Medicine
   (2016-I2M-3-020); National Basic Research Program of China
   (2015CB554301); and National Science and Technology Major Project
   (2017ZX10304402-001-013).
CR Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Atianand MK, 2017, ANNU REV IMMUNOL, V35, P177, DOI 10.1146/annurev-immunol-041015-055459
   Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075
   Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200
   Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012
   Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925
   Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022
   Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y
   Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309
   de Groen RA, 2015, EUR J IMMUNOL, V45, P250, DOI 10.1002/eji.201444903
   Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275
   Feng M, 2013, PROTEIN CELL, V4, P142, DOI 10.1007/s13238-012-2088-4
   Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014
   Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jiang MH, 2018, CELL, V173, P906, DOI 10.1016/j.cell.2018.03.064
   Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
   Nishitsuji H, 2016, P NATL ACAD SCI USA, V113, P10388, DOI 10.1073/pnas.1525022113
   Ouyang J, 2016, WIRES RNA, V7, P129, DOI 10.1002/wrna.1321
   Ouyang J, 2014, CELL HOST MICROBE, V16, P616, DOI 10.1016/j.chom.2014.10.001
   Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x
   Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10
   Ramanjulu JM, 2018, NATURE, V564, P439, DOI 10.1038/s41586-018-0705-y
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Sanchez-Aparicio MT, 2017, J VIROL, V91, DOI 10.1128/JVI.01155-16
   Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019
   Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08
   Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456
   Xu J, 2015, MBIO, V6, DOI 10.1128/mBio.01265-15
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Zhang XL, 2018, PROTEIN CELL, V9, P799, DOI 10.1007/s13238-018-0511-1
NR 32
TC 3
Z9 3
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 19
PY 2019
VL 10
AR 1711
DI 10.3389/fimmu.2019.01711
PG 8
WC Immunology
SC Immunology
GA IK7CA
UT WOS:000476745000002
PM 31379885
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bellan, SE
   Eggo, RM
   Gsell, PS
   Kucharski, AJ
   Dean, NE
   Donohue, R
   Zook, M
   Edmunds, WJ
   Odhiambo, F
   Longini, IM
   Brisson, M
   Mahon, BE
   Henao-Restrepo, AM
AF Bellan, Steven E.
   Eggo, Rosalind M.
   Gsell, Pierre-Stephane
   Kucharski, Adam J.
   Dean, Natalie E.
   Donohue, Richard
   Zook, Matt
   Edmunds, W. John
   Odhiambo, Frank
   Longini, Ira M., Jr.
   Brisson, Marc
   Mahon, Barbara E.
   Henao-Restrepo, Ana Maria
TI An online decision tree for vaccine efficacy trial design during
   infectious disease epidemics: The InterVax-Tool
SO VACCINE
LA English
DT Article
DE Vaccine trial design; Outbreaks; Epidemics; Vaccines; Public Health
   Emergency; Emerging infectious diseases; Scientific communication; Phase
   III trial; Decision support system
AB Background: Licensed vaccines are urgently needed for emerging infectious diseases, but the nature of these epidemics causes challenges for the design of phase III trials to evaluate vaccine efficacy. Designing and executing rigorous, fast, and ethical, vaccine efficacy trials is difficult, and the decisions and limitations in the design of these trials encompass epidemiological, logistical, regulatory, statistical, and ethical dimensions.
   Results: Trial design decisions are complex and interrelated, but current guidance documents do not lend themselves to efficient decision-making. We created InterVax-Tool (http://vaxeval.com), an online, interactive decision-support tool, to help diverse stakeholders navigate the decisions in the design of phase Ill vaccine trials.
   InterVax-Tool offers high-level visual and interactive assistance through a set of four decision trees, guiding users through selection of the: (1) Primary Endpoint, (2) Target Population, (3) Randomization Scheme, and, (4) Comparator. We provide guidance on how key considerations-grouped as Epidemiological, Vaccine-related, Infrastructural, or Sociocultural-inform each decision in the trial design process.
   Conclusions: InterVax-Tool facilitates structured, transparent, and collaborative discussion of trial design, while recording the decision-making process. Users can save and share their decisions, which is useful both for comparing proposed trial designs, and for justifying particular design choices.
   Here, we describe the goals and features of InterVax-Tool as well as its application to the design of a Zika vaccine efficacy trial. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Bellan, Steven E.] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Bellan, Steven E.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Eggo, Rosalind M.; Kucharski, Adam J.; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Gsell, Pierre-Stephane; Henao-Restrepo, Ana Maria] WHO, Geneva, Switzerland.
   [Dean, Natalie E.; Longini, Ira M., Jr.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Donohue, Richard; Zook, Matt] Univ Kentucky, Dept Geog, Lexington, KY USA.
   [Odhiambo, Frank] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.
   [Brisson, Marc] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada.
   [Brisson, Marc] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada.
   [Brisson, Marc] Imperial Coll, Dept Infect Dis Epidemiol, London, England.
   [Mahon, Barbara E.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Bellan, SE; Eggo, RM (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
EM steve.bellan@uga.edu; r.eggo@lshtm.ac.uk
OI Eggo, Rosalind M/0000-0002-0362-6717
FU National Institute of Health (NIH) National Institute of Allergy and
   Infectious Diseases [K01A1125830]; National Institute for Health
   Research through the Health Protection Research Unit in Immunisation at
   the London School of Hygiene & Tropical Medicine; HDR UK Innovation
   Fellowship [MR/S003975/1]; Innovative Medicines Initiative 2 (IMI2)
   Joint Undertaking under grant agreement EBOVAC1 [115854]; European
   UnionEuropean Union (EU); European Federation of Pharmaceutical
   Industries and Associations; National Institutes of Health (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U54 GM111274, R37-A1032042]; WHOWorld Health
   Organization; VEEPED (Vaccine Efficacy Evaluation for Priority Emerging
   Diseases); National Institute for Health Research using Official
   Development Assistance (ODA); Public Health England; Sir Henry Dale
   Fellowship - Wellcome Trust [206250/Z/17/Z]; Sir Henry Dale Fellowship -
   Royal Society [206250/Z/17/Z]
FX SEB was supported by National Institute of Health (NIH) National
   Institute of Allergy and Infectious Diseases grant K01A1125830. RME
   acknowledges funding from the National Institute for Health Research
   through the Health Protection Research Unit in Immunisation at the
   London School of Hygiene & Tropical Medicine in partnership with Public
   Health England, from an HDR UK Innovation Fellowship (grant
   MR/S003975/1), and from the Innovative Medicines Initiative 2 (IMI2)
   Joint Undertaking under grant agreement EBOVAC1 (grant 115854). The IMI2
   is supported by the European Union Horizon 2020 Research and Innovation
   Programme and the European Federation of Pharmaceutical Industries and
   Associations. AJK was supported by a Sir Henry Dale Fellowship jointly
   funded by the Wellcome Trust and the Royal Society (grant
   206250/Z/17/Z). NED and IML were supported by National Institutes of
   Health (NIH) grants U54 GM111274 and R37-A1032042, and WHO funding. WJE
   acknowledges VEEPED (Vaccine Efficacy Evaluation for Priority Emerging
   Diseases) for funding. VEEPED is funded by the National Institute for
   Health Research using Official Development Assistance (ODA) funding.;
   The views expressed are those of the authors and not necessarily those
   of the funders. The funders had no role in study design; in the writing
   of the report; or in the decision to submit the paper for publication.
   The findings and conclusions in this report are those of the authors and
   do not necessarily represent the official position of the US Centers for
   Disease Control and Prevention.
CR Afzal S, 2011, 2011 IEEE C VIS AN S, P189
   [Anonymous], 2017, INTEGRATING CLIN RES
   [Anonymous], 2015, BMJ
   Baden LR, 2017, NEW ENGL J MED, V377, P1482, DOI 10.1056/NEJMe1712330
   Bellan SE, QUANTIFYING ETHICAL
   Bellan SE, 2015, LANCET INFECT DIS, V3099, P1
   Bowles Kathryn H, 2012, NI 2012 (2012), V2012, P41
   Camacho A, 2017, VACCINE, V35, P544, DOI 10.1016/j.vaccine.2016.12.019
   Camacho A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009346
   Dean NE, 2018, BIORXIV, DOI [10.1021/bi0121656, DOI 10.1021/BI0121656]
   Ebola ca Suffit ring vaccination trial consortium, BMJ
   Eyal N., 2017, J MED ETHICS
   Fogli D, 2013, DECIS SUPPORT SYST, V55, P336, DOI 10.1016/j.dss.2013.01.022
   Geoghegan JL, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170189
   Halloran ME, 2017, INFECT DIS
   Halloran ME, 2010, DESIGN ANAL VACCINE
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Kieny MP, 2017, LANCET, V389, P2469, DOI 10.1016/S0140-6736(17)31635-5
   Rid A, 2016, AM J PUBLIC HEALTH, pe1
   von Winterfeldt D, 2013, P NATL ACAD SCI USA, V110, P14055, DOI 10.1073/pnas.1213532110
   WHO, 2017, EFF TRIALS ZIKV VACC
NR 21
TC 1
Z9 1
U1 3
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUL 18
PY 2019
VL 37
IS 31
BP 4376
EP 4381
DI 10.1016/j.vaccine.2019.06.019
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IL0CM
UT WOS:000476963700021
PM 31242963
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reyes-Sandoval, A
   Ludert, JE
AF Reyes-Sandoval, Arturo
   Ludert, Juan E.
TI The Dual Role of the Antibody Response Against the Flavivirus
   Non-structural Protein 1 (NS1) in Protection and Immuno-Pathogenesis
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE dengue; Zika; flavivirus; NS1 protein; arbovirus; vaccines against
   flavivirus; immuno-pathogenesis; molecular mimicry
ID ENDOTHELIAL-CELL APOPTOSIS; YELLOW-FEVER; CROSS-REACT; DNA VACCINE;
   VIRUS; IMMUNIZATION; MICE; ENCEPHALITIS; DYSFUNCTION; EXPRESSION
AB Dengue and Zika viruses are closely related mosquito-borne flaviviruses responsible for major public health problems in tropical and sub-tropical countries. The genomes of both, dengue and zika viruses encodes 10 genes that are translated into three structural proteins (C, prM, and E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). The non-structural protein 1 (NS1) is a highly conserved glycoprotein of approximately 48-50 KDa. In infected cells, NS1 is found as a homodimer associated with intracellular membranes and replication complexes, serving as a scaffolding protein in virus replication and morphogenesis. NS1 is secreted efficiently from infected cells as a hexamer and is found in patient's sera during the acute phase of the disease. NS1 detection in sera is a valuable diagnostic marker and immunization with NS1 has been shown to protect animal models from lethal challenges with dengue and Zika viruses. Nevertheless, soluble NS1 has been associated with severe dengue and anti-NS1 antibodies have been reported to cross-react with host platelets and endothelial cells and thus presumably contribute to pathogenesis. Due to the implications of NS1 in arbovirus pathogenesis and its relevance as vaccine candidate, we discuss the dual role that anti-NS1 antibodies may play in protection and disease and the challenges that need to be overcome to develop safe and effective NS1-based vaccines against dengue and Zika.
C1 [Reyes-Sandoval, Arturo] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England.
   [Ludert, Juan E.] CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico.
RP Reyes-Sandoval, A (corresponding author), Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England.; Ludert, JE (corresponding author), CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico.
EM arturo.reyes@ndm.ox.ac.uk; jludert@cinvestav.mx
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcala AC, 2016, VIROLOGY, V488, P278, DOI 10.1016/j.virol.2015.11.020
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Alcon-LePoder S, 2006, Novartis Found Symp, V277, P233, DOI 10.1002/0470058005.ch17
   ALCONLEPODER S, 2006, NOVART FDN SYMP, V277, P247
   Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bailey MJ, 2019, MBIO, V10, DOI [10.1128/mBio.02861-18, 10.1128/mbio.02861-18]
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Chao CH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007625
   Chen CL, 2013, J IMMUNOL, V191, P1744, DOI 10.4049/jimmunol.1201976
   Chen HR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0462-0
   Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Chuang YC, 2016, J IMMUNOL, V196, P1218, DOI 10.4049/jimmunol.1500057
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   Goncalves AJS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004277
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Hertz T, 2017, J IMMUNOL, V198, P4025, DOI 10.4049/jimmunol.1700029
   Lai YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09707-y
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261
   Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657
   Lin CF, 2008, LAB INVEST, V88, P1079, DOI 10.1038/labinvest.2008.70
   Lin SW, 2012, J INFECTION, V64, P325, DOI 10.1016/j.jinf.2011.11.023
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Poonsiri T, 2018, J VIROL, V92, DOI [10.1128/JVI.01868-17, 10.1128/jvi.01868-17]
   Prompetchara Eakachai, 2019, Asian Pac J Allergy Immunol, DOI 10.12932/AP-100518-0309
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Puerta-Guardo H, 2013, J VIROL, V87, P7486, DOI 10.1128/JVI.00085-13
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   Sharma M, 2020, J INFECT DIS, V221, P867, DOI 10.1093/infdis/jiz081
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545
   Wan SW, 2016, THROMB HAEMOSTASIS, V115, P646, DOI 10.1160/TH15-06-0498
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
NR 56
TC 4
Z9 4
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 18
PY 2019
VL 10
AR 1651
DI 10.3389/fimmu.2019.01651
PG 6
WC Immunology
SC Immunology
GA IJ4ZG
UT WOS:000475912000002
PM 31379848
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Figueiredo, LTM
AF Moraes Figueiredo, Luiz Tadeu
TI Human Urban Arboviruses Can Infect Wild Animals and Jump to Sylvatic
   Maintenance Cycles in South America
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE yellow fever; arbovirus sylvatic cycle; arbovirus infecting non-human
   primates; arboviruses in brazil; reservoirs and vectors of arboviruses
ID BRAZIL; FEVER; VIRUS; PHYLOGENY; MANAUS
AB The present study shows that the most prominent human arboviruses worldwide (dengue viruses 1, 2, 3, and 4, Chikungunya virus, and Zika virus) can infect wild animals and transfer from urban to sylvatic maintenance cycles in South America, as did the yellow fever virus (YFV) in the past. All these viruses are transmitted by the anthropophilic mosquito Aedes aegypti and cause epidemics throughout Brazil. The YFV is the oldest example of an urban arbovirus that became sylvatic in South America. Currently, the disease is a zoonosis of non-human primates that moves like a wave through the forests of the Brazilian countryside, traveling thousands of kilometers, killing many animals and eventually infecting man. However, since 2016, this zoonotic wave has reached the highly populated areas of Southeast Brazil, producing the largest human outbreak in the past 60 years. As with the YFV, sylvatic cycles may occur with dengue, Chikungunya, and Zika. In order to become sylvatic, arboviruses require an apparently unlikely conjunction of factors to unexpectedly take place. These arboviruses could start to infect sylvatic primates and be transmitted by Haemagogus mosquitoes that inhabit tree canopies. We mention here publications reporting evidence of sylvatic cycles of dengue, Chikungunya, and Zika virus in South America. Indeed, it is almost unfeasible to control these cycles of arboviruses since it is impossible to know where, when or why an arboviral spill-over would occur in wild animals. The sylvatic maintenance cycle could preclude the eradication of an arbovirus. Moreover, an arbovirus in a sylvatic cycle could re-emerge anytime, infecting humans and producing outbreaks. In case of the reemergence of an arbovirus, it is crucial to prevent the occurrence of an urban cycle as a spill-back from the sylvatic cycle.
C1 [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
RP Figueiredo, LTM (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
EM ltmfigue@fmrp.usp.br
FU FAPESP -Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/02438-6]
FX FAPESP -Sao Paulo Research Foundation - Grant 2014/02438-6.
CR Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Bonotto R. M., 2018, F1000RESEARCH, V7, P1730, DOI [10.12688/f1000research.16498.1, DOI 10.12688/F1000RESEARCH.16498.1]
   Brazilian Ministry of Health, 2019, EPIDEMIOLOGICAL B
   Brazilian Ministry of Health, 2018, EPIDEMIOLOGICAL B
   Calderon A, 2019, VECTOR-BORNE ZOONOT, V19, P747, DOI 10.1089/vbz.2018.2324
   Catenacci LS, 2018, ECOHEALTH, V15, P777, DOI 10.1007/s10393-018-1361-2
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Figueiredo M. L. G., 2010, VIROL J, V7, P1, DOI [10.1186/1743-422X-7-152, DOI 10.1186/1743-422X-7-152]
   Fioravanti G. H., 2018, HIST FEBRE AMARELA E
   Fonseca B. A. L., 2010, TRATADO INFECTOLOGIA, P397
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Franco O., 1976, HIST FEBRE AMARELA B
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LEE NS, 2019, PLOS NEGLECT TROP D, V13, DOI DOI 10.1371/JOURNAL.PNTD.0007072
   Lopes V., 2017, EM COM BR GERAIS
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 31
TC 4
Z9 4
U1 4
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUL 17
PY 2019
VL 9
AR 259
DI 10.3389/fcimb.2019.00259
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA IJ5DL
UT WOS:000475922900001
PM 31380302
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

EF